Citrus Sinensis ID: 024959

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260
Protein Sequence
MAAAAKDSSSGGATSSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccEEEEEEcccEEEEccccccccccccccccEEEEEEEEcccccEEEEEEcccccccHHHHHHHHHHHHHHcccccccccccccccccccccccccEEEEEEccccHHHHHHHccccccHHHHHHHHHHHHHHHHcHHcccccccccccccEEccccccEEccccccccccccccccccccccccccccHHccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHcc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccccccccccEEEEEEcccEEEEcccccccEEEEEEEccEEEEEEEEccccEEEEEEEEccccccHHHHHHHHHHHHHHHHcccccEccccEEEccccccccccEEEEEccccEEHHHHHHHccccHHHHHHHHHHHHHHHHHHHHHcccccccccHHHEEEcccccEEEccccccEEcccccccccccccHHHccHHHHccccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHH
Coil and Loop (DISEMBL)
maaaakdsssggatssvkgvlthggkyvqyNVYGNLFevsskyvppirpigrgAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIkdiirppkkdtfndVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYvhsasvlhrdlkpsnlllnascdlkigdfglarttsetdfMTEYVVTrwyrapelllncteyTAAIDIWSVGCIlgeimtreplfpgkdyvhqlrLITEV
Flexible Loop (DISEMBL)
maaaakdsssggatssvkgvlthggKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKignafdniiDARRTLREIKLLRHMEHEnviaikdiirppkkdTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFglarttsetdfMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTreplfpgkdyvhqlrlitev
Low Complexity Region (SEG)
MaaaakdsssggatssVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV
Disordered region (IsUnstruct)
*****************KGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI***
Disordered Region (DISOPRED)
***************************VQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV
Disordered Region (DISEMBL)
******************GVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV
Disordered Region (DISPRO)
***********************GGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MAAAAKDSSSGGATSSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	260	2.2.26 [Sep-21-2011]
Q39024	376	Mitogen-activated protein	yes	no	0.996	0.688	0.861	1e-134
Q5J4W4	394	Mitogen-activated protein	yes	no	0.946	0.624	0.857	1e-129
Q40353	371	Mitogen-activated protein	N/A	no	0.969	0.679	0.841	1e-129
Q336X9	376	Mitogen-activated protein	no	no	0.942	0.651	0.853	1e-127
Q39025	376	Mitogen-activated protein	no	no	0.996	0.688	0.803	1e-127
Q9LMM5	369	Mitogen-activated protein	no	no	0.942	0.663	0.861	1e-124
Q40531	371	Mitogen-activated protein	N/A	no	0.930	0.652	0.826	1e-121
Q8GYQ5	372	Mitogen-activated protein	no	no	0.938	0.655	0.831	1e-121
Q84UI5	398	Mitogen-activated protein	no	no	0.942	0.615	0.767	1e-119
Q40532	393	Mitogen-activated protein	N/A	no	0.984	0.651	0.734	1e-118

>sp|Q39024|MPK4_ARATH Mitogen-activated protein kinase 4 OS=Arabidopsis thaliana GN=MPK4 PE=1 SV=2

 Score =  476 bits (1224), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 224/260 (86%), Positives = 244/260 (93%), Gaps = 1/260 (0%)

Query: 1   MAAAAKDSSSGGATSSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCA 60
           M+A +   SSG  +SS KGV THGG YVQYNVYGNLFEVS KYVPP+RPIGRGAYGIVCA
Sbjct: 1   MSAESCFGSSGDQSSS-KGVATHGGSYVQYNVYGNLFEVSRKYVPPLRPIGRGAYGIVCA 59

Query: 61  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 120
           A NSET EEVAIKKIGNAFDNIIDA+RTLREIKLL+HM+HENVIA+KDII+PP+++ FND
Sbjct: 60  ATNSETGEEVAIKKIGNAFDNIIDAKRTLREIKLLKHMDHENVIAVKDIIKPPQRENFND 119

Query: 121 VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 180
           VYIVYELMDTDLHQIIRS+Q LTDDHC++FLYQLLRGLKYVHSA+VLHRDLKPSNLLLNA
Sbjct: 120 VYIVYELMDTDLHQIIRSNQPLTDDHCRFFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 179

Query: 181 SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           +CDLK+GDFGLART SETDFMTEYVVTRWYRAPELLLNC+EYTAAIDIWSVGCILGE MT
Sbjct: 180 NCDLKLGDFGLARTKSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGETMT 239

Query: 241 REPLFPGKDYVHQLRLITEV 260
           REPLFPGKDYVHQLRLITE+
Sbjct: 240 REPLFPGKDYVHQLRLITEL 259

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1. Involved in root hair development process. Negative regulator of systemic acquired resistance (SAR) and salicylic acid- (SA) mediated defense response. Required for jasmonic acid- (JA) mediated defense gene expression. May regulate activity of transcription factor controlling pathogenesis-related (PR) gene expression. Seems to act independently of the SAR regulatory protein NPR1 (Nonexpresser of PR1). Phosphorylates MKS1 and transcription factors WRKY25 and WRKY33. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). May act as negative regulator of salt tolerance.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 4

>sp|Q5J4W4|MPK2_ORYSJ Mitogen-activated protein kinase 2 OS=Oryza sativa subsp. japonica GN=MPK2 PE=2 SV=1

 Score =  462 bits (1189), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 211/246 (85%), Positives = 236/246 (95%)

Query: 15  SSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKK 74
           + +KG LTHGG+YVQYNVYGNLFEVSSKYVPPIRP+GRGA GI+CA VN++TR+EVAIKK
Sbjct: 32  AQIKGTLTHGGRYVQYNVYGNLFEVSSKYVPPIRPVGRGACGIICAVVNAQTRQEVAIKK 91

Query: 75  IGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQ 134
           IGNAFDN IDA+RTLREIKLLRHM+H+NVI+IKDIIRPP+++ FNDVYIVYELMDTDLH 
Sbjct: 92  IGNAFDNQIDAKRTLREIKLLRHMDHDNVISIKDIIRPPRRENFNDVYIVYELMDTDLHH 151

Query: 135 IIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART 194
           ++RS+Q LTDDHCQYFLYQ+LRGLKYVHSA+VLHRDL+PSNLLLNA CDLKIGDFGLART
Sbjct: 152 LLRSNQPLTDDHCQYFLYQVLRGLKYVHSANVLHRDLRPSNLLLNAKCDLKIGDFGLART 211

Query: 195 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
           T+ETDFM EYVVTRWYRAPELLLNC+EYTAAIDIWSVGCILGEI+TREPLFPGKDYVHQL
Sbjct: 212 TNETDFMMEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIVTREPLFPGKDYVHQL 271

Query: 255 RLITEV 260
           RLITE+
Sbjct: 272 RLITEL 277

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q40353|MMK2_MEDSA Mitogen-activated protein kinase homolog MMK2 OS=Medicago sativa GN=MMK2 PE=2 SV=1

 Score =  461 bits (1187), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 212/252 (84%), Positives = 240/252 (95%)

Query: 9   SSGGATSSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETRE 68
           S   A ++++GV THGG+Y+QYN+YGNLFEVS KYVPPIR +GRGAYGIVCAAVN+ETRE
Sbjct: 2   SVESAENNIRGVPTHGGRYLQYNIYGNLFEVSRKYVPPIRSVGRGAYGIVCAAVNAETRE 61

Query: 69  EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM 128
           EVAIKKIGNAFDN IDA+RTLREIKLLRHM+HENV++IKDIIRPP+K+ FN VYIV ELM
Sbjct: 62  EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENVMSIKDIIRPPQKENFNHVYIVSELM 121

Query: 129 DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD 188
           DTDLHQIIRS+Q +TDDHC+YF+YQLLRGLKYVHSA+VLHRDLKPSNLLLNA+CDLKIGD
Sbjct: 122 DTDLHQIIRSNQPMTDDHCRYFVYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 181

Query: 189 FGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK 248
           FGLARTTSETDFMTEYVVTRWYRAPELLLNC++YTAAIDIWSVGCILGEI+TR+PLFPG+
Sbjct: 182 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSDYTAAIDIWSVGCILGEIVTRQPLFPGR 241

Query: 249 DYVHQLRLITEV 260
           DYVHQLRL+TE+
Sbjct: 242 DYVHQLRLVTEL 253

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q336X9|MPK6_ORYSJ Mitogen-activated protein kinase 6 OS=Oryza sativa subsp. japonica GN=MPK6 PE=2 SV=1

 Score =  453 bits (1166), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 209/245 (85%), Positives = 230/245 (93%)

Query: 16  SVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKI 75
            +KG+ THGG+YV YNVYGN FEVSSKY PPIRPIGRGAYGIVCAAVNSE  EEVAIKKI
Sbjct: 15  QIKGMGTHGGRYVLYNVYGNFFEVSSKYAPPIRPIGRGAYGIVCAAVNSENGEEVAIKKI 74

Query: 76  GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQI 135
           GNAFDN IDA+RTLREIKLLRHM+HEN+IAIKDIIRPP++D FNDVYIV ELMDTDLHQI
Sbjct: 75  GNAFDNHIDAKRTLREIKLLRHMDHENIIAIKDIIRPPRRDNFNDVYIVSELMDTDLHQI 134

Query: 136 IRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT 195
           IRS+Q LTDDHCQYFLYQLLRGLKYVHSA+VLHRDLKPSNL LNA+CDLKI DFGLARTT
Sbjct: 135 IRSNQPLTDDHCQYFLYQLLRGLKYVHSANVLHRDLKPSNLFLNANCDLKIADFGLARTT 194

Query: 196 SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR 255
           +ETD MTEYVVTRWYRAPELLLNC++YTAAID+WSVGCILGEI+TR+PLFPG+DY+ QL+
Sbjct: 195 TETDLMTEYVVTRWYRAPELLLNCSQYTAAIDVWSVGCILGEIVTRQPLFPGRDYIQQLK 254

Query: 256 LITEV 260
           LITE+
Sbjct: 255 LITEL 259

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q39025|MPK5_ARATH Mitogen-activated protein kinase 5 OS=Arabidopsis thaliana GN=MPK5 PE=2 SV=2

 Score =  453 bits (1165), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 209/260 (80%), Positives = 237/260 (91%), Gaps = 1/260 (0%)

Query: 1   MAAAAKDSSSGGATSSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCA 60
           MA   + ++  G T+ +KGVL HGG+Y QYNVYGNLFEVS+KYVPPIRPIGRGAYG VCA
Sbjct: 1   MAKEIESATDLGDTN-IKGVLVHGGRYFQYNVYGNLFEVSNKYVPPIRPIGRGAYGFVCA 59

Query: 61  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 120
           AV+SET EE+AIKKIG AFDN +DA+RTLREIKLLRH+EHENV+ IKDIIRPPKK+ F D
Sbjct: 60  AVDSETHEEIAIKKIGKAFDNKVDAKRTLREIKLLRHLEHENVVVIKDIIRPPKKEDFVD 119

Query: 121 VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 180
           VYIV+ELMDTDLHQIIRS+Q L DDHCQYFLYQ+LRGLKY+HSA+VLHRDLKPSNLLLN+
Sbjct: 120 VYIVFELMDTDLHQIIRSNQSLNDDHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNS 179

Query: 181 SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           +CDLKI DFGLARTTSET++MTEYVVTRWYRAPELLLN +EYT+AID+WSVGCI  EIMT
Sbjct: 180 NCDLKITDFGLARTTSETEYMTEYVVTRWYRAPELLLNSSEYTSAIDVWSVGCIFAEIMT 239

Query: 241 REPLFPGKDYVHQLRLITEV 260
           REPLFPGKDYVHQL+LITE+
Sbjct: 240 REPLFPGKDYVHQLKLITEL 259

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q9LMM5|MPK11_ARATH Mitogen-activated protein kinase 11 OS=Arabidopsis thaliana GN=MPK11 PE=1 SV=1

 Score =  446 bits (1146), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 211/245 (86%), Positives = 229/245 (93%)

Query: 16  SVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKI 75
           S +GV  +GG+YVQYNVYGNLFEVS KYVPP+RPIGRGA GIVCAA NSET EEVAIKKI
Sbjct: 12  SNRGVSINGGRYVQYNVYGNLFEVSKKYVPPLRPIGRGASGIVCAAWNSETGEEVAIKKI 71

Query: 76  GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQI 135
           GNAF NIIDA+RTLREIKLL+HM+H+NVIAI DIIRPP+ D FNDV+IVYELMDTDLH I
Sbjct: 72  GNAFGNIIDAKRTLREIKLLKHMDHDNVIAIIDIIRPPQPDNFNDVHIVYELMDTDLHHI 131

Query: 136 IRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT 195
           IRS+Q LTDDH ++FLYQLLRGLKYVHSA+VLHRDLKPSNLLLNA+CDLKIGDFGLART 
Sbjct: 132 IRSNQPLTDDHSRFFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTK 191

Query: 196 SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR 255
           SETDFMTEYVVTRWYRAPELLLNC+EYTAAIDIWSVGCILGEIMTREPLFPG+DYV QLR
Sbjct: 192 SETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTREPLFPGRDYVQQLR 251

Query: 256 LITEV 260
           LITE+
Sbjct: 252 LITEL 256

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q40531|NTF6_TOBAC Mitogen-activated protein kinase homolog NTF6 OS=Nicotiana tabacum GN=NTF6 PE=2 SV=1

 Score =  435 bits (1119), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 200/242 (82%), Positives = 221/242 (91%)

Query: 16  SVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKI 75
            +KG+ TH GKYV+YNV GN FEV+SKY+PPI+P+GRGAYG+VC A NSET+EEVAIKKI
Sbjct: 10  EIKGIPTHEGKYVEYNVLGNFFEVTSKYIPPIQPVGRGAYGMVCCATNSETKEEVAIKKI 69

Query: 76  GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQI 135
           GNAF+N IDA+RTLREIKLL HM+HEN+I IKDI+RPP ++ FNDVYIVYELMDTDLHQI
Sbjct: 70  GNAFENRIDAKRTLREIKLLSHMDHENIIKIKDIVRPPDREEFNDVYIVYELMDTDLHQI 129

Query: 136 IRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT 195
           IRS Q LTDDHCQYFLYQLLRGLKYVHSA+VLHRDLKPSNLLLNA+CDLKI DFGLARTT
Sbjct: 130 IRSSQALTDDHCQYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT 189

Query: 196 SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR 255
           SE DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL E++ REPLFPG+DY  QL 
Sbjct: 190 SEADFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILMELIKREPLFPGRDYAQQLG 249

Query: 256 LI 257
           LI
Sbjct: 250 LI 251

Nicotiana tabacum (taxid: 4097)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q8GYQ5|MPK12_ARATH Mitogen-activated protein kinase 12 OS=Arabidopsis thaliana GN=MPK12 PE=1 SV=1

 Score =  434 bits (1117), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 203/244 (83%), Positives = 227/244 (93%)

Query: 17  VKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIG 76
           +K V THGG+YVQYNVYG LFEVS KYVPPIRPIGRGA GIVCAAVNS T E+VAIKKIG
Sbjct: 14  IKVVPTHGGRYVQYNVYGQLFEVSRKYVPPIRPIGRGACGIVCAAVNSVTGEKVAIKKIG 73

Query: 77  NAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII 136
           NAFDNIIDA+RTLREIKLLRHM+HENVI IKDI+RPP++D FNDVYIVYELMDTDL +I+
Sbjct: 74  NAFDNIIDAKRTLREIKLLRHMDHENVITIKDIVRPPQRDIFNDVYIVYELMDTDLQRIL 133

Query: 137 RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS 196
           RS+Q LT D C++ +YQLLRGLKYVHSA++LHRDL+PSN+LLN+  +LKIGDFGLARTTS
Sbjct: 134 RSNQTLTSDQCRFLVYQLLRGLKYVHSANILHRDLRPSNVLLNSKNELKIGDFGLARTTS 193

Query: 197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL 256
           +TDFMTEYVVTRWYRAPELLLNC+EYTAAIDIWSVGCILGEIMT +PLFPGKDYVHQLRL
Sbjct: 194 DTDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTGQPLFPGKDYVHQLRL 253

Query: 257 ITEV 260
           ITE+
Sbjct: 254 ITEL 257

Negative regulator of the auxin transduction signaling pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q84UI5|MPK1_ORYSJ Mitogen-activated protein kinase 1 OS=Oryza sativa subsp. japonica GN=MPK1 PE=1 SV=1

 Score =  427 bits (1098), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 188/245 (76%), Positives = 229/245 (93%)

Query: 16  SVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKI 75
           +++  L+HGG+++QYN++GN+FEV++KY PPI PIG+GAYGIVC+A+NSET E+VAIKKI
Sbjct: 39  NIQATLSHGGRFIQYNIFGNVFEVTAKYKPPILPIGKGAYGIVCSALNSETGEQVAIKKI 98

Query: 76  GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQI 135
            NAFDN IDA+RTLREIKLLRHM+HEN++AI+DII PP++++FNDVYI YELMDTDLHQI
Sbjct: 99  ANAFDNKIDAKRTLREIKLLRHMDHENIVAIRDIIPPPQRNSFNDVYIAYELMDTDLHQI 158

Query: 136 IRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT 195
           IRS+Q L+++HCQYFLYQ+LRGLKY+HSA+VLHRDLKPSNLLLNA+CDLKI DFGLARTT
Sbjct: 159 IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT 218

Query: 196 SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR 255
           SETDFMTEYVVTRWYRAPELLLN +EYTAAID+WSVGCI  E+M R+PLFPG+D+VHQLR
Sbjct: 219 SETDFMTEYVVTRWYRAPELLLNSSEYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 278

Query: 256 LITEV 260
           L+ E+
Sbjct: 279 LLMEL 283

Involved in sphingolipid elicitor (SE)-dependent defense signaling pathway. Acts downstream of heterotrimeric G protein alpha subunit and small GTPase RAC1. May regulate the expression of various genes involved in biotic and abiotic stress response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q40532|NTF4_TOBAC Mitogen-activated protein kinase homolog NTF4 OS=Nicotiana tabacum GN=NTF4 PE=2 SV=1

 Score =  424 bits (1091), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 188/256 (73%), Positives = 227/256 (88%)

Query: 5   AKDSSSGGATSSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNS 64
           A  S       ++   L+HGG+++QYN++GN+FEV++KY PPI PIG+GAYGIVC+A+NS
Sbjct: 21  APPSQPVAGIDNIPATLSHGGRFIQYNIFGNIFEVTAKYKPPIMPIGKGAYGIVCSALNS 80

Query: 65  ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV 124
           ET E VAIKKI NAFDN IDA+RTLREIKLLRHM+HEN++AI+DII PP+++ FNDVYI 
Sbjct: 81  ETNEHVAIKKIANAFDNKIDAKRTLREIKLLRHMDHENIVAIRDIIPPPQREAFNDVYIA 140

Query: 125 YELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 184
           YELMDTDLHQIIRS+Q L+++HCQYFLYQ+LRGLKY+HSA+VLHRDLKPSNLLLNA+CDL
Sbjct: 141 YELMDTDLHQIIRSNQGLSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDL 200

Query: 185 KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL 244
           KI DFGLAR TSETDFMTEYVVTRWYRAPELLLN ++YTAAID+WSVGCI  E+M R+PL
Sbjct: 201 KICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL 260

Query: 245 FPGKDYVHQLRLITEV 260
           FPG+D+VHQLRL+ E+
Sbjct: 261 FPGRDHVHQLRLLMEL 276

Nicotiana tabacum (taxid: 4097)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	260
449452284	383	PREDICTED: mitogen-activated protein kin	0.988	0.671	0.899	1e-136
297748121	377	mitogen-activated protein kinase 4 [Goss	0.984	0.679	0.910	1e-136
225426166	375	PREDICTED: mitogen-activated protein kin	0.984	0.682	0.894	1e-134
399106788	380	MAP kinase [Nicotiana tabacum]	1.0	0.684	0.869	1e-134
224067920	372	predicted protein [Populus trichocarpa]	0.969	0.677	0.884	1e-133
224075008	362	predicted protein [Populus trichocarpa]	0.946	0.679	0.918	1e-133
255537569	387	big map kinase/bmk, putative [Ricinus co	0.946	0.635	0.914	1e-133
25052804	374	mitogen-activated protein kinase 4 [Petr	0.969	0.673	0.886	1e-133
359489658	375	PREDICTED: mitogen-activated protein kin	0.984	0.682	0.863	1e-133
363808060	373	uncharacterized protein LOC100815697 [Gl	0.969	0.675	0.873	1e-132

>gi|449452284|ref|XP_004143889.1| PREDICTED: mitogen-activated protein kinase 4-like [Cucumis sativus] gi|449518403|ref|XP_004166231.1| PREDICTED: mitogen-activated protein kinase 4-like [Cucumis sativus]

 Score =  491 bits (1265), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 232/258 (89%), Positives = 247/258 (95%), Gaps = 1/258 (0%)

Query: 4   AAKDSSSGGATS-SVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAV 62
           A K+SSS  AT   +KGVLTHGG+YVQYNVYGNLFEVS+KYVPP+RPIGRGAYG+VCAAV
Sbjct: 2   ATKESSSTTATEGKIKGVLTHGGRYVQYNVYGNLFEVSAKYVPPLRPIGRGAYGLVCAAV 61

Query: 63  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 122
           NSET EEVAIKKIGNAFDNIIDA+RTLREIKLL HMEHEN+IAI+DIIRPPK++ FNDVY
Sbjct: 62  NSETHEEVAIKKIGNAFDNIIDAKRTLREIKLLCHMEHENIIAIRDIIRPPKREVFNDVY 121

Query: 123 IVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC 182
           IVYELMDTDLHQIIRSDQ LTDDHCQYFLYQLLRGLKYVHSA VLHRDLKPSNLLLNA+C
Sbjct: 122 IVYELMDTDLHQIIRSDQPLTDDHCQYFLYQLLRGLKYVHSAKVLHRDLKPSNLLLNANC 181

Query: 183 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTRE 242
           DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC+EYTAAID+WSVGCILGEIMTRE
Sbjct: 182 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDVWSVGCILGEIMTRE 241

Query: 243 PLFPGKDYVHQLRLITEV 260
           PLFPGKDYVHQLRLITE+
Sbjct: 242 PLFPGKDYVHQLRLITEL 259

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297748121|gb|ADI52627.1| mitogen-activated protein kinase 4 [Gossypium hirsutum]

 Score =  490 bits (1261), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 235/258 (91%), Positives = 245/258 (94%), Gaps = 2/258 (0%)

Query: 3   AAAKDSSSGGATSSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAV 62
            + K SSS G  SS+KGV THGGKYV YNVYGNLFEVSSKYVPPIRPIGRGA GIVCAAV
Sbjct: 6   GSTKHSSSEG--SSIKGVPTHGGKYVHYNVYGNLFEVSSKYVPPIRPIGRGANGIVCAAV 63

Query: 63  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 122
           NSETR+EVAIKKIGNAFDNIIDARRTLREIKLLRHM+HENVIAIKDIIRPPKK+TFNDVY
Sbjct: 64  NSETRQEVAIKKIGNAFDNIIDARRTLREIKLLRHMDHENVIAIKDIIRPPKKETFNDVY 123

Query: 123 IVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC 182
           IVYELMDTDLH IIRSDQ LTDDHCQYFLYQLLRGLKYVHSA+VLHRDLKPS+LLLNA C
Sbjct: 124 IVYELMDTDLHHIIRSDQPLTDDHCQYFLYQLLRGLKYVHSANVLHRDLKPSSLLLNAKC 183

Query: 183 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTRE 242
           DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC+EYTAAID+WSVGCI GEIMTRE
Sbjct: 184 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDMWSVGCIFGEIMTRE 243

Query: 243 PLFPGKDYVHQLRLITEV 260
           PLFPGKDYVHQLRLITE+
Sbjct: 244 PLFPGKDYVHQLRLITEL 261

Source: Gossypium hirsutum

Species: Gossypium hirsutum

Genus: Gossypium

Family: Malvaceae

Order: Malvales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225426166|ref|XP_002278860.1| PREDICTED: mitogen-activated protein kinase homolog MMK2 [Vitis vinifera] gi|297742231|emb|CBI34380.3| unnamed protein product [Vitis vinifera]

 Score =  484 bits (1247), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 230/257 (89%), Positives = 246/257 (95%), Gaps = 1/257 (0%)

Query: 5   AKDSSSG-GATSSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVN 63
           + D+SSG G   ++KGV THGG+YV+YNVYGN FEVS+KYVPPIRP+GRGAYGIVCAAVN
Sbjct: 2   SMDASSGSGDGGNIKGVPTHGGRYVRYNVYGNFFEVSAKYVPPIRPVGRGAYGIVCAAVN 61

Query: 64  SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI 123
           SET EEVAIKKIGNAFDN IDA+RTLREIKLLRHM+HENVIAIKDIIRPPKK+TFNDVYI
Sbjct: 62  SETHEEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENVIAIKDIIRPPKKETFNDVYI 121

Query: 124 VYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD 183
           VYELMDTDLHQII S+Q LTDDHCQYFLYQLLRGLKYVHSA+VLHRDLKPSNLLLNA+CD
Sbjct: 122 VYELMDTDLHQIICSNQSLTDDHCQYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 181

Query: 184 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREP 243
           LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC+EYTAAIDIWSVGCILGEIMTREP
Sbjct: 182 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTREP 241

Query: 244 LFPGKDYVHQLRLITEV 260
           LFPGKDYVHQLRLITE+
Sbjct: 242 LFPGKDYVHQLRLITEL 258

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|399106788|gb|AFP20227.1| MAP kinase [Nicotiana tabacum]

 Score =  484 bits (1245), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 226/260 (86%), Positives = 245/260 (94%)

Query: 1   MAAAAKDSSSGGATSSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCA 60
           MA     +SS G +  ++GVL HGGKYV+YNVYGNLFEVSSKYVPPIRPIGRGAYG+VCA
Sbjct: 1   MANQIGGASSNGNSREIRGVLIHGGKYVRYNVYGNLFEVSSKYVPPIRPIGRGAYGLVCA 60

Query: 61  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 120
           A+NSETREEVAIKKIGNAFDN IDA+RTLREIKLLRHMEHENVIAIKDIIRPPK++ FND
Sbjct: 61  AINSETREEVAIKKIGNAFDNKIDAKRTLREIKLLRHMEHENVIAIKDIIRPPKEEAFND 120

Query: 121 VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 180
           VYI+YELMDTDLHQIIRS+Q LT+DHCQYF+YQLLRGLKYVHSA+VLHRDLKPSNLLLNA
Sbjct: 121 VYIIYELMDTDLHQIIRSEQPLTNDHCQYFMYQLLRGLKYVHSANVLHRDLKPSNLLLNA 180

Query: 181 SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           +CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC+ YTAAID+WSVGCILGEIMT
Sbjct: 181 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSVYTAAIDVWSVGCILGEIMT 240

Query: 241 REPLFPGKDYVHQLRLITEV 260
           REPLFPGKDY HQLRLITE+
Sbjct: 241 REPLFPGKDYGHQLRLITEL 260

Source: Nicotiana tabacum

Species: Nicotiana tabacum

Genus: Nicotiana

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224067920|ref|XP_002302599.1| predicted protein [Populus trichocarpa] gi|222844325|gb|EEE81872.1| predicted protein [Populus trichocarpa]

 Score =  481 bits (1237), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 223/252 (88%), Positives = 242/252 (96%)

Query: 9   SSGGATSSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETRE 68
           SS G   ++KG+ THGG+YVQYNVYGNLFEVS KYVPPIRP+GRGAYGIVCAAVN+ETRE
Sbjct: 6   SSSGGDPNIKGIPTHGGRYVQYNVYGNLFEVSMKYVPPIRPVGRGAYGIVCAAVNAETRE 65

Query: 69  EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM 128
           EVAIKKIGNAFDN IDA+RTLREIKLLRHM+HENVIAIKDIIRPP+ + FNDVYIVYELM
Sbjct: 66  EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENVIAIKDIIRPPQTENFNDVYIVYELM 125

Query: 129 DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD 188
           DTDLHQIIRS+QQLTDDHC+YFLYQLLRGLKYVHSA+VLHRDLKPSNL LNA+CDLKIGD
Sbjct: 126 DTDLHQIIRSNQQLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLFLNANCDLKIGD 185

Query: 189 FGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK 248
           FGLARTTSETDFMTEYVVTRWYRAPELLLNC+EYTAAIDIWSVGCILGEI+TR+PLFPGK
Sbjct: 186 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEILTRQPLFPGK 245

Query: 249 DYVHQLRLITEV 260
           DYVHQLRL+TE+
Sbjct: 246 DYVHQLRLVTEL 257

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224075008|ref|XP_002304516.1| predicted protein [Populus trichocarpa] gi|222841948|gb|EEE79495.1| predicted protein [Populus trichocarpa]

 Score =  480 bits (1236), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 226/246 (91%), Positives = 238/246 (96%)

Query: 15  SSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKK 74
           S +KGVLTHGG+YVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNS+T EEVAIKK
Sbjct: 1   SKIKGVLTHGGRYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSDTHEEVAIKK 60

Query: 75  IGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQ 134
           IGNAFDN IDA+RTLREI LLRHM+HENVIAI+DI RPPKK+ FNDVYIVYELMDTDLHQ
Sbjct: 61  IGNAFDNRIDAKRTLREIMLLRHMDHENVIAIRDITRPPKKEAFNDVYIVYELMDTDLHQ 120

Query: 135 IIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART 194
           IIRSDQ L DDHCQYFLYQLLRGLKYVHSA+VLHRDLKPSNLLLN++CDLKIGDFGLART
Sbjct: 121 IIRSDQALNDDHCQYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNSNCDLKIGDFGLART 180

Query: 195 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
           TSETDFMTEYVVTRWYRAPELLLNC+EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL
Sbjct: 181 TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL 240

Query: 255 RLITEV 260
           RLITE+
Sbjct: 241 RLITEL 246

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255537569|ref|XP_002509851.1| big map kinase/bmk, putative [Ricinus communis] gi|223549750|gb|EEF51238.1| big map kinase/bmk, putative [Ricinus communis]

 Score =  480 bits (1235), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 225/246 (91%), Positives = 238/246 (96%)

Query: 15  SSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKK 74
           + +KGV THGG+YVQYN YGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKK
Sbjct: 24  NKIKGVPTHGGRYVQYNAYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKK 83

Query: 75  IGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQ 134
           IGNAFDN +DA+RTLREIKLLRHM+HEN+IAI+DIIRPPKK+ FNDVYIVYELMDTDLH 
Sbjct: 84  IGNAFDNRVDAKRTLREIKLLRHMDHENIIAIRDIIRPPKKEAFNDVYIVYELMDTDLHH 143

Query: 135 IIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART 194
           IIRSDQ LTDDHCQYFLYQLLRGLKYVHSA VLHRDLKPSNLLLNA+CDLKIGDFGLART
Sbjct: 144 IIRSDQPLTDDHCQYFLYQLLRGLKYVHSAHVLHRDLKPSNLLLNANCDLKIGDFGLART 203

Query: 195 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
           TSETDFMTEYVVTRWYRAPELLLNC+EYTAAIDIWSVGCILGEI+TREPLFPGKDYVHQL
Sbjct: 204 TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIVTREPLFPGKDYVHQL 263

Query: 255 RLITEV 260
           RLITE+
Sbjct: 264 RLITEL 269

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|25052804|gb|AAN65180.1| mitogen-activated protein kinase 4 [Petroselinum crispum]

 Score =  479 bits (1234), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 226/255 (88%), Positives = 244/255 (95%), Gaps = 3/255 (1%)

Query: 9   SSGGATSS---VKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSE 65
           SS  AT+    +KGV THGG+YVQYNVYGNLFEVS KYVPPIRP+GRGAYGIVCAA+NS+
Sbjct: 3   SSSAATADHTHIKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSD 62

Query: 66  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY 125
           TREEVAIKKIGNAFDN IDA+RTLREIKLLRHM HENVIAIKDIIRPP+ ++FNDVYIVY
Sbjct: 63  TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMNHENVIAIKDIIRPPQIESFNDVYIVY 122

Query: 126 ELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLK 185
           ELMDTDLHQIIRS+QQLTDDHC+YFLYQLLRGLKYVHSA+VLHRDLKPSNLLLNA+CDLK
Sbjct: 123 ELMDTDLHQIIRSNQQLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 182

Query: 186 IGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 245
           IGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC+EYTAAIDIWSVGCILGE+MTR+PLF
Sbjct: 183 IGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEVMTRQPLF 242

Query: 246 PGKDYVHQLRLITEV 260
           PGKDYVHQLRLITE+
Sbjct: 243 PGKDYVHQLRLITEL 257

Source: Petroselinum crispum

Species: Petroselinum crispum

Genus: Petroselinum

Family: Apiaceae

Order: Apiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359489658|ref|XP_003633959.1| PREDICTED: mitogen-activated protein kinase homolog MMK2-like [Vitis vinifera] gi|147786894|emb|CAN75543.1| hypothetical protein VITISV_000466 [Vitis vinifera] gi|297745345|emb|CBI40425.3| unnamed protein product [Vitis vinifera]

 Score =  479 bits (1233), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 221/256 (86%), Positives = 244/256 (95%)

Query: 5   AKDSSSGGATSSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNS 64
           + +SS+G    +++GV THGG+YVQYNVYGNLFEVS KYVPPIRP+GRGAYGIVCAA+NS
Sbjct: 2   SMESSAGSVEGNIRGVSTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNS 61

Query: 65  ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV 124
           ETREEVAIKKIGNAFDN IDA+RTLREIKLLRHM+HENVI +KDIIRPPK++ FNDVYIV
Sbjct: 62  ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENVIVLKDIIRPPKRENFNDVYIV 121

Query: 125 YELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 184
           YELMDTDLHQIIRS+Q L DDHC+YFLYQ+LRGLKYVHSA+VLHRDLKPSNLLLNA+CDL
Sbjct: 122 YELMDTDLHQIIRSNQPLNDDHCRYFLYQVLRGLKYVHSANVLHRDLKPSNLLLNANCDL 181

Query: 185 KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL 244
           KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC+EYTAAIDIWSVGCILGEIMTR+PL
Sbjct: 182 KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL 241

Query: 245 FPGKDYVHQLRLITEV 260
           FPG+DYVHQLRLITE+
Sbjct: 242 FPGRDYVHQLRLITEL 257

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|363808060|ref|NP_001242213.1| uncharacterized protein LOC100815697 [Glycine max] gi|255640002|gb|ACU20292.1| unknown [Glycine max]

 Score =  478 bits (1229), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 220/252 (87%), Positives = 242/252 (96%)

Query: 9   SSGGATSSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETRE 68
            S  A++ ++GV THGG+YVQYN+YGNLFEVS KYVPPIRP+GRGAYGIVCAAVN+ETRE
Sbjct: 4   ESAPASADIRGVHTHGGRYVQYNIYGNLFEVSRKYVPPIRPVGRGAYGIVCAAVNAETRE 63

Query: 69  EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM 128
           EVAIKK+GNAFDN IDA+RTLREIKLLRHM+HENVIA+KDIIRPP++D FNDVYIVYELM
Sbjct: 64  EVAIKKVGNAFDNRIDAKRTLREIKLLRHMDHENVIALKDIIRPPQRDNFNDVYIVYELM 123

Query: 129 DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD 188
           DTDLHQIIRS+QQLTDDHC+YFLYQLLRGLKYVHSA+VLHRDLKPSNLLLNA+CDLKI D
Sbjct: 124 DTDLHQIIRSNQQLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIAD 183

Query: 189 FGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK 248
           FGLAR TSETDFMTEYVVTRWYRAPELLLNC+EYTAAIDIWSVGCILGEI+TR+PLFPGK
Sbjct: 184 FGLARATSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIITRQPLFPGK 243

Query: 249 DYVHQLRLITEV 260
           DYVHQLRLITE+
Sbjct: 244 DYVHQLRLITEL 255

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	260
TAIR|locus:2124943	376	MPK4 "MAP kinase 4" [Arabidops	0.934	0.646	0.893	2.9e-119
TAIR|locus:2128263	376	MPK5 "MAP kinase 5" [Arabidops	0.938	0.648	0.840	5.8e-114
TAIR|locus:2025341	369	MPK11 "MAP kinase 11" [Arabido	0.934	0.658	0.864	1.4e-112
TAIR|locus:2062897	372	MPK12 "mitogen-activated prote	0.938	0.655	0.831	2.9e-110
TAIR|locus:2043904	395	MPK6 "MAP kinase 6" [Arabidops	0.938	0.617	0.758	4.6e-105
TAIR|locus:2026484	363	ATMPK13 [Arabidopsis thaliana	0.930	0.666	0.789	4.1e-104
TAIR|locus:2085632	370	MPK3 "mitogen-activated protei	0.926	0.651	0.730	1.5e-99
TAIR|locus:2080457	393	MPK10 "MAP kinase 10" [Arabido	0.938	0.620	0.692	2.3e-94
TAIR|locus:2053119	368	MPK7 "MAP kinase 7" [Arabidops	0.919	0.649	0.650	4.3e-86
TAIR|locus:2115445	361	MPK14 "mitogen-activated prote	0.911	0.656	0.648	2.1e-84

TAIR|locus:2124943 MPK4 "MAP kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 1174 (418.3 bits), Expect = 2.9e-119, P = 2.9e-119
 Identities = 217/243 (89%), Positives = 234/243 (96%)

Query:    18 KGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGN 77
             KGV THGG YVQYNVYGNLFEVS KYVPP+RPIGRGAYGIVCAA NSET EEVAIKKIGN
Sbjct:    17 KGVATHGGSYVQYNVYGNLFEVSRKYVPPLRPIGRGAYGIVCAATNSETGEEVAIKKIGN 76

Query:    78 AFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIR 137
             AFDNIIDA+RTLREIKLL+HM+HENVIA+KDII+PP+++ FNDVYIVYELMDTDLHQIIR
Sbjct:    77 AFDNIIDAKRTLREIKLLKHMDHENVIAVKDIIKPPQRENFNDVYIVYELMDTDLHQIIR 136

Query:   138 SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE 197
             S+Q LTDDHC++FLYQLLRGLKYVHSA+VLHRDLKPSNLLLNA+CDLK+GDFGLART SE
Sbjct:   137 SNQPLTDDHCRFFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKLGDFGLARTKSE 196

Query:   198 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
             TDFMTEYVVTRWYRAPELLLNC+EYTAAIDIWSVGCILGE MTREPLFPGKDYVHQLRLI
Sbjct:   197 TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGETMTREPLFPGKDYVHQLRLI 256

Query:   258 TEV 260
             TE+
Sbjct:   257 TEL 259

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0009868 "jasmonic acid and ethylene-dependent systemic resistance, jasmonic acid mediated signaling pathway" evidence=TAS

GO:0004707 "MAP kinase activity" evidence=ISS;IDA

GO:0007165 "signal transduction" evidence=IC;RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA;IMP;TAS

GO:0005515 "protein binding" evidence=IPI

GO:0009409 "response to cold" evidence=RCA;IDA

GO:0009651 "response to salt stress" evidence=RCA;IDA

GO:0006972 "hyperosmotic response" evidence=RCA;IMP

GO:0042539 "hypotonic salinity response" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0016310 "phosphorylation" evidence=IDA

GO:0009620 "response to fungus" evidence=IMP

GO:0009861 "jasmonic acid and ethylene-dependent systemic resistance" evidence=IMP

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0043622 "cortical microtubule organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0007112 "male meiosis cytokinesis" evidence=IMP

GO:0009555 "pollen development" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006096 "glycolysis" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006833 "water transport" evidence=RCA

GO:0006970 "response to osmotic stress" evidence=RCA

GO:0007030 "Golgi organization" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009266 "response to temperature stimulus" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0046686 "response to cadmium ion" evidence=RCA

GO:0048481 "ovule development" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

GO:0004672 "protein kinase activity" evidence=IDA

TAIR|locus:2128263 MPK5 "MAP kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 1124 (400.7 bits), Expect = 5.8e-114, P = 5.8e-114
 Identities = 205/244 (84%), Positives = 229/244 (93%)

Query:    17 VKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIG 76
             +KGVL HGG+Y QYNVYGNLFEVS+KYVPPIRPIGRGAYG VCAAV+SET EE+AIKKIG
Sbjct:    16 IKGVLVHGGRYFQYNVYGNLFEVSNKYVPPIRPIGRGAYGFVCAAVDSETHEEIAIKKIG 75

Query:    77 NAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII 136
              AFDN +DA+RTLREIKLLRH+EHENV+ IKDIIRPPKK+ F DVYIV+ELMDTDLHQII
Sbjct:    76 KAFDNKVDAKRTLREIKLLRHLEHENVVVIKDIIRPPKKEDFVDVYIVFELMDTDLHQII 135

Query:   137 RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS 196
             RS+Q L DDHCQYFLYQ+LRGLKY+HSA+VLHRDLKPSNLLLN++CDLKI DFGLARTTS
Sbjct:   136 RSNQSLNDDHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNSNCDLKITDFGLARTTS 195

Query:   197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL 256
             ET++MTEYVVTRWYRAPELLLN +EYT+AID+WSVGCI  EIMTREPLFPGKDYVHQL+L
Sbjct:   196 ETEYMTEYVVTRWYRAPELLLNSSEYTSAIDVWSVGCIFAEIMTREPLFPGKDYVHQLKL 255

Query:   257 ITEV 260
             ITE+
Sbjct:   256 ITEL 259

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

TAIR|locus:2025341 MPK11 "MAP kinase 11" [Arabidopsis thaliana (taxid:3702)]

 Score = 1111 (396.2 bits), Expect = 1.4e-112, P = 1.4e-112
 Identities = 210/243 (86%), Positives = 228/243 (93%)

Query:    18 KGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGN 77
             +GV  +GG+YVQYNVYGNLFEVS KYVPP+RPIGRGA GIVCAA NSET EEVAIKKIGN
Sbjct:    14 RGVSINGGRYVQYNVYGNLFEVSKKYVPPLRPIGRGASGIVCAAWNSETGEEVAIKKIGN 73

Query:    78 AFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIR 137
             AF NIIDA+RTLREIKLL+HM+H+NVIAI DIIRPP+ D FNDV+IVYELMDTDLH IIR
Sbjct:    74 AFGNIIDAKRTLREIKLLKHMDHDNVIAIIDIIRPPQPDNFNDVHIVYELMDTDLHHIIR 133

Query:   138 SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE 197
             S+Q LTDDH ++FLYQLLRGLKYVHSA+VLHRDLKPSNLLLNA+CDLKIGDFGLART SE
Sbjct:   134 SNQPLTDDHSRFFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTKSE 193

Query:   198 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
             TDFMTEYVVTRWYRAPELLLNC+EYTAAIDIWSVGCILGEIMTREPLFPG+DYV QLRLI
Sbjct:   194 TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTREPLFPGRDYVQQLRLI 253

Query:   258 TEV 260
             TE+
Sbjct:   254 TEL 256

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC;RCA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0005515 "protein binding" evidence=IPI

GO:0005829 "cytosol" evidence=IDA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2062897 MPK12 "mitogen-activated protein kinase 12" [Arabidopsis thaliana (taxid:3702)]

 Score = 1089 (388.4 bits), Expect = 2.9e-110, P = 2.9e-110
 Identities = 203/244 (83%), Positives = 227/244 (93%)

Query:    17 VKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIG 76
             +K V THGG+YVQYNVYG LFEVS KYVPPIRPIGRGA GIVCAAVNS T E+VAIKKIG
Sbjct:    14 IKVVPTHGGRYVQYNVYGQLFEVSRKYVPPIRPIGRGACGIVCAAVNSVTGEKVAIKKIG 73

Query:    77 NAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII 136
             NAFDNIIDA+RTLREIKLLRHM+HENVI IKDI+RPP++D FNDVYIVYELMDTDL +I+
Sbjct:    74 NAFDNIIDAKRTLREIKLLRHMDHENVITIKDIVRPPQRDIFNDVYIVYELMDTDLQRIL 133

Query:   137 RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS 196
             RS+Q LT D C++ +YQLLRGLKYVHSA++LHRDL+PSN+LLN+  +LKIGDFGLARTTS
Sbjct:   134 RSNQTLTSDQCRFLVYQLLRGLKYVHSANILHRDLRPSNVLLNSKNELKIGDFGLARTTS 193

Query:   197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL 256
             +TDFMTEYVVTRWYRAPELLLNC+EYTAAIDIWSVGCILGEIMT +PLFPGKDYVHQLRL
Sbjct:   194 DTDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTGQPLFPGKDYVHQLRL 253

Query:   257 ITEV 260
             ITE+
Sbjct:   254 ITEL 257

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0005515 "protein binding" evidence=IPI

GO:0007243 "intracellular protein kinase cascade" evidence=IC

GO:0009733 "response to auxin stimulus" evidence=IMP

GO:0080026 "response to indolebutyric acid stimulus" evidence=IMP

TAIR|locus:2043904 MPK6 "MAP kinase 6" [Arabidopsis thaliana (taxid:3702)]

 Score = 1040 (371.2 bits), Expect = 4.6e-105, P = 4.6e-105
 Identities = 185/244 (75%), Positives = 223/244 (91%)

Query:    17 VKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIG 76
             +   L+HGG+++QYN++GN+FEV++KY PPI PIG+GAYGIVC+A+NSET E VAIKKI 
Sbjct:    36 IPATLSHGGRFIQYNIFGNIFEVTAKYKPPIMPIGKGAYGIVCSAMNSETNESVAIKKIA 95

Query:    77 NAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII 136
             NAFDN IDA+RTLREIKLLRHM+HEN++AI+DII PP ++ FNDVYI YELMDTDLHQII
Sbjct:    96 NAFDNKIDAKRTLREIKLLRHMDHENIVAIRDIIPPPLRNAFNDVYIAYELMDTDLHQII 155

Query:   137 RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS 196
             RS+Q L+++HCQYFLYQ+LRGLKY+HSA+VLHRDLKPSNLLLNA+CDLKI DFGLAR TS
Sbjct:   156 RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS 215

Query:   197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL 256
             E+DFMTEYVVTRWYRAPELLLN ++YTAAID+WSVGCI  E+M R+PLFPG+D+VHQLRL
Sbjct:   216 ESDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL 275

Query:   257 ITEV 260
             + E+
Sbjct:   276 LMEL 279

GO:0005634 "nucleus" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0004707 "MAP kinase activity" evidence=ISS;IDA

GO:0006979 "response to oxidative stress" evidence=IEP

GO:0000302 "response to reactive oxygen species" evidence=IEP

GO:0042742 "defense response to bacterium" evidence=IEP

GO:0007165 "signal transduction" evidence=IC

GO:0006970 "response to osmotic stress" evidence=RCA;IDA

GO:0009723 "response to ethylene stimulus" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0009409 "response to cold" evidence=RCA;IDA

GO:0009651 "response to salt stress" evidence=IGI;RCA

GO:2000037 "regulation of stomatal complex patterning" evidence=IGI

GO:2000038 "regulation of stomatal complex development" evidence=IGI

GO:0009864 "induced systemic resistance, jasmonic acid mediated signaling pathway" evidence=IMP

GO:0042542 "response to hydrogen peroxide" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP;RCA

GO:0048481 "ovule development" evidence=IGI;RCA

GO:0010120 "camalexin biosynthetic process" evidence=IMP

GO:0080136 "priming of cellular response to stress" evidence=IMP

GO:0005802 "trans-Golgi network" evidence=IDA

GO:0009524 "phragmoplast" evidence=IDA

GO:0009574 "preprophase band" evidence=IDA

GO:0048364 "root development" evidence=IMP

GO:0051301 "cell division" evidence=IMP

GO:0010224 "response to UV-B" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0000303 "response to superoxide" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009743 "response to carbohydrate stimulus" evidence=RCA

GO:0009751 "response to salicylic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0009873 "ethylene mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0004672 "protein kinase activity" evidence=IDA

GO:0010229 "inflorescence development" evidence=IMP

TAIR|locus:2026484 ATMPK13 [Arabidopsis thaliana (taxid:3702)]

 Score = 1031 (368.0 bits), Expect = 4.1e-104, P = 4.1e-104
 Identities = 191/242 (78%), Positives = 215/242 (88%)

Query:    19 GVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNA 78
             G+LT+ G+YV YNV GN+FE+SSKY+PPI PIGRGAYGIVC A NSET EEVAIKKI NA
Sbjct:     8 GILTYDGRYVMYNVLGNIFELSSKYIPPIEPIGRGAYGIVCCATNSETNEEVAIKKIANA 67

Query:    79 FDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS 138
             FDN +DA+RTLREIKLL HM+H+NVI IKDII  P+K+ F DVYIVYELMDTDLHQIIRS
Sbjct:    68 FDNRVDAKRTLREIKLLSHMDHDNVIKIKDIIELPEKERFEDVYIVYELMDTDLHQIIRS 127

Query:   139 DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 198
              Q LTDDHCQYFLYQ+LRGLKY+HSA+VLHRDLKPSNL+LN +CDLKI DFGLART++ET
Sbjct:   128 TQTLTDDHCQYFLYQILRGLKYIHSANVLHRDLKPSNLVLNTNCDLKICDFGLARTSNET 187

Query:   199 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT 258
             + MTEYVVTRWYRAPELLLN +EYT AIDIWSVGCI  EI+ RE LFPGKDYV QL+LIT
Sbjct:   188 EIMTEYVVTRWYRAPELLLNSSEYTGAIDIWSVGCIFMEILRRETLFPGKDYVQQLKLIT 247

Query:   259 EV 260
             E+
Sbjct:   248 EL 249

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2085632 MPK3 "mitogen-activated protein kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 988 (352.9 bits), Expect = 1.5e-99, P = 1.5e-99
 Identities = 176/241 (73%), Positives = 218/241 (90%)

Query:    20 VLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF 79
             V THGG+++ Y+++G+LFE++SKY PPI PIGRGAYGIVC+ +++ET E VA+KKI NAF
Sbjct:    14 VETHGGQFISYDIFGSLFEITSKYRPPIIPIGRGAYGIVCSVLDTETNELVAMKKIANAF 73

Query:    80 DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD 139
             DN +DA+RTLREIKLLRH++HEN+IAI+D++ PP +  F+DVYI  ELMDTDLHQIIRS+
Sbjct:    74 DNHMDAKRTLREIKLLRHLDHENIIAIRDVVPPPLRRQFSDVYISTELMDTDLHQIIRSN 133

Query:   140 QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD 199
             Q L+++HCQYFLYQLLRGLKY+HSA+++HRDLKPSNLLLNA+CDLKI DFGLAR TSE D
Sbjct:   134 QSLSEEHCQYFLYQLLRGLKYIHSANIIHRDLKPSNLLLNANCDLKICDFGLARPTSEND 193

Query:   200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
             FMTEYVVTRWYRAPELLLN ++YTAAID+WSVGCI  E+M R+PLFPGKD+VHQ+RL+TE
Sbjct:   194 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRKPLFPGKDHVHQMRLLTE 253

Query:   260 V 260
             +
Sbjct:   254 L 254

GO:0005634 "nucleus" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0006979 "response to oxidative stress" evidence=IEP;TAS

GO:0004707 "MAP kinase activity" evidence=ISS

GO:0007165 "signal transduction" evidence=IC

GO:0000169 "activation of MAPK activity involved in osmosensory signaling pathway" evidence=IDA

GO:0006970 "response to osmotic stress" evidence=RCA;IDA

GO:0004672 "protein kinase activity" evidence=IDA;TAS

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

GO:0005515 "protein binding" evidence=IPI

GO:0010200 "response to chitin" evidence=IEP;RCA

GO:2000037 "regulation of stomatal complex patterning" evidence=IGI

GO:2000038 "regulation of stomatal complex development" evidence=IGI

GO:0009611 "response to wounding" evidence=IEP

GO:0048481 "ovule development" evidence=IGI;RCA

GO:0010120 "camalexin biosynthetic process" evidence=IMP

GO:0009617 "response to bacterium" evidence=IEP;RCA

GO:0080136 "priming of cellular response to stress" evidence=IMP

GO:0010224 "response to UV-B" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0001666 "response to hypoxia" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009409 "response to cold" evidence=IEP;RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0019684 "photosynthesis, light reaction" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

GO:0010229 "inflorescence development" evidence=IGI

TAIR|locus:2080457 MPK10 "MAP kinase 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 939 (335.6 bits), Expect = 2.3e-94, P = 2.3e-94
 Identities = 169/244 (69%), Positives = 211/244 (86%)

Query:    17 VKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIG 76
             + G L+H G+Y+QYN++G++FE+ +KY PPIRPIGRGA GIVC+AV+SET E+VAIKKI 
Sbjct:    33 IPGTLSHDGRYIQYNLFGHIFELPAKYKPPIRPIGRGACGIVCSAVDSETNEKVAIKKIT 92

Query:    77 NAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII 136
               FDN I+A+RTLREIKLLRH +HEN++AI+D+I PP++D+F DVYIV ELM+ DL++ +
Sbjct:    93 QVFDNTIEAKRTLREIKLLRHFDHENIVAIRDVILPPQRDSFEDVYIVNELMEFDLYRTL 152

Query:   137 RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS 196
             +SDQ+LT DH  YF+YQ+LRGLKY+HSA+VLHRDLKPSNLLL+  CDLKI DFGLAR T 
Sbjct:   153 KSDQELTKDHGMYFMYQILRGLKYIHSANVLHRDLKPSNLLLSTQCDLKICDFGLARATP 212

Query:   197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL 256
             E++ MTEYVVTRWYRAPELLL  ++YTAAID+WSVGCI  EIM REPLFPGKD V+QLRL
Sbjct:   213 ESNLMTEYVVTRWYRAPELLLGSSDYTAAIDVWSVGCIFMEIMNREPLFPGKDQVNQLRL 272

Query:   257 ITEV 260
             + E+
Sbjct:   273 LLEL 276

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2053119 MPK7 "MAP kinase 7" [Arabidopsis thaliana (taxid:3702)]

 Score = 861 (308.1 bits), Expect = 4.3e-86, P = 4.3e-86
 Identities = 158/243 (65%), Positives = 199/243 (81%)

Query:    19 GVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNA 78
             G+   G  Y  Y+++  LFE+ +KYVP I+PIGRGAYG+VC+++N ET E VAIKKI N 
Sbjct:    10 GIKQQGKHY--YSMWQTLFEIDTKYVP-IKPIGRGAYGVVCSSINRETNERVAIKKIHNV 66

Query:    79 FDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS 138
             F+N +DA RTLRE+KLLRH+ HENVIA+KD++ P  + +F DVY+VYELMDTDLHQII+S
Sbjct:    67 FENRVDALRTLRELKLLRHVRHENVIALKDVMLPANRSSFKDVYLVYELMDTDLHQIIKS 126

Query:   139 DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 198
              Q L+DDHC+YFL+QLLRGLKY+HSA++LHRDLKP NLL+NA+CDLKI DFGLART+   
Sbjct:   127 SQSLSDDHCKYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSQGN 186

Query:   199 D-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
             + FMTEYVVTRWYRAPELLL C  Y  +ID+WSVGCI  EI+ R+P+FPG + ++QL+LI
Sbjct:   187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLI 246

Query:   258 TEV 260
               V
Sbjct:   247 INV 249

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0007623 "circadian rhythm" evidence=TAS

GO:0042542 "response to hydrogen peroxide" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2115445 MPK14 "mitogen-activated protein kinase 14" [Arabidopsis thaliana (taxid:3702)]

 Score = 845 (302.5 bits), Expect = 2.1e-84, P = 2.1e-84
 Identities = 157/242 (64%), Positives = 198/242 (81%)

Query:    19 GVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNA 78
             G+   G  Y  Y ++  LFE+ +KYVP I+PIGRGAYG+VC+++NSET E VAIKKI N 
Sbjct:    10 GIRQEGKHY--YTMWQTLFEIDTKYVP-IKPIGRGAYGVVCSSINSETNERVAIKKIHNV 66

Query:    79 FDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS 138
             F+N IDA RTLRE+KLLRH+ HENVI++KD++ P  + +F DVY+VYELMD+DL+QII+S
Sbjct:    67 FENRIDALRTLRELKLLRHVRHENVISLKDVMLPTHRYSFRDVYLVYELMDSDLNQIIKS 126

Query:   139 DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 198
              Q L+DDHC+YFL+QLLRGLKY+HSA++LHRDLKP NLL+NA+CDLKI DFGLART  + 
Sbjct:   127 SQSLSDDHCKYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTYEQ- 185

Query:   199 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT 258
              FMTEYVVTRWYRAPELLL C  Y  +ID+WSVGCI  EI+ R+P+FPG + ++QL+LI 
Sbjct:   186 -FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLII 244

Query:   259 EV 260
              V
Sbjct:   245 NV 246

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q06060	MAPK_PEA	2, ., 7, ., 1, 1, ., 2, 4	0.7479	0.9461	0.6243	N/A	no
Q5J4W4	MPK2_ORYSJ	2, ., 7, ., 1, 1, ., 2, 4	0.8577	0.9461	0.6243	yes	no
Q40531	NTF6_TOBAC	2, ., 7, ., 1, 1, ., 2, 4	0.8264	0.9307	0.6522	N/A	no
Q40532	NTF4_TOBAC	2, ., 7, ., 1, 1, ., 2, 4	0.7343	0.9846	0.6513	N/A	no
Q39024	MPK4_ARATH	2, ., 7, ., 1, 1, ., 2, 4	0.8615	0.9961	0.6888	yes	no
A2XFC8	MPK5_ORYSI	2, ., 7, ., 1, 1, ., 2, 4	0.704	0.9615	0.6775	N/A	no
P27638	SPK1_SCHPO	2, ., 7, ., 1, 1, ., 2, 4	0.5340	0.9730	0.6801	yes	no
Q07176	MMK1_MEDSA	2, ., 7, ., 1, 1, ., 2, 4	0.7307	0.9961	0.6692	N/A	no
Q40353	MMK2_MEDSA	2, ., 7, ., 1, 1, ., 2, 4	0.8412	0.9692	0.6792	N/A	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.24	0.946
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.963

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	260
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-178
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-151
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-130
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-128
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-112
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-108
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-108
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-99
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-97
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-92
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-92
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	9e-90
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-88
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-84
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	7e-83
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-82
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-81
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-81
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-80
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-74
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-73
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	6e-73
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	7e-71
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-70
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-67
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-67
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	6e-67
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-66
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-65
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-62
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-60
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	5e-60
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	8e-59
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-57
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-57
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-56
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-56
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-56
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-55
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	9e-55
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-54
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-54
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-54
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	6e-54
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-53
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-51
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-51
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-50
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	7e-48
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-47
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-47
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-45
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-45
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-45
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-44
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-43
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-43
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-42
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	7e-40
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	8e-40
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-39
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-37
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	7e-37
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	8e-37
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-36
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-36
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	5e-35
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-34
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-33
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	6e-32
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-31
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-30
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-30
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-30
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-29
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-28
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	9e-28
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-27
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-27
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-26
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-25
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-25
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-25
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-25
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-25
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-24
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-24
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	5e-24
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-23
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-23
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	8e-23
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	9e-23
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-22
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-22
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-22
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	6e-22
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	7e-22
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-21
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-21
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-21
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-21
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-21
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-21
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-21
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	9e-21
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-20
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-20
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-20
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-20
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-20
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-19
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-19
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-19
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-19
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-18
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-18
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-18
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-18
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-18
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-18
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-18
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-18
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-18
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	8e-18
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-17
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-17
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-17
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-17
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-17
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-17
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-17
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	8e-17
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	9e-17
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	9e-17
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-16
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-16
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-16
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-16
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-16
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-16
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-16
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-16
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-16
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	7e-16
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	7e-16
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	7e-16
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-15
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-15
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-15
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-15
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-15
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-15
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-15
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-15
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-15
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	5e-15
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	5e-15
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-15
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	7e-15
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	7e-15
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	7e-15
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	7e-15
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	7e-15
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	9e-15
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-14
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-14
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-14
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-14
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-14
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-14
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-14
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-14
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-14
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-14
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-14
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-14
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-14
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-14
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-14
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	7e-14
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	7e-14
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	7e-14
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	8e-14
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-13
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-13
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-13
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-13
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-13
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-13
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-13
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-13
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-13
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-13
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-13
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-13
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-13
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-13
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	6e-13
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	7e-13
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	7e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	7e-13
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	8e-13
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	8e-13
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	8e-13
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	8e-13
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	9e-13
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-12
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-12
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-12
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-12
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-12
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-12
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-12
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-12
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-12
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-12
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-12
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-12
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-12
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	5e-12
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	5e-12
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	6e-12
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	6e-12
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	7e-12
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	8e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	8e-12
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-11
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-11
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-11
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-11
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-11
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-11
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-11
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-11
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-11
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-11
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-11
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-11
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-11
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-11
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-11
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	5e-11
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-11
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	8e-11
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	9e-11
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-10
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-10
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-10
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-10
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-10
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-10
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-10
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-10
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-10
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-10
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-10
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-10
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-10
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-10
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	7e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	8e-10
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	8e-10
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	9e-10
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	9e-10
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-09
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-09
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-09
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-09
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-09
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-09
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	5e-09
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-09
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-08
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-08
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-08
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-08
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-08
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-08
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-08
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	5e-08
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-07
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-07
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-07
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	4e-07
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-07
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-07
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-07
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	6e-07
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	7e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-06
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	5e-06
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-05
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	4e-04
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	0.001
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	0.002

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  491 bits (1267), Expect = e-178
 Identities = 185/225 (82%), Positives = 205/225 (91%), Gaps = 2/225 (0%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           FEV +KYVP   PIGRGAYGIVC+A NSET E+VAIKKI NAFDN IDA+RTLREIKLLR
Sbjct: 1   FEVDTKYVPIK-PIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLR 59

Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 156
           H++HENVIAIKDI+ PP ++ FNDVYIVYELMDTDLHQIIRS Q L+DDHCQYFLYQLLR
Sbjct: 60  HLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLR 119

Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPEL 215
           GLKY+HSA+VLHRDLKPSNLLLNA+CDLKI DFGLARTTSE  DFMTEYVVTRWYRAPEL
Sbjct: 120 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPEL 179

Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           LLNC+EYT AID+WSVGCI  E++ R+PLFPGKDYVHQL+LITE+
Sbjct: 180 LLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITEL 224

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  425 bits (1096), Expect = e-151
 Identities = 148/219 (67%), Positives = 182/219 (83%), Gaps = 4/219 (1%)

Query: 46  PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA 105
            ++PIG GAYG+VC+AV+  T  +VAIKKI N FD++IDA+R LREIKLLRH+ HEN+I 
Sbjct: 4   LLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIG 63

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
           + DI+RPP  + FNDVYIV ELM+TDLH++I+S Q LTDDH QYFLYQ+LRGLKY+HSA+
Sbjct: 64  LLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN 123

Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTT----SETDFMTEYVVTRWYRAPELLLNCTE 221
           V+HRDLKPSN+L+N++CDLKI DFGLAR       E  F+TEYVVTRWYRAPELLL+ + 
Sbjct: 124 VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSR 183

Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           YT AIDIWSVGCI  E++TR+PLFPG+DY+ QL LI EV
Sbjct: 184 YTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEV 222

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  371 bits (954), Expect = e-130
 Identities = 145/229 (63%), Positives = 187/229 (81%), Gaps = 7/229 (3%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           F+V S+Y  PI  IG GAYG+VC+A+++ + ++VAIKKI +AFD    A+RTLRE+K+LR
Sbjct: 1   FDVGSRY-KPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILR 59

Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 156
           H +H+N+IAI+DI+RPP  D F DVY+V +LM++DLH II SDQ LT++H +YFLYQLLR
Sbjct: 60  HFKHDNIIAIRDILRPPGAD-FKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLR 118

Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETD---FMTEYVVTRWYR 211
           GLKY+HSA+V+HRDLKPSNLL+N  C+L+IGDFG+AR  ++S T+   FMTEYV TRWYR
Sbjct: 119 GLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYR 178

Query: 212 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           APELLL+  EYT AID+WSVGCI  E++ R  LFPGK+YVHQL+LI  V
Sbjct: 179 APELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSV 227

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  367 bits (943), Expect = e-128
 Identities = 142/228 (62%), Positives = 177/228 (77%), Gaps = 7/228 (3%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           F+V  +Y   +  IG GAYG+VC+A +  T  +VAIKKI + F++    +RTLREIK+LR
Sbjct: 1   FDVGPRYQN-LSYIGEGAYGMVCSATHKPTGVKVAIKKI-SPFEHQTFCQRTLREIKILR 58

Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 156
             +HEN+I I DIIRPP  ++FNDVYIV ELM+TDL+++I++ Q L++DH QYFLYQ+LR
Sbjct: 59  RFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKT-QHLSNDHIQYFLYQILR 117

Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE----TDFMTEYVVTRWYRA 212
           GLKY+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV TRWYRA
Sbjct: 118 GLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA 177

Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           PE++LN   YT AIDIWSVGCIL E+++  PLFPGKDY+HQL LI  V
Sbjct: 178 PEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGV 225

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  325 bits (836), Expect = e-112
 Identities = 116/235 (49%), Positives = 166/235 (70%), Gaps = 5/235 (2%)

Query: 27  YVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR 86
           + +  +   ++EV  +Y   + P+G GAYG VC+A +++T  +VAIKK+   F + I A+
Sbjct: 1   FYRQELNKTVWEVPDRYQN-LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAK 59

Query: 87  RTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDD 145
           RT RE++LL+HM+HENVI + D+  P    + F DVY+V  LM  DL+ I++  Q+L+DD
Sbjct: 60  RTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC-QKLSDD 118

Query: 146 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 205
           H Q+ +YQ+LRGLKY+HSA ++HRDLKPSN+ +N  C+LKI DFGLAR T +   MT YV
Sbjct: 119 HIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE--MTGYV 176

Query: 206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
            TRWYRAPE++LN   Y   +DIWSVGCI+ E++T + LFPG D++ QL+ I  +
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNL 231

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  316 bits (812), Expect = e-108
 Identities = 135/224 (60%), Positives = 165/224 (73%), Gaps = 13/224 (5%)

Query: 47  IRPIGRGAYGIVCAAVNSETREE--VAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENV 103
           I+ +G+GAYGIVC+A N+ET EE  VAIKKI N F   I A+R LRE+KLLRH   H+N+
Sbjct: 5   IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNI 64

Query: 104 IAI--KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
             +   DI+ P     FN++Y+  ELM+ DLHQIIRS Q LTD H Q F+YQ+L GLKY+
Sbjct: 65  TCLYDMDIVFP---GNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYI 121

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-----TDFMTEYVVTRWYRAPELL 216
           HSA+VLHRDLKP NLL+NA C+LKI DFGLAR  SE       FMTEYV TRWYRAPE++
Sbjct: 122 HSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIM 181

Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           L+   YT AID+WSVGCIL E++ R+P+F GKDYV QL  I +V
Sbjct: 182 LSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQV 225

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  315 bits (809), Expect = e-108
 Identities = 124/219 (56%), Positives = 167/219 (76%), Gaps = 11/219 (5%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG+G+YG+VC+A+++ T E+VAIKKI + F+++ DA R LREIKLLR + H +++ IK I
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67

Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 169
           + PP +  F D+Y+V+ELM++DLHQ+I+++  LT +H Q+FLYQLLR LKY+H+A+V HR
Sbjct: 68  MLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHR 127

Query: 170 DLKPSNLLLNASCDLKIGDFGLART----TSETDFMTEYVVTRWYRAPELLLNC----TE 221
           DLKP N+L NA C LKI DFGLAR     T    F T+YV TRWYRAPEL   C    ++
Sbjct: 128 DLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL---CGSFFSK 184

Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           YT AIDIWS+GCI  E++T +PLFPGK+ VHQL LIT++
Sbjct: 185 YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDL 223

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  291 bits (746), Expect = 3e-99
 Identities = 104/216 (48%), Positives = 138/216 (63%), Gaps = 7/216 (3%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A +  T E VAIKKI   F++    +  LREIKLL+ + H N+I +
Sbjct: 4   LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKL 63

Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSAS 165
            D+ R        D+Y+V+E MDTDL+++I+  Q+ L +   + +LYQLL+GL + HS  
Sbjct: 64  LDVFRHK-----GDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG 118

Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           +LHRDLKP NLL+N    LK+ DFGLAR+  S     T YVVTRWYRAPELLL    Y+ 
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYST 178

Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
            +DIWSVGCI  E+++R PLFPGK  + QL  I   
Sbjct: 179 PVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRT 214

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  288 bits (739), Expect = 2e-97
 Identities = 113/230 (49%), Positives = 163/230 (70%), Gaps = 12/230 (5%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRH 97
            +  KY   ++ +G+GAYGIV  A++  T+E VA+KKI +AF N  DA+RT REI  L+ 
Sbjct: 4   HILRKY-EILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQE 62

Query: 98  M-EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 156
           + +H N++ + ++I+    +   D+Y+V+E M+TDLH +IR++  L D H +Y +YQLL+
Sbjct: 63  LGDHPNIVKLLNVIK---AENDKDIYLVFEYMETDLHAVIRANI-LEDVHKRYIMYQLLK 118

Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD------FMTEYVVTRWY 210
            LKY+HS +V+HRDLKPSN+LLN+ C +K+ DFGLAR+ SE +       +T+YV TRWY
Sbjct: 119 ALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWY 178

Query: 211 RAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           RAPE+LL  T YT  +D+WSVGCILGE++  +PLFPG   ++QL  I EV
Sbjct: 179 RAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEV 228

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  276 bits (707), Expect = 3e-92
 Identities = 111/218 (50%), Positives = 156/218 (71%), Gaps = 2/218 (0%)

Query: 44  VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV 103
           V P RPIG GA+G+V +  +    + VA+KK+ N F N++  +R  RE+K+L   +H+NV
Sbjct: 2   VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNV 61

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           ++  DI++PP  D F ++Y+V ELM +DLH+II S Q L+ DH + FLYQ+LRGLKY+HS
Sbjct: 62  LSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS 121

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS--ETDFMTEYVVTRWYRAPELLLNCTE 221
           A +LHRD+KP NLL+N++C LKI DFGLAR     E+  MT+ VVT++YRAPE+L+    
Sbjct: 122 AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRH 181

Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           YT+A+DIWSVGCI  E++ R  LF  +  + QL LIT+
Sbjct: 182 YTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITD 219

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  274 bits (703), Expect = 3e-92
 Identities = 118/229 (51%), Positives = 165/229 (72%), Gaps = 8/229 (3%)

Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           ++G +FE++++YV  ++P+G GA+G+VC+A +  T + VAIKKI   F   + A+RT RE
Sbjct: 1   IFGTVFEITNRYVD-LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRE 59

Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           +KLL+H+ HEN+I++ DI   P      D+Y V EL+ TDLH+++ S + L     QYFL
Sbjct: 60  LKLLKHLRHENIISLSDIFISP----LEDIYFVTELLGTDLHRLLTS-RPLEKQFIQYFL 114

Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYR 211
           YQ+LRGLKYVHSA V+HRDLKPSN+L+N +CDLKI DFGLAR       MT YV TR+YR
Sbjct: 115 YQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ--MTGYVSTRYYR 172

Query: 212 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           APE++L   +Y   +DIWS GCI  E++  +PLFPGKD+V+Q  +IT++
Sbjct: 173 APEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDL 221

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  269 bits (688), Expect = 9e-90
 Identities = 117/226 (51%), Positives = 164/226 (72%), Gaps = 5/226 (2%)

Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VC+A ++  R++VA+KK+   F ++I ARRT RE++LL
Sbjct: 10  VWEVPERY-QNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLL 68

Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P    + FN+VY+V  LM  DL+ I++  Q+L+D+H Q+ +YQL
Sbjct: 69  KHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKC-QKLSDEHVQFLIYQL 127

Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSN+ +N  C+L+I DFGLAR     D MT YV TRWYRAPE
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD--DEMTGYVATRWYRAPE 185

Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           ++LN   Y   +DIWSVGCI+ E++  + LFPG DY+ QL+ I EV
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEV 231

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  266 bits (680), Expect = 1e-88
 Identities = 121/223 (54%), Positives = 164/223 (73%), Gaps = 5/223 (2%)

Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 12  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 70

Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 71  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 129

Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T +   MT YV TRWYRAPE
Sbjct: 130 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPE 187

Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 188 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 230

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  253 bits (650), Expect = 1e-84
 Identities = 93/215 (43%), Positives = 129/215 (60%), Gaps = 11/215 (5%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA--RRTLREIKLLRHMEHENVIAIK 107
           +G G YG+V  A + +T E VA+KKI    DN  +      LREI LL+ ++H N++ + 
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHPNIVKLL 64

Query: 108 DIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           D+I   +K     +Y+V+E  D DL + +      L+ +  +  +YQLLRGL Y HS  +
Sbjct: 65  DVIHTERK-----LYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRI 119

Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           LHRDLKP N+L+N    LK+ DFGLAR         T  VVT WYRAPE+LL    Y+ A
Sbjct: 120 LHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTA 179

Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           +DIWSVGCI  E++T +PLFPG   + QL  I ++
Sbjct: 180 VDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQI 214

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  251 bits (642), Expect = 7e-83
 Identities = 112/226 (49%), Positives = 151/226 (66%), Gaps = 6/226 (2%)

Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++E+  +Y    + +G GAYG VC+A++  T E+VAIKK+   F + I A+R  RE+ LL
Sbjct: 10  VWELPERYTSL-KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLL 68

Query: 96  RHMEHENVIAIKDIIRP-PKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+       D F D Y+V   M TDL +I+     L++D  QY +YQ+
Sbjct: 69  KHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIM--GHPLSEDKVQYLVYQM 126

Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           L GLKY+HSA ++HRDLKP NL +N  C+LKI DFGLAR       MT YVVTRWYRAPE
Sbjct: 127 LCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPE 184

Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           ++LN   Y   +DIWSVGCI+ E++T + LF GKDY+ QL  I +V
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 230

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  250 bits (640), Expect = 2e-82
 Identities = 107/225 (47%), Positives = 151/225 (67%), Gaps = 5/225 (2%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           F V  +Y   ++PIG GA GIVCAA ++ T + VAIKK+   F N+  A+R  RE+ L++
Sbjct: 12  FTVLKRYQN-LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMK 70

Query: 97  HMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLL 155
            + H+N+I + ++  P K  + F DVY+V ELMD +L Q+I+ D  L  +   Y LYQ+L
Sbjct: 71  LVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD--LDHERMSYLLYQML 128

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL 215
            G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE+
Sbjct: 129 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 188

Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           +L    Y   +DIWSVGCI+GE++    LFPG D++ Q   I E 
Sbjct: 189 ILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQ 232

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  245 bits (629), Expect = 2e-81
 Identities = 91/219 (41%), Positives = 131/219 (59%), Gaps = 10/219 (4%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIID--ARRTLREIKLLRHMEHENVI 104
           I  IG G YG V  A N +T E VA+KKI    +N  +      +REIKLL+ + H N++
Sbjct: 4   IAQIGEGTYGQVYKARNKKTGELVALKKI--RMENEKEGFPITAIREIKLLQKLRHPNIV 61

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHS 163
            +K+I+    K     +Y+V+E MD DL  ++ S + + T+   + ++ QLL GL+Y+HS
Sbjct: 62  RLKEIVTSKGK---GSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS 118

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS--ETDFMTEYVVTRWYRAPELLLNCTE 221
             +LHRD+K SN+L+N    LK+ DFGLAR  +   +   T  V+T WYR PELLL  T 
Sbjct: 119 NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATR 178

Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           Y   +D+WSVGCIL E+   +P+F G   + QL  I E+
Sbjct: 179 YGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFEL 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  247 bits (632), Expect = 3e-81
 Identities = 112/235 (47%), Positives = 163/235 (69%), Gaps = 5/235 (2%)

Query: 27  YVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR 86
           Y +  V   ++EV  +Y   ++ +G GAYG VC+A++  T  +VAIKK+   F + + A+
Sbjct: 1   YYRQEVNKTIWEVPDRY-RDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAK 59

Query: 87  RTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDD 145
           R  RE++LL+HM+HENVI + D+  P    D F+D Y+V   M TDL ++++  ++L++D
Sbjct: 60  RAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH-EKLSED 118

Query: 146 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 205
             Q+ +YQ+L+GLKY+H+A ++HRDLKP NL +N  C+LKI DFGLAR T     MT YV
Sbjct: 119 RIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE--MTGYV 176

Query: 206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           VTRWYRAPE++LN   YT  +DIWSVGCI+ E++T +PLF G D++ QL  I +V
Sbjct: 177 VTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKV 231

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  242 bits (619), Expect = 2e-80
 Identities = 77/204 (37%), Positives = 124/204 (60%), Gaps = 8/204 (3%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  +G G++G V  A + +T + VAIK I        D  R LREIK+L+ ++H N++ +
Sbjct: 4   LEKLGEGSFGKVYLARDKKTGKLVAIKVI-KKKKIKKDRERILREIKILKKLKHPNIVRL 62

Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            D+      +  + +Y+V E  +  DL  +++   +L++D  +++L Q+L  L+Y+HS  
Sbjct: 63  YDVF-----EDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG 117

Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKP N+LL+    +K+ DFGLAR     + +T +V T  Y APE+LL    Y  A
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL-GKGYGKA 176

Query: 226 IDIWSVGCILGEIMTREPLFPGKD 249
           +DIWS+G IL E++T +P FPG D
Sbjct: 177 VDIWSLGVILYELLTGKPPFPGDD 200

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  227 bits (581), Expect = 5e-74
 Identities = 96/226 (42%), Positives = 129/226 (57%), Gaps = 15/226 (6%)

Query: 42  KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKI-----GNAFDNIIDARRTLREIKLLR 96
           +Y    + +G G Y +V  A + ET   VAIKKI       A D I      LREIKLL+
Sbjct: 1   RYEK-GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGI--NFTALREIKLLQ 57

Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLL 155
            ++H N+I + D+     K   N   +V+E M+TDL ++I+     LT    + ++   L
Sbjct: 58  ELKHPNIIGLLDVF--GHKSNIN---LVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTL 112

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPE 214
           RGL+Y+HS  +LHRDLKP+NLL+ +   LK+ DFGLAR+  S    MT  VVTRWYRAPE
Sbjct: 113 RGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPE 172

Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           LL     Y   +D+WSVGCI  E++ R P  PG   + QL  I E 
Sbjct: 173 LLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEA 218

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  223 bits (570), Expect = 5e-73
 Identities = 75/216 (34%), Positives = 125/216 (57%), Gaps = 7/216 (3%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +G G++G V  A +  T + VA+K +    +     +   REI++LR + H N++ +
Sbjct: 4   LRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRL 63

Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            D          + +Y+V E  +  DL   +     L++D  +    Q+LRGL+Y+HS  
Sbjct: 64  IDAFE-----DKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG 118

Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCTEYTA 224
           ++HRDLKP N+LL+ +  +KI DFGLA+   ++   +T +V T WY APE+LL    Y  
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGP 178

Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
            +D+WS+G IL E++T +P F G++ + QL+LI  +
Sbjct: 179 KVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRI 214

Length = 260

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  226 bits (577), Expect = 6e-73
 Identities = 102/237 (43%), Positives = 156/237 (65%), Gaps = 18/237 (7%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           F++ S+Y+  +RP+G G+ G+V +AV+S+  + VA+KKI     +    +  LREIK++R
Sbjct: 1   FDLGSRYMD-LRPLGCGSNGLVFSAVDSDCDKRVAVKKI--VLTDPQSVKHALREIKIIR 57

Query: 97  HMEHENVIAIKDIIRPPKKD---------TFNDVYIVYELMDTDLHQIIRSDQQLTDDHC 147
            ++H+N++ + +++ P   D           N VYIV E M+TDL  ++     L+++H 
Sbjct: 58  RLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVL-EQGPLSEEHA 116

Query: 148 QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTT----SETDFMT 202
           + F+YQLLRGLKY+HSA+VLHRDLKP+N+ +N     LKIGDFGLAR      S   +++
Sbjct: 117 RLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLS 176

Query: 203 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           E +VT+WYR+P LLL+   YT AID+W+ GCI  E++T +PLF G   + Q++LI E
Sbjct: 177 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  218 bits (558), Expect = 7e-71
 Identities = 88/217 (40%), Positives = 133/217 (61%), Gaps = 9/217 (4%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIA 105
           I+ +G G +G V  A N ET E VAIKK+   F +  +    LRE+K LR + EH N++ 
Sbjct: 4   IKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNEHPNIVK 62

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHS 163
           +K++ R       +++Y V+E M+ +L+Q+++  +    ++   +  +YQ+L+GL ++H 
Sbjct: 63  LKEVFR-----ENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
               HRDLKP NLL++    +KI DFGLAR        T+YV TRWYRAPE+LL  T Y+
Sbjct: 118 HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYS 177

Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           + +DIW++GCI+ E+ T  PLFPG   + QL  I  V
Sbjct: 178 SPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSV 214

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  217 bits (554), Expect = 3e-70
 Identities = 84/213 (39%), Positives = 128/213 (60%), Gaps = 12/213 (5%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKI--GNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           IG GA+GIV  A + ET E VA+KK+        I    + LREIK L+  +H  V+ + 
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGI--PNQALREIKALQACQHPYVVKLL 65

Query: 108 DIIRPPKKDTFNDVYIVYELMDTDLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           D+         +   +V E M +DL +++R  ++ L +   + ++  LL+G+ Y+H+  +
Sbjct: 66  DVFPHG-----SGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGI 120

Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTA 224
           +HRDLKP+NLL++A   LKI DFGLAR  SE +    +  V TRWYRAPELL    +Y  
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDP 180

Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
            +D+W+VGCI  E++   PLFPG++ + QL ++
Sbjct: 181 GVDLWAVGCIFAELLNGSPLFPGENDIEQLAIV 213

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  211 bits (538), Expect = 4e-67
 Identities = 106/235 (45%), Positives = 155/235 (65%), Gaps = 5/235 (2%)

Query: 26  KYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA 85
           ++    V  + F V  +Y   ++PIG GA GIVCAA ++     VAIKK+   F N   A
Sbjct: 2   QFYSVEVGDSTFTVLKRY-QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA 60

Query: 86  RRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTD 144
           +R  RE+ L++ + H+N+I++ ++  P K  + F DVY+V ELMD +L Q+I+   +L  
Sbjct: 61  KRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ--MELDH 118

Query: 145 DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY 204
           +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART   +  MT Y
Sbjct: 119 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 178

Query: 205 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           VVTR+YRAPE++L    Y   +DIWSVGCI+GE++  + LFPG+DY+ Q   + E
Sbjct: 179 VVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  211 bits (539), Expect = 4e-67
 Identities = 105/224 (46%), Positives = 148/224 (66%), Gaps = 5/224 (2%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           F V  +Y   ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++
Sbjct: 20  FTVLKRY-QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMK 78

Query: 97  HMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLL 155
            + H+N+I + ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQML 136

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL 215
            G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE+
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196

Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           +L    Y   +DIWSVGCI+GE++    LFPG D++ Q   + E
Sbjct: 197 ILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  209 bits (533), Expect = 6e-67
 Identities = 85/211 (40%), Positives = 131/211 (62%), Gaps = 8/211 (3%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G GAYG+V    N  T E VAIKK   + D+    +  LRE+K+LR + HEN++ +K+ 
Sbjct: 9   VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68

Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
            R   +     +Y+V+E ++  L +++  S   L  D  + +++QLL+ + Y HS +++H
Sbjct: 69  FRRKGR-----LYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIH 123

Query: 169 RDLKPSNLLLNASCDLKIGDFGLARTTSE--TDFMTEYVVTRWYRAPELLLNCTEYTAAI 226
           RD+KP N+L++ S  LK+ DFG AR         +T+YV TRWYRAPELL+  T Y   +
Sbjct: 124 RDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPV 183

Query: 227 DIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           D+W++GCI+ E++  EPLFPG   + QL LI
Sbjct: 184 DVWAIGCIMAELLDGEPLFPGDSDIDQLYLI 214

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  207 bits (530), Expect = 2e-66
 Identities = 87/212 (41%), Positives = 125/212 (58%), Gaps = 9/212 (4%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIID--ARRTLREIKLLRHMEHENVIAIK 107
           I  G YG+V  A + +T E VA+KK+    +   +     +LREI +L  ++H N++ +K
Sbjct: 13  IEEGTYGVVYRARDKKTGEIVALKKL--KMEKEKEGFPITSLREINILLKLQHPNIVTVK 70

Query: 108 DIIRPPKKDTFNDVYIVYELMDTDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           +++        + +Y+V E ++ DL  ++    Q       +  + QLL G+ ++H   +
Sbjct: 71  EVV---VGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWI 127

Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           LHRDLK SNLLLN    LKI DFGLAR         T+ VVT WYRAPELLL   EY+ A
Sbjct: 128 LHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTA 187

Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ID+WSVGCI  E++T++PLFPGK  + QL  I
Sbjct: 188 IDMWSVGCIFAELLTKKPLFPGKSEIDQLNKI 219

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  207 bits (529), Expect = 1e-65
 Identities = 103/237 (43%), Positives = 150/237 (63%), Gaps = 5/237 (2%)

Query: 25  GKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIID 84
            ++    V  + F V  +Y   ++PIG GA GIVCAA ++     VA+KK+   F N   
Sbjct: 5   SQFYSVQVADSTFTVLKRY-QQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTH 63

Query: 85  ARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLT 143
           A+R  RE+ LL+ + H+N+I++ ++  P K  + F DVY+V ELMD +L Q+I  +  L 
Sbjct: 64  AKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHME--LD 121

Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
            +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART      MT 
Sbjct: 122 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTP 181

Query: 204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           YVVTR+YRAPE++L    Y   +DIWSVGCI+GE++    +F G D++ Q   + E 
Sbjct: 182 YVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQ 237

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  197 bits (504), Expect = 2e-62
 Identities = 94/212 (44%), Positives = 130/212 (61%), Gaps = 9/212 (4%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR--RTLREIKLLRHMEHENVIAIK 107
           IG G YGIV  A ++ + E VA+KK+    DN  D     +LREI LL ++ H N++ +K
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKV--RMDNERDGIPISSLREITLLLNLRHPNIVELK 72

Query: 108 DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSASV 166
           +++        + +++V E  + DL  ++ +     ++   +  + QLLRGL+Y+H   +
Sbjct: 73  EVV---VGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFI 129

Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLLNCTEYTAA 225
           +HRDLK SNLLL     LKI DFGLART       MT  VVT WYRAPELLL CT YT A
Sbjct: 130 IHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTA 189

Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ID+W+VGCIL E++  +PL PGK  + QL LI
Sbjct: 190 IDMWAVGCILAELLAHKPLLPGKSEIEQLDLI 221

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  192 bits (490), Expect = 1e-60
 Identities = 86/221 (38%), Positives = 122/221 (55%), Gaps = 16/221 (7%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR-----TLREIKLLRHME---HE 101
           IG GAYG V  A +  T   VA+KK+      +  +       TLREI LL+ +E   H 
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKV-----RVPLSEEGIPLSTLREIALLKQLESFEHP 61

Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIR--SDQQLTDDHCQYFLYQLLRGLK 159
           N++ + D+   P+ D    + +V+E +D DL   +       L  +  +  + QLLRG+ 
Sbjct: 62  NIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVD 121

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 219
           ++HS  ++HRDLKP N+L+ +   +KI DFGLAR  S    +T  VVT WYRAPE+LL  
Sbjct: 122 FLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQS 181

Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           + Y   +D+WSVGCI  E+  R PLF G     QL  I +V
Sbjct: 182 S-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDV 221

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  191 bits (488), Expect = 5e-60
 Identities = 91/228 (39%), Positives = 126/228 (55%), Gaps = 24/228 (10%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKI--GNAFDNI-IDARRTLREIKLLRHMEHENVIAI 106
           +G G +G V  A   +T   VA+KKI   N  D   I A   LREIK+L+ ++H NV+ +
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITA---LREIKILKKLKHPNVVPL 72

Query: 107 KDII--RPPK-KDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVH 162
            D+   RP K K     VY+V   MD DL  ++ +   +LT+   + ++ QLL G+ Y+H
Sbjct: 73  IDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLH 132

Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLAR-------------TTSETDFMTEYVVTRW 209
              +LHRD+K +N+L++    LKI DFGLAR                   + T  VVTRW
Sbjct: 133 ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKY-TNLVVTRW 191

Query: 210 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           YR PELLL    YT A+DIW +GC+  E+ TR P+  GK  + QL LI
Sbjct: 192 YRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  187 bits (478), Expect = 8e-59
 Identities = 89/213 (41%), Positives = 123/213 (57%), Gaps = 18/213 (8%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G YG+V  A +  T E VA+KKI    ++       +REI LL+ + H N++ + D+
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
           +    K     +Y+V+E +D DL + + S     L     + +LYQLL+G+ Y HS  VL
Sbjct: 67  VHSENK-----LYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVL 121

Query: 168 HRDLKPSNLLLNASCDLKIGDFGLARTTSETDF------MTEYVVTRWYRAPELLLNCTE 221
           HRDLKP NLL++    LK+ DFGLAR      F       T  VVT WYRAPE+LL   +
Sbjct: 122 HRDLKPQNLLIDREGALKLADFGLARA-----FGVPVRTYTHEVVTLWYRAPEILLGSRQ 176

Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
           Y+  +DIWS+GCI  E++ R PLFPG   + QL
Sbjct: 177 YSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQL 209

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  186 bits (474), Expect = 1e-57
 Identities = 87/245 (35%), Positives = 134/245 (54%), Gaps = 32/245 (13%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGN-AFDNIIDARR-------- 87
           F +S +Y+     +G G YG V  A ++ T + VAIKK+      N +   R        
Sbjct: 4   FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGI 63

Query: 88  ---TLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTD 144
              TLRE+K++  ++HEN++ + D+    + D  N   +V ++M +DL +++    +LT+
Sbjct: 64  HFTTLRELKIMNEIKHENIMGLVDVY--VEGDFIN---LVMDIMASDLKKVVDRKIRLTE 118

Query: 145 DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR----------- 193
              +  L Q+L GL  +H    +HRDL P+N+ +N+    KI DFGLAR           
Sbjct: 119 SQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTL 178

Query: 194 ----TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
               T    + MT  VVT WYRAPELL+   +Y  A+D+WSVGCI  E++T +PLFPG++
Sbjct: 179 SKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238

Query: 250 YVHQL 254
            + QL
Sbjct: 239 EIDQL 243

Length = 335

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  184 bits (468), Expect = 3e-57
 Identities = 89/218 (40%), Positives = 125/218 (57%), Gaps = 10/218 (4%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG V  A N ET E VA+K++    D+       LREI LL+ ++H+N++ +
Sbjct: 5   LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 64

Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDH-CQYFLYQLLRGLKYVHSAS 165
            D++   KK T     +V+E  D DL +   S     D    + F++QLL+GL + HS +
Sbjct: 65  YDVLHSDKKLT-----LVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN 119

Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLART--TSETDFMTEYVVTRWYRAPELLLNCTEYT 223
           VLHRDLKP NLL+N + +LK+ DFGLAR        +  E VVT WYR P++L     Y+
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE-VVTLWYRPPDVLFGAKLYS 178

Query: 224 AAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITEV 260
            +ID+WS GCI  E+     PLFPG D   QL+ I  +
Sbjct: 179 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  181 bits (462), Expect = 3e-56
 Identities = 97/228 (42%), Positives = 133/228 (58%), Gaps = 20/228 (8%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN-----IIDARRTLREIKLLRHMEHE 101
           I  IG G YG V  A + +T E VA+KK+    DN      I A   +REIK+LR + H 
Sbjct: 12  IGQIGEGTYGQVYKARDKDTGELVALKKV--RLDNEKEGFPITA---IREIKILRQLNHR 66

Query: 102 NVIAIKDIIRPP------KKDTFNDVYIVYELMDTDLHQIIRSDQ-QLTDDHCQYFLYQL 154
           N++ +K+I+         KKD     Y+V+E MD DL  ++ S     ++DH + F+ QL
Sbjct: 67  NIVNLKEIVTDKQDALDFKKDKGA-FYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL 125

Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMTEYVVTRWYRA 212
           L GL Y H  + LHRD+K SN+LLN    +K+ DFGLAR   + E+   T  V+T WYR 
Sbjct: 126 LEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRP 185

Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           PELLL    Y  AID+WS GCILGE+ T++P+F     + QL LI+ +
Sbjct: 186 PELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRL 233

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  181 bits (460), Expect = 4e-56
 Identities = 76/211 (36%), Positives = 132/211 (62%), Gaps = 7/211 (3%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G+YG+V    N ET + VAIKK   + D+ +  +  LREI++L+ ++H N++ + ++
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 110 IRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
            R  +K     +++V+E  D T L+++ ++ + + +   +  ++Q L+ + + H  + +H
Sbjct: 69  FRRKRK-----LHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIH 123

Query: 169 RDLKPSNLLLNASCDLKIGDFGLARTTSETDFM-TEYVVTRWYRAPELLLNCTEYTAAID 227
           RD+KP N+L+     +K+ DFG AR  +      T+YV TRWYRAPELL+  T+Y   +D
Sbjct: 124 RDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVD 183

Query: 228 IWSVGCILGEIMTREPLFPGKDYVHQLRLIT 258
           +W++GC+  E++T +PL+PGK  V QL LI 
Sbjct: 184 VWAIGCVFAELLTGQPLWPGKSDVDQLYLIR 214

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  180 bits (459), Expect = 5e-56
 Identities = 88/211 (41%), Positives = 122/211 (57%), Gaps = 8/211 (3%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 5   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 64

Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I    K     +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 65  LDVIHTENK-----LYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 179

Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
            A+DIWS+GCI  E++TR  LFPG   + QL
Sbjct: 180 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 210

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  179 bits (455), Expect = 3e-55
 Identities = 91/221 (41%), Positives = 121/221 (54%), Gaps = 21/221 (9%)

Query: 49  PIGRGAYGIVCAAVNSETREEVAIKKI------GNAFDNIIDARRTLREIKLLRHMEHEN 102
            +G G+Y  V    +  T + VA+K+I      G  F  I       RE  LL+ ++H N
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI-------REASLLKDLKHAN 64

Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDH-CQYFLYQLLRGLKYV 161
           ++ + DII   K  T      V+E +DTDL Q +         H  + FL+QLLRGL Y 
Sbjct: 65  IVTLHDIIHTKKTLTL-----VFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYC 119

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCT 220
           H   VLHRDLKP NLL++   +LK+ DFGLAR  S  +   +  VVT WYR P++LL  T
Sbjct: 120 HQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGST 179

Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPG-KDYVHQLRLITEV 260
           EY+ ++D+W VGCI  E+ T  PLFPG  D   QL  I  V
Sbjct: 180 EYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRV 220

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  177 bits (451), Expect = 9e-55
 Identities = 76/215 (35%), Positives = 123/215 (57%), Gaps = 11/215 (5%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKD 108
           IG G +  V  A + +T +  AIK +   F ++ +    LREI+ LR +  H N++ + +
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQVNNLREIQALRRLSPHPNILRLIE 65

Query: 109 II--RPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSAS 165
           ++  R   +        V+ELMD +L+++I+  ++ L +   + ++YQLL+ L ++H   
Sbjct: 66  VLFDRKTGRLAL-----VFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG 120

Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           + HRD+KP N+L+     LK+ DFG  R        TEY+ TRWYRAPE LL    Y   
Sbjct: 121 IFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPK 179

Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           +DIW+VGC+  EI++  PLFPG + + Q+  I +V
Sbjct: 180 MDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDV 214

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  174 bits (444), Expect = 2e-54
 Identities = 67/193 (34%), Positives = 111/193 (57%), Gaps = 10/193 (5%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G +G V  A + +T ++VAIK I    D+       LREI++L+ + H N++ +  +
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKII-KKEDSSSLLEELLREIEILKKLNHPNIVKLYGV 59

Query: 110 IRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSASVL 167
                 +  N +Y+V E  +   L  +++ ++  L++D     L Q+L GL+Y+HS  ++
Sbjct: 60  F-----EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGII 114

Query: 168 HRDLKPSNLLLNASCD-LKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           HRDLKP N+LL++    +K+ DFGL++  TS+   +   V T  Y APE+LL    Y+  
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEK 174

Query: 226 IDIWSVGCILGEI 238
            DIWS+G IL E+
Sbjct: 175 SDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  177 bits (450), Expect = 2e-54
 Identities = 86/230 (37%), Positives = 127/230 (55%), Gaps = 16/230 (6%)

Query: 41  SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKI--GNAFDNI-IDARRTLREIKLLRH 97
           SKY   +  IG+G +G V  A + +T++ VA+KK+   N  +   I A   LREIK+L+ 
Sbjct: 12  SKYEK-LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITA---LREIKILQL 67

Query: 98  MEHENVIAIKDIIRPPKKDTFN---DVYIVYELMDTDLHQIIRSDQ-QLTDDHCQYFLYQ 153
           ++HENV+ + +I R             Y+V+E  + DL  ++ +   + T    +  +  
Sbjct: 68  LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKM 127

Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-----DFMTEYVVTR 208
           LL GL Y+H   +LHRD+K +N+L+     LK+ DFGLAR  S +     +  T  VVT 
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTL 187

Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT 258
           WYR PELLL   +Y   ID+W  GCI+ E+ TR P+  G    HQL LI+
Sbjct: 188 WYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLIS 237

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  176 bits (448), Expect = 2e-54
 Identities = 84/211 (39%), Positives = 139/211 (65%), Gaps = 7/211 (3%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G+YG+V    + ET + VAIKK   + D+ +  +  +REI++L+ + HEN++ + ++
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68

Query: 110 IRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
            R  K+     +Y+V+E +D T L  + +    L +   + +L+Q+LRG+++ HS +++H
Sbjct: 69  FRRKKR-----LYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIH 123

Query: 169 RDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAID 227
           RD+KP N+L++ S  +K+ DFG ART  +  +  T+YV TRWYRAPELL+  T+Y  A+D
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVD 183

Query: 228 IWSVGCILGEIMTREPLFPGKDYVHQLRLIT 258
           IW+VGC++ E++T EPLFPG   + QL  I 
Sbjct: 184 IWAVGCLVTEMLTGEPLFPGDSDIDQLYHII 214

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  175 bits (445), Expect = 6e-54
 Identities = 90/218 (41%), Positives = 125/218 (57%), Gaps = 22/218 (10%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR-----TLREIKLLRHMEHENVI 104
           +G G Y  V    N  T E VA+K+I       +DA        +REI L++ ++HEN++
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIH------LDAEEGTPSTAIREISLMKELKHENIV 61

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ---LTDDHCQYFLYQLLRGLKYV 161
            + D+I      T N + +V+E MD DL + + +      L  +  + F YQLL+G+ + 
Sbjct: 62  RLHDVIH-----TENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC 116

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLART--TSETDFMTEYVVTRWYRAPELLLNC 219
           H   VLHRDLKP NLL+N   +LK+ DFGLAR        F  E VVT WYRAP++LL  
Sbjct: 117 HENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNE-VVTLWYRAPDVLLGS 175

Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
             Y+ +IDIWSVGCI+ E++T  PLFPG +   QL  I
Sbjct: 176 RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKI 213

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  174 bits (443), Expect = 2e-53
 Identities = 86/209 (41%), Positives = 126/209 (60%), Gaps = 9/209 (4%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G YG+V  A +  T E +A+KKI    ++       +REI LL+ M+H N++ ++D+
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDH--CQYFLYQLLRGLKYVHSASVL 167
           +   K+     +Y+V+E +D DL + + S      +    + +LYQ+LRG+ Y HS  VL
Sbjct: 70  VHSEKR-----LYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVL 124

Query: 168 HRDLKPSNLLLNASCD-LKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           HRDLKP NLL++   + LK+ DFGLAR         T  VVT WYRAPE+LL    Y+  
Sbjct: 125 HRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTP 184

Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQL 254
           +DIWSVGCI  E++ ++PLFPG   + +L
Sbjct: 185 VDIWSVGCIFAEMVNQKPLFPGDSEIDEL 213

Length = 294

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  170 bits (432), Expect = 2e-51
 Identities = 85/218 (38%), Positives = 122/218 (55%), Gaps = 25/218 (11%)

Query: 50  IGRGAYGIVCAAVNSETR--EEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IGRG YG V  A     +  +E AIKK  G+       ++   REI LLR ++HENV+++
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIR-----SDQQLTDDHCQYFLYQLLRGLKYV 161
            ++     +     VY++++  + DL QII+         +     +  L+Q+L G+ Y+
Sbjct: 68  VEVFL---EHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124

Query: 162 HSASVLHRDLKPSNLLLNASCD----LKIGDFGLAR-------TTSETDFMTEYVVTRWY 210
           HS  VLHRDLKP+N+L+         +KIGD GLAR         ++ D     VVT WY
Sbjct: 125 HSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD---PVVVTIWY 181

Query: 211 RAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK 248
           RAPELLL    YT AIDIW++GCI  E++T EP+F G+
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGR 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  169 bits (429), Expect = 2e-51
 Identities = 86/214 (40%), Positives = 135/214 (63%), Gaps = 9/214 (4%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G GAYG+V    + ET+E VAIKK  ++ +N      TLRE+K+LR ++ EN++ +K+ 
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
            R   K     +Y+V+E ++ ++ +++      +  +  + ++YQL++ + + H   ++H
Sbjct: 69  FRRRGK-----LYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVH 123

Query: 169 RDLKPSNLLLNASCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAI 226
           RD+KP NLL++ +  LK+ DFG AR  SE      TEYV TRWYR+PELLL    Y  A+
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG-APYGKAV 182

Query: 227 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           D+WSVGCILGE+   +PLFPG+  + QL  I +V
Sbjct: 183 DMWSVGCILGELSDGQPLFPGESEIDQLFTIQKV 216

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  166 bits (422), Expect = 2e-50
 Identities = 79/212 (37%), Positives = 122/212 (57%), Gaps = 9/212 (4%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           I  IG G YG+V    N +T + VA+KKI    +        +REI LL+ ++H N++ +
Sbjct: 5   IEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCL 64

Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQI---IRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           +D++    +     +Y+++E +  DL +    +   Q +  +  + +LYQ+L+G+ + HS
Sbjct: 65  QDVLMQESR-----LYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS 119

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRDLKP NLL++    +K+ DFGLAR         T  VVT WYRAPE+LL    Y
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRY 179

Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
           +  +DIWS+G I  E+ T++PLF G   + QL
Sbjct: 180 STPVDIWSIGTIFAEMATKKPLFHGDSEIDQL 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  160 bits (406), Expect = 7e-48
 Identities = 82/216 (37%), Positives = 120/216 (55%), Gaps = 8/216 (3%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN-VIA 105
           +  IG G YG V  A +  T + VA+KK     D        LREI LL+ +     ++ 
Sbjct: 6   LEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVR 65

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ-----LTDDHCQYFLYQLLRGLKY 160
           + D+    +K+    +Y+V+E +D+DL + + S+ +     L     + F+YQLL+G+ +
Sbjct: 66  LLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH 125

Query: 161 VHSASVLHRDLKPSNLLLNASCD-LKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLN 218
            H   V+HRDLKP NLL++     LKI D GL R  +      T  +VT WYRAPE+LL 
Sbjct: 126 CHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLG 185

Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
            T Y+  +DIWSVGCI  E+  ++PLFPG   + QL
Sbjct: 186 STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL 221

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  159 bits (403), Expect = 1e-47
 Identities = 86/210 (40%), Positives = 122/210 (58%), Gaps = 8/210 (3%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G Y  V    +  T   VA+K+I    +        +RE+ LL++++H N++ + DI
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCT-AIREVSLLKNLKHANIVTLHDI 71

Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDH-CQYFLYQLLRGLKYVHSASVLH 168
           I   +  T     +V+E +D+DL Q + +   L   H  + F++QLLRGL Y H   +LH
Sbjct: 72  IHTERCLT-----LVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILH 126

Query: 169 RDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAID 227
           RDLKP NLL+N   +LK+ DFGLAR  S  T   +  VVT WYR P++LL  TEY+  ID
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPID 186

Query: 228 IWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           +W VGCIL E+ T  P+FPG     +L LI
Sbjct: 187 MWGVGCILYEMATGRPMFPGSTVKEELHLI 216

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  158 bits (400), Expect = 5e-47
 Identities = 87/210 (41%), Positives = 117/210 (55%), Gaps = 8/210 (3%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G Y  V    +  T   VA+K+I    +        +RE+ LL+ ++H N++ + DI
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCT-AIREVSLLKDLKHANIVTLHDI 72

Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDH-CQYFLYQLLRGLKYVHSASVLH 168
           I   K  T     +V+E +D DL Q +       + H  + FL+QLLRGL Y H   VLH
Sbjct: 73  IHTEKSLT-----LVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLH 127

Query: 169 RDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAID 227
           RDLKP NLL+N   +LK+ DFGLAR  S  T   +  VVT WYR P++LL  T+Y+  ID
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQID 187

Query: 228 IWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           +W VGCI  E+ T  PLFPG     QL  I
Sbjct: 188 MWGVGCIFYEMSTGRPLFPGSTVEEQLHFI 217

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  154 bits (390), Expect = 1e-45
 Identities = 86/228 (37%), Positives = 130/228 (57%), Gaps = 12/228 (5%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIG-NAFDNIIDARRTLREIKLL 95
           F  ++ Y+  +  +G G+Y  V   ++    + VA+K I     + +      +RE  LL
Sbjct: 1   FGAATSYLN-LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGV--PFTAIREASLL 57

Query: 96  RHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQ-IIRSDQQLTDDHCQYFLYQL 154
           + ++H N++ + DII   +  TF     V+E M TDL Q +I+    L   + + F++QL
Sbjct: 58  KGLKHANIVLLHDIIHTKETLTF-----VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQL 112

Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAP 213
           LRGL Y+H   +LHRDLKP NLL++   +LK+ DFGLAR  S  +   +  VVT WYR P
Sbjct: 113 LRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPP 172

Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG-KDYVHQLRLITEV 260
           ++LL  T+Y++A+DIW  GCI  E++  +P FPG  D   QL  I  V
Sbjct: 173 DVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTV 220

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  153 bits (389), Expect = 1e-45
 Identities = 63/211 (29%), Positives = 113/211 (53%), Gaps = 8/211 (3%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
             +GRG++G V  A++ +T E +A+K +  + D+  +     REI++L  ++H N++   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 108 DIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
              R  +K+T N   I  E +    L  +++   +L +   + +  Q+L GL Y+HS  +
Sbjct: 66  GSERDEEKNTLN---IFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGI 122

Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLART--TSETDFMTEYVV-TRWYRAPELLLNCTEYT 223
           +HRD+K +N+L+++   +K+ DFG A+     ET   T  V  T ++ APE ++   EY 
Sbjct: 123 VHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE-VIRGEEYG 181

Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
            A DIWS+GC + E+ T +P +         
Sbjct: 182 RAADIWSLGCTVIEMATGKPPWSELGNPMAA 212

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  153 bits (389), Expect = 2e-45
 Identities = 85/210 (40%), Positives = 118/210 (56%), Gaps = 8/210 (3%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G Y  V    +  T   VA+K+I    +        +RE+ LL+ ++H N++ + DI
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCT-AIREVSLLKDLKHANIVTLHDI 72

Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDH-CQYFLYQLLRGLKYVHSASVLH 168
           +   K  T     +V+E +D DL Q +     +   H  + FLYQ+LRGL Y H   VLH
Sbjct: 73  VHTDKSLT-----LVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLH 127

Query: 169 RDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAID 227
           RDLKP NLL+N   +LK+ DFGLAR  S  T   +  VVT WYR P++LL  +EY+  ID
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQID 187

Query: 228 IWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           +W VGCI  E+ +  PLFPG     +L LI
Sbjct: 188 MWGVGCIFFEMASGRPLFPGSTVEDELHLI 217

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  150 bits (379), Expect = 5e-44
 Identities = 85/221 (38%), Positives = 126/221 (57%), Gaps = 7/221 (3%)

Query: 46  PIRPIGRGAYGIVCAAVNSETREE-VAIKKIGNAFDNIIDARRTLREIKLLRHME---HE 101
            +  IG GAYG V  A + +     VA+K++            T+RE+ +LRH+E   H 
Sbjct: 5   CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHP 64

Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLRGLK 159
           NV+ + D+    + D    + +V+E +D DL   +    +  +  +  +  ++QLLRGL 
Sbjct: 65  NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 124

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 219
           ++HS  V+HRDLKP N+L+ +S  +K+ DFGLAR  S    +T  VVT WYRAPE+LL  
Sbjct: 125 FLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ- 183

Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           + Y   +D+WSVGCI  E+  R+PLF G   V QL  I +V
Sbjct: 184 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 224

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  147 bits (373), Expect = 4e-43
 Identities = 81/222 (36%), Positives = 122/222 (54%), Gaps = 10/222 (4%)

Query: 46  PIRPIGRGAYGIVCAAVNSETREEVAIK--KIGNAFDNIIDARRTLREIKLLR---HMEH 100
           P+  IG GAYG V  A +  +   VA+K  ++    D +     T+RE+ LL+     +H
Sbjct: 4   PVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGL--PLSTVREVALLKRLEAFDH 61

Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLRGL 158
            N++ + D+    + D    V +V+E +D DL   +       L  +  +  + Q LRGL
Sbjct: 62  PNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121

Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
            ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    +T  VVT WYRAPE+LL 
Sbjct: 122 DFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQ 181

Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
            T Y   +D+WSVGCI  E+  R+PLF G     QL  I ++
Sbjct: 182 ST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 222

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  146 bits (371), Expect = 5e-43
 Identities = 68/216 (31%), Positives = 113/216 (52%), Gaps = 19/216 (8%)

Query: 42  KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE 101
           KY   I+ IG+G++G V         +   +K+I  +  +  +    L E+K+L+ + H 
Sbjct: 1   KYEI-IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHP 59

Query: 102 NVIAIKDIIRPPKKDTFND---VYIVYELMD-TDLHQIIRSDQQ----LTDDHCQYFLYQ 153
           N+I   +        +F +   + IV E  D  DL Q I+  ++      ++    +  Q
Sbjct: 60  NIIKYYE--------SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ 111

Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV-TRWYRA 212
           L   LKY+HS  +LHRD+KP N+ L ++  +K+GDFG+++  S T  + + VV T +Y +
Sbjct: 112 LCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLS 171

Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK 248
           PEL  N   Y    DIWS+GC+L E+ T +  F G+
Sbjct: 172 PELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGE 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  144 bits (365), Expect = 3e-42
 Identities = 62/204 (30%), Positives = 110/204 (53%), Gaps = 12/204 (5%)

Query: 43  YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN 102
               +  IG+G +G V  A +  T +EVAIK I    ++     + + EI++L+  +H N
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVI--KLESKEKKEKIINEIQILKKCKHPN 58

Query: 103 VIA-IKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLK 159
           ++      ++       ++++IV E      L  +++S +Q LT+    Y   +LL+GL+
Sbjct: 59  IVKYYGSYLKK------DELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLE 112

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 219
           Y+HS  ++HRD+K +N+LL +  ++K+ DFGL+   S+T      V T ++ APE ++N 
Sbjct: 113 YLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPE-VING 171

Query: 220 TEYTAAIDIWSVGCILGEIMTREP 243
             Y    DIWS+G    E+   +P
Sbjct: 172 KPYDYKADIWSLGITAIELAEGKP 195

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  139 bits (352), Expect = 7e-40
 Identities = 85/220 (38%), Positives = 123/220 (55%), Gaps = 21/220 (9%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI------GNAFDNIIDARRTLREIKLLRHMEH 100
           +  +G G+Y  V    +    + VA+K I      G  F  I       RE  LL+ ++H
Sbjct: 10  LEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI-------REASLLKGLKH 62

Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII-RSDQQLTDDHCQYFLYQLLRGLK 159
            N++ + DII    K+T     +V+E + TDL Q + +    L  ++ + FL+QLLRGL 
Sbjct: 63  ANIVLLHDIIH--TKETLT---LVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLS 117

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLN 218
           Y+H   +LHRDLKP NLL++ + +LK+ DFGLAR  S  +   +  VVT WYR P++LL 
Sbjct: 118 YIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLG 177

Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPG-KDYVHQLRLI 257
            TEY+  +D+W VGCI  E++     FPG KD   QL  I
Sbjct: 178 STEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERI 217

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  142 bits (359), Expect = 8e-40
 Identities = 80/221 (36%), Positives = 128/221 (57%), Gaps = 18/221 (8%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G+V  A+  +T E+VAIKK+      + D +   RE+ +++++ H N+I +KD 
Sbjct: 74  IGNGSFGVVYEAICIDTSEKVAIKKV------LQDPQYKNRELLIMKNLNHINIIFLKDY 127

Query: 110 -----IRPPKKDTFNDVYIVYELMDTDLHQII----RSDQQLTDDHCQYFLYQLLRGLKY 160
                 +  +K+ F +V  V E +   +H+ +    R++  L     + + YQL R L Y
Sbjct: 128 YYTECFKKNEKNIFLNV--VMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAY 185

Query: 161 VHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 219
           +HS  + HRDLKP NLL++ +   LK+ DFG A+          Y+ +R+YRAPEL+L  
Sbjct: 186 IHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGA 245

Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           T YT  ID+WS+GCI+ E++   P+F G+  V QL  I +V
Sbjct: 246 TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQV 286

Length = 440

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  140 bits (352), Expect = 2e-39
 Identities = 64/219 (29%), Positives = 113/219 (51%), Gaps = 24/219 (10%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA-RRTLREIKLLRHM-EHENVI 104
           +R +G G++G V  A +   R+ VA+K +    ++      R LREI++L  +    N++
Sbjct: 5   LRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIV 61

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ---LTDDHCQYFLYQLLRGLKY 160
            + D  +         +Y+V E +D   L  +++   +   L++    + L Q+L  L+Y
Sbjct: 62  KLYDFFQDE-----GSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116

Query: 161 VHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETD-------FMTEYVVTRWYRA 212
           +HS  ++HRD+KP N+LL+     +K+ DFGLA+   +           +  V T  Y A
Sbjct: 117 LHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176

Query: 213 PELLL--NCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
           PE+LL  +    +++ DIWS+G  L E++T  P F G+ 
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215

Length = 384

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  132 bits (335), Expect = 2e-37
 Identities = 64/202 (31%), Positives = 109/202 (53%), Gaps = 22/202 (10%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG GA G V  A +  T +EVAIKK+     N       + EI +++  +H N++   D 
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQNK---ELIINEILIMKDCKHPNIV---DY 80

Query: 110 IRPPKKDTF---NDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
                 D++   +++++V E MD    TD+  I ++  ++ +    Y   ++L+GL+Y+H
Sbjct: 81  Y-----DSYLVGDELWVVMEYMDGGSLTDI--ITQNFVRMNEPQIAYVCREVLQGLEYLH 133

Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
           S +V+HRD+K  N+LL+    +K+ DFG  A+ T E       V T ++ APE++    +
Sbjct: 134 SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR-KD 192

Query: 222 YTAAIDIWSVGCILGEIMTREP 243
           Y   +DIWS+G +  E+   EP
Sbjct: 193 YGPKVDIWSLGIMCIEMAEGEP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  130 bits (330), Expect = 7e-37
 Identities = 65/211 (30%), Positives = 108/211 (51%), Gaps = 21/211 (9%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-REIKLLRHMEHENVI- 104
           ++ +G+G+ G+V    +  T +  A+KKI    D   + R+ L RE+K LR  E   V+ 
Sbjct: 6   VKVLGQGSSGVVYKVRHKPTGKIYALKKI--HVDGDEEFRKQLLRELKTLRSCESPYVVK 63

Query: 105 ---AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
              A     +        ++ IV E MD   L  +++   ++ +    Y   Q+L+GL Y
Sbjct: 64  CYGAF---YKE------GEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDY 114

Query: 161 VHSAS-VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLN 218
           +H+   ++HRD+KPSNLL+N+  ++KI DFG+++    T      +V T  Y +PE  + 
Sbjct: 115 LHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPE-RIQ 173

Query: 219 CTEYTAAIDIWSVGCILGE-IMTREPLFPGK 248
              Y+ A DIWS+G  L E  + + P  P  
Sbjct: 174 GESYSYAADIWSLGLTLLECALGKFPFLPPG 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  130 bits (329), Expect = 8e-37
 Identities = 64/218 (29%), Positives = 101/218 (46%), Gaps = 27/218 (12%)

Query: 47  IRPIGRGAYGIVCAAV----NSETREEVAIKKIGNAFDNIIDARRT-LREIKLLRHMEHE 101
            + +G GA+G V              EVA+K +    D         LRE +++R ++H 
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKE--DASEQQIEEFLREARIMRKLDHP 61

Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS--DQQLTDDHCQYFLYQLLRGL 158
           N++ +  +    +      + IV E M   DL   +R    ++L+      F  Q+ RG+
Sbjct: 62  NIVKLLGVCTEEEP-----LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGM 116

Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRA 212
           +Y+ S + +HRDL   N L+  +  +KI DFGL+R   + D    Y V       RW  A
Sbjct: 117 EYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD---YYKVKGGKLPIRWM-A 172

Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKD 249
           PE L    ++T+  D+WS G +L EI T  E  +PG  
Sbjct: 173 PESLKEG-KFTSKSDVWSFGVLLWEIFTLGEEPYPGMS 209

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  129 bits (327), Expect = 2e-36
 Identities = 66/217 (30%), Positives = 108/217 (49%), Gaps = 26/217 (11%)

Query: 47  IRPIGRGAYGIVCAAV----NSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHE 101
            + +G GA+G V          + + EVA+K +  +A +  I+    LRE +++R ++H 
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEE--FLREARIMRKLDHP 61

Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR-SDQQLTDDHCQYFLYQLLRGLK 159
           NV+ +  +    +      +YIV E M+  DL   +R +  +L+      F  Q+ RG++
Sbjct: 62  NVVKLLGVCTEEEP-----LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGME 116

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAP 213
           Y+ S + +HRDL   N L+  +  +KI DFGL+R   + D    Y         RW  AP
Sbjct: 117 YLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD---YYRKRGGKLPIRWM-AP 172

Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKD 249
           E L    ++T+  D+WS G +L EI T  E  +PG  
Sbjct: 173 ESLKEG-KFTSKSDVWSFGVLLWEIFTLGEQPYPGMS 208

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  129 bits (326), Expect = 2e-36
 Identities = 65/196 (33%), Positives = 109/196 (55%), Gaps = 8/196 (4%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IGRGA+G+V   +N ET + VAIK+I          +  ++EI LL++++H N++     
Sbjct: 8   IGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGS 67

Query: 110 IRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           I      T + +YI+ E  +   L QII+      +     ++YQ+L+GL Y+H   V+H
Sbjct: 68  IE-----TSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIH 122

Query: 169 RDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV-TRWYRAPELLLNCTEYTAAID 227
           RD+K +N+L      +K+ DFG+A   ++       VV T ++ APE++   +  + A D
Sbjct: 123 RDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM-SGASTASD 181

Query: 228 IWSVGCILGEIMTREP 243
           IWS+GC + E++T  P
Sbjct: 182 IWSLGCTVIELLTGNP 197

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  127 bits (319), Expect = 5e-35
 Identities = 79/215 (36%), Positives = 116/215 (53%), Gaps = 26/215 (12%)

Query: 50  IGRGAYGIVCAAVNSETREE--VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           +GRG YG V  A   + ++E   A+K+I    +    +    REI LLR ++H NVIA++
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQI----EGTGISMSACREIALLRELKHPNVIALQ 64

Query: 108 DIIRPPKKDTFNDVYIVYELMDTDLHQIIR---------SDQQLTDDHCQYFLYQLLRGL 158
            +       +   V+++++  + DL  II+            QL     +  LYQ+L G+
Sbjct: 65  KVFL---SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121

Query: 159 KYVHSASVLHRDLKPSNLLLNASCD----LKIGDFGLARTTSET----DFMTEYVVTRWY 210
            Y+H+  VLHRDLKP+N+L+         +KI D G AR  +        +   VVT WY
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181

Query: 211 RAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 245
           RAPELLL    YT AIDIW++GCI  E++T EP+F
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  124 bits (313), Expect = 2e-34
 Identities = 69/225 (30%), Positives = 119/225 (52%), Gaps = 24/225 (10%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT--LREIKLLRHMEHENVIAIK 107
           IG+G++G V         + +  K+I   + N+ +  +   + E+ +LR ++H N++   
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEI--DYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 108 D-IIRPPKKDTFNDVYIVYELMDT-DLHQII----RSDQQLTDDHCQYFLYQLLRGLKYV 161
           D II    +     +YIV E  +  DL Q+I    +  + + ++     L QLL  L   
Sbjct: 66  DRIIDRSNQT----LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYEC 121

Query: 162 H-----SASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPEL 215
           H       +VLHRDLKP+N+ L+A+ ++K+GDFGLA+    ++ F   YV T +Y +PE 
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQ 181

Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           L +   Y    DIWS+GC++ E+    P F  ++   QL+L +++
Sbjct: 182 LNH-MSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLASKI 222

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  123 bits (310), Expect = 1e-33
 Identities = 77/215 (35%), Positives = 116/215 (53%), Gaps = 26/215 (12%)

Query: 50  IGRGAYGIVCAAVNSETREE--VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           +GRG YG V  A   + +++   A+K+I    +    +    REI LLR ++H NVI+++
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACREIALLRELKHPNVISLQ 64

Query: 108 DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ---------QLTDDHCQYFLYQLLRGL 158
            +           V+++++  + DL  II+  +         QL     +  LYQ+L G+
Sbjct: 65  KVFLSHAD---RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121

Query: 159 KYVHSASVLHRDLKPSNLLLNASCD----LKIGDFGLARTTSET----DFMTEYVVTRWY 210
            Y+H+  VLHRDLKP+N+L+         +KI D G AR  +        +   VVT WY
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181

Query: 211 RAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 245
           RAPELLL    YT AIDIW++GCI  E++T EP+F
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  117 bits (295), Expect = 6e-32
 Identities = 53/199 (26%), Positives = 105/199 (52%), Gaps = 11/199 (5%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL----REIKLLRHMEHENVIA 105
           +G G++G V   +N +  +  A+K++ +  D+    +  +    +EI LL  ++H N++ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEV-SLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
                R         +YI  EL+    L ++++      +   + +  Q+L GL+Y+H  
Sbjct: 67  YLGTEREEDN-----LYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR 121

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           + +HRD+K +N+L++ +  +K+ DFG+A+   E  F   +  + ++ APE++     Y  
Sbjct: 122 NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGL 181

Query: 225 AIDIWSVGCILGEIMTREP 243
           A DIWS+GC + E+ T +P
Sbjct: 182 AADIWSLGCTVLEMATGKP 200

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  115 bits (291), Expect = 2e-31
 Identities = 59/205 (28%), Positives = 110/205 (53%), Gaps = 13/205 (6%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR---RTLREIKLLRHMEHENVIAI 106
           +G+G++G V      +T +  A+K +      II  +    TL E  +L  + H  ++ +
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKK--KIIKRKEVEHTLTERNILSRINHPFIVKL 58

Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
               +  +K     +Y+V E     +L   +  + + +++  +++  +++  L+Y+HS  
Sbjct: 59  HYAFQTEEK-----LYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG 113

Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           +++RDLKP N+LL+A   +K+ DFGLA+  +SE      +  T  Y APE+LL    Y  
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLG-KGYGK 172

Query: 225 AIDIWSVGCILGEIMTREPLFPGKD 249
           A+D WS+G +L E++T +P F  +D
Sbjct: 173 AVDWWSLGVLLYEMLTGKPPFYAED 197

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  114 bits (288), Expect = 1e-30
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 27/218 (12%)

Query: 47  IRPIGRGAYGIVCAAV----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN 102
            + +G GA+G V           T  +VA+K +     +  +    L E  +++ + H N
Sbjct: 4   GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL-KEGASEEEREEFLEEASIMKKLSHPN 62

Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKY 160
           ++ +  +    +      +YIV E M   DL   +R   ++LT         Q+ +G++Y
Sbjct: 63  IVRLLGVCTQGEP-----LYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEY 117

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAP 213
           + S + +HRDL   N L+  +  +KI DFGL+R   E D    Y          +W  AP
Sbjct: 118 LESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD---YYRKRGGGKLPIKWM-AP 173

Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPGKD 249
           E L +  ++T+  D+WS G +L EI T   +P +PG  
Sbjct: 174 ESLKDG-KFTSKSDVWSFGVLLWEIFTLGEQP-YPGMS 209

Length = 258

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  114 bits (287), Expect = 1e-30
 Identities = 68/204 (33%), Positives = 113/204 (55%), Gaps = 25/204 (12%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR---RTLREIKLLRHMEHENVI 104
           + IG+G + +V  A+       VA+KK+   F+ ++DA+     L+EI LL+ ++H NVI
Sbjct: 8   KKIGKGQFSVVYKAICLLDGRVVALKKV-QIFE-MMDAKARQDCLKEIDLLKQLDHPNVI 65

Query: 105 AIKDIIRPPKKDTF---NDVYIVYELMDT-DLHQII---RSDQQLTDDHC--QYFLYQLL 155
                       +F   N++ IV EL D  DL ++I   +  ++L  +    +YF  QL 
Sbjct: 66  KYLA--------SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYF-VQLC 116

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPE 214
             L+++HS  ++HRD+KP+N+ + A+  +K+GD GL R  +S+T      V T +Y +PE
Sbjct: 117 SALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 215 LLLNCTEYTAAIDIWSVGCILGEI 238
            +     Y    DIWS+GC+L E+
Sbjct: 177 RIHE-NGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  113 bits (285), Expect = 3e-30
 Identities = 67/225 (29%), Positives = 109/225 (48%), Gaps = 37/225 (16%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKI------GNAFDNIIDARRTLREIKLLRHMEHENV 103
           IG G +G V  AVN +T E +A+K+I            I D      E+K+L  ++H N+
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIAD------EMKVLELLKHPNL 61

Query: 104 -----IAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHC-QYFLYQLLR 156
                + +              VYI  E      L +++   + L D+H  + +  QLL 
Sbjct: 62  VKYYGVEVHR----------EKVYIFMEYCSGGTLEELLEHGRIL-DEHVIRVYTLQLLE 110

Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA-----RTTSETDFMTEYVVTRWYR 211
           GL Y+HS  ++HRD+KP+N+ L+ +  +K+GDFG A      TT+  + +     T  Y 
Sbjct: 111 GLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYM 170

Query: 212 APELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
           APE++       +  A DIWS+GC++ E+ T +  +   D   Q+
Sbjct: 171 APEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI 215

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  111 bits (281), Expect = 1e-29
 Identities = 61/234 (26%), Positives = 102/234 (43%), Gaps = 34/234 (14%)

Query: 48  RPIGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI 104
           + +G GA+G V             EVA+K +     +  + +  L+E ++++ + H NV+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL-KEDASEEERKDFLKEARVMKKLGHPNVV 59

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS---------DQQLTDDHCQYFLYQL 154
            +  +           +Y+V E M+  DL   +R             L+      F  Q+
Sbjct: 60  RLLGVCT-----EEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQI 114

Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------- 207
            +G++Y+ S   +HRDL   N L+     +KI DFGL+R   + D+   Y          
Sbjct: 115 AKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY---YRKKTGGKLPI 171

Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR--EPLFPGKDYVHQLRLITE 259
           RW  APE L +   +T+  D+WS G +L EI T    P +PG      L  + +
Sbjct: 172 RWM-APESLKD-GIFTSKSDVWSFGVLLWEIFTLGATP-YPGLSNEEVLEYLRK 222

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  108 bits (272), Expect = 2e-28
 Identities = 63/213 (29%), Positives = 107/213 (50%), Gaps = 24/213 (11%)

Query: 46  PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           PIR +G+GA+G       +E    V  K++     +  + R  L EI +L  ++H N+IA
Sbjct: 4   PIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIA 63

Query: 106 -----IKDIIRPPKKDTFNDVYIVYELMDT-DLHQII--RSDQQLTDDHCQYFLYQLLRG 157
                + D          N + I  E  +   L+  I  +  Q   ++   ++L+Q++  
Sbjct: 64  YYNHFMDD----------NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSA 113

Query: 158 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV-TRWYRAPELL 216
           + Y+H A +LHRD+K  N+ L  +  +K+GDFG+++       M E VV T +Y +PEL 
Sbjct: 114 VSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPEL- 172

Query: 217 LNCT--EYTAAIDIWSVGCILGEIMTREPLFPG 247
             C   +Y    DIW++GC+L E++T +  F  
Sbjct: 173 --CQGVKYNFKSDIWALGCVLYELLTLKRTFDA 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  106 bits (267), Expect = 9e-28
 Identities = 59/190 (31%), Positives = 96/190 (50%), Gaps = 21/190 (11%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKK--IGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           +G G+YG V  A++ ET + VAIK   +      II      +EI +L+  +   ++   
Sbjct: 11  LGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEII------KEISILKQCDSPYIVKYY 64

Query: 108 DIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
                  K+   D++IV E       +D+ +I      LT++     LYQ L+GL+Y+HS
Sbjct: 65  GSYF---KN--TDLWIVMEYCGAGSVSDIMKITNK--TLTEEEIAAILYQTLKGLEYLHS 117

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV-TRWYRAPELLLNCTEY 222
              +HRD+K  N+LLN     K+ DFG++   ++T      V+ T ++ APE++     Y
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGY 176

Query: 223 TAAIDIWSVG 232
               DIWS+G
Sbjct: 177 NNKADIWSLG 186

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  105 bits (265), Expect = 3e-27
 Identities = 68/240 (28%), Positives = 105/240 (43%), Gaps = 56/240 (23%)

Query: 46  PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIK----------LL 95
             + IG G++  V  A   ET +E AIK        I+D R+ ++E K          L 
Sbjct: 5   FGKIIGEGSFSTVVLAKEKETNKEYAIK--------ILDKRQLIKEKKVKYVKIEKEVLT 56

Query: 96  RHMEHENVIAIKDIIRPPKK--DTFND---VYIVYELM-DTDLHQIIRSDQQLTDDHCQY 149
           R   H  +I          K   TF D   +Y V E   + +L Q IR    L +   ++
Sbjct: 57  RLNGHPGII----------KLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF 106

Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE------ 203
           +  ++L  L+Y+HS  ++HRDLKP N+LL+    +KI DFG A+                
Sbjct: 107 YAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166

Query: 204 ---------------YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK 248
                          +V T  Y +PELL        + D+W++GCI+ +++T +P F G 
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGS 225

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  105 bits (263), Expect = 3e-27
 Identities = 63/210 (30%), Positives = 104/210 (49%), Gaps = 22/210 (10%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR--TLREIKLLRHMEHENVIAIK 107
           +G+G+YG V         +  A+K++     ++    R   + EI++L  + H N+I+ K
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVD--LGSMSQKEREDAVNEIRILASVNHPNIISYK 65

Query: 108 DIIRPPKKDTF---NDVYIVYELMD-TDLHQIIRSDQQ----LTDDHCQYFLYQLLRGLK 159
           +         F   N + IV E     DL + I   ++    + +        QLLRGL+
Sbjct: 66  E--------AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 219
            +H   +LHRDLK +N+LL A+  +KIGD G+++   +    T+ + T  Y APE+    
Sbjct: 118 ALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQ-IGTPHYMAPEVWKG- 175

Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
             Y+   DIWS+GC+L E+ T  P F  + 
Sbjct: 176 RPYSYKSDIWSLGCLLYEMATFAPPFEARS 205

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  103 bits (258), Expect = 2e-26
 Identities = 56/210 (26%), Positives = 114/210 (54%), Gaps = 18/210 (8%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR----EIKLLRHMEHENVIA 105
           +G+GA+G V    + +T  E+A+K++    D+  + ++ +     EI+LL++++HE ++ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSP-ETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               +R  +      + I  E M    +   +++   LT+   + +  Q+L G++Y+HS 
Sbjct: 69  YYGCLRDDET-----LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN 123

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFG----LARTTSETDFMTEYVVTRWYRAPELLLNCT 220
            ++HRD+K +N+L +++ ++K+GDFG    L    S    M     T ++ +PE++    
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183

Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDY 250
            Y    D+WSVGC + E++T +P  P  ++
Sbjct: 184 -YGRKADVWSVGCTVVEMLTEKP--PWAEF 210

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  100 bits (251), Expect = 1e-25
 Identities = 61/197 (30%), Positives = 103/197 (52%), Gaps = 14/197 (7%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG+G++G+V   V    +   A+K+I  +  N  +    + E ++L  ++   +I   + 
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67

Query: 110 IRPPKKDTFNDVYIVYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASV 166
                K     + IV E  +  DLH++++    + L +D    F  Q+L GL ++HS  +
Sbjct: 68  FLDKGK-----LNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKI 122

Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTE--YT 223
           LHRD+K  NL L+A  ++KIGD G+A+  S  T+F    V T +Y +PEL   C +  Y 
Sbjct: 123 LHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPEL---CEDKPYN 179

Query: 224 AAIDIWSVGCILGEIMT 240
              D+W++G +L E  T
Sbjct: 180 EKSDVWALGVVLYECCT 196

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  102 bits (255), Expect = 2e-25
 Identities = 74/213 (34%), Positives = 110/213 (51%), Gaps = 25/213 (11%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           +  IG GA G V   ++  T    A+K I GN  D +   R+  REI++LR + H NV+ 
Sbjct: 79  VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTV--RRQICREIEILRDVNHPNVVK 136

Query: 106 IKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
             D+      D   ++ ++ E MD       H  I  +Q L D        Q+L G+ Y+
Sbjct: 137 CHDMF-----DHNGEIQVLLEFMDGGSLEGTH--IADEQFLAD-----VARQILSGIAYL 184

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELL---L 217
           H   ++HRD+KPSNLL+N++ ++KI DFG++R  ++T D     V T  Y +PE +   L
Sbjct: 185 HRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDL 244

Query: 218 NCTEYTA-AIDIWSVG-CILGEIMTREPLFPGK 248
           N   Y   A DIWS+G  IL   + R P   G+
Sbjct: 245 NHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277

Length = 353

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  100 bits (250), Expect = 2e-25
 Identities = 67/213 (31%), Positives = 109/213 (51%), Gaps = 17/213 (7%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI--GNAFDNIIDARRTLREIKLLRHMEHENVI 104
           +R +G G++G      +  + ++ A+K+I    +   + D+R+   E  LL  M+H N++
Sbjct: 5   LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK---EAVLLAKMKHPNIV 61

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQ---LTDDHCQYFLYQLLRGLKY 160
           A K+       +    +YIV E  D  DL Q I+  Q+     +D    +  Q+  G+++
Sbjct: 62  AFKESF-----EADGHLYIVMEYCDGGDLMQKIK-LQRGKLFPEDTILQWFVQMCLGVQH 115

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNC 219
           +H   VLHRD+K  N+ L  +  +K+GDFG AR  TS   +   YV T +Y  PE+  N 
Sbjct: 116 IHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWEN- 174

Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH 252
             Y    DIWS+GCIL E+ T +  F    + +
Sbjct: 175 MPYNNKSDIWSLGCILYELCTLKHPFQANSWKN 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 99.6 bits (248), Expect = 4e-25
 Identities = 65/215 (30%), Positives = 111/215 (51%), Gaps = 12/215 (5%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           I+ IG G++G +  A      E   IK+I      + +   + +E+ LL  M+H N++  
Sbjct: 5   IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF 64

Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQL--TDDHCQYFLYQLLRGLKYVHS 163
               +   +     ++IV E  D  DL + I   + +  ++D    +  Q+  GLK++H 
Sbjct: 65  FASFQENGR-----LFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119

Query: 164 ASVLHRDLKPSNLLLNASCDL-KIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTE 221
             +LHRD+K  N+ L+ +  + K+GDFG+AR  +++ +     V T +Y +PE+  N   
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQN-RP 178

Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL 256
           Y    DIWS+GC+L E+ T +  F G +  HQL L
Sbjct: 179 YNNKTDIWSLGCVLYELCTLKHPFEGNNL-HQLVL 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 99.9 bits (249), Expect = 5e-25
 Identities = 62/208 (29%), Positives = 108/208 (51%), Gaps = 19/208 (9%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKI-------GNAFDNIIDARRTLR-EIKLLRHMEHE 101
           IG+G YG V  A+N  T E +A+K++       G       D  + LR EI+ L+ ++H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           N++                + I  E +    +   +R+  +  +   ++F  Q+L GL Y
Sbjct: 69  NIVQYLGFETTE-----EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAY 123

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE---TDFMTEYVVTRWYRAPELLL 217
           +HS  +LHRDLK  NLL++A    KI DFG+++ + +    D       + ++ APE++ 
Sbjct: 124 LHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIH 183

Query: 218 NCTE-YTAAIDIWSVGCILGEIMT-REP 243
           + ++ Y+A +DIWS+GC++ E+   R P
Sbjct: 184 SYSQGYSAKVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 98.5 bits (246), Expect = 1e-24
 Identities = 62/209 (29%), Positives = 104/209 (49%), Gaps = 21/209 (10%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNA---FDNIIDARRTLREIKLLRHMEHENVIAI 106
           I +GAYG V  A    T +  AIK I  A     N +D   T R+I  L   +   V+ +
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDI--LSQAQSPYVVKL 58

Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
               +        ++Y+V E +   DL  ++ +   L +D  + ++ +++  L+Y+HS  
Sbjct: 59  YYSFQ-----GKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG 113

Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLART--TSETDFM-------TEYVVTRWYRAPELL 216
           ++HRDLKP N+L++++  LK+ DFGL++         +          V T  Y APE++
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173

Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLF 245
           L    ++  +D WS+GCIL E +   P F
Sbjct: 174 LG-QGHSKTVDWWSLGCILYEFLVGIPPF 201

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 97.8 bits (243), Expect = 3e-24
 Identities = 73/213 (34%), Positives = 118/213 (55%), Gaps = 25/213 (11%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR---TLREIKLLRHMEHENVI 104
           + IGRG +  V  A     R+ VA+KK+   F+ ++DA+     ++EI LL+ + H NVI
Sbjct: 8   KKIGRGQFSEVYRATCLLDRKPVALKKV-QIFE-MMDAKARQDCVKEIDLLKQLNHPNVI 65

Query: 105 AIKDIIRPPKKDTF---NDVYIVYELMDT-DLHQII---RSDQQLTDDHC--QYFLYQLL 155
              D        +F   N++ IV EL D  DL Q+I   +  ++L  +    +YF+ QL 
Sbjct: 66  KYLD--------SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFV-QLC 116

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPE 214
             ++++HS  V+HRD+KP+N+ + A+  +K+GD GL R  +S+T      V T +Y +PE
Sbjct: 117 SAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG 247
             ++   Y    DIWS+GC+L E+   +  F G
Sbjct: 177 -RIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 96.9 bits (242), Expect = 5e-24
 Identities = 62/220 (28%), Positives = 104/220 (47%), Gaps = 30/220 (13%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG--NAFDNIIDARRTLREIKLLRHMEHENVI--- 104
           IG+G++G V  A++  T + VAIK I    A D I D     +EI+ L       +    
Sbjct: 9   IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIED---IQQEIQFLSQCRSPYITKYY 65

Query: 105 --AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
              +K           + ++I+ E        DL +  +    L + +  + L ++L GL
Sbjct: 66  GSFLKG----------SKLWIIMEYCGGGSCLDLLKPGK----LDETYIAFILREVLLGL 111

Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA-RTTSETDFMTEYVVTRWYRAPELLL 217
           +Y+H    +HRD+K +N+LL+   D+K+ DFG++ + TS       +V T ++ APE++ 
Sbjct: 112 EYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIK 171

Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
             + Y    DIWS+G    E+   EP       +  L LI
Sbjct: 172 Q-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI 210

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 95.7 bits (238), Expect = 2e-23
 Identities = 65/204 (31%), Positives = 107/204 (52%), Gaps = 16/204 (7%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+G YGIV AA +  T+  +AIK+I          +    EI L  +++H N      I
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSR--YVQPLHEEIALHSYLKHRN------I 67

Query: 110 IRPPKKDTFNDVYIVY--ELMDTDLHQIIRSDQQLTDDHCQ---YFLYQLLRGLKYVHSA 164
           ++    D+ N  + ++  ++    L  ++RS      D+ Q   ++  Q+L GLKY+H  
Sbjct: 68  VQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN 127

Query: 165 SVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTE- 221
            ++HRD+K  N+L+N  S  +KI DFG ++  +  +  TE +  T  Y APE++      
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRG 187

Query: 222 YTAAIDIWSVGCILGEIMTREPLF 245
           Y A  DIWS+GC + E+ T +P F
Sbjct: 188 YGAPADIWSLGCTIVEMATGKPPF 211

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 94.3 bits (235), Expect = 6e-23
 Identities = 59/196 (30%), Positives = 97/196 (49%), Gaps = 17/196 (8%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKD 108
           IG G YG V  A + +T + VAIK +    D   + +    E  +LR    H N+     
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKE---EYNILRKYSNHPNIATFYG 70

Query: 109 IIRPPKKDTFND-VYIVYELMD----TDLHQ-IIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
                     +D +++V EL      TDL + + +  ++L ++   Y L + LRGL Y+H
Sbjct: 71  AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH 130

Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTE 221
              V+HRD+K  N+LL  + ++K+ DFG++     T      ++ T ++ APE++  C E
Sbjct: 131 ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIA-CDE 189

Query: 222 -----YTAAIDIWSVG 232
                Y A  D+WS+G
Sbjct: 190 QPDASYDARSDVWSLG 205

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 93.5 bits (233), Expect = 8e-23
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 27/211 (12%)

Query: 46  PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA 105
            +  +G G  G+V   ++  T + +A+K I    +  I  ++ LRE+ +L       ++ 
Sbjct: 5   YLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQ-KQILRELDILHKCNSPYIV- 62

Query: 106 IKDIIRPPKKDTF-------NDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFL-YQLLR 156
                       F        D+ I  E MD   L +I++  Q    +     +   +L+
Sbjct: 63  -----------GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLK 111

Query: 157 GLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL 215
           GL Y+H    ++HRD+KPSN+L+N+   +K+ DFG++     +   T +V T  Y APE 
Sbjct: 112 GLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT-FVGTSSYMAPE- 169

Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFP 246
            +   +Y+   DIWS+G  L E+ T    FP
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGR--FP 198

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 93.1 bits (232), Expect = 9e-23
 Identities = 54/211 (25%), Positives = 105/211 (49%), Gaps = 20/211 (9%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT---LREIKLLRHMEHENV 103
           +R IG+GA+G VC     +T++  A+K +       ++       L E ++L+ + H  +
Sbjct: 5   LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQ--KCVEKGSVRNVLNERRILQELNHPFL 62

Query: 104 IAIKDIIRPPKKDTFND---VYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
           + +          +F D   +Y+V +L+   DL   +    + +++  ++++ +++  L+
Sbjct: 63  VNLWY--------SFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALE 114

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 219
           Y+HS  ++HRD+KP N+LL+    + I DF +A   +     T    T  Y APE +L  
Sbjct: 115 YLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPE-VLCR 173

Query: 220 TEYTAAIDIWSVGCILGE-IMTREPLFPGKD 249
             Y+ A+D WS+G    E +  + P + G  
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRGKRP-YRGHS 203

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 92.7 bits (231), Expect = 2e-22
 Identities = 52/207 (25%), Positives = 95/207 (45%), Gaps = 18/207 (8%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD- 108
           +G G +G V            A+K +       I        I   +      ++   + 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKK---RHIVETGQQEHIFSEK-----EILEECNH 52

Query: 109 --IIRPPKKDTFNDVYIVYELMDT----DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
             I++  +  TF D   +Y LM+     +L  I+R      +   ++++  ++   +Y+H
Sbjct: 53  PFIVKLYR--TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLH 110

Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           +  +++RDLKP NLLL+++  +K+ DFG A+          +  T  Y APE++LN   Y
Sbjct: 111 NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILN-KGY 169

Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKD 249
             ++D WS+G +L E++T  P F   D
Sbjct: 170 DFSVDYWSLGILLYELLTGRPPFGEDD 196

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 92.2 bits (229), Expect = 2e-22
 Identities = 59/211 (27%), Positives = 110/211 (52%), Gaps = 17/211 (8%)

Query: 42  KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE 101
           KYV  ++ IG G++G      + E  ++  IK+I  +  +  +   + +E+ +L +M+H 
Sbjct: 1   KYVK-VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHP 59

Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQL--TDDHCQYFLYQLL 155
           N++  ++        +F +   +Y +MD     DL++ I + + +   +D    +  Q+ 
Sbjct: 60  NIVQYQE--------SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQIC 111

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPE 214
             LK+VH   +LHRD+K  N+ L     +K+GDFG+AR  + T +     + T +Y +PE
Sbjct: 112 LALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPE 171

Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLF 245
           +  N   Y    DIW++GC+L E+ T +  F
Sbjct: 172 ICEN-RPYNNKSDIWALGCVLYEMCTLKHAF 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 92.0 bits (228), Expect = 4e-22
 Identities = 73/215 (33%), Positives = 116/215 (53%), Gaps = 29/215 (13%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR---TLREIKLLRHMEHENVI 104
           + IGRG +  V  A        VA+KK+   FD ++DA+     ++EI LL+ + H NVI
Sbjct: 8   KKIGRGQFSEVYRATCLLDGVPVALKKV-QIFD-LMDAKARADCIKEIDLLKQLNHPNVI 65

Query: 105 A-----IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR---SDQQLTDDHC--QYFLYQ 153
                 I+D          N++ IV EL D  DL ++I+     ++L  +    +YF+ Q
Sbjct: 66  KYYASFIED----------NELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV-Q 114

Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRA 212
           L   L+++HS  V+HRD+KP+N+ + A+  +K+GD GL R  +S+T      V T +Y +
Sbjct: 115 LCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMS 174

Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG 247
           PE  ++   Y    DIWS+GC+L E+   +  F G
Sbjct: 175 PE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 91.2 bits (226), Expect = 6e-22
 Identities = 57/207 (27%), Positives = 107/207 (51%), Gaps = 9/207 (4%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +G+G+YG V    +    ++  IKK+     +  + +   +E +LL  ++H N++A 
Sbjct: 5   VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64

Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHS 163
           ++      +D    +YIV    +  DL+  ++    + L ++    +  Q+   L+Y+H 
Sbjct: 65  RESWE--GEDGL--LYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE 120

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEY 222
             +LHRDLK  N+ L  +  +K+GD G+AR   ++ D  +  + T +Y +PEL  N   Y
Sbjct: 121 KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN-KPY 179

Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKD 249
               D+W++GC + E+ T +  F  KD
Sbjct: 180 NYKSDVWALGCCVYEMATLKHAFNAKD 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 91.3 bits (227), Expect = 7e-22
 Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 14/214 (6%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG--NAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           IGRGAYG V    +  T   VA+K I      D++ D +R   E+ LL  +         
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQR---EVALLSQLRQS---QPP 62

Query: 108 DIIR---PPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           +I +      K     ++I+ E  +    + +     + + +    + ++L  LKY+H  
Sbjct: 63  NITKYYGSYLKGP--RLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKV 120

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
            V+HRD+K +N+L+  + ++K+ DFG+ A     +   + +V T ++ APE++     Y 
Sbjct: 121 GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYD 180

Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
              DIWS+G  + E+ T  P +   D    + LI
Sbjct: 181 TKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI 214

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 90.0 bits (224), Expect = 2e-21
 Identities = 62/198 (31%), Positives = 99/198 (50%), Gaps = 26/198 (13%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHEN 102
           I+ IG G YG V  A +  T E VAIK I    G+ F+ I       +EI +L+   H N
Sbjct: 8   IQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQ------QEISMLKECRHPN 61

Query: 103 VIA-IKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRG 157
           ++A     +R  K      ++IV E        D++Q+ R    L++    Y   + L+G
Sbjct: 62  IVAYFGSYLRRDK------LWIVMEYCGGGSLQDIYQVTRG--PLSELQIAYVCRETLKG 113

Query: 158 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELL 216
           L Y+H    +HRD+K +N+LL    D+K+ DFG+ A+ T+       ++ T ++ APE+ 
Sbjct: 114 LAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVA 173

Query: 217 LNCTE--YTAAIDIWSVG 232
               +  Y    DIW++G
Sbjct: 174 AVERKGGYDGKCDIWALG 191

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 90.1 bits (223), Expect = 2e-21
 Identities = 59/206 (28%), Positives = 113/206 (54%), Gaps = 20/206 (9%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE-------IKLLRHMEHEN 102
           +G+GA+G V    +++T  E+A+K++   FD   ++  T +E       I+LL+++ HE 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQV--QFDP--ESPETSKEVNALECEIQLLKNLLHER 65

Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           ++     +R P + T +   I  E M    +   ++S   LT++  + +  Q+L G+ Y+
Sbjct: 66  IVQYYGCLRDPMERTLS---IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYL 122

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELLL 217
           HS  ++HRD+K +N+L ++  ++K+GDFG ++           M     T ++ +PE ++
Sbjct: 123 HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE-VI 181

Query: 218 NCTEYTAAIDIWSVGCILGEIMTREP 243
           +   Y    DIWSVGC + E++T +P
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 89.8 bits (223), Expect = 3e-21
 Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 23/209 (11%)

Query: 47  IRPIGRGAYGIVCAA----VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN 102
           I+ +G G +G V       +   T E+VA+K + N            REI++LR ++HEN
Sbjct: 9   IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL-NHSGEEQHRSDFEREIEILRTLDHEN 67

Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKY 160
           ++  K +   P       + ++ E + +   +      +   +  +  L+  Q+ +G+ Y
Sbjct: 68  IVKYKGVCEKPGG---RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDY 124

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--------WYRA 212
           + S   +HRDL   N+L+ +   +KI DFGLA+   E     +Y   +        WY A
Sbjct: 125 LGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK---DYYYVKEPGESPIFWY-A 180

Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMTR 241
           PE L      +A+ D+WS G  L E+ T 
Sbjct: 181 PECLRTSKFSSAS-DVWSFGVTLYELFTY 208

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 89.3 bits (222), Expect = 3e-21
 Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 33/221 (14%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI-----GNAFDNIIDARRTLREIKLLRHMEHE 101
           I  IG GA  +V AA+     E+VAIK+I       + D +       +E++ +    H 
Sbjct: 6   IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDEL------RKEVQAMSQCNHP 59

Query: 102 NVIAIKDIIRPPKKDTF---NDVYIVYELMDT-DLHQIIRS--DQQLTDDHC-QYFLYQL 154
           NV+            +F   +++++V   +    L  I++S   +   D+      L ++
Sbjct: 60  NVVK--------YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEV 111

Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-----YVVTRW 209
           L+GL+Y+HS   +HRD+K  N+LL     +KI DFG++ + ++    T      +V T  
Sbjct: 112 LKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPC 171

Query: 210 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY 250
           + APE++     Y    DIWS G    E+ T     P   Y
Sbjct: 172 WMAPEVMEQVHGYDFKADIWSFGITAIELATGAA--PYSKY 210

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 89.0 bits (221), Expect = 4e-21
 Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 22/221 (9%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           R +G G +G V   +       VAIK + +  D+++  +   +E++ L+ + H+++I++ 
Sbjct: 12  RKLGSGYFGEVWEGLWKNRVR-VAIKILKS--DDLLKQQDFQKEVQALKRLRHKHLISLF 68

Query: 108 DII---RPPKKDTFNDVYIVYELMDT-DLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYV 161
            +     P        VYI+ ELM+   L   +RS   Q L          Q+  G+ Y+
Sbjct: 69  AVCSVGEP--------VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL 120

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE--YVVTRWYRAPELLLNC 219
              + +HRDL   N+L+      K+ DFGLAR   E  +++    +  +W  APE   + 
Sbjct: 121 EEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKW-TAPE-AASH 178

Query: 220 TEYTAAIDIWSVGCILGEIMTREPL-FPGKDYVHQLRLITE 259
             ++   D+WS G +L E+ T   + +PG +       IT 
Sbjct: 179 GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA 219

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 89.7 bits (222), Expect = 4e-21
 Identities = 63/227 (27%), Positives = 114/227 (50%), Gaps = 25/227 (11%)

Query: 42  KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHME 99
           +Y+     IG G+ GIVC A    T ++VA+KK+    D     RR L   E+ ++R   
Sbjct: 22  EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKM----DLRKQQRRELLFNEVVIMRDYH 77

Query: 100 HENVIAIKDIIRPPKKDTFN------DVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           HENV+           D +N      ++++V E ++      I +  ++ ++        
Sbjct: 78  HENVV-----------DMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLS 126

Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRA 212
           +LR L Y+H+  V+HRD+K  ++LL +   +K+ DFG  A+ + E       V T ++ A
Sbjct: 127 VLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMA 186

Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           PE +++   Y   +DIWS+G ++ E++  EP +  +  +  +R I +
Sbjct: 187 PE-VISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD 232

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 89.7 bits (222), Expect = 5e-21
 Identities = 62/200 (31%), Positives = 106/200 (53%), Gaps = 16/200 (8%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA-RRTLREIKLLRHMEHENVIAIKD 108
           IG G++G V  A NS T E VA+KK+  +     +  +  ++E+K L+ ++H N I  K 
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 109 IIRPPKKDTFNDVYIVYELM---DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
                K+ T    ++V E      +DL ++ +  + L +       +  L+GL Y+HS +
Sbjct: 89  CYL--KEHT---AWLVMEYCLGSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN 141

Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE--YT 223
           ++HRD+K  N+LL     +K+ DFG A  +S  +    +V T ++ APE++L   E  Y 
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN---SFVGTPYWMAPEVILAMDEGQYD 198

Query: 224 AAIDIWSVGCILGEIMTREP 243
             +D+WS+G    E+  R+P
Sbjct: 199 GKVDVWSLGITCIELAERKP 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 88.2 bits (218), Expect = 9e-21
 Identities = 57/207 (27%), Positives = 119/207 (57%), Gaps = 22/207 (10%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE-------IKLLRHMEHEN 102
           +GRGA+G V    +++T  E+A+K++   FD   D++ T +E       I+LL+++ H+ 
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQV--PFDP--DSQETSKEVNALECEIQLLKNLRHDR 65

Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           ++     +R P++   +   I  E M    +   +++   LT++  + +  Q+L+G+ Y+
Sbjct: 66  IVQYYGCLRDPEEKKLS---IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYL 122

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV-----TRWYRAPELL 216
           HS  ++HRD+K +N+L +++ ++K+GDFG ++   +T  M+   +     T ++ +PE +
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRI-QTICMSGTGIKSVTGTPYWMSPE-V 180

Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREP 243
           ++   Y    D+WSV C + E++T +P
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 87.2 bits (216), Expect = 2e-20
 Identities = 58/203 (28%), Positives = 105/203 (51%), Gaps = 14/203 (6%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR---HMEHENV 103
           ++PI +GA+G V  A    T +  AIK +  +    + A+  +  +K  R    ++ E+ 
Sbjct: 1   LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKS---DMIAKNQVTNVKAERAIMMIQGESP 57

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
              K       KD    +Y+V E ++  D   +I++   L +D  + ++ +++ G++ +H
Sbjct: 58  YVAKLYYSFQSKDY---LYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLH 114

Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
              ++HRD+KP NLL++ +  LK+ DFGL+R   E     ++V T  Y APE +L   + 
Sbjct: 115 QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN---KKFVGTPDYLAPETILGVGD- 170

Query: 223 TAAIDIWSVGCILGEIMTREPLF 245
               D WS+GC++ E +   P F
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPPF 193

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 87.5 bits (217), Expect = 2e-20
 Identities = 56/206 (27%), Positives = 107/206 (51%), Gaps = 27/206 (13%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIK 107
           IG G+ GIVC A +  T  +VA+KK+    D     RR L   E+ ++R  +H N++ + 
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKM----DLRKQQRRELLFNEVVIMRDYQHPNIVEMY 82

Query: 108 DIIRPPKKDTF---NDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
                    ++   +++++V E ++    TD    I +  ++ ++        +L+ L +
Sbjct: 83  S--------SYLVGDELWVVMEFLEGGALTD----IVTHTRMNEEQIATVCLAVLKALSF 130

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNC 219
           +H+  V+HRD+K  ++LL +   +K+ DFG  A+ + E       V T ++ APE++   
Sbjct: 131 LHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISR- 189

Query: 220 TEYTAAIDIWSVGCILGEIMTREPLF 245
             Y   +DIWS+G ++ E++  EP +
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 86.8 bits (215), Expect = 2e-20
 Identities = 66/208 (31%), Positives = 100/208 (48%), Gaps = 12/208 (5%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT-LREIKLLRHMEHENVIA 105
           IR +GRGA+GIV        ++ V IK+I        D R     E ++L+ + H N+I 
Sbjct: 5   IRVVGRGAFGIVHLCRRKADQKLVIIKQI-PVEQMTKDERLAAQNECQVLKLLSHPNIIE 63

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDT-DLHQII--RSDQQLTDDHCQYFLYQLLRGLKYVH 162
             +     K      + IV E      L + I  R +  L +D   +F  Q+L  L +VH
Sbjct: 64  YYENFLEDKA-----LMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH 118

Query: 163 SASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
           +  +LHRDLK  N+LL+     +KIGDFG+++  S        V T  Y +PE L     
Sbjct: 119 TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPE-LCEGKP 177

Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKD 249
           Y    DIW++GC+L E+ + +  F   +
Sbjct: 178 YNQKSDIWALGCVLYELASLKRAFEAAN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 86.8 bits (215), Expect = 3e-20
 Identities = 57/211 (27%), Positives = 106/211 (50%), Gaps = 19/211 (9%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG-NAFDNIIDARRT------LREIKLLRHMEHEN 102
           IG G++G V   +N+ + E +A+K++   +       R+        REI LL+ ++HEN
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           ++                 Y+    +   L+     ++ L  +    F+ Q+L+GL Y+H
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRN----FVRQILKGLNYLH 123

Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR-------WYRAPEL 215
           +  ++HRD+K +N+L++    +KI DFG+++        T+    R       ++ APE+
Sbjct: 124 NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEV 183

Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFP 246
           +   T YT   DIWS+GC++ E++T +  FP
Sbjct: 184 VKQ-TSYTRKADIWSLGCLVVEMLTGKHPFP 213

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 87.1 bits (216), Expect = 3e-20
 Identities = 64/223 (28%), Positives = 111/223 (49%), Gaps = 27/223 (12%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG-NAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G GA+G V  A + ET    A K I   + + + D    + EI +L   +H N++ + +
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELED---FMVEIDILSECKHPNIVGLYE 69

Query: 109 IIRPPKKDTF---NDVYIVYELMDTD-LHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHS 163
                    +   N ++I+ E  D   L  I+   ++ LT+   +Y   Q+L  L ++HS
Sbjct: 70  --------AYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS 121

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNC--- 219
             V+HRDLK  N+LL    D+K+ DFG+ A+  S       ++ T ++ APE ++ C   
Sbjct: 122 HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPE-VVACETF 180

Query: 220 --TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
               Y    DIWS+G  L E+   EP  P  + ++ +R++ ++
Sbjct: 181 KDNPYDYKADIWSLGITLIELAQMEP--PHHE-LNPMRVLLKI 220

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 85.3 bits (212), Expect = 1e-19
 Identities = 53/214 (24%), Positives = 106/214 (49%), Gaps = 36/214 (16%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR---TLREIKLLRHMEHENV 103
           I+ +G G++G V    +  + +  A+K +  +   I+  ++    L E ++L+ + H  +
Sbjct: 6   IKTLGTGSFGRVMLVRHKGSGKYYALKIL--SKAKIVKLKQVEHVLNEKRILQSIRHPFL 63

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
           + +          +F D   +Y +M+     +L   +R   +  +   +++  Q++  L+
Sbjct: 64  VNLYG--------SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALE 115

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR-W-------YR 211
           Y+HS  +++RDLKP NLLL++   +KI DFG A+           V  R +       Y 
Sbjct: 116 YLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAK----------RVKGRTYTLCGTPEYL 165

Query: 212 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 245
           APE++L+   Y  A+D W++G ++ E++   P F
Sbjct: 166 APEIILS-KGYGKAVDWWALGILIYEMLAGYPPF 198

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 85.6 bits (212), Expect = 1e-19
 Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 21/208 (10%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIG-NAFDNIIDARRTLREIKLLRHMEHENVIA 105
           +R IG G++G V  A +  T E VAIKK+  +   +    +  ++E++ L+ + H N I 
Sbjct: 20  LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE 79

Query: 106 IKDIIRPPKKDTFNDVYIVYELM---DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
            K      ++ T    ++V E      +D+ ++ +  + L +       +  L+GL Y+H
Sbjct: 80  YKGCYL--REHT---AWLVMEYCLGSASDILEVHK--KPLQEVEIAAICHGALQGLAYLH 132

Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE- 221
           S   +HRD+K  N+LL     +K+ DFG A   S  +    +V T ++ APE++L   E 
Sbjct: 133 SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN---SFVGTPYWMAPEVILAMDEG 189

Query: 222 -YTAAIDIWSVG--CILGEIMTRE-PLF 245
            Y   +D+WS+G  CI  E+  R+ PLF
Sbjct: 190 QYDGKVDVWSLGITCI--ELAERKPPLF 215

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 85.1 bits (210), Expect = 3e-19
 Identities = 62/209 (29%), Positives = 107/209 (51%), Gaps = 18/209 (8%)

Query: 42  KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA-RRTLREIKLLRHMEH 100
           K    +R IG G++G V  A +  T E VAIKK+  +     +  +  ++E+K L+ ++H
Sbjct: 25  KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH 84

Query: 101 ENVIAIKDI-IRPPKKDTFNDVYIVYELM---DTDLHQIIRSDQQLTDDHCQYFLYQLLR 156
            N I  K   +R       +  ++V E      +DL ++ +  + L +       +  L+
Sbjct: 85  PNSIEYKGCYLRE------HTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAITHGALQ 136

Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 216
           GL Y+HS +++HRD+K  N+LL     +K+ DFG A   S  +    +V T ++ APE++
Sbjct: 137 GLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN---SFVGTPYWMAPEVI 193

Query: 217 LNCTE--YTAAIDIWSVGCILGEIMTREP 243
           L   E  Y   +D+WS+G    E+  R+P
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERKP 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 83.8 bits (207), Expect = 3e-19
 Identities = 58/223 (26%), Positives = 111/223 (49%), Gaps = 25/223 (11%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL----REIKLLRHMEHENVIA 105
           +G GA+     A + +T   +A+K++    +   +    +    +EI+L+  + H ++I 
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 106 IKDIIRPPKKDTFNDVYIVYELM-----DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           +       +   FN   +  E M        L +     + +  ++ +    QLLRGL Y
Sbjct: 68  MLGATC--EDSHFN---LFVEWMAGGSVSHLLSKYGAFKEAVIINYTE----QLLRGLSY 118

Query: 161 VHSASVLHRDLKPSNLLLNASC-DLKIGDFGLA-----RTTSETDFMTEYVVTRWYRAPE 214
           +H   ++HRD+K +NLL++++   L+I DFG A     + T   +F  + + T  + APE
Sbjct: 119 LHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178

Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           +L    +Y  + D+WSVGC++ E+ T +P +  + + + L LI
Sbjct: 179 VLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI 220

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 83.1 bits (205), Expect = 1e-18
 Identities = 66/215 (30%), Positives = 112/215 (52%), Gaps = 27/215 (12%)

Query: 42  KYVPPIRPIGRGAYGIV--CA--AVNSETREEVAIK--KIGNAFDNIIDARRTLREIKLL 95
           +++  IR +G G +G V  C        T E+VA+K  K  +  ++I D ++   EI++L
Sbjct: 4   RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKK---EIEIL 60

Query: 96  RHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQII-RSDQQLTDDHCQYFLYQ 153
           R++ HEN++  K I     +D  N + ++ E + +  L + + R+  ++       +  Q
Sbjct: 61  RNLYHENIVKYKGIC---TEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQ 117

Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR----- 208
           + +G+ Y+ S   +HRDL   N+L+ +   +KIGDFGL +   ETD   EY   +     
Sbjct: 118 ICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETD--KEYYTVKDDLDS 174

Query: 209 ---WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
              WY APE L+    Y A+ D+WS G  L E++T
Sbjct: 175 PVFWY-APECLIQSKFYIAS-DVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 82.9 bits (205), Expect = 1e-18
 Identities = 65/229 (28%), Positives = 102/229 (44%), Gaps = 42/229 (18%)

Query: 47  IRPIGRGAYGIV-----CAAVNSETREEVAIKKIGNAFDNIIDARRTL-REIKLLRHMEH 100
            R +G GA+G V             +E VA+K +     N  DAR+   RE +LL + +H
Sbjct: 10  KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN--DARKDFEREAELLTNFQH 67

Query: 101 ENVIAIKDII---RPPKKDTFNDVYIVYELMDT-DLHQIIRSD--------------QQL 142
           EN++    +     PP         +V+E M+  DL++ +RS                +L
Sbjct: 68  ENIVKFYGVCTEGDPP--------IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGEL 119

Query: 143 TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM- 201
           T         Q+  G+ Y+ S   +HRDL   N L+     +KIGDFG++R    TD+  
Sbjct: 120 TLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR 179

Query: 202 ---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLF 245
                 +  RW   PE ++    +T   D+WS G +L EI T  ++P +
Sbjct: 180 VGGHTMLPIRWM-PPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWY 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 82.6 bits (204), Expect = 1e-18
 Identities = 51/176 (28%), Positives = 87/176 (49%), Gaps = 21/176 (11%)

Query: 78  AFDNIIDARRTLREIKLLR-HMEHENVIAIKDIIRPPKKDTFND-VYIVYELMD-TDLHQ 134
           +  +I+       E+ +++  + H N      I+R  K    ND +YIV +L++   L +
Sbjct: 51  SIGDIVS------EVTIIKEQLRHPN------IVRYYKTFLENDRLYIVMDLIEGAPLGE 98

Query: 135 IIRS----DQQLTDDHCQYFLYQLLRGLKYVHSAS-VLHRDLKPSNLLLNASCDLKIGDF 189
              S     Q+ T++       Q++  L+Y+H    ++HRDL P+N++L     + I DF
Sbjct: 99  HFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDF 158

Query: 190 GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 245
           GLA+       +T  V T  Y  PE++ N   Y    D+W+ GCIL ++ T +P F
Sbjct: 159 GLAKQKQPESKLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPF 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 82.8 bits (204), Expect = 1e-18
 Identities = 57/213 (26%), Positives = 110/213 (51%), Gaps = 13/213 (6%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIK 107
           IG G+ GIVC A    + + VA+KK+    D     RR L   E+ ++R  +HENV+ + 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKM----DLRKQQRRELLFNEVVIMRDYQHENVVEMY 83

Query: 108 DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
           +          +++++V E ++      I +  ++ ++        +L+ L  +H+  V+
Sbjct: 84  N-----SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVI 138

Query: 168 HRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 226
           HRD+K  ++LL     +K+ DFG  A+ + E       V T ++ APE L++   Y   +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPE-LISRLPYGPEV 197

Query: 227 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           DIWS+G ++ E++  EP +  +  +  +++I +
Sbjct: 198 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD 230

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 82.8 bits (205), Expect = 2e-18
 Identities = 59/209 (28%), Positives = 102/209 (48%), Gaps = 28/209 (13%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+G YG V  A   +T E VA+K++          +  L ++  +RH+  E     +DI
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRM---------KKSLLFKLNEVRHVLTE-----RDI 54

Query: 110 IRPPKKD-------TFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           +   K +        F D   +Y  M+     D   ++ +   L++DH ++++ ++   +
Sbjct: 55  LTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAV 114

Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
             +H    +HRDLKP N L++AS  +K+ DFGL++      +    V +  Y APE +L 
Sbjct: 115 DALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANSVVGSPDYMAPE-VLR 171

Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPG 247
              Y   +D WS+GC+L E +   P F G
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCGFPPFSG 200

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 82.4 bits (203), Expect = 2e-18
 Identities = 59/208 (28%), Positives = 107/208 (51%), Gaps = 16/208 (7%)

Query: 42  KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA-RRTLREIKLLRHMEH 100
           K    +R IG G++G V  A +    E VAIKK+  +     +  +  ++E++ L+ + H
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74

Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELM---DTDLHQIIRSDQQLTDDHCQYFLYQLLRG 157
            N I  +      ++ T    ++V E      +DL ++ +  + L +       +  L+G
Sbjct: 75  PNTIQYRGCYL--REHT---AWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQG 127

Query: 158 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 217
           L Y+HS +++HRD+K  N+LL+    +K+GDFG A   +  +    +V T ++ APE++L
Sbjct: 128 LAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---XFVGTPYWMAPEVIL 184

Query: 218 NCTE--YTAAIDIWSVGCILGEIMTREP 243
              E  Y   +D+WS+G    E+  R+P
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 81.7 bits (201), Expect = 3e-18
 Identities = 54/212 (25%), Positives = 115/212 (54%), Gaps = 20/212 (9%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE-------IKLLRHMEHEN 102
           +G+GA+G V    + +T  E+A K++   FD   ++  T +E       I+LL++++HE 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQV--QFDP--ESPETSKEVSALECEIQLLKNLQHER 65

Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           ++     +R   + T   +++ Y +    +   +++   LT+   + +  Q+L G+ Y+H
Sbjct: 66  IVQYYGCLRDRAEKTLT-IFMEY-MPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLH 123

Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELLLN 218
           S  ++HRD+K +N+L +++ ++K+GDFG ++           +     T ++ +PE +++
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE-VIS 182

Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDY 250
              Y    D+WS+GC + E++T +P  P  +Y
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKP--PWAEY 212

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 81.3 bits (201), Expect = 4e-18
 Identities = 67/230 (29%), Positives = 108/230 (46%), Gaps = 28/230 (12%)

Query: 46  PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA 105
            I  +GRGAYG+V    +  T   +A+K+I  A  N  + +R L ++ +           
Sbjct: 5   VIEELGRGAYGVVDKMRHVPTGTIMAVKRI-RATVNSQEQKRLLMDLDISMRSVD----- 58

Query: 106 IKDIIRPPKKDTF-------NDVYIVYELMDTDLH----QIIRSDQQLTDDHCQYFLYQL 154
                  P   TF        DV+I  E+MDT L     ++      + +D        +
Sbjct: 59  ------CPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSI 112

Query: 155 LRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           ++ L+Y+HS  SV+HRD+KPSN+L+N +  +K+ DFG++    ++   T     + Y AP
Sbjct: 113 VKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAP 172

Query: 214 ELL---LNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITE 259
           E +   LN   Y    D+WS+G  + E+ T R P    K    QL+ + E
Sbjct: 173 ERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE 222

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 81.2 bits (200), Expect = 4e-18
 Identities = 56/202 (27%), Positives = 102/202 (50%), Gaps = 23/202 (11%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR------EIKLLRHMEHENV 103
           IG G+ GIVC A    +  +VA+K        ++D R+  R      E+ ++R  +H+NV
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVK--------MMDLRKQQRRELLFNEVVIMRDYQHQNV 80

Query: 104 IAI-KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           + + K  +         +++++ E +       I S  +L ++        +L+ L Y+H
Sbjct: 81  VEMYKSYL------VGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLH 134

Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
           S  V+HRD+K  ++LL     +K+ DFG  A+ + +       V T ++ APE++   T 
Sbjct: 135 SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR-TP 193

Query: 222 YTAAIDIWSVGCILGEIMTREP 243
           Y   +DIWS+G ++ E++  EP
Sbjct: 194 YGTEVDIWSLGIMVIEMVDGEP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 80.3 bits (198), Expect = 8e-18
 Identities = 58/212 (27%), Positives = 108/212 (50%), Gaps = 15/212 (7%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT---LREIKLLRHMEHENVIAI 106
           IG+GA G V  A++  T +EVAIK++     N+    +    + EI ++R  +H N++  
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQM-----NLQQQPKKELIINEILVMRENKHPNIVNY 81

Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
            D          +++++V E +       + ++  + +        + L+ L+++HS  V
Sbjct: 82  LD-----SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 136

Query: 167 LHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           +HRD+K  N+LL     +K+ DFG  A+ T E    +  V T ++ APE++     Y   
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPK 195

Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           +DIWS+G +  E++  EP +  ++ +  L LI
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 227

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 80.0 bits (197), Expect = 2e-17
 Identities = 58/201 (28%), Positives = 104/201 (51%), Gaps = 13/201 (6%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII---DARRTLREIKLLRHMEHENVIAI 106
           IG+G++G V      +T+   A+K I  A   I+   +   TL E  +L  +    ++ +
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAH--IVSRSEVTHTLAERTVLAQVNCPFIVPL 58

Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
           K   + P+K     +Y+V   ++  +L   ++ + +      +++  +LL  L+ +H  +
Sbjct: 59  KFSFQSPEK-----LYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFN 113

Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           V++RDLKP N+LL+    + + DFGL +    + D    +  T  Y APELLL    YT 
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLG-HGYTK 172

Query: 225 AIDIWSVGCILGEIMTREPLF 245
           A+D W++G +L E++T  P F
Sbjct: 173 AVDWWTLGVLLYEMLTGLPPF 193

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 79.2 bits (195), Expect = 2e-17
 Identities = 61/216 (28%), Positives = 108/216 (50%), Gaps = 10/216 (4%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR---EIKLLRHMEHENVIAI 106
           +G+G++G V    + +   E  +K +       ++   T++   E +LL  ++H  ++  
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67

Query: 107 KDIIRPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
                  ++D F  +    E  D D  L ++  + + L+++    +  QLL G+ Y+H  
Sbjct: 68  HASFL--ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
            +LHRDLK  N+ L  +  LKIGDFG++R      D  T +  T +Y +PE L +   Y 
Sbjct: 126 RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH-QGYD 183

Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           +  DIWS+GCIL E+      F G++++  +  I E
Sbjct: 184 SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE 219

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 79.4 bits (195), Expect = 2e-17
 Identities = 55/209 (26%), Positives = 105/209 (50%), Gaps = 9/209 (4%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG+GA G V  A++  T +EVAI+++             + EI ++R  ++ N++   D 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLD- 84

Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 169
                    +++++V E +       + ++  + +        + L+ L+++HS  V+HR
Sbjct: 85  ----SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHR 140

Query: 170 DLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDI 228
           D+K  N+LL     +K+ DFG  A+ T E    +  V T ++ APE++     Y   +DI
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDI 199

Query: 229 WSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           WS+G +  E++  EP +  ++ +  L LI
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLI 228

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 78.9 bits (194), Expect = 3e-17
 Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 20/207 (9%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           I  +G GA+G V  A N ET    A K I    +   +    + EI +L   +H N++ +
Sbjct: 10  IGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEE--ELEDYMVEIDILASCDHPNIVKL 67

Query: 107 KDIIRPPKKDTFNDVYIVYEL-----MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
            D          N+++I+ E      +D  + ++ R    LT+   +    Q L  L Y+
Sbjct: 68  LDAFYYE-----NNLWILIEFCAGGAVDAVMLELERP---LTEPQIRVVCKQTLEALNYL 119

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           H   ++HRDLK  N+L     D+K+ DFG+ A+ T        ++ T ++ APE+++  T
Sbjct: 120 HENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET 179

Query: 221 E----YTAAIDIWSVGCILGEIMTREP 243
                Y    D+WS+G  L E+   EP
Sbjct: 180 SKDRPYDYKADVWSLGITLIEMAQIEP 206

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 78.4 bits (193), Expect = 3e-17
 Identities = 56/207 (27%), Positives = 104/207 (50%), Gaps = 21/207 (10%)

Query: 50  IGRGAYGIV-CAAVNSETREEVAIKKIGNAFDNIIDARRTLR----EIKLLRHMEHENVI 104
           +G+GAYG V C   N    + +A+K++     N++ A +       E+ LL+ ++H N++
Sbjct: 8   LGKGAYGTVYCGLTN--QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 105 AIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
                +     D  N + I  E +    +  I+     L +     +  Q+L G+ Y+H+
Sbjct: 66  QY---LGTCLDD--NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHN 120

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLAR-------TTSETDFMTEYVVTRWYRAPELL 216
             V+HRD+K +N++L  +  +K+ DFG AR         + ++ +     T ++ APE +
Sbjct: 121 NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE-V 179

Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREP 243
           +N + Y    DIWS+GC + E+ T +P
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKP 206

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 77.9 bits (192), Expect = 4e-17
 Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 20/206 (9%)

Query: 48  RPIGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI 104
           R IG+G +G V       +   +   A+K + N   ++ +  + L+E  +++   H NV+
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSL-NRITDLEEVEQFLKEGIIMKDFSHPNVL 59

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHS 163
           ++  I  P +      V + Y +   DL   IRS+    T      F  Q+ +G++Y+ S
Sbjct: 60  SLLGICLPSEGSPL--VVLPY-MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS 116

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL-------- 215
              +HRDL   N +L+ S  +K+ DFGLAR   +     EY     +   +L        
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDIYD----KEYYSVHNHTGAKLPVKWMALE 172

Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTR 241
            L   ++T   D+WS G +L E+MTR
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELMTR 198

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 78.8 bits (194), Expect = 4e-17
 Identities = 57/217 (26%), Positives = 113/217 (52%), Gaps = 17/217 (7%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR----TLREIKLL-RHMEHEN-- 102
           IG+G +G V      +TR   A+K +       I A++    T+ E  +L R +  E+  
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSK---KEIVAKKEVAHTIGERNILVRTLLDESPF 57

Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           ++ +K   +       +D+Y+V + M   +L   ++ + + ++D  ++++ +L+  L+++
Sbjct: 58  IVGLKFSFQTD-----SDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHL 112

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCT 220
           H   +++RDLKP N+LL+A+  + + DFGL++   ++      +  T  Y APE+LL+  
Sbjct: 113 HKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEK 172

Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
            YT  +D WS+G ++ E+      F  +D     R I
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI 209

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 77.4 bits (190), Expect = 8e-17
 Identities = 62/211 (29%), Positives = 107/211 (50%), Gaps = 15/211 (7%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG--NAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           IG+G++G V   +++ T+E VAIK I    A D I D ++   EI +L   +   +    
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYITRYY 68

Query: 108 DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
                  K     ++I+ E +       +     L + +    L ++L+GL Y+HS   +
Sbjct: 69  GSYLKGTK-----LWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKI 123

Query: 168 HRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM-TEYVVTRWYRAPELLLNCTEYTAAI 226
           HRD+K +N+LL+   D+K+ DFG+A   ++T      +V T ++ APE++   + Y    
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ-SAYDFKA 182

Query: 227 DIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           DIWS+G    E+   EP  P  D +H +R++
Sbjct: 183 DIWSLGITAIELAKGEP--PNSD-LHPMRVL 210

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 77.4 bits (190), Expect = 9e-17
 Identities = 61/211 (28%), Positives = 106/211 (50%), Gaps = 15/211 (7%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG--NAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           IG+G++G V   +++ T++ VAIK I    A D I D ++   EI +L   +   V    
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYVTKYY 68

Query: 108 DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
                  K     ++I+ E +       +       +      L ++L+GL Y+HS   +
Sbjct: 69  GSYLKGTK-----LWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKI 123

Query: 168 HRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEYTAAI 226
           HRD+K +N+LL+   D+K+ DFG+A   ++T      +V T ++ APE++   + Y +  
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQ-SAYDSKA 182

Query: 227 DIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           DIWS+G    E+   EP  P  D +H +R++
Sbjct: 183 DIWSLGITAIELAKGEP--PNSD-MHPMRVL 210

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 77.9 bits (192), Expect = 9e-17
 Identities = 55/216 (25%), Positives = 110/216 (50%), Gaps = 11/216 (5%)

Query: 47  IRPIGRGAYG---IVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV 103
           ++ +G+G++G   +V      +  +  A+K +  A   + D  RT  E  +L  + H  +
Sbjct: 1   LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFI 60

Query: 104 IAIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           + +    +   K     +Y++ + L   DL   +  +   T++  +++L +L   L ++H
Sbjct: 61  VKLHYAFQTEGK-----LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH 115

Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCTE 221
           S  +++RDLKP N+LL+    +K+ DFGL++ + + +     +  T  Y APE ++N   
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE-VVNRRG 174

Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           +T + D WS G ++ E++T    F GKD    + +I
Sbjct: 175 HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 76.6 bits (188), Expect = 1e-16
 Identities = 60/214 (28%), Positives = 104/214 (48%), Gaps = 33/214 (15%)

Query: 48  RPIGRGAYGIV-CAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           + +G G +G V  A  N  T+  V   K G+     +     L E  +++ ++H+ ++ +
Sbjct: 12  KKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDKLVKL 66

Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQYFLYQLLRGL 158
             ++      T   +YI+ E M    L   ++SD+       +L D     F  Q+  G+
Sbjct: 67  HAVV------TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID-----FSAQIAEGM 115

Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE---YVVTRWYRAPEL 215
            ++   + +HRDL+ +N+L++AS   KI DFGLAR   + ++          +W  APE 
Sbjct: 116 AFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPE- 173

Query: 216 LLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
            +N   +T   D+WS G +L EI+T  R P +PG
Sbjct: 174 AINFGSFTIKSDVWSFGILLMEIVTYGRIP-YPG 206

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 76.6 bits (189), Expect = 2e-16
 Identities = 61/218 (27%), Positives = 107/218 (49%), Gaps = 31/218 (14%)

Query: 39  VSSKYVPPIRPIGRGAYGIVCAA---VNSETREEVAIK--KIGNAFDNIIDARRTLREIK 93
           +   YV   + IG G +G VC     +  +   +VAIK  K G++    +D    L E  
Sbjct: 1   IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD---FLTEAS 57

Query: 94  LLRHMEHENVIAIKDII---RPPKKDTFNDVYIVYELMDT-DLHQIIR-SDQQLTDDHCQ 148
           ++   +H N+I ++ ++   RP        V I+ E M+   L + +R +D + T     
Sbjct: 58  IMGQFDHPNIIRLEGVVTKSRP--------VMIITEYMENGSLDKFLRENDGKFTVGQLV 109

Query: 149 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT- 207
             L  +  G+KY+   + +HRDL   N+L+N++   K+ DFGL+R   +++    Y    
Sbjct: 110 GMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE--ATYTTKG 167

Query: 208 -----RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                RW  APE  +   ++T+A D+WS G ++ E+M+
Sbjct: 168 GKIPIRW-TAPE-AIAYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 76.7 bits (188), Expect = 2e-16
 Identities = 56/209 (26%), Positives = 104/209 (49%), Gaps = 9/209 (4%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG+GA G V  A++  T +EVAIK++             + EI ++R  ++ N++   D 
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMN--LQQQPKKELIINEILVMRENKNPNIVNYLD- 83

Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 169
                    +++++V E +       + ++  + +        + L+ L ++HS  V+HR
Sbjct: 84  ----SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHR 139

Query: 170 DLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDI 228
           D+K  N+LL     +K+ DFG  A+ T E    +  V T ++ APE++     Y   +DI
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDI 198

Query: 229 WSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           WS+G +  E++  EP +  ++ +  L LI
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPLRALYLI 227

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 76.2 bits (188), Expect = 2e-16
 Identities = 60/218 (27%), Positives = 100/218 (45%), Gaps = 36/218 (16%)

Query: 47  IRPIGRGAYGIV---CAA--VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE 101
           IR +G+G++G+V    A   V  E    VAIK + N   ++ +    L E  +++     
Sbjct: 11  IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTV-NENASMRERIEFLNEASVMKEFNCH 69

Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHC--------QYFLY 152
           +V+ +  ++      T     +V ELM   DL   +RS ++   ++         Q F+ 
Sbjct: 70  HVVRLLGVV-----STGQPTLVVMELMAKGDLKSYLRS-RRPEAENNPGLGPPTLQKFIQ 123

Query: 153 ---QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-- 207
              ++  G+ Y+ +   +HRDL   N ++     +KIGDFG+ R   ETD+   Y     
Sbjct: 124 MAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDY---YRKGGK 180

Query: 208 -----RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                RW  APE L +   +T   D+WS G +L E+ T
Sbjct: 181 GLLPVRWM-APESLKDGV-FTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 76.1 bits (187), Expect = 3e-16
 Identities = 67/242 (27%), Positives = 100/242 (41%), Gaps = 37/242 (15%)

Query: 42  KYVPPIRPIGRGAYGIVCA----AVNSETREEVAIK--KIGNAFDNIIDARRTLREIKLL 95
           +Y+  IR +G G +G V        N  T E VA+K  K      N        +EI +L
Sbjct: 4   RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQN---TSGWKKEINIL 60

Query: 96  RHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLL 155
           + + HEN++  K             + ++ E +     +      +L       F  Q+ 
Sbjct: 61  KTLYHENIVKYKGCCSEQGGKG---LQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQIC 117

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR------- 208
            G+ Y+HS   +HRDL   N+LL+    +KIGDFGLA+   E     EY   R       
Sbjct: 118 EGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPV 174

Query: 209 -WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR------------EPLFPGKDYVHQLR 255
            WY A E L       A+ D+WS G  L E++T             E + P +  +  +R
Sbjct: 175 FWY-AVECLKENKFSYAS-DVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVR 232

Query: 256 LI 257
           LI
Sbjct: 233 LI 234

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 75.8 bits (186), Expect = 4e-16
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 10/205 (4%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR----TLREIKLLRHMEHENV 103
           R +G+G +G VCA     T +  A K++       I  R+     L E ++L  +  + V
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKRLEK---KRIKKRKGESMALNEKQILEKVNSQFV 62

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           + +        KD    V  +    D   H     +    ++   ++  ++L GL+ +H 
Sbjct: 63  VNLAYAYE--TKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR 120

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
            + ++RDLKP N+LL+    ++I D GLA    E + +   V T  Y APE+L N   YT
Sbjct: 121 ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNN-QRYT 179

Query: 224 AAIDIWSVGCILGEIMTREPLFPGK 248
            + D W +GC++ E++  +  F G+
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSPFRGR 204

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 75.8 bits (186), Expect = 4e-16
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 18/210 (8%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHM-EHENVI 104
           I  IG+G YG V    N +     A+K      D I D    +  E  +L+ +  H NV+
Sbjct: 27  IETIGKGTYGKVYKVTNKKDGSLAAVK----ILDPISDVDEEIEAEYNILQSLPNHPNVV 82

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQ-IIRSDQQLTDDHCQYFLYQLLRGLK 159
               +     K     +++V EL +    T+L + ++   Q+L +    Y LY  L GL+
Sbjct: 83  KFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQ 142

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLN 218
           ++H+  ++HRD+K +N+LL     +K+ DFG+ A+ TS        V T ++ APE++  
Sbjct: 143 HLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA- 201

Query: 219 CTE-----YTAAIDIWSVGCILGEIMTREP 243
           C +     Y A  D+WS+G    E+   +P
Sbjct: 202 CEQQYDYSYDARCDVWSLGITAIELGDGDP 231

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 75.9 bits (186), Expect = 4e-16
 Identities = 55/209 (26%), Positives = 106/209 (50%), Gaps = 9/209 (4%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG+GA G V  A++  T +EVAIK+I             + EI +++ +++ N++   D 
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQIN--LQKQPKKELIINEILVMKELKNPNIVNFLD- 83

Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 169
                    +++++V E +       + ++  + +        + L+ L+++H+  V+HR
Sbjct: 84  ----SFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHR 139

Query: 170 DLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDI 228
           D+K  N+LL     +K+ DFG  A+ T E    +  V T ++ APE++     Y   +DI
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDI 198

Query: 229 WSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           WS+G +  E++  EP +  ++ +  L LI
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPLRALYLI 227

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 75.5 bits (185), Expect = 5e-16
 Identities = 59/200 (29%), Positives = 102/200 (51%), Gaps = 12/200 (6%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIG--NAFDNIIDARRTLREIKLLRHMEHENVI 104
           +  IG+G++G V   +++ T++ VAIK I    A D I D ++   EI +L   +   V 
Sbjct: 9   LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYVT 65

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
                     KDT   ++I+ E +       +     L +      L ++L+GL Y+HS 
Sbjct: 66  KYYGSYL---KDT--KLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSE 120

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM-TEYVVTRWYRAPELLLNCTEYT 223
             +HRD+K +N+LL+   ++K+ DFG+A   ++T      +V T ++ APE++   + Y 
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ-SAYD 179

Query: 224 AAIDIWSVGCILGEIMTREP 243
           +  DIWS+G    E+   EP
Sbjct: 180 SKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 75.1 bits (184), Expect = 7e-16
 Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 22/205 (10%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G GA+G V  A N ET    A K I    +   +    + EI++L    H  ++ +   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEE--ELEDYMVEIEILATCNHPYIVKLLGA 77

Query: 110 IRPPKKDTFNDVYIVYEL-----MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
                K     ++I+ E      +D  + ++   D+ LT+   Q    Q+L  L+Y+HS 
Sbjct: 78  FYWDGK-----LWIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM 129

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNC---- 219
            ++HRDLK  N+LL    D+K+ DFG+ A+          ++ T ++ APE+++ C    
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVM-CETMK 188

Query: 220 -TEYTAAIDIWSVGCILGEIMTREP 243
            T Y    DIWS+G  L E+   EP
Sbjct: 189 DTPYDYKADIWSLGITLIEMAQIEP 213

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 75.1 bits (185), Expect = 7e-16
 Identities = 59/220 (26%), Positives = 95/220 (43%), Gaps = 37/220 (16%)

Query: 49  PIGRGAYGIVCAA-----VNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHM-EHE 101
           P+G GA+G V  A      N      VA+K +  +A +   D    + E+++++ + +H+
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKHK 76

Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYEL-----------------MDTDLHQIIRSDQQLTD 144
           N+I +  +           +Y+V E                             ++ LT 
Sbjct: 77  NIINLLGVCTQEGP-----LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131

Query: 145 DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY 204
                F YQ+ RG++++ S   +HRDL   N+L+     +KI DFGLAR     D+  + 
Sbjct: 132 KDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191

Query: 205 VVTR----WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
              R    W  APE L +   YT   D+WS G +L EI T
Sbjct: 192 TNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 75.1 bits (184), Expect = 7e-16
 Identities = 62/224 (27%), Positives = 109/224 (48%), Gaps = 36/224 (16%)

Query: 48  RPIGRGAYGIVCAA-----VNSETREEVAIKKIGNAFDNIIDARRTL-REIKLLRHMEHE 101
           R +G GA+G V  A        + +  VA+K + +A DN   AR+   RE +LL +++HE
Sbjct: 11  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDN---ARKDFHREAELLTNLQHE 67

Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-------------QQLTDDHC 147
           +++    +         + + +V+E M   DL++ +R+               +LT    
Sbjct: 68  HIVKFYGVCVEG-----DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQM 122

Query: 148 QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT----E 203
            +   Q+  G+ Y+ S   +HRDL   N L+  +  +KIGDFG++R    TD+       
Sbjct: 123 LHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 182

Query: 204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLF 245
            +  RW   PE ++   ++T   D+WS+G +L EI T  ++P +
Sbjct: 183 MLPIRWM-PPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWY 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 74.8 bits (184), Expect = 1e-15
 Identities = 50/209 (23%), Positives = 101/209 (48%), Gaps = 20/209 (9%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR---EIKLLRHMEHENV 103
           I+ +G G +G V    +  +    A+K +  A   +I  ++      E ++L+ + H  +
Sbjct: 6   IKTVGTGTFGRVHLVRDRISEHYYALKVM--AIPEVIRLKQEQHVHNEKRVLKEVSHPFI 63

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
           I +          T +D   +Y LM+     +L   +R+  + ++    ++  +++  L+
Sbjct: 64  IRLFW--------TEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALE 115

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 219
           Y+HS  +++RDLKP N+LL+    +K+ DFG A+     D       T  Y APE++ + 
Sbjct: 116 YLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR--DRTWTLCGTPEYLAPEVIQS- 172

Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGK 248
             +  A+D W++G ++ E++   P F   
Sbjct: 173 KGHNKAVDWWALGILIYEMLVGYPPFFDD 201

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 74.2 bits (182), Expect = 1e-15
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 22/205 (10%)

Query: 48  RPIGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRT-LREIKLLRHMEHENV 103
           + IG G +G VC+    +  +    VAIK +   +      RR  L E  ++   +H N+
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTE--KQRRDFLSEASIMGQFDHPNI 67

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYV 161
           I ++ ++   K      V IV E M+   L   +R  D Q T       L  +  G+KY+
Sbjct: 68  IHLEGVVTKSKP-----VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL 122

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPEL 215
                +HRDL   N+L+N++   K+ DFGL+R   E D    Y         RW  APE 
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRW-TAPE- 179

Query: 216 LLNCTEYTAAIDIWSVGCILGEIMT 240
            +   ++T+A D+WS G ++ E+M+
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 75.9 bits (186), Expect = 1e-15
 Identities = 65/283 (22%), Positives = 116/283 (40%), Gaps = 50/283 (17%)

Query: 3   AAAKDSSSGGATSSVKGVLTHGGKYVQ-YNVYGNLFEVSSKYVPPIRPIGRGAYG-IVCA 60
            A  D++     +  K  L H  +++  + V  +L                GA+G I   
Sbjct: 124 EAPPDAAGPVPLAQAK--LKHDDEFLAHFRVIDDLPA--------------GAFGKIFIC 167

Query: 61  AVNSETREEVAIKKIGNAFDNIIDARRTL---------------REIKLLRHMEHENVIA 105
           A+ + T E  A + + +         R +                EI  L  + HEN++ 
Sbjct: 168 ALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTDLHQII-RSDQQLTDD----HCQYFLYQLLRGLKY 160
           I++I+R        + Y++ +  D DL+  +        D       +  + QLL  ++Y
Sbjct: 228 IEEILRSE-----ANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEY 282

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY--VVTRWYRAPELLLN 218
           +H   ++HRD+K  N+ LN    + +GDFG A    +     +Y  V T    +PE+L  
Sbjct: 283 IHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG 342

Query: 219 CTEYTAAIDIWSVGCILGEIMTRE--PLFPGKDYVHQ--LRLI 257
              Y    DIWS G IL ++++ +  P+  G     +  L++I
Sbjct: 343 -DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKII 384

Length = 501

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 74.6 bits (184), Expect = 2e-15
 Identities = 60/234 (25%), Positives = 99/234 (42%), Gaps = 58/234 (24%)

Query: 46  PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA 105
            I+ IGRGA+G V    + +T +  A+K               LR+  +++  +  +V A
Sbjct: 5   VIKVIGRGAFGEVWLVRDKDTGQVYAMKV--------------LRKSDMIKRNQIAHVRA 50

Query: 106 IKDIIRPPKKD-------TFNDVYIVYELMD----TDL-HQIIRSDQQLTDDHCQYFLYQ 153
            +DI+             +F D   +Y +M+     DL + +IR D    ++  ++++ +
Sbjct: 51  ERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDV-FPEETARFYIAE 109

Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA------------RTTSETDFM 201
           L+  L  VH    +HRD+KP N+L++A   +K+ DFGL                S     
Sbjct: 110 LVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169

Query: 202 TEYVVTRW------------------YRAPELLLNCTEYTAAIDIWSVGCILGE 237
            + V+ R                   Y APE+L   T Y    D WS+G IL E
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYE 222

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 74.1 bits (182), Expect = 2e-15
 Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 37/214 (17%)

Query: 48  RPIGRGAYGIVCAAV-----NSETREEVAIKKIGNAFDNIIDARRTL-REIKLLRHM-EH 100
           + +G GA+G V  A       S+   +VA+K +     +    R  L  E+K++ H+  H
Sbjct: 41  KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHS--SEREALMSELKIMSHLGNH 98

Query: 101 ENVIAIKD--IIRPPKKDTFNDVYIVYEL-MDTDLHQIIRSDQQ--LTDDHCQYFLYQLL 155
           EN++ +     I  P       + ++ E     DL   +R  ++  LT +    F YQ+ 
Sbjct: 99  ENIVNLLGACTIGGP-------ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVA 151

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE--YVV------- 206
           +G+ ++ S + +HRDL   N+LL     +KI DFGLAR     D M +  YVV       
Sbjct: 152 KGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR-----DIMNDSNYVVKGNARLP 206

Query: 207 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
            +W  APE + NC  YT   D+WS G +L EI +
Sbjct: 207 VKWM-APESIFNCV-YTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 74.3 bits (183), Expect = 2e-15
 Identities = 62/215 (28%), Positives = 97/215 (45%), Gaps = 31/215 (14%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAF-------DNIIDARRTLREIKLLRHMEHEN 102
           +GRG +G V  A   +T E  AIK +           ++++  +R        RH    N
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 103 VIAIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           + A           T + V  V E     DL   I +D   ++    ++   ++ GL+Y+
Sbjct: 67  LFACFQ--------TEDHVCFVMEYAAGGDLMMHIHTDV-FSEPRAVFYAACVVLGLQYL 117

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-------TTSETDFMTEYVVTRWYRAPE 214
           H   +++RDLK  NLLL+    +KI DFGL +        TS       +  T  + APE
Sbjct: 118 HENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS------TFCGTPEFLAPE 171

Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
           +L   T YT A+D W +G ++ E++  E  FPG D
Sbjct: 172 VLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 73.6 bits (181), Expect = 2e-15
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 25/210 (11%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD- 108
           IGRGA+G V   ++  +   +A+K+I +  D         +E K L  M+ + V+   D 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--------KEQKRLL-MDLDVVMRSSDC 62

Query: 109 --IIRPPKKDTFN--DVYIVYELMDTDLHQIIR-----SDQQLTDDHCQYFLYQLLRGLK 159
             I++      F   D +I  ELMD  L +  +         + ++         ++ L 
Sbjct: 63  PYIVKF-YGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALN 121

Query: 160 YVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
           Y+     ++HRD+KPSN+LL+ + ++K+ DFG++    ++   T     R Y APE +  
Sbjct: 122 YLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDP 181

Query: 219 CTE--YTAAIDIWSVGCILGEIMTREPLFP 246
                Y    D+WS+G  L E+ T +  FP
Sbjct: 182 SARDGYDVRSDVWSLGITLYEVATGK--FP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 73.1 bits (179), Expect = 3e-15
 Identities = 60/221 (27%), Positives = 103/221 (46%), Gaps = 34/221 (15%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRT--LREI 92
           E+   ++   + IG G +G V      +       VAIK +   +    + +R   L E 
Sbjct: 1   EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY---TEKQRQDFLSEA 57

Query: 93  KLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY 152
            ++    H N+I ++ ++       F    I+ E M+         D+ L D   ++  Y
Sbjct: 58  SIMGQFSHHNIIRLEGVV-----TKFKPAMIITEYMENG-----ALDKYLRDHDGEFSSY 107

Query: 153 QL---LRG----LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 205
           QL   LRG    +KY+   + +HRDL   N+L+N++ + K+ DFGL+R   E D    Y 
Sbjct: 108 QLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL-EDDPEGTYT 166

Query: 206 VT------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
            +      RW  APE  +   ++T+A D+WS G ++ E+M+
Sbjct: 167 TSGGKIPIRW-TAPE-AIAYRKFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 72.7 bits (178), Expect = 4e-15
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 20/199 (10%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G +G V       T ++VA+K I       + A+  L E  ++  + H+N++ +  +
Sbjct: 14  IGEGEFGAVLQG--EYTGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGV 67

Query: 110 IRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQL--LRGLKYVHSASV 166
           I        N +YIV ELM   +L   +R+  +      Q   + L    G++Y+ S  +
Sbjct: 68  I------LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKL 121

Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 226
           +HRDL   N+L++     K+ DFGLAR  S     ++  V +W  APE L +  ++++  
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV-KW-TAPEALKH-KKFSSKS 178

Query: 227 DIWSVGCILGEIMT--REP 243
           D+WS G +L E+ +  R P
Sbjct: 179 DVWSYGVLLWEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 73.1 bits (179), Expect = 5e-15
 Identities = 57/204 (27%), Positives = 105/204 (51%), Gaps = 15/204 (7%)

Query: 47  IRPIGRGAYG-IVCAAVNSETREEVAIKKIGNAFDNIIDARRT---LREIKLLRHMEHEN 102
           IR +G G++G ++ A   +E    VAIK+   +   II  ++      E K+L ++ H  
Sbjct: 35  IRTLGTGSFGRVILATYKNEDFPPVAIKRFEKS--KIIKQKQVDHVFSERKILNYINHPF 92

Query: 103 VIAIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
            + +       K +++  +Y+V E ++  +    +R +++  +D   ++  Q++   +Y+
Sbjct: 93  CVNLYGSF---KDESY--LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYL 147

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
            S ++++RDLKP NLLL+    +K+ DFG A+      +      T  Y APE+LLN   
Sbjct: 148 QSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT--LCGTPEYIAPEILLNVGH 205

Query: 222 YTAAIDIWSVGCILGEIMTREPLF 245
             AA D W++G  + EI+   P F
Sbjct: 206 GKAA-DWWTLGIFIYEILVGCPPF 228

Length = 340

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 73.5 bits (180), Expect = 5e-15
 Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 38/201 (18%)

Query: 53  GAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR--TLREIKLLRHMEHENVIAIKDII 110
           GA G   A ++++T E V IK            +R  T  E  +LR + H ++I +K   
Sbjct: 103 GAEGFAFACIDNKTCEHVVIKA----------GQRGGTATEAHILRAINHPSIIQLKGTF 152

Query: 111 RPPKKDTFNDVY-IVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ--LLRGLKYVHSASVL 167
                 T+N    ++     TDL+  + + + +    C     +  +LR ++Y+H   ++
Sbjct: 153 ------TYNKFTCLILPRYKTDLYCYLAAKRNIAI--CDILAIERSVLRAIQYLHENRII 204

Query: 168 HRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWY--------RAPELLLNC 219
           HRD+K  N+ +N   D+ +GDFG A       F  +    ++Y         APELL   
Sbjct: 205 HRDIKAENIFINHPGDVCLGDFGAAC------FPVDINANKYYGWAGTIATNAPELLAR- 257

Query: 220 TEYTAAIDIWSVGCILGEIMT 240
             Y  A+DIWS G +L E+ T
Sbjct: 258 DPYGPAVDIWSAGIVLFEMAT 278

Length = 391

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 72.1 bits (177), Expect = 6e-15
 Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 17/213 (7%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREE---VAIKKIGNAFDNIIDARRTLREIK 93
           +E+  + +   R IG G +G V   V      E   VA+K   N         + L+E  
Sbjct: 1   YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPS-VREKFLQEAY 59

Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQII-RSDQQLTDDHCQYFL 151
           ++R  +H +++ +  +I      T N V+IV EL    +L   +  +   L       + 
Sbjct: 60  IMRQFDHPHIVKLIGVI------TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYS 113

Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV---TR 208
           YQL   L Y+ S   +HRD+   N+L+++   +K+GDFGL+R   +  +          +
Sbjct: 114 YQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK 173

Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR 241
           W  APE  +N   +T+A D+W  G  + EI+  
Sbjct: 174 WM-APE-SINFRRFTSASDVWMFGVCMWEILML 204

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 72.1 bits (177), Expect = 7e-15
 Identities = 53/223 (23%), Positives = 98/223 (43%), Gaps = 31/223 (13%)

Query: 46  PIRPIGRGAYGIVCAAVNSETREE-----VAIKKIGNAFDNII--DARRTLREIKLLRHM 98
            I  +GRG +G V  A      EE     V +K +    D  +  + RR   E+ + R +
Sbjct: 9   EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRR---ELDMFRKL 65

Query: 99  EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIR---------SDQQLTDDHCQ 148
            H+NV+ +  + R  + +     Y++ E  D  DL Q +R             L+     
Sbjct: 66  SHKNVVRLLGLCR--EAEPH---YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKV 120

Query: 149 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYV 205
               Q+  G+ ++ +A  +HRDL   N L+++  ++K+    L++    ++        +
Sbjct: 121 ALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI 180

Query: 206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 247
             RW  APE +    +++   D+WS G ++ E+ T+  L F G
Sbjct: 181 PLRWL-APEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFYG 221

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 72.2 bits (177), Expect = 7e-15
 Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 16/208 (7%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR----TLREIKLLRHMEHENV 103
           R +G+G +G VCA     T +  A KK+       I  R+     L E ++L  +    V
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEK---KRIKKRKGEAMALNEKQILEKVNSRFV 62

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM---DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           +++         +T + + +V  LM   D   H     +    ++   ++  ++  GL+ 
Sbjct: 63  VSLA-----YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLED 117

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +H   +++RDLKP N+LL+    ++I D GLA    E + +   V T  Y APE++ N  
Sbjct: 118 LHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKN-E 176

Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGK 248
            YT + D W +GC++ E++  +  F  +
Sbjct: 177 RYTFSPDWWGLGCLIYEMIEGKSPFRQR 204

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 72.4 bits (178), Expect = 7e-15
 Identities = 54/219 (24%), Positives = 102/219 (46%), Gaps = 36/219 (16%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII---DARRTLREIKLLRHMEHENVI 104
           + +G+G++G V  A    T E  A+K +    D I+   D   T+ E ++L         
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKK--DVILQDDDVECTMTEKRVLALAG----- 53

Query: 105 AIKDIIRPPKK-------DTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 156
                 + P          T + ++ V E ++  DL   I+   +  +   +++  +++ 
Sbjct: 54  ------KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVL 107

Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW------Y 210
           GL+++H   +++RDLK  N+LL++   +KI DFG+ +     + +   V T        Y
Sbjct: 108 GLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCK-----EGILGGVTTSTFCGTPDY 162

Query: 211 RAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
            APE+L     Y  A+D W++G +L E++  +  F G D
Sbjct: 163 IAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 72.0 bits (176), Expect = 7e-15
 Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 21/206 (10%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHEN 102
           I+ IG G YG V  A N  T E  AIK I    G  F  +       +EI +++  +H N
Sbjct: 14  IQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVV------QQEIIMMKDCKHSN 67

Query: 103 VIA-IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           ++A     +R  K      ++I  E      L  I      L++    Y   + L+GL Y
Sbjct: 68  IVAYFGSYLRRDK------LWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYY 121

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPEL--LL 217
           +HS   +HRD+K +N+LL  +  +K+ DFG+ A+ T+       ++ T ++ APE+  + 
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVE 181

Query: 218 NCTEYTAAIDIWSVGCILGEIMTREP 243
               Y    DIW+VG    E+   +P
Sbjct: 182 RKGGYNQLCDIWAVGITAIELAELQP 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 71.6 bits (176), Expect = 7e-15
 Identities = 64/219 (29%), Positives = 99/219 (45%), Gaps = 40/219 (18%)

Query: 47  IRPIGRGAYGIVCAAV-NSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHMEHENV 103
            R +G G +G V     N  T  +VA+K  K G      +     L+E ++++ + H+ +
Sbjct: 11  ERKLGAGQFGEVWMGTWNGTT--KVAVKTLKPGT-----MSPEAFLQEAQIMKKLRHDKL 63

Query: 104 IAIKDII--RPPKKDTFNDVYIVYELMDT-DLHQIIRSD-------QQLTDDHCQYFLYQ 153
           + +  +     P       +YIV E M    L   ++S         QL D        Q
Sbjct: 64  VQLYAVCSEEEP-------IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVD-----MAAQ 111

Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---Y 210
           +  G+ Y+ S + +HRDL   N+L+  +   KI DFGLAR   E D  T     ++   +
Sbjct: 112 IAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLI-EDDEYTAREGAKFPIKW 170

Query: 211 RAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
            APE   N   +T   D+WS G +L EI+T  R P +PG
Sbjct: 171 TAPE-AANYGRFTIKSDVWSFGILLTEIVTYGRVP-YPG 207

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 72.0 bits (176), Expect = 9e-15
 Identities = 62/227 (27%), Positives = 113/227 (49%), Gaps = 21/227 (9%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHM-EHENVI 104
           I  IG+G YG V   +N +   + A+K      D I D    +  E  +L+ + +H NV+
Sbjct: 23  IETIGKGTYGKVFKVLNKKNGSKAAVK----ILDPIHDIDEEIEAEYNILKALSDHPNVV 78

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQ-IIRSDQQLTDDHCQYFLYQLLRGLK 159
               +         + +++V EL +    TDL +  ++  +++ +    Y L++ L GL+
Sbjct: 79  KFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQ 138

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLN 218
           ++H    +HRD+K +N+LL     +K+ DFG+ A+ TS        V T ++ APE++  
Sbjct: 139 HLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA- 197

Query: 219 C-----TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           C     + Y A  D+WS+G    E+   +P  P  D +H +R + ++
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIELGDGDP--PLAD-LHPMRALFKI 241

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 71.6 bits (175), Expect = 1e-14
 Identities = 58/224 (25%), Positives = 108/224 (48%), Gaps = 30/224 (13%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           +E+  + +  ++ +G G +G V     N+ T+  V   K G      +  +  L E  L+
Sbjct: 1   WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-----MSVQAFLEEANLM 55

Query: 96  RHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQ-------QLTDDHC 147
           + ++H+ ++ +  ++   +      +YI+ E M    L   ++SD+       +L D   
Sbjct: 56  KTLQHDKLVRLYAVVTKEEP-----IYIITEYMAKGSLLDFLKSDEGGKVLLPKLID--- 107

Query: 148 QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE---Y 204
             F  Q+  G+ Y+   + +HRDL+ +N+L++ S   KI DFGLAR   + ++       
Sbjct: 108 --FSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAK 165

Query: 205 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 247
              +W  APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 166 FPIKW-TAPE-AINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG 207

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 71.6 bits (175), Expect = 1e-14
 Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 19/205 (9%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHEN 102
           I+ +G G YG V  A N  T E  A+K I    G+ F  I       +EI +++  +H N
Sbjct: 14  IQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLI------QQEIFMVKECKHCN 67

Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           ++A        +K     ++I  E      L  I      L++    Y   + L+GL Y+
Sbjct: 68  IVAYFGSYLSREK-----LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYL 122

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPEL--LLN 218
           HS   +HRD+K +N+LL  + D+K+ DFG+ A+ T+       ++ T ++ APE+  +  
Sbjct: 123 HSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEK 182

Query: 219 CTEYTAAIDIWSVGCILGEIMTREP 243
              Y    DIW+VG    E+   +P
Sbjct: 183 NGGYNQLCDIWAVGITAIELAELQP 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 71.4 bits (175), Expect = 1e-14
 Identities = 54/202 (26%), Positives = 96/202 (47%), Gaps = 26/202 (12%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR---------TLREIKLLRHMEH 100
           +G+G +G VCA     T +  A KK+        D +R          L E K+L  +  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKL--------DKKRLKKRKGEQMALNEKKILEKVSS 52

Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLY--QLLRG 157
             ++++         +T +D+ +V  LM+  DL   I +  +      +   Y  Q++ G
Sbjct: 53  RFIVSLAYAF-----ETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG 107

Query: 158 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 217
           L+++H   +++RDLKP N+LL+   +++I D GLA        +     T  Y APE+L 
Sbjct: 108 LEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQ 167

Query: 218 NCTEYTAAIDIWSVGCILGEIM 239
               Y  ++D +++GC L E++
Sbjct: 168 G-EVYDFSVDWFALGCTLYEMI 188

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 71.1 bits (174), Expect = 1e-14
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 28/207 (13%)

Query: 50  IGRGAYGIVCAA-VNSETREE--VAIKKIGNAFDNIIDARRT-LREIKLLRHMEHENVIA 105
           IG G +G VC   +    + E  VAIK + + +      RR  L E  ++   +H N+I 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTE--KQRRDFLSEASIMGQFDHPNIIH 69

Query: 106 IKDII---RPPKKDTFNDVYIVYELMDT-DLHQIIR-SDQQLTDDHCQYFLYQLLRGLKY 160
           ++ ++   RP        V I+ E M+   L   +R +D Q T       L  +  G+KY
Sbjct: 70  LEGVVTKSRP--------VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKY 121

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-------TDFMTEYVVTRWYRAP 213
           +   + +HRDL   N+L+N++   K+ DFGL+R   +       T  +   +  RW  AP
Sbjct: 122 LSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW-TAP 180

Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMT 240
           E  +   ++T+A D+WS G ++ E+M+
Sbjct: 181 E-AIAYRKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 71.7 bits (176), Expect = 1e-14
 Identities = 62/222 (27%), Positives = 106/222 (47%), Gaps = 26/222 (11%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII---DARRTLREIKLLRHMEHENVIAI 106
           +G+G++G V  A    T E  AIK +    D II   D   T+ E         + V+A+
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKK--DVIIQDDDVECTMVE---------KRVLAL 56

Query: 107 KDIIRPP-------KKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
               +PP          T + +Y V E ++  DL   I+   +  + H  ++  ++  GL
Sbjct: 57  PG--KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGL 114

Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLL 217
            ++HS  +++RDLK  N++L+A   +KI DFG+ +        T  +  T  Y APE++ 
Sbjct: 115 FFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIA 174

Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
               Y  ++D W+ G +L E++  +P F G+D     + I E
Sbjct: 175 Y-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME 215

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 71.6 bits (176), Expect = 2e-14
 Identities = 62/252 (24%), Positives = 103/252 (40%), Gaps = 69/252 (27%)

Query: 46  PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA 105
            I+ IGRGA+G V      +T    A+KK              LR+ ++L   +  +V A
Sbjct: 5   SIKVIGRGAFGEVRLVQKKDTGHIYAMKK--------------LRKSEMLEKEQVAHVRA 50

Query: 106 IKDIIRPPKKD-------TFNDVYIVYELMD----TDLH-QIIRSDQQLTDDHCQYFLYQ 153
            +DI+             +F D   +Y +M+     D+   +++ D   T++  ++++ +
Sbjct: 51  ERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDT-FTEEETRFYIAE 109

Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY--------- 204
            +  +  +H    +HRD+KP NLLL+A   +K+ DFGL  T  +    TE+         
Sbjct: 110 TILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLC-TGLKKSHRTEFYRILSHALP 168

Query: 205 -------------------------------VVTRWYRAPELLLNCTEYTAAIDIWSVGC 233
                                          V T  Y APE+ L  T Y    D WS+G 
Sbjct: 169 SNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGV 227

Query: 234 ILGEIMTREPLF 245
           I+ E++   P F
Sbjct: 228 IMYEMLVGYPPF 239

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 71.3 bits (175), Expect = 2e-14
 Identities = 46/132 (34%), Positives = 73/132 (55%), Gaps = 7/132 (5%)

Query: 119 NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 176
            ++ I  E MD   L Q+++   ++ ++        +LRGL Y+     ++HRD+KPSN+
Sbjct: 72  GEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNI 131

Query: 177 LLNASCDLKIGDFGLARTTSETDFM-TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 235
           L+N+  ++K+ DFG++      D M   +V TR Y +PE L   T YT   DIWS+G  L
Sbjct: 132 LVNSRGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSL 188

Query: 236 GEIMT-REPLFP 246
            E+   R P+ P
Sbjct: 189 VEMAIGRYPIPP 200

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 71.4 bits (175), Expect = 3e-14
 Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 30/226 (13%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           I+ +  G+ G V  A     + +  + KIG           TL E  LL+++ H +VI +
Sbjct: 71  IKTLTPGSEGRVFVA-TKPGQPDPVVLKIGQK-------GTTLIEAMLLQNVNHPSVIRM 122

Query: 107 KD-IIRPPKKDTFNDVYIVYELMDTDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           KD ++            +V     +DL+  + +  + L  D       Q+L GL+Y+H+ 
Sbjct: 123 KDTLVSGAI------TCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ 176

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
            ++HRD+K  N+ +N    + IGD G A+       F+     T    APE+L    +Y 
Sbjct: 177 RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG-LAGTVETNAPEVLAR-DKYN 234

Query: 224 AAIDIWSVGCILGEIMT------REPLFPGKDYV-----HQLRLIT 258
           +  DIWS G +L E++        +P    ++YV     H L++I+
Sbjct: 235 SKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIIS 280

Length = 357

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 70.2 bits (172), Expect = 3e-14
 Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 48/215 (22%)

Query: 47  IRPIGRGAYGIVCAAVNSETR--EEVAIKKIGN---AFDNIIDARRTLREIKLLRHMEHE 101
           ++ +G G +G+V      + R   +VAIK I     + D+ I+      E K++  + H 
Sbjct: 9   LKELGSGQFGVV---HLGKWRGKIDVAIKMIREGAMSEDDFIE------EAKVMMKLSHP 59

Query: 102 NVIAIKDII---RPPKKDTFNDVYIVYELMDTD-LHQIIRSDQ-----QLTDDHCQYFLY 152
           N++ +  +    RP        ++IV E M    L   +R  +     +   D C     
Sbjct: 60  NLVQLYGVCTKQRP--------IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCS---- 107

Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-------TTSETDFMTEYV 205
            +   ++Y+ S   +HRDL   N L+     +K+ DFGLAR       T+S+    T++ 
Sbjct: 108 DVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG---TKFP 164

Query: 206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           V +W  AP  + + + +++  D+WS G ++ E+ +
Sbjct: 165 V-KW--APPEVFDYSRFSSKSDVWSFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 70.4 bits (172), Expect = 3e-14
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 16/205 (7%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR----TLREIKLLRHMEHENV 103
           R +G+G +G VCA     T +  A KK+       I  R+     L E ++L  +    V
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEK---KRIKKRKGESMALNEKQILEKVNSRFV 62

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM---DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           +++         +T + + +V  LM   D   H     +    +    ++  ++  GL+ 
Sbjct: 63  VSLA-----YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLED 117

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +H   +++RDLKP N+LL+    ++I D GLA    E   +   V T  Y APE++ N  
Sbjct: 118 LHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN-E 176

Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            YT + D W++GC+L E++  +  F
Sbjct: 177 RYTFSPDWWALGCLLYEMIAGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 70.6 bits (173), Expect = 3e-14
 Identities = 62/209 (29%), Positives = 109/209 (52%), Gaps = 26/209 (12%)

Query: 47  IRPIGRGAYGIV--CA--AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN 102
           I+ +G+G +G V  C    +   T E VA+KK+ ++    +  R   REI++L+ ++H+N
Sbjct: 9   IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHL--RDFEREIEILKSLQHDN 66

Query: 103 VIAIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLK 159
           ++  K +     +    ++ +V E L    L   ++  ++  D H +  LY  Q+ +G++
Sbjct: 67  IVKYKGVCYSAGR---RNLRLVMEYLPYGSLRDYLQKHRERLD-HRKLLLYASQICKGME 122

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--------WYR 211
           Y+ S   +HRDL   N+L+ +   +KIGDFGL +   +     EY   R        WY 
Sbjct: 123 YLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD---KEYYKVREPGESPIFWY- 178

Query: 212 APELLLNCTEYTAAIDIWSVGCILGEIMT 240
           APE  L  ++++ A D+WS G +L E+ T
Sbjct: 179 APE-SLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 70.6 bits (173), Expect = 4e-14
 Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 22/204 (10%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA---- 105
           +G G++G V  A +  T E  AIK         +  R  L+ +K ++H+  E  I     
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIK--------CLKKREILK-MKQVQHVAQEKSILMELS 76

Query: 106 ---IKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
              I +++   + +  N VY + E ++  +L   +R   +  +D  +++  +L+   +Y+
Sbjct: 77  HPFIVNMMCSFQDE--NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYL 134

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
           HS  +++RDLKP NLLL+    +K+ DFG A+   +  F      T  Y APE ++    
Sbjct: 135 HSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT--LCGTPEYLAPE-VIQSKG 191

Query: 222 YTAAIDIWSVGCILGEIMTREPLF 245
           +  A+D W++G +L E +   P F
Sbjct: 192 HGKAVDWWTMGVLLYEFIAGYPPF 215

Length = 329

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 69.8 bits (171), Expect = 4e-14
 Identities = 62/230 (26%), Positives = 104/230 (45%), Gaps = 42/230 (18%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIK--KIGNAFDNIIDARRTLREIK 93
           +E+    +  +R +G G +G V   + N+ T   VA+K  K G       D +  L E +
Sbjct: 1   WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTT--PVAVKTLKPGTM-----DPKDFLAEAQ 53

Query: 94  LLRHMEHENVI---AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSD-------QQL 142
           +++ + H  +I   A+  +  P        +YIV ELM    L + ++          QL
Sbjct: 54  IMKKLRHPKLIQLYAVCTLEEP--------IYIVTELMKYGSLLEYLQGGAGRALKLPQL 105

Query: 143 TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 202
            D        Q+  G+ Y+ + + +HRDL   N+L+  +   K+ DFGLAR   E  +  
Sbjct: 106 ID-----MAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-E 159

Query: 203 EYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
                ++   + APE       ++   D+WS G +L EI+T  R P +PG
Sbjct: 160 AREGAKFPIKWTAPE-AALYNRFSIKSDVWSFGILLTEIVTYGRMP-YPG 207

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 70.1 bits (171), Expect = 5e-14
 Identities = 59/222 (26%), Positives = 109/222 (49%), Gaps = 37/222 (16%)

Query: 48  RPIGRGAYGIVCAA----VNSETREE---VAIKKI-GNAFDNIIDARRTLREIKLLRHM- 98
           +P+G G +G V  A    ++ +  +E   VA+K +  +A +   D    + E+++++ + 
Sbjct: 21  KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIG 78

Query: 99  EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR----------------SDQQ 141
           +H+N+I   +++    +D    +Y++ E     +L + +R                 D+Q
Sbjct: 79  KHKNII---NLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133

Query: 142 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM 201
           +T        YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  D+ 
Sbjct: 134 MTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYY 193

Query: 202 TEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
            +    R    + APE L +   YT   D+WS G ++ EI T
Sbjct: 194 KKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 70.0 bits (171), Expect = 5e-14
 Identities = 67/251 (26%), Positives = 109/251 (43%), Gaps = 56/251 (22%)

Query: 48  RPIGRGAYGIVCAA----VNSETREE---VAIKKI-GNAFDNIIDARRTLREIKLLRHM- 98
           +P+G G +G V  A    ++    ++   VA+K +  NA D   D    + E++L++ + 
Sbjct: 18  KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDK--DLADLISEMELMKLIG 75

Query: 99  EHENVIAIKDII-------------------------RPPKKDTFNDVYIVYELMDTDLH 133
           +H+N+I +  +                          RPP  D   D+  V E       
Sbjct: 76  KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPE------- 128

Query: 134 QIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR 193
                 +QL+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR
Sbjct: 129 ------EQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR 182

Query: 194 TTSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMTR--EPLFPGK 248
              + D+  +    R    + APE L +   YT   D+WS G ++ EI T    P +PG 
Sbjct: 183 GVHDIDYYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSP-YPGI 240

Query: 249 DYVHQLRLITE 259
                 +L+ E
Sbjct: 241 PVEELFKLLRE 251

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 69.8 bits (171), Expect = 5e-14
 Identities = 50/197 (25%), Positives = 89/197 (45%), Gaps = 11/197 (5%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  +G GA G V       T    A+K I     N    ++ LRE+++ +  +   ++  
Sbjct: 6   LSRLGEGAGGSVTKCRLKNTGMIFALKTI-TTDPNPDLQKQILRELEINKSCKSPYIVKY 64

Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQL----LRGLKYV 161
                     +   + I  E  +   L  I +  ++      +  L ++    L+GL Y+
Sbjct: 65  YGAFLDESSSS---IGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
           HS  ++HRD+KPSN+LL     +K+ DFG++     +   T +  T +Y APE +     
Sbjct: 122 HSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT-FTGTSFYMAPERIQG-KP 179

Query: 222 YTAAIDIWSVGCILGEI 238
           Y+   D+WS+G  L E+
Sbjct: 180 YSITSDVWSLGLTLLEV 196

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 69.1 bits (169), Expect = 7e-14
 Identities = 56/219 (25%), Positives = 107/219 (48%), Gaps = 21/219 (9%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           +EV  + +  ++ +G G +G V     +   + VAIK +       +     L E  L++
Sbjct: 1   WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTK-VAIKSLK---QGSMSPEAFLAEANLMK 56

Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ--QLTDDHCQYFLYQ 153
            ++H  ++ +  ++      T   +YI+ E M+   L   +++ +  +LT +       Q
Sbjct: 57  QLQHPRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQ 110

Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE---YVVTRWY 210
           +  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + ++          +W 
Sbjct: 111 IAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKW- 169

Query: 211 RAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
            APE  +N   +T   D+WS G +L EI+T  R P +PG
Sbjct: 170 TAPE-AINYGTFTIKSDVWSFGILLTEIVTYGRIP-YPG 206

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 69.7 bits (170), Expect = 7e-14
 Identities = 53/213 (24%), Positives = 105/213 (49%), Gaps = 13/213 (6%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR----RTLREIKLLRHMEHENVIA 105
           +G+G +G V       + +  A+K +      +I A+     TL E ++L++  H  + +
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKK---EVIIAKDEVAHTLTESRVLKNTRHPFLTS 59

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
           +K   +   +  F   Y+       +L   +  ++  ++D  +++  +++  L Y+HS  
Sbjct: 60  LKYSFQTKDRLCFVMEYV----NGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK 115

Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           +++RDLK  NL+L+    +KI DFGL +   ++   M  +  T  Y APE+L +  +Y  
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLED-NDYGR 174

Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           A+D W +G ++ E+M     F  +D+     LI
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 207

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 70.9 bits (173), Expect = 7e-14
 Identities = 68/238 (28%), Positives = 107/238 (44%), Gaps = 33/238 (13%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           I+ IG G +G V    +  T+E    K I        +  + + E+ ++R ++H+N++  
Sbjct: 18  IKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRY 77

Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQL---TDDHCQY-FLYQLLRGLKYV 161
            D  R   K     +YI+ E  D  DL + I+   ++    ++H       QLL  L Y 
Sbjct: 78  ID--RFLNKAN-QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYC 134

Query: 162 HS-------ASVLHRDLKPSNLLL-----------------NASCDLKIGDFGLARTTSE 197
           H+         VLHRDLKP N+ L                 N     KIGDFGL++    
Sbjct: 135 HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI 194

Query: 198 TDFMTEYVVTRWYRAPELLLNCTE-YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
                  V T +Y +PELLL+ T+ Y    D+W++GCI+ E+ + +  F   +   QL
Sbjct: 195 ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQL 252

Length = 1021

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 69.6 bits (170), Expect = 8e-14
 Identities = 51/212 (24%), Positives = 109/212 (51%), Gaps = 17/212 (8%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIK-----LLRHMEHENVI 104
           IG+G++G V  A      +  A+K +      I+  R+  + I      LL++++H  ++
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQK---KIVLNRKEQKHIMAERNVLLKNVKHPFLV 59

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
            +    +  +K     +Y V + ++  +L   ++ ++   +   +++  ++   L Y+HS
Sbjct: 60  GLHYSFQTTEK-----LYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS 114

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEY 222
            ++++RDLKP N+LL++   + + DFGL +   +++D  T +  T  Y APE++     Y
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRK-QPY 173

Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
              +D W +G +L E++   P F  +D V ++
Sbjct: 174 DNTVDWWCLGAVLYEMLYGLPPFYCRD-VAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 69.3 bits (169), Expect = 1e-13
 Identities = 56/212 (26%), Positives = 102/212 (48%), Gaps = 11/212 (5%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRH 97
           E+       I  +G G  G+V    +  +   +A K I       I   + +RE+++L  
Sbjct: 1   ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAI-RNQIIRELQVLHE 59

Query: 98  MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 156
                ++            +  ++ I  E MD   L Q+++  +++ ++        +LR
Sbjct: 60  CNSPYIVGFYGAFY-----SDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLR 114

Query: 157 GLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL 215
           GL Y+     ++HRD+KPSN+L+N+  ++K+ DFG++    ++     +V TR Y +PE 
Sbjct: 115 GLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE- 172

Query: 216 LLNCTEYTAAIDIWSVGCILGEI-MTREPLFP 246
            L  T Y+   DIWS+G  L E+ + R P+ P
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 69.0 bits (169), Expect = 1e-13
 Identities = 66/234 (28%), Positives = 110/234 (47%), Gaps = 54/234 (23%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           I+ I  GAYG V    + ETR+  A+KKI     N+I           LR+ + + V   
Sbjct: 6   IKLISNGAYGAVYLVRHKETRQRFAMKKINK--QNLI-----------LRN-QIQQVFVE 51

Query: 107 KDIIRPPKKDTFND------VYIVYE-------LMD----TDLHQIIRSDQQLTDDHCQY 149
           +DI+      TF +      ++  +E       +M+     D   ++++   L  D  + 
Sbjct: 52  RDIL------TFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARM 105

Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR------TTS------E 197
           +  + +  L+Y+H+  ++HRDLKP NLL+ +   +K+ DFGL++      TT+      E
Sbjct: 106 YFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIE 165

Query: 198 TD---FMTEYVV-TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG 247
            D   F+ + V  T  Y APE++L    Y   +D W++G IL E +     F G
Sbjct: 166 KDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFG 218

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 69.1 bits (169), Expect = 1e-13
 Identities = 58/214 (27%), Positives = 106/214 (49%), Gaps = 15/214 (7%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR----RTLREIKLLRHMEHENVIA 105
           +G+G +G V       T +  A+K +      +I A+     TL E ++L++  H  + A
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKE---VIIAKDEVAHTLTESRVLQNTRHPFLTA 59

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           +K   +   +  F     V E  +  +L   +  ++  ++D  +++  +++  L Y+HS 
Sbjct: 60  LKYSFQTHDRLCF-----VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSC 114

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYT 223
            V++RDLK  NL+L+    +KI DFGL +   S+   M  +  T  Y APE+L +  +Y 
Sbjct: 115 DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYG 173

Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
            A+D W +G ++ E+M     F  +D+     LI
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 207

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 68.5 bits (167), Expect = 1e-13
 Identities = 62/217 (28%), Positives = 100/217 (46%), Gaps = 36/217 (16%)

Query: 50  IGRGAYGIV----CAAVNSET-REEVAIKKIGNAFDNIIDARRTL-REIKLLRHMEHENV 103
           +G GA+G V    C  +  E  +  VA+K +  A ++   AR+   RE +LL  ++H+++
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES---ARQDFQREAELLTVLQHQHI 69

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRS--------DQ-------QLTDDHC 147
           +    +    +      + +V+E M   DL++ +RS                 QLT    
Sbjct: 70  VRFYGVCTEGRP-----LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQM 124

Query: 148 QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TE 203
                Q+  G+ Y+ S   +HRDL   N L+     +KIGDFG++R    TD+       
Sbjct: 125 LAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 184

Query: 204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
            +  RW   PE +L   ++T   DIWS G +L EI T
Sbjct: 185 MLPIRWM-PPESILY-RKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 68.5 bits (167), Expect = 1e-13
 Identities = 67/227 (29%), Positives = 111/227 (48%), Gaps = 39/227 (17%)

Query: 48  RPIGRGAYGIVCAAVN---SETREE--VAIKKIGNAFDNIIDARRTL-REIKLLRHMEHE 101
           R +G GA+G V  A     S T+++  VA+K +    D  + AR+   RE +LL +++HE
Sbjct: 11  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK---DPTLAARKDFQREAELLTNLQHE 67

Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS---------DQQLTDDHCQYFL 151
           +++    +         + + +V+E M   DL++ +R+         D Q      +  L
Sbjct: 68  HIVKFYGVCGDG-----DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122

Query: 152 YQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT-- 202
            Q+L        G+ Y+ S   +HRDL   N L+ A+  +KIGDFG++R    TD+    
Sbjct: 123 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 182

Query: 203 --EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLF 245
               +  RW   PE ++   ++T   D+WS G IL EI T  ++P F
Sbjct: 183 GHTMLPIRWM-PPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWF 227

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 37/101 (36%), Positives = 58/101 (57%), Gaps = 4/101 (3%)

Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET---DFMTEYVV 206
             YQ++  L  VHS  ++HRDLK +N+ L  +  +K+GDFG ++  S++   D  + +  
Sbjct: 174 LFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCG 233

Query: 207 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG 247
           T +Y APEL      Y+   D+WS+G IL E++T    F G
Sbjct: 234 TPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKG 273

Length = 478

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 68.5 bits (167), Expect = 2e-13
 Identities = 58/219 (26%), Positives = 107/219 (48%), Gaps = 25/219 (11%)

Query: 50  IGRGAYGIVCAAVNSET---------REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH 100
           +G+G +G V       T         R+EV I K     D +     T+ E ++L++  H
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAK-----DEVA---HTVTESRVLQNTRH 54

Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
             + A+K   +     T + +  V E  +  +L   +  ++  T++  +++  +++  L+
Sbjct: 55  PFLTALKYAFQ-----THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 109

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLN 218
           Y+HS  V++RD+K  NL+L+    +KI DFGL +   S+   M  +  T  Y APE+L +
Sbjct: 110 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED 169

Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
             +Y  A+D W +G ++ E+M     F  +D+     LI
Sbjct: 170 -NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 207

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 68.3 bits (167), Expect = 2e-13
 Identities = 33/107 (30%), Positives = 64/107 (59%), Gaps = 2/107 (1%)

Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
           +D   ++L ++   L+++H   +++RDLKP N+LL+A   +K+ DFGL + +     +T 
Sbjct: 99  EDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158

Query: 204 -YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
            +  T  Y APE+L+    +  A+D WS+G ++ +++T  P F  ++
Sbjct: 159 TFCGTIEYMAPEILMRSG-HGKAVDWWSLGALMYDMLTGAPPFTAEN 204

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 67.8 bits (165), Expect = 2e-13
 Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 25/210 (11%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA---- 105
           +G G YG V    + +T +  AIK +    D   +     +EI +L+   H   IA    
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYG 70

Query: 106 --IKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
             IK    PP  D  + +++V E       TDL +  + +  L ++   Y   ++LRGL 
Sbjct: 71  AFIKK--NPPGMD--DQLWLVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICREILRGLS 125

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLN 218
           ++H   V+HRD+K  N+LL  + ++K+ DFG++     T      ++ T ++ APE++  
Sbjct: 126 HLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA- 184

Query: 219 CTE-----YTAAIDIWSVGCILGEIMTREP 243
           C E     Y    D+WS+G    E+    P
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEGAP 214

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 67.5 bits (165), Expect = 2e-13
 Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 23/203 (11%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
             IG+G +G V   V  +   EVA+K    +       R+ L+E ++L+  +H N++ + 
Sbjct: 1   EKIGKGNFGDVYKGV-LKGNTEVAVKTC-RSTLPPDLKRKFLQEAEILKQYDHPNIVKLI 58

Query: 108 DII--RPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
            +   + P       +YIV EL+     L  + +   +LT             G++Y+ S
Sbjct: 59  GVCVQKQP-------IYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES 111

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM------TEYVVTRWYRAPELLL 217
            + +HRDL   N L+  +  LKI DFG++R   E   +       + +  +W  APE  L
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKW-TAPE-AL 167

Query: 218 NCTEYTAAIDIWSVGCILGEIMT 240
           N   YT+  D+WS G +L E  +
Sbjct: 168 NYGRYTSESDVWSYGILLWETFS 190

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 67.7 bits (165), Expect = 3e-13
 Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 10/202 (4%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR----TLREIKLLRHMEHENV 103
           R +G+G +G VCA     T +  A KK+       I  R+     L E ++L  +    V
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEK---KRIKKRKGEAMALNEKRILEKVNSRFV 62

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           +++        KD    V  +    D   H     +    +    ++  +L  GL+ +  
Sbjct: 63  VSLAYAYE--TKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
             +++RDLKP N+LL+    ++I D GLA    E + +   V T  Y APE++ N  +YT
Sbjct: 121 ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINN-EKYT 179

Query: 224 AAIDIWSVGCILGEIMTREPLF 245
            + D W +GC++ E++  +  F
Sbjct: 180 FSPDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 67.7 bits (165), Expect = 3e-13
 Identities = 42/135 (31%), Positives = 74/135 (54%), Gaps = 3/135 (2%)

Query: 117 TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 175
           T  +++ V E ++  DL   I+S  +       ++  +++ GL+++HS  +++RDLK  N
Sbjct: 67  TKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDN 126

Query: 176 LLLNASCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 234
           +LL+    +KI DFG+ +     D  T  +  T  Y APE+LL   +Y  ++D WS G +
Sbjct: 127 ILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG-QKYNTSVDWWSFGVL 185

Query: 235 LGEIMTREPLFPGKD 249
           L E++  +  F G D
Sbjct: 186 LYEMLIGQSPFHGHD 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 68.1 bits (166), Expect = 3e-13
 Identities = 66/258 (25%), Positives = 107/258 (41%), Gaps = 74/258 (28%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           I+ +G GA+G VC A   +T                + A +TLR+  +L   +  +V A 
Sbjct: 6   IKTLGIGAFGEVCLARKVDT--------------KALYAMKTLRKKDVLLRNQVAHVKAE 51

Query: 107 KDIIRPPKKD-------TFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLL 155
           +DI+     +       +F D   +Y +MD     D+  ++       +D  ++++ +L 
Sbjct: 52  RDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELT 111

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSET-------------- 198
             ++ VH    +HRD+KP N+L++    +K+ DFGL    R T ++              
Sbjct: 112 CAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSM 171

Query: 199 DFMTEY-------------------------------VVTRWYRAPELLLNCTEYTAAID 227
           DF  E+                               V T  Y APE+LL  T YT   D
Sbjct: 172 DFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCD 230

Query: 228 IWSVGCILGEIMTREPLF 245
            WSVG IL E++  +P F
Sbjct: 231 WWSVGVILYEMLVGQPPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 67.5 bits (165), Expect = 4e-13
 Identities = 35/120 (29%), Positives = 66/120 (55%), Gaps = 2/120 (1%)

Query: 131 DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG 190
           DL   I+S  +  +   +++  +++ GL+++H   +++RDLK  N+LL+    +KI DFG
Sbjct: 82  DLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFG 141

Query: 191 LARTTSETDFMTE-YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
           + +     +     +  T  Y APE+L    +Y  ++D WS G +L E++  +  F G+D
Sbjct: 142 MCKENMNGEGKASTFCGTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGED 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 67.0 bits (163), Expect = 4e-13
 Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 33/212 (15%)

Query: 50  IGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G +G V     N  TR  VAIK +       +     L+E ++++ + HE ++ +  
Sbjct: 14  LGQGCFGEVWMGTWNGTTR--VAIKTLKPG---TMSPEAFLQEAQVMKKLRHEKLVQLYA 68

Query: 109 IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKY 160
           ++      +   +YIV E M    L   ++ +        QL D        Q+  G+ Y
Sbjct: 69  VV------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD-----MAAQIASGMAY 117

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPELLL 217
           V   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L
Sbjct: 118 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL 176

Query: 218 NCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
               +T   D+WS G +L E+ T  R P +PG
Sbjct: 177 Y-GRFTIKSDVWSFGILLTELTTKGRVP-YPG 206

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 67.7 bits (165), Expect = 4e-13
 Identities = 45/136 (33%), Positives = 64/136 (47%), Gaps = 5/136 (3%)

Query: 128 MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG 187
           MD         ++QLT        YQ+ RG++Y+ S   +HRDL   N+L+     +KI 
Sbjct: 117 MDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIA 176

Query: 188 DFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL 244
           DFGLAR     D+  +    R    + APE L +   YT   D+WS G +L EI T    
Sbjct: 177 DFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGS 235

Query: 245 -FPGKDYVHQLRLITE 259
            +PG       +L+ E
Sbjct: 236 PYPGIPVEELFKLLKE 251

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 66.3 bits (162), Expect = 6e-13
 Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 40/216 (18%)

Query: 50  IGRGAYGIVCAAVNSE---TREEVAIK--KIGNAFDNIIDARRTLREIKLLRHMEHENVI 104
           +G G++G+V     S        VA+K  K     D + D    L+E  ++  ++HEN+I
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDD---FLKEAAIMHSLDHENLI 59

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY--------QLLR 156
            +  ++                +M T+L  +     +L  D   +FL         Q+  
Sbjct: 60  RLYGVVLTHPL-----------MMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIAN 108

Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYR----- 211
           G++Y+ S   +HRDL   N+LL +   +KIGDFGL R   + +   ++ V   +      
Sbjct: 109 GMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE---DHYVMEEHLKVPFA 165

Query: 212 --APELLLNCTEYTAAIDIWSVGCILGEIMT--REP 243
             APE  L    ++ A D+W  G  L E+ T   EP
Sbjct: 166 WCAPE-SLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 67.1 bits (164), Expect = 7e-13
 Identities = 65/254 (25%), Positives = 105/254 (41%), Gaps = 70/254 (27%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           I+ IG GA+G VC     +T    A+K              TLR+  +L   +  +V A 
Sbjct: 6   IKTIGIGAFGEVCLVRKVDTNALYAMK--------------TLRKADVLMRNQAAHVKAE 51

Query: 107 KDIIRPPKKD-------TFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLL 155
           +DI+     +       +F D   +Y +MD     D+  ++       +D  ++++ +L 
Sbjct: 52  RDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELT 111

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSET-------------- 198
             ++ VH    +HRD+KP N+L++    +K+ DFGL    R T ++              
Sbjct: 112 CAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSM 171

Query: 199 DFMTEY---------------------------VVTRWYRAPELLLNCTEYTAAIDIWSV 231
           +   E+                           V T  Y APE+LL  T YT   D WSV
Sbjct: 172 EPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSV 230

Query: 232 GCILGEIMTREPLF 245
           G IL E++  +P F
Sbjct: 231 GVILYEMLVGQPPF 244

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 66.3 bits (162), Expect = 7e-13
 Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 23/205 (11%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG+G +G V         ++VA+K +    D+   A+  L E  ++  + H N++ +  +
Sbjct: 14  IGKGEFGDVMLGDYR--GQKVAVKCLK---DDSTAAQAFLAEASVMTTLRHPNLVQLLGV 68

Query: 110 IRPPKKDTFNDVYIVYELMDT-DLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           +        N +YIV E M    L   +RS     +T      F   +  G++Y+   + 
Sbjct: 69  VL-----QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNF 123

Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 226
           +HRDL   N+L++     K+ DFGLA+  S+     +  V +W  APE L    +++   
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPV-KW-TAPEALRE-KKFSTKS 180

Query: 227 DIWSVGCILGEIMT-------REPL 244
           D+WS G +L EI +       R PL
Sbjct: 181 DVWSFGILLWEIYSFGRVPYPRIPL 205

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 66.6 bits (162), Expect = 7e-13
 Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 27/214 (12%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIA 105
           +  +G G YG V    + +T +  AIK      D   D    ++ EI +L+   H   IA
Sbjct: 21  VEVVGNGTYGQVYKGRHVKTGQLAAIK----VMDVTEDEEEEIKLEINMLKKYSHHRNIA 76

Query: 106 ------IKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLL 155
                 IK    PP  D  + +++V E       TDL +  + +  L +D   Y   ++L
Sbjct: 77  TYYGAFIKK--SPPGHD--DQLWLVMEFCGAGSVTDLVKNTKGNA-LKEDWIAYICREIL 131

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPE 214
           RGL ++H+  V+HRD+K  N+LL  + ++K+ DFG++     T      ++ T ++ APE
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE 191

Query: 215 LLLNCTE-----YTAAIDIWSVGCILGEIMTREP 243
           ++  C E     Y    DIWS+G    E+    P
Sbjct: 192 VIA-CDENPDATYDYRSDIWSLGITAIEMAEGAP 224

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 66.9 bits (163), Expect = 8e-13
 Identities = 54/209 (25%), Positives = 102/209 (48%), Gaps = 20/209 (9%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+G++G V  A    T E  AIK        I+     +++  +   M  + V+A+   
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIK--------ILKKDVVIQDDDVECTMVEKRVLALSG- 58

Query: 110 IRPPKK-------DTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
            +PP          T + +Y V E ++  DL   I+   +  + H  ++  ++  GL ++
Sbjct: 59  -KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFL 117

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCT 220
           HS  +++RDLK  N++L++   +KI DFG+ +        T+ +  T  Y APE ++   
Sbjct: 118 HSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPE-IIAYQ 176

Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKD 249
            Y  ++D W+ G +L E++  +  F G+D
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQAPFEGED 205

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 67.5 bits (165), Expect = 8e-13
 Identities = 65/229 (28%), Positives = 102/229 (44%), Gaps = 44/229 (19%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           IR IG+G  G V  A +      VA+KKI  +  +N +  +R LRE K+   + H  ++ 
Sbjct: 7   IRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66

Query: 106 IKDIIRPPKKDTFNDVYIVYELM----DTDLHQIIRSDQQ---LTDDHCQ-----YFL-- 151
           +  I         +D   VY  M       L  +++S  Q   L+ +  +      FL  
Sbjct: 67  VYSI--------CSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSI 118

Query: 152 -YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT--------------- 195
            +++   ++YVHS  VLHRDLKP N+LL    ++ I D+G A                  
Sbjct: 119 FHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178

Query: 196 ----SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               S      + V T  Y APE LL     + + DI+++G IL +++T
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 66.2 bits (161), Expect = 8e-13
 Identities = 61/244 (25%), Positives = 111/244 (45%), Gaps = 29/244 (11%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVC-----AAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           +EV+ + +   R +G+G++G+V        V  E    VAIK + N   ++ +    L E
Sbjct: 1   WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTV-NEAASMRERIEFLNE 59

Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS---DQQLTDDHC 147
             +++     +V+ +  ++   +        ++ ELM   DL   +RS   + +      
Sbjct: 60  ASVMKEFNCHHVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPEMENNPVQA 114

Query: 148 QYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 200
              L ++++       G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+
Sbjct: 115 PPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 174

Query: 201 MTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLR 255
             +     +  RW  +PE L +   +T   D+WS G +L EI T  E  + G      LR
Sbjct: 175 YRKGGKGLLPVRWM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR 232

Query: 256 LITE 259
            + E
Sbjct: 233 FVME 236

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 67.3 bits (164), Expect = 8e-13
 Identities = 63/245 (25%), Positives = 109/245 (44%), Gaps = 21/245 (8%)

Query: 30  YNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL 89
           Y V G   +VS++    +  +G G +G V  A + + +E  A+K + N      DA+  +
Sbjct: 117 YVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEI 176

Query: 90  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQY 149
           + ++ +R  +  +   +  I R  + +T   + IV       L   I      +  H   
Sbjct: 177 QFMEKVRQADPADRFPLMKIQRYFQNET-GHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQ 235

Query: 150 FLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNAS----------------CDLKIGDFGLA 192
            ++Q    L Y H+   ++H DLKP N+L+  S                C ++I D G  
Sbjct: 236 IIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG-- 293

Query: 193 RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH 252
               E    T  V TR YR+PE++L    +  + D+WS+GCI+ E+ T + L+   D + 
Sbjct: 294 GCCDERHSRTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352

Query: 253 QLRLI 257
            L L+
Sbjct: 353 HLHLM 357

Length = 467

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 66.0 bits (161), Expect = 9e-13
 Identities = 49/219 (22%), Positives = 103/219 (47%), Gaps = 17/219 (7%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ +G G +G+V        + +VAIK I    +  +     + E K++  + H  ++ +
Sbjct: 9   MKELGSGQFGVVHLG-KWRAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQL 64

Query: 107 KDIIRPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
             +    K      +YIV E M+    L+ + +   +L+ D        +  G++Y+   
Sbjct: 65  YGVCTQQKP-----LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN 119

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPELLLNCTE 221
           S +HRDL   N L++++  +K+ DFG+ R   + ++ +        +W   PE + N ++
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKW-SPPE-VFNFSK 177

Query: 222 YTAAIDIWSVGCILGEIMTREPL-FPGKDYVHQLRLITE 259
           Y++  D+WS G ++ E+ T   + F  K     + +I+ 
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR 216

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 66.7 bits (163), Expect = 1e-12
 Identities = 57/213 (26%), Positives = 100/213 (46%), Gaps = 15/213 (7%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI--IDARRTLREIKLLRHMEHENVI 104
           I+ IGRGA+G V    +  +++  A+K + + F+ I   D+     E  ++ H   E ++
Sbjct: 48  IKVIGRGAFGEVQLVRHKSSKQVYAMKLL-SKFEMIKRSDSAFFWEERDIMAHANSEWIV 106

Query: 105 AIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
            +    +  K      +Y+V E M   DL  ++ S+  + +   +++  +++  L  +HS
Sbjct: 107 QLHYAFQDDKY-----LYMVMEYMPGGDLVNLM-SNYDIPEKWARFYTAEVVLALDAIHS 160

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLN--- 218
              +HRD+KP N+LL+ S  LK+ DFG          +     V T  Y +PE+L +   
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGG 220

Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV 251
              Y    D WSVG  L E++  +  F     V
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 66.6 bits (162), Expect = 1e-12
 Identities = 56/218 (25%), Positives = 106/218 (48%), Gaps = 30/218 (13%)

Query: 46  PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA 105
            +  +G+G++G V  A    T E  AIK        I+     +++  +   M  + V+A
Sbjct: 4   FLMVLGKGSFGKVMLAERKGTDELYAIK--------ILKKDVVIQDDDVECTMVEKRVLA 55

Query: 106 IKDIIRPPKK-------DTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRG 157
           ++D  +PP          T + +Y V E ++  DL   I+   +  +    ++  ++  G
Sbjct: 56  LQD--KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVG 113

Query: 158 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW------YR 211
           L ++H   +++RDLK  N++L++   +KI DFG+ +     + M + V TR       Y 
Sbjct: 114 LFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCK-----EHMVDGVTTRTFCGTPDYI 168

Query: 212 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
           APE++     Y  ++D W+ G +L E++  +P F G+D
Sbjct: 169 APEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 65.8 bits (160), Expect = 1e-12
 Identities = 54/203 (26%), Positives = 100/203 (49%), Gaps = 27/203 (13%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR---------TLRE---IKLLRH 97
           IGRG +G V     ++T +  A+K         +D +R          L E   + L+  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMK--------CLDKKRIKMKQGETLALNERIMLSLVST 53

Query: 98  MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 156
            +   ++ +      P K  F     + +LM+  DLH  +      ++   +++  +++ 
Sbjct: 54  GDCPFIVCMTYAFHTPDKLCF-----ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIIL 108

Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 216
           GL+++H+  V++RDLKP+N+LL+    ++I D GLA   S+       V T  Y APE+L
Sbjct: 109 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVL 167

Query: 217 LNCTEYTAAIDIWSVGCILGEIM 239
              T Y ++ D +S+GC+L +++
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 67.2 bits (164), Expect = 1e-12
 Identities = 53/202 (26%), Positives = 86/202 (42%), Gaps = 30/202 (14%)

Query: 65  ETREEVAIKKIGNAFDNIIDAR---RTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV 121
            T  EVAIK +    D   +     R  RE  L   + H N++A+ D    P       +
Sbjct: 1   MTGHEVAIKLLRT--DAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAP--PGL--L 54

Query: 122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 180
           + V+E +    L +++ +D  L        + Q+L  L   H+  ++HRDLKP N++++ 
Sbjct: 55  FAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQ 114

Query: 181 SCD---LKIGDFGL------------ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           +      K+ DFG+            A  T      TE + T  Y APE L      T  
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRT----TEVLGTPTYCAPEQLRG-EPVTPN 169

Query: 226 IDIWSVGCILGEIMTREPLFPG 247
            D+++ G I  E +T + +  G
Sbjct: 170 SDLYAWGLIFLECLTGQRVVQG 191

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 66.4 bits (162), Expect = 1e-12
 Identities = 67/261 (25%), Positives = 100/261 (38%), Gaps = 40/261 (15%)

Query: 3   AAAKDSSSGGATSSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAV 62
              + +SS    S V+         +QYN+  +L         P    G      VC   
Sbjct: 76  EPCETTSSSDPASVVR---------MQYNILSSL--------TP----GSEGEVFVCTKH 114

Query: 63  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 122
             E R++V +K +          +   REI +L+ + H  +I +    R   K T   V 
Sbjct: 115 GDEQRKKVIVKAV-------TGGKTPGREIDILKTISHRAIINLIHAYR--WKSTVCMVM 165

Query: 123 IVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC 182
             Y+    DL   +     L  +       +LL  L Y+H   ++HRD+K  N+ L+   
Sbjct: 166 PKYK---CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPE 222

Query: 183 DLKIGDFGLARTTSETDFMTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 239
           +  +GDFG A          +   +  T    +PELL     Y A  DIWS G +L E+ 
Sbjct: 223 NAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLA-LDPYCAKTDIWSAGLVLFEMS 281

Query: 240 T-REPLF--PGKDYVHQLRLI 257
                LF    K    QLR I
Sbjct: 282 VKNVTLFGKQVKSSSSQLRSI 302

Length = 392

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 66.1 bits (161), Expect = 2e-12
 Identities = 45/140 (32%), Positives = 68/140 (48%), Gaps = 19/140 (13%)

Query: 108 DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
           D  R  +  ++ D  +  E+++ D       +  L  +    F YQ+ +G+ ++ S + +
Sbjct: 184 DKRRSVRSGSYIDQDVTSEILEED-------ELALDTEDLLSFSYQVAKGMSFLASKNCI 236

Query: 168 HRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV-------TRWYRAPELLLNCT 220
           HRDL   N+LL      KI DFGLAR     D  + YVV        +W  APE + NC 
Sbjct: 237 HRDLAARNILLTHGRITKICDFGLARDIR-ND--SNYVVKGNARLPVKWM-APESIFNCV 292

Query: 221 EYTAAIDIWSVGCILGEIMT 240
            YT   D+WS G +L EI +
Sbjct: 293 -YTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 65.3 bits (159), Expect = 2e-12
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 35/207 (16%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR---------TLRE---IKLLRH 97
           IGRG +G V     ++T +  A+K         +D +R          L E   + L+  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMK--------CLDKKRIKMKQGETLALNERIMLSLVST 53

Query: 98  MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 156
            +   ++ +      P K +F     + +LM+  DLH  +      ++   +++  +++ 
Sbjct: 54  GDCPFIVCMSYAFHTPDKLSF-----ILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIIL 108

Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTRWYRA 212
           GL+++H+  V++RDLKP+N+LL+    ++I D GLA      DF  +     V T  Y A
Sbjct: 109 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKPHASVGTHGYMA 163

Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIM 239
           PE+L     Y ++ D +S+GC+L +++
Sbjct: 164 PEVLQKGVAYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 64.9 bits (158), Expect = 2e-12
 Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 17/209 (8%)

Query: 48  RPIGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI 104
           R +G+G +G V  A       + ++VA+K +     +  D    LRE   ++  +H NVI
Sbjct: 5   RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64

Query: 105 AIKDI-IRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ------QLTDDHCQYFLYQLLR 156
            +  + +R   K       ++   M   DLH  +   +       L       F+  +  
Sbjct: 65  KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124

Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT----RWYRA 212
           G++Y+ S + +HRDL   N +LN +  + + DFGL++     D+  +   +    +W   
Sbjct: 125 GMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLAL 184

Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMTR 241
             L  N   YT   D+W+ G  + EIMTR
Sbjct: 185 ESLADNV--YTTHSDVWAFGVTMWEIMTR 211

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 65.4 bits (159), Expect = 2e-12
 Identities = 38/105 (36%), Positives = 55/105 (52%), Gaps = 4/105 (3%)

Query: 139 DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 198
           ++QL+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 193

Query: 199 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           D+  +    R    + APE L +   YT   D+WS G +L EI T
Sbjct: 194 DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 65.6 bits (160), Expect = 2e-12
 Identities = 40/109 (36%), Positives = 58/109 (53%), Gaps = 19/109 (17%)

Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE--YVV- 206
           F  Q+ +G+ ++ S + +HRD+   N+LL      KI DFGLAR     D M +  YVV 
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLAR-----DIMNDSNYVVK 271

Query: 207 ------TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
                  +W  APE + +C  YT   D+WS G +L EI +  + P +PG
Sbjct: 272 GNARLPVKWM-APESIFDCV-YTVQSDVWSYGILLWEIFSLGKSP-YPG 317

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 65.0 bits (158), Expect = 3e-12
 Identities = 49/204 (24%), Positives = 102/204 (50%), Gaps = 18/204 (8%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG+G++G V  A +    +  A+K +          ++ + + K  +H+  E  + +K++
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVL---------QKKAILKKKEEKHIMSERNVLLKNV 53

Query: 110 IRP------PKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
             P          T + +Y V + ++  +L   ++ ++   +   +++  ++   L Y+H
Sbjct: 54  KHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLH 113

Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTE 221
           S ++++RDLKP N+LL++   + + DFGL +   E +  T  +  T  Y APE +L+   
Sbjct: 114 SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPE-VLHKQP 172

Query: 222 YTAAIDIWSVGCILGEIMTREPLF 245
           Y   +D W +G +L E++   P F
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 64.5 bits (157), Expect = 3e-12
 Identities = 31/85 (36%), Positives = 49/85 (57%), Gaps = 2/85 (2%)

Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +++GL Y+ S  +LHRD+KPSN+L+N    +K+ DFG++     +     YV T  Y AP
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTYVGTNAYMAP 162

Query: 214 ELLLNCTEYTAAIDIWSVGCILGEI 238
           E +    +Y    D+WS+G    E+
Sbjct: 163 ERISG-EQYGIHSDVWSLGISFMEL 186

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 64.9 bits (158), Expect = 5e-12
 Identities = 40/126 (31%), Positives = 72/126 (57%), Gaps = 8/126 (6%)

Query: 131 DLHQIIRSDQQLTD---DHCQYFLY-QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI 186
           DL Q I+S  +      +H    L+ Q+L  + +VHS  ++HRD+K +N+LL ++  +K+
Sbjct: 125 DLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKL 184

Query: 187 GDFGLARTTSET---DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREP 243
           GDFG ++  + T   D    +  T +Y APE+      Y+   D++S+G +L E++T + 
Sbjct: 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKP-YSKKADMFSLGVLLYELLTLKR 243

Query: 244 LFPGKD 249
            F G++
Sbjct: 244 PFDGEN 249

Length = 496

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 64.2 bits (156), Expect = 5e-12
 Identities = 50/213 (23%), Positives = 104/213 (48%), Gaps = 28/213 (13%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG+G++G V           +A +K   +F     A + L++  +L+  E  +++A +++
Sbjct: 3   IGKGSFGKVL----------LAKRKSDGSFY----AVKVLQKKTILKKKEQNHIMAERNV 48

Query: 110 IRPPKKDTF-----------NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRG 157
           +    K  F             +Y V + ++  +L   ++ ++   +   +++  ++   
Sbjct: 49  LLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASA 108

Query: 158 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELL 216
           + Y+HS ++++RDLKP N+LL++   + + DFGL +   E +  T  +  T  Y APE+L
Sbjct: 109 IGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVL 168

Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
                Y   +D W +G +L E++   P F  +D
Sbjct: 169 RK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 63.8 bits (155), Expect = 5e-12
 Identities = 52/205 (25%), Positives = 99/205 (48%), Gaps = 12/205 (5%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+G +G VCA     T +  A KK+    D     +++  ++ LL     E V +   +
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKL----DKKRLKKKSGEKMALLEKEILEKVNSPFIV 56

Query: 110 IRPPKKDTFNDVYIVYELM---DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
                 ++   + +V  LM   D   H     ++ L  +   ++  Q+  G+ ++HS  +
Sbjct: 57  NLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDI 116

Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 226
           ++RD+KP N+LL+   + ++ D GLA    +   +T+   T  Y APE+L     Y+  +
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKE-EPYSYPV 175

Query: 227 DIWSVGCILGEIMT-REPLFPGKDY 250
           D +++GC + E++  R P    KD+
Sbjct: 176 DWFAMGCSIYEMVAGRTPF---KDH 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 64.1 bits (156), Expect = 6e-12
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 24/209 (11%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +GRG +G V       T +  A+K +  +          L +  +    E  ++++I + 
Sbjct: 9   VGRGHFGEVQVVREKATGDIYAMKVMKKS--------VLLAQETVSFFEEERDILSISNS 60

Query: 110 IRPPK-KDTFND---VYIVYELM-DTDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHS 163
              P+ +  F D   +Y+V E     DL  ++ R + Q  +D  Q++L +L+  +  VH 
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMTEYVVTRWYRAPELLL---- 217
              +HRD+KP N+L++ +  +K+ DFG A   T ++       V T  Y APE+L     
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNG 180

Query: 218 --NCTEYTAAIDIWSVGCILGE-IMTREP 243
               T Y    D WS+G I  E I  R P
Sbjct: 181 DGKGT-YGVECDWWSLGVIAYEMIYGRSP 208

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 64.3 bits (156), Expect = 6e-12
 Identities = 57/215 (26%), Positives = 106/215 (49%), Gaps = 16/215 (7%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR----RTLREIKLLRHMEHENVIA 105
           +G+G +G V       T    A+K +      +I A+     TL E ++L++  H  + A
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKK---EVIVAKDEVAHTLTENRVLQNSRHPFLTA 59

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           +K   +     T + +  V E  +  +L   +  ++  ++D  +++  +++  L Y+HS 
Sbjct: 60  LKYSFQ-----THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 114

Query: 165 -SVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEY 222
            +V++RDLK  NL+L+    +KI DFGL +    +   M  +  T  Y APE+L +  +Y
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED-NDY 173

Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
             A+D W +G ++ E+M     F  +D+     LI
Sbjct: 174 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 208

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 64.0 bits (156), Expect = 7e-12
 Identities = 49/208 (23%), Positives = 103/208 (49%), Gaps = 18/208 (8%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG+G++G V  A +    +  A+K         +  ++ + + K  +H+  E  + +K++
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVK---------VLQKKAILKKKEQKHIMAERNVLLKNV 53

Query: 110 IRP------PKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
             P          T + +Y V + ++  +L   ++ ++   +   +++  ++   L Y+H
Sbjct: 54  KHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLH 113

Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLNCTE 221
           S ++++RDLKP N+LL++   + + DFGL +   E +   + +  T  Y APE+L     
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRK-QP 172

Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKD 249
           Y   +D W +G +L E++   P F  +D
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRD 200

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 63.3 bits (154), Expect = 8e-12
 Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 35/219 (15%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 110 I--RPPKKDTFNDVYIVYELMDT-DLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R    Q++      Y   Q+   ++Y+   
Sbjct: 71  CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 123

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---------RWYRAPEL 215
           + +HRDL   N L+  +  +K+ DFGL+R       MT    T         +W  APE 
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSR------LMTGDTYTAHAGAKFPIKW-TAPES 176

Query: 216 LLNCTEYTAAIDIWSVGCILGEIMT--REPLFPGKDYVH 252
           L     ++   D+W+ G +L EI T    P +PG D   
Sbjct: 177 LAYNK-FSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQ 213

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 63.9 bits (155), Expect = 8e-12
 Identities = 41/130 (31%), Positives = 73/130 (56%), Gaps = 5/130 (3%)

Query: 120 DVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLL 177
           ++ I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KPSN+L
Sbjct: 77  EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNIL 136

Query: 178 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 237
           +N+  ++K+ DFG++    ++     +V TR Y +PE  L  T Y+   DIWS+G  L E
Sbjct: 137 VNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVE 194

Query: 238 I-MTREPLFP 246
           + + R P+ P
Sbjct: 195 MAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 63.7 bits (155), Expect = 1e-11
 Identities = 54/202 (26%), Positives = 100/202 (49%), Gaps = 14/202 (6%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII---DARRTLREIKLLR-HMEHENVIA 105
           +G+G++G V  A    T E  AIK +    D I+   D   T+ E ++L    +H  + A
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKK--DVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           +    +   +     ++ V E ++  DL   I+  ++  +   +++  ++   L ++H  
Sbjct: 61  LHCCFQTKDR-----LFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH 115

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEYT 223
            V++RDLK  N+LL+A    K+ DFG+ +        T  +  T  Y APE+L    EY 
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQE-LEYG 174

Query: 224 AAIDIWSVGCILGEIMTREPLF 245
            ++D W++G ++ E+M  +P F
Sbjct: 175 PSVDWWALGVLMYEMMAGQPPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 63.5 bits (154), Expect = 1e-11
 Identities = 50/203 (24%), Positives = 101/203 (49%), Gaps = 13/203 (6%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAF---DNIIDARRTLREIKLLRHMEHENVI 104
           R IGRG+Y  V      +T    A+K +       D  ID  +T + +   +   H  ++
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHV-FEQASNHPFLV 59

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
            +    +     T + ++ V E ++  DL   ++  ++L ++H +++  ++   L Y+H 
Sbjct: 60  GLHSCFQ-----TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 114

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEY 222
             +++RDLK  N+LL++   +K+ D+G+ +      D  + +  T  Y APE+L    +Y
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDY 173

Query: 223 TAAIDIWSVGCILGEIMT-REPL 244
             ++D W++G ++ E+M  R P 
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 62.9 bits (153), Expect = 1e-11
 Identities = 42/174 (24%), Positives = 83/174 (47%), Gaps = 33/174 (18%)

Query: 86  RRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF-------NDVYIVYELMDTD-LHQIIR 137
           ++ LRE++++       ++            +F       N++ +  E MD   L +I +
Sbjct: 48  KQILRELQIMHECRSPYIV------------SFYGAFLNENNICMCMEFMDCGSLDRIYK 95

Query: 138 SDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFG----LA 192
               +  +        ++ GL Y+++   ++HRD+KPSN+L+N+   +K+ DFG    L 
Sbjct: 96  KGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155

Query: 193 RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFP 246
            + ++T     +V T  Y +PE  +   +YT   D+WS+G  + E+   +  FP
Sbjct: 156 NSIADT-----FVGTSTYMSPE-RIQGGKYTVKSDVWSLGISIIELALGK--FP 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 61.9 bits (150), Expect = 2e-11
 Identities = 44/161 (27%), Positives = 77/161 (47%), Gaps = 16/161 (9%)

Query: 87  RTLREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQL 142
           + L E ++L+  +H N++ +  +   R P       +YIV EL+     L  + +   +L
Sbjct: 38  KFLSEARILKQYDHPNIVKLIGVCTQRQP-------IYIVMELVPGGDFLSFLRKKKDEL 90

Query: 143 TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 202
                  F      G+ Y+ S + +HRDL   N L+  +  LKI DFG++R   +  + +
Sbjct: 91  KTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS 150

Query: 203 ---EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
              + +  +W  APE  LN   Y++  D+WS G +L E  +
Sbjct: 151 SGLKQIPIKW-TAPE-ALNYGRYSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 62.4 bits (152), Expect = 2e-11
 Identities = 54/200 (27%), Positives = 91/200 (45%), Gaps = 38/200 (19%)

Query: 70  VAIKKIGNAFDNIIDARRT-LREIKLLRHMEHENVIAIKDIIR--PPKKDTFNDVYIVYE 126
           VA+K +    D   +AR   L+E+K+L  +   N+  +  +    PP       + ++ E
Sbjct: 49  VAVKVLRP--DASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPP-------LCMIME 99

Query: 127 LMDT-DLHQIIRSDQQLTDDHCQY--------FLY---QLLRGLKYVHSASVLHRDLKPS 174
            M+  DL+Q ++     T               LY   Q+  G++Y+ S + +HRDL   
Sbjct: 100 YMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR 159

Query: 175 NLLLNASCDLKIGDFGLARTTSETDFMTEYVV-------TRWYRAPELLLNCTEYTAAID 227
           N L+  +  +KI DFG++R    +D+   Y V        RW     +LL   ++T   D
Sbjct: 160 NCLVGKNYTIKIADFGMSRNLYSSDY---YRVQGRAPLPIRWMAWESVLL--GKFTTKSD 214

Query: 228 IWSVGCILGEIMT--REPLF 245
           +W+ G  L EI+T  RE  +
Sbjct: 215 VWAFGVTLWEILTLCREQPY 234

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 63.0 bits (153), Expect = 2e-11
 Identities = 49/162 (30%), Positives = 75/162 (46%), Gaps = 26/162 (16%)

Query: 88  TLREIKLLRHMEHENVIAIKDIIRP---------PKKDTFNDVYIVYELMDTDLHQIIRS 138
           ++ E +LLR + H  V+A+ D +R          PK  +    Y+   L    L Q+   
Sbjct: 207 SVHEARLLRRLSHPAVLALLD-VRVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAV 265

Query: 139 DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG---LARTT 195
            +            QLL  + Y+H   ++HRD+K  N+L+N   D+ +GDFG    AR +
Sbjct: 266 AR------------QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313

Query: 196 SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 237
             T F      T    APE+L     YT ++DIWS G ++ E
Sbjct: 314 WSTPFHYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 62.3 bits (151), Expect = 2e-11
 Identities = 33/102 (32%), Positives = 60/102 (58%), Gaps = 2/102 (1%)

Query: 149 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-MTEYVVT 207
           ++  +++ GL+++HS  +++RDLK  N++L+    +KI DFG+ +     D   + +  T
Sbjct: 100 FYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT 159

Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
             Y APE+L    +YT ++D WS G +L E++  +  F G D
Sbjct: 160 PDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDD 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 61.9 bits (150), Expect = 2e-11
 Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 35/226 (15%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           +E+  + +  I+ +G G +G V     N  T+  V   K G      +     L E +++
Sbjct: 1   WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-----MSPESFLEEAQIM 55

Query: 96  RHMEHENVIAIKDII-RPPKKDTFNDVYIVYELMDTDLHQIIRSD--------QQLTDDH 146
           + + H+ ++ +  ++   P       +YIV E M          D          L D  
Sbjct: 56  KKLRHDKLVQLYAVVSEEP-------IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVD-- 106

Query: 147 CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY-- 204
                 Q+  G+ Y+   + +HRDL+ +N+L+      KI DFGLAR   + ++      
Sbjct: 107 ---MAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGA 163

Query: 205 -VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
               +W  APE  L    +T   D+WS G +L E++T  R P +PG
Sbjct: 164 KFPIKW-TAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVP-YPG 206

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 62.3 bits (151), Expect = 2e-11
 Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 6/95 (6%)

Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YV 205
           F +Q+ RG++Y+    ++HRDL   N+L+     +KI DFGL+R   E D   +     +
Sbjct: 132 FAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRI 191

Query: 206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             +W  A E L +   YT   D+WS G +L EI+T
Sbjct: 192 PVKWM-AIESLFDHI-YTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 62.1 bits (151), Expect = 3e-11
 Identities = 51/202 (25%), Positives = 99/202 (49%), Gaps = 13/202 (6%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAF---DNIIDARRTLREIKLLRHMEHENVI 104
           R IGRG+Y  V      +TR   A+K I       D  ID  +T + +       H  ++
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHV-FETASNHPFLV 59

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
            +    +   +     ++ V E +   DL   ++  ++L ++H +++  ++   L ++H 
Sbjct: 60  GLHSCFQTESR-----LFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHE 114

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEY 222
             +++RDLK  N+LL+A   +K+ D+G+ +      D  + +  T  Y APE+L    +Y
Sbjct: 115 RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRG-EDY 173

Query: 223 TAAIDIWSVGCILGEIMT-REP 243
             ++D W++G ++ E+M  R P
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 61.6 bits (149), Expect = 3e-11
 Identities = 54/226 (23%), Positives = 101/226 (44%), Gaps = 21/226 (9%)

Query: 48  RPIGRGAYGIVCAAV--NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           + +G G +G V        ++  +VA+K +  A     +    L E   ++  +H NV+ 
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64

Query: 106 IKDI-IRPPKKDTFNDVYIVYELMD-TDLHQII------RSDQQLTDDHCQYFLYQLLRG 157
           +  + ++  + + +    ++   M   DLH  +         Q L       F+  +  G
Sbjct: 65  LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124

Query: 158 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPE 214
           ++Y+ S S +HRDL   N +LN + ++ + DFGL++     D+  +  + +    + A E
Sbjct: 125 MEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIE 184

Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPG------KDYVHQ 253
            L +   YT   D+WS G  + EI TR +  +PG       DY+ Q
Sbjct: 185 SLADRV-YTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ 229

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 61.4 bits (149), Expect = 3e-11
 Identities = 63/236 (26%), Positives = 106/236 (44%), Gaps = 36/236 (15%)

Query: 50  IGRGAYGIVCAAV------NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV 103
           +G GA+G V                 VA+K +        + +  L+E  L+ +  H N+
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG-ATDQEKKEFLKEAHLMSNFNHPNI 61

Query: 104 IAIKDIIRPPKKDTFND-VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLL------ 155
           + +  +         N+  YI+ ELM+  DL   +R  +          L +LL      
Sbjct: 62  VKLLGVC------LLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDV 115

Query: 156 -RGLKYVHSASVLHRDLKPSNLLLNAS---CD--LKIGDFGLARTTSETDFMTE----YV 205
            +G  Y+     +HRDL   N L++      D  +KIGDFGLAR   ++D+  +     +
Sbjct: 116 AKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175

Query: 206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPGKDYVHQLRLITE 259
             RW  APE LL+  ++T   D+WS G ++ EI+T  ++P +P  +    L+ +T 
Sbjct: 176 PVRWM-APESLLD-GKFTTQSDVWSFGVLMWEILTLGQQP-YPALNNQEVLQHVTA 228

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 61.8 bits (150), Expect = 3e-11
 Identities = 51/200 (25%), Positives = 100/200 (50%), Gaps = 19/200 (9%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR----TLREIKLLRHMEHENVIA 105
           +G+G +G V A     T +  A KK+       +  R+     + E ++L  +    +++
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNK---KRLKKRKGYEGAMVEKRILAKVHSRFIVS 57

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDT-DL-HQIIRSDQQ---LTDDHCQYFLYQLLRGLKY 160
           +    +     T  D+ +V  +M+  DL + I   D++     +    ++  Q++ GL++
Sbjct: 58  LAYAFQ-----TKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEH 112

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNC 219
           +H   +++RDLKP N+LL+   +++I D GLA    +    T+ Y  T  + APELL   
Sbjct: 113 LHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQG- 171

Query: 220 TEYTAAIDIWSVGCILGEIM 239
            EY  ++D +++G  L E++
Sbjct: 172 EEYDFSVDYFALGVTLYEMI 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 61.2 bits (148), Expect = 3e-11
 Identities = 52/194 (26%), Positives = 90/194 (46%), Gaps = 14/194 (7%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IGRG +G V +         VA+K         + A+  L+E ++L+   H N++ +  +
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK-FLQEARILKQYSHPNIVRLIGV 61

Query: 110 IRPPKKDTFNDVYIVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVL 167
               +      +YIV EL+   D    +R++  +L        +     G++Y+ S   +
Sbjct: 62  CTQKQP-----IYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCI 116

Query: 168 HRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT----EYVVTRWYRAPELLLNCTEYT 223
           HRDL   N L+     LKI DFG++R   +  + +    + +  +W  APE  LN   Y+
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW-TAPE-ALNYGRYS 174

Query: 224 AAIDIWSVGCILGE 237
           +  D+WS G +L E
Sbjct: 175 SESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 61.2 bits (148), Expect = 4e-11
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 20/212 (9%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG+G +G V   +      +VA+K I N       A+  L E  ++  + H N++ +
Sbjct: 11  LQTIGKGEFGDV--MLGDYRGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQL 64

Query: 107 KDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHS 163
             +I   K      +YIV E M    L   +RS  +  L  D    F   +   ++Y+ +
Sbjct: 65  LGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA 120

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
            + +HRDL   N+L++     K+ DFGL +  S T    +  V +W  APE L    +++
Sbjct: 121 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-KW-TAPEALRE-KKFS 177

Query: 224 AAIDIWSVGCILGEIMT----REPLFPGKDYV 251
              D+WS G +L EI +      P  P KD V
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 209

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 61.0 bits (148), Expect = 4e-11
 Identities = 50/206 (24%), Positives = 95/206 (46%), Gaps = 30/206 (14%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGN---AFDNIIDARRTLREIKLLRHMEHENV 103
           ++ +G G +G+V        + +VAIK I     + D  I+      E K++  + HE +
Sbjct: 9   LKELGTGQFGVVKYG-KWRGQYDVAIKMIKEGSMSEDEFIE------EAKVMMKLSHEKL 61

Query: 104 IAIKDII---RPPKKDTFNDVYIVYELMDTD-LHQIIRSDQQ-LTDDHCQYFLYQLLRGL 158
           + +  +    RP        +YIV E M    L   +R   +             +  G+
Sbjct: 62  VQLYGVCTKQRP--------IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGM 113

Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAPE 214
            Y+ S   +HRDL   N L++    +K+ DFGL+R   + ++     +++ V RW   PE
Sbjct: 114 AYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPV-RW-SPPE 171

Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMT 240
           +LL   ++++  D+W+ G ++ E+ +
Sbjct: 172 VLLYS-KFSSKSDVWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 60.8 bits (148), Expect = 5e-11
 Identities = 49/203 (24%), Positives = 88/203 (43%), Gaps = 22/203 (10%)

Query: 50  IGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +G G +G V   V    S    EVA+K +          +  LRE  ++  ++H  ++ +
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQE-HIAAGKKEFLREASVMAQLDHPCIVRL 61

Query: 107 KDIIRPPKKDTFNDVYIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
             + +         + +V EL     L + ++  +++     +   +Q+  G+ Y+ S  
Sbjct: 62  IGVCKGEP------LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH 115

Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLN 218
            +HRDL   N+LL      KI DFG++R          Y  T       +WY APE  +N
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS--DYYRATTAGRWPLKWY-APE-CIN 171

Query: 219 CTEYTAAIDIWSVGCILGEIMTR 241
             ++++  D+WS G  L E  + 
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFSY 194

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 60.7 bits (147), Expect = 5e-11
 Identities = 45/196 (22%), Positives = 96/196 (48%), Gaps = 16/196 (8%)

Query: 50  IGRGAYGIVCAAV--NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           +G G +G V   +    ++ + VA+K + N  ++       LRE  +++ +++  ++ + 
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 108 DIIRPPKKDTFNDVYIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
            I             +V EL +   L++ ++ ++ +T+ +    ++Q+  G+KY+   + 
Sbjct: 63  GICEA------ESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNF 116

Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-----RWYRAPELLLNCTE 221
           +HRDL   N+LL      KI DFGL++     +   +         +WY APE  +N  +
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY-APE-CMNYYK 174

Query: 222 YTAAIDIWSVGCILGE 237
           +++  D+WS G ++ E
Sbjct: 175 FSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 60.7 bits (147), Expect = 5e-11
 Identities = 50/201 (24%), Positives = 99/201 (49%), Gaps = 26/201 (12%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G +G+V      E R+ VAIK I       +     + E +++  + H  ++ +  +
Sbjct: 12  IGSGQFGLVWLGYWLEKRK-VAIKTIREGA---MSEEDFIEEAQVMMKLSHPKLVQLYGV 67

Query: 110 I--RPPKKDTFNDVYIVYELMDTD-LHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSAS 165
              R P       + +V+E M+   L   +R+ + + + +        +  G+ Y+ S++
Sbjct: 68  CTERSP-------ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN 120

Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLART------TSETDFMTEYVVTRWYRAPELLLNC 219
           V+HRDL   N L+  +  +K+ DFG+ R       TS T   T++ V +W  +PE + + 
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTG--TKFPV-KW-SSPE-VFSF 175

Query: 220 TEYTAAIDIWSVGCILGEIMT 240
           ++Y++  D+WS G ++ E+ +
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 60.8 bits (147), Expect = 8e-11
 Identities = 40/151 (26%), Positives = 82/151 (54%), Gaps = 12/151 (7%)

Query: 117 TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 175
           T + +++V E ++  DL   ++  ++L ++H +++  ++   L ++H   +++RDLK  N
Sbjct: 67  TTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDN 126

Query: 176 LLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 234
           +LL+A   +K+ D+G+ +      D  + +  T  Y APE+L    EY  ++D W++G +
Sbjct: 127 VLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVL 185

Query: 235 LGEIM---------TREPLFPGKDYVHQLRL 256
           + E+M         T  P    +DY+ Q+ L
Sbjct: 186 MFEMMAGRSPFDIITDNPDMNTEDYLFQVIL 216

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 60.8 bits (147), Expect = 9e-11
 Identities = 59/247 (23%), Positives = 107/247 (43%), Gaps = 64/247 (25%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IGRGA+G V           V  K  G+ +     A + LR+  +L   +  ++ A 
Sbjct: 6   LKVIGRGAFGEV---------RLVQKKDTGHVY-----AMKILRKADMLEKEQVGHIRAE 51

Query: 107 KDIIRPPK-----------KDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +DI+               +D  N +Y++ E +   D+  ++     LT++  Q+++ + 
Sbjct: 52  RDILVEADSLWVVKMFYSFQDKLN-LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAET 110

Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA-------RT--------TSETD 199
           +  +  +H    +HRD+KP NLLL++   +K+ DFGL        RT        +  +D
Sbjct: 111 VLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSD 170

Query: 200 FMTEYVVTR-----WYR----------------APELLLNCTEYTAAIDIWSVGCILGEI 238
           F  + + ++     W R                APE+ +  T Y    D WS+G I+ E+
Sbjct: 171 FTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEM 229

Query: 239 MTREPLF 245
           +   P F
Sbjct: 230 LIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 60.8 bits (147), Expect = 1e-10
 Identities = 38/118 (32%), Positives = 68/118 (57%), Gaps = 8/118 (6%)

Query: 129 DTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI 186
           D+++  ++  D  + LT      F YQ+ RG++++ S + +HRDL   N+LL     +KI
Sbjct: 219 DSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKI 278

Query: 187 GDFGLAR-TTSETDFMTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
            DFGLAR    +++++++   ++  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 279 CDFGLARDIMHDSNYVSKGSTFLPVKWM-APESIFD-NLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 60.8 bits (147), Expect = 1e-10
 Identities = 40/135 (29%), Positives = 68/135 (50%), Gaps = 6/135 (4%)

Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 169
           I     ++  D Y+      T    +I     L+      F YQ+  G++++ S + +HR
Sbjct: 204 IESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHR 263

Query: 170 DLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTE---YVVTRWYRAPELLLNCTEYTAA 225
           DL   N+L+     +KI DFGLAR    +++++++   ++  +W  APE + N   YT  
Sbjct: 264 DLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWM-APESIFN-NLYTTL 321

Query: 226 IDIWSVGCILGEIMT 240
            D+WS G +L EI T
Sbjct: 322 SDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 60.8 bits (147), Expect = 1e-10
 Identities = 59/246 (23%), Positives = 106/246 (43%), Gaps = 62/246 (25%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IGRGA+G V           V  K  G+ +     A + LR+  +L   +  ++ A 
Sbjct: 6   LKVIGRGAFGEV---------RLVQKKDTGHIY-----AMKILRKADMLEKEQVAHIRAE 51

Query: 107 KDIIRPPKKD-------TFND---VYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLL 155
           +DI+             +F D   +Y++ E +   D+  ++     L+++  Q+++ + +
Sbjct: 52  RDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETV 111

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA-------RT--------TSETDF 200
             +  +H    +HRD+KP NLLL+A   +K+ DFGL        RT           +DF
Sbjct: 112 LAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDF 171

Query: 201 MTEYVVTR-----W----------------YRAPELLLNCTEYTAAIDIWSVGCILGEIM 239
             + + ++     W                Y APE+ +  T Y    D WS+G I+ E++
Sbjct: 172 SFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEML 230

Query: 240 TREPLF 245
              P F
Sbjct: 231 IGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 59.8 bits (145), Expect = 1e-10
 Identities = 46/211 (21%), Positives = 98/211 (46%), Gaps = 29/211 (13%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL-RHMEHENVIA 105
           +R +G GAYG V             ++K+G      + A + L++  ++ +    E+   
Sbjct: 5   LRVLGTGAYGKV-----------FLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRT 53

Query: 106 IKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIR------------SDQQLTDDHCQYFLY 152
            + ++   ++  F  V + Y    DT LH I+               +  T+   + ++ 
Sbjct: 54  ERQVLEAVRRCPFL-VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA 112

Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMTEYVVTRWY 210
           +++  L ++H   +++RD+K  N+LL++   + + DFGL++     E +    +  T  Y
Sbjct: 113 EIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEY 172

Query: 211 RAPELLLNCTE-YTAAIDIWSVGCILGEIMT 240
            APE++   +  +  A+D WS+G +  E++T
Sbjct: 173 MAPEVIRGGSGGHDKAVDWWSLGVLTFELLT 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 60.4 bits (146), Expect = 1e-10
 Identities = 61/258 (23%), Positives = 100/258 (38%), Gaps = 74/258 (28%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           I+ +G GA+G VC A   +T    A+K              TLR+  +L   +  +V A 
Sbjct: 6   IKTLGIGAFGEVCLACKVDTHALYAMK--------------TLRKKDVLNRNQVAHVKAE 51

Query: 107 KDIIRPPKKD-------TFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLL 155
           +DI+     +       +F D   +Y +MD     D+  ++   +   +   ++++ +L 
Sbjct: 52  RDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELT 111

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL------------------------ 191
             ++ VH    +HRD+KP N+L++    +K+ DFGL                        
Sbjct: 112 LAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSM 171

Query: 192 ------------------------ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAID 227
                                   A    +       V T  Y APE+LL    YT   D
Sbjct: 172 EPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCD 230

Query: 228 IWSVGCILGEIMTREPLF 245
            WSVG IL E++  +P F
Sbjct: 231 WWSVGVILFEMLVGQPPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 59.6 bits (144), Expect = 2e-10
 Identities = 56/224 (25%), Positives = 106/224 (47%), Gaps = 28/224 (12%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAA-----VNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           +EVS + +  +R +G+G++G+V        +  E    VA+K + N   ++ +    L E
Sbjct: 1   WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV-NESASLRERIEFLNE 59

Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRS---DQQLTDDHC 147
             +++     +V+ +  ++   +        +V ELM   DL   +RS   + +      
Sbjct: 60  ASVMKGFTCHHVVRLLGVVSKGQP-----TLVVMELMAHGDLKSYLRSLRPEAENNPGRP 114

Query: 148 QYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 200
              L ++++       G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+
Sbjct: 115 PPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY 174

Query: 201 MTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             +     +  RW  APE L +   +T + D+WS G +L EI +
Sbjct: 175 YRKGGKGLLPVRWM-APESLKDGV-FTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 59.6 bits (144), Expect = 2e-10
 Identities = 44/169 (26%), Positives = 79/169 (46%), Gaps = 24/169 (14%)

Query: 89  LREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQI-----IRSDQQL 142
           L+EIK++  +++ N+I +  +         + + ++ E M+  DL+Q      I S    
Sbjct: 65  LKEIKIMSRLKNPNIIRLLGVCVSD-----DPLCMITEYMENGDLNQFLSQREIESTFTH 119

Query: 143 TDD-------HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT 195
            ++       +  Y   Q+  G+KY+ S + +HRDL   N L+     +KI DFG++R  
Sbjct: 120 ANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL 179

Query: 196 SETDFM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
              D+        +  RW     +LL   ++T A D+W+ G  L E+ T
Sbjct: 180 YSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 59.7 bits (145), Expect = 2e-10
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 24/210 (11%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKI---GNAFDNIIDARRTLR--EIKLLRHMEHENVI 104
           IG G  G V      +T   +A+K++   GN  +N    +R L   ++ L  H     V 
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEEN----KRILMDLDVVLKSHDCPYIVK 78

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDD----HCQYFLYQLLRGLKY 160
                I         DV+I  ELM T L ++++  Q    +         + + L  LK 
Sbjct: 79  CYGYFITDS------DVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE 132

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL---L 217
            H   V+HRD+KPSN+LL+AS ++K+ DFG++    ++   T       Y APE +    
Sbjct: 133 KHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPD 190

Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPLFPG 247
              +Y    D+WS+G  L E+ T +  +  
Sbjct: 191 PNPKYDIRADVWSLGISLVELATGQFPYKN 220

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 59.3 bits (143), Expect = 2e-10
 Identities = 56/212 (26%), Positives = 98/212 (46%), Gaps = 33/212 (15%)

Query: 50  IGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G +G V     N  T+  VAIK +       +     L+E ++++ + H+ ++ +  
Sbjct: 14  LGQGCFGEVWMGTWNGTTK--VAIKTLKPG---TMMPEAFLQEAQIMKKLRHDKLVPLYA 68

Query: 109 IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKY 160
           ++      +   +YIV E M    L   ++          QL D        Q+  G+ Y
Sbjct: 69  VV------SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVD-----MAAQIADGMAY 117

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPELLL 217
           +   + +HRDL+ +N+L+  +   KI DFGLAR   + ++          +W  APE  L
Sbjct: 118 IERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL 176

Query: 218 NCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
               +T   D+WS G +L E++T  R P +PG
Sbjct: 177 Y-GRFTIKSDVWSFGILLTELVTKGRVP-YPG 206

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 59.5 bits (144), Expect = 2e-10
 Identities = 44/169 (26%), Positives = 81/169 (47%), Gaps = 25/169 (14%)

Query: 89  LREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHC 147
           L+EIK++  ++  N+I +  +       T + + ++ E M+  DL+Q + S  +  +   
Sbjct: 67  LKEIKIMSRLKDPNIIRLLAVCI-----TSDPLCMITEYMENGDLNQFL-SRHEPQEAAE 120

Query: 148 Q------------YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT 195
           +            +   Q+  G+KY+ S + +HRDL   N L+  +  +KI DFG++R  
Sbjct: 121 KADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180

Query: 196 SETDFM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
              D+        +  RW     +LL   ++T A D+W+ G  L EI+T
Sbjct: 181 YSGDYYRIQGRAVLPIRWMSWESILLG--KFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 59.2 bits (144), Expect = 3e-10
 Identities = 55/262 (20%), Positives = 108/262 (41%), Gaps = 65/262 (24%)

Query: 46  PIRPIGRGAYGIVCAAVNSETREEVAIKKIG-NAFDNIIDARRTLREIKLLRHMEHENVI 104
            I+ +G+G  G V       T +  A+K +           +R L E ++L  ++H  + 
Sbjct: 5   KIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFL- 63

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQII--RSDQQLTDDHCQYFLYQLLRGL 158
                  P    +F     +  +MD     +L +++  +  + L+++  +++  ++L  L
Sbjct: 64  -------PTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLAL 116

Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---------------------- 196
           +Y+H   +++RDLKP N+LL+ S  + + DF L++ +                       
Sbjct: 117 EYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176

Query: 197 -------ETDFMT-EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE----------- 237
                  E  F +  +V T  Y APE++     + +A+D W++G +L E           
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGS 235

Query: 238 --------IMTREPLFPGKDYV 251
                   I+ +E  FPG   V
Sbjct: 236 NRDETFSNILKKEVTFPGSPPV 257

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 59.3 bits (143), Expect = 3e-10
 Identities = 56/223 (25%), Positives = 103/223 (46%), Gaps = 32/223 (14%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IGRGA+G            EVA+ K+ NA D +  A + L + ++L+  E       
Sbjct: 6   LKVIGRGAFG------------EVAVVKLKNA-DKVF-AMKILNKWEMLKRAETACFREE 51

Query: 107 KDIIRPPKKD-------TFNDVYIVYELMD----TDLHQII-RSDQQLTDDHCQYFLYQL 154
           +D++              F D   +Y +MD     DL  ++ + + +L +D  +++L ++
Sbjct: 52  RDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEM 111

Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRA 212
           +  +  VH    +HRD+KP N+L++ +  +++ DFG      E   +   V   T  Y +
Sbjct: 112 VIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 171

Query: 213 PELLLNCTE----YTAAIDIWSVGCILGEIMTREPLFPGKDYV 251
           PE+L    +    Y    D WS+G  + E++  E  F  +  V
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 58.7 bits (142), Expect = 4e-10
 Identities = 43/211 (20%), Positives = 83/211 (39%), Gaps = 21/211 (9%)

Query: 48  RPIGRGAYGIVCAAVNSE---TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI 104
           + +G G +G V     S+   ++ +VA+K +        +    L E   ++  +H NV+
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64

Query: 105 AIKDI-IRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLL------- 155
            +  +              ++   M   DLH  +   +       +    Q L       
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSR--LGGLPEKLPLQTLLKFMVDI 122

Query: 156 -RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT----RWY 210
             G++Y+ + + +HRDL   N +L     + + DFGL++     D+  +  +     +W 
Sbjct: 123 ALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182

Query: 211 RAPELLLNCTEYTAAIDIWSVGCILGEIMTR 241
               L      YT+  D+W+ G  + EI TR
Sbjct: 183 AIESLADRV--YTSKSDVWAFGVTMWEIATR 211

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 58.2 bits (141), Expect = 4e-10
 Identities = 57/229 (24%), Positives = 100/229 (43%), Gaps = 38/229 (16%)

Query: 47  IRPIGRGAYGIVCAAV----NSETREEVAIKKIGN-----AFDNIIDARRTLREIKLLRH 97
           I+ +G GA+G V   V      + +  VAIK +       A   I      L E  ++  
Sbjct: 12  IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEI------LDEAYVMAS 65

Query: 98  MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-QLTDDHCQYFLYQLL 155
           ++H +V+ +  I    +      V ++ +LM    L   +R+ +  +   +   +  Q+ 
Sbjct: 66  VDHPHVVRLLGICLSSQ------VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIA 119

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RW 209
           +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     +   EY         +W
Sbjct: 120 KGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE--KEYHAEGGKVPIKW 177

Query: 210 YRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPL--FPGKDYVHQL 254
             A E +L+   YT   D+WS G  + E+MT   +P    P  + +  L
Sbjct: 178 M-ALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-IPDL 223

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 58.5 bits (142), Expect = 5e-10
 Identities = 46/184 (25%), Positives = 75/184 (40%), Gaps = 35/184 (19%)

Query: 70  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF---NDVYIVYE 126
           VA+KKI     +  D +   +EI   R ++H N++        P   +F   +++Y+V  
Sbjct: 28  VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNIL--------PYVTSFIVDSELYVVSP 79

Query: 127 LMDTDLHQIIRSDQQLTDDHC---------QYFLYQLLRGLKYVHSASVLHRDLKPSNLL 177
           LM         S + L   H           + L  +L  L Y+HS   +HR +K S++L
Sbjct: 80  LMAYG------SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHIL 133

Query: 178 LNASCDLKIGDFGLA--------RTTSETDFMTEYVVTRWYRAPELL-LNCTEYTAAIDI 228
           L+    + +     +        R     DF    V    + +PE+L  N   Y    DI
Sbjct: 134 LSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDI 193

Query: 229 WSVG 232
           +SVG
Sbjct: 194 YSVG 197

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 58.7 bits (142), Expect = 7e-10
 Identities = 41/160 (25%), Positives = 78/160 (48%), Gaps = 25/160 (15%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PI RGA+G V         +  A+K +  A  ++I+           ++M H+ V A 
Sbjct: 9   VKPISRGAFGKVYLGRKKNNSKLYAVKVVKKA--DMIN-----------KNMVHQ-VQAE 54

Query: 107 KDIIRPPKK----------DTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLL 155
           +D +   K            + N+VY+V E L+  D+  ++       ++    ++ ++ 
Sbjct: 55  RDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVA 114

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT 195
             L Y+H   ++HRDLKP N+L++    +K+ DFGL++ T
Sbjct: 115 LALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 58.1 bits (140), Expect = 8e-10
 Identities = 33/95 (34%), Positives = 56/95 (58%), Gaps = 6/95 (6%)

Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFM---TEYV 205
           + +Q+ RG++++ S   +HRDL   N+LL+ +  +KI DFGLAR    + D++   +  +
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238

Query: 206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             +W  APE + +   YT   D+WS G +L EI +
Sbjct: 239 PLKWM-APESIFDKV-YTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 58.0 bits (140), Expect = 8e-10
 Identities = 46/197 (23%), Positives = 93/197 (47%), Gaps = 12/197 (6%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAF---DNIIDARRTLREIKLLRHMEHENVI 104
           R +G+G++G V  A   E+    A+K +       D+ ++   T + I  L    H  + 
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLT 59

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
            +    + P +     ++ V E ++  DL   I+  ++  +   +++  ++   L ++H 
Sbjct: 60  QLYCCFQTPDR-----LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHD 114

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEY 222
             +++RDLK  N+LL+     K+ DFG+ +        T  +  T  Y APE+L     Y
Sbjct: 115 KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQE-MLY 173

Query: 223 TAAIDIWSVGCILGEIM 239
             ++D W++G +L E++
Sbjct: 174 GPSVDWWAMGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 57.7 bits (139), Expect = 9e-10
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 20/217 (9%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           I+ IGRGA+G V A V  +  E +   KI N ++ +  A     E    R  E  NV+  
Sbjct: 6   IKVIGRGAFGEV-AVVKMKHTERIYAMKILNKWEMLKRA-----ETACFR--EERNVLVN 57

Query: 107 KDIIRPPKKD-TFNDVYIVYELMD----TDLHQII-RSDQQLTDDHCQYFLYQLLRGLKY 160
            D          F D   +Y +MD     DL  ++ + + +L +D  ++++ +++  +  
Sbjct: 58  GDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHS 117

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFG--LARTTSETDFMTEYVVTRWYRAPELLLN 218
           +H    +HRD+KP N+LL+ +  +++ DFG  L      T   +  V T  Y +PE+L  
Sbjct: 118 IHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQA 177

Query: 219 CTE----YTAAIDIWSVGCILGEIMTREPLFPGKDYV 251
             +    Y    D WS+G  + E++  E  F  +  V
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 57.4 bits (139), Expect = 9e-10
 Identities = 59/253 (23%), Positives = 100/253 (39%), Gaps = 49/253 (19%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAV-----NSETREEVAIKKIGNAFDNIIDARRT---- 88
           EV    +  +R +G GA+G V   +           +VA+K +                 
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPE------SCSEQDESD 55

Query: 89  -LREIKLLRHMEHENVIAI--KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTD 144
            L E  ++    H+N++ +      R P+       +I+ ELM   DL   +R ++   +
Sbjct: 56  FLMEALIMSKFNHQNIVRLIGVSFERLPR-------FILLELMAGGDLKSFLRENRPRPE 108

Query: 145 DHCQYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCD-----LKIGDFGLA 192
                 +  LL        G KY+     +HRD+   N LL  +C       KI DFG+A
Sbjct: 109 RPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLL--TCKGPGRVAKIADFGMA 166

Query: 193 RTTSETDFMTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFP 246
           R      +  +     +  +W   PE  L+   +T+  D+WS G +L EI +    P +P
Sbjct: 167 RDIYRASYYRKGGRAMLPIKWM-PPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMP-YP 223

Query: 247 GKDYVHQLRLITE 259
           G+     +  +T 
Sbjct: 224 GRTNQEVMEFVTG 236

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 57.6 bits (139), Expect = 1e-09
 Identities = 36/110 (32%), Positives = 58/110 (52%), Gaps = 12/110 (10%)

Query: 138 SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE 197
             + LT +    + +Q+ RG++++ S   +HRDL   N+LL+ +  +KI DFGLAR   +
Sbjct: 166 YKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 225

Query: 198 TDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                +YV         +W  APE + +   YT   D+WS G +L EI +
Sbjct: 226 D---PDYVRKGDARLPLKWM-APESIFDKV-YTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 57.7 bits (139), Expect = 1e-09
 Identities = 30/115 (26%), Positives = 65/115 (56%), Gaps = 6/115 (5%)

Query: 128 MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG 187
           M T L+Q        ++D  +++  +++  L+++H   +++RD+K  N+LL++   + + 
Sbjct: 92  MFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLT 147

Query: 188 DFGLART--TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           DFGL++   + E +    +  T  Y APE++     +  A+D WS+G ++ E++T
Sbjct: 148 DFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLT 202

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 57.2 bits (138), Expect = 1e-09
 Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 20/213 (9%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVC-AAVNSETREE--VAIKKIGNAFDNIIDARRT--LREI 92
           E+ +K +   R +G G +G +C   +   ++ E  VAI  +        D +R   L E 
Sbjct: 1   ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLR---AGCSDKQRRGFLAEA 57

Query: 93  KLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD-LHQIIRSDQ-QLTDDHCQYF 150
             L   +H N++ ++ +I        N + IV E M    L   +R  + QL        
Sbjct: 58  LTLGQFDHSNIVRLEGVI-----TRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGM 112

Query: 151 LYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG-LARTTSETDF--MTEYVVT 207
           L  L  G+KY+     +H+ L    +L+N+    KI  F  L    SE  +  M+     
Sbjct: 113 LPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPV 172

Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
            W  APE  +    +++A D+WS G ++ E+M+
Sbjct: 173 LW-AAPE-AIQYHHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 57.1 bits (138), Expect = 1e-09
 Identities = 48/173 (27%), Positives = 78/173 (45%), Gaps = 34/173 (19%)

Query: 90  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQ-IIR----SDQQLT 143
           +E +L+  ++H N++ +  +    +        +++E +   DLH+ ++R    SD    
Sbjct: 57  QEAELMSDLQHPNIVCLLGVCTKEQP-----TCMLFEYLAHGDLHEFLVRNSPHSDVGAE 111

Query: 144 DDH--------CQYFL---YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA 192
                      C  FL    Q+  G++Y+ S   +HRDL   N L+     +KI DFGL+
Sbjct: 112 SGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLS 171

Query: 193 RTTSETDFMTEYVV-------TRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 238
           R     D+   Y V        RW   PE +L   ++T   DIWS G +L EI
Sbjct: 172 RDIYSADY---YRVQSKSLLPVRWM-PPEAILY-GKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 57.3 bits (138), Expect = 1e-09
 Identities = 34/103 (33%), Positives = 59/103 (57%), Gaps = 6/103 (5%)

Query: 142 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDF 200
           LT +    + +Q+ +G++++ S   +HRDL   N+LL+ +  +KI DFGLAR    + D+
Sbjct: 176 LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 235

Query: 201 MTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           + +    +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 236 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 57.3 bits (138), Expect = 1e-09
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 19/209 (9%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL----REIKLLRHMEHEN 102
           ++ IGRGA+G V   V  ++ ++V   K+ + F+ I  +        R+I     M   N
Sbjct: 48  VKVIGRGAFGEV-QLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDI-----MAFAN 101

Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
              +  +    + D +  +Y+V E M   DL  ++ S+  + +   +++  +++  L  +
Sbjct: 102 SPWVVQLFCAFQDDKY--LYMVMEYMPGGDLVNLM-SNYDVPEKWAKFYTAEVVLALDAI 158

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNC 219
           HS  ++HRD+KP N+LL+    LK+ DFG      ET  +     V T  Y +PE+L + 
Sbjct: 159 HSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQ 218

Query: 220 ---TEYTAAIDIWSVGCILGEIMTREPLF 245
                Y    D WSVG  L E++  +  F
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 56.7 bits (137), Expect = 1e-09
 Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 41/213 (19%)

Query: 51  GRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII 110
           GR  YGI+      +  EEV +K + +   + I     L+E  LL  + H+N++ I  + 
Sbjct: 20  GRIFYGILIDEKPGKE-EEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVC 77

Query: 111 ----RPPKKDTFNDVYIVYELM---------------DTDLHQIIRSDQQLTDDHCQYFL 151
                PP         ++Y  M               + +  Q + S QQL         
Sbjct: 78  IEDGEPPF--------VLYPYMNWGNLKLFLQQCRLGEANNPQAL-STQQLVH-----MA 123

Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TEYVVT 207
            Q+  G+ Y+H   V+H+D+   N +++    +KI D  L+R     D+      E    
Sbjct: 124 IQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV 183

Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           +W  A E L+N  EY++A D+WS G +L E+MT
Sbjct: 184 KWM-ALESLVN-KEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 55.8 bits (134), Expect = 5e-09
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 19/209 (9%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL----REIKLLRHMEHEN 102
           ++ IGRGA+G V    +  TR+  A+K + + F+ I  +        R+I     M   N
Sbjct: 48  VKVIGRGAFGEVQLVRHKSTRKVYAMKLL-SKFEMIKRSDSAFFWEERDI-----MAFAN 101

Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
              +  +    + D +  +Y+V E M   DL  ++ S+  + +   +++  +++  L  +
Sbjct: 102 SPWVVQLFYAFQDDRY--LYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTAEVVLALDAI 158

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNC 219
           HS   +HRD+KP N+LL+ S  LK+ DFG     ++   +     V T  Y +PE+L + 
Sbjct: 159 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 218

Query: 220 ---TEYTAAIDIWSVGCILGEIMTREPLF 245
                Y    D WSVG  L E++  +  F
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 55.8 bits (134), Expect = 5e-09
 Identities = 52/204 (25%), Positives = 96/204 (47%), Gaps = 19/204 (9%)

Query: 47  IRPIGRGAYGIVCAAV----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN 102
           I+ +G GA+G V   +      + +  VAIK++  A     + +  L E  ++  +++ +
Sbjct: 12  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYVMASVDNPH 70

Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTD-LHQIIRSDQ-QLTDDHCQYFLYQLLRGLKY 160
           V  +  I         + V ++ +LM    L   +R  +  +   +   +  Q+ +G+ Y
Sbjct: 71  VCRLLGICLT------STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 124

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMTE--YVVTRWYRAPELL 216
           +    ++HRDL   N+L+     +KI DFGLA+     E ++  E   V  +W  A E +
Sbjct: 125 LEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM-ALESI 183

Query: 217 LNCTEYTAAIDIWSVGCILGEIMT 240
           L+   YT   D+WS G  + E+MT
Sbjct: 184 LHRI-YTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 54.1 bits (130), Expect = 1e-08
 Identities = 55/210 (26%), Positives = 87/210 (41%), Gaps = 27/210 (12%)

Query: 50  IGRGAYG-IVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI-- 106
           IG G +G ++    +    +   + K   A     +    L+E++  R + H NV+    
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQ-----LLRGLKY 160
           + I   P         +V E     DL   +RS++ +     Q  + Q     +  GL +
Sbjct: 63  QCIESIP-------YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLW 115

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT----EYVVTRWYRAPELL 216
           +H A  +H DL   N  L A   +KIGD+GLA      D+        V  RW  APEL+
Sbjct: 116 LHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWL-APELV 174

Query: 217 ------LNCTEYTAAIDIWSVGCILGEIMT 240
                 L   + T   +IWS+G  + E+ T
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 53.8 bits (129), Expect = 1e-08
 Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 31/212 (14%)

Query: 48  RPIGRGAYG-IVCAAVNSE-TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI- 104
           + IG G +G ++   VNS  T  +V +K++     ++ +  + L E +  R ++H N++ 
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKEL-RVSASVQEQMKFLEEAQPYRSLQHSNLLQ 59

Query: 105 --AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHC-----QYFLYQLLR 156
                  + P          +V E     DL   +RS ++           Q    ++  
Sbjct: 60  CLGQCTEVTP--------YLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIAL 111

Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTRWYRA 212
           GL ++H  + +H DL   N LL A   +KIGD+GL+    + D+       +V  RW  A
Sbjct: 112 GLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWI-A 170

Query: 213 PELL------LNCTEYTAAIDIWSVGCILGEI 238
           PEL+      L   + T   ++WS+G  + E+
Sbjct: 171 PELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 53.7 bits (129), Expect = 2e-08
 Identities = 28/92 (30%), Positives = 44/92 (47%), Gaps = 6/92 (6%)

Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TEYVVTR 208
           Q+  G+ Y+     +HRDL   N L+  +  +KI DFGL+R     D+      + +  R
Sbjct: 138 QVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIR 197

Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           W     +  N   YT   D+W+ G +L EI +
Sbjct: 198 WMPPESIFYN--RYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 53.5 bits (128), Expect = 2e-08
 Identities = 25/104 (24%), Positives = 59/104 (56%), Gaps = 3/104 (2%)

Query: 140 QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART--TSE 197
           ++  +   Q +  +++  L+++H   +++RD+K  N+LL+++  + + DFGL++     E
Sbjct: 100 ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE 159

Query: 198 TDFMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMT 240
            +    +  T  Y AP+++      +  A+D WS+G ++ E++T
Sbjct: 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLT 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 53.1 bits (127), Expect = 3e-08
 Identities = 53/216 (24%), Positives = 92/216 (42%), Gaps = 27/216 (12%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIK---KIGNAFDNIIDARRTLREIKLLRHMEHENV 103
           ++ +G GA+G V   +     E V I    KI N           + E  ++  M+H ++
Sbjct: 12  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 71

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           + +  +   P       + +V +LM     L  +      +       +  Q+ +G+ Y+
Sbjct: 72  VRLLGVCLSPT------IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYL 125

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS--ETDFMTE--YVVTRWYRAPELLL 217
               ++HRDL   N+L+ +   +KI DFGLAR     E ++  +   +  +W     + L
Sbjct: 126 EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKW-----MAL 180

Query: 218 NCTEY---TAAIDIWSVGCILGEIMTREPLFPGKDY 250
            C  Y   T   D+WS G  + E+MT    F GK Y
Sbjct: 181 ECIHYRKFTHQSDVWSYGVTIWELMT----FGGKPY 212

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 52.5 bits (126), Expect = 4e-08
 Identities = 60/234 (25%), Positives = 110/234 (47%), Gaps = 42/234 (17%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+G YG V   ++  T   +A+K+I    D      + + E+ +L    H+ V      
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDES-KFNQIIMELDIL----HKAV------ 57

Query: 110 IRPPKKDTF------NDVYIVYELMDT----DLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
             P   D +        VY+  E MD      L+    + + + +D  +   Y +++GLK
Sbjct: 58  -SPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLK 116

Query: 160 YVHSA-SVLHRDLKPSNLLLNASCDLKIGDFG----LARTTSETDFMTEYVVTRWYRAPE 214
           ++    +++HRD+KP+N+L+N +  +K+ DFG    L  + ++T+     +  + Y APE
Sbjct: 117 FLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN-----IGCQSYMAPE 171

Query: 215 LLLNCT-----EYTAAIDIWSVG-CILGEIMTREPLFPGKDYVH---QLRLITE 259
            + +        YT   D+WS+G  IL   + R P +P + Y +   QL  I +
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP-YPPETYANIFAQLSAIVD 224

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 52.3 bits (125), Expect = 4e-08
 Identities = 32/92 (34%), Positives = 52/92 (56%), Gaps = 6/92 (6%)

Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMTE--YVVTR 208
           Q+ +G+ Y+    ++HRDL   N+L+ +   +KI DFGLAR     ET++  +   V  +
Sbjct: 117 QIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK 176

Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           W  A E +L+   +T   D+WS G  + E+MT
Sbjct: 177 WM-ALESILH-RRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 52.3 bits (125), Expect = 5e-08
 Identities = 41/173 (23%), Positives = 79/173 (45%), Gaps = 29/173 (16%)

Query: 90  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQ 148
           +E  L+  + H N++ +  ++   +      V +++E ++  DLH+ +      +D  C 
Sbjct: 56  QEASLMAELHHPNIVCLLGVVTQEQP-----VCMLFEYLNQGDLHEFLIMRSPHSDVGCS 110

Query: 149 Y--------------FLY---QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 191
                          FL+   Q+  G++Y+ S   +H+DL   N+L+     +KI D GL
Sbjct: 111 SDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGL 170

Query: 192 ARTTSETDFM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           +R     D+        +  RW   PE ++   ++++  DIWS G +L EI +
Sbjct: 171 SREIYSADYYRVQPKSLLPIRWM-PPEAIMY-GKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 51.1 bits (122), Expect = 1e-07
 Identities = 46/176 (26%), Positives = 81/176 (46%), Gaps = 33/176 (18%)

Query: 89  LREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTD--- 144
           L+E+K+L  ++  N+I +  +         + + ++ E M+  DL+Q + S   L D   
Sbjct: 67  LKEVKILSRLKDPNIIRLLGVCVDE-----DPLCMITEYMENGDLNQFL-SSHHLDDKEE 120

Query: 145 --------DHC------QYFLY---QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG 187
                    HC         L+   Q+  G+KY+ S + +HRDL   N L+  +  +KI 
Sbjct: 121 NGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIA 180

Query: 188 DFGLARTTSETDFM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 239
           DFG++R     D+        +  RW     +L+   ++T A D+W+ G  L EI+
Sbjct: 181 DFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG--KFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 50.2 bits (121), Expect = 2e-07
 Identities = 30/118 (25%), Positives = 61/118 (51%), Gaps = 11/118 (9%)

Query: 129 DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD-LKIG 187
           D DL  +++ + +L++   +  + QL+  L  +H  +++H D+K  N+L + + D + + 
Sbjct: 93  DGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLC 152

Query: 188 DFGLAR---TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTRE 242
           D+GL +   T S  D   +Y       +PE  +    Y  + D W+VG +  E++T +
Sbjct: 153 DYGLCKIIGTPSCYDGTLDYF------SPE-KIKGHNYDVSFDWWAVGVLTYELLTGK 203

Length = 267

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 50.4 bits (120), Expect = 2e-07
 Identities = 45/197 (22%), Positives = 89/197 (45%), Gaps = 29/197 (14%)

Query: 65  ETREEVAIKKIGNAFDNIIDARRTLREIKLLR-HMEHENVIAIKDIIRPPKKDTFNDVYI 123
           E  + VAIK + +  +     R   +   ++R  ++H N++ +  ++   +  +    Y 
Sbjct: 33  EQTQAVAIKTLKDKAE--GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYC 90

Query: 124 VYELMDTDLHQII-----RSDQQLTDDHCQ-----------YFLYQLLRGLKYVHSASVL 167
            +    +DLH+ +      SD   TDD              + + Q+  G++++ S  V+
Sbjct: 91  SH----SDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVV 146

Query: 168 HRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAPELLLNCTEYT 223
           H+DL   N+L+    ++KI D GL R     D+        +  RW  +PE ++   +++
Sbjct: 147 HKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWM-SPEAIMY-GKFS 204

Query: 224 AAIDIWSVGCILGEIMT 240
              DIWS G +L E+ +
Sbjct: 205 IDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 50.4 bits (120), Expect = 3e-07
 Identities = 32/105 (30%), Positives = 49/105 (46%), Gaps = 3/105 (2%)

Query: 137 RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS 196
            +   L+     +F   + RG+ Y+     +HRDL   N+L+  +   KI DFGL+R   
Sbjct: 116 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE 175

Query: 197 ETDFMTE-YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                T   +  RW       LN + YT   D+WS G +L EI++
Sbjct: 176 VYVKKTMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 49.5 bits (118), Expect = 4e-07
 Identities = 33/131 (25%), Positives = 61/131 (46%), Gaps = 16/131 (12%)

Query: 123 IVYELMDT-DLHQIIRSDQQLTDD----HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 177
           +V+E  +  DL   +  +Q    +      Q    ++  G+ ++H  + LH DL   N  
Sbjct: 72  LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCF 131

Query: 178 LNASCDLKIGDFGLARTTSETDFMT----EYVVTRWYRAPELL------LNCTEYTAAID 227
           L +   +K+GD+G+  +  + D++     + V  RW  APEL+      L   E T   +
Sbjct: 132 LTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL-APELVGEFHGGLITAEQTKPSN 190

Query: 228 IWSVGCILGEI 238
           +W++G  L E+
Sbjct: 191 VWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 49.7 bits (118), Expect = 4e-07
 Identities = 31/98 (31%), Positives = 48/98 (48%), Gaps = 14/98 (14%)

Query: 153 QLLR-------GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY- 204
           QLL        G+ Y+     +HRDL   N+L+  +   KI DFGL+R   +  ++ +  
Sbjct: 113 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTM 170

Query: 205 --VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             +  RW       LN + YT   D+WS G +L EI++
Sbjct: 171 GRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 49.2 bits (117), Expect = 5e-07
 Identities = 34/119 (28%), Positives = 56/119 (47%), Gaps = 17/119 (14%)

Query: 140 QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD 199
            ++T  +    ++Q+  G+KY+   + +HRDL   N+LL      KI DFGL++     D
Sbjct: 90  DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADD 149

Query: 200 FMTEYVVTR--------WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY 250
               Y   R        WY APE  +N  ++++  D+WS G  + E  +    +  K Y
Sbjct: 150 ---SYYKARSAGKWPLKWY-APE-CINFRKFSSRSDVWSYGITMWEAFS----YGQKPY 199

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 49.5 bits (118), Expect = 5e-07
 Identities = 36/157 (22%), Positives = 76/157 (48%), Gaps = 25/157 (15%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG+GA+G        E R    ++K        I A +TL + ++ +  +  +V A 
Sbjct: 6   VKVIGKGAFG--------EVR---LVQKKD---TGKIYAMKTLLKSEMFKKDQLAHVKAE 51

Query: 107 KDIIRPPKKD-------TFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLL 155
           +D++             +F D   +Y +M+     DL  ++      ++D  ++++ + +
Sbjct: 52  RDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECV 111

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA 192
             ++ VH    +HRD+KP N+L++    +K+ DFGL+
Sbjct: 112 LAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 48.7 bits (116), Expect = 6e-07
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 3/88 (3%)

Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRA 212
           +++  L  +H   ++ RDL P+N+LL+    +++  F   R +   D      V   Y A
Sbjct: 93  EMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDGEAVENMYCA 150

Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMT 240
           PE +   +E T A D WS+G IL E++T
Sbjct: 151 PE-VGGISEETEACDWWSLGAILFELLT 177

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 48.8 bits (116), Expect = 7e-07
 Identities = 32/102 (31%), Positives = 50/102 (49%), Gaps = 7/102 (6%)

Query: 142 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM 201
           LT      F   +  G++Y+     +HRDL   N+L+  +   KI DFGL+R   E  ++
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYV 173

Query: 202 TEY---VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
            +    +  RW       LN + YT   D+WS G +L EI++
Sbjct: 174 KKTMGRLPVRWMAIES--LNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 47.5 bits (113), Expect = 3e-06
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 28/215 (13%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IGRGA+G V   V  +   +V   KI N ++ +  A     E    R  E  +V+  
Sbjct: 6   LKVIGRGAFGEVAV-VKMKNTGQVYAMKILNKWEMLKRA-----ETACFR--EERDVLVN 57

Query: 107 KDIIRPPKKDT-----FNDVYIVYELMD----TDLHQII-RSDQQLTDDHCQYFLYQLLR 156
            D     +  T     F D   +Y +MD     DL  ++ + + +L +D  +++L +++ 
Sbjct: 58  GD----RRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVL 113

Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG--LARTTSETDFMTEYVVTRWYRAPE 214
            +  VH    +HRD+KP N+LL+ +  +++ DFG  L      T      V T  Y +PE
Sbjct: 114 AIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPE 173

Query: 215 LLLNCTE----YTAAIDIWSVGCILGEIMTREPLF 245
           +L    +    Y    D WS+G  + E++  E  F
Sbjct: 174 ILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 46.6 bits (110), Expect = 5e-06
 Identities = 19/42 (45%), Positives = 28/42 (66%)

Query: 151 LYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA 192
           + Q+L GL+ +H   ++HRD+KP NLL+     +KI DFG A
Sbjct: 315 MRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 44.9 bits (106), Expect = 1e-05
 Identities = 27/92 (29%), Positives = 47/92 (51%), Gaps = 6/92 (6%)

Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVT-R 208
           Q+ +G+ Y+    ++HR+L   N+LL +   ++I DFG+A      D   F +E+    +
Sbjct: 117 QIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK 176

Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           W     +L     YT   D+WS G  + E+M+
Sbjct: 177 WMALESILFG--RYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 41.0 bits (97), Expect = 4e-04
 Identities = 34/169 (20%), Positives = 60/169 (35%), Gaps = 27/169 (15%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIG-------NAFDNIIDARRTLR 90
           E   +   P   IG+GA   +      E     A+ K            D  +   RT  
Sbjct: 329 EEVKRRKIPDHLIGKGAEADI---KKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRA 385

Query: 91  EIKLLRHMEHENVIA--IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQ 148
           E +LL       V    I D+      D      ++  +   DL  ++  + +L      
Sbjct: 386 EARLLSEARRAGVPTPVIYDV------DPEEKTIVMEYIGGKDLKDVLEGNPEL------ 433

Query: 149 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE 197
             + ++   +  +H A ++H DL  SN ++     L + DFGL + +  
Sbjct: 434 --VRKVGEIVAKLHKAGIVHGDLTTSNFIVRDD-RLYLIDFGLGKYSDL 479

Length = 535

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 38.2 bits (89), Expect = 0.001
 Identities = 26/107 (24%), Positives = 38/107 (35%), Gaps = 20/107 (18%)

Query: 151 LYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG-LARTTSETDFMTEYVVTRW 209
             Q L  L+ +H  +     L   + LL           G +A  T E      Y +   
Sbjct: 23  CLQCLGALRELHRQAKSGNILLTWDGLLKL--------DGSVAFKTPEQSRPDPYFM--- 71

Query: 210 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL 256
             APE++     YT   DI+S+G  L E +  E       Y  +  L
Sbjct: 72  --APEVIQ-GQSYTEKADIYSLGITLYEALDYEL-----PYNEEREL 110

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 38.6 bits (90), Expect = 0.002
 Identities = 44/185 (23%), Positives = 80/185 (43%), Gaps = 16/185 (8%)

Query: 73  KKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK----DIIRPPKKDTFNDVYIVYELM 128
           KK       +ID   T  EIK LR ++  N++ I     DI+     D    + ++ E  
Sbjct: 52  KKFHKGHKVLIDI--TENEIKNLRRIDSNNILKIYGFIIDIV-----DDLPRLSLILEYC 104

Query: 129 DTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH-SASVLHRDLKPSNLLLNASCDLKI 186
               L +++  ++ L+            +GL  ++   +  +++L   + L+  +  LKI
Sbjct: 105 TRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKI 164

Query: 187 GDFGLARTTSETDFMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLF 245
              GL +  S   F  + V    Y + ++L +  +EYT   DI+S+G +L EI T +  F
Sbjct: 165 ICHGLEKILSSPPF--KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPF 222

Query: 246 PGKDY 250
                
Sbjct: 223 ENLTT 227

Length = 283

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	260
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.97
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
KOG3653	534	consensus Transforming growth factor beta/activin	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.94
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.93
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.92
PLN00181	793	protein SPA1-RELATED; Provisional	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.91
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.91
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.9
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.89
PRK12274	218	serine/threonine protein kinase; Provisional	99.88
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.88
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.88
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.87
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.86
PRK10345	210	hypothetical protein; Provisional	99.86
smart00090	237	RIO RIO-like kinase.	99.85
PRK14879	211	serine/threonine protein kinase; Provisional	99.84
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.82
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.78
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.77
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.77
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.77
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.76
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.76
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.72
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.7
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.69
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.65
KOG1243	690	consensus Protein kinase [General function predict	99.63
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.62
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.61
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.6
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.57
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.5
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.49
KOG3087	229	consensus Serine/threonine protein kinase [General	99.49
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.45
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.44
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.43
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.37
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.32
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.29
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.28
COG4248	637	Uncharacterized protein with protein kinase and he	99.27
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.26
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.26
PRK09902	216	hypothetical protein; Provisional	99.25
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.24
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.22
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.98
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.87
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.69
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.64
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.6
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.46
PF01636	239	APH: Phosphotransferase enzyme family This family	98.45
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.42
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.41
KOG2270	520	consensus Serine/threonine protein kinase involved	98.35
PLN02876	822	acyl-CoA dehydrogenase	98.32
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.28
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.28
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.13
PRK09550	401	mtnK methylthioribose kinase; Reviewed	98.1
KOG2268	465	consensus Serine/threonine protein kinase [Signal	98.05
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.02
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.01
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.95
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.83
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.83
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.73
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.71
PRK05231	319	homoserine kinase; Provisional	97.7
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.66
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.59
PRK12396	409	5-methylribose kinase; Reviewed	97.52
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.52
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.35
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.35
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	97.3
PLN02756	418	S-methyl-5-thioribose kinase	97.28
PLN02236	344	choline kinase	97.19
KOG2269	531	consensus Serine/threonine protein kinase [Signal	97.15
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.91
PRK10593	297	hypothetical protein; Provisional	96.85
PTZ00384	383	choline kinase; Provisional	96.85
PTZ00296	442	choline kinase; Provisional	96.66
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.37
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.34
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.31
PRK11768	325	serine/threonine protein kinase; Provisional	95.97
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	95.86
COG2334	331	Putative homoserine kinase type II (protein kinase	95.83
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.54
PRK10271	188	thiK thiamine kinase; Provisional	95.46
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.41

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-50  Score=324.66  Aligned_cols=212  Identities=32%  Similarity=0.521  Sum_probs=195.8

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      ..|.+.+.||+|+|++||+++++.++..||||.+.......+..+-+..|+++|+.++|||||.++++++..     +.+
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~-----~~i   84 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDD-----DFI   84 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC-----CeE
Confidence            456678889999999999999999999999999977655666777788999999999999999999999988     569


Q ss_pred             EEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccC------CCEEEeecccccc
Q 024959          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS------CDLKIGDFGLART  194 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~------~~~~l~df~~~~~  194 (260)
                      |+|||||. |+|.++++..+.+++.+++.++.||+.|+++||+++|+||||||+|||++..      -.+||+|||+++.
T Consensus        85 ~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   85 YLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            99999998 7999999999999999999999999999999999999999999999999765      3489999999999


Q ss_pred             cCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          195 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      ........+.+|++.|||||+... ..|+.++|+||+|+++|++++|+.||...+..+.+..|++
T Consensus       165 L~~~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k  228 (429)
T KOG0595|consen  165 LQPGSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKK  228 (429)
T ss_pred             CCchhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc
Confidence            998888888999999999999987 8899999999999999999999999999999888877653

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.8e-50  Score=306.94  Aligned_cols=218  Identities=30%  Similarity=0.479  Sum_probs=194.6

Q ss_pred             EeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCC
Q 024959           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (260)
Q Consensus        38 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~  117 (260)
                      ......|.+.++||+|.||.||++++..++..+|.|.++...-+....++..+|+.+|++|+|||||+++++-.....  
T Consensus        15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~--   92 (375)
T KOG0591|consen   15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN--   92 (375)
T ss_pred             cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc--
Confidence            344667889999999999999999999999999999998877777788999999999999999999999994333322  


Q ss_pred             CccEEEEEecCC-cchHHHhhh----CCCCCHHHHHHHHHHHHHHHHHHHh--CC--ceeccCCCCCeEeccCCCEEEee
Q 024959          118 FNDVYIVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHS--AS--VLHRDLKPSNLLLNASCDLKIGD  188 (260)
Q Consensus       118 ~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~--~~--i~H~di~~~nili~~~~~~~l~d  188 (260)
                       ..++||||+|+ |+|.+.++.    ++.+++..+|.++.|++.||..+|+  ..  +.||||||.|||++.+|.+||+|
T Consensus        93 -evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGD  171 (375)
T KOG0591|consen   93 -EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGD  171 (375)
T ss_pred             -hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeecc
Confidence             44889999998 788888763    5679999999999999999999998  44  99999999999999999999999


Q ss_pred             cccccccCCCccc-ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          189 FGLARTTSETDFM-TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       189 f~~~~~~~~~~~~-~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      ||+++.......+ .+..|||.||+||.+.. .+|+.++||||+||++|||+.-..||.+.+..+..++|++
T Consensus       172 fGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~q  242 (375)
T KOG0591|consen  172 FGLGRFLSSKTTFAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQ  242 (375)
T ss_pred             chhHhHhcchhHHHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHc
Confidence            9999988776544 45688999999999998 8999999999999999999999999999999999999975

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-48  Score=324.99  Aligned_cols=213  Identities=33%  Similarity=0.551  Sum_probs=197.4

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCc-ccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNA-FDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      ...|...+.||+|||+.+|.+.+..+|+.||+|++.+. .......+...+|+++.+.|+|||||+++++|++.     +
T Consensus        17 ~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs-----~   91 (592)
T KOG0575|consen   17 SKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDS-----N   91 (592)
T ss_pred             cceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecC-----C
Confidence            36688899999999999999999999999999999653 23455678888999999999999999999999998     6


Q ss_pred             cEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          120 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       120 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      ++|||.|.|. ++|..+++..++++|.+++.+++||+.+|.|||+++|+|||||..|+|++++.++||+|||+|.....+
T Consensus        92 nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   92 NVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             ceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCc
Confidence            6999999999 799999998999999999999999999999999999999999999999999999999999999988755


Q ss_pred             -cccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          199 -DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       199 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                       ....+.+|||-|+|||++.. ...+..+||||+||+||.||.|.+||+..+..++.+.|+.
T Consensus       172 ~Erk~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~  232 (592)
T KOG0575|consen  172 GERKKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL  232 (592)
T ss_pred             ccccceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh
Confidence             67778899999999999987 7889999999999999999999999999999999999874

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-48  Score=307.97  Aligned_cols=216  Identities=26%  Similarity=0.496  Sum_probs=196.3

Q ss_pred             EeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc-cchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        38 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      ....+++++++.||+|+||.||+++.+++++.||+|++++.. ...........|..+|.+++||.||+++-.|...   
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~---   97 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTE---   97 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccC---
Confidence            455778889999999999999999999999999999996653 2333567778999999999999999999999887   


Q ss_pred             CCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccc-
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-  194 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~-  194 (260)
                        ..+|+|+||+. |.|...++.++.|++..++.++..|+.||.|||+.||+|||+||+|||++.+|+++|+|||+++. 
T Consensus        98 --~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~  175 (357)
T KOG0598|consen   98 --EKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKED  175 (357)
T ss_pred             --CeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence              55999999998 59999999999999999999999999999999999999999999999999999999999999985 


Q ss_pred             cCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          195 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      ........+.+||+.|+|||.+.. ..++..+|.||||+++|+|++|.+||.+.+.....+.|.+
T Consensus       176 ~~~~~~t~tfcGT~eYmAPEil~~-~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~  239 (357)
T KOG0598|consen  176 LKDGDATRTFCGTPEYMAPEILLG-KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILK  239 (357)
T ss_pred             ccCCCccccccCCccccChHHHhc-CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhc
Confidence            444456666799999999999999 7899999999999999999999999999999988888864

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.6e-48  Score=302.18  Aligned_cols=212  Identities=37%  Similarity=0.722  Sum_probs=195.0

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~  122 (260)
                      .|+.+..+|+|+||+||+++++.+|+.||||++....+.+...+..++|+++|++|+|||+|.++++|...     ..++
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrk-----rklh   77 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRK-----RKLH   77 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhc-----ceeE
Confidence            57788999999999999999999999999999998877788888889999999999999999999999988     4599


Q ss_pred             EEEecCCcchHHHhhhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccC-CCcc
Q 024959          123 IVYELMDTDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDF  200 (260)
Q Consensus       123 lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~-~~~~  200 (260)
                      +|+|||+-++.+.++... .++.+.+..+++|++.++.|+|+++++||||||+|||++.+|.+||+|||+|+... ....
T Consensus        78 LVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~  157 (396)
T KOG0593|consen   78 LVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN  157 (396)
T ss_pred             EEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcch
Confidence            999999988888877754 58999999999999999999999999999999999999999999999999999877 4444


Q ss_pred             cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       201 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      .....-|..|.|||.+.+...|...+|||++||++.||++|.+.|+|.++-+++-.|..
T Consensus       158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~k  216 (396)
T KOG0593|consen  158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRK  216 (396)
T ss_pred             hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHH
Confidence            55566789999999999989999999999999999999999999999999999988864

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-47  Score=301.50  Aligned_cols=233  Identities=72%  Similarity=1.219  Sum_probs=216.5

Q ss_pred             eeEEeeecceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeee
Q 024959           27 YVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI  106 (260)
Q Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~  106 (260)
                      +.....+...|++...+. .+++||.|++|.|+.+.++.+|+.||||++...+.+....++..+|+++|+.++|+||+.+
T Consensus         8 ~~~~~~~~~~~~i~~~y~-~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l   86 (359)
T KOG0660|consen    8 YYDYEVFGELFEIPRYYV-LIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGL   86 (359)
T ss_pred             ceEEEeeeeEEeccceec-ccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceE
Confidence            566778889999987777 5899999999999999999999999999999888899999999999999999999999999


Q ss_pred             eceecCCCCCCCccEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEE
Q 024959          107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI  186 (260)
Q Consensus       107 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l  186 (260)
                      ++++..+....++.+|+|+|+|+.+|.+.++.+..++++.+..+++|++.+|.|+|+.+++|||+||.|++++.+..+|+
T Consensus        87 ~di~~p~~~~~f~DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI  166 (359)
T KOG0660|consen   87 LDIFRPPSRDKFNDVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKI  166 (359)
T ss_pred             EeecccccccccceeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEe
Confidence            99999877777789999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eecccccccCC---CcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcC
Q 024959          187 GDFGLARTTSE---TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV  260 (260)
Q Consensus       187 ~df~~~~~~~~---~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~~  260 (260)
                      +|||+++....   .........|..|.|||.......|+...||||.||++.||++|++.|.|.+..+|++.|.++
T Consensus       167 ~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~  243 (359)
T KOG0660|consen  167 CDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILEL  243 (359)
T ss_pred             ccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHh
Confidence            99999988764   334455667999999999999899999999999999999999999999999999999999864

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-47  Score=313.88  Aligned_cols=220  Identities=40%  Similarity=0.669  Sum_probs=198.8

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      .......|+.++.||+|.||.||++++..+|+.||+|++..+...+....-..+|+.+|++|+||||+++.++..+... 
T Consensus       112 ~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~-  190 (560)
T KOG0600|consen  112 GPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLS-  190 (560)
T ss_pred             cccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCC-
Confidence            3555677889999999999999999999999999999997776555556666799999999999999999999988743 


Q ss_pred             CCccEEEEEecCCcchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccccc
Q 024959          117 TFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (260)
Q Consensus       117 ~~~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~  195 (260)
                        ..+|+|+|||+-+|.-++.. .-+|++.++..++.||+++|+|+|++|+.|||||..||||+.+|.+||+|||++...
T Consensus       191 --~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  191 --GSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             --ceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeec
Confidence              56999999999988888776 568999999999999999999999999999999999999999999999999999965


Q ss_pred             CCCc--ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          196 SETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       196 ~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      ....  .....+.|..|.|||.+++...|+...|+||.||+|.||+.|++.|.+.+..+|+..|-+
T Consensus       269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfk  334 (560)
T KOG0600|consen  269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFK  334 (560)
T ss_pred             cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHH
Confidence            5443  456667899999999999989999999999999999999999999999999999999865

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.3e-48  Score=310.55  Aligned_cols=215  Identities=34%  Similarity=0.575  Sum_probs=187.3

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccch-----HHHHHHHHHHHHHHHcCCCCeeeeeceecCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI-----IDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~  113 (260)
                      .-.++|.+.+.||+|+||.|-+|..+.+++.||||++.+.....     .......+|+++|++|+|||||+++++|...
T Consensus       169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~  248 (475)
T KOG0615|consen  169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP  248 (475)
T ss_pred             hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence            34667779999999999999999999999999999996542111     1223456899999999999999999999988


Q ss_pred             CCCCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccC---CCEEEeec
Q 024959          114 KKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDF  189 (260)
Q Consensus       114 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~---~~~~l~df  189 (260)
                           ...|+||||++ |.|.+.+-.++.+.+..-+.+++||+.|+.|||++||+||||||+|||+..+   -.+||+||
T Consensus       249 -----ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  249 -----DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             -----CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEeccc
Confidence                 44899999998 6999999999999999999999999999999999999999999999999776   56899999


Q ss_pred             ccccccCCCcccccccccccccccccccCc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHhh
Q 024959          190 GLARTTSETDFMTEYVVTRWYRAPELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH-QLRLIT  258 (260)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-~~~~i~  258 (260)
                      |+++..++.....+.+||+.|.|||.+.+.  ..++.++|+|||||++|-+|+|.+||.+..... .-++|.
T Consensus       324 GlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~  395 (475)
T KOG0615|consen  324 GLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQIL  395 (475)
T ss_pred             chhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHh
Confidence            999999988888999999999999999763  224458899999999999999999998776655 444443

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-47  Score=300.28  Aligned_cols=214  Identities=27%  Similarity=0.424  Sum_probs=194.0

Q ss_pred             EeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCC
Q 024959           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (260)
Q Consensus        38 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~  117 (260)
                      .+...+++.++.||+|..|+||++.|+.+++.+|+|++... ..+...+++.+|+++++..+|||||++|+.|..+    
T Consensus        75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~----  149 (364)
T KOG0581|consen   75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-IDPALQKQILRELEILRSCQSPYIVGFYGAFYSN----  149 (364)
T ss_pred             ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC----
Confidence            35555788899999999999999999999999999999544 4566778899999999999999999999999988    


Q ss_pred             Cc-cEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          118 FN-DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       118 ~~-~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                       . .++|+||||+ |+|.+.+..-+++++..+..++.+++++|.|||+ ++|+||||||+|+|++..|.+||+|||.+..
T Consensus       150 -~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~  228 (364)
T KOG0581|consen  150 -GEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGI  228 (364)
T ss_pred             -CceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHH
Confidence             4 4999999999 6999999988999999999999999999999995 8999999999999999999999999999988


Q ss_pred             cCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHhhc
Q 024959          195 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK-----DYVHQLRLITE  259 (260)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~-----~~~~~~~~i~~  259 (260)
                      ...+ ...+..||..|||||++.+ ..|+.++||||||++++|++.|+.||...     +..+++..|+.
T Consensus       229 lvnS-~a~tfvGT~~YMsPERi~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~  296 (364)
T KOG0581|consen  229 LVNS-IANTFVGTSAYMSPERISG-ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD  296 (364)
T ss_pred             hhhh-hcccccccccccChhhhcC-CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc
Confidence            8777 5677899999999999999 78999999999999999999999999875     66777777653

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-46  Score=289.12  Aligned_cols=213  Identities=24%  Similarity=0.467  Sum_probs=195.7

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~  117 (260)
                      ...++|++++.||.|+||.|.+++++.++..||+|++.+..- .-.+.+...+|.++|+.+.||.++++++.+.+.    
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~----  116 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDN----  116 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccC----
Confidence            556778999999999999999999999999999999966422 233456667899999999999999999999988    


Q ss_pred             CccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccC
Q 024959          118 FNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (260)
Q Consensus       118 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~  196 (260)
                       ..+|+||||.+ |.|.+++++.++|++..++.++.|++.||+|||+++|++||+||+|||++.+|.+||+|||+++...
T Consensus       117 -~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~  195 (355)
T KOG0616|consen  117 -SNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS  195 (355)
T ss_pred             -CeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence             66999999998 6999999999999999999999999999999999999999999999999999999999999999877


Q ss_pred             CCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       197 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      ..  .-+.+||+.|+|||.+.. .+++..+|.|+||+++|||+.|.+||-..+.....++|.+
T Consensus       196 ~r--T~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~  255 (355)
T KOG0616|consen  196 GR--TWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILE  255 (355)
T ss_pred             Cc--EEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHh
Confidence            65  567799999999999998 8999999999999999999999999999999999988865

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-47  Score=308.22  Aligned_cols=214  Identities=41%  Similarity=0.750  Sum_probs=197.0

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-CCCeeeeeceecCCCCCCCcc
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      ..|.+++.||.|.||.||++..+.++..||||.++.......+. --++|++.|++|+ ||||+++.+++.++.    ..
T Consensus        10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~-~nLREvksL~kln~hpniikL~Evi~d~~----~~   84 (538)
T KOG0661|consen   10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDND----RI   84 (538)
T ss_pred             HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccC----ce
Confidence            45678999999999999999999999999999998876552222 2258999999998 999999999999984    26


Q ss_pred             EEEEEecCCcchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc
Q 024959          121 VYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (260)
Q Consensus       121 ~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~  199 (260)
                      +|+|||+|+.+|.++++. ++.|++..++.|+.||+++|+++|.+|+.|||+||+|||+.....+||+|||+|+......
T Consensus        85 L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp  164 (538)
T KOG0661|consen   85 LYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKP  164 (538)
T ss_pred             EeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCC
Confidence            999999999999999987 4569999999999999999999999999999999999999988899999999999999998


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcC
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV  260 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~~  260 (260)
                      +....+.|..|.|||+++....|+.+.|+|++||+++|+.+-++.|+|.++.+++-+|.+|
T Consensus       165 PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~V  225 (538)
T KOG0661|consen  165 PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEV  225 (538)
T ss_pred             CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHH
Confidence            8999999999999999999899999999999999999999999999999999999999875

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.4e-45  Score=304.93  Aligned_cols=216  Identities=27%  Similarity=0.451  Sum_probs=191.7

Q ss_pred             EeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc-cchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        38 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      .++.++|++++.||+|+||.||+|+.+.||+.+|+|++++.. ....+......|-.+|...++|.||++|-.|.+.   
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~---  213 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK---  213 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC---
Confidence            567888999999999999999999999999999999997653 2333556677899999999999999999999888   


Q ss_pred             CCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccccc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~  195 (260)
                        ..+||||||++ |++..++...+.|+++.++.++.+++-||+.||+.|++||||||+|+||+..|++||+|||++...
T Consensus       214 --~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl  291 (550)
T KOG0605|consen  214 --EYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL  291 (550)
T ss_pred             --CeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchh
Confidence              66999999998 699999999999999999999999999999999999999999999999999999999999998422


Q ss_pred             CC----------------------Cccc--------------------------ccccccccccccccccCcCCCCChhh
Q 024959          196 SE----------------------TDFM--------------------------TEYVVTRWYRAPELLLNCTEYTAAID  227 (260)
Q Consensus       196 ~~----------------------~~~~--------------------------~~~~~~~~~~~PE~~~~~~~~~~~~D  227 (260)
                      ..                      +...                          .+.+|||.|+|||++.+ ..|+...|
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~cD  370 (550)
T KOG0605|consen  292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKECD  370 (550)
T ss_pred             hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCcccc
Confidence            11                      0000                          01467899999999999 77999999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          228 IWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       228 i~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      .|||||++||||.|++||.+.+..+++++|+.
T Consensus       371 wWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~n  402 (550)
T KOG0605|consen  371 WWSLGCIMYEMLVGYPPFCSETPQETYRKIVN  402 (550)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            99999999999999999999999999999974

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1e-45  Score=305.92  Aligned_cols=217  Identities=26%  Similarity=0.462  Sum_probs=192.1

Q ss_pred             EeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchH-HHHHHHHHHHHHHHc-CCCCeeeeeceecCCCC
Q 024959           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII-DARRTLREIKLLRHM-EHENVIAIKDIIRPPKK  115 (260)
Q Consensus        38 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~-~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~  115 (260)
                      .....+|..++.||.|+|++|++|.++.+++.||||++.+..-... .......|-..|.+| .||.|++++-.|.++  
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~--  146 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE--  146 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc--
Confidence            4456778899999999999999999999999999999966543222 234445788899999 799999999999988  


Q ss_pred             CCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          116 DTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       116 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                         ..+|+|+||++ |.|.+++.+-+.|++...+.++.+|+.+|+|||++||+||||||+|||++++++++|+|||-++.
T Consensus       147 ---~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  147 ---ESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             ---cceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeecccccc
Confidence               55999999998 89999999999999999999999999999999999999999999999999999999999999976


Q ss_pred             cCCCcc--------------cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcC
Q 024959          195 TSETDF--------------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV  260 (260)
Q Consensus       195 ~~~~~~--------------~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~~  260 (260)
                      +.....              ..+.+||-.|.+||.+.. ...++.+|||+|||++|+|+.|.+||.+.|...++++|+++
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l  302 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL  302 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh
Confidence            543311              134678999999999988 88899999999999999999999999999999999999864

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.4e-45  Score=279.62  Aligned_cols=212  Identities=41%  Similarity=0.719  Sum_probs=192.1

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~  122 (260)
                      .|...+.+|+|.||+||++++..+|+.||||+++.......-....++|++.|+.++|+||+.++++|...     ..+.
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~-----~~l~   77 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHK-----SNLS   77 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCC-----CceE
Confidence            46678999999999999999999999999999977644444456778999999999999999999999887     5589


Q ss_pred             EEEecCCcchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCccc
Q 024959          123 IVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  201 (260)
Q Consensus       123 lv~e~~~~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  201 (260)
                      +|+|||+.+|...++.+ ..++...+..++.+++++++|+|.+.|.||||||.|+||+.+|.+||+|||+++........
T Consensus        78 lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   78 LVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             EEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            99999999999999875 56899999999999999999999999999999999999999999999999999987765433


Q ss_pred             cc-ccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          202 TE-YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       202 ~~-~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      .. ...|..|.|||.+++.+.|....|+||.||++.||+.|.+.|.|.++.+|+..|.+
T Consensus       158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~  216 (318)
T KOG0659|consen  158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFR  216 (318)
T ss_pred             cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHH
Confidence            33 36799999999999999999999999999999999999999999999999998864

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.6e-46  Score=290.62  Aligned_cols=219  Identities=40%  Similarity=0.652  Sum_probs=197.6

Q ss_pred             EeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCC
Q 024959           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (260)
Q Consensus        38 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~  117 (260)
                      +.+-+.|+++..|+.|.||.||++.++.+++.||+|.++.+.+...-.-..++|+.+|.+++|||||.+.++......  
T Consensus        72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~--  149 (419)
T KOG0663|consen   72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM--  149 (419)
T ss_pred             cccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc--
Confidence            445667889999999999999999999999999999997765444444456799999999999999999999987765  


Q ss_pred             CccEEEEEecCCcchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccC
Q 024959          118 FNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (260)
Q Consensus       118 ~~~~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~  196 (260)
                       +.+|+|||||+-+|.+++..- .+|...+++.++.|++++++|||.+.|+|||+|++|+|++..|.+|++|||+|+...
T Consensus       150 -d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  150 -DKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             -ceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhc
Confidence             569999999999999999874 589999999999999999999999999999999999999999999999999999887


Q ss_pred             CCcc-cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          197 ETDF-MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       197 ~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      .+.. ......|..|.|||.+.+...|+...|+||+||++.||+++++.|.|....+|+.+|.+
T Consensus       229 sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~  292 (419)
T KOG0663|consen  229 SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFK  292 (419)
T ss_pred             CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHH
Confidence            7643 34456699999999999989999999999999999999999999999999999999875

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-44  Score=300.87  Aligned_cols=216  Identities=32%  Similarity=0.512  Sum_probs=192.6

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccc---hHHHHHHHHHHHHHHHcC-CCCeeeeeceecCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN---IIDARRTLREIKLLRHME-HENVIAIKDIIRPPK  114 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~  114 (260)
                      .....|.+++.||+|.||.|+++.+..++..||+|++......   ....+.+.+|+.++++++ ||||+++++++... 
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~-   92 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP-   92 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC-
Confidence            4456677999999999999999999999999999977654111   123455668999999999 99999999999988 


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccC-CCEEEeecccc
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDFGLA  192 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~-~~~~l~df~~~  192 (260)
                          ..+|+||||+. |.|.+.+.+.+++.+..++.++.|+++|++|+|++|++||||||+|++++.+ +++||+|||++
T Consensus        93 ----~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   93 ----TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             ----CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence                44999999998 5999999999999999999999999999999999999999999999999999 99999999999


Q ss_pred             ccc-CCCcccccccccccccccccccCcCCC-CChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          193 RTT-SETDFMTEYVVTRWYRAPELLLNCTEY-TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       193 ~~~-~~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      ... .......+.+|++.|+|||.+.+...| ..++||||||++||.|++|..||...+.....+.|.+
T Consensus       169 ~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~  237 (370)
T KOG0583|consen  169 AISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK  237 (370)
T ss_pred             cccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc
Confidence            988 566778889999999999999985525 5899999999999999999999999999888888764

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=8e-45  Score=302.00  Aligned_cols=211  Identities=32%  Similarity=0.532  Sum_probs=195.7

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~  122 (260)
                      .|-+.+.||+|.||+||+++.+.+.+.||+|.+.+......+...+.+|+++++.++||||+.++++|+..     ..++
T Consensus         3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~-----~~~~   77 (808)
T KOG0597|consen    3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETS-----AHLW   77 (808)
T ss_pred             chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhccc-----ceEE
Confidence            35578899999999999999999999999999988888888888999999999999999999999999887     5699


Q ss_pred             EEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCccc-
Q 024959          123 IVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM-  201 (260)
Q Consensus       123 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~~-  201 (260)
                      +|+||+.|+|..++...+.++++.++.++.+++.+|.|||+++|.|+|+||.||++..++.+|++|||+++.+...... 
T Consensus        78 vVte~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vl  157 (808)
T KOG0597|consen   78 VVTEYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVL  157 (808)
T ss_pred             EEehhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceee
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999988765433 


Q ss_pred             ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       202 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      ....|+|.|||||.+.+ .+++..+|+|||||++||+..|.+||-..+..+..+.|..
T Consensus       158 tsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~  214 (808)
T KOG0597|consen  158 TSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILK  214 (808)
T ss_pred             eeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhc
Confidence            34578999999999997 9999999999999999999999999998888888887753

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=9.8e-45  Score=287.86  Aligned_cols=212  Identities=39%  Similarity=0.673  Sum_probs=189.0

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~  122 (260)
                      .|.-.+.+|+|+||.||.+....+++.||||+.-.+..      ---+|+++|+.++|||||++.-+|........-...
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln   98 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN   98 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence            34566889999999999999999999999999854321      122699999999999999999988776543223566


Q ss_pred             EEEecCCcchHHHhhh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccC-CCEEEeecccccccCC
Q 024959          123 IVYELMDTDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSE  197 (260)
Q Consensus       123 lv~e~~~~~l~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~-~~~~l~df~~~~~~~~  197 (260)
                      +|||||+.+|.+.++.    +.+++...++-+.+||+++|.|||+.||+||||||.|+|++.+ |.+||+|||-|+....
T Consensus        99 lVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~  178 (364)
T KOG0658|consen   99 LVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK  178 (364)
T ss_pred             HHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence            8999999999998874    6789999999999999999999999999999999999999986 8999999999999988


Q ss_pred             CcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcC
Q 024959          198 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV  260 (260)
Q Consensus       198 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~~  260 (260)
                      ..+..+..++.+|.|||.+.+...|+.+.||||.||++.||+-|.+.|.|.+.-+|+..|.++
T Consensus       179 ~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~  241 (364)
T KOG0658|consen  179 GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKV  241 (364)
T ss_pred             CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHH
Confidence            888899999999999999999899999999999999999999999999999999999998753

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-43  Score=289.59  Aligned_cols=218  Identities=28%  Similarity=0.389  Sum_probs=190.4

Q ss_pred             ecceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecC
Q 024959           33 YGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRP  112 (260)
Q Consensus        33 ~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~  112 (260)
                      ....+++......+.+.||+|+||+||++..+.+ ..+|+|++............+.+|+.+|.+++|||||++++++..
T Consensus        32 ~~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~-~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~  110 (362)
T KOG0192|consen   32 ELPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGT-DVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTS  110 (362)
T ss_pred             cccceecChHHhhhhhhcccCCceeEEEEEeCCc-eeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            3467888888888889999999999999988764 239999998766555557889999999999999999999999988


Q ss_pred             CCCCCCccEEEEEecCC-cchHHHhhh--CCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeccCCCCCeEeccCC-CEEEe
Q 024959          113 PKKDTFNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSAS-VLHRDLKPSNLLLNASC-DLKIG  187 (260)
Q Consensus       113 ~~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~-i~H~di~~~nili~~~~-~~~l~  187 (260)
                      +..    .+++||||++ |+|.+++..  +..++...+..++.||+++++|||+++ |+|+||||+|+|++.++ ++||+
T Consensus       111 ~~~----~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~  186 (362)
T KOG0192|consen  111 PPG----SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIA  186 (362)
T ss_pred             CCC----ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEEC
Confidence            731    5899999998 799999987  688999999999999999999999999 99999999999999997 99999


Q ss_pred             ecccccccCCC-cccccccccccccccccccC-cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024959          188 DFGLARTTSET-DFMTEYVVTRWYRAPELLLN-CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  255 (260)
Q Consensus       188 df~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~-~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~  255 (260)
                      |||+++..... .......||+.|||||.+.+ ...++.++||||||+++|||+||+.||.+.+..+...
T Consensus       187 DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~  256 (362)
T KOG0192|consen  187 DFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVAS  256 (362)
T ss_pred             CCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            99999877665 23334688999999999995 2789999999999999999999999999998844433

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-44  Score=296.36  Aligned_cols=216  Identities=27%  Similarity=0.474  Sum_probs=193.0

Q ss_pred             cceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCC
Q 024959           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (260)
Q Consensus        34 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~  113 (260)
                      ...|++..+.+.+++.||+|.||.||.+..+.+ ..|++|.++..   ....++|.+|+++|++|+|++||++++++..+
T Consensus       198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~---~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~  273 (468)
T KOG0197|consen  198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEG---SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQ  273 (468)
T ss_pred             cCCeeecHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEecc---ccChhHHHHHHHHHHhCcccCeEEEEEEEecC
Confidence            578999999999999999999999999988764 47999999764   33457788999999999999999999999987


Q ss_pred             CCCCCccEEEEEecCC-cchHHHhhh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecc
Q 024959          114 KKDTFNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG  190 (260)
Q Consensus       114 ~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~  190 (260)
                           ..++||||||. |+|.++++.  +..+...+...++.||+++++||++++++||||...|||+++++.+||+|||
T Consensus       274 -----~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFG  348 (468)
T KOG0197|consen  274 -----EPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFG  348 (468)
T ss_pred             -----CceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccc
Confidence                 34999999999 899999997  5679999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcccc--cccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhc
Q 024959          191 LARTTSETDFMT--EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       191 ~~~~~~~~~~~~--~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~~  259 (260)
                      +++...++....  .......|+|||.+.. ..++.++||||||++||||+| |+.||++++..+.+++|.+
T Consensus       349 LAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~  419 (468)
T KOG0197|consen  349 LARLIGDDEYTASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLER  419 (468)
T ss_pred             cccccCCCceeecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhc
Confidence            999655443322  2334778999999988 789999999999999999999 9999999999999998864

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.5e-43  Score=279.80  Aligned_cols=218  Identities=42%  Similarity=0.715  Sum_probs=192.6

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCC-eeeeeceecCCCC-CCCc
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN-VIAIKDIIRPPKK-DTFN  119 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-iv~~~~~~~~~~~-~~~~  119 (260)
                      ..|..++.||+|.||+||+|+++.+|+.||+|++....+.+.......+|+.+++.++|+| |+++++++..... .+..
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            3456678899999999999999999999999999766443334556789999999999999 9999999987652 2224


Q ss_pred             cEEEEEecCCcchHHHhhhCC----CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccccc
Q 024959          120 DVYIVYELMDTDLHQIIRSDQ----QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (260)
Q Consensus       120 ~~~lv~e~~~~~l~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~  195 (260)
                      .+++|+|++..+|..++....    .++...++.+++||+.+|+|||+++|+||||||+|++|+++|.+||+|||++...
T Consensus        91 ~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~  170 (323)
T KOG0594|consen   91 KLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAF  170 (323)
T ss_pred             eEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHh
Confidence            689999999999999998754    5788899999999999999999999999999999999999999999999999977


Q ss_pred             CCC-cccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          196 SET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       196 ~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      ..+ ......++|..|.|||.+.+...|+...|+||+||++.||+++...|.+.+..+++..|-+
T Consensus       171 ~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~  235 (323)
T KOG0594|consen  171 SIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFR  235 (323)
T ss_pred             cCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHH
Confidence            744 4466678899999999999988899999999999999999999999999999999988865

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-43  Score=284.67  Aligned_cols=214  Identities=27%  Similarity=0.491  Sum_probs=198.4

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCc-ccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNA-FDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      ...|++.+.||+|.||.|-++.....|+.||||.+.++ .....+.-.+.+|+++|..|+||||+.+|++|+-.     .
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENk-----d  126 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENK-----D  126 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCC-----c
Confidence            44588999999999999999999999999999999654 34555667788999999999999999999999876     4


Q ss_pred             cEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          120 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       120 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      .+.|||||.. |.|.+++...+.+++.+++.+++||++++.|+|.++++|+|+|.+|||++.++++||.|||++......
T Consensus       127 KIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~  206 (668)
T KOG0611|consen  127 KIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK  206 (668)
T ss_pred             eEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc
Confidence            5999999987 799999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          199 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       199 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      ....+.+|++.|.+||++.+.+.-.+.+|.||||++||.|+.|..||+|.+.-...++|.+
T Consensus       207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~  267 (668)
T KOG0611|consen  207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISR  267 (668)
T ss_pred             cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhc
Confidence            9999999999999999999966667999999999999999999999999999999999864

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-43  Score=284.34  Aligned_cols=215  Identities=27%  Similarity=0.446  Sum_probs=183.5

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc------------chHHHHHHHHHHHHHHHcCCCCeeeeece
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD------------NIIDARRTLREIKLLRHMEHENVIAIKDI  109 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~------------~~~~~~~~~~e~~~l~~l~~~~iv~~~~~  109 (260)
                      ..|++++.||+|.||.|-++++..+++.||||++.+...            .....++..+|+.+|+++.|||||+++++
T Consensus        97 Nqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv  176 (576)
T KOG0585|consen   97 NQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV  176 (576)
T ss_pred             hheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence            457799999999999999999999999999999954411            11123577899999999999999999999


Q ss_pred             ecCCCCCCCccEEEEEecCCcchHHHhhhCCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEee
Q 024959          110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD  188 (260)
Q Consensus       110 ~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~d  188 (260)
                      .-+...   ..+|+|+|||...-..+....++ +++.+++.++++++.+|+|||.+||+||||||.|+|++.+|++||+|
T Consensus       177 LDDP~s---~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsD  253 (576)
T KOG0585|consen  177 LDDPES---DKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISD  253 (576)
T ss_pred             ecCccc---CceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeec
Confidence            988765   67999999998433334444455 99999999999999999999999999999999999999999999999


Q ss_pred             ccccccc------CCCcccccccccccccccccccCc---CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          189 FGLARTT------SETDFMTEYVVTRWYRAPELLLNC---TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       189 f~~~~~~------~~~~~~~~~~~~~~~~~PE~~~~~---~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      ||.+...      +.........||+.|+|||.+.+.   .....+.||||+|++||+|+.|..||-+....++..+|++
T Consensus       254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn  333 (576)
T KOG0585|consen  254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVN  333 (576)
T ss_pred             cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhc
Confidence            9988755      223344557899999999999873   3346789999999999999999999999999999999975

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.4e-43  Score=295.68  Aligned_cols=211  Identities=28%  Similarity=0.428  Sum_probs=194.1

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc-cchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~  122 (260)
                      |++++.||.|+.|.|-+|.|..||+..|||++.+.. ........+.+|+-+|+.+.|||++++|++|+.+     ..+|
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~-----~~ly   88 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENK-----QHLY   88 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccC-----ceEE
Confidence            457899999999999999999999999999997652 2333456677999999999999999999999988     6699


Q ss_pred             EEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCccc
Q 024959          123 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  201 (260)
Q Consensus       123 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  201 (260)
                      +|.||++ |.|.+++..++++++.++..+++||+.++.|+|..+|+|+|+||+|++++..++|||+|||.|..-.+....
T Consensus        89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklL  168 (786)
T KOG0588|consen   89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLL  168 (786)
T ss_pred             EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCccc
Confidence            9999998 799999999999999999999999999999999999999999999999999999999999999988888888


Q ss_pred             ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       202 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      .+.+|++.|.+||++.+.+....++||||+|++||.||+|+.||++.|....+.++.+
T Consensus       169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~  226 (786)
T KOG0588|consen  169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQR  226 (786)
T ss_pred             cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHc
Confidence            9999999999999999966667899999999999999999999999999998888753

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=5.8e-42  Score=288.86  Aligned_cols=210  Identities=24%  Similarity=0.410  Sum_probs=182.4

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      .|++++.||+|++|+||++.+..+++.||+|++..... .......+.+|+.++..++||+|+++++.+.+.     ..+
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~-----~~~   76 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDK-----LNL   76 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecC-----CeE
Confidence            56788999999999999999999999999999965322 223345677899999999999999999999876     569


Q ss_pred             EEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc-
Q 024959          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~-  199 (260)
                      |+||||++ ++|.+++.....+++..++.++.|++.+|+|||++|++||||||+||+++.++.++|+|||++....... 
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          77 YLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence            99999997 6999999888899999999999999999999999999999999999999999999999999986543211 


Q ss_pred             -----------------------------------ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCC
Q 024959          200 -----------------------------------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL  244 (260)
Q Consensus       200 -----------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~p  244 (260)
                                                         ......|++.|+|||.+.+ ..++.++|+|||||++|+|++|..|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCCC
Confidence                                               0123467899999999987 7789999999999999999999999


Q ss_pred             CCCCChHHHHHHhh
Q 024959          245 FPGKDYVHQLRLIT  258 (260)
Q Consensus       245 f~~~~~~~~~~~i~  258 (260)
                      |.+.+..+..+.|.
T Consensus       236 f~~~~~~~~~~~i~  249 (363)
T cd05628         236 FCSETPQETYKKVM  249 (363)
T ss_pred             CCCCCHHHHHHHHH
Confidence            99988888777765

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=8.5e-42  Score=285.22  Aligned_cols=214  Identities=56%  Similarity=1.024  Sum_probs=183.0

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~l  123 (260)
                      |++.+.||+|++|.||++.+..++..|++|.+............+.+|+++++.++||||+++++++..........+|+
T Consensus         2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l   81 (338)
T cd07859           2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV   81 (338)
T ss_pred             eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence            56789999999999999999999999999998754444445567889999999999999999999987655444456899


Q ss_pred             EEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCcc---
Q 024959          124 VYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---  200 (260)
Q Consensus       124 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~---  200 (260)
                      |||+++++|.+.+.....+++..+..++.|++++|.|||++|++|+||||+||+++.++.++|+|||++........   
T Consensus        82 v~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  161 (338)
T cd07859          82 VFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAI  161 (338)
T ss_pred             EEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCccc
Confidence            99999999999998888999999999999999999999999999999999999999999999999999875432211   


Q ss_pred             -cccccccccccccccccCc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          201 -MTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       201 -~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                       .....+++.|+|||.+.+. ..++.++||||||+++|+|++|+.||.+.+...++..+
T Consensus       162 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~  220 (338)
T cd07859         162 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLI  220 (338)
T ss_pred             cccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Confidence             1234678899999988642 56788999999999999999999999988876655443

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-42  Score=291.80  Aligned_cols=217  Identities=24%  Similarity=0.390  Sum_probs=194.3

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc-cchHHHHHHHHHHHHHHHcC-CCCeeeeeceecCCC
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPK  114 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~  114 (260)
                      ..+..+.+++++.||+|.||+|+++..+.+++.||||.+++.. -...+.+....|.+++...+ ||.++.++..|... 
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~-  441 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTK-  441 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccC-
Confidence            3566788899999999999999999999999999999997763 34445677888999888885 99999999999887 


Q ss_pred             CCCCccEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          115 KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                          ..+|+||||+.|.-...+...+.|++..++.++..++.+|.|||++||+|||||.+|||++.+|++||+|||+++.
T Consensus       442 ----~~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe  517 (694)
T KOG0694|consen  442 ----EHLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKE  517 (694)
T ss_pred             ----CeEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccc
Confidence                6699999999864444445568899999999999999999999999999999999999999999999999999987


Q ss_pred             cC-CCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          195 TS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       195 ~~-~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      .- ....+.+.+||+.|+|||.+.+ ..|+..+|.|+||++|||||.|..||++.+.++.+..|+.
T Consensus       518 ~m~~g~~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~  582 (694)
T KOG0694|consen  518 GMGQGDRTSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN  582 (694)
T ss_pred             cCCCCCccccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc
Confidence            55 5567778899999999999998 8899999999999999999999999999999999999864

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.6e-43  Score=262.29  Aligned_cols=214  Identities=25%  Similarity=0.414  Sum_probs=193.4

Q ss_pred             ccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCc-ccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCC
Q 024959           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNA-FDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~  118 (260)
                      ..++++++++||.|.||.||+++.++++..||+|++.+. .......+++.+|+++-..|+||||+++|++|.+.     
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~-----   94 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS-----   94 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc-----
Confidence            346778899999999999999999999999999998543 23333457778999999999999999999999988     


Q ss_pred             ccEEEEEecCC-cchHHHhh--hCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccccc
Q 024959          119 NDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (260)
Q Consensus       119 ~~~~lv~e~~~-~~l~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~  195 (260)
                      ...|+++||.+ |++...++  ...++++...+.++.|++.|+.|+|.++++||||+|+|+|++.++.+|++|||.+...
T Consensus        95 ~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~  174 (281)
T KOG0580|consen   95 KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHA  174 (281)
T ss_pred             ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence            55999999998 79999998  5678999999999999999999999999999999999999999999999999998877


Q ss_pred             CCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcC
Q 024959          196 SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV  260 (260)
Q Consensus       196 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~~  260 (260)
                      . .....+.+||..|.+||...+ ...+..+|+|++|++.||++.|.+||+..+..++.+.|.++
T Consensus       175 p-~~kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~  237 (281)
T KOG0580|consen  175 P-SNKRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV  237 (281)
T ss_pred             C-CCCceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc
Confidence            6 445677899999999999988 88999999999999999999999999999999999998764

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-41  Score=277.01  Aligned_cols=208  Identities=22%  Similarity=0.386  Sum_probs=181.5

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      .|++.+.||+|+||.||++.+..+++.+++|++..... .......+.+|+++++.++||||+++++.+...     ..+
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~   76 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQ-----RFL   76 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccC-----CeE
Confidence            46788999999999999999999999999999864321 223455678899999999999999999988776     568


Q ss_pred             EEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCcc
Q 024959          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  200 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~  200 (260)
                      ++||||++ ++|.+++.....+++..++.++.|++.+|++||++|++|+||+|+||+++.++.++|+|||++......  
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--  154 (291)
T cd05612          77 YMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--  154 (291)
T ss_pred             EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence            99999998 689999998889999999999999999999999999999999999999999999999999998765433  


Q ss_pred             cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       201 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+..+.|.
T Consensus       155 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~  211 (291)
T cd05612         155 TWTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKIL  211 (291)
T ss_pred             cccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            223467889999999877 678899999999999999999999999988777666654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.3e-41  Score=287.89  Aligned_cols=207  Identities=37%  Similarity=0.642  Sum_probs=186.5

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-C-----CCeeeeeceecCCCCC
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-H-----ENVIAIKDIIRPPKKD  116 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~-----~~iv~~~~~~~~~~~~  116 (260)
                      .|++.+.||+|.||.|.+|.+..+++.||||++++.   .....+...|+++|..|+ |     -|+|+++++|...   
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr---  260 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR---  260 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc---
Confidence            567899999999999999999999999999999875   334566778999999997 3     4999999999887   


Q ss_pred             CCccEEEEEecCCcchHHHhhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccC--CCEEEeecccc
Q 024959          117 TFNDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS--CDLKIGDFGLA  192 (260)
Q Consensus       117 ~~~~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~--~~~~l~df~~~  192 (260)
                        +..|||+|.+..+|.++++.+  ..++...++.++.||+.+|.+||+.+|+|+||||+|||+..-  ..+||+|||.+
T Consensus       261 --~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  261 --NHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             --cceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccc
Confidence              669999999999999999875  468999999999999999999999999999999999999653  46999999988


Q ss_pred             cccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcC
Q 024959          193 RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV  260 (260)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~~  260 (260)
                      ........  +...+.+|.|||++.+ .+|+.+.|+|||||++.||++|.+.|.|.+..+|++.|.++
T Consensus       339 c~~~q~vy--tYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~  403 (586)
T KOG0667|consen  339 CFESQRVY--TYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEV  403 (586)
T ss_pred             cccCCcce--eeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHH
Confidence            76655543  6778999999999999 89999999999999999999999999999999999999875

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=7.2e-41  Score=283.15  Aligned_cols=215  Identities=51%  Similarity=0.933  Sum_probs=187.3

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~l  123 (260)
                      +++++.||+|+||.||++.+..+++.||+|.+............+.+|+++++.++||||+++++++...........++
T Consensus         2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l   81 (372)
T cd07853           2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV   81 (372)
T ss_pred             CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence            56889999999999999999999999999999765445555677889999999999999999999998765433346899


Q ss_pred             EEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc--cc
Q 024959          124 VYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--FM  201 (260)
Q Consensus       124 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~--~~  201 (260)
                      |+||++++|.+.+.....+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++.......  ..
T Consensus        82 v~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~  161 (372)
T cd07853          82 VTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHM  161 (372)
T ss_pred             EeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccccC
Confidence            9999999999999888899999999999999999999999999999999999999999999999999987643322  22


Q ss_pred             ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       202 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ....+++.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+++..|.
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~  218 (372)
T cd07853         162 TQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT  218 (372)
T ss_pred             CCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence            233567889999999875667899999999999999999999999999888877764

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-41  Score=273.52  Aligned_cols=202  Identities=29%  Similarity=0.475  Sum_probs=174.3

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      ...+...+.||+|+||.||++.+.++|...|+|.+....  ....+.+.+|+++|++++|||||++++.......   ..
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~--~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~---~~   90 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED--SPTSESLEREIRILSRLNHPNIVQYYGSSSSREN---DE   90 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc--chhHHHHHHHHHHHHhCCCCCEEeeCCccccccC---ee
Confidence            445667899999999999999999999999999997652  2226778899999999999999999997444321   35


Q ss_pred             EEEEEecCC-cchHHHhhhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecc-CCCEEEeecccccccCC
Q 024959          121 VYIVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSE  197 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~-~~~~~l~df~~~~~~~~  197 (260)
                      +++.|||+. |+|.+.+...+ ++++..++.+..|++++|+|||++|++|+||||+|||++. ++.+||+|||++.....
T Consensus        91 ~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   91 YNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             eEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            899999998 69999999866 8999999999999999999999999999999999999999 79999999999887663


Q ss_pred             ----CcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 024959          198 ----TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG  247 (260)
Q Consensus       198 ----~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~  247 (260)
                          ........+++.|+|||.+........++|||||||++.||+||+.||.+
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~  224 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE  224 (313)
T ss_pred             ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence                23344567899999999998623444699999999999999999999987

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.6e-41  Score=281.28  Aligned_cols=210  Identities=25%  Similarity=0.396  Sum_probs=183.7

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc-cchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      ...|++.+.||+|++|.||++.++.+++.|++|++.... ........+.+|+++++.++||||+++++.+...     .
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~   91 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE-----N   91 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC-----C
Confidence            355778999999999999999999999999999986532 1223456678999999999999999999999877     5


Q ss_pred             cEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          120 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       120 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      ..++||||+. ++|.+.+.....+++..++.++.|++.+|+|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus        92 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         92 RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             EEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            6999999997 699999998889999999999999999999999999999999999999999999999999998766443


Q ss_pred             cccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          199 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       199 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      .  ....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+..+.|.
T Consensus       172 ~--~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~  228 (329)
T PTZ00263        172 T--FTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL  228 (329)
T ss_pred             c--ceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh
Confidence            2  23467899999999987 677899999999999999999999999888777766654

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=8e-41  Score=273.48  Aligned_cols=211  Identities=39%  Similarity=0.707  Sum_probs=180.5

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      ..|++.+.||.|++|.||++.+..++..|++|.++.... ......+.+|+++++.++||||+++++++...     ...
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~   78 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTE-----RCL   78 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC-----CeE
Confidence            457788999999999999999999999999999865322 12234567899999999999999999999776     558


Q ss_pred             EEEEecCCcchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc-
Q 024959          122 YIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (260)
Q Consensus       122 ~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~-  199 (260)
                      ++|||+++++|.+.+... ..+++..+..++.|++++|++||++|++|+||+|+||+++.++.++|+|||++....... 
T Consensus        79 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          79 TLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             EEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            999999999999988764 457999999999999999999999999999999999999999999999999987644322 


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ......+++.|+|||.+.+...++.++|+||||+++|+|++|..||.+.+..+.+..|.
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~  217 (288)
T cd07871         159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIF  217 (288)
T ss_pred             cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            22344668899999998765678999999999999999999999999988877766553

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=4.8e-41  Score=279.04  Aligned_cols=205  Identities=26%  Similarity=0.443  Sum_probs=177.7

Q ss_pred             ccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEEEEe
Q 024959           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYE  126 (260)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv~e  126 (260)
                      +.||+|+||.||++.++.+++.||+|+++.... .......+.+|+++++.++||||+++++.+..+     ..+++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTH-----DRLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcC-----CEEEEEEe
Confidence            468999999999999999999999999965422 233445677899999999999999999999877     56999999


Q ss_pred             cCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCC-Ccccccc
Q 024959          127 LMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTEY  204 (260)
Q Consensus       127 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~-~~~~~~~  204 (260)
                      |++ ++|.+.+..+..+++..++.++.||+.+|+|||++|++|+||||+||+++.++.++|+|||+++.... .......
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  155 (323)
T cd05571          76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF  155 (323)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccce
Confidence            998 58989988888999999999999999999999999999999999999999999999999999875322 2233345


Q ss_pred             cccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          205 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       205 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      .+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+.......|.
T Consensus       156 ~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~  208 (323)
T cd05571         156 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL  208 (323)
T ss_pred             ecCccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH
Confidence            67999999999987 778999999999999999999999999888776666553

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-41  Score=284.48  Aligned_cols=210  Identities=26%  Similarity=0.432  Sum_probs=180.7

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc-cchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      .|++++.||+|+||.||++.+..+++.||+|++.... ........+.+|+.+++.++||||+++++.+..+     ..+
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~-----~~~   76 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDE-----NYL   76 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC-----CeE
Confidence            5678899999999999999999999999999996532 1223445677899999999999999999999877     569


Q ss_pred             EEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCcc
Q 024959          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  200 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~  200 (260)
                      ++||||++ ++|.+++.....+++..++.++.|++.+|+|||++|++|+||||+||+++.++.++|+|||++........
T Consensus        77 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          77 YLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             EEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence            99999997 68999998888999999999999999999999999999999999999999999999999999865422110


Q ss_pred             ---------------------------------------cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhC
Q 024959          201 ---------------------------------------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR  241 (260)
Q Consensus       201 ---------------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g  241 (260)
                                                             .....+++.|+|||.+.. ..++.++|+|||||++|+|++|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhcC
Confidence                                                   012357899999999877 7789999999999999999999


Q ss_pred             CCCCCCCChHHHHHHhh
Q 024959          242 EPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       242 ~~pf~~~~~~~~~~~i~  258 (260)
                      ..||.+.+..+....|.
T Consensus       236 ~~Pf~~~~~~~~~~~i~  252 (364)
T cd05599         236 YPPFCSDNPQETYRKII  252 (364)
T ss_pred             CCCCCCCCHHHHHHHHH
Confidence            99999888777666553

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-41  Score=285.77  Aligned_cols=210  Identities=23%  Similarity=0.380  Sum_probs=179.8

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      .|.+++.||+|+||.||++.+..+++.||+|++..... .......+.+|+++++.++||||+++++.+...     ..+
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~-----~~~   76 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDA-----QYL   76 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC-----Cee
Confidence            46688999999999999999999999999999854321 223445677899999999999999999999876     569


Q ss_pred             EEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCcc
Q 024959          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  200 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~  200 (260)
                      |+||||++ ++|.+++.....+++..++.++.|++.+|+|||++|++|+||||+||+++.++.++|+|||++........
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~  156 (377)
T cd05629          77 YLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence            99999997 69999998888999999999999999999999999999999999999999999999999998853211000


Q ss_pred             ------------------------------------------------cccccccccccccccccCcCCCCChhhHHHHH
Q 024959          201 ------------------------------------------------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVG  232 (260)
Q Consensus       201 ------------------------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG  232 (260)
                                                                      .....+++.|+|||.+.+ ..++.++|+||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG  235 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLG  235 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEecc
Confidence                                                            002357889999999877 6789999999999


Q ss_pred             HHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          233 CILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       233 ~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      |++|+|++|..||.+.+..+.+..|.
T Consensus       236 vil~elltG~~Pf~~~~~~~~~~~i~  261 (377)
T cd05629         236 AIMFECLIGWPPFCSENSHETYRKII  261 (377)
T ss_pred             hhhhhhhcCCCCCCCCCHHHHHHHHH
Confidence            99999999999999888877776664

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.4e-40  Score=272.14  Aligned_cols=215  Identities=39%  Similarity=0.654  Sum_probs=179.6

Q ss_pred             cCCCcccccccCceEEEEEEeCC-CCeEEEEEecCCcccchHHHHHHHHHHHHHHHc---CCCCeeeeeceecCCCCCCC
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSE-TREEVAIKKIGNAFDNIIDARRTLREIKLLRHM---EHENVIAIKDIIRPPKKDTF  118 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~iv~~~~~~~~~~~~~~  118 (260)
                      .|++.+.||+|++|.||++.+.. ++..+|+|.+............+.+|+++++.+   +||||+++++++........
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            56788999999999999999854 467899998865433333334455677776666   69999999999865443333


Q ss_pred             ccEEEEEecCCcchHHHhhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccC
Q 024959          119 NDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (260)
Q Consensus       119 ~~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~  196 (260)
                      ..+++|||+++++|.+++...  ..+++..++.++.|++++|.|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus        82 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T cd07862          82 TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS  161 (290)
T ss_pred             CcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEecc
Confidence            568999999999999988753  458999999999999999999999999999999999999999999999999997765


Q ss_pred             CCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       197 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      .........+++.|+|||.+.+ ..++.++|+||||+++|+|++|.+||.+.+..+.+..|.
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~  222 (290)
T cd07862         162 FQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL  222 (290)
T ss_pred             CCcccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHH
Confidence            5444445567899999999877 678899999999999999999999999998888777764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=6.5e-41  Score=284.19  Aligned_cols=209  Identities=26%  Similarity=0.429  Sum_probs=179.1

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc-cchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      .|++++.||+|+||+||++.+..+++.||+|++.... ........+.+|+++++.++||||+++++.+.+.     ..+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~-----~~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDK-----DNL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecC-----CEE
Confidence            4678899999999999999999999999999996532 2233456778899999999999999999999876     569


Q ss_pred             EEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc-
Q 024959          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~-  199 (260)
                      ++||||++ ++|.+++.....+++..++.++.|++.+|++||+.|++|+||||+||+++.++.++|+|||++....... 
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~  156 (381)
T cd05626          77 YFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN  156 (381)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence            99999997 6999999888889999999999999999999999999999999999999999999999999875321100 


Q ss_pred             -----------------------------------------------ccccccccccccccccccCcCCCCChhhHHHHH
Q 024959          200 -----------------------------------------------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVG  232 (260)
Q Consensus       200 -----------------------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG  232 (260)
                                                                     ......+++.|+|||.+.+ ..++.++||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG  235 (381)
T cd05626         157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVG  235 (381)
T ss_pred             cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeehh
Confidence                                                           0112357899999999987 6789999999999


Q ss_pred             HHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          233 CILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       233 ~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      |++|+|++|..||...+..+....|
T Consensus       236 ~il~elltG~~Pf~~~~~~~~~~~i  260 (381)
T cd05626         236 VILFEMLVGQPPFLAPTPTETQLKV  260 (381)
T ss_pred             hHHHHHHhCCCCCcCCCHHHHHHHH
Confidence            9999999999999888776655544

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-41  Score=279.83  Aligned_cols=208  Identities=26%  Similarity=0.505  Sum_probs=182.8

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      .|++++.||+|++|.||++.+..+++.||+|++..... .......+.+|+.+++.++||||+++++.+...     ...
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~~   76 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDD-----EYL   76 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcC-----CEE
Confidence            46788999999999999999999999999999965422 223456678899999999999999999999876     569


Q ss_pred             EEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCcc
Q 024959          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  200 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~  200 (260)
                      ++||||++ ++|.+++.....+++..++.++.|++.+|.+||+++++|+||+|+||+++.++.++|+|||++.....  .
T Consensus        77 ~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~  154 (333)
T cd05600          77 YLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--Y  154 (333)
T ss_pred             EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--c
Confidence            99999997 69999998888999999999999999999999999999999999999999999999999999876544  2


Q ss_pred             cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       201 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+.+..|.
T Consensus       155 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~  211 (333)
T cd05600         155 ANSVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK  211 (333)
T ss_pred             cCCcccCccccChhHhcC-CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHH
Confidence            334567899999999987 678999999999999999999999999888877766554

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.4e-40  Score=276.23  Aligned_cols=205  Identities=25%  Similarity=0.438  Sum_probs=176.9

Q ss_pred             ccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEEEEe
Q 024959           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYE  126 (260)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv~e  126 (260)
                      +.||+|+||.||++.+..++..||+|++..... .......+.+|+++++.++||||+++++.+..+     ...++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~-----~~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----DRLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC-----CEEEEEEe
Confidence            468999999999999999999999999965422 223445667899999999999999999999877     56999999


Q ss_pred             cCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCC-Ccccccc
Q 024959          127 LMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTEY  204 (260)
Q Consensus       127 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~-~~~~~~~  204 (260)
                      |++ ++|...+.....+++..++.++.|++.+|+|||++|++|+||+|+||+++.++.++|+|||++..... .......
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~  155 (323)
T cd05595          76 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF  155 (323)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccc
Confidence            998 68888888888899999999999999999999999999999999999999999999999998875322 2223345


Q ss_pred             cccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          205 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       205 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      .+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.....+.+.
T Consensus       156 ~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~  208 (323)
T cd05595         156 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL  208 (323)
T ss_pred             cCCcCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence            67899999999977 678999999999999999999999999888777666553

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-41  Score=280.77  Aligned_cols=213  Identities=30%  Similarity=0.509  Sum_probs=195.6

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      ..|+.++.+|+|+||.+++++++.++..|++|.+.............+.|+.++++++|||||.+++.|.++.    ..+
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~----~~l   79 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG----QLL   79 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCC----ceE
Confidence            4577899999999999999999999999999999877767777778899999999999999999999999883    238


Q ss_pred             EEEEecCC-cchHHHhhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          122 YIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      +|||+|++ |++.+.+...  ..|+++.++.|+.|++.++.|||+++|+|||||+.|||++.++.++|+|||+++.....
T Consensus        80 ~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   80 CIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             EEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            99999998 5888888763  57999999999999999999999999999999999999999999999999999999888


Q ss_pred             c-ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          199 D-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       199 ~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      . ...+..||+.|++||.+.+ .+|+.++|||||||++|||++-+++|...|......+|.+
T Consensus       160 ~~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~  220 (426)
T KOG0589|consen  160 DSLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINR  220 (426)
T ss_pred             hhhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhh
Confidence            7 6677899999999999998 8999999999999999999999999999999998888764

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.9e-41  Score=268.74  Aligned_cols=219  Identities=21%  Similarity=0.334  Sum_probs=189.2

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCC
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~  113 (260)
                      ....+..+.+++++.||+|.-|+||++....++..+|+|++.+... ......+...|.++|..++||.++.+|+.|...
T Consensus        70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~  149 (459)
T KOG0610|consen   70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD  149 (459)
T ss_pred             CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence            3455666778899999999999999999999999999999976543 344567777899999999999999999999988


Q ss_pred             CCCCCccEEEEEecCC-cchHHHhhh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecc
Q 024959          114 KKDTFNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG  190 (260)
Q Consensus       114 ~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~  190 (260)
                           ...+++||||+ |+|..++++  ++.|++..++.++..++-||+|||..||++||+||+||||.++|++.|+||.
T Consensus       150 -----~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFD  224 (459)
T KOG0610|consen  150 -----KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFD  224 (459)
T ss_pred             -----ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeecc
Confidence                 55999999998 688888776  4579999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCc---------------------------------------------------------cccccccccccccc
Q 024959          191 LARTTSETD---------------------------------------------------------FMTEYVVTRWYRAP  213 (260)
Q Consensus       191 ~~~~~~~~~---------------------------------------------------------~~~~~~~~~~~~~P  213 (260)
                      ++..+....                                                         ...+.+||-.|+||
T Consensus       225 LS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAP  304 (459)
T KOG0610|consen  225 LSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAP  304 (459)
T ss_pred             ccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccc
Confidence            975431100                                                         00112456779999


Q ss_pred             ccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       214 E~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      |++.+ ...+..+|.|+|||++||||.|.-||.|.+..+++.+|+-
T Consensus       305 EvI~G-~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~  349 (459)
T KOG0610|consen  305 EVIRG-EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG  349 (459)
T ss_pred             eeeec-CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc
Confidence            99998 7789999999999999999999999999999999999863

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3e-40  Score=278.09  Aligned_cols=214  Identities=46%  Similarity=0.839  Sum_probs=183.2

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC-CCc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD-TFN  119 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~-~~~  119 (260)
                      .+.|++.+.||+|+||.||++.+..++..+++|.+............+.+|+.+++.++||||+++++++...... ...
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            3556789999999999999999999999999999976555555667788999999999999999999998755431 224


Q ss_pred             cEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc
Q 024959          120 DVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (260)
Q Consensus       120 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~  199 (260)
                      .+++|||++++++.+.+.  ..+++..+..++.|++++|.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus       100 ~~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~  177 (359)
T cd07876         100 DVYLVMELMDANLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF  177 (359)
T ss_pred             eeEEEEeCCCcCHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccCc
Confidence            589999999998887764  358899999999999999999999999999999999999999999999999987654444


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+.+..+
T Consensus       178 ~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~  234 (359)
T cd07876         178 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKV  234 (359)
T ss_pred             cCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            4444567889999999987 77889999999999999999999999988876665544

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=4.4e-41  Score=284.88  Aligned_cols=209  Identities=28%  Similarity=0.432  Sum_probs=178.7

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      +|++++.||+|++|.||++.++.+++.||+|++..... .......+.+|+.+++.++||||+++++.+..+     +.+
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~-----~~~   76 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDK-----DNL   76 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcC-----CEE
Confidence            57789999999999999999999999999999864321 222345677899999999999999999999877     569


Q ss_pred             EEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC--
Q 024959          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET--  198 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~--  198 (260)
                      ++||||++ ++|.+++.....+++..++.++.||+.+|+|||++|++|+||||+||+++.++.++|+|||++......  
T Consensus        77 ~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          77 YFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence            99999997 699999988888999999999999999999999999999999999999999999999999987432100  


Q ss_pred             ------------------------------------------cccccccccccccccccccCcCCCCChhhHHHHHHHHH
Q 024959          199 ------------------------------------------DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG  236 (260)
Q Consensus       199 ------------------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~  236 (260)
                                                                .......+++.|+|||.+.+ ..++.++|||||||++|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvily  235 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILY  235 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeeccceee
Confidence                                                      00112357889999999987 77899999999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHh
Q 024959          237 EIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       237 ~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      +|++|+.||.+.+..+....|
T Consensus       236 ell~G~~Pf~~~~~~~~~~~i  256 (376)
T cd05598         236 EMLVGQPPFLADTPAETQLKV  256 (376)
T ss_pred             ehhhCCCCCCCCCHHHHHHHH
Confidence            999999999988876665544

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=8.2e-41  Score=283.75  Aligned_cols=209  Identities=27%  Similarity=0.434  Sum_probs=178.5

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      .|++++.||+|+||.||++.+..+++.+|+|++..... .......+.+|+.+++.++||||+++++.+...     ..+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~-----~~~   76 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDK-----DNL   76 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC-----CEE
Confidence            46788999999999999999999999999999865321 223456677899999999999999999999876     569


Q ss_pred             EEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC--
Q 024959          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET--  198 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~--  198 (260)
                      ++||||++ ++|.+++.....+++..++.++.||+.+|++||+++++|+||||+|||++.++.++|+|||++......  
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~  156 (382)
T cd05625          77 YFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (382)
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence            99999998 689999888888999999999999999999999999999999999999999999999999987432100  


Q ss_pred             ----------------------------------------------cccccccccccccccccccCcCCCCChhhHHHHH
Q 024959          199 ----------------------------------------------DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVG  232 (260)
Q Consensus       199 ----------------------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG  232 (260)
                                                                    .......+++.|+|||.+.+ ..++.++|+||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG  235 (382)
T cd05625         157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVG  235 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEech
Confidence                                                          00112357889999999987 6789999999999


Q ss_pred             HHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          233 CILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       233 ~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      |++|+|++|..||.+.+..+....|
T Consensus       236 vil~elltG~~Pf~~~~~~~~~~~i  260 (382)
T cd05625         236 VILYEMLVGQPPFLAQTPLETQMKV  260 (382)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            9999999999999988876665554

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.5e-40  Score=272.44  Aligned_cols=204  Identities=37%  Similarity=0.674  Sum_probs=174.6

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      ...|++.+.||.|++|.||++.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~   77 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTK-----ET   77 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecC-----Ce
Confidence            35677899999999999999999999999999998654322 2234567899999999999999999999876     55


Q ss_pred             EEEEEecCCcchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC-
Q 024959          121 VYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-  198 (260)
Q Consensus       121 ~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~-  198 (260)
                      .++||||++++|.+.+... ..+++..++.++.|++.+|+|||+.+++|+||||+||+++.++.++|+|||++...... 
T Consensus        78 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          78 LTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             EEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            8999999999998888764 56899999999999999999999999999999999999999999999999998754322 


Q ss_pred             cccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024959          199 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (260)
Q Consensus       199 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  250 (260)
                      .......+++.|+|||.+.+...++.++|+||||+++|+|++|..||.+.+.
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~  209 (303)
T cd07869         158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD  209 (303)
T ss_pred             ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc
Confidence            2223456688999999987656688999999999999999999999987543

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-40  Score=273.34  Aligned_cols=203  Identities=29%  Similarity=0.499  Sum_probs=176.4

Q ss_pred             ccccCceEEEEEEeCCCCeEEEEEecCCcc-cchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEEEEecC
Q 024959           50 IGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM  128 (260)
Q Consensus        50 lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv~e~~  128 (260)
                      ||+|+||.||++.+..+++.||+|++.... ........+.+|+.+++.++||||+++++.+...     ...++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSP-----EKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecC-----CeEEEEEcCC
Confidence            699999999999999999999999986432 1233456677899999999999999999999776     5689999999


Q ss_pred             C-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC-cccccccc
Q 024959          129 D-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMTEYVV  206 (260)
Q Consensus       129 ~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~-~~~~~~~~  206 (260)
                      + ++|.+++.....+++..+..++.|++.+|.|||+++++|+||+|+||+++.++.++|+|||++...... .......+
T Consensus        76 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  155 (312)
T cd05585          76 NGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCG  155 (312)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccC
Confidence            8 699999988889999999999999999999999999999999999999999999999999998754322 22334467


Q ss_pred             cccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          207 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       207 ~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+..+.+.
T Consensus       156 t~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~  206 (312)
T cd05585         156 TPEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL  206 (312)
T ss_pred             CcccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHH
Confidence            899999999987 778999999999999999999999999888877766654

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-41  Score=279.64  Aligned_cols=210  Identities=29%  Similarity=0.515  Sum_probs=185.2

Q ss_pred             ccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCc
Q 024959           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      ...+|.....||+|+.|.||.+....+++.||+|.+......  ..+-+++|+.+|+..+|+|||++++.|...     .
T Consensus       271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~--~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-----d  343 (550)
T KOG0578|consen  271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP--KKELLLNEILVMRDLHHPNIVNFLDSYLVG-----D  343 (550)
T ss_pred             hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC--chhhhHHHHHHHHhccchHHHHHHHHhccc-----c
Confidence            345677888999999999999999999999999999765433  456678999999999999999999999877     6


Q ss_pred             cEEEEEecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          120 DVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       120 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      .+|+|||||+| +|.+.+ ....+++.++..+++.+++||+|||.+||+|+|||.+||+++.+|.+||+|||++......
T Consensus       344 eLWVVMEym~ggsLTDvV-t~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~  422 (550)
T KOG0578|consen  344 ELWVVMEYMEGGSLTDVV-TKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE  422 (550)
T ss_pred             eeEEEEeecCCCchhhhh-hcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence            69999999994 666654 4455999999999999999999999999999999999999999999999999988766554


Q ss_pred             c-ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          199 D-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       199 ~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      . ...+..||++|||||.+.. ..|.++.||||||++++||+-|.+||=..+....+.+|-
T Consensus       423 ~~KR~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa  482 (550)
T KOG0578|consen  423 QSKRSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA  482 (550)
T ss_pred             cCccccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh
Confidence            4 5566789999999999987 889999999999999999999999998888877777763

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.2e-40  Score=278.21  Aligned_cols=214  Identities=25%  Similarity=0.398  Sum_probs=183.3

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCCCC-eEEEEEecCCcc-cchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETR-EEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~-~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      ..+..+.|.+.+.||+|++|.||++.++.++ ..+++|.+.... ........+.+|+++++.++||||+++++++... 
T Consensus        25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-  103 (340)
T PTZ00426         25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE-  103 (340)
T ss_pred             CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC-
Confidence            3445567888999999999999999876654 689999885432 1223456677899999999999999999999877 


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                          ...++||||++ ++|.+++..+..+++..++.++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++.
T Consensus       104 ----~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~  179 (340)
T PTZ00426        104 ----SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK  179 (340)
T ss_pred             ----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCe
Confidence                56999999997 6999999988899999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          194 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      .....  .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+.....+.|.
T Consensus       180 ~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~  241 (340)
T PTZ00426        180 VVDTR--TYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKIL  241 (340)
T ss_pred             ecCCC--cceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHh
Confidence            65432  234567899999999987 678899999999999999999999999888776666654

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.9e-40  Score=274.86  Aligned_cols=204  Identities=25%  Similarity=0.452  Sum_probs=176.7

Q ss_pred             ccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEEEEe
Q 024959           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYE  126 (260)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv~e  126 (260)
                      +.||+|+||.||++.++.+++.||+|++..... .......+.+|+++++.++||||+++++.+...     ..+++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTK-----DRLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC-----CEEEEEEe
Confidence            358999999999999999999999999965422 233456778899999999999999999999876     56999999


Q ss_pred             cCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCC-Ccccccc
Q 024959          127 LMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTEY  204 (260)
Q Consensus       127 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~-~~~~~~~  204 (260)
                      |++ ++|...+.....+++..++.++.||+.+|+|||+++++|+||||+||+++.++.++|+|||++..... .......
T Consensus        76 y~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~  155 (328)
T cd05593          76 YVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF  155 (328)
T ss_pred             CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccc
Confidence            998 58888888888899999999999999999999999999999999999999999999999999875432 2223345


Q ss_pred             cccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          205 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       205 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      .+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+..+.|
T Consensus       156 ~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~  207 (328)
T cd05593         156 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI  207 (328)
T ss_pred             cCCcCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHh
Confidence            67899999999977 67899999999999999999999999988877766655

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-41  Score=280.85  Aligned_cols=211  Identities=26%  Similarity=0.416  Sum_probs=183.9

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccc-hHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN-IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      .|.+.+.||+|++|.||++.+..+++.||+|++...... ......+.+|++++..++||||+++++.+...     ..+
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~   76 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDE-----EHL   76 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecC-----CeE
Confidence            467889999999999999999999999999999654221 13456677899999999999999999999876     569


Q ss_pred             EEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc-
Q 024959          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~-  199 (260)
                      ++||||++ ++|.+++.....+++..++.++.|++.+|++||+.|++|+||+|+||+++.++.++|+|||++....... 
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          77 YLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             EEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence            99999997 6999999888899999999999999999999999999999999999999999999999999987654432 


Q ss_pred             -----------------------------ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024959          200 -----------------------------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (260)
Q Consensus       200 -----------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  250 (260)
                                                   ......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~  235 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDTL  235 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence                                         2233467899999999988 6889999999999999999999999999888


Q ss_pred             HHHHHHhhc
Q 024959          251 VHQLRLITE  259 (260)
Q Consensus       251 ~~~~~~i~~  259 (260)
                      .+....|.+
T Consensus       236 ~~~~~~i~~  244 (350)
T cd05573         236 QETYNKIIN  244 (350)
T ss_pred             HHHHHHHhc
Confidence            777766653

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=4.2e-40  Score=268.98  Aligned_cols=210  Identities=40%  Similarity=0.762  Sum_probs=179.6

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~  122 (260)
                      .|++.+.||+|++|.||++.++.+++.+++|++............+.+|+++++.++||||+++++.+...     ...+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~   76 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRR-----GKLY   76 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecC-----CEEE
Confidence            46788999999999999999999999999999976544444556778899999999999999999999776     5689


Q ss_pred             EEEecCCcchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc--
Q 024959          123 IVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--  199 (260)
Q Consensus       123 lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~--  199 (260)
                      +||||+++.+.+.+.. ...+++..++.++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||++.......  
T Consensus        77 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  156 (287)
T cd07848          77 LVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA  156 (287)
T ss_pred             EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence            9999999766665544 4679999999999999999999999999999999999999999999999999987754322  


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+..+.+..+.
T Consensus       157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~  214 (287)
T cd07848         157 NYTEYVATRWYRSPELLLG-APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQ  214 (287)
T ss_pred             cccccccccccCCcHHHcC-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            2223467889999999977 668999999999999999999999999887766655443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=5.4e-40  Score=268.18  Aligned_cols=202  Identities=26%  Similarity=0.435  Sum_probs=173.8

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~  122 (260)
                      |...+.||+|+||.||++.+..+++.||+|.+..... .......+.+|+.+++.++|++|+++++.+...     +..+
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~-----~~~~   76 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK-----DALC   76 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC-----CeEE
Confidence            4567889999999999999999999999999864322 222334567899999999999999999999877     5689


Q ss_pred             EEEecCC-cchHHHhhh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc
Q 024959          123 IVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (260)
Q Consensus       123 lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~  199 (260)
                      +|||+++ ++|.+.+..  ...+++..+..++.|++.+|+|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus        77 lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          77 LVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             EEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            9999998 588777654  3468999999999999999999999999999999999999999999999999998765444


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  251 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~  251 (260)
                      ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..
T Consensus       157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~  207 (285)
T cd05631         157 TVRGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER  207 (285)
T ss_pred             eecCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcc
Confidence            4445577999999999987 77899999999999999999999999876653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=6.6e-40  Score=276.53  Aligned_cols=215  Identities=47%  Similarity=0.863  Sum_probs=186.3

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC-CCCc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFN  119 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~-~~~~  119 (260)
                      .+.|.+.+.||+|++|.||++.+..+++.+++|++............+.+|+.+++.++||||+++++++..... ....
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            455678999999999999999999999999999997665555566778899999999999999999998865432 2224


Q ss_pred             cEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc
Q 024959          120 DVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (260)
Q Consensus       120 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~  199 (260)
                      .+|+|||+++++|.+.+..  .+++..+..++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus       103 ~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~  180 (364)
T cd07875         103 DVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF  180 (364)
T ss_pred             eEEEEEeCCCCCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCC
Confidence            6899999999998887753  58889999999999999999999999999999999999999999999999998766554


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+.+..+.
T Consensus       181 ~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~  238 (364)
T cd07875         181 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI  238 (364)
T ss_pred             cccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            4445577899999999987 778999999999999999999999999998877776654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.2e-40  Score=280.61  Aligned_cols=210  Identities=25%  Similarity=0.417  Sum_probs=181.0

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc-cchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      .|++++.||+|++|.||++.++.+++.||+|++.... ........+.+|+.++..++||+|+++++.+...     ..+
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-----~~~   76 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDK-----RNL   76 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----CEE
Confidence            4677899999999999999999999999999996432 1223455677899999999999999999999876     569


Q ss_pred             EEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc-
Q 024959          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~-  199 (260)
                      ++||||++ ++|.+++.....+++..++.++.|++.+|++||++|++|+||||+||+++.++.++|+|||++....... 
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          77 YLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             EEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence            99999998 6899999888899999999999999999999999999999999999999999999999999886432210 


Q ss_pred             -----------------------------------ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCC
Q 024959          200 -----------------------------------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL  244 (260)
Q Consensus       200 -----------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~p  244 (260)
                                                         ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|..|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCCC
Confidence                                               0113467899999999987 7789999999999999999999999


Q ss_pred             CCCCChHHHHHHhh
Q 024959          245 FPGKDYVHQLRLIT  258 (260)
Q Consensus       245 f~~~~~~~~~~~i~  258 (260)
                      |.+.+..+....|.
T Consensus       236 f~~~~~~~~~~~i~  249 (360)
T cd05627         236 FCSETPQETYRKVM  249 (360)
T ss_pred             CCCCCHHHHHHHHH
Confidence            99888877766654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.6e-40  Score=280.42  Aligned_cols=217  Identities=24%  Similarity=0.374  Sum_probs=184.1

Q ss_pred             eeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc-cchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        36 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      ...+....|++.+.||+|+||.||++.+..+++.+|+|++.... ........+.+|+.+++.++||||+++++.+..+ 
T Consensus        37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~-  115 (370)
T cd05621          37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD-  115 (370)
T ss_pred             hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-
Confidence            34556677889999999999999999999999999999985421 1222345567899999999999999999999876 


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                          ..+++||||++ ++|.+++.. ..+++..+..++.|++.+|++||+++++||||||+||+++.++.++|+|||++.
T Consensus       116 ----~~~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~  190 (370)
T cd05621         116 ----KYLYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCM  190 (370)
T ss_pred             ----CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccce
Confidence                56999999997 688888754 468999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCcc--cccccccccccccccccCc---CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          194 TTSETDF--MTEYVVTRWYRAPELLLNC---TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       194 ~~~~~~~--~~~~~~~~~~~~PE~~~~~---~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      .......  .....+++.|+|||.+...   ..++.++|+||||+++|+|++|..||.+.+.......|.
T Consensus       191 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~  260 (370)
T cd05621         191 KMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM  260 (370)
T ss_pred             ecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            7644322  2345689999999998753   236789999999999999999999999988877777765

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-40  Score=266.55  Aligned_cols=212  Identities=26%  Similarity=0.393  Sum_probs=184.1

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      ..|-+..+.|++...||.|..++||+++...+++.||||++..+..+. ....+.+|+..++.++||||++++..|... 
T Consensus        19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~-~ld~l~kE~~~msl~~HPNIv~~~~sFvv~-   96 (516)
T KOG0582|consen   19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN-DLDALRKEVQTMSLIDHPNIVTYHCSFVVD-   96 (516)
T ss_pred             ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh-hHHHHHHHHHHhhhcCCCCcceEEEEEEec-
Confidence            445566788889999999999999999999999999999997764333 367888999999999999999999999888 


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccc
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~  191 (260)
                          ..+|+||++|. |++.+++...  .-+++..+..++++++++|.|||.+|.+|||||+.||||+.+|.++|+|||.
T Consensus        97 ----~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgv  172 (516)
T KOG0582|consen   97 ----SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGV  172 (516)
T ss_pred             ----ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCcee
Confidence                56999999998 7999999873  4599999999999999999999999999999999999999999999999997


Q ss_pred             ccccCCCccc-----ccccccccccccccccC-cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 024959          192 ARTTSETDFM-----TEYVVTRWYRAPELLLN-CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  252 (260)
Q Consensus       192 ~~~~~~~~~~-----~~~~~~~~~~~PE~~~~-~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~  252 (260)
                      +..+..+...     .+..++++|+|||.+.. ...|+.++||||||++..||.+|..||.......
T Consensus       173 sa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk  239 (516)
T KOG0582|consen  173 SASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK  239 (516)
T ss_pred             eeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH
Confidence            7654443211     44577999999999654 3779999999999999999999999998766543

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=4.1e-40  Score=283.46  Aligned_cols=214  Identities=35%  Similarity=0.587  Sum_probs=179.5

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC--
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD--  116 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~--  116 (260)
                      .....|.+++.||+|+||.||++.+..+++.||+|++....      ....+|+.+++.++||||+++++++......  
T Consensus        63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~  136 (440)
T PTZ00036         63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN  136 (440)
T ss_pred             CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence            34567889999999999999999999999999999885431      2234799999999999999999987543211  


Q ss_pred             -CCccEEEEEecCCcchHHHhh----hCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCC-CEEEeecc
Q 024959          117 -TFNDVYIVYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-DLKIGDFG  190 (260)
Q Consensus       117 -~~~~~~lv~e~~~~~l~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~-~~~l~df~  190 (260)
                       ....+++||||+++++.+.+.    ....+++..++.++.||+.+|.|||+++++||||||+||+++.++ .++|+|||
T Consensus       137 ~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        137 EKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             CCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence             113467999999998877765    356799999999999999999999999999999999999998664 69999999


Q ss_pred             cccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          191 LARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      +++............+++.|+|||.+.+...++.++|||||||++|+|++|.+||.+.+..+++..|.
T Consensus       217 la~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~  284 (440)
T PTZ00036        217 SAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRII  284 (440)
T ss_pred             cchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            99876555444556778999999998775678999999999999999999999999988877776664

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=8.1e-40  Score=275.12  Aligned_cols=214  Identities=48%  Similarity=0.889  Sum_probs=184.6

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC-CCCc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFN  119 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~-~~~~  119 (260)
                      .+.|.+.+.||+|+||.||++.+..+++.+++|.+............+.+|+.+++.++||||+++++++..... ....
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   95 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ   95 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence            355678899999999999999999999999999997665555566778899999999999999999998865432 2224


Q ss_pred             cEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc
Q 024959          120 DVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (260)
Q Consensus       120 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~  199 (260)
                      ..+++||++++++.+.+..  .+++..++.++.|++++|.+||++|++|+||||+||+++.++.++|+|||++.......
T Consensus        96 ~~~lv~e~~~~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~  173 (355)
T cd07874          96 DVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF  173 (355)
T ss_pred             eeEEEhhhhcccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCcc
Confidence            6899999999988887654  58899999999999999999999999999999999999999999999999998766554


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+.+..+
T Consensus       174 ~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  230 (355)
T cd07874         174 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV  230 (355)
T ss_pred             ccCCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            4455677899999999987 67899999999999999999999999998876665543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.2e-39  Score=270.72  Aligned_cols=209  Identities=25%  Similarity=0.410  Sum_probs=178.7

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCC-CCeeeeeceecCCCCCCCccE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEH-ENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~-~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      |++++.||+|++|.||++.+..+++.||+|++..... .......+..|.+++..++| ++|+++++.+...     +.+
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~~   76 (324)
T cd05587           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM-----DRL   76 (324)
T ss_pred             ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC-----CEE
Confidence            5688999999999999999999999999999865421 22345567788999999976 4688888888776     569


Q ss_pred             EEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCC-Cc
Q 024959          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TD  199 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~-~~  199 (260)
                      |+||||++ ++|.+++.....+++..+..++.|++.+|+|||++|++|+||+|+||+++.++.++|+|||++..... ..
T Consensus        77 ~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05587          77 YFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK  156 (324)
T ss_pred             EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence            99999997 69999998888999999999999999999999999999999999999999999999999999865322 22


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+....|.
T Consensus       157 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~  214 (324)
T cd05587         157 TTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM  214 (324)
T ss_pred             ceeeecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            2334567899999999987 678899999999999999999999999988877776664

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.1e-39  Score=266.56  Aligned_cols=214  Identities=37%  Similarity=0.651  Sum_probs=178.0

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHc---CCCCeeeeeceecCCCCCCCcc
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM---EHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      |++.+.||+|++|.||++.++.+++.+++|.+..............+|+++++.+   +||||+++++++..........
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~   81 (288)
T cd07863           2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK   81 (288)
T ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence            5678999999999999999999999999999865432222223445666666655   6999999999987654433456


Q ss_pred             EEEEEecCCcchHHHhhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          121 VYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       121 ~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      .++++|+++++|.+++...  ..+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        82 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd07863          82 VTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQ  161 (288)
T ss_pred             EEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccCc
Confidence            8999999999998888763  45899999999999999999999999999999999999999999999999998766544


Q ss_pred             cccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          199 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       199 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      .......++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||.+.+..+.+..|.
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~  220 (288)
T cd07863         162 MALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF  220 (288)
T ss_pred             ccCCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHH
Confidence            43444566888999999977 678999999999999999999999999888776665543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-40  Score=273.03  Aligned_cols=213  Identities=27%  Similarity=0.474  Sum_probs=195.0

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      .-|.+.+.||+|.|++|-+++|.-+|+.||||++.+..........+.+|++.|+.++|||||++|+++-.+.     .+
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQT-----Kl   92 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQT-----KL   92 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccc-----eE
Confidence            3466889999999999999999999999999999887666667788899999999999999999999997774     49


Q ss_pred             EEEEecCC-cchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecc-CCCEEEeecccccccCCC
Q 024959          122 YIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSET  198 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~-~~~~~l~df~~~~~~~~~  198 (260)
                      |+|.|.-. |+|.+++.+. ..++++.+.++++||+.++.|+|+..++|||+||+||.+.+ -|-+||.|||++..+...
T Consensus        93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            99999877 5999999885 46999999999999999999999999999999999998766 488999999999999999


Q ss_pred             cccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          199 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       199 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      ....+.+|+..|.|||++.+...-.+.+||||||++||.|+||.+||+..|..+++-.|++
T Consensus       173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImD  233 (864)
T KOG4717|consen  173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMD  233 (864)
T ss_pred             chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhc
Confidence            8889999999999999999977667899999999999999999999999999999988874

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=278.73  Aligned_cols=217  Identities=22%  Similarity=0.341  Sum_probs=188.7

Q ss_pred             ceeeEEeeecceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCee
Q 024959           25 GKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI  104 (260)
Q Consensus        25 ~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv  104 (260)
                      ++.....+....|+|....+.+...||+|.||+||++.+..   .||||++..........+.|..|+..+++-+|.||+
T Consensus       375 ~~~r~~s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIl  451 (678)
T KOG0193|consen  375 GKNRQASDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENIL  451 (678)
T ss_pred             cccccCCccccccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhhe
Confidence            33445556669999999999999999999999999999876   499999998888888999999999999999999999


Q ss_pred             eeeceecCCCCCCCccEEEEEecCCc-chHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCC
Q 024959          105 AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC  182 (260)
Q Consensus       105 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~  182 (260)
                      -+.+++..+.      +.||+-+|+| +|..++.. ..+|.+.+.+.|+.|+++++.|||.++|+|+|+|..|||+.+++
T Consensus       452 LFMG~~~~p~------~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~  525 (678)
T KOG0193|consen  452 LFMGACMNPP------LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDL  525 (678)
T ss_pred             eeehhhcCCc------eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCC
Confidence            9999998752      4999999996 78888765 46799999999999999999999999999999999999999999


Q ss_pred             CEEEeecccccccCCC---cccccccccccccccccccCc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024959          183 DLKIGDFGLARTTSET---DFMTEYVVTRWYRAPELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (260)
Q Consensus       183 ~~~l~df~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  250 (260)
                      ++||+|||++..-...   .......+...|+|||.+..+  .++++.+||||||+++|||++|..||...+.
T Consensus       526 kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~  598 (678)
T KOG0193|consen  526 KVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR  598 (678)
T ss_pred             cEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh
Confidence            9999999998643322   233344567889999999743  6789999999999999999999999994443

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1e-39  Score=270.76  Aligned_cols=205  Identities=23%  Similarity=0.407  Sum_probs=176.0

Q ss_pred             ccccccCceEEEEEEeCCCCeEEEEEecCCcc-cchHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCCCCCccEEEEE
Q 024959           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVY  125 (260)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~~~~~~lv~  125 (260)
                      +.||+|++|.||++.++.+++.||+|++.... ........+..|..++..+ +||||+++++.+...     ..+++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-----~~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP-----DRLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcC-----CEEEEEE
Confidence            36899999999999999999999999986532 1223445667788888876 699999999999876     5699999


Q ss_pred             ecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCC-Cccccc
Q 024959          126 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTE  203 (260)
Q Consensus       126 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~-~~~~~~  203 (260)
                      ||++ ++|.+.+.....+++..++.++.|++.+|+|||+++++|+||+|+||+++.++.++|+|||++..... ......
T Consensus        76 Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (320)
T cd05590          76 EFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST  155 (320)
T ss_pred             cCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccc
Confidence            9998 69999988888999999999999999999999999999999999999999999999999999875432 222334


Q ss_pred             ccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       204 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ..+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+..+.|.
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~  209 (320)
T cd05590         156 FCGTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL  209 (320)
T ss_pred             cccCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHh
Confidence            567899999999877 678899999999999999999999999998887777664

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.2e-39  Score=270.69  Aligned_cols=209  Identities=24%  Similarity=0.397  Sum_probs=178.7

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCCCCCccE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      |.+.+.||+|+||.||++.+..+++.+++|++..... ..........|..++..+ .|++|+++++.+...     ..+
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~~   76 (323)
T cd05616           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM-----DRL   76 (323)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC-----CEE
Confidence            5678999999999999999999999999999865421 222334556677887777 489999999998776     568


Q ss_pred             EEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC-c
Q 024959          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-D  199 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~-~  199 (260)
                      ++||||++ ++|.+.+.....+++..+..++.|++.+|+|||++|++|+||+|+||+++.++.++|+|||++...... .
T Consensus        77 ~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~  156 (323)
T cd05616          77 YFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV  156 (323)
T ss_pred             EEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence            99999997 699999888889999999999999999999999999999999999999999999999999998754322 2


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+..+..+.|.
T Consensus       157 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~  214 (323)
T cd05616         157 TTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM  214 (323)
T ss_pred             ccccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            2334567899999999987 778999999999999999999999999988887777664

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=6.4e-40  Score=276.88  Aligned_cols=218  Identities=25%  Similarity=0.364  Sum_probs=184.4

Q ss_pred             eeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc-cchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        36 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      ...+..+.|++.+.||+|+||.||++.++.+++.+|+|++.... ........+.+|+.+++.++||||+++++.+... 
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~-  115 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD-  115 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC-
Confidence            35666788899999999999999999999999999999985421 1222345567899999999999999999999776 


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                          ..+++||||++ ++|.+++.. ..+++..++.++.||+.+|++||+++++|+||||+||+++.++.++|+|||++.
T Consensus       116 ----~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~  190 (371)
T cd05622         116 ----RYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (371)
T ss_pred             ----CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence                56999999997 688887754 468999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCc--ccccccccccccccccccCc---CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          194 TTSETD--FMTEYVVTRWYRAPELLLNC---TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       194 ~~~~~~--~~~~~~~~~~~~~PE~~~~~---~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      ......  ......+++.|+|||.+...   ..++.++|+||||+++|+|++|..||.+.+.....+.|.+
T Consensus       191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~  261 (371)
T cd05622         191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN  261 (371)
T ss_pred             EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence            654332  22345689999999998753   2378899999999999999999999999988777777653

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.4e-39  Score=270.22  Aligned_cols=206  Identities=25%  Similarity=0.467  Sum_probs=175.0

Q ss_pred             cccccccCceEEEEEEeC---CCCeEEEEEecCCccc--chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           47 IRPIGRGAYGIVCAAVNS---ETREEVAIKKIGNAFD--NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~---~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      ++.||+|+||.||++.+.   .+++.||+|+++....  .......+.+|+++++.++||||+++++.+..+     ..+
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~-----~~~   75 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG-----GKL   75 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC-----CeE
Confidence            367999999999999864   4678899999865321  222345567899999999999999999999876     568


Q ss_pred             EEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC-c
Q 024959          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-D  199 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~-~  199 (260)
                      |+||||++ ++|.+.+.....+++..+..++.|++.+|+|||++|++|+||+|+||+++.++.++|+|||++...... .
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (323)
T cd05584          76 YLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT  155 (323)
T ss_pred             EEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence            99999998 589999988888999999999999999999999999999999999999999999999999998653322 2


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+....+..|.
T Consensus       156 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~  213 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL  213 (323)
T ss_pred             cccccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            2233467899999999987 667899999999999999999999999988877766654

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.3e-39  Score=270.17  Aligned_cols=205  Identities=26%  Similarity=0.422  Sum_probs=176.2

Q ss_pred             ccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCCCCCccEEEEE
Q 024959           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVY  125 (260)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~~~~~~lv~  125 (260)
                      +.||+|+||.||++.++.+++.||+|++..... .......+..|.+++..+ +||||+++++.+..+     ..+++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~-----~~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK-----DRLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC-----CeEEEEE
Confidence            468999999999999999999999999865321 223445566788888876 699999999999877     5599999


Q ss_pred             ecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC-ccccc
Q 024959          126 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMTE  203 (260)
Q Consensus       126 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~-~~~~~  203 (260)
                      ||++ ++|...+.....+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++...... .....
T Consensus        76 E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (321)
T cd05591          76 EYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT  155 (321)
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccc
Confidence            9998 589899888889999999999999999999999999999999999999999999999999998754322 22334


Q ss_pred             ccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       204 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ..+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+.++.|.
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~  209 (321)
T cd05591         156 FCGTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL  209 (321)
T ss_pred             cccCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            467899999999877 678999999999999999999999999999888777664

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.1e-39  Score=270.97  Aligned_cols=205  Identities=23%  Similarity=0.465  Sum_probs=173.1

Q ss_pred             ccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHH-HHHHcCCCCeeeeeceecCCCCCCCccEEEEE
Q 024959           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIK-LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY  125 (260)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~-~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv~  125 (260)
                      +.||+|++|+||++.++.+++.|++|++..... .......+.+|.. +++.++||||+++++.+...     ...++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~-----~~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTA-----DKLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC-----CEEEEEE
Confidence            468999999999999999999999999864321 1223344455544 56788999999999999776     5689999


Q ss_pred             ecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCC-Cccccc
Q 024959          126 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTE  203 (260)
Q Consensus       126 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~-~~~~~~  203 (260)
                      ||++ ++|..++..+..+++..++.++.||+.+|+|||++|++|+||+|+||+++.++.++|+|||++..... ......
T Consensus        76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (323)
T cd05575          76 DYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST  155 (323)
T ss_pred             cCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccc
Confidence            9998 58999988888999999999999999999999999999999999999999999999999999875332 223334


Q ss_pred             ccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       204 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ..+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+..+.|.
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~  209 (323)
T cd05575         156 FCGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL  209 (323)
T ss_pred             ccCChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHH
Confidence            467899999999887 778999999999999999999999999988877766654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.5e-40  Score=254.90  Aligned_cols=211  Identities=30%  Similarity=0.524  Sum_probs=188.7

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc------cchHHHHHHHHHHHHHHHcC-CCCeeeeeceecCCCCC
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF------DNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKD  116 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~------~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~  116 (260)
                      |+..+.||.|..++|-++.++.++..+++|++....      ......+...+|+.+|+++. ||+|+++.++++.+   
T Consensus        19 y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~---   95 (411)
T KOG0599|consen   19 YEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD---   95 (411)
T ss_pred             cChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc---
Confidence            557889999999999999999999999999984332      12223455567999999995 99999999999988   


Q ss_pred             CCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccccc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~  195 (260)
                        ...++|+|.|+ |.|.+++.+.-.+++...+.+++|++++++|||.++|+|+|+||+||+++++.+++|+|||++...
T Consensus        96 --sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l  173 (411)
T KOG0599|consen   96 --AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL  173 (411)
T ss_pred             --chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence              45899999999 899999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCccccccccccccccccccc-----CcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          196 SETDFMTEYVVTRWYRAPELLL-----NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       196 ~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      .........+|||+|+|||.+.     +.+.|+...|+|++|++||.||.|.+||........++.|++
T Consensus       174 ~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Ime  242 (411)
T KOG0599|consen  174 EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIME  242 (411)
T ss_pred             CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHh
Confidence            9988888899999999999985     336788999999999999999999999988777777777764

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-39  Score=270.88  Aligned_cols=211  Identities=23%  Similarity=0.370  Sum_probs=179.1

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc-cchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      .|++++.||+|+||.||++.+..+++.||+|++.... ........+.+|+.+++.++|+||+++++.+..+     ..+
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~   76 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDE-----NNL   76 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC-----CeE
Confidence            5678999999999999999999999999999986421 1223445577899999999999999999999877     569


Q ss_pred             EEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc
Q 024959          122 YIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~  199 (260)
                      ++||||++ ++|.+++.. ...+++..++.++.|++.+|+|||+++++|+||+|+||+++.++.++|+|||++.......
T Consensus        77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             EEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence            99999997 699999876 5679999999999999999999999999999999999999999999999999987654432


Q ss_pred             cc--ccccccccccccccccC----cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          200 FM--TEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       200 ~~--~~~~~~~~~~~PE~~~~----~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ..  ....+++.|+|||.+..    ...++.++|+|||||++|+|++|..||.+.+..+....|.
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~  221 (331)
T cd05597         157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM  221 (331)
T ss_pred             CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence            21  22457899999999863    2456789999999999999999999999888777766654

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=6.8e-40  Score=272.38  Aligned_cols=204  Identities=26%  Similarity=0.447  Sum_probs=176.1

Q ss_pred             ccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEEEEe
Q 024959           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYE  126 (260)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv~e  126 (260)
                      +.||+|+||.||++.+..++..|++|++..... .......+.+|+++++.++||||+++++.+..+     ..+++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~-----~~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-----DRLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcC-----CEEEEEEe
Confidence            368999999999999999999999999965422 223445667899999999999999999999877     56999999


Q ss_pred             cCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEeccCCCEEEeecccccccCC-Cccccc
Q 024959          127 LMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTE  203 (260)
Q Consensus       127 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~-~~~~~~  203 (260)
                      |++ ++|...+.....+++..++.++.|++.+|.|||+ .|++|+||||+||+++.++.++|+|||++..... ......
T Consensus        76 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (325)
T cd05594          76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT  155 (325)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccc
Confidence            998 5888888888889999999999999999999997 7999999999999999999999999999875332 222334


Q ss_pred             ccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       204 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      ..+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+..+.|
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i  208 (325)
T cd05594         156 FCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI  208 (325)
T ss_pred             ccCCcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH
Confidence            567899999999977 67899999999999999999999999988877766655

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.3e-39  Score=270.21  Aligned_cols=205  Identities=23%  Similarity=0.447  Sum_probs=172.1

Q ss_pred             ccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHH-HHHHHcCCCCeeeeeceecCCCCCCCccEEEEE
Q 024959           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREI-KLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY  125 (260)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~-~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv~  125 (260)
                      +.||+|+||.||++.+..+++.|++|++..... .......+.+|. .+++.++||||+++++.+...     ...++||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~-----~~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTA-----EKLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcC-----CEEEEEE
Confidence            368999999999999999999999999864321 122233444454 467888999999999998776     5699999


Q ss_pred             ecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCC-Cccccc
Q 024959          126 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTE  203 (260)
Q Consensus       126 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~-~~~~~~  203 (260)
                      ||++ ++|...+.....+++..++.++.|++++|.|||+.+++|+||+|+||+++.++.++|+|||++..... ......
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (321)
T cd05603          76 DYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST  155 (321)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccc
Confidence            9998 58888888888899999999999999999999999999999999999999999999999999875322 222334


Q ss_pred             ccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       204 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ..+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+..+.|.
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~  209 (321)
T cd05603         156 FCGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL  209 (321)
T ss_pred             ccCCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHh
Confidence            467899999999877 678899999999999999999999999888776666553

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-39  Score=269.30  Aligned_cols=214  Identities=32%  Similarity=0.499  Sum_probs=191.6

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcC-CCCeeeeeceecCCCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKD  116 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~  116 (260)
                      -....|++.+.||.|.||.||++.++.+|+.+|+|.+.+... .......+.+|+++|+.+. ||||+.+++.|+..   
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~---  108 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP---  108 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC---
Confidence            335567788999999999999999999999999999966533 2224567889999999998 99999999999998   


Q ss_pred             CCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccC----CCEEEeeccc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS----CDLKIGDFGL  191 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~----~~~~l~df~~  191 (260)
                        ..+++|||++. |.|.+.+... .+++..+..++.|+++++.|||+.|++|+|+||+|+|+...    +.++++|||+
T Consensus       109 --~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  109 --DSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             --CeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence              56999999998 6999998877 59999999999999999999999999999999999999543    4799999999


Q ss_pred             ccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          192 ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      +............+|++.|+|||.+.. ..++...|+||+|+++|.|++|..||.+.+.......|.+
T Consensus       186 a~~~~~~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~  252 (382)
T KOG0032|consen  186 AKFIKPGERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILR  252 (382)
T ss_pred             ceEccCCceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHc
Confidence            999888777888899999999999987 7899999999999999999999999999998888877754

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.4e-40  Score=272.75  Aligned_cols=205  Identities=25%  Similarity=0.462  Sum_probs=177.2

Q ss_pred             ccccccCceEEEEEEe---CCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEEE
Q 024959           48 RPIGRGAYGIVCAAVN---SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV  124 (260)
Q Consensus        48 ~~lg~G~~g~vy~~~~---~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv  124 (260)
                      +.||+|++|.||++.+   +.++..+++|++............+..|++++++++||||+++++.+..+     ..+|+|
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv   76 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTE-----GKLYLI   76 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcC-----CEEEEE
Confidence            5799999999999976   45788999999976433333455667899999999999999999999877     568999


Q ss_pred             EecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC-cccc
Q 024959          125 YELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMT  202 (260)
Q Consensus       125 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~-~~~~  202 (260)
                      |||++ ++|.+++.....+++..++.++.|++++|+|||+++++|+||+|+||+++.++.++|+|||++...... ....
T Consensus        77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~  156 (318)
T cd05582          77 LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY  156 (318)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCcee
Confidence            99997 699999988888999999999999999999999999999999999999999999999999998765443 2233


Q ss_pred             cccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          203 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       203 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ...+++.|+|||.+.. ..++.++|+||||+++|+|++|+.||.+.+..+....|.
T Consensus       157 ~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~  211 (318)
T cd05582         157 SFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL  211 (318)
T ss_pred             cccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHH
Confidence            4567889999999977 677899999999999999999999999888877776654

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.7e-39  Score=267.73  Aligned_cols=205  Identities=26%  Similarity=0.448  Sum_probs=172.8

Q ss_pred             ccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCCCCCccEEEEE
Q 024959           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVY  125 (260)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~~~~~~lv~  125 (260)
                      +.||+|+||.||++.+..+++.||+|+++.... ..........|..++..+ +||||+++++.+..+     ..+++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~-----~~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTK-----EHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcC-----CEEEEEE
Confidence            368999999999999999999999999965421 122334445566666654 799999999999776     5699999


Q ss_pred             ecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC-ccccc
Q 024959          126 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMTE  203 (260)
Q Consensus       126 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~-~~~~~  203 (260)
                      ||++ ++|.+++.....+++..+..++.|++.+|+|||+++++|+||+|+||+++.++.++|+|||++...... .....
T Consensus        76 e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  155 (316)
T cd05592          76 EYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST  155 (316)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccc
Confidence            9997 689999888889999999999999999999999999999999999999999999999999998754322 22334


Q ss_pred             ccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       204 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ..+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+....|.
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~  209 (316)
T cd05592         156 FCGTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL  209 (316)
T ss_pred             ccCCccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            467999999999987 678999999999999999999999999988877666553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.9e-39  Score=270.03  Aligned_cols=209  Identities=27%  Similarity=0.477  Sum_probs=172.9

Q ss_pred             eEeccccCCCcccccccCceEEEEEEe-----CCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeeeecee
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVN-----SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDII  110 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~  110 (260)
                      |.++.+.|++.+.||+|+||.||++.+     ..++..||+|.+... ........+.+|+++++.+ +||||+++++.+
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~   80 (338)
T cd05102           2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGAC   80 (338)
T ss_pred             cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence            778888999999999999999999975     334567999999754 2333456788999999999 899999999988


Q ss_pred             cCCCCCCCccEEEEEecCC-cchHHHhhhC--------------------------------------------------
Q 024959          111 RPPKKDTFNDVYIVYELMD-TDLHQIIRSD--------------------------------------------------  139 (260)
Q Consensus       111 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~--------------------------------------------------  139 (260)
                      ....    ..++++|||++ |+|.+++...                                                  
T Consensus        81 ~~~~----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (338)
T cd05102          81 TKPN----GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGS  156 (338)
T ss_pred             cCCC----CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcc
Confidence            6542    45899999998 6898887642                                                  


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCccc---ccc
Q 024959          140 ------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM---TEY  204 (260)
Q Consensus       140 ------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~~---~~~  204 (260)
                                  ..+++..+..++.|++++|+|||+++++|+||||+||+++.++.++|+|||++.........   ...
T Consensus       157 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~  236 (338)
T cd05102         157 TNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA  236 (338)
T ss_pred             cccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCC
Confidence                        24778889999999999999999999999999999999999999999999998765332211   122


Q ss_pred             cccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 024959          205 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYV  251 (260)
Q Consensus       205 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~  251 (260)
                      .++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+.+..
T Consensus       237 ~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~  283 (338)
T cd05102         237 RLPLKWMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN  283 (338)
T ss_pred             CCCccccCcHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc
Confidence            34578999999977 678999999999999999997 99999876543

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.1e-39  Score=269.62  Aligned_cols=219  Identities=52%  Similarity=1.010  Sum_probs=184.3

Q ss_pred             eeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC
Q 024959           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (260)
Q Consensus        36 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~  115 (260)
                      .|++. +.|.+++.||.|+||.||++.+..++..||+|.+............+.+|+++++.++||||+++++++.....
T Consensus        10 ~~~~~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07878          10 VWEVP-ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS   88 (343)
T ss_pred             Hhhhh-hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence            45554 45668999999999999999999999999999997654444455667789999999999999999998865432


Q ss_pred             -CCCccEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          116 -DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       116 -~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                       ......++++++++++|.+++. ...+++..++.++.|++++|.|||+.+++|+||+|+||+++.++.++|+|||++..
T Consensus        89 ~~~~~~~~~~~~~~~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~  167 (343)
T cd07878          89 IENFNEVYLVTNLMGADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQ  167 (343)
T ss_pred             ccccCcEEEEeecCCCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCcccee
Confidence             2224589999999988887764 45799999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          195 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ....  .....+++.|+|||.+.+...++.++||||||+++|+|++|..||.+.+..+.+..+.
T Consensus       168 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  229 (343)
T cd07878         168 ADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIM  229 (343)
T ss_pred             cCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            5443  2344678899999998775678899999999999999999999999888776666553

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.3e-39  Score=269.23  Aligned_cols=205  Identities=23%  Similarity=0.454  Sum_probs=172.2

Q ss_pred             ccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHH-HHHHHcCCCCeeeeeceecCCCCCCCccEEEEE
Q 024959           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREI-KLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY  125 (260)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~-~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv~  125 (260)
                      +.||+|+||.||++.+..+++.|++|++..... .......+.+|. .+++.++||||+++++.+...     ...++||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~-----~~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA-----DKLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC-----CeEEEEE
Confidence            468999999999999999999999999864321 111223334443 456788999999999999877     5689999


Q ss_pred             ecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCC-Cccccc
Q 024959          126 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTE  203 (260)
Q Consensus       126 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~-~~~~~~  203 (260)
                      ||++ ++|.+.+.....+++..++.++.||+++|+|||++|++|+||||+||+++.++.++|+|||++..... ......
T Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~  155 (325)
T cd05602          76 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST  155 (325)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccc
Confidence            9998 58999988888899999999999999999999999999999999999999999999999999875432 223334


Q ss_pred             ccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       204 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ..+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+.++.|.
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~  209 (325)
T cd05602         156 FCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL  209 (325)
T ss_pred             ccCCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            567899999999987 778899999999999999999999999888877766654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=9.2e-39  Score=266.23  Aligned_cols=208  Identities=25%  Similarity=0.414  Sum_probs=181.5

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~  118 (260)
                      +..+.|++++.||+|++|.||++.+..++..+++|.+.... .......+.+|+++++.++||||+++++++...     
T Consensus         2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----   75 (331)
T cd06649           2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----   75 (331)
T ss_pred             CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-----
Confidence            45677889999999999999999999999999999997542 234456788999999999999999999999776     


Q ss_pred             ccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEeccCCCEEEeecccccccC
Q 024959          119 NDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (260)
Q Consensus       119 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~H~di~~~nili~~~~~~~l~df~~~~~~~  196 (260)
                      ...++||||++ ++|.+++.....+++..+..++.|++.+|.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  155 (331)
T cd06649          76 GEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (331)
T ss_pred             CEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence            56899999998 59999998888899999999999999999999986 69999999999999999999999999987654


Q ss_pred             CCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024959          197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  254 (260)
Q Consensus       197 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  254 (260)
                      ... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+..+..
T Consensus       156 ~~~-~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~  211 (331)
T cd06649         156 DSM-ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE  211 (331)
T ss_pred             ccc-cccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            332 234467889999999987 67899999999999999999999999877665443

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.9e-39  Score=269.77  Aligned_cols=205  Identities=24%  Similarity=0.470  Sum_probs=173.3

Q ss_pred             ccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHH-HHHHcCCCCeeeeeceecCCCCCCCccEEEEE
Q 024959           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIK-LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY  125 (260)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~-~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv~  125 (260)
                      +.||+|+||.||++.+..+++.+++|++..... .......+..|.. +++.++||||+++++.+...     ...++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~-----~~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT-----EKLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecC-----CEEEEEE
Confidence            468999999999999999999999999965321 2223344455544 56778999999999999876     5699999


Q ss_pred             ecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCC-Cccccc
Q 024959          126 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTE  203 (260)
Q Consensus       126 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~-~~~~~~  203 (260)
                      ||++ ++|...+.....+++..++.++.||+.+|+|||++|++|+||+|+||+++.++.++|+|||++..... ......
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (325)
T cd05604          76 DFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT  155 (325)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccc
Confidence            9998 58888888888999999999999999999999999999999999999999999999999999875322 223334


Q ss_pred             ccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       204 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ..+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+..+.+.
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~  209 (325)
T cd05604         156 FCGTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL  209 (325)
T ss_pred             ccCChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHH
Confidence            567899999999987 778899999999999999999999999988877766654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.4e-39  Score=274.87  Aligned_cols=217  Identities=25%  Similarity=0.388  Sum_probs=183.0

Q ss_pred             eeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc-cchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        36 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      .+.+....|++.+.||+|++|.||++.++.++..||+|++.... ........+.+|+.+++.++||||+++++.+..+ 
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~-  115 (370)
T cd05596          37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD-  115 (370)
T ss_pred             cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC-
Confidence            34556677889999999999999999999999999999985432 1222344567899999999999999999999876 


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                          ..+++||||++ ++|.+++.. ..+++..+..++.|++.+|+|||+.+++|+||+|+||+++.++.++|+|||++.
T Consensus       116 ----~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~  190 (370)
T cd05596         116 ----KYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (370)
T ss_pred             ----CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEecccee
Confidence                56999999997 688887654 468999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCc--ccccccccccccccccccCc---CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          194 TTSETD--FMTEYVVTRWYRAPELLLNC---TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       194 ~~~~~~--~~~~~~~~~~~~~PE~~~~~---~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ......  ......+++.|+|||.+.+.   ..++.++|+|||||++|+|++|..||.+.+.......|.
T Consensus       191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~  260 (370)
T cd05596         191 KMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM  260 (370)
T ss_pred             eccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHH
Confidence            654332  22345679999999998652   347889999999999999999999999988877777764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=3e-39  Score=268.45  Aligned_cols=208  Identities=27%  Similarity=0.422  Sum_probs=172.7

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHH---HHcCCCCeeeeeceecCCCCCCCc
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLL---RHMEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l---~~l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      |++.+.||+|++|.||++.+..+++.|++|+++.... .......+.+|++++   +.++||||+++++++...     .
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~-----~   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE-----D   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC-----C
Confidence            4578899999999999999999999999999965421 222344566666655   456799999999999876     5


Q ss_pred             cEEEEEecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          120 DVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       120 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      ..|+||||+++ +|...+. ...+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        76 ~~~lv~E~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF  154 (324)
T ss_pred             EEEEEEcCCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence            69999999984 7766654 457999999999999999999999999999999999999999999999999988653322


Q ss_pred             -cccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          199 -DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       199 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                       .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+....|.
T Consensus       155 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~  214 (324)
T cd05589         155 GDRTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV  214 (324)
T ss_pred             CCcccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence             22334567899999999987 678899999999999999999999999988877766653

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=4.6e-39  Score=265.61  Aligned_cols=211  Identities=38%  Similarity=0.708  Sum_probs=179.5

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      ..|.+.+.||+|++|.||++.++.++..+++|.+...... .....+.+|++++++++||||+++++++..+     ...
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~   79 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTD-----KSL   79 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeC-----CeE
Confidence            4467889999999999999999999999999998654322 2234567899999999999999999999876     558


Q ss_pred             EEEEecCCcchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc-
Q 024959          122 YIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (260)
Q Consensus       122 ~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~-  199 (260)
                      ++||||++++|.+.+... ..+++..++.++.|++.+|++||++|++|+||+|+||+++.++.++|+|||++....... 
T Consensus        80 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          80 TLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            999999999998888764 458999999999999999999999999999999999999999999999999987644332 


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ......+++.|+|||.+.+...++.++|+||||+++|+|++|..||.+.+..+.+..+.
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~  218 (309)
T cd07872         160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIF  218 (309)
T ss_pred             ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            22334568889999998765678899999999999999999999999888776666553

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=4.7e-39  Score=267.06  Aligned_cols=209  Identities=24%  Similarity=0.404  Sum_probs=177.6

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcC-CCCeeeeeceecCCCCCCCccE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      |+..+.||+|++|.||++.++.+++.||+|++..... .......+..|..++..+. |++|+++++.+...     ..+
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~~   76 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV-----DRL   76 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecC-----CEE
Confidence            4567889999999999999999999999999865321 2223455677888888886 57788898888776     569


Q ss_pred             EEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc-
Q 024959          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~-  199 (260)
                      |+||||++ ++|.+++.....+++..++.++.|++.+|++||++|++|+||+|+||+++.++.++|+|||++....... 
T Consensus        77 ~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~  156 (323)
T cd05615          77 YFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV  156 (323)
T ss_pred             EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence            99999997 6999999888899999999999999999999999999999999999999999999999999987543222 


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+..+.|.
T Consensus       157 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~  214 (323)
T cd05615         157 TTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM  214 (323)
T ss_pred             cccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            2234457899999999877 678999999999999999999999999988877777664

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.4e-39  Score=269.70  Aligned_cols=211  Identities=23%  Similarity=0.374  Sum_probs=179.1

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc-cchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      .|.+.+.||+|+||.||++.++.+++.||+|++.... ........+.+|..++..++|++|+++++.+...     +..
T Consensus         2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~-----~~~   76 (331)
T cd05624           2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDE-----NYL   76 (331)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----CEE
Confidence            5678899999999999999999999999999986421 1222345567899999999999999999999876     569


Q ss_pred             EEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc
Q 024959          122 YIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~  199 (260)
                      |+||||+. ++|.+++.. ...+++..+..++.|++.+|++||+++++|+||||+||+++.++.++|+|||++.......
T Consensus        77 ~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             EEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence            99999997 699999877 5689999999999999999999999999999999999999999999999999987655433


Q ss_pred             cc--ccccccccccccccccCc----CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          200 FM--TEYVVTRWYRAPELLLNC----TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       200 ~~--~~~~~~~~~~~PE~~~~~----~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ..  ....+++.|+|||.+...    ..++.++|+||||+++|+|++|+.||...+..+....|.
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~  221 (331)
T cd05624         157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM  221 (331)
T ss_pred             ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHH
Confidence            22  234678999999988642    346789999999999999999999999888777666654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.6e-39  Score=271.68  Aligned_cols=195  Identities=26%  Similarity=0.381  Sum_probs=171.6

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~  118 (260)
                      +....|.+++.||+|++|.||++.+..+++.||+|....        ..+.+|+++++.++||||+++++++..+     
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~-----  155 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYN-----  155 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEEC-----
Confidence            445678899999999999999999999999999997632        3467899999999999999999999776     


Q ss_pred             ccEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          119 NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       119 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      ...++++|++.++|..++.....+++..++.++.|++.+|.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus       156 ~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~  235 (391)
T PHA03212        156 KFTCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI  235 (391)
T ss_pred             CeeEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence            55899999999999999988888999999999999999999999999999999999999999999999999998653322


Q ss_pred             --cccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 024959          199 --DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG  247 (260)
Q Consensus       199 --~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~  247 (260)
                        .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||-+
T Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~  285 (391)
T PHA03212        236 NANKYYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFE  285 (391)
T ss_pred             cccccccccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence              12234567999999999977 6789999999999999999999987743

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.1e-39  Score=271.77  Aligned_cols=211  Identities=24%  Similarity=0.339  Sum_probs=180.6

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      .|.+.+.||+|++|.||++.++.+++.|++|+++.... .......+.+|+.+++.++||||+++++.+...     ...
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~-----~~~   76 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDK-----DNL   76 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecC-----CeE
Confidence            46688999999999999999999999999999975432 223445677899999999999999999998876     558


Q ss_pred             EEEEecCC-cchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc
Q 024959          122 YIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~  199 (260)
                      ++||||++ ++|.+++... ..+++..++.++.|++++|++||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          77 YLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK  156 (330)
T ss_pred             EEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence            99999997 6999998875 689999999999999999999999999999999999999999999999999997654433


Q ss_pred             c--cccccccccccccccccC-----cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          200 F--MTEYVVTRWYRAPELLLN-----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       200 ~--~~~~~~~~~~~~PE~~~~-----~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      .  .....+++.|+|||.+..     ...++.++||||||+++|+|++|..||...+....+..|.
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~  222 (330)
T cd05601         157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM  222 (330)
T ss_pred             ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHH
Confidence            2  223457889999999863     2557789999999999999999999999888777776654

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-38  Score=260.43  Aligned_cols=205  Identities=26%  Similarity=0.422  Sum_probs=174.8

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~  122 (260)
                      |++.+.||+|++|.||++.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++.+...     ...+
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~   76 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK-----DALC   76 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC-----CeEE
Confidence            5678899999999999999999999999999865322 222334567899999999999999999999876     5589


Q ss_pred             EEEecCC-cchHHHhhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc
Q 024959          123 IVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (260)
Q Consensus       123 lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~  199 (260)
                      +||||++ ++|.+.+...  ..+++..+..++.|++.+|.+||+.+++|+||+|+||++++++.++|+|||++.......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          77 LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             EEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            9999998 5888777543  469999999999999999999999999999999999999999999999999987765444


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  254 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  254 (260)
                      ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+.....
T Consensus       157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~  210 (285)
T cd05605         157 TIRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR  210 (285)
T ss_pred             ccccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH
Confidence            4344567889999999977 67889999999999999999999999987664443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1e-39  Score=236.37  Aligned_cols=211  Identities=41%  Similarity=0.713  Sum_probs=193.0

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~l  123 (260)
                      |...+.||+|.+|+||+++++++++.|++|.+..+.+.+......++|+.+++.++|.|||+++++....     ..+-+
T Consensus         4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd-----kkltl   78 (292)
T KOG0662|consen    4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKLTL   78 (292)
T ss_pred             hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC-----ceeEE
Confidence            3456789999999999999999999999999988777777778899999999999999999999998777     44889


Q ss_pred             EEecCCcchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc-cc
Q 024959          124 VYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FM  201 (260)
Q Consensus       124 v~e~~~~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~-~~  201 (260)
                      |+|+|...|..++.+ ++.++.+.++.++.|+++++.++|+.++.|+|+||.|.+|+.+|.+||.|||+++..+.+- ..
T Consensus        79 vfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcy  158 (292)
T KOG0662|consen   79 VFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY  158 (292)
T ss_pred             eHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEee
Confidence            999999999999887 7889999999999999999999999999999999999999999999999999999887664 45


Q ss_pred             ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhc
Q 024959          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       202 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~~  259 (260)
                      .....+..|.+|..+.+-.-|+...|+||-||++.|+.. |.+.|++.+..++++.|.+
T Consensus       159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~  217 (292)
T KOG0662|consen  159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR  217 (292)
T ss_pred             eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHH
Confidence            556779999999999997789999999999999999988 8899999999999999865

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=8.1e-39  Score=265.13  Aligned_cols=205  Identities=25%  Similarity=0.435  Sum_probs=175.5

Q ss_pred             ccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCCCCCccEEEEE
Q 024959           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVY  125 (260)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~~~~~~lv~  125 (260)
                      +.||+|+||.||++.+..++..||+|+++.... .......+..|.++++.+ +||||+++++++...     ..+++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~-----~~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK-----DRLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC-----CEEEEEE
Confidence            468999999999999999999999999965421 223445667788888888 699999999999876     5699999


Q ss_pred             ecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCC-Cccccc
Q 024959          126 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTE  203 (260)
Q Consensus       126 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~-~~~~~~  203 (260)
                      ||++ ++|...+.....+++..+..++.|++.+|.|||+++++|+||+|+||+++.++.++|+|||++..... ......
T Consensus        76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (318)
T cd05570          76 EYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST  155 (318)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccc
Confidence            9997 68988888888999999999999999999999999999999999999999999999999998865322 222333


Q ss_pred             ccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       204 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ..++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+....|.
T Consensus       156 ~~g~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~  209 (318)
T cd05570         156 FCGTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL  209 (318)
T ss_pred             eecCccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence            467899999999987 778999999999999999999999999888777766553

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=7.1e-39  Score=265.21  Aligned_cols=205  Identities=25%  Similarity=0.411  Sum_probs=173.7

Q ss_pred             ccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCCCCCccEEEEE
Q 024959           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVY  125 (260)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~~~~~~lv~  125 (260)
                      +.||+|+||.||++.++.++..||+|+++.... ..........|..++..+ +||+|+++++.+...     ..+|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTK-----EHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeC-----CEEEEEE
Confidence            468999999999999999999999999965421 112334556677777655 799999999999876     5699999


Q ss_pred             ecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCC-Cccccc
Q 024959          126 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTE  203 (260)
Q Consensus       126 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~-~~~~~~  203 (260)
                      ||+. ++|.+.+.....+++..+..++.|++++|+|||++|++|+||+|+||+++.++.++|+|||++..... ......
T Consensus        76 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (316)
T cd05620          76 EFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST  155 (316)
T ss_pred             CCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceec
Confidence            9998 58999988888999999999999999999999999999999999999999999999999998865322 222334


Q ss_pred             ccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       204 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ..+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+.++.|.
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~  209 (316)
T cd05620         156 FCGTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR  209 (316)
T ss_pred             cCCCcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            567899999999987 678999999999999999999999999888877666553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1e-38  Score=264.24  Aligned_cols=205  Identities=27%  Similarity=0.440  Sum_probs=173.4

Q ss_pred             ccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCCCCCccEEEEE
Q 024959           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVY  125 (260)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~~~~~~lv~  125 (260)
                      +.||+|+||.||++.+..+++.||+|.++.... ..........|..++..+ +||||+++++.+...     ..+++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~-----~~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK-----ENLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC-----CEEEEEE
Confidence            468999999999999999999999999965421 112334455677777764 899999999999876     5599999


Q ss_pred             ecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC-ccccc
Q 024959          126 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMTE  203 (260)
Q Consensus       126 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~-~~~~~  203 (260)
                      ||++ ++|.+.+.....+++..+..++.|++.+|+|||+++++|+||+|+||+++.++.++|+|||++...... .....
T Consensus        76 ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (316)
T cd05619          76 EYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT  155 (316)
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceee
Confidence            9997 699999988888999999999999999999999999999999999999999999999999998753222 22334


Q ss_pred             ccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       204 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ..++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+.++.|.
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~  209 (316)
T cd05619         156 FCGTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR  209 (316)
T ss_pred             ecCCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            467889999999887 678999999999999999999999999888877766553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=5.4e-39  Score=267.72  Aligned_cols=211  Identities=23%  Similarity=0.376  Sum_probs=179.0

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc-cchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      .|.+.+.||+|+||.||++.++.+++.+++|++.... ........+.+|+.++..++|++|+++++.+...     ..+
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~   76 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDE-----NNL   76 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC-----CEE
Confidence            4678899999999999999999999999999985422 1222334567899999999999999999999876     569


Q ss_pred             EEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc
Q 024959          122 YIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~  199 (260)
                      ++||||++ ++|.+++.. ...+++..++.++.|++.+|++||+++++|+||||+||+++.++.++|+|||++.......
T Consensus        77 ~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  156 (332)
T ss_pred             EEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence            99999997 699999876 5679999999999999999999999999999999999999999999999999987643322


Q ss_pred             c--cccccccccccccccccC----cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          200 F--MTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       200 ~--~~~~~~~~~~~~PE~~~~----~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      .  .....+++.|+|||.+..    ...++.++|+||||+++|+|++|+.||.+.+..+....|.
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~  221 (332)
T cd05623         157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM  221 (332)
T ss_pred             cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHh
Confidence            2  223467999999999862    2457889999999999999999999999988877777664

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=6.9e-39  Score=257.88  Aligned_cols=207  Identities=32%  Similarity=0.557  Sum_probs=180.6

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~l  123 (260)
                      |++++.||+|++|+||++.+..+++.+++|.+..............+|+.++++++||||+++++++...     ...++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~   75 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDD-----NYLYI   75 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEES-----SEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccc-----ccccc
Confidence            4578999999999999999999999999999987655544444556799999999999999999999885     66899


Q ss_pred             EEecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccccc-CCCccc
Q 024959          124 VYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFM  201 (260)
Q Consensus       124 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~-~~~~~~  201 (260)
                      +||++++ +|.+++.....+++..++.++.|++++|++||+.+++|+||+|+||+++.++.++|+|||.+... ......
T Consensus        76 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~  155 (260)
T PF00069_consen   76 VMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENF  155 (260)
T ss_dssp             EEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEB
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999996 99999998889999999999999999999999999999999999999999999999999998763 333344


Q ss_pred             ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024959          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  255 (260)
Q Consensus       202 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~  255 (260)
                      ....++..|+|||.+......+.++|+||||+++++|++|..||...+......
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~  209 (260)
T PF00069_consen  156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLE  209 (260)
T ss_dssp             SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccchhhhh
Confidence            456678899999998833788999999999999999999999999874443333

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.2e-38  Score=275.30  Aligned_cols=214  Identities=26%  Similarity=0.442  Sum_probs=177.6

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCC------CCeeeeec
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH------ENVIAIKD  108 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~------~~iv~~~~  108 (260)
                      ...+.....|++.+.||+|+||.||++.+..+++.||||+++...   ........|+++++.++|      .+++++++
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~  198 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQR  198 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEE
Confidence            344555677889999999999999999999999999999996431   123344567777777754      45888888


Q ss_pred             eecCCCCCCCccEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEeccCC-----
Q 024959          109 IIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASC-----  182 (260)
Q Consensus       109 ~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~di~~~nili~~~~-----  182 (260)
                      ++..+.    ..+++|||+++++|.+++.+...+++..++.++.||+.+|+|||+ .||+|+||||+|||++.++     
T Consensus       199 ~~~~~~----~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~  274 (467)
T PTZ00284        199 YFQNET----GHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDP  274 (467)
T ss_pred             EEEcCC----ceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccc
Confidence            886542    458999999999999999888899999999999999999999997 5999999999999998765     


Q ss_pred             -----------CEEEeecccccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH
Q 024959          183 -----------DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  251 (260)
Q Consensus       183 -----------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~  251 (260)
                                 .+||+|||.+......  .....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..
T Consensus       275 ~~~~~~~~~~~~vkl~DfG~~~~~~~~--~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~  351 (467)
T PTZ00284        275 VTNRALPPDPCRVRICDLGGCCDERHS--RTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL  351 (467)
T ss_pred             ccccccCCCCceEEECCCCccccCccc--cccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence                       4999999987543322  234567899999999987 77899999999999999999999999998887


Q ss_pred             HHHHHhh
Q 024959          252 HQLRLIT  258 (260)
Q Consensus       252 ~~~~~i~  258 (260)
                      +.+..|.
T Consensus       352 ~~~~~i~  358 (467)
T PTZ00284        352 EHLHLME  358 (467)
T ss_pred             HHHHHHH
Confidence            7776654

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=9e-39  Score=266.04  Aligned_cols=194  Identities=25%  Similarity=0.454  Sum_probs=168.7

Q ss_pred             ccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCCCCCccEEEEE
Q 024959           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVY  125 (260)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~~~~~~lv~  125 (260)
                      +.||+|+||.||++.++.+++.||+|+++.... .......+.+|..+++.+ +||||+++++++...     ..+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~-----~~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE-----SRLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC-----CEEEEEE
Confidence            368999999999999999999999999975432 223445677899999888 699999999999877     5689999


Q ss_pred             ecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccC-CCccccc
Q 024959          126 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTE  203 (260)
Q Consensus       126 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~-~~~~~~~  203 (260)
                      ||++ ++|.+++.....+++..++.++.|++.+|+|||++|++|+||+|+||+++.++.++|+|||++.... .......
T Consensus        76 e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (329)
T cd05588          76 EFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST  155 (329)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcccc
Confidence            9998 5898888888899999999999999999999999999999999999999999999999999987532 2223344


Q ss_pred             ccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 024959          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG  247 (260)
Q Consensus       204 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~  247 (260)
                      ..+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||..
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~  198 (329)
T cd05588         156 FCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDI  198 (329)
T ss_pred             ccCCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCccc
Confidence            567899999999987 7788999999999999999999999963

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=6.9e-39  Score=267.14  Aligned_cols=200  Identities=20%  Similarity=0.368  Sum_probs=170.0

Q ss_pred             CCCcccccccCceEEEEEEeC---CCCeEEEEEecCCcc--cchHHHHHHHHHHHHHHHcC-CCCeeeeeceecCCCCCC
Q 024959           44 VPPIRPIGRGAYGIVCAAVNS---ETREEVAIKKIGNAF--DNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDT  117 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~---~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~  117 (260)
                      |++++.||+|++|.||++.+.   .++..|++|++....  ........+.+|+++++.++ ||+|+++++++..+    
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~----   77 (332)
T cd05614           2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE----   77 (332)
T ss_pred             ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC----
Confidence            567899999999999999864   478899999986432  12233456778999999995 99999999998876    


Q ss_pred             CccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccC
Q 024959          118 FNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (260)
Q Consensus       118 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~  196 (260)
                       ..+++||||++ ++|.+++.....+++..++.++.|++.+|.|||+++++|+||||+||+++.++.++|+|||++....
T Consensus        78 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          78 -AKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             -CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence             56899999998 5999999888899999999999999999999999999999999999999999999999999987643


Q ss_pred             CCc--ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 024959          197 ETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK  248 (260)
Q Consensus       197 ~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  248 (260)
                      ...  ......+++.|+|||.+.+...++.++||||||+++|+|++|..||...
T Consensus       157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~  210 (332)
T cd05614         157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE  210 (332)
T ss_pred             ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence            322  2223467899999999987456788999999999999999999999653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.8e-38  Score=259.97  Aligned_cols=211  Identities=39%  Similarity=0.717  Sum_probs=179.6

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      +.|++.+.||.|++|.||++.+..++..|++|.+...... .....+.+|+++++.++||||+++++++...     ...
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~-----~~~   79 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTE-----KSL   79 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecC-----CeE
Confidence            4567889999999999999999999999999998654222 2234567899999999999999999999876     558


Q ss_pred             EEEEecCCcchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc-
Q 024959          122 YIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (260)
Q Consensus       122 ~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~-  199 (260)
                      ++||||++++|.+.+.. ...+++..++.++.|++++|++||+.+++|+||+|+||+++.++.++|+|||++....... 
T Consensus        80 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          80 TLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             EEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            99999999999988876 4568999999999999999999999999999999999999999999999999987644322 


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ......+++.|+|||.+.+...++.++|+||||+++|+|++|++||.+.+..+++..+.
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~  218 (301)
T cd07873         160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIF  218 (301)
T ss_pred             cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            22234558889999998775668889999999999999999999999888777665543

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.8e-38  Score=264.17  Aligned_cols=193  Identities=24%  Similarity=0.460  Sum_probs=167.3

Q ss_pred             ccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCCCCCccEEEEE
Q 024959           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVY  125 (260)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~~~~~~lv~  125 (260)
                      +.||+|+||.||++.++.+++.+++|+++.... .......+.+|+.++.++ +||||+++++++...     ..+++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~-----~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-----SRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC-----CEEEEEE
Confidence            469999999999999999999999999976432 233445567888888777 799999999999876     5699999


Q ss_pred             ecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCC-Cccccc
Q 024959          126 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTE  203 (260)
Q Consensus       126 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~-~~~~~~  203 (260)
                      ||++ ++|..++.....+++..++.++.|++.+|+|||+++++|+||+|+||+++.++.++|+|||++..... ......
T Consensus        76 E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (329)
T cd05618          76 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST  155 (329)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccc
Confidence            9998 68988888888999999999999999999999999999999999999999999999999999875322 222334


Q ss_pred             ccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 024959          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFP  246 (260)
Q Consensus       204 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~  246 (260)
                      ..++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~  197 (329)
T cd05618         156 FCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFD  197 (329)
T ss_pred             ccCCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCc
Confidence            567899999999987 778899999999999999999999995

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.1e-38  Score=274.31  Aligned_cols=222  Identities=24%  Similarity=0.360  Sum_probs=185.8

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      .......+.|.+.+.||+|+||+||++.+..+++.||+|++............+.+|+..+..++|+|++++++.+....
T Consensus        25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~  104 (496)
T PTZ00283         25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD  104 (496)
T ss_pred             ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence            34445566788999999999999999999999999999999765445556677889999999999999999988775443


Q ss_pred             CC---CCccEEEEEecCC-cchHHHhhh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEE
Q 024959          115 KD---TFNDVYIVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI  186 (260)
Q Consensus       115 ~~---~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l  186 (260)
                      ..   ....+++||||++ ++|.+.+..    ...+++..++.++.|++.+|.|||+++++|+||||+||+++.++.++|
T Consensus       105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEE
Confidence            21   1124789999998 699888864    346899999999999999999999999999999999999999999999


Q ss_pred             eecccccccCCC---cccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          187 GDFGLARTTSET---DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       187 ~df~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      +|||+++.....   .......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+.+..+
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~  257 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT  257 (496)
T ss_pred             EecccCeeccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            999998764432   12234567899999999987 77899999999999999999999999988877766654

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-39  Score=268.26  Aligned_cols=204  Identities=26%  Similarity=0.470  Sum_probs=172.0

Q ss_pred             ccccCceEEEEEEeCCCCeEEEEEecCCcc-cchHHHHHHHHHHHHHHHc---CCCCeeeeeceecCCCCCCCccEEEEE
Q 024959           50 IGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHM---EHENVIAIKDIIRPPKKDTFNDVYIVY  125 (260)
Q Consensus        50 lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l---~~~~iv~~~~~~~~~~~~~~~~~~lv~  125 (260)
                      ||+|+||+||++.+..+++.||+|++.... ...........|..++..+   +||+|+++++.+...     ..+++||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~-----~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD-----SDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC-----CeEEEEE
Confidence            699999999999999999999999985432 1222334455666776665   699999999999877     5599999


Q ss_pred             ecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCC-Cccccc
Q 024959          126 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTE  203 (260)
Q Consensus       126 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~-~~~~~~  203 (260)
                      ||++ ++|.+.+.....+++..++.++.|++++|+|||+++++|+||+|+||+++.++.++|+|||++..... ......
T Consensus        76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~  155 (330)
T cd05586          76 DYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT  155 (330)
T ss_pred             cCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccC
Confidence            9997 68999988888999999999999999999999999999999999999999999999999999875432 222334


Q ss_pred             ccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       204 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ..++..|+|||.+.+...++.++||||||+++|+|++|..||.+.+..+..+.|.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~  210 (330)
T cd05586         156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIA  210 (330)
T ss_pred             ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHH
Confidence            5678999999998765568899999999999999999999999888777666653

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=251.12  Aligned_cols=213  Identities=29%  Similarity=0.475  Sum_probs=186.1

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      .+.|.+.+.||+|.|+.||++.+..+|+.+++|++....-.....+++.+|+++-+.|+||||+++.+.+.+.     ..
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~-----~~   84 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-----SF   84 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccc-----ce
Confidence            4556788999999999999999999999999999855444444667888999999999999999999999887     55


Q ss_pred             EEEEEecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccC---CCEEEeecccccccC
Q 024959          121 VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTS  196 (260)
Q Consensus       121 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~---~~~~l~df~~~~~~~  196 (260)
                      .|+|+|+|.| .|-.-+-...-+++..+...+.||+++|.|+|.++|+|||++|+|+++...   --+||+|||++...+
T Consensus        85 ~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   85 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             eEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            8999999985 665555555668999999999999999999999999999999999999543   348999999999888


Q ss_pred             CCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       197 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      ....--...|+|.|++||.+.. .+++..+|||+.|++||-||.|++||.+.+.....++|++
T Consensus       165 ~g~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~  226 (355)
T KOG0033|consen  165 DGEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKA  226 (355)
T ss_pred             CccccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhc
Confidence            5555556788999999999998 8899999999999999999999999999999999998874

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=5.9e-38  Score=261.50  Aligned_cols=207  Identities=25%  Similarity=0.417  Sum_probs=179.6

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~  118 (260)
                      +..+.|++.+.||.|++|.||++.+..++..+++|.+.... .......+.+|+++++.++||||+++++++...     
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----   75 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----   75 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC-----
Confidence            45678889999999999999999999999999999986542 233456788999999999999999999999876     


Q ss_pred             ccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEeccCCCEEEeecccccccC
Q 024959          119 NDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (260)
Q Consensus       119 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~H~di~~~nili~~~~~~~l~df~~~~~~~  196 (260)
                      +..++||||+. ++|.+++.....+++..+..++.|++++|.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~  155 (333)
T cd06650          76 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (333)
T ss_pred             CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence            56999999997 69999998888899999999999999999999975 79999999999999999999999999987553


Q ss_pred             CCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024959          197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  253 (260)
Q Consensus       197 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~  253 (260)
                      .. ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+..+.
T Consensus       156 ~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~  210 (333)
T cd06650         156 DS-MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL  210 (333)
T ss_pred             hh-ccccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHH
Confidence            32 1223457889999999977 6788999999999999999999999987665443

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-39  Score=269.17  Aligned_cols=223  Identities=25%  Similarity=0.374  Sum_probs=194.3

Q ss_pred             EeeecceeEeccccCCCcccccccCceEEEEEEeCCCCe---E-EEEEecCCc-ccchHHHHHHHHHHHHHHHcCCCCee
Q 024959           30 YNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETRE---E-VAIKKIGNA-FDNIIDARRTLREIKLLRHMEHENVI  104 (260)
Q Consensus        30 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~---~-~~iK~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~iv  104 (260)
                      .....+.|++.-....+.+.||+|+||.||++..+..+.   . ||+|..+.. .........+.+|+++++.++|||||
T Consensus       145 ~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVV  224 (474)
T KOG0194|consen  145 RPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVV  224 (474)
T ss_pred             ccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEE
Confidence            345568899999999999999999999999998765422   3 899999863 35677888999999999999999999


Q ss_pred             eeeceecCCCCCCCccEEEEEecCC-cchHHHhhhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCC
Q 024959          105 AIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC  182 (260)
Q Consensus       105 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~  182 (260)
                      ++||+....     ..+++|||+|. |+|.+++++++ .++..+...++.+.+.+|+|||+++++||||...|+|++.++
T Consensus       225 r~yGVa~~~-----~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~  299 (474)
T KOG0194|consen  225 RFYGVAVLE-----EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKG  299 (474)
T ss_pred             EEEEEEcCC-----CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCC
Confidence            999999888     55999999998 69999999987 499999999999999999999999999999999999999999


Q ss_pred             CEEEeecccccccCCCcccc-cccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          183 DLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       183 ~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      .+||+|||++.....-.... ...-...|+|||.+.. ..++.++||||+|+++||+++ |..||.+.+..+..+.|.
T Consensus       300 ~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~  376 (474)
T KOG0194|consen  300 VVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV  376 (474)
T ss_pred             eEEeCccccccCCcceeeccccccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH
Confidence            99999999987765222111 2234688999999988 689999999999999999999 889999999999888883

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.4e-39  Score=270.38  Aligned_cols=212  Identities=25%  Similarity=0.419  Sum_probs=197.2

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      ....-..|.+.+.||+|.|+.|.++.+..++..||||.+++...+....+.+.+|+++|+.|+|||||+++.++..+   
T Consensus        51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~---  127 (596)
T KOG0586|consen   51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETE---  127 (596)
T ss_pred             ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeec---
Confidence            34445668899999999999999999999999999999999888888778889999999999999999999999887   


Q ss_pred             CCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccccc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~  195 (260)
                        ..+|+||||.- +.+.+++.++++..+..++.++.|++++++|+|+++++|+|||++|++++.+.++||+|||++...
T Consensus       128 --~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~  205 (596)
T KOG0586|consen  128 --ATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFF  205 (596)
T ss_pred             --ceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceee
Confidence              56999999986 799999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024959          196 SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  253 (260)
Q Consensus       196 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~  253 (260)
                      .......+.++++.|.|||.+.+.....++.|+|+||+++|.|+.|..||++.+..+.
T Consensus       206 ~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L  263 (596)
T KOG0586|consen  206 DYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL  263 (596)
T ss_pred             cccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc
Confidence            9888889999999999999999867677999999999999999999999998887554

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6.4e-38  Score=272.68  Aligned_cols=207  Identities=25%  Similarity=0.404  Sum_probs=177.4

Q ss_pred             cCCCcccccccCceEEEEEEeCCC-CeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSET-REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~-~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      .|.+.+.||+|++|.||++.+..+ +..+++|.+...  .......+.+|+.+++.++||||+++++.+..+     ..+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~-----~~~  140 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSD-----DKL  140 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC-----CEE
Confidence            367889999999999999998887 788999987543  334455677899999999999999999999877     569


Q ss_pred             EEEEecCC-cchHHHhhh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccC
Q 024959          122 YIVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~  196 (260)
                      |+||||++ ++|.+.+..    ..++++..+..++.|++.+|++||+++++||||||+||+++.++.++|+|||++....
T Consensus       141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~  220 (478)
T PTZ00267        141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS  220 (478)
T ss_pred             EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence            99999997 688877643    4568999999999999999999999999999999999999999999999999998754


Q ss_pred             CCc---ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          197 ETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       197 ~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      ...   ......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+
T Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~  283 (478)
T PTZ00267        221 DSVSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQV  283 (478)
T ss_pred             CccccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            432   1234467999999999877 77899999999999999999999999988877766654

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=6.4e-38  Score=263.40  Aligned_cols=215  Identities=48%  Similarity=0.882  Sum_probs=184.3

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC-CCCc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFN  119 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~-~~~~  119 (260)
                      .+.|.+.+.||+|++|.||++.+..+++.+++|.+............+.+|+.++++++||||+++++++..... ....
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            355668899999999999999999999999999997654444555677789999999999999999999875543 2234


Q ss_pred             cEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc
Q 024959          120 DVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (260)
Q Consensus       120 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~  199 (260)
                      ..++|||+++++|.+.+...  +++..+..++.|++.+|++||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus        95 ~~~lv~e~~~~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~  172 (353)
T cd07850          95 DVYLVMELMDANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF  172 (353)
T ss_pred             cEEEEEeccCCCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCC
Confidence            68999999999998887654  8999999999999999999999999999999999999999999999999998765544


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ......++..|+|||.+.+ ..++.++|+||||+++++|++|+.||...+...++..|.
T Consensus       173 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~  230 (353)
T cd07850         173 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKII  230 (353)
T ss_pred             CCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            4344556888999999987 778999999999999999999999999888776666553

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3.7e-38  Score=262.12  Aligned_cols=194  Identities=23%  Similarity=0.442  Sum_probs=168.5

Q ss_pred             ccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCCCCCccEEEEE
Q 024959           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVY  125 (260)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~~~~~~lv~  125 (260)
                      +.||+|+||.||++.+..+++.+++|++..... .......+.+|+.++.++ +||+|+++++.+...     ..+++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT-----SRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC-----CEEEEEE
Confidence            469999999999999999999999999975432 223455677899998888 599999999999776     5699999


Q ss_pred             ecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCC-Cccccc
Q 024959          126 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTE  203 (260)
Q Consensus       126 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~-~~~~~~  203 (260)
                      ||++ ++|...+.....+++..++.++.|++.+|+|||++|++|+||+|+||+++.++.++|+|||++..... ......
T Consensus        76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (327)
T cd05617          76 EYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST  155 (327)
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceec
Confidence            9997 68988888888999999999999999999999999999999999999999999999999999875322 223344


Q ss_pred             ccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 024959          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG  247 (260)
Q Consensus       204 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~  247 (260)
                      ..+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||..
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~  198 (327)
T cd05617         156 FCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDI  198 (327)
T ss_pred             ccCCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCc
Confidence            567899999999987 7789999999999999999999999953

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=5.9e-39  Score=278.67  Aligned_cols=223  Identities=26%  Similarity=0.447  Sum_probs=195.3

Q ss_pred             EeeecceeEeccccCCCcccccccCceEEEEEEeCC-----CCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCee
Q 024959           30 YNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSE-----TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI  104 (260)
Q Consensus        30 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv  104 (260)
                      .+......+++...++..+.||+|+||+||++.-..     ....||||.++.. ......++|.+|++++..|+|||||
T Consensus       474 ~~~~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIV  552 (774)
T KOG1026|consen  474 LNPDLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIV  552 (774)
T ss_pred             CCCccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeE
Confidence            344567789999999999999999999999997543     3456999999875 3444788999999999999999999


Q ss_pred             eeeceecCCCCCCCccEEEEEecCC-cchHHHhhhC----------C----CCCHHHHHHHHHHHHHHHHHHHhCCceec
Q 024959          105 AIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----------Q----QLTDDHCQYFLYQLLRGLKYVHSASVLHR  169 (260)
Q Consensus       105 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~----------~----~~~~~~~~~~~~~i~~~l~~lh~~~i~H~  169 (260)
                      +++++|.+.     +.+++|+|||. |+|.++++..          .    +++..+...|+.||+.+++||-++.+|||
T Consensus       553 rLlGVC~~~-----~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHR  627 (774)
T KOG1026|consen  553 RLLGVCREG-----DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHR  627 (774)
T ss_pred             EEEEEEccC-----CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCccccc
Confidence            999999998     55999999998 9999999742          2    28889999999999999999999999999


Q ss_pred             cCCCCCeEeccCCCEEEeecccccccCCCcccc---cccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCC
Q 024959          170 DLKPSNLLLNASCDLKIGDFGLARTTSETDFMT---EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLF  245 (260)
Q Consensus       170 di~~~nili~~~~~~~l~df~~~~~~~~~~~~~---~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf  245 (260)
                      ||...|+||.++..+||+|||+++.....+...   ...-..+|||||.+.. ++++.++||||+|++|||+++ |+.||
T Consensus       628 DLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy  706 (774)
T KOG1026|consen  628 DLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPY  706 (774)
T ss_pred             chhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcc
Confidence            999999999999999999999998765554332   2344789999999998 899999999999999999999 99999


Q ss_pred             CCCChHHHHHHhhc
Q 024959          246 PGKDYVHQLRLITE  259 (260)
Q Consensus       246 ~~~~~~~~~~~i~~  259 (260)
                      .+..+++.++.|.+
T Consensus       707 ~glSn~EVIe~i~~  720 (774)
T KOG1026|consen  707 YGLSNQEVIECIRA  720 (774)
T ss_pred             cccchHHHHHHHHc
Confidence            99999999998863

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-40  Score=266.94  Aligned_cols=203  Identities=28%  Similarity=0.458  Sum_probs=182.5

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      ..-|+..+.||+|.||.||++.+..+++.||+|++..+ .......++.+|+.+|..++++||.++|+.+...     ..
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le-~~~deIediqqei~~Ls~~~~~~it~yygsyl~g-----~~   85 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLE-EAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG-----TK   85 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechh-hcchhhHHHHHHHHHHHhcCcchHHhhhhheeec-----cc
Confidence            34456678999999999999999999999999999765 3445678888999999999999999999999887     55


Q ss_pred             EEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc
Q 024959          121 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~  199 (260)
                      ++++|||++ |++.+.+.....+.+..+..++++++.++.|||..+.+|+||++.||++..+|.++|.|||.+-......
T Consensus        86 LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~  165 (467)
T KOG0201|consen   86 LWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV  165 (467)
T ss_pred             HHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechh
Confidence            899999998 6999999988888999999999999999999999999999999999999999999999999886655543


Q ss_pred             -ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024959          200 -FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (260)
Q Consensus       200 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  250 (260)
                       ...+..||++|||||++.. ..|+.++||||||++.+||++|.+|+.....
T Consensus       166 ~rr~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hP  216 (467)
T KOG0201|consen  166 KRRKTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHP  216 (467)
T ss_pred             hccccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCc
Confidence             3367789999999999996 8899999999999999999999999987765

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=8.6e-38  Score=255.00  Aligned_cols=206  Identities=39%  Similarity=0.719  Sum_probs=175.3

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~l  123 (260)
                      |++.+.||.|++|.||++.+..++..|++|.+............+.+|+.+++.++|||++++++.+..+     ..+++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~   76 (285)
T cd07861           2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE-----SRLYL   76 (285)
T ss_pred             ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC-----CeEEE
Confidence            5678899999999999999999999999999865433333446677899999999999999999999876     56899


Q ss_pred             EEecCCcchHHHhhh---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc-
Q 024959          124 VYELMDTDLHQIIRS---DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (260)
Q Consensus       124 v~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~-  199 (260)
                      |||+++++|.+++..   +..+++..++.++.|++++|.+||+.+++|+||+|+||+++.++.++|+|||++....... 
T Consensus        77 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          77 IFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             EEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            999999888888764   2568999999999999999999999999999999999999999999999999987654332 


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  254 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  254 (260)
                      ......+++.|+|||.+.+...++.++|+||||+++++|++|..||.+.+..+..
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~  211 (285)
T cd07861         157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQL  211 (285)
T ss_pred             cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence            1223355788999999876566789999999999999999999999877664433

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.5e-38  Score=262.73  Aligned_cols=215  Identities=82%  Similarity=1.346  Sum_probs=183.6

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~  122 (260)
                      .|.+.+.||.|++|.||++.+..++..|++|.+............+.+|+.+++.++||||+++++++...........+
T Consensus         6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~   85 (337)
T cd07858           6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY   85 (337)
T ss_pred             ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence            35578899999999999999999999999999876544444556677899999999999999999988766544445689


Q ss_pred             EEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc-cc
Q 024959          123 IVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FM  201 (260)
Q Consensus       123 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~-~~  201 (260)
                      +++|+++++|.+++.....+++..+..++.|++.+|.+||+++++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        86 lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~  165 (337)
T cd07858          86 IVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM  165 (337)
T ss_pred             EEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCcccc
Confidence            99999999999999888899999999999999999999999999999999999999999999999999987654432 22


Q ss_pred             ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       202 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      ....++..|+|||.+.....++.++|+||||+++|+|++|..||.+.+.......+
T Consensus       166 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~  221 (337)
T cd07858         166 TEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLI  221 (337)
T ss_pred             cccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Confidence            33456788999999876456889999999999999999999999988765555444

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=4.4e-38  Score=256.62  Aligned_cols=209  Identities=39%  Similarity=0.696  Sum_probs=175.8

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~l  123 (260)
                      |++.+.||+|++|.||++.++.++..+++|.+............+.+|+++++.++||||+++++.+...     ..+++
T Consensus         2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-----~~~~l   76 (284)
T cd07839           2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD-----KKLTL   76 (284)
T ss_pred             ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC-----CceEE
Confidence            5678899999999999999999999999999865433333335567899999999999999999999876     56899


Q ss_pred             EEecCCcchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc-cc
Q 024959          124 VYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FM  201 (260)
Q Consensus       124 v~e~~~~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~-~~  201 (260)
                      ++||++++|.+.+.. ...+++..++.++.|++++|.+||+++++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        77 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  156 (284)
T cd07839          77 VFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY  156 (284)
T ss_pred             EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCc
Confidence            999999999888765 5679999999999999999999999999999999999999999999999999987654332 22


Q ss_pred             ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHh
Q 024959          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGKDYVHQLRLI  257 (260)
Q Consensus       202 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~p-f~~~~~~~~~~~i  257 (260)
                      ....++..|+|||.+.+...++.++|+||||+++|+|++|..| |.+.+..+.++.|
T Consensus       157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~  213 (284)
T cd07839         157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI  213 (284)
T ss_pred             CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHH
Confidence            2345578899999987756678999999999999999998887 4656655555544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=9.9e-38  Score=252.38  Aligned_cols=213  Identities=23%  Similarity=0.368  Sum_probs=176.1

Q ss_pred             eccccCCCcccccccCceEEEEEEeC---CCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNS---ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~  115 (260)
                      +....|.+.+.||+|+||.||++.++   ..+..+++|.++.... ......+.+|+..++.++||||+++++++..+  
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--   78 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS-DKQRRGFLAEALTLGQFDHSNIVRLEGVITRG--   78 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC--
Confidence            45566788999999999999999765   3456899999976532 33456788999999999999999999998776  


Q ss_pred             CCCccEEEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          116 DTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       116 ~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                         ...++||||++ ++|.+++.. ...+++..++.++.|++.+|++||+++++|+||+|+||+++.++.++++|||...
T Consensus        79 ---~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~  155 (266)
T cd05064          79 ---NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ  155 (266)
T ss_pred             ---CCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccc
Confidence               55899999998 578888776 4578999999999999999999999999999999999999999999999999876


Q ss_pred             ccCCCcccc--cccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          194 TTSETDFMT--EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       194 ~~~~~~~~~--~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      .........  ...++..|+|||.+.+ ..++.++||||||+++|++++ |..||.+.+..+..+.+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~  222 (266)
T cd05064         156 EDKSEAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE  222 (266)
T ss_pred             cccccchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH
Confidence            543222111  1223567999999877 778999999999999999775 999999888777666654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-38  Score=263.50  Aligned_cols=199  Identities=27%  Similarity=0.419  Sum_probs=170.9

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      +.|.....||+|+||.||++..... ..||||.+.......  ..+|.+|+.++.+++|||+|+++|+|.+...    ..
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~----~~  147 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGE----HR  147 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCc----eE
Confidence            4555667899999999999988765 789999886643322  3459999999999999999999999998731    48


Q ss_pred             EEEEecCC-cchHHHhhhCC--CCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCCCCeEeccCCCEEEeeccccccc
Q 024959          122 YIVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA---SVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~---~i~H~di~~~nili~~~~~~~l~df~~~~~~  195 (260)
                      ++|+|||+ |+|.+++....  .++|..+..|+.+++++|+|||+.   .++|||||+.|||++++.+.||+|||++...
T Consensus       148 ~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~  227 (361)
T KOG1187|consen  148 LLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLG  227 (361)
T ss_pred             EEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccC
Confidence            99999999 79999988754  899999999999999999999974   4999999999999999999999999999766


Q ss_pred             CC-Ccccccc-cccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 024959          196 SE-TDFMTEY-VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK  248 (260)
Q Consensus       196 ~~-~~~~~~~-~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  248 (260)
                      .. ....... .++.+|++||.... ...+.++||||||++++|+++|+.|.+..
T Consensus       228 ~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~  281 (361)
T KOG1187|consen  228 PEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQS  281 (361)
T ss_pred             CccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCC
Confidence            55 4333333 78999999999987 77899999999999999999999888754

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=7.9e-38  Score=258.26  Aligned_cols=216  Identities=43%  Similarity=0.721  Sum_probs=182.7

Q ss_pred             ccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCc
Q 024959           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      +...|++.+.||+|++|.||++.+..+++.|++|.+..............+|+.++++++|+|++++++++.....   .
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---~   81 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHL---D   81 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCC---C
Confidence            4567888999999999999999999999999999986543332223345679999999999999999999876533   4


Q ss_pred             cEEEEEecCCcchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          120 DVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       120 ~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      .+++|||+++++|.+++.. ...+++..++.++.|++++|++||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        82 ~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          82 SIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP  161 (309)
T ss_pred             eEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence            5899999999988888876 467999999999999999999999999999999999999999999999999998776543


Q ss_pred             c-ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          199 D-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       199 ~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      . ......++..|+|||.+.+...++.++|+||||+++|+|++|..||.+.+..+.+..+.
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~  222 (309)
T cd07845         162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLII  222 (309)
T ss_pred             cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            2 22223446779999998765678899999999999999999999999998888777654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.3e-37  Score=253.55  Aligned_cols=195  Identities=25%  Similarity=0.421  Sum_probs=165.5

Q ss_pred             ccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEEEEecC
Q 024959           50 IGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM  128 (260)
Q Consensus        50 lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv~e~~  128 (260)
                      ||+|+||+||++.+..+++.+++|.+..... .......+..|+++++.++||||+++.+.+...     ...++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTK-----TDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCC-----CeEEEEEeCC
Confidence            6999999999999999999999999864322 222335667899999999999999999998776     5589999999


Q ss_pred             C-cchHHHhh----hCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc-ccc
Q 024959          129 D-TDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FMT  202 (260)
Q Consensus       129 ~-~~l~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~-~~~  202 (260)
                      + ++|...+.    .+..+++..++.++.|++++|+|||+++++|+||+|+||+++.++.++|+|||++....... ...
T Consensus        76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~  155 (280)
T cd05608          76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK  155 (280)
T ss_pred             CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccc
Confidence            8 57877663    24569999999999999999999999999999999999999999999999999987654432 223


Q ss_pred             cccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024959          203 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (260)
Q Consensus       203 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  250 (260)
                      ...+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+.
T Consensus       156 ~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~  202 (280)
T cd05608         156 GYAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGE  202 (280)
T ss_pred             ccCCCcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCc
Confidence            3467889999999987 6788999999999999999999999986543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-38  Score=274.07  Aligned_cols=213  Identities=24%  Similarity=0.392  Sum_probs=179.4

Q ss_pred             cceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-CCCeeeeeceecC
Q 024959           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRP  112 (260)
Q Consensus        34 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~  112 (260)
                      +..+++....+++.+.|.+|||+.||+|.+...+..||+|++-..  ++...+...+|+.+|+.|+ |+|||.++|....
T Consensus        29 G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~  106 (738)
T KOG1989|consen   29 GQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAI  106 (738)
T ss_pred             ceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Confidence            577889999999999999999999999999998889999998654  5556788889999999998 9999999994332


Q ss_pred             CC-CCC-CccEEEEEecCC-cchHHHhhh--CCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCeEeccCCCEE
Q 024959          113 PK-KDT-FNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKPSNLLLNASCDLK  185 (260)
Q Consensus       113 ~~-~~~-~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~H~di~~~nili~~~~~~~  185 (260)
                      .. ..+ .-.++|+||||+ ++|.++|+.  ...|++.++++|++|+++|+.+||..+  |+|||||-+|||++.+|+.|
T Consensus       107 ~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~K  186 (738)
T KOG1989|consen  107 NRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYK  186 (738)
T ss_pred             cccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEE
Confidence            22 222 246889999999 699999985  566999999999999999999999886  99999999999999999999


Q ss_pred             EeecccccccCCCccc-cc---------ccccccccccccccCc--CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 024959          186 IGDFGLARTTSETDFM-TE---------YVVTRWYRAPELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGK  248 (260)
Q Consensus       186 l~df~~~~~~~~~~~~-~~---------~~~~~~~~~PE~~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~  248 (260)
                      |+|||-+...-..... ..         ...|+.|.+||.+.-+  .+.++++|||+|||+||-||....||++.
T Consensus       187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s  261 (738)
T KOG1989|consen  187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES  261 (738)
T ss_pred             eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence            9999977543322211 11         1238899999997532  66789999999999999999999999876

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=7.3e-38  Score=264.62  Aligned_cols=215  Identities=26%  Similarity=0.394  Sum_probs=177.4

Q ss_pred             eeecceeEeccccCCCcccccccCceEEEEEEeCCC-----CeEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCee
Q 024959           31 NVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSET-----REEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVI  104 (260)
Q Consensus        31 ~~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~-----~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv  104 (260)
                      -++.+.|.+....|.+.+.||+|+||.||++.+...     ...|++|.++... .......+.+|+++++.+ +||||+
T Consensus        27 ~~~~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv  105 (374)
T cd05106          27 LPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIV  105 (374)
T ss_pred             ccccccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCcee
Confidence            445678889999999999999999999999986443     3579999997542 233456788999999999 799999


Q ss_pred             eeeceecCCCCCCCccEEEEEecCC-cchHHHhhhC--------------------------------------------
Q 024959          105 AIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--------------------------------------------  139 (260)
Q Consensus       105 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~--------------------------------------------  139 (260)
                      ++++.+...     ...++||||+. ++|.+++...                                            
T Consensus       106 ~~~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (374)
T cd05106         106 NLLGACTHG-----GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDT  180 (374)
T ss_pred             eEeeEecCC-----CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccccccccc
Confidence            999999877     55899999998 6888877532                                            


Q ss_pred             --------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          140 --------------------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       140 --------------------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                                                .++++..++.++.|++++|.|||++|++|+||||+||+++.++.++|+|||++.
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~  260 (374)
T cd05106         181 YVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLAR  260 (374)
T ss_pred             ccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeee
Confidence                                      247888899999999999999999999999999999999999999999999987


Q ss_pred             ccCCCcccc---cccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 024959          194 TTSETDFMT---EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVH  252 (260)
Q Consensus       194 ~~~~~~~~~---~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~  252 (260)
                      .........   ...++..|+|||.+.. ..++.++|+||||+++|+|++ |..||.......
T Consensus       261 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~  322 (374)
T cd05106         261 DIMNDSNYVVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS  322 (374)
T ss_pred             eccCCcceeeccCCCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccH
Confidence            654332111   1223567999999877 678999999999999999997 999998765433

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.5e-37  Score=253.65  Aligned_cols=210  Identities=35%  Similarity=0.704  Sum_probs=176.2

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~  122 (260)
                      .|++.+.||+|++|.||++.++.+++.|++|.+............+.+|+++++.++|||++++++.+...     ...+
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~   76 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRK-----RKLH   76 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeC-----CEEE
Confidence            46678999999999999999999999999999865433223345677899999999999999999999876     5689


Q ss_pred             EEEecCCcc-hHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc-c
Q 024959          123 IVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-F  200 (260)
Q Consensus       123 lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~-~  200 (260)
                      +||||++++ |..++.....+++..++.++.|++.+|++||+.+++|+||+|+||+++.++.++|+|||++....... .
T Consensus        77 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07847          77 LVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD  156 (286)
T ss_pred             EEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence            999999964 44454556679999999999999999999999999999999999999999999999999987765433 2


Q ss_pred             cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       201 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      .....++..|++||.+.+...++.++|+||||+++|+|++|..||.+.+..+.+..+
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~  213 (286)
T cd07847         157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLI  213 (286)
T ss_pred             ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            223345778999999876566788999999999999999999999988776655443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.3e-37  Score=251.70  Aligned_cols=194  Identities=25%  Similarity=0.412  Sum_probs=165.7

Q ss_pred             ccccCceEEEEEEeCCCCeEEEEEecCCcccc-hHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEEEEecC
Q 024959           50 IGRGAYGIVCAAVNSETREEVAIKKIGNAFDN-IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM  128 (260)
Q Consensus        50 lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv~e~~  128 (260)
                      ||+|+||.||++.++.+++.|++|.+...... ......+..|+++++.++||||+++++.+...     ..+++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~-----~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESK-----THLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecC-----CeEEEEEecC
Confidence            69999999999999999999999998643221 12233455799999999999999999999776     5689999999


Q ss_pred             C-cchHHHhhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCccccccc
Q 024959          129 D-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV  205 (260)
Q Consensus       129 ~-~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  205 (260)
                      + ++|.+++...  ..+++..+..++.|++.+|++||+.|++|+||+|+||+++.++.++|+|||++.............
T Consensus        76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~  155 (277)
T cd05607          76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA  155 (277)
T ss_pred             CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccC
Confidence            7 5888777543  358899999999999999999999999999999999999999999999999988766544444456


Q ss_pred             ccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 024959          206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  249 (260)
Q Consensus       206 ~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  249 (260)
                      ++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+
T Consensus       156 ~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~p~~~~~  198 (277)
T cd05607         156 GTNGYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPFKDHK  198 (277)
T ss_pred             CCCCccCHHHHcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCc
Confidence            7889999999987 568999999999999999999999997653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-39  Score=268.78  Aligned_cols=200  Identities=28%  Similarity=0.455  Sum_probs=183.4

Q ss_pred             cceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCC
Q 024959           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (260)
Q Consensus        34 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~  113 (260)
                      ...|+++-+.+.-++=||.|++|.||+++..  ++.||||+++..         -..+++=|++|+||||+.+.++|...
T Consensus       116 ~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqs  184 (904)
T KOG4721|consen  116 EELWEIPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQS  184 (904)
T ss_pred             hhhccCCHHHhhhhhhhccCcccceeeeecc--CceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCC
Confidence            3789999888888899999999999999765  468999998532         23578899999999999999999887


Q ss_pred             CCCCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccc
Q 024959          114 KKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (260)
Q Consensus       114 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~  192 (260)
                           ..++||||||. |.|...++.+..+....+..|..+|+.++.|||.+.|+|||+|.-||||+.+..+||+|||-+
T Consensus       185 -----PcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS  259 (904)
T KOG4721|consen  185 -----PCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTS  259 (904)
T ss_pred             -----ceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccch
Confidence                 66999999998 899999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024959          193 RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (260)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  250 (260)
                      +......+.....||..|||||.+.+ .+++.++||||||++|||||||..||.+-+.
T Consensus       260 ~e~~~~STkMSFaGTVaWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdVds  316 (904)
T KOG4721|consen  260 KELSDKSTKMSFAGTVAWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS  316 (904)
T ss_pred             HhhhhhhhhhhhhhhHhhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccccch
Confidence            98888878888899999999999998 8999999999999999999999999976554

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.9e-37  Score=253.74  Aligned_cols=207  Identities=25%  Similarity=0.461  Sum_probs=180.5

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      .|.+.+.||+|++|.||++.+..+++.+++|.+..... .......+.+|++++++++||||+++++.+...     ...
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   76 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD-----SNL   76 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC-----CeE
Confidence            46678999999999999999999999999999864321 223456778899999999999999999999876     568


Q ss_pred             EEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCcc
Q 024959          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  200 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~  200 (260)
                      ++|||+++ ++|.+++.....+++..+..++.|++++|.+||+.|++|+||+|.||+++.++.++|+|||++......  
T Consensus        77 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          77 YLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence            99999995 799999998889999999999999999999999999999999999999999999999999998776544  


Q ss_pred             cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       201 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      .....+++.|++||.+.+ ...+.++|+||||+++|+|++|..||...+..+..+++
T Consensus       155 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  210 (290)
T cd05580         155 TYTLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI  210 (290)
T ss_pred             CCCCCCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            233456888999999876 67789999999999999999999999888766655554

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.5e-37  Score=280.95  Aligned_cols=214  Identities=30%  Similarity=0.473  Sum_probs=179.0

Q ss_pred             EeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCC
Q 024959           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (260)
Q Consensus        38 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~  117 (260)
                      +.....|++++.||.|+||.||++.+..++..+++|.+............+..|+.+++.|+||||++++++|.....  
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~--   86 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN--   86 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC--
Confidence            344456778999999999999999999999999999997654455566778899999999999999999998865432  


Q ss_pred             CccEEEEEecCC-cchHHHhhh----CCCCCHHHHHHHHHHHHHHHHHHHhC-------CceeccCCCCCeEecc-----
Q 024959          118 FNDVYIVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSA-------SVLHRDLKPSNLLLNA-----  180 (260)
Q Consensus       118 ~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~-------~i~H~di~~~nili~~-----  180 (260)
                       ..+||||||++ ++|.+++..    ...+++..++.|+.||+.+|.|||+.       +|+|+||+|+|||++.     
T Consensus        87 -~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l  165 (1021)
T PTZ00266         87 -QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI  165 (1021)
T ss_pred             -CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence             56899999998 689888865    35799999999999999999999984       4999999999999954     


Q ss_pred             ------------CCCEEEeecccccccCCCcccccccccccccccccccCc-CCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 024959          181 ------------SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPG  247 (260)
Q Consensus       181 ------------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~  247 (260)
                                  .+.++|+|||++.............+++.|+|||.+... ..++.++|||||||++|+|++|..||..
T Consensus       166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        166 GKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             ccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                        234899999999876554444455789999999998642 4578899999999999999999999987


Q ss_pred             CChHHHH
Q 024959          248 KDYVHQL  254 (260)
Q Consensus       248 ~~~~~~~  254 (260)
                      .+...++
T Consensus       246 ~~~~~ql  252 (1021)
T PTZ00266        246 ANNFSQL  252 (1021)
T ss_pred             CCcHHHH
Confidence            6654443

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.9e-37  Score=252.06  Aligned_cols=207  Identities=26%  Similarity=0.445  Sum_probs=174.3

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~  122 (260)
                      |+..+.||+|+||+||++.+..+++.+++|.+..... .......+.+|+++++.++|++++++.+.+...     +..+
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-----~~~~   76 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK-----DALC   76 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC-----CEEE
Confidence            4466889999999999999999999999999854321 222334567899999999999999999998876     5689


Q ss_pred             EEEecCC-cchHHHhhh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc
Q 024959          123 IVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (260)
Q Consensus       123 lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~  199 (260)
                      ++||+++ ++|.+.+..  ...+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          77 LVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             EEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence            9999998 578777754  3469999999999999999999999999999999999999999999999999987654433


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  256 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  256 (260)
                      ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+.....+.
T Consensus       157 ~~~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~  212 (285)
T cd05632         157 SIRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE  212 (285)
T ss_pred             cccCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            3344567899999999977 6789999999999999999999999988766544333

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-37  Score=247.28  Aligned_cols=208  Identities=25%  Similarity=0.457  Sum_probs=177.3

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccc---hHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCc
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN---IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      .|.+.+.||+|++|.||.+.+..+++.+++|.+......   ......+.+|++++++++||||+++++++..+     .
T Consensus         3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~   77 (263)
T cd06625           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD-----E   77 (263)
T ss_pred             cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC-----C
Confidence            467889999999999999999999999999998654222   22345677899999999999999999999877     5


Q ss_pred             cEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          120 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       120 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      ..++++|+++ ++|.+.+.....+++..++.++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus        78 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          78 TLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  157 (263)
T ss_pred             eEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence            6999999997 589999888888999999999999999999999999999999999999999999999999998765432


Q ss_pred             ccc----ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 024959          199 DFM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  256 (260)
Q Consensus       199 ~~~----~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  256 (260)
                      ...    ....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+.......
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~  218 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK  218 (263)
T ss_pred             ccccccccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHH
Confidence            211    22345778999999987 6688999999999999999999999987766554433

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.6e-37  Score=253.79  Aligned_cols=212  Identities=24%  Similarity=0.362  Sum_probs=172.7

Q ss_pred             eccccCCCcccccccCceEEEEEEeCC----------------CCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSE----------------TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN  102 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~----------------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~  102 (260)
                      +..+.|++.+.||+|+||.||++.+..                ++..|++|.+.... ......++.+|++++++++|||
T Consensus         2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~n   80 (304)
T cd05096           2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPN   80 (304)
T ss_pred             CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCC
Confidence            345678889999999999999997543                34479999987542 3345667889999999999999


Q ss_pred             eeeeeceecCCCCCCCccEEEEEecCC-cchHHHhhhC-------------------CCCCHHHHHHHHHHHHHHHHHHH
Q 024959          103 VIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-------------------QQLTDDHCQYFLYQLLRGLKYVH  162 (260)
Q Consensus       103 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-------------------~~~~~~~~~~~~~~i~~~l~~lh  162 (260)
                      |+++++++...     ...+++|||++ ++|.+++...                   ..+++..++.++.|++.+|.+||
T Consensus        81 iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH  155 (304)
T cd05096          81 IIRLLGVCVDE-----DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS  155 (304)
T ss_pred             eeEEEEEEecC-----CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence            99999999876     45899999997 5888887542                   23677889999999999999999


Q ss_pred             hCCceeccCCCCCeEeccCCCEEEeecccccccCCCccc---ccccccccccccccccCcCCCCChhhHHHHHHHHHHHH
Q 024959          163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM  239 (260)
Q Consensus       163 ~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll  239 (260)
                      +.|++|+||+|+||+++.++.++|+|||++.........   ....++..|+|||.+.. ..++.++|+||||+++|+|+
T Consensus       156 ~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~  234 (304)
T cd05096         156 SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEIL  234 (304)
T ss_pred             HCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHH
Confidence            999999999999999999999999999998765433211   12233678999999877 67899999999999999998


Q ss_pred             h--CCCCCCCCChHHHHHHh
Q 024959          240 T--REPLFPGKDYVHQLRLI  257 (260)
Q Consensus       240 ~--g~~pf~~~~~~~~~~~i  257 (260)
                      +  +..||.+.+..+.+..+
T Consensus       235 ~~~~~~p~~~~~~~~~~~~~  254 (304)
T cd05096         235 MLCKEQPYGELTDEQVIENA  254 (304)
T ss_pred             HccCCCCCCcCCHHHHHHHH
Confidence            6  67889877766555443

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.2e-37  Score=260.10  Aligned_cols=198  Identities=30%  Similarity=0.411  Sum_probs=165.4

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      ...++.++.||+|++|.||++.+..+++.|++|++.... .......+.+|+++++.++|+||+++++++..+     ..
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~  146 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHN-----GE  146 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC-----Ce
Confidence            455678899999999999999999999999999986542 333456788999999999999999999999876     56


Q ss_pred             EEEEEecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc
Q 024959          121 VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (260)
Q Consensus       121 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~  199 (260)
                      +++||||+.+ +|.+    ....++..+..++.||+.+|+|||+++++|+||+|+||+++.++.++|+|||++.......
T Consensus       147 ~~lv~e~~~~~~L~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~  222 (353)
T PLN00034        147 IQVLLEFMDGGSLEG----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM  222 (353)
T ss_pred             EEEEEecCCCCcccc----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence            8999999985 5543    2345678888999999999999999999999999999999999999999999987654332


Q ss_pred             -ccccccccccccccccccCc----CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 024959          200 -FMTEYVVTRWYRAPELLLNC----TEYTAAIDIWSVGCILGEIMTREPLFPGK  248 (260)
Q Consensus       200 -~~~~~~~~~~~~~PE~~~~~----~~~~~~~Di~slG~~l~~ll~g~~pf~~~  248 (260)
                       ......++..|+|||.+...    ...+.++|||||||++|+|++|+.||...
T Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~  276 (353)
T PLN00034        223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG  276 (353)
T ss_pred             ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence             22345678999999987431    23456899999999999999999999743

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4.5e-37  Score=250.66  Aligned_cols=217  Identities=20%  Similarity=0.229  Sum_probs=180.3

Q ss_pred             cceeEeccccCCCc--ccccccCceEEEEEEeCCCCeEEEEEecCCcccch-HHHHHHHHHHHHHHHcCCCCeeeeecee
Q 024959           34 GNLFEVSSKYVPPI--RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI-IDARRTLREIKLLRHMEHENVIAIKDII  110 (260)
Q Consensus        34 ~~~~~~~~~~~~~~--~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~iv~~~~~~  110 (260)
                      .+...+...++...  ..|++|+++.||++..  +++.|++|.+....... .....+.+|+.++++++||||+++++++
T Consensus        10 ~~~~~i~~~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~   87 (283)
T PHA02988         10 NDIKCIESDDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFI   87 (283)
T ss_pred             CcceecCHHHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeE
Confidence            34455555665555  6799999999999977  57899999997653332 2246677999999999999999999998


Q ss_pred             cC--CCCCCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEeccCCCEEE
Q 024959          111 RP--PKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKI  186 (260)
Q Consensus       111 ~~--~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~di~~~nili~~~~~~~l  186 (260)
                      .+  +..   ..+++||||++ ++|.+++.+...+++.....++.+++.+|.+||+ .+++|+||+|+||+++.++.++|
T Consensus        88 ~~~~~~~---~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl  164 (283)
T PHA02988         88 IDIVDDL---PRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKI  164 (283)
T ss_pred             EecccCC---CceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEE
Confidence            76  222   45899999999 6899999888889999999999999999999998 49999999999999999999999


Q ss_pred             eecccccccCCCcccccccccccccccccccCc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          187 GDFGLARTTSETDFMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       187 ~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      +|||++.......  ....++..|+|||.+.+. ..++.++||||||+++|+|++|..||.+.+..+....+
T Consensus       165 ~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i  234 (283)
T PHA02988        165 ICHGLEKILSSPP--FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI  234 (283)
T ss_pred             cccchHhhhcccc--ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            9999987654332  234567889999998652 56889999999999999999999999988877766655

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.2e-37  Score=256.50  Aligned_cols=196  Identities=39%  Similarity=0.695  Sum_probs=163.0

Q ss_pred             cccccccCceEEEEEEeC--CCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEEE
Q 024959           47 IRPIGRGAYGIVCAAVNS--ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV  124 (260)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv  124 (260)
                      .+.||+|+||+||++.++  .+++.+++|.+.....    ...+.+|+++++.++||||+++++.+.....   ..++++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~~lv   78 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHAD---RKVWLL   78 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCC---cEEEEE
Confidence            568999999999999965  4668899999865322    2346789999999999999999999865432   458999


Q ss_pred             EecCCcchHHHhhhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEe----ccCCCEEEeeccc
Q 024959          125 YELMDTDLHQIIRSD---------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGL  191 (260)
Q Consensus       125 ~e~~~~~l~~~l~~~---------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili----~~~~~~~l~df~~  191 (260)
                      +|+++++|.+++...         ..+++..++.++.|++.+|.|||+.|++|+||||+||++    +.++.++|+|||+
T Consensus        79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          79 FDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             EeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            999999988887532         258999999999999999999999999999999999999    4567899999999


Q ss_pred             ccccCCCc----ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 024959          192 ARTTSETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  249 (260)
Q Consensus       192 ~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  249 (260)
                      +.......    ......+++.|+|||.+.+...++.++|+|||||++|+|++|..||.+.+
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            97654322    12234668899999999875668899999999999999999999997654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=6.9e-37  Score=245.76  Aligned_cols=208  Identities=28%  Similarity=0.478  Sum_probs=179.8

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~l  123 (260)
                      |.+.+.||+|++|.||++.++.+++.+++|.+............+.+|+++++.++|||++++++.+...     ...++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l   76 (256)
T cd08529           2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK-----GKLNI   76 (256)
T ss_pred             ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC-----CEEEE
Confidence            5577889999999999999999999999999865544455677888999999999999999999998876     56899


Q ss_pred             EEecCC-cchHHHhhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCcc
Q 024959          124 VYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  200 (260)
Q Consensus       124 v~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~  200 (260)
                      |||+++ ++|.+++...  ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          77 VMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             EEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            999997 6999988764  5789999999999999999999999999999999999999999999999998876554322


Q ss_pred             -cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          201 -MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       201 -~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                       .....+++.|+|||...+ ..++.++|+||||+++++|++|..||...+..+..+.+
T Consensus       157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  213 (256)
T cd08529         157 FANTIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI  213 (256)
T ss_pred             hhhccccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence             223356788999999987 66889999999999999999999999888866655544

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=3.4e-37  Score=253.12  Aligned_cols=209  Identities=42%  Similarity=0.717  Sum_probs=178.8

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccc---hHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN---IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      |.+.+.||.|++|.||++.+..+++.|++|.+......   ......+..|+++++.++|+||+++++++...     ..
T Consensus         2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~   76 (298)
T cd07841           2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK-----SN   76 (298)
T ss_pred             ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecC-----CE
Confidence            45678899999999999999999999999999655332   22345567899999999999999999999875     56


Q ss_pred             EEEEEecCCcchHHHhhhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc
Q 024959          121 VYIVYELMDTDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (260)
Q Consensus       121 ~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~  199 (260)
                      .++|||+++++|.+++.... .+++..++.++.|++++|.+||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus        77 ~~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          77 INLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             EEEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence            89999999889999988766 89999999999999999999999999999999999999999999999999987765432


Q ss_pred             -ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          200 -FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       200 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                       ......++..|+|||.+.+...++.++|+||||+++++|++|.+||.+.+..+.++.+
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~  215 (298)
T cd07841         157 RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKI  215 (298)
T ss_pred             ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHH
Confidence             2223345778999999866567789999999999999999999999888876666554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.1e-37  Score=252.85  Aligned_cols=213  Identities=41%  Similarity=0.689  Sum_probs=180.9

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      +.|++.+.||+|++|.||++.++.+++.+++|.++...........+.+|+.++++++||||+++++++.....   ...
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~---~~~   81 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNL---DKI   81 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCC---CcE
Confidence            46778999999999999999999999999999996543333333456789999999999999999998876532   569


Q ss_pred             EEEEecCCcchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC-c
Q 024959          122 YIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-D  199 (260)
Q Consensus       122 ~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~-~  199 (260)
                      ++|+|+++++|.+++... ..+++..++.++.|++++|++||+.+++|+||+|+||+++.++.++|+|||++...... .
T Consensus        82 ~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  161 (293)
T cd07843          82 YMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK  161 (293)
T ss_pred             EEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence            999999999999888764 45899999999999999999999999999999999999999999999999998876554 2


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      ......++..|+|||.+.+....+.++|+||||+++++|++|..||...+..+.+..+
T Consensus       162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~  219 (293)
T cd07843         162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKI  219 (293)
T ss_pred             ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            2333456788999999876555788999999999999999999999988876666554

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-38  Score=249.13  Aligned_cols=212  Identities=26%  Similarity=0.426  Sum_probs=189.0

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      -+++..++.||+|.||.|-+++.+.+++.||+|+++++.- ........+.|-++|+..+||.+..+.-.|..+     .
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~-----d  241 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ-----D  241 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccC-----c
Confidence            3456669999999999999999999999999999977632 333456667899999999999999888877766     5


Q ss_pred             cEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccccc-CC
Q 024959          120 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SE  197 (260)
Q Consensus       120 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~-~~  197 (260)
                      .+++||||.. |.|.-.+....-|++...+.+...|+.||.|||+++|++||+|.+|.+++.+|++||.|||+++.. ..
T Consensus       242 rlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~  321 (516)
T KOG0690|consen  242 RLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY  321 (516)
T ss_pred             eEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccc
Confidence            6999999998 588888888889999999999999999999999999999999999999999999999999999864 44


Q ss_pred             CcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          198 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       198 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      .....+.+|+|.|+|||.+-. ..|...+|.|.+|+++|||+||..||...+....+.+|.
T Consensus       322 g~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl  381 (516)
T KOG0690|consen  322 GDTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL  381 (516)
T ss_pred             cceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH
Confidence            556677899999999999987 899999999999999999999999999999999988875

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-37  Score=258.28  Aligned_cols=214  Identities=63%  Similarity=1.058  Sum_probs=179.8

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      +.|.+.+.||+|++|.||++.+..+++.|++|.+... ........+.+|+.+++.++||||+++++++...........
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF-EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc-ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            4577899999999999999999999999999998642 223345667889999999999999999998876655444568


Q ss_pred             EEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCcc-
Q 024959          122 YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-  200 (260)
Q Consensus       122 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~-  200 (260)
                      ++++|++++++.+.+. ...+++..++.++.|++++|.+||+.+++|+||+|+||+++.++.++|+|||++........ 
T Consensus        84 ~lv~e~~~~~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  162 (336)
T cd07849          84 YIVQELMETDLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH  162 (336)
T ss_pred             EEEehhcccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccc
Confidence            9999999998887764 45799999999999999999999999999999999999999999999999999876543221 


Q ss_pred             ---cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          201 ---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       201 ---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                         .....++..|+|||.+.+...++.++|+||||+++|+|++|+.||.+.+...++..+
T Consensus       163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~  222 (336)
T cd07849         163 TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLI  222 (336)
T ss_pred             cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence               122356788999998766567889999999999999999999999988776655443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3.9e-37  Score=248.47  Aligned_cols=213  Identities=24%  Similarity=0.439  Sum_probs=181.0

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      |++....+.+.+.||+|++|.||++.++.++..+++|.+...   ......+.+|++.++.++||||+++++++...   
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---   74 (263)
T cd05052           1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE---   74 (263)
T ss_pred             CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCC---
Confidence            566777788899999999999999999999999999998653   22356688899999999999999999998776   


Q ss_pred             CCccEEEEEecCC-cchHHHhhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                        ..++++||+++ ++|.+.+...  ..+++..++.++.|++++|++||+++++|+||+|+||+++.++.++|+|||++.
T Consensus        75 --~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~  152 (263)
T cd05052          75 --PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR  152 (263)
T ss_pred             --CCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccc
Confidence              55899999997 6899888653  458999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCcccc--cccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          194 TTSETDFMT--EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       194 ~~~~~~~~~--~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      .........  ....+..|++||.+.+ ..++.++|+||||+++|+|++ |..||.+.+..+..+.+.
T Consensus       153 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~  219 (263)
T cd05052         153 LMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE  219 (263)
T ss_pred             ccccceeeccCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            765432211  1223567999998876 678899999999999999998 999999888777666654

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=5.2e-37  Score=250.43  Aligned_cols=209  Identities=40%  Similarity=0.709  Sum_probs=181.0

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~l  123 (260)
                      |++.+.||.|++|.||++.+..++..+++|.+............+.+|+.++++++||||+++++++...     ...++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~~   76 (286)
T cd07832           2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG-----SGFVL   76 (286)
T ss_pred             ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC-----CeeEE
Confidence            5678999999999999999999999999999976544344567788999999999999999999999876     56899


Q ss_pred             EEecCCcchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc--c
Q 024959          124 VYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--F  200 (260)
Q Consensus       124 v~e~~~~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~--~  200 (260)
                      |+|+++++|.+++.. ...+++.+++.++.|++++|++||+.+++|+||+|+||+++.++.++|+|||++.......  .
T Consensus        77 v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~  156 (286)
T cd07832          77 VMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL  156 (286)
T ss_pred             EecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence            999998899998865 4679999999999999999999999999999999999999999999999999887665432  2


Q ss_pred             cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       201 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      .....++..|+|||.+.+...++.++|+||||+++++|++|.+||.+.+....+..+
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~  213 (286)
T cd07832         157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIV  213 (286)
T ss_pred             cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHH
Confidence            334456888999999876566789999999999999999999999888776665544

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.5e-37  Score=260.66  Aligned_cols=212  Identities=27%  Similarity=0.437  Sum_probs=174.8

Q ss_pred             ecceeEeccccCCCcccccccCceEEEEEEe-----CCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeee
Q 024959           33 YGNLFEVSSKYVPPIRPIGRGAYGIVCAAVN-----SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAI  106 (260)
Q Consensus        33 ~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~  106 (260)
                      ....|.++...|++.+.||+|+||.||++.+     ..++..||+|+++... .......+.+|+++++.+ +||||+++
T Consensus        26 ~~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l  104 (375)
T cd05104          26 YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNL  104 (375)
T ss_pred             CccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeee
Confidence            3456788888999999999999999999964     3456789999986542 233456788999999999 79999999


Q ss_pred             eceecCCCCCCCccEEEEEecCC-cchHHHhhhC----------------------------------------------
Q 024959          107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----------------------------------------------  139 (260)
Q Consensus       107 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~----------------------------------------------  139 (260)
                      ++.+...     ...++||||++ |+|.+++...                                              
T Consensus       105 ~~~~~~~-----~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  179 (375)
T cd05104         105 LGACTVG-----GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVV  179 (375)
T ss_pred             eeeeccC-----CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccc
Confidence            9999877     45899999998 6888877542                                              


Q ss_pred             -----------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecc
Q 024959          140 -----------------------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG  190 (260)
Q Consensus       140 -----------------------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~  190 (260)
                                                   ..+++..+..++.|++++|.|||+++++|+||||+||+++.++.++|+|||
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG  259 (375)
T cd05104         180 PTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFG  259 (375)
T ss_pred             ccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCc
Confidence                                         147788899999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcccc---cccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 024959          191 LARTTSETDFMT---EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYV  251 (260)
Q Consensus       191 ~~~~~~~~~~~~---~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~  251 (260)
                      ++..........   ....+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+....
T Consensus       260 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~  323 (375)
T cd05104         260 LARDIRNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD  323 (375)
T ss_pred             cceeccCcccccccCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch
Confidence            987654332111   1223467999999987 778999999999999999998 89999876543

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.5e-37  Score=259.26  Aligned_cols=214  Identities=64%  Similarity=1.127  Sum_probs=182.5

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      ..|++.+.||+|++|.||++.++.++..|++|++............+.+|+.+++.++||||+++++++..... ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~   83 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGA-DFKDV   83 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCC-CCceE
Confidence            56778899999999999999999999999999997654444456677889999999999999999998865432 22568


Q ss_pred             EEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCcc-
Q 024959          122 YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-  200 (260)
Q Consensus       122 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~-  200 (260)
                      ++|+|+++++|.+.+.....+++..++.++.|++++|.+||+++++|+||+|+||+++.++.++|+|||++........ 
T Consensus        84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  163 (334)
T cd07855          84 YVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE  163 (334)
T ss_pred             EEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcC
Confidence            9999999999999998888899999999999999999999999999999999999999999999999999876433221 


Q ss_pred             ----cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 024959          201 ----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  256 (260)
Q Consensus       201 ----~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  256 (260)
                          .....++..|+|||.+.+...++.++|+||||+++|+|++|+.||.+.+...++..
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~  223 (334)
T cd07855         164 HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKL  223 (334)
T ss_pred             CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHH
Confidence                12335678899999987655688999999999999999999999988876655544

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.6e-37  Score=250.62  Aligned_cols=208  Identities=42%  Similarity=0.738  Sum_probs=177.0

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~l  123 (260)
                      |++++.||.|++|.||++.+..++..+++|.+............+.+|++++++++||||+++++++...     ...++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~~   76 (284)
T cd07860           2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-----NKLYL   76 (284)
T ss_pred             ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC-----CcEEE
Confidence            5678999999999999999999999999999875544443446788899999999999999999998766     55899


Q ss_pred             EEecCCcchHHHhhh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc-c
Q 024959          124 VYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-F  200 (260)
Q Consensus       124 v~e~~~~~l~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~-~  200 (260)
                      +|||++++|.+++..  ...+++..++.++.|++++|+|||+.+++|+||+|+||+++.++.++|+|||++....... .
T Consensus        77 v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~  156 (284)
T cd07860          77 VFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT  156 (284)
T ss_pred             EeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence            999999888888765  4568999999999999999999999999999999999999999999999999987654332 1


Q ss_pred             cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 024959          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  256 (260)
Q Consensus       201 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  256 (260)
                      .....++..|+|||.+.+...++.++|+||||+++|+|++|+.||.+.+..+...+
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~  212 (284)
T cd07860         157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR  212 (284)
T ss_pred             cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            22234577899999987755578899999999999999999999988776655444

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-37  Score=264.25  Aligned_cols=199  Identities=26%  Similarity=0.388  Sum_probs=171.4

Q ss_pred             eccccCCCcccccccCceEEEEEEeC--CCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNS--ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      +....|++++.||.|++|.||++...  .++..+++|.+...       ....+|+++++.++||||+++++.+...   
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~---  158 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWK---  158 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeC---
Confidence            34456889999999999999999754  35678999988542       2345799999999999999999998766   


Q ss_pred             CCccEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccC
Q 024959          117 TFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (260)
Q Consensus       117 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~  196 (260)
                        ...+++||++.++|.+++.....+++..++.++.|++.+|.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus       159 --~~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~  236 (392)
T PHA03207        159 --STVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLD  236 (392)
T ss_pred             --CEEEEEehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence              568999999999999999778889999999999999999999999999999999999999999999999999987654


Q ss_pred             CCcc---cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024959          197 ETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (260)
Q Consensus       197 ~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  250 (260)
                      ....   .....+++.|+|||.+.. ..++.++|+|||||++|+|++|..||.+.+.
T Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~  292 (392)
T PHA03207        237 AHPDTPQCYGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQV  292 (392)
T ss_pred             cccccccccccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCC
Confidence            4322   223467899999999987 6789999999999999999999999976543

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-38  Score=237.16  Aligned_cols=211  Identities=28%  Similarity=0.350  Sum_probs=182.5

Q ss_pred             cceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCC
Q 024959           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (260)
Q Consensus        34 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~  113 (260)
                      .....+..+.|++.+.||.|||+-||++.+..+++.||+|++.-.  .....+..++|+...++++|||+++++++....
T Consensus        13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~--~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~   90 (302)
T KOG2345|consen   13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH--SQEDIEEALREIDNHRKFNSPNVLRLVDHQLRE   90 (302)
T ss_pred             CCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc--chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHh
Confidence            456778899999999999999999999999999999999999654  356778889999999999999999999998877


Q ss_pred             CCCCCccEEEEEecCC-cchHHHhhh----CCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCeEeccCCCEEE
Q 024959          114 KKDTFNDVYIVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKPSNLLLNASCDLKI  186 (260)
Q Consensus       114 ~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~H~di~~~nili~~~~~~~l  186 (260)
                      ..++....|++++|+. |+|.+.++.    +..+++.++..|+.+++++|++||+..  ++|+||||.||++++.+.++|
T Consensus        91 ~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl  170 (302)
T KOG2345|consen   91 EKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVL  170 (302)
T ss_pred             hccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEE
Confidence            7766678999999998 789888864    447999999999999999999999987  999999999999999999999


Q ss_pred             eecccccccCCCcccc----------cccccccccccccccC--cCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 024959          187 GDFGLARTTSETDFMT----------EYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFP  246 (260)
Q Consensus       187 ~df~~~~~~~~~~~~~----------~~~~~~~~~~PE~~~~--~~~~~~~~Di~slG~~l~~ll~g~~pf~  246 (260)
                      .|||-+....-.....          ...++..|.|||.+.-  ....+.++|||||||++|+|+.|.-||+
T Consensus       171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe  242 (302)
T KOG2345|consen  171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFE  242 (302)
T ss_pred             EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcch
Confidence            9999876543221111          1245888999999853  3556889999999999999999999996

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.9e-37  Score=257.14  Aligned_cols=216  Identities=68%  Similarity=1.189  Sum_probs=188.8

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~l  123 (260)
                      |.+.+.||.|++|.||++.+..++..+++|.+............+.+|+.+++.++||||+++++++......+....|+
T Consensus         2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l   81 (330)
T cd07834           2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI   81 (330)
T ss_pred             ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence            56789999999999999999999999999999765544555677889999999999999999999998775444457899


Q ss_pred             EEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc----
Q 024959          124 VYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD----  199 (260)
Q Consensus       124 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~----  199 (260)
                      +||+++++|.+.+.....+++..++.++.|++++|++||+.|++|+||+|.||+++.++.++|+|||++.......    
T Consensus        82 v~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~  161 (330)
T cd07834          82 VTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKG  161 (330)
T ss_pred             EecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccc
Confidence            9999999999999888899999999999999999999999999999999999999999999999999998765543    


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      ......++..|+|||.+.+...++.++|+||||+++++|++|..||.+.+..+..+.|.+
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~  221 (330)
T cd07834         162 FLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVE  221 (330)
T ss_pred             cccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHH
Confidence            233345678899999998844789999999999999999999999999998877776653

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-38  Score=268.49  Aligned_cols=203  Identities=30%  Similarity=0.430  Sum_probs=175.5

Q ss_pred             CcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC-CCCccEEEE
Q 024959           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDVYIV  124 (260)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~-~~~~~~~lv  124 (260)
                      .-+.||+|+||.||+++++.+|+.||||.+.... .....+...+|+++|++++|||||+++++=++... .-...-.++
T Consensus        17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv   95 (732)
T KOG4250|consen   17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV   95 (732)
T ss_pred             ehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence            3567999999999999999999999999997653 34456777899999999999999999998665431 011456899


Q ss_pred             EecCC-cchHHHhhhC---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecc--CCC--EEEeecccccccC
Q 024959          125 YELMD-TDLHQIIRSD---QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA--SCD--LKIGDFGLARTTS  196 (260)
Q Consensus       125 ~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~--~~~--~~l~df~~~~~~~  196 (260)
                      ||||. |+|...+++-   ..+++.+++.++.++..||.|||++||+||||||.||++..  +|+  .||+|||+++...
T Consensus        96 mEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~  175 (732)
T KOG4250|consen   96 MEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELD  175 (732)
T ss_pred             EeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCC
Confidence            99998 6999998763   45999999999999999999999999999999999999843  343  5999999999999


Q ss_pred             CCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 024959          197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  249 (260)
Q Consensus       197 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  249 (260)
                      +.....+..||..|++||.+-.++.++...|.||||+++|+..||..||.-..
T Consensus       176 d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~  228 (732)
T KOG4250|consen  176 DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG  228 (732)
T ss_pred             CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence            99889999999999999999855889999999999999999999999995443

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=6.1e-37  Score=250.17  Aligned_cols=200  Identities=27%  Similarity=0.448  Sum_probs=170.8

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~  122 (260)
                      |++.+.||+|+||.||++.+..+++.|++|.+..... .......+.+|+.+++.++|++++++++.+...     ...+
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-----~~~~   76 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETK-----DALC   76 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC-----CEEE
Confidence            4567889999999999999999999999999864322 222334567899999999999999999998776     5589


Q ss_pred             EEEecCC-cchHHHhhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc
Q 024959          123 IVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (260)
Q Consensus       123 lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~  199 (260)
                      +||||++ ++|.+.+...  ..+++..+..++.|++.+|.|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus        77 lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          77 LVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            9999997 5888887543  468999999999999999999999999999999999999999999999999987654443


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  249 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  249 (260)
                      ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||....
T Consensus       157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~  205 (285)
T cd05630         157 TIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRK  205 (285)
T ss_pred             cccCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence            3334567899999999977 678999999999999999999999998654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=7.9e-37  Score=255.04  Aligned_cols=216  Identities=38%  Similarity=0.644  Sum_probs=181.9

Q ss_pred             EeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchH------------HHHHHHHHHHHHHHcCCCCeee
Q 024959           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII------------DARRTLREIKLLRHMEHENVIA  105 (260)
Q Consensus        38 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~------------~~~~~~~e~~~l~~l~~~~iv~  105 (260)
                      .++.+|..+.+.||.|++|+||++.+..+++.|++|.+........            ....+.+|+++++.++||||++
T Consensus         5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   84 (335)
T PTZ00024          5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG   84 (335)
T ss_pred             ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence            4566777777889999999999999999999999999854322110            0124678999999999999999


Q ss_pred             eeceecCCCCCCCccEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEE
Q 024959          106 IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLK  185 (260)
Q Consensus       106 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~  185 (260)
                      +++++...     ...+++||+++++|.+.+.....+++..+..++.|++.+|++||+.+++|+||+|+||+++.++.++
T Consensus        85 ~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~k  159 (335)
T PTZ00024         85 LVDVYVEG-----DFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICK  159 (335)
T ss_pred             eeEEEecC-----CcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEE
Confidence            99999776     5589999999999999998888899999999999999999999999999999999999999999999


Q ss_pred             EeecccccccCCC---------------cccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024959          186 IGDFGLARTTSET---------------DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (260)
Q Consensus       186 l~df~~~~~~~~~---------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  250 (260)
                      |+|||++......               .......++..|+|||.+.+...++.++|+||||+++|+|++|..||.+.+.
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~  239 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE  239 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            9999988765411               1111234467899999987755678999999999999999999999999888


Q ss_pred             HHHHHHhh
Q 024959          251 VHQLRLIT  258 (260)
Q Consensus       251 ~~~~~~i~  258 (260)
                      .+++..|.
T Consensus       240 ~~~~~~i~  247 (335)
T PTZ00024        240 IDQLGRIF  247 (335)
T ss_pred             HHHHHHHH
Confidence            77776553

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.7e-36  Score=243.66  Aligned_cols=209  Identities=28%  Similarity=0.491  Sum_probs=182.4

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~l  123 (260)
                      |+.++.||.|++|.||.+.+..++..+++|.+...........++.+|++++++++|+||+++++++...     ...++
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~~   76 (256)
T cd08221           2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD-----NTLLI   76 (256)
T ss_pred             ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC-----CeEEE
Confidence            6678999999999999999999999999999876544555667788999999999999999999999876     56899


Q ss_pred             EEecCC-cchHHHhhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc-
Q 024959          124 VYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (260)
Q Consensus       124 v~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~-  199 (260)
                      +|||++ ++|.+.+...  ..+++..+..++.|+++++.+||+.+++|+||+|+||+++.++.++|+|||++....... 
T Consensus        77 ~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          77 EMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             EEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            999998 5999988764  568999999999999999999999999999999999999999999999999987654433 


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ......+++.|.|||...+ ..++.++|+||||+++|+|++|..||...+..+....|.
T Consensus       157 ~~~~~~~~~~y~ape~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~  214 (256)
T cd08221         157 MAETVVGTPYYMSPELCQG-VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIV  214 (256)
T ss_pred             cccccCCCccccCHhhcCC-CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            2233456889999999877 567889999999999999999999999888777766653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-36  Score=245.14  Aligned_cols=212  Identities=25%  Similarity=0.443  Sum_probs=179.0

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      |++....+++.+.||+|++|.||++.+.. +..|++|.++....   ....+.+|++++++++||||+++++++...   
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---   73 (261)
T cd05068           1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTLE---   73 (261)
T ss_pred             CccchhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEecC---
Confidence            56777889999999999999999998755 46799999865422   345688899999999999999999998776   


Q ss_pred             CCccEEEEEecCC-cchHHHhhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                        +..+++||+++ ++|.+++....  .+++..+..++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||++.
T Consensus        74 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~  151 (261)
T cd05068          74 --EPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLAR  151 (261)
T ss_pred             --CCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEE
Confidence              55899999995 79999987644  78999999999999999999999999999999999999999999999999988


Q ss_pred             ccCCCcccc--cccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          194 TTSETDFMT--EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       194 ~~~~~~~~~--~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      .........  ....+..|+|||...+ ..++.++|+||||+++++|++ |..||.+.+..+.+..+.
T Consensus       152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~  218 (261)
T cd05068         152 VIKEDIYEAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD  218 (261)
T ss_pred             EccCCcccccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            765332111  1122457999998877 678899999999999999999 999999888777666654

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.8e-36  Score=244.81  Aligned_cols=209  Identities=26%  Similarity=0.467  Sum_probs=175.6

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc---cchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCc
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF---DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      .|++.+.||+|++|.||.+.+..++..|++|.+....   ........+.+|++++++++||||+++++.+.+...   .
T Consensus         3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---~   79 (265)
T cd06652           3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPME---R   79 (265)
T ss_pred             cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCC---c
Confidence            4667899999999999999999999999999885432   122345677889999999999999999998876432   4


Q ss_pred             cEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          120 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       120 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      .++++||+++ ++|.+++.....+++..+..++.|++.+|++||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus        80 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~  159 (265)
T cd06652          80 TLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI  159 (265)
T ss_pred             eEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence            5789999997 589999888788999999999999999999999999999999999999999999999999988754322


Q ss_pred             c----ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024959          199 D----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  255 (260)
Q Consensus       199 ~----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~  255 (260)
                      .    ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+......
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~  219 (265)
T cd06652         160 CLSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF  219 (265)
T ss_pred             cccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHH
Confidence            1    1222346788999999877 678899999999999999999999998766554443

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-37  Score=250.64  Aligned_cols=208  Identities=40%  Similarity=0.711  Sum_probs=173.5

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      +.|++.+.||+|++|.||++.++.+++.|++|.+...... .....+.+|+++++.++||||+++++++...     ...
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~   78 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTK-----KTL   78 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecC-----CeE
Confidence            4567889999999999999999999999999998654222 1223466899999999999999999999876     568


Q ss_pred             EEEEecCCcchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc-
Q 024959          122 YIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (260)
Q Consensus       122 ~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~-  199 (260)
                      ++||||++++|.+++... ..+++..++.++.|++++|.+||+++++|+||+|+||+++.++.++|+|||++....... 
T Consensus        79 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          79 TLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            999999999999988764 468999999999999999999999999999999999999999999999999886543221 


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHH
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD-YVHQLR  255 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~-~~~~~~  255 (260)
                      ......++..|+|||.+.+...++.++|+||+|+++|+|++|..||.+.+ ..++++
T Consensus       159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~  215 (291)
T cd07844         159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLH  215 (291)
T ss_pred             cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHH
Confidence            11223457789999998765667899999999999999999999997766 344433

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-36  Score=248.34  Aligned_cols=209  Identities=43%  Similarity=0.754  Sum_probs=177.5

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~l  123 (260)
                      |++.+.||.|++|.||++.++.++..|++|.+............+.+|++.++.++|||++++++++...     ...++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~-----~~~~i   75 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE-----NKLYL   75 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccC-----CeEEE
Confidence            4578899999999999999999999999999865543333345677899999999999999999999876     56899


Q ss_pred             EEecCCcchHHHhhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc-c
Q 024959          124 VYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-F  200 (260)
Q Consensus       124 v~e~~~~~l~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~-~  200 (260)
                      ++|+++++|.+++....  .+++..+..++.|++++|++||+++++|+||+|+||+++.++.++|+|||++....... .
T Consensus        76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~  155 (283)
T cd07835          76 VFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT  155 (283)
T ss_pred             EEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence            99999989999987765  79999999999999999999999999999999999999999999999999987554322 1


Q ss_pred             cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       201 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      .....++..|+|||.+.+...++.++|+||||+++|+|++|+.||...+.......+
T Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~  212 (283)
T cd07835         156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRI  212 (283)
T ss_pred             cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            222345778999998876456788999999999999999999999888776554443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.3e-36  Score=247.62  Aligned_cols=209  Identities=36%  Similarity=0.655  Sum_probs=176.3

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-CCCeeeeeceecCCCCCCCccEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDVY  122 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~~~~~~  122 (260)
                      |++.+.||+|++|.||++.+..++..+++|.++........ ....+|+..++++. |||++++++++..+..   ...+
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~---~~~~   76 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKT---GRLA   76 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCC---CcEE
Confidence            45688999999999999999999999999998765333322 23457888888885 9999999999987633   4589


Q ss_pred             EEEecCCcchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCccc
Q 024959          123 IVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  201 (260)
Q Consensus       123 lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  201 (260)
                      +|+|++++++.+.+.. ...+++..++.++.|++.+|++||+.+++|+||+|+||+++. +.++|+|||++.........
T Consensus        77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~  155 (282)
T cd07831          77 LVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY  155 (282)
T ss_pred             EEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence            9999999999888876 457899999999999999999999999999999999999999 99999999999876555444


Q ss_pred             ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       202 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      ....++..|+|||.+......+.++|+||||+++|+|++|..||.+.+..+....+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~  211 (282)
T cd07831         156 TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKI  211 (282)
T ss_pred             CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHH
Confidence            44566888999998765466788999999999999999999999988876655544

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.4e-36  Score=258.14  Aligned_cols=214  Identities=27%  Similarity=0.416  Sum_probs=177.4

Q ss_pred             EeeecceeEeccccCCCcccccccCceEEEEEEeCCC-----CeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-CCCe
Q 024959           30 YNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSET-----REEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENV  103 (260)
Q Consensus        30 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~-----~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i  103 (260)
                      +..+..+|+++...|++++.||.|+||.||++.+...     +..||+|++... ......+.+.+|+++++.+. ||||
T Consensus        25 ~~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~~Ei~~l~~l~~HpnI  103 (400)
T cd05105          25 QLPYDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT-ARSSEKQALMSELKIMTHLGPHLNI  103 (400)
T ss_pred             cCCCCCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCCe
Confidence            3455679999999999999999999999999986432     346999999654 23344567889999999996 9999


Q ss_pred             eeeeceecCCCCCCCccEEEEEecCC-cchHHHhhhC-------------------------------------------
Q 024959          104 IAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-------------------------------------------  139 (260)
Q Consensus       104 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-------------------------------------------  139 (260)
                      +++++++...     ...++||||++ ++|.+++...                                           
T Consensus       104 v~l~~~~~~~-----~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (400)
T cd05105         104 VNLLGACTKS-----GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYM  178 (400)
T ss_pred             eeEEEEEccC-----CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccc
Confidence            9999999776     55899999998 6888776532                                           


Q ss_pred             -----------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 024959          140 -----------------------------------------------------QQLTDDHCQYFLYQLLRGLKYVHSASV  166 (260)
Q Consensus       140 -----------------------------------------------------~~~~~~~~~~~~~~i~~~l~~lh~~~i  166 (260)
                                                                           ..+++..+..++.|++++|.|||+.++
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~i  258 (400)
T cd05105         179 DMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNC  258 (400)
T ss_pred             ccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence                                                                 237788889999999999999999999


Q ss_pred             eeccCCCCCeEeccCCCEEEeecccccccCCCcc---cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CC
Q 024959          167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-RE  242 (260)
Q Consensus       167 ~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~  242 (260)
                      +|+||+|+||+++.++.++|+|||++........   .....++..|+|||.+.+ ..++.++||||||+++|+|++ |.
T Consensus       259 vH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~  337 (400)
T cd05105         259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGG  337 (400)
T ss_pred             eCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCC
Confidence            9999999999999999999999999876543221   122234677999999877 678999999999999999997 99


Q ss_pred             CCCCCCCh
Q 024959          243 PLFPGKDY  250 (260)
Q Consensus       243 ~pf~~~~~  250 (260)
                      .||.....
T Consensus       338 ~P~~~~~~  345 (400)
T cd05105         338 TPYPGMIV  345 (400)
T ss_pred             CCCcccch
Confidence            99987544

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.5e-36  Score=247.42  Aligned_cols=212  Identities=24%  Similarity=0.423  Sum_probs=177.0

Q ss_pred             ccccCCCcccccccCceEEEEEEeCCCC-----eEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           40 SSKYVPPIRPIGRGAYGIVCAAVNSETR-----EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      ....+++.+.||+|++|.||++.+...+     ..+++|.+.... .......+.+|++.++.++||||+++++++... 
T Consensus         3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-   80 (283)
T cd05048           3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE-   80 (283)
T ss_pred             ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC-
Confidence            3456788999999999999999876654     679999986542 334456788999999999999999999998766 


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeE
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL  177 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nil  177 (260)
                          ...+++||+++ ++|.+++...                ..+++..++.++.|++.+|.+||+++++|+||+|+||+
T Consensus        81 ----~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil  156 (283)
T cd05048          81 ----QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCL  156 (283)
T ss_pred             ----CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEE
Confidence                45899999998 6899888754                45788999999999999999999999999999999999


Q ss_pred             eccCCCEEEeecccccccCCCcc---cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 024959          178 LNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQ  253 (260)
Q Consensus       178 i~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~  253 (260)
                      ++.++.++|+|||++........   .....+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+.+..+.
T Consensus       157 ~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~  235 (283)
T cd05048         157 VGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV  235 (283)
T ss_pred             EcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            99999999999999876433221   122344678999999877 678999999999999999998 9999998887776


Q ss_pred             HHHhh
Q 024959          254 LRLIT  258 (260)
Q Consensus       254 ~~~i~  258 (260)
                      ...|.
T Consensus       236 ~~~i~  240 (283)
T cd05048         236 IEMIR  240 (283)
T ss_pred             HHHHH
Confidence            66553

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.6e-36  Score=246.70  Aligned_cols=215  Identities=26%  Similarity=0.474  Sum_probs=176.6

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCC-----CCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceec
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSE-----TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIR  111 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~  111 (260)
                      |++..+.|++.+.||+|++|.||++.++.     ++..+++|.+... ........+.+|+.+++.++||||+++++++.
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~   79 (277)
T cd05062           1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            56677889999999999999999998652     3567999998653 22334566889999999999999999999997


Q ss_pred             CCCCCCCccEEEEEecCC-cchHHHhhhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecc
Q 024959          112 PPKKDTFNDVYIVYELMD-TDLHQIIRSDQ----------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA  180 (260)
Q Consensus       112 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~----------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~  180 (260)
                      ..     ...++|||+++ ++|.+++....          .+++..+..++.|++++|.+||+.+++|+||+|+||+++.
T Consensus        80 ~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~  154 (277)
T cd05062          80 QG-----QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE  154 (277)
T ss_pred             CC-----CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcC
Confidence            76     55899999998 68988886522          3577889999999999999999999999999999999999


Q ss_pred             CCCEEEeecccccccCCCccc---ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 024959          181 SCDLKIGDFGLARTTSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRL  256 (260)
Q Consensus       181 ~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~  256 (260)
                      ++.++|+|||++.........   ....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+.+..+..+.
T Consensus       155 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~  233 (277)
T cd05062         155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF  233 (277)
T ss_pred             CCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            999999999998754433211   11233567999999877 678999999999999999999 7899998887776665


Q ss_pred             hh
Q 024959          257 IT  258 (260)
Q Consensus       257 i~  258 (260)
                      +.
T Consensus       234 ~~  235 (277)
T cd05062         234 VM  235 (277)
T ss_pred             HH
Confidence            43

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.2e-36  Score=243.23  Aligned_cols=203  Identities=22%  Similarity=0.407  Sum_probs=171.7

Q ss_pred             cccccCceEEEEEEe--CCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEEEEe
Q 024959           49 PIGRGAYGIVCAAVN--SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYE  126 (260)
Q Consensus        49 ~lg~G~~g~vy~~~~--~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv~e  126 (260)
                      .||+|++|.||++..  +.++..+++|++..........+.+.+|+.+++.++||||+++++++..      ...++|||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~lv~e   75 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA------ESWMLVME   75 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC------CCcEEEEe
Confidence            589999999999964  4567889999997665555567788899999999999999999998753      33689999


Q ss_pred             cCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCccc----
Q 024959          127 LMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----  201 (260)
Q Consensus       127 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~~----  201 (260)
                      +++ ++|.+++.....+++..+..++.|++.+|++||++|++|+||+|.||+++.++.++|+|||++.........    
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  155 (257)
T cd05116          76 LAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK  155 (257)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence            998 689999988888999999999999999999999999999999999999999999999999998765443321    


Q ss_pred             ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       202 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      ....++..|+|||.+.. ..++.++|+||||+++|+|++ |..||.+.+..+..+.|.
T Consensus       156 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~  212 (257)
T cd05116         156 THGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE  212 (257)
T ss_pred             CCCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            11122468999998866 678889999999999999998 999999877766666554

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=9.4e-37  Score=251.67  Aligned_cols=217  Identities=37%  Similarity=0.615  Sum_probs=178.4

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC---C
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD---T  117 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~---~  117 (260)
                      .+.|++.+.||+|++|.||++.+..+++.|++|.+............+.+|++++++++||||+++++++......   .
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            3456788999999999999999999999999999865433333334566899999999999999999988765321   1


Q ss_pred             CccEEEEEecCCcchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccC
Q 024959          118 FNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (260)
Q Consensus       118 ~~~~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~  196 (260)
                      ....++|||+++++|.+.+... ..+++.+++.++.|++++|++||+++++|+||+|+||+++.++.++|+|||++....
T Consensus        91 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  170 (310)
T cd07865          91 KGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFS  170 (310)
T ss_pred             CceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccccc
Confidence            2457999999999988887764 378999999999999999999999999999999999999999999999999987654


Q ss_pred             CCcc-----cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          197 ETDF-----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       197 ~~~~-----~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      ....     .....++..|+|||.+.+...++.++|+||||+++|+|++|..||.+.+.......|
T Consensus       171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~  236 (310)
T cd07865         171 LSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLI  236 (310)
T ss_pred             CCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            3321     122345778999999876555788999999999999999999999988776655544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.1e-38  Score=264.98  Aligned_cols=210  Identities=26%  Similarity=0.416  Sum_probs=183.3

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCc--ccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCC
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNA--FDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~  118 (260)
                      ..|.+....||+|+|-+||+|.|..+|..||.-.++..  ...+...+++.+|+.+|+.|+||||+++|+.|.+...   
T Consensus        39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n---  115 (632)
T KOG0584|consen   39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN---  115 (632)
T ss_pred             CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC---
Confidence            45556677899999999999999999988885443222  2455567899999999999999999999999998866   


Q ss_pred             ccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhC--CceeccCCCCCeEeccC-CCEEEeecccccc
Q 024959          119 NDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA--SVLHRDLKPSNLLLNAS-CDLKIGDFGLART  194 (260)
Q Consensus       119 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~--~i~H~di~~~nili~~~-~~~~l~df~~~~~  194 (260)
                      ..+-+|+|.+. |+|+.++++.++.+...++.|++||+++|.|||++  .|+|||||.+||||+.+ |.+||+|+|+|..
T Consensus       116 ~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl  195 (632)
T KOG0584|consen  116 KTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL  195 (632)
T ss_pred             ceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHH
Confidence            56889999998 89999999999999999999999999999999987  59999999999999875 9999999999988


Q ss_pred             cCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 024959          195 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  256 (260)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  256 (260)
                      ...+... +..|||.|||||.+-  ..|+..+||||||+|++||+|+..||....+..+.-+
T Consensus       196 ~r~s~ak-svIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYK  254 (632)
T KOG0584|consen  196 LRKSHAK-SVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYK  254 (632)
T ss_pred             hhccccc-eeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHH
Confidence            7776433 478999999999986  5799999999999999999999999988777666543

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.1e-36  Score=248.64  Aligned_cols=210  Identities=39%  Similarity=0.765  Sum_probs=176.1

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~  122 (260)
                      .|++.+.||+|++|.||++.++.+++.+++|.+............+.+|+++++.++||||+++++++...     ...+
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   76 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRK-----KRLY   76 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccC-----CeEE
Confidence            46678999999999999999999999999999866544433456678899999999999999999999766     5689


Q ss_pred             EEEecCCcc-hHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc-c
Q 024959          123 IVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-F  200 (260)
Q Consensus       123 lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~-~  200 (260)
                      +|+||+++. +..+......+++..+..++.|++++|.|||+.+++|+||+|+||+++.++.++|+|||++....... .
T Consensus        77 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07846          77 LVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV  156 (286)
T ss_pred             EEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc
Confidence            999999964 55444455579999999999999999999999999999999999999999999999999987654332 2


Q ss_pred             cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       201 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      .....++..|++||.+.+...++.++|+||||+++++|++|.+||.+.+..+.+..+
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~  213 (286)
T cd07846         157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHI  213 (286)
T ss_pred             cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHH
Confidence            223456788999999876566788999999999999999999999887766554443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=3.2e-36  Score=242.05  Aligned_cols=209  Identities=27%  Similarity=0.480  Sum_probs=176.9

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~l  123 (260)
                      |++.+.||.|++|.||++.++.+++.+++|.+............+.+|++++++++|+|++++++.+....    ..+++
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~l   77 (257)
T cd08223           2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGED----GLLYI   77 (257)
T ss_pred             ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCC----CEEEE
Confidence            56889999999999999999999999999999765444455667888999999999999999998875432    45799


Q ss_pred             EEecCC-cchHHHhhh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc-
Q 024959          124 VYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (260)
Q Consensus       124 v~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~-  199 (260)
                      ++|+++ ++|.+++..  ...+++.+++.++.+++.++++||+.|++|+||+|+||+++.++.++|+|||++....... 
T Consensus        78 v~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          78 VMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             EecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            999998 588888876  3468999999999999999999999999999999999999999999999999987654322 


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      ......+++.|+|||.+.+ ..++.++|+||||+++++|++|..||...+.......+
T Consensus       158 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~  214 (257)
T cd08223         158 MASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI  214 (257)
T ss_pred             ccccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence            2223456788999999877 67889999999999999999999999987766554443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.3e-36  Score=273.84  Aligned_cols=204  Identities=29%  Similarity=0.398  Sum_probs=171.5

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      +.|++.+.||+|++|.||++.+..+++.||+|++..... ......++.+|+++++.++||||+++++++..+     ..
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~-----~~   76 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG-----DP   76 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC-----CE
Confidence            356788999999999999999999999999999965432 233456788999999999999999999999876     55


Q ss_pred             EEEEEecCC-cchHHHhhhC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEee
Q 024959          121 VYIVYELMD-TDLHQIIRSD-----------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD  188 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~~-----------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~d  188 (260)
                      .+++||+++ ++|.+++...           ...+...+..++.|++++|++||+.|++||||||+||+++.++.++|+|
T Consensus        77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiD  156 (932)
T PRK13184         77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILD  156 (932)
T ss_pred             EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEe
Confidence            899999998 5888887531           2356677889999999999999999999999999999999999999999


Q ss_pred             cccccccCCCc-------------------ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 024959          189 FGLARTTSETD-------------------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  249 (260)
Q Consensus       189 f~~~~~~~~~~-------------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  249 (260)
                      ||++.......                   ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||...+
T Consensus       157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~~~  235 (932)
T PRK13184        157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLSFPYRRKK  235 (932)
T ss_pred             cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCCcc
Confidence            99987652110                   0112357899999999887 678999999999999999999999998755


Q ss_pred             hH
Q 024959          250 YV  251 (260)
Q Consensus       250 ~~  251 (260)
                      ..
T Consensus       236 ~~  237 (932)
T PRK13184        236 GR  237 (932)
T ss_pred             hh
Confidence            43

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.7e-36  Score=247.19  Aligned_cols=209  Identities=41%  Similarity=0.731  Sum_probs=178.0

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~l  123 (260)
                      |++.+.||.|++|.||++.+..++..+++|.+..... ......+.+|+++++.++||||+++++.+...     +..++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~l   75 (284)
T cd07836           2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTE-----NKLML   75 (284)
T ss_pred             ceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC-----CcEEE
Confidence            5678999999999999999999999999999865432 22345567899999999999999999999876     55899


Q ss_pred             EEecCCcchHHHhhhC---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc-
Q 024959          124 VYELMDTDLHQIIRSD---QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (260)
Q Consensus       124 v~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~-  199 (260)
                      |||+++++|.+++...   ..+++..+..++.|++++|.+||+.+++|+||+|+||+++.++.++|+|||++....... 
T Consensus        76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          76 VFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             EEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence            9999999998887653   468999999999999999999999999999999999999999999999999987554322 


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ......++..|++||.+.+...++.++|+|+||+++|+|++|..||.+.+..++...+.
T Consensus       156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~  214 (284)
T cd07836         156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIF  214 (284)
T ss_pred             ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence            12233457789999998765667899999999999999999999999888777666543

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.2e-36  Score=246.12  Aligned_cols=205  Identities=28%  Similarity=0.380  Sum_probs=174.4

Q ss_pred             ccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCc
Q 024959           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      ....|++.+.||+|++|.||++.+..+++.+++|++....  ......+.+|+.+++.++||||+++++.+...     .
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~-----~   79 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR-----E   79 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-----C
Confidence            3456889999999999999999999999999999996532  22345677899999999999999999999776     5


Q ss_pred             cEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          120 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       120 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      .+++||||++ ++|.+++.....+++..+..++.|+++++.+||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus        80 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06646          80 KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT  159 (267)
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence            6899999998 589898888888999999999999999999999999999999999999999999999999998765432


Q ss_pred             c-ccccccccccccccccccC--cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH
Q 024959          199 D-FMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  251 (260)
Q Consensus       199 ~-~~~~~~~~~~~~~PE~~~~--~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~  251 (260)
                      . ......++..|+|||.+..  ...++.++|+||||+++|+|++|..||...+..
T Consensus       160 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~  215 (267)
T cd06646         160 IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM  215 (267)
T ss_pred             ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh
Confidence            2 1233456788999998752  244678999999999999999999999655443

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2e-36  Score=250.64  Aligned_cols=207  Identities=25%  Similarity=0.368  Sum_probs=171.9

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCeE----EEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREE----VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~----~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      +....|++.+.||+|+||.||++.+..++..    |++|.++.. ........+.+|+.+++.++||||+++++++... 
T Consensus         4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-   81 (316)
T cd05108           4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   81 (316)
T ss_pred             cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence            3456788999999999999999987665553    899998653 2334556788999999999999999999998754 


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccc
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~  192 (260)
                           ..++++|++. ++|.+.+... ..+++..+..++.|++.+|+|||+++++|+||+|+||+++.++.++|+|||++
T Consensus        82 -----~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a  156 (316)
T cd05108          82 -----TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLA  156 (316)
T ss_pred             -----CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccc
Confidence                 2578899887 7899988774 46889999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCcccc---cccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 024959          193 RTTSETDFMT---EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQ  253 (260)
Q Consensus       193 ~~~~~~~~~~---~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~  253 (260)
                      ..........   ....+..|++||.+.+ ..++.++|+||||+++|+|++ |..||.+.+..+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~  220 (316)
T cd05108         157 KLLGADEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI  220 (316)
T ss_pred             ccccCCCcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            8765432211   1223567999999877 778999999999999999997 9999987765543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.2e-36  Score=247.88  Aligned_cols=210  Identities=41%  Similarity=0.744  Sum_probs=175.1

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~  122 (260)
                      .|++.+.||.|++|.||++.++.+++.|++|.+............+.+|+++++.++||||+++++.+...     ..++
T Consensus         3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   77 (294)
T PLN00009          3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE-----KRLY   77 (294)
T ss_pred             ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecC-----CeEE
Confidence            46678899999999999999999999999999865433333445677899999999999999999999876     5699


Q ss_pred             EEEecCCcchHHHhhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecc-CCCEEEeecccccccCCCc
Q 024959          123 IVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETD  199 (260)
Q Consensus       123 lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~-~~~~~l~df~~~~~~~~~~  199 (260)
                      +||||++++|.+.+....  .+++..++.++.|++.+|++||+++++|+||+|+||+++. ++.++|+|||++.......
T Consensus        78 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         78 LVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             EEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            999999988888876544  3578889999999999999999999999999999999985 4578999999987654322


Q ss_pred             -ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          200 -FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       200 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                       ......+++.|+|||.+.+...++.++|+||||+++|+|++|..||...+..+...++
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~  216 (294)
T PLN00009        158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI  216 (294)
T ss_pred             cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence             2223455788999999876556789999999999999999999999887765555443

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-36  Score=243.42  Aligned_cols=207  Identities=29%  Similarity=0.410  Sum_probs=176.4

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      .+.|++.+.||.|++|.||++.+..++..+++|.+.....  .....+.+|+.++++++||||+++++.+...     ..
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~   74 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLRR-----DK   74 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEeC-----CE
Confidence            3567788999999999999999999999999999965432  2567788999999999999999999998776     56


Q ss_pred             EEEEEecCC-cchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          121 VYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      ++++||+++ ++|.+++... ..+++.+++.++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus        75 ~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  154 (262)
T cd06613          75 LWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT  154 (262)
T ss_pred             EEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence            999999998 5888888776 78999999999999999999999999999999999999999999999999988765433


Q ss_pred             c-ccccccccccccccccccCc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024959          199 D-FMTEYVVTRWYRAPELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  254 (260)
Q Consensus       199 ~-~~~~~~~~~~~~~PE~~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  254 (260)
                      . ......++..|++||.+...  ..++.++|+||||+++|+|++|..||.+.+.....
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~  213 (262)
T cd06613         155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL  213 (262)
T ss_pred             hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            2 22234567789999998762  26788999999999999999999999877654443

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.4e-36  Score=253.69  Aligned_cols=213  Identities=51%  Similarity=0.959  Sum_probs=180.6

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCCCCCc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      .+.|++.+.||+|++|.||++.+..++..+++|.+............+.+|+.+++++ +||||+++++++.....   .
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~---~   82 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND---K   82 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC---c
Confidence            4567789999999999999999998999999998865444444556677899999999 99999999999876532   4


Q ss_pred             cEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc
Q 024959          120 DVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (260)
Q Consensus       120 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~  199 (260)
                      ..++|||+++++|.+.+..+ .+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus        83 ~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~  161 (337)
T cd07852          83 DIYLVFEYMETDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE  161 (337)
T ss_pred             eEEEEecccccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence            58999999999999888766 88899999999999999999999999999999999999999999999999887654322


Q ss_pred             ------ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          200 ------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       200 ------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                            ......++..|+|||.+.+....+.++|+||||+++|+|++|..||.+.+..+..+.+
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~  225 (337)
T cd07852         162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKI  225 (337)
T ss_pred             ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence                  1122356788999998876566788999999999999999999999988777665544

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.8e-36  Score=244.20  Aligned_cols=212  Identities=24%  Similarity=0.468  Sum_probs=178.1

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      |++..+.|++++.||+|++|.||++.+.. +..+++|.+...   ....+.+.+|+.+++.++|+||+++++.+...   
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---   73 (261)
T cd05072           1 WEIPRESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPG---TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE---   73 (261)
T ss_pred             CcCchHHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCC---chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCC---
Confidence            67788899999999999999999998754 567999988643   22356788999999999999999999998766   


Q ss_pred             CCccEEEEEecCC-cchHHHhhh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                        ...++++|+++ ++|.+++..  ...+++..++.++.|++++|++||+.+++|+||+|+||+++.++.++|+|||++.
T Consensus        74 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~  151 (261)
T cd05072          74 --EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLAR  151 (261)
T ss_pred             --CCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccce
Confidence              55899999997 699998865  4568899999999999999999999999999999999999999999999999997


Q ss_pred             ccCCCccc--ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          194 TTSETDFM--TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       194 ~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      ........  ....++..|+|||.+.. ..++.++|+||||+++|+|++ |..||.+.+..+....+.
T Consensus       152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~  218 (261)
T cd05072         152 VIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ  218 (261)
T ss_pred             ecCCCceeccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHH
Confidence            65543211  12233567999999876 668889999999999999998 999998877766655543

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-36  Score=246.73  Aligned_cols=212  Identities=42%  Similarity=0.708  Sum_probs=181.3

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~l  123 (260)
                      |.+.+.||.|++|.||++.+..+++.+++|.+............+.+|+++++.++|||++++++++....   ....++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence            45788999999999999999999999999999765433444567788999999999999999999987663   145899


Q ss_pred             EEecCCcchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc--c
Q 024959          124 VYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--F  200 (260)
Q Consensus       124 v~e~~~~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~--~  200 (260)
                      |+|+++++|.+++... ..+++..++.++.|++++|++||+.+++|+||+|+||+++.++.++|+|||++.......  .
T Consensus        78 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~  157 (287)
T cd07840          78 VFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD  157 (287)
T ss_pred             EeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence            9999999998888765 679999999999999999999999999999999999999999999999999987665543  1


Q ss_pred             cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       201 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      .....++..|+|||.+.+...++.++|+||||+++|+|++|+.||...+....+..+.
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~  215 (287)
T cd07840         158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIF  215 (287)
T ss_pred             ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            2233457789999988765667899999999999999999999999888776666543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.4e-36  Score=253.58  Aligned_cols=209  Identities=28%  Similarity=0.476  Sum_probs=172.4

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCC-----CCeEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeeeecee
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSE-----TREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDII  110 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~  110 (260)
                      |.++.+.|++.+.||+|+||.||++....     +++.|++|++.... .......+.+|+++++++ +||||+++++++
T Consensus         2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~   80 (337)
T cd05054           2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGAC   80 (337)
T ss_pred             cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence            77888899999999999999999997543     45789999986542 233456678899999999 799999999988


Q ss_pred             cCCCCCCCccEEEEEecCC-cchHHHhhhC--------------------------------------------------
Q 024959          111 RPPKKDTFNDVYIVYELMD-TDLHQIIRSD--------------------------------------------------  139 (260)
Q Consensus       111 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~--------------------------------------------------  139 (260)
                      ....    ..+++++||++ ++|.+++...                                                  
T Consensus        81 ~~~~----~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (337)
T cd05054          81 TKPG----GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDV  156 (337)
T ss_pred             ecCC----CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhc
Confidence            6542    45889999998 5888777532                                                  


Q ss_pred             -----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCcc---ccccc
Q 024959          140 -----------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYV  205 (260)
Q Consensus       140 -----------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~---~~~~~  205 (260)
                                 ..+++..+..++.|++++|+|||+++++|+||+|.||+++.++.++|+|||++........   .....
T Consensus       157 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~  236 (337)
T cd05054         157 EEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  236 (337)
T ss_pred             ccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCC
Confidence                       2578899999999999999999999999999999999999999999999999876543221   11223


Q ss_pred             ccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 024959          206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYV  251 (260)
Q Consensus       206 ~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~  251 (260)
                      ++..|+|||.+.+ ..++.++|+|||||++++|++ |..||.+....
T Consensus       237 ~~~~y~aPE~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~  282 (337)
T cd05054         237 LPLKWMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID  282 (337)
T ss_pred             CCccccCcHHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc
Confidence            3567999999987 788999999999999999998 99999875543

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-36  Score=247.85  Aligned_cols=209  Identities=40%  Similarity=0.754  Sum_probs=178.7

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~  122 (260)
                      .|++.+.||+|++|.||++.++.+++.|++|.++...........+.+|+++++.++|+||+++++.+...     ...+
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   76 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRK-----GRLY   76 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEEC-----CEEE
Confidence            46788999999999999999999999999999876544444567788999999999999999999999775     5699


Q ss_pred             EEEecCCcchHHHh-hhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc--
Q 024959          123 IVYELMDTDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--  199 (260)
Q Consensus       123 lv~e~~~~~l~~~l-~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~--  199 (260)
                      +++||+++++.+.+ .....+++..++.++.|+++++.+||+.+++|+||+|+||+++.++.++|+|||++.......  
T Consensus        77 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~  156 (288)
T cd07833          77 LVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS  156 (288)
T ss_pred             EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence            99999997655544 445679999999999999999999999999999999999999999999999999987765543  


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  256 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  256 (260)
                      ......++..|+|||.+.+...++.++|+||||+++|+|++|..||.+.+..+.+..
T Consensus       157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~  213 (288)
T cd07833         157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYL  213 (288)
T ss_pred             cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            233345678899999998844788999999999999999999999988776655443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.3e-36  Score=242.70  Aligned_cols=210  Identities=30%  Similarity=0.530  Sum_probs=180.1

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~l  123 (260)
                      |++.+.||.|++|.||++.+..++..+++|.+............+..|+++++.++||||+++++.+.....   ...++
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---~~~~~   78 (265)
T cd08217           2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSN---QTLYI   78 (265)
T ss_pred             ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCC---CEEEE
Confidence            567899999999999999999999999999987654555566778899999999999999999998765432   55899


Q ss_pred             EEecCC-cchHHHhhh----CCCCCHHHHHHHHHHHHHHHHHHH-----hCCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          124 VYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVH-----SASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       124 v~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh-----~~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                      +||+++ ++|.+++..    ..++++..++.++.|++.+|.+||     +.+++|+||+|+||+++.++.++|+|||++.
T Consensus        79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~  158 (265)
T cd08217          79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK  158 (265)
T ss_pred             EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccc
Confidence            999997 588888765    467999999999999999999999     8999999999999999999999999999988


Q ss_pred             ccCCCcc-cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          194 TTSETDF-MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       194 ~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      ....... .....++..|++||.+.+ ..++.++|+||||+++++|++|..||...+..+..+.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~  222 (265)
T cd08217         159 ILGHDSSFAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI  222 (265)
T ss_pred             cccCCcccccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHH
Confidence            7665443 334467888999999877 66889999999999999999999999988765554443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-36  Score=249.77  Aligned_cols=210  Identities=22%  Similarity=0.380  Sum_probs=178.0

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccc-hHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN-IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      .|.+.+.||+|++|.||++.+..+++.+++|.+...... ......+.+|++.++.++||||+++++.+...     ...
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~   76 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTE-----TYL   76 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecC-----CEE
Confidence            466788999999999999999999999999999764322 23556788999999999999999999998776     568


Q ss_pred             EEEEecCC-cchHHHhhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          122 YIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      +++||++. ++|.+++...  ..+++..++.++.|++++|++||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          77 CLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            99999997 5898888753  57899999999999999999999999999999999999999999999999988654332


Q ss_pred             ccc------------------------------ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 024959          199 DFM------------------------------TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK  248 (260)
Q Consensus       199 ~~~------------------------------~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  248 (260)
                      ...                              ....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence            111                              11245778999999987 66789999999999999999999999988


Q ss_pred             ChHHHHHHhh
Q 024959          249 DYVHQLRLIT  258 (260)
Q Consensus       249 ~~~~~~~~i~  258 (260)
                      +....+..+.
T Consensus       236 ~~~~~~~~~~  245 (316)
T cd05574         236 NRDETFSNIL  245 (316)
T ss_pred             chHHHHHHHh
Confidence            8777666543

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.4e-36  Score=248.41  Aligned_cols=202  Identities=27%  Similarity=0.432  Sum_probs=175.3

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~  122 (260)
                      .|++.+.||+|++|.||++.+..++..+++|.++... ......++.+|++++++++||||+++++.+..+     ..++
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~   75 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD-----GEIS   75 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-----CEEE
Confidence            4678899999999999999999999999999986542 233456788999999999999999999999876     5699


Q ss_pred             EEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEeccCCCEEEeecccccccCCCcc
Q 024959          123 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  200 (260)
Q Consensus       123 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~  200 (260)
                      ++|||++ ++|.+++.....+++..+..++.|++++|.|||+ .+++|+||+|+||+++.++.++|+|||++....... 
T Consensus        76 lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  154 (308)
T cd06615          76 ICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  154 (308)
T ss_pred             EEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence            9999998 5999999888889999999999999999999997 599999999999999999999999999886553322 


Q ss_pred             cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 024959          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  252 (260)
Q Consensus       201 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~  252 (260)
                      .....++..|++||.+.+ ..++.++|+||||+++++|++|..||...+...
T Consensus       155 ~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~  205 (308)
T cd06615         155 ANSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE  205 (308)
T ss_pred             cccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcchhh
Confidence            233456889999999876 668899999999999999999999998666443

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-36  Score=242.86  Aligned_cols=211  Identities=25%  Similarity=0.473  Sum_probs=177.5

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc---cchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCc
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF---DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      .|.+.+.||+|++|.||++.+..++..+++|.+....   ........+.+|++++++++||||+++++.+.....   .
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~---~   79 (264)
T cd06653           3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE---K   79 (264)
T ss_pred             ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCC---C
Confidence            4668899999999999999999999999999875432   123345678889999999999999999998866432   4


Q ss_pred             cEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          120 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       120 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      .+++++|+++ ++|.+.+.....+++..+..++.|++++|.+||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus        80 ~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  159 (264)
T cd06653          80 KLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI  159 (264)
T ss_pred             EEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence            5889999997 589999888788999999999999999999999999999999999999999999999999998765332


Q ss_pred             c----ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          199 D----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       199 ~----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      .    ......++..|+|||.+.+ ..++.++|+||||+++++|++|..||.+.+..+...++
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  221 (264)
T cd06653         160 CMSGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI  221 (264)
T ss_pred             cccCccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHH
Confidence            1    1123356788999999887 66789999999999999999999999877665554443

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.8e-36  Score=247.27  Aligned_cols=215  Identities=39%  Similarity=0.656  Sum_probs=177.2

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-CCCeeeeeceecCCCCCCCccE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      .|++.+.||+|++|.||++.+..+++.|++|.+............+.+|+.+++.+. ||||+++++++...........
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            466788999999999999999999999999998665433333456778999999995 6999999998876644333458


Q ss_pred             EEEEecCCcchHHHhhhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecc-CCCEEEeeccccccc
Q 024959          122 YIVYELMDTDLHQIIRSD-----QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTT  195 (260)
Q Consensus       122 ~lv~e~~~~~l~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~-~~~~~l~df~~~~~~  195 (260)
                      |++|||++++|.+++...     ..+++..++.++.|++++|.|||+++++|+||+|+||+++. ++.++|+|||++...
T Consensus        82 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~  161 (295)
T cd07837          82 YLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF  161 (295)
T ss_pred             EEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceec
Confidence            999999999888887642     45899999999999999999999999999999999999998 889999999998765


Q ss_pred             CCCc-ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          196 SETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       196 ~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      .... ......+++.|+|||.+.+...++.++|+||||+++|+|++|..||.+.+..+.+..+
T Consensus       162 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~  224 (295)
T cd07837         162 SIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHI  224 (295)
T ss_pred             CCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence            3321 1222345778999998876566789999999999999999999999887776655443

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.4e-36  Score=244.74  Aligned_cols=213  Identities=27%  Similarity=0.459  Sum_probs=181.1

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      |+.+...|.+.+.||.|++|.||++.+.. +..+++|.+...  .......+.+|+.+++.++||||+++++++...   
T Consensus         1 ~~~~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---   74 (261)
T cd05148           1 WERPREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVG---   74 (261)
T ss_pred             CcCcHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEecccc--chhhHHHHHHHHHHHhcCCCcchhheeeeEecC---
Confidence            45667788899999999999999999988 788999998654  233456788999999999999999999999877   


Q ss_pred             CCccEEEEEecCC-cchHHHhhh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                        ...+++||+++ ++|.+++.+  ...+++..++.++.|++++|.+||++|++|+||+|+||+++.++.++|+|||.+.
T Consensus        75 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~  152 (261)
T cd05148          75 --EPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLAR  152 (261)
T ss_pred             --CCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchh
Confidence              55899999998 599999876  3468999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCcccc-cccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          194 TTSETDFMT-EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       194 ~~~~~~~~~-~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      ......... ....+..|++||.+.. ..++.++|+||||+++++|++ |..||.+.+..+.++.+.
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~  218 (261)
T cd05148         153 LIKEDVYLSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT  218 (261)
T ss_pred             hcCCccccccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH
Confidence            654432211 2233567999999876 678899999999999999998 899999888777766654

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-36  Score=245.34  Aligned_cols=215  Identities=26%  Similarity=0.465  Sum_probs=179.4

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCCC-----CeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceec
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSET-----REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIR  111 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~-----~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~  111 (260)
                      |++..+.|.+.+.||+|++|.||++.++..     +..+++|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   79 (277)
T cd05032           1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence            567788889999999999999999987644     3789999986542 3334567789999999999999999999998


Q ss_pred             CCCCCCCccEEEEEecCC-cchHHHhhhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecc
Q 024959          112 PPKKDTFNDVYIVYELMD-TDLHQIIRSD----------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA  180 (260)
Q Consensus       112 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~  180 (260)
                      ..     ...+++||+++ ++|.+++...          ..+++..++.++.|++.+|.|||+.+++|+||+|+||+++.
T Consensus        80 ~~-----~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~  154 (277)
T cd05032          80 TG-----QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAE  154 (277)
T ss_pred             CC-----CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcC
Confidence            77     55899999997 6999888642          23678899999999999999999999999999999999999


Q ss_pred             CCCEEEeecccccccCCCcc---cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 024959          181 SCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRL  256 (260)
Q Consensus       181 ~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~  256 (260)
                      ++.++|+|||++........   .....++..|+|||.+.+ ..++.++|+||||+++|++++ |..||.+.+..+..+.
T Consensus       155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  233 (277)
T cd05032         155 DLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKF  233 (277)
T ss_pred             CCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHH
Confidence            99999999999876544321   112234678999999876 668899999999999999998 9999998887776665


Q ss_pred             hh
Q 024959          257 IT  258 (260)
Q Consensus       257 i~  258 (260)
                      +.
T Consensus       234 ~~  235 (277)
T cd05032         234 VI  235 (277)
T ss_pred             Hh
Confidence            53

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-39  Score=247.65  Aligned_cols=220  Identities=49%  Similarity=0.888  Sum_probs=200.6

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      ..+++.-++||-|+||+||.+.++.+|+.+++|++.+-..+-....++.+|+++|..++|.|++..+++.......-++.
T Consensus        52 q~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE  131 (449)
T KOG0664|consen   52 QQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE  131 (449)
T ss_pred             cccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence            34566789999999999999999999999999999887777778889999999999999999999999998877666678


Q ss_pred             EEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc-
Q 024959          121 VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (260)
Q Consensus       121 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~-  199 (260)
                      +|+++|.|..+|+.++-+-..++.+.+..+++||+++|.|||+.+|.||||||.|.+++.+-.+||+|||+++...... 
T Consensus       132 iYV~TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~  211 (449)
T KOG0664|consen  132 LYVLTELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR  211 (449)
T ss_pred             HHHHHHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhh
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999998765443 


Q ss_pred             -ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcC
Q 024959          200 -FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV  260 (260)
Q Consensus       200 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~~  260 (260)
                       .......+.+|.+||.+++.+.|+...||||.||++.|++..+..|...+.-++++.|.++
T Consensus       212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdL  273 (449)
T KOG0664|consen  212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDL  273 (449)
T ss_pred             hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHH
Confidence             2334466899999999999899999999999999999999999999999999999998753

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=8.6e-37  Score=245.97  Aligned_cols=206  Identities=29%  Similarity=0.483  Sum_probs=172.6

Q ss_pred             CcccccccCceEEEEEEeC----CCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           46 PIRPIGRGAYGIVCAAVNS----ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      +.+.||.|.||.||+|...    ..+..|+||.++.. ........+.+|++.+++++||||+++++++...     ...
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~-----~~~   76 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN-----EPL   76 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS-----SSE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeeccccccccccccccccccccccc-----ccc
Confidence            4678999999999999887    45677999999653 3444578899999999999999999999999955     448


Q ss_pred             EEEEecCC-cchHHHhhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          122 YIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      ++|+|+++ ++|.+++...  ..+++..+..|+.|++++|.|||+++++|+||+++||+++.++.+||+|||++......
T Consensus        77 ~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~  156 (259)
T PF07714_consen   77 FLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK  156 (259)
T ss_dssp             EEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999998 7999999886  78999999999999999999999999999999999999999999999999999876332


Q ss_pred             cc---cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          199 DF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       199 ~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      ..   .........|+|||.+.. ..++.++||||||+++||+++ |..||.+.+..+....+.
T Consensus       157 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~  219 (259)
T PF07714_consen  157 SKYKNDSSQQLPLRYLAPEVLKD-GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLK  219 (259)
T ss_dssp             SSEEESTTSESGGGGS-HHHHHH-SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHH
T ss_pred             ccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccc
Confidence            21   223345778999999877 568999999999999999999 789999988888777664

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6e-37  Score=257.71  Aligned_cols=191  Identities=28%  Similarity=0.398  Sum_probs=166.3

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      ...|++++.||+|++|.||++.+..++..|++|+....        ....|+.++++++||||+++++++...     ..
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~  131 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSG-----AI  131 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeC-----Ce
Confidence            34588999999999999999999999999999986432        234689999999999999999999876     55


Q ss_pred             EEEEEecCCcchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc
Q 024959          121 VYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (260)
Q Consensus       121 ~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~  199 (260)
                      .++|+|++.++|.+++.. ...+++..++.++.|++.+|.|||+++++|+||||+||+++.++.++|+|||++.......
T Consensus       132 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  211 (357)
T PHA03209        132 TCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP  211 (357)
T ss_pred             eEEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence            899999999999988865 4679999999999999999999999999999999999999999999999999987654444


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCC
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF  245 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf  245 (260)
                      ......++..|+|||.+.+ ..++.++|+||||+++|+|+++..|+
T Consensus       212 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        212 AFLGLAGTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ccccccccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            4445567899999999987 67899999999999999999855444

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-37  Score=275.10  Aligned_cols=213  Identities=27%  Similarity=0.470  Sum_probs=184.7

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCC-----eEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETR-----EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~  113 (260)
                      ++....+..+.||+|+||.||.+......     ..|++|.+.+. .......+|++|..+|+.++|||||++++++.+.
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~  767 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS  767 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence            55778888999999999999999875432     34999999775 4556788999999999999999999999999986


Q ss_pred             CCCCCccEEEEEecCC-cchHHHhhhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEE
Q 024959          114 KKDTFNDVYIVYELMD-TDLHQIIRSD-------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLK  185 (260)
Q Consensus       114 ~~~~~~~~~lv~e~~~-~~l~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~  185 (260)
                           ...+|++|||+ |+|+.++++.       ..+++..+..++.|+++++.||++++++||||...|+|++....+|
T Consensus       768 -----~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VK  842 (1025)
T KOG1095|consen  768 -----GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVK  842 (1025)
T ss_pred             -----CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEE
Confidence                 55899999998 7999999875       3589999999999999999999999999999999999999999999


Q ss_pred             EeecccccccCCCccccc---ccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          186 IGDFGLARTTSETDFMTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       186 l~df~~~~~~~~~~~~~~---~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      |+|||+++..........   ..-...|||||.+.. ..++.++||||||+++||+++ |..||.+.++++.+...+
T Consensus       843 IaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~  918 (1025)
T KOG1095|consen  843 IADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVL  918 (1025)
T ss_pred             EcccchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHH
Confidence            999999985443322211   123578999999998 889999999999999999999 999999999999887543

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.1e-36  Score=249.16  Aligned_cols=210  Identities=25%  Similarity=0.342  Sum_probs=170.8

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeE--EEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCCCC
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREE--VAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDT  117 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~--~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~  117 (260)
                      ...|.+.+.||+|+||.||++.++.++..  +++|.+... ........+.+|+.++.++ +||||+++++++...    
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~----   80 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR----   80 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC----
Confidence            44677889999999999999998877654  577776542 2334456778899999999 899999999999876    


Q ss_pred             CccEEEEEecCC-cchHHHhhhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecc
Q 024959          118 FNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA  180 (260)
Q Consensus       118 ~~~~~lv~e~~~-~~l~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~  180 (260)
                       ..++++|||++ ++|.+++...                ..+++..++.++.|++.++++||++|++|+||+|+||+++.
T Consensus        81 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~  159 (303)
T cd05088          81 -GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE  159 (303)
T ss_pred             -CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecC
Confidence             55899999997 6899888653                25789999999999999999999999999999999999999


Q ss_pred             CCCEEEeecccccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHh
Q 024959          181 SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLI  257 (260)
Q Consensus       181 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  257 (260)
                      ++.++|+|||++..............+..|+|||.... ..++.++|+||||+++++|++ |..||.+.+..+..+.+
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~  236 (303)
T cd05088         160 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL  236 (303)
T ss_pred             CCcEEeCccccCcccchhhhcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence            99999999999864322211111223567999998876 668899999999999999998 99999887776655544

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=5.3e-36  Score=245.00  Aligned_cols=212  Identities=27%  Similarity=0.450  Sum_probs=175.8

Q ss_pred             eccccCCCcccccccCceEEEEEEe-----CCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVN-----SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~  113 (260)
                      +....|.+.+.||+|++|.||++.+     ..++..+++|.+...  .......+.+|+.++++++||||+++++++...
T Consensus         2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (288)
T cd05093           2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG   79 (288)
T ss_pred             CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            3456678899999999999999985     335567999998653  234566788999999999999999999999776


Q ss_pred             CCCCCccEEEEEecCC-cchHHHhhhCC-------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec
Q 024959          114 KKDTFNDVYIVYELMD-TDLHQIIRSDQ-------------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN  179 (260)
Q Consensus       114 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~-------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~  179 (260)
                           ...++++|+++ ++|.+++....             .+++..++.++.|++.+|++||++|++|+||+|+||+++
T Consensus        80 -----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~  154 (288)
T cd05093          80 -----DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG  154 (288)
T ss_pred             -----CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc
Confidence                 55899999998 68988886533             489999999999999999999999999999999999999


Q ss_pred             cCCCEEEeecccccccCCCcc---cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 024959          180 ASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLR  255 (260)
Q Consensus       180 ~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~  255 (260)
                      .++.++|+|||++........   .....++..|+|||.+.+ ..++.++|+||||+++++|++ |..||...+..+...
T Consensus       155 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~  233 (288)
T cd05093         155 ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE  233 (288)
T ss_pred             cCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            999999999999876543221   112233567999999877 678899999999999999998 999998887766655


Q ss_pred             Hhh
Q 024959          256 LIT  258 (260)
Q Consensus       256 ~i~  258 (260)
                      .|.
T Consensus       234 ~i~  236 (288)
T cd05093         234 CIT  236 (288)
T ss_pred             HHH
Confidence            543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=7.1e-36  Score=239.52  Aligned_cols=203  Identities=25%  Similarity=0.419  Sum_probs=168.8

Q ss_pred             ccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEEEEec
Q 024959           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYEL  127 (260)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv~e~  127 (260)
                      +.||+|++|.||++.++.+++.+++|.+.... .......+.+|+++++.++||||+++++++...     ...++|||+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~   74 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-----QPIYIVMEL   74 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-----CCeEEEEee
Confidence            36899999999999999999999999886542 233456788999999999999999999999776     558999999


Q ss_pred             CC-cchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCcccc---
Q 024959          128 MD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT---  202 (260)
Q Consensus       128 ~~-~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~---  202 (260)
                      ++ ++|.+++... ..+++..++.++.|++++|.|||+++++|+||+|.||+++.++.++|+|||++..........   
T Consensus        75 ~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          75 VQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             ccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence            97 5888888654 468999999999999999999999999999999999999999999999999987644321111   


Q ss_pred             cccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHh
Q 024959          203 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLI  257 (260)
Q Consensus       203 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  257 (260)
                      ....+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+.......+
T Consensus       155 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~  209 (252)
T cd05084         155 MKQIPVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI  209 (252)
T ss_pred             CCCCceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHH
Confidence            1112356999999877 668899999999999999998 99999877765544443

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=6.5e-36  Score=241.68  Aligned_cols=210  Identities=24%  Similarity=0.446  Sum_probs=176.3

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc---chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCc
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD---NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      .|...+.||+|++|.||++.+..++..+++|.+.....   .......+.+|+.+++.++||||+++++.+.....   .
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---~   79 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAE---K   79 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCC---C
Confidence            46688999999999999999999999999998854322   22344567789999999999999999998875432   4


Q ss_pred             cEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          120 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       120 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      ..++++|+++ ++|.+++.....+++..++.++.|++.+|++||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus        80 ~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd06651          80 TLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  159 (266)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence            5889999998 589999988888999999999999999999999999999999999999999999999999998755332


Q ss_pred             c----ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 024959          199 D----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  256 (260)
Q Consensus       199 ~----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  256 (260)
                      .    ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~  220 (266)
T cd06651         160 CMSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK  220 (266)
T ss_pred             cccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHH
Confidence            1    1122346788999999877 6788999999999999999999999987765554443

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3.1e-36  Score=245.18  Aligned_cols=212  Identities=28%  Similarity=0.440  Sum_probs=176.9

Q ss_pred             ccccCCCcccccccCceEEEEEEeCC-----CCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           40 SSKYVPPIRPIGRGAYGIVCAAVNSE-----TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      ..+.|.+.+.||+|++|.||++.+..     ++..+++|.+..... ......+.+|+++++.++||||+++++++... 
T Consensus         3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-   80 (280)
T cd05049           3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEG-   80 (280)
T ss_pred             ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecC-
Confidence            35567789999999999999998753     357899999976432 33457888999999999999999999999877 


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhhC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRSD--------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN  179 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~~--------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~  179 (260)
                          ...+++||+++ ++|.+++...              ..+++..+..++.|++.++.+||+++++|+||+|+||+++
T Consensus        81 ----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~  156 (280)
T cd05049          81 ----DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG  156 (280)
T ss_pred             ----CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEc
Confidence                55899999998 6899888653              3478889999999999999999999999999999999999


Q ss_pred             cCCCEEEeecccccccCCCcc---cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 024959          180 ASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLR  255 (260)
Q Consensus       180 ~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~  255 (260)
                      .++.++|+|||++........   ......++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+.+..+...
T Consensus       157 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~  235 (280)
T cd05049         157 YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE  235 (280)
T ss_pred             CCCeEEECCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence            999999999999875433221   122234678999999877 678999999999999999998 999998888777666


Q ss_pred             Hhh
Q 024959          256 LIT  258 (260)
Q Consensus       256 ~i~  258 (260)
                      .+.
T Consensus       236 ~~~  238 (280)
T cd05049         236 CIT  238 (280)
T ss_pred             HHH
Confidence            553

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.8e-36  Score=250.87  Aligned_cols=196  Identities=40%  Similarity=0.705  Sum_probs=162.1

Q ss_pred             cccccccCceEEEEEEeCC--CCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEEE
Q 024959           47 IRPIGRGAYGIVCAAVNSE--TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV  124 (260)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv  124 (260)
                      ...||+|+||.||++.++.  ++..+++|.+....    ....+.+|+++++.++||||+++++++.....   ...+++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~~lv   78 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHSD---RKVWLL   78 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCC---CeEEEE
Confidence            4579999999999998654  56789999886532    12356789999999999999999999865432   568999


Q ss_pred             EecCCcchHHHhhh---------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEe----ccCCCEEEeeccc
Q 024959          125 YELMDTDLHQIIRS---------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGL  191 (260)
Q Consensus       125 ~e~~~~~l~~~l~~---------~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili----~~~~~~~l~df~~  191 (260)
                      +|+++++|.+.+..         ...+++..++.++.|++++|.+||+.+++|+||||+||++    +.++.++|+|||+
T Consensus        79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07867          79 FDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             EeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence            99999988887752         1258899999999999999999999999999999999999    4567899999999


Q ss_pred             ccccCCCc----ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 024959          192 ARTTSETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  249 (260)
Q Consensus       192 ~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  249 (260)
                      +.......    ......+++.|+|||.+.+...++.++|+||||+++|+|++|.+||...+
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence            97654332    12234568889999998775668899999999999999999999997554

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-38  Score=279.09  Aligned_cols=218  Identities=24%  Similarity=0.363  Sum_probs=191.2

Q ss_pred             EeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc-cchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        38 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      .+...+|++++.||+|+||.|.+++++.+++.||+|++.+-. -....-.-|.+|-.+|---+.+=|+.+.-.|.++   
T Consensus        71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~---  147 (1317)
T KOG0612|consen   71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE---  147 (1317)
T ss_pred             hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc---
Confidence            456788999999999999999999999999999999995521 1122334567788888877889999998888888   


Q ss_pred             CCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccccc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~  195 (260)
                        .++|+|||||+ |+|..++.+..++++.-++.++..|+-||..||+.|+|||||||+|||++..|+++|+|||-+-.+
T Consensus       148 --~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm  225 (1317)
T KOG0612|consen  148 --RYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKM  225 (1317)
T ss_pred             --cceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhc
Confidence              66999999998 699999999889999999999999999999999999999999999999999999999999988777


Q ss_pred             CCCc--ccccccccccccccccccCc----CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcC
Q 024959          196 SETD--FMTEYVVTRWYRAPELLLNC----TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV  260 (260)
Q Consensus       196 ~~~~--~~~~~~~~~~~~~PE~~~~~----~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~~  260 (260)
                      +.++  .....+|||.|++||++...    +.|.+..|.||+|+++|||+.|.-||...+.-++..+|+.+
T Consensus       226 ~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h  296 (1317)
T KOG0612|consen  226 DADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH  296 (1317)
T ss_pred             CCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch
Confidence            6544  44567899999999999632    56889999999999999999999999999999999999864

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.5e-36  Score=244.24  Aligned_cols=201  Identities=26%  Similarity=0.507  Sum_probs=176.9

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~  122 (260)
                      |++.+.||.|++|.||++.+..++..+++|.+..... .......+.+|++++++++||||+++++.+..+     ...+
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   76 (258)
T cd05578           2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDE-----ENMY   76 (258)
T ss_pred             ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCC-----CeEE
Confidence            5678899999999999999999999999999965422 223567788999999999999999999999776     5699


Q ss_pred             EEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCccc
Q 024959          123 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  201 (260)
Q Consensus       123 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  201 (260)
                      +|+|++. ++|.+.+.....+++..+..++.|++++|.+||+++++|+||+|.||+++.++.++|+|||.+.........
T Consensus        77 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  156 (258)
T cd05578          77 LVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT  156 (258)
T ss_pred             EEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccc
Confidence            9999997 589988887788999999999999999999999999999999999999999999999999998876555444


Q ss_pred             ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024959          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (260)
Q Consensus       202 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  250 (260)
                      ....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.
T Consensus       157 ~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~  204 (258)
T cd05578         157 TSTSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSR  204 (258)
T ss_pred             cccCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence            45566788999999877 6688999999999999999999999987774

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=5.5e-36  Score=244.11  Aligned_cols=210  Identities=27%  Similarity=0.452  Sum_probs=175.5

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      .++|++.+.||+|++|.||++.+..++..+++|.+...  .......+.+|+++++.++|||++++++.+...     ..
T Consensus         4 ~~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-----~~   76 (282)
T cd06643           4 EEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-----NN   76 (282)
T ss_pred             HHHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC-----CE
Confidence            34567889999999999999999999999999998653  334566788899999999999999999998776     56


Q ss_pred             EEEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          121 VYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      .++|+||++ ++|...+.. ..++++..+..++.|++++|.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        77 ~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  156 (282)
T cd06643          77 LWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  156 (282)
T ss_pred             EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc
Confidence            899999998 477666654 567999999999999999999999999999999999999999999999999988654332


Q ss_pred             -cccccccccccccccccccC----cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          199 -DFMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       199 -~~~~~~~~~~~~~~PE~~~~----~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                       .......++..|+|||.+..    ...++.++|+||||+++|+|++|..||...+..+....+
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~  220 (282)
T cd06643         157 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKI  220 (282)
T ss_pred             ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHH
Confidence             12233456888999999742    245678999999999999999999999887765554443

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=4.5e-36  Score=242.17  Aligned_cols=210  Identities=25%  Similarity=0.443  Sum_probs=174.9

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      |++....|++.+.||+|++|.||++.+..+ ..+++|.+.....   ....+.+|+++++.++||||+++++.+..    
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~----   72 (262)
T cd05071           1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE----   72 (262)
T ss_pred             CCCChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEECC----
Confidence            456677889999999999999999988766 4599999975322   23467889999999999999999998744    


Q ss_pred             CCccEEEEEecCC-cchHHHhhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                        ...+++||+++ ++|.+++...  ..+++..+..++.|++++|++||+.+++|+||+|.||+++.++.++|+|||.+.
T Consensus        73 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~  150 (262)
T cd05071          73 --EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR  150 (262)
T ss_pred             --CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCcee
Confidence              33689999998 5999998763  458899999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCccc--ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHh
Q 024959          194 TTSETDFM--TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLI  257 (260)
Q Consensus       194 ~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  257 (260)
                      ........  ....++..|++||...+ ..++.++|+||||+++|+|++ |..||.+.+..+....+
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~  216 (262)
T cd05071         151 LIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV  216 (262)
T ss_pred             eccccccccccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH
Confidence            65443321  12234567999998876 678999999999999999999 88999888776665554

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.8e-36  Score=248.11  Aligned_cols=220  Identities=41%  Similarity=0.700  Sum_probs=182.0

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC----
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK----  114 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~----  114 (260)
                      ...+.|++.+.||.|++|.||++.++.+++.|++|.++...........+.+|+++++.++|||++++++++....    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            3456778899999999999999999999999999999654333334456678999999999999999999987653    


Q ss_pred             -CCCCccEEEEEecCCcchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccc
Q 024959          115 -KDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (260)
Q Consensus       115 -~~~~~~~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~  192 (260)
                       ......+++++|++++++...+... ..+++..++.++.|++.+|++||+.+++|+||+|+||+++.++.++|+|||++
T Consensus        84 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~  163 (302)
T cd07864          84 FKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA  163 (302)
T ss_pred             ccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccc
Confidence             1111368999999999888877754 46899999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCc--ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          193 RTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       193 ~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      .......  .......+..|++||.+.+....+.++|+||||+++++|++|+.||...+..+.++.+.
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~  231 (302)
T cd07864         164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELIS  231 (302)
T ss_pred             ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            7654432  11223446779999988764567889999999999999999999999888777666554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-36  Score=244.56  Aligned_cols=209  Identities=49%  Similarity=0.834  Sum_probs=181.4

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~l  123 (260)
                      |.+.+.||.|++|.||++.++.+++.+++|.+............+.+|++++++++||||+++++++..+     ...++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~   75 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK-----GDLYL   75 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC-----CCEEE
Confidence            4567899999999999999999999999999876544444566788899999999999999999999877     56899


Q ss_pred             EEecCCcchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc-cc
Q 024959          124 VYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FM  201 (260)
Q Consensus       124 v~e~~~~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~-~~  201 (260)
                      ++|++++++.+.+.. ...+++..++.++.|++++|.+||+.+++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus        76 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~  155 (283)
T cd05118          76 VFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY  155 (283)
T ss_pred             EEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccc
Confidence            999999999888876 4689999999999999999999999999999999999999999999999999987665543 22


Q ss_pred             ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       202 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      ....++..|++||.+.+...++.++|+||||+++|+|++|+.||.+.+..+++..+
T Consensus       156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~  211 (283)
T cd05118         156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI  211 (283)
T ss_pred             cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            23456778999999887457899999999999999999999999988887766554

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=5e-36  Score=246.19  Aligned_cols=209  Identities=25%  Similarity=0.352  Sum_probs=171.1

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCe--EEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCCCCC
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETRE--EVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTF  118 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~--~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~~  118 (260)
                      +.|.+.+.||+|++|.||++..+.++.  .+++|.++.. ......+.+.+|++++.++ +||||+++++.+...     
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-----   75 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENR-----   75 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC-----
Confidence            356788999999999999999877664  4688887642 2333456788899999999 699999999998776     


Q ss_pred             ccEEEEEecCC-cchHHHhhhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccC
Q 024959          119 NDVYIVYELMD-TDLHQIIRSDQ----------------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS  181 (260)
Q Consensus       119 ~~~~lv~e~~~-~~l~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~  181 (260)
                      ..+++++|+++ ++|.+++....                .+++..++.++.|++.+|++||++|++|+||+|+||+++.+
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~  155 (297)
T cd05089          76 GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN  155 (297)
T ss_pred             CcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCC
Confidence            55899999997 69998886532                48889999999999999999999999999999999999999


Q ss_pred             CCEEEeecccccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHh
Q 024959          182 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLI  257 (260)
Q Consensus       182 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  257 (260)
                      +.++|+|||++..............+..|++||.... ..++.++||||||+++|+|++ |..||.+.+..+.++.+
T Consensus       156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~  231 (297)
T cd05089         156 LASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL  231 (297)
T ss_pred             CeEEECCcCCCccccceeccCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            9999999999864332211111222456999999876 678899999999999999997 99999988877666554

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=8.1e-36  Score=244.35  Aligned_cols=209  Identities=29%  Similarity=0.427  Sum_probs=175.1

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~  118 (260)
                      ...+.|++++.||+|++|.||++.+..++..+++|.+...  .......+.+|+++++.++|||++++++.+...     
T Consensus         9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----   81 (292)
T cd06644           9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWD-----   81 (292)
T ss_pred             CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC-----
Confidence            3456788999999999999999999999999999999653  344567788999999999999999999998766     


Q ss_pred             ccEEEEEecCCc-chHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccC
Q 024959          119 NDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (260)
Q Consensus       119 ~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~  196 (260)
                      ...++|||++++ +|..++.+ ...+++..++.++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||++....
T Consensus        82 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  161 (292)
T cd06644          82 GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNV  161 (292)
T ss_pred             CeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecc
Confidence            568999999985 66666554 5678999999999999999999999999999999999999999999999999876543


Q ss_pred             CCc-ccccccccccccccccccC----cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024959          197 ETD-FMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  254 (260)
Q Consensus       197 ~~~-~~~~~~~~~~~~~PE~~~~----~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  254 (260)
                      ... ......++..|+|||.+..    ...++.++|+||||+++|+|++|..||...+.....
T Consensus       162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~  224 (292)
T cd06644         162 KTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL  224 (292)
T ss_pred             ccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHH
Confidence            321 2233456788999999852    245678999999999999999999999876654433

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.1e-36  Score=241.82  Aligned_cols=207  Identities=26%  Similarity=0.464  Sum_probs=174.7

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccch-------HHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI-------IDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      |.+.+.||+|++|.||++.+..++..+++|.+.......       .....+.+|+.+++.++||||+++++.+...   
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---   78 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA---   78 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC---
Confidence            457789999999999999999999999999886543221       1235677899999999999999999998876   


Q ss_pred             CCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccccc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~  195 (260)
                        ...++++|+++ ++|.+++.....+++..+..++.|++.+|++||+.+++|+||+|+||+++.++.++|+|||.+...
T Consensus        79 --~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          79 --DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             --CccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence              55899999997 589999988888999999999999999999999999999999999999999999999999988765


Q ss_pred             CCCc-------ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 024959          196 SETD-------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  256 (260)
Q Consensus       196 ~~~~-------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  256 (260)
                      ....       ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+.......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~  223 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK  223 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHH
Confidence            4221       1112345778999999877 6778899999999999999999999987766554443

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=6.5e-36  Score=240.52  Aligned_cols=204  Identities=28%  Similarity=0.484  Sum_probs=176.7

Q ss_pred             ccccccCceEEEEEEeCCC---CeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEEE
Q 024959           48 RPIGRGAYGIVCAAVNSET---REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV  124 (260)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv  124 (260)
                      +.||+|++|.||++.+...   +..+++|.+....... ....+.+|++.++.++|+|++++++++...     ..++++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~lv   74 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEE-----EPLYLV   74 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCC-----CceEEE
Confidence            4689999999999999866   8899999997754433 467788999999999999999999999875     569999


Q ss_pred             EecCC-cchHHHhhhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          125 YELMD-TDLHQIIRSD---------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       125 ~e~~~-~~l~~~l~~~---------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                      ||+++ ++|.+++...         ..+++..++.++.|++++|++||+++++|+||+|+||+++.++.++|+|||.+..
T Consensus        75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~  154 (262)
T cd00192          75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRD  154 (262)
T ss_pred             EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccc
Confidence            99995 7999998875         7899999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCc---ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          195 TSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       195 ~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      .....   ......++..|+|||.+.. ..++.++|+||||+++++|++ |..||...+..+..+.+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~  221 (262)
T cd00192         155 VYDDDYYRKKTGGKLPIRWMAPESLKD-GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR  221 (262)
T ss_pred             cccccccccccCCCcCccccCHHHhcc-CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            65542   2223345778999999887 578899999999999999999 699999888777666654

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-36  Score=244.64  Aligned_cols=209  Identities=29%  Similarity=0.434  Sum_probs=176.6

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      .+.|++.+.||.|++|.||++.+..++..+++|.+...  .......+.+|+++++.++||||+++++.+..+     ..
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~   76 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYE-----NK   76 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC-----Ce
Confidence            34578899999999999999999989999999998643  344557788999999999999999999999876     56


Q ss_pred             EEEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          121 VYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      .++|||+++ ++|.+++.. ...+++..++.++.|++.+|.+||+++++|+||+|+||+++.++.++|+|||++......
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~  156 (280)
T cd06611          77 LWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST  156 (280)
T ss_pred             EEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence            899999998 488888776 457999999999999999999999999999999999999999999999999987654332


Q ss_pred             c-ccccccccccccccccccC----cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 024959          199 D-FMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  256 (260)
Q Consensus       199 ~-~~~~~~~~~~~~~PE~~~~----~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  256 (260)
                      . ......++..|++||.+..    ...++.++|+||||+++|+|++|..||.+.+....+..
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~  219 (280)
T cd06611         157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLK  219 (280)
T ss_pred             ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHH
Confidence            2 2233456888999998752    24567899999999999999999999988776554433

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.8e-36  Score=251.20  Aligned_cols=217  Identities=55%  Similarity=1.026  Sum_probs=180.7

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC-
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-  115 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~-  115 (260)
                      |++. +.|.+.+.||+|++|.||++.+..+++.|++|++............+.+|+.++++++||||+++++++..... 
T Consensus        13 ~~~~-~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~   91 (345)
T cd07877          13 WEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL   91 (345)
T ss_pred             hhcc-CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccc
Confidence            4454 44668899999999999999999999999999997654444445677889999999999999999998865432 


Q ss_pred             CCCccEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccccc
Q 024959          116 DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (260)
Q Consensus       116 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~  195 (260)
                      ......++++++++++|.+++.. ..+++..++.++.|++++|.+||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus        92 ~~~~~~~lv~~~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~  170 (345)
T cd07877          92 EEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT  170 (345)
T ss_pred             cccccEEEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence            12245789999998888877654 46999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          196 SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       196 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      ...  .....++..|+|||.+.+...++.++|+||||+++++|++|..||...+....++.+
T Consensus       171 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~  230 (345)
T cd07877         171 DDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI  230 (345)
T ss_pred             ccc--ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            432  233456788999999876556788999999999999999999999888776665554

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=4.9e-36  Score=247.38  Aligned_cols=217  Identities=28%  Similarity=0.481  Sum_probs=179.0

Q ss_pred             cceeEeccccCCCcccccccCceEEEEEEeCC-------CCeEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeee
Q 024959           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSE-------TREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIA  105 (260)
Q Consensus        34 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~  105 (260)
                      ...|++....|.+.+.||+|+||.||++.+..       +...+++|.+.... .......+.+|+++++.+ +||||++
T Consensus        10 ~~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~   88 (307)
T cd05098          10 DPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIIN   88 (307)
T ss_pred             CCcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEee
Confidence            45678888889999999999999999998643       23469999997542 334456788899999999 7999999


Q ss_pred             eeceecCCCCCCCccEEEEEecCC-cchHHHhhhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 024959          106 IKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKYVHSASVLH  168 (260)
Q Consensus       106 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H  168 (260)
                      +++.+...     ...++|||+++ ++|.+++...                ..+++.++..++.|++.+|++||++|++|
T Consensus        89 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H  163 (307)
T cd05098          89 LLGACTQD-----GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIH  163 (307)
T ss_pred             EEEEEecC-----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            99999876     45899999998 6999998753                24788999999999999999999999999


Q ss_pred             ccCCCCCeEeccCCCEEEeecccccccCCCcccc---cccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCC
Q 024959          169 RDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT---EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPL  244 (260)
Q Consensus       169 ~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~---~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p  244 (260)
                      +||+|+||+++.++.++|+|||++..........   ....+..|+|||.+.+ ..++.++|+||||+++|+|++ |..|
T Consensus       164 ~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p  242 (307)
T cd05098         164 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSP  242 (307)
T ss_pred             ccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCC
Confidence            9999999999999999999999987654322111   1122467999999877 678899999999999999998 8999


Q ss_pred             CCCCChHHHHHHh
Q 024959          245 FPGKDYVHQLRLI  257 (260)
Q Consensus       245 f~~~~~~~~~~~i  257 (260)
                      |.+.+..+..+.+
T Consensus       243 ~~~~~~~~~~~~~  255 (307)
T cd05098         243 YPGVPVEELFKLL  255 (307)
T ss_pred             CCcCCHHHHHHHH
Confidence            9887776655544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1e-35  Score=241.11  Aligned_cols=213  Identities=23%  Similarity=0.401  Sum_probs=173.7

Q ss_pred             CCcccccccCceEEEEEEeCCCCe--EEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC-CCCccE
Q 024959           45 PPIRPIGRGAYGIVCAAVNSETRE--EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDV  121 (260)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~--~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~-~~~~~~  121 (260)
                      .+.+.||+|++|.||++.+..++.  .+++|.++...........+.+|+++++.++||||+++++.+..... ......
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            467889999999999999877765  58999987765555667788899999999999999999998754322 222457


Q ss_pred             EEEEecCC-cchHHHhhh------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          122 YIVYELMD-TDLHQIIRS------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~------~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                      ++++||++ ++|.+++..      ...+++..+..++.|++++|.|||+++++|+||+|+||+++.++.++|+|||++..
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  161 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKK  161 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccc
Confidence            89999998 688877642      23488999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCccc---ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          195 TSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       195 ~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      .......   .....+..|++||...+ ..++.++|+||||+++|+|++ |..||.+.+..+..+.+.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  228 (272)
T cd05075         162 IYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR  228 (272)
T ss_pred             cCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            5433211   12234567999999887 678999999999999999999 899998877766555543

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=8e-36  Score=241.15  Aligned_cols=212  Identities=25%  Similarity=0.445  Sum_probs=176.6

Q ss_pred             ccccCCCcccccccCceEEEEEEeCCC---CeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           40 SSKYVPPIRPIGRGAYGIVCAAVNSET---REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      ..+.|++.+.||+|+||.||++.+..+   ...+++|.++... .......+.+|+..++.++||||+++++.+...   
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---   77 (266)
T cd05033           2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS---   77 (266)
T ss_pred             ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC---
Confidence            345678899999999999999988654   4579999987543 333456788999999999999999999998776   


Q ss_pred             CCccEEEEEecCC-cchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                        ...+++||+++ ++|.+++... ..+++..++.++.|++.++++||+++++|+||+|+||+++.++.++|+|||++..
T Consensus        78 --~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~  155 (266)
T cd05033          78 --RPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRR  155 (266)
T ss_pred             --CceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhc
Confidence              55899999997 5899988763 4789999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCc-ccc--cccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          195 TSETD-FMT--EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       195 ~~~~~-~~~--~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      ..... ...  ....+..|++||.+.+ ..++.++|+||||+++|+|++ |..||......+..+.+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~  222 (266)
T cd05033         156 LEDSEATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE  222 (266)
T ss_pred             ccccccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Confidence            65221 111  1223567999999877 678899999999999999998 999998877776666554

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=5.8e-36  Score=240.37  Aligned_cols=208  Identities=30%  Similarity=0.441  Sum_probs=179.3

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~l  123 (260)
                      |++.+.||+|++|.||++.+..+++.+++|.+............+.+|+++++.++|||++++++.+...     ...++
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~l   76 (256)
T cd08220           2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED-----KALMI   76 (256)
T ss_pred             ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC-----CEEEE
Confidence            5678999999999999999999999999999866544445567888999999999999999999988765     56899


Q ss_pred             EEecCC-cchHHHhhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCC-CEEEeecccccccCCCc
Q 024959          124 VYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETD  199 (260)
Q Consensus       124 v~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~-~~~l~df~~~~~~~~~~  199 (260)
                      |+|+++ ++|.+++...  ..+++..+..++.++++++++||+++++|+||+|.||+++.++ .++|+|||++.......
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          77 VMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            999997 5899988763  4589999999999999999999999999999999999998654 57999999998766554


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      ......++..|+|||.+.. ..++.++|+||||+++|+|++|..||.+.+.......+
T Consensus       157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~  213 (256)
T cd08220         157 KAYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKI  213 (256)
T ss_pred             cccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHH
Confidence            4444567888999999877 66788999999999999999999999988776655554

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=4.7e-36  Score=244.49  Aligned_cols=199  Identities=28%  Similarity=0.448  Sum_probs=165.4

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHH-HHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIK-LLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      .|++.+.||+|+||.||++.++.+++.||+|.+......... .++..|+. .++.++|||++++++.+...     ...
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~-----~~~   75 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFRE-----GDV   75 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEecC-----CcE
Confidence            467789999999999999999999999999998765433333 34444555 46667899999999999876     558


Q ss_pred             EEEEecCCcchHHHhhh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEeccCCCEEEeecccccccC
Q 024959          122 YIVYELMDTDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (260)
Q Consensus       122 ~lv~e~~~~~l~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~H~di~~~nili~~~~~~~l~df~~~~~~~  196 (260)
                      +++||+++++|.+.+..    +..+++..++.++.|++.+|++||++ +++|+||+|+||+++.++.++|+|||++....
T Consensus        76 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          76 WICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV  155 (283)
T ss_pred             EEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            99999999988777654    35689999999999999999999997 99999999999999999999999999987665


Q ss_pred             CCcccccccccccccccccccCc---CCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 024959          197 ETDFMTEYVVTRWYRAPELLLNC---TEYTAAIDIWSVGCILGEIMTREPLFPG  247 (260)
Q Consensus       197 ~~~~~~~~~~~~~~~~PE~~~~~---~~~~~~~Di~slG~~l~~ll~g~~pf~~  247 (260)
                      .........++..|+|||.+.+.   ..++.++|+||||+++|+|++|..||..
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  209 (283)
T cd06617         156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS  209 (283)
T ss_pred             cccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence            44333334567889999988542   3467899999999999999999999975

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.4e-36  Score=240.93  Aligned_cols=212  Identities=25%  Similarity=0.435  Sum_probs=179.6

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      |++..+.|++.+.||+|++|.||++.+.. +..+++|.+.....   ...++.+|+++++.++||||+++++.+...   
T Consensus         1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---   73 (261)
T cd05034           1 WEIPRESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTM---SPEAFLQEAQIMKKLRHDKLVQLYAVCSEE---   73 (261)
T ss_pred             CccchhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCcc---CHHHHHHHHHHHhhCCCCCEeeeeeeeecC---
Confidence            67788899999999999999999999764 46799999865422   345688999999999999999999998765   


Q ss_pred             CCccEEEEEecCC-cchHHHhhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                        ...+++||+++ ++|.+++...  ..+++..+..++.|++.++.+||+++++|+||+|+||+++.++.++|+|||++.
T Consensus        74 --~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~  151 (261)
T cd05034          74 --EPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLAR  151 (261)
T ss_pred             --CceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccce
Confidence              45899999997 5899988764  468999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCccc--ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          194 TTSETDFM--TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       194 ~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      ........  .....+..|+|||.+.+ ..++.++|+||||++++++++ |+.||.+.+....++.+.
T Consensus       152 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~  218 (261)
T cd05034         152 LIEDDEYTAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE  218 (261)
T ss_pred             eccchhhhhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            66532211  11223467999999886 678899999999999999998 999999888877776654

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-36  Score=242.93  Aligned_cols=204  Identities=25%  Similarity=0.442  Sum_probs=175.8

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~  122 (260)
                      .|++.+.||.|++|.||++.+..+++.+++|.+.... .......+.+|+++++.++|||++++++.+...     ...+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   75 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG-----SKLW   75 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC-----CeEE
Confidence            4668899999999999999999999999999986542 233456678899999999999999999998776     5589


Q ss_pred             EEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC-cc
Q 024959          123 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DF  200 (260)
Q Consensus       123 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~-~~  200 (260)
                      +|+|+++ ++|.+++... ++++..++.++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||++...... ..
T Consensus        76 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  154 (274)
T cd06609          76 IIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK  154 (274)
T ss_pred             EEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccc
Confidence            9999998 5888887765 8899999999999999999999999999999999999999999999999998776544 22


Q ss_pred             cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024959          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  254 (260)
Q Consensus       201 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  254 (260)
                      .....++..|++||.+.+ ..++.++|+||||+++|+|++|..||...+.....
T Consensus       155 ~~~~~~~~~y~~PE~~~~-~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~  207 (274)
T cd06609         155 RNTFVGTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL  207 (274)
T ss_pred             cccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHH
Confidence            233456778999999987 56899999999999999999999999876654443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=6.6e-36  Score=248.68  Aligned_cols=202  Identities=21%  Similarity=0.292  Sum_probs=167.7

Q ss_pred             Cccccccc--CceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEE
Q 024959           46 PIRPIGRG--AYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (260)
Q Consensus        46 ~~~~lg~G--~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~l  123 (260)
                      +++.||+|  ++++||++.++.+++.||+|.+............+.+|+++++.++||||+++++++..+     ...++
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~~l   76 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-----NELWV   76 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-----CEEEE
Confidence            56789999  678999999999999999999976544444556677899999999999999999999877     56899


Q ss_pred             EEecCC-cchHHHhhh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc-
Q 024959          124 VYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (260)
Q Consensus       124 v~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~-  199 (260)
                      ||||++ ++|.+++..  ...+++..++.++.|++.+|+|||+++++|+||+|+||+++.++.+++.||+......... 
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          77 VTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             EEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            999998 688888865  3458999999999999999999999999999999999999999999999998643322111 


Q ss_pred             -------ccccccccccccccccccCc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 024959          200 -------FMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  252 (260)
Q Consensus       200 -------~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~  252 (260)
                             ......++..|+|||.+.+. ..++.++|+||||+++|+|++|..||......+
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~  217 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ  217 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH
Confidence                   11122346679999998753 457899999999999999999999998765543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-39  Score=248.75  Aligned_cols=200  Identities=27%  Similarity=0.468  Sum_probs=178.0

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      .+-+.+++.||.|+||.||++.|+.+|+.+|||.+..    ..+.+.+.+|+.++++++.|++|++|+.+..+     ..
T Consensus        32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~-----sD  102 (502)
T KOG0574|consen   32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKH-----SD  102 (502)
T ss_pred             HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhccC-----Cc
Confidence            3445678999999999999999999999999999965    34678899999999999999999999988776     56


Q ss_pred             EEEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          121 VYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      +|||||||+ |+..++++. ++++++.++..++++.+++|+|||...-+|||||..|||++.+|..||.|||.+-...+.
T Consensus       103 LWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT  182 (502)
T KOG0574|consen  103 LWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT  182 (502)
T ss_pred             eEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhh
Confidence            999999999 899999886 678999999999999999999999999999999999999999999999999988654433


Q ss_pred             -cccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024959          199 -DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (260)
Q Consensus       199 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  250 (260)
                       ....+..|+++|+|||.+.. -.|+..+||||||++..||.-|++||.+-..
T Consensus       183 MAKRNTVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHP  234 (502)
T KOG0574|consen  183 MAKRNTVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHP  234 (502)
T ss_pred             HHhhCccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCcccccc
Confidence             33456788999999999977 6789999999999999999999999976543

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=7.5e-36  Score=239.99  Aligned_cols=208  Identities=23%  Similarity=0.431  Sum_probs=174.1

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      ...+++.+.||+|+||.||++..+. +..+++|.+.....   ...++.+|++++++++||||+++++++...     ..
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~   73 (256)
T cd05114           3 PSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAM---SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ-----KP   73 (256)
T ss_pred             HHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCc---cHHHHHHHHHHHHHCCCCCceeEEEEEccC-----CC
Confidence            3456778999999999999998754 46799998864322   245678899999999999999999999776     55


Q ss_pred             EEEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          121 VYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      .+++|||++ ++|.+++.. ...+++..++.++.|++++|++||+++++|+||+|+||+++.++.++|+|||++......
T Consensus        74 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~  153 (256)
T cd05114          74 LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD  153 (256)
T ss_pred             EEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence            899999997 689888865 356899999999999999999999999999999999999999999999999988765432


Q ss_pred             cccc--cccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          199 DFMT--EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       199 ~~~~--~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      ....  ...++..|+|||.+.. ..++.++|+||||+++|+|++ |+.||...+..+....|.
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~  215 (256)
T cd05114         154 EYTSSSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS  215 (256)
T ss_pred             ceeccCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            2211  1233567999999876 678899999999999999999 999999888877776664

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-35  Score=240.93  Aligned_cols=214  Identities=21%  Similarity=0.376  Sum_probs=174.6

Q ss_pred             CCCcccccccCceEEEEEEeCCC---CeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC-CCCc
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSET---REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFN  119 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~-~~~~  119 (260)
                      |.+.+.||+|+||.||.+....+   +..+++|.++...........+.+|++.++.++||||+++++.+..... ....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            35788999999999999987653   4789999997654455566778899999999999999999998876543 2224


Q ss_pred             cEEEEEecCC-cchHHHhhh------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccc
Q 024959          120 DVYIVYELMD-TDLHQIIRS------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (260)
Q Consensus       120 ~~~lv~e~~~-~~l~~~l~~------~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~  192 (260)
                      ..++++||++ ++|...+..      ...+++..++.++.|++.+|.|||+.+++|+||+|+||++++++.++|+|||++
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  160 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS  160 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence            5799999998 688877743      236899999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCccc---ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          193 RTTSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       193 ~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      .........   .....+..|++||.+.. ..++.++|+||||+++|+|++ |..||.+.+..+..+.+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~  229 (273)
T cd05035         161 KKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR  229 (273)
T ss_pred             eeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            765433211   11223567999999866 778899999999999999999 999998887766665543

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=6e-36  Score=249.45  Aligned_cols=214  Identities=61%  Similarity=0.983  Sum_probs=178.8

Q ss_pred             CCCcccccccCceEEEEEEeCCC--CeEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCCCCCcc
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSET--REEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~--~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      |.+.+.||+|++|.||++.+..+  +..+++|.+............+.+|+.+++++ +||||+++++...... .....
T Consensus         2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~~   80 (332)
T cd07857           2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFNE   80 (332)
T ss_pred             ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCCc
Confidence            55788999999999999999888  88999999875444444456778899999999 4999999998754321 12245


Q ss_pred             EEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCcc
Q 024959          121 VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  200 (260)
Q Consensus       121 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~  200 (260)
                      .++++|+++++|.+.+.....+++..++.++.|++.+|++||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~  160 (332)
T cd07857          81 LYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPG  160 (332)
T ss_pred             EEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccc
Confidence            88999999999999998888999999999999999999999999999999999999999999999999999876543211


Q ss_pred             -----cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          201 -----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       201 -----~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                           .....++..|+|||...+...++.++|+||||+++|+|++|..||.+.+....+..+.
T Consensus       161 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~  223 (332)
T cd07857         161 ENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQIL  223 (332)
T ss_pred             cccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHH
Confidence                 1233568889999988765678899999999999999999999999888766655443

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=240.93  Aligned_cols=203  Identities=29%  Similarity=0.477  Sum_probs=176.1

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-CCCeeeeeceecCCCCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDT  117 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~  117 (260)
                      +-.+|-.-.+.||-|-.|.|-.+.++.+++++|+|++..       ..+..+|++..-... |||||.++++|+- ...+
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-------s~KARrEVeLHw~~s~h~~iV~IidVyeN-s~~~  130 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-------SPKARREVELHWMASGHPHIVSIIDVYEN-SYQG  130 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-------CHHHHhHhhhhhhhcCCCceEEeehhhhh-hccC
Confidence            333444445789999999999999999999999999953       245678888777764 9999999999863 3334


Q ss_pred             CccEEEEEecCC-cchHHHhhhCCC--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccC---CCEEEeeccc
Q 024959          118 FNDVYIVYELMD-TDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGL  191 (260)
Q Consensus       118 ~~~~~lv~e~~~-~~l~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~---~~~~l~df~~  191 (260)
                      ...+.+|||.|+ |.|.+.++.++.  |++.++..|++||..|+.|||+.+|.||||||+|+|...+   -.+||+|||+
T Consensus       131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccc
Confidence            467889999998 699999988654  9999999999999999999999999999999999999654   4589999999


Q ss_pred             ccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024959          192 ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (260)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  250 (260)
                      ++.........+.+.|++|.|||.+.. ..++...|+||+|+++|-||+|++||-.+..
T Consensus       211 AK~t~~~~~L~TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS~hg  268 (400)
T KOG0604|consen  211 AKETQEPGDLMTPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHG  268 (400)
T ss_pred             ccccCCCccccCCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccccCC
Confidence            999998888899999999999999877 7799999999999999999999999976654

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-36  Score=243.37  Aligned_cols=214  Identities=40%  Similarity=0.661  Sum_probs=178.9

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHc---CCCCeeeeeceecCCCCCCCcc
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM---EHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      |++.+.||+|++|.||++.++.+++.+++|.+............+.+|+.+++++   +|||++++++.+..........
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            4567889999999999999998899999999975443333344555677777666   5999999999998775433345


Q ss_pred             EEEEEecCCcchHHHhhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          121 VYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       121 ~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      ++++||+++++|.+++...  ..+++..++.++.|++++|.+||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~  160 (287)
T cd07838          81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE  160 (287)
T ss_pred             eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence            8999999999998888764  35899999999999999999999999999999999999999999999999998776554


Q ss_pred             cccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          199 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       199 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      .......++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||.+.+..+.+..|.
T Consensus       161 ~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~  219 (287)
T cd07838         161 MALTSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIF  219 (287)
T ss_pred             cccccccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHH
Confidence            43334456788999999987 678899999999999999999999999888777666553

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=4e-36  Score=246.20  Aligned_cols=218  Identities=28%  Similarity=0.513  Sum_probs=181.4

Q ss_pred             cceeEeccccCCCcccccccCceEEEEEEeCCC-----CeEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeeee
Q 024959           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSET-----REEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIK  107 (260)
Q Consensus        34 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~-----~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~  107 (260)
                      ...|++....|.+.+.||+|++|.||++.+...     ...+++|.+.... .......+.+|+.+++++ +||||++++
T Consensus         4 ~~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~   82 (293)
T cd05053           4 DPEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLL   82 (293)
T ss_pred             CcccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence            456888888999999999999999999987643     3689999987643 233456688999999999 799999999


Q ss_pred             ceecCCCCCCCccEEEEEecCC-cchHHHhhh----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecc
Q 024959          108 DIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS----------------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRD  170 (260)
Q Consensus       108 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~----------------~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~d  170 (260)
                      +++...     ..++++|||++ ++|.+++..                ...+++..++.++.|++.+|.|||+.+++|+|
T Consensus        83 ~~~~~~-----~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~d  157 (293)
T cd05053          83 GVCTQE-----GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRD  157 (293)
T ss_pred             EEEcCC-----CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccc
Confidence            999776     55899999997 688888853                34688999999999999999999999999999


Q ss_pred             CCCCCeEeccCCCEEEeecccccccCCCccc---ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCC
Q 024959          171 LKPSNLLLNASCDLKIGDFGLARTTSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFP  246 (260)
Q Consensus       171 i~~~nili~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~  246 (260)
                      |+|.||+++.++.++|+|||++.........   .....+..|+|||.+.+ ..++.++|+||||+++|++++ |..||.
T Consensus       158 lkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~  236 (293)
T cd05053         158 LAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYP  236 (293)
T ss_pred             cceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCC
Confidence            9999999999999999999998765443211   11223467999999876 678899999999999999998 999999


Q ss_pred             CCChHHHHHHhh
Q 024959          247 GKDYVHQLRLIT  258 (260)
Q Consensus       247 ~~~~~~~~~~i~  258 (260)
                      +.+..+..+.+.
T Consensus       237 ~~~~~~~~~~~~  248 (293)
T cd05053         237 GIPVEELFKLLK  248 (293)
T ss_pred             CCCHHHHHHHHH
Confidence            888777666543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=9.3e-36  Score=246.45  Aligned_cols=217  Identities=27%  Similarity=0.491  Sum_probs=179.2

Q ss_pred             cceeEeccccCCCcccccccCceEEEEEEeC-------CCCeEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeee
Q 024959           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNS-------ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIA  105 (260)
Q Consensus        34 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~  105 (260)
                      ...|.++...+.+.+.||+|++|.||++.+.       .....+++|.+.... .......+.+|+++++.+ +||||++
T Consensus         4 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~   82 (314)
T cd05099           4 DPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIIN   82 (314)
T ss_pred             cccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeee
Confidence            4567888889999999999999999999763       234568999987542 234456788899999999 5999999


Q ss_pred             eeceecCCCCCCCccEEEEEecCC-cchHHHhhhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 024959          106 IKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKYVHSASVLH  168 (260)
Q Consensus       106 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H  168 (260)
                      +++++...     ..++++|||++ ++|.+++...                ..+++..+..++.|++.+|.+||++|++|
T Consensus        83 ~~~~~~~~-----~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H  157 (314)
T cd05099          83 LLGVCTQE-----GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIH  157 (314)
T ss_pred             EEEEEccC-----CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence            99999776     45899999998 6899988653                34888999999999999999999999999


Q ss_pred             ccCCCCCeEeccCCCEEEeecccccccCCCccc---ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCC
Q 024959          169 RDLKPSNLLLNASCDLKIGDFGLARTTSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPL  244 (260)
Q Consensus       169 ~di~~~nili~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p  244 (260)
                      +||+|+||+++.++.++|+|||++.........   .....+..|+|||.+.+ ..++.++|+||||+++|+|++ |..|
T Consensus       158 ~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p  236 (314)
T cd05099         158 RDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSP  236 (314)
T ss_pred             ccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999765433211   11122457999999877 678899999999999999999 8999


Q ss_pred             CCCCChHHHHHHh
Q 024959          245 FPGKDYVHQLRLI  257 (260)
Q Consensus       245 f~~~~~~~~~~~i  257 (260)
                      |.+.+..+..+.+
T Consensus       237 ~~~~~~~~~~~~~  249 (314)
T cd05099         237 YPGIPVEELFKLL  249 (314)
T ss_pred             CCCCCHHHHHHHH
Confidence            9988776666554

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=5.4e-36  Score=240.62  Aligned_cols=207  Identities=30%  Similarity=0.509  Sum_probs=176.5

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~l  123 (260)
                      |++.+.||.|++|.||++.+..++..+++|.+.... .....+.+.+|+.+++.++|||++++++.+...     ..+++
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l   75 (255)
T cd08219           2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD-----GHLYI   75 (255)
T ss_pred             ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-----CEEEE
Confidence            567899999999999999999999999999986432 233556778899999999999999999999776     56999


Q ss_pred             EEecCC-cchHHHhhh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCcc
Q 024959          124 VYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  200 (260)
Q Consensus       124 v~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~  200 (260)
                      ++||++ ++|.+++..  ...+++..++.++.|++.+|.+||+++++|+||+|+||+++.++.++|+|||.+........
T Consensus        76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  155 (255)
T cd08219          76 VMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA  155 (255)
T ss_pred             EEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence            999997 588888765  34589999999999999999999999999999999999999999999999999876544322


Q ss_pred             -cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          201 -MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       201 -~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                       .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+
T Consensus       156 ~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~  212 (255)
T cd08219         156 YACTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKV  212 (255)
T ss_pred             ccccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHH
Confidence             223456788999999877 66889999999999999999999999987766555443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=3.2e-36  Score=248.59  Aligned_cols=217  Identities=38%  Similarity=0.650  Sum_probs=179.1

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC---CC
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK---DT  117 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~---~~  117 (260)
                      .+.|++.+.||.|++|.||++.++.+++.+++|.+............+.+|+++++.++||||+++++++.....   ..
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            456778999999999999999999999999999885443322223456789999999999999999998765432   12


Q ss_pred             CccEEEEEecCCcchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccC
Q 024959          118 FNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (260)
Q Consensus       118 ~~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~  196 (260)
                      ...+++++||+++++...+.. ...+++..++.++.|++++|.+||++|++|+||+|+||+++.++.++|+|||++....
T Consensus        87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  166 (311)
T cd07866          87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD  166 (311)
T ss_pred             CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence            246899999999888887765 4579999999999999999999999999999999999999999999999999987544


Q ss_pred             CCccc------------ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          197 ETDFM------------TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       197 ~~~~~------------~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      .....            ....+++.|+|||.+.+...++.++|+||||+++|+|++|+.||.+.+.....+.+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~  239 (311)
T cd07866         167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI  239 (311)
T ss_pred             CCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            32211            12244677999999876556789999999999999999999999988887766654

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=4.1e-36  Score=242.88  Aligned_cols=203  Identities=28%  Similarity=0.397  Sum_probs=173.6

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      ...|.+.+.||+|++|.||++.+..+++.+++|.++...  ......+.+|+.+++.++||||+++++.+...     ..
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~-----~~   80 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR-----DK   80 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-----CE
Confidence            346778899999999999999999999999999986542  23345677899999999999999999998766     56


Q ss_pred             EEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc
Q 024959          121 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~  199 (260)
                      .++++|+++ ++|.+++...+.+++.+++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06645          81 LWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI  160 (267)
T ss_pred             EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence            899999998 5999998888899999999999999999999999999999999999999999999999999986554322


Q ss_pred             -ccccccccccccccccccC--cCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024959          200 -FMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (260)
Q Consensus       200 -~~~~~~~~~~~~~PE~~~~--~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  250 (260)
                       ......++..|+|||.+..  ...++.++|+||||+++|+|++|..||...+.
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~  214 (267)
T cd06645         161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP  214 (267)
T ss_pred             cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc
Confidence             2233467889999998742  24578899999999999999999999865544

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-35  Score=238.04  Aligned_cols=207  Identities=26%  Similarity=0.404  Sum_probs=177.1

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      |.+....|++.+.||+|++|.||++...  ++.+++|.+.....   ...++.+|+.+++.++|+||+++++++...   
T Consensus         1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---   72 (256)
T cd05039           1 WAINSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQG---   72 (256)
T ss_pred             CccChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCC---
Confidence            4456778889999999999999999765  67899999976432   467788999999999999999999998875   


Q ss_pred             CCccEEEEEecCC-cchHHHhhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                        ...++|||+++ ++|.+++....  .+++..++.++.|++.+|.+||+++++|+||+|+||+++.++.++|+|||.+.
T Consensus        73 --~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~  150 (256)
T cd05039          73 --NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK  150 (256)
T ss_pred             --CCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccc
Confidence              55899999998 69999987765  79999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 024959          194 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRL  256 (260)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~  256 (260)
                      .......  ....+..|+|||.+.. ..++.++|+||||++++++++ |..||...+..+....
T Consensus       151 ~~~~~~~--~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~  211 (256)
T cd05039         151 EASQGQD--SGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPH  211 (256)
T ss_pred             ccccccc--cCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            7643322  2233567999999876 678889999999999999997 9999987776655443

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-35  Score=238.20  Aligned_cols=203  Identities=21%  Similarity=0.358  Sum_probs=170.0

Q ss_pred             ccccccCceEEEEEEeCCCC---eEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEEE
Q 024959           48 RPIGRGAYGIVCAAVNSETR---EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV  124 (260)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv  124 (260)
                      +.||+|++|.||++....+.   ..+++|.+...... .....+.+|+++++.++|||++++++++..      ...+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v   73 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG------EPLMLV   73 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC------CceEEE
Confidence            46999999999999775544   78999999765332 455678899999999999999999998754      347999


Q ss_pred             EecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCccccc
Q 024959          125 YELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE  203 (260)
Q Consensus       125 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  203 (260)
                      ||+++ ++|.+++.....+++..+..++.|++.+|++||+.+++|+||+|+||+++.++.++|+|||++...........
T Consensus        74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          74 MELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             EEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            99987 69999998888899999999999999999999999999999999999999999999999999876544332111


Q ss_pred             ----ccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          204 ----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       204 ----~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                          ..++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+..+..+.+.
T Consensus       154 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~  212 (257)
T cd05060         154 ATTAGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE  212 (257)
T ss_pred             cccCccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence                112357999999876 678999999999999999998 999998888766655543

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.4e-35  Score=241.43  Aligned_cols=211  Identities=24%  Similarity=0.350  Sum_probs=173.5

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCe----EEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETRE----EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      +....+++.+.||+|++|+||++.+..+++    .|++|.+.... .......+.+|+.+++.++||||+++++++... 
T Consensus         4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-   81 (279)
T cd05109           4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-   81 (279)
T ss_pred             cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-
Confidence            345677889999999999999998776665    48999986542 333456778899999999999999999988643 


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccc
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~  192 (260)
                           ..++++|+++ ++|.+.+.. ...+++..+..++.|++.+|+|||+++++|+||+|+||+++.++.++|+|||++
T Consensus        82 -----~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~  156 (279)
T cd05109          82 -----TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLA  156 (279)
T ss_pred             -----CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCce
Confidence                 3678999998 799998876 456999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCcccc---cccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHh
Q 024959          193 RTTSETDFMT---EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLI  257 (260)
Q Consensus       193 ~~~~~~~~~~---~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  257 (260)
                      ..........   ....+..|++||...+ ..++.++|+||||+++|+|++ |..||...........+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~  224 (279)
T cd05109         157 RLLDIDETEYHADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL  224 (279)
T ss_pred             eecccccceeecCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            8765432211   1233567999999877 678899999999999999998 99999877665544433

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.6e-35  Score=244.16  Aligned_cols=210  Identities=26%  Similarity=0.399  Sum_probs=177.1

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      .|.+.+.||+|++|.||++.+..+++.|++|.+..... .......+.+|+++++.++||||+++++.+..+     ...
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~   76 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETK-----RHL   76 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecC-----CEE
Confidence            46678999999999999999999999999999865422 123455677899999999999999999998776     568


Q ss_pred             EEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc-
Q 024959          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~-  199 (260)
                      ++|||+++ ++|.+++.....+++..+..++.|++.++.+||+++++|+||+|.||+++.++.++|+|||+++...... 
T Consensus        77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          77 CMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence            99999998 5899999888889999999999999999999999999999999999999999999999999876321110 


Q ss_pred             ---------------ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          200 ---------------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       200 ---------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                                     ......++..|+|||.+.. ..++.++|+||||+++|+|++|..||.+.+..+.+..+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~  229 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI  229 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence                           0011245678999999877 678999999999999999999999999887766665543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.1e-35  Score=248.08  Aligned_cols=218  Identities=28%  Similarity=0.487  Sum_probs=180.6

Q ss_pred             cceeEeccccCCCcccccccCceEEEEEEeCC-------CCeEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeee
Q 024959           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSE-------TREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIA  105 (260)
Q Consensus        34 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~  105 (260)
                      ...|++....|++++.||+|+||.||++.+..       .+..+++|.+... ........+.+|+++++++ +||||++
T Consensus         4 ~~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~   82 (334)
T cd05100           4 DPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIIN   82 (334)
T ss_pred             CcccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeee
Confidence            36788989999999999999999999998643       2236899988653 2334567788999999999 7999999


Q ss_pred             eeceecCCCCCCCccEEEEEecCC-cchHHHhhhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 024959          106 IKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKYVHSASVLH  168 (260)
Q Consensus       106 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H  168 (260)
                      +++.+...     ...++++||++ ++|.+++...                ..+++..+..++.|++++|.+||++|++|
T Consensus        83 ~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH  157 (334)
T cd05100          83 LLGACTQD-----GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIH  157 (334)
T ss_pred             eeEEEccC-----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            99999876     45899999998 5999988653                24778889999999999999999999999


Q ss_pred             ccCCCCCeEeccCCCEEEeecccccccCCCccc---ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCC
Q 024959          169 RDLKPSNLLLNASCDLKIGDFGLARTTSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPL  244 (260)
Q Consensus       169 ~di~~~nili~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p  244 (260)
                      +||+|+||+++.++.++|+|||++.........   ....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..|
T Consensus       158 ~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p  236 (334)
T cd05100         158 RDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSP  236 (334)
T ss_pred             cccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCC
Confidence            999999999999999999999998765443211   11122457999999977 778899999999999999998 8999


Q ss_pred             CCCCChHHHHHHhh
Q 024959          245 FPGKDYVHQLRLIT  258 (260)
Q Consensus       245 f~~~~~~~~~~~i~  258 (260)
                      |.+.+..+..+.+.
T Consensus       237 ~~~~~~~~~~~~~~  250 (334)
T cd05100         237 YPGIPVEELFKLLK  250 (334)
T ss_pred             CCCCCHHHHHHHHH
Confidence            99888877766653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=9.4e-36  Score=239.52  Aligned_cols=208  Identities=21%  Similarity=0.410  Sum_probs=172.7

Q ss_pred             ccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCc
Q 024959           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      ..+.|++.+.||+|++|.||.+.... +..+++|.+.....   ....+.+|++++++++||||+++++++...     .
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~   72 (256)
T cd05113           2 DPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ-----R   72 (256)
T ss_pred             ChHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEccC-----C
Confidence            34567788999999999999997754 34699998865322   235688999999999999999999999776     4


Q ss_pred             cEEEEEecCC-cchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCC
Q 024959          120 DVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (260)
Q Consensus       120 ~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~  197 (260)
                      ..+++||++. ++|.+++... ..+++..++.++.|++.+|++||+.+++|+||+|.||+++.++.++|+|||.+.....
T Consensus        73 ~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05113          73 PIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD  152 (256)
T ss_pred             CcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCC
Confidence            5899999997 6899988763 4789999999999999999999999999999999999999999999999998876543


Q ss_pred             Ccccc--cccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHh
Q 024959          198 TDFMT--EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLI  257 (260)
Q Consensus       198 ~~~~~--~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  257 (260)
                      .....  ...++..|++||...+ ..++.++|+||||+++|+|++ |..||...+..+....+
T Consensus       153 ~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~  214 (256)
T cd05113         153 DEYTSSVGSKFPVRWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV  214 (256)
T ss_pred             CceeecCCCccChhhCCHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH
Confidence            32211  1233567999999976 668899999999999999998 99999887776655554

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.4e-35  Score=238.42  Aligned_cols=207  Identities=27%  Similarity=0.487  Sum_probs=176.7

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc---chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD---NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      |+..+.||+|++|.||++.+..++..|++|.+.....   .......+.+|+.+++.++||||+++++.+...     ..
T Consensus         2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~   76 (258)
T cd06632           2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE-----DN   76 (258)
T ss_pred             ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC-----Ce
Confidence            4567889999999999999998899999998854321   223456788999999999999999999998776     56


Q ss_pred             EEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc
Q 024959          121 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~  199 (260)
                      +++++||++ ++|.+++.....+++..++.++.|+++++.+||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          77 LYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence            899999998 5899999888889999999999999999999999999999999999999999999999999987765544


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  255 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~  255 (260)
                      ......++..|++||.+.....++.++|+||||+++|+|++|..||...+..+...
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~  212 (258)
T cd06632         157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVF  212 (258)
T ss_pred             cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHH
Confidence            33445678889999998763338899999999999999999999998776544433

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.3e-35  Score=239.30  Aligned_cols=202  Identities=24%  Similarity=0.434  Sum_probs=174.3

Q ss_pred             ccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEEEEecC
Q 024959           50 IGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM  128 (260)
Q Consensus        50 lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv~e~~  128 (260)
                      ||.|++|.||++.+..++..+++|++..... .......+.+|+++++.++||||+++++.+..+     ...++++|++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK-----KYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC-----CccEEEEecC
Confidence            6899999999999999999999999965422 223456788999999999999999999998776     5589999998


Q ss_pred             C-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCccccccccc
Q 024959          129 D-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT  207 (260)
Q Consensus       129 ~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~  207 (260)
                      + ++|.+.+.+...+++..+..++.|++++|++||+++++|+||+|+||+++.++.++|+|||++.............++
T Consensus        76 ~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~  155 (262)
T cd05572          76 LGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGT  155 (262)
T ss_pred             CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCC
Confidence            7 699999988888999999999999999999999999999999999999999999999999998876554333344568


Q ss_pred             ccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHh
Q 024959          208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD--YVHQLRLI  257 (260)
Q Consensus       208 ~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~--~~~~~~~i  257 (260)
                      ..|++||.+.. ..++.++|+||||+++|+|++|..||...+  ..+..+.+
T Consensus       156 ~~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  206 (262)
T cd05572         156 PEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDI  206 (262)
T ss_pred             cCccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHH
Confidence            88999999876 668899999999999999999999998777  44444443

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-37  Score=256.65  Aligned_cols=203  Identities=29%  Similarity=0.507  Sum_probs=182.2

Q ss_pred             cccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEEEEe
Q 024959           47 IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYE  126 (260)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv~e  126 (260)
                      -+.||+|.||+||-+.++++|+.||||++.+..-......++..|+.+|+.+.||.||.+.-.|+..     +.+|+|||
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~-----ervFVVME  643 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETP-----ERVFVVME  643 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCC-----ceEEEEeh
Confidence            4679999999999999999999999999977665566668888999999999999999999999888     55999999


Q ss_pred             cCCcchHHHhhh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccC---CCEEEeecccccccCCCccc
Q 024959          127 LMDTDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFM  201 (260)
Q Consensus       127 ~~~~~l~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~---~~~~l~df~~~~~~~~~~~~  201 (260)
                      .+.|+..+.+.+  .+++++..-..++.||+.||.|||-++|+|+|+||+|||+...   -++||+|||+++...+....
T Consensus       644 Kl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR  723 (888)
T KOG4236|consen  644 KLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR  723 (888)
T ss_pred             hhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence            999987777764  6789999999999999999999999999999999999999654   45899999999999999988


Q ss_pred             ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHH
Q 024959          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY-VHQLR  255 (260)
Q Consensus       202 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-~~~~~  255 (260)
                      .+..||+.|+|||.+.+ +.|+...|+||.|+++|--|+|.-||...++ .+|.+
T Consensus       724 rsVVGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQ  777 (888)
T KOG4236|consen  724 RSVVGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQ  777 (888)
T ss_pred             hhhcCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCCccchhHHhh
Confidence            99999999999999998 8899999999999999999999999965433 34443

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1e-36  Score=224.93  Aligned_cols=217  Identities=27%  Similarity=0.437  Sum_probs=186.4

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCC
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKK  115 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~  115 (260)
                      +++...++..+..||+|++|.|=+.++..+|...|+|.+..... .....+.+.|+.+..+. .+|.+|.+|+.....  
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re--  117 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE--  117 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc--
Confidence            88889999999999999999999999999999999999977643 34556677788766655 599999999987776  


Q ss_pred             CCCccEEEEEecCCcchHHHh----hhCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEeccCCCEEEeecc
Q 024959          116 DTFNDVYIVYELMDTDLHQII----RSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFG  190 (260)
Q Consensus       116 ~~~~~~~lv~e~~~~~l~~~l----~~~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~H~di~~~nili~~~~~~~l~df~  190 (260)
                         ...+|.||.|.-||..+-    ..+..+++..+-.|+..++++|.+||++ .++|||+||.||||+.+|++|++|||
T Consensus       118 ---gdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFG  194 (282)
T KOG0984|consen  118 ---GDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFG  194 (282)
T ss_pred             ---ccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccc
Confidence               569999999998776554    4578899999999999999999999965 99999999999999999999999999


Q ss_pred             cccccCCCcccccccccccccccccccCc---CCCCChhhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHhhc
Q 024959          191 LARTTSETDFMTEYVVTRWYRAPELLLNC---TEYTAAIDIWSVGCILGEIMTREPLFPG-KDYVHQLRLITE  259 (260)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~---~~~~~~~Di~slG~~l~~ll~g~~pf~~-~~~~~~~~~i~~  259 (260)
                      .+-...++.......|-..|+|||.+...   ..|+.++||||||+++.||.++..||+. ....++++++++
T Consensus       195 IsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  195 ISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             cceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            98777766555545667789999998642   4689999999999999999999999964 567899998875

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-35  Score=238.55  Aligned_cols=208  Identities=20%  Similarity=0.370  Sum_probs=172.3

Q ss_pred             ccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCc
Q 024959           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      +..++++.+.||+|++|.||++.++. +..+++|.+.....   ....+.+|+++++.++||||+++++++...     .
T Consensus         2 ~~~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~   72 (256)
T cd05059           2 DPSELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ-----R   72 (256)
T ss_pred             ChHHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcCC-----C
Confidence            34567889999999999999998764 56799999864322   234677899999999999999999998776     4


Q ss_pred             cEEEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCC
Q 024959          120 DVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (260)
Q Consensus       120 ~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~  197 (260)
                      ..++|||+++ ++|.+++.. ...+++..++.++.|++.++++||+++++|+||+|+||+++.++.++|+|||++.....
T Consensus        73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~  152 (256)
T cd05059          73 PIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD  152 (256)
T ss_pred             ceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccc
Confidence            5899999997 689998875 45789999999999999999999999999999999999999999999999998876543


Q ss_pred             Cccc--ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHh
Q 024959          198 TDFM--TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLI  257 (260)
Q Consensus       198 ~~~~--~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  257 (260)
                      ....  .....+..|+|||.+.+ ..++.++|+||||+++|++++ |..||...+..+....+
T Consensus       153 ~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~  214 (256)
T cd05059         153 DQYTSSQGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV  214 (256)
T ss_pred             ccccccCCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Confidence            2211  11122457999999877 678899999999999999998 89999887776665554

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1e-35  Score=245.10  Aligned_cols=217  Identities=28%  Similarity=0.488  Sum_probs=180.3

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEeC-------CCCeEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeee
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNS-------ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAI  106 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~  106 (260)
                      ..|++....|.+.+.||+|+||.||++.+.       .++..+++|.+.... .......+.+|+.+++.+ +||||+++
T Consensus         8 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~   86 (304)
T cd05101           8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINL   86 (304)
T ss_pred             CcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchhe
Confidence            457888889999999999999999999742       234579999987542 234456788999999999 79999999


Q ss_pred             eceecCCCCCCCccEEEEEecCC-cchHHHhhhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q 024959          107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHR  169 (260)
Q Consensus       107 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~  169 (260)
                      ++.+...     ...+++|||++ ++|.+++...                ..++...+..++.|++++|.|||++|++|+
T Consensus        87 ~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~  161 (304)
T cd05101          87 LGACTQD-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHR  161 (304)
T ss_pred             eEEEecC-----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence            9999876     55899999998 6999888753                247788899999999999999999999999


Q ss_pred             cCCCCCeEeccCCCEEEeecccccccCCCccc---ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCC
Q 024959          170 DLKPSNLLLNASCDLKIGDFGLARTTSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLF  245 (260)
Q Consensus       170 di~~~nili~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf  245 (260)
                      ||+|+||+++.++.++|+|||++.........   ....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||
T Consensus       162 dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~  240 (304)
T cd05101         162 DLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPY  240 (304)
T ss_pred             ccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCc
Confidence            99999999999999999999998876543222   11233567999999877 678899999999999999998 88999


Q ss_pred             CCCChHHHHHHhh
Q 024959          246 PGKDYVHQLRLIT  258 (260)
Q Consensus       246 ~~~~~~~~~~~i~  258 (260)
                      .+.+..+..+.+.
T Consensus       241 ~~~~~~~~~~~~~  253 (304)
T cd05101         241 PGIPVEELFKLLK  253 (304)
T ss_pred             ccCCHHHHHHHHH
Confidence            9888777666553

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.5e-35  Score=237.99  Aligned_cols=203  Identities=28%  Similarity=0.495  Sum_probs=176.1

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      .+.|++.+.||.|++|.||++.+..++..+++|.+....    ....+.+|+++++.++||||+++++.+...     ..
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~   72 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKN-----TD   72 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecC-----Cc
Confidence            456788999999999999999999888999999986532    267788999999999999999999999877     55


Q ss_pred             EEEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          121 VYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      .++++|+++ ++|.+++.. ...+++..++.++.|+++++.+||+.+++|+||+|.||+++.++.++|+|||++......
T Consensus        73 ~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~  152 (256)
T cd06612          73 LWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT  152 (256)
T ss_pred             EEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence            899999998 588888875 567899999999999999999999999999999999999999999999999998876544


Q ss_pred             c-ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024959          199 D-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  253 (260)
Q Consensus       199 ~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~  253 (260)
                      . ......++..|++||.+.+ ..++.++|+||||+++|+|++|..||...+....
T Consensus       153 ~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~  207 (256)
T cd06612         153 MAKRNTVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA  207 (256)
T ss_pred             ccccccccCCccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh
Confidence            3 2223346788999999877 6788999999999999999999999987665443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=9.2e-36  Score=243.86  Aligned_cols=203  Identities=37%  Similarity=0.668  Sum_probs=170.0

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      ..|.+.+.||+|++|.||++.+..++..+++|.+..... ......+.+|+.+++.++|+||+++++++...     ...
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~~~   78 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTK-----ETL   78 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecC-----CeE
Confidence            456688999999999999999999999999999865422 11233567899999999999999999998766     558


Q ss_pred             EEEEecCCcchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc-
Q 024959          122 YIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (260)
Q Consensus       122 ~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~-  199 (260)
                      ++|+|++++++.+.+.. ...+++..+..++.|++++|++||+.+++|+||+|+||+++.++.++|+|||++....... 
T Consensus        79 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          79 TFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             EEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence            99999999888877655 3567888999999999999999999999999999999999999999999999886543221 


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  250 (260)
                      ......++..|+|||.+.+...++.++|+||||+++|+|++|..||.+.+.
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~  209 (291)
T cd07870         159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD  209 (291)
T ss_pred             CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh
Confidence            122334578899999987645678899999999999999999999976554

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.4e-35  Score=241.86  Aligned_cols=211  Identities=22%  Similarity=0.407  Sum_probs=172.4

Q ss_pred             ccccCCCcccccccCceEEEEEEe----CCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC
Q 024959           40 SSKYVPPIRPIGRGAYGIVCAAVN----SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~  115 (260)
                      .-..+++.+.||+|+||.||++..    ..++..+++|.+.... .......+.+|+++++.++||||+++++++...  
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--   79 (283)
T cd05090           3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE--   79 (283)
T ss_pred             ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC--
Confidence            345677889999999999999985    3456789999997542 333456788899999999999999999998776  


Q ss_pred             CCCccEEEEEecCC-cchHHHhhhC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeE
Q 024959          116 DTFNDVYIVYELMD-TDLHQIIRSD-----------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL  177 (260)
Q Consensus       116 ~~~~~~~lv~e~~~-~~l~~~l~~~-----------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nil  177 (260)
                         ...+++|||++ ++|.+++...                 ..+++..+..++.|++.+|+|||+++++|+||+|+||+
T Consensus        80 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nil  156 (283)
T cd05090          80 ---QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNIL  156 (283)
T ss_pred             ---CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEE
Confidence               45899999998 5888887532                 24788899999999999999999999999999999999


Q ss_pred             eccCCCEEEeecccccccCCCcc---cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 024959          178 LNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQ  253 (260)
Q Consensus       178 i~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~  253 (260)
                      ++.++.++|+|||++........   .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+.+..+.
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~  235 (283)
T cd05090         157 IGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV  235 (283)
T ss_pred             EcCCCcEEeccccccccccCCcceecccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            99999999999999876543221   122234567999999876 668999999999999999998 9999988776554


Q ss_pred             HHHh
Q 024959          254 LRLI  257 (260)
Q Consensus       254 ~~~i  257 (260)
                      .+.+
T Consensus       236 ~~~~  239 (283)
T cd05090         236 IEMV  239 (283)
T ss_pred             HHHH
Confidence            4433

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.5e-35  Score=239.75  Aligned_cols=213  Identities=24%  Similarity=0.423  Sum_probs=176.6

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCe---EEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~---~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~  115 (260)
                      +....|+..+.||+|++|.||++.++.++.   .+++|.+.... .......+..|+++++.++|||++++.+.+...  
T Consensus         2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--   78 (268)
T cd05063           2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF--   78 (268)
T ss_pred             CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC--
Confidence            344566778999999999999999876554   69999986542 233456788999999999999999999999776  


Q ss_pred             CCCccEEEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          116 DTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       116 ~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                         ...++|||+++ ++|.+++.. ...+++..+..++.|++.++++||+.+++|+||+|+||+++.++.++|+|||++.
T Consensus        79 ---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~  155 (268)
T cd05063          79 ---KPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSR  155 (268)
T ss_pred             ---CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccce
Confidence               55899999998 588888865 4678999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCcccc----cccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          194 TTSETDFMT----EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       194 ~~~~~~~~~----~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      .........    ....+..|++||.+.. ..++.++|+||||+++|++++ |..||...+..+..+.|.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~  224 (268)
T cd05063         156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN  224 (268)
T ss_pred             ecccccccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh
Confidence            654332111    1112356999999876 678899999999999999997 999998888777777664

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-35  Score=242.38  Aligned_cols=208  Identities=41%  Similarity=0.769  Sum_probs=179.0

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-CCCeeeeeceecCCCCCCCccEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDVY  122 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~~~~~~  122 (260)
                      |.+.+.||+|++|+||++....+++.+++|.+...... .......+|+..+++++ |||++++++.+..+     ...+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~-----~~~~   74 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFREN-----DELY   74 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcC-----CcEE
Confidence            45788999999999999999989999999998665332 22334457899999999 99999999999875     5689


Q ss_pred             EEEecCCcchHHHhhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCcc
Q 024959          123 IVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  200 (260)
Q Consensus       123 lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~  200 (260)
                      +|||+++++|.+.+....  .+++..+..++.|++++|.+||+++++|+||+|+||+++.++.++|+|||++........
T Consensus        75 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (283)
T cd07830          75 FVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP  154 (283)
T ss_pred             EEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence            999999999999887754  789999999999999999999999999999999999999999999999999987765544


Q ss_pred             cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       201 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      .....++..|+|||.+.....++.++|+||||+++++|++|+.||...+..++...+
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~  211 (283)
T cd07830         155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKI  211 (283)
T ss_pred             cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHH
Confidence            445566888999998866566889999999999999999999999888776665544

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=7.6e-36  Score=243.37  Aligned_cols=212  Identities=20%  Similarity=0.371  Sum_probs=174.6

Q ss_pred             ccccCCCcccccccCceEEEEEEeCCC-----CeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           40 SSKYVPPIRPIGRGAYGIVCAAVNSET-----REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~-----~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      ....|.+.+.||.|++|.||++.+..+     +..+++|++..... ......+.+|+.+++.++||||+++++++... 
T Consensus         3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-   80 (283)
T cd05091           3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE-   80 (283)
T ss_pred             CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC-
Confidence            344577899999999999999987543     57899999975432 33456678899999999999999999999877 


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhh----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeE
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRS----------------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL  177 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~----------------~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nil  177 (260)
                          ...++++|++. ++|.+++..                ...+++..+..++.|++.+|.+||++|++|+||||.||+
T Consensus        81 ----~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil  156 (283)
T cd05091          81 ----QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVL  156 (283)
T ss_pred             ----CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheE
Confidence                45899999998 578888742                234788899999999999999999999999999999999


Q ss_pred             eccCCCEEEeecccccccCCCccc---ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 024959          178 LNASCDLKIGDFGLARTTSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQ  253 (260)
Q Consensus       178 i~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~  253 (260)
                      ++.++.++|+|||++.........   .....++.|+|||.... ..++.++|+||||+++|+|++ |..||.+.+..+.
T Consensus       157 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~  235 (283)
T cd05091         157 VFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV  235 (283)
T ss_pred             ecCCCceEecccccccccccchheeeccCccCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            999999999999998765433211   12234678999999876 668899999999999999998 8899998888777


Q ss_pred             HHHhh
Q 024959          254 LRLIT  258 (260)
Q Consensus       254 ~~~i~  258 (260)
                      .+.|.
T Consensus       236 ~~~i~  240 (283)
T cd05091         236 IEMIR  240 (283)
T ss_pred             HHHHH
Confidence            77664

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.1e-36  Score=250.34  Aligned_cols=220  Identities=50%  Similarity=0.917  Sum_probs=181.6

Q ss_pred             ecceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecC
Q 024959           33 YGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRP  112 (260)
Q Consensus        33 ~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~  112 (260)
                      ....|++.. .|.+.+.||+|++|.||++.+..+++.+++|.+............+.+|+++++.++||||+++++++..
T Consensus         7 ~~~~~~~~~-~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~   85 (342)
T cd07879           7 NKTVWELPE-RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTS   85 (342)
T ss_pred             hhhhhcccc-ceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecc
Confidence            345677755 4568899999999999999999999999999987643333344567889999999999999999999876


Q ss_pred             CCCC-CCccEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccc
Q 024959          113 PKKD-TFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (260)
Q Consensus       113 ~~~~-~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~  191 (260)
                      .... ....+++++|++..+|.+.+  ...+++..+..++.|++.+|++||+.+++|+||+|+||+++.++.++|+|||+
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879          86 AVSGDEFQDFYLVMPYMQTDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             cccCCCCceEEEEecccccCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCC
Confidence            5321 22457999999988777664  34689999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          192 ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      +......  .....++..|+|||.+.+...++.++|+||||+++|+|++|+.||.+.+....+..+
T Consensus       164 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~  227 (342)
T cd07879         164 ARHADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI  227 (342)
T ss_pred             CcCCCCC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            8765332  223455788999999876556789999999999999999999999988876655544

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.5e-35  Score=238.72  Aligned_cols=211  Identities=24%  Similarity=0.463  Sum_probs=175.9

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      |++..+.|++.+.||+|++|.||++.+.. +..+++|.+......   ...+.+|+.++++++|++++++++++..    
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~----   72 (260)
T cd05070           1 WEIPRESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVSE----   72 (260)
T ss_pred             CCCchHHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEECC----
Confidence            56777889999999999999999998764 466999998654332   3568899999999999999999998754    


Q ss_pred             CCccEEEEEecCC-cchHHHhhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                        ...+++||+++ ++|.+++...  ..+++..++.++.|++.+|.+||+++++|+||+|+||+++.++.++|+|||++.
T Consensus        73 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~  150 (260)
T cd05070          73 --EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLAR  150 (260)
T ss_pred             --CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeee
Confidence              33689999997 5899988753  458999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCccc--ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          194 TTSETDFM--TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       194 ~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      ........  ....++..|+|||.... ..++.++|+||||+++|+|++ |..||.+.+..+....+.
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~  217 (260)
T cd05070         151 LIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE  217 (260)
T ss_pred             eccCcccccccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            65443211  11233567999999876 678899999999999999999 999999888777666653

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.2e-35  Score=243.80  Aligned_cols=206  Identities=26%  Similarity=0.474  Sum_probs=174.4

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      ..|.+.+.||.|++|.||++.+..+++.+++|.+.....  .....+.+|+..++.++|||++++++.+...     ..+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~   91 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLVG-----DEL   91 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEecC-----ceE
Confidence            446678899999999999999999999999999865422  2356678899999999999999999999876     569


Q ss_pred             EEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCcc
Q 024959          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  200 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~  200 (260)
                      ++|+|+++ ++|..++. ...+++.++..++.|++.++++||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus        92 ~lv~e~~~~~~L~~~~~-~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~  170 (296)
T cd06655          92 FVVMEYLAGGSLTDVVT-ETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS  170 (296)
T ss_pred             EEEEEecCCCcHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence            99999998 57777665 44689999999999999999999999999999999999999999999999998876543322


Q ss_pred             -cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 024959          201 -MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  256 (260)
Q Consensus       201 -~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  256 (260)
                       .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+....+..
T Consensus       171 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~  226 (296)
T cd06655         171 KRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL  226 (296)
T ss_pred             cCCCcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence             223356788999999877 6788999999999999999999999988776554433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-35  Score=239.69  Aligned_cols=203  Identities=26%  Similarity=0.374  Sum_probs=166.3

Q ss_pred             ccccccCceEEEEEEeCCCCe--EEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCCCCCccEEEE
Q 024959           48 RPIGRGAYGIVCAAVNSETRE--EVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIV  124 (260)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~--~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~~~~~~lv  124 (260)
                      +.||+|++|.||++.++.++.  .+++|.++.. ........+.+|++.+.++ +||||+++++++...     +..+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-----~~~~lv   74 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----GYLYLA   74 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC-----CCceEE
Confidence            358999999999999988765  4688888643 2233456788999999999 799999999999876     558999


Q ss_pred             EecCC-cchHHHhhhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEe
Q 024959          125 YELMD-TDLHQIIRSDQ----------------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG  187 (260)
Q Consensus       125 ~e~~~-~~l~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~  187 (260)
                      ||+++ ++|.+++....                .+++..++.++.|++.+|++||+.+++|+||+|+||+++.++.++|+
T Consensus        75 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~  154 (270)
T cd05047          75 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA  154 (270)
T ss_pred             EEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEEC
Confidence            99997 69999886532                47899999999999999999999999999999999999999999999


Q ss_pred             ecccccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHh
Q 024959          188 DFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLI  257 (260)
Q Consensus       188 df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  257 (260)
                      |||++..............+..|+|||.+.. ..++.++|+||||+++++|++ |..||.+.+..+..+.+
T Consensus       155 dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~  224 (270)
T cd05047         155 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL  224 (270)
T ss_pred             CCCCccccchhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHH
Confidence            9999854322211111223556999998876 678899999999999999997 99999888776666554

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.1e-35  Score=244.11  Aligned_cols=204  Identities=25%  Similarity=0.462  Sum_probs=173.7

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      ..|++.+.||+|++|.||++.+..++..+++|.+.....  .....+.+|+.+++.++|||++++++.+..+     ...
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~-----~~~   92 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVG-----DEL   92 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc--chHHHHHHHHHHHHhCCCCCEeeEEEEEEeC-----CEE
Confidence            456788999999999999999999999999999865432  2356688899999999999999999998876     568


Q ss_pred             EEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc-
Q 024959          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~-  199 (260)
                      ++||||++ ++|.+++.. ..+++.++..++.|++++|.+||+.|++|+||+|+||+++.++.++|+|||++....... 
T Consensus        93 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~  171 (296)
T cd06654          93 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (296)
T ss_pred             EEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence            99999998 588887654 468999999999999999999999999999999999999999999999999887644322 


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  254 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  254 (260)
                      ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+....+
T Consensus       172 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~  225 (296)
T cd06654         172 KRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL  225 (296)
T ss_pred             ccCcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH
Confidence            1223456788999999877 67789999999999999999999999877664433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.1e-35  Score=241.99  Aligned_cols=193  Identities=26%  Similarity=0.410  Sum_probs=166.3

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~  122 (260)
                      .|.+.+.||+|++|.||++.+..++..+++|.+.... .......+.+|++++++++||||+++++.+...     ...+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~   75 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVE-----NRIS   75 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC-----CEEE
Confidence            4667899999999999999999999999999986542 233456788999999999999999999999876     5589


Q ss_pred             EEEecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCccc
Q 024959          123 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  201 (260)
Q Consensus       123 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  201 (260)
                      ++|||+++ +|...    ..+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||++....... .
T Consensus        76 lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-~  150 (279)
T cd06619          76 ICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-A  150 (279)
T ss_pred             EEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-c
Confidence            99999996 44332    357889999999999999999999999999999999999999999999999987654332 2


Q ss_pred             ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 024959          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG  247 (260)
Q Consensus       202 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~  247 (260)
                      ....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..
T Consensus       151 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~  195 (279)
T cd06619         151 KTYVGTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQ  195 (279)
T ss_pred             cCCCCChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence            33467889999999987 6788999999999999999999999965

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-38  Score=240.97  Aligned_cols=230  Identities=34%  Similarity=0.571  Sum_probs=196.7

Q ss_pred             EeeecceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeece
Q 024959           30 YNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI  109 (260)
Q Consensus        30 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~  109 (260)
                      ++.....++.....|+-...||+|.||.||+++.+++++.|++|+.-.+.+.+......++|+++|..|+|+|++.++++
T Consensus         5 ~~s~~~P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEi   84 (376)
T KOG0669|consen    5 KDSMYEPFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI   84 (376)
T ss_pred             hhcccCCceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHH
Confidence            34455667777788888999999999999999999999999998774433333345667899999999999999999999


Q ss_pred             ecCCCCC---CCccEEEEEecCCcchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEE
Q 024959          110 IRPPKKD---TFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLK  185 (260)
Q Consensus       110 ~~~~~~~---~~~~~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~  185 (260)
                      |......   ....+|+|+++|+-+|.-++.+. .+++..++..++.++.++|.|+|.+.|+|||+|+.|++|+.+|.++
T Consensus        85 c~tk~Tp~~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilk  164 (376)
T KOG0669|consen   85 CRTKATPTNRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILK  164 (376)
T ss_pred             HhhccCCcccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEE
Confidence            8764432   23469999999998888887764 6899999999999999999999999999999999999999999999


Q ss_pred             EeecccccccCCCc-----ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          186 IGDFGLARTTSETD-----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       186 l~df~~~~~~~~~~-----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      |+|||+++.+..+.     .......|..|.+||.+.+.+.++++.|+|.-||++.+|+++.+.|.++...+++..|..
T Consensus       165 lADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~  243 (376)
T KOG0669|consen  165 LADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQ  243 (376)
T ss_pred             eeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHH
Confidence            99999996554332     223345689999999999999999999999999999999999999999999999998854

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.5e-35  Score=239.34  Aligned_cols=207  Identities=27%  Similarity=0.408  Sum_probs=176.5

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~  122 (260)
                      .|++.+.||.|++|+||++....++..+++|++....... ....+.+|++.++.++|+|++++++.+...     ...+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   75 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVG-----DELW   75 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeC-----CEEE
Confidence            5678999999999999999999899999999986543333 567788999999999999999999988776     5689


Q ss_pred             EEEecCC-cchHHHhhhC---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          123 IVYELMD-TDLHQIIRSD---QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       123 lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      +++|+++ ++|.+++...   ..+++..++.++.|++.++++||+.|++|+||+|+||++++++.++|+|||++......
T Consensus        76 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~  155 (267)
T cd06610          76 LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADG  155 (267)
T ss_pred             EEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence            9999997 5888888764   45899999999999999999999999999999999999999999999999998765543


Q ss_pred             ccc-----ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024959          199 DFM-----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  255 (260)
Q Consensus       199 ~~~-----~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~  255 (260)
                      ...     ....++..|++||.+......+.++|+||||+++++|++|+.||...+....+.
T Consensus       156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~  217 (267)
T cd06610         156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLM  217 (267)
T ss_pred             ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHH
Confidence            222     223567889999998774478899999999999999999999998776654443

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.7e-35  Score=240.69  Aligned_cols=211  Identities=25%  Similarity=0.454  Sum_probs=173.6

Q ss_pred             ccccCCCcccccccCceEEEEEEeCC-----CCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           40 SSKYVPPIRPIGRGAYGIVCAAVNSE-----TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      ..+.|.+.+.||+|++|.||++.+..     ++..+++|.+.... .......+.+|+.+++.++|+||+++++++.+. 
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-   81 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER-   81 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC-
Confidence            34567788999999999999999987     77889999886542 233446688899999999999999999988776 


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCC---C
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC---D  183 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~~~-------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~---~  183 (260)
                          ...+++||+++ ++|.+++....       .+++..+..++.|++.+|++||+++++|+||+|+||+++.++   .
T Consensus        82 ----~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~  157 (277)
T cd05036          82 ----LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRV  157 (277)
T ss_pred             ----CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcc
Confidence                45789999997 69999887643       589999999999999999999999999999999999998654   5


Q ss_pred             EEEeecccccccCCCccc---ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHh
Q 024959          184 LKIGDFGLARTTSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLI  257 (260)
Q Consensus       184 ~~l~df~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  257 (260)
                      ++|+|||++.........   .....+..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+.+..+..+.+
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~  234 (277)
T cd05036         158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV  234 (277)
T ss_pred             eEeccCccccccCCccceecCCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            899999998765332211   11122457999999977 678999999999999999997 99999988776665544

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.8e-35  Score=242.23  Aligned_cols=211  Identities=27%  Similarity=0.447  Sum_probs=173.8

Q ss_pred             ccccCCCcccccccCceEEEEEEeC-----CCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           40 SSKYVPPIRPIGRGAYGIVCAAVNS-----ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      ....|.+.+.||+|++|.||++.+.     .++..+++|.+...  .......+.+|++.+++++||||+++++++... 
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-   79 (291)
T cd05094           3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGDG-   79 (291)
T ss_pred             chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC-
Confidence            3455667899999999999999753     34556889988653  333456788999999999999999999999876 


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeE
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL  177 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nil  177 (260)
                          ...++||||++ ++|.+++..+                ..+++..++.++.|++.++++||+++++|+||+|+||+
T Consensus        80 ----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil  155 (291)
T cd05094          80 ----DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCL  155 (291)
T ss_pred             ----CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEE
Confidence                55899999997 6999988653                24889999999999999999999999999999999999


Q ss_pred             eccCCCEEEeecccccccCCCcc---cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 024959          178 LNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQ  253 (260)
Q Consensus       178 i~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~  253 (260)
                      ++.++.++|+|||++........   .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+..+.
T Consensus       156 ~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  234 (291)
T cd05094         156 VGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV  234 (291)
T ss_pred             EccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999999876543321   122334678999999887 678899999999999999998 9999988777666


Q ss_pred             HHHhh
Q 024959          254 LRLIT  258 (260)
Q Consensus       254 ~~~i~  258 (260)
                      .+.+.
T Consensus       235 ~~~~~  239 (291)
T cd05094         235 IECIT  239 (291)
T ss_pred             HHHHh
Confidence            55443

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.1e-35  Score=240.48  Aligned_cols=201  Identities=25%  Similarity=0.428  Sum_probs=171.5

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccc----hHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCc
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN----IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      |...+.||+|++|.||++.+..++..+++|.+......    ......+.+|++++++++||||+++++++...     +
T Consensus         2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~   76 (268)
T cd06630           2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED-----S   76 (268)
T ss_pred             ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC-----C
Confidence            55778899999999999999999999999998643211    22456788999999999999999999999876     5


Q ss_pred             cEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCC-CEEEeecccccccCC
Q 024959          120 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSE  197 (260)
Q Consensus       120 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~-~~~l~df~~~~~~~~  197 (260)
                      .+++|+|+++ ++|.+++....++++..+..++.|++.+|.+||++|++|+||+|.||+++.++ .++|+|||.+.....
T Consensus        77 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~  156 (268)
T cd06630          77 HFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA  156 (268)
T ss_pred             eEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence            6899999998 58999988888899999999999999999999999999999999999998775 599999999876543


Q ss_pred             Ccc-----cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024959          198 TDF-----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (260)
Q Consensus       198 ~~~-----~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  250 (260)
                      ...     .....++..|+|||.+.+ ..++.++|+||||+++++|++|..||...+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~  213 (268)
T cd06630         157 KGTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKH  213 (268)
T ss_pred             ccccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence            311     122356788999999876 6788999999999999999999999976554

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.1e-35  Score=242.28  Aligned_cols=211  Identities=23%  Similarity=0.375  Sum_probs=176.4

Q ss_pred             ccccCCCcccccccCceEEEEEEeCCCC----------------eEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCe
Q 024959           40 SSKYVPPIRPIGRGAYGIVCAAVNSETR----------------EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV  103 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~----------------~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i  103 (260)
                      ..+.|++++.||+|+||.||++.+...+                ..+++|.+.... .......+.+|+++++.++||||
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i   81 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNI   81 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCE
Confidence            4567889999999999999999876543                457999987543 23456778899999999999999


Q ss_pred             eeeeceecCCCCCCCccEEEEEecCC-cchHHHhhhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCceeccC
Q 024959          104 IAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ-----------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDL  171 (260)
Q Consensus       104 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-----------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di  171 (260)
                      +++++++...     ...++++|++. ++|.+++....           .+++..++.++.|++++|.+||+.+++|+||
T Consensus        82 ~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dl  156 (296)
T cd05051          82 ARLLGVCTVD-----PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDL  156 (296)
T ss_pred             eEEEEEEecC-----CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccc
Confidence            9999999876     55899999997 68988887655           7899999999999999999999999999999


Q ss_pred             CCCCeEeccCCCEEEeecccccccCCCcc---cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh--CCCCCC
Q 024959          172 KPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFP  246 (260)
Q Consensus       172 ~~~nili~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~--g~~pf~  246 (260)
                      +|+||+++.++.++|+|||++........   .....++..|+|||.+.. ..++.++|+||||+++|+|++  +..||.
T Consensus       157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~  235 (296)
T cd05051         157 ATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPYE  235 (296)
T ss_pred             chhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence            99999999999999999999876543321   122334678999999877 678999999999999999998  788998


Q ss_pred             CCChHHHHHHh
Q 024959          247 GKDYVHQLRLI  257 (260)
Q Consensus       247 ~~~~~~~~~~i  257 (260)
                      ..+..+.++.+
T Consensus       236 ~~~~~~~~~~~  246 (296)
T cd05051         236 HLTDQQVIENA  246 (296)
T ss_pred             CcChHHHHHHH
Confidence            87776666554

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.6e-35  Score=239.69  Aligned_cols=209  Identities=27%  Similarity=0.438  Sum_probs=173.6

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCe---EEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCC
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~---~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~  118 (260)
                      .++.+.+.||+|++|.||++.+..++.   .|++|.+.... .......+..|+.+++.++||||+++++++...     
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----   77 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS-----   77 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC-----
Confidence            456778999999999999999877654   59999987642 344567788999999999999999999998766     


Q ss_pred             ccEEEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccC
Q 024959          119 NDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (260)
Q Consensus       119 ~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~  196 (260)
                      ...++|||+++ ++|.+++.. ...+++.+++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||++....
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          78 RPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             CceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccc
Confidence            55899999998 588888875 4568999999999999999999999999999999999999999999999999886554


Q ss_pred             CCccccc---cc---ccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHh
Q 024959          197 ETDFMTE---YV---VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLI  257 (260)
Q Consensus       197 ~~~~~~~---~~---~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  257 (260)
                      .......   ..   .+..|++||.+.. ..++.++|+||||+++|++++ |..||.+.+..+..+.|
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i  224 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI  224 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence            3321111   11   1346999999876 678999999999999999886 99999888776665554

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.2e-35  Score=238.35  Aligned_cols=205  Identities=25%  Similarity=0.432  Sum_probs=172.8

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc----chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCc
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD----NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~----~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      |.+.+.||+|++|.||++.+. +++.+++|.+.....    .......+.+|+++++.++|+||+++++.+...     .
T Consensus         2 ~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~   75 (265)
T cd06631           2 WTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD-----N   75 (265)
T ss_pred             ccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC-----C
Confidence            567889999999999999864 678899998864322    222345678899999999999999999999877     5


Q ss_pred             cEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCC-
Q 024959          120 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-  197 (260)
Q Consensus       120 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~-  197 (260)
                      ..++++|+++ ++|.+++.+..++++..+..++.|++.+|++||+.+++|+||+|+||+++.++.++|+|||++..... 
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          76 TISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV  155 (265)
T ss_pred             eEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence            6899999997 59999998888899999999999999999999999999999999999999999999999998875422 


Q ss_pred             ------CcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024959          198 ------TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  255 (260)
Q Consensus       198 ------~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~  255 (260)
                            ........++..|+|||.+.+ ..++.++|+||||+++++|++|..||...+......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~  218 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF  218 (265)
T ss_pred             cccccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH
Confidence                  111223456788999999877 667899999999999999999999998776654433

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.8e-36  Score=250.16  Aligned_cols=220  Identities=52%  Similarity=0.997  Sum_probs=184.9

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      ..|++..+ |++.+.||+|++|.||++.+..++..|++|.+............+.+|+.+++.++|||++++.+++....
T Consensus         9 ~~~~~~~~-y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (343)
T cd07851           9 TVWEVPDR-YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPAS   87 (343)
T ss_pred             ceecccCc-eEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccc
Confidence            45666554 56899999999999999999999999999998765444445566778999999999999999999886654


Q ss_pred             C-CCCccEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          115 K-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       115 ~-~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                      . ......++|+|+++++|.+++.. .++++..++.++.|++++|.+||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus        88 ~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~  166 (343)
T cd07851          88 SLEDFQDVYLVTHLMGADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  166 (343)
T ss_pred             cccccccEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccc
Confidence            3 22345899999999999888765 579999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          194 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      .....  .....++..|+|||.+.+...++.++|+||||+++|++++|+.||.+.+..+.+..|.
T Consensus       167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~  229 (343)
T cd07851         167 HTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIM  229 (343)
T ss_pred             ccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            66443  2233557789999998764567899999999999999999999999888777666543

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-35  Score=247.37  Aligned_cols=219  Identities=48%  Similarity=0.905  Sum_probs=181.8

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      ..|.+. +.|.+.+.||+|++|.||++.+..++..|++|.+............+.+|+++++.++||||+++++++....
T Consensus         9 ~~~~~~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (343)
T cd07880           9 TIWEVP-DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL   87 (343)
T ss_pred             hhhccc-cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence            345553 4466889999999999999999999999999998655444445567889999999999999999999987654


Q ss_pred             CC-CCccEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          115 KD-TFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       115 ~~-~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                      .. ....+++|||+++++|.+++. ...+++..++.++.|++++|++||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus        88 ~~~~~~~~~lv~e~~~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~  166 (343)
T cd07880          88 SLDRFHDFYLVMPFMGTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR  166 (343)
T ss_pred             cccccceEEEEEecCCCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccc
Confidence            32 223578999999888887765 4579999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          194 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      ......  ....+++.|++||.+.+...++.++|+||||++++++++|..||.+.+.......+
T Consensus       167 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~  228 (343)
T cd07880         167 QTDSEM--TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEI  228 (343)
T ss_pred             ccccCc--cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            654332  23355788999999876456789999999999999999999999988776555544

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.1e-35  Score=241.87  Aligned_cols=195  Identities=26%  Similarity=0.436  Sum_probs=167.5

Q ss_pred             ccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEEEEecC
Q 024959           50 IGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM  128 (260)
Q Consensus        50 lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv~e~~  128 (260)
                      ||+|++|+||++.++.+++.+++|.+..... .......+..|+++++.++|||++++++.+...     ...++||||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETK-----DDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecC-----CeEEEEEecC
Confidence            6899999999999999999999999865322 122344567899999999999999999999776     5589999999


Q ss_pred             C-cchHHHhhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCccccccc
Q 024959          129 D-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV  205 (260)
Q Consensus       129 ~-~~l~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  205 (260)
                      + ++|.+++....  .+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||.+.............
T Consensus        76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  155 (277)
T cd05577          76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA  155 (277)
T ss_pred             CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcccccc
Confidence            8 58998887655  79999999999999999999999999999999999999999999999999887655443334445


Q ss_pred             ccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024959          206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (260)
Q Consensus       206 ~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  250 (260)
                      ++..|++||.+.+ ..++.++|+||||+++++|++|+.||...+.
T Consensus       156 ~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~  199 (277)
T cd05577         156 GTPGYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQRKE  199 (277)
T ss_pred             CCCCcCCHHHhcC-CCCCchhhhHHHHHHHHHHhhCCCCCCCCcc
Confidence            6778999999877 5588999999999999999999999977654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.8e-35  Score=239.16  Aligned_cols=201  Identities=32%  Similarity=0.502  Sum_probs=170.5

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc-cchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      ..|++.+.||+|++|.||++.+..++..+++|.+.... ........+.+|+++++.++||||+++++.+...     ..
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~   76 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED-----NE   76 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC-----Ce
Confidence            35678899999999999999999999999999875422 2344456778899999999999999999998876     55


Q ss_pred             EEEEEecCC-cchHHHhhh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccccc
Q 024959          121 VYIVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~  195 (260)
                      .++++|+++ ++|.+++..    ...+++..+..++.|++++|.+||+++++|+||+|+||+++.++.++|+|||++...
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~  156 (267)
T cd08228          77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence            899999998 588877753    345899999999999999999999999999999999999999999999999988765


Q ss_pred             CCCcc-cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 024959          196 SETDF-MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK  248 (260)
Q Consensus       196 ~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  248 (260)
                      ..... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...
T Consensus       157 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~  209 (267)
T cd08228         157 SSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             cchhHHHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence            43321 123356778999999877 66789999999999999999999999654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2e-35  Score=245.73  Aligned_cols=212  Identities=53%  Similarity=0.971  Sum_probs=176.7

Q ss_pred             cceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCC
Q 024959           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (260)
Q Consensus        34 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~  113 (260)
                      +..+.+ .+.|.+.+.||.|++|.||++.+..+++.+++|.+............+.+|+++++.++||||+++++++...
T Consensus         3 ~~~~~~-~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   81 (328)
T cd07856           3 GTVFEI-TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP   81 (328)
T ss_pred             cceecc-ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC
Confidence            344454 4447789999999999999999999999999998865433334456777899999999999999999988653


Q ss_pred             CCCCCccEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          114 KKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       114 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                      .    ...++++|+++++|.+++. ..++++..+..++.|++++|.+||+.+++|+||+|.||+++.++.++|+|||++.
T Consensus        82 ~----~~~~lv~e~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~  156 (328)
T cd07856          82 L----EDIYFVTELLGTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLAR  156 (328)
T ss_pred             C----CcEEEEeehhccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCcccccc
Confidence            2    4588999999988887765 4568899999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024959          194 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  253 (260)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~  253 (260)
                      .....  .....++..|++||.+.+...++.++|+||||+++++|++|..||...+....
T Consensus       157 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~  214 (328)
T cd07856         157 IQDPQ--MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQ  214 (328)
T ss_pred             ccCCC--cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            65432  22335577899999876646688999999999999999999999988776443

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.6e-35  Score=239.82  Aligned_cols=208  Identities=22%  Similarity=0.350  Sum_probs=169.5

Q ss_pred             ccccCCCcccccccCceEEEEEEeCCCCe----EEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC
Q 024959           40 SSKYVPPIRPIGRGAYGIVCAAVNSETRE----EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~  115 (260)
                      ....|++++.||+|++|+||++.+..++.    .+++|.+... ........+..|+..++.++||||+++++++...  
T Consensus         5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~--   81 (279)
T cd05111           5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGA--   81 (279)
T ss_pred             CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECCC--
Confidence            34567788999999999999999877665    4777877543 2223345677788889999999999999987543  


Q ss_pred             CCCccEEEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          116 DTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       116 ~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                          ..++++|+++ ++|.+++.. ...+++..+..++.|++.+|+|||+++++|+||+|+||+++.++.++|+|||++.
T Consensus        82 ----~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~  157 (279)
T cd05111          82 ----SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVAD  157 (279)
T ss_pred             ----ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccce
Confidence                3678899987 799999876 4578999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCc---ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 024959          194 TTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLR  255 (260)
Q Consensus       194 ~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~  255 (260)
                      ......   ......++..|++||.+.+ ..++.++|+||||+++|++++ |..||.+.+.....+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~  222 (279)
T cd05111         158 LLYPDDKKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPD  222 (279)
T ss_pred             eccCCCcccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            543322   1122334667999999877 678999999999999999998 999998877655443

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4e-36  Score=258.48  Aligned_cols=191  Identities=26%  Similarity=0.357  Sum_probs=164.9

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      ...|.+.+.||+|++|.||++.+..+++.|++|....        ..+.+|++++++++|+||+++++++...     ..
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~-----~~  234 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVG-----GL  234 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEEC-----CE
Confidence            3357788999999999999999999999999996532        2356899999999999999999998776     55


Q ss_pred             EEEEEecCCcchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc
Q 024959          121 VYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (260)
Q Consensus       121 ~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~  199 (260)
                      .+++||++.++|.+++... ..+++..++.++.|++.+|.|||++|++|+||||+|||++.++.++|+|||++.......
T Consensus       235 ~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~  314 (461)
T PHA03211        235 TCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW  314 (461)
T ss_pred             EEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence            8999999999999888764 569999999999999999999999999999999999999999999999999987654332


Q ss_pred             c---cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCC
Q 024959          200 F---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF  245 (260)
Q Consensus       200 ~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf  245 (260)
                      .   .....++..|++||.+.+ ..++.++|||||||++|+|++|..|+
T Consensus       315 ~~~~~~~~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~l  362 (461)
T PHA03211        315 STPFHYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASL  362 (461)
T ss_pred             ccccccccCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCc
Confidence            1   123457899999999987 67899999999999999999977543

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=232.99  Aligned_cols=219  Identities=22%  Similarity=0.376  Sum_probs=186.1

Q ss_pred             cceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-CCCeeeeeceecC
Q 024959           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRP  112 (260)
Q Consensus        34 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~  112 (260)
                      ++......+.+..+..||+|..|.||+++.+.++...|||.+... .+....++++..+.++..-. +|+||+.+++|..
T Consensus        84 g~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt-~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~  162 (391)
T KOG0983|consen   84 GQRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT-GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT  162 (391)
T ss_pred             CcccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc-CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee
Confidence            345555566677889999999999999999999999999999776 44556677777887766664 9999999999988


Q ss_pred             CCCCCCccEEEEEecCCcchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEeccCCCEEEeecc
Q 024959          113 PKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFG  190 (260)
Q Consensus       113 ~~~~~~~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~di~~~nili~~~~~~~l~df~  190 (260)
                      +     ...++.||.|.-.+..++.. .+++++..+-.+...+++||.||-+ .+++|||+||+|||+++.|++||+|||
T Consensus       163 n-----~dV~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFG  237 (391)
T KOG0983|consen  163 N-----TDVFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFG  237 (391)
T ss_pred             C-----chHHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeeccc
Confidence            7     55889999998776666654 6779999999999999999999985 589999999999999999999999999


Q ss_pred             cccccCCCcccccccccccccccccccCc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHhh
Q 024959          191 LARTTSETDFMTEYVVTRWYRAPELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDY-VHQLRLIT  258 (260)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-~~~~~~i~  258 (260)
                      .+-..-++.......|-+.||+||.+-..  ..|+.++||||||++++||.||..||.+.+. .+.+..|.
T Consensus       238 IsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvl  308 (391)
T KOG0983|consen  238 ISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVL  308 (391)
T ss_pred             ccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHH
Confidence            99988888877778889999999998642  5688999999999999999999999998554 55555553

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3e-35  Score=240.52  Aligned_cols=214  Identities=26%  Similarity=0.474  Sum_probs=175.0

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCC-----CCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceec
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSE-----TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIR  111 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~  111 (260)
                      |++....|.+.+.||+|++|.||++.++.     .+..+++|.+.... .......+.+|+..++.++||||+++++++.
T Consensus         1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   79 (288)
T cd05061           1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVS   79 (288)
T ss_pred             CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            67778889999999999999999997642     35579999986543 2334456788999999999999999999987


Q ss_pred             CCCCCCCccEEEEEecCC-cchHHHhhhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecc
Q 024959          112 PPKKDTFNDVYIVYELMD-TDLHQIIRSD----------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA  180 (260)
Q Consensus       112 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~  180 (260)
                      ..     ...+++|||++ ++|.+++...          ..++...+..++.|++.+|.+||+++++|+||+|+||+++.
T Consensus        80 ~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~  154 (288)
T cd05061          80 KG-----QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAH  154 (288)
T ss_pred             CC-----CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcC
Confidence            76     45899999997 6999998652          23466788999999999999999999999999999999999


Q ss_pred             CCCEEEeecccccccCCCccc---ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 024959          181 SCDLKIGDFGLARTTSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRL  256 (260)
Q Consensus       181 ~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~  256 (260)
                      ++.++|+|||++.........   ....++..|+|||.+.. ..++.++|+||||+++|+|++ |..||.+.+..+..+.
T Consensus       155 ~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~  233 (288)
T cd05061         155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF  233 (288)
T ss_pred             CCcEEECcCCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            999999999998754332211   11223567999999877 678899999999999999998 7889988777666554


Q ss_pred             h
Q 024959          257 I  257 (260)
Q Consensus       257 i  257 (260)
                      +
T Consensus       234 ~  234 (288)
T cd05061         234 V  234 (288)
T ss_pred             H
Confidence            4

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3e-35  Score=237.21  Aligned_cols=200  Identities=31%  Similarity=0.473  Sum_probs=177.2

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~  122 (260)
                      .|++.+.||.|++|.||++.+..+++.+++|.+...... .....+.+|++.+.+++|||++++++.+...     ...+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   75 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKE-----GEIS   75 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccC-----CeEE
Confidence            456789999999999999999999999999998765332 4567788999999999999999999999877     5699


Q ss_pred             EEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEeccCCCEEEeecccccccCCCcc
Q 024959          123 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  200 (260)
Q Consensus       123 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~  200 (260)
                      +++|+++ ++|.+++.....+++..++.++.|+++++.+||+ .+++|+||+|+||+++.++.++|+|||.+........
T Consensus        76 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          76 IVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD  155 (264)
T ss_pred             EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence            9999999 7999999888899999999999999999999999 9999999999999999999999999998877654433


Q ss_pred             cc-cccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 024959          201 MT-EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  249 (260)
Q Consensus       201 ~~-~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  249 (260)
                      .. ...++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+
T Consensus       156 ~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~  204 (264)
T cd06623         156 QCNTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPG  204 (264)
T ss_pred             cccceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence            22 4456788999999877 678899999999999999999999998774

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.9e-35  Score=238.15  Aligned_cols=210  Identities=24%  Similarity=0.462  Sum_probs=176.1

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      |++..+.|.+++.||+|++|.||++..+. +..+++|.+.....   ...++.+|+.++++++|||++++++.+..    
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----   72 (260)
T cd05067           1 WEVPRETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVTQ----   72 (260)
T ss_pred             CccchHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEcc----
Confidence            57788889999999999999999998654 57899999865432   24578889999999999999999998743    


Q ss_pred             CCccEEEEEecCC-cchHHHhhh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                        ...+++||++. ++|.+++..  ...+++.++..++.|++.+|++||+.+++|+||+|+||+++.++.++|+|||++.
T Consensus        73 --~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~  150 (260)
T cd05067          73 --EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLAR  150 (260)
T ss_pred             --CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCccee
Confidence              34799999997 689988865  3468999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCccc--ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHh
Q 024959          194 TTSETDFM--TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLI  257 (260)
Q Consensus       194 ~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  257 (260)
                      ........  ....++..|+|||.+.. ..++.++|+||||++++++++ |+.||.+.+..+..+.+
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~  216 (260)
T cd05067         151 LIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL  216 (260)
T ss_pred             ecCCCCcccccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH
Confidence            65532211  12234567999999876 678899999999999999999 99999988877665554

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-37  Score=259.05  Aligned_cols=209  Identities=28%  Similarity=0.459  Sum_probs=184.3

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc-cchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      .+.|.-++.||+|+||.||.+++..+.+.||||++...- .....++++++|+++|++++|||++.+.++|..+     .
T Consensus        25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre-----~   99 (948)
T KOG0577|consen   25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE-----H   99 (948)
T ss_pred             HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc-----c
Confidence            445667899999999999999999999999999996553 3556789999999999999999999999999887     4


Q ss_pred             cEEEEEecCCcchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          120 DVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       120 ~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      ..|+|||||-|+-.+++.- .+++-+-.+..|..+.+.+|+|||+.+.+|+|||..|||+++.|.+||+|||-+......
T Consensus       100 TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA  179 (948)
T KOG0577|consen  100 TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA  179 (948)
T ss_pred             hHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch
Confidence            4899999999998888876 567899999999999999999999999999999999999999999999999988665544


Q ss_pred             cccccccccccccccccccC--cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          199 DFMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       199 ~~~~~~~~~~~~~~PE~~~~--~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                         .+.+|||+|||||++..  .+.|+-++|||||||+..+|.-.++|+=++|-...+--|
T Consensus       180 ---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHI  237 (948)
T KOG0577|consen  180 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI  237 (948)
T ss_pred             ---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHH
Confidence               46788999999999863  367899999999999999999999999877766555444

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.3e-35  Score=237.01  Aligned_cols=208  Identities=27%  Similarity=0.485  Sum_probs=177.7

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~l  123 (260)
                      |++.+.||+|++|.+|.+.+..+++.+++|.+............+.+|+.++++++||||+++++.+...     +..++
T Consensus         2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l   76 (256)
T cd08218           2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN-----GNLYI   76 (256)
T ss_pred             ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC-----CeEEE
Confidence            5678999999999999999999999999999865433344556788999999999999999999999776     56899


Q ss_pred             EEecCC-cchHHHhhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCcc
Q 024959          124 VYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  200 (260)
Q Consensus       124 v~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~  200 (260)
                      |+|++. ++|.+.+...  ..+++..+..++.|++.++.+||+++++|+||+|+||+++.++.++|+|||++........
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          77 VMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            999997 5898888764  3589999999999999999999999999999999999999999999999999876544322


Q ss_pred             c-ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          201 M-TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       201 ~-~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      . ....+++.|+|||.+.+ ...+.++|+||||+++++|++|..||...+..+....+
T Consensus       157 ~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~  213 (256)
T cd08218         157 LARTCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI  213 (256)
T ss_pred             hhhhccCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHH
Confidence            1 22346778999999877 66888999999999999999999999887776665544

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.1e-35  Score=238.79  Aligned_cols=211  Identities=26%  Similarity=0.427  Sum_probs=174.3

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCC---eEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCC
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETR---EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~  117 (260)
                      ...|.+.+.||+|++|.||++.+..++   ..+++|.++.... ......+.+|+.+++.++||||+++++++...    
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----   77 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS----   77 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC----
Confidence            445678899999999999999886544   3699999865432 33456788999999999999999999998766    


Q ss_pred             CccEEEEEecCC-cchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccccc
Q 024959          118 FNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (260)
Q Consensus       118 ~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~  195 (260)
                       ...+++||+++ ++|.+++... ..+++.++..++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus        78 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd05066          78 -KPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL  156 (267)
T ss_pred             -CccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence             55899999997 5899888764 56899999999999999999999999999999999999999999999999998765


Q ss_pred             CCCcccc----cccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          196 SETDFMT----EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       196 ~~~~~~~----~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      .......    ....+..|++||.+.+ ..++.++|+||||+++|++++ |..||.+.+..+....+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~  223 (267)
T cd05066         157 EDDPEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE  223 (267)
T ss_pred             ccccceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHh
Confidence            4432111    1122457999999977 678999999999999999886 999998887766655544

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.3e-35  Score=237.14  Aligned_cols=208  Identities=26%  Similarity=0.434  Sum_probs=173.0

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      |.+....|.+.+.||+|++|.||++...  +..+++|.+....    ....+.+|+.++++++|+|++++++.+....  
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--   72 (256)
T cd05082           1 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK--   72 (256)
T ss_pred             CCccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC--
Confidence            4566678889999999999999999765  6689999986432    3456889999999999999999999765432  


Q ss_pred             CCccEEEEEecCC-cchHHHhhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                        +..++++|+++ ++|.+++....  .+++..+..++.|++.+|++||++|++|+||+|+||+++.++.++|+|||++.
T Consensus        73 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~  150 (256)
T cd05082          73 --GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK  150 (256)
T ss_pred             --CceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccce
Confidence              45899999998 59999887643  48899999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHh
Q 024959          194 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLI  257 (260)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  257 (260)
                      ......  .....+..|+|||.... ..++.++|+||||+++|+|++ |+.||...+..+....|
T Consensus       151 ~~~~~~--~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~  212 (256)
T cd05082         151 EASSTQ--DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV  212 (256)
T ss_pred             eccccC--CCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            654332  12233567999999876 678899999999999999997 99999887776655544

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.2e-35  Score=239.40  Aligned_cols=210  Identities=28%  Similarity=0.427  Sum_probs=173.1

Q ss_pred             ccccCCCcccccccCceEEEEEEeC-----CCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           40 SSKYVPPIRPIGRGAYGIVCAAVNS-----ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      ....+...+.||+|++|.||++...     .++..+++|.+...  .......+.+|++.++.++|+||+++++++... 
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-   79 (280)
T cd05092           3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG-   79 (280)
T ss_pred             ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC-
Confidence            3456778999999999999999743     35667999988653  344566788999999999999999999998776 


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhhC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEe
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRSD---------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL  178 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~~---------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili  178 (260)
                          ...+++||+++ ++|.+++...               ..+++..++.++.|++.+++|||+.+++|+||+|+||++
T Consensus        80 ----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~  155 (280)
T cd05092          80 ----RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV  155 (280)
T ss_pred             ----CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEE
Confidence                45899999998 6888888654               248899999999999999999999999999999999999


Q ss_pred             ccCCCEEEeecccccccCCCcc---cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 024959          179 NASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL  254 (260)
Q Consensus       179 ~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~  254 (260)
                      ++++.++|+|||++........   .....+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+..+..
T Consensus       156 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  234 (280)
T cd05092         156 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI  234 (280)
T ss_pred             cCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH
Confidence            9999999999999875433221   112223567999999877 678999999999999999998 99999877766655


Q ss_pred             HHh
Q 024959          255 RLI  257 (260)
Q Consensus       255 ~~i  257 (260)
                      ..+
T Consensus       235 ~~~  237 (280)
T cd05092         235 ECI  237 (280)
T ss_pred             HHH
Confidence            544

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.8e-35  Score=241.49  Aligned_cols=204  Identities=23%  Similarity=0.445  Sum_probs=171.1

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~  122 (260)
                      .|++++.||+|++|.||++.+..++..+++|.+.... .......+.+|+.++++++||||+++++.+..+     ...+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~   75 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIE-----GAVY   75 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC-----CeEE
Confidence            5678999999999999999999999999999886542 333456788999999999999999999998876     5699


Q ss_pred             EEEecCCc-chHHHhhhC---CCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEeccCCCEEEeecccccccCC
Q 024959          123 IVYELMDT-DLHQIIRSD---QQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (260)
Q Consensus       123 lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~  197 (260)
                      +||||+++ +|.+++...   ..+++..+..++.|++++|.+||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus        76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  155 (286)
T cd06622          76 MCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA  155 (286)
T ss_pred             EEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence            99999985 787777653   379999999999999999999996 5999999999999999999999999999876543


Q ss_pred             CcccccccccccccccccccCc-----CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024959          198 TDFMTEYVVTRWYRAPELLLNC-----TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  253 (260)
Q Consensus       198 ~~~~~~~~~~~~~~~PE~~~~~-----~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~  253 (260)
                      .. .....++..|++||.+.+.     ..++.++|+||||+++|+|++|..||...+....
T Consensus       156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~  215 (286)
T cd06622         156 SL-AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI  215 (286)
T ss_pred             Cc-cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH
Confidence            32 2233567789999998542     2357899999999999999999999976555443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.1e-35  Score=243.49  Aligned_cols=207  Identities=28%  Similarity=0.540  Sum_probs=173.5

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      +++.....||+|++|.||++.+..++..+++|.+...  .......+.+|+.+++.++|||++++++.+...     +..
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-----~~~   94 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVG-----DEL   94 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecC-----CeE
Confidence            3344567799999999999999999999999998653  233456688999999999999999999998776     568


Q ss_pred             EEEEecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc-
Q 024959          122 YIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (260)
Q Consensus       122 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~-  199 (260)
                      ++|||++++ +|.+++ ....+++..++.++.|++.+|.+||+.+++|+||+|.||+++.++.++|+|||++....... 
T Consensus        95 ~lv~e~~~~~~L~~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~  173 (292)
T cd06658          95 WVVMEFLEGGALTDIV-THTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP  173 (292)
T ss_pred             EEEEeCCCCCcHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence            999999985 677665 44578999999999999999999999999999999999999999999999999886543322 


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+..+.+..+
T Consensus       174 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~  230 (292)
T cd06658         174 KRKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI  230 (292)
T ss_pred             cCceeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            1223456888999999876 67889999999999999999999999887766554443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-35  Score=241.36  Aligned_cols=209  Identities=43%  Similarity=0.737  Sum_probs=180.0

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~l  123 (260)
                      |+..+.||+|++|.||++.+..+++.+++|.+............+..|+.+++.++|+|++++++++...     ...++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~~   75 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE-----RKLYL   75 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-----CceEE
Confidence            3467889999999999999999999999999977543344456677899999999999999999999877     56999


Q ss_pred             EEecCCcchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc-cc
Q 024959          124 VYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FM  201 (260)
Q Consensus       124 v~e~~~~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~-~~  201 (260)
                      |+|+++++|.+++... ..+++..+..++.|++++|++||+.+++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        76 v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~  155 (282)
T cd07829          76 VFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY  155 (282)
T ss_pred             EecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcccc
Confidence            9999999999999876 689999999999999999999999999999999999999999999999999987655433 22


Q ss_pred             ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       202 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      .....+..|+|||.+.+...++.++|+||||++++++++|..||.+.+..+.+..|
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~  211 (282)
T cd07829         156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKI  211 (282)
T ss_pred             CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence            23344677999999877457889999999999999999999999988876665544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=6.3e-35  Score=234.86  Aligned_cols=201  Identities=21%  Similarity=0.375  Sum_probs=165.2

Q ss_pred             cccccCceEEEEEEeC--CCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEEEEe
Q 024959           49 PIGRGAYGIVCAAVNS--ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYE  126 (260)
Q Consensus        49 ~lg~G~~g~vy~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv~e  126 (260)
                      .||+|++|.||++.+.  ..+..+++|.+.... .......+.+|++++++++||||+++++++..      ...++|||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~------~~~~lv~e   74 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA------EALMLVME   74 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC------CCeEEEEE
Confidence            4899999999999764  445679999997642 33445678899999999999999999998753      34789999


Q ss_pred             cCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCccc---
Q 024959          127 LMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM---  201 (260)
Q Consensus       127 ~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~~---  201 (260)
                      +++ ++|.+++.. ...+++..++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||++.........   
T Consensus        75 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          75 MASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             eCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence            997 688888875 557899999999999999999999999999999999999999999999999998755433211   


Q ss_pred             -ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHh
Q 024959          202 -TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLI  257 (260)
Q Consensus       202 -~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  257 (260)
                       ....++..|+|||.+.. ..++.++|+||||+++|++++ |..||.+.+..+....+
T Consensus       155 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~  211 (257)
T cd05115         155 RSAGKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFI  211 (257)
T ss_pred             cCCCCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH
Confidence             11122467999999876 668899999999999999996 99999887776655443

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-38  Score=240.65  Aligned_cols=229  Identities=24%  Similarity=0.359  Sum_probs=189.4

Q ss_pred             eCceeeEEeeecceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHH-cCCC
Q 024959           23 HGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRH-MEHE  101 (260)
Q Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~-l~~~  101 (260)
                      .......+......+++....++-+..||.|+||+|++..++.+|+..|||.+..... +....+++.|.....+ -++|
T Consensus        45 ~s~g~l~~p~~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp  123 (361)
T KOG1006|consen   45 YSTGTLKLPDDAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCP  123 (361)
T ss_pred             hccCceecCCcccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCc
Confidence            3333556667778999999999999999999999999999999999999999966533 3456677777775444 4699


Q ss_pred             CeeeeeceecCCCCCCCccEEEEEecCCcchHHHhh-----hCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCC
Q 024959          102 NVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIR-----SDQQLTDDHCQYFLYQLLRGLKYVH-SASVLHRDLKPSN  175 (260)
Q Consensus       102 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~-----~~~~~~~~~~~~~~~~i~~~l~~lh-~~~i~H~di~~~n  175 (260)
                      |||++|+.+..+     ...||.||.|.-++..+..     .+..+++..+-.+.-..+.||.||- +.+++|||+||+|
T Consensus       124 ~IVkfyGa~F~E-----GdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSN  198 (361)
T KOG1006|consen  124 NIVKFYGALFSE-----GDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSN  198 (361)
T ss_pred             HHHHHhhhhhcC-----CceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhh
Confidence            999999988776     5689999999976655443     3678999999999999999999998 5689999999999


Q ss_pred             eEeccCCCEEEeecccccccCCCcccccccccccccccccccCcCC-CCChhhHHHHHHHHHHHHhCCCCCCCCCh-HHH
Q 024959          176 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE-YTAAIDIWSVGCILGEIMTREPLFPGKDY-VHQ  253 (260)
Q Consensus       176 ili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~-~~~  253 (260)
                      ||++..|.+||+|||.+-...++.......|-..|+|||.+-.... ++.++|+||||++|+|+.||..||.+-+. .+|
T Consensus       199 ILldr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeq  278 (361)
T KOG1006|consen  199 ILLDRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQ  278 (361)
T ss_pred             eEEecCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHH
Confidence            9999999999999999877766655555667778999999976544 89999999999999999999999987655 444


Q ss_pred             HHHh
Q 024959          254 LRLI  257 (260)
Q Consensus       254 ~~~i  257 (260)
                      +.++
T Consensus       279 l~~V  282 (361)
T KOG1006|consen  279 LCQV  282 (361)
T ss_pred             HHHH
Confidence            4443

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.2e-35  Score=241.93  Aligned_cols=213  Identities=27%  Similarity=0.430  Sum_probs=177.0

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEe-----CCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeeeec
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVN-----SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKD  108 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~  108 (260)
                      -.|.+....|.+.+.||+|++|.||++.+     ..++..+++|.++... .......+.+|+++++++ +||||+++++
T Consensus        28 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~  106 (302)
T cd05055          28 LKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLG  106 (302)
T ss_pred             ccccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEE
Confidence            45778888899999999999999999975     3345679999987543 233456788999999999 7999999999


Q ss_pred             eecCCCCCCCccEEEEEecCC-cchHHHhhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEE
Q 024959          109 IIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLK  185 (260)
Q Consensus       109 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~  185 (260)
                      .+...     ...+++|||+. ++|.+++....  .+++.++..++.|++.+|+|||+++++|+||+|+||+++.++.++
T Consensus       107 ~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~  181 (302)
T cd05055         107 ACTIG-----GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVK  181 (302)
T ss_pred             EEecC-----CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEE
Confidence            98776     45899999998 68999887543  389999999999999999999999999999999999999999999


Q ss_pred             EeecccccccCCCcc---cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 024959          186 IGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL  254 (260)
Q Consensus       186 l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~  254 (260)
                      |+|||++........   .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+.+..+.+
T Consensus       182 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~  253 (302)
T cd05055         182 ICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF  253 (302)
T ss_pred             ECCCcccccccCCCceeecCCCCcccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH
Confidence            999999876543321   112234677999999877 668899999999999999998 99999877655443

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2e-35  Score=238.83  Aligned_cols=201  Identities=31%  Similarity=0.482  Sum_probs=171.2

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc-cchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      .|.+.+.||+|++|.||++.+..++..+++|.+.... .......++.+|+++++.++||||+++++.+..+     ...
T Consensus         3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~   77 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-----NEL   77 (267)
T ss_pred             hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC-----CeE
Confidence            4667899999999999999999999999999885432 2333456788999999999999999999999876     558


Q ss_pred             EEEEecCC-cchHHHhhh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccC
Q 024959          122 YIVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~  196 (260)
                      +++||+++ ++|.+++..    ...+++..++.++.|++++|.+||++|++|+||+|+||+++.++.++|+|||++....
T Consensus        78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd08229          78 NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence            99999998 588887763    4568999999999999999999999999999999999999999999999999887654


Q ss_pred             CCcc-cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 024959          197 ETDF-MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  249 (260)
Q Consensus       197 ~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  249 (260)
                      .... .....++..|+|||.+.+ ...+.++|+||||+++|+|++|..||.+.+
T Consensus       158 ~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  210 (267)
T cd08229         158 SKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDK  210 (267)
T ss_pred             cCCcccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCccccc
Confidence            3322 223456788999999877 678899999999999999999999997554

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.3e-35  Score=248.30  Aligned_cols=213  Identities=46%  Similarity=0.856  Sum_probs=174.6

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCC----
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT----  117 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~----  117 (260)
                      ..|.+.+.||.|++|.||++.+..++..|++|.+.....  .....+.+|+++++.++||||+++++.+.......    
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV   82 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence            456689999999999999999999999999999865432  34566788999999999999999998877653211    


Q ss_pred             -----CccEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecc-CCCEEEeeccc
Q 024959          118 -----FNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGL  191 (260)
Q Consensus       118 -----~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~-~~~~~l~df~~  191 (260)
                           ....++++|+++++|.+.+. ...+++..++.++.|++++|.+||+.|++|+||+|+||+++. ++.++|+|||+
T Consensus        83 ~~~~~~~~~~lv~e~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~  161 (342)
T cd07854          83 GSLTELNSVYIVQEYMETDLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGL  161 (342)
T ss_pred             ccccccceEEEEeecccccHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCccc
Confidence                 13579999999988888765 357899999999999999999999999999999999999974 56789999999


Q ss_pred             ccccCCCc----ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          192 ARTTSETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       192 ~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      +.......    ......++..|+|||.+.....++.++|+||||+++|+|++|..||.+.+..+....+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~  231 (342)
T cd07854         162 ARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI  231 (342)
T ss_pred             ceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            87653321    1122345778999998766566788999999999999999999999888776655443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=3.9e-35  Score=236.59  Aligned_cols=201  Identities=30%  Similarity=0.477  Sum_probs=174.8

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~l  123 (260)
                      |.+.+.||+|++|.||++.+..++..+++|.++...........+.+|+.+++.++|+||+++++.+...     ..+++
T Consensus         2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~l   76 (264)
T cd06626           2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR-----EKVYI   76 (264)
T ss_pred             ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC-----CEEEE
Confidence            5678899999999999999998999999999976655445678888999999999999999999988765     56899


Q ss_pred             EEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCcccc
Q 024959          124 VYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT  202 (260)
Q Consensus       124 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~  202 (260)
                      |+|+++ ++|.+++.....+++..++.++.++++++.+||+.+++|+||+|+||+++.++.++|+|||++..........
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          77 FMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             EEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence            999998 6899998888789999999999999999999999999999999999999999999999999987755433221


Q ss_pred             -----cccccccccccccccCcC--CCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 024959          203 -----EYVVTRWYRAPELLLNCT--EYTAAIDIWSVGCILGEIMTREPLFPGKD  249 (260)
Q Consensus       203 -----~~~~~~~~~~PE~~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~~  249 (260)
                           ...++..|++||.+....  ..+.++|+||||++++++++|..||...+
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~  210 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD  210 (264)
T ss_pred             cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc
Confidence                 235578899999987632  27889999999999999999999997664

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3.1e-35  Score=246.10  Aligned_cols=208  Identities=29%  Similarity=0.493  Sum_probs=170.3

Q ss_pred             eEeccccCCCcccccccCceEEEEEEe-----CCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeeeecee
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVN-----SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDII  110 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~  110 (260)
                      |+++.+.|++.+.||+|+||.||++.+     ..+++.||+|.++... .......+.+|+.++.++ +||||+++++.+
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~   80 (343)
T cd05103           2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGAC   80 (343)
T ss_pred             cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence            778888999999999999999999984     3467889999996542 233456788899999999 589999999988


Q ss_pred             cCCCCCCCccEEEEEecCC-cchHHHhhhC--------------------------------------------------
Q 024959          111 RPPKKDTFNDVYIVYELMD-TDLHQIIRSD--------------------------------------------------  139 (260)
Q Consensus       111 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~--------------------------------------------------  139 (260)
                      ....    ...+++|||++ ++|.+++...                                                  
T Consensus        81 ~~~~----~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (343)
T cd05103          81 TKPG----GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEK  156 (343)
T ss_pred             ecCC----CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCC
Confidence            6542    35789999998 6888887542                                                  


Q ss_pred             -----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCccc-
Q 024959          140 -----------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM-  201 (260)
Q Consensus       140 -----------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~~-  201 (260)
                                       ..+++..+..++.|++++|+|||+++++|+||+|.||+++.++.++|+|||++......... 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  236 (343)
T cd05103         157 SLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV  236 (343)
T ss_pred             ccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchh
Confidence                             23677888999999999999999999999999999999999999999999998764332111 


Q ss_pred             --ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 024959          202 --TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDY  250 (260)
Q Consensus       202 --~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~  250 (260)
                        ....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.....
T Consensus       237 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~  287 (343)
T cd05103         237 RKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  287 (343)
T ss_pred             hcCCCCCCcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccc
Confidence              11223567999999877 678899999999999999997 9999977554

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=4.6e-35  Score=235.94  Aligned_cols=211  Identities=25%  Similarity=0.440  Sum_probs=173.6

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      |++....|++.+.||.|++|.||++.+..+. .+++|.+.....   ....+.+|++++++++|||++++++++..    
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----   72 (260)
T cd05069           1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVSE----   72 (260)
T ss_pred             CcCChHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEcC----
Confidence            4556667888999999999999999886654 589998864322   34567889999999999999999998754    


Q ss_pred             CCccEEEEEecCC-cchHHHhhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                        ...+++||+++ ++|.+++...  ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus        73 --~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~  150 (260)
T cd05069          73 --EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLAR  150 (260)
T ss_pred             --CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccce
Confidence              33689999998 5899998753  348899999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCccc--ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          194 TTSETDFM--TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       194 ~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      ........  ....++..|++||...+ ..++.++|+||||+++|+|++ |..||.+.+..+....+.
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~  217 (260)
T cd05069         151 LIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE  217 (260)
T ss_pred             EccCCcccccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            65433211  12234567999998876 678899999999999999999 999999887776665543

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.4e-35  Score=239.47  Aligned_cols=198  Identities=27%  Similarity=0.466  Sum_probs=173.6

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~  122 (260)
                      .|++.+.||.|++|.||++.++.+++.+++|.+..... .....++.+|++++++++||||+++++.+...     ..++
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~   75 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNN-----GDIS   75 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecC-----CEEE
Confidence            46678999999999999999999999999999876533 24556788999999999999999999998777     5699


Q ss_pred             EEEecCC-cchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEeccCCCEEEeecccccccCCCc
Q 024959          123 IVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (260)
Q Consensus       123 lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~  199 (260)
                      +++|+++ ++|.+++... ..+++..+..++.|+++++++||+ .+++|+||+|+||+++.++.++|+|||.+.......
T Consensus        76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          76 ICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             EEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            9999999 6999988775 789999999999999999999999 999999999999999999999999999886654332


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK  248 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  248 (260)
                      ... ..++..|++||.+.+ ..++.++|+||||+++++|++|..||...
T Consensus       156 ~~~-~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  202 (265)
T cd06605         156 AKT-FVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPE  202 (265)
T ss_pred             hhc-ccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence            222 556788999999877 67899999999999999999999999765

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.8e-35  Score=238.01  Aligned_cols=206  Identities=26%  Similarity=0.441  Sum_probs=175.0

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      ..|...+.||.|++|.||.+.+..++..+++|.+.... .......+.+|+++++.++||||+++++.+..+     ...
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   77 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG-----TKL   77 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----CEE
Confidence            34667899999999999999999999999999986542 234567788999999999999999999999876     569


Q ss_pred             EEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc-
Q 024959          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~-  199 (260)
                      ++|||+++ ++|.+++.. .++++..+..++.|++.++++||+.+++|+||+|+||+++.++.++|+|||++....... 
T Consensus        78 ~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          78 WIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             EEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            99999998 588887764 578999999999999999999999999999999999999999999999999987654332 


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  255 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~  255 (260)
                      ......++..|+|||.+.+ ...+.++|+||||+++|+|++|..||.+.+......
T Consensus       157 ~~~~~~~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~  211 (277)
T cd06640         157 KRNTFVGTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF  211 (277)
T ss_pred             ccccccCcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh
Confidence            1222345778999999876 678899999999999999999999998776554433

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-35  Score=245.57  Aligned_cols=204  Identities=41%  Similarity=0.684  Sum_probs=171.0

Q ss_pred             CCCcccccccCceEEEEEEeCC--CCeEEEEEecCCcc-cchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSE--TREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~--~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      |.+.+.||+|++|.||++.+..  ++..|++|.+.... ........+.+|+.+++.++||||+++++++.....   ..
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---~~   78 (316)
T cd07842           2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHAD---KS   78 (316)
T ss_pred             ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCC---ce
Confidence            5578889999999999999988  88999999997632 112233567789999999999999999999987633   45


Q ss_pred             EEEEEecCCcchHHHhhhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecc----CCCEEEeeccc
Q 024959          121 VYIVYELMDTDLHQIIRSD-----QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA----SCDLKIGDFGL  191 (260)
Q Consensus       121 ~~lv~e~~~~~l~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~----~~~~~l~df~~  191 (260)
                      +++|||++++++.+.+...     ..+++..++.++.|++.+|.+||+.+++|+||+|+||+++.    ++.++|+|||+
T Consensus        79 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~  158 (316)
T cd07842          79 VYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL  158 (316)
T ss_pred             EEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence            8999999998888776532     36899999999999999999999999999999999999999    89999999999


Q ss_pred             ccccCCCcc----cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024959          192 ARTTSETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (260)
Q Consensus       192 ~~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  250 (260)
                      +........    .....++..|+|||.+.+...++.++|+||||+++++|++|..||.+.+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~  221 (316)
T cd07842         159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA  221 (316)
T ss_pred             ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence            876544322    12335577899999887756678999999999999999999999987654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=5e-35  Score=248.59  Aligned_cols=215  Identities=27%  Similarity=0.434  Sum_probs=177.0

Q ss_pred             eecceeEeccccCCCcccccccCceEEEEEEeC-----CCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-CCCeee
Q 024959           32 VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNS-----ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIA  105 (260)
Q Consensus        32 ~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~  105 (260)
                      .+...|+++.+.+.+.+.||+|+||.||++.+.     .++..|++|+++... .....+.+.+|++++.++. ||||++
T Consensus        27 ~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~  105 (401)
T cd05107          27 PYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVN  105 (401)
T ss_pred             CCCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEE
Confidence            444679999999999999999999999999854     345689999997642 2333457889999999997 999999


Q ss_pred             eeceecCCCCCCCccEEEEEecCC-cchHHHhhhCC--------------------------------------------
Q 024959          106 IKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ--------------------------------------------  140 (260)
Q Consensus       106 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--------------------------------------------  140 (260)
                      +++.+..+     ...++|+||+. ++|.+++....                                            
T Consensus       106 ~~~~~~~~-----~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (401)
T cd05107         106 LLGACTKG-----GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMD  180 (401)
T ss_pred             EEEEEccC-----CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccc
Confidence            99999876     45899999998 68988875421                                            


Q ss_pred             ------------------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 024959          141 ------------------------------------------------------QLTDDHCQYFLYQLLRGLKYVHSASV  166 (260)
Q Consensus       141 ------------------------------------------------------~~~~~~~~~~~~~i~~~l~~lh~~~i  166 (260)
                                                                            .+++..+..++.|++.+|+|||+.++
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~i  260 (401)
T cd05107         181 MSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNC  260 (401)
T ss_pred             cCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCc
Confidence                                                                  25667788999999999999999999


Q ss_pred             eeccCCCCCeEeccCCCEEEeecccccccCCCcc---cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CC
Q 024959          167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-RE  242 (260)
Q Consensus       167 ~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~  242 (260)
                      +|+||+|.||+++.++.++|+|||++........   .....++..|++||.+.. ..++.++|+||||+++|+|++ |.
T Consensus       261 vHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~  339 (401)
T cd05107         261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGG  339 (401)
T ss_pred             CcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCC
Confidence            9999999999999999999999999876432211   112345678999999977 678899999999999999998 89


Q ss_pred             CCCCCCChHHH
Q 024959          243 PLFPGKDYVHQ  253 (260)
Q Consensus       243 ~pf~~~~~~~~  253 (260)
                      .||......+.
T Consensus       340 ~P~~~~~~~~~  350 (401)
T cd05107         340 TPYPELPMNEQ  350 (401)
T ss_pred             CCCCCCCchHH
Confidence            99987655443

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-37  Score=254.42  Aligned_cols=215  Identities=25%  Similarity=0.445  Sum_probs=194.0

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCc-ccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNA-FDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~  117 (260)
                      ....++.++..||-|+||.|=++..+.....+|+|++++. .-.....+....|-++|...+.|.||++|..|.++    
T Consensus       417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~----  492 (732)
T KOG0614|consen  417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDS----  492 (732)
T ss_pred             cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccc----
Confidence            3455677889999999999999988776666899988654 23444566677899999999999999999999998    


Q ss_pred             CccEEEEEecC-CcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccC
Q 024959          118 FNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (260)
Q Consensus       118 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~  196 (260)
                       ..+|++||.| +|.+...+++.+.|++.+.+.++.+++++++|||.+||++||+||+|.+++.+|.+||.|||+++...
T Consensus       493 -kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~  571 (732)
T KOG0614|consen  493 -KYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG  571 (732)
T ss_pred             -hhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc
Confidence             4589999987 47999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       197 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      ....+-+.+||+.|.|||.+.+ +..+..+|.|+||++++|||+|.+||.+-|...+...|.+
T Consensus       572 ~g~KTwTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILk  633 (732)
T KOG0614|consen  572 SGRKTWTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILK  633 (732)
T ss_pred             cCCceeeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHh
Confidence            9988889999999999999998 8889999999999999999999999999999988888753

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.8e-35  Score=240.11  Aligned_cols=202  Identities=28%  Similarity=0.436  Sum_probs=166.4

Q ss_pred             cccCCCcccccccCceEEEEEE----eCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAV----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~----~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      .+++.+.+.||+|++|+||++.    ...++..+++|.++... .......+.+|+++++.++||||+++++++..... 
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-   80 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG-   80 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC-
Confidence            4667889999999999998764    34567889999997542 22345667889999999999999999998765432 


Q ss_pred             CCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccccc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~  195 (260)
                        ...+++||+++ ++|.+++.. ..+++..++.++.|++.+|.+||+++++|+||+|+||+++.++.++|+|||++...
T Consensus        81 --~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  157 (283)
T cd05080          81 --KGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  157 (283)
T ss_pred             --ceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence              45899999998 588887765 45999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCccc----ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 024959          196 SETDFM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK  248 (260)
Q Consensus       196 ~~~~~~----~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  248 (260)
                      ......    ....++..|++||.+.+ ..++.++|+||||+++++|++|..||...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~  213 (283)
T cd05080         158 PEGHEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSP  213 (283)
T ss_pred             CCcchhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence            433211    11233566999999876 67889999999999999999999998643

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=7.2e-35  Score=240.39  Aligned_cols=205  Identities=28%  Similarity=0.469  Sum_probs=174.6

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc-cchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      .+.|.+.+.||+|++|.||++.+..+++.|++|.+.... ........+.+|+++++.++|||++++.+++...     .
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~-----~   88 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE-----H   88 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC-----C
Confidence            345778899999999999999999999999999985432 2333456788999999999999999999999876     5


Q ss_pred             cEEEEEecCCcchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          120 DVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       120 ~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      ..++|+|++++++.+.+.. ...+++..+..++.|++.+|.|||+.+++|+||+|.||+++.++.++|+|||++......
T Consensus        89 ~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          89 TAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             eEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            5899999999988887764 557999999999999999999999999999999999999999999999999988765433


Q ss_pred             cccccccccccccccccccC--cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024959          199 DFMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  253 (260)
Q Consensus       199 ~~~~~~~~~~~~~~PE~~~~--~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~  253 (260)
                      .   ...++..|+|||.+.+  ...++.++|+||||+++|+|++|..||.+.+....
T Consensus       169 ~---~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~  222 (307)
T cd06607         169 N---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA  222 (307)
T ss_pred             C---CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH
Confidence            2   3356778999998752  25578899999999999999999999987765443

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-35  Score=240.69  Aligned_cols=212  Identities=24%  Similarity=0.385  Sum_probs=172.3

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCC--------------CeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCee
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSET--------------REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI  104 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~--------------~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv  104 (260)
                      ++...|++.+.||+|+||.||++.+..+              ...|++|.+.... .......+.+|++++++++|||++
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~   80 (295)
T cd05097           2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNII   80 (295)
T ss_pred             CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcC
Confidence            4566788999999999999999987543              2358999987542 334456788999999999999999


Q ss_pred             eeeceecCCCCCCCccEEEEEecCC-cchHHHhhhC------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccC
Q 024959          105 AIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDL  171 (260)
Q Consensus       105 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di  171 (260)
                      ++++++...     ...++|||+++ ++|.+++...            ..+++..+..++.|++.+|.|||+.+++|+||
T Consensus        81 ~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dl  155 (295)
T cd05097          81 RLLGVCVSD-----DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDL  155 (295)
T ss_pred             eEEEEEcCC-----CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeecccc
Confidence            999999766     55899999998 5888887542            13688899999999999999999999999999


Q ss_pred             CCCCeEeccCCCEEEeecccccccCCCccc---ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh--CCCCCC
Q 024959          172 KPSNLLLNASCDLKIGDFGLARTTSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFP  246 (260)
Q Consensus       172 ~~~nili~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~--g~~pf~  246 (260)
                      +|+||+++.++.++|+|||++.........   ....++..|+|||.+.. ..++.++|+||||+++++|++  +..||.
T Consensus       156 kp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~~  234 (295)
T cd05097         156 ATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPYS  234 (295)
T ss_pred             ChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCCc
Confidence            999999999999999999998764332211   11233567999999877 678999999999999999988  778998


Q ss_pred             CCChHHHHHHh
Q 024959          247 GKDYVHQLRLI  257 (260)
Q Consensus       247 ~~~~~~~~~~i  257 (260)
                      ..+..+..+.+
T Consensus       235 ~~~~~~~~~~~  245 (295)
T cd05097         235 LLSDEQVIENT  245 (295)
T ss_pred             ccChHHHHHHH
Confidence            77765554443

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2e-35  Score=242.65  Aligned_cols=202  Identities=26%  Similarity=0.460  Sum_probs=172.5

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      .+.|.+.+.||+|++|.||++.+..++..|++|.+.....  .....+.+|+.+++.++||||+++++.+...     ..
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~   90 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVG-----DE   90 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----CE
Confidence            3557788999999999999999999999999999965432  2346678899999999999999999999876     56


Q ss_pred             EEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc
Q 024959          121 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~  199 (260)
                      .++||||++ ++|.+++.+ ..+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus        91 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~  169 (297)
T cd06656          91 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (297)
T ss_pred             EEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence            899999998 578777654 568899999999999999999999999999999999999999999999999987654332


Q ss_pred             c-cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH
Q 024959          200 F-MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  251 (260)
Q Consensus       200 ~-~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~  251 (260)
                      . .....+++.|++||.+.+ ..++.++|+||||+++|++++|..||.+.+..
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~  221 (297)
T cd06656         170 SKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL  221 (297)
T ss_pred             cCcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc
Confidence            2 223456788999999877 77889999999999999999999999776543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.4e-35  Score=243.51  Aligned_cols=206  Identities=26%  Similarity=0.486  Sum_probs=172.8

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~  122 (260)
                      .+.....||+|++|.||++.+..++..|++|.+.....  .....+.+|+.+++.++|||++++++.+..+     ...+
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~~~   94 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVG-----EELW   94 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeC-----CeEE
Confidence            34456679999999999999999999999999854322  2345678899999999999999999998876     5689


Q ss_pred             EEEecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc-c
Q 024959          123 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-F  200 (260)
Q Consensus       123 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~-~  200 (260)
                      +++|++++ +|.+.+ ....+++..++.++.|++++|.+||+.+++|+||+|.||+++.++.++|+|||++....... .
T Consensus        95 iv~e~~~~~~L~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~  173 (297)
T cd06659          95 VLMEFLQGGALTDIV-SQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK  173 (297)
T ss_pred             EEEecCCCCCHHHHH-hhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc
Confidence            99999984 666654 44678999999999999999999999999999999999999999999999999886544322 1


Q ss_pred             cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       201 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      .....++..|+|||.+.+ ..++.++|+||||+++++|++|+.||...+..+.+..+
T Consensus       174 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~  229 (297)
T cd06659         174 RKSLVGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL  229 (297)
T ss_pred             ccceecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            223456888999999977 67889999999999999999999999877766655544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=6.2e-35  Score=238.87  Aligned_cols=208  Identities=27%  Similarity=0.441  Sum_probs=170.4

Q ss_pred             CCCcccccccCceEEEEEEeCC-----CCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCC
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSE-----TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~  118 (260)
                      |++.+.||+|+||.||++.+..     ....+++|.+..... ......+.+|+.+++.++||||+++++.+...     
T Consensus         2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----   75 (290)
T cd05045           2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-SSELRDLLSEFNLLKQVNHPHVIKLYGACSQD-----   75 (290)
T ss_pred             ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC-----
Confidence            5678999999999999998753     235688888865432 23456788999999999999999999998776     


Q ss_pred             ccEEEEEecCC-cchHHHhhhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCC
Q 024959          119 NDVYIVYELMD-TDLHQIIRSD------------------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP  173 (260)
Q Consensus       119 ~~~~lv~e~~~-~~l~~~l~~~------------------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~  173 (260)
                      ...++++||+. ++|.+++...                        ..+++..++.++.|++.+|++||+.+++|+||+|
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp  155 (290)
T cd05045          76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAA  155 (290)
T ss_pred             CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhh
Confidence            45899999998 6888887542                        2478899999999999999999999999999999


Q ss_pred             CCeEeccCCCEEEeecccccccCCCcc---cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCC
Q 024959          174 SNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKD  249 (260)
Q Consensus       174 ~nili~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~  249 (260)
                      +||+++.++.++|+|||++........   ......+..|++||.+.+ ..++.++||||||+++++|++ |..||.+.+
T Consensus       156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  234 (290)
T cd05045         156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA  234 (290)
T ss_pred             heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence            999999999999999999875433221   112233567999999876 678999999999999999998 999999888


Q ss_pred             hHHHHHHhh
Q 024959          250 YVHQLRLIT  258 (260)
Q Consensus       250 ~~~~~~~i~  258 (260)
                      ....++.+.
T Consensus       235 ~~~~~~~~~  243 (290)
T cd05045         235 PERLFNLLK  243 (290)
T ss_pred             HHHHHHHHh
Confidence            776665543

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=5.3e-35  Score=235.59  Aligned_cols=211  Identities=25%  Similarity=0.471  Sum_probs=176.1

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      |++..+.|.+.+.||+|++|.||++.+.. +..+++|.+...   ......+.+|+++++.++|+||+++++.+..    
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----   72 (260)
T cd05073           1 WEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK----   72 (260)
T ss_pred             CcccccceeEEeEecCccceEEEEEEecC-CccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC----
Confidence            67788899999999999999999998654 456999988653   2245678899999999999999999998865    


Q ss_pred             CCccEEEEEecCC-cchHHHhhh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                        ...+++||+++ ++|.+++..  ...+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||.+.
T Consensus        73 --~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~  150 (260)
T cd05073          73 --EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR  150 (260)
T ss_pred             --CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCccee
Confidence              23789999997 699999876  3467888999999999999999999999999999999999999999999999887


Q ss_pred             ccCCCccc--ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          194 TTSETDFM--TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       194 ~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      ........  ....++..|+|||.+.. ..++.++|+||||++++++++ |..||.+.+..+..+.+.
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~  217 (260)
T cd05073         151 VIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE  217 (260)
T ss_pred             eccCCCcccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Confidence            65432211  12233567999999876 678889999999999999998 999999888776665543

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=6.8e-35  Score=236.21  Aligned_cols=212  Identities=26%  Similarity=0.412  Sum_probs=175.0

Q ss_pred             EeccccCCCcccccccCceEEEEEEeCCC---CeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSET---REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        38 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      ++....+.+.+.||+|++|.||++.+...   ...+++|....... ....+.+.+|+.+++.++||||+++++++... 
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-   79 (270)
T cd05056           2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-PSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-   79 (270)
T ss_pred             eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-
Confidence            45667788899999999999999987543   34689998865432 34556788999999999999999999988753 


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccc
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~  192 (260)
                           ..++|||+++ ++|.+++... ..+++..++.++.|++.+|++||+.+++|+||+|+||+++.++.++|+|||++
T Consensus        80 -----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~  154 (270)
T cd05056          80 -----PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLS  154 (270)
T ss_pred             -----CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCcee
Confidence                 3679999997 6999998764 46899999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCccccc--ccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHh
Q 024959          193 RTTSETDFMTE--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLI  257 (260)
Q Consensus       193 ~~~~~~~~~~~--~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  257 (260)
                      ...........  ...+..|+|||.+.. ..++.++|+||||++++++++ |..||.+.+..+....+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~  221 (270)
T cd05056         155 RYLEDESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI  221 (270)
T ss_pred             eecccccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence            76544322111  122457999998876 678899999999999999986 99999888876665554

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-35  Score=238.08  Aligned_cols=204  Identities=26%  Similarity=0.447  Sum_probs=173.2

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC---CCCeeeeeceecCCCCCCCc
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME---HENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~iv~~~~~~~~~~~~~~~  119 (260)
                      .|++.+.||+|++|.||++.+..++..+++|.+.... ......++.+|+++++.++   |||++++++.+...     .
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~-----~   75 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG-----P   75 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC-----C
Confidence            4667889999999999999999999999999986542 2334566778999999996   99999999998766     5


Q ss_pred             cEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          120 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       120 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      ..+++||+++ ++|.+++.. ..+++..++.++.|++++|.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          76 RLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             EEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            6899999997 588887755 47899999999999999999999999999999999999999999999999998765543


Q ss_pred             cc-cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024959          199 DF-MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  253 (260)
Q Consensus       199 ~~-~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~  253 (260)
                      .. .....++..|+|||.+.+...++.++|+||||+++|+|++|..||.+.+....
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~  210 (277)
T cd06917         155 SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA  210 (277)
T ss_pred             ccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh
Confidence            32 22335678899999987656678899999999999999999999987765443

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.6e-36  Score=236.47  Aligned_cols=206  Identities=42%  Similarity=0.692  Sum_probs=177.5

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCe----EEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETRE----EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      ...|+.++.||.|.||.||++..++++.    .+|||.++...+...-.....+|+.+++.++|||++.+..+|...+  
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d--  100 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD--  100 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC--
Confidence            4567889999999999999996555433    6899999876555555677889999999999999999999998742  


Q ss_pred             CCccEEEEEecCCcchHHHhhh-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccC----CCEEEe
Q 024959          117 TFNDVYIVYELMDTDLHQIIRS-----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS----CDLKIG  187 (260)
Q Consensus       117 ~~~~~~lv~e~~~~~l~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~----~~~~l~  187 (260)
                        ..+++++||.+-+|.+++.-     ...++...++.++.||+.++.|||++-+.|||+||.||++..+    |.+||+
T Consensus       101 --~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  101 --KKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             --ceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEee
Confidence              56999999999999888863     3469999999999999999999999999999999999999887    899999


Q ss_pred             ecccccccCCCcc----cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024959          188 DFGLARTTSETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (260)
Q Consensus       188 df~~~~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  250 (260)
                      |+|+++....+..    ......|..|.|||.+.+-..|++..|+|+.||++.||++-.+.|.+.+.
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~  245 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREE  245 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhh
Confidence            9999988766532    23346699999999999988899999999999999999999998876543

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=4.5e-35  Score=235.15  Aligned_cols=207  Identities=29%  Similarity=0.483  Sum_probs=179.2

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~l  123 (260)
                      |++.+.||.|++|.||++.++.+++.+++|.+............+.+|+++++.++||||+++++.+...     ...++
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~   76 (256)
T cd08530           2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG-----NKLCI   76 (256)
T ss_pred             ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC-----CEEEE
Confidence            5678899999999999999999999999999976544455567778999999999999999999999876     56899


Q ss_pred             EEecCC-cchHHHhhh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          124 VYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       124 v~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      |+|+++ ++|.+++..    ...+++..++.++.|++++|.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~  156 (256)
T cd08530          77 VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN  156 (256)
T ss_pred             EehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence            999997 588888765    467899999999999999999999999999999999999999999999999998776554


Q ss_pred             cccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          199 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       199 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                       ......++..|++||.+.+ ..++.++|+||||+++++|++|..||...+..+....+
T Consensus       157 -~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~  213 (256)
T cd08530         157 -MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV  213 (256)
T ss_pred             -CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence             2333456788999999877 67888999999999999999999999988876554443

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.8e-35  Score=240.66  Aligned_cols=202  Identities=25%  Similarity=0.439  Sum_probs=169.9

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-CCCeeeeeceecCCCCCCCcc
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      .+++..+.||+|++|.||++.+..++..+++|.+...... .....+.+|+..+.++. ||||+++++++..+     ..
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~-----~~   77 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE-----GD   77 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC-----Cc
Confidence            3556778999999999999999999999999998654322 44567788999999996 99999999998766     55


Q ss_pred             EEEEEecCCcchHHHhh-----hCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          121 VYIVYELMDTDLHQIIR-----SDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       121 ~~lv~e~~~~~l~~~l~-----~~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                      .+++||+++.++.++..     ....+++..+..++.|++++|+|||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus        78 ~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  157 (288)
T cd06616          78 CWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQ  157 (288)
T ss_pred             EEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHH
Confidence            88999999876655432     246799999999999999999999974 999999999999999999999999999876


Q ss_pred             cCCCcccccccccccccccccccCc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 024959          195 TSETDFMTEYVVTRWYRAPELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKD  249 (260)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  249 (260)
                      ...........++..|+|||.+.+.  ..++.++|+||||+++|+|++|+.||...+
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~  214 (288)
T cd06616         158 LVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN  214 (288)
T ss_pred             hccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc
Confidence            5544433444668889999998764  368899999999999999999999997654

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=6.7e-35  Score=234.29  Aligned_cols=207  Identities=29%  Similarity=0.504  Sum_probs=176.5

Q ss_pred             CCcccccccCceEEEEEEeCCCC----eEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           45 PPIRPIGRGAYGIVCAAVNSETR----EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      ++.+.||.|++|.||++.+..++    ..+++|.+..... ......+..|+.+++.++|+||+++++++...     +.
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~   75 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-----EP   75 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-----Ce
Confidence            56789999999999999998766    8899999965422 22567788999999999999999999999887     55


Q ss_pred             EEEEEecCC-cchHHHhhhCCC--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCC
Q 024959          121 VYIVYELMD-TDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~  197 (260)
                      .+++||+++ ++|.+++.....  +++..+..++.|++.+|++||+.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        76 ~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       76 LMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             eEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence            899999997 589998876554  99999999999999999999999999999999999999999999999999877655


Q ss_pred             Cccccc--ccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          198 TDFMTE--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       198 ~~~~~~--~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      ......  ..++..|++||...+ ..++.++|+||||+++++|++ |..||...+..+..+.+.
T Consensus       156 ~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~  218 (258)
T smart00219      156 DDYYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLK  218 (258)
T ss_pred             ccccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence            422221  224678999999865 778999999999999999998 899998887777666554

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=5.5e-35  Score=236.89  Aligned_cols=210  Identities=23%  Similarity=0.418  Sum_probs=172.8

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCCCC-C
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDT-F  118 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~-~  118 (260)
                      ...|++.+.||+|++|.||++.+..+++.+++|.+.....   ....+..|+.+++++ +|||++++++.+....... .
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            3456788999999999999999999999999999965432   234677899999998 6999999999987643221 2


Q ss_pred             ccEEEEEecCC-cchHHHhhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccccc
Q 024959          119 NDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (260)
Q Consensus       119 ~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~  195 (260)
                      ..++++||+++ ++|.+++...  ..+++..+..++.|++.++.|||+++++|+||+|.||+++.++.++|+|||++...
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~  161 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  161 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence            45899999998 5888888763  46899999999999999999999999999999999999999999999999998765


Q ss_pred             CCC-cccccccccccccccccccC----cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024959          196 SET-DFMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  253 (260)
Q Consensus       196 ~~~-~~~~~~~~~~~~~~PE~~~~----~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~  253 (260)
                      ... .......++..|+|||.+..    ...++.++|+||||+++|+|++|..||...+....
T Consensus       162 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~  224 (272)
T cd06637         162 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA  224 (272)
T ss_pred             ccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH
Confidence            432 22233466888999999863    24578899999999999999999999976554433

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.4e-35  Score=239.75  Aligned_cols=203  Identities=26%  Similarity=0.447  Sum_probs=172.2

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~  122 (260)
                      .|...+.||+|++|.||++.+..++..+++|.+..... ......+.+|+++++.++||||+++++.+..+     ...+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   78 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKG-----TKLW   78 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccC-----CceE
Confidence            45577889999999999999999999999999865422 33456788999999999999999999999876     5589


Q ss_pred             EEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCcc-
Q 024959          123 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-  200 (260)
Q Consensus       123 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~-  200 (260)
                      +|+|+++ ++|.+++. ...+++..++.++.|+++++.+||+++++|+||+|+||+++.++.++|+|||++........ 
T Consensus        79 lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06642          79 IIMEYLGGGSALDLLK-PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             EEEEccCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchh
Confidence            9999998 57777765 45789999999999999999999999999999999999999999999999999876544321 


Q ss_pred             cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024959          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  253 (260)
Q Consensus       201 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~  253 (260)
                      .....++..|++||.+.+ ..++.++|+||||+++|+|++|..||...+....
T Consensus       158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~  209 (277)
T cd06642         158 RNTFVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV  209 (277)
T ss_pred             hhcccCcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH
Confidence            122346778999999877 6788999999999999999999999976655443

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=8.3e-35  Score=235.57  Aligned_cols=204  Identities=26%  Similarity=0.382  Sum_probs=162.8

Q ss_pred             ccccccCceEEEEEEeCC--CCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEEEE
Q 024959           48 RPIGRGAYGIVCAAVNSE--TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY  125 (260)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv~  125 (260)
                      +.||+|+||.||++....  ....+++|.+.... .......+.+|++.++.++||||+++++.+...     ...++||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~-----~~~~lv~   74 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES-----IPYLLVL   74 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC-----CceEEEE
Confidence            368999999999996433  44568888875432 333456678899999999999999999998876     5589999


Q ss_pred             ecCC-cchHHHhhhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc
Q 024959          126 ELMD-TDLHQIIRSDQ-----QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (260)
Q Consensus       126 e~~~-~~l~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~  199 (260)
                      |+++ ++|.+++....     ..++..+..++.|++.+|+|||+++++|+||+|+||+++.++.++|+|||++.......
T Consensus        75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  154 (269)
T cd05042          75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED  154 (269)
T ss_pred             EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccch
Confidence            9998 69999887643     34677889999999999999999999999999999999999999999999886533221


Q ss_pred             c---cccccccccccccccccC------cCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHh
Q 024959          200 F---MTEYVVTRWYRAPELLLN------CTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLI  257 (260)
Q Consensus       200 ~---~~~~~~~~~~~~PE~~~~------~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  257 (260)
                      .   .....++..|+|||.+..      ...++.++|+||||+++|+|++ |..||......+.+.++
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~  222 (269)
T cd05042         155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV  222 (269)
T ss_pred             heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH
Confidence            1   122234567999998743      2456789999999999999999 88899888776665543

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.5e-35  Score=236.50  Aligned_cols=206  Identities=27%  Similarity=0.460  Sum_probs=172.2

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccc--------hHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN--------IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~--------~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~  115 (260)
                      |.+.+.||.|++|.||++.+..+++.+++|.++.....        ....+.+.+|+.+++.++|||++++++.+...  
T Consensus         3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--   80 (272)
T cd06629           3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE--   80 (272)
T ss_pred             eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC--
Confidence            45788999999999999999999999999988532111        11234567899999999999999999998776  


Q ss_pred             CCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          116 DTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       116 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                         ...++|+|+++ ++|.+++.....+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||++..
T Consensus        81 ---~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~  157 (272)
T cd06629          81 ---EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKK  157 (272)
T ss_pred             ---CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence               56899999997 68999998888899999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCc---ccccccccccccccccccCcC-CCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024959          195 TSETD---FMTEYVVTRWYRAPELLLNCT-EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  254 (260)
Q Consensus       195 ~~~~~---~~~~~~~~~~~~~PE~~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  254 (260)
                      .....   ......++..|++||.+.... .++.++|+||||++++++++|..||...+..+.+
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  221 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM  221 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHH
Confidence            54321   122334678899999987633 4788999999999999999999999766554433

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.6e-35  Score=236.72  Aligned_cols=211  Identities=26%  Similarity=0.382  Sum_probs=174.7

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCe----EEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETRE----EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      +....|.+.+.||+|++|.||++.++.++.    .+++|...... .......+.+|+..+++++||||+++++++..  
T Consensus         4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--   80 (279)
T cd05057           4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS--   80 (279)
T ss_pred             cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--
Confidence            345667788999999999999999876654    58999886543 24455678899999999999999999999875  


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccc
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~  192 (260)
                          ...++++|+++ ++|.+.+.. ...+++..+..++.|++.+|++||+++++|+||+|+||+++.++.++|+|||++
T Consensus        81 ----~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~  156 (279)
T cd05057          81 ----SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLA  156 (279)
T ss_pred             ----CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccc
Confidence                34789999997 699998876 456999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCccccc---ccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHh
Q 024959          193 RTTSETDFMTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLI  257 (260)
Q Consensus       193 ~~~~~~~~~~~---~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  257 (260)
                      ...........   ...+..|++||.+.. ..++.++|+||||++++++++ |..||.+.+..+..+.+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~  224 (279)
T cd05057         157 KLLDVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL  224 (279)
T ss_pred             ccccCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence            76553322111   122457999998866 678899999999999999998 99999988776655544

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1e-34  Score=237.70  Aligned_cols=214  Identities=26%  Similarity=0.410  Sum_probs=175.3

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCCCCCc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      ...|.+.+.||+|++|.||++.+..+++.+++|.+....   .....+.+|+.+++++ +|||++++++.+.........
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   97 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG   97 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence            455778899999999999999999999999999986431   2234566889999998 799999999998765443335


Q ss_pred             cEEEEEecCC-cchHHHhhh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          120 DVYIVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       120 ~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                      ..++|+||++ ++|.+++..    ...+++..++.++.|++.+|++||+.+++|+||+|+||+++.++.++|+|||++..
T Consensus        98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~  177 (291)
T cd06639          98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ  177 (291)
T ss_pred             eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence            6899999997 588887653    46789999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCc-ccccccccccccccccccCcC----CCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          195 TSETD-FMTEYVVTRWYRAPELLLNCT----EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       195 ~~~~~-~~~~~~~~~~~~~PE~~~~~~----~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      ..... ......++..|+|||.+....    .++.++|+||||+++|+|++|..||...+.......+
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~  245 (291)
T cd06639         178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI  245 (291)
T ss_pred             cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHH
Confidence            54332 122345678899999875422    3578999999999999999999999887765554443

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=6.6e-35  Score=238.48  Aligned_cols=211  Identities=24%  Similarity=0.401  Sum_probs=174.0

Q ss_pred             ccccCCCcccccccCceEEEEEEeCC-----CCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           40 SSKYVPPIRPIGRGAYGIVCAAVNSE-----TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      ...+|++.+.||+|++|.||++.++.     ++..+++|.+.... .......+.+|+.+++.++||||+++++++... 
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~-   80 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVG-   80 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-
Confidence            45668889999999999999998753     67789999987543 233456688899999999999999999998876 


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhhC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccC
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRSD----------------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDL  171 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~~----------------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di  171 (260)
                          ...++++|+++ ++|.+++...                      ..+++..++.++.|++.+|.+||+++++|+||
T Consensus        81 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl  156 (288)
T cd05050          81 ----KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDL  156 (288)
T ss_pred             ----CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccc
Confidence                45899999998 5898888642                      24788889999999999999999999999999


Q ss_pred             CCCCeEeccCCCEEEeecccccccCCCcc---cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 024959          172 KPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPG  247 (260)
Q Consensus       172 ~~~nili~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~  247 (260)
                      +|.||+++.++.++|+|||++........   ......+..|+|||...+ ..++.++|+||||+++|+|++ |..||.+
T Consensus       157 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p~~~  235 (288)
T cd05050         157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQPYYG  235 (288)
T ss_pred             cHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999998875433221   112233567999998876 678999999999999999998 8889988


Q ss_pred             CChHHHHHHh
Q 024959          248 KDYVHQLRLI  257 (260)
Q Consensus       248 ~~~~~~~~~i  257 (260)
                      .+..+..+.+
T Consensus       236 ~~~~~~~~~~  245 (288)
T cd05050         236 MAHEEVIYYV  245 (288)
T ss_pred             CCHHHHHHHH
Confidence            7777666554

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=8.1e-35  Score=237.44  Aligned_cols=200  Identities=26%  Similarity=0.473  Sum_probs=166.3

Q ss_pred             cccCCCcccccccCceEEEEEE----eCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAV----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~----~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      .+.+++.+.||+|+||.||.+.    +..++..|++|.+...  .......+.+|+++++.++||||+++++++..... 
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-   79 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR-   79 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC-
Confidence            4567789999999999999997    4567889999998653  34455678899999999999999999998765432 


Q ss_pred             CCccEEEEEecCC-cchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                        ..+++|+||++ ++|.+++... ..+++..++.++.|++.+|++||++|++|+||+|+||+++.++.++|+|||++..
T Consensus        80 --~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          80 --RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             --CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccc
Confidence              45899999997 6999988764 5689999999999999999999999999999999999999999999999999886


Q ss_pred             cCCCccc----ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 024959          195 TSETDFM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFP  246 (260)
Q Consensus       195 ~~~~~~~----~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~  246 (260)
                      .......    .....+..|+|||.+.+ ..++.++|+||||+++++|++|..|+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~  212 (284)
T cd05081         158 LPQDKEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSC  212 (284)
T ss_pred             ccCCCcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence            5433211    11122446899999876 678899999999999999999877654

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=9.5e-35  Score=236.45  Aligned_cols=194  Identities=26%  Similarity=0.444  Sum_probs=160.8

Q ss_pred             cccccCceEEEEEEeCCCCeEEEEEecCCcccch-HHHHHHHHHH---HHHHHcCCCCeeeeeceecCCCCCCCccEEEE
Q 024959           49 PIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI-IDARRTLREI---KLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV  124 (260)
Q Consensus        49 ~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~---~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv  124 (260)
                      .||+|++|.||++.+..+++.|++|.+....... .....+..|.   +.++...||+|+++++.+...     ...++|
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-----DKLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC-----CEEEEE
Confidence            4899999999999999999999999986542221 1112233333   344445799999999999877     558999


Q ss_pred             EecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCccccc
Q 024959          125 YELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE  203 (260)
Q Consensus       125 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  203 (260)
                      |||+. ++|.+++.....+++..++.++.|++++++|||+.+++|+||+|+||+++.++.++|+|||++....... ...
T Consensus        76 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-~~~  154 (278)
T cd05606          76 LDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHA  154 (278)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-CcC
Confidence            99997 5888888888889999999999999999999999999999999999999999999999999987554332 223


Q ss_pred             ccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 024959          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK  248 (260)
Q Consensus       204 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  248 (260)
                      ..++..|+|||.+.+...++.++|+||+|+++|+|++|..||.+.
T Consensus       155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~  199 (278)
T cd05606         155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH  199 (278)
T ss_pred             cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence            467889999999876456889999999999999999999999866

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-36  Score=234.63  Aligned_cols=195  Identities=27%  Similarity=0.449  Sum_probs=169.3

Q ss_pred             cccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-CCCeeeeeceecCCCCCCCccEEEEE
Q 024959           47 IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDVYIVY  125 (260)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~~~~~~lv~  125 (260)
                      .+.||.|+++.|--+.+..++..||||++.+...  ....+..+|++++...+ |+||+.++++|+++     ...|+||
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g--HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd-----~~FYLVf  155 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG--HSRSRVFREVETFYQCQGHKNILQLIEFFEDD-----TRFYLVF  155 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCc--hHHHHHHHHHHHHHHhcCCccHHHHHHHhccc-----ceEEEEE
Confidence            3579999999999999999999999999987633  35778899999999996 99999999999998     5599999


Q ss_pred             ecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCC---EEEeecccccccCCC---
Q 024959          126 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLARTTSET---  198 (260)
Q Consensus       126 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~---~~l~df~~~~~~~~~---  198 (260)
                      |.|. |+|.+.+.+...|++.++.++..+|+.+|.+||.+||.|||+||+|||-...+.   +||+||.+.......   
T Consensus       156 EKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~  235 (463)
T KOG0607|consen  156 EKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC  235 (463)
T ss_pred             ecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence            9997 699999999999999999999999999999999999999999999999966544   799999987543222   


Q ss_pred             -----cccccccccccccccccccC----cCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 024959          199 -----DFMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGK  248 (260)
Q Consensus       199 -----~~~~~~~~~~~~~~PE~~~~----~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  248 (260)
                           ....+.+|+-.|||||.+.-    -..|+.+.|+||||+++|-||+|++||.|+
T Consensus       236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~  294 (463)
T KOG0607|consen  236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH  294 (463)
T ss_pred             CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence                 12234567888999999742    256899999999999999999999999775

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=8.3e-35  Score=235.08  Aligned_cols=202  Identities=31%  Similarity=0.497  Sum_probs=171.6

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc-cchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      +.|.+.+.||+|++|.||++.+..+++.+++|.++... ........+.+|++++++++|++++++++.+...     +.
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~-----~~   76 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN-----NE   76 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC-----Ce
Confidence            35678899999999999999999999999999886422 2333467788999999999999999999999876     55


Q ss_pred             EEEEEecCC-cchHHHhhh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccccc
Q 024959          121 VYIVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~  195 (260)
                      .+++|||++ ++|.+++..    ...+++..++.++.+++++|.+||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~  156 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeec
Confidence            899999998 588888754    345899999999999999999999999999999999999999999999999998765


Q ss_pred             CCCc-ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 024959          196 SETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  249 (260)
Q Consensus       196 ~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  249 (260)
                      .... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||....
T Consensus       157 ~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~  210 (267)
T cd08224         157 SSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDK  210 (267)
T ss_pred             cCCCcccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCC
Confidence            4332 1223456788999999876 678899999999999999999999996543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-36  Score=258.17  Aligned_cols=198  Identities=31%  Similarity=0.480  Sum_probs=173.9

Q ss_pred             ccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEEEEec
Q 024959           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYEL  127 (260)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv~e~  127 (260)
                      -.||+|.||+||.+++..+...+|||.+....  ....+.+++|+.+.+.|+|.|||++++.+.++     +.+-|.||-
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~sen-----Gf~kIFMEq  653 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSEN-----GFFKIFMEQ  653 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCCC-----CeEEEEeec
Confidence            36999999999999999999999999997653  33567899999999999999999999998887     446789999


Q ss_pred             CC-cchHHHhhh-CCCC--CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecc-CCCEEEeecccccccCCC-ccc
Q 024959          128 MD-TDLHQIIRS-DQQL--TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSET-DFM  201 (260)
Q Consensus       128 ~~-~~l~~~l~~-~~~~--~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~-~~~~~l~df~~~~~~~~~-~~~  201 (260)
                      ++ |+|.++++. .+++  .+.++-.+-+||+++|.|||++.|+|||||-+||+|+. .|.+||+|||-+++...- ..+
T Consensus       654 VPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~T  733 (1226)
T KOG4279|consen  654 VPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCT  733 (1226)
T ss_pred             CCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccc
Confidence            98 699999886 6777  78889999999999999999999999999999999976 688999999999886654 455


Q ss_pred             ccccccccccccccccC-cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 024959          202 TEYVVTRWYRAPELLLN-CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  252 (260)
Q Consensus       202 ~~~~~~~~~~~PE~~~~-~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~  252 (260)
                      .+..||..|||||.+.. .+.|...+|||||||++.||.||++||-....++
T Consensus       734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq  785 (1226)
T KOG4279|consen  734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ  785 (1226)
T ss_pred             cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh
Confidence            66788999999999864 3668999999999999999999999997766543

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.9e-35  Score=240.10  Aligned_cols=203  Identities=23%  Similarity=0.375  Sum_probs=175.7

Q ss_pred             ccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCc
Q 024959           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      ....|++.+.||+|++|+||++.+..++..+++|++.... .......+.+|+++++.++||||+++++.+...     .
T Consensus         3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~   76 (284)
T cd06620           3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE-----N   76 (284)
T ss_pred             cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-----C
Confidence            4567888999999999999999999999999999886542 233456788999999999999999999999877     5


Q ss_pred             cEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEeccCCCEEEeecccccccCC
Q 024959          120 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (260)
Q Consensus       120 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~  197 (260)
                      .+++|+||++ ++|.+++...+.+++..++.++.+++.+|.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus        77 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~  156 (284)
T cd06620          77 NICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN  156 (284)
T ss_pred             EEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence            6899999998 5888888888889999999999999999999997 5899999999999999999999999998765433


Q ss_pred             CcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024959          198 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (260)
Q Consensus       198 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  250 (260)
                      .. .....++..|+|||.+.+ ..++.++|+||||+++|++++|..||...+.
T Consensus       157 ~~-~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~  207 (284)
T cd06620         157 SI-ADTFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFAFSNI  207 (284)
T ss_pred             hc-cCccccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence            22 223466889999999876 6788999999999999999999999986554

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-34  Score=233.29  Aligned_cols=201  Identities=27%  Similarity=0.443  Sum_probs=167.2

Q ss_pred             ccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHH-HHHcCCCCeeeeeceecCCCCCCCccEEEEE
Q 024959           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKL-LRHMEHENVIAIKDIIRPPKKDTFNDVYIVY  125 (260)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~-l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv~  125 (260)
                      +.||.|++|.||++.+..+++.+++|.+..... .......+..|..+ ....+|||++++++.+...     ..+++++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSK-----DYLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcC-----CeEEEEE
Confidence            579999999999999999999999999865321 11222233444443 3445799999999999876     5699999


Q ss_pred             ecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCcccccc
Q 024959          126 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY  204 (260)
Q Consensus       126 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~  204 (260)
                      ||++ ++|.+++.....+++..+..++.|++++|.+||+.+++|+||+|.||+++.++.++|+|||++......   ...
T Consensus        77 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~~~  153 (260)
T cd05611          77 EYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN---KKF  153 (260)
T ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceecccc---ccC
Confidence            9997 599999988888999999999999999999999999999999999999999999999999988765432   233


Q ss_pred             cccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          205 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       205 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      .++..|++||.+.+ ..++.++|+||||+++|+|++|..||...+..+....+
T Consensus       154 ~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~  205 (260)
T cd05611         154 VGTPDYLAPETILG-VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI  205 (260)
T ss_pred             CCCcCccChhhhcC-CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            46778999999887 55889999999999999999999999988876665554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.2e-34  Score=232.71  Aligned_cols=207  Identities=31%  Similarity=0.524  Sum_probs=180.0

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~l  123 (260)
                      |.+.+.||.|++|.||++.+..++..+++|.+............+.+|+++++.++|||++++.+.+...     ...++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-----~~~~l   76 (258)
T cd08215           2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-----GKLCI   76 (258)
T ss_pred             ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-----CEEEE
Confidence            5678899999999999999999999999999977655556677788999999999999999999998876     56899


Q ss_pred             EEecCC-cchHHHhhhC----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          124 VYELMD-TDLHQIIRSD----QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       124 v~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      ++|+++ ++|.+.+...    ..+++..+..++.+++++|.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  156 (258)
T cd08215          77 VMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST  156 (258)
T ss_pred             EEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence            999998 5898888763    77999999999999999999999999999999999999999999999999998766554


Q ss_pred             c-ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 024959          199 D-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  256 (260)
Q Consensus       199 ~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  256 (260)
                      . ......+++.|+|||.... ..++.++|+||+|+++++|++|..||...+..+....
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~  214 (258)
T cd08215         157 VDLAKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALK  214 (258)
T ss_pred             cceecceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHH
Confidence            3 2233466888999999877 6688999999999999999999999988776555444

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2e-34  Score=238.75  Aligned_cols=208  Identities=29%  Similarity=0.474  Sum_probs=175.1

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc-cchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      ..|...+.||+|++|.||++.+..++..+++|.+.... ........+.+|+++++.++|||++++++++...     ..
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~   99 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE-----HT   99 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC-----Ce
Confidence            34667889999999999999999999999999986432 2334456788899999999999999999999876     55


Q ss_pred             EEEEEecCCcchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc
Q 024959          121 VYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (260)
Q Consensus       121 ~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~  199 (260)
                      .++||||+++++.+.+.. ..++++..+..++.|++.++.+||+++++|+||+|+||+++.++.++|+|||++...... 
T Consensus       100 ~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-  178 (317)
T cd06635         100 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-  178 (317)
T ss_pred             EEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence            899999999988887754 567899999999999999999999999999999999999999999999999988654432 


Q ss_pred             ccccccccccccccccccC--cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          200 FMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~--~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                        ....++..|+|||.+..  ....+.++|+||||+++|+|++|..||...+.......+
T Consensus       179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~  236 (317)
T cd06635         179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI  236 (317)
T ss_pred             --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence              23456788999999742  255788999999999999999999999877665544443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.1e-34  Score=233.13  Aligned_cols=203  Identities=27%  Similarity=0.415  Sum_probs=170.1

Q ss_pred             ccccccCceEEEEEEeCC-CC--eEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEEE
Q 024959           48 RPIGRGAYGIVCAAVNSE-TR--EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV  124 (260)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~-~~--~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv  124 (260)
                      +.||+|++|.||++.+.. .+  ..+++|.+...... .....+.+|++.+++++||||+++++.+..      ...+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v   73 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMV   73 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEE
Confidence            468999999999998765 33  35899999765433 566788899999999999999999999876      347999


Q ss_pred             EecCC-cchHHHhhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCcc-
Q 024959          125 YELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-  200 (260)
Q Consensus       125 ~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~-  200 (260)
                      +|+++ ++|.+.+....  .+++..++.++.|++++|++||+++++|+||+|+||+++.++.++|+|||++........ 
T Consensus        74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  153 (257)
T cd05040          74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH  153 (257)
T ss_pred             EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc
Confidence            99997 69999987754  689999999999999999999999999999999999999999999999999876544221 


Q ss_pred             ---cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          201 ---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       201 ---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                         .....++..|+|||.+.. ..++.++|+||||+++++|++ |..||...+..+..+.+.
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~  214 (257)
T cd05040         154 YVMEEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID  214 (257)
T ss_pred             eecccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence               112234678999999876 678899999999999999998 999998877777665543

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.1e-34  Score=238.95  Aligned_cols=208  Identities=22%  Similarity=0.351  Sum_probs=170.3

Q ss_pred             ccccCCCcccccccCceEEEEEEeCCCCe----EEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC
Q 024959           40 SSKYVPPIRPIGRGAYGIVCAAVNSETRE----EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~  115 (260)
                      ....++..+.||+|++|.||++.+..++.    .+++|.+.... .......+.+|+.+++.++||||+++++++...  
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--   81 (303)
T cd05110           5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP--   81 (303)
T ss_pred             chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC--
Confidence            45567788999999999999999877765    47888886542 233345678899999999999999999988653  


Q ss_pred             CCCccEEEEEecCC-cchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          116 DTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       116 ~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                          ..++++|+++ ++|.+.+... ..+++..+..++.|++.+|.|||+++++|+||+|+||+++.++.++|+|||++.
T Consensus        82 ----~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~  157 (303)
T cd05110          82 ----TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLAR  157 (303)
T ss_pred             ----CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccc
Confidence                2568899998 6899888764 468999999999999999999999999999999999999999999999999997


Q ss_pred             ccCCCcc---cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 024959          194 TTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLR  255 (260)
Q Consensus       194 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~  255 (260)
                      .......   .....++..|++||.+.+ ..++.++|+||||+++|++++ |..||.+....+..+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~  222 (303)
T cd05110         158 LLEGDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD  222 (303)
T ss_pred             cccCcccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            6543321   112234568999999876 778999999999999999997 999998776554433

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.2e-34  Score=230.55  Aligned_cols=202  Identities=25%  Similarity=0.437  Sum_probs=167.3

Q ss_pred             ccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEEEEec
Q 024959           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYEL  127 (260)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv~e~  127 (260)
                      +.||+|++|.||++... ++..+++|.+..... ......+.+|+++++.++||||+++++++...     ...++|||+
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~   73 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLP-QELKIKFLSEARILKQYDHPNIVKLIGVCTQR-----QPIYIVMEL   73 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC-----CccEEEEEC
Confidence            36899999999999865 578899999876532 33445688999999999999999999999776     458999999


Q ss_pred             CC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCcccc--c
Q 024959          128 MD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT--E  203 (260)
Q Consensus       128 ~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~--~  203 (260)
                      ++ ++|.+++.. ...+++..+..++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||++..........  .
T Consensus        74 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (250)
T cd05085          74 VPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL  153 (250)
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence            97 688888765 4568999999999999999999999999999999999999999999999999886543332111  1


Q ss_pred             ccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHh
Q 024959          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLI  257 (260)
Q Consensus       204 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  257 (260)
                      ...+..|+|||.+.. ..++.++|+||||+++|++++ |..||.+.+.......+
T Consensus       154 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~  207 (250)
T cd05085         154 KQIPIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV  207 (250)
T ss_pred             CCCcccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence            122567999999876 678899999999999999998 99999888776655544

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.1e-34  Score=236.21  Aligned_cols=213  Identities=24%  Similarity=0.388  Sum_probs=175.2

Q ss_pred             eccccCCCcccccccCceEEEEEEeCC----CCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSE----TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      +....|.+.+.||+|+||.||++.+..    ++..+++|.+... ........+.+|+.++++++||||+++++++....
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   81 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG   81 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            456677788999999999999999876    3577999988643 34455677889999999999999999999876542


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEE
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRSD--------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLK  185 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~~--------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~  185 (260)
                          ...++++|+++ ++|.+++...        ..+++..++.++.|++.+|+|||+++++|+||+|+||+++.++.++
T Consensus        82 ----~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~k  157 (280)
T cd05043          82 ----EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVK  157 (280)
T ss_pred             ----CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEE
Confidence                44789999987 6888887653        4589999999999999999999999999999999999999999999


Q ss_pred             EeecccccccCCCccc---ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHh
Q 024959          186 IGDFGLARTTSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLI  257 (260)
Q Consensus       186 l~df~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  257 (260)
                      |+|||+++........   ....++..|+|||.+.+ ..++.++||||||+++|++++ |..||...+..+....+
T Consensus       158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~  232 (280)
T cd05043         158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYL  232 (280)
T ss_pred             ECCCCCcccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHH
Confidence            9999998765433211   12234567999999877 678999999999999999999 99999877765544433

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.9e-34  Score=230.57  Aligned_cols=203  Identities=30%  Similarity=0.519  Sum_probs=177.3

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~  122 (260)
                      +|+..+.||+|++|.||++.+..++..+++|++.....  .....+.+|+++++.++||+++++++.+...     ...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   73 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKK-----DELW   73 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEE
Confidence            35678899999999999999998999999999976433  3567788999999999999999999999877     5589


Q ss_pred             EEEecCC-cchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCcc
Q 024959          123 IVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  200 (260)
Q Consensus       123 lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~  200 (260)
                      +++|+++ ++|.+++... ..+++..+..++.|+++++.+||+.+++|+||+|+||+++.++.++|+|||.+........
T Consensus        74 l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  153 (253)
T cd05122          74 IVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA  153 (253)
T ss_pred             EEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence            9999999 6899888776 6899999999999999999999999999999999999999999999999999877665443


Q ss_pred             cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024959          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  253 (260)
Q Consensus       201 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~  253 (260)
                      .....++..|++||.+.+ ..++.++|+||||+++++|++|..||...+..+.
T Consensus       154 ~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~  205 (253)
T cd05122         154 RNTMVGTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYSELPPMKA  205 (253)
T ss_pred             ccceecCCcccCHHHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH
Confidence            344566888999999887 5688999999999999999999999987744333

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-34  Score=235.16  Aligned_cols=213  Identities=26%  Similarity=0.448  Sum_probs=175.2

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCC-CCC
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKK-DTF  118 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~-~~~  118 (260)
                      .+.|++.+.||+|++|.||++.++.+++.+++|.+.....   ....+.+|+.+++++ +|+||+++++.+..... ...
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            4667889999999999999999999999999999865422   346688999999999 69999999999876543 223


Q ss_pred             ccEEEEEecCC-cchHHHhhh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          119 NDVYIVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       119 ~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                      ..++++||+++ ++|.+++..    +..+++..++.++.|++++|.+||+.+++|+||+|+||+++.++.++|+|||++.
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~  161 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA  161 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence            56899999998 488887764    4579999999999999999999999999999999999999999999999999886


Q ss_pred             ccCCCc-ccccccccccccccccccCc----CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 024959          194 TTSETD-FMTEYVVTRWYRAPELLLNC----TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  256 (260)
Q Consensus       194 ~~~~~~-~~~~~~~~~~~~~PE~~~~~----~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  256 (260)
                      ...... ......++..|+|||.+...    ..++.++|+||||+++++|++|..||...+......+
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~  229 (275)
T cd06608         162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK  229 (275)
T ss_pred             ecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHH
Confidence            544322 22334567889999987532    3467889999999999999999999987655444433

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.1e-34  Score=236.16  Aligned_cols=195  Identities=26%  Similarity=0.446  Sum_probs=160.4

Q ss_pred             cccccCceEEEEEEeCCCCeEEEEEecCCcccchH-HHHHHHHHHHHHHH---cCCCCeeeeeceecCCCCCCCccEEEE
Q 024959           49 PIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII-DARRTLREIKLLRH---MEHENVIAIKDIIRPPKKDTFNDVYIV  124 (260)
Q Consensus        49 ~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~-~~~~~~~e~~~l~~---l~~~~iv~~~~~~~~~~~~~~~~~~lv  124 (260)
                      .||+|+||.||++.+..+++.+++|.+........ ....+.++..+++.   .+||+++.+++.+...     +..++|
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP-----DKLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC-----CeEEEE
Confidence            48999999999999999999999998865432211 12223344444443   4699999999999876     458999


Q ss_pred             EecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCccccc
Q 024959          125 YELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE  203 (260)
Q Consensus       125 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  203 (260)
                      |||++ ++|.+++..+..+++..+..++.|++.+|++||+.+++|+||+|+||+++.++.++|+|||++....... ...
T Consensus        76 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~  154 (279)
T cd05633          76 LDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHA  154 (279)
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccC
Confidence            99998 6888888888889999999999999999999999999999999999999999999999999986554332 223


Q ss_pred             ccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 024959          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  249 (260)
Q Consensus       204 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  249 (260)
                      ..++..|+|||.+.....++.++|+||+|+++++|++|..||...+
T Consensus       155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  200 (279)
T cd05633         155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK  200 (279)
T ss_pred             cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCC
Confidence            4578899999998654667899999999999999999999997543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1e-34  Score=238.32  Aligned_cols=210  Identities=24%  Similarity=0.410  Sum_probs=170.4

Q ss_pred             eccccCCCcccccccCceEEEEEEeCC----------------CCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSE----------------TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN  102 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~----------------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~  102 (260)
                      +..+.|++.+.||+|++|.||++.+..                ++..+++|.+... .......++.+|+++++.++|+|
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~~E~~~l~~l~~~~   80 (296)
T cd05095           2 FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-ANKNARNDFLKEIKIMSRLKDPN   80 (296)
T ss_pred             CChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCC
Confidence            345668899999999999999986432                3456899998654 23344567889999999999999


Q ss_pred             eeeeeceecCCCCCCCccEEEEEecCC-cchHHHhhhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCceecc
Q 024959          103 VIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ-----------QLTDDHCQYFLYQLLRGLKYVHSASVLHRD  170 (260)
Q Consensus       103 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-----------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~d  170 (260)
                      |+++++++...     ...+++||+++ ++|.+++....           .+++.++..++.|++.+|++||+.|++|+|
T Consensus        81 i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~d  155 (296)
T cd05095          81 IIRLLAVCITS-----DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRD  155 (296)
T ss_pred             cceEEEEEecC-----CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeeccc
Confidence            99999999776     45899999997 68988886532           367788999999999999999999999999


Q ss_pred             CCCCCeEeccCCCEEEeecccccccCCCccc---ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh--CCCCC
Q 024959          171 LKPSNLLLNASCDLKIGDFGLARTTSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLF  245 (260)
Q Consensus       171 i~~~nili~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~--g~~pf  245 (260)
                      |+|+||+++.++.++|+|||++.........   .....+..|++||.... ..++.++|+||||+++|+|++  |..||
T Consensus       156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~  234 (296)
T cd05095         156 LATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPY  234 (296)
T ss_pred             CChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCc
Confidence            9999999999999999999998765433211   11223567999998876 678999999999999999998  77899


Q ss_pred             CCCChHHHHH
Q 024959          246 PGKDYVHQLR  255 (260)
Q Consensus       246 ~~~~~~~~~~  255 (260)
                      ...+..+...
T Consensus       235 ~~~~~~~~~~  244 (296)
T cd05095         235 SQLSDEQVIE  244 (296)
T ss_pred             cccChHHHHH
Confidence            8766655443

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.2e-34  Score=236.59  Aligned_cols=212  Identities=24%  Similarity=0.399  Sum_probs=173.1

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDT  117 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~  117 (260)
                      .....|++.+.||+|++|.||++.+..+++.+++|++....   .....+.+|+++++.+ +||||+++++.+.......
T Consensus        15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   91 (286)
T cd06638          15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN   91 (286)
T ss_pred             CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence            34556778999999999999999999999999999885421   1234567899999999 6999999999886544333


Q ss_pred             CccEEEEEecCC-cchHHHhh----hCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccc
Q 024959          118 FNDVYIVYELMD-TDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (260)
Q Consensus       118 ~~~~~lv~e~~~-~~l~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~  192 (260)
                      ....+++|||++ ++|.+++.    ....+++..++.++.|++++|.+||+.+++|+||+|+||+++.++.++|+|||++
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~  171 (286)
T cd06638          92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS  171 (286)
T ss_pred             CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence            367899999997 58877764    3456899999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCc-ccccccccccccccccccC----cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024959          193 RTTSETD-FMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  253 (260)
Q Consensus       193 ~~~~~~~-~~~~~~~~~~~~~PE~~~~----~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~  253 (260)
                      ....... ......++..|+|||.+..    ...++.++|+||||+++|+|++|..||...+....
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~  237 (286)
T cd06638         172 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA  237 (286)
T ss_pred             eecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH
Confidence            7654322 2223457888999998753    14478899999999999999999999987665443

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.6e-34  Score=234.54  Aligned_cols=212  Identities=23%  Similarity=0.398  Sum_probs=174.8

Q ss_pred             ccccCCCcccccccCceEEEEEEeCC-----CCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           40 SSKYVPPIRPIGRGAYGIVCAAVNSE-----TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      ....|.+++.||.|+||.||++..+.     +...+++|.+.... .......+.+|++++++++||||+++++++... 
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-   80 (275)
T cd05046           3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA-   80 (275)
T ss_pred             ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC-
Confidence            34677889999999999999999754     34679999886532 223456788999999999999999999998776 


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhhCC---------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCE
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRSDQ---------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL  184 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~  184 (260)
                          ...++|||+++ ++|.+++....         .+++..+..++.|++++|+|||+.+++|+||+|+||+++.++.+
T Consensus        81 ----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~  156 (275)
T cd05046          81 ----EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREV  156 (275)
T ss_pred             ----CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcE
Confidence                45899999998 69999987655         68999999999999999999999999999999999999999999


Q ss_pred             EEeecccccccCCCc--ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          185 KIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       185 ~l~df~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      +++||+++.......  ......++..|++||.+.+ ...+.++|+||||++++++++ |..||.+.+....+..+.
T Consensus       157 ~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~  232 (275)
T cd05046         157 KVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ  232 (275)
T ss_pred             EEcccccccccCcccccccCCceeEEeecChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHH
Confidence            999999876543221  1122344677999999876 567889999999999999998 888998776666555543

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-34  Score=230.31  Aligned_cols=205  Identities=31%  Similarity=0.526  Sum_probs=179.0

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~l  123 (260)
                      |++.+.||+|++|.||++.+..+++.+++|.+............+.+|++++++++|||++++++++...     +..++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~   76 (254)
T cd06627           2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS-----DSLYI   76 (254)
T ss_pred             ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC-----CEEEE
Confidence            5678999999999999999999999999999977655445677889999999999999999999998766     56899


Q ss_pred             EEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCcc-c
Q 024959          124 VYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-M  201 (260)
Q Consensus       124 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~-~  201 (260)
                      ++|+++ ++|.+++.....+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||++........ .
T Consensus        77 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  156 (254)
T cd06627          77 ILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD  156 (254)
T ss_pred             EEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccc
Confidence            999998 58999988888999999999999999999999999999999999999999999999999999877655432 2


Q ss_pred             ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024959          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  254 (260)
Q Consensus       202 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  254 (260)
                      ....++..|++||.... ..++.++|+|+||+++++|++|..||...+.....
T Consensus       157 ~~~~~~~~y~~pe~~~~-~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~  208 (254)
T cd06627         157 ASVVGTPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL  208 (254)
T ss_pred             cccccchhhcCHhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH
Confidence            23456788999999877 55789999999999999999999999876654433

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.1e-35  Score=257.93  Aligned_cols=200  Identities=26%  Similarity=0.409  Sum_probs=157.2

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCe-EEEEE--------------ec-CCcccchHHHHHHHHHHHHHHHcCCCCee
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETRE-EVAIK--------------KI-GNAFDNIIDARRTLREIKLLRHMEHENVI  104 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~-~~~iK--------------~~-~~~~~~~~~~~~~~~e~~~l~~l~~~~iv  104 (260)
                      ...|++++.||+|+||+||++..+.... ..+.|              .+ +...........+.+|+.+++.++||||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            3568899999999999999987643221 11111              11 11111222345677899999999999999


Q ss_pred             eeeceecCCCCCCCccEEEEEecCCcchHHHhhhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec
Q 024959          105 AIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-----QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN  179 (260)
Q Consensus       105 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~  179 (260)
                      ++++++...     ...|++++++++++.+++...     .......++.++.|++.+|+|||++|++|+||||+|||++
T Consensus       227 ~l~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~  301 (501)
T PHA03210        227 KIEEILRSE-----ANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN  301 (501)
T ss_pred             cEeEEEEEC-----CeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence            999999877     558999999998888876542     2344667888999999999999999999999999999999


Q ss_pred             cCCCEEEeecccccccCCCc--ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCC-CCC
Q 024959          180 ASCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREP-LFP  246 (260)
Q Consensus       180 ~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~-pf~  246 (260)
                      .++.++|+|||++.......  ......++..|+|||.+.+ ..++.++|||||||++|+|++|.. ||.
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~~~~~p~~  370 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIG  370 (501)
T ss_pred             CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCcc
Confidence            99999999999997654432  2223567999999999987 678999999999999999999875 443

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=8.9e-35  Score=238.42  Aligned_cols=211  Identities=16%  Similarity=0.167  Sum_probs=162.8

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCCC---CeEEEEEecCCcccchHHH---------HHHHHHHHHHHHcCCCCee
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSET---REEVAIKKIGNAFDNIIDA---------RRTLREIKLLRHMEHENVI  104 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~---~~~~~iK~~~~~~~~~~~~---------~~~~~e~~~l~~l~~~~iv  104 (260)
                      .++..+.|.+.+.||+|+||.||++.+..+   +..+++|+...........         .....+...+..++|++++
T Consensus         7 ~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~   86 (294)
T PHA02882          7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP   86 (294)
T ss_pred             eccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence            445667788899999999999999998877   6677777653322111100         1122333445566899999


Q ss_pred             eeeceecCCCCCCCccEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCE
Q 024959          105 AIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL  184 (260)
Q Consensus       105 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~  184 (260)
                      ++++........ ....+++++.+..++.+.+......++..+..++.|++++|++||+.+++||||||+||+++.++.+
T Consensus        87 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         87 KYYGCGSFKRCR-MYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             cEEEeeeEecCC-ceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence            999876543211 1235788888888888777766667889999999999999999999999999999999999999999


Q ss_pred             EEeecccccccCCCc--------ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 024959          185 KIGDFGLARTTSETD--------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  249 (260)
Q Consensus       185 ~l~df~~~~~~~~~~--------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  249 (260)
                      +|+|||++.......        ......+++.|+|||.+.+ ..++.++||||||+++++|++|..||.+.+
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~  237 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFG  237 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence            999999987653221        1122357899999999887 778999999999999999999999998774

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=9.2e-35  Score=236.31  Aligned_cols=209  Identities=29%  Similarity=0.481  Sum_probs=179.0

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcC-CCCeeeeeceecCCCCCCCcc
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      .|.+.+.||+|++|.||++.+..++..+++|++..... .......+.+|.+++++++ ||||+++++++...     ..
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-----~~   76 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE-----EN   76 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC-----ce
Confidence            46688899999999999999999999999999965322 2334466778999999998 99999999998776     55


Q ss_pred             EEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc
Q 024959          121 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~  199 (260)
                      .+++||+++ ++|.+.+.+...+++..++.++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~  156 (280)
T cd05581          77 LYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS  156 (280)
T ss_pred             EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence            899999995 7999999988899999999999999999999999999999999999999999999999999987654432


Q ss_pred             c---------------------cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          200 F---------------------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       200 ~---------------------~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      .                     .....++..|++||.... ..++.++|+||||++++++++|..||...+....++.+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~  234 (280)
T cd05581         157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI  234 (280)
T ss_pred             ccccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence            1                     112244678999999877 66888999999999999999999999988776665554

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.6e-34  Score=235.88  Aligned_cols=208  Identities=30%  Similarity=0.521  Sum_probs=179.0

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      ...|+..+.||+|++|.||++.+..++..+++|.+.....   ....+.+|++.++.++|+|++++++.+...     ..
T Consensus        18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~   89 (286)
T cd06614          18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVG-----DE   89 (286)
T ss_pred             cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-----CE
Confidence            4456788999999999999999998899999999965433   456778899999999999999999999877     56


Q ss_pred             EEEEEecCC-cchHHHhhhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          121 VYIVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      .++++|+++ ++|.+++.... .+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  169 (286)
T cd06614          90 LWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE  169 (286)
T ss_pred             EEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence            899999999 69999998876 8999999999999999999999999999999999999999999999999987654432


Q ss_pred             c-ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          199 D-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       199 ~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      . ......++..|++||.+.+ ..++.++|+||||+++|+|++|..||...+.......+
T Consensus       170 ~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~  228 (286)
T cd06614         170 KSKRNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI  228 (286)
T ss_pred             hhhhccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            2 1223345778999999876 67889999999999999999999999887766555443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-34  Score=229.89  Aligned_cols=202  Identities=28%  Similarity=0.453  Sum_probs=168.7

Q ss_pred             ccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEEEEec
Q 024959           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYEL  127 (260)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv~e~  127 (260)
                      +.||+|++|.||++.+.. ++.+++|.+...... .....+.+|+++++.++||||+++++++...     ...++|+|+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v~e~   73 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQK-----QPIYIVMEL   73 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecC-----CCeEEEEEc
Confidence            468999999999999887 899999998765333 4566788999999999999999999998876     558999999


Q ss_pred             CC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCcccc---
Q 024959          128 MD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT---  202 (260)
Q Consensus       128 ~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~---  202 (260)
                      ++ ++|.+++.. ...+++..+..++.+++.+|.+||+++++|+||+|+||+++.++.++|+|||++..........   
T Consensus        74 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (251)
T cd05041          74 VPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG  153 (251)
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence            97 689888865 4568999999999999999999999999999999999999999999999999987654221111   


Q ss_pred             cccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHh
Q 024959          203 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLI  257 (260)
Q Consensus       203 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  257 (260)
                      ....+..|+|||.+.+ ..++.++|+||||+++++|++ |..||...+.......+
T Consensus       154 ~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~  208 (251)
T cd05041         154 LKQIPIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI  208 (251)
T ss_pred             cCcceeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH
Confidence            1122456999999876 678999999999999999998 89999877765544443

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.3e-34  Score=233.98  Aligned_cols=206  Identities=26%  Similarity=0.447  Sum_probs=173.2

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      ..|.+.+.||.|++|.||++.+..++..+++|.+.... .......+.+|++.++.++||||+++++.+..+     ...
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~   77 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-----TKL   77 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC-----CeE
Confidence            34667889999999999999999899999999986542 233456788999999999999999999999877     558


Q ss_pred             EEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCcc
Q 024959          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  200 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~  200 (260)
                      ++||||++ ++|.+++. ...+++..+..++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||++........
T Consensus        78 ~lv~e~~~~~~l~~~i~-~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06641          78 WIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             EEEEEeCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence            99999998 47777765 45789999999999999999999999999999999999999999999999998876543321


Q ss_pred             -cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024959          201 -MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  255 (260)
Q Consensus       201 -~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~  255 (260)
                       .....++..|++||.+.. ...+.++|+||||+++|+|++|..||...+......
T Consensus       157 ~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  211 (277)
T cd06641         157 KRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF  211 (277)
T ss_pred             hhccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHH
Confidence             222355778999999876 677889999999999999999999998766554443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-35  Score=250.04  Aligned_cols=215  Identities=23%  Similarity=0.423  Sum_probs=192.6

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      ..||+...++.+.++||.|.||.||.+.+++-.-.||||.++.+   ....+.|++|+.+|+.++|||+|+++++|..+ 
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED---tMeveEFLkEAAvMKeikHpNLVqLLGVCT~E-  335 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE-  335 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc---chhHHHHHHHHHHHHhhcCccHHHHhhhhccC-
Confidence            77999999999999999999999999999988888999999764   56788999999999999999999999999988 


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccc
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~  191 (260)
                          ..+|||+|||. |+|.++++.-  ..++.-.+..|+.||.++++||..++++|||+...|+|+.++..+|+.|||+
T Consensus       336 ----pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGL  411 (1157)
T KOG4278|consen  336 ----PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGL  411 (1157)
T ss_pred             ----CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccch
Confidence                55899999998 8999999873  4577778899999999999999999999999999999999999999999999


Q ss_pred             ccccCCCccccc--ccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          192 ARTTSETDFMTE--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       192 ~~~~~~~~~~~~--~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      ++.+..+.....  ....+-|.|||.+-- +.++.++|||+||++|||+.| |.-||++-+..+...+++
T Consensus       412 sRlMtgDTYTAHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLE  480 (1157)
T KOG4278|consen  412 SRLMTGDTYTAHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLE  480 (1157)
T ss_pred             hhhhcCCceecccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHh
Confidence            998877643322  344778999999876 788999999999999999999 889999999887776654

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.5e-34  Score=232.98  Aligned_cols=203  Identities=30%  Similarity=0.482  Sum_probs=173.3

Q ss_pred             ccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEEEEecC
Q 024959           50 IGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM  128 (260)
Q Consensus        50 lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv~e~~  128 (260)
                      ||.|++|.||++.+..+++.+++|.+..... .......+.+|++++++++||||+++++.+...     ...++++|++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGK-----KNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecC-----cEEEEEEecC
Confidence            6899999999999999999999999965422 223456778899999999999999999988766     5689999999


Q ss_pred             C-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc--------
Q 024959          129 D-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--------  199 (260)
Q Consensus       129 ~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~--------  199 (260)
                      + ++|.+++.....+++..+..++.|++++|.+||+.+++|+||+|+||+++.++.++|+|||++.......        
T Consensus        76 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          76 PGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence            7 5999998887789999999999999999999999999999999999999999999999999887644331        


Q ss_pred             -ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          200 -FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       200 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                       ......++..|++||.... ...+.++|+||||++++++++|..||...+..+....+.
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~  214 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNIL  214 (265)
T ss_pred             ccccCcccCccccCHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence             1122345778999999877 558889999999999999999999998887766665543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.9e-35  Score=243.12  Aligned_cols=207  Identities=28%  Similarity=0.433  Sum_probs=177.3

Q ss_pred             cceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-CCCeeeeeceecC
Q 024959           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRP  112 (260)
Q Consensus        34 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~  112 (260)
                      .+.+.+.+..|++++.||+||.+.||++..... ..|++|.+...........-+..|++.|.+|+ |.+|++++++=..
T Consensus       353 ~~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~  431 (677)
T KOG0596|consen  353 NEIIKVKGREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT  431 (677)
T ss_pred             CeeEEECcchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc
Confidence            478889999999999999999999999987554 56788877666667778889999999999997 9999999998776


Q ss_pred             CCCCCCccEEEEEecCCcchHHHhhhCCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccc
Q 024959          113 PKKDTFNDVYIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (260)
Q Consensus       113 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~  191 (260)
                      +     +.+|+|||+-+-+|.+++++... .+...++.+..||+.++.++|..||||.|+||.|+++ -.|.+||+|||.
T Consensus       432 d-----~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGI  505 (677)
T KOG0596|consen  432 D-----GYLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGI  505 (677)
T ss_pred             C-----ceEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeech
Confidence            5     66999999877899999988654 4435788999999999999999999999999999988 457899999999


Q ss_pred             ccccCCCc---ccccccccccccccccccCc----------CCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 024959          192 ARTTSETD---FMTEYVVTRWYRAPELLLNC----------TEYTAAIDIWSVGCILGEIMTREPLFPG  247 (260)
Q Consensus       192 ~~~~~~~~---~~~~~~~~~~~~~PE~~~~~----------~~~~~~~Di~slG~~l~~ll~g~~pf~~  247 (260)
                      +.....+.   ...+.+||+.||+||.+...          -...+++|||||||+||+|+.|+.||..
T Consensus       506 A~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~  574 (677)
T KOG0596|consen  506 ANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ  574 (677)
T ss_pred             hcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH
Confidence            98877664   33567899999999998532          1146789999999999999999999974

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.5e-34  Score=234.79  Aligned_cols=207  Identities=25%  Similarity=0.512  Sum_probs=174.8

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~  122 (260)
                      .+.-.+.||+|++|.||++.+..+++.+++|.+...  .......+.+|+.+++.++|||++++++.+...     +..+
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~-----~~~~   92 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG-----DELW   92 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEcC-----CeEE
Confidence            344567899999999999999999999999988543  233455678999999999999999999998776     5689


Q ss_pred             EEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc-c
Q 024959          123 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-F  200 (260)
Q Consensus       123 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~-~  200 (260)
                      +++|++. ++|.+++.. .++++..+..++.|++.++++||+.+++|+||+|+||+++.++.++|+|||.+....... .
T Consensus        93 ~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~  171 (285)
T cd06648          93 VVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR  171 (285)
T ss_pred             EEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc
Confidence            9999997 588888776 678999999999999999999999999999999999999999999999999876543322 2


Q ss_pred             cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       201 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      .....++..|++||.+.+ ..++.++|+||||+++++|++|..||...+..+..+.+.
T Consensus       172 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~  228 (285)
T cd06648         172 RKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIR  228 (285)
T ss_pred             cccccCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH
Confidence            223456888999999877 668899999999999999999999998877666555443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.2e-34  Score=230.14  Aligned_cols=202  Identities=29%  Similarity=0.490  Sum_probs=178.3

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~l  123 (260)
                      |.+.+.||+|++|.||++.+..++..+++|.+............+.+|+..+++++||||+++++.+.....   ..+++
T Consensus         2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---~~~~l   78 (260)
T cd06606           2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEK---NTLNI   78 (260)
T ss_pred             ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCC---CeEEE
Confidence            456788999999999999999999999999997665444567788899999999999999999999887631   45899


Q ss_pred             EEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCcc--
Q 024959          124 VYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF--  200 (260)
Q Consensus       124 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~--  200 (260)
                      ++|+++ ++|.+++.....+++..++.++.|++.+|++||+.+++|+||+|+||+++.++.++|+|||.+........  
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  158 (260)
T cd06606          79 FLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE  158 (260)
T ss_pred             EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence            999995 79999998888999999999999999999999999999999999999999999999999999887766543  


Q ss_pred             -cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 024959          201 -MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  249 (260)
Q Consensus       201 -~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  249 (260)
                       .....++..|++||.+.. ...+.++|+||||+++++|++|..||...+
T Consensus       159 ~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  207 (260)
T cd06606         159 GTGSVRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELG  207 (260)
T ss_pred             cccCCCCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence             344566888999999877 558899999999999999999999998776

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.4e-34  Score=232.36  Aligned_cols=206  Identities=26%  Similarity=0.430  Sum_probs=171.8

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      |.+..+.|++.+.||+|++|.||++.  .+++.+++|.+....    ....+.+|+.+++.++|||++++++.+..+   
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---   71 (254)
T cd05083           1 WLLNLQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN---   71 (254)
T ss_pred             CcccHHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC---
Confidence            44556778899999999999999985  466789999986532    345688899999999999999999998653   


Q ss_pred             CCccEEEEEecCC-cchHHHhhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                         ..+++||++. ++|.+++....  .+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus        72 ---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~  148 (254)
T cd05083          72 ---GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLAR  148 (254)
T ss_pred             ---CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccce
Confidence               3689999998 69999987643  58899999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHh
Q 024959          194 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLI  257 (260)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  257 (260)
                      ......  .....+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+..+....+
T Consensus       149 ~~~~~~--~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~  210 (254)
T cd05083         149 VGSMGV--DNSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV  210 (254)
T ss_pred             eccccC--CCCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH
Confidence            644321  22233567999999876 678899999999999999997 99999888776655544

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.2e-34  Score=236.59  Aligned_cols=201  Identities=26%  Similarity=0.452  Sum_probs=167.7

Q ss_pred             ccccCCCcccccccCceEEEEEEe----CCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC
Q 024959           40 SSKYVPPIRPIGRGAYGIVCAAVN----SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~  115 (260)
                      ..+.|.+++.||+|++|.||++..    ..++..|++|.++... .......+.+|+++++.++|||++++++++.....
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (284)
T cd05079           2 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG   80 (284)
T ss_pred             chhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence            356778999999999999999973    4678889999987543 33345678899999999999999999998876532


Q ss_pred             CCCccEEEEEecCC-cchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          116 DTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       116 ~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                         ...+++|||++ ++|.+++... ..+++..+..++.|++.+|++||++|++|+||+|+||+++.++.++|+|||++.
T Consensus        81 ---~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          81 ---NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             ---CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccc
Confidence               45899999997 6899988664 468999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCcc----cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCC
Q 024959          194 TTSETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF  245 (260)
Q Consensus       194 ~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf  245 (260)
                      .......    .....++..|+|||.+.+ ..++.++|+||||+++|+|+++..|+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~  212 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSE  212 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCC
Confidence            6544321    112334667999999877 67889999999999999999977654

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.9e-34  Score=233.83  Aligned_cols=200  Identities=25%  Similarity=0.395  Sum_probs=169.3

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~  122 (260)
                      .|+..+.||.|++|.||++.+..+++.+++|.+..... ......+.+|++++++++||||+++++++.....   ..++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~~~   77 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESS---SSIG   77 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCC---CeEE
Confidence            35568899999999999999999999999999865422 2445678899999999999999999999866533   4689


Q ss_pred             EEEecCC-cchHHHhhh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCC
Q 024959          123 IVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (260)
Q Consensus       123 lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~  197 (260)
                      +|||+++ ++|.+++..    ...+++..+..++.|++++|.|||+.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            9999997 588776543    45689999999999999999999999999999999999999999999999999865443


Q ss_pred             CcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 024959          198 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK  248 (260)
Q Consensus       198 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  248 (260)
                      ... ....++..|++||.+.+ ..++.++|+||||+++|+|++|..||...
T Consensus       158 ~~~-~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~  206 (287)
T cd06621         158 SLA-GTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPE  206 (287)
T ss_pred             ccc-ccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence            321 12345778999999877 67889999999999999999999999866

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4.1e-34  Score=231.52  Aligned_cols=201  Identities=24%  Similarity=0.356  Sum_probs=161.5

Q ss_pred             ccccccCceEEEEEEeC--CCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEEEE
Q 024959           48 RPIGRGAYGIVCAAVNS--ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY  125 (260)
Q Consensus        48 ~~lg~G~~g~vy~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv~  125 (260)
                      +.||+|+||.||++...  .++..+++|.+..... ......+.+|+.+++.++||||+++++.+...     ...++||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~   74 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV-----TPYLLVM   74 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-----CCcEEEE
Confidence            46899999999999754  3456799998865432 23345688899999999999999999998776     4589999


Q ss_pred             ecCC-cchHHHhhhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc
Q 024959          126 ELMD-TDLHQIIRSD-----QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (260)
Q Consensus       126 e~~~-~~l~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~  199 (260)
                      ||++ ++|.+++...     ...++..+..++.|++.+++|||+++++|+||+|+||+++.++.++|+|||++.......
T Consensus        75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~  154 (269)
T cd05087          75 EFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED  154 (269)
T ss_pred             ECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence            9998 6898888653     245677888999999999999999999999999999999999999999999986543322


Q ss_pred             c---cccccccccccccccccCc------CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 024959          200 F---MTEYVVTRWYRAPELLLNC------TEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL  254 (260)
Q Consensus       200 ~---~~~~~~~~~~~~PE~~~~~------~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~  254 (260)
                      .   .....++..|+|||.+...      ..++.++|+||||+++|+|++ |..||...+..+..
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~  219 (269)
T cd05087         155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL  219 (269)
T ss_pred             eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH
Confidence            1   1123446779999998542      135789999999999999996 99999877665544

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=4e-34  Score=231.95  Aligned_cols=213  Identities=24%  Similarity=0.391  Sum_probs=171.3

Q ss_pred             CCCcccccccCceEEEEEEeC---CCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCC-Cc
Q 024959           44 VPPIRPIGRGAYGIVCAAVNS---ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT-FN  119 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~-~~  119 (260)
                      |.+.+.||+|++|.||++...   .++..+++|.+...........++.+|+++++.++||||+++++++......+ ..
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            456789999999999999864   35788999999776555556777889999999999999999999886643221 12


Q ss_pred             cEEEEEecCC-cchHHHhhhC------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccc
Q 024959          120 DVYIVYELMD-TDLHQIIRSD------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (260)
Q Consensus       120 ~~~lv~e~~~-~~l~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~  192 (260)
                      ..++++|++. ++|.+++...      ..++...++.++.|++.+|+|||+++++|+||+|+||+++.++.++|+|||++
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~  160 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS  160 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence            3578889987 6887766421      24788999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCccc---ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHh
Q 024959          193 RTTSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLI  257 (260)
Q Consensus       193 ~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  257 (260)
                      .........   .....+..|++||...+ ..++.++|+||||+++|+|++ |..||.+.+..+....+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~  228 (273)
T cd05074         161 KKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL  228 (273)
T ss_pred             ccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Confidence            765433211   11223567899999876 677889999999999999999 89999888776655544

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.5e-34  Score=236.03  Aligned_cols=210  Identities=24%  Similarity=0.392  Sum_probs=174.7

Q ss_pred             ecceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-CCCeeeeeceec
Q 024959           33 YGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIR  111 (260)
Q Consensus        33 ~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~  111 (260)
                      .++.+.+..+.|++.+.||+|++|.||++.++.+++.+++|.++.... ......+.+|+..+.++. ||||+++++.+.
T Consensus         6 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~   84 (296)
T cd06618           6 DGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYFI   84 (296)
T ss_pred             cceeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheeee
Confidence            345667777888999999999999999999999899999999965422 223445666777666664 999999999997


Q ss_pred             CCCCCCCccEEEEEecCCcchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEeccCCCEEEeec
Q 024959          112 PPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDF  189 (260)
Q Consensus       112 ~~~~~~~~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~di~~~nili~~~~~~~l~df  189 (260)
                      ..     ...+++||++++++.+++.. ...+++..+..++.|++++++|||+ .+++|+||+|+||+++.++.++|+||
T Consensus        85 ~~-----~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~df  159 (296)
T cd06618          85 TD-----SDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDF  159 (296)
T ss_pred             cC-----CeEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECcc
Confidence            76     56999999999888777765 4578999999999999999999997 59999999999999999999999999


Q ss_pred             ccccccCCCcccccccccccccccccccCc---CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 024959          190 GLARTTSETDFMTEYVVTRWYRAPELLLNC---TEYTAAIDIWSVGCILGEIMTREPLFPGK  248 (260)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~---~~~~~~~Di~slG~~l~~ll~g~~pf~~~  248 (260)
                      |++.............++..|+|||.+.+.   ..++.++|+||||+++|+|++|+.||...
T Consensus       160 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  221 (296)
T cd06618         160 GISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNC  221 (296)
T ss_pred             ccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcc
Confidence            998765544333344567789999998653   34778999999999999999999999764

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=8.1e-34  Score=234.75  Aligned_cols=205  Identities=28%  Similarity=0.472  Sum_probs=173.2

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~  122 (260)
                      +...+.||+|++|.||++.+..++..+++|.+..... .......+.+|+++++.++|||++++++++...     ...+
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~   97 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE-----HTAW   97 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-----CEEE
Confidence            4456789999999999999999999999999864322 333456778899999999999999999999876     5589


Q ss_pred             EEEecCCcchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCccc
Q 024959          123 IVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  201 (260)
Q Consensus       123 lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  201 (260)
                      +|||++.+++.+.+.. ..++++..+..++.|++.++.+||++|++|+||+|+||+++.++.++|+|||++......   
T Consensus        98 lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~---  174 (313)
T cd06633          98 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA---  174 (313)
T ss_pred             EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCCC---
Confidence            9999999988888765 457899999999999999999999999999999999999999999999999988654322   


Q ss_pred             ccccccccccccccccC--cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 024959          202 TEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  256 (260)
Q Consensus       202 ~~~~~~~~~~~PE~~~~--~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  256 (260)
                      ....++..|+|||.+..  ...++.++|+||||+++|+|++|..||.+.+.......
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~  231 (313)
T cd06633         175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH  231 (313)
T ss_pred             CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence            23456788999999842  25578899999999999999999999987776554444

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.9e-34  Score=229.31  Aligned_cols=207  Identities=21%  Similarity=0.435  Sum_probs=171.9

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      ...+++.+.||+|++|.||++.+.. +..+++|.+......   ...+.+|++++++++|||++++++.+...     ..
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~   73 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTER-----SP   73 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccC-----Cc
Confidence            3456678999999999999998764 568999998654322   34678899999999999999999998776     45


Q ss_pred             EEEEEecCC-cchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          121 VYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      .++++|+++ ++|.+++... ..++++.++.++.|++.++++||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus        74 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  153 (256)
T cd05112          74 ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD  153 (256)
T ss_pred             eEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccC
Confidence            899999998 5888888764 56899999999999999999999999999999999999999999999999988755433


Q ss_pred             cc--cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHh
Q 024959          199 DF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLI  257 (260)
Q Consensus       199 ~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  257 (260)
                      ..  ......+..|++||.+.+ ..++.++|+||||+++|+|++ |..||...+.....+.+
T Consensus       154 ~~~~~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~  214 (256)
T cd05112         154 QYTSSTGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETI  214 (256)
T ss_pred             cccccCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence            21  112233567999999876 678899999999999999998 99999887776666554

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-35  Score=246.27  Aligned_cols=216  Identities=24%  Similarity=0.367  Sum_probs=184.8

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      ..-+++.+.+.+++.||+|.||.|.++.-.. +..||+|+++... ......+|.+|+++|.+|+||||++++++|... 
T Consensus       531 al~EfPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D-  607 (807)
T KOG1094|consen  531 ALVEFPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQD-  607 (807)
T ss_pred             chhhcchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecC-
Confidence            4558888899999999999999999998654 6889999998753 344568999999999999999999999999988 


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccc
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~  191 (260)
                          +.+++|+|||+ |+|.+++..+  ..+.......|+.||+++++||.+.+++||||.+.|+|+++++++||+|||.
T Consensus       608 ----ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgm  683 (807)
T KOG1094|consen  608 ----DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGM  683 (807)
T ss_pred             ----CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccc
Confidence                44899999999 8999999886  3345566677999999999999999999999999999999999999999999


Q ss_pred             ccccCCCccccc---ccccccccccccccCcCCCCChhhHHHHHHHHHHHH--hCCCCCCCCChHHHHHHhh
Q 024959          192 ARTTSETDFMTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM--TREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       192 ~~~~~~~~~~~~---~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll--~g~~pf~~~~~~~~~~~i~  258 (260)
                      ++.....+....   ..-..+|+|||.+.. ++.+.++|+|++|+++||++  +...||+....++..++..
T Consensus       684 sR~lysg~yy~vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~  754 (807)
T KOG1094|consen  684 SRNLYSGDYYRVQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAG  754 (807)
T ss_pred             ccccccCCceeeecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhh
Confidence            986544432221   233788999999998 88999999999999999985  5899999998888776644

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-36  Score=254.23  Aligned_cols=211  Identities=28%  Similarity=0.438  Sum_probs=181.8

Q ss_pred             ccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCc
Q 024959           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      +.+.|+|+..||-|+||.||++.++.++-.-|.|++.-  .......+++-|+.+|..++||+||++++.|...     +
T Consensus        30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet--kseEELEDylVEIeILa~CdHP~ivkLl~ayy~e-----n  102 (1187)
T KOG0579|consen   30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET--KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE-----N  102 (1187)
T ss_pred             HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc--cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc-----C
Confidence            45668899999999999999999999888888898854  4556788999999999999999999999988877     5


Q ss_pred             cEEEEEecCCcchHHH-hh-hCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccC-
Q 024959          120 DVYIVYELMDTDLHQI-IR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-  196 (260)
Q Consensus       120 ~~~lv~e~~~~~l~~~-l~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~-  196 (260)
                      .++|+.|||+|.-.+. +. -...+.+.++..+++|++.+|.|||+++|+|||+|..|||++-+|.++|.|||.+-... 
T Consensus       103 kLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~  182 (1187)
T KOG0579|consen  103 KLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS  182 (1187)
T ss_pred             ceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh
Confidence            6999999999654443 33 46789999999999999999999999999999999999999999999999999765433 


Q ss_pred             CCccccccccccccccccccc----CcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          197 ETDFMTEYVVTRWYRAPELLL----NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       197 ~~~~~~~~~~~~~~~~PE~~~----~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      .-....+..|+|+|||||...    ...+|+.++||||||++|.+|..+.+|-...+..-.+-+|
T Consensus       183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKi  247 (1187)
T KOG0579|consen  183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI  247 (1187)
T ss_pred             HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHH
Confidence            333456778999999999974    4488999999999999999999999999888876655544

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-34  Score=228.20  Aligned_cols=203  Identities=28%  Similarity=0.506  Sum_probs=174.5

Q ss_pred             ccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEEEEecC
Q 024959           50 IGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM  128 (260)
Q Consensus        50 lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv~e~~  128 (260)
                      ||.|++|.||++.+..+++.+++|.+..... .......+.+|+++++.++|||++++++.+..+     ...+++||++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTE-----EKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecC-----CeeEEEEecC
Confidence            6899999999999998899999999865432 223456778899999999999999999998776     5689999999


Q ss_pred             C-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC-cccccccc
Q 024959          129 D-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMTEYVV  206 (260)
Q Consensus       129 ~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~-~~~~~~~~  206 (260)
                      + ++|.+++.....+++..+..++.|+++++.+||+.+++|+||+|+||+++.++.++|+|||.+...... .......+
T Consensus        76 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~  155 (250)
T cd05123          76 PGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCG  155 (250)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcC
Confidence            5 799999988888999999999999999999999999999999999999999999999999998765543 22334456


Q ss_pred             cccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          207 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       207 ~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      +..|++||...+ ...+.++|+|+||+++|++++|..||...+..+..+.+.
T Consensus       156 ~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~  206 (250)
T cd05123         156 TPEYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKIL  206 (250)
T ss_pred             CccccChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence            788999999877 667889999999999999999999998887665555543

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-36  Score=259.25  Aligned_cols=217  Identities=26%  Similarity=0.433  Sum_probs=192.6

Q ss_pred             eeEeccccCCCcccccccCceEEEEEEeCCCCe---EEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecC
Q 024959           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRP  112 (260)
Q Consensus        36 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~---~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~  112 (260)
                      ..||+..++.|.+.||.|-||.|++++.+..++   .||||.++... .+..+.+|+.|+.+|-+++||||+++.++...
T Consensus       623 akEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk  701 (996)
T KOG0196|consen  623 AKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK  701 (996)
T ss_pred             hhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-cHHHHhhhhhhhhhcccCCCCcEEEEEEEEec
Confidence            458888899999999999999999999887664   49999998764 45678899999999999999999999999987


Q ss_pred             CCCCCCccEEEEEecCC-cchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecc
Q 024959          113 PKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG  190 (260)
Q Consensus       113 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~  190 (260)
                      .     ....||+|||+ |+|..+++.+ ++|+..++..|++.|+.++.||-+.++|||||...|||++.+..+|++|||
T Consensus       702 s-----~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFG  776 (996)
T KOG0196|consen  702 S-----KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFG  776 (996)
T ss_pred             C-----ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEecccc
Confidence            7     44899999998 7999998874 679999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCc-ccccccc---cccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhc
Q 024959          191 LARTTSETD-FMTEYVV---TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       191 ~~~~~~~~~-~~~~~~~---~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~~  259 (260)
                      +++...++. ...+..|   ..+|.|||.+.- ++.+..+||||+|++|||+++ |..||.++.+++.++.|++
T Consensus       777 LSRvledd~~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~  849 (996)
T KOG0196|consen  777 LSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQ  849 (996)
T ss_pred             ceeecccCCCccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHh
Confidence            998775543 2223333   578999999876 889999999999999999988 9999999999999999875

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.6e-35  Score=222.02  Aligned_cols=213  Identities=31%  Similarity=0.625  Sum_probs=184.8

Q ss_pred             eeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-CCCeeeeeceecCCC
Q 024959           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPK  114 (260)
Q Consensus        36 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~  114 (260)
                      .|. ..++|++++.+|.|.++.||.+.+..+.+.++||+++.     .....+.+|+++|+.|. +|||++++++..++.
T Consensus        33 ~wg-~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~  106 (338)
T KOG0668|consen   33 DWG-NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPE  106 (338)
T ss_pred             ecc-ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCcc
Confidence            444 45678899999999999999999999999999999953     35677889999999997 999999999999887


Q ss_pred             CCCCccEEEEEecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccC-CCEEEeecccc
Q 024959          115 KDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDFGLA  192 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~-~~~~l~df~~~  192 (260)
                      .   ....+|+|+++. +...+   -..++...++.++.+++.||.|+|++||.|||+||+|++|+.. ..++|+|||++
T Consensus       107 S---ktpaLiFE~v~n~Dfk~l---y~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLA  180 (338)
T KOG0668|consen  107 S---KTPSLIFEYVNNTDFKQL---YPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLA  180 (338)
T ss_pred             c---cCchhHhhhhccccHHHH---hhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchH
Confidence            6   568899999985 44443   3458888999999999999999999999999999999999875 66999999999


Q ss_pred             cccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHhhcC
Q 024959          193 RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF-PGKDYVHQLRLITEV  260 (260)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf-~~~~~~~~~~~i~~~  260 (260)
                      ..........-..-+..|-.||.+...+.++...|+|||||++..|...+.|| .|.++.+|+-+|.+|
T Consensus       181 EFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakV  249 (338)
T KOG0668|consen  181 EFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKV  249 (338)
T ss_pred             hhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHH
Confidence            88776666666666888999999999889999999999999999999977665 889999999888654

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=3e-34  Score=230.56  Aligned_cols=208  Identities=30%  Similarity=0.508  Sum_probs=174.8

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~l  123 (260)
                      |.+.+.||+|++|.||++.++.++..+++|.+............+.+|+++++.++|+|++++++.+...     ...++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~-----~~~~l   76 (257)
T cd08225           2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN-----GRLFI   76 (257)
T ss_pred             ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC-----CeEEE
Confidence            5578899999999999999999999999999865433333456778899999999999999999998776     56899


Q ss_pred             EEecCC-cchHHHhhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCC-EEEeecccccccCCCc
Q 024959          124 VYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD-LKIGDFGLARTTSETD  199 (260)
Q Consensus       124 v~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~-~~l~df~~~~~~~~~~  199 (260)
                      ++|+++ ++|.+++....  .+++..+..++.|++++|.+||+.+++|+||+|+||+++.++. ++|+|||.+.......
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          77 VMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            999997 58988886643  5799999999999999999999999999999999999988864 6999999887665433


Q ss_pred             cc-ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          200 FM-TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       200 ~~-~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      .. ....+++.|+|||.+.. ..++.++|+||||+++++|++|..||...+..+....+
T Consensus       157 ~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~  214 (257)
T cd08225         157 ELAYTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKI  214 (257)
T ss_pred             ccccccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence            22 22356788999998876 66889999999999999999999999877765555443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=5.4e-34  Score=232.34  Aligned_cols=209  Identities=23%  Similarity=0.411  Sum_probs=171.1

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCC-CCC
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKK-DTF  118 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~-~~~  118 (260)
                      ...|++.+.||.|++|.||++.+..+++.+++|.+...   ......+..|+.+++++ +|||++++++.+..... ...
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   91 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD   91 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence            45677889999999999999999999999999998543   22345677889999998 69999999999864322 122


Q ss_pred             ccEEEEEecCC-cchHHHhhh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccccc
Q 024959          119 NDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (260)
Q Consensus       119 ~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~  195 (260)
                      ..++++|||++ ++|.+++..  ...+++..++.++.|+++++.|||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus        92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~  171 (282)
T cd06636          92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  171 (282)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence            56899999998 488888765  345888899999999999999999999999999999999999999999999998765


Q ss_pred             CCC-cccccccccccccccccccC----cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 024959          196 SET-DFMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  252 (260)
Q Consensus       196 ~~~-~~~~~~~~~~~~~~PE~~~~----~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~  252 (260)
                      ... .......++..|+|||.+..    ...++.++|+||||+++|+|++|..||.......
T Consensus       172 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~  233 (282)
T cd06636         172 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR  233 (282)
T ss_pred             hccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh
Confidence            432 12233456888999998753    2457789999999999999999999997665433

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=4.3e-34  Score=234.16  Aligned_cols=204  Identities=25%  Similarity=0.496  Sum_probs=171.1

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~l  123 (260)
                      +.....||+|++|.||++.++.++..+++|.+...  .......+.+|+.+++.++|+|++++++.+...     +..++
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~l   94 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELWV   94 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeC-----CEEEE
Confidence            44457899999999999999999999999998543  233456688999999999999999999999876     56899


Q ss_pred             EEecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc-cc
Q 024959          124 VYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FM  201 (260)
Q Consensus       124 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~-~~  201 (260)
                      +||++++ +|.+++ ....+++..++.++.|++.++++||+.|++|+||+|.||+++.++.++|+|||++....... ..
T Consensus        95 v~e~~~~~~L~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~  173 (292)
T cd06657          95 VMEFLEGGALTDIV-THTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR  173 (292)
T ss_pred             EEecCCCCcHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccc
Confidence            9999985 676654 45578999999999999999999999999999999999999999999999999876544322 12


Q ss_pred             ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 024959          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  256 (260)
Q Consensus       202 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  256 (260)
                      ....++..|++||.+.. ..++.++|+||+|+++|+|++|..||.+.+..+....
T Consensus       174 ~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~  227 (292)
T cd06657         174 KSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM  227 (292)
T ss_pred             cccccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            23456788999998876 6678999999999999999999999987766554443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3e-34  Score=235.19  Aligned_cols=203  Identities=26%  Similarity=0.463  Sum_probs=171.8

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      +.|.+.+.||+|++|.||++.+..++..+++|.+....  ......+.+|+.+++.++|||++++++.+...     +..
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~~   91 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLVG-----DEL   91 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeeeC-----CcE
Confidence            45678899999999999999998889999999985432  23456678899999999999999999998776     558


Q ss_pred             EEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc-
Q 024959          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~-  199 (260)
                      ++|+|+++ ++|.+++.+ ..+++..+..++.|++.++.+||++|++|+||+|+||+++.++.++|+|||++....... 
T Consensus        92 ~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647          92 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             EEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence            99999998 588887654 468899999999999999999999999999999999999999999999999876544332 


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  253 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~  253 (260)
                      ......+++.|++||.+.. ..++.++|+||||+++|++++|..||...+..+.
T Consensus       171 ~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~  223 (293)
T cd06647         171 KRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA  223 (293)
T ss_pred             ccccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh
Confidence            2223356778999999877 6788999999999999999999999987665443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.8e-34  Score=231.61  Aligned_cols=203  Identities=28%  Similarity=0.481  Sum_probs=166.8

Q ss_pred             ccccccCceEEEEEEeCCCC------eEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           48 RPIGRGAYGIVCAAVNSETR------EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~------~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      +.||+|++|.||++.++...      ..+++|.+.... .......+.+|+++++.++||||+++++++...     ...
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   74 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN-----EPQ   74 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC-----CCe
Confidence            36899999999999886543      679999886542 223456788999999999999999999998776     458


Q ss_pred             EEEEecCC-cchHHHhhhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCC-----CEEEee
Q 024959          122 YIVYELMD-TDLHQIIRSD-------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-----DLKIGD  188 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~-----~~~l~d  188 (260)
                      +++||+++ ++|.+++...       ..+++..+..++.|++++|.|||+.+++|+||+|+||+++.++     .++|+|
T Consensus        75 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~d  154 (269)
T cd05044          75 YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGD  154 (269)
T ss_pred             EEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECC
Confidence            99999997 6898888642       3478899999999999999999999999999999999999877     899999


Q ss_pred             cccccccCCCccc---ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHh
Q 024959          189 FGLARTTSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLI  257 (260)
Q Consensus       189 f~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  257 (260)
                      ||++.........   .....+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+..+....+
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~  226 (269)
T cd05044         155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV  226 (269)
T ss_pred             cccccccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHH
Confidence            9998765432211   12233577999999877 678999999999999999998 99999888777666554

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=9.2e-34  Score=229.34  Aligned_cols=204  Identities=30%  Similarity=0.453  Sum_probs=168.9

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~  118 (260)
                      +..........||+|++|.||++.+..++..+++|.+...  .....+.+.+|+++++.++|+||+++++++..+     
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----   77 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN-----   77 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC-----
Confidence            3334444556899999999999999999999999988653  333556788999999999999999999998876     


Q ss_pred             ccEEEEEecCC-cchHHHhhhC-CCC--CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecc-CCCEEEeeccccc
Q 024959          119 NDVYIVYELMD-TDLHQIIRSD-QQL--TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLAR  193 (260)
Q Consensus       119 ~~~~lv~e~~~-~~l~~~l~~~-~~~--~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~-~~~~~l~df~~~~  193 (260)
                      ...++++|+++ ++|.+.+... ..+  ++..+..++.|++.+|++||+++++|+||+|+||+++. ++.++|+|||.+.
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~  157 (268)
T cd06624          78 GFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSK  157 (268)
T ss_pred             CEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence            56899999998 6899888764 455  88889999999999999999999999999999999976 6789999999887


Q ss_pred             ccCCCc-ccccccccccccccccccCc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 024959          194 TTSETD-FMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKD  249 (260)
Q Consensus       194 ~~~~~~-~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  249 (260)
                      ...... ......++..|+|||.+... ..++.++|+||||+++|+|++|..||...+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~  215 (268)
T cd06624         158 RLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG  215 (268)
T ss_pred             ecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence            654322 22233467889999998652 347889999999999999999999997544

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=5.9e-34  Score=237.07  Aligned_cols=203  Identities=19%  Similarity=0.261  Sum_probs=165.7

Q ss_pred             ccccccc--CceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEEE
Q 024959           47 IRPIGRG--AYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV  124 (260)
Q Consensus        47 ~~~lg~G--~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv  124 (260)
                      ...||.|  ++++||++.+..+++.|++|+...........+.+.+|+.+++.++||||+++++++...     ...++|
T Consensus         3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-----~~~~~v   77 (328)
T cd08226           3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG-----SWLWVI   77 (328)
T ss_pred             HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecC-----CceEEE
Confidence            3456666  899999999999999999999976544445567788999999999999999999999876     558999


Q ss_pred             EecCC-cchHHHhhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCccc
Q 024959          125 YELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  201 (260)
Q Consensus       125 ~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  201 (260)
                      +|++. +++.+++...  ..+++..+..++.|++.+|+|||+++++|+||||+||+++.++.+++.||+.+.........
T Consensus        78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~  157 (328)
T cd08226          78 SPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK  157 (328)
T ss_pred             EecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence            99998 5888887764  45899999999999999999999999999999999999999999999999854332111100


Q ss_pred             --------ccccccccccccccccCc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024959          202 --------TEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  254 (260)
Q Consensus       202 --------~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  254 (260)
                              ....++..|++||.+.+. ..++.++|+||||+++++|++|..||.+....+..
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~  219 (328)
T cd08226         158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML  219 (328)
T ss_pred             ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH
Confidence                    111234569999998753 34688999999999999999999999877654443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=4.8e-34  Score=233.59  Aligned_cols=201  Identities=20%  Similarity=0.373  Sum_probs=168.2

Q ss_pred             CCCcccccccCceEEEEEEeC---CCCeEEEEEecCCccc--chHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCCCC
Q 024959           44 VPPIRPIGRGAYGIVCAAVNS---ETREEVAIKKIGNAFD--NIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDT  117 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~---~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~  117 (260)
                      |++.+.||.|++|.||++.+.   .++..|++|++.....  .......+.+|+++++++ +|++|+++++.+..+    
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~----   77 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD----   77 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC----
Confidence            567889999999999999874   4788999999865321  122345667899999999 599999999998876    


Q ss_pred             CccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccC
Q 024959          118 FNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (260)
Q Consensus       118 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~  196 (260)
                       ...++|+|+++ ++|.+++.....+++..+..++.|++++|.+||+.+++|+||+|+||+++.++.++|+|||++....
T Consensus        78 -~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          78 -TKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             -CeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence             55899999998 5899999888889999999999999999999999999999999999999999999999999987654


Q ss_pred             CCc--ccccccccccccccccccCc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 024959          197 ETD--FMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKD  249 (260)
Q Consensus       197 ~~~--~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  249 (260)
                      ...  ......++..|++||.+... ..++.++|+||||+++|+|++|..||...+
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~  212 (290)
T cd05613         157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG  212 (290)
T ss_pred             cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCC
Confidence            332  12234567889999998752 346788999999999999999999997543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=9.9e-34  Score=229.22  Aligned_cols=208  Identities=26%  Similarity=0.497  Sum_probs=172.5

Q ss_pred             CCCcccccccCceEEEEEEeCC-CCeEEEEEecCCcc--------cchHHHHHHHHHHHHHHH-cCCCCeeeeeceecCC
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSE-TREEVAIKKIGNAF--------DNIIDARRTLREIKLLRH-MEHENVIAIKDIIRPP  113 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~-~~~~~~iK~~~~~~--------~~~~~~~~~~~e~~~l~~-l~~~~iv~~~~~~~~~  113 (260)
                      |++.+.||+|++|.||++.+.. ++..+++|.+....        .......++..|+.++.+ ++||||+++++.+...
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   81 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN   81 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence            5678999999999999999988 67889999875321        223344566778887765 6899999999999876


Q ss_pred             CCCCCccEEEEEecCC-cchHHHhhh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEeccCCCEEEe
Q 024959          114 KKDTFNDVYIVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIG  187 (260)
Q Consensus       114 ~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~di~~~nili~~~~~~~l~  187 (260)
                           ...+++|||++ ++|.+++..    ...+++..++.++.|++.+|.+||+ .+++|+||+|.||+++.++.++|+
T Consensus        82 -----~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~  156 (269)
T cd08528          82 -----DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTIT  156 (269)
T ss_pred             -----CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEe
Confidence                 56899999998 478777643    4568999999999999999999996 789999999999999999999999


Q ss_pred             ecccccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          188 DFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       188 df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      |||.+.............++..|++||.+.+ ..++.++|+||||+++|+|++|..||...+.......+
T Consensus       157 dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~  225 (269)
T cd08528         157 DFGLAKQKQPESKLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKI  225 (269)
T ss_pred             cccceeecccccccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHH
Confidence            9999887655543444567888999999987 66899999999999999999999999877765544443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=241.88  Aligned_cols=212  Identities=26%  Similarity=0.412  Sum_probs=184.7

Q ss_pred             eeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        36 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      .+-+....+..-+.||+|+||.||-++...+|+.||+|++.+..- ......-.+.|..+|.+++.+.||.+--.|+.. 
T Consensus       179 ~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTk-  257 (591)
T KOG0986|consen  179 LQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETK-  257 (591)
T ss_pred             hhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCC-
Confidence            356667778888999999999999999999999999999854322 122233456799999999999999998888777 


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccc
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~  191 (260)
                          ..+++|+..|+ |+|.-++-+.+  -|++..++.++.+|+-+|++||+.+||+||+||+|||+++.|++.|+|+|+
T Consensus       258 ----d~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGL  333 (591)
T KOG0986|consen  258 ----DALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGL  333 (591)
T ss_pred             ----CceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccce
Confidence                55999999998 58877776644  699999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024959          192 ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  253 (260)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~  253 (260)
                      +.......+.....||.+|||||.+.+ ..|+...|.|+|||+||+|+.|.-||.....-..
T Consensus       334 Avei~~g~~~~~rvGT~GYMAPEvl~n-e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk  394 (591)
T KOG0986|consen  334 AVEIPEGKPIRGRVGTVGYMAPEVLQN-EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK  394 (591)
T ss_pred             EEecCCCCccccccCcccccCHHHHcC-CcccCCccHHHHHhHHHHHHcccCchhhhhhhhh
Confidence            999999888888899999999999998 6699999999999999999999999976555333

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.2e-33  Score=227.79  Aligned_cols=204  Identities=28%  Similarity=0.487  Sum_probs=162.5

Q ss_pred             ccccccCceEEEEEEeCC---CCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEEE
Q 024959           48 RPIGRGAYGIVCAAVNSE---TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV  124 (260)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv  124 (260)
                      +.||+|++|.||++.+..   .+..+++|.+... ........+.+|+.+++.++||||+++++++....    ...+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~~lv   75 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE----GSPLVV   75 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC----CCcEEE
Confidence            468999999999998643   3457999988543 23344567888999999999999999999775432    347899


Q ss_pred             EecCC-cchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCcc--
Q 024959          125 YELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF--  200 (260)
Q Consensus       125 ~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~--  200 (260)
                      +|++. ++|.+++... ...++..+..++.|++++|.+||+.+++|+||+|+||+++.++.++|+|||++........  
T Consensus        76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          76 LPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            99998 6999988764 4567788889999999999999999999999999999999999999999999875433211  


Q ss_pred             ---cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHh
Q 024959          201 ---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLI  257 (260)
Q Consensus       201 ---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  257 (260)
                         .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |.+||...+..+..+.+
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~  215 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL  215 (262)
T ss_pred             ecccccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence               112233567999999876 678899999999999999999 56778776665544433

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-35  Score=245.52  Aligned_cols=213  Identities=24%  Similarity=0.419  Sum_probs=184.4

Q ss_pred             cceeEeccccCCCcccccccCceEEEEEEeCCC--C--eEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeece
Q 024959           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSET--R--EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI  109 (260)
Q Consensus        34 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~--~--~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~  109 (260)
                      ...+++....+++.++||.|.||.||.+.....  |  -.||||..+.+++.. ..+.|+.|+-+|+.++||||++++++
T Consensus       381 ~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d-~tekflqEa~iMrnfdHphIikLIGv  459 (974)
T KOG4257|consen  381 VRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPD-DTEKFLQEASIMRNFDHPHIIKLIGV  459 (974)
T ss_pred             CCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChh-hHHHHHHHHHHHHhCCCcchhheeee
Confidence            457788899999999999999999999975332  2  348999998875544 47889999999999999999999999


Q ss_pred             ecCCCCCCCccEEEEEecCC-cchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEe
Q 024959          110 IRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG  187 (260)
Q Consensus       110 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~  187 (260)
                      |.++      ..|||||.++ |.|+.+++.+ ..++...+..++.||+.+|.|||+.+++||||...||++....-+||+
T Consensus       460 ~~e~------P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLa  533 (974)
T KOG4257|consen  460 CVEQ------PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLA  533 (974)
T ss_pred             eecc------ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeec
Confidence            9875      3799999999 8999999875 469999999999999999999999999999999999999999899999


Q ss_pred             ecccccccCCCcccccccc--cccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 024959          188 DFGLARTTSETDFMTEYVV--TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL  254 (260)
Q Consensus       188 df~~~~~~~~~~~~~~~~~--~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~  254 (260)
                      |||+++...+........+  ..-|+|||.+.- +.++.++|||.||+++||++. |.+||.+-.+.+..
T Consensus       534 DFGLSR~~ed~~yYkaS~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI  602 (974)
T KOG4257|consen  534 DFGLSRYLEDDAYYKASRGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI  602 (974)
T ss_pred             ccchhhhccccchhhccccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCccccccccceE
Confidence            9999998877654444333  677999999876 788999999999999999988 99999887665543

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=239.10  Aligned_cols=217  Identities=24%  Similarity=0.388  Sum_probs=186.8

Q ss_pred             EeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCC
Q 024959           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKK  115 (260)
Q Consensus        38 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~  115 (260)
                      .+...++..+..||+|+||.|.++..+.+.+.||||+++++.- ...+.+-.+.|-++|... +-|.++.+...|..-  
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm--  422 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM--  422 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh--
Confidence            5666777889999999999999999999999999999977632 111233334566666655 367777887777655  


Q ss_pred             CCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          116 DTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       116 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                         ..+|+||||+. |+|--.++.-+++.+..+..++..|+-+|-+||++||++||+|.+||+++.+|++||.|||+++.
T Consensus       423 ---DRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE  499 (683)
T KOG0696|consen  423 ---DRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  499 (683)
T ss_pred             ---hheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccc
Confidence               56999999998 68888889999999999999999999999999999999999999999999999999999999986


Q ss_pred             cCC-CcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcC
Q 024959          195 TSE-TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV  260 (260)
Q Consensus       195 ~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~~  260 (260)
                      .-. ..+..+.+||+.|+|||++.- .+|...+|.||+|++||||+.|.+||++.+..+.++.|++.
T Consensus       500 ni~~~~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh  565 (683)
T KOG0696|consen  500 NIFDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH  565 (683)
T ss_pred             cccCCcceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc
Confidence            543 345667799999999999987 88999999999999999999999999999999999999874

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.3e-33  Score=227.88  Aligned_cols=195  Identities=21%  Similarity=0.275  Sum_probs=157.9

Q ss_pred             ccccccCceEEEEEEeCC------------CCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC
Q 024959           48 RPIGRGAYGIVCAAVNSE------------TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (260)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~------------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~  115 (260)
                      +.||+|++|.||++....            ....+++|.+...  .......+.+|+.+++.++||||+++++++...  
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~--   76 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRD--   76 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--
Confidence            368999999999997532            2335888987553  233456778899999999999999999998776  


Q ss_pred             CCCccEEEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCC-------EEE
Q 024959          116 DTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD-------LKI  186 (260)
Q Consensus       116 ~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~-------~~l  186 (260)
                         ...+++||+++ ++|..++.. ...+++..++.++.|++++|+|||+++++|+||+|+||+++.++.       +++
T Consensus        77 ---~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l  153 (262)
T cd05077          77 ---VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKL  153 (262)
T ss_pred             ---CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEe
Confidence               45799999998 466666654 456999999999999999999999999999999999999987654       899


Q ss_pred             eecccccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHH-hCCCCCCCCChHH
Q 024959          187 GDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM-TREPLFPGKDYVH  252 (260)
Q Consensus       187 ~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll-~g~~pf~~~~~~~  252 (260)
                      +|||++......   ....++..|+|||.+.....++.++||||||+++|+|+ +|..||......+
T Consensus       154 ~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~  217 (262)
T cd05077         154 SDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE  217 (262)
T ss_pred             CCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH
Confidence            999987654322   23345778999998875577889999999999999998 5889987765443

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=6.5e-35  Score=260.68  Aligned_cols=198  Identities=32%  Similarity=0.486  Sum_probs=164.7

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC-----
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD-----  116 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~-----  116 (260)
                      .+++.++.||+||||.||+++++-+|+.||||++.... .......+.+|++.|.+|+|||||+++..|.+....     
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            34677899999999999999999999999999998775 566778889999999999999999998866431100     


Q ss_pred             ----------------------------------------------C---------------------------------
Q 024959          117 ----------------------------------------------T---------------------------------  117 (260)
Q Consensus       117 ----------------------------------------------~---------------------------------  117 (260)
                                                                    .                                 
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                          0                                 


Q ss_pred             ----------------------C--------ccEEEEEecCCcchHHHhhhCCCC--CHHHHHHHHHHHHHHHHHHHhCC
Q 024959          118 ----------------------F--------NDVYIVYELMDTDLHQIIRSDQQL--TDDHCQYFLYQLLRGLKYVHSAS  165 (260)
Q Consensus       118 ----------------------~--------~~~~lv~e~~~~~l~~~l~~~~~~--~~~~~~~~~~~i~~~l~~lh~~~  165 (260)
                                            .        ..+||-||||+.++.+.+.....+  .....|.++++|+++|.|+|+.|
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g  717 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG  717 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence                                  0        127899999997666666555444  47889999999999999999999


Q ss_pred             ceeccCCCCCeEeccCCCEEEeecccccccC-------------------CCcccccccccccccccccccCcC--CCCC
Q 024959          166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTS-------------------ETDFMTEYVVTRWYRAPELLLNCT--EYTA  224 (260)
Q Consensus       166 i~H~di~~~nili~~~~~~~l~df~~~~~~~-------------------~~~~~~~~~~~~~~~~PE~~~~~~--~~~~  224 (260)
                      ++||||||.|||++.++.+||+|||++....                   ......+..||-.|.|||.+.+..  .|+.
T Consensus       718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~  797 (1351)
T KOG1035|consen  718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS  797 (1351)
T ss_pred             eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence            9999999999999999999999999997611                   111334567899999999998765  6999


Q ss_pred             hhhHHHHHHHHHHHHh
Q 024959          225 AIDIWSVGCILGEIMT  240 (260)
Q Consensus       225 ~~Di~slG~~l~~ll~  240 (260)
                      ++|+||||++++||+.
T Consensus       798 KiDmYSLGIVlFEM~y  813 (1351)
T KOG1035|consen  798 KIDMYSLGIVLFEMLY  813 (1351)
T ss_pred             hhhhHHHHHHHHHHhc
Confidence            9999999999999964

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=9.5e-34  Score=233.82  Aligned_cols=206  Identities=27%  Similarity=0.475  Sum_probs=173.0

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCc-ccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNA-FDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      ...|...+.||+|++|.||++.+..++..+++|.+... ........++.+|+++++.++|+|++++.+++...     .
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~   88 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----H   88 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC-----C
Confidence            33466788999999999999999999999999988543 12334456778899999999999999999998876     5


Q ss_pred             cEEEEEecCCcchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          120 DVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       120 ~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      ..++|+|++.+++.+.+.. ...+++..+..++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus        89 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          89 TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             eeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence            5899999999988887754 556899999999999999999999999999999999999999999999999988765433


Q ss_pred             cccccccccccccccccccC--cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024959          199 DFMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  254 (260)
Q Consensus       199 ~~~~~~~~~~~~~~PE~~~~--~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  254 (260)
                      .   ...++..|+|||.+..  ....+.++|+||||+++|+|++|..||...+..+..
T Consensus       169 ~---~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~  223 (308)
T cd06634         169 N---XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL  223 (308)
T ss_pred             c---cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH
Confidence            2   3355778999999752  245788999999999999999999999776654443

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.3e-33  Score=229.20  Aligned_cols=194  Identities=19%  Similarity=0.217  Sum_probs=156.8

Q ss_pred             cccccCceEEEEEEeCC------------------------CCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCee
Q 024959           49 PIGRGAYGIVCAAVNSE------------------------TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI  104 (260)
Q Consensus        49 ~lg~G~~g~vy~~~~~~------------------------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv  104 (260)
                      .||+|+||.||++....                        ....+++|.+...  .......+.+|+.+++.++||||+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv   79 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA   79 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence            58999999999997432                        2245888888543  233445678899999999999999


Q ss_pred             eeeceecCCCCCCCccEEEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCC
Q 024959          105 AIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC  182 (260)
Q Consensus       105 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~  182 (260)
                      ++++++...     ...++||||++ ++|..++.. ...+++..+..++.|++++|+|||+++++|+||+|+||+++..+
T Consensus        80 ~~~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~  154 (274)
T cd05076          80 FVHGVCVRG-----SENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLG  154 (274)
T ss_pred             eEEEEEEeC-----CceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccC
Confidence            999999876     45899999998 577777765 56789999999999999999999999999999999999997643


Q ss_pred             -------CEEEeecccccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHH-hCCCCCCCCChHH
Q 024959          183 -------DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM-TREPLFPGKDYVH  252 (260)
Q Consensus       183 -------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll-~g~~pf~~~~~~~  252 (260)
                             .++++|||.+......   ....++..|+|||.+.+...++.++|+||||+++|+++ +|..||.+....+
T Consensus       155 ~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  229 (274)
T cd05076         155 LAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE  229 (274)
T ss_pred             cccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence                   3799999987543222   12345677999999876566889999999999999995 6999998766544

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.3e-33  Score=228.50  Aligned_cols=190  Identities=21%  Similarity=0.355  Sum_probs=159.3

Q ss_pred             CCCcccc--cccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCCCCCcc
Q 024959           44 VPPIRPI--GRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        44 ~~~~~~l--g~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      +++.+.+  |+|+||.||++.++.++..+++|.+.......       .|+.....+ +|||++++++.+..+     +.
T Consensus        16 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~-----~~   83 (267)
T PHA03390         16 CEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTL-----KG   83 (267)
T ss_pred             hccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecC-----Ce
Confidence            3445554  99999999999999999999999986532111       122222222 699999999999887     56


Q ss_pred             EEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCC-CEEEeecccccccCCC
Q 024959          121 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSET  198 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~-~~~l~df~~~~~~~~~  198 (260)
                      +++||||++ ++|.+++..+..+++..++.++.|++++|.+||+.+++|+||+|+||+++.++ .++|+|||++......
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~  163 (267)
T PHA03390         84 HVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP  163 (267)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence            999999997 69999998888999999999999999999999999999999999999999988 9999999998765433


Q ss_pred             cccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 024959          199 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  249 (260)
Q Consensus       199 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  249 (260)
                      .   ...++..|+|||.+.+ ..++.++|+||||+++++|++|..||....
T Consensus       164 ~---~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~  210 (267)
T PHA03390        164 S---CYDGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDE  210 (267)
T ss_pred             c---cCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence            2   3356788999999977 668899999999999999999999997554

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.1e-33  Score=227.52  Aligned_cols=191  Identities=20%  Similarity=0.289  Sum_probs=159.6

Q ss_pred             ccccccCceEEEEEEeCCCC----------eEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCC
Q 024959           48 RPIGRGAYGIVCAAVNSETR----------EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (260)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~----------~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~  117 (260)
                      +.||+|++|.||++.+..++          ..+++|.+.....   ....+.+|+.+++.++||||+++++.+.. .   
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~---   73 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR-D---   73 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec-C---
Confidence            46899999999999998776          3578887754321   15778899999999999999999998866 2   


Q ss_pred             CccEEEEEecCC-cchHHHhhhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCC-------CEEEee
Q 024959          118 FNDVYIVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-------DLKIGD  188 (260)
Q Consensus       118 ~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~-------~~~l~d  188 (260)
                        ..++|||+++ ++|.+++.... .+++..+..++.|++.+|.|||+++++|+||+|+||+++.++       .++|+|
T Consensus        74 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D  151 (259)
T cd05037          74 --ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD  151 (259)
T ss_pred             --CcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCC
Confidence              2589999998 68888887765 789999999999999999999999999999999999999887       799999


Q ss_pred             cccccccCCCcccccccccccccccccccCc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 024959          189 FGLARTTSETDFMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMT-REPLFPGKDY  250 (260)
Q Consensus       189 f~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~  250 (260)
                      ||++......   ....+...|+|||.+... ..++.++|+||||+++|+|++ |..||...+.
T Consensus       152 fg~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~  212 (259)
T cd05037         152 PGIPITVLSR---EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS  212 (259)
T ss_pred             CCcccccccc---cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc
Confidence            9998765442   223446679999998773 368899999999999999999 6888876653

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.3e-34  Score=230.08  Aligned_cols=196  Identities=17%  Similarity=0.278  Sum_probs=160.3

Q ss_pred             ccccccCceEEEEEEeCCCCe-------EEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           48 RPIGRGAYGIVCAAVNSETRE-------EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~-------~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      +.||+|+||.||++.+...+.       .+++|.+...  .....+.+.+|+.+++.++|||++++++++...     ..
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~   73 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-----DE   73 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC-----CC
Confidence            369999999999998865543       3888887543  233456778899999999999999999999876     44


Q ss_pred             EEEEEecCC-cchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCC--------EEEeecc
Q 024959          121 VYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD--------LKIGDFG  190 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~--------~~l~df~  190 (260)
                      .++||||++ ++|.+++..+ ..+++..+..++.|++.+|++||+++++|+||+|+||+++.++.        ++++|||
T Consensus        74 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g  153 (258)
T cd05078          74 SIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG  153 (258)
T ss_pred             cEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence            789999998 5898888764 45899999999999999999999999999999999999987665        6999999


Q ss_pred             cccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhC-CCCCCCCChHHH
Q 024959          191 LARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQ  253 (260)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g-~~pf~~~~~~~~  253 (260)
                      ++......   ....++..|+|||.+.+...++.++|+||||+++|+|++| ..||...+....
T Consensus       154 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~  214 (258)
T cd05078         154 ISITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK  214 (258)
T ss_pred             cccccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH
Confidence            87654432   2234577899999997655678999999999999999998 577776655443

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.1e-33  Score=230.55  Aligned_cols=203  Identities=27%  Similarity=0.443  Sum_probs=169.6

Q ss_pred             cccCCCcccccccCceEEEEEEeC----CCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNS----ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      .+++.+.+.||+|++|.||++...    .++..+++|.+...... .....+.+|++.++.++||||+++++++..... 
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~-   80 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG-   80 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC-
Confidence            456778899999999999999864    34788999999765433 356778899999999999999999998876432 


Q ss_pred             CCccEEEEEecCC-cchHHHhhhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                        ...+++||+++ ++|.+++.... .+++..+..++.|++.+|++||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus        81 --~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          81 --RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             --CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence              56899999997 69999887654 689999999999999999999999999999999999999999999999999887


Q ss_pred             cCCCcccc----cccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 024959          195 TSETDFMT----EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK  248 (260)
Q Consensus       195 ~~~~~~~~----~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  248 (260)
                      ........    ....+..|++||...+ ..++.++|+||||+++++|++|..||...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~  215 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPSQSP  215 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCcccc
Confidence            65322111    1123456899999877 67889999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=5.5e-33  Score=224.87  Aligned_cols=203  Identities=20%  Similarity=0.303  Sum_probs=159.9

Q ss_pred             ccccccCceEEEEEEeCCC--CeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEEEE
Q 024959           48 RPIGRGAYGIVCAAVNSET--REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY  125 (260)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~--~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv~  125 (260)
                      +.||+|+||.||++....+  ...+++|.+... ........+.+|+..++.++||||+++++.+...     ...++||
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-----~~~~lv~   74 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKAN-ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEA-----IPYLLVF   74 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCC-CChHHHHHHHHHHHHHhccCCcchhheEEEecCC-----CccEEEE
Confidence            3699999999999975433  335667776543 2233456788999999999999999999999876     4589999


Q ss_pred             ecCC-cchHHHhhhC----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC--
Q 024959          126 ELMD-TDLHQIIRSD----QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET--  198 (260)
Q Consensus       126 e~~~-~~l~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~--  198 (260)
                      ||++ ++|.+++...    ...++..++.++.|++++|+|||+.+++|+||+|+||+++.++.++|+|||++......  
T Consensus        75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~  154 (268)
T cd05086          75 EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY  154 (268)
T ss_pred             ecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchh
Confidence            9998 6999888753    34677788899999999999999999999999999999999999999999987542211  


Q ss_pred             -cccccccccccccccccccCc------CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 024959          199 -DFMTEYVVTRWYRAPELLLNC------TEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRL  256 (260)
Q Consensus       199 -~~~~~~~~~~~~~~PE~~~~~------~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~  256 (260)
                       .......++..|+|||.+...      ..++.++|+||||+++|+|++ |..||...+..+.+..
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~  220 (268)
T cd05086         155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNH  220 (268)
T ss_pred             hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence             111234557889999987531      235778999999999999997 6779987776655554

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-34  Score=245.99  Aligned_cols=214  Identities=25%  Similarity=0.380  Sum_probs=186.8

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCCCC---eEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCC
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETR---EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~  113 (260)
                      .-|..+.+.+.+.||+|.||+|+++.+...+   ..||||++..+.... ...+|++|+..|.+|+|||++++|++..+.
T Consensus       105 clIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~q  183 (1039)
T KOG0199|consen  105 CLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLDQ  183 (1039)
T ss_pred             eeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeeccc
Confidence            3466777888999999999999999886532   359999998765443 678999999999999999999999999863


Q ss_pred             CCCCCccEEEEEecCC-cchHHHhhh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecc
Q 024959          114 KKDTFNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG  190 (260)
Q Consensus       114 ~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~  190 (260)
                      .      ..+|+|.++ |+|++.+.+  ...|....+..++.||+.++.||..++++|||+...|+++.....+||+|||
T Consensus       184 p------~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFG  257 (1039)
T KOG0199|consen  184 P------AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFG  257 (1039)
T ss_pred             h------hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeeccc
Confidence            2      679999999 899999987  4568889999999999999999999999999999999999998999999999


Q ss_pred             cccccCCCcccccc----cccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          191 LARTTSETDFMTEY----VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       191 ~~~~~~~~~~~~~~----~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      +++...........    .....|+|||.+.. ..++.++|+|++|++||||++ |..||.|.+..+.+++|.
T Consensus       258 LmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD  329 (1039)
T KOG0199|consen  258 LMRALGENEDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID  329 (1039)
T ss_pred             ceeccCCCCcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc
Confidence            99988776544432    22567999999987 889999999999999999999 899999999999999874

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=5.6e-33  Score=229.77  Aligned_cols=193  Identities=23%  Similarity=0.308  Sum_probs=159.9

Q ss_pred             CceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEEEEecCC-cch
Q 024959           54 AYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDL  132 (260)
Q Consensus        54 ~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l  132 (260)
                      +.+.||.+.+..+++.+++|++............+.+|+++++.++||||+++++.+...     ...+++||+++ ++|
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~-----~~~~~~~e~~~~~~l   86 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD-----SELYVVSPLMAYGSC   86 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecC-----CeEEEEEeccCCCCH
Confidence            446677777788899999999976534455667888999999999999999999998876     55899999998 688


Q ss_pred             HHHhhh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCcc--------cc
Q 024959          133 HQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF--------MT  202 (260)
Q Consensus       133 ~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~--------~~  202 (260)
                      .+++..  ...+++..+..++.|++++|+|||+++++|+||+|+||+++.++.++|+||+.+........        ..
T Consensus        87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~  166 (314)
T cd08216          87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK  166 (314)
T ss_pred             HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccc
Confidence            888875  35689999999999999999999999999999999999999999999999998765432211        12


Q ss_pred             cccccccccccccccCc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChH
Q 024959          203 EYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  251 (260)
Q Consensus       203 ~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~  251 (260)
                      ...++..|+|||.+... ..++.++|+||||+++|+|++|..||...+..
T Consensus       167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~  216 (314)
T cd08216         167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT  216 (314)
T ss_pred             cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            22346679999998653 35788999999999999999999999876543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-34  Score=240.17  Aligned_cols=199  Identities=28%  Similarity=0.422  Sum_probs=174.3

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHH------HHHHHHHHHHHHcC---CCCeeeeeceecCC
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA------RRTLREIKLLRHME---HENVIAIKDIIRPP  113 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~------~~~~~e~~~l~~l~---~~~iv~~~~~~~~~  113 (260)
                      .|..++++|.|+||.|++|.++.+...|+||.+.+..--...+      ...-.|+++|..++   |+||++++++|+++
T Consensus       562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd  641 (772)
T KOG1152|consen  562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD  641 (772)
T ss_pred             cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence            3778999999999999999999999999999986542211111      11235999999997   99999999999998


Q ss_pred             CCCCCccEEEEEecCC-c-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccc
Q 024959          114 KKDTFNDVYIVYELMD-T-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (260)
Q Consensus       114 ~~~~~~~~~lv~e~~~-~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~  191 (260)
                           ..+||+||-.+ + +|.+++..+.++++.++..|++|++.++++||+.||+|||||.+||.++.+|-+||+|||-
T Consensus       642 -----d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgs  716 (772)
T KOG1152|consen  642 -----DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGS  716 (772)
T ss_pred             -----CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccc
Confidence                 56999999887 3 8999999999999999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 024959          192 ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG  247 (260)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~  247 (260)
                      +-.... .++....||..|.|||.+.+.+.....-|||+||++||.++....||-+
T Consensus       717 aa~~ks-gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  717 AAYTKS-GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhhhcC-CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            755443 3567788999999999999977778899999999999999999999863

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.4e-34  Score=240.02  Aligned_cols=211  Identities=27%  Similarity=0.423  Sum_probs=179.2

Q ss_pred             EeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        38 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      ..+..+|..++.||-|+||+|.++....+...||+|.+.+.+. ..........|..+|..-+.+-||++|-.|.+.   
T Consensus       625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDk---  701 (1034)
T KOG0608|consen  625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDK---  701 (1034)
T ss_pred             hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccC---
Confidence            4566778889999999999999999999999999999966432 233445556788899999999999999999887   


Q ss_pred             CCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccccc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~  195 (260)
                        ..+|+||||++ |++-++|-.-+-|.++.++.++..+.-+++..|+.|++||||||+||||+.+|+|||+|||++.-+
T Consensus       702 --dnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGf  779 (1034)
T KOG0608|consen  702 --DNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF  779 (1034)
T ss_pred             --CceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccc
Confidence              56999999998 688899888899999999999999999999999999999999999999999999999999998533


Q ss_pred             CCCcc-------------------------------------------cccccccccccccccccCcCCCCChhhHHHHH
Q 024959          196 SETDF-------------------------------------------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVG  232 (260)
Q Consensus       196 ~~~~~-------------------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG  232 (260)
                      ...-.                                           .....|++.|+|||.+.. ..++...|.||.|
T Consensus       780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~g  858 (1034)
T KOG0608|consen  780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVG  858 (1034)
T ss_pred             eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHhh
Confidence            21100                                           001346888999999988 7889999999999


Q ss_pred             HHHHHHHhCCCCCCCCChHHHH
Q 024959          233 CILGEIMTREPLFPGKDYVHQL  254 (260)
Q Consensus       233 ~~l~~ll~g~~pf~~~~~~~~~  254 (260)
                      ++||+|+.|.+||-.....++-
T Consensus       859 vil~em~~g~~pf~~~tp~~tq  880 (1034)
T KOG0608|consen  859 VILYEMLVGQPPFLADTPGETQ  880 (1034)
T ss_pred             HHHHHHhhCCCCccCCCCCcce
Confidence            9999999999999877665443

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=6.4e-33  Score=226.71  Aligned_cols=200  Identities=21%  Similarity=0.355  Sum_probs=166.0

Q ss_pred             CCCcccccccCceEEEEEEeC---CCCeEEEEEecCCccc--chHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCCCC
Q 024959           44 VPPIRPIGRGAYGIVCAAVNS---ETREEVAIKKIGNAFD--NIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDT  117 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~---~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~  117 (260)
                      |.+.+.||+|++|.||++.+.   .++..+++|.++....  .......+.+|+++++++ +||+|+++++.+...    
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~----   77 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD----   77 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC----
Confidence            557889999999999999864   4667899999864321  122345677899999999 599999999998766    


Q ss_pred             CccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccC
Q 024959          118 FNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (260)
Q Consensus       118 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~  196 (260)
                       ...++||||+. ++|.+.+.....+++..++.++.|++++|.+||+.+++|+||+|.||+++.++.++|+|||++....
T Consensus        78 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          78 -TKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             -CEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence             55899999998 5899998888889999999999999999999999999999999999999999999999999887644


Q ss_pred             CCcc--cccccccccccccccccCcC-CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 024959          197 ETDF--MTEYVVTRWYRAPELLLNCT-EYTAAIDIWSVGCILGEIMTREPLFPGK  248 (260)
Q Consensus       197 ~~~~--~~~~~~~~~~~~PE~~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~  248 (260)
                      ....  .....++..|++||.+.+.. ..+.++|+||||+++++|++|..||...
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~  211 (288)
T cd05583         157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVD  211 (288)
T ss_pred             cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccC
Confidence            3321  12234678899999986632 3678999999999999999999999644

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-34  Score=226.42  Aligned_cols=207  Identities=31%  Similarity=0.552  Sum_probs=177.0

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC--CC----CeeeeeceecCCC
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME--HE----NVIAIKDIIRPPK  114 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~--~~----~iv~~~~~~~~~~  114 (260)
                      ...|.+++.+|+|.||.|-.+.+..++..+|||+++.-   ....+..+-|+++|+++.  .|    -++.+.++|... 
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr-  163 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR-  163 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc-
Confidence            56677999999999999999999999999999999652   334556667999999994  22    466777778666 


Q ss_pred             CCCCccEEEEEecCCcchHHHhhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec-------------
Q 024959          115 KDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN-------------  179 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~-------------  179 (260)
                          +..+||+|.++.|+.+.+.++.  +++...++.|++|+++++++||+.+++|.|+||+||++-             
T Consensus       164 ----ghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  164 ----GHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             ----CceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence                5589999999999999998764  699999999999999999999999999999999999982             


Q ss_pred             -------cCCCEEEeecccccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 024959          180 -------ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  252 (260)
Q Consensus       180 -------~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~  252 (260)
                             .+-.++++|||-+....+..  .....|..|.|||++++ -.++...||||+||+|.|+.+|...|...++.+
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             cceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheec-cCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence                   12348999999988766553  45567999999999999 899999999999999999999999999999988


Q ss_pred             HHHHhh
Q 024959          253 QLRLIT  258 (260)
Q Consensus       253 ~~~~i~  258 (260)
                      .++-+.
T Consensus       317 HLaMMe  322 (415)
T KOG0671|consen  317 HLAMME  322 (415)
T ss_pred             HHHHHH
Confidence            775543

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-35  Score=263.64  Aligned_cols=202  Identities=29%  Similarity=0.444  Sum_probs=176.6

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~l  123 (260)
                      +.-...||.|.||.||-+.+..+|+..|+|-++.............+|.+++..++|||+|++|++=.+.     +..+|
T Consensus      1237 Wqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR-----ekv~I 1311 (1509)
T KOG4645|consen 1237 WQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR-----EKVYI 1311 (1509)
T ss_pred             eccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH-----HHHHH
Confidence            4456789999999999999999999999999977765555667778999999999999999999987665     55899


Q ss_pred             EEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc---
Q 024959          124 VYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---  199 (260)
Q Consensus       124 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~---  199 (260)
                      .||||. |+|.+.++..+..++...+.+-.|++.++.|||+.|||||||||.||+++.+|.+|++|||.+.....+.   
T Consensus      1312 FMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred             HHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence            999998 6999998888889999999999999999999999999999999999999999999999999998766552   


Q ss_pred             --ccccccccccccccccccCcC--CCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024959          200 --FMTEYVVTRWYRAPELLLNCT--EYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (260)
Q Consensus       200 --~~~~~~~~~~~~~PE~~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  250 (260)
                        ......||+.|||||.+.+.+  ...-++|||||||++.||+||+.||...+.
T Consensus      1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn 1446 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN 1446 (1509)
T ss_pred             CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc
Confidence              234567899999999997642  345689999999999999999999976655

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=3.9e-32  Score=244.34  Aligned_cols=147  Identities=24%  Similarity=0.414  Sum_probs=130.9

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc-cchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      ..|.+++.||.|+||.||++.+..+++.||+|++.... ........+.+|+.+++.++||||+++++.+...     ..
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-----~~   78 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSA-----NN   78 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC-----CE
Confidence            45667899999999999999999999999999996532 2333456778899999999999999999988766     56


Q ss_pred             EEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          121 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                      +|+||||+. ++|.+++.....+++..++.++.||+.+|.|||.++++|+||||+|||++.++.++|+|||+++
T Consensus        79 ~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          79 VYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999996 6999999888889999999999999999999999999999999999999999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-33  Score=221.36  Aligned_cols=208  Identities=22%  Similarity=0.402  Sum_probs=181.2

Q ss_pred             ecceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHH-HHHHHHHHHHHHHc-CCCCeeeeecee
Q 024959           33 YGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIID-ARRTLREIKLLRHM-EHENVIAIKDII  110 (260)
Q Consensus        33 ~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~-~~~~~~e~~~l~~l-~~~~iv~~~~~~  110 (260)
                      .+..|.+..+++.+++.||.|+|+.|.+++++++.+.||+|++++..-+... ..=...|-.+...- +||.+|-+...|
T Consensus       241 ~~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf  320 (593)
T KOG0695|consen  241 IKISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF  320 (593)
T ss_pred             cccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh
Confidence            3466788899999999999999999999999999999999999776433322 22233455555554 699999999988


Q ss_pred             cCCCCCCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeec
Q 024959          111 RPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF  189 (260)
Q Consensus       111 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df  189 (260)
                      ..+     +.+++|.||++ |+|--.++.+.+++++.++.+...|+-+|.|||++||+++|+|.+||+++..|++||+|+
T Consensus       321 qte-----srlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdy  395 (593)
T KOG0695|consen  321 QTE-----SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDY  395 (593)
T ss_pred             ccc-----ceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeeccc
Confidence            777     66999999998 588888889999999999999999999999999999999999999999999999999999


Q ss_pred             cccccc-CCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 024959          190 GLARTT-SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFP  246 (260)
Q Consensus       190 ~~~~~~-~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~  246 (260)
                      |.++.. .......+.+|++.|.|||.+.+ ..|....|.|+||++++||+.|..||+
T Consensus       396 gmcke~l~~gd~tstfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfd  452 (593)
T KOG0695|consen  396 GMCKEGLGPGDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFD  452 (593)
T ss_pred             chhhcCCCCCcccccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcc
Confidence            998764 44456677899999999999999 889999999999999999999999995

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=100.00  E-value=9.2e-32  Score=211.54  Aligned_cols=209  Identities=33%  Similarity=0.558  Sum_probs=177.2

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~l  123 (260)
                      |.+.+.||.|++|.||++.+..+++.+++|.+...... .....+.+|++.+++++|+|++++++.+...     ...++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-----~~~~~   74 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDP-----EPLYL   74 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecC-----CceEE
Confidence            34678899999999999999988899999999764332 2467788899999999999999999998766     55899


Q ss_pred             EEecCCc-chHHHhhhCCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc--
Q 024959          124 VYELMDT-DLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--  199 (260)
Q Consensus       124 v~e~~~~-~l~~~l~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~--  199 (260)
                      ++|++++ +|.+++..... +++..++.++.+++.++.+||+.+++|+||+|.||+++.++.++|+|||.+.......  
T Consensus        75 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~  154 (225)
T smart00221       75 VMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA  154 (225)
T ss_pred             EEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence            9999996 99999888766 8999999999999999999999999999999999999999999999999888765543  


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCC--CChHHHHHHhh
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG--KDYVHQLRLIT  258 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~--~~~~~~~~~i~  258 (260)
                      ......+...|++||.+.+...++.++|+|+||+++++|++|+.||..  .+.....+.|.
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~  215 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWS  215 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHh
Confidence            333445677899999984336677899999999999999999999977  44445555543

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=3.9e-32  Score=218.78  Aligned_cols=207  Identities=28%  Similarity=0.486  Sum_probs=167.4

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc---cchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF---DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      |.+.+.||+|++|.||++.+...+..+++|..+...   .......++..|+.+++.++||||+++++.+...     ..
T Consensus         2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~   76 (260)
T cd08222           2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER-----DA   76 (260)
T ss_pred             ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC-----Cc
Confidence            567899999999999999998877767666664321   1222344566789999999999999999998776     45


Q ss_pred             EEEEEecCC-cchHHHhhh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccccc
Q 024959          121 VYIVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~  195 (260)
                      .++++|+++ ++|.+++..    ...+++..++.++.|+++++.+||+.|++|+||+|+||+++. +.++|+|||++...
T Consensus        77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~  155 (260)
T cd08222          77 FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLL  155 (260)
T ss_pred             eEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeec
Confidence            899999998 578777653    457999999999999999999999999999999999999975 57999999988765


Q ss_pred             CCCc-ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          196 SETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       196 ~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      .... ......++..|++||.+.. ..++.++|+||||+++|+|++|..||...+.......+
T Consensus       156 ~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~  217 (260)
T cd08222         156 MGSCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI  217 (260)
T ss_pred             CCCcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence            4332 2223345778999999866 66788999999999999999999999877665554443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=3.6e-32  Score=216.25  Aligned_cols=181  Identities=22%  Similarity=0.321  Sum_probs=153.2

Q ss_pred             cCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEEEEecCC-cc
Q 024959           53 GAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TD  131 (260)
Q Consensus        53 G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~  131 (260)
                      |.++.||++.++.+++.+++|.+....       ...+|...+....||||+++++.+...     ...+++||+++ ++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~   71 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSE-----DSVFLVLQHAEGGK   71 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecC-----CeEEEEEecCCCCC
Confidence            889999999999999999999996542       122344444555799999999998876     56899999998 59


Q ss_pred             hHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCccccccccccccc
Q 024959          132 LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYR  211 (260)
Q Consensus       132 l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~  211 (260)
                      |.+++.....+++..+..++.|++++|++||+++++|+||+|+||+++.++.++++|||.+.......  .....+..|+
T Consensus        72 L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~y~  149 (237)
T cd05576          72 LWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC--DGEAVENMYC  149 (237)
T ss_pred             HHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc--ccCCcCcccc
Confidence            99998888889999999999999999999999999999999999999999999999999876554432  2234466799


Q ss_pred             ccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 024959          212 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK  248 (260)
Q Consensus       212 ~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  248 (260)
                      +||.... ..++.++|+||+|+++|+|++|..||...
T Consensus       150 aPE~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~  185 (237)
T cd05576         150 APEVGGI-SEETEACDWWSLGAILFELLTGKTLVECH  185 (237)
T ss_pred             CCcccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcC
Confidence            9998866 66789999999999999999999887543

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-33  Score=234.48  Aligned_cols=202  Identities=30%  Similarity=0.471  Sum_probs=170.0

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCCCCCc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      .+.|++...+|.|+|+.+-.+.+..+++..++|++.+.      ..+..+|+.++... +||||+++.+.+.++     .
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~------~~~~~~e~~~~~~~~~h~niv~~~~v~~~~-----~  389 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR------ADDNQDEIPISLLVRDHPNIVKSHDVYEDG-----K  389 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccc------ccccccccchhhhhcCCCcceeecceecCC-----c
Confidence            45566888899999999999999999999999999664      12233566555555 699999999999988     5


Q ss_pred             cEEEEEecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEe-ccCCCEEEeecccccccCC
Q 024959          120 DVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL-NASCDLKIGDFGLARTTSE  197 (260)
Q Consensus       120 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili-~~~~~~~l~df~~~~~~~~  197 (260)
                      ..|+|||.+.+ .+.+.+.....++ ..+..|+++|+.++.+||++|++|||++|+|||+ +..++++|+|||.+.....
T Consensus       390 ~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  390 EIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER  468 (612)
T ss_pred             eeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence            59999999984 6667666666666 7888899999999999999999999999999999 6889999999999887665


Q ss_pred             CcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHh
Q 024959          198 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV-HQLRLI  257 (260)
Q Consensus       198 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-~~~~~i  257 (260)
                      .  ..+.+.+..|.|||.+.. ..+++..|+||||++||+||+|..||...... +....|
T Consensus       469 ~--~~tp~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i  526 (612)
T KOG0603|consen  469 S--CDTPALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI  526 (612)
T ss_pred             h--hcccchhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh
Confidence            5  455677889999999986 88999999999999999999999999877665 444443

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-33  Score=219.87  Aligned_cols=213  Identities=48%  Similarity=0.833  Sum_probs=190.4

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC-CCccE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD-TFNDV  121 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~-~~~~~  121 (260)
                      .|.-+++++.|.. .|..+.+.-.++++++|.......+...+.+..+|...+..++|+||++++.+|...... .+...
T Consensus        18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~   96 (369)
T KOG0665|consen   18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV   96 (369)
T ss_pred             eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence            3446789999998 899999999999999999988777777888899999999999999999999999876542 33579


Q ss_pred             EEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCccc
Q 024959          122 YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  201 (260)
Q Consensus       122 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  201 (260)
                      |+|||+|..+|.+.+.  ..++-+++..++.|++.++.+||+.||+|||+||+||+++.+..+|+.|||++...+..-..
T Consensus        97 y~v~e~m~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~m  174 (369)
T KOG0665|consen   97 YLVMELMDANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDFMM  174 (369)
T ss_pred             HHHHHhhhhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCccccc
Confidence            9999999999988877  56778899999999999999999999999999999999999999999999999887776445


Q ss_pred             ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       202 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      .....+..|.|||...+ ..+.+.+||||+||++.||++|+..|.|.+..+++.+|.+
T Consensus       175 tpyVvtRyyrapevil~-~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~  231 (369)
T KOG0665|consen  175 TPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIE  231 (369)
T ss_pred             CchhheeeccCchheec-cCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHH
Confidence            55677999999999999 5589999999999999999999999999999999998865

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-33  Score=229.57  Aligned_cols=205  Identities=22%  Similarity=0.429  Sum_probs=169.1

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc-----cchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-----DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~-----~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      +.|-++..||.|||+.||++++....+.||+|+-....     ..........+|.++.+.|+||.||++|++|....  
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt--  540 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT--  540 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc--
Confidence            34558899999999999999999999999999863321     12223455668999999999999999999997653  


Q ss_pred             CCccEEEEEecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhC--CceeccCCCCCeEecc---CCCEEEeecc
Q 024959          117 TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA--SVLHRDLKPSNLLLNA---SCDLKIGDFG  190 (260)
Q Consensus       117 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~--~i~H~di~~~nili~~---~~~~~l~df~  190 (260)
                        ..++.|.|||+| +|.-++..++-+++.+++.|+.||+.+|.||.+.  .|+|-|+||.|||+-.   .|.+||+|||
T Consensus       541 --dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  541 --DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             --ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence              458899999996 6777777888899999999999999999999965  6999999999999843   4789999999


Q ss_pred             cccccCCCcc--------cccccccccccccccccCc---CCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024959          191 LARTTSETDF--------MTEYVVTRWYRAPELLLNC---TEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (260)
Q Consensus       191 ~~~~~~~~~~--------~~~~~~~~~~~~PE~~~~~---~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  250 (260)
                      +++.+.....        .....|+..|++||.+.-.   +..+.++||||.|+++|+.+.|++||..+..
T Consensus       619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs  689 (775)
T KOG1151|consen  619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS  689 (775)
T ss_pred             hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh
Confidence            9988765432        2234568899999998642   4567899999999999999999999986554

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=1.3e-30  Score=206.99  Aligned_cols=195  Identities=36%  Similarity=0.678  Sum_probs=168.9

Q ss_pred             CceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEEEEecCCc-ch
Q 024959           54 AYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DL  132 (260)
Q Consensus        54 ~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l  132 (260)
                      ++|.||++.+..+++.+++|++........ ...+.+|++.+++++|+|++++.+.+...     ...++++|++++ +|
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L   74 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDE-----DKLYLVMEYCDGGDL   74 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeC-----CEEEEEEeCCCCCCH
Confidence            578999999999899999999976533221 57788999999999999999999998876     558999999996 99


Q ss_pred             HHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCcccccccccccccc
Q 024959          133 HQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRA  212 (260)
Q Consensus       133 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~  212 (260)
                      .+++.....+++..++.++.++++++.+||+.+++|+||+|.||+++.++.++|+|||.+.............++..|++
T Consensus        75 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  154 (244)
T smart00220       75 FDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMA  154 (244)
T ss_pred             HHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCC
Confidence            99988777799999999999999999999999999999999999999999999999999988766544455567888999


Q ss_pred             cccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCC-CChHHHHH
Q 024959          213 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG-KDYVHQLR  255 (260)
Q Consensus       213 PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~-~~~~~~~~  255 (260)
                      ||.... ...+.++|+|+||++++++++|..||.. .+.....+
T Consensus       155 pE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~  197 (244)
T smart00220      155 PEVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFK  197 (244)
T ss_pred             HHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence            999876 6678899999999999999999999987 44443333

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=8e-31  Score=232.86  Aligned_cols=219  Identities=26%  Similarity=0.473  Sum_probs=186.2

Q ss_pred             ecceeEeccccCCCcccccccCceEEEEEEeCC-------CCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-CCCee
Q 024959           33 YGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSE-------TREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVI  104 (260)
Q Consensus        33 ~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv  104 (260)
                      ....|++..+...+.+.||.|.||.|+++.-..       ....||+|..+..... .....+..|+++|+.+. ||||+
T Consensus       287 ~~~~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv  365 (609)
T KOG0200|consen  287 EDPKWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIV  365 (609)
T ss_pred             cCCceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchh
Confidence            444899999999999999999999999997431       1456999999876555 67888999999999995 99999


Q ss_pred             eeeceecCCCCCCCccEEEEEecCC-cchHHHhhhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCce
Q 024959          105 AIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ----------------QLTDDHCQYFLYQLLRGLKYVHSASVL  167 (260)
Q Consensus       105 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~~i~  167 (260)
                      .+++.+...     ...++|+||+. |+|..+++..+                .++...+..++.||+.+++||++.+++
T Consensus       366 ~llG~~t~~-----~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~v  440 (609)
T KOG0200|consen  366 NLLGACTQD-----GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCV  440 (609)
T ss_pred             hheeeeccC-----CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCcc
Confidence            999999884     56899999998 89999988755                488999999999999999999999999


Q ss_pred             eccCCCCCeEeccCCCEEEeecccccccCCCcccccc--c--ccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CC
Q 024959          168 HRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY--V--VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-RE  242 (260)
Q Consensus       168 H~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~--~--~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~  242 (260)
                      |||+...|||++.+..+|++|||+++...........  .  -...|+|||.+.. ..++.++||||+|++|||+++ |.
T Consensus       441 HRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~  519 (609)
T KOG0200|consen  441 HRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGG  519 (609)
T ss_pred             chhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCC
Confidence            9999999999999999999999999875554433211  1  2456999999998 899999999999999999999 99


Q ss_pred             CCCCCCC-hHHHHHHhh
Q 024959          243 PLFPGKD-YVHQLRLIT  258 (260)
Q Consensus       243 ~pf~~~~-~~~~~~~i~  258 (260)
                      .||++-. ..+.++.++
T Consensus       520 ~PYp~~~~~~~l~~~l~  536 (609)
T KOG0200|consen  520 TPYPGIPPTEELLEFLK  536 (609)
T ss_pred             CCCCCCCcHHHHHHHHh
Confidence            9999855 555555443

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=4.4e-31  Score=229.71  Aligned_cols=212  Identities=24%  Similarity=0.412  Sum_probs=181.1

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-CCCeeeeeceecCCCCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDT  117 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~  117 (260)
                      .....+++...||.|.+|.||++.++++++..|+|+.....+.   ...+..|.++|+.+. |||++.+|+++.-.+...
T Consensus        16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~---deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~   92 (953)
T KOG0587|consen   16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE---EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN   92 (953)
T ss_pred             CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc---cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence            3455677899999999999999999999999999999765443   344567888998885 999999999998877777


Q ss_pred             CccEEEEEecCC-cchHHHhhh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          118 FNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       118 ~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                      .+++|||||+|+ |+.-++++.  ..++.|+.+..|++.++.++.+||.+.++|+||+-.||+++.++.+||.|||.+..
T Consensus        93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQ  172 (953)
T KOG0587|consen   93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  172 (953)
T ss_pred             CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeee
Confidence            789999999999 688888765  56899999999999999999999999999999999999999999999999998755


Q ss_pred             cCC-CcccccccccccccccccccCc----CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024959          195 TSE-TDFMTEYVVTRWYRAPELLLNC----TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  253 (260)
Q Consensus       195 ~~~-~~~~~~~~~~~~~~~PE~~~~~----~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~  253 (260)
                      ... .....+..|++.|||||.+.-.    ..++.++|+||||++..||.-|.+|+.++...-.
T Consensus       173 ldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra  236 (953)
T KOG0587|consen  173 LDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA  236 (953)
T ss_pred             eecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh
Confidence            443 3455667889999999998532    4567899999999999999999999987766433

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-31  Score=217.20  Aligned_cols=190  Identities=24%  Similarity=0.358  Sum_probs=152.4

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHc--CCCCeeeeeceecCCCCCCCc
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM--EHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l--~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      +.+.+.+.||+|.||.||++..+  |+.||||++....     .....+|.++.+..  +|+||+.+++.-.... ..--
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~-gs~T  282 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGFIAADNKDN-GSWT  282 (513)
T ss_pred             heeEEEEEecCccccceeecccc--CCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhhhhccccCC-CceE
Confidence            34457899999999999999776  6799999995532     23455666666654  8999999888644332 1114


Q ss_pred             cEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHh-----C---CceeccCCCCCeEeccCCCEEEeecc
Q 024959          120 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-----A---SVLHRDLKPSNLLLNASCDLKIGDFG  190 (260)
Q Consensus       120 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-----~---~i~H~di~~~nili~~~~~~~l~df~  190 (260)
                      ++++|++|.+ |||.+++.. ..++.+....++..++.+|++||.     +   .|.|||||..||++..++.+-|+|+|
T Consensus       283 QLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG  361 (513)
T KOG2052|consen  283 QLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  361 (513)
T ss_pred             EEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence            6999999999 899999887 678889999999999999999994     2   39999999999999999999999999


Q ss_pred             cccccCCC-----cccccccccccccccccccCcCCC-----CChhhHHHHHHHHHHHHh
Q 024959          191 LARTTSET-----DFMTEYVVTRWYRAPELLLNCTEY-----TAAIDIWSVGCILGEIMT  240 (260)
Q Consensus       191 ~~~~~~~~-----~~~~~~~~~~~~~~PE~~~~~~~~-----~~~~Di~slG~~l~~ll~  240 (260)
                      ++......     ......+||.+|||||.+...-..     =..+||||||.++||++.
T Consensus       362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar  421 (513)
T KOG2052|consen  362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR  421 (513)
T ss_pred             eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence            99765444     344567889999999999653221     136999999999999976

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.7e-31  Score=229.68  Aligned_cols=207  Identities=25%  Similarity=0.365  Sum_probs=177.7

Q ss_pred             CCCcccccccCceEEEEEEeCCCCe----EEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCc
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETRE----EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      ....+.||+|+||+||++..--.++    +|++|++... ........+++|+-+|.+++|||++++++++....     
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~-t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-----  771 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF-TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-----  771 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeecc-CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-----
Confidence            4467789999999999998754444    5888888654 45555678899999999999999999999998753     


Q ss_pred             cEEEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCC
Q 024959          120 DVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (260)
Q Consensus       120 ~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~  197 (260)
                       .-||+++++ |+|.++++. +.++.......|..||++++.|||++.++||||-..|||+..-..+|+.|||+++....
T Consensus       772 -~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~  850 (1177)
T KOG1025|consen  772 -LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP  850 (1177)
T ss_pred             -HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence             678999999 899999987 46789999999999999999999999999999999999999999999999999998776


Q ss_pred             Cccccccc---ccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          198 TDFMTEYV---VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       198 ~~~~~~~~---~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      ........   ..+-|+|-|.+.. ..++.++||||+|+++||++| |..||.+....+....++
T Consensus       851 d~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle  914 (1177)
T KOG1025|consen  851 DEKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE  914 (1177)
T ss_pred             ccccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh
Confidence            65443332   2677999999887 889999999999999999999 999999999888776654

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=7.9e-32  Score=222.78  Aligned_cols=213  Identities=33%  Similarity=0.557  Sum_probs=182.4

Q ss_pred             EeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCC------CCeeeeeceec
Q 024959           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH------ENVIAIKDIIR  111 (260)
Q Consensus        38 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~------~~iv~~~~~~~  111 (260)
                      |+-...|++....|+|=|++|..|.+..-+..||||++.+.   +.-...=++|+++|++|+.      -|+++++..|.
T Consensus       428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN---E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~  504 (752)
T KOG0670|consen  428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN---EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK  504 (752)
T ss_pred             hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc---hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence            33344566778889999999999999999999999999652   2233445689999999962      48899999888


Q ss_pred             CCCCCCCccEEEEEecCCcchHHHhhhCC---CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccC-CCEEEe
Q 024959          112 PPKKDTFNDVYIVYELMDTDLHQIIRSDQ---QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIG  187 (260)
Q Consensus       112 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~-~~~~l~  187 (260)
                      ..     +.+|+|+|.+.-+|.+.+.+.+   .+....++.++.||+-||..|-.+|++|.||||+|||+++. ..+||+
T Consensus       505 hk-----nHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLC  579 (752)
T KOG0670|consen  505 HK-----NHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLC  579 (752)
T ss_pred             hc-----ceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeec
Confidence            76     6799999999989999998743   47888999999999999999999999999999999999986 457999


Q ss_pred             ecccccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcC
Q 024959          188 DFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV  260 (260)
Q Consensus       188 df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~~  260 (260)
                      |||-+-...+... ..+..+.+|.|||++++ .+|+...|+||.||+||||.||+..|+|..+-+.+++.+++
T Consensus       580 DfGSA~~~~enei-tPYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~  650 (752)
T KOG0670|consen  580 DFGSASFASENEI-TPYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMEL  650 (752)
T ss_pred             cCccccccccccc-cHHHHHHhccCcceeec-CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHh
Confidence            9999877766643 34566888999999999 89999999999999999999999999999999999988764

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=6.9e-31  Score=214.89  Aligned_cols=193  Identities=26%  Similarity=0.357  Sum_probs=157.4

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHc--CCCCeeeeeceecCCCCCCCc
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM--EHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l--~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      .-..+.+.+|+|+||+||++...  ++.||||++...     ..+.+..|-++.+..  +|+||+++++.=...... ..
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~-----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~-~~  281 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQ-----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD-RM  281 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc--CceeEEEecCHH-----HHHHHHhHHHHHhccCccchhHHHhhchhccCCcc-cc
Confidence            33456788999999999999654  589999999543     566777777776655  699999999876655433 36


Q ss_pred             cEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHh---------CCceeccCCCCCeEeccCCCEEEeec
Q 024959          120 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS---------ASVLHRDLKPSNLLLNASCDLKIGDF  189 (260)
Q Consensus       120 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~---------~~i~H~di~~~nili~~~~~~~l~df  189 (260)
                      .++||++|.+ |+|.+++.. ..+++.....|+..|+++|+|||+         ..|+|||||..|||+..|+++.|+||
T Consensus       282 eywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF  360 (534)
T KOG3653|consen  282 EYWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF  360 (534)
T ss_pred             ceeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence            7999999998 899998654 468999999999999999999995         23999999999999999999999999


Q ss_pred             ccccccCCC---cccccccccccccccccccCcCCCC-----ChhhHHHHHHHHHHHHhCCC
Q 024959          190 GLARTTSET---DFMTEYVVTRWYRAPELLLNCTEYT-----AAIDIWSVGCILGEIMTREP  243 (260)
Q Consensus       190 ~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~-----~~~Di~slG~~l~~ll~g~~  243 (260)
                      |++......   .......||.+|||||.+-+--+..     .+.||||+|.++|||+++..
T Consensus       361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~  422 (534)
T KOG3653|consen  361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCT  422 (534)
T ss_pred             ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcc
Confidence            999776543   3344578899999999997632222     36999999999999998654

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.9e-30  Score=210.14  Aligned_cols=133  Identities=28%  Similarity=0.463  Sum_probs=116.5

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC--------CCCeeeeeceecCC
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME--------HENVIAIKDIIRPP  113 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~--------~~~iv~~~~~~~~~  113 (260)
                      ..|.+.++||.|.|++||++++....+.||+|+.+.+   ....+..+.|+++|++++        ..+||++++.|...
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs  154 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS  154 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence            5677899999999999999999999999999999764   234566788999999994        25899999999876


Q ss_pred             CCCCCccEEEEEecCCcchHHHhhhC--CCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCCeEe
Q 024959          114 KKDTFNDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVH-SASVLHRDLKPSNLLL  178 (260)
Q Consensus       114 ~~~~~~~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh-~~~i~H~di~~~nili  178 (260)
                      ...+ ..+++|+|+++.+|+.++...  +-++...+++|++|++.+|.||| ++||+|.||||+|||+
T Consensus       155 GpNG-~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  155 GPNG-QHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL  221 (590)
T ss_pred             CCCC-cEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence            5433 679999999999999999874  56899999999999999999999 5699999999999999

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.97  E-value=4.9e-30  Score=240.97  Aligned_cols=185  Identities=19%  Similarity=0.360  Sum_probs=153.5

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~l  123 (260)
                      +...+.||+|+||.||++.+..++..||+|.+......      ..+|++.+++++||||+++++++...     ...++
T Consensus       692 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~-----~~~~l  760 (968)
T PLN00113        692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSE-----KGAYL  760 (968)
T ss_pred             CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcC-----CCCEE
Confidence            34566899999999999999999999999998643221      22468889999999999999999876     45899


Q ss_pred             EEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCCCCeEeccCCCEEEeecccccccCCCc
Q 024959          124 VYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH---SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (260)
Q Consensus       124 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~  199 (260)
                      ||||++ ++|.+++.   .+++..+..++.|++++++|||   +.+++|+||||+||+++.++..++. ++........ 
T Consensus       761 v~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-  835 (968)
T PLN00113        761 IHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-  835 (968)
T ss_pred             EEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-
Confidence            999998 68998885   3889999999999999999999   6699999999999999988887765 5543322111 


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG  247 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~  247 (260)
                        ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       836 --~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~  880 (968)
T PLN00113        836 --TKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADA  880 (968)
T ss_pred             --CCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence              12356789999999877 7789999999999999999999999853

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.96  E-value=2.7e-29  Score=221.21  Aligned_cols=203  Identities=21%  Similarity=0.291  Sum_probs=142.4

Q ss_pred             EeccccCCCcccccccCceEEEEEEeCCC----CeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCC
Q 024959           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSET----REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (260)
Q Consensus        38 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~----~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~  113 (260)
                      .+..+.|++.+.||+|+||.||++.+..+    +..|++|.+......    +....+  .++...+.++..+...+...
T Consensus       128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~----e~~~~e--~l~~~~~~~~~~~~~~~~~~  201 (566)
T PLN03225        128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV----EIWMNE--RVRRACPNSCADFVYGFLEP  201 (566)
T ss_pred             CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh----HHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence            34556788999999999999999999988    899999988543211    111111  12222233333333332221


Q ss_pred             CC-CCCccEEEEEecCC-cchHHHhhhCC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccC
Q 024959          114 KK-DTFNDVYIVYELMD-TDLHQIIRSDQ--------------------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDL  171 (260)
Q Consensus       114 ~~-~~~~~~~lv~e~~~-~~l~~~l~~~~--------------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di  171 (260)
                      .. .....+++|+||++ ++|.+++....                    ......+..++.|++.+|+|||+++|+|+||
T Consensus       202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL  281 (566)
T PLN03225        202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV  281 (566)
T ss_pred             cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence            11 22356899999998 58888876432                    1123456789999999999999999999999


Q ss_pred             CCCCeEecc-CCCEEEeecccccccCCCc--ccccccccccccccccccCcC---------------------CCCChhh
Q 024959          172 KPSNLLLNA-SCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCT---------------------EYTAAID  227 (260)
Q Consensus       172 ~~~nili~~-~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~---------------------~~~~~~D  227 (260)
                      ||+|||++. ++.+||+|||++.......  ......+++.|+|||.+....                     .++.+.|
T Consensus       282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            999999986 5789999999997653321  223456688999999764311                     2334569


Q ss_pred             HHHHHHHHHHHHhCCCCCC
Q 024959          228 IWSVGCILGEIMTREPLFP  246 (260)
Q Consensus       228 i~slG~~l~~ll~g~~pf~  246 (260)
                      ||||||++|+|+++..|++
T Consensus       362 VwSlGviL~el~~~~~~~~  380 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSD  380 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCc
Confidence            9999999999999776654

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=9e-29  Score=213.33  Aligned_cols=207  Identities=19%  Similarity=0.300  Sum_probs=151.1

Q ss_pred             eccccCCCcccccccCceEEEEEEeC----------------CCCeEEEEEecCCcccchHHHHH--------------H
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNS----------------ETREEVAIKKIGNAFDNIIDARR--------------T   88 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~----------------~~~~~~~iK~~~~~~~~~~~~~~--------------~   88 (260)
                      .+.+.|++.+.||+|+||.||++...                ..++.|+||.+......  ...+              .
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~--~~~~fl~e~~~~~~~~e~~  219 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQG--VRQDFLKTGTLAKGSAETG  219 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchh--hHHHHHhhhhhhhcccchh
Confidence            45778899999999999999999642                34467999998653221  1222              2


Q ss_pred             HHHHHHHHHcCCCCe-----eeeeceecCCCCC---CCccEEEEEecCC-cchHHHhhhC--------------------
Q 024959           89 LREIKLLRHMEHENV-----IAIKDIIRPPKKD---TFNDVYIVYELMD-TDLHQIIRSD--------------------  139 (260)
Q Consensus        89 ~~e~~~l~~l~~~~i-----v~~~~~~~~~~~~---~~~~~~lv~e~~~-~~l~~~l~~~--------------------  139 (260)
                      ..|+.++.+++|.++     ++++++|......   .....++|+||++ ++|.+++...                    
T Consensus       220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~  299 (507)
T PLN03224        220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD  299 (507)
T ss_pred             HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence            346667777765543     6677776543221   1245899999998 5888877531                    


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCccccc--cccccccccc
Q 024959          140 ----QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE--YVVTRWYRAP  213 (260)
Q Consensus       140 ----~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~--~~~~~~~~~P  213 (260)
                          ..+++..++.++.|++++|.+||+.+++|+||||+||+++.++.++|+|||++...........  ...++.|++|
T Consensus       300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             hcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence                1245678899999999999999999999999999999999999999999999866543322222  2336889999


Q ss_pred             ccccCcCC---------------------CCChhhHHHHHHHHHHHHhCCC-CCCC
Q 024959          214 ELLLNCTE---------------------YTAAIDIWSVGCILGEIMTREP-LFPG  247 (260)
Q Consensus       214 E~~~~~~~---------------------~~~~~Di~slG~~l~~ll~g~~-pf~~  247 (260)
                      |.+.....                     .....|+||+||++++|+++.. ||.+
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~  435 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN  435 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence            99864211                     1134699999999999999875 7754

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=8.9e-30  Score=195.47  Aligned_cols=197  Identities=22%  Similarity=0.357  Sum_probs=157.3

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-CCCeeeeeceecCCCCCCCcc
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      +-|.|.+.||.|.||.+-++.|+.++..+++|.++...   ....+|.+|...---|. |.||+.-|++-.+..    +.
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~----d~   96 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS----DA   96 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhcC----ce
Confidence            34678999999999999999999999999999997653   35677888887655564 899999888755442    56


Q ss_pred             EEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecc--CCCEEEeecccccccCC
Q 024959          121 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA--SCDLKIGDFGLARTTSE  197 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~--~~~~~l~df~~~~~~~~  197 (260)
                      +++++|+++ |+|.+-+.. ..+.+.....++.|+++||.|||+.+++|||||.+||||..  .-.+||+|||+....+.
T Consensus        97 YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~  175 (378)
T KOG1345|consen   97 YVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT  175 (378)
T ss_pred             EEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence            889999999 788887665 34667788889999999999999999999999999999943  35699999999866543


Q ss_pred             CcccccccccccccccccccCc----CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 024959          198 TDFMTEYVVTRWYRAPELLLNC----TEYTAAIDIWSVGCILGEIMTREPLFPGK  248 (260)
Q Consensus       198 ~~~~~~~~~~~~~~~PE~~~~~----~~~~~~~Di~slG~~l~~ll~g~~pf~~~  248 (260)
                      .-  ........|.+||....-    -..++.+|+|.||++++..|+|+.||...
T Consensus       176 tV--~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka  228 (378)
T KOG1345|consen  176 TV--KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA  228 (378)
T ss_pred             ee--hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh
Confidence            21  111224557888876431    23578899999999999999999999743

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=7.2e-28  Score=189.82  Aligned_cols=200  Identities=20%  Similarity=0.273  Sum_probs=171.3

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-CCCeeeeeceecCCCCCCCc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~~~  119 (260)
                      +-.|.++++||+|.||+++.+.+.-++++||||.-....+    ..++..|.+..+.|. .++|...|-+-.+...    
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~----   98 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE----APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKY----   98 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccCC----cchHHHHHHHHHHHcCCCCCCceeeeccccch----
Confidence            5567789999999999999999999999999999865443    456777888888885 7899988877666633    


Q ss_pred             cEEEEEecCCcchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccC-----CCEEEeeccccc
Q 024959          120 DVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-----CDLKIGDFGLAR  193 (260)
Q Consensus       120 ~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~-----~~~~l~df~~~~  193 (260)
                       -.+|+|.++.+|.+++.- .++|+..++..++.||+.-++++|++.+++|||||+|+||..-     ..|-++|||+++
T Consensus        99 -NiLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK  177 (449)
T KOG1165|consen   99 -NILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK  177 (449)
T ss_pred             -hhhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence             469999999999999875 6789999999999999999999999999999999999999533     448999999999


Q ss_pred             ccCCCcccc--------cccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024959          194 TTSETDFMT--------EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (260)
Q Consensus       194 ~~~~~~~~~--------~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  250 (260)
                      ...++.+..        +..||-+||+-..+++ ...+.+.|+-+||-++++.|.|..||.|..-
T Consensus       178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA  241 (449)
T KOG1165|consen  178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKA  241 (449)
T ss_pred             hhcCccccccCccccccccccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence            877665433        3356889999999999 8889999999999999999999999987643

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=5.5e-27  Score=181.94  Aligned_cols=183  Identities=35%  Similarity=0.639  Sum_probs=157.8

Q ss_pred             ccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEEEEecCC
Q 024959           50 IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD  129 (260)
Q Consensus        50 lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv~e~~~  129 (260)
                      ||.|.+|.||++.+..+++.+++|++....... ....+.+|++.++.++|++++++++++...     ...++++|+++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~~~e~~~   74 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDE-----NHLYLVMEYCE   74 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecC-----CeEEEEEecCC
Confidence            689999999999998889999999997653322 356788999999999999999999999876     55899999999


Q ss_pred             -cchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecc-CCCEEEeecccccccCCCc-cccccc
Q 024959          130 -TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETD-FMTEYV  205 (260)
Q Consensus       130 -~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~-~~~~~l~df~~~~~~~~~~-~~~~~~  205 (260)
                       ++|.+++... ..+++..++.++.++++++.+||+.+++|+||+|.||+++. ++.++|+||+.+....... ......
T Consensus        75 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~  154 (215)
T cd00180          75 GGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV  154 (215)
T ss_pred             CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhccc
Confidence             7999988775 57899999999999999999999999999999999999999 8999999999987665442 122345


Q ss_pred             ccccccccccccCcCCCCChhhHHHHHHHHHHH
Q 024959          206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI  238 (260)
Q Consensus       206 ~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l  238 (260)
                      ....|++||........+.+.|+|++|++++++
T Consensus       155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l  187 (215)
T cd00180         155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL  187 (215)
T ss_pred             CCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence            577899999987733778999999999999987

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=4.5e-29  Score=216.32  Aligned_cols=197  Identities=31%  Similarity=0.412  Sum_probs=158.4

Q ss_pred             ccCCCcccccccCceE-EEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-CCCeeeeeceecCCCCCCCc
Q 024959           42 KYVPPIRPIGRGAYGI-VCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~-vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~~~  119 (260)
                      ..+...+.+|.|+.|+ ||++..  .++.||||.+-..     ......+|+..|+.-+ ||||+++|+.=.+.     +
T Consensus       509 ~~~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e-----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~-----q  576 (903)
T KOG1027|consen  509 LFFSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEE-----FFDFAQREIQLLQESDEHPNVIRYYCSEQDR-----Q  576 (903)
T ss_pred             eeeccHHHcccCCCCcEEEEEee--CCceehHHHHhhH-----hHHHHHHHHHHHHhccCCCceEEEEeeccCC-----c
Confidence            3344556788999876 899965  4679999999543     3345678999999885 99999998866555     6


Q ss_pred             cEEEEEecCCcchHHHhhhC-CC---CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecc---C--CCEEEeecc
Q 024959          120 DVYIVYELMDTDLHQIIRSD-QQ---LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---S--CDLKIGDFG  190 (260)
Q Consensus       120 ~~~lv~e~~~~~l~~~l~~~-~~---~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~---~--~~~~l~df~  190 (260)
                      ..||..|.|..+|.+++... ..   ......+..+.|++++|++||+.+|+||||||+||||..   +  ..++|+|||
T Consensus       577 F~YIalELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfg  656 (903)
T KOG1027|consen  577 FLYIALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFG  656 (903)
T ss_pred             eEEEEehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccc
Confidence            69999999999999999874 11   222456788999999999999999999999999999976   3  458999999


Q ss_pred             cccccCCCccc----ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhC-CCCCCCCChH
Q 024959          191 LARTTSETDFM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYV  251 (260)
Q Consensus       191 ~~~~~~~~~~~----~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g-~~pf~~~~~~  251 (260)
                      ++++.+.....    ....|+.+|+|||.+.. ...+..+|||||||++|+.++| ..||.+.-.+
T Consensus       657 lsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~-~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R  721 (903)
T KOG1027|consen  657 LSKKLAGGKSSFSRLSGGSGTSGWQAPEQLRE-DRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER  721 (903)
T ss_pred             cccccCCCcchhhcccCCCCcccccCHHHHhc-cccCcccchhhcCceEEEEecCCccCCCchHHh
Confidence            99988766433    34467999999999988 5556799999999999999995 8999865443

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=4.6e-28  Score=183.22  Aligned_cols=207  Identities=23%  Similarity=0.316  Sum_probs=171.2

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-CCCeeeeeceecCCCCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDT  117 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~  117 (260)
                      +....|.++++||+|+||.+|++.+..+|+.||||+-......    .++.-|.++.+.|+ ...|+.++.+..+.    
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~----   83 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTEK----   83 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhcccc----
Confidence            4456677899999999999999999999999999998554332    35667889999997 56777787777766    


Q ss_pred             CccEEEEEecCCcchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccC---CCEEEeeccccc
Q 024959          118 FNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLAR  193 (260)
Q Consensus       118 ~~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~---~~~~l~df~~~~  193 (260)
                       ..-.+|||..+++|.+++.- ...|+..++..++-|++.-++|+|.++++|+||||+|+++.-+   ..+.|+|||+++
T Consensus        84 -~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK  162 (341)
T KOG1163|consen   84 -DYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK  162 (341)
T ss_pred             -ccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchh
Confidence             34689999999999999875 6789999999999999999999999999999999999999654   568999999998


Q ss_pred             ccCCCcccc--------cccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024959          194 TTSETDFMT--------EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  255 (260)
Q Consensus       194 ~~~~~~~~~--------~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~  255 (260)
                      ...+.....        ...||..|.+-..+.+ ...+.+.|+-|+|.++.++..|..||.+.......+
T Consensus       163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q  231 (341)
T KOG1163|consen  163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ  231 (341)
T ss_pred             hhccccccccCccccCCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH
Confidence            765543222        2356778888777766 566789999999999999999999999876654443

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=3.3e-26  Score=189.69  Aligned_cols=201  Identities=22%  Similarity=0.276  Sum_probs=162.9

Q ss_pred             cCCCcccccccCceEEEEEEeCCCC-eEEEEEecCCcccchHHHHHHHHHHHHHHHcC----CCCeeeeeceec-CCCCC
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETR-EEVAIKKIGNAFDNIIDARRTLREIKLLRHME----HENVIAIKDIIR-PPKKD  116 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~-~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~----~~~iv~~~~~~~-~~~~~  116 (260)
                      .|.+.+.||+|+||.||.+.+..++ ..+|+|.........  ...+..|..++..+.    .+++..+++... .+   
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~--~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~---   93 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK--PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE---   93 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC--CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC---
Confidence            5778999999999999999988875 578888875532221  114666788888876    368888888884 43   


Q ss_pred             CCccEEEEEecCCcchHHHhhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccC-----CCEEEeec
Q 024959          117 TFNDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-----CDLKIGDF  189 (260)
Q Consensus       117 ~~~~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~-----~~~~l~df  189 (260)
                        ..-|+||+.++.+|.++....  +.++..++..++.|++.+|++||+.|++||||||.|+++...     ..+.|.||
T Consensus        94 --~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf  171 (322)
T KOG1164|consen   94 --DFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDF  171 (322)
T ss_pred             --ceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence              457999999999999988553  689999999999999999999999999999999999999764     46999999


Q ss_pred             ccccccC--CCc--------c-cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH
Q 024959          190 GLARTTS--ETD--------F-MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  251 (260)
Q Consensus       190 ~~~~~~~--~~~--------~-~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~  251 (260)
                      |+++...  ...        . .....||..|.++..+.+ ...+.+.|+||++.++.+++.|..||.+....
T Consensus       172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~  243 (322)
T KOG1164|consen  172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPWEALEMT  243 (322)
T ss_pred             CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCCcccccc
Confidence            9998222  111        1 122347999999999988 88899999999999999999999999776653

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.94  E-value=1.5e-27  Score=193.01  Aligned_cols=206  Identities=32%  Similarity=0.498  Sum_probs=167.1

Q ss_pred             eccccCCCcccccccCceEEEEEEeCC---CCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-CCCeeeeeceecCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSE---TREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPK  114 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~  114 (260)
                      .-...|..+.+||.|.|++||++.+..   ..+.|++|.+...    ....++..|+++|..+. +.||+++.+.+.-+ 
T Consensus        33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t----s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn-  107 (418)
T KOG1167|consen   33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT----SSPSRILNELEMLYRLGGSDNIIKLNGCFRNN-  107 (418)
T ss_pred             hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc----cCchHHHHHHHHHHHhccchhhhcchhhhccC-
Confidence            335667789999999999999999888   7788999999553    24466889999999996 99999999999887 


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecc-CCCEEEeecccc
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLA  192 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~-~~~~~l~df~~~  192 (260)
                          +...+|+||++ ....++...   ++...++.+++.++.+|.++|.+||+||||||.|++.+. .+.-.|.|||++
T Consensus       108 ----d~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA  180 (418)
T KOG1167|consen  108 ----DQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLA  180 (418)
T ss_pred             ----CeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhH
Confidence                55899999999 566666554   668899999999999999999999999999999999986 477899999998


Q ss_pred             cccCCC--------------cc-------------------------------cccccccccccccccccCcCCCCChhh
Q 024959          193 RTTSET--------------DF-------------------------------MTEYVVTRWYRAPELLLNCTEYTAAID  227 (260)
Q Consensus       193 ~~~~~~--------------~~-------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~~D  227 (260)
                      ...+..              ..                               .....||++|.|||.+...+..+++.|
T Consensus       181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD  260 (418)
T KOG1167|consen  181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID  260 (418)
T ss_pred             HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence            621000              00                               001246889999999998888899999


Q ss_pred             HHHHHHHHHHHHhCCCCC-CCCChHHHHHH
Q 024959          228 IWSVGCILGEIMTREPLF-PGKDYVHQLRL  256 (260)
Q Consensus       228 i~slG~~l~~ll~g~~pf-~~~~~~~~~~~  256 (260)
                      +||.|++++.++++..|| ...++.+.+..
T Consensus       261 iws~GVI~Lslls~~~PFf~a~dd~~al~e  290 (418)
T KOG1167|consen  261 IWSAGVILLSLLSRRYPFFKAKDDADALAE  290 (418)
T ss_pred             eeeccceeehhhccccccccCccccchHHH
Confidence            999999999999999887 33444444433

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.93  E-value=4.8e-26  Score=183.02  Aligned_cols=218  Identities=21%  Similarity=0.299  Sum_probs=176.2

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEeCC-----CCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeece
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSE-----TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI  109 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~  109 (260)
                      ....+....++..-.+-+|.||.||.+...+     +.+.+.+|.++.. ....+...++.|.-.+..+.|||+..+.++
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            3445555566677778899999999996553     3345778888654 455567788899999999999999999998


Q ss_pred             ecCCCCCCCccEEEEEecCC-cchHHHhhh--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecc
Q 024959          110 IRPPKKDTFNDVYIVYELMD-TDLHQIIRS--------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA  180 (260)
Q Consensus       110 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~--------~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~  180 (260)
                      .-+..    ...++++.+++ |+|..++.-        -..++..++..++.|++.++++||+.+++|.||...|.+|++
T Consensus       356 ~ie~~----~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd  431 (563)
T KOG1024|consen  356 SIEDY----ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDD  431 (563)
T ss_pred             Eeecc----CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehh
Confidence            76542    45788999998 899998872        134777888999999999999999999999999999999999


Q ss_pred             CCCEEEeecccccccCCCc---ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 024959          181 SCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRL  256 (260)
Q Consensus       181 ~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~  256 (260)
                      ..++||+|=.+++..-..+   .-...-....||+||.+.+ ..++..+|+||||+++|||++ |+.||-.-|..+.-..
T Consensus       432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y  510 (563)
T KOG1024|consen  432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY  510 (563)
T ss_pred             heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH
Confidence            9999999999987643322   1111223667999999988 889999999999999999999 9999999999887766


Q ss_pred             hh
Q 024959          257 IT  258 (260)
Q Consensus       257 i~  258 (260)
                      ++
T Consensus       511 lk  512 (563)
T KOG1024|consen  511 LK  512 (563)
T ss_pred             Hh
Confidence            55

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=2.4e-27  Score=201.25  Aligned_cols=200  Identities=27%  Similarity=0.416  Sum_probs=172.2

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~  118 (260)
                      -+..+|+.+..+|.|.+|.||+++++.+++..++|+++....  ....-...|+-+++..+||||+.+++.+...     
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--dd~~~iqqei~~~~dc~h~nivay~gsylr~-----   84 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR-----   84 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCC--ccccccccceeeeecCCCcChHHHHhhhhhh-----
Confidence            346778899999999999999999999999999999976533  3455667899999999999999999998877     


Q ss_pred             ccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccC-
Q 024959          119 NDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-  196 (260)
Q Consensus       119 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~-  196 (260)
                      ..+++.||||+ |+|.+.-.-.+++++.++...++..+++++|||+.|-+|||||-.||++++.|.+||.|||.+-... 
T Consensus        85 dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita  164 (829)
T KOG0576|consen   85 DKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA  164 (829)
T ss_pred             cCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh
Confidence            45999999999 6899888888999999999999999999999999999999999999999999999999999764433 


Q ss_pred             CCccccccccccccccccccc--CcCCCCChhhHHHHHHHHHHHHhCCCCC
Q 024959          197 ETDFMTEYVVTRWYRAPELLL--NCTEYTAAIDIWSVGCILGEIMTREPLF  245 (260)
Q Consensus       197 ~~~~~~~~~~~~~~~~PE~~~--~~~~~~~~~Di~slG~~l~~ll~g~~pf  245 (260)
                      .-....+..|+++|++||..-  ....|....|+|++|++..|+---.+|-
T Consensus       165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl  215 (829)
T KOG0576|consen  165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL  215 (829)
T ss_pred             hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc
Confidence            233455678999999999863  1256889999999999999986655554

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=8e-25  Score=181.59  Aligned_cols=164  Identities=19%  Similarity=0.240  Sum_probs=123.7

Q ss_pred             eccccCCCcccccccCceEEEEEEeCC-CCeEEEEEecCCccc---chHHHHHHHHHHHHHHHcCCCCeee-eeceecCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSE-TREEVAIKKIGNAFD---NIIDARRTLREIKLLRHMEHENVIA-IKDIIRPP  113 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~-~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~-~~~~~~~~  113 (260)
                      .-...|.+.+.||+|+||+||+++++. +++.++||+......   .......+.+|+++|+.++|+|+++ +++ +   
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-~---   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-T---   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-c---
Confidence            334567789999999999999999876 677789998753211   2234566889999999999999985 443 2   


Q ss_pred             CCCCCccEEEEEecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccC-CCCCeEeccCCCEEEeeccc
Q 024959          114 KKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDL-KPSNLLLNASCDLKIGDFGL  191 (260)
Q Consensus       114 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di-~~~nili~~~~~~~l~df~~  191 (260)
                           ...|+||||++| +|. .+...   .   ...++.+++++|.+||+.|++|||| ||+||+++.++.++|+|||+
T Consensus        91 -----~~~~LVmE~~~G~~L~-~~~~~---~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGl  158 (365)
T PRK09188         91 -----GKDGLVRGWTEGVPLH-LARPH---G---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQL  158 (365)
T ss_pred             -----CCcEEEEEccCCCCHH-HhCcc---c---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence                 236999999986 554 32211   1   1467899999999999999999999 99999999899999999999


Q ss_pred             ccccCCCccc---------ccccccccccccccccC
Q 024959          192 ARTTSETDFM---------TEYVVTRWYRAPELLLN  218 (260)
Q Consensus       192 ~~~~~~~~~~---------~~~~~~~~~~~PE~~~~  218 (260)
                      +.........         ....++..|.+||.+..
T Consensus       159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            9865543211         12344667888888753

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.92  E-value=1.5e-24  Score=165.89  Aligned_cols=143  Identities=19%  Similarity=0.222  Sum_probs=110.1

Q ss_pred             cccccccCceEEEEEEeCCCCeEEEEEecCCcccchHH------------------------HHHHHHHHHHHHHcCCCC
Q 024959           47 IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIID------------------------ARRTLREIKLLRHMEHEN  102 (260)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~------------------------~~~~~~e~~~l~~l~~~~  102 (260)
                      ...||+|++|.||++.+. +|+.||+|+++........                        ......|++.+.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            568999999999999997 8999999999654321111                        112235999999998877


Q ss_pred             eeeeeceecCCCCCCCccEEEEEecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHH-HhCCceeccCCCCCeEecc
Q 024959          103 VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV-HSASVLHRDLKPSNLLLNA  180 (260)
Q Consensus       103 iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~l-h~~~i~H~di~~~nili~~  180 (260)
                      +.....+..       ...++||||+++ ++.........++...+..++.|++.+|.++ |+.|++|+||||.||+++ 
T Consensus        81 v~~p~~~~~-------~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-  152 (190)
T cd05147          81 IPCPEPILL-------KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCCcEEEe-------cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-
Confidence            644333221       123799999996 4444444567899999999999999999999 699999999999999998 


Q ss_pred             CCCEEEeecccccccCCC
Q 024959          181 SCDLKIGDFGLARTTSET  198 (260)
Q Consensus       181 ~~~~~l~df~~~~~~~~~  198 (260)
                      ++.++|+|||++...+++
T Consensus       153 ~~~v~LiDFG~a~~~~~~  170 (190)
T cd05147         153 DGKLYIIDVSQSVEHDHP  170 (190)
T ss_pred             CCcEEEEEccccccCCCc
Confidence            478999999998765443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.91  E-value=9.6e-25  Score=200.78  Aligned_cols=149  Identities=17%  Similarity=0.258  Sum_probs=112.6

Q ss_pred             cCC-CCeeeeeceecCCCCCC--CccEEEEEecCCcchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCC
Q 024959           98 MEH-ENVIAIKDIIRPPKKDT--FNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP  173 (260)
Q Consensus        98 l~~-~~iv~~~~~~~~~~~~~--~~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~  173 (260)
                      ++| +||+++++.|.....+.  ....++++|+++.+|.+++.. ...+++..++.++.||+++|.|||++||+||||||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP  108 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRP  108 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCc
Confidence            344 57777777763332211  135778899999999999976 45699999999999999999999999999999999


Q ss_pred             CCeEeccCCC-------------------EEEeecccccccCCCc-----------------cccccccccccccccccc
Q 024959          174 SNLLLNASCD-------------------LKIGDFGLARTTSETD-----------------FMTEYVVTRWYRAPELLL  217 (260)
Q Consensus       174 ~nili~~~~~-------------------~~l~df~~~~~~~~~~-----------------~~~~~~~~~~~~~PE~~~  217 (260)
                      +|||++..+.                   +|++|||+++......                 ......+++.|+|||.+.
T Consensus       109 ~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~  188 (793)
T PLN00181        109 SCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDN  188 (793)
T ss_pred             hhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhc
Confidence            9999965444                   4555555543211100                 001124577899999988


Q ss_pred             CcCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 024959          218 NCTEYTAAIDIWSVGCILGEIMTREPLFPG  247 (260)
Q Consensus       218 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~  247 (260)
                      + ..++.++|||||||+||||++|..|+..
T Consensus       189 ~-~~~~~~sDVwSlGviL~ELl~~~~~~~~  217 (793)
T PLN00181        189 G-SSSNCASDVYRLGVLLFELFCPVSSREE  217 (793)
T ss_pred             c-CCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence            7 6789999999999999999999998764

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.91  E-value=4.8e-24  Score=165.30  Aligned_cols=176  Identities=13%  Similarity=0.150  Sum_probs=131.2

Q ss_pred             ccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHH-HHH------HHHHHHHHHHcCCCCeeeeeceecC
Q 024959           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIID-ARR------TLREIKLLRHMEHENVIAIKDIIRP  112 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~-~~~------~~~e~~~l~~l~~~~iv~~~~~~~~  112 (260)
                      -...|.+++.+|.|++|.||++..  ++..+++|.+......... ...      +.+|++.+.++.||+|..+.+++..
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            355678999999999999999765  3568999999655433222 222      5689999999999999999988665


Q ss_pred             CCCCC---CccEEEEEecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEee
Q 024959          113 PKKDT---FNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD  188 (260)
Q Consensus       113 ~~~~~---~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~d  188 (260)
                      .....   ....+++|||++| +|.+..    .+++    ....+++.++..+|..|++|+|++|.|++++.+| ++|+|
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liD  177 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIID  177 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEE
Confidence            43211   2458999999996 676652    2333    2456999999999999999999999999999988 99999


Q ss_pred             cccccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHH
Q 024959          189 FGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI  238 (260)
Q Consensus       189 f~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l  238 (260)
                      ||......+......           .+.. ..++.++|+|+||+++..+
T Consensus       178 fg~~~~~~e~~a~d~-----------~vle-r~y~~~~di~~lg~~~~~~  215 (232)
T PRK10359        178 LSGKRCTAQRKAKDR-----------IDLE-RHYGIKNEIKDLGYYLLIY  215 (232)
T ss_pred             CCCcccccchhhHHH-----------HHHH-hHhcccccccceeEeehHH
Confidence            998765543321111           2222 4566789999999887664

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.91  E-value=2.5e-23  Score=159.72  Aligned_cols=144  Identities=19%  Similarity=0.160  Sum_probs=112.5

Q ss_pred             CcccccccCceEEEEEEeCCCCeEEEEEecCCcccchH------------------------HHHHHHHHHHHHHHcCCC
Q 024959           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII------------------------DARRTLREIKLLRHMEHE  101 (260)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~------------------------~~~~~~~e~~~l~~l~~~  101 (260)
                      +.++||+|++|.||++.+. +|+.||+|++........                        .......|.+.+.++.++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            4578999999999999987 899999999865422100                        012234788999999998


Q ss_pred             CeeeeeceecCCCCCCCccEEEEEecCCcc-hHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEec
Q 024959          102 NVIAIKDIIRPPKKDTFNDVYIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLN  179 (260)
Q Consensus       102 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~di~~~nili~  179 (260)
                      ++.....+....       .++|||++++. +........+++...+..++.|++.++.++|. .|++|+||+|.||+++
T Consensus        80 ~i~~p~~~~~~~-------~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~  152 (190)
T cd05145          80 GVPVPEPILLKK-------NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH  152 (190)
T ss_pred             CCCCceEEEecC-------CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE
Confidence            875544443222       47999999964 43333345678888999999999999999999 9999999999999998


Q ss_pred             cCCCEEEeecccccccCCC
Q 024959          180 ASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       180 ~~~~~~l~df~~~~~~~~~  198 (260)
                       ++.++|+|||++......
T Consensus       153 -~~~~~liDFG~a~~~~~~  170 (190)
T cd05145         153 -DGKPYIIDVSQAVELDHP  170 (190)
T ss_pred             -CCCEEEEEcccceecCCC
Confidence             889999999998766543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.90  E-value=4e-22  Score=164.83  Aligned_cols=199  Identities=32%  Similarity=0.579  Sum_probs=168.6

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchH-HHHHHHHHHHHHHHcCCC-CeeeeeceecCCCCCCCccE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII-DARRTLREIKLLRHMEHE-NVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~-~iv~~~~~~~~~~~~~~~~~  121 (260)
                      |.+.+.||.|+++.||.+.+.   ..+++|.+........ ....+.+|+..+..+.|+ +++++++.+...     ...
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~   73 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDE-----GSL   73 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecC-----CEE
Confidence            456788999999999999887   6789999977655543 577788999999999988 799999999554     337


Q ss_pred             EEEEecCC-cchHHHhhhCC---CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCC-CEEEeecccccccC
Q 024959          122 YIVYELMD-TDLHQIIRSDQ---QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTS  196 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~-~~~l~df~~~~~~~  196 (260)
                      +++++++. +++.+.+....   .++......++.|++.++.++|..+++|+|++|+|++++..+ .+++.|||.+....
T Consensus        74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~  153 (384)
T COG0515          74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP  153 (384)
T ss_pred             EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence            99999998 47776666654   799999999999999999999999999999999999999988 69999999987554


Q ss_pred             CCc-------ccccccccccccccccccCc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024959          197 ETD-------FMTEYVVTRWYRAPELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (260)
Q Consensus       197 ~~~-------~~~~~~~~~~~~~PE~~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  250 (260)
                      ...       ......++..|++||.....  .......|+|++|++++++++|..||.....
T Consensus       154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~  216 (384)
T COG0515         154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN  216 (384)
T ss_pred             CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Confidence            443       23556779999999999874  4678899999999999999999999887764

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.89  E-value=3.1e-23  Score=165.43  Aligned_cols=204  Identities=23%  Similarity=0.293  Sum_probs=134.3

Q ss_pred             CCcccccccCceEEEEEEeCCCCeEEEEEecCCcc-cchHHHHHHHHHHHHHHHcC----------CCCeeeeeceecCC
Q 024959           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHME----------HENVIAIKDIIRPP  113 (260)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~----------~~~iv~~~~~~~~~  113 (260)
                      ...+.||.|+++.||.+.+..+++.+++|++.... ......+++.+|.-....+.          |-.++...+.....
T Consensus        15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~   94 (288)
T PF14531_consen   15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP   94 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred             EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence            45678999999999999999999999999884432 22334566666554443321          22344444433322


Q ss_pred             CCCC-------Cc-----cEEEEEecCCcchHHHhhh---CCC----CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCC
Q 024959          114 KKDT-------FN-----DVYIVYELMDTDLHQIIRS---DQQ----LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS  174 (260)
Q Consensus       114 ~~~~-------~~-----~~~lv~e~~~~~l~~~l~~---~~~----~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~  174 (260)
                      ....       ..     +.+++|+.+.++|.+.+..   ...    +.......+-.|+++.+++||..|++|+||+|+
T Consensus        95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~  174 (288)
T PF14531_consen   95 GKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPE  174 (288)
T ss_dssp             TS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGG
T ss_pred             CCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccccee
Confidence            1100       01     3578999999888887653   211    223334556689999999999999999999999


Q ss_pred             CeEeccCCCEEEeecccccccCCCcccccccccccccccccccCc-------CCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 024959          175 NLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC-------TEYTAAIDIWSVGCILGEIMTREPLFPG  247 (260)
Q Consensus       175 nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-------~~~~~~~Di~slG~~l~~ll~g~~pf~~  247 (260)
                      |++++.+|.+.|+||+.....+.....  ...+..|.|||.....       ..++.+.|.|+||+++|.|+|+..||+.
T Consensus       175 nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~  252 (288)
T PF14531_consen  175 NFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGL  252 (288)
T ss_dssp             GEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCC
T ss_pred             eEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCC
Confidence            999999999999999988776654432  3345778999876431       3467899999999999999999999986


Q ss_pred             CCh
Q 024959          248 KDY  250 (260)
Q Consensus       248 ~~~  250 (260)
                      ...
T Consensus       253 ~~~  255 (288)
T PF14531_consen  253 SSP  255 (288)
T ss_dssp             CGG
T ss_pred             CCc
Confidence            543

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=1.8e-21  Score=148.08  Aligned_cols=186  Identities=15%  Similarity=0.065  Sum_probs=135.4

Q ss_pred             CcccccccCceEEEEEEeCCCCeEEEEEecCCccc--chHHHHHHHHHHHHHHHcC-CCCeeeeeceecCCCCCCCccEE
Q 024959           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD--NIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDVY  122 (260)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~~~~~~  122 (260)
                      +...|+.|+||+||++..  .+.+++.+.+.....  .......+.+|+++|++|. ++++++++++.         ..+
T Consensus         6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~---------~~~   74 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD---------GRH   74 (218)
T ss_pred             cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------CEE
Confidence            467899999999998855  567888777755432  1112235778999999995 58899998851         258


Q ss_pred             EEEecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccC-CCCCeEeccCCCEEEeecccccccCCCcc
Q 024959          123 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDL-KPSNLLLNASCDLKIGDFGLARTTSETDF  200 (260)
Q Consensus       123 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di-~~~nili~~~~~~~l~df~~~~~~~~~~~  200 (260)
                      ++|||+.| +|.+....      . ...++.|++++|+++|+.|++|+|| +|.||+++.++.++|+|||++........
T Consensus        75 lvmeyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~  147 (218)
T PRK12274         75 LDRSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR  147 (218)
T ss_pred             EEEeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence            99999986 55443211      1 1357789999999999999999999 79999999999999999999985544321


Q ss_pred             cc--------------cccccccccccccccCcCCCC-ChhhHHHHHHHHHHHHhCCCCCCCCC
Q 024959          201 MT--------------EYVVTRWYRAPELLLNCTEYT-AAIDIWSVGCILGEIMTREPLFPGKD  249 (260)
Q Consensus       201 ~~--------------~~~~~~~~~~PE~~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~  249 (260)
                      ..              ....++.++.|+...--...+ ...+.++.|..+|.++|+..|.-+.+
T Consensus       148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            10              011255566666554322334 56788899999999999998876544

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.88  E-value=2.3e-22  Score=181.39  Aligned_cols=197  Identities=21%  Similarity=0.291  Sum_probs=157.8

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC---CCCeeeeeceec
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME---HENVIAIKDIIR  111 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~iv~~~~~~~  111 (260)
                      ..+++.+..|.|-+.||.|+||.||.|.+.+ |+.+|+|+-+....    ++ |.=-.+++.+|+   -+.|..+...+.
T Consensus       691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~----WE-fYI~~q~~~RLk~~~~~~~~~~~~a~~  764 (974)
T KOG1166|consen  691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP----WE-FYICLQVMERLKPQMLPSIMHISSAHV  764 (974)
T ss_pred             ceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc----ee-eeehHHHHHhhchhhhcchHHHHHHHc
Confidence            4567777778889999999999999999887 89999999865421    11 111123444454   345555555444


Q ss_pred             CCCCCCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecc-------CCC
Q 024959          112 PPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-------SCD  183 (260)
Q Consensus       112 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~-------~~~  183 (260)
                      ..     +..++|+||.+ |+|.++++..+.+++..+..++.||+..+++||..+|+||||||+|+++..       ..-
T Consensus       765 ~~-----~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~  839 (974)
T KOG1166|consen  765 FQ-----NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKG  839 (974)
T ss_pred             cC-----CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccc
Confidence            44     44789999999 899999998899999999999999999999999999999999999999942       234


Q ss_pred             EEEeecccccccC---CCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCC
Q 024959          184 LKIGDFGLARTTS---ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREP  243 (260)
Q Consensus       184 ~~l~df~~~~~~~---~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~  243 (260)
                      ++|+|||.+..+.   +.-.+...+.+..+-++|..-+ ++++...|.|.|+-+++.||.|+.
T Consensus       840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHHH
Confidence            8999999886543   3335556677999999999988 999999999999999999999874

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.88  E-value=6.2e-22  Score=150.17  Aligned_cols=108  Identities=26%  Similarity=0.358  Sum_probs=94.6

Q ss_pred             cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCcccccccccc
Q 024959          130 TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR  208 (260)
Q Consensus       130 ~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  208 (260)
                      |+|.+++.. +..+++..++.++.|++++|.|||+.+      ||+||+++.++.+++  ||.+.......    ..+++
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----~~g~~   68 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----SRVDP   68 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc----CCCcc
Confidence            578888887 456999999999999999999999998      999999999999999  99887654432    25689


Q ss_pred             cccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024959          209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (260)
Q Consensus       209 ~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  250 (260)
                      .|+|||.+.+ ..++.++||||||+++|+|++|..||...+.
T Consensus        69 ~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~  109 (176)
T smart00750       69 YFMAPEVIQG-QSYTEKADIYSLGITLYEALDYELPYNEERE  109 (176)
T ss_pred             cccChHHhcC-CCCcchhhHHHHHHHHHHHHhCCCCccccch
Confidence            9999999987 7789999999999999999999999976543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.87  E-value=1.8e-22  Score=180.31  Aligned_cols=196  Identities=24%  Similarity=0.356  Sum_probs=154.4

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccch--HHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI--IDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      .+...+.||.+.|=.|.++.+.+.  .|++|++-+.....  ....+.++|++ ....++||.+++.-+...+     ..
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG--~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~-----kA   95 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREG--LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTD-----KA   95 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCc--eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhh-----HH
Confidence            344578899999999999988764  59999996654322  23344445666 5556899999988876655     44


Q ss_pred             EEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCC--C
Q 024959          121 VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE--T  198 (260)
Q Consensus       121 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~--~  198 (260)
                      .|+|-+|+..+|.+++..+.=+..-+.+-|+.|++.+|..+|+.|++|||||.+||||+.-+++.|+||.-.+..--  +
T Consensus        96 AylvRqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen   96 AYLVRQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             HHHHHHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence            78899999999999998888788888999999999999999999999999999999999999999999997764322  2


Q ss_pred             ccc------ccccccccccccccccCc---------CC-CCChhhHHHHHHHHHHHHh-CCCCCC
Q 024959          199 DFM------TEYVVTRWYRAPELLLNC---------TE-YTAAIDIWSVGCILGEIMT-REPLFP  246 (260)
Q Consensus       199 ~~~------~~~~~~~~~~~PE~~~~~---------~~-~~~~~Di~slG~~l~~ll~-g~~pf~  246 (260)
                      .+.      .+.....+|+|||.+...         .. .+++.||||+||++.||++ |.+||+
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~  240 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT  240 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence            111      122235679999998652         12 5789999999999999988 799985

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=1.6e-22  Score=178.18  Aligned_cols=212  Identities=29%  Similarity=0.332  Sum_probs=167.0

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecC----CcccchHHHHHHHHHHHHHHHcCCCCeeeeecee
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEHENVIAIKDII  110 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~----~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~  110 (260)
                      ....+...|-...+.+|.|++|.++.+........+..|.+.    ...........+..|+.+-..+.|||++...+.+
T Consensus       311 ~~~~~~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~  390 (601)
T KOG0590|consen  311 SPIGFSEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIV  390 (601)
T ss_pred             CccccccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHH
Confidence            444455566677889999999988888877766666666553    2222222222266788888888999999988888


Q ss_pred             cCCCCCCCccEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecc
Q 024959          111 RPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG  190 (260)
Q Consensus       111 ~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~  190 (260)
                      .+...     ..-.|||++++|..++.....+....+..++.|++.++.|||+.|+.|+|+|++|+++..+|.+||+|||
T Consensus       391 ~~~~~-----~~~~mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg  465 (601)
T KOG0590|consen  391 QEIDG-----ILQSMEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFG  465 (601)
T ss_pred             hhccc-----chhhhhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecC
Confidence            77643     3344999999888888888899999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCc-----ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH
Q 024959          191 LARTTSETD-----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  251 (260)
Q Consensus       191 ~~~~~~~~~-----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~  251 (260)
                      .+.....+.     ......++..|+|||.+.+...-....||||.|+++..|.+|..||.-....
T Consensus       466 ~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~  531 (601)
T KOG0590|consen  466 AASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKS  531 (601)
T ss_pred             cceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccc
Confidence            887654442     2344577889999999988333345799999999999999999999654443

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=1.6e-20  Score=145.13  Aligned_cols=137  Identities=19%  Similarity=0.225  Sum_probs=106.1

Q ss_pred             CcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHc-----CCCCeeeeeceecCCCCCCCcc
Q 024959           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-----EHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      -.+.||+|+++.||.  ++.++.. +||+......  .....+.+|++.++.+     +||||+++++++..+...  ..
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~--g~   78 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGT--GY   78 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCe-EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCC--eE
Confidence            456799999999995  7777666 6898865322  2346688999999999     579999999999876321  23


Q ss_pred             -EEEEEecCC---cchHHHhhhCCCCCHHHHHHHHHHHHHHH-HHHHhCCceeccCCCCCeEeccC----CCEEEeeccc
Q 024959          121 -VYIVYELMD---TDLHQIIRSDQQLTDDHCQYFLYQLLRGL-KYVHSASVLHRDLKPSNLLLNAS----CDLKIGDFGL  191 (260)
Q Consensus       121 -~~lv~e~~~---~~l~~~l~~~~~~~~~~~~~~~~~i~~~l-~~lh~~~i~H~di~~~nili~~~----~~~~l~df~~  191 (260)
                       +.+|+|+.+   ++|.+++... .+++.  ..++.+++.++ +|||+.+|+|+||||+||+++..    ..++|+|++.
T Consensus        79 v~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         79 VYDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             EEEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence             337899955   6999999664 56665  35677888777 99999999999999999999743    3799999544


Q ss_pred             c
Q 024959          192 A  192 (260)
Q Consensus       192 ~  192 (260)
                      +
T Consensus       156 ~  156 (210)
T PRK10345        156 E  156 (210)
T ss_pred             C
Confidence            3

>smart00090 RIO RIO-like kinase

Probab=99.85  E-value=1.1e-20  Score=149.46  Aligned_cols=146  Identities=15%  Similarity=0.104  Sum_probs=112.2

Q ss_pred             cCCCcccccccCceEEEEEE-eCCCCeEEEEEecCCcccch----------------------HHHHHHHHHHHHHHHcC
Q 024959           43 YVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNI----------------------IDARRTLREIKLLRHME   99 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~-~~~~~~~~~iK~~~~~~~~~----------------------~~~~~~~~e~~~l~~l~   99 (260)
                      .|.+.++||+|++|.||+|. +..+|+.|++|++.......                      .....+..|++.++++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            46788999999999999998 67789999999986532110                      01123457999999997


Q ss_pred             CC--CeeeeeceecCCCCCCCccEEEEEecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeccCCCCC
Q 024959          100 HE--NVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS-VLHRDLKPSN  175 (260)
Q Consensus       100 ~~--~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~-i~H~di~~~n  175 (260)
                      +.  .++++++.   .      ..++|||++++ ++.........+....+..++.|+++++++||+.| ++|+||+|+|
T Consensus       109 ~~~i~~p~~~~~---~------~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~N  179 (237)
T smart00090      109 EAGVPVPKPIAW---R------RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYN  179 (237)
T ss_pred             hcCCCCCeeeEe---c------CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhh
Confidence            53  23344432   1      24799999997 55555445556777778899999999999999999 9999999999


Q ss_pred             eEeccCCCEEEeecccccccCCC
Q 024959          176 LLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       176 ili~~~~~~~l~df~~~~~~~~~  198 (260)
                      |+++ ++.++|+|||.+.....+
T Consensus       180 Ili~-~~~i~LiDFg~a~~~~~~  201 (237)
T smart00090      180 ILVH-DGKVVIIDVSQSVELDHP  201 (237)
T ss_pred             EEEE-CCCEEEEEChhhhccCCc
Confidence            9999 889999999988654443

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.84  E-value=1.1e-19  Score=142.01  Aligned_cols=137  Identities=25%  Similarity=0.271  Sum_probs=109.3

Q ss_pred             ccccccCceEEEEEEeCCCCeEEEEEecCCcccch------HHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI------IDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~------~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      +.||+|++|.||++.+  .+..+++|.........      .....+.+|++++..+.+++++....++...     ...
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~   74 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP-----ENF   74 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC-----CCC
Confidence            5799999999999987  56678999765432211      1234567899999999998887766665544     347


Q ss_pred             EEEEecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccC
Q 024959          122 YIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (260)
Q Consensus       122 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~  196 (260)
                      +++||+++| +|.+.+.....    .+..++.+++.+|.+||+.+++|+|++|.||+++ ++.++|+|||.+....
T Consensus        75 ~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~  145 (211)
T PRK14879         75 IIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFSK  145 (211)
T ss_pred             EEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence            899999985 88887765332    7888999999999999999999999999999999 7889999999887643

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.82  E-value=1.4e-21  Score=165.99  Aligned_cols=195  Identities=24%  Similarity=0.390  Sum_probs=162.2

Q ss_pred             cccccCceEEEEEEe---CCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-CCCeeeeeceecCCCCCCCccEEEE
Q 024959           49 PIGRGAYGIVCAAVN---SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDVYIV  124 (260)
Q Consensus        49 ~lg~G~~g~vy~~~~---~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~~~~~~lv  124 (260)
                      .+|+|.+|.|++++.   ...+.-|++|+.++.............|..++...+ ||.++++.-.+...     ...+++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~-----~kl~l~   75 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTD-----GKLYLI   75 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccc-----cchhHh
Confidence            378999999998854   234667899988665443333334556788888887 99999999888777     458899


Q ss_pred             EecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCccccc
Q 024959          125 YELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE  203 (260)
Q Consensus       125 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  203 (260)
                      .++.. +.+...+.+...+.+.....+...++-+++++|+.+++|+|+|++||+++.+|++++.|||+++..-....   
T Consensus        76 ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~---  152 (612)
T KOG0603|consen   76 LDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI---  152 (612)
T ss_pred             hhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh---
Confidence            99987 48888888888999999999999999999999999999999999999999999999999999887554432   


Q ss_pred             ccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       204 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      .+|+..|++||.+.   ......|.||+|+++++|++|..||.+    ++++.|.
T Consensus       153 ~cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il  200 (612)
T KOG0603|consen  153 ACGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRIL  200 (612)
T ss_pred             cccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHh
Confidence            28899999999997   357889999999999999999999997    4555543

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.78  E-value=2.8e-18  Score=132.77  Aligned_cols=134  Identities=25%  Similarity=0.302  Sum_probs=101.7

Q ss_pred             cccccCceEEEEEEeCCCCeEEEEEecCCccc------chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEE
Q 024959           49 PIGRGAYGIVCAAVNSETREEVAIKKIGNAFD------NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (260)
Q Consensus        49 ~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~  122 (260)
                      .||+|++|.||++..  ++..+++|.......      ......++.+|+++++.+.++++.....++...     ...+
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP-----DNKT   73 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC-----CCCE
Confidence            389999999999984  467899998643211      111235567899999999887655443333333     3368


Q ss_pred             EEEecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCC
Q 024959          123 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (260)
Q Consensus       123 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~  197 (260)
                      ++||+++| +|.+.+.....       .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||++.....
T Consensus        74 lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~~  141 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSDE  141 (199)
T ss_pred             EEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCCCc
Confidence            99999984 77776654321       7889999999999999999999999999999 88999999999876543

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.77  E-value=5.8e-18  Score=130.86  Aligned_cols=138  Identities=20%  Similarity=0.197  Sum_probs=103.7

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccch--------------------HHHHHHHHHHHHHHHcCCCC-
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI--------------------IDARRTLREIKLLRHMEHEN-  102 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~--------------------~~~~~~~~e~~~l~~l~~~~-  102 (260)
                      |.+.++||+|++|.||++.+. +++.+++|++.......                    ........|...+..+.+++ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            557789999999999999875 78999999875432110                    01123567888888887764 


Q ss_pred             -eeeeeceecCCCCCCCccEEEEEecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecc
Q 024959          103 -VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA  180 (260)
Q Consensus       103 -iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~  180 (260)
                       ++..++.         ...+++||++++ +|.....      ......++.++++++.++|..|++|+||+|.||+++.
T Consensus        96 ~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~  160 (198)
T cd05144          96 PVPKPIDW---------NRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDD  160 (198)
T ss_pred             CCCceeec---------CCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcC
Confidence             3333331         235899999986 5554322      1345678899999999999999999999999999999


Q ss_pred             CCCEEEeecccccccCC
Q 024959          181 SCDLKIGDFGLARTTSE  197 (260)
Q Consensus       181 ~~~~~l~df~~~~~~~~  197 (260)
                      ++.++|+|||.+.....
T Consensus       161 ~~~~~liDfg~~~~~~~  177 (198)
T cd05144         161 DEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CCcEEEEECCccccCCC
Confidence            99999999998865543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.77  E-value=5.2e-19  Score=136.77  Aligned_cols=201  Identities=17%  Similarity=0.259  Sum_probs=157.3

Q ss_pred             EeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCC
Q 024959           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (260)
Q Consensus        38 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~  117 (260)
                      .++-..+.++.+|.....|..|+++.+.+  .++.|++...........+|.+|.-.|+.+.||||+.+++.|..+    
T Consensus       186 gid~~~lnl~tkl~e~hsgelwrgrwqgn--divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp----  259 (448)
T KOG0195|consen  186 GIDVSSLNLITKLAESHSGELWRGRWQGN--DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP----  259 (448)
T ss_pred             CcchhhhhhhhhhccCCCcccccccccCc--chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC----
Confidence            34445566678899999999999988754  678888876655555567788999999999999999999999887    


Q ss_pred             CccEEEEEecCC-cchHHHhhhCCC--CCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCeEeccCCCEEEe--ecc
Q 024959          118 FNDVYIVYELMD-TDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKPSNLLLNASCDLKIG--DFG  190 (260)
Q Consensus       118 ~~~~~lv~e~~~-~~l~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~--i~H~di~~~nili~~~~~~~l~--df~  190 (260)
                       ..+.++..||+ ++|...+.....  .+-.++.+++.+++++++|||+..  +.--.++...|+|+++.+.+|.  |--
T Consensus       260 -pnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~k  338 (448)
T KOG0195|consen  260 -PNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTK  338 (448)
T ss_pred             -CCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccce
Confidence             56899999999 799999877544  567788999999999999999874  4456789999999998775553  322


Q ss_pred             cccccCCCcccccccccccccccccccCcCCC---CChhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 024959          191 LARTTSETDFMTEYVVTRWYRAPELLLNCTEY---TAAIDIWSVGCILGEIMTREPLFPGKDYVH  252 (260)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~---~~~~Di~slG~~l~~ll~g~~pf~~~~~~~  252 (260)
                      ++  ++    .......+.|++||.+.. .+.   -...|+|||++++||+.|...||.+....+
T Consensus       339 fs--fq----e~gr~y~pawmspealqr-kped~n~raadmwsfaillwel~trevpfadlspme  396 (448)
T KOG0195|consen  339 FS--FQ----EVGRAYSPAWMSPEALQR-KPEDLNIRAADMWSFAILLWELNTREVPFADLSPME  396 (448)
T ss_pred             ee--ee----ccccccCcccCCHHHHhc-CchhcchhhhhHHHHHHHHHHhhccccccccCCchh
Confidence            22  11    123344788999999976 332   247999999999999999999998766543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.77  E-value=6.6e-19  Score=157.37  Aligned_cols=174  Identities=29%  Similarity=0.454  Sum_probs=131.1

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      ...++.++.|..|++|.||+++|+.+.+++++|+-+..        .+.+.  ++.....|                   
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~--------lilRn--ilt~a~np-------------------  132 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN--------LILRN--ILTFAGNP-------------------  132 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccccc--------hhhhc--cccccCCc-------------------
Confidence            45667899999999999999999999999999544321        11111  11111122                   


Q ss_pred             EEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCcc
Q 024959          121 VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  200 (260)
Q Consensus       121 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~  200 (260)
                       +.|     |+=...+..-++++...        +.+++|||+.|++|+|++|+|.+|+.-|++|+.|||+++.......
T Consensus       133 -fvv-----gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  133 -FVV-----GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             -cee-----chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence             233     33333444444555433        7789999999999999999999999999999999999875432211


Q ss_pred             c----------------ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          201 M----------------TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       201 ~----------------~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      .                ...++++.|.|||++.- ..|...+|.|+||+++|+.+-|+.||.+...++.+.++.
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi  271 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI  271 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh
Confidence            1                12367999999999987 778999999999999999999999999999999988754

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.76  E-value=9.3e-18  Score=128.54  Aligned_cols=138  Identities=22%  Similarity=0.266  Sum_probs=96.7

Q ss_pred             cccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHH----------------------HHHHHHHHHcCCCC--
Q 024959           47 IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT----------------------LREIKLLRHMEHEN--  102 (260)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~----------------------~~e~~~l~~l~~~~--  102 (260)
                      .+.||+|++|.||++.+. +++.|++|++.............                      ..|...+..+.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            578999999999999987 78899999986542221111111                      24555555554332  


Q ss_pred             eeeeeceecCCCCCCCccEEEEEecCCc-chH-HHhhhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEec
Q 024959          103 VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLH-QIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLN  179 (260)
Q Consensus       103 iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~-~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~di~~~nili~  179 (260)
                      +.++++.         ...+++||++++ .+. ..+... ... ..+..++.+++.++.++|. .+++|+||+|+||+++
T Consensus        81 ~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~  149 (187)
T cd05119          81 VPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD  149 (187)
T ss_pred             CCceEec---------CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE
Confidence            3333332         125899999996 211 111111 111 6678899999999999999 9999999999999999


Q ss_pred             cCCCEEEeecccccccCC
Q 024959          180 ASCDLKIGDFGLARTTSE  197 (260)
Q Consensus       180 ~~~~~~l~df~~~~~~~~  197 (260)
                       ++.++|+|||.+.....
T Consensus       150 -~~~~~liDfg~a~~~~~  166 (187)
T cd05119         150 -DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             -CCcEEEEECcccccccC
Confidence             88999999999866544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.76  E-value=1.4e-17  Score=147.05  Aligned_cols=137  Identities=23%  Similarity=0.292  Sum_probs=105.8

Q ss_pred             CCcccccccCceEEEEEEeCCCCeEEEEEec-CCccc-----chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCC
Q 024959           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKI-GNAFD-----NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (260)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~-~~~~~-----~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~  118 (260)
                      ...+.||+|++|+||++.....  .+++|.. .....     .......+.+|+++++.++|++++....+....     
T Consensus       336 ~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----  408 (535)
T PRK09605        336 IPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP-----  408 (535)
T ss_pred             CccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC-----
Confidence            4578999999999999876544  3343332 11111     112345677899999999999998876665554     


Q ss_pred             ccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCC
Q 024959          119 NDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (260)
Q Consensus       119 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~  197 (260)
                      ...++||||++ ++|.+.+.        ....++.+++++|.+||+.+++|+||+|.||++ .++.++|+|||++.....
T Consensus       409 ~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~~~  479 (535)
T PRK09605        409 EEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYSDL  479 (535)
T ss_pred             CCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccCCc
Confidence            34689999998 48887765        356789999999999999999999999999999 678899999999977543

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.72  E-value=7e-17  Score=131.07  Aligned_cols=148  Identities=24%  Similarity=0.340  Sum_probs=114.5

Q ss_pred             CCCCeeeeeceecCCCC----------------------CCCccEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHH
Q 024959           99 EHENVIAIKDIIRPPKK----------------------DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR  156 (260)
Q Consensus        99 ~~~~iv~~~~~~~~~~~----------------------~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~  156 (260)
                      +|||||++...|.+.-.                      .....+|+||..+..+|+.++..+.+ +....+.++.|+++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~~-s~r~~~~~laQlLE  352 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRHR-SYRTGRVILAQLLE  352 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCCC-chHHHHHHHHHHHH
Confidence            59999999988765321                      11245999999999999999887655 45667789999999


Q ss_pred             HHHHHHhCCceeccCCCCCeEec--cC--CCEEEeecccccccCCCc-------ccccccccccccccccccCcCCC---
Q 024959          157 GLKYVHSASVLHRDLKPSNLLLN--AS--CDLKIGDFGLARTTSETD-------FMTEYVVTRWYRAPELLLNCTEY---  222 (260)
Q Consensus       157 ~l~~lh~~~i~H~di~~~nili~--~~--~~~~l~df~~~~~~~~~~-------~~~~~~~~~~~~~PE~~~~~~~~---  222 (260)
                      ++.|||..|+.|+|+|.+||++.  +|  -++++.|||++-..+...       ......|+-..+|||+....+..   
T Consensus       353 av~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~av  432 (598)
T KOG4158|consen  353 AVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAV  432 (598)
T ss_pred             HHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCcee
Confidence            99999999999999999999993  33  347999999875444321       11223456778999998642221   


Q ss_pred             --CChhhHHHHHHHHHHHHhCCCCCCC
Q 024959          223 --TAAIDIWSVGCILGEIMTREPLFPG  247 (260)
Q Consensus       223 --~~~~Di~slG~~l~~ll~g~~pf~~  247 (260)
                        -.++|.|+.|-+.||+++...||.+
T Consensus       433 vny~kAD~WA~GalaYEIfg~~NPFY~  459 (598)
T KOG4158|consen  433 VNYEKADTWAAGALAYEIFGRSNPFYK  459 (598)
T ss_pred             eccchhhhhhhhhhHHHHhccCCcccc
Confidence              2479999999999999999999976

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.70  E-value=4.3e-16  Score=123.45  Aligned_cols=141  Identities=17%  Similarity=0.213  Sum_probs=104.3

Q ss_pred             ccccc-ccCceEEEEEEeCCCCeEEEEEecCCcc-----------cchHHHHHHHHHHHHHHHcCCCCe--eeeeceecC
Q 024959           47 IRPIG-RGAYGIVCAAVNSETREEVAIKKIGNAF-----------DNIIDARRTLREIKLLRHMEHENV--IAIKDIIRP  112 (260)
Q Consensus        47 ~~~lg-~G~~g~vy~~~~~~~~~~~~iK~~~~~~-----------~~~~~~~~~~~e~~~l~~l~~~~i--v~~~~~~~~  112 (260)
                      ...|| .|+.|+||.+...  +..+++|.+....           ........+.+|++++..|+++++  ++.++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            34577 8889999999765  5678998874311           011234567789999999998775  566665443


Q ss_pred             CCCCCCccEEEEEecCCc--chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecc
Q 024959          113 PKKDTFNDVYIVYELMDT--DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG  190 (260)
Q Consensus       113 ~~~~~~~~~~lv~e~~~~--~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~  190 (260)
                      .... ....++|||++++  +|.+++.. .++++..    +.+++.+|.+||+.|++|+||+|.|||++.++.++|+|||
T Consensus       114 ~~~~-~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg  187 (239)
T PRK01723        114 RHGL-FYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFD  187 (239)
T ss_pred             ecCc-ceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECC
Confidence            3211 1224699999985  77777654 4566543    5689999999999999999999999999998899999999


Q ss_pred             ccccc
Q 024959          191 LARTT  195 (260)
Q Consensus       191 ~~~~~  195 (260)
                      .+...
T Consensus       188 ~~~~~  192 (239)
T PRK01723        188 RGELR  192 (239)
T ss_pred             CcccC
Confidence            87664

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.69  E-value=4.4e-16  Score=114.66  Aligned_cols=131  Identities=20%  Similarity=0.237  Sum_probs=107.2

Q ss_pred             CcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCC--CCeeeeeceecCCCCCCCccEEE
Q 024959           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH--ENVIAIKDIIRPPKKDTFNDVYI  123 (260)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~iv~~~~~~~~~~~~~~~~~~l  123 (260)
                      +++.|++|.++.||++....  ..+++|.......    ...+.+|+..++.+++  ..+++++......     +..++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~-----~~~~~   70 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESD-----GWSYL   70 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-----CccEE
Confidence            56789999999999998755  6799999865432    4567789999999976  5888888877654     45899


Q ss_pred             EEecCCcc-hHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          124 VYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA---SVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       124 v~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                      ++|++++. +...       +......++.+++++++.||..   +++|+|++|.||+++.++.++++||+.+..
T Consensus        71 v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          71 LMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             EEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            99999863 3332       5566778899999999999974   699999999999999989999999998754

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.65  E-value=5.4e-17  Score=135.86  Aligned_cols=118  Identities=31%  Similarity=0.541  Sum_probs=104.3

Q ss_pred             ccEEEEEecCC-cchHHHhhhC---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          119 NDVYIVYELMD-TDLHQIIRSD---QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       119 ~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                      ...||.|++|. .+|.+++...   ...+......++.|++.+++|   ++.+|+|++|.||+...+..++|+|||+...
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts  405 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS  405 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence            45889999998 7999999743   346778889999999999999   9999999999999999999999999999887


Q ss_pred             cCCCc-------ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh
Q 024959          195 TSETD-------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT  240 (260)
Q Consensus       195 ~~~~~-------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~  240 (260)
                      .....       ......++..|++||.+.+ ..++.++|||+||++++|++.
T Consensus       406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             cccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHH
Confidence            76655       4445678999999999998 889999999999999999987

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.63  E-value=6.5e-15  Score=126.93  Aligned_cols=168  Identities=19%  Similarity=0.377  Sum_probs=129.8

Q ss_pred             EEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEEEEecCCcchHHHhhhC
Q 024959           60 AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD  139 (260)
Q Consensus        60 ~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~  139 (260)
                      .+..+.++.++.+..++....  .......+.++.|+.++||||+++++.++..     ...|+|+|.+.+ |...+.. 
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~-----~~~ylvTErV~P-l~~~lk~-  100 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEE-----GTLYLVTERVRP-LETVLKE-  100 (690)
T ss_pred             ccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhccc-----CceEEEeecccc-HHHHHHH-
Confidence            456677888999999877543  4556678899999999999999999999887     459999998863 3344443 


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCCeEeccCCCEEEeecccccccCCCcc-ccccccccccccccccc
Q 024959          140 QQLTDDHCQYFLYQLLRGLKYVH-SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLL  217 (260)
Q Consensus       140 ~~~~~~~~~~~~~~i~~~l~~lh-~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~PE~~~  217 (260)
                        +....+...++||+.||.+|| +.+++|+||....|+++..|.++|++|.++........ .....--..|..|+...
T Consensus       101 --l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~  178 (690)
T KOG1243|consen  101 --LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEID  178 (690)
T ss_pred             --hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcC
Confidence              236778889999999999998 67899999999999999999999999998865444332 12222233456666543


Q ss_pred             CcCCCCChhhHHHHHHHHHHHHhC
Q 024959          218 NCTEYTAAIDIWSVGCILGEIMTR  241 (260)
Q Consensus       218 ~~~~~~~~~Di~slG~~l~~ll~g  241 (260)
                      . ..  -..|.|.||+++++++.|
T Consensus       179 ~-s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  179 P-SE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             c-cc--cchhhhhHHHHHHHHhCc
Confidence            3 11  356999999999999998

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.62  E-value=8.6e-16  Score=130.54  Aligned_cols=150  Identities=29%  Similarity=0.434  Sum_probs=123.8

Q ss_pred             HHHcCCCCeeeeeceecCCCCCCCccEEEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCc-eeccC
Q 024959           95 LRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASV-LHRDL  171 (260)
Q Consensus        95 l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i-~H~di  171 (260)
                      |+.+.|.|+.++++.+...     ...++|.++|. |+|.+.+.. ...+++.-...++++++.+++|||+..+ +|+.+
T Consensus         1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeee
Confidence            3567899999999999887     56899999999 799999887 5578888889999999999999998765 99999


Q ss_pred             CCCCeEeccCCCEEEeecccccccCCC---cccccccccccccccccccCc---C---CCCChhhHHHHHHHHHHHHhCC
Q 024959          172 KPSNLLLNASCDLKIGDFGLARTTSET---DFMTEYVVTRWYRAPELLLNC---T---EYTAAIDIWSVGCILGEIMTRE  242 (260)
Q Consensus       172 ~~~nili~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~---~---~~~~~~Di~slG~~l~~ll~g~  242 (260)
                      ++.|.+++....+||+|||+.......   .......-...|.|||.+...   .   ..+.+.|+||+|++++|+++..
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            999999999999999999987665321   111112235679999999763   1   1467799999999999999999


Q ss_pred             CCCCCCC
Q 024959          243 PLFPGKD  249 (260)
Q Consensus       243 ~pf~~~~  249 (260)
                      .||+..+
T Consensus       156 ~~~~~~~  162 (484)
T KOG1023|consen  156 GPFDLRN  162 (484)
T ss_pred             Ccccccc
Confidence            9998743

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.61  E-value=8.9e-15  Score=111.27  Aligned_cols=142  Identities=18%  Similarity=0.232  Sum_probs=101.0

Q ss_pred             cccccccCceEEEEEEeCC------CCeEEEEEecCCcc----------------c----chHHHHHHH----HHHHHHH
Q 024959           47 IRPIGRGAYGIVCAAVNSE------TREEVAIKKIGNAF----------------D----NIIDARRTL----REIKLLR   96 (260)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~------~~~~~~iK~~~~~~----------------~----~~~~~~~~~----~e~~~l~   96 (260)
                      ..+||.|.-+.||.+....      .+..+|+|+++-..                .    .......+.    +|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4679999999999998654      34789999873210                0    011122233    7999999


Q ss_pred             HcCC--CCeeeeeceecCCCCCCCccEEEEEecCCcc-hHHHhhhCCCCCHHHHHHHHHHHHHHHHHH-HhCCceeccCC
Q 024959           97 HMEH--ENVIAIKDIIRPPKKDTFNDVYIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYV-HSASVLHRDLK  172 (260)
Q Consensus        97 ~l~~--~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~l~~l-h~~~i~H~di~  172 (260)
                      ++..  -.+++++++.         .-+||||++++. +..-..+...++.+.+..+..+++.++..| |..|++|+|++
T Consensus        82 rl~~~Gv~vP~pi~~~---------~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs  152 (197)
T cd05146          82 RMQKAGIPCPEVVVLK---------KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLS  152 (197)
T ss_pred             HHHHcCCCCCeEEEec---------CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            9953  3455555531         147999999853 222122233456667778889999999988 89999999999


Q ss_pred             CCCeEeccCCCEEEeecccccccCCC
Q 024959          173 PSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       173 ~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      +.||+++ ++.+.|+||+.+....++
T Consensus       153 ~~NIL~~-~~~v~iIDF~qav~~~hp  177 (197)
T cd05146         153 EYNMLWH-DGKVWFIDVSQSVEPTHP  177 (197)
T ss_pred             HHHEEEE-CCcEEEEECCCceeCCCC
Confidence            9999997 468999999998776654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.60  E-value=7.4e-16  Score=131.13  Aligned_cols=213  Identities=28%  Similarity=0.321  Sum_probs=173.7

Q ss_pred             eEeccccCCCcccccc--cCceEEEEEEe--CCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-CCCeeeeeceec
Q 024959           37 FEVSSKYVPPIRPIGR--GAYGIVCAAVN--SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIR  111 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~--G~~g~vy~~~~--~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~  111 (260)
                      .+...+.+.+.+.+|.  |.+|.+|.+..  ..+++.+++|.-+...........-.+|+...+.++ |++.++.+..+.
T Consensus       109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e  188 (524)
T KOG0601|consen  109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE  188 (524)
T ss_pred             cchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc
Confidence            3455556678889999  99999999998  889999999997666555555555567777777775 999999777777


Q ss_pred             CCCCCCCccEEEEEecCCcchHHHhhhCCC-CCHHHHHHHHHHHHH----HHHHHHhCCceeccCCCCCeEeccC-CCEE
Q 024959          112 PPKKDTFNDVYIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLR----GLKYVHSASVLHRDLKPSNLLLNAS-CDLK  185 (260)
Q Consensus       112 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~-~~~~~~~~~~~~i~~----~l~~lh~~~i~H~di~~~nili~~~-~~~~  185 (260)
                      ..     +..|+-+|.++.+|.++...... +++..++....+..+    ++.++|+.+++|.|++|.||++..+ ..++
T Consensus       189 ~~-----~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~  263 (524)
T KOG0601|consen  189 GS-----GILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCK  263 (524)
T ss_pred             cC-----CcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceee
Confidence            66     56899999999999998877655 888999999999999    9999999999999999999999999 8899


Q ss_pred             EeecccccccCCCccccc------ccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCC--ChHHHHHH
Q 024959          186 IGDFGLARTTSETDFMTE------YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK--DYVHQLRL  256 (260)
Q Consensus       186 l~df~~~~~~~~~~~~~~------~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~--~~~~~~~~  256 (260)
                      ++||++............      ..+...|++||...+  -++...|+|+||.++.+..++..++...  +.|.++++
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence            999999987766542221      245677999998764  5788999999999999998887777665  66666554

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.57  E-value=1.9e-16  Score=140.06  Aligned_cols=205  Identities=27%  Similarity=0.386  Sum_probs=162.1

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCC-eEEEEEecCCcccchHHHHHHHHHHHHHHHcC-CCCeeeeeceecCCCCCCC
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETR-EEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTF  118 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~-~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~~  118 (260)
                      ..-|.+.+.||+|+++.+-++.+..+. ..++.|.+...............|..+-+.+. |+|++.+++.....     
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~-----   93 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSP-----   93 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCC-----
Confidence            344567788999999999999875543 34666666544333444455556777777776 99999999999887     


Q ss_pred             ccEEEEEecCC-cchHHHh-hhCC-CCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCCeEeccCC-CEEEeeccccc
Q 024959          119 NDVYIVYELMD-TDLHQII-RSDQ-QLTDDHCQYFLYQLLRGLKYVH-SASVLHRDLKPSNLLLNASC-DLKIGDFGLAR  193 (260)
Q Consensus       119 ~~~~lv~e~~~-~~l~~~l-~~~~-~~~~~~~~~~~~~i~~~l~~lh-~~~i~H~di~~~nili~~~~-~~~l~df~~~~  193 (260)
                      +..++++++.. +++.+.+ .... ..+......++.|+..++.|+| ..++.|+||+|+|.+++..+ .+++.|||++.
T Consensus        94 ~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At  173 (601)
T KOG0590|consen   94 RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLAT  173 (601)
T ss_pred             cccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhc
Confidence            55889999876 4666666 4443 5777788899999999999999 99999999999999999999 99999999997


Q ss_pred             ccCC-C---cccccccc-cccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024959          194 TTSE-T---DFMTEYVV-TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (260)
Q Consensus       194 ~~~~-~---~~~~~~~~-~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  250 (260)
                      .... .   ......++ ++.|.+||.+.+.....+..|+||+|+++..+++|..|+.....
T Consensus       174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~  235 (601)
T KOG0590|consen  174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSR  235 (601)
T ss_pred             cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccc
Confidence            6655 2   23344567 89999999998855667889999999999999999999975544

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.50  E-value=1.7e-13  Score=103.18  Aligned_cols=128  Identities=18%  Similarity=0.193  Sum_probs=92.8

Q ss_pred             cccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCe-eeeeceecCCCCCCCccEEEEE
Q 024959           47 IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV-IAIKDIIRPPKKDTFNDVYIVY  125 (260)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-v~~~~~~~~~~~~~~~~~~lv~  125 (260)
                      +++++.|..+.||++...  +..+++|.......   ....+.+|++.++.+...++ ++++.....       ..++||
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~-------~~~lv~   70 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDPE-------TGVLIT   70 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeCC-------CCeEEE
Confidence            467899999999999865  67899999865421   12245678888888864443 445554322       247999


Q ss_pred             ecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eeccCCCCCeEeccCCCEEEeeccccccc
Q 024959          126 ELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV-----LHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (260)
Q Consensus       126 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i-----~H~di~~~nili~~~~~~~l~df~~~~~~  195 (260)
                      |+++| ++...     ..   .....+.+++++|..||..++     +|+|++|.||+++ ++.++++||+.+...
T Consensus        71 e~i~G~~l~~~-----~~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~  137 (170)
T cd05151          71 EFIEGSELLTE-----DF---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN  137 (170)
T ss_pred             EecCCCccccc-----cc---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence            99997 33321     11   123456789999999999885     9999999999998 668999999987543

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.49  E-value=4.9e-13  Score=114.85  Aligned_cols=143  Identities=21%  Similarity=0.264  Sum_probs=96.1

Q ss_pred             cccccccCceEEEEEEeCCCCeEEEEEecCCcccchHH--------------------------------------HHHH
Q 024959           47 IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIID--------------------------------------ARRT   88 (260)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~--------------------------------------~~~~   88 (260)
                      .++||.|+.|.||+|..+ +|+.||||+.+........                                      .-++
T Consensus       122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            368999999999999875 6889999998543211000                                      0123


Q ss_pred             HHHHHHHHHcC----CCCeeeeeceecCCCCCCCccEEEEEecCCc-chHHHhhhC-CCCCHHHHHHHHHHHHH-HHHHH
Q 024959           89 LREIKLLRHME----HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLR-GLKYV  161 (260)
Q Consensus        89 ~~e~~~l~~l~----~~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~~~~i~~-~l~~l  161 (260)
                      .+|++.+.++.    +..-+.+..++.+-.    ...++||||++| +|.+..... ....   ...++.+++. .+..+
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~----~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql  273 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRT----SERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQV  273 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhc----CCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHH
Confidence            44555555552    233334333443221    236899999985 666554321 1222   3345666666 47889


Q ss_pred             HhCCceeccCCCCCeEeccCCCEEEeecccccccCC
Q 024959          162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (260)
Q Consensus       162 h~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~  197 (260)
                      |..|++|+|++|.||+++.++.++++|||++.....
T Consensus       274 ~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       274 LRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HhCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            999999999999999999999999999999877654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.49  E-value=1e-12  Score=96.76  Aligned_cols=144  Identities=23%  Similarity=0.292  Sum_probs=105.8

Q ss_pred             CcccccccCceEEEEEEeCCCCeEEEEEec-CCcc-----cchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCc
Q 024959           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKI-GNAF-----DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~-~~~~-----~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      ....+-||+-+.|+.+..  .|+.++||.- .+..     +......+...|++.|.++.--.|.-..-++.+.     .
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~-----~   83 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT-----Y   83 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec-----C
Confidence            467788999999999965  4677777754 2222     3333456667799999998755555444444443     2


Q ss_pred             cEEEEEecCCc--chHHHhhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCC---EEEeecccc
Q 024959          120 DVYIVYELMDT--DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLA  192 (260)
Q Consensus       120 ~~~lv~e~~~~--~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~---~~l~df~~~  192 (260)
                      .-.|+|||++|  ++.+.+.+.  .....+....++.++-+.+.-||.++++|||+..+||++..++.   +.++|||++
T Consensus        84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls  163 (229)
T KOG3087|consen   84 GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLS  163 (229)
T ss_pred             CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecch
Confidence            35799999997  888888774  33444445789999999999999999999999999999976543   589999998


Q ss_pred             cccC
Q 024959          193 RTTS  196 (260)
Q Consensus       193 ~~~~  196 (260)
                      ....
T Consensus       164 ~~s~  167 (229)
T KOG3087|consen  164 SVSR  167 (229)
T ss_pred             hccc
Confidence            6543

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.45  E-value=2e-12  Score=95.54  Aligned_cols=134  Identities=23%  Similarity=0.281  Sum_probs=95.2

Q ss_pred             ccccccCceEEEEEEeCCCCeEEEEEec-CCcccchH-----HHHHHHHHHHHHHHcCCCCee--eeeceecCCCCCCCc
Q 024959           48 RPIGRGAYGIVCAAVNSETREEVAIKKI-GNAFDNII-----DARRTLREIKLLRHMEHENVI--AIKDIIRPPKKDTFN  119 (260)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~~~iK~~-~~~~~~~~-----~~~~~~~e~~~l~~l~~~~iv--~~~~~~~~~~~~~~~  119 (260)
                      ..+++|+-+.+|.+...  +..+++|.- ++....+.     ...+..+|++++.+++--.|.  .++++.+.+      
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~------   73 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDN------   73 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCC------
Confidence            35789999999999553  334666643 33332222     334556799999998754444  344444433      


Q ss_pred             cEEEEEecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          120 DVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       120 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                       ..|+|||++| .|.+.+...       ...++..+-.-+.-||..|++|||+.++|+.+..++ +.++|||++...+..
T Consensus        74 -~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~~~  144 (204)
T COG3642          74 -GLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFSDEV  144 (204)
T ss_pred             -CEEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccccccH
Confidence             6799999997 555576665       134667777888889999999999999999998765 999999998765443

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.44  E-value=3.4e-13  Score=117.43  Aligned_cols=144  Identities=15%  Similarity=0.244  Sum_probs=92.4

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccch--------------------------------HHH-----
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI--------------------------------IDA-----   85 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~--------------------------------~~~-----   85 (260)
                      .|+. ++||.|+.|.||+|..+.+|+.||||+........                                ...     
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            3444 79999999999999998889999999996432110                                001     


Q ss_pred             -HHHHHHHHHHHHcC----CCCeeeeeceecCCCCCCCccEEEEEecCCc-chHHH--hhhCC----CCCHHHHHHHHHH
Q 024959           86 -RRTLREIKLLRHME----HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQI--IRSDQ----QLTDDHCQYFLYQ  153 (260)
Q Consensus        86 -~~~~~e~~~l~~l~----~~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~--l~~~~----~~~~~~~~~~~~~  153 (260)
                       -++.+|+..+.+++    +...+.+..++.+-.    ...++||||+.| .+.+.  +...+    .+.+..+..++.|
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~s----t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q  275 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYC----SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ  275 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccC----CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence             12233444444442    333333333333211    336899999986 66553  22222    2333334444444


Q ss_pred             HHHHHHHHHhCCceeccCCCCCeEeccCC----CEEEeecccccccCCC
Q 024959          154 LLRGLKYVHSASVLHRDLKPSNLLLNASC----DLKIGDFGLARTTSET  198 (260)
Q Consensus       154 i~~~l~~lh~~~i~H~di~~~nili~~~~----~~~l~df~~~~~~~~~  198 (260)
                      +       ...|++|+|++|.||+++.++    .++++|||.+......
T Consensus       276 i-------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        276 V-------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             H-------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence            4       468999999999999999888    8999999998766443

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.43  E-value=4.7e-12  Score=106.64  Aligned_cols=171  Identities=15%  Similarity=0.232  Sum_probs=134.2

Q ss_pred             CceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEEEEecCC--cc
Q 024959           54 AYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD--TD  131 (260)
Q Consensus        54 ~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv~e~~~--~~  131 (260)
                      .-.+.|+++...+|..|++|.++.....  .......-++.++++.|+|+|++.++|... ..++..+++|++|++  ++
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~--~~nk~t~lve~wkkl~h~NvV~frevf~t~-tF~D~SlvlvYDYyP~s~T  364 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQ--STNKDTSLVEAWKKLCHTNVVPFREVFLTY-TFGDLSLVLVYDYYPSSPT  364 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeecccccc--CcccchHHHHHHHHhccCceeehhhhhhhh-ccCcceEEEEEecCCCCch
Confidence            4467999999999999999999543222  122334567889999999999999999843 334467999999999  47


Q ss_pred             hHHHhhh---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccC
Q 024959          132 LHQIIRS---------------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (260)
Q Consensus       132 l~~~l~~---------------~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~  196 (260)
                      |.++.-.               +...++..+|.++.|++.+|.++|+.|+..+-+.+.+|+++.+-.++|...|......
T Consensus       365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence            7776532               2347889999999999999999999999999999999999999899999999887766


Q ss_pred             CCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCC
Q 024959          197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL  244 (260)
Q Consensus       197 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~p  244 (260)
                      .+.           .+|  +    .--.+.|.=.||.+++.|.||..-
T Consensus       445 ~d~-----------~~~--l----e~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  445 EDP-----------TEP--L----ESQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCC-----------Ccc--h----hHHhhhhHHHHHHHHHHHhhcccc
Confidence            553           111  1    112356888999999999998654

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.37  E-value=1.9e-13  Score=108.85  Aligned_cols=149  Identities=22%  Similarity=0.295  Sum_probs=113.2

Q ss_pred             HHHcCCCCeeeeeceecCCCCCCCccEEEEEecCC-cchHHHhhh----CCCCCHHHHHHHHHHHHHHHHHHHhC--Cce
Q 024959           95 LRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSA--SVL  167 (260)
Q Consensus        95 l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~--~i~  167 (260)
                      |-.+.|.||+++..++.+.+........+++|||. +++.+.+++    +..+......+|+.||+++|.|||+.  .++
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii  200 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII  200 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence            33446999999999998877766678899999998 788888865    45688888999999999999999987  599


Q ss_pred             eccCCCCCeEeccCCCEEEeecccccccCCCc-----ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCC
Q 024959          168 HRDLKPSNLLLNASCDLKIGDFGLARTTSETD-----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTRE  242 (260)
Q Consensus       168 H~di~~~nili~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~  242 (260)
                      |+++..+.|++..+|-+|+..-.-........     ......+.++|.+||.-.. ...+-.+|||++|.+.++|.-+.
T Consensus       201 hgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlemailE  279 (458)
T KOG1266|consen  201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEMAILE  279 (458)
T ss_pred             cCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcc-cccccchhhhhhhHHHHHHHHhe
Confidence            99999999999998888876543221111110     0111234677889987544 44567899999999999998876


Q ss_pred             CC
Q 024959          243 PL  244 (260)
Q Consensus       243 ~p  244 (260)
                      .-
T Consensus       280 iq  281 (458)
T KOG1266|consen  280 IQ  281 (458)
T ss_pred             ec
Confidence            53

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.32  E-value=3e-11  Score=94.58  Aligned_cols=142  Identities=20%  Similarity=0.161  Sum_probs=103.6

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc--------------------cchHHHHHHHHHHHHHHHcCCC-
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF--------------------DNIIDARRTLREIKLLRHMEHE-  101 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~--------------------~~~~~~~~~~~e~~~l~~l~~~-  101 (260)
                      ...++..||-|.-|.||.+.++ .|.++++|.-....                    .-........+|.+.|.+|... 
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G  170 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG  170 (304)
T ss_pred             HHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence            3467889999999999999987 46789999642110                    1122334556799999998644 


Q ss_pred             -CeeeeeceecCCCCCCCccEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecc
Q 024959          102 -NVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA  180 (260)
Q Consensus       102 -~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~  180 (260)
                       .+++.+++-.         -++|||+++|.....+.    ++.+....++..|++.+..+-..|++|||+++-||++++
T Consensus       171 ~~VP~P~~~nR---------HaVvMe~ieG~eL~~~r----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~  237 (304)
T COG0478         171 VKVPKPIAWNR---------HAVVMEYIEGVELYRLR----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCCCcccccc---------ceeeeehcccceeeccc----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEec
Confidence             6666666543         46999999983322222    134445556677777777777999999999999999999


Q ss_pred             CCCEEEeecccccccCCC
Q 024959          181 SCDLKIGDFGLARTTSET  198 (260)
Q Consensus       181 ~~~~~l~df~~~~~~~~~  198 (260)
                      +|.+.++||..+....++
T Consensus       238 dg~~~vIDwPQ~v~~~hp  255 (304)
T COG0478         238 DGDIVVIDWPQAVPISHP  255 (304)
T ss_pred             CCCEEEEeCcccccCCCC
Confidence            999999999988776655

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.29  E-value=5.2e-11  Score=90.37  Aligned_cols=130  Identities=24%  Similarity=0.276  Sum_probs=82.1

Q ss_pred             EEEEEEeCCCCeEEEEEecCCc------------------------ccchHHHHHHHHHHHHHHHcCCC--Ceeeeecee
Q 024959           57 IVCAAVNSETREEVAIKKIGNA------------------------FDNIIDARRTLREIKLLRHMEHE--NVIAIKDII  110 (260)
Q Consensus        57 ~vy~~~~~~~~~~~~iK~~~~~------------------------~~~~~~~~~~~~e~~~l~~l~~~--~iv~~~~~~  110 (260)
                      .||.|.... +..+|+|+....                        ...........+|.+.|.++...  ++++++++.
T Consensus         1 ~Vy~~~~~~-~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDPD-GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEECT-TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECCC-CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            378887754 568999987322                        01111234456799999999755  456666543


Q ss_pred             cCCCCCCCccEEEEEecCC--cchHHHhhhCCCCCHHHHHHHHHHHHHHHHH-HHhCCceeccCCCCCeEeccCCCEEEe
Q 024959          111 RPPKKDTFNDVYIVYELMD--TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY-VHSASVLHRDLKPSNLLLNASCDLKIG  187 (260)
Q Consensus       111 ~~~~~~~~~~~~lv~e~~~--~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~-lh~~~i~H~di~~~nili~~~~~~~l~  187 (260)
                      .         -+|||||++  |.....+.... ++.+....++.+++..+.. +|..|++|||+++.||+++++ .+.++
T Consensus        80 ~---------~~ivME~I~~~G~~~~~l~~~~-~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iI  148 (188)
T PF01163_consen   80 R---------NVIVMEYIGEDGVPLPRLKDVD-LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYII  148 (188)
T ss_dssp             T---------TEEEEE--EETTEEGGCHHHCG-GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE-
T ss_pred             C---------CEEEEEecCCCccchhhHHhcc-ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEE
Confidence            1         379999999  63333333221 1134556677888885444 679999999999999999887 89999


Q ss_pred             ecccccccCCC
Q 024959          188 DFGLARTTSET  198 (260)
Q Consensus       188 df~~~~~~~~~  198 (260)
                      ||+.+....++
T Consensus       149 Df~qav~~~~p  159 (188)
T PF01163_consen  149 DFGQAVDSSHP  159 (188)
T ss_dssp             -GTTEEETTST
T ss_pred             ecCcceecCCc
Confidence            99988766544

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.28  E-value=9.6e-11  Score=94.05  Aligned_cols=135  Identities=13%  Similarity=0.058  Sum_probs=92.4

Q ss_pred             EEEEEeCCCCeEEEEEecCCcccchHH---------HHHHHHHHHHHHHcCCCCeee--eeceecCCCCCCCccEEEEEe
Q 024959           58 VCAAVNSETREEVAIKKIGNAFDNIID---------ARRTLREIKLLRHMEHENVIA--IKDIIRPPKKDTFNDVYIVYE  126 (260)
Q Consensus        58 vy~~~~~~~~~~~~iK~~~~~~~~~~~---------~~~~~~e~~~l~~l~~~~iv~--~~~~~~~~~~~~~~~~~lv~e  126 (260)
                      |.++..  .|+.|.||...........         ...+.+|.+.+.++...+|..  +.++............++|||
T Consensus        38 vvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte  115 (268)
T PRK15123         38 TLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE  115 (268)
T ss_pred             EEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence            455533  4568999976432211100         013667888888885434333  333332221111245789999


Q ss_pred             cCCc--chHHHhhh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecc-------CCCEEEeecccccc
Q 024959          127 LMDT--DLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-------SCDLKIGDFGLART  194 (260)
Q Consensus       127 ~~~~--~l~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~-------~~~~~l~df~~~~~  194 (260)
                      ++++  +|.+++..  ..+.+......++.+++..+..||..|++|+|+++.|||++.       +..+.|+||+.+..
T Consensus       116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            9996  68888764  345667778899999999999999999999999999999975       46799999998854

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.27  E-value=1.1e-10  Score=96.51  Aligned_cols=198  Identities=13%  Similarity=0.103  Sum_probs=138.9

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCC---CC
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKK---DT  117 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~---~~  117 (260)
                      .-+...+.||+|+-+.+|-.-.-   ...+.|+++.....  ...+.   +..|-.. .||-+-. .-.+.....   ..
T Consensus        11 e~i~~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa--~~aqk---~a~la~~p~~p~~~~-rvaWPqa~L~G~~~   81 (637)
T COG4248          11 EPIPPGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPA--AQAQK---VAELAATPDAPLLNY-RVAWPQATLHGGRR   81 (637)
T ss_pred             cccCCCccccCCccceeeecchh---hchhheeecCCCch--HHHHH---HHHhccCCCCcchhh-hhcccHHHhhCCCc
Confidence            33456889999999999987332   23567888664322  11221   2222222 3553322 111111110   00


Q ss_pred             CccEEEEEecCCc--chHHHhhh------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeec
Q 024959          118 FNDVYIVYELMDT--DLHQIIRS------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF  189 (260)
Q Consensus       118 ~~~~~lv~e~~~~--~l~~~l~~------~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df  189 (260)
                      ...+-++|+.+.+  ....+.+.      ...+.+.-+...++.++.+.+.||..|.+-||++++|+|+++++.++|.|-
T Consensus        82 ~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVds  161 (637)
T COG4248          82 GKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDS  161 (637)
T ss_pred             cceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcc
Confidence            0226678888764  44444432      345788999999999999999999999999999999999999999999998


Q ss_pred             ccccccCCCcccccccccccccccccccC----cCCCCChhhHHHHHHHHHHHHhC-CCCCCCC
Q 024959          190 GLARTTSETDFMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTR-EPLFPGK  248 (260)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~----~~~~~~~~Di~slG~~l~~ll~g-~~pf~~~  248 (260)
                      .-.....+........+...|++||.-.-    ....+...|.|.||++++++|.| ..||.|-
T Consensus       162 Dsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI  225 (637)
T COG4248         162 DSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI  225 (637)
T ss_pred             cceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence            87777777777777788999999998651    14457789999999999999885 8999764

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.26  E-value=7.7e-11  Score=92.46  Aligned_cols=143  Identities=17%  Similarity=0.256  Sum_probs=98.6

Q ss_pred             cccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCC--CeeeeeceecCCCCCCCccEEEE
Q 024959           47 IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE--NVIAIKDIIRPPKKDTFNDVYIV  124 (260)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~iv~~~~~~~~~~~~~~~~~~lv  124 (260)
                      .++|+.|..+.+|++...+ |..+++|........ .....+..|+++++.+.+.  .+++++.+.....  .....++|
T Consensus         3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v   78 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYV   78 (223)
T ss_pred             ceecCCCccceEEEEEecC-CcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEE
Confidence            3678999999999998754 578999998554221 1345677899999999753  3566666665432  11346899


Q ss_pred             EecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 024959          125 YELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS----------------------------------------  163 (260)
Q Consensus       125 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~----------------------------------------  163 (260)
                      ||+++| ++.+.+. ...+++.....++.++++.|..||+                                        
T Consensus        79 ~e~i~G~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (223)
T cd05154          79 MERVDGRVLRDRLL-RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM  157 (223)
T ss_pred             EEEeCCEecCCCCC-CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence            999986 3433221 1345555566666666666666662                                        


Q ss_pred             ----------------CCceeccCCCCCeEecc--CCCEEEeecccccc
Q 024959          164 ----------------ASVLHRDLKPSNLLLNA--SCDLKIGDFGLART  194 (260)
Q Consensus       164 ----------------~~i~H~di~~~nili~~--~~~~~l~df~~~~~  194 (260)
                                      ..++|+|+.+.||+++.  ++.+.|+||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                            23689999999999998  56689999997744

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.26  E-value=1.6e-12  Score=117.21  Aligned_cols=215  Identities=22%  Similarity=0.211  Sum_probs=158.4

Q ss_pred             EeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchH-HHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII-DARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        38 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      ..+...+.+.+.+-.|.++.++.+.-..++....+|+......-.. ..+....+-+++-...+|.+++...-+...   
T Consensus       800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~r---  876 (1205)
T KOG0606|consen  800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCR---  876 (1205)
T ss_pred             cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCC---
Confidence            3445556678899999999999998877887667666644321111 112222233333323456656554443333   


Q ss_pred             CCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccccc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~  195 (260)
                        ...++++++.+ ++|...+.+-+..+.+-.+..+..+...+++||...+.|+|++|.|.++..++..++.||+.....
T Consensus       877 --sP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v  954 (1205)
T KOG0606|consen  877 --SPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV  954 (1205)
T ss_pred             --CCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccc
Confidence              55899999997 588888888777888888899999999999999999999999999999999999999999843221


Q ss_pred             CCC--------------------------------cccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCC
Q 024959          196 SET--------------------------------DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREP  243 (260)
Q Consensus       196 ~~~--------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~  243 (260)
                      ...                                .......+++.|.+||...+ ......+|.|+.|+++++.++|.+
T Consensus       955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg-~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen  955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG-RRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred             ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc-ccCCCcchhhhhhhhhhhhhcCCC
Confidence            100                                00111245788999999998 777888999999999999999999


Q ss_pred             CCCCCChHHHHHHhh
Q 024959          244 LFPGKDYVHQLRLIT  258 (260)
Q Consensus       244 pf~~~~~~~~~~~i~  258 (260)
                      ||........+++|.
T Consensus      1034 p~na~tpq~~f~ni~ 1048 (1205)
T KOG0606|consen 1034 PFNAETPQQIFENIL 1048 (1205)
T ss_pred             CCCCcchhhhhhccc
Confidence            999999888888764

>PRK09902 hypothetical protein; Provisional

Probab=99.25  E-value=3e-10  Score=86.83  Aligned_cols=141  Identities=15%  Similarity=0.146  Sum_probs=102.2

Q ss_pred             cccCceEEEEEEeCCCCeEEEEEecCCcccc----hHHHHHHHHHHHHHHHcCCCC--eeeeeceecCCCCCCCccEEEE
Q 024959           51 GRGAYGIVCAAVNSETREEVAIKKIGNAFDN----IIDARRTLREIKLLRHMEHEN--VIAIKDIIRPPKKDTFNDVYIV  124 (260)
Q Consensus        51 g~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~~e~~~l~~l~~~~--iv~~~~~~~~~~~~~~~~~~lv  124 (260)
                      +.||-+.|+......  ..+-+|.-.+....    +.-...+.+|...+++|...+  ++++. ++........-..+||
T Consensus        27 ~rgG~SgV~r~~~~g--~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         27 RRNGMSGVQCVERNG--KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             CCCCcceEEEEEeCC--cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            358888899886543  36888877422111    223456778888888885322  33333 3332322233567899


Q ss_pred             EecCC--cchHHHhhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCC--EEEeecccccc
Q 024959          125 YELMD--TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD--LKIGDFGLART  194 (260)
Q Consensus       125 ~e~~~--~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~--~~l~df~~~~~  194 (260)
                      +|.++  .+|.+++...  .+.+......++.+++.++.-||..|+.|+|+.+.||+++.++.  +.++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            99998  4898887663  35678888899999999999999999999999999999986667  99999997644

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.24  E-value=5.1e-12  Score=108.01  Aligned_cols=200  Identities=23%  Similarity=0.235  Sum_probs=150.5

Q ss_pred             ccccCCCcccccccCceEEEEEEeC-CCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-CCCeeeeeceecCCCCCC
Q 024959           40 SSKYVPPIRPIGRGAYGIVCAAVNS-ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDT  117 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~  117 (260)
                      ....+..+..|+.|.++.++.+... .++..|++|...+..........-+.|+-+...+. |.++++++..|...    
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~----  338 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL----  338 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc----
Confidence            3455678899999999999988755 67788999998776655554444456776666664 89999988888777    


Q ss_pred             CccEEEEEecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccC-CCEEEeeccccccc
Q 024959          118 FNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTT  195 (260)
Q Consensus       118 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~-~~~~l~df~~~~~~  195 (260)
                       ...|+-.|++.+ ++.........+.+..++.+..|++.++.++|+..++|.|++|+||++..+ +..++.||++....
T Consensus       339 -r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~  417 (524)
T KOG0601|consen  339 -RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL  417 (524)
T ss_pred             -ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccc
Confidence             446789999974 444444445567888899999999999999999999999999999999886 77899999988653


Q ss_pred             CCCccccccccccccc-ccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 024959          196 SETDFMTEYVVTRWYR-APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFP  246 (260)
Q Consensus       196 ~~~~~~~~~~~~~~~~-~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~  246 (260)
                      .....  ......+++ .+|.+.....+..+.|+++||..+.+..++.+.-+
T Consensus       418 ~~~~~--~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~  467 (524)
T KOG0601|consen  418 AFSSG--VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE  467 (524)
T ss_pred             ceecc--cccccccccccchhhccccccccccccccccccccccccCcccCc
Confidence            22211  111233344 35666655778899999999999999888776433

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.22  E-value=2.1e-10  Score=89.07  Aligned_cols=111  Identities=23%  Similarity=0.298  Sum_probs=85.7

Q ss_pred             HHHHHHHHHHHHHHcCCCC--eeeeeceecCCCCCCCccEEEEEecCCc--chHHHhhhCCCCCHHHHHHHHHHHHHHHH
Q 024959           84 DARRTLREIKLLRHMEHEN--VIAIKDIIRPPKKDTFNDVYIVYELMDT--DLHQIIRSDQQLTDDHCQYFLYQLLRGLK  159 (260)
Q Consensus        84 ~~~~~~~e~~~l~~l~~~~--iv~~~~~~~~~~~~~~~~~~lv~e~~~~--~l~~~l~~~~~~~~~~~~~~~~~i~~~l~  159 (260)
                      ......+|.+.+..|...+  .++++++........ ...++|+|++++  +|.+.+......+......++.++++.+.
T Consensus        54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~-~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGG-YRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIA  132 (206)
T ss_pred             cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCc-eeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHH
Confidence            3455677888777775333  334455544432211 456899999985  78998887666778888999999999999


Q ss_pred             HHHhCCceeccCCCCCeEeccCC---CEEEeeccccccc
Q 024959          160 YVHSASVLHRDLKPSNLLLNASC---DLKIGDFGLARTT  195 (260)
Q Consensus       160 ~lh~~~i~H~di~~~nili~~~~---~~~l~df~~~~~~  195 (260)
                      -||..|++|+|+++.|||++.++   .+.|+||+.+...
T Consensus       133 ~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  133 KLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99999999999999999999887   7999999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.98  E-value=6.9e-09  Score=80.65  Aligned_cols=143  Identities=18%  Similarity=0.163  Sum_probs=96.6

Q ss_pred             CcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHH-----------------HH-----HHHHHHHHHHcCCCC-
Q 024959           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA-----------------RR-----TLREIKLLRHMEHEN-  102 (260)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~-----------------~~-----~~~e~~~l~~l~~~~-  102 (260)
                      +..+|.+|..+.||+|.. .++..+|+|+++.........                 .+     ..+|++-|+++...+ 
T Consensus        52 ~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV  130 (268)
T COG1718          52 LVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV  130 (268)
T ss_pred             eEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence            455888999999999976 446789999984432111110                 11     125777777775333 


Q ss_pred             -eeeeeceecCCCCCCCccEEEEEecCCcch-HHHhhhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEec
Q 024959          103 -VIAIKDIIRPPKKDTFNDVYIVYELMDTDL-HQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLN  179 (260)
Q Consensus       103 -iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l-~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~di~~~nili~  179 (260)
                       +++.+.+.         .-.+|||+++... .-=..+..++..+....+..++++.+.-|-. .+++|+|++.-|||+.
T Consensus       131 rvP~Pi~~~---------~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~  201 (268)
T COG1718         131 RVPEPIAFR---------NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH  201 (268)
T ss_pred             CCCCceeec---------CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE
Confidence             33333332         2479999998431 0000112233444677788899999888876 8999999999999999


Q ss_pred             cCCCEEEeecccccccCCCc
Q 024959          180 ASCDLKIGDFGLARTTSETD  199 (260)
Q Consensus       180 ~~~~~~l~df~~~~~~~~~~  199 (260)
                       ++.+.++||+.+....++.
T Consensus       202 -~~~p~iID~~QaV~~~hp~  220 (268)
T COG1718         202 -DGEPYIIDVSQAVTIDHPN  220 (268)
T ss_pred             -CCeEEEEECccccccCCCc
Confidence             8899999999998777663

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.87  E-value=4e-08  Score=75.57  Aligned_cols=143  Identities=13%  Similarity=0.107  Sum_probs=84.2

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHH-------HHHHHHHHHHHHcC---CCCeeeeecee
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA-------RRTLREIKLLRHME---HENVIAIKDII  110 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~-------~~~~~e~~~l~~l~---~~~iv~~~~~~  110 (260)
                      ...|.+.+.+-.....-|.+..  -++..+++|............       ....+.+..+.+++   .....+++.+.
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            3445555666555555555553  346789999886543221111       11123444444443   33333333333


Q ss_pred             cCCCCCCCccEEEEEecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeec
Q 024959          111 RPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF  189 (260)
Q Consensus       111 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df  189 (260)
                      +-....-....+++|||++| .|.+..    .+++    .+...+.+++..||+.|++|||++|.|++++.+ .+.++||
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~----~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~  178 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIE----DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDT  178 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccch----hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEEC
Confidence            22221111446789999997 444432    1222    244567788999999999999999999999865 4999999


Q ss_pred             ccccc
Q 024959          190 GLART  194 (260)
Q Consensus       190 ~~~~~  194 (260)
                      +....
T Consensus       179 ~~k~~  183 (229)
T PF06176_consen  179 QGKRM  183 (229)
T ss_pred             ccccc
Confidence            86543

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.69  E-value=3.9e-07  Score=71.69  Aligned_cols=134  Identities=17%  Similarity=0.195  Sum_probs=80.0

Q ss_pred             cccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCC--eeeeeceecCCCCCCCccEEEE
Q 024959           47 IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN--VIAIKDIIRPPKKDTFNDVYIV  124 (260)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--iv~~~~~~~~~~~~~~~~~~lv  124 (260)
                      ..+|++|..+.||+.    .+..+++|......    ......+|.++++.+..-.  +++.+++....     +...+|
T Consensus         6 ~~~i~~G~t~~~y~~----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~-----~~~glv   72 (226)
T TIGR02172         6 WTQTGEGGNGESYTH----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDG-----GRLGLI   72 (226)
T ss_pred             heeecCCCCcceeEe----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecC-----Ceeeee
Confidence            367899999999984    24468899986532    2234678999998886333  35566666554     336789


Q ss_pred             EecCCcc--hHHHh--------------hh-----C----CCCCHHHHHH-HHH----------HHHH-HHHHHH----h
Q 024959          125 YELMDTD--LHQII--------------RS-----D----QQLTDDHCQY-FLY----------QLLR-GLKYVH----S  163 (260)
Q Consensus       125 ~e~~~~~--l~~~l--------------~~-----~----~~~~~~~~~~-~~~----------~i~~-~l~~lh----~  163 (260)
                      ||+++|.  +...+              -.     +    ...+...... +-.          .+.+ ...+|.    .
T Consensus        73 ~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~  152 (226)
T TIGR02172        73 YELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDT  152 (226)
T ss_pred             eeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCC
Confidence            9999873  11111              00     0    0111111000 000          0111 112222    2


Q ss_pred             CCceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          164 ASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       164 ~~i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                      ..++|+|+.|.||++++++ +.++||+.+..
T Consensus       153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       153 STCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            2478999999999999888 99999998754

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.64  E-value=5.9e-09  Score=91.07  Aligned_cols=94  Identities=26%  Similarity=0.444  Sum_probs=74.3

Q ss_pred             HHHHHHHHh-CCceeccCCCCCeEeccCCCEEEeecccccccCCCcccc----------cccccccccccccccCcCCCC
Q 024959          155 LRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT----------EYVVTRWYRAPELLLNCTEYT  223 (260)
Q Consensus       155 ~~~l~~lh~-~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~----------~~~~~~~~~~PE~~~~~~~~~  223 (260)
                      +.++.++|. .+++|++|.|++|.++.++.+||..|+++..........          .......|.+||.+.. ...+
T Consensus       109 ~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~~~  187 (700)
T KOG2137|consen  109 ADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TTNT  187 (700)
T ss_pred             cchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-cccc
Confidence            389999995 589999999999999999999999999887655421111          1122567999999988 7788


Q ss_pred             ChhhHHHHHHHHHHHH-hCCCCCCCCC
Q 024959          224 AAIDIWSVGCILGEIM-TREPLFPGKD  249 (260)
Q Consensus       224 ~~~Di~slG~~l~~ll-~g~~pf~~~~  249 (260)
                      +++|+||||+++|.+. .|+..+...+
T Consensus       188 ~~sd~fSlG~li~~i~~~gk~i~~a~~  214 (700)
T KOG2137|consen  188 PASDVFSLGVLIYTIYNGGKSIIAANG  214 (700)
T ss_pred             ccccceeeeeEEEEEecCCcchhhccC
Confidence            9999999999999998 4665555443

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.60  E-value=7e-07  Score=77.87  Aligned_cols=142  Identities=19%  Similarity=0.288  Sum_probs=90.7

Q ss_pred             ccccccCceEEEEEEeCCCCeEEEEEecCCcccc--------------------------------------hHHHHHHH
Q 024959           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN--------------------------------------IIDARRTL   89 (260)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~--------------------------------------~~~~~~~~   89 (260)
                      .+|+.++-|.||.|..+. |+.||||+.......                                      -...-++.
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            789999999999999866 899999987333100                                      00112334


Q ss_pred             HHHHHHHHcC----CCCeeeeeceecCCCCCCCccEEEEEecCCc-chHHH--hhhCCCCCHHHHHHHHHHHHHH-HHHH
Q 024959           90 REIKLLRHME----HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQI--IRSDQQLTDDHCQYFLYQLLRG-LKYV  161 (260)
Q Consensus        90 ~e~~~l~~l~----~~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~--l~~~~~~~~~~~~~~~~~i~~~-l~~l  161 (260)
                      +|+..+.+++    ..--+++-.++.+-.    ..-.++|||++| .+.+.  +.. ..++...   ++..++++ +..+
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t----~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~---ia~~~~~~f~~q~  281 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYT----TRRVLTMEWIDGIKISDIAALKS-AGIDRKE---LAELLVRAFLRQL  281 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhcc----CCcEEEEEeeCCEecccHHHHHh-cCCCHHH---HHHHHHHHHHHHH
Confidence            5666666663    222233333333211    336899999997 44444  233 3344332   33333332 3444


Q ss_pred             HhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       162 h~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      -..|+.|+|.+|.||+++.+|.+.+.|||.+...++.
T Consensus       282 ~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         282 LRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             HhcCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            4589999999999999999999999999998665543

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.46  E-value=3.7e-06  Score=67.04  Aligned_cols=71  Identities=13%  Similarity=0.084  Sum_probs=47.0

Q ss_pred             ccccccCc-eEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-CCCeeeeeceecCCCCCCCccEEEEE
Q 024959           48 RPIGRGAY-GIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDVYIVY  125 (260)
Q Consensus        48 ~~lg~G~~-g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~~~~~~lv~  125 (260)
                      ..|..|.. +.||++...  +..+++|......     .....+|+++++.+. +--+++++++....     ...++||
T Consensus         4 ~~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~-----~~~~lv~   71 (244)
T cd05150           4 ERVTEGQSGATVYRLDGK--NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDD-----GRAWLLT   71 (244)
T ss_pred             eecCCCCCcCeEEEEcCC--CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecC-----CccEEEE
Confidence            34555555 779999654  3678889885532     234567888888884 33355666666543     3468999


Q ss_pred             ecCCc
Q 024959          126 ELMDT  130 (260)
Q Consensus       126 e~~~~  130 (260)
                      |+++|
T Consensus        72 e~i~G   76 (244)
T cd05150          72 SAVPG   76 (244)
T ss_pred             EeeCC
Confidence            99986

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.45  E-value=3.1e-06  Score=66.72  Aligned_cols=76  Identities=20%  Similarity=0.214  Sum_probs=50.8

Q ss_pred             cccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCC--CeeeeeceecCCCCCCCccEEEE
Q 024959           47 IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE--NVIAIKDIIRPPKKDTFNDVYIV  124 (260)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~iv~~~~~~~~~~~~~~~~~~lv  124 (260)
                      +++++.|..+.||++....  ..+++|.....    .....+.+|..+++.+...  -+++++........  ....+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~--~~~~~~~   73 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEF--NGFPYLL   73 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEE--TSEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccc--cccceEE
Confidence            4678889999999998776  38999998543    3455667888888888533  24555553322211  1347899


Q ss_pred             EecCCc
Q 024959          125 YELMDT  130 (260)
Q Consensus       125 ~e~~~~  130 (260)
                      |++++|
T Consensus        74 ~~~i~g   79 (239)
T PF01636_consen   74 MEYIPG   79 (239)
T ss_dssp             EEEESS
T ss_pred             EEEecc
Confidence            999986

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.42  E-value=4.3e-06  Score=72.89  Aligned_cols=143  Identities=17%  Similarity=0.250  Sum_probs=88.3

Q ss_pred             cccccccCceEEEEEEeCCCCeEEEEEecCCcccchH-----------------------------------HHHHHHHH
Q 024959           47 IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII-----------------------------------DARRTLRE   91 (260)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~-----------------------------------~~~~~~~e   91 (260)
                      -++||..+.|.|++++-+. |+.||||+-+.......                                   ..-+|.+|
T Consensus       166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E  244 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE  244 (538)
T ss_pred             cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence            3689999999999999877 89999998755422110                                   11223344


Q ss_pred             HHHHHHc----CCCC---eeeeeceecCCCCCCCccEEEEEecCCc---chHHHhhhCCCCCHHHHHHHHHHHHHHH-HH
Q 024959           92 IKLLRHM----EHEN---VIAIKDIIRPPKKDTFNDVYIVYELMDT---DLHQIIRSDQQLTDDHCQYFLYQLLRGL-KY  160 (260)
Q Consensus        92 ~~~l~~l----~~~~---iv~~~~~~~~~~~~~~~~~~lv~e~~~~---~l~~~l~~~~~~~~~~~~~~~~~i~~~l-~~  160 (260)
                      ++-..++    +|-+   -|.+-.++.+-.    ....++||||+|   +=.+.+.+. .++..   .++..+.++. +.
T Consensus       245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s----t~RVLtME~~~G~~i~Dl~~i~~~-gi~~~---~i~~~l~~~~~~q  316 (538)
T KOG1235|consen  245 AKNAERFRENFKDFSLLTYVLVPKVYWDLS----TKRVLTMEYVDGIKINDLDAIDKR-GISPH---DILNKLVEAYLEQ  316 (538)
T ss_pred             HHhHHHHHHHHHhcccccceeCCeehhhcC----cceEEEEEecCCccCCCHHHHHHc-CCCHH---HHHHHHHHHHHHH
Confidence            4444433    2334   122222322211    237899999996   222333333 34443   3444455543 33


Q ss_pred             HHhCCceeccCCCCCeEecc----CCCEEEeecccccccCCC
Q 024959          161 VHSASVLHRDLKPSNLLLNA----SCDLKIGDFGLARTTSET  198 (260)
Q Consensus       161 lh~~~i~H~di~~~nili~~----~~~~~l~df~~~~~~~~~  198 (260)
                      |=..|++|+|=.|.||++..    ++.+.+.|||+.....+.
T Consensus       317 If~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  317 IFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             HHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence            34678999999999999984    577999999998765543

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.41  E-value=4.6e-06  Score=61.78  Aligned_cols=138  Identities=20%  Similarity=0.189  Sum_probs=94.7

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeee-eeceecCCCC
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA-IKDIIRPPKK  115 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~-~~~~~~~~~~  115 (260)
                      ++....-.+..+.|++|.+|.||++....  ..+++|+-..+.    ....+..|+++|..++-.++.+ +|.+-.    
T Consensus        17 ~~~~~~~~~v~~~L~KG~~s~Vyl~~~~~--~~~a~Kvrr~ds----~r~~l~kEakiLeil~g~~~~p~vy~yg~----   86 (201)
T COG2112          17 VEEGKYELRVEKELAKGTTSVVYLGEWRG--GEVALKVRRRDS----PRRNLEKEAKILEILAGEGVTPEVYFYGE----   86 (201)
T ss_pred             eeccchhhhhhhhhhcccccEEEEeeccC--ceEEEEEecCCc----chhhHHHHHHHHHHhhhcCCCceEEEech----
Confidence            34444445677889999999999997754  478899885543    3455778999999998665554 443332    


Q ss_pred             CCCccEEEEEecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCC-CCCeEeccCCCEEEeeccccc
Q 024959          116 DTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK-PSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       116 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~-~~nili~~~~~~~l~df~~~~  193 (260)
                           .++.|||..| .|.+.....   +    +.-+..+++..--|-..||-|+.|+ |...++-.++.+.|+||.-+.
T Consensus        87 -----~~i~me~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At  154 (201)
T COG2112          87 -----DFIRMEYIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT  154 (201)
T ss_pred             -----hhhhhhhhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence                 2466999997 666653321   2    2334556777677788999999997 444444455589999999887


Q ss_pred             ccC
Q 024959          194 TTS  196 (260)
Q Consensus       194 ~~~  196 (260)
                      ...
T Consensus       155 ~k~  157 (201)
T COG2112         155 FKK  157 (201)
T ss_pred             hcc
Confidence            433

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=98.35  E-value=3e-06  Score=69.84  Aligned_cols=146  Identities=18%  Similarity=0.195  Sum_probs=104.3

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc---------------------cc-h--HHHHHHHHHHHHHHHcC
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF---------------------DN-I--IDARRTLREIKLLRHME   99 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~---------------------~~-~--~~~~~~~~e~~~l~~l~   99 (260)
                      .++-.+|..|.-+.||.+... +|..+|||+++-..                     .. +  ...-=..+|++-|+++.
T Consensus       146 ~~inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~  224 (520)
T KOG2270|consen  146 VEINGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLN  224 (520)
T ss_pred             eecccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHH
Confidence            356778999999999999764 56779999873321                     10 1  11111246888888887


Q ss_pred             CCCeeeeeceecCCCCCCCccEEEEEecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCCeE
Q 024959          100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH-SASVLHRDLKPSNLL  177 (260)
Q Consensus       100 ~~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~i~H~di~~~nil  177 (260)
                      ...|+-.-.+...+       -.|||+++++ .+..=..+...++...+..+-.+++.-+.-|. .+++||.||+--|+|
T Consensus       225 ~aGIP~PePIlLk~-------hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~L  297 (520)
T KOG2270|consen  225 NAGIPCPEPILLKN-------HVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLL  297 (520)
T ss_pred             hcCCCCCCceeeec-------ceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhhe
Confidence            76655444444333       4799999984 33222334556778888888888988888885 679999999999999


Q ss_pred             eccCCCEEEeecccccccCCC
Q 024959          178 LNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       178 i~~~~~~~l~df~~~~~~~~~  198 (260)
                      +. +|.+.++|.+.+...+++
T Consensus       298 yh-dG~lyiIDVSQSVE~DHP  317 (520)
T KOG2270|consen  298 YH-DGKLYIIDVSQSVEHDHP  317 (520)
T ss_pred             EE-CCEEEEEEccccccCCCh
Confidence            85 468999999988766655

>PLN02876 acyl-CoA dehydrogenase

Probab=98.32  E-value=1.2e-05  Score=75.04  Aligned_cols=82  Identities=13%  Similarity=0.193  Sum_probs=55.8

Q ss_pred             cccccccCceEEEEEEeCCCC--eEEEEEecCCcccchHHHHHHHHHHHHHHHcC-CCCe--eeeeceecCCCCCCCccE
Q 024959           47 IRPIGRGAYGIVCAAVNSETR--EEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENV--IAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~~--~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i--v~~~~~~~~~~~~~~~~~  121 (260)
                      ++.++.|..+.+|++.....+  ..+++|+...... ......+.+|+++++.+. |+++  ++++.++.+...  ....
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~-~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v--~G~~  119 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL-LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV--IGTA  119 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc-CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc--CCCc
Confidence            577888999999998765432  4678887644321 112356779999999995 6665  666766655321  1347


Q ss_pred             EEEEecCCcc
Q 024959          122 YIVYELMDTD  131 (260)
Q Consensus       122 ~lv~e~~~~~  131 (260)
                      |+|||+++|.
T Consensus       120 flVME~v~G~  129 (822)
T PLN02876        120 FYIMEYLEGR  129 (822)
T ss_pred             eEEEEecCCc
Confidence            8999999863

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.28  E-value=1.2e-05  Score=63.85  Aligned_cols=31  Identities=32%  Similarity=0.404  Sum_probs=26.0

Q ss_pred             CceeccCCCCCeEeccCCCEEEeeccccccc
Q 024959          165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (260)
Q Consensus       165 ~i~H~di~~~nili~~~~~~~l~df~~~~~~  195 (260)
                      .++|+|+.+.||++++++..-|+||+.+...
T Consensus       165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~g  195 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGVG  195 (235)
T ss_pred             eEEeCCCCCCcEEEECCCEEEEEeCcccCcC
Confidence            4899999999999987655679999987544

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.28  E-value=4e-05  Score=58.84  Aligned_cols=132  Identities=17%  Similarity=0.251  Sum_probs=90.1

Q ss_pred             cccccccCceEEEEEEeCCCCeEEEEEecCCcc--------------cchHHHHHHHHHHHHHHHcC------CCCeeee
Q 024959           47 IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF--------------DNIIDARRTLREIKLLRHME------HENVIAI  106 (260)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~--------------~~~~~~~~~~~e~~~l~~l~------~~~iv~~  106 (260)
                      ..+||+|+.-.+|.-  +.+ ...+||+.....              .......+..+|+.-...+.      +.+|.++
T Consensus         6 ~~~i~~G~~R~cy~H--P~d-p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQH--PDD-PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEEC--CCC-CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            456999999999865  444 357899886653              00112344555665555554      7899999


Q ss_pred             eceecCCCCCCCccEEEEEecCC-------cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec
Q 024959          107 KDIIRPPKKDTFNDVYIVYELMD-------TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN  179 (260)
Q Consensus       107 ~~~~~~~~~~~~~~~~lv~e~~~-------~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~  179 (260)
                      +|+.+.+.     ..-+|+|.+.       .+|.+++.. +.++.    .+...+-+...+|-..+|+.+|++|.||++.
T Consensus        83 ~G~veT~~-----G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   83 YGFVETNL-----GLGLVVELIRDADGNISPTLEDYLKE-GGLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQ  152 (199)
T ss_pred             eEEEecCC-----ceEEEEEEEECCCCCcCccHHHHHHc-CCccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEE
Confidence            99998873     4667777753       267887744 34555    3334455667788899999999999999995


Q ss_pred             cC--C--CEEEee-ccc
Q 024959          180 AS--C--DLKIGD-FGL  191 (260)
Q Consensus       180 ~~--~--~~~l~d-f~~  191 (260)
                      ..  +  .+.|+| ||.
T Consensus       153 ~~~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  153 RRDSGEFRLVLIDGLGE  169 (199)
T ss_pred             ecCCCceEEEEEeCCCC
Confidence            43  2  477777 553

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.13  E-value=1.3e-05  Score=61.06  Aligned_cols=95  Identities=20%  Similarity=0.130  Sum_probs=76.3

Q ss_pred             HHHHHHHHcCC-CCeeeeeceecCCCCCCCccEEEEEecCC-cchHH---HhhhCCCCCHHHHHHHHHHHHHHHHHHHh-
Q 024959           90 REIKLLRHMEH-ENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQ---IIRSDQQLTDDHCQYFLYQLLRGLKYVHS-  163 (260)
Q Consensus        90 ~e~~~l~~l~~-~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~---~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-  163 (260)
                      .|.-+++.+.+ +++++++|.|..         ++++|+.+ +++..   .+......++..+..++.++++.+++++. 
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~---------~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~   78 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR---------FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHG   78 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC---------EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC
Confidence            57888888875 699999999954         46889988 34432   12223356899999999999999999986 


Q ss_pred             --CCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          164 --ASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       164 --~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                        ..+.-.|++++|+.++.+++++++|...+.
T Consensus        79 ~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~  110 (188)
T PF12260_consen   79 PLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVF  110 (188)
T ss_pred             CCCcEEEeecchHHeEEeCCCcEEEEechhcc
Confidence              347779999999999999999999999764

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=98.10  E-value=0.00011  Score=62.40  Aligned_cols=77  Identities=18%  Similarity=0.177  Sum_probs=52.9

Q ss_pred             cccccccCceEEEEEEeCCCCeEEEEEecCCcc----cc-hHHHHHHHHHHHHHHHcC---CCCeeeeeceecCCCCCCC
Q 024959           47 IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF----DN-IIDARRTLREIKLLRHME---HENVIAIKDIIRPPKKDTF  118 (260)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~----~~-~~~~~~~~~e~~~l~~l~---~~~iv~~~~~~~~~~~~~~  118 (260)
                      .+.||.|....||++.....++.++||.-....    .. +....+...|.+.|+.+.   -.++++++.+-.+.     
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~~~-----  105 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDEEL-----  105 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECCCC-----
Confidence            467999999999999986544689999853111    11 123455667788888763   34577777775433     


Q ss_pred             ccEEEEEecCCc
Q 024959          119 NDVYIVYELMDT  130 (260)
Q Consensus       119 ~~~~lv~e~~~~  130 (260)
                        .++|||++++
T Consensus       106 --~~lVME~L~~  115 (401)
T PRK09550        106 --AVTVMEDLSD  115 (401)
T ss_pred             --CEEEEecCCC
Confidence              5799999874

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=98.05  E-value=1.3e-05  Score=65.17  Aligned_cols=139  Identities=17%  Similarity=0.160  Sum_probs=93.2

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCc--------------------ccchHHHHHHHHHHHHHHHcCCCC-
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNA--------------------FDNIIDARRTLREIKLLRHMEHEN-  102 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~--------------------~~~~~~~~~~~~e~~~l~~l~~~~-  102 (260)
                      +.++..||-|.-+.+|.+-+.. |...++|.-...                    ..-....-...+|...|+.|.... 
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            4678899999999999998764 567788753111                    011112233457888888885221 


Q ss_pred             -eeeeeceecCCCCCCCccEEEEEecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecc
Q 024959          103 -VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA  180 (260)
Q Consensus       103 -iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~  180 (260)
                       +++.+++         +.-++|||.+.+ .|.+.-.-   ..   +..+...+...+--|-..|++|+|.+-=||++++
T Consensus       173 pVPkpiD~---------~RH~Vvmelv~g~Pl~~v~~v---~d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~d  237 (465)
T KOG2268|consen  173 PVPKPIDH---------NRHCVVMELVDGYPLRQVRHV---ED---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKD  237 (465)
T ss_pred             CCCCcccc---------cceeeHHHhhcccceeeeeec---CC---hHHHHHHHHHHHHHHHHcCceecccchheeEEec
Confidence             2233333         345799999885 44443211   11   2234455666677788899999999999999999


Q ss_pred             CCCEEEeecccccccCCC
Q 024959          181 SCDLKIGDFGLARTTSET  198 (260)
Q Consensus       181 ~~~~~l~df~~~~~~~~~  198 (260)
                      ++.++++||..+....+.
T Consensus       238 d~~i~vIDFPQmvS~sh~  255 (465)
T KOG2268|consen  238 DDKIVVIDFPQMVSTSHP  255 (465)
T ss_pred             CCCEEEeechHhhccCCC
Confidence            999999999987665544

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.02  E-value=7.6e-05  Score=57.03  Aligned_cols=134  Identities=20%  Similarity=0.200  Sum_probs=89.3

Q ss_pred             ccccCCCcccccccCc-eEEEEEEeCCCCeEEEEEecCC---cc--------cc-h-------HHHHHHHHHHHHHHHc-
Q 024959           40 SSKYVPPIRPIGRGAY-GIVCAAVNSETREEVAIKKIGN---AF--------DN-I-------IDARRTLREIKLLRHM-   98 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~-g~vy~~~~~~~~~~~~iK~~~~---~~--------~~-~-------~~~~~~~~e~~~l~~l-   98 (260)
                      -...++.++.||.|.. |.||++.-.  |+.||+|++..   ..        .. .       .....|..|-+..-+| 
T Consensus        35 h~~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLk  112 (207)
T PF13095_consen   35 HGDDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLK  112 (207)
T ss_pred             CCCcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHH
Confidence            3367778899999999 999999654  67999999311   10        00 0       1223455555544444 


Q ss_pred             --CCCCe--eeeeceecCCC-C------------CCCccEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHH
Q 024959           99 --EHENV--IAIKDIIRPPK-K------------DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV  161 (260)
Q Consensus        99 --~~~~i--v~~~~~~~~~~-~------------~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~l  161 (260)
                        .+.++  ++.+++..-.. .            .......||-|+....-        .+...    -+.+|.+-+..+
T Consensus       113 e~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~~~~----~~~~~~~dl~~~  180 (207)
T PF13095_consen  113 EAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PLQIR----DIPQMLRDLKIL  180 (207)
T ss_pred             hccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------ccchh----HHHHHHHHHHHH
Confidence              56677  89999885431 0            11134678888776432        23333    345677778889


Q ss_pred             HhCCceeccCCCCCeEeccCCCEEEeecccc
Q 024959          162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (260)
Q Consensus       162 h~~~i~H~di~~~nili~~~~~~~l~df~~~  192 (260)
                      |..||+-+|+++.|..     .-+|+||+.+
T Consensus       181 ~k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  181 HKLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHCCeeeccCcccccc-----CCEEEecccC
Confidence            9999999999999997     3488999853

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.01  E-value=5.2e-05  Score=60.91  Aligned_cols=135  Identities=15%  Similarity=0.184  Sum_probs=75.5

Q ss_pred             cccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCe-eeeeceecCCCCCCCccEEEEEec
Q 024959           49 PIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV-IAIKDIIRPPKKDTFNDVYIVYEL  127 (260)
Q Consensus        49 ~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-v~~~~~~~~~~~~~~~~~~lv~e~  127 (260)
                      .+..|-.+.+|++.  .++..+++|.........  .-...+|.++++.+....+ ++++....         -++|+|+
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~i~~~~---------~~~v~e~   69 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL--GVDRQREYQILQALSALGLAPKPILVNE---------HWLLVEW   69 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCcccccc--cCcHHHHHHHHHHHHhcCCCCceEEEeC---------CEEEEEe
Confidence            45668888999986  445688899865432111  0124568888888853333 33443321         2589999


Q ss_pred             CCcc-hH--------------HHhhh-------CCCCCHH-HHHHHHHHH---------HHHHHHHHh--------CCce
Q 024959          128 MDTD-LH--------------QIIRS-------DQQLTDD-HCQYFLYQL---------LRGLKYVHS--------ASVL  167 (260)
Q Consensus       128 ~~~~-l~--------------~~l~~-------~~~~~~~-~~~~~~~~i---------~~~l~~lh~--------~~i~  167 (260)
                      ++|. +.              +.+.+       ..+++.. .+..+..++         ...+..+-.        ..++
T Consensus        70 i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  149 (256)
T TIGR02721        70 LEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPL  149 (256)
T ss_pred             ccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeee
Confidence            8862 21              11111       1112211 111211111         112222221        2489


Q ss_pred             eccCCCCCeEeccCCCEEEeecccccccCC
Q 024959          168 HRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (260)
Q Consensus       168 H~di~~~nili~~~~~~~l~df~~~~~~~~  197 (260)
                      |+|+.|.||++++++ +.|+||+.+.....
T Consensus       150 H~Dl~~~Nil~~~~~-~~lIDwE~a~~gdp  178 (256)
T TIGR02721       150 HMDVHAYNLVVTPQG-LKLIDWEYASDGDI  178 (256)
T ss_pred             cCCCCcCcEEEeCCC-CEEEeccccCcCCH
Confidence            999999999999877 78999998865443

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.95  E-value=0.00016  Score=57.29  Aligned_cols=72  Identities=14%  Similarity=0.264  Sum_probs=44.7

Q ss_pred             cccccccCceEEEEEEeCC-CCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCC-eeeeeceecCCCCCCCccEEEE
Q 024959           47 IRPIGRGAYGIVCAAVNSE-TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN-VIAIKDIIRPPKKDTFNDVYIV  124 (260)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-iv~~~~~~~~~~~~~~~~~~lv  124 (260)
                      ++.|..|-...+|++.... ++..|++|+......   ...+..+|+.+++.+...+ .++++.... .        .++
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~--------~~l   70 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LIIDRERELRIHKLLSKHGLAPKLYATFQ-N--------GLI   70 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ceecHHHHHHHHHHHHhCCCCCeEEEEeC-C--------cEE
Confidence            4567778888999997553 346789998754311   1122346888888885333 334444332 1        379


Q ss_pred             EecCCc
Q 024959          125 YELMDT  130 (260)
Q Consensus       125 ~e~~~~  130 (260)
                      |||++|
T Consensus        71 ~e~i~G   76 (235)
T cd05157          71 YEFIPG   76 (235)
T ss_pred             EEeeCC
Confidence            999875

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.83  E-value=0.0002  Score=67.14  Aligned_cols=158  Identities=19%  Similarity=0.235  Sum_probs=114.1

Q ss_pred             HHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHh
Q 024959           85 ARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS  163 (260)
Q Consensus        85 ~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~  163 (260)
                      .....-|...+..+.|+|++.++.+-.+....+ -...+..+++. .++...+..-...+..+++.+..++.+++.++|+
T Consensus       226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~  304 (1351)
T KOG1035|consen  226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS  304 (1351)
T ss_pred             HHHHHHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH
Confidence            333445777888889999999999876654321 11224446666 4788888888889999999999999999999999


Q ss_pred             CCceeccCCCC---CeEeccCCCEEEe--ecccccccCCCcccccccccccccccccccCcCCCC--ChhhHHHHHHHHH
Q 024959          164 ASVLHRDLKPS---NLLLNASCDLKIG--DFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT--AAIDIWSVGCILG  236 (260)
Q Consensus       164 ~~i~H~di~~~---nili~~~~~~~l~--df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~--~~~Di~slG~~l~  236 (260)
                      ..+.|.-+...   +.-++..+.....  ||+.+.................+.+||.... +..+  ...|+|.+|....
T Consensus       305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~-~~~~~~r~~dL~~lgll~~  383 (1351)
T KOG1035|consen  305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKE-NTAKKSRLTDLWCLGLLLL  383 (1351)
T ss_pred             hccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCcccccccccccc-ccchhhhhhHHHHHHHHHh
Confidence            87666666655   4444555556555  8888877766655555555666777777655 3333  3479999999999


Q ss_pred             HHHhCCCC
Q 024959          237 EIMTREPL  244 (260)
Q Consensus       237 ~ll~g~~p  244 (260)
                      .+..|..+
T Consensus       384 ~~~~~~~i  391 (1351)
T KOG1035|consen  384 QLSQGEDI  391 (1351)
T ss_pred             hhhhcCcc
Confidence            99887654

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.83  E-value=0.00034  Score=57.46  Aligned_cols=142  Identities=15%  Similarity=0.048  Sum_probs=79.4

Q ss_pred             CcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCC--eeeeeceecCCCC-CCCccEE
Q 024959           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN--VIAIKDIIRPPKK-DTFNDVY  122 (260)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--iv~~~~~~~~~~~-~~~~~~~  122 (260)
                      -++.+..|....+|++...  +..+++|+....     .......|+++++.+...+  +++++........ ...+..+
T Consensus        18 ~i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~~-----~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~   90 (296)
T cd05153          18 SFEGISAGIENTNYFVTTD--SGRYVLTLFEKV-----SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA   90 (296)
T ss_pred             heecccCccccceEEEEeC--CCcEEEEEcCCC-----ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence            3567888888899998653  346899988541     1234556777777774322  3444332111100 0113468


Q ss_pred             EEEecCCcchH------------HHhhh----CCCC----------CHHHH----------HHHHHHHHHHHHHHHh---
Q 024959          123 IVYELMDTDLH------------QIIRS----DQQL----------TDDHC----------QYFLYQLLRGLKYVHS---  163 (260)
Q Consensus       123 lv~e~~~~~l~------------~~l~~----~~~~----------~~~~~----------~~~~~~i~~~l~~lh~---  163 (260)
                      +++++++|...            ..+..    ...+          .+...          ......+..++..+..   
T Consensus        91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~  170 (296)
T cd05153          91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP  170 (296)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence            99999975211            00000    0000          00000          0011112233344432   


Q ss_pred             ----CCceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          164 ----ASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       164 ----~~i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                          .+++|+|+.|.|+++++++.+.|+||+.+..
T Consensus       171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             hcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence                4699999999999999887778999998754

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.73  E-value=0.00052  Score=57.32  Aligned_cols=81  Identities=15%  Similarity=0.044  Sum_probs=51.4

Q ss_pred             cccccCceEEEEEEeCCCCeEEEEEecCCcc-----cchHHHHHHHHHHHHHHHcC--CC-CeeeeeceecCCCCCCCcc
Q 024959           49 PIGRGAYGIVCAAVNSETREEVAIKKIGNAF-----DNIIDARRTLREIKLLRHME--HE-NVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        49 ~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~-----~~~~~~~~~~~e~~~l~~l~--~~-~iv~~~~~~~~~~~~~~~~  120 (260)
                      .||.|...-||++.++..+..++||.-..-.     .-+....+..-|.+.|+...  .| .++++|.+-.+.       
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~e~-------   74 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDTEM-------   74 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEcccc-------
Confidence            5788999999999986544678988652111     11233445556777777764  44 555666665544       


Q ss_pred             EEEEEecCCc--chHHHh
Q 024959          121 VYIVYELMDT--DLHQII  136 (260)
Q Consensus       121 ~~lv~e~~~~--~l~~~l  136 (260)
                      ..+|||+++.  .|+..+
T Consensus        75 ~~~vMEdL~~~~ilR~~L   92 (370)
T TIGR01767        75 AVTVMEDLSHHKIARKGL   92 (370)
T ss_pred             ceehHhhCccchHHHHHH
Confidence            5689999863  444444

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.71  E-value=7.9e-06  Score=71.58  Aligned_cols=184  Identities=18%  Similarity=0.123  Sum_probs=127.8

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCC-eeeeeceecCCCCCCCccEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN-VIAIKDIIRPPKKDTFNDVY  122 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-iv~~~~~~~~~~~~~~~~~~  122 (260)
                      +...+-+++++++.+++.+...+...+ .+.+...       ....-++++|.+++||| .+..++-+..+     ...+
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E-----~~~~  310 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGE-----DYLW  310 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcc-----cccc
Confidence            445567789999999998766553333 4444221       22345788999999999 55555555444     5578


Q ss_pred             EEEecCCcc--hHHHhh-hCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc
Q 024959          123 IVYELMDTD--LHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (260)
Q Consensus       123 lv~e~~~~~--l~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~  199 (260)
                      +.++++.+.  ....+. ..-.+..-+...+.+.-++.++++|+..-+|+|    ||+..+ +..++.+|+.........
T Consensus       311 i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~  385 (829)
T KOG0576|consen  311 IPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM  385 (829)
T ss_pred             hhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc
Confidence            999988743  222111 122344455666777778899999988778888    666554 578999999887776665


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFP  246 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~  246 (260)
                      ...+..+++.+++||.... ..+....|.|+++.-..++.-|.+|-.
T Consensus       386 ~~~t~~~~~~~~~pev~~~-~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  386 KPRTAIGTPEPLAPEVIQE-NTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             ccccCCCCCCCCCchhhcc-cccccCCCccCCCcchhhcCCCCCCCC
Confidence            5666778999999998877 777888999999987667766666543

>PRK05231 homoserine kinase; Provisional

Probab=97.70  E-value=0.0021  Score=53.41  Aligned_cols=31  Identities=29%  Similarity=0.296  Sum_probs=26.3

Q ss_pred             CCceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          164 ASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       164 ~~i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                      .+++|+|+.+.||+++.+...-++||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            3799999999999998765568999998744

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.66  E-value=0.00067  Score=55.90  Aligned_cols=32  Identities=31%  Similarity=0.353  Sum_probs=27.7

Q ss_pred             CceeccCCCCCeEeccC----CCEEEeecccccccC
Q 024959          165 SVLHRDLKPSNLLLNAS----CDLKIGDFGLARTTS  196 (260)
Q Consensus       165 ~i~H~di~~~nili~~~----~~~~l~df~~~~~~~  196 (260)
                      .++|+|+.+.||+++.+    +.+.++||+++....
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~~  215 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYNY  215 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCCC
Confidence            58999999999999885    889999999986543

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.59  E-value=0.0028  Score=52.25  Aligned_cols=150  Identities=14%  Similarity=0.174  Sum_probs=85.3

Q ss_pred             CcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCee--eeeceecCCCCCCCccEEE
Q 024959           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI--AIKDIIRPPKKDTFNDVYI  123 (260)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv--~~~~~~~~~~~~~~~~~~l  123 (260)
                      +++.+..|--..+|.....  ++.++++ ............+..+|.+.++.+.---+.  +.++.+.+..   ....|.
T Consensus        29 ~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~---~g~pf~  102 (321)
T COG3173          29 IVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGY---LGTPFY  102 (321)
T ss_pred             eeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCC---CCCceE
Confidence            3444434444556666554  6788888 332223334556667788888887432333  3444444442   245689


Q ss_pred             EEecCCcc----------hH-HHhh--------h------------C--CCCCHHHHHHHHHHH--------------HH
Q 024959          124 VYELMDTD----------LH-QIIR--------S------------D--QQLTDDHCQYFLYQL--------------LR  156 (260)
Q Consensus       124 v~e~~~~~----------l~-~~l~--------~------------~--~~~~~~~~~~~~~~i--------------~~  156 (260)
                      ||++++|.          .. ++..        .            .  ......++..+..+.              ..
T Consensus       103 v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~  182 (321)
T COG3173         103 VMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADR  182 (321)
T ss_pred             EEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHH
Confidence            99998761          11 1111        0            0  001112222222222              22


Q ss_pred             HHHHHHhC--------CceeccCCCCCeEeccCCCEEEeecccccccCCCccc
Q 024959          157 GLKYVHSA--------SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  201 (260)
Q Consensus       157 ~l~~lh~~--------~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  201 (260)
                      ...+++.+        .++|||+++.|++++.++-+-++||+.+...+.....
T Consensus       183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~~Dl  235 (321)
T COG3173         183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPLEDL  235 (321)
T ss_pred             HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCcHHHH
Confidence            34555532        3899999999999999988999999999876655433

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.52  E-value=0.0009  Score=56.64  Aligned_cols=83  Identities=18%  Similarity=0.142  Sum_probs=53.1

Q ss_pred             cccccccCceEEEEEEeCCCCeEEEEEecCCc----ccchHHHHHHHHHHHHHHHcC--CC-CeeeeeceecCCCCCCCc
Q 024959           47 IRPIGRGAYGIVCAAVNSETREEVAIKKIGNA----FDNIIDARRTLREIKLLRHME--HE-NVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~~~e~~~l~~l~--~~-~iv~~~~~~~~~~~~~~~  119 (260)
                      .++||-|...-||++.+...+..++||.-..-    ..-+....+..-|.+.|+...  .| .++++|.+-.+.      
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~e~------  107 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDSVM------  107 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECcHH------
Confidence            67899999999999988543457888864211    111234455666778887764  45 556677665544      


Q ss_pred             cEEEEEecCCc--chHHHh
Q 024959          120 DVYIVYELMDT--DLHQII  136 (260)
Q Consensus       120 ~~~lv~e~~~~--~l~~~l  136 (260)
                       ..+|||+++.  .|++.+
T Consensus       108 -~~~vMEdL~~~~ilR~~L  125 (409)
T PRK12396        108 -NCCVMEDLSDHTILRTAL  125 (409)
T ss_pred             -hhHHHHhCcccHHHHHHH
Confidence             5688888863  344444

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.52  E-value=0.0027  Score=52.46  Aligned_cols=143  Identities=15%  Similarity=0.114  Sum_probs=78.1

Q ss_pred             CcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCC--eeeeeceecCCC-CCCCccEE
Q 024959           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN--VIAIKDIIRPPK-KDTFNDVY  122 (260)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--iv~~~~~~~~~~-~~~~~~~~  122 (260)
                      .++.++.|....+|++...  +..+++|+..... .   ......|.++++.|...+  +++++....... ....+..+
T Consensus        26 ~i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~-~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~   99 (307)
T TIGR00938        26 SLKGIAEGVENSNYLLTTD--VGRYILTLYEKRV-K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA   99 (307)
T ss_pred             eccccCCccccceEEEEeC--CCcEEEEEecCCC-C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence            4677888888899998643  3368889875421 1   223445666776664222  334333221110 00114578


Q ss_pred             EEEecCCcc-h----HHH-------hhh----CCCCC-------HHHHH----------------HHHHHHHHHHHHHH-
Q 024959          123 IVYELMDTD-L----HQI-------IRS----DQQLT-------DDHCQ----------------YFLYQLLRGLKYVH-  162 (260)
Q Consensus       123 lv~e~~~~~-l----~~~-------l~~----~~~~~-------~~~~~----------------~~~~~i~~~l~~lh-  162 (260)
                      +++++++|. +    ...       +..    ...++       ....+                .....+.+.++++. 
T Consensus       100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~  179 (307)
T TIGR00938       100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK  179 (307)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence            999998762 1    111       100    00000       00000                00111223444443 


Q ss_pred             ------hCCceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          163 ------SASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       163 ------~~~i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                            ..+++|+|+.+.|++++.++...++||+.+..
T Consensus       180 ~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       180 FWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             hhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence                  25799999999999999887678999998744

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.35  E-value=0.0035  Score=52.41  Aligned_cols=30  Identities=33%  Similarity=0.433  Sum_probs=26.1

Q ss_pred             ceeccCCCCCeEecc-CCCEEEeeccccccc
Q 024959          166 VLHRDLKPSNLLLNA-SCDLKIGDFGLARTT  195 (260)
Q Consensus       166 i~H~di~~~nili~~-~~~~~l~df~~~~~~  195 (260)
                      ++|+|+.+.||++++ ++.++++||+++-..
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~n  214 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS  214 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence            899999999999975 478999999998543

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.35  E-value=0.004  Score=50.64  Aligned_cols=33  Identities=21%  Similarity=0.434  Sum_probs=26.9

Q ss_pred             CceeccCCCCCeEeccCCC-EEEeecccccccCC
Q 024959          165 SVLHRDLKPSNLLLNASCD-LKIGDFGLARTTSE  197 (260)
Q Consensus       165 ~i~H~di~~~nili~~~~~-~~l~df~~~~~~~~  197 (260)
                      .++|+|+++.||+++.++. .-|+||+.+...+.
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGDP  219 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVGDP  219 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccCCH
Confidence            4899999999999997555 46999998866543

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=97.30  E-value=0.002  Score=53.62  Aligned_cols=71  Identities=20%  Similarity=0.314  Sum_probs=58.5

Q ss_pred             ccEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          119 NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       119 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                      ...|++|++-++.+...-    .-..+++..++.+.+..+.-+..+ ..-|+|+...||+|+ +|++.|+||.+++.
T Consensus       299 ~y~yl~~kdhgt~is~ik----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl  370 (488)
T COG5072         299 LYLYLHFKDHGTPISIIK----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL  370 (488)
T ss_pred             eEEEEEEecCCceeeeee----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence            457889998887654431    234677888999999999988865 799999999999999 99999999999974

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.28  E-value=0.0062  Score=51.95  Aligned_cols=76  Identities=20%  Similarity=0.239  Sum_probs=50.6

Q ss_pred             CcccccccCceEEEEEEeCCCCeEEEEEecCCccc--ch---HHHHHHHHHHHHHHHcC---CCCeeeeeceecCCCCCC
Q 024959           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD--NI---IDARRTLREIKLLRHME---HENVIAIKDIIRPPKKDT  117 (260)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~--~~---~~~~~~~~e~~~l~~l~---~~~iv~~~~~~~~~~~~~  117 (260)
                      -.+.||.|....||++.+.  +..++||.-.....  ..   ....+...|.+.|+.+.   ...+++++.++.+.    
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~----  109 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM----  109 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC----
Confidence            4677899999999999874  34688987642111  00   12344445566666664   24788888888755    


Q ss_pred             CccEEEEEecCCc
Q 024959          118 FNDVYIVYELMDT  130 (260)
Q Consensus       118 ~~~~~lv~e~~~~  130 (260)
                         .+++||++++
T Consensus       110 ---~vlvME~L~~  119 (418)
T PLN02756        110 ---ALIGMRYLEP  119 (418)
T ss_pred             ---CEEEEeecCC
Confidence               5788999965

>PLN02236 choline kinase

Probab=97.19  E-value=0.0092  Score=50.17  Aligned_cols=139  Identities=17%  Similarity=0.205  Sum_probs=77.4

Q ss_pred             CcccccccCceEEEEEEeCC----CCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCee-eeeceecCCCCCCCcc
Q 024959           46 PIRPIGRGAYGIVCAAVNSE----TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-AIKDIIRPPKKDTFND  120 (260)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv-~~~~~~~~~~~~~~~~  120 (260)
                      -++++..|-...+|++....    .++.+++|+......  .... ...|..+++.+...++. ++++.+...       
T Consensus        40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~--~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g-------  109 (344)
T PLN02236         40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE--LFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG-------  109 (344)
T ss_pred             EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC--eeec-hHHHHHHHHHHHHcCCCCceEEEECCc-------
Confidence            34566568889999986432    246799998865321  1112 25678888887533333 455555322       


Q ss_pred             EEEEEecCCc-chH-----------HH---hhh----C---C--CCCHHHHHHHHHHH-----------------HHHHH
Q 024959          121 VYIVYELMDT-DLH-----------QI---IRS----D---Q--QLTDDHCQYFLYQL-----------------LRGLK  159 (260)
Q Consensus       121 ~~lv~e~~~~-~l~-----------~~---l~~----~---~--~~~~~~~~~~~~~i-----------------~~~l~  159 (260)
                        .|.+|+++ ++.           ..   +.+    .   .  ......+..++.++                 ...+.
T Consensus       110 --~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~  187 (344)
T PLN02236        110 --RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEIN  187 (344)
T ss_pred             --eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHH
Confidence              46777764 221           00   110    0   0  01122232332221                 11122


Q ss_pred             HHH--------hCCceeccCCCCCeEecc-CCCEEEeecccccccC
Q 024959          160 YVH--------SASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTS  196 (260)
Q Consensus       160 ~lh--------~~~i~H~di~~~nili~~-~~~~~l~df~~~~~~~  196 (260)
                      .|.        ...++|+|+++.||++++ ++.+.++||.++....
T Consensus       188 ~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~~  233 (344)
T PLN02236        188 LLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYNP  233 (344)
T ss_pred             HHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccccc
Confidence            221        225899999999999986 4679999999886543

>KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=97.15  E-value=0.00098  Score=54.57  Aligned_cols=142  Identities=20%  Similarity=0.210  Sum_probs=94.0

Q ss_pred             CCcccccccCceEEEEEEe-------CC---CCeEEEEEecCCcccchHHH----------------------HHH--HH
Q 024959           45 PPIRPIGRGAYGIVCAAVN-------SE---TREEVAIKKIGNAFDNIIDA----------------------RRT--LR   90 (260)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~-------~~---~~~~~~iK~~~~~~~~~~~~----------------------~~~--~~   90 (260)
                      .|-..|..|.-+.|+.+.-       ..   ....+|||+++-........                      ...  .+
T Consensus       255 ~i~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEk  334 (531)
T KOG2269|consen  255 SIDGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEK  334 (531)
T ss_pred             hhhhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHHHH
Confidence            4566788999999999943       11   34468899874331111111                      111  12


Q ss_pred             HHHHHHHc-----CCCCeeeeeceecCCCCCCCccEEEEEecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHH-h
Q 024959           91 EIKLLRHM-----EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH-S  163 (260)
Q Consensus        91 e~~~l~~l-----~~~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh-~  163 (260)
                      |..-|.++     .+|-+|.+.-            -.+||-+++. .+.-=-.++..++..+.+..-.|+..++..|. .
T Consensus       335 EmhNL~RMq~~GlpcP~vV~lkk------------hvLVMsFiGd~~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY~E  402 (531)
T KOG2269|consen  335 EMHNLSRMQKHGLPCPQVVKLKK------------HVLVMSFIGDQGLAAPKLKNVELTDDERRNAYDQVQSIMCRLYKE  402 (531)
T ss_pred             HHHHHHHHHhcCCCCCceeeeec------------ceEEEEeecCCCCCCccccccccChHHHHHHHHHHHHHHHHHHHh
Confidence            33334443     2566666544            3589999883 22222234456888888888899999888874 7


Q ss_pred             CCceeccCCCCCeEeccCCCEEEeecccccccCCCc
Q 024959          164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (260)
Q Consensus       164 ~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~  199 (260)
                      +-++|.|++--|+|...+ .+.++|...+....++.
T Consensus       403 c~LVHADlSEyN~Lw~~g-Kvw~IDVsQsvep~HP~  437 (531)
T KOG2269|consen  403 CLLVHADLSEYNLLWTPG-KVWVIDVSQSVEPSHPR  437 (531)
T ss_pred             hheeecchhhhhheecCC-ceEEEechhccCCCCcc
Confidence            789999999999999876 89999999876655553

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.91  E-value=0.00021  Score=68.86  Aligned_cols=153  Identities=18%  Similarity=0.151  Sum_probs=106.6

Q ss_pred             HHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEEEEecCC-cchHHHhhhC----CCCCHHHHHHHHHHHHHHHHHHHh
Q 024959           89 LREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----QQLTDDHCQYFLYQLLRGLKYVHS  163 (260)
Q Consensus        89 ~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lh~  163 (260)
                      ..|..-++...|+++...+.-+.....   ...+..++++. |.+.+.+-++    ..+...-+.....+.+.....+|.
T Consensus      1277 l~e~de~~~~~h~~~~~~p~rI~ps~s---~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSES---TEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred             hhhhhhhhhhhceeeecccccCCCCCC---hHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence            345555556689998887776655433   34677888876 6777777653    334444444444443555555553


Q ss_pred             C-----CceeccCCCCCeEeccCCCEEEeeccccc-ccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHH
Q 024959          164 A-----SVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE  237 (260)
Q Consensus       164 ~-----~i~H~di~~~nili~~~~~~~l~df~~~~-~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~  237 (260)
                      .     --+|.++++.|.+|..+..+++.++|+.+ ............+++.|+.|+.... -.++.++|+|..++.+|.
T Consensus      1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred             cccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHHHH
Confidence            2     27899999999999999999999999998 3333333344566777888877654 556777999999999999


Q ss_pred             HHhCCCCC
Q 024959          238 IMTREPLF  245 (260)
Q Consensus       238 ll~g~~pf  245 (260)
                      ...|..+|
T Consensus      1433 rs~~n~~f 1440 (2724)
T KOG1826|consen 1433 RSDGNAYF 1440 (2724)
T ss_pred             HhcccHHH
Confidence            88887776

>PRK10593 hypothetical protein; Provisional

Probab=96.85  E-value=0.011  Score=48.58  Aligned_cols=79  Identities=9%  Similarity=0.050  Sum_probs=53.9

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCC---CCeeeeeceecCCCCCCCcc
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH---ENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~---~~iv~~~~~~~~~~~~~~~~  120 (260)
                      ..-.+.|+.|..+.||.......  .+++|..+..    .....+..|++.|+.+.-   -.++++++++..+..  .+.
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~~~--~~~~k~~~~~----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~--~g~   87 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDSQG--NPMPLMARSF----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQS--PGP   87 (297)
T ss_pred             hheeeecCCccceeEEEEEcCCC--CEEEEEeccc----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCc--CCC
Confidence            34467899999999999965432  5777876431    112467789999998853   356777776654321  144


Q ss_pred             EEEEEecCCc
Q 024959          121 VYIVYELMDT  130 (260)
Q Consensus       121 ~~lv~e~~~~  130 (260)
                      .++|||++++
T Consensus        88 ~~LVmE~i~G   97 (297)
T PRK10593         88 DVLLLERLRG   97 (297)
T ss_pred             eEEEEeccCC
Confidence            7999999986

>PTZ00384 choline kinase; Provisional

Probab=96.85  E-value=0.024  Score=48.29  Aligned_cols=30  Identities=27%  Similarity=0.192  Sum_probs=25.1

Q ss_pred             CCceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          164 ASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       164 ~~i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                      ..++|+|+.+.||+.++ +.+.++||.++..
T Consensus       227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~~  256 (383)
T PTZ00384        227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAGF  256 (383)
T ss_pred             eeeeeccCCcccEEecC-CCEEEEEeccccC
Confidence            46899999999998754 4699999998853

>PTZ00296 choline kinase; Provisional

Probab=96.66  E-value=0.045  Score=47.62  Aligned_cols=29  Identities=24%  Similarity=0.370  Sum_probs=24.6

Q ss_pred             CceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          165 SVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       165 ~i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                      .++|+|+.+.||+.+.+ .+.|+||.++-.
T Consensus       285 VfCHNDl~~~NiL~~~~-~l~LIDfEYAg~  313 (442)
T PTZ00296        285 VFCHNDLQENNIINTNK-CLRLIDFEYSGY  313 (442)
T ss_pred             eEEeCCCCccceeecCC-CEEEEeeccccc
Confidence            48999999999987654 499999998854

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.37  E-value=0.018  Score=47.10  Aligned_cols=73  Identities=12%  Similarity=0.105  Sum_probs=45.3

Q ss_pred             CCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC---CCCeeeeeceecCCCCCCCccE
Q 024959           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME---HENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      +-.+.++.|..+.+|++.  .++..+++|+-....     ...+..|++-|+.|.   .-.+++++++....     +..
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~-----~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~-----~~~   87 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG-----RDMFEGEAEGLKALAEANPIRVPKVIAWGEYD-----DDA   87 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG-----CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S-----SCC
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecChhh-----HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec-----CCc
Confidence            345778889999999996  667789999986321     234667888888883   34566777776554     235


Q ss_pred             EEEEecCC
Q 024959          122 YIVYELMD  129 (260)
Q Consensus       122 ~lv~e~~~  129 (260)
                      ++++|+++
T Consensus        88 fLlle~l~   95 (288)
T PF03881_consen   88 FLLLEFLE   95 (288)
T ss_dssp             EEEEE---
T ss_pred             eEEEEeec
Confidence            89999976

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.34  E-value=0.06  Score=42.19  Aligned_cols=73  Identities=12%  Similarity=0.104  Sum_probs=47.7

Q ss_pred             CCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCC---eeeeeceecCCCCCCCccE
Q 024959           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN---VIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~---iv~~~~~~~~~~~~~~~~~  121 (260)
                      ...+.+..|.-...|.+.+-  ..++.+|+-...     ....|..|+.-|+.+.-.|   +.+++.+-...     ...
T Consensus        19 ~er~~v~gG~inea~~v~dg--~~~~FvK~n~~~-----~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~-----~~s   86 (286)
T COG3001          19 KEREEVSGGDINEAWRLRDG--TDPFFVKCNQRE-----QLSMFTAEADGLELLARSNTITVPKVIAVGASR-----DHS   86 (286)
T ss_pred             hcccccCCccccceeEeecC--CcceEEEecchh-----hHHHHHHHHHHHHHHHhcCCccccceEEecCCC-----Cee
Confidence            34456666666777777553  357899987432     4456777888777775444   44555554444     558


Q ss_pred             EEEEecCC
Q 024959          122 YIVYELMD  129 (260)
Q Consensus       122 ~lv~e~~~  129 (260)
                      |+|+||++
T Consensus        87 ylVle~L~   94 (286)
T COG3001          87 YLVLEYLP   94 (286)
T ss_pred             EEEEeecc
Confidence            99999987

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.31  E-value=0.016  Score=50.61  Aligned_cols=118  Identities=24%  Similarity=0.386  Sum_probs=76.5

Q ss_pred             HHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 024959           86 RRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS  165 (260)
Q Consensus        86 ~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~  165 (260)
                      .+++-...+++.+.|+|...++++.....    ....+|+|+++-++.+.+..+. +-.....                 
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~----~r~IVV~e~~~~Sled~~~~~~-l~~~s~~-----------------   84 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKH----ERVIVVMEHYTMSLEDILKTGN-LKDESLL-----------------   84 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCcc----ceEEEEehhhccchHHHHHhcc-cchhhhc-----------------
Confidence            44566778899999999999999887653    3488999999999999887655 3222111                 


Q ss_pred             ceeccCCCCCeEeccCCCEEEeecccccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCC
Q 024959          166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF  245 (260)
Q Consensus       166 i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf  245 (260)
                       +|+=+. .|+       +..+| .++..               +  |      .+..+++|||++|.++.++.-|...+
T Consensus        85 -~~~~~~-~~~-------~~~td-~~~t~---------------~--~------~~~~pKsdVwsl~~i~~el~L~~~l~  131 (725)
T KOG1093|consen   85 -AHGVLH-LNI-------IYITD-HFLTK---------------Y--P------SPIGPKSDVWSLGFIILELYLGISLE  131 (725)
T ss_pred             -ccccce-ehh-------hhccc-ccccc---------------C--C------CCCCcchhhhhHHHHHHHHHHhhHHH
Confidence             222111 111       12222 00000               0  1      11125999999999999999998888


Q ss_pred             CCCChHHHHHHhh
Q 024959          246 PGKDYVHQLRLIT  258 (260)
Q Consensus       246 ~~~~~~~~~~~i~  258 (260)
                      ......+.++.|.
T Consensus       132 ~~~~~s~~l~~i~  144 (725)
T KOG1093|consen  132 AELTESEYLEILL  144 (725)
T ss_pred             HHHHHHHHHHHHH
Confidence            8777777766654

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.97  E-value=0.35  Score=40.38  Aligned_cols=29  Identities=31%  Similarity=0.365  Sum_probs=24.2

Q ss_pred             CCceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          164 ASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       164 ~~i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                      .+++|+|+.+.||+++ + .+.++||+.+..
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~  224 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM  224 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence            3689999999999995 4 588999997643

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=95.86  E-value=0.017  Score=46.71  Aligned_cols=50  Identities=32%  Similarity=0.326  Sum_probs=38.3

Q ss_pred             HHHHHHHHHHHHHHHHHhC--CceeccCCCCCeEeccCCCEEEeeccccccc
Q 024959          146 HCQYFLYQLLRGLKYVHSA--SVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (260)
Q Consensus       146 ~~~~~~~~i~~~l~~lh~~--~i~H~di~~~nili~~~~~~~l~df~~~~~~  195 (260)
                      .+...+..+-..+...+..  -++|+|+.|.|++.++.+.++|+||..+...
T Consensus       133 ~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~~  184 (269)
T COG0510         133 LLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGLN  184 (269)
T ss_pred             HHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCCc
Confidence            3444555555556655544  6999999999999999999999999998544

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.83  E-value=0.35  Score=40.36  Aligned_cols=28  Identities=36%  Similarity=0.584  Sum_probs=25.4

Q ss_pred             ceeccCCCCCeEeccCCC-EEEeeccccc
Q 024959          166 VLHRDLKPSNLLLNASCD-LKIGDFGLAR  193 (260)
Q Consensus       166 i~H~di~~~nili~~~~~-~~l~df~~~~  193 (260)
                      ++|+|+.|.||+++.+.. +.++||+.+.
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEccccc
Confidence            899999999999999875 8999999764

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.54  E-value=0.034  Score=45.95  Aligned_cols=29  Identities=24%  Similarity=0.384  Sum_probs=25.4

Q ss_pred             CCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          164 ASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       164 ~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                      .+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            47899999999999987 678999999664

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK10271 thiK thiamine kinase; Provisional

Probab=95.46  E-value=0.015  Score=44.17  Aligned_cols=32  Identities=31%  Similarity=0.389  Sum_probs=27.1

Q ss_pred             CceeccCCCCCeEeccCCCEEEeecccccccCC
Q 024959          165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (260)
Q Consensus       165 ~i~H~di~~~nili~~~~~~~l~df~~~~~~~~  197 (260)
                      -.+|+|+.|.|+++++++ ++|+||+++-..+.
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~gDp  109 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAGDGDI  109 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCcccCCCH
Confidence            479999999999998877 99999999865443

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.41  E-value=0.15  Score=43.57  Aligned_cols=59  Identities=14%  Similarity=0.138  Sum_probs=41.4

Q ss_pred             EEEEEecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCCeEecc
Q 024959          121 VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH-SASVLHRDLKPSNLLLNA  180 (260)
Q Consensus       121 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~i~H~di~~~nili~~  180 (260)
                      ..++-+|..| ++... -+....+++....++.-.++++-.|- -.+++|.|+.|.||++..
T Consensus       320 ~vl~E~~~~Gl~v~~~-v~~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRF-VKWKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF  380 (565)
T ss_pred             ceeeeeccccccHHhh-hhcccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence            4556666666 44443 34455666777778887888766665 568999999999999954

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	260
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-77
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-77
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-69
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-69
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-69
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-69
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-69
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-69
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-69
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-69
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-69
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-69
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-69
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-69
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-69
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-69
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-69
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-69
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-69
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-69
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-69
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-69
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-69
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-69
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-69
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		4e-69
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-69
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-69
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-69
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-69
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-69
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		6e-69
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		6e-69
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		6e-69
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		6e-69
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		7e-69
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		7e-69
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		7e-69
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		7e-69
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		7e-69
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		7e-69
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		7e-69
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		7e-69
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		7e-69
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		7e-69
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		8e-69
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		8e-69
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		8e-69
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		8e-69
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		8e-69
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		8e-69
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		9e-69
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-68
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-68
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-68
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-68
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-68
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-68
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-68
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-68
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-68
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-68
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-68
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-68
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-68
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-68
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-68
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-68
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		5e-68
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		5e-68
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		6e-68
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		6e-68
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-68
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		7e-68
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		7e-68
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		7e-68
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		7e-68
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		8e-68
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-68
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		9e-68
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-67
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-67
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-67
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-67
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-67
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		6e-67
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		6e-67
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-66
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-66
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-66
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-65
4exu_A	371	Mapk13, Inactive Form Length = 371		8e-60
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-59
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-58
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-55
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-54
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-54
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-54
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-54
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-54
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-54
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-54
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-54
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-54
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-54
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-54
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-54
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-54
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-54
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		7e-54
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-54
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		8e-54
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-53
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-53
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-53
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-53
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-53
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-53
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-53
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		5e-53
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		6e-53
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		9e-53
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-52
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-52
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-52
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		8e-52
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-51
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-49
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-48
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-46
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-46
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-44
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-44
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-41
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-41
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-41
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-41
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-41
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-41
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-41
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-41
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		8e-41
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		8e-41
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-41
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		9e-41
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-40
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-40
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-40
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-40
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-40
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-40
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-40
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-40
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-40
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-40
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-40
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-40
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-40
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-40
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-40
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-40
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-40
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-40
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-40
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-40
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-40
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-40
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		5e-40
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		5e-40
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		7e-39
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-39
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-39
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-38
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-38
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-37
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-37
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-37
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-37
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-37
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-37
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		7e-37
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-35
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-35
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-35
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-34
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-34
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-34
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-34
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-33
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-33
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-33
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-33
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-33
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-33
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-33
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-33
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-33
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-33
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-33
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		5e-33
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		7e-33
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		7e-33
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		8e-33
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-32
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-32
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-32
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-32
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-32
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-32
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-32
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-32
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-32
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-32
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-32
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-32
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-28
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-27
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		6e-27
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		4e-24
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-24
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		5e-24
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		5e-24
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		7e-24
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		8e-24
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-23
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-23
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-23
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-23
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-23
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-23
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		5e-23
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		5e-23
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		5e-23
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-22
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-22
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-22
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-22
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		6e-22
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		7e-22
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		1e-21
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		2e-21
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		2e-21
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		2e-21
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		2e-21
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		2e-21
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		2e-21
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		2e-21
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		2e-21
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		2e-21
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		2e-21
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		2e-21
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		3e-21
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-21
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-21
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-21
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		6e-21
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		8e-21
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		8e-21
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		9e-21
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		9e-21
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		9e-21
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-20
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-20
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-20
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-20
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-20
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-20
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-20
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-20
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-20
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-20
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-20
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-20
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		2e-20
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		2e-20
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		2e-20
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		2e-20
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		2e-20
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		2e-20
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		2e-20
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		3e-20
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		3e-20
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		3e-20
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-20
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-20
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		4e-20
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		7e-20
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-19
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-19
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-19
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-19
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-19
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-19
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-19
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-19
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-19
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-19
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-19
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-19
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-19
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-19
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-18
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-18
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-18
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-18
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-18
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-18
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-18
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-18
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-18
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-18
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-18
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-18
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-18
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-18
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-18
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-18
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-18
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-18
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-18
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-18
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-18
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-18
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-18
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		6e-18
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		7e-18
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-18
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-18
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		7e-18
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		8e-18
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		9e-18
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		9e-18
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		9e-18
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-17
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-17
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-17
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-17
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-17
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-17
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-17
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-17
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-17
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-17
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-17
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-17
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-17
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-17
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-17
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-17
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-17
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-17
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-17
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-17
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-17
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-17
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-17
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		5e-17
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-17
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		5e-17
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		6e-17
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		7e-17
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		7e-17
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		8e-17
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		8e-17
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		8e-17
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		8e-17
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		8e-17
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		8e-17
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		8e-17
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		9e-17
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		9e-17
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		9e-17
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		9e-17
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-16
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-16
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-16
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-16
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-16
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-16
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-16
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-16
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-16
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-16
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-16
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-16
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-16
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-16
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-16
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-16
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-16
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-16
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-16
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-16
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-16
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-16
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-16
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-16
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-16
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-16
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-16
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-16
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-16
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		4e-16
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		5e-16
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		5e-16
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		5e-16
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-16
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		7e-16
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		7e-16
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		8e-16
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		9e-16
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		9e-16
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-15
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-15
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-15
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-15
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-15
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-15
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-15
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		2e-15
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-15
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-15
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-15
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-15
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-15
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-15
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-15
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-15
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-15
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-15
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-15
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-15
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-15
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-15
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		5e-15
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		5e-15
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		6e-15
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		6e-15
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		6e-15
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		6e-15
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		6e-15
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		7e-15
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		8e-15
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		9e-15
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		9e-15
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		9e-15
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		9e-15
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-14
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-14
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-14
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-14
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-14
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-14
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-14
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-14
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-14
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-14
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-14
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-14
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-14
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-14
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-14
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-14
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-14
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-14
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-14
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-14
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-14
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-14
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-14
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-14
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-14
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-14
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-14
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-14
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-14
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-14
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-14
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-14
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-14
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-14
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-14
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-14
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-14
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-14
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-14
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-14
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-14
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-14
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-14
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-14
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-14
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-14
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-14
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-14
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-14
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-14
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-14
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-14
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-14
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-14
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		4e-14
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-14
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		5e-14
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		5e-14
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-14
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-14
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		6e-14
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-14
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		6e-14
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-14
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-14
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-14
3a7f_A	303	Human Mst3 Kinase Length = 303		7e-14
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		7e-14
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		7e-14
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		7e-14
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		8e-14
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		8e-14
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		8e-14
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		9e-14
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		9e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-13
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-13
3soa_A	444	Full-Length Human Camkii Length = 444		1e-13
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-13
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-13
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-13
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-13
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-13
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-13
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-13
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-13
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-13
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-13
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-13
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-13
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-13
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-13
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-13
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-13
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-13
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-13
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-13
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-13
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-13
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-13
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-13
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-13
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-13
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-13
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-13
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-13
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-13
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-13
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-13
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-13
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-13
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-13
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-13
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-13
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-13
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-13
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-13
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-13
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-13
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-13
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-13
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-13
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-13
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-13
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-13
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-13
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-13
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-13
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-13
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-13
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-13
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-13
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-13
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-13
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-13
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-13
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-13
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		3e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-13
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-13
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-13
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-13
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-13
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-13
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-13
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-13
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-13
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-13
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-13
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-13
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-13
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-13
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-13
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-13
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-13
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-13
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		4e-13
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		4e-13
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-13
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-13
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-13
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-13
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-13
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-13
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-13
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-13
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		5e-13
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-13
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-13
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		6e-13
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		6e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		6e-13
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		6e-13
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		7e-13
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		7e-13
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		8e-13
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		8e-13
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		8e-13
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		8e-13
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		8e-13
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		9e-13
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		9e-13
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		9e-13
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-12
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-12
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-12
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-12
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-12
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-12
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-12
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-12
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-12
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-12
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-12
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-12
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-12
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-12
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-12
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-12
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-12
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-12
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-12
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-12
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-12
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-12
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-12
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-12
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-12
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		4e-12
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		4e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-12
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-12
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		5e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		5e-12
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-12
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		6e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		6e-12
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-12
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		6e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		6e-12
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		6e-12
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		7e-12
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		7e-12
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		7e-12
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		7e-12
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		7e-12
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		7e-12
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		7e-12
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		7e-12
3b2t_A	311	Structure Of Phosphotransferase Length = 311		7e-12
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		7e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		7e-12
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		8e-12
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		8e-12
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-12
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-12
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		8e-12
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		8e-12
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-12
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-12
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		8e-12
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		8e-12
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		8e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-12
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		8e-12
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		9e-12
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		9e-12
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-12
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		9e-12
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-11
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-11
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-11
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-11
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-11
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-11
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-11
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-11
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-11
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-11
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-11
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-11
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-11
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-11
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-11
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-11
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-11
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-11
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-11
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-11
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-11
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-11
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-11
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-11
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-11
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-11
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-11
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-11
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-11
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-11
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-11
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-11
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-11
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-11
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-11
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-11
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-11
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-11
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-11
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-11
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-11
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-11
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-11
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-11
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-11
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-11
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		4e-11
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		4e-11
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-11
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-11
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-11
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-11
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-11
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		4e-11
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-11
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		5e-11
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-11
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		6e-11
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		6e-11
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		6e-11
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		6e-11
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		6e-11
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		6e-11
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		6e-11
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		6e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-11
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		7e-11
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-11
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		8e-11
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		8e-11
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		8e-11
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		9e-11
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		9e-11
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		9e-11
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-10
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-10
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-10
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-10
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-10
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-10
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-10
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-10
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-10
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-10
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-10
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-10
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-10
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-10
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-10
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-10
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-10
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-10
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-10
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-10
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-10
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-10
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-10
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-10
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-10
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-10
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-10
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-10
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-10
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-10
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-10
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-10
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-10
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-10
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-10
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-10
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-10
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-10
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-10
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-10
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-10
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-10
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-10
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-10
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-10
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-10
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-10
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-10
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-10
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-10
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-10
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-10
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-10
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-10
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-10
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-10
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-10
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-10
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-10
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-10
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-10
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-10
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-10
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-10
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-10
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-10
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-10
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		4e-10
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		4e-10
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-10
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		5e-10
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-10
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		5e-10
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-10
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		5e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		6e-10
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		6e-10
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		6e-10
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		6e-10
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		7e-10
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		7e-10
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		7e-10
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		7e-10
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		7e-10
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-10
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-10
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-10
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		8e-10
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		9e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		9e-10
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		9e-10
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		9e-10
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		9e-10
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		1e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-09
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-09
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-09
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-09
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		1e-09
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-09
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-09
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-09
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-09
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-09
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-09
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-09
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-09
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-09
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-09
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-09
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-09
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-09
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-09
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-09
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-09
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-09
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-09
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-09
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-09
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		3e-09
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-09
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-09
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-09
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-09
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-09
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-09
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		5e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		6e-09
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		7e-09
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		7e-09
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		7e-09
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		8e-09
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		8e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		8e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		9e-09
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		9e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		9e-09
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		9e-09
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		9e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-09
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-08
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-08
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-08
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-08
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-08
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-08
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-08
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-08
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-08
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-08
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-08
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-08
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-08
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-08
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-08
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-08
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-08
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		4e-08
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-08
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		4e-08
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		4e-08
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-08
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-08
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-08
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		5e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		5e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-07
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-07
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-07
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-07
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-07
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-07
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		1e-07
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-07

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  285 bits (730), Expect = 1e-77,   Method: Compositional matrix adjust.
 Identities = 142/230 (61%), Positives = 178/230 (77%), Gaps = 7/230 (3%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           F+V  +Y   I  IG GAYG+V +A    T ++VAIKKI NAFD + +A+RTLRE+K+L+
Sbjct: 50  FDVGDEY-EIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILK 108
Query: 97  HMEHENVIAIKDIIRPP-KKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLL 155
           H +H+N+IAIKDI+RP      F  VY+V +LM++DLHQII S Q LT +H +YFLYQLL
Sbjct: 109 HFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLL 168
Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETD---FMTEYVVTRWY 210
           RGLKY+HSA V+HRDLKPSNLL+N +C+LKIGDFG+AR   TS  +   FMTEYV TRWY
Sbjct: 169 RGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWY 228
Query: 211 RAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           RAPEL+L+  EYT AID+WSVGCI GE++ R  LFPGK+YVHQL+LI  V
Sbjct: 229 RAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMV 278

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  285 bits (729), Expect = 2e-77,   Method: Compositional matrix adjust.
 Identities = 139/220 (63%), Positives = 173/220 (78%), Gaps = 6/220 (2%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           I  IG GAYG+V +A    T ++VAIKKI NAFD + +A+RTLRE+K+L+H +H+N+IAI
Sbjct: 60  IETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAI 119
Query: 107 KDIIRPP-KKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
           KDI+RP      F  VY+V +LM++DLHQII S Q LT +H +YFLYQLLRGLKY+HSA 
Sbjct: 120 KDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ 179
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETD---FMTEYVVTRWYRAPELLLNCT 220
           V+HRDLKPSNLL+N +C+LKIGDFG+AR   TS  +   FMTEYV TRWYRAPEL+L+  
Sbjct: 180 VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLH 239
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           EYT AID+WSVGCI GE++ R  LFPGK+YVHQL+LI  V
Sbjct: 240 EYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMV 279

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  258 bits (660), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 130/230 (56%), Positives = 169/230 (73%), Gaps = 7/230 (3%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 34  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLRE 91
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 92  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 150
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT----SETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV T
Sbjct: 151 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 210
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I
Sbjct: 211 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 260

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  258 bits (660), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 130/230 (56%), Positives = 169/230 (73%), Gaps = 7/230 (3%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 16  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLRE 73
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 74  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 132
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT----SETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV T
Sbjct: 133 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 242

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  258 bits (660), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 130/230 (56%), Positives = 169/230 (73%), Gaps = 7/230 (3%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 22  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLRE 79
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 80  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 138
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT----SETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV T
Sbjct: 139 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 198
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I
Sbjct: 199 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 248

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  258 bits (660), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 130/230 (56%), Positives = 169/230 (73%), Gaps = 7/230 (3%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 14  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLRE 71
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 72  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 130
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT----SETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV T
Sbjct: 131 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 240

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  258 bits (660), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 130/230 (56%), Positives = 169/230 (73%), Gaps = 7/230 (3%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 12  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLRE 69
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 70  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 128
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT----SETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV T
Sbjct: 129 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 188
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I
Sbjct: 189 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 238

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  258 bits (660), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 130/230 (56%), Positives = 169/230 (73%), Gaps = 7/230 (3%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 14  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLRE 71
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 72  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 130
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT----SETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV T
Sbjct: 131 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 240

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  258 bits (660), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 130/230 (56%), Positives = 169/230 (73%), Gaps = 7/230 (3%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 16  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLRE 73
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 74  IKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 132
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT----SETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV T
Sbjct: 133 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 242

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  258 bits (660), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 130/230 (56%), Positives = 169/230 (73%), Gaps = 7/230 (3%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 19  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLRE 76
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 77  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 135
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT----SETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV T
Sbjct: 136 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 195
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I
Sbjct: 196 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 245

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  258 bits (660), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 130/230 (56%), Positives = 169/230 (73%), Gaps = 7/230 (3%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 20  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLRE 77
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 78  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 136
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT----SETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV T
Sbjct: 137 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 196
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I
Sbjct: 197 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 246

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  258 bits (660), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 130/230 (56%), Positives = 169/230 (73%), Gaps = 7/230 (3%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 11  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLRE 68
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 69  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 127
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT----SETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV T
Sbjct: 128 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 187
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I
Sbjct: 188 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 237

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  258 bits (660), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 130/230 (56%), Positives = 169/230 (73%), Gaps = 7/230 (3%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 18  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLRE 75
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 76  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 134
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT----SETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV T
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 244

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  258 bits (659), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 130/230 (56%), Positives = 169/230 (73%), Gaps = 7/230 (3%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 12  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLRE 69
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 70  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 128
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT----SETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV T
Sbjct: 129 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 188
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I
Sbjct: 189 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 238

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  258 bits (658), Expect = 3e-69,   Method: Compositional matrix adjust.
 Identities = 122/223 (54%), Positives = 164/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 17  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 134
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPE 192
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  258 bits (658), Expect = 3e-69,   Method: Compositional matrix adjust.
 Identities = 122/223 (54%), Positives = 164/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 23  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 82  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 140
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 141 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPE 198
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 241

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  258 bits (658), Expect = 3e-69,   Method: Compositional matrix adjust.
 Identities = 122/223 (54%), Positives = 164/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 37  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 95
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 96  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 154
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 155 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPE 212
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 213 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 255

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  258 bits (658), Expect = 3e-69,   Method: Compositional matrix adjust.
 Identities = 122/223 (54%), Positives = 164/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 36  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 94
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 95  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 153
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 154 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPE 211
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 212 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 254

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  257 bits (657), Expect = 4e-69,   Method: Compositional matrix adjust.
 Identities = 122/223 (54%), Positives = 165/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 24  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 83  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 141
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T+  D MT YV TRWYRAPE
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA--DEMTGYVATRWYRAPE 199
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 242

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  257 bits (657), Expect = 4e-69,   Method: Compositional matrix adjust.
 Identities = 130/230 (56%), Positives = 168/230 (73%), Gaps = 7/230 (3%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 18  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLRE 75
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL+++++  Q L++DH  YFL
Sbjct: 76  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKC-QHLSNDHICYFL 134
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT----SETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV T
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 244

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  257 bits (657), Expect = 4e-69,   Method: Compositional matrix adjust.
 Identities = 122/223 (54%), Positives = 165/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 24  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 83  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 141
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T+  D MT YV TRWYRAPE
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA--DEMTGYVATRWYRAPE 199
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 242

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  257 bits (657), Expect = 4e-69,   Method: Compositional matrix adjust.
 Identities = 122/223 (54%), Positives = 164/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 13  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 72  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 130
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPE 188
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 231

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  257 bits (657), Expect = 4e-69,   Method: Compositional matrix adjust.
 Identities = 122/223 (54%), Positives = 164/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 17  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 134
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPE 192
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 193 IMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  257 bits (657), Expect = 4e-69,   Method: Compositional matrix adjust.
 Identities = 122/223 (54%), Positives = 164/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 27  IWEVPERY-QNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 85
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 86  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 144
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 145 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPE 202
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 203 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 245

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  257 bits (657), Expect = 4e-69,   Method: Compositional matrix adjust.
 Identities = 122/223 (54%), Positives = 165/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 24  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 83  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 141
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T+  D MT YV TRWYRAPE
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA--DEMTGYVATRWYRAPE 199
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 242

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  257 bits (657), Expect = 4e-69,   Method: Compositional matrix adjust.
 Identities = 129/230 (56%), Positives = 169/230 (73%), Gaps = 7/230 (3%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAI+KI + F++    +RTLRE
Sbjct: 18  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIRKI-SPFEHQTYCQRTLRE 75
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 76  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 134
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT----SETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV T
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 244

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  257 bits (656), Expect = 5e-69,   Method: Compositional matrix adjust.
 Identities = 122/223 (54%), Positives = 164/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 17  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKX-QKLTDDHVQFLIYQI 134
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPE 192
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  257 bits (656), Expect = 5e-69,   Method: Compositional matrix adjust.
 Identities = 122/223 (54%), Positives = 164/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 23  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 82  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 140
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 141 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPE 198
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 241

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  257 bits (656), Expect = 5e-69,   Method: Compositional matrix adjust.
 Identities = 122/223 (54%), Positives = 164/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 29  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLL 87
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 88  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 146
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 147 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPE 204
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 205 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 247

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  256 bits (655), Expect = 6e-69,   Method: Compositional matrix adjust.
 Identities = 122/223 (54%), Positives = 164/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 17  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 134
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPE 192
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  256 bits (655), Expect = 6e-69,   Method: Compositional matrix adjust.
 Identities = 122/223 (54%), Positives = 164/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 17  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 134
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPE 192
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  256 bits (655), Expect = 6e-69,   Method: Compositional matrix adjust.
 Identities = 122/223 (54%), Positives = 164/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 24  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 83  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 141
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPE 199
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 242

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  256 bits (655), Expect = 6e-69,   Method: Compositional matrix adjust.
 Identities = 122/223 (54%), Positives = 164/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 29  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 87
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 88  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 146
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 147 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPE 204
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 205 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 247

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  256 bits (655), Expect = 6e-69,   Method: Compositional matrix adjust.
 Identities = 122/223 (54%), Positives = 164/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 40  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 98
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 99  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 157
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 158 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPE 215
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 216 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 258

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  256 bits (655), Expect = 6e-69,   Method: Compositional matrix adjust.
 Identities = 122/223 (54%), Positives = 164/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 29  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 87
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 88  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 146
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 147 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPE 204
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 205 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 247

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  256 bits (655), Expect = 7e-69,   Method: Compositional matrix adjust.
 Identities = 122/223 (54%), Positives = 164/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 17  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 134
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPE 192
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  256 bits (655), Expect = 7e-69,   Method: Compositional matrix adjust.
 Identities = 122/223 (54%), Positives = 164/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 28  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 86
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 87  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 145
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 146 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPE 203
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 204 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 246

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  256 bits (655), Expect = 7e-69,   Method: Compositional matrix adjust.
 Identities = 122/223 (54%), Positives = 164/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 17  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 134
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPE 192
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  256 bits (655), Expect = 7e-69,   Method: Compositional matrix adjust.
 Identities = 122/223 (54%), Positives = 164/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 19  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 78  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 136
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 137 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPE 194
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 237

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  256 bits (655), Expect = 7e-69,   Method: Compositional matrix adjust.
 Identities = 122/223 (54%), Positives = 164/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 36  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 94
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 95  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 153
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 154 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPE 211
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 212 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 254

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  256 bits (655), Expect = 7e-69,   Method: Compositional matrix adjust.
 Identities = 122/223 (54%), Positives = 164/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 37  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 95
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 96  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 154
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 155 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPE 212
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 213 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 255

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  256 bits (655), Expect = 7e-69,   Method: Compositional matrix adjust.
 Identities = 122/223 (54%), Positives = 164/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 19  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 78  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 136
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 137 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPE 194
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 237

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  256 bits (655), Expect = 7e-69,   Method: Compositional matrix adjust.
 Identities = 122/223 (54%), Positives = 164/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 17  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 134
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPE 192
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  256 bits (655), Expect = 7e-69,   Method: Compositional matrix adjust.
 Identities = 122/223 (54%), Positives = 164/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 22  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 81  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 139
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 140 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPE 197
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 240

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  256 bits (655), Expect = 7e-69,   Method: Compositional matrix adjust.
 Identities = 122/223 (54%), Positives = 164/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 16  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 74
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 75  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 133
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 134 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPE 191
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 192 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 234

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  256 bits (655), Expect = 8e-69,   Method: Compositional matrix adjust.
 Identities = 122/223 (54%), Positives = 164/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 23  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 82  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 140
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 141 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPE 198
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 241

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  256 bits (654), Expect = 8e-69,   Method: Compositional matrix adjust.
 Identities = 122/223 (54%), Positives = 164/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 14  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 72
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 73  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 131
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 132 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPE 189
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 190 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 232

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  256 bits (654), Expect = 8e-69,   Method: Compositional matrix adjust.
 Identities = 122/223 (54%), Positives = 164/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 22  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 81  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 139
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 140 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPE 197
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 240

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  256 bits (654), Expect = 8e-69,   Method: Compositional matrix adjust.
 Identities = 122/223 (54%), Positives = 164/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 17  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 134
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPE 192
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  256 bits (654), Expect = 8e-69,   Method: Compositional matrix adjust.
 Identities = 122/223 (54%), Positives = 164/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 17  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 134
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPE 192
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  256 bits (654), Expect = 8e-69,   Method: Compositional matrix adjust.
 Identities = 122/223 (54%), Positives = 164/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 19  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 78  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 136
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 137 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPE 194
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 237

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  256 bits (654), Expect = 9e-69,   Method: Compositional matrix adjust.
 Identities = 122/223 (54%), Positives = 164/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 15  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 73
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 74  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 132
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 133 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPE 190
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 191 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 233

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  256 bits (654), Expect = 1e-68,   Method: Compositional matrix adjust.
 Identities = 122/223 (54%), Positives = 164/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 14  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 72
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 73  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 131
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 132 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPE 189
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 190 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 232

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  256 bits (653), Expect = 1e-68,   Method: Compositional matrix adjust.
 Identities = 122/223 (54%), Positives = 164/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 13  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 72  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 130
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPE 188
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 231

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  255 bits (651), Expect = 2e-68,   Method: Compositional matrix adjust.
 Identities = 129/230 (56%), Positives = 168/230 (73%), Gaps = 7/230 (3%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 14  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLRE 71
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 72  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 130
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT----SETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN + DLKI DFGLAR        T F+TEYV T
Sbjct: 131 YQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVAT 190
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 240

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  255 bits (651), Expect = 2e-68,   Method: Compositional matrix adjust.
 Identities = 121/223 (54%), Positives = 164/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 17  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 134
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI D+GLAR T   D MT YV TRWYRAPE
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLARHTD--DEMTGYVATRWYRAPE 192
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  255 bits (651), Expect = 2e-68,   Method: Compositional matrix adjust.
 Identities = 121/223 (54%), Positives = 163/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 13  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++   +LTDDH Q+ +YQ+
Sbjct: 72  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-AKLTDDHVQFLIYQI 130
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPE 188
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 231

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  255 bits (651), Expect = 2e-68,   Method: Compositional matrix adjust.
 Identities = 121/223 (54%), Positives = 163/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 40  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 98
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 99  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 157
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D M  YV TRWYRAPE
Sbjct: 158 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMXGYVATRWYRAPE 215
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 216 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 258

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  254 bits (650), Expect = 2e-68,   Method: Compositional matrix adjust.
 Identities = 129/230 (56%), Positives = 168/230 (73%), Gaps = 7/230 (3%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 16  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLRE 73
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 74  IKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 132
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT----SETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN + DLKI DFGLAR        T F+TEYV T
Sbjct: 133 YQILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 242

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  254 bits (650), Expect = 2e-68,   Method: Compositional matrix adjust.
 Identities = 123/219 (56%), Positives = 159/219 (72%), Gaps = 13/219 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G GAYG+VC+A +  T E VAIKKI   FD  + A RTLREIK+L+H +HEN+I I +I
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 169
            RP   + FN+VYI+ ELM TDLH++I S Q L+DDH QYF+YQ LR +K +H ++V+HR
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVI-STQMLSDDHIQYFIYQTLRAVKVLHGSNVIHR 136
Query: 170 DLKPSNLLLNASCDLKIGDFGLAR-----------TTSETDFMTEYVVTRWYRAPELLLN 218
           DLKPSNLL+N++CDLK+ DFGLAR            T +   MTEYV TRWYRAPE++L 
Sbjct: 137 DLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEVMLT 196
Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
             +Y+ A+D+WS GCIL E+  R P+FPG+DY HQL LI
Sbjct: 197 SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI 235

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  254 bits (650), Expect = 3e-68,   Method: Compositional matrix adjust.
 Identities = 120/223 (53%), Positives = 163/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 17  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 134
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D M  +V TRWYRAPE
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMAGFVATRWYRAPE 192
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  254 bits (650), Expect = 3e-68,   Method: Compositional matrix adjust.
 Identities = 129/230 (56%), Positives = 168/230 (73%), Gaps = 7/230 (3%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 14  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLRE 71
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 72  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 130
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT----SETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN + DLKI DFGLAR        T F+TEYV T
Sbjct: 131 YQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 240

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  254 bits (650), Expect = 3e-68,   Method: Compositional matrix adjust.
 Identities = 120/223 (53%), Positives = 163/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 17  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 134
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D M  +V TRWYRAPE
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMAGFVATRWYRAPE 192
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  254 bits (649), Expect = 3e-68,   Method: Compositional matrix adjust.
 Identities = 129/230 (56%), Positives = 168/230 (73%), Gaps = 7/230 (3%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 18  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYXQRTLRE 75
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 76  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 134
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT----SETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN + DLKI DFGLAR        T F+TEYV T
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 244

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  254 bits (649), Expect = 3e-68,   Method: Compositional matrix adjust.
 Identities = 120/223 (53%), Positives = 163/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 13  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 72  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 130
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D M  +V TRWYRAPE
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMAGFVATRWYRAPE 188
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 231

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  254 bits (649), Expect = 3e-68,   Method: Compositional matrix adjust.
 Identities = 129/230 (56%), Positives = 168/230 (73%), Gaps = 7/230 (3%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 14  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLRE 71
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 72  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 130
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT----SETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN + DLKI DFGLAR        T F+TEYV T
Sbjct: 131 YQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 240

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  254 bits (649), Expect = 4e-68,   Method: Compositional matrix adjust.
 Identities = 129/230 (56%), Positives = 168/230 (73%), Gaps = 7/230 (3%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 18  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLRE 75
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 76  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 134
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT----SETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN + DLKI DFGLAR        T F+TEYV T
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 244

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  254 bits (648), Expect = 4e-68,   Method: Compositional matrix adjust.
 Identities = 121/223 (54%), Positives = 163/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 17  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 134
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DF LAR T   D MT YV TRWYRAPE
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLARHTD--DEMTGYVATRWYRAPE 192
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  254 bits (648), Expect = 5e-68,   Method: Compositional matrix adjust.
 Identities = 121/223 (54%), Positives = 163/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 17  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 134
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI  FGLAR T   D MT YV TRWYRAPE
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLARHTD--DEMTGYVATRWYRAPE 192
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  253 bits (647), Expect = 5e-68,   Method: Compositional matrix adjust.
 Identities = 121/223 (54%), Positives = 163/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 23  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 82  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 140
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N   +LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 141 LRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTD--DEMTGYVATRWYRAPE 198
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 241

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  253 bits (647), Expect = 6e-68,   Method: Compositional matrix adjust.
 Identities = 121/223 (54%), Positives = 163/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 17  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 134
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT  V TRWYRAPE
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGXVATRWYRAPE 192
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  253 bits (647), Expect = 6e-68,   Method: Compositional matrix adjust.
 Identities = 121/223 (54%), Positives = 163/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 17  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++S Q+LTDDH Q+ +YQ+
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKS-QKLTDDHVQFLIYQI 134
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N   +LKI DFGL R T   D MT YV TRWYRAPE
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCRHTD--DEMTGYVATRWYRAPE 192
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  253 bits (647), Expect = 6e-68,   Method: Compositional matrix adjust.
 Identities = 121/223 (54%), Positives = 163/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 17  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKX-QKLTDDHVQFLIYQI 134
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N   +LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTD--DEMTGYVATRWYRAPE 192
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  253 bits (646), Expect = 7e-68,   Method: Compositional matrix adjust.
 Identities = 121/223 (54%), Positives = 163/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 19  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 78  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 136
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N   +LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 137 LRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTD--DEMTGYVATRWYRAPE 194
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 237

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  253 bits (646), Expect = 7e-68,   Method: Compositional matrix adjust.
 Identities = 121/223 (54%), Positives = 163/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 17  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 134
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI D GLAR T   D MT YV TRWYRAPE
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLARHTD--DEMTGYVATRWYRAPE 192
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  253 bits (646), Expect = 7e-68,   Method: Compositional matrix adjust.
 Identities = 128/230 (55%), Positives = 167/230 (72%), Gaps = 7/230 (3%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 18  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLRE 75
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 76  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 134
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT----SETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+ E V T
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVAT 194
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 244

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  253 bits (646), Expect = 7e-68,   Method: Compositional matrix adjust.
 Identities = 128/230 (55%), Positives = 167/230 (72%), Gaps = 7/230 (3%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 19  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLRE 76
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFL
Sbjct: 77  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFL 135
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT----SETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+ E V T
Sbjct: 136 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVAT 195
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I
Sbjct: 196 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 245

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  253 bits (646), Expect = 8e-68,   Method: Compositional matrix adjust.
 Identities = 122/223 (54%), Positives = 163/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + PIG GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 22  IWEVPERY-QNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 81  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 139
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N   +LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 140 LRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTD--DEMTGYVATRWYRAPE 197
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 240

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  253 bits (645), Expect = 8e-68,   Method: Compositional matrix adjust.
 Identities = 121/223 (54%), Positives = 163/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 17  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 134
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI D GLAR T   D MT YV TRWYRAPE
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLARHTD--DEMTGYVATRWYRAPE 192
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  253 bits (645), Expect = 9e-68,   Method: Compositional matrix adjust.
 Identities = 121/223 (54%), Positives = 163/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 28  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 86
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 87  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 145
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N   +LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 146 LRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTD--DEMTGYVATRWYRAPE 203
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 204 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 246

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  253 bits (645), Expect = 1e-67,   Method: Compositional matrix adjust.
 Identities = 121/223 (54%), Positives = 163/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 17  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 134
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI D GLAR T   D MT YV TRWYRAPE
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLARHTD--DEMTGYVATRWYRAPE 192
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  253 bits (645), Expect = 1e-67,   Method: Compositional matrix adjust.
 Identities = 120/223 (53%), Positives = 162/223 (72%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 37  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 95
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 96  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 154
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D M   V TRWYRAPE
Sbjct: 155 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMXGXVATRWYRAPE 212
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 213 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 255

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  252 bits (644), Expect = 1e-67,   Method: Compositional matrix adjust.
 Identities = 121/223 (54%), Positives = 163/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A+RT RE++LL
Sbjct: 22  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 81  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 139
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N   +LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 140 LRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTD--DEMTGYVATRWYRAPE 197
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 240

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  251 bits (642), Expect = 2e-67,   Method: Compositional matrix adjust.
 Identities = 122/219 (55%), Positives = 158/219 (72%), Gaps = 13/219 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G GAYG+VC+A +  T E VAIKKI   FD  + A RTLREIK+L+H +HEN+I I +I
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 169
            RP   + FN+VYI+ ELM TDLH++I S Q L+DDH QYF+YQ LR +K +H ++V+HR
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVI-STQMLSDDHIQYFIYQTLRAVKVLHGSNVIHR 136
Query: 170 DLKPSNLLLNASCDLKIGDFGLAR-----------TTSETDFMTEYVVTRWYRAPELLLN 218
           DLKPSNLL+N++CDLK+ DFGLAR            T +   MTE V TRWYRAPE++L 
Sbjct: 137 DLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEVMLT 196
Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
             +Y+ A+D+WS GCIL E+  R P+FPG+DY HQL LI
Sbjct: 197 SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI 235

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  251 bits (642), Expect = 2e-67,   Method: Compositional matrix adjust.
 Identities = 121/219 (55%), Positives = 158/219 (72%), Gaps = 13/219 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G GAYG+VC+A +  T E VAIKKI   FD  + A RTLREIK+L+H +HEN+I I +I
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 169
            RP   + FN+VYI+ ELM TDLH++I S Q L+DDH QYF+YQ LR +K +H ++V+HR
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVI-STQMLSDDHIQYFIYQTLRAVKVLHGSNVIHR 136
Query: 170 DLKPSNLLLNASCDLKIGDFGLAR-----------TTSETDFMTEYVVTRWYRAPELLLN 218
           DLKPSNLL+N++CDLK+ DFGLAR            T +   M E+V TRWYRAPE++L 
Sbjct: 137 DLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT 196
Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
             +Y+ A+D+WS GCIL E+  R P+FPG+DY HQL LI
Sbjct: 197 SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI 235

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  250 bits (638), Expect = 6e-67,   Method: Compositional matrix adjust.
 Identities = 127/230 (55%), Positives = 165/230 (71%), Gaps = 7/230 (3%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLRE
Sbjct: 34  VRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLRE 91
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           IK+L    HEN+I I DIIR P  +   DVY+V  LM  DL++++++ Q L++DH  YFL
Sbjct: 92  IKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFL 150
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT----SETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLLLN + DLKI DFGLAR        T F+TEYV T
Sbjct: 151 YQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 210
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I
Sbjct: 211 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 260

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  250 bits (638), Expect = 6e-67,   Method: Compositional matrix adjust.
 Identities = 127/230 (55%), Positives = 167/230 (72%), Gaps = 7/230 (3%)
Query: 32  VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           V G  F+V  +Y   ++ IG GAYG+V +A +   +  VAIKKI + F++    +RTLRE
Sbjct: 34  VKGQPFDVGPRYTQ-LQYIGEGAYGMVSSAYDHVRKTRVAIKKI-SPFEHQTYCQRTLRE 91
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           I++L    HENVI I+DI+R    +   DVYIV +LM+TDL+++++S QQL++DH  YFL
Sbjct: 92  IQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKS-QQLSNDHICYFL 150
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT----SETDFMTEYVVT 207
           YQ+LRGLKY+HSA+VLHRDLKPSNLL+N +CDLKI DFGLAR        T F+TE V T
Sbjct: 151 YQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVAT 210
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           RWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I
Sbjct: 211 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 260

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  249 bits (635), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 113/215 (52%), Positives = 158/215 (73%), Gaps = 4/215 (1%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +RP+G GAYG VC+A ++  R++VA+KK+   F ++I ARRT RE++LL+H++HENVI +
Sbjct: 25  LRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGL 84
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            D+  P    + F++VY+V  LM  DL+ I++  Q L+D+H Q+ +YQLLRGLKY+HSA 
Sbjct: 85  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKC-QALSDEHVQFLVYQLLRGLKYIHSAG 143
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+ +N  C+L+I DFGLAR   E   MT YV TRWYRAPE++LN   Y   
Sbjct: 144 IIHRDLKPSNVAVNEDCELRILDFGLARQADEE--MTGYVATRWYRAPEIMLNWMHYNQT 201
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           +DIWSVGCI+ E++  + LFPG DY+ QL+ I EV
Sbjct: 202 VDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEV 236

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  248 bits (634), Expect = 2e-66,   Method: Compositional matrix adjust.
 Identities = 113/215 (52%), Positives = 158/215 (73%), Gaps = 4/215 (1%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +RP+G GAYG VC+A ++  R++VA+KK+   F ++I ARRT RE++LL+H++HENVI +
Sbjct: 33  LRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            D+  P    + F++VY+V  LM  DL+ I++S Q L+D+H Q+ +YQLLRGLKY+HSA 
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKS-QALSDEHVQFLVYQLLRGLKYIHSAG 151
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+ +N   +L+I DFGLAR   E   MT YV TRWYRAPE++LN   Y   
Sbjct: 152 IIHRDLKPSNVAVNEDSELRILDFGLARQADEE--MTGYVATRWYRAPEIMLNWMHYNQT 209
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           +DIWSVGCI+ E++  + LFPG DY+ QL+ I EV
Sbjct: 210 VDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEV 244

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  248 bits (634), Expect = 2e-66,   Method: Compositional matrix adjust.
 Identities = 117/223 (52%), Positives = 163/223 (73%), Gaps = 5/223 (2%)
Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           ++EV  +Y   + P+G GAYG VC++ + ++  ++A+KK+   F +II A+RT RE++LL
Sbjct: 46  IWEVPERYQT-LSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLL 104
Query: 96  RHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +HM+HENVI + D+  P    + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+
Sbjct: 105 KHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 163
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE
Sbjct: 164 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPE 221
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++LN   Y   +DIWSVGCI+ E++T   LFPG D+++QL+ I
Sbjct: 222 IMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQI 264

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  245 bits (626), Expect = 1e-65,   Method: Compositional matrix adjust.
 Identities = 112/215 (52%), Positives = 157/215 (73%), Gaps = 4/215 (1%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +RP+G GAYG VC+A ++  R++VA+KK+   F ++I ARRT RE++LL+H++HENVI +
Sbjct: 33  LRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            D+  P    + F++VY+V  LM  DL+ I++  Q L+D+H Q+ +YQLLRGLKY+HSA 
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKC-QALSDEHVQFLVYQLLRGLKYIHSAG 151
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+ +N   +L+I DFGLAR   E   MT YV TRWYRAPE++LN   Y   
Sbjct: 152 IIHRDLKPSNVAVNEDSELRILDFGLARQADEE--MTGYVATRWYRAPEIMLNWMHYNQT 209
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           +DIWSVGCI+ E++  + LFPG DY+ QL+ I EV
Sbjct: 210 VDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEV 244

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  226 bits (577), Expect = 8e-60,   Method: Compositional matrix adjust.
 Identities = 112/235 (47%), Positives = 155/235 (65%), Gaps = 6/235 (2%)
Query: 27  YVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR 86
           + + +V    +E+   YV P   +G GAYG VC+A++  + E+VAIKK+   F + I A+
Sbjct: 28  FYKQDVNKTAWELPKTYVSPTH-VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK 86
Query: 87  RTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDD 145
           R  RE+ LL+HM+HENVI + D+  P      F D Y+V   M TDL +I+    + +++
Sbjct: 87  RAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM--GMEFSEE 144
Query: 146 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 205
             QY +YQ+L+GLKY+HSA V+HRDLKP NL +N  C+LKI DFGLAR       MT YV
Sbjct: 145 KIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYV 202
Query: 206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           VTRWYRAPE++L+   Y   +DIWSVGCI+ E++T + LF GKDY+ QL  I +V
Sbjct: 203 VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 257

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  225 bits (574), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 112/235 (47%), Positives = 155/235 (65%), Gaps = 6/235 (2%)
Query: 27  YVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR 86
           + + +V    +E+   YV P   +G GAYG VC+A++  + E+VAIKK+   F + I A+
Sbjct: 10  FYKQDVNKTAWELPKTYVSPTH-VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK 68
Query: 87  RTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDD 145
           R  RE+ LL+HM+HENVI + D+  P      F D Y+V   M TDL +I+    + +++
Sbjct: 69  RAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM--GLKFSEE 126
Query: 146 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 205
             QY +YQ+L+GLKY+HSA V+HRDLKP NL +N  C+LKI DFGLAR       MT YV
Sbjct: 127 KIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYV 184
Query: 206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           VTRWYRAPE++L+   Y   +DIWSVGCI+ E++T + LF GKDY+ QL  I +V
Sbjct: 185 VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 239

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  221 bits (564), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 104/215 (48%), Positives = 150/215 (69%), Gaps = 4/215 (1%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++P+G GAYG VC+AV+  T  +VAIKK+   F + + A+R  RE++LL+HM HENVI +
Sbjct: 30  LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGL 89
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            D+  P +  D F D Y+V   M TDL ++++  ++L +D  Q+ +YQ+L+GL+Y+H+A 
Sbjct: 90  LDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG 148
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKP NL +N  C+LKI DFGLAR       M   VVTRWYRAPE++LN   YT  
Sbjct: 149 IIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MXGXVVTRWYRAPEVILNWMRYTQT 206
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           +DIWSVGCI+ E++T + LF G D++ QL+ I +V
Sbjct: 207 VDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV 241

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  212 bits (539), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 106/237 (44%), Positives = 155/237 (65%), Gaps = 27/237 (11%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIA 105
           ++ +G+GAYGIV  +++  T E VA+KKI +AF N  DA+RT REI +L  +  HEN++ 
Sbjct: 14  VKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVN 73
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
           + +++R    D   DVY+V++ M+TDLH +IR++  L   H QY +YQL++ +KY+HS  
Sbjct: 74  LLNVLRA---DNDRDVYLVFDYMETDLHAVIRANI-LEPVHKQYVVYQLIKVIKYLHSGG 129
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLART----------------------TSETDFMTE 203
           +LHRD+KPSN+LLNA C +K+ DFGL+R+                        +   +T+
Sbjct: 130 LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTD 189
Query: 204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           YV TRWYRAPE+LL  T+YT  ID+WS+GCILGEI+  +P+FPG   ++QL  I  V
Sbjct: 190 YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGV 246

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  209 bits (532), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 102/214 (47%), Positives = 146/214 (68%), Gaps = 4/214 (1%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I +
Sbjct: 34  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 93
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 94  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 151
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 152 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 210
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           +D+WSVGCI+GE++  + LFPG+DY+ Q   + E
Sbjct: 211 VDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIE 244

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  209 bits (532), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 102/214 (47%), Positives = 147/214 (68%), Gaps = 4/214 (1%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++
Sbjct: 67  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 126
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 184
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 185 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 243
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           +DIWSVGCI+GE++  + LFPG+DY+ Q   + E
Sbjct: 244 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 277

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  209 bits (532), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 102/214 (47%), Positives = 147/214 (68%), Gaps = 4/214 (1%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++
Sbjct: 67  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 126
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 184
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 185 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKEN 243
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           +DIWSVGCI+GE++  + LFPG+DY+ Q   + E
Sbjct: 244 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 277

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  209 bits (531), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 102/214 (47%), Positives = 146/214 (68%), Gaps = 4/214 (1%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I +
Sbjct: 23  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 82
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 83  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 140
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 141 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 199
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           +D+WSVGCI+GE++  + LFPG+DY+ Q   + E
Sbjct: 200 VDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIE 233

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  209 bits (531), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 102/214 (47%), Positives = 147/214 (68%), Gaps = 4/214 (1%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++
Sbjct: 30  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 89
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 90  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 147
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 206
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           +DIWSVGCI+GE++  + LFPG+DY+ Q   + E
Sbjct: 207 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 240

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  209 bits (531), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 102/214 (47%), Positives = 147/214 (68%), Gaps = 4/214 (1%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++
Sbjct: 29  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 88
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 146
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 205
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           +DIWSVGCI+GE++  + LFPG+DY+ Q   + E
Sbjct: 206 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 239

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  209 bits (531), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 102/214 (47%), Positives = 147/214 (68%), Gaps = 4/214 (1%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++
Sbjct: 28  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 87
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 88  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 145
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 146 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 204
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           +DIWSVGCI+GE++  + LFPG+DY+ Q   + E
Sbjct: 205 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 238

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  209 bits (531), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 102/214 (47%), Positives = 147/214 (68%), Gaps = 4/214 (1%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++
Sbjct: 30  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 89
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 90  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 147
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 206
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           +DIWSVGCI+GE++  + LFPG+DY+ Q   + E
Sbjct: 207 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 240

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  209 bits (531), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 102/214 (47%), Positives = 147/214 (68%), Gaps = 4/214 (1%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++
Sbjct: 29  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 88
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 146
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 205
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           +DIWSVGCI+GE++  + LFPG+DY+ Q   + E
Sbjct: 206 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 239

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  209 bits (531), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 102/214 (47%), Positives = 147/214 (68%), Gaps = 4/214 (1%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++
Sbjct: 23  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 82
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 83  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 140
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 141 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 199
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           +DIWSVGCI+GE++  + LFPG+DY+ Q   + E
Sbjct: 200 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 233

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  208 bits (530), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 102/214 (47%), Positives = 147/214 (68%), Gaps = 4/214 (1%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++
Sbjct: 23  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 82
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 83  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 140
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 141 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 199
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           +DIWSVGCI+GE++  + LFPG+DY+ Q   + E
Sbjct: 200 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 233

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  208 bits (530), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 102/214 (47%), Positives = 147/214 (68%), Gaps = 4/214 (1%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++
Sbjct: 22  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 82  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 139
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 140 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 198
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           +DIWSVGCI+GE++  + LFPG+DY+ Q   + E
Sbjct: 199 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  207 bits (528), Expect = 3e-54,   Method: Compositional matrix adjust.
 Identities = 101/214 (47%), Positives = 146/214 (68%), Gaps = 4/214 (1%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++
Sbjct: 29  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISL 88
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQMLXGIKHLHSAG 146
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ +   LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 205
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           +DIWSVGCI+GE++  + LFPG+DY+ Q   + E
Sbjct: 206 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 239

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  207 bits (527), Expect = 5e-54,   Method: Compositional matrix adjust.
 Identities = 102/214 (47%), Positives = 144/214 (67%), Gaps = 4/214 (1%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I +
Sbjct: 29  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 146
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 205
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           +DIWSVGCI+GE++    LFPG D++ Q   + E
Sbjct: 206 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  207 bits (526), Expect = 7e-54,   Method: Compositional matrix adjust.
 Identities = 101/214 (47%), Positives = 146/214 (68%), Gaps = 4/214 (1%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++
Sbjct: 29  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 88
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQMLXGIKHLHSAG 146
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ +   LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 205
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           +DIWSVGCI+GE++  + LFPG+DY+ Q   + E
Sbjct: 206 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 239

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  207 bits (526), Expect = 7e-54,   Method: Compositional matrix adjust.
 Identities = 101/214 (47%), Positives = 146/214 (68%), Gaps = 4/214 (1%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++
Sbjct: 29  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISL 88
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 146
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ +   LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 205
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           +DIWSVGCI+GE++  + LFPG+DY+ Q   + E
Sbjct: 206 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 239

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  206 bits (525), Expect = 8e-54,   Method: Compositional matrix adjust.
 Identities = 101/214 (47%), Positives = 146/214 (68%), Gaps = 4/214 (1%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++
Sbjct: 22  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 82  LNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQMLXGIKHLHSAG 139
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ +   LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 140 IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 198
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           +DIWSVGCI+GE++  + LFPG+DY+ Q   + E
Sbjct: 199 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  206 bits (524), Expect = 1e-53,   Method: Compositional matrix adjust.
 Identities = 102/214 (47%), Positives = 144/214 (67%), Gaps = 4/214 (1%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I +
Sbjct: 29  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 146
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 205
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           +DIWSVGCI+GE++    LFPG D++ Q   + E
Sbjct: 206 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  206 bits (524), Expect = 1e-53,   Method: Compositional matrix adjust.
 Identities = 101/214 (47%), Positives = 146/214 (68%), Gaps = 4/214 (1%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++
Sbjct: 29  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISL 88
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 146
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ +   LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 205
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           +DIWSVGCI+GE++  + LFPG+DY+ Q   + E
Sbjct: 206 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 239

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  206 bits (523), Expect = 1e-53,   Method: Compositional matrix adjust.
 Identities = 102/214 (47%), Positives = 144/214 (67%), Gaps = 4/214 (1%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I +
Sbjct: 30  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 89
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 90  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 147
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 206
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           +DIWSVGCI+GE++    LFPG D++ Q   + E
Sbjct: 207 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 240

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  206 bits (523), Expect = 1e-53,   Method: Compositional matrix adjust.
 Identities = 102/214 (47%), Positives = 144/214 (67%), Gaps = 4/214 (1%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I +
Sbjct: 29  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 146
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 205
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           +DIWSVGCI+GE++    LFPG D++ Q   + E
Sbjct: 206 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  205 bits (521), Expect = 3e-53,   Method: Compositional matrix adjust.
 Identities = 101/214 (47%), Positives = 143/214 (66%), Gaps = 4/214 (1%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I +
Sbjct: 29  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGL 88
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQMLVGIKHLHSAG 146
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ +   LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 205
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           +DIWSVGCI+GE++    LFPG D++ Q   + E
Sbjct: 206 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  204 bits (520), Expect = 3e-53,   Method: Compositional matrix adjust.
 Identities = 101/214 (47%), Positives = 144/214 (67%), Gaps = 4/214 (1%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I +
Sbjct: 29  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 146
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ + C LKI DFGLART   +  M   VVTR+YRAPE++L    Y   
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMG-YKEN 205
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           +DIWSVGCI+GE++  + LFPG+DY+ Q   + E
Sbjct: 206 VDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIE 239

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  204 bits (518), Expect = 5e-53,   Method: Compositional matrix adjust.
 Identities = 101/214 (47%), Positives = 143/214 (66%), Gaps = 4/214 (1%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I +
Sbjct: 29  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGL 88
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 146
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ +   LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 205
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           +DIWSVGCI+GE++    LFPG D++ Q   + E
Sbjct: 206 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  204 bits (518), Expect = 5e-53,   Method: Compositional matrix adjust.
 Identities = 101/214 (47%), Positives = 143/214 (66%), Gaps = 4/214 (1%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I +
Sbjct: 29  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 146
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ +   LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 205
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           +DIWSVGCI+GE++    LFPG D++ Q   + E
Sbjct: 206 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  204 bits (518), Expect = 6e-53,   Method: Compositional matrix adjust.
 Identities = 100/214 (46%), Positives = 144/214 (67%), Gaps = 4/214 (1%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I +
Sbjct: 29  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 146
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ + C LKI DFGLART   +  M   VVTR+YRAPE++L    Y   
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMG-YKEN 205
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           +D+WSVGCI+GE++  + LFPG+DY+ Q   + E
Sbjct: 206 VDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIE 239

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  203 bits (516), Expect = 9e-53,   Method: Compositional matrix adjust.
 Identities = 100/214 (46%), Positives = 143/214 (66%), Gaps = 4/214 (1%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I +
Sbjct: 31  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 90
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 91  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 148
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ + C LKI DFGLART   +  M  +VVTR+YRAPE++L    Y   
Sbjct: 149 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGMG-YKEN 207
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           +DIWSVGCI+GE++    LFPG D++ Q   + E
Sbjct: 208 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 241

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  202 bits (515), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 101/214 (47%), Positives = 143/214 (66%), Gaps = 4/214 (1%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I +
Sbjct: 29  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 146
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ + C LKI DFGLART   +  MT  VVTR+YRAPE++L    Y   
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVILGMG-YKEN 205
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           +DIWSVGCI+GE++    LFPG D++ Q   + E
Sbjct: 206 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  201 bits (512), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 104/236 (44%), Positives = 151/236 (63%), Gaps = 5/236 (2%)
Query: 25  GKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIID 84
            ++    V  + F V  +Y   ++PIG GA GIVCAA ++     VA+KK+   F N   
Sbjct: 6   SQFYSVQVADSTFTVLKRY-QQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTH 64
Query: 85  ARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLT 143
           A+R  RE+ LL+ + H+N+I++ ++  P K  + F DVY+V ELMD +L Q+I    +L 
Sbjct: 65  AKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIH--MELD 122
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
            +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART S    MT 
Sbjct: 123 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTP 182
Query: 204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           YVVTR+YRAPE++L    Y   +DIWSVGCI+GE++    +F G D++ Q   + E
Sbjct: 183 YVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIE 237

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  201 bits (512), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 100/214 (46%), Positives = 142/214 (66%), Gaps = 4/214 (1%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIVCAA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I +
Sbjct: 29  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGL 88
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQMLVGIKHLHSAG 146
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ +   LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 205
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           +DIWSVG I+GE++    LFPG D++ Q   + E
Sbjct: 206 VDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIE 239

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  200 bits (508), Expect = 8e-52,   Method: Compositional matrix adjust.
 Identities = 104/236 (44%), Positives = 151/236 (63%), Gaps = 5/236 (2%)
Query: 25  GKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIID 84
            ++    V  + F V  +Y   ++PIG GA GIVCAA ++     VA+KK+   F N   
Sbjct: 8   NQFYSVEVADSTFTVLKRY-QQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTH 66
Query: 85  ARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLT 143
           A+R  RE+ LL+ + H+N+I++ ++  P K  + F DVY+V ELMD +L Q+I    +L 
Sbjct: 67  AKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIH--MELD 124
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
            +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART      MT 
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTP 184
Query: 204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           YVVTR+YRAPE++L    Y A +DIWSVGCI+GE++    +F G D++ Q   + E
Sbjct: 185 YVVTRYYRAPEVILGMG-YAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIE 239

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  198 bits (503), Expect = 3e-51,   Method: Compositional matrix adjust.
 Identities = 99/214 (46%), Positives = 141/214 (65%), Gaps = 4/214 (1%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++PIG GA GIV AA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I +
Sbjct: 29  LKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGL 88
Query: 107 KDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQMLVGIKHLHSAG 146
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKPSN+++ +   LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKEN 205
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           +DIWSVG I+GE++    LFPG D++ Q   + E
Sbjct: 206 VDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIE 239

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  191 bits (484), Expect = 4e-49,   Method: Compositional matrix adjust.
 Identities = 103/243 (42%), Positives = 155/243 (63%), Gaps = 20/243 (8%)
Query: 31  NVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR 90
           N++G  F++ S+Y+  ++P+G G  G+V +AV+++  + VAIKKI     +    +  LR
Sbjct: 3   NIHG--FDLGSRYMD-LKPLGCGGNGLVFSAVDNDCDKRVAIKKI--VLTDPQSVKHALR 57
Query: 91  EIKLLRHMEHENVIAIKDIIRPPKKD---------TFNDVYIVYELMDTDLHQIIRSDQQ 141
           EIK++R ++H+N++ + +I+ P               N VYIV E M+TDL  ++     
Sbjct: 58  EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP- 116
Query: 142 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTT----S 196
           L ++H + F+YQLLRGLKY+HSA+VLHRDLKP+NL +N     LKIGDFGLAR      S
Sbjct: 117 LLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176
Query: 197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL 256
               ++E +VT+WYR+P LLL+   YT AID+W+ GCI  E++T + LF G   + Q++L
Sbjct: 177 HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQL 236
Query: 257 ITE 259
           I E
Sbjct: 237 ILE 239

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  189 bits (480), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 100/237 (42%), Positives = 139/237 (58%), Gaps = 39/237 (16%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G+YG VC A +   +  VAIKKI   F+++ID +R LREI +L  + H++V+ + DI
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDI 120
Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 169
           + P   + F+++Y+V E+ D+D  ++ R+   LT+ H +  LY LL G+KYVHSA +LHR
Sbjct: 121 VIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHR 180
Query: 170 DLKPSNLLLNASCDLKIGDFGLARTTS--------------ETDF--------------M 201
           DLKP+N L+N  C +K+ DFGLART                E D               +
Sbjct: 181 DLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQL 240
Query: 202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-----------REPLFPG 247
           T +VVTRWYRAPEL+L    YT AID+WS+GCI  E++            R PLFPG
Sbjct: 241 TGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPG 297

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  182 bits (462), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 96/232 (41%), Positives = 137/232 (59%), Gaps = 34/232 (14%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IGRG+YG V  A +  T + VAIKK+   F+++ID +R LREI +L  ++ + +I + D+
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93
Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 169
           I P     F+++YIV E+ D+DL ++ ++   LT++H +  LY LL G  ++H + ++HR
Sbjct: 94  IIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHR 153
Query: 170 DLKPSNLLLNASCDLKIGDFGLART-TSETDF----------------------MTEYVV 206
           DLKP+N LLN  C +K+ DFGLART  SE D                       +T +VV
Sbjct: 154 DLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVV 213
Query: 207 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM-----------TREPLFPG 247
           TRWYRAPEL+L    YT +IDIWS GCI  E++            R PLFPG
Sbjct: 214 TRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPG 265

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  181 bits (460), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 96/235 (40%), Positives = 136/235 (57%), Gaps = 37/235 (15%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IGRG+YG V  A +    + VAIKK+   F+++ID +R LREI +L  ++ + +I + D+
Sbjct: 36  IGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLHDL 95
Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 169
           I P     F+++YIV E+ D+DL ++ ++   LT+ H +  LY LL G K++H + ++HR
Sbjct: 96  IIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKFIHESGIIHR 155
Query: 170 DLKPSNLLLNASCDLKIGDFGLART-TSETDF-------------------------MTE 203
           DLKP+N LLN  C +KI DFGLART  S+ D                          +T 
Sbjct: 156 DLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHNKNLKKQLTS 215
Query: 204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM-----------TREPLFPG 247
           +VVTRWYRAPEL+L    YT +IDIWS GCI  E++            R PLFPG
Sbjct: 216 HVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHINNPTNRFPLFPG 270

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  176 bits (445), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 99/247 (40%), Positives = 142/247 (57%), Gaps = 14/247 (5%)
Query: 25  GKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD---- 80
           G+    ++   L  + S Y    R I  G+YG VCA V+SE    VAIK++ N       
Sbjct: 6   GEAAMRDLIAELHAMQSPYTVQ-RFISSGSYGAVCAGVDSEGIP-VAIKRVFNTVSDGRT 63
Query: 81  -NIID----ARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQI 135
            NI+      +R LREI+LL H  H N++ ++DI    ++   + +Y+V ELM TDL Q+
Sbjct: 64  VNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQV 123
Query: 136 IRSDQQL--TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR 193
           I  DQ++  +  H QYF+Y +L GL  +H A V+HRDL P N+LL  + D+ I DF LAR
Sbjct: 124 IH-DQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR 182
Query: 194 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 253
             +     T YV  RWYRAPEL++    +T  +D+WS GC++ E+  R+ LF G  + +Q
Sbjct: 183 EDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242
Query: 254 LRLITEV 260
           L  I EV
Sbjct: 243 LNKIVEV 249

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  176 bits (445), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 99/247 (40%), Positives = 142/247 (57%), Gaps = 14/247 (5%)
Query: 25  GKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD---- 80
           G+    ++   L  + S Y    R I  G+YG VCA V+SE    VAIK++ N       
Sbjct: 6   GEAAMRDLIAELHAMQSPYTVQ-RFISSGSYGAVCAGVDSEGIP-VAIKRVFNTVSDGRT 63
Query: 81  -NIID----ARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQI 135
            NI+      +R LREI+LL H  H N++ ++DI    ++   + +Y+V ELM TDL Q+
Sbjct: 64  VNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQV 123
Query: 136 IRSDQQL--TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR 193
           I  DQ++  +  H QYF+Y +L GL  +H A V+HRDL P N+LL  + D+ I DF LAR
Sbjct: 124 IH-DQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR 182
Query: 194 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 253
             +     T YV  RWYRAPEL++    +T  +D+WS GC++ E+  R+ LF G  + +Q
Sbjct: 183 EDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242
Query: 254 LRLITEV 260
           L  I EV
Sbjct: 243 LNKIVEV 249

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  165 bits (417), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 89/211 (42%), Positives = 123/211 (58%), Gaps = 8/211 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 15  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 74
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 75  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 129
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+
Sbjct: 130 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 189
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
            A+DIWS+GCI  E++TR  LFPG   + QL
Sbjct: 190 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 220

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  165 bits (417), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 89/211 (42%), Positives = 123/211 (58%), Gaps = 8/211 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 68  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSH 122
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
            A+DIWS+GCI  E++TR  LFPG   + QL
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  165 bits (417), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 89/211 (42%), Positives = 123/211 (58%), Gaps = 8/211 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 69  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+
Sbjct: 124 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 183
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
            A+DIWS+GCI  E++TR  LFPG   + QL
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 214

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  164 bits (416), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 89/211 (42%), Positives = 123/211 (58%), Gaps = 8/211 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 68  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
            A+DIWS+GCI  E++TR  LFPG   + QL
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  164 bits (416), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 89/211 (42%), Positives = 123/211 (58%), Gaps = 8/211 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 68  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
            A+DIWS+GCI  E++TR  LFPG   + QL
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  164 bits (416), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 89/211 (42%), Positives = 123/211 (58%), Gaps = 8/211 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 67  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
            A+DIWS+GCI  E++TR  LFPG   + QL
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 212

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  164 bits (416), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 89/211 (42%), Positives = 123/211 (58%), Gaps = 8/211 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 67  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
            A+DIWS+GCI  E++TR  LFPG   + QL
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 212

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  164 bits (415), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 89/211 (42%), Positives = 123/211 (58%), Gaps = 8/211 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 12  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 71
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 72  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 126
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+
Sbjct: 127 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 186
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
            A+DIWS+GCI  E++TR  LFPG   + QL
Sbjct: 187 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 217

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  163 bits (413), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 89/211 (42%), Positives = 123/211 (58%), Gaps = 8/211 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +D DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 71  LDVIH-----TENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
            A+DIWS+GCI  E++TR  LFPG   + QL
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 216

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  163 bits (413), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 90/229 (39%), Positives = 134/229 (58%), Gaps = 15/229 (6%)
Query: 40  SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT-LREIKLLRHM 98
           SS     +  +G G Y  V   +N  T   VA+K++    D+      T +REI L++ +
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV--KLDSEEGTPSTAIREISLMKEL 60
Query: 99  EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS------DQQLTDDHCQYFLY 152
           +HEN++ + D+I      T N + +V+E MD DL + + S       + L  +  +YF +
Sbjct: 61  KHENIVRLYDVIH-----TENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW 115
Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYR 211
           QLL+GL + H   +LHRDLKP NLL+N    LK+GDFGLAR      +  +  VVT WYR
Sbjct: 116 QLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYR 175
Query: 212 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           AP++L+    Y+ +IDIWS GCIL E++T +PLFPG +   QL+LI ++
Sbjct: 176 APDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDI 224

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  163 bits (413), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 88/211 (41%), Positives = 122/211 (57%), Gaps = 8/211 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 69  LDVIH-----TENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 124 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
            A+DIWS+GCI  E++TR  LFPG   + QL
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 214

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  163 bits (413), Expect = 9e-41,   Method: Compositional matrix adjust.
 Identities = 88/211 (41%), Positives = 122/211 (57%), Gaps = 8/211 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 71  LDVIH-----TENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 126 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
            A+DIWS+GCI  E++TR  LFPG   + QL
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 216

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  162 bits (411), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 88/211 (41%), Positives = 122/211 (57%), Gaps = 8/211 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 71  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
            A+DIWS+GCI  E++TR  LFPG   + QL
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 216

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  162 bits (411), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 88/211 (41%), Positives = 122/211 (57%), Gaps = 8/211 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 71  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
            A+DIWS+GCI  E++TR  LFPG   + QL
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 216

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  162 bits (411), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 88/211 (41%), Positives = 122/211 (57%), Gaps = 8/211 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 10  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 69
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 70  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 125 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
            A+DIWS+GCI  E++TR  LFPG   + QL
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 215

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  162 bits (411), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 88/211 (41%), Positives = 122/211 (57%), Gaps = 8/211 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 12  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 71
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 72  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 126
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 127 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 186
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
            A+DIWS+GCI  E++TR  LFPG   + QL
Sbjct: 187 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 217

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  162 bits (411), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 88/211 (41%), Positives = 122/211 (57%), Gaps = 8/211 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 69  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 124 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
            A+DIWS+GCI  E++TR  LFPG   + QL
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 214

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  162 bits (411), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 88/211 (41%), Positives = 122/211 (57%), Gaps = 8/211 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 10  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 69
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 70  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 125 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
            A+DIWS+GCI  E++TR  LFPG   + QL
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 215

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  162 bits (411), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 88/211 (41%), Positives = 122/211 (57%), Gaps = 8/211 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 68  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
            A+DIWS+GCI  E++TR  LFPG   + QL
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  162 bits (411), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 88/211 (41%), Positives = 122/211 (57%), Gaps = 8/211 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 68  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
            A+DIWS+GCI  E++TR  LFPG   + QL
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  162 bits (411), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 88/211 (41%), Positives = 122/211 (57%), Gaps = 8/211 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 67  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 181
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
            A+DIWS+GCI  E++TR  LFPG   + QL
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 212

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  162 bits (411), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 88/211 (41%), Positives = 122/211 (57%), Gaps = 8/211 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 69  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 124 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
            A+DIWS+GCI  E++TR  LFPG   + QL
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 214

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  162 bits (411), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 88/211 (41%), Positives = 122/211 (57%), Gaps = 8/211 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 10  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 69
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 70  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 125 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
            A+DIWS+GCI  E++TR  LFPG   + QL
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 215

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  162 bits (411), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 88/211 (41%), Positives = 122/211 (57%), Gaps = 8/211 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 67  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 181
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
            A+DIWS+GCI  E++TR  LFPG   + QL
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 212

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  162 bits (411), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 88/211 (41%), Positives = 122/211 (57%), Gaps = 8/211 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 68  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
            A+DIWS+GCI  E++TR  LFPG   + QL
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  162 bits (411), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 88/211 (41%), Positives = 122/211 (57%), Gaps = 8/211 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 69  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 124 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
            A+DIWS+GCI  E++TR  LFPG   + QL
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 214

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  162 bits (411), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 88/211 (41%), Positives = 122/211 (57%), Gaps = 8/211 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 68  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
            A+DIWS+GCI  E++TR  LFPG   + QL
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 88/211 (41%), Positives = 122/211 (57%), Gaps = 8/211 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+ KI    +        +REI LL+ + H N++ +
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 68  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
            A+DIWS+GCI  E++TR  LFPG   + QL
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 88/211 (41%), Positives = 122/211 (57%), Gaps = 8/211 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+ KI    +        +REI LL+ + H N++ +
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 67  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
            A+DIWS+GCI  E++TR  LFPG   + QL
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 212

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 88/211 (41%), Positives = 121/211 (57%), Gaps = 8/211 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL   + +     +     + +L+QLL+GL + HS 
Sbjct: 71  LDVIH-----TENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
            A+DIWS+GCI  E++TR  LFPG   + QL
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 216

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 88/211 (41%), Positives = 121/211 (57%), Gaps = 8/211 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 10  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 69
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL   + +     +     + +L+QLL+GL + HS 
Sbjct: 70  LDVIH-----TENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 125 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
            A+DIWS+GCI  E++TR  LFPG   + QL
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 215

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  162 bits (409), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 88/211 (41%), Positives = 121/211 (57%), Gaps = 8/211 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL   + +     +     + +L+QLL+GL + HS 
Sbjct: 71  LDVIH-----TENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
            A+DIWS+GCI  E++TR  LFPG   + QL
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 216

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  162 bits (409), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 88/211 (41%), Positives = 121/211 (57%), Gaps = 8/211 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL   + +     +     + +L+QLL+GL + HS 
Sbjct: 68  LDVIH-----TENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+
Sbjct: 123 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
            A+DIWS+GCI  E++TR  LFPG   + QL
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  161 bits (408), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 89/211 (42%), Positives = 122/211 (57%), Gaps = 8/211 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL   + +     +     + +L+QLL+GL + HS 
Sbjct: 67  LDVIH-----TENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
            A+DIWS+GCI  E++TR  LFPG   + QL
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 212

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  160 bits (406), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 88/211 (41%), Positives = 122/211 (57%), Gaps = 8/211 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 68  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL    Y+
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYS 182
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
            A+DIWS+GCI  E++TR  LFPG   + QL
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  160 bits (406), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 88/211 (41%), Positives = 122/211 (57%), Gaps = 8/211 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 15  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 74
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 75  LDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 129
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL    Y+
Sbjct: 130 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYS 189
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
            A+DIWS+GCI  E++TR  LFPG   + QL
Sbjct: 190 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 220

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  157 bits (396), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 89/211 (42%), Positives = 124/211 (58%), Gaps = 8/211 (3%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G YG V  A N ET E VA+K++    D+       LREI LL+ ++H+N++ + D+
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           +   KK T     +V+E  D DL +   S +  L  +  + FL+QLL+GL + HS +VLH
Sbjct: 70  LHSDKKLT-----LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLH 124
Query: 169 RDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAID 227
           RDLKP NLL+N + +LK+ DFGLAR         +  VVT WYR P++L     Y+ +ID
Sbjct: 125 RDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSID 184
Query: 228 IWSVGCILGEIM-TREPLFPGKDYVHQLRLI 257
           +WS GCI  E+     PLFPG D   QL+ I
Sbjct: 185 MWSAGCIFAELANAARPLFPGNDVDDQLKRI 215

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  157 bits (396), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 84/201 (41%), Positives = 128/201 (63%), Gaps = 10/201 (4%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG-NAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G G YG+V  A +S+ R  VA+K+I  +A D  I +   +REI LL+ + H N++++ D
Sbjct: 29  VGEGTYGVVYKAKDSQGRI-VALKRIRLDAEDEGIPST-AIREISLLKELHHPNIVSLID 86
Query: 109 IIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSASVL 167
           +I   +  T     +V+E M+ DL +++  ++  L D   + +LYQLLRG+ + H   +L
Sbjct: 87  VIHSERCLT-----LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRIL 141
Query: 168 HRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAI 226
           HRDLKP NLL+N+   LK+ DFGLAR         T  VVT WYRAP++L+   +Y+ ++
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSV 201
Query: 227 DIWSVGCILGEIMTREPLFPG 247
           DIWS+GCI  E++T +PLFPG
Sbjct: 202 DIWSIGCIFAEMITGKPLFPG 222

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  156 bits (395), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 84/201 (41%), Positives = 128/201 (63%), Gaps = 10/201 (4%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG-NAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G G YG+V  A +S+ R  VA+K+I  +A D  I +   +REI LL+ + H N++++ D
Sbjct: 29  VGEGTYGVVYKAKDSQGRI-VALKRIRLDAEDEGIPST-AIREISLLKELHHPNIVSLID 86
Query: 109 IIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSASVL 167
           +I   +  T     +V+E M+ DL +++  ++  L D   + +LYQLLRG+ + H   +L
Sbjct: 87  VIHSERCLT-----LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRIL 141
Query: 168 HRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAI 226
           HRDLKP NLL+N+   LK+ DFGLAR         T  VVT WYRAP++L+   +Y+ ++
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSV 201
Query: 227 DIWSVGCILGEIMTREPLFPG 247
           DIWS+GCI  E++T +PLFPG
Sbjct: 202 DIWSIGCIFAEMITGKPLFPG 222

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  155 bits (392), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 88/211 (41%), Positives = 124/211 (58%), Gaps = 8/211 (3%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G YG V  A N ET E VA+K++    D+       LREI LL+ ++H+N++ + D+
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           +   KK T     +V+E  D DL +   S +  L  +  + FL+QLL+GL + HS +VLH
Sbjct: 70  LHSDKKLT-----LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLH 124
Query: 169 RDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAID 227
           RDLKP NLL+N + +LK+ +FGLAR         +  VVT WYR P++L     Y+ +ID
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSID 184
Query: 228 IWSVGCILGEIMTR-EPLFPGKDYVHQLRLI 257
           +WS GCI  E+     PLFPG D   QL+ I
Sbjct: 185 MWSAGCIFAELANAGRPLFPGNDVDDQLKRI 215

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  155 bits (391), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 89/218 (40%), Positives = 125/218 (57%), Gaps = 14/218 (6%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKI-----GNAFDNIIDARRTLREIKLLRHMEHENVI 104
           +G G +  V  A +  T + VAIKKI       A D I   R  LREIKLL+ + H N+I
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGI--NRTALREIKLLQELSHPNII 75
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHS 163
            + D          +++ +V++ M+TDL  II+ +   LT  H + ++   L+GL+Y+H 
Sbjct: 76  GLLDAF-----GHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 130
Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEY 222
             +LHRDLKP+NLLL+ +  LK+ DFGLA++  S        VVTRWYRAPELL     Y
Sbjct: 131 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMY 190
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
              +D+W+VGCIL E++ R P  PG   + QL  I E 
Sbjct: 191 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFET 228

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  152 bits (385), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 87/213 (40%), Positives = 118/213 (55%), Gaps = 8/213 (3%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G Y  V    +  T   VA+K+I    +        +RE+ LL+ ++H N++ + DI
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCT-AIREVSLLKDLKHANIVTLHDI 68
Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDH-CQYFLYQLLRGLKYVHSASVLH 168
           I   K  T     +V+E +D DL Q +     + + H  + FL+QLLRGL Y H   VLH
Sbjct: 69  IHTEKSLT-----LVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLH 123
Query: 169 RDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAID 227
           RDLKP NLL+N   +LK+ DFGLAR  S  T      VVT WYR P++LL  T+Y+  ID
Sbjct: 124 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQID 183
Query: 228 IWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           +W VGCI  E+ T  PLFPG     QL  I  +
Sbjct: 184 MWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRI 216

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  152 bits (383), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 87/216 (40%), Positives = 123/216 (56%), Gaps = 8/216 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N+   E  A+KKI    ++      T+REI +L+ ++H N++ +
Sbjct: 7   LEKIGEGTYGVVYKAQNNYG-ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            D+I   K+     + +V+E +D DL +++   +  L     + FL QLL G+ Y H   
Sbjct: 66  YDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           VLHRDLKP NLL+N   +LKI DFGLAR         T  VVT WYRAP++L+   +Y+ 
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYST 180
Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
            IDIWSVGCI  E++   PLFPG     QL  I  +
Sbjct: 181 TIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRI 216

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  152 bits (383), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 87/216 (40%), Positives = 123/216 (56%), Gaps = 8/216 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N+   E  A+KKI    ++      T+REI +L+ ++H N++ +
Sbjct: 7   LEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            D+I   K+     + +V+E +D DL +++   +  L     + FL QLL G+ Y H   
Sbjct: 66  YDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           VLHRDLKP NLL+N   +LKI DFGLAR         T  VVT WYRAP++L+   +Y+ 
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYST 180
Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
            IDIWSVGCI  E++   PLFPG     QL  I  +
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRI 216

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  151 bits (382), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 83/220 (37%), Positives = 125/220 (56%), Gaps = 11/220 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           I  +G G YG V  A+++ T E VAIK+I    +        +RE+ LL+ ++H N+I +
Sbjct: 39  ITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIEL 98
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           K +I    +     +++++E  + DL + +  +  ++    + FLYQL+ G+ + HS   
Sbjct: 99  KSVIHHNHR-----LHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRC 153
Query: 167 LHRDLKPSNLLLNASCD-----LKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCT 220
           LHRDLKP NLLL+ S       LKIGDFGLAR         T  ++T WYR PE+LL   
Sbjct: 154 LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSR 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
            Y+ ++DIWS+ CI  E++ + PLFPG   + QL  I EV
Sbjct: 214 HYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEV 253

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  151 bits (381), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 86/216 (39%), Positives = 123/216 (56%), Gaps = 8/216 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N+   E  A+KKI    ++      T+REI +L+ ++H N++ +
Sbjct: 7   LEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            D+I   K+     + +V+E +D DL +++   +  L     + FL QLL G+ Y H   
Sbjct: 66  YDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           VLHRDLKP NLL+N   +LKI DFGLAR         T  +VT WYRAP++L+   +Y+ 
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180
Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
            IDIWSVGCI  E++   PLFPG     QL  I  +
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRI 216

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  151 bits (381), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 133/222 (59%), Gaps = 7/222 (3%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
           NL+  S +    +  +G G+YG+V    N +T   VAIKK   + D+ +  +  +REIKL
Sbjct: 18  NLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKL 77
Query: 95  LRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQ 153
           L+ + HEN++ + ++ +  K+      Y+V+E +D T L  +      L     Q +L+Q
Sbjct: 78  LKQLRHENLVNLLEVCKKKKR-----WYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQ 132
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRA 212
           ++ G+ + HS +++HRD+KP N+L++ S  +K+ DFG ART  +  +   + V TRWYRA
Sbjct: 133 IINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRA 192
Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
           PELL+   +Y  A+D+W++GC++ E+   EPLFPG   + QL
Sbjct: 193 PELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQL 234

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  150 bits (379), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 75/213 (35%), Positives = 131/213 (61%), Gaps = 7/213 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           I  IG G+YG+V    N +T + VAIKK   + D+ +  +  LREI++L+ ++H N++ +
Sbjct: 8   IGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNL 67
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++ R  ++     +++V+E  D T LH++ R  + + +   +   +Q L+ + + H  +
Sbjct: 68  LEVFRRKRR-----LHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN 122
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
            +HRD+KP N+L+     +K+ DFG AR  T  +D+  + V TRWYR+PELL+  T+Y  
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGP 182
Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
            +D+W++GC+  E+++  PL+PGK  V QL LI
Sbjct: 183 PVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLI 215

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  144 bits (364), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 85/217 (39%), Positives = 125/217 (57%), Gaps = 7/217 (3%)
Query: 50  IGRGAYGIVCAAVNSETREE-VAIKKIGNAFDNIIDARRTLREIKLLRHME---HENVIA 105
           IG GAYG V  A + +     VA+K++            T+RE+ +LRH+E   H NV+ 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHS 163
           + D+    + D    + +V+E +D DL   +    +  +  +  +  ++QLLRGL ++HS
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 138
Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
             V+HRDLKP N+L+ +S  +K+ DFGLAR  S    +T  VVT WYRAPE+LL  + Y 
Sbjct: 139 HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ-SSYA 197
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
             +D+WSVGCI  E+  R+PLF G   V QL  I +V
Sbjct: 198 TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 234

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  144 bits (363), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 85/217 (39%), Positives = 125/217 (57%), Gaps = 7/217 (3%)
Query: 50  IGRGAYGIVCAAVNSETREE-VAIKKIGNAFDNIIDARRTLREIKLLRHME---HENVIA 105
           IG GAYG V  A + +     VA+K++            T+RE+ +LRH+E   H NV+ 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHS 163
           + D+    + D    + +V+E +D DL   +    +  +  +  +  ++QLLRGL ++HS
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 138
Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
             V+HRDLKP N+L+ +S  +K+ DFGLAR  S    +T  VVT WYRAPE+LL  + Y 
Sbjct: 139 HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ-SSYA 197
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
             +D+WSVGCI  E+  R+PLF G   V QL  I +V
Sbjct: 198 TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 234

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  144 bits (362), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 85/217 (39%), Positives = 125/217 (57%), Gaps = 7/217 (3%)
Query: 50  IGRGAYGIVCAAVNSETREE-VAIKKIGNAFDNIIDARRTLREIKLLRHME---HENVIA 105
           IG GAYG V  A + +     VA+K++            T+RE+ +LRH+E   H NV+ 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHS 163
           + D+    + D    + +V+E +D DL   +    +  +  +  +  ++QLLRGL ++HS
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 138
Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
             V+HRDLKP N+L+ +S  +K+ DFGLAR  S    +T  VVT WYRAPE+LL  + Y 
Sbjct: 139 HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ-SSYA 197
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
             +D+WSVGCI  E+  R+PLF G   V QL  I +V
Sbjct: 198 TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 234

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  142 bits (357), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 81/222 (36%), Positives = 132/222 (59%), Gaps = 22/222 (9%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKI--GNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           IG G++G+V  A   ++ E VAIKK+  G AF N        RE++++R ++H N++ ++
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN--------RELQIMRKLDHCNIVRLR 79
Query: 108 DIIRPP--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLK 159
                   KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L 
Sbjct: 80  YFFYSSGEKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 160 YVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
           Y+HS  + HRD+KP NLLL+  +  LK+ DFG A+     +    Y+ +R+YRAPEL+  
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196
Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
            T+YT++ID+WS GC+L E++  +P+FPG   V QL  I +V
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 238

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  141 bits (356), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 81/222 (36%), Positives = 132/222 (59%), Gaps = 22/222 (9%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKI--GNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           IG G++G+V  A   ++ E VAIKK+  G AF N        RE++++R ++H N++ ++
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN--------RELQIMRKLDHCNIVRLR 79
Query: 108 DIIRPP--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLK 159
                   KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L 
Sbjct: 80  YFFYSSGEKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 160 YVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
           Y+HS  + HRD+KP NLLL+  +  LK+ DFG A+     +    Y+ +R+YRAPEL+  
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196
Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
            T+YT++ID+WS GC+L E++  +P+FPG   V QL  I +V
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 238

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  140 bits (354), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 85/229 (37%), Positives = 124/229 (54%), Gaps = 9/229 (3%)
Query: 34  GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIK--KIGNAFDNIIDAR-RTLR 90
           G L  +++    P+  IG GAYG V  A +  +   VA+K  ++ N           T+R
Sbjct: 1   GPLGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR 60
Query: 91  EIKLLRHME---HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII--RSDQQLTDD 145
           E+ LLR +E   H NV+ + D+    + D    V +V+E +D DL   +       L  +
Sbjct: 61  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE 120
Query: 146 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 205
             +  + Q LRGL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    +T  V
Sbjct: 121 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVV 180
Query: 206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
           VT WYRAPE+LL  T Y   +D+WSVGCI  E+  R+PLF G     QL
Sbjct: 181 VTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL 228

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  140 bits (354), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 84/223 (37%), Positives = 125/223 (56%), Gaps = 11/223 (4%)
Query: 39  VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIK--KIGNAFDNIIDARRTLREIKLLR 96
            +S+Y P +  IG GAYG V  A +  +   VA+K  ++ N  + +  +  T+RE+ LLR
Sbjct: 2   ATSRYEP-VAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPIS--TVREVALLR 58
Query: 97  HME---HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII--RSDQQLTDDHCQYFL 151
            +E   H NV+ + D+    + D    V +V+E +D DL   +       L  +  +  +
Sbjct: 59  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 118
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYR 211
            Q LRGL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    +   VVT WYR
Sbjct: 119 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYR 178
Query: 212 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
           APE+LL  T Y   +D+WSVGCI  E+  R+PLF G     QL
Sbjct: 179 APEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL 220

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 84/223 (37%), Positives = 125/223 (56%), Gaps = 11/223 (4%)
Query: 39  VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIK--KIGNAFDNIIDARRTLREIKLLR 96
            +S+Y P +  IG GAYG V  A +  +   VA+K  ++ N  + +  +  T+RE+ LLR
Sbjct: 2   ATSRYEP-VAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPIS--TVREVALLR 58
Query: 97  HME---HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII--RSDQQLTDDHCQYFL 151
            +E   H NV+ + D+    + D    V +V+E +D DL   +       L  +  +  +
Sbjct: 59  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 118
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYR 211
            Q LRGL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    +   VVT WYR
Sbjct: 119 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYR 178
Query: 212 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
           APE+LL  T Y   +D+WSVGCI  E+  R+PLF G     QL
Sbjct: 179 APEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL 220

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 84/223 (37%), Positives = 125/223 (56%), Gaps = 11/223 (4%)
Query: 39  VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIK--KIGNAFDNIIDARRTLREIKLLR 96
            +S+Y P +  IG GAYG V  A +  +   VA+K  ++ N  + +  +  T+RE+ LLR
Sbjct: 2   ATSRYEP-VAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPIS--TVREVALLR 58
Query: 97  HME---HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII--RSDQQLTDDHCQYFL 151
            +E   H NV+ + D+    + D    V +V+E +D DL   +       L  +  +  +
Sbjct: 59  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 118
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYR 211
            Q LRGL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    +   VVT WYR
Sbjct: 119 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYR 178
Query: 212 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
           APE+LL  T Y   +D+WSVGCI  E+  R+PLF G     QL
Sbjct: 179 APEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL 220

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 79/220 (35%), Positives = 131/220 (59%), Gaps = 18/220 (8%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G+V  A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++  
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYF 160
Query: 110 IRPP--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYV 161
                 KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+
Sbjct: 161 FYSSGEKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 217
Query: 162 HSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  + HRD+KP NLLL+  +  LK+ DFG A+     +    Y+ +R+YRAPEL+   T
Sbjct: 218 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 277
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           +YT++ID+WS GC+L E++  +P+FPG   V QL  I +V
Sbjct: 278 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 317

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 79/220 (35%), Positives = 131/220 (59%), Gaps = 18/220 (8%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G+V  A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++  
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYF 119
Query: 110 IRPP--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYV 161
                 KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+
Sbjct: 120 FYSSGEKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 176
Query: 162 HSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  + HRD+KP NLLL+  +  LK+ DFG A+     +    Y+ +R+YRAPEL+   T
Sbjct: 177 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 236
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           +YT++ID+WS GC+L E++  +P+FPG   V QL  I +V
Sbjct: 237 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 276

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  139 bits (350), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 79/220 (35%), Positives = 131/220 (59%), Gaps = 18/220 (8%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G+V  A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++  
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYF 109
Query: 110 IRPP--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYV 161
                 KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+
Sbjct: 110 FYSSGEKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 166
Query: 162 HSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  + HRD+KP NLLL+  +  LK+ DFG A+     +    Y+ +R+YRAPEL+   T
Sbjct: 167 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 226
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           +YT++ID+WS GC+L E++  +P+FPG   V QL  I +V
Sbjct: 227 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 266

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  139 bits (350), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 79/220 (35%), Positives = 131/220 (59%), Gaps = 18/220 (8%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G+V  A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++  
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYF 94
Query: 110 IRPP--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYV 161
                 KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+
Sbjct: 95  FYSSGEKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 151
Query: 162 HSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  + HRD+KP NLLL+  +  LK+ DFG A+     +    Y+ +R+YRAPEL+   T
Sbjct: 152 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 211
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           +YT++ID+WS GC+L E++  +P+FPG   V QL  I +V
Sbjct: 212 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 251

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  139 bits (350), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 79/220 (35%), Positives = 131/220 (59%), Gaps = 18/220 (8%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G+V  A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++  
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYF 115
Query: 110 IRPP--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYV 161
                 KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+
Sbjct: 116 FYSSGEKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172
Query: 162 HSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  + HRD+KP NLLL+  +  LK+ DFG A+     +    Y+ +R+YRAPEL+   T
Sbjct: 173 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 232
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           +YT++ID+WS GC+L E++  +P+FPG   V QL  I +V
Sbjct: 233 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 272

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  139 bits (350), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 79/220 (35%), Positives = 131/220 (59%), Gaps = 18/220 (8%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G+V  A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++  
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYF 117
Query: 110 IRPP--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYV 161
                 KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+
Sbjct: 118 FYSSGEKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 174
Query: 162 HSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  + HRD+KP NLLL+  +  LK+ DFG A+     +    Y+ +R+YRAPEL+   T
Sbjct: 175 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 234
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           +YT++ID+WS GC+L E++  +P+FPG   V QL  I +V
Sbjct: 235 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 274

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 79/220 (35%), Positives = 131/220 (59%), Gaps = 18/220 (8%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G+V  A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++  
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYF 86
Query: 110 IRPP--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYV 161
                 KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+
Sbjct: 87  FYSSGEKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 143
Query: 162 HSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  + HRD+KP NLLL+  +  LK+ DFG A+     +    Y+ +R+YRAPEL+   T
Sbjct: 144 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 203
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           +YT++ID+WS GC+L E++  +P+FPG   V QL  I +V
Sbjct: 204 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 243

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 131/222 (59%), Gaps = 22/222 (9%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKI--GNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           IG G++G+V  A   ++ E VAIKK+  G AF N        RE++++R ++H N++ ++
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN--------RELQIMRKLDHCNIVRLR 79
Query: 108 DIIRPP--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLK 159
                   KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L 
Sbjct: 80  YFFYSSGEKKD---EVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 160 YVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
           Y+HS  + HRD+KP NLLL+  +  LK+ DFG A+     +     + +R+YRAPEL+  
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 196
Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
            T+YT++ID+WS GC+L E++  +P+FPG   V QL  I +V
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 238

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 79/220 (35%), Positives = 131/220 (59%), Gaps = 18/220 (8%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G+V  A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++  
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYF 81
Query: 110 IRPP--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYV 161
                 KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+
Sbjct: 82  FYSSGEKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 162 HSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  + HRD+KP NLLL+  +  LK+ DFG A+     +    Y+ +R+YRAPEL+   T
Sbjct: 139 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 198
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           +YT++ID+WS GC+L E++  +P+FPG   V QL  I +V
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 238

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  137 bits (346), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 139/262 (53%), Gaps = 44/262 (16%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
            E SSK     + +G G++GIVC   + E+ +  A+KK+      + D R   RE+ +++
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV------LQDPRYKNRELDIMK 55
Query: 97  HMEHENVIAIKDII--------RPP-----------KKDTFND--------------VYI 123
            ++H N+I + D          +PP           K +  N+              + +
Sbjct: 56  VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115
Query: 124 VYELMDTDLHQI----IRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 179
           + E +   LH++    IRS + +  +    ++YQL R + ++HS  + HRD+KP NLL+N
Sbjct: 116 IMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN 175
Query: 180 ASCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 238
           +  + LK+ DFG A+    ++     + +R+YRAPEL+L  TEYT +ID+WS+GC+ GE+
Sbjct: 176 SKDNTLKLCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235
Query: 239 MTREPLFPGKDYVHQLRLITEV 260
           +  +PLF G+  + QL  I ++
Sbjct: 236 ILGKPLFSGETSIDQLVRIIQI 257

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  137 bits (344), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 79/220 (35%), Positives = 123/220 (55%), Gaps = 9/220 (4%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG+G +G V  A + +T ++VA+KK+    +        LREIK+L+ ++HENV+ + +I
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 110 IR---PPKKDTFNDVYIVYELMDTDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSAS 165
            R    P       +Y+V++  + DL  ++ +   + T    +  +  LL GL Y+H   
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK 145
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLART-----TSETDFMTEYVVTRWYRAPELLLNCT 220
           +LHRD+K +N+L+     LK+ DFGLAR       S+ +     VVT WYR PELLL   
Sbjct: 146 ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGER 205
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           +Y   ID+W  GCI+ E+ TR P+  G    HQL LI+++
Sbjct: 206 DYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 245

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  137 bits (344), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 79/220 (35%), Positives = 123/220 (55%), Gaps = 9/220 (4%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG+G +G V  A + +T ++VA+KK+    +        LREIK+L+ ++HENV+ + +I
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 110 IR---PPKKDTFNDVYIVYELMDTDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSAS 165
            R    P       +Y+V++  + DL  ++ +   + T    +  +  LL GL Y+H   
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK 145
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLART-----TSETDFMTEYVVTRWYRAPELLLNCT 220
           +LHRD+K +N+L+     LK+ DFGLAR       S+ +     VVT WYR PELLL   
Sbjct: 146 ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGER 205
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           +Y   ID+W  GCI+ E+ TR P+  G    HQL LI+++
Sbjct: 206 DYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 245

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  137 bits (344), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 79/220 (35%), Positives = 123/220 (55%), Gaps = 9/220 (4%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG+G +G V  A + +T ++VA+KK+    +        LREIK+L+ ++HENV+ + +I
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 110 IR---PPKKDTFNDVYIVYELMDTDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSAS 165
            R    P       +Y+V++  + DL  ++ +   + T    +  +  LL GL Y+H   
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK 144
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLART-----TSETDFMTEYVVTRWYRAPELLLNCT 220
           +LHRD+K +N+L+     LK+ DFGLAR       S+ +     VVT WYR PELLL   
Sbjct: 145 ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGER 204
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           +Y   ID+W  GCI+ E+ TR P+  G    HQL LI+++
Sbjct: 205 DYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 244

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 78/220 (35%), Positives = 130/220 (59%), Gaps = 18/220 (8%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G+V  A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++  
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYF 85
Query: 110 IRPP--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYV 161
                 KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+
Sbjct: 86  FYSSGEKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 142
Query: 162 HSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  + HRD+KP NLLL+  +  LK+ DFG A+     +     + +R+YRAPEL+   T
Sbjct: 143 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGAT 202
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           +YT++ID+WS GC+L E++  +P+FPG   V QL  I +V
Sbjct: 203 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 242

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 78/220 (35%), Positives = 130/220 (59%), Gaps = 18/220 (8%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G+V  A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++  
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYF 93
Query: 110 IRPP--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYV 161
                 KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+
Sbjct: 94  FYSSGEKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 150
Query: 162 HSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  + HRD+KP NLLL+  +  LK+ DFG A+     +     + +R+YRAPEL+   T
Sbjct: 151 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGAT 210
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           +YT++ID+WS GC+L E++  +P+FPG   V QL  I +V
Sbjct: 211 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 250

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 80/221 (36%), Positives = 125/221 (56%), Gaps = 11/221 (4%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG+G +G V  A + +T ++VA+KK+    +        LREIK+L+ ++HENV+ + +I
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 110 IRPPKKDTFN----DVYIVYELMDTDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSA 164
            R  K   +N     +Y+V++  + DL  ++ +   + T    +  +  LL GL Y+H  
Sbjct: 86  CRT-KASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN 144
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLART-----TSETDFMTEYVVTRWYRAPELLLNC 219
            +LHRD+K +N+L+     LK+ DFGLAR       S+ +     VVT WYR PELLL  
Sbjct: 145 KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGE 204
Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
            +Y   ID+W  GCI+ E+ TR P+  G    HQL LI+++
Sbjct: 205 RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 245

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 78/220 (35%), Positives = 130/220 (59%), Gaps = 18/220 (8%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G+V  A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++  
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYF 81
Query: 110 IRPP--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYV 161
                 KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+
Sbjct: 82  FYSSGEKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 162 HSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  + HRD+KP NLLL+  +  LK+ DFG A+     +     + +R+YRAPEL+   T
Sbjct: 139 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGAT 198
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           +YT++ID+WS GC+L E++  +P+FPG   V QL  I +V
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 238

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  136 bits (342), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 78/220 (35%), Positives = 130/220 (59%), Gaps = 18/220 (8%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G+V  A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++  
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYF 100
Query: 110 IRPP--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYV 161
                 KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+
Sbjct: 101 FYSSGEKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 157
Query: 162 HSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  + HRD+KP NLLL+  +  LK+ DFG A+     +     + +R+YRAPEL+   T
Sbjct: 158 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGAT 217
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           +YT++ID+WS GC+L E++  +P+FPG   V QL  I +V
Sbjct: 218 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 257

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  136 bits (342), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 78/220 (35%), Positives = 130/220 (59%), Gaps = 18/220 (8%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G+V  A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++  
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYF 89
Query: 110 IRPP--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYV 161
                 KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+
Sbjct: 90  FYSSGEKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 146
Query: 162 HSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  + HRD+KP NLLL+  +  LK+ DFG A+     +     + +R+YRAPEL+   T
Sbjct: 147 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGAT 206
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           +YT++ID+WS GC+L E++  +P+FPG   V QL  I +V
Sbjct: 207 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 246

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  136 bits (342), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 78/220 (35%), Positives = 130/220 (59%), Gaps = 18/220 (8%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G+V  A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++  
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYF 115
Query: 110 IRPP--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYV 161
                 KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+
Sbjct: 116 FYSSGEKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172
Query: 162 HSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  + HRD+KP NLLL+  +  LK+ DFG A+     +     + +R+YRAPEL+   T
Sbjct: 173 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGAT 232
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           +YT++ID+WS GC+L E++  +P+FPG   V QL  I +V
Sbjct: 233 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 272

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  136 bits (342), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 78/220 (35%), Positives = 130/220 (59%), Gaps = 18/220 (8%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G+V  A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++  
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYF 93
Query: 110 IRPP--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYV 161
                 KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+
Sbjct: 94  FYSSGEKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 150
Query: 162 HSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  + HRD+KP NLLL+  +  LK+ DFG A+     +     + +R+YRAPEL+   T
Sbjct: 151 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGAT 210
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           +YT++ID+WS GC+L E++  +P+FPG   V QL  I +V
Sbjct: 211 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 250

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  136 bits (342), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 78/220 (35%), Positives = 130/220 (59%), Gaps = 18/220 (8%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G+V  A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++  
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYF 82
Query: 110 IRPP--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYV 161
                 KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+
Sbjct: 83  FYSSGEKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 139
Query: 162 HSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  + HRD+KP NLLL+  +  LK+ DFG A+     +     + +R+YRAPEL+   T
Sbjct: 140 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGAT 199
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           +YT++ID+WS GC+L E++  +P+FPG   V QL  I +V
Sbjct: 200 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 239

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  136 bits (342), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 78/220 (35%), Positives = 130/220 (59%), Gaps = 18/220 (8%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G+V  A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++  
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYF 81
Query: 110 IRPP--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYV 161
                 KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+
Sbjct: 82  FYSSGEKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 162 HSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  + HRD+KP NLLL+  +  LK+ DFG A+     +     + +R+YRAPEL+   T
Sbjct: 139 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGAT 198
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           +YT++ID+WS GC+L E++  +P+FPG   V QL  I +V
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 238

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  135 bits (340), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 78/220 (35%), Positives = 129/220 (58%), Gaps = 18/220 (8%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G+V  A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++  
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYF 81
Query: 110 IRPP--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYV 161
                 KKD    VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+
Sbjct: 82  FYSSGEKKDV---VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 162 HSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  + HRD+KP NLLL+  +  LK+ DFG A+     +     + +R+YRAPEL+   T
Sbjct: 139 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGAT 198
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           +YT++ID+WS GC+L E++  +P+FPG   V QL  I +V
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 238

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  135 bits (339), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 81/218 (37%), Positives = 126/218 (57%), Gaps = 15/218 (6%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G+V  A   E+ +EVAIKK+      + D R   RE++++R ++H NV+ +K  
Sbjct: 48  IGNGSFGVVFQAKLVES-DEVAIKKV------LQDKRFKNRELQIMRIVKHPNVVDLKAF 100
Query: 110 IRPPKKDTFNDVYI--VYELMDTDLHQIIRSDQQLTDDH----CQYFLYQLLRGLKYVHS 163
                 D  ++V++  V E +   +++  R   +L         + ++YQLLR L Y+HS
Sbjct: 101 FYS-NGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS 159
Query: 164 ASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             + HRD+KP NLLL+  S  LK+ DFG A+     +     + +R+YRAPEL+   T Y
Sbjct: 160 IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRAPELIFGATNY 219
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           T  IDIWS GC++ E+M  +PLFPG+  + QL  I +V
Sbjct: 220 TTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKV 257

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 79/225 (35%), Positives = 121/225 (53%), Gaps = 18/225 (8%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM---EHENVI 104
           R  G+G +G V       T   VAIKK+      I D R   RE+++++ +    H N++
Sbjct: 29  RMAGQGTFGTVQLGKEKSTGMSVAIKKV------IQDPRFRNRELQIMQDLAVLHHPNIV 82
Query: 105 AIKDIIRPPKKDTFNDVY--IVYELMDTDLHQIIRS--DQQLTDDHC--QYFLYQLLRGL 158
            ++       +    D+Y  +V E +   LH+  R+   +Q+       + FL+QL+R +
Sbjct: 83  QLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSI 142
Query: 159 KYVH--SASVLHRDLKPSNLLLN-ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL 215
             +H  S +V HRD+KP N+L+N A   LK+ DFG A+  S ++    Y+ +R+YRAPEL
Sbjct: 143 GCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPEL 202
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           +     YT A+DIWSVGCI  E+M  EP+F G +   QL  I  V
Sbjct: 203 IFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  119 bits (297), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 76/215 (35%), Positives = 115/215 (53%), Gaps = 26/215 (12%)
Query: 50  IGRGAYGIV--CAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           +GRG YG V      + +  ++ A+K+I     ++       REI LLR ++H NVI+++
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISM----SACREIALLRELKHPNVISLQ 84
Query: 108 DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ---------QLTDDHCQYFLYQLLRGL 158
            +           V+++++  + DL  II+  +         QL     +  LYQ+L G+
Sbjct: 85  KVFL---SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141
Query: 159 KYVHSASVLHRDLKPSNLLLNASCD----LKIGDFGLARTTSET----DFMTEYVVTRWY 210
            Y+H+  VLHRDLKP+N+L+         +KI D G AR  +        +   VVT WY
Sbjct: 142 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 201
Query: 211 RAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 245
           RAPELLL    YT AIDIW++GCI  E++T EP+F
Sbjct: 202 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 236

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  117 bits (293), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 73/218 (33%), Positives = 122/218 (55%), Gaps = 15/218 (6%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH-ENVIA 105
           +R +GRG Y  V  A+N    E+V +K +     N I      REIK+L ++    N+I 
Sbjct: 42  VRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIK-----REIKILENLRGGPNIIT 96
Query: 106 IKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y HS 
Sbjct: 97  LADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM 150
Query: 165 SVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
            ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++   Y 
Sbjct: 151 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 210
Query: 224 AAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITEV 260
            ++D+WS+GC+L  ++ R EP F G D   QL  I +V
Sbjct: 211 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 248

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 121/219 (55%), Gaps = 11/219 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG+G++G V  A + +  + VA+K + N        R+   EI++L H+  ++    
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRF---HRQAAEEIRILEHLRKQDKDNT 158
Query: 107 KDIIRPPKKDTF-NDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHS 163
            ++I   +  TF N + + +EL+  +L+++I+ +  Q  +    + F + +L+ L  +H 
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK 218
Query: 164 ASVLHRDLKPSNLLL--NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
             ++H DLKP N+LL       +K+ DFG   +  E   +   + +R+YRAPE++L    
Sbjct: 219 NRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYTXIQSRFYRAPEVILG-AR 275
Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           Y   ID+WS+GCIL E++T  PL PG+D   QL  + E+
Sbjct: 276 YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIEL 314

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 110/204 (53%), Gaps = 11/204 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+G++G V    +  T++E A+K I  A     D    LRE++LL+ ++H N++ + +I
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 110 IRPPKKDTFNDVYIVYEL-MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           +        +  YIV EL    +L   I   ++ ++      + Q+  G+ Y+H  +++H
Sbjct: 90  LEDS-----SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVH 144
Query: 169 RDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           RDLKP N+LL +    CD+KI DFGL+    +   M + + T +Y APE+L     Y   
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEK 202
Query: 226 IDIWSVGCILGEIMTREPLFPGKD 249
            D+WS G IL  +++  P F GK+
Sbjct: 203 CDVWSAGVILYILLSGTPPFYGKN 226

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score =  107 bits (268), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 121/219 (55%), Gaps = 11/219 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG+G++G V  A + +  + VA+K + N        R+   EI++L H+  ++    
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRF---HRQAAEEIRILEHLRKQDKDNT 158
Query: 107 KDIIRPPKKDTF-NDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHS 163
            ++I   +  TF N + + +EL+  +L+++I+ +  Q  +    + F + +L+ L  +H 
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK 218
Query: 164 ASVLHRDLKPSNLLL--NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
             ++H DLKP N+LL       +K+ DFG   +  E   +   + +R+YRAPE++L    
Sbjct: 219 NRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYTXIQSRFYRAPEVILG-AR 275
Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           Y   ID+WS+GCIL E++T  PL PG+D   QL  + E+
Sbjct: 276 YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIEL 314

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  107 bits (268), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 110/204 (53%), Gaps = 11/204 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+G++G V    +  T++E A+K I  A     D    LRE++LL+ ++H N++ + +I
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 110 IRPPKKDTFNDVYIVYEL-MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           +        +  YIV EL    +L   I   ++ ++      + Q+  G+ Y+H  +++H
Sbjct: 90  LEDS-----SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVH 144
Query: 169 RDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           RDLKP N+LL +    CD+KI DFGL+    +   M + + T +Y APE+L     Y   
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEK 202
Query: 226 IDIWSVGCILGEIMTREPLFPGKD 249
            D+WS G IL  +++  P F GK+
Sbjct: 203 CDVWSAGVILYILLSGTPPFYGKN 226

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  107 bits (267), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 110/204 (53%), Gaps = 11/204 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+G++G V    +  T++E A+K I  A     D    LRE++LL+ ++H N++ + +I
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 110 IRPPKKDTFNDVYIVYEL-MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           +        +  YIV EL    +L   I   ++ ++      + Q+  G+ Y+H  +++H
Sbjct: 90  LEDS-----SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVH 144
Query: 169 RDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           RDLKP N+LL +    CD+KI DFGL+    +   M + + T +Y APE+L     Y   
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEK 202
Query: 226 IDIWSVGCILGEIMTREPLFPGKD 249
            D+WS G IL  +++  P F GK+
Sbjct: 203 CDVWSAGVILYILLSGTPPFYGKN 226

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score =  107 bits (266), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 120/219 (54%), Gaps = 11/219 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG+G +G V  A + +  + VA+K + N        R+   EI++L H+  ++    
Sbjct: 102 LKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRF---HRQAAEEIRILEHLRKQDKDNT 158
Query: 107 KDIIRPPKKDTF-NDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHS 163
            ++I   +  TF N + + +EL+  +L+++I+ +  Q  +    + F + +L+ L  +H 
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK 218
Query: 164 ASVLHRDLKPSNLLL--NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
             ++H DLKP N+LL       +K+ DFG   +  E   +   + +R+YRAPE++L    
Sbjct: 219 NRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYXXIQSRFYRAPEVILG-AR 275
Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           Y   ID+WS+GCIL E++T  PL PG+D   QL  + E+
Sbjct: 276 YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIEL 314

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 110/210 (52%), Gaps = 18/210 (8%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT------LREIKLLRHMEHE 101
           + +G GA G V  A   +T ++VAIK I      I  AR          EI++L+ + H 
Sbjct: 22  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 81
Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
            +I IK+           D YIV ELM+  +L   +  +++L +  C+ + YQ+L  ++Y
Sbjct: 82  CIIKIKNFFDA------EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 135
Query: 161 VHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LL++    C +KI DFG ++   ET  M     T  Y APE+L+
Sbjct: 136 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 195
Query: 218 N--CTEYTAAIDIWSVGCILGEIMTREPLF 245
           +     Y  A+D WS+G IL   ++  P F
Sbjct: 196 SVGTAGYNRAVDCWSLGVILFICLSGYPPF 225

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 110/210 (52%), Gaps = 18/210 (8%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT------LREIKLLRHMEHE 101
           + +G GA G V  A   +T ++VAIK I      I  AR          EI++L+ + H 
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
            +I IK+           D YIV ELM+  +L   +  +++L +  C+ + YQ+L  ++Y
Sbjct: 76  CIIKIKNFFDA------EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 161 VHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LL++    C +KI DFG ++   ET  M     T  Y APE+L+
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 189
Query: 218 N--CTEYTAAIDIWSVGCILGEIMTREPLF 245
           +     Y  A+D WS+G IL   ++  P F
Sbjct: 190 SVGTAGYNRAVDCWSLGVILFICLSGYPPF 219

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  105 bits (263), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 110/210 (52%), Gaps = 18/210 (8%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT------LREIKLLRHMEHE 101
           + +G GA G V  A   +T ++VAIK I      I  AR          EI++L+ + H 
Sbjct: 15  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 74
Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
            +I IK+           D YIV ELM+  +L   +  +++L +  C+ + YQ+L  ++Y
Sbjct: 75  CIIKIKNFFDA------EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 128
Query: 161 VHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LL++    C +KI DFG ++   ET  M     T  Y APE+L+
Sbjct: 129 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 188
Query: 218 N--CTEYTAAIDIWSVGCILGEIMTREPLF 245
           +     Y  A+D WS+G IL   ++  P F
Sbjct: 189 SVGTAGYNRAVDCWSLGVILFICLSGYPPF 218

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  105 bits (263), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 110/210 (52%), Gaps = 18/210 (8%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT------LREIKLLRHMEHE 101
           + +G GA G V  A   +T ++VAIK I      I  AR          EI++L+ + H 
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
            +I IK+           D YIV ELM+  +L   +  +++L +  C+ + YQ+L  ++Y
Sbjct: 76  CIIKIKNFFDA------EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 161 VHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LL++    C +KI DFG ++   ET  M     T  Y APE+L+
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 189
Query: 218 N--CTEYTAAIDIWSVGCILGEIMTREPLF 245
           +     Y  A+D WS+G IL   ++  P F
Sbjct: 190 SVGTAGYNRAVDCWSLGVILFICLSGYPPF 219

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  105 bits (263), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 110/210 (52%), Gaps = 18/210 (8%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT------LREIKLLRHMEHE 101
           + +G GA G V  A   +T ++VAIK I      I  AR          EI++L+ + H 
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
            +I IK+           D YIV ELM+  +L   +  +++L +  C+ + YQ+L  ++Y
Sbjct: 76  CIIKIKNFFDA------EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 161 VHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LL++    C +KI DFG ++   ET  M     T  Y APE+L+
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 189
Query: 218 N--CTEYTAAIDIWSVGCILGEIMTREPLF 245
           +     Y  A+D WS+G IL   ++  P F
Sbjct: 190 SVGTAGYNRAVDCWSLGVILFICLSGYPPF 219

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 110/201 (54%), Gaps = 9/201 (4%)
Query: 39  VSSKYVPP--IRP-IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR-RTLREIKL 94
           +S +++ P  IR  +G G++G V  A + +T+++VA+K I        D   R  REI  
Sbjct: 3   ISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISY 62
Query: 95  LRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           L+ + H ++I + D+I  P      D+ +V E    +L   I   +++T+D  + F  Q+
Sbjct: 63  LKLLRHPHIIKLYDVITTP-----TDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQI 117
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
           +  ++Y H   ++HRDLKP NLLL+ + ++KI DFGL+   ++ +F+     +  Y APE
Sbjct: 118 ICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPE 177
Query: 215 LLLNCTEYTAAIDIWSVGCIL 235
           ++         +D+WS G +L
Sbjct: 178 VINGKLYAGPEVDVWSCGIVL 198

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  104 bits (260), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 110/210 (52%), Gaps = 18/210 (8%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT------LREIKLLRHMEHE 101
           + +G GA G V  A   +T ++VAI+ I      I  AR          EI++L+ + H 
Sbjct: 155 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 214
Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
            +I IK+           D YIV ELM+  +L   +  +++L +  C+ + YQ+L  ++Y
Sbjct: 215 CIIKIKNFFDA------EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 268
Query: 161 VHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LL++    C +KI DFG ++   ET  M     T  Y APE+L+
Sbjct: 269 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 328
Query: 218 N--CTEYTAAIDIWSVGCILGEIMTREPLF 245
           +     Y  A+D WS+G IL   ++  P F
Sbjct: 329 SVGTAGYNRAVDCWSLGVILFICLSGYPPF 358

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  104 bits (259), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 121/217 (55%), Gaps = 13/217 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V  A+N    E+VA+K +          +R ++ ++ LR     N+I +
Sbjct: 42  VRKLGRGKYSEVFEAINITNNEKVAVKILKPV--KKKKIKREIKILENLR--GGPNIITL 97
Query: 107 KDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y HS  
Sbjct: 98  ADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG 151
Query: 166 VLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           ++HRD+KP N+L++     L++ D+GLA            V +R+++ PELL++   Y  
Sbjct: 152 IMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 225 AIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITEV 260
           ++D+WS+GC+L  ++ R EP F G D   QL  I +V
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 248

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  104 bits (259), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 110/210 (52%), Gaps = 18/210 (8%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT------LREIKLLRHMEHE 101
           + +G GA G V  A   +T ++VAI+ I      I  AR          EI++L+ + H 
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
            +I IK+           D YIV ELM+  +L   +  +++L +  C+ + YQ+L  ++Y
Sbjct: 201 CIIKIKNFFDA------EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 254
Query: 161 VHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LL++    C +KI DFG ++   ET  M     T  Y APE+L+
Sbjct: 255 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 314
Query: 218 N--CTEYTAAIDIWSVGCILGEIMTREPLF 245
           +     Y  A+D WS+G IL   ++  P F
Sbjct: 315 SVGTAGYNRAVDCWSLGVILFICLSGYPPF 344

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  102 bits (254), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 107/200 (53%), Gaps = 6/200 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR-RTLREIKLLRHMEHENVIA 105
           ++ +G G++G V  A ++ T ++VA+K I        D + R  REI  LR + H ++I 
Sbjct: 18  VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIK 77
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
           + D+I+     + +++ +V E    +L   I    ++++   + F  Q++  ++Y H   
Sbjct: 78  LYDVIK-----SKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK 132
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKP NLLL+   ++KI DFGL+   ++ +F+     +  Y APE++         
Sbjct: 133 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE 192
Query: 226 IDIWSVGCILGEIMTREPLF 245
           +D+WS G IL  ++ R   F
Sbjct: 193 VDVWSCGVILYVMLCRRLPF 212

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  102 bits (254), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 107/200 (53%), Gaps = 6/200 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR-RTLREIKLLRHMEHENVIA 105
           ++ +G G++G V  A ++ T ++VA+K I        D + R  REI  LR + H ++I 
Sbjct: 13  VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIK 72
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
           + D+I+     + +++ +V E    +L   I    ++++   + F  Q++  ++Y H   
Sbjct: 73  LYDVIK-----SKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK 127
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKP NLLL+   ++KI DFGL+   ++ +F+     +  Y APE++         
Sbjct: 128 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE 187
Query: 226 IDIWSVGCILGEIMTREPLF 245
           +D+WS G IL  ++ R   F
Sbjct: 188 VDVWSCGVILYVMLCRRLPF 207

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  102 bits (254), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 107/200 (53%), Gaps = 6/200 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR-RTLREIKLLRHMEHENVIA 105
           ++ +G G++G V  A ++ T ++VA+K I        D + R  REI  LR + H ++I 
Sbjct: 9   VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIK 68
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
           + D+I+     + +++ +V E    +L   I    ++++   + F  Q++  ++Y H   
Sbjct: 69  LYDVIK-----SKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK 123
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKP NLLL+   ++KI DFGL+   ++ +F+     +  Y APE++         
Sbjct: 124 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE 183
Query: 226 IDIWSVGCILGEIMTREPLF 245
           +D+WS G IL  ++ R   F
Sbjct: 184 VDVWSCGVILYVMLCRRLPF 203

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  102 bits (254), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 107/200 (53%), Gaps = 6/200 (3%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR-RTLREIKLLRHMEHENVIA 105
           ++ +G G++G V  A ++ T ++VA+K I        D + R  REI  LR + H ++I 
Sbjct: 19  VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIK 78
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
           + D+I+     + +++ +V E    +L   I    ++++   + F  Q++  ++Y H   
Sbjct: 79  LYDVIK-----SKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK 133
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLKP NLLL+   ++KI DFGL+   ++ +F+     +  Y APE++         
Sbjct: 134 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE 193
Query: 226 IDIWSVGCILGEIMTREPLF 245
           +D+WS G IL  ++ R   F
Sbjct: 194 VDVWSCGVILYVMLCRRLPF 213

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score =  100 bits (250), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 118/217 (54%), Gaps = 13/217 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V  A+N    E V +K +          +R ++ ++ LR     N+I +
Sbjct: 48  VRKLGRGKYSEVFEAINITNNERVVVKILKPV--KKKKIKREVKILENLR--GGTNIIKL 103
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            D ++ P   T     +V+E ++ TD  Q+    Q LTD   ++++Y+LL+ L Y HS  
Sbjct: 104 IDTVKDPVSKT---PALVFEYINNTDFKQLY---QILTDFDIRFYMYELLKALDYCHSKG 157
Query: 166 VLHRDLKPSNLLLN-ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++   Y  
Sbjct: 158 IMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDY 217
Query: 225 AIDIWSVGCILGE-IMTREPLFPGKDYVHQLRLITEV 260
           ++D+WS+GC+L   I  REP F G+D   QL  I +V
Sbjct: 218 SLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKV 254

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score =  100 bits (250), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 118/217 (54%), Gaps = 13/217 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V  A+N    E V +K +          +R ++ ++ LR     N+I +
Sbjct: 43  VRKLGRGKYSEVFEAINITNNERVVVKILKPV--KKKKIKREVKILENLR--GGTNIIKL 98
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            D ++ P   T     +V+E ++ TD  Q+    Q LTD   ++++Y+LL+ L Y HS  
Sbjct: 99  IDTVKDPVSKT---PALVFEYINNTDFKQLY---QILTDFDIRFYMYELLKALDYCHSKG 152
Query: 166 VLHRDLKPSNLLLN-ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++   Y  
Sbjct: 153 IMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDY 212
Query: 225 AIDIWSVGCILGE-IMTREPLFPGKDYVHQLRLITEV 260
           ++D+WS+GC+L   I  REP F G+D   QL  I +V
Sbjct: 213 SLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKV 249

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 120/217 (55%), Gaps = 13/217 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V  A+N    E+V +K +          +R ++ ++ LR     N+I +
Sbjct: 42  VRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLR--GGPNIITL 97
Query: 107 KDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y HS  
Sbjct: 98  ADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG 151
Query: 166 VLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++   Y  
Sbjct: 152 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 225 AIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITEV 260
           ++D+WS+GC+L  ++ R EP F G D   QL  I +V
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 248

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 120/217 (55%), Gaps = 13/217 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V  A+N    E+V +K +          +R ++ ++ LR     N+I +
Sbjct: 42  VRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLR--GGPNIITL 97
Query: 107 KDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y HS  
Sbjct: 98  ADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG 151
Query: 166 VLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++   Y  
Sbjct: 152 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 225 AIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITEV 260
           ++D+WS+GC+L  ++ R EP F G D   QL  I +V
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 248

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 120/217 (55%), Gaps = 13/217 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V  A+N    E+V +K +          +R ++ ++ LR     N+I +
Sbjct: 42  VRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLR--GGPNIITL 97
Query: 107 KDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y HS  
Sbjct: 98  ADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG 151
Query: 166 VLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++   Y  
Sbjct: 152 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 225 AIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITEV 260
           ++D+WS+GC+L  ++ R EP F G D   QL  I +V
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 248

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 120/217 (55%), Gaps = 13/217 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V  A+N    E+V +K +          +R ++ ++ LR     N+I +
Sbjct: 41  VRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLR--GGPNIITL 96
Query: 107 KDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y HS  
Sbjct: 97  ADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG 150
Query: 166 VLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++   Y  
Sbjct: 151 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 210
Query: 225 AIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITEV 260
           ++D+WS+GC+L  ++ R EP F G D   QL  I +V
Sbjct: 211 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 247

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 120/217 (55%), Gaps = 13/217 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V  A+N    E+V +K +          +R ++ ++ LR     N+I +
Sbjct: 42  VRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLR--GGPNIITL 97
Query: 107 KDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y HS  
Sbjct: 98  ADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG 151
Query: 166 VLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++   Y  
Sbjct: 152 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 225 AIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITEV 260
           ++D+WS+GC+L  ++ R EP F G D   QL  I +V
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 248

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 120/217 (55%), Gaps = 13/217 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V  A+N    E+V +K +          +R ++ ++ LR     N+I +
Sbjct: 42  VRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLR--GGPNIITL 97
Query: 107 KDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y HS  
Sbjct: 98  ADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG 151
Query: 166 VLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++   Y  
Sbjct: 152 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 225 AIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITEV 260
           ++D+WS+GC+L  ++ R EP F G D   QL  I +V
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 248

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 120/217 (55%), Gaps = 13/217 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V  A+N    E+V +K +          +R ++ ++ LR     N+I +
Sbjct: 47  VRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLR--GGPNIITL 102
Query: 107 KDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y HS  
Sbjct: 103 ADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG 156
Query: 166 VLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++   Y  
Sbjct: 157 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 216
Query: 225 AIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITEV 260
           ++D+WS+GC+L  ++ R EP F G D   QL  I +V
Sbjct: 217 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 253

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 120/217 (55%), Gaps = 13/217 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V  A+N    E+V +K +          +R ++ ++ LR     N+I +
Sbjct: 42  VRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLR--GGPNIITL 97
Query: 107 KDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y HS  
Sbjct: 98  ADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG 151
Query: 166 VLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++   Y  
Sbjct: 152 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 225 AIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITEV 260
           ++D+WS+GC+L  ++ R EP F G D   QL  I +V
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 248

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 120/217 (55%), Gaps = 13/217 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V  A+N    E+V +K +          +R ++ ++ LR     N+I +
Sbjct: 42  VRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLR--GGPNIITL 97
Query: 107 KDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y HS  
Sbjct: 98  ADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG 151
Query: 166 VLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++   Y  
Sbjct: 152 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 225 AIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITEV 260
           ++D+WS+GC+L  ++ R EP F G D   QL  I +V
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 248

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 120/217 (55%), Gaps = 13/217 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V  A+N    E+V +K +          +R ++ ++ LR     N+I +
Sbjct: 41  VRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLR--GGPNIITL 96
Query: 107 KDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y HS  
Sbjct: 97  ADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG 150
Query: 166 VLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++   Y  
Sbjct: 151 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 210
Query: 225 AIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITEV 260
           ++D+WS+GC+L  ++ R EP F G D   QL  I +V
Sbjct: 211 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 247

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 120/217 (55%), Gaps = 13/217 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V  A+N    E+V +K +          +R ++ ++ LR     N+I +
Sbjct: 40  VRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLR--GGPNIITL 95
Query: 107 KDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y HS  
Sbjct: 96  ADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG 149
Query: 166 VLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++   Y  
Sbjct: 150 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 209
Query: 225 AIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITEV 260
           ++D+WS+GC+L  ++ R EP F G D   QL  I +V
Sbjct: 210 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 246

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 120/217 (55%), Gaps = 13/217 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V  A+N    E+V +K +          +R ++ ++ LR     N+I +
Sbjct: 42  VRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLR--GGPNIITL 97
Query: 107 KDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y HS  
Sbjct: 98  ADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG 151
Query: 166 VLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++   Y  
Sbjct: 152 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 225 AIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITEV 260
           ++D+WS+GC+L  ++ R EP F G D   QL  I +V
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 248

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 98.6 bits (244), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 120/217 (55%), Gaps = 13/217 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V  A+N    E+V +K +          +R ++ ++ LR     N+I +
Sbjct: 42  VRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLR--GGPNIITL 97
Query: 107 KDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y HS  
Sbjct: 98  ADIVKDPVSRT---PALVFEHVNNTDFKQL---RQTLTDYDIRFYMYEILKALDYCHSMG 151
Query: 166 VLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++   Y  
Sbjct: 152 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 225 AIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITEV 260
           ++D+WS+GC+L  ++ R EP F G D   QL  I +V
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 248

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 98.6 bits (244), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 111/216 (51%), Gaps = 11/216 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V   +N    E+  IK +          +       L   M   N++ +
Sbjct: 36  VRKVGRGKYSEVFEGINVNNNEKCIIKILKPV----KKKKIKREIKILQNLMGGPNIVKL 91
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
            DI+R     T +   +++E ++    +++     LTD   +Y++Y+LL+ L Y HS  +
Sbjct: 92  LDIVRDQHSKTPS---LIFEYVNNTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGI 146
Query: 167 LHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           +HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  +Y  +
Sbjct: 147 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 206
Query: 226 IDIWSVGCIL-GEIMTREPLFPGKDYVHQLRLITEV 260
           +D+WS+GC+  G I  +EP F G D   QL  I +V
Sbjct: 207 LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 242

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHME 99
           ++ +G GAYG V  AVN  T E VA+K        I+D +R +       +EI + + + 
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEIXINKMLN 63
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ G+
Sbjct: 64  HENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPEL 215
            Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APEL
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 178
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTRE 242
           L     +   +D+WS G +L  ++  E
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHME 99
           ++ +G GAYG V  AVN  T E VA+K        I+D +R +       +EI + + + 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEIXINKMLN 62
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ G+
Sbjct: 63  HENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPEL 215
            Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APEL
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTRE 242
           L     +   +D+WS G +L  ++  E
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 97.8 bits (242), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHME 99
           ++ +G GAYG V  AVN  T E VA+K        I+D +R +       +EI + + + 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEIXINKMLN 62
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ G+
Sbjct: 63  HENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPEL 215
            Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APEL
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTRE 242
           L     +   +D+WS G +L  ++  E
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 97.1 bits (240), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHME 99
           ++ +G GAYG V  AVN  T E VA+K        I+D +R +       +EI + + + 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLN 62
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ G+
Sbjct: 63  HENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPEL 215
            Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APEL
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTRE 242
           L     +   +D+WS G +L  ++  E
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 97.1 bits (240), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHME 99
           ++ +G GAYG V  AVN  T E VA+K        I+D +R +       +EI + + + 
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLN 63
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ G+
Sbjct: 64  HENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPEL 215
            Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APEL
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTRE 242
           L     +   +D+WS G +L  ++  E
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 97.1 bits (240), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHME 99
           ++ +G GAYG V  AVN  T E VA+K        I+D +R +       +EI + + + 
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLN 63
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ G+
Sbjct: 64  HENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPEL 215
            Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APEL
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTRE 242
           L     +   +D+WS G +L  ++  E
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 97.1 bits (240), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHME 99
           ++ +G GAYG V  AVN  T E VA+K        I+D +R +       +EI + + + 
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLN 63
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ G+
Sbjct: 64  HENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPEL 215
            Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APEL
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTRE 242
           L     +   +D+WS G +L  ++  E
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 97.1 bits (240), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHME 99
           ++ +G GAYG V  AVN  T E VA+K        I+D +R +       +EI + + + 
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLN 63
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ G+
Sbjct: 64  HENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPEL 215
            Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APEL
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTRE 242
           L     +   +D+WS G +L  ++  E
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHME 99
           ++ +G GAYG V  AVN  T E VA+K        I+D +R +       +EI + + + 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLN 62
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ G+
Sbjct: 63  HENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPEL 215
            Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APEL
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTRE 242
           L     +   +D+WS G +L  ++  E
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHME 99
           ++ +G GAYG V  AVN  T E VA+K        I+D +R +       +EI + + + 
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLN 63
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ G+
Sbjct: 64  HENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPEL 215
            Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APEL
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTRE 242
           L     +   +D+WS G +L  ++  E
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHME 99
           ++ +G GAYG V  AVN  T E VA+K        I+D +R +       +EI + + + 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLN 62
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ G+
Sbjct: 63  HENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPEL 215
            Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APEL
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTRE 242
           L     +   +D+WS G +L  ++  E
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHME 99
           ++ +G GAYG V  AVN  T E VA+K        I+D +R +       +EI + + + 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLN 62
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ G+
Sbjct: 63  HENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPEL 215
            Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APEL
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTRE 242
           L     +   +D+WS G +L  ++  E
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHME 99
           ++ +G GAYG V  AVN  T E VA+K        I+D +R +       +EI + + + 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLN 62
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ G+
Sbjct: 63  HENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPEL 215
            Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APEL
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTRE 242
           L     +   +D+WS G +L  ++  E
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHME 99
           ++ +G GAYG V  AVN  T E VA+K        I+D +R +       +EI + + + 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLN 62
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ G+
Sbjct: 63  HENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPEL 215
            Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APEL
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTRE 242
           L     +   +D+WS G +L  ++  E
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHME 99
           ++ +G GAYG V  AVN  T E VA+K        I+D +R +       +EI + + + 
Sbjct: 10  VQTLGEGAYGEVQLAVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLN 61
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ G+
Sbjct: 62  HENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 116
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPEL 215
            Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APEL
Sbjct: 117 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTRE 242
           L     +   +D+WS G +L  ++  E
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGE 203

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHME 99
           ++ +G GAYG V  AVN  T E VA+K        I+D +R +       +EI + + + 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLN 62
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ G+
Sbjct: 63  HENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPEL 215
            Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APEL
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTRE 242
           L     +   +D+WS G +L  ++  E
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHME 99
           ++ +G GAYG V  AVN  T E VA+K        I+D +R +       +EI + + + 
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLN 63
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ G+
Sbjct: 64  HENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPEL 215
            Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APEL
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTRE 242
           L     +   +D+WS G +L  ++  E
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHME 99
           ++ +G GAYG V  AVN  T E VA+K        I+D +R +       +EI + + + 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLN 62
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ G+
Sbjct: 63  HENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPEL 215
            Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APEL
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTRE 242
           L     +   +D+WS G +L  ++  E
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHME 99
           ++ +G GAYG V  AVN  T E VA+K        I+D +R +       +EI + + + 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLN 62
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ G+
Sbjct: 63  HENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPEL 215
            Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APEL
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTRE 242
           L     +   +D+WS G +L  ++  E
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 110/216 (50%), Gaps = 11/216 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V   +N    E+  IK +          +       L       N++ +
Sbjct: 36  VRKVGRGKYSEVFEGINVNNNEKCIIKILKPV----KKKKIKREIKILQNLXGGPNIVKL 91
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
            DI+R     T +   +++E ++    +++     LTD   +Y++Y+LL+ L Y HS  +
Sbjct: 92  LDIVRDQHSKTPS---LIFEYVNNTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGI 146
Query: 167 LHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           +HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  +Y  +
Sbjct: 147 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 206
Query: 226 IDIWSVGCIL-GEIMTREPLFPGKDYVHQLRLITEV 260
           +D+WS+GC+  G I  +EP F G D   QL  I +V
Sbjct: 207 LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 242

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 110/216 (50%), Gaps = 11/216 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V   +N    E+  IK +          +       L       N++ +
Sbjct: 36  VRKVGRGKYSEVFEGINVNNNEKCIIKILKPV----KKKKIKREIKILQNLXGGPNIVKL 91
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
            DI+R     T +   +++E ++    +++     LTD   +Y++Y+LL+ L Y HS  +
Sbjct: 92  LDIVRDQHSKTPS---LIFEYVNNTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGI 146
Query: 167 LHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           +HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  +Y  +
Sbjct: 147 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 206
Query: 226 IDIWSVGCIL-GEIMTREPLFPGKDYVHQLRLITEV 260
           +D+WS+GC+  G I  +EP F G D   QL  I +V
Sbjct: 207 LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 242

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 110/216 (50%), Gaps = 11/216 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V   +N    E+  IK +          +       L       N++ +
Sbjct: 37  VRKVGRGKYSEVFEGINVNNNEKCIIKILKPV----KKKKIKREIKILQNLXGGPNIVKL 92
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
            DI+R     T +   +++E ++    +++     LTD   +Y++Y+LL+ L Y HS  +
Sbjct: 93  LDIVRDQHSKTPS---LIFEYVNNTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGI 147
Query: 167 LHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           +HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  +Y  +
Sbjct: 148 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 207
Query: 226 IDIWSVGCIL-GEIMTREPLFPGKDYVHQLRLITEV 260
           +D+WS+GC+  G I  +EP F G D   QL  I +V
Sbjct: 208 LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 243

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 110/216 (50%), Gaps = 11/216 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V   +N    E+  IK +          +       L       N++ +
Sbjct: 57  VRKVGRGKYSEVFEGINVNNNEKCIIKILKPV----KKKKIKREIKILQNLXGGPNIVKL 112
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
            DI+R     T +   +++E ++    +++     LTD   +Y++Y+LL+ L Y HS  +
Sbjct: 113 LDIVRDQHSKTPS---LIFEYVNNTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGI 167
Query: 167 LHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           +HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  +Y  +
Sbjct: 168 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 227
Query: 226 IDIWSVGCIL-GEIMTREPLFPGKDYVHQLRLITEV 260
           +D+WS+GC+  G I  +EP F G D   QL  I +V
Sbjct: 228 LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 263

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 110/216 (50%), Gaps = 11/216 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V   +N    E+  IK +          +       L       N++ +
Sbjct: 36  VRKVGRGKYSEVFEGINVNNNEKCIIKILKPV----KKKKIKREIKILQNLXGGPNIVKL 91
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
            DI+R     T +   +++E ++    +++     LTD   +Y++Y+LL+ L Y HS  +
Sbjct: 92  LDIVRDQHSKTPS---LIFEYVNNTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGI 146
Query: 167 LHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           +HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  +Y  +
Sbjct: 147 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 206
Query: 226 IDIWSVGCIL-GEIMTREPLFPGKDYVHQLRLITEV 260
           +D+WS+GC+  G I  +EP F G D   QL  I +V
Sbjct: 207 LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 242

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 110/216 (50%), Gaps = 11/216 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V   +N    E+  IK +          +       L       N++ +
Sbjct: 36  VRKVGRGKYSEVFEGINVNNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKL 91
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
            DI+R     T +   +++E ++    +++     LTD   +Y++Y+LL+ L Y HS  +
Sbjct: 92  LDIVRDQHSKTPS---LIFEYVNNTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGI 146
Query: 167 LHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           +HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  +Y  +
Sbjct: 147 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 206
Query: 226 IDIWSVGCIL-GEIMTREPLFPGKDYVHQLRLITEV 260
           +D+WS+GC+  G I  +EP F G D   QL  I +V
Sbjct: 207 LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 242

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 95.5 bits (236), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 110/216 (50%), Gaps = 11/216 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V   +N    E+  IK +          +       L       N++ +
Sbjct: 38  VRKVGRGKYSEVFEGINVNNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKL 93
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
            DI+R     T +   +++E ++    +++     LTD   +Y++Y+LL+ L Y HS  +
Sbjct: 94  LDIVRDQHSKTPS---LIFEYVNNTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGI 148
Query: 167 LHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           +HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  +Y  +
Sbjct: 149 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 208
Query: 226 IDIWSVGCIL-GEIMTREPLFPGKDYVHQLRLITEV 260
           +D+WS+GC+  G I  +EP F G D   QL  I +V
Sbjct: 209 LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 244

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 95.5 bits (236), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 110/216 (50%), Gaps = 11/216 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V   +N    E+  IK +          +       L       N++ +
Sbjct: 36  VRKVGRGKYSEVFEGINVNNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKL 91
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
            DI+R     T +   +++E ++    +++     LTD   +Y++Y+LL+ L Y HS  +
Sbjct: 92  LDIVRDQHSKTPS---LIFEYVNNTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGI 146
Query: 167 LHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           +HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  +Y  +
Sbjct: 147 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 206
Query: 226 IDIWSVGCIL-GEIMTREPLFPGKDYVHQLRLITEV 260
           +D+WS+GC+  G I  +EP F G D   QL  I +V
Sbjct: 207 LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 242

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 110/216 (50%), Gaps = 11/216 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +GRG Y  V   +N    E+  IK +          +       L       N++ +
Sbjct: 37  VRKVGRGKYSEVFEGINVNNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKL 92
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
            DI+R     T +   +++E ++    +++     LTD   +Y++Y+LL+ L Y HS  +
Sbjct: 93  LDIVRDQHSKTPS---LIFEYVNNTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGI 147
Query: 167 LHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           +HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  +Y  +
Sbjct: 148 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 207
Query: 226 IDIWSVGCIL-GEIMTREPLFPGKDYVHQLRLITEV 260
           +D+WS+GC+  G I  +EP F G D   QL  I +V
Sbjct: 208 LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 243

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 73/220 (33%), Positives = 121/220 (55%), Gaps = 17/220 (7%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGN--AFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           IG+G++G V  A +   +E VAIK I N  AF N     +   E++LL  M   +     
Sbjct: 62  IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLN-----QAQIEVRLLELMNKHDTEMKY 116
Query: 108 DIIRPPKKDTF-NDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSA 164
            I+   +   F N + +V+E++  +L+ ++R+   + ++ +  + F  Q+   L ++ + 
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP 176
Query: 165 --SVLHRDLKPSNLLL--NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
             S++H DLKP N+LL       +KI DFG +    +  +  + + +R+YR+PE+LL   
Sbjct: 177 ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY--QXIQSRFYRSPEVLLGMP 234
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
            Y  AID+WS+GCIL E+ T EPLF G + V Q+  I EV
Sbjct: 235 -YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV 273

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 95.1 bits (235), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 73/220 (33%), Positives = 121/220 (55%), Gaps = 17/220 (7%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGN--AFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           IG+G++G V  A +   +E VAIK I N  AF N     +   E++LL  M   +     
Sbjct: 43  IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLN-----QAQIEVRLLELMNKHDTEMKY 97
Query: 108 DIIRPPKKDTF-NDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSA 164
            I+   +   F N + +V+E++  +L+ ++R+   + ++ +  + F  Q+   L ++ + 
Sbjct: 98  YIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP 157
Query: 165 --SVLHRDLKPSNLLL--NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
             S++H DLKP N+LL       +KI DFG +    +  +  + + +R+YR+PE+LL   
Sbjct: 158 ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY--QXIQSRFYRSPEVLLGMP 215
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
            Y  AID+WS+GCIL E+ T EPLF G + V Q+  I EV
Sbjct: 216 -YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV 254

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 95.1 bits (235), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 70/209 (33%), Positives = 111/209 (53%), Gaps = 19/209 (9%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIK 107
           IG G+YG  C  +  ++  ++ + K  + + ++ +A + +   E+ LLR ++H N++   
Sbjct: 14  IGTGSYG-RCQKIRRKSDGKILVWKELD-YGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 108 DIIRPPKKDTFNDVYIVYELMDT-DLHQII----RSDQQLTDDHCQYFLYQLLRGLKYVH 162
           D I      T   +YIV E  +  DL  +I    +  Q L ++     + QL   LK  H
Sbjct: 72  DRIIDRTNTT---LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 128
Query: 163 SAS-----VLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELL 216
             S     VLHRDLKP+N+ L+   ++K+GDFGLAR  + + DF  E+V T +Y +PE  
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPE-Q 187
Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLF 245
           +N   Y    DIWS+GC+L E+    P F
Sbjct: 188 MNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 100/207 (48%), Gaps = 24/207 (11%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHME 99
           ++ +G GAYG V  AVN  T E VA+K        I+D +R +       +EI +   + 
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINAMLN 63
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ G+
Sbjct: 64  HENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPEL 215
            Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APEL
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTRE 242
           L     +   +D+WS G +L  ++  E
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 123/223 (55%), Gaps = 23/223 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGN--AFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           IG+G++G V  A +   +E VAIK I N  AF N     +   E++LL  M   +     
Sbjct: 62  IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLN-----QAQIEVRLLELMNKHDTEMKY 116
Query: 108 DIIRPPKKDTF-NDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSA 164
            I+   +   F N + +V+E++  +L+ ++R+   + ++ +  + F  Q+   L ++ + 
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP 176
Query: 165 --SVLHRDLKPSNLLLNASCD-----LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 217
             S++H DLKP N+LL   C+     +KI DFG +    +  +  + + +R+YR+PE+LL
Sbjct: 177 ELSIIHCDLKPENILL---CNPKRXAIKIVDFGSSCQLGQRIY--QXIQSRFYRSPEVLL 231
Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
               Y  AID+WS+GCIL E+ T EPLF G + V Q+  I EV
Sbjct: 232 GMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV 273

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 94.0 bits (232), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGN-AFDNIIDARRTLREIKLLRHMEHENVIAI 106
           R +G+G++G V    +  T +E A+K I         D    LRE++LL+ ++H N++ +
Sbjct: 38  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 97
Query: 107 KDIIRPPKKDTF---NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
            +      K  F    +VY   EL D      I S ++ ++      + Q+L G+ Y+H 
Sbjct: 98  YEFFED--KGYFYLVGEVYTGGELFDE-----IISRKRFSEVDAARIIRQVLSGITYMHK 150
Query: 164 ASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
             ++HRDLKP NLLL +     +++I DFGL+     +  M + + T +Y APE+L    
Sbjct: 151 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT- 209
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKD 249
            Y    D+WS G IL  +++  P F G +
Sbjct: 210 -YDEKCDVWSTGVILYILLSGCPPFNGAN 237

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 100/207 (48%), Gaps = 24/207 (11%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHME 99
           ++ +G GA G V  AVN  T E VA+K        I+D +R +       +EI + + + 
Sbjct: 11  VQTLGEGAAGEVQLAVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLN 62
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ G+
Sbjct: 63  HENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPEL 215
            Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APEL
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTRE 242
           L     +   +D+WS G +L  ++  E
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 105/207 (50%), Gaps = 16/207 (7%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGN-AFDNIIDARRTLREIKLLRHMEHENVIAI 106
           R +G+G++G V    +  T +E A+K I         D    LRE++LL+ ++H N++ +
Sbjct: 55  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 114
Query: 107 KDIIRPPKKDTF---NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
            +      K  F    +VY   EL D      I S ++ ++      + Q+L G+ Y+H 
Sbjct: 115 YEFFED--KGYFYLVGEVYTGGELFDE-----IISRKRFSEVDAARIIRQVLSGITYMHK 167
Query: 164 ASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
             ++HRDLKP NLLL +     +++I DFGL+     +  M + + T +Y APE+L    
Sbjct: 168 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT- 226
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPG 247
            Y    D+WS G IL  +++  P F G
Sbjct: 227 -YDEKCDVWSTGVILYILLSGCPPFNG 252

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 105/207 (50%), Gaps = 16/207 (7%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGN-AFDNIIDARRTLREIKLLRHMEHENVIAI 106
           R +G+G++G V    +  T +E A+K I         D    LRE++LL+ ++H N++ +
Sbjct: 56  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 115
Query: 107 KDIIRPPKKDTF---NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
            +      K  F    +VY   EL D      I S ++ ++      + Q+L G+ Y+H 
Sbjct: 116 YEFFED--KGYFYLVGEVYTGGELFDE-----IISRKRFSEVDAARIIRQVLSGITYMHK 168
Query: 164 ASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
             ++HRDLKP NLLL +     +++I DFGL+     +  M + + T +Y APE+L    
Sbjct: 169 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT- 227
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPG 247
            Y    D+WS G IL  +++  P F G
Sbjct: 228 -YDEKCDVWSTGVILYILLSGCPPFNG 253

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 105/207 (50%), Gaps = 16/207 (7%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGN-AFDNIIDARRTLREIKLLRHMEHENVIAI 106
           R +G+G++G V    +  T +E A+K I         D    LRE++LL+ ++H N++ +
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 107 KDIIRPPKKDTF---NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
            +      K  F    +VY   EL D      I S ++ ++      + Q+L G+ Y+H 
Sbjct: 92  YEFFED--KGYFYLVGEVYTGGELFDE-----IISRKRFSEVDAARIIRQVLSGITYMHK 144
Query: 164 ASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
             ++HRDLKP NLLL +     +++I DFGL+     +  M + + T +Y APE+L    
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT- 203
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPG 247
            Y    D+WS G IL  +++  P F G
Sbjct: 204 -YDEKCDVWSTGVILYILLSGCPPFNG 229

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 117/215 (54%), Gaps = 13/215 (6%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+GA+ +V   V+  T  E A K I     +  D ++  RE ++ R ++H N++ + D 
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 110 IRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           I+   +++F+  Y+V++L+   +L + I + +  ++    + + Q+L  + Y HS  ++H
Sbjct: 74  IQ---EESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVH 128
Query: 169 RDLKPSNLLLNASCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           R+LKP NLLL +      +K+ DFGLA   ++++    +  T  Y +PE+L     Y+  
Sbjct: 129 RNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK-DPYSKP 187
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           +DIW+ G IL  ++   P F  +D   Q RL  ++
Sbjct: 188 VDIWACGVILYILLVGYPPFWDED---QHRLYAQI 219

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 110/209 (52%), Gaps = 19/209 (9%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIK 107
           IG G+YG  C  +  ++  ++ + K  + + ++ +A + +   E+ LLR ++H N++   
Sbjct: 14  IGTGSYG-RCQKIRRKSDGKILVWKELD-YGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 108 DIIRPPKKDTFNDVYIVYELMDT-DLHQII----RSDQQLTDDHCQYFLYQLLRGLKYVH 162
           D I      T   +YIV E  +  DL  +I    +  Q L ++     + QL   LK  H
Sbjct: 72  DRIIDRTNTT---LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 128
Query: 163 SAS-----VLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELL 216
             S     VLHRDLKP+N+ L+   ++K+GDFGLAR  + +T F   +V T +Y +PE  
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPE-Q 187
Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLF 245
           +N   Y    DIWS+GC+L E+    P F
Sbjct: 188 MNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 117/215 (54%), Gaps = 13/215 (6%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+GA+ +V   V+  T  E A K I     +  D ++  RE ++ R ++H N++ + D 
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 110 IRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           I   ++++F+  Y+V++L+   +L + I + +  ++    + + Q+L  + Y HS  ++H
Sbjct: 74  I---QEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVH 128
Query: 169 RDLKPSNLLLNASCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           R+LKP NLLL +      +K+ DFGLA   ++++    +  T  Y +PE+L     Y+  
Sbjct: 129 RNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK-DPYSKP 187
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           +DIW+ G IL  ++   P F  +D   Q RL  ++
Sbjct: 188 VDIWACGVILYILLVGYPPFWDED---QHRLYAQI 219

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 110/209 (52%), Gaps = 19/209 (9%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIK 107
           IG G+YG  C  +  ++  ++ + K  + + ++ +A + +   E+ LLR ++H N++   
Sbjct: 14  IGTGSYG-RCQKIRRKSDGKILVWKELD-YGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 108 DIIRPPKKDTFNDVYIVYELMDT-DLHQII----RSDQQLTDDHCQYFLYQLLRGLKYVH 162
           D I      T   +YIV E  +  DL  +I    +  Q L ++     + QL   LK  H
Sbjct: 72  DRIIDRTNTT---LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 128
Query: 163 SAS-----VLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELL 216
             S     VLHRDLKP+N+ L+   ++K+GDFGLAR  + +T F   +V T +Y +PE  
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPE-Q 187
Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLF 245
           +N   Y    DIWS+GC+L E+    P F
Sbjct: 188 MNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 117/215 (54%), Gaps = 13/215 (6%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+GA+ +V   V+  T  E A K I     +  D ++  RE ++ R ++H N++ + D 
Sbjct: 13  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 72
Query: 110 IRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           I   ++++F+  Y+V++L+   +L + I + +  ++    + + Q+L  + Y HS  ++H
Sbjct: 73  I---QEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVH 127
Query: 169 RDLKPSNLLLNASCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           R+LKP NLLL +      +K+ DFGLA   ++++    +  T  Y +PE+L     Y+  
Sbjct: 128 RNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK-DPYSKP 186
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           +DIW+ G IL  ++   P F  +D   Q RL  ++
Sbjct: 187 VDIWACGVILYILLVGYPPFWDED---QHRLYAQI 218

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 117/215 (54%), Gaps = 13/215 (6%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+GA+ +V   V+  T  E A K I     +  D ++  RE ++ R ++H N++ + D 
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 110 IRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           I   ++++F+  Y+V++L+   +L + I + +  ++    + + Q+L  + Y HS  ++H
Sbjct: 97  I---QEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVH 151
Query: 169 RDLKPSNLLLNASCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           R+LKP NLLL +      +K+ DFGLA   ++++    +  T  Y +PE+L     Y+  
Sbjct: 152 RNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK-DPYSKP 210
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           +DIW+ G IL  ++   P F  +D   Q RL  ++
Sbjct: 211 VDIWACGVILYILLVGYPPFWDED---QHRLYAQI 242

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 98/191 (51%), Gaps = 13/191 (6%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGN----AFDNIIDARRTLREIKLLRHMEHENVIA 105
           +G G +G V    +  T  +VA+K +      + D +   RR ++ +KL RH    ++I 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH---PHIIK 80
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           +  +I  P     +D+++V E +   +L   I  + +L +   +    Q+L G+ Y H  
Sbjct: 81  LYQVISTP-----SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH 135
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
            V+HRDLKP N+LL+A  + KI DFGL+   S+ +F+     +  Y APE++        
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGP 195
Query: 225 AIDIWSVGCIL 235
            +DIWS G IL
Sbjct: 196 EVDIWSSGVIL 206

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 107/213 (50%), Gaps = 30/213 (14%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKI------------------------GNAFDNIIDA 85
           IG+G+YG+V  A N       A+K +                        G         
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 86  RRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDD 145
            +  +EI +L+ ++H NV+ + +++  P +D    +Y+V+EL++      + + + L++D
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNED---HLYMVFELVNQGPVMEVPTLKPLSED 137
Query: 146 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FMTEY 204
             +++   L++G++Y+H   ++HRD+KPSNLL+     +KI DFG++     +D  ++  
Sbjct: 138 QARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNT 197
Query: 205 VVTRWYRAPELLLNCTEYTA--AIDIWSVGCIL 235
           V T  + APE L    +  +  A+D+W++G  L
Sbjct: 198 VGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 18/205 (8%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL---REIKLLRHMEHENVIAI 106
           +G+G YGIV A  +   +  +AIK+I        D+R +     EI L +H++H+N++  
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPER-----DSRYSQPLHEEIALHKHLKHKNIV-- 68
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQ---YFLYQLLRGLKYVHS 163
              +    ++ F  +++  ++    L  ++RS      D+ Q   ++  Q+L GLKY+H 
Sbjct: 69  -QYLGSFSENGFIKIFME-QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD 126
Query: 164 ASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTE 221
             ++HRD+K  N+L+N  S  LKI DFG ++  +  +  TE +  T  Y APE++     
Sbjct: 127 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPR 186
Query: 222 -YTAAIDIWSVGCILGEIMTREPLF 245
            Y  A DIWS+GC + E+ T +P F
Sbjct: 187 GYGKAADIWSLGCTIIEMATGKPPF 211

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 18/205 (8%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL---REIKLLRHMEHENVIAI 106
           +G+G YGIV A  +   +  +AIK+I        D+R +     EI L +H++H+N++  
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPER-----DSRYSQPLHEEIALHKHLKHKNIV-- 82
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQ---YFLYQLLRGLKYVHS 163
              +    ++ F  +++  ++    L  ++RS      D+ Q   ++  Q+L GLKY+H 
Sbjct: 83  -QYLGSFSENGFIKIFME-QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD 140
Query: 164 ASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTE 221
             ++HRD+K  N+L+N  S  LKI DFG ++  +  +  TE +  T  Y APE++     
Sbjct: 141 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPR 200
Query: 222 -YTAAIDIWSVGCILGEIMTREPLF 245
            Y  A DIWS+GC + E+ T +P F
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKPPF 225

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 13/207 (6%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ +G GAYG V    +  T  E AIK I     +     + L E+ +L+ ++H N++ +
Sbjct: 42  VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101
Query: 107 KDIIRPPKKDTF--NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
            D     K++ +   + Y   EL D  +H++     +  +      + Q+L G+ Y+H  
Sbjct: 102 YDFFED-KRNYYLVMECYKGGELFDEIIHRM-----KFNEVDAAVIIKQVLSGVTYLHKH 155
Query: 165 SVLHRDLKPSNLLLNASCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
           +++HRDLKP NLLL +      +KI DFGL+        M E + T +Y APE+L    +
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK--K 213
Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGK 248
           Y    D+WS+G IL  ++   P F G+
Sbjct: 214 YDEKCDVWSIGVILFILLAGYPPFGGQ 240

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 107/204 (52%), Gaps = 6/204 (2%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG+G +  V  A +  T +EVA++ I     N    ++  RE+++++ + H N++ +
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++I     +T   +Y+V E     ++   + +  ++ +   +    Q++  ++Y H   
Sbjct: 79  FEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLK  NLLL+A  ++KI DFG +   +  + + E+  +  Y APEL          
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDGPE 193
Query: 226 IDIWSVGCILGEIMTREPLFPGKD 249
           +D+WS+G IL  +++    F G++
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 107/201 (53%), Gaps = 13/201 (6%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAIKD 108
           +G+G +       +++T+E  A K +  +       R  +  EI + R + H++V+    
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 109 IIRPPKKDTFND-VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
                     ND V++V EL     L ++ +  + LT+   +Y+L Q++ G +Y+H   V
Sbjct: 109 FFED------NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRV 162
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCTEYTA 224
           +HRDLK  NL LN   ++KIGDFGLA T  E D   + V+  T  Y APE +L+   ++ 
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKVLCGTPNYIAPE-VLSKKGHSF 220
Query: 225 AIDIWSVGCILGEIMTREPLF 245
            +D+WS+GCI+  ++  +P F
Sbjct: 221 EVDVWSIGCIMYTLLVGKPPF 241

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/233 (33%), Positives = 120/233 (51%), Gaps = 37/233 (15%)
Query: 30  YNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR-- 87
           YN   N F +  K       IGRG +  V  A        VA+KK+   FD ++DA+   
Sbjct: 28  YNTLAN-FRIEKK-------IGRGQFSEVYRAACLLDGVPVALKKV-QIFD-LMDAKARA 77
Query: 88  -TLREIKLLRHMEHENVIA-----IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--- 137
             ++EI LL+ + H NVI      I+D          N++ IV EL D  DL ++I+   
Sbjct: 78  DCIKEIDLLKQLNHPNVIKYYASFIED----------NELNIVLELADAGDLSRMIKHFK 127
Query: 138 SDQQLTDDHC--QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART- 194
             ++L  +    +YF+ QL   L+++HS  V+HRD+KP+N+ + A+  +K+GD GL R  
Sbjct: 128 KQKRLIPERTVWKYFV-QLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186
Query: 195 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG 247
           +S+T      V T +Y +PE +     Y    DIWS+GC+L E+   +  F G
Sbjct: 187 SSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYG 238

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 110/216 (50%), Gaps = 17/216 (7%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           F+   KYV  ++ IG G++G      ++E   +  IK+I  +  +  +   + RE+ +L 
Sbjct: 20  FQSMEKYVR-LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLA 78
Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQ--LTDDHCQYF 150
           +M+H N++  ++        +F +   +Y +MD     DL + I + +     +D    +
Sbjct: 79  NMKHPNIVQYRE--------SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW 130
Query: 151 LYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRW 209
             Q+   LK+VH   +LHRD+K  N+ L     +++GDFG+AR  + T +     + T +
Sbjct: 131 FVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPY 190
Query: 210 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 245
           Y +PE+  N   Y    DIW++GC+L E+ T +  F
Sbjct: 191 YLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAF 225

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 110/213 (51%), Gaps = 13/213 (6%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIK 107
           IG G+ GIVC A    T ++VA+KK+    D     RR L   E+ ++R   H+NV+ + 
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKM----DLRKQQRRELLFNEVVIMRDYHHDNVVDMY 108
Query: 108 DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
                      +++++V E ++      I +  ++ ++        +LR L Y+H+  V+
Sbjct: 109 S-----SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVI 163
Query: 168 HRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 226
           HRD+K  ++LL +   +K+ DFG  A+ + E       V T ++ APE +++   Y   +
Sbjct: 164 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPE-VISRLPYGTEV 222
Query: 227 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           DIWS+G ++ E++  EP +  +  +  +R I +
Sbjct: 223 DIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD 255

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 107/201 (53%), Gaps = 13/201 (6%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAIKD 108
           +G+G +       +++T+E  A K +  +       R  +  EI + R + H++V+    
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 109 IIRPPKKDTFND-VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
                     ND V++V EL     L ++ +  + LT+   +Y+L Q++ G +Y+H   V
Sbjct: 83  FFED------NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRV 136
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCTEYTA 224
           +HRDLK  NL LN   ++KIGDFGLA T  E D   + V+  T  Y APE +L+   ++ 
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKVLCGTPNYIAPE-VLSKKGHSF 194
Query: 225 AIDIWSVGCILGEIMTREPLF 245
            +D+WS+GCI+  ++  +P F
Sbjct: 195 EVDVWSIGCIMYTLLVGKPPF 215

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 107/201 (53%), Gaps = 13/201 (6%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAIKD 108
           +G+G +       +++T+E  A K +  +       R  +  EI + R + H++V+    
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 109 IIRPPKKDTFND-VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
                     ND V++V EL     L ++ +  + LT+   +Y+L Q++ G +Y+H   V
Sbjct: 107 FFED------NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRV 160
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCTEYTA 224
           +HRDLK  NL LN   ++KIGDFGLA T  E D   + V+  T  Y APE +L+   ++ 
Sbjct: 161 IHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKVLCGTPNYIAPE-VLSKKGHSF 218
Query: 225 AIDIWSVGCILGEIMTREPLF 245
            +D+WS+GCI+  ++  +P F
Sbjct: 219 EVDVWSIGCIMYTLLVGKPPF 239

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 89.0 bits (219), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 16/207 (7%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGN-AFDNIIDARRTLREIKLLRHMEHENVIAI 106
           R +G+G++G V    +  T +E A+K I         D    LRE++LL+ ++H N+  +
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKL 91
Query: 107 KDIIRPPKKDTF---NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
            +      K  F    +VY   EL D      I S ++ ++      + Q+L G+ Y H 
Sbjct: 92  YEFFED--KGYFYLVGEVYTGGELFDE-----IISRKRFSEVDAARIIRQVLSGITYXHK 144
Query: 164 ASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
             ++HRDLKP NLLL +     +++I DFGL+     +    + + T +Y APE+L    
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHGT- 203
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPG 247
            Y    D+WS G IL  +++  P F G
Sbjct: 204 -YDEKCDVWSTGVILYILLSGCPPFNG 229

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 106/204 (51%), Gaps = 6/204 (2%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG+G +  V  A +  T +EVA+K I     N    ++  RE+++++ + H N++ +
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++I     +T   +Y+V E     ++   + +  ++ +   +    Q++  ++Y H   
Sbjct: 79  FEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLK  NLLL+A  ++KI DFG +   +  + +  +  +  Y APEL          
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 226 IDIWSVGCILGEIMTREPLFPGKD 249
           +D+WS+G IL  +++    F G++
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 106/204 (51%), Gaps = 6/204 (2%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG+G +  V  A +  T +EVA+K I     N    ++  RE+++++ + H N++ +
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++I     +T   +Y+V E     ++   + +  ++ +   +    Q++  ++Y H   
Sbjct: 79  FEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLK  NLLL+A  ++KI DFG +   +  + +  +  +  Y APEL          
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 226 IDIWSVGCILGEIMTREPLFPGKD 249
           +D+WS+G IL  +++    F G++
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 71/233 (30%), Positives = 120/233 (51%), Gaps = 16/233 (6%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL-L 95
           FEV +  + PI  +GRGAYG+V    +  + + +A+K+I  A  N  + +R L ++ + +
Sbjct: 46  FEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISM 104
Query: 96  RHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDL----HQIIRSDQQLTDDHCQYFL 151
           R ++    +     +         DV+I  ELMDT L     Q+I   Q + +D      
Sbjct: 105 RTVDCPFTVTFYGALF-----REGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIA 159
Query: 152 YQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWY 210
             +++ L+++HS  SV+HRD+KPSN+L+NA   +K+ DFG++    ++   T     + Y
Sbjct: 160 VSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPY 219
Query: 211 RAPELL---LNCTEYTAAIDIWSVGCILGEI-MTREPLFPGKDYVHQLRLITE 259
            APE +   LN   Y+   DIWS+G  + E+ + R P         QL+ + E
Sbjct: 220 MAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE 272

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 88.2 bits (217), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 105/204 (51%), Gaps = 6/204 (2%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG+G +  V  A +  T +EVA+K I     N    ++  RE+++++ + H N++ +
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++I     +T   +Y+V E     ++   + +  ++ +   +    Q++  ++Y H   
Sbjct: 79  FEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLK  NLLL+A  ++KI DFG +   +  + +  +     Y APEL          
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPE 193
Query: 226 IDIWSVGCILGEIMTREPLFPGKD 249
           +D+WS+G IL  +++    F G++
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 88.2 bits (217), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 107/205 (52%), Gaps = 11/205 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+GA+ +V   V     +E A K I     +  D ++  RE ++ R ++H N++ + D 
Sbjct: 39  LGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 98
Query: 110 IRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           I    ++ F+  Y+V++L+   +L + I + +  ++    + ++Q+L  + ++H   ++H
Sbjct: 99  I---SEEGFH--YLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQHDIVH 153
Query: 169 RDLKPSNLLLNASCD---LKIGDFGLA-RTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           RDLKP NLLL + C    +K+ DFGLA     E      +  T  Y +PE+L     Y  
Sbjct: 154 RDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRK-DPYGK 212
Query: 225 AIDIWSVGCILGEIMTREPLFPGKD 249
            +DIW+ G IL  ++   P F  +D
Sbjct: 213 PVDIWACGVILYILLVGYPPFWDED 237

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 88.2 bits (217), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 106/201 (52%), Gaps = 13/201 (6%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAIKD 108
           +G+G +       +++T+E  A K +  +       R  +  EI + R + H++V+    
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 109 IIRPPKKDTFND-VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
                     ND V++V EL     L ++ +  + LT+   +Y+L Q++ G +Y+H   V
Sbjct: 85  FFED------NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRV 138
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCTEYTA 224
           +HRDLK  NL LN   ++KIGDFGLA T  E D   +  +  T  Y APE +L+   ++ 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKTLCGTPNYIAPE-VLSKKGHSF 196
Query: 225 AIDIWSVGCILGEIMTREPLF 245
            +D+WS+GCI+  ++  +P F
Sbjct: 197 EVDVWSIGCIMYTLLVGKPPF 217

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 88.2 bits (217), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 106/201 (52%), Gaps = 13/201 (6%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAIKD 108
           +G+G +       +++T+E  A K +  +       R  +  EI + R + H++V+    
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 109 IIRPPKKDTFND-VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
                     ND V++V EL     L ++ +  + LT+   +Y+L Q++ G +Y+H   V
Sbjct: 85  FFED------NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRV 138
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCTEYTA 224
           +HRDLK  NL LN   ++KIGDFGLA T  E D   +  +  T  Y APE +L+   ++ 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKTLCGTPNYIAPE-VLSKKGHSF 196
Query: 225 AIDIWSVGCILGEIMTREPLF 245
            +D+WS+GCI+  ++  +P F
Sbjct: 197 EVDVWSIGCIMYTLLVGKPPF 217

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 88.2 bits (217), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 106/201 (52%), Gaps = 13/201 (6%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAIKD 108
           +G+G +       +++T+E  A K +  +       R  +  EI + R + H++V+    
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 109 IIRPPKKDTFND-VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
                     ND V++V EL     L ++ +  + LT+   +Y+L Q++ G +Y+H   V
Sbjct: 89  FFED------NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRV 142
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCTEYTA 224
           +HRDLK  NL LN   ++KIGDFGLA T  E D   +  +  T  Y APE +L+   ++ 
Sbjct: 143 IHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKTLCGTPNYIAPE-VLSKKGHSF 200
Query: 225 AIDIWSVGCILGEIMTREPLF 245
            +D+WS+GCI+  ++  +P F
Sbjct: 201 EVDVWSIGCIMYTLLVGKPPF 221

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 88.2 bits (217), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 104/204 (50%), Gaps = 6/204 (2%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG+G +  V  A +  T  EVAIK I     N    ++  RE+++++ + H N++ +
Sbjct: 17  LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 76
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++I     +T   +Y++ E     ++   + +  ++ +   +    Q++  ++Y H   
Sbjct: 77  FEVI-----ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 131
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLK  NLLL+A  ++KI DFG +   +    +  +  +  Y APEL          
Sbjct: 132 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDGPE 191
Query: 226 IDIWSVGCILGEIMTREPLFPGKD 249
           +D+WS+G IL  +++    F G++
Sbjct: 192 VDVWSLGVILYTLVSGSLPFDGQN 215

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 87.8 bits (216), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 72/243 (29%), Positives = 119/243 (48%), Gaps = 38/243 (15%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           I  +G+GA+G V  A N+      AIKKI +  + +      L E+ LL  + H+ V+  
Sbjct: 11  IAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL---STILSEVMLLASLNHQYVVRY 67
Query: 107 -------KDIIRP----PKKDTFNDVYIVYELMDTD-LHQIIRSDQ--QLTDDHCQYFLY 152
                  ++ ++P     KK T   ++I  E  +   L+ +I S+   Q  D++ + F  
Sbjct: 68  YAAWLERRNFVKPMTAVKKKST---LFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF-R 123
Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT---------------SE 197
           Q+L  L Y+HS  ++HRDLKP N+ ++ S ++KIGDFGLA+                   
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 198 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           +D +T  + T  Y A E+L     Y   ID++S+G I  E++   P   G + V+ L+ +
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNILKKL 241
Query: 258 TEV 260
             V
Sbjct: 242 RSV 244

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 87.8 bits (216), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 72/243 (29%), Positives = 119/243 (48%), Gaps = 38/243 (15%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           I  +G+GA+G V  A N+      AIKKI +  + +      L E+ LL  + H+ V+  
Sbjct: 11  IAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL---STILSEVMLLASLNHQYVVRY 67
Query: 107 -------KDIIRP----PKKDTFNDVYIVYELMDT-DLHQIIRSDQ--QLTDDHCQYFLY 152
                  ++ ++P     KK T   ++I  E  +   L+ +I S+   Q  D++ + F  
Sbjct: 68  YAAWLERRNFVKPMTAVKKKST---LFIQMEYCENRTLYDLIHSENLNQQRDEYWRLF-R 123
Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT---------------SE 197
           Q+L  L Y+HS  ++HRDLKP N+ ++ S ++KIGDFGLA+                   
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 198 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           +D +T  + T  Y A E+L     Y   ID++S+G I  E++   P   G + V+ L+ +
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNILKKL 241
Query: 258 TEV 260
             V
Sbjct: 242 RSV 244

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 87.8 bits (216), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 109/219 (49%), Gaps = 22/219 (10%)
Query: 46  PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNA-FDN--IIDARRTLR--------EIKL 94
            +R +G GAYG V          E AIK I  + FD     D  + +         EI L
Sbjct: 40  KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 95  LRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQ 153
           L+ ++H N+I + D+    K       Y+V E  +  +L + I +  +  +      + Q
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKY-----FYLVTEFYEGGELFEQIINRHKFDECDAANIMKQ 154
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWY 210
           +L G+ Y+H  +++HRD+KP N+LL   N+  ++KI DFGL+   S+   + + + T +Y
Sbjct: 155 ILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYY 214
Query: 211 RAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
            APE+L    +Y    D+WS G I+  ++   P F G++
Sbjct: 215 IAPEVLK--KKYNEKCDVWSCGVIMYILLCGYPPFGGQN 251

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 87.8 bits (216), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 105/204 (51%), Gaps = 6/204 (2%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG+G +  V  A +  T +EVA+K I     N    ++  RE+++++ + H N++ +
Sbjct: 12  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 71
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++I     +T   +Y+V E     ++   + +   + +   +    Q++  ++Y H   
Sbjct: 72  FEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKF 126
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLK  NLLL+A  ++KI DFG +   +  + +  +  +  Y APEL          
Sbjct: 127 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 186
Query: 226 IDIWSVGCILGEIMTREPLFPGKD 249
           +D+WS+G IL  +++    F G++
Sbjct: 187 VDVWSLGVILYTLVSGSLPFDGQN 210

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 106/204 (51%), Gaps = 6/204 (2%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG+G +  V  A +  T +EVA++ I     N    ++  RE+++++ + H N++ +
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++I     +T   +Y+V E     ++   + +  ++ +   +    Q++  ++Y H   
Sbjct: 79  FEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLK  NLLL+A  ++KI DFG +   +  + +  +  +  Y APEL          
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 226 IDIWSVGCILGEIMTREPLFPGKD 249
           +D+WS+G IL  +++    F G++
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 87.4 bits (215), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 103/204 (50%), Gaps = 6/204 (2%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG+G +  V  A +  T  EVAIK I     N    ++  RE+++++ + H N++ +
Sbjct: 20  LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++I     +T   +Y++ E     ++   + +  ++ +   +    Q++  ++Y H   
Sbjct: 80  FEVI-----ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 134
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLK  NLLL+A  ++KI DFG +   +    +  +     Y APEL          
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPE 194
Query: 226 IDIWSVGCILGEIMTREPLFPGKD 249
           +D+WS+G IL  +++    F G++
Sbjct: 195 VDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 87.4 bits (215), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 107/218 (49%), Gaps = 15/218 (6%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 74  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +   TE   T  Y  PE ++    +
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTELCGTLDYLPPE-MIEGRMH 183
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
              +D+WS+G +  E +  +P F    Y    + I+ V
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 221

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 87.4 bits (215), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 107/201 (53%), Gaps = 9/201 (4%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           R +G+G +       + +T+E  A K +  +       +  +  EI + + +++ +V+  
Sbjct: 48  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF 107
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
                  + D F  VY+V E+     L ++ +  + +T+   +YF+ Q ++G++Y+H+  
Sbjct: 108 HGFF---EDDDF--VYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR 162
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLA-RTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           V+HRDLK  NL LN   D+KIGDFGLA +   + +   +   T  Y APE+L     ++ 
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCK-KGHSF 221
Query: 225 AIDIWSVGCILGEIMTREPLF 245
            +DIWS+GCIL  ++  +P F
Sbjct: 222 EVDIWSLGCILYTLLVGKPPF 242

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 87.4 bits (215), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIK 107
           +G GA+  V  A    T +  A+K I       +  + +    EI +LR ++HEN++A++
Sbjct: 30  LGTGAFSEVVLAEEKATGKLFAVKCIPK---KALKGKESSIENEIAVLRKIKHENIVALE 86
Query: 108 DIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           DI   P     N +Y+V +L+   +L   I      T+      + Q+L  + Y+H   +
Sbjct: 87  DIYESP-----NHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGI 141
Query: 167 LHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
           +HRDLKP NLL    +    + I DFGL++   + D M+    T  Y APE+L     Y+
Sbjct: 142 VHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQ-KPYS 200
Query: 224 AAIDIWSVGCILGEIMTREPLF 245
            A+D WS+G I   ++   P F
Sbjct: 201 KAVDCWSIGVIAYILLCGYPPF 222

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 87.4 bits (215), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 108/202 (53%), Gaps = 11/202 (5%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           R +G+G +       + +T+E  A K +  +       +  +  EI + + +++ +V+  
Sbjct: 48  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF 107
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
                  + D F  VY+V E+     L ++ +  + +T+   +YF+ Q ++G++Y+H+  
Sbjct: 108 HGFF---EDDDF--VYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR 162
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCTEYT 223
           V+HRDLK  NL LN   D+KIGDFGLA T  E D   +  +  T  Y APE+L     ++
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLA-TKIEFDGERKKTLCGTPNYIAPEVLCK-KGHS 220
Query: 224 AAIDIWSVGCILGEIMTREPLF 245
             +DIWS+GCIL  ++  +P F
Sbjct: 221 FEVDIWSLGCILYTLLVGKPPF 242

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 87.4 bits (215), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 107/201 (53%), Gaps = 9/201 (4%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           R +G+G +       + +T+E  A K +  +       +  +  EI + + +++ +V+  
Sbjct: 32  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF 91
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
                  + D F  VY+V E+     L ++ +  + +T+   +YF+ Q ++G++Y+H+  
Sbjct: 92  HGFF---EDDDF--VYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR 146
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLA-RTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           V+HRDLK  NL LN   D+KIGDFGLA +   + +   +   T  Y APE+L     ++ 
Sbjct: 147 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCK-KGHSF 205
Query: 225 AIDIWSVGCILGEIMTREPLF 245
            +DIWS+GCIL  ++  +P F
Sbjct: 206 EVDIWSLGCILYTLLVGKPPF 226

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 87.0 bits (214), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 99/195 (50%), Gaps = 17/195 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI--GNAFDNIIDARRTLREIKLLRHMEHENVI 104
           ++ IG G +G+     +  T+E VA+K I  G A D  +      REI   R + H N++
Sbjct: 25  VKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ-----REIINHRSLRHPNIV 79
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
             K++I  P       + I+ E     +L++ I +  + ++D  ++F  QLL G+ Y HS
Sbjct: 80  RFKEVILTPTH-----LAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHS 134
Query: 164 ASVLHRDLKPSNLLLNASCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
             + HRDLK  N LL+ S    LKI DFG ++++         V T  Y APE+LL   E
Sbjct: 135 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR-QE 193
Query: 222 YTAAI-DIWSVGCIL 235
           Y   I D+WS G  L
Sbjct: 194 YDGKIADVWSCGVTL 208

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 87.0 bits (214), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 107/211 (50%), Gaps = 23/211 (10%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAI 106
           +P+G G++ I    V+ ++ +  A+K I    +       T +EI  L+  E H N++ +
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISKRME-----ANTQKEITALKLCEGHPNIVKL 71
Query: 107 KDIIRPPKKDTFND---VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
            ++        F+D    ++V EL++  +L + I+  +  ++    Y + +L+  + ++H
Sbjct: 72  HEV--------FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMH 123
Query: 163 SASVLHRDLKPSNLLL---NASCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLN 218
              V+HRDLKP NLL    N + ++KI DFG AR    +   +     T  Y APE LLN
Sbjct: 124 DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE-LLN 182
Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
              Y  + D+WS+G IL  +++ +  F   D
Sbjct: 183 QNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 87.0 bits (214), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 108/202 (53%), Gaps = 11/202 (5%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           R +G+G +       + +T+E  A K +  +       +  +  EI + + +++ +V+  
Sbjct: 48  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF 107
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
                  + D F  VY+V E+     L ++ +  + +T+   +YF+ Q ++G++Y+H+  
Sbjct: 108 HGFF---EDDDF--VYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR 162
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCTEYT 223
           V+HRDLK  NL LN   D+KIGDFGLA T  E D   +  +  T  Y APE+L     ++
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLA-TKIEFDGERKKXLCGTPNYIAPEVLCK-KGHS 220
Query: 224 AAIDIWSVGCILGEIMTREPLF 245
             +DIWS+GCIL  ++  +P F
Sbjct: 221 FEVDIWSLGCILYTLLVGKPPF 242

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 103/203 (50%), Gaps = 6/203 (2%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           + IG+G +  V  A +  T  EVA+K I     N    ++  RE+++++ + H N++ + 
Sbjct: 21  KTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 108 DIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           ++I     +T   +Y+V E     ++   + +  ++ +   +    Q++  ++Y H   +
Sbjct: 81  EVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKYI 135
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 226
           +HRDLK  NLLL+   ++KI DFG +   +  + +  +  +  Y APEL          +
Sbjct: 136 VHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDGPEV 195
Query: 227 DIWSVGCILGEIMTREPLFPGKD 249
           D+WS+G IL  +++    F G++
Sbjct: 196 DVWSLGVILYTLVSGSLPFDGQN 218

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 21/208 (10%)
Query: 31  NVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR 90
           +   + FEV S+       +GRGA  IV       T++  A+K         +D +    
Sbjct: 49  DALSDFFEVESE-------LGRGATSIVYRCKQKGTQKPYALK----VLKKTVDKKIVRT 97
Query: 91  EIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQY 149
           EI +L  + H N+I +K+I   P      ++ +V EL+   +L   I      ++     
Sbjct: 98  EIGVLLRLSHPNIIKLKEIFETP-----TEISLVLELVTGGELFDRIVEKGYYSERDAAD 152
Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVV 206
            + Q+L  + Y+H   ++HRDLKP NLL         LKI DFGL++       M     
Sbjct: 153 AVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCG 212
Query: 207 TRWYRAPELLLNCTEYTAAIDIWSVGCI 234
           T  Y APE+L  C  Y   +D+WSVG I
Sbjct: 213 TPGYCAPEILRGCA-YGPEVDMWSVGII 239

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 115/226 (50%), Gaps = 19/226 (8%)
Query: 46  PIRPIGRGAYGIVCAAVNSETREEVAIKKI----GNAF--DNIIDARR-TLREIKLLRHM 98
           P   +GRG   +V   ++  T +E A+K I    G +F  + + + R  TL+E+ +LR +
Sbjct: 21  PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 99  E-HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 156
             H N+I +KD     + +TF   ++V++LM   +L   +     L++   +  +  LL 
Sbjct: 81  SGHPNIIQLKDTY---ETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 135
Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 216
            +  +H  +++HRDLKP N+LL+   ++K+ DFG +      + + E   T  Y APE++
Sbjct: 136 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEII 195
Query: 217 L-----NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
                 N   Y   +D+WS G I+  ++   P F  +  +  LR+I
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 241

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 95/191 (49%), Gaps = 13/191 (6%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGN----AFDNIIDARRTLREIKLLRHMEHENVIA 105
           +G G +G V    +  T  +VA+K +      + D +   +R ++ +KL RH    ++I 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH---PHIIK 75
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           +  +I  P      D ++V E +   +L   I    ++ +   +    Q+L  + Y H  
Sbjct: 76  LYQVISTP-----TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
            V+HRDLKP N+LL+A  + KI DFGL+   S+ +F+ +   +  Y APE++        
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGP 190
Query: 225 AIDIWSVGCIL 235
            +DIWS G IL
Sbjct: 191 EVDIWSCGVIL 201

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 107/218 (49%), Gaps = 15/218 (6%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 79  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 130
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +   T+   T  Y  PE ++    +
Sbjct: 131 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPE-MIEGRMH 188
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
              +D+WS+G +  E +  +P F    Y    + I+ V
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 226

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 12/207 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIG-NAFDNIIDARRTLREIKLLRHMEHENVIA 105
           ++ +G GAYG V    +  T  E AIK I  ++     ++   L E+ +L+ ++H N++ 
Sbjct: 26  VKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMK 85
Query: 106 IKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + +     +     + Y+V E+    +L   I   Q+ ++      + Q+L G  Y+H  
Sbjct: 86  LYEFFEDKR-----NYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKH 140
Query: 165 SVLHRDLKPSNLLLNASCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
           +++HRDLKP NLLL +      +KI DFGL+        M E + T +Y APE+L    +
Sbjct: 141 NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRK--K 198
Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGK 248
           Y    D+WS G IL  ++   P F G+
Sbjct: 199 YDEKCDVWSCGVILYILLCGYPPFGGQ 225

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 107/218 (49%), Gaps = 15/218 (6%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 74  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +   T+   T  Y  PE ++    +
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPE-MIEGRMH 183
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
              +D+WS+G +  E +  +P F    Y    + I+ V
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 221

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 115/226 (50%), Gaps = 19/226 (8%)
Query: 46  PIRPIGRGAYGIVCAAVNSETREEVAIKKI----GNAF--DNIIDARR-TLREIKLLRHM 98
           P   +GRG   +V   ++  T +E A+K I    G +F  + + + R  TL+E+ +LR +
Sbjct: 8   PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 67
Query: 99  E-HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 156
             H N+I +KD     + +TF   ++V++LM   +L   +     L++   +  +  LL 
Sbjct: 68  SGHPNIIQLKDTY---ETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 122
Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 216
            +  +H  +++HRDLKP N+LL+   ++K+ DFG +      + + E   T  Y APE++
Sbjct: 123 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEII 182
Query: 217 L-----NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
                 N   Y   +D+WS G I+  ++   P F  +  +  LR+I
Sbjct: 183 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 228

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 107/218 (49%), Gaps = 15/218 (6%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 74  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +   T+   T  Y  PE ++    +
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPE-MIEGRMH 183
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
              +D+WS+G +  E +  +P F    Y    + I+ V
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 221

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 107/218 (49%), Gaps = 15/218 (6%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 75  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 126
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +   T+   T  Y  PE ++    +
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPE-MIEGRMH 184
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
              +D+WS+G +  E +  +P F    Y    + I+ V
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 222

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 103/204 (50%), Gaps = 6/204 (2%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG+G +  V  A +  T +EVA+K I     N    ++  RE+++ + + H N++ +
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKL 78
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            ++I     +T   +Y+V E     ++   + +  +  +   +    Q++  ++Y H   
Sbjct: 79  FEVI-----ETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKF 133
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           ++HRDLK  NLLL+A  ++KI DFG +   +  + +  +     Y APEL          
Sbjct: 134 IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPE 193
Query: 226 IDIWSVGCILGEIMTREPLFPGKD 249
           +D+WS+G IL  +++    F G++
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 105/205 (51%), Gaps = 11/205 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG+GA+ +V   V   T  E A K I     +  D ++  RE ++ R ++H N++ + D 
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 110 IRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           I    ++ F+  Y+V++L+   +L + I + +  ++    + + Q+L  + + H   V+H
Sbjct: 72  I---SEEGFH--YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVH 126
Query: 169 RDLKPSNLLLNASCD---LKIGDFGLA-RTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           RDLKP NLLL + C    +K+ DFGLA     +      +  T  Y +PE+L     Y  
Sbjct: 127 RDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK-EAYGK 185
Query: 225 AIDIWSVGCILGEIMTREPLFPGKD 249
            +DIW+ G IL  ++   P F  +D
Sbjct: 186 PVDIWACGVILYILLVGYPPFWDED 210

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 15/218 (6%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 74  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +   T    T  Y  PE ++    +
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTXLCGTLDYLPPE-MIEGRMH 183
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
              +D+WS+G +  E +  +P F    Y    + I+ V
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 221

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 94/191 (49%), Gaps = 13/191 (6%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGN----AFDNIIDARRTLREIKLLRHMEHENVIA 105
           +G G +G V    +  T  +VA+K +      + D +   +R ++ +KL RH    ++I 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH---PHIIK 75
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           +  +I  P      D ++V E +   +L   I    ++ +   +    Q+L  + Y H  
Sbjct: 76  LYQVISTP-----TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
            V+HRDLKP N+LL+A  + KI DFGL+   S+ +F+     +  Y APE++        
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGP 190
Query: 225 AIDIWSVGCIL 235
            +DIWS G IL
Sbjct: 191 EVDIWSCGVIL 201

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 15/218 (6%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 18  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 78  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 129
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +   T    T  Y  PE ++    +
Sbjct: 130 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMH 187
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
              +D+WS+G +  E +  +P F    Y    + I+ V
Sbjct: 188 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 225

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 15/218 (6%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 13  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 72
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 73  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 124
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +   T    T  Y  PE ++    +
Sbjct: 125 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMH 182
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
              +D+WS+G +  E +  +P F    Y    + I+ V
Sbjct: 183 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 220

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 15/218 (6%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 77  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 128
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +   T    T  Y  PE ++    +
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMH 186
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
              +D+WS+G +  E +  +P F    Y    + I+ V
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 224

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 15/218 (6%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 74  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +   T    T  Y  PE ++    +
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMH 183
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
              +D+WS+G +  E +  +P F    Y    + I+ V
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 221

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 12/207 (5%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIG-NAFDNIIDARRTLREIKLLRHMEHENVIA 105
           ++ +G GAYG V    +  T  E AIK I  ++     ++   L E+ +L+ ++H N++ 
Sbjct: 9   VKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMK 68
Query: 106 IKDIIRPPKKDTFNDVYIVYEL-MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + +     +     + Y+V E+    +L   I   Q+ ++      + Q+L G  Y+H  
Sbjct: 69  LYEFFEDKR-----NYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKH 123
Query: 165 SVLHRDLKPSNLLLNASCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
           +++HRDLKP NLLL +      +KI DFGL+        M E + T +Y APE+L    +
Sbjct: 124 NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRK--K 181
Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGK 248
           Y    D+WS G IL  ++   P F G+
Sbjct: 182 YDEKCDVWSCGVILYILLCGYPPFGGQ 208

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 15/218 (6%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 77  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 128
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +   T    T  Y  PE ++    +
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMH 186
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
              +D+WS+G +  E +  +P F    Y    + I+ V
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 224

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 84.7 bits (208), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 116/240 (48%), Gaps = 38/240 (15%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI--- 106
           +G+GA+G V  A N+      AIKKI +  + +      L E+ LL  + H+ V+     
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL---STILSEVXLLASLNHQYVVRYYAA 70
Query: 107 ----KDIIRP----PKKDTFNDVYIVYELMDT-DLHQIIRSDQ--QLTDDHCQYFLYQLL 155
               ++ ++P     KK T   ++I  E  +   L+ +I S+   Q  D++ + F  Q+L
Sbjct: 71  WLERRNFVKPXTAVKKKST---LFIQXEYCENRTLYDLIHSENLNQQRDEYWRLF-RQIL 126
Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT---------------SETDF 200
             L Y+HS  ++HR+LKP N+ ++ S ++KIGDFGLA+                   +D 
Sbjct: 127 EALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           +T  + T  Y A E+L     Y   ID +S+G I  E +   P   G + V+ L+ +  V
Sbjct: 187 LTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIY--PFSTGXERVNILKKLRSV 244

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 15/218 (6%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 40  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 99
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 100 YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 151
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +   T    T  Y  PE ++    +
Sbjct: 152 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMH 209
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
              +D+WS+G +  E +  +P F    Y    + I+ V
Sbjct: 210 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 247

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 84.7 bits (208), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 15/218 (6%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 79  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 130
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +   T    T  Y  PE ++    +
Sbjct: 131 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMH 188
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
              +D+WS+G +  E +  +P F    Y    + I+ V
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 226

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 15/218 (6%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 75  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 126
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +   T    T  Y  PE ++    +
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFGWS-CHAPSSRRTTLSGTLDYLPPE-MIEGRMH 184
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
              +D+WS+G +  E +  +P F    Y    + I+ V
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 222

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 15/218 (6%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 31  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 90
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 91  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 142
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +   T    T  Y  PE ++    +
Sbjct: 143 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMH 200
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
              +D+WS+G +  E +  +P F    Y    + I+ V
Sbjct: 201 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 238

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 84.3 bits (207), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 107/222 (48%), Gaps = 23/222 (10%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 107 KDIIRPPKKDTFNDVYIVYELMD--------TDLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
                      F+D   VY +++         +L ++ + D+Q T      ++ +L   L
Sbjct: 79  YGY--------FHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTAT----YITELANAL 126
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
            Y HS  V+HRD+KP NLLL ++ +LKI DFG +   + +   T    T  Y  PE ++ 
Sbjct: 127 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIE 184
Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
              +   +D+WS+G +  E +  +P F    Y    + I+ V
Sbjct: 185 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 226

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 15/218 (6%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 79  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 130
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +   T    T  Y  PE  +    +
Sbjct: 131 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-XIEGRXH 188
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
              +D+WS+G +  E +  +P F    Y    + I+ V
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 226

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 109/213 (51%), Gaps = 13/213 (6%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIK 107
           IG G+ GIVC A    + + VA+KK+    D     RR L   E+ ++R  +HENV+ + 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKM----DLRKQQRRELLFNEVVIMRDYQHENVVEMY 137
Query: 108 DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
           +          +++++V E ++      I +  ++ ++        +L+ L  +H+  V+
Sbjct: 138 N-----SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVI 192
Query: 168 HRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 226
           HRD+K  ++LL     +K+ DFG  A+ + E       V T ++ APEL+     Y   +
Sbjct: 193 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP-YGPEV 251
Query: 227 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           DIWS+G ++ E++  EP +  +  +  +++I +
Sbjct: 252 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD 284

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 84.0 bits (206), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 109/209 (52%), Gaps = 22/209 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIK-LLRHMEHENVIAIKD 108
           IG G+Y +    ++  T  E A+K I  +       R    EI+ LLR+ +H N+I +KD
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKIIDKS------KRDPTEEIEILLRYGQHPNIITLKD 83
Query: 109 IIRPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           +      D    VY+V ELM     L +I+R  +  ++      L+ + + ++Y+H+  V
Sbjct: 84  VY-----DDGKYVYVVTELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 167 LHRDLKPSNLL-LNASCD---LKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTE 221
           +HRDLKPSN+L ++ S +   ++I DFG A+   +E   +     T  + APE +L    
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPE-VLERQG 196
Query: 222 YTAAIDIWSVGCILGEIMTR-EPLFPGKD 249
           Y AA DIWS+G +L  ++T   P   G D
Sbjct: 197 YDAACDIWSLGVLLYTMLTGYTPFANGPD 225

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 114/226 (50%), Gaps = 19/226 (8%)
Query: 46  PIRPIGRGAYGIVCAAVNSETREEVAIKKI----GNAF--DNIIDARR-TLREIKLLRHM 98
           P   +GRG   +V   ++  T +E A+K I    G +F  + + + R  TL+E+ +LR +
Sbjct: 21  PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 99  E-HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 156
             H N+I +KD     + +TF   ++V++LM   +L   +     L++   +  +  LL 
Sbjct: 81  SGHPNIIQLKDTY---ETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 135
Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 216
            +  +H  +++HRDLKP N+LL+   ++K+ DFG +      + +     T  Y APE++
Sbjct: 136 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEII 195
Query: 217 L-----NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
                 N   Y   +D+WS G I+  ++   P F  +  +  LR+I
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 241

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 100/206 (48%), Gaps = 20/206 (9%)
Query: 48  RPIGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI 104
           R IG+G +G+V        ++ R + AIK +      +      LRE  L+R + H NV+
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR-ITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHS 163
           A+  I+ PP  +    V + Y +   DL Q IRS Q+  T      F  Q+ RG++Y+  
Sbjct: 86  ALIGIMLPP--EGLPHVLLPY-MCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE 142
Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT--- 220
              +HRDL   N +L+ S  +K+ DFGLAR   +     EY   + +R   L +  T   
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILD----REYYSVQQHRHARLPVKWTALE 198
Query: 221 -----EYTAAIDIWSVGCILGEIMTR 241
                 +T   D+WS G +L E++TR
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTR 224

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 110/213 (51%), Gaps = 13/213 (6%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIK 107
           IG G+ GIVC A    + + VA+KK+    D     RR L   E+ ++R  +HENV+ + 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKM----DLRKQQRRELLFNEVVIMRDYQHENVVEMY 87
Query: 108 DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
           +          +++++V E ++      I +  ++ ++        +L+ L  +H+  V+
Sbjct: 88  N-----SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVI 142
Query: 168 HRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 226
           HRD+K  ++LL     +K+ DFG  A+ + E       V T ++ APE L++   Y   +
Sbjct: 143 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEV 201
Query: 227 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           DIWS+G ++ E++  EP +  +  +  +++I +
Sbjct: 202 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD 234

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 110/213 (51%), Gaps = 13/213 (6%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIK 107
           IG G+ GIVC A    + + VA+KK+    D     RR L   E+ ++R  +HENV+ + 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKM----DLRKQQRRELLFNEVVIMRDYQHENVVEMY 92
Query: 108 DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
           +          +++++V E ++      I +  ++ ++        +L+ L  +H+  V+
Sbjct: 93  N-----SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVI 147
Query: 168 HRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 226
           HRD+K  ++LL     +K+ DFG  A+ + E       V T ++ APE L++   Y   +
Sbjct: 148 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEV 206
Query: 227 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           DIWS+G ++ E++  EP +  +  +  +++I +
Sbjct: 207 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD 239

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 110/213 (51%), Gaps = 13/213 (6%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIK 107
           IG G+ GIVC A    + + VA+KK+    D     RR L   E+ ++R  +HENV+ + 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKM----DLRKQQRRELLFNEVVIMRDYQHENVVEMY 94
Query: 108 DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
           +          +++++V E ++      I +  ++ ++        +L+ L  +H+  V+
Sbjct: 95  N-----SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVI 149
Query: 168 HRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 226
           HRD+K  ++LL     +K+ DFG  A+ + E       V T ++ APE L++   Y   +
Sbjct: 150 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEV 208
Query: 227 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           DIWS+G ++ E++  EP +  +  +  +++I +
Sbjct: 209 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD 241

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 110/213 (51%), Gaps = 13/213 (6%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIK 107
           IG G+ GIVC A    + + VA+KK+    D     RR L   E+ ++R  +HENV+ + 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKM----DLRKQQRRELLFNEVVIMRDYQHENVVEMY 83
Query: 108 DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
           +          +++++V E ++      I +  ++ ++        +L+ L  +H+  V+
Sbjct: 84  N-----SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVI 138
Query: 168 HRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 226
           HRD+K  ++LL     +K+ DFG  A+ + E       V T ++ APE L++   Y   +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEV 197
Query: 227 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           DIWS+G ++ E++  EP +  +  +  +++I +
Sbjct: 198 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD 230

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 58/175 (33%), Positives = 95/175 (54%), Gaps = 21/175 (12%)
Query: 86  RRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY-IVYELMD-TDLHQIIRSDQQLT 143
           +R  RE+     + H+N++++ D+      D  +D Y +V E ++   L + I S   L+
Sbjct: 56  KRFEREVHNSSQLSHQNIVSMIDV------DEEDDCYYLVMEYIEGPTLSEYIESHGPLS 109
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-MT 202
            D    F  Q+L G+K+ H   ++HRD+KP N+L++++  LKI DFG+A+  SET    T
Sbjct: 110 VDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT 169
Query: 203 EYVV-TRWYRAPELLL-----NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV 251
            +V+ T  Y +PE         CT      DI+S+G +L E++  EP F G+  V
Sbjct: 170 NHVLGTVQYFSPEQAKGEATDECT------DIYSIGIVLYEMLVGEPPFNGETAV 218

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 15/218 (6%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   + +  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 11  RPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 70
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 71  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 122
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +   T    T  Y  PE ++    +
Sbjct: 123 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMH 180
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
              +D+WS+G +  E +  +P F    Y    + I+ V
Sbjct: 181 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 218

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 83.6 bits (205), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IGRG++G V  AV   TR   A KKI   F  + D  R  +EI++++ ++H N+I + + 
Sbjct: 34  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYF--VEDVDRFKQEIEIMKSLDHPNIIRLYET 91
Query: 110 IRPPKKDTFNDVYIVYEL-MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
                 +   D+Y+V EL    +L + +   +   +      +  +L  + Y H  +V H
Sbjct: 92  F-----EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAH 146
Query: 169 RDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           RDLKP N L    +    LK+ DFGLA        M   V T +Y +P++L     Y   
Sbjct: 147 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL--YGPE 204
Query: 226 IDIWSVGCILGEIMTREPLF 245
            D WS G ++  ++   P F
Sbjct: 205 CDEWSAGVMMYVLLCGYPPF 224

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 83.6 bits (205), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 106/218 (48%), Gaps = 15/218 (6%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 77  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 128
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +    +   T  Y  PE ++    +
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPE-MIEGRMH 186
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
              +D+WS+G +  E +  +P F    Y    + I+ V
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 224

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 83.6 bits (205), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 63/195 (32%), Positives = 95/195 (48%), Gaps = 17/195 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI--GNAFDNIIDARRTLREIKLLRHMEHENVI 104
           ++ IG G +G+     + +  E VA+K I  G   D  +      REI   R + H N++
Sbjct: 24  VKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVK-----REIINHRSLRHPNIV 78
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
             K++I  P       + IV E     +L + I +  + ++D  ++F  QL+ G+ Y H+
Sbjct: 79  RFKEVILTP-----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHA 133
Query: 164 ASVLHRDLKPSNLLLNASCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
             V HRDLK  N LL+ S    LKI DFG ++ +         V T  Y APE+LL   E
Sbjct: 134 MQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLK-KE 192
Query: 222 YTAAI-DIWSVGCIL 235
           Y   + D+WS G  L
Sbjct: 193 YDGKVADVWSCGVTL 207

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 15/218 (6%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 74  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +        T  Y  PE ++    +
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPE-MIEGRMH 183
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
              +D+WS+G +  E +  +P F    Y    + I+ V
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 221

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 109/213 (51%), Gaps = 13/213 (6%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIK 107
           IG G+ GIVC A    + + VA+KK+    D     RR L   E+ ++R  +HENV+ + 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKM----DLRKQQRRELLFNEVVIMRDYQHENVVEMY 214
Query: 108 DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
           +          +++++V E ++      I +  ++ ++        +L+ L  +H+  V+
Sbjct: 215 NSYL-----VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVI 269
Query: 168 HRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 226
           HRD+K  ++LL     +K+ DFG  A+ + E       V T ++ APEL+     Y   +
Sbjct: 270 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP-YGPEV 328
Query: 227 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           DIWS+G ++ E++  EP +  +  +  +++I +
Sbjct: 329 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD 361

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IGRG++G V  AV   TR   A KKI   F  + D  R  +EI++++ ++H N+I + + 
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYF--VEDVDRFKQEIEIMKSLDHPNIIRLYET 74
Query: 110 IRPPKKDTFNDVYIVYEL-MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
                 +   D+Y+V EL    +L + +   +   +      +  +L  + Y H  +V H
Sbjct: 75  F-----EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAH 129
Query: 169 RDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           RDLKP N L    +    LK+ DFGLA        M   V T +Y +P++L     Y   
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL--YGPE 187
Query: 226 IDIWSVGCILGEIMTREPLF 245
            D WS G ++  ++   P F
Sbjct: 188 CDEWSAGVMMYVLLCGYPPF 207

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 106/218 (48%), Gaps = 15/218 (6%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 77  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 128
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI +FG +   + +   T    T  Y  PE ++    +
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMH 186
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
              +D+WS+G +  E +  +P F    Y    + I+ V
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 224

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 11/206 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G +G V   ++ +T E+VAIK+           R  L EI++++ + H NV++ +++
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL-EIQIMKKLNHPNVVSAREV 80
Query: 110 IRPPKKDTFNDV-YIVYELMDT-DLHQIIRSDQQ---LTDDHCQYFLYQLLRGLKYVHSA 164
               +K   ND+  +  E  +  DL + +   +    L +   +  L  +   L+Y+H  
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 165 SVLHRDLKPSNLLLNASCDL---KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
            ++HRDLKP N++L         KI D G A+   + +  TE+V T  Y APELL    +
Sbjct: 141 RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQ-KK 199
Query: 222 YTAAIDIWSVGCILGEIMTR-EPLFP 246
           YT  +D WS G +  E +T   P  P
Sbjct: 200 YTVTVDYWSFGTLAFECITGFRPFLP 225

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIK 107
           +G GA+  V  A +  T++ VAIK I       ++ +      EI +L  ++H N++A+ 
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAK---KALEGKEGSMENEIAVLHKIKHPNIVALD 82
Query: 108 DIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           DI      ++   +Y++ +L+   +L   I      T+      ++Q+L  +KY+H   +
Sbjct: 83  DIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 167 LHRDLKPSNLL---LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
           +HRDLKP NLL   L+    + I DFGL++       ++    T  Y APE+L     Y+
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ-KPYS 196
Query: 224 AAIDIWSVGCILGEIMTREPLF 245
            A+D WS+G I   ++   P F
Sbjct: 197 KAVDCWSIGVIAYILLCGYPPF 218

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 11/206 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G +G V   ++ +T E+VAIK+           R  L EI++++ + H NV++ +++
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL-EIQIMKKLNHPNVVSAREV 81
Query: 110 IRPPKKDTFNDV-YIVYELMDT-DLHQIIRSDQQ---LTDDHCQYFLYQLLRGLKYVHSA 164
               +K   ND+  +  E  +  DL + +   +    L +   +  L  +   L+Y+H  
Sbjct: 82  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 141
Query: 165 SVLHRDLKPSNLLLNASCDL---KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
            ++HRDLKP N++L         KI D G A+   + +  TE+V T  Y APELL    +
Sbjct: 142 RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQ-KK 200
Query: 222 YTAAIDIWSVGCILGEIMTR-EPLFP 246
           YT  +D WS G +  E +T   P  P
Sbjct: 201 YTVTVDYWSFGTLAFECITGFRPFLP 226

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 15/218 (6%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 77  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 128
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +        T  Y  PE ++    +
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPE-MIEGRMH 186
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
              +D+WS+G +  E +  +P F    Y    + I+ V
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 224

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 106/218 (48%), Gaps = 15/218 (6%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 40  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 99
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 100 YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 151
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +    +   T  Y  PE ++    +
Sbjct: 152 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPE-MIEGRMH 209
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
              +D+WS+G +  E +  +P F    Y    + I+ V
Sbjct: 210 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 247

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 106/222 (47%), Gaps = 23/222 (10%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +     +      +  RE+++  H+ H N++ +
Sbjct: 18  RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 107 KDIIRPPKKDTFNDVYIVYELMD--------TDLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
                      F+D   VY +++         +L ++ R D+Q T      ++ +L   L
Sbjct: 78  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTAT----YITELANAL 125
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
            Y HS  V+HRD+KP NLLL ++ +LKI DFG +   + +   T    T  Y  PE ++ 
Sbjct: 126 SYCHSKRVIHRDIKPENLLLGSNGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIE 183
Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
              +   +D+WS+G +  E +   P F    Y    R I+ V
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV 225

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 15/218 (6%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 74  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +        T  Y  PE ++    +
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPE-MIEGRMH 183
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
              +D+WS+G +  E +  +P F    Y    + I+ V
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 221

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/195 (32%), Positives = 97/195 (49%), Gaps = 17/195 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI--GNAFDNIIDARRTLREIKLLRHMEHENVI 104
           ++ IG G +G+     + ++ E VA+K I  G   D  +      REI   R + H N++
Sbjct: 23  VKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVK-----REIINHRSLRHPNIV 77
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
             K++I  P       + IV E     +L + I +  + ++D  ++F  QL+ G+ Y H+
Sbjct: 78  RFKEVILTPTH-----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 132
Query: 164 ASVLHRDLKPSNLLLNASCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
             V HRDLK  N LL+ S    LKI DFG ++++         V T  Y APE+LL   E
Sbjct: 133 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK-KE 191
Query: 222 YTAAI-DIWSVGCIL 235
           Y   + D+WS G  L
Sbjct: 192 YDGKVADVWSCGVTL 206

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 106/218 (48%), Gaps = 15/218 (6%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 16  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 75
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 76  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 127
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI +FG +   + +   T    T  Y  PE ++    +
Sbjct: 128 SKRVIHRDIKPENLLLGSAGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMH 185
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
              +D+WS+G +  E +  +P F    Y    + I+ V
Sbjct: 186 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 223

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIK 107
           +G GA+  V  A +  T++ VAIK I       ++ +      EI +L  ++H N++A+ 
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAK---EALEGKEGSMENEIAVLHKIKHPNIVALD 82
Query: 108 DIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           DI      ++   +Y++ +L+   +L   I      T+      ++Q+L  +KY+H   +
Sbjct: 83  DIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 167 LHRDLKPSNLL---LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
           +HRDLKP NLL   L+    + I DFGL++       ++    T  Y APE+L     Y+
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ-KPYS 196
Query: 224 AAIDIWSVGCILGEIMTREPLF 245
            A+D WS+G I   ++   P F
Sbjct: 197 KAVDCWSIGVIAYILLCGYPPF 218

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIK 107
           +G GA+  V  A +  T++ VAIK I       ++ +      EI +L  ++H N++A+ 
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAK---EALEGKEGSMENEIAVLHKIKHPNIVALD 82
Query: 108 DIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           DI      ++   +Y++ +L+   +L   I      T+      ++Q+L  +KY+H   +
Sbjct: 83  DIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 167 LHRDLKPSNLL---LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
           +HRDLKP NLL   L+    + I DFGL++       ++    T  Y APE+L     Y+
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ-KPYS 196
Query: 224 AAIDIWSVGCILGEIMTREPLF 245
            A+D WS+G I   ++   P F
Sbjct: 197 KAVDCWSIGVIAYILLCGYPPF 218

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 15/218 (6%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 16  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 75
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 76  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 127
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +        T  Y  PE ++    +
Sbjct: 128 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPE-MIEGRMH 185
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
              +D+WS+G +  E +  +P F    Y    + I+ V
Sbjct: 186 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 223

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 15/218 (6%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 77  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 128
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +        T  Y  PE ++    +
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPE-MIEGRMH 186
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
              +D+WS+G +  E +  +P F    Y    + I+ V
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 224

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 107/220 (48%), Gaps = 19/220 (8%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 75  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 126
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLA--RTTSETDFMTEYVVTRWYRAPELLLNCT 220
           S  V+HRD+KP NLLL ++ +LKI DFG +    +S  D +     T  Y  PE ++   
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTL---CGTLDYLPPE-MIEGR 182
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
            +   +D+WS+G +  E +  +P F    Y    + I+ V
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 222

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 112/216 (51%), Gaps = 11/216 (5%)
Query: 47  IRPIGRGAYG---IVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV 103
           ++ +G+G++G   +V     S+ R+  A+K +  A   + D  RT  E  +L  + H  +
Sbjct: 29  LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFI 88
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           + +    +     T   +Y++ + +   DL   +  +   T++  +++L +L   L ++H
Sbjct: 89  VKLHYAFQ-----TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH 143
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCTE 221
           S  +++RDLKP N+LL+    +K+ DFGL++ + + +     +  T  Y APE ++N   
Sbjct: 144 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE-VVNRRG 202
Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           +T + D WS G ++ E++T    F GKD    + +I
Sbjct: 203 HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI 238

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 117/233 (50%), Gaps = 16/233 (6%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL-L 95
            EV +  + PI  +GRGAYG+V    +  + + +A+K+I  A  N  + +R L ++ + +
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISM 60
Query: 96  RHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDL----HQIIRSDQQLTDDHCQYFL 151
           R ++    +     +         DV+I  ELMDT L     Q+I   Q + +D      
Sbjct: 61  RTVDCPFTVTFYGALF-----REGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIA 115
Query: 152 YQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWY 210
             +++ L+++HS  SV+HRD+KPSN+L+NA   +K+ DFG++    +          + Y
Sbjct: 116 VSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPY 175
Query: 211 RAPELL---LNCTEYTAAIDIWSVGCILGEI-MTREPLFPGKDYVHQLRLITE 259
            APE +   LN   Y+   DIWS+G  + E+ + R P         QL+ + E
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE 228

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIK 107
           +G GA+  V  A +  T++ VAIK I       ++ +      EI +L  ++H N++A+ 
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAK---EALEGKEGSMENEIAVLHKIKHPNIVALD 82
Query: 108 DIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           DI      ++   +Y++ +L+   +L   I      T+      ++Q+L  +KY+H   +
Sbjct: 83  DIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 167 LHRDLKPSNLL---LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
           +HRDLKP NLL   L+    + I DFGL++       ++    T  Y APE+L     Y+
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ-KPYS 196
Query: 224 AAIDIWSVGCILGEIMTREPLF 245
            A+D WS+G I   ++   P F
Sbjct: 197 KAVDCWSIGVIAYILLCGYPPF 218

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 112/216 (51%), Gaps = 11/216 (5%)
Query: 47  IRPIGRGAYG---IVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV 103
           ++ +G+G++G   +V     S+ R+  A+K +  A   + D  RT  E  +L  + H  +
Sbjct: 30  LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFI 89
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           + +    +     T   +Y++ + +   DL   +  +   T++  +++L +L   L ++H
Sbjct: 90  VKLHYAFQ-----TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH 144
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCTE 221
           S  +++RDLKP N+LL+    +K+ DFGL++ + + +     +  T  Y APE ++N   
Sbjct: 145 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE-VVNRRG 203
Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           +T + D WS G ++ E++T    F GKD    + +I
Sbjct: 204 HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI 239

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 112/216 (51%), Gaps = 11/216 (5%)
Query: 47  IRPIGRGAYG---IVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV 103
           ++ +G+G++G   +V     S+ R+  A+K +  A   + D  RT  E  +L  + H  +
Sbjct: 29  LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFI 88
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           + +    +     T   +Y++ + +   DL   +  +   T++  +++L +L   L ++H
Sbjct: 89  VKLHYAFQ-----TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH 143
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCTE 221
           S  +++RDLKP N+LL+    +K+ DFGL++ + + +     +  T  Y APE ++N   
Sbjct: 144 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE-VVNRRG 202
Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           +T + D WS G ++ E++T    F GKD    + +I
Sbjct: 203 HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI 238

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 97/193 (50%), Gaps = 13/193 (6%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG G +G+     + ++ E VA+K I    + I  A    REI   R + H N++  
Sbjct: 24  VKDIGSGNFGVARLMRDKQSNELVAVKYIERG-EKI--AANVKREIINHRSLRHPNIVRF 80
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
           K++I  P       + IV E     +L + I +  + ++D  ++F  QL+ G+ Y H+  
Sbjct: 81  KEVILTPTH-----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 135
Query: 166 VLHRDLKPSNLLLNASCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
           V HRDLK  N LL+ S    LKI DFG ++++         V T  Y APE+LL   EY 
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK-KEYD 194
Query: 224 AAI-DIWSVGCIL 235
             + D+WS G  L
Sbjct: 195 GKVADVWSCGVTL 207

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 99/195 (50%), Gaps = 23/195 (11%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIK-LLRHMEHENVIAIKD 108
           IG G+Y      V+  T  E A+K I  +       R    EI+ LLR+ +H N+I +KD
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVIDKS------KRDPSEEIEILLRYGQHPNIITLKD 88
Query: 109 IIRPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           +      D    VY+V ELM     L +I+R  +  ++    + L+ + + ++Y+HS  V
Sbjct: 89  VY-----DDGKHVYLVTELMRGGELLDKILR-QKFFSEREASFVLHTIGKTVEYLHSQGV 142
Query: 167 LHRDLKPSNLLL-----NASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCT 220
           +HRDLKPSN+L      N  C L+I DFG A+   +E   +     T  + APE+L    
Sbjct: 143 VHRDLKPSNILYVDESGNPEC-LRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKR-Q 200
Query: 221 EYTAAIDIWSVGCIL 235
            Y    DIWS+G +L
Sbjct: 201 GYDEGCDIWSLGILL 215

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 106/222 (47%), Gaps = 23/222 (10%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 107 KDIIRPPKKDTFNDVYIVYELMD--------TDLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
                      F+D   VY +++         +L ++ + D+Q T      ++ +L   L
Sbjct: 79  YGY--------FHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTAT----YITELANAL 126
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
            Y HS  V+HRD+KP NLLL ++ +LKI DFG +   + +        T  Y  PE ++ 
Sbjct: 127 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLXGTLDYLPPE-MIE 184
Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
              +   +D+WS+G +  E +  +P F    Y    + I+ V
Sbjct: 185 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 226

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 99/195 (50%), Gaps = 23/195 (11%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIK-LLRHMEHENVIAIKD 108
           IG G+Y      V+  T  E A+K I  +       R    EI+ LLR+ +H N+I +KD
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVIDKS------KRDPSEEIEILLRYGQHPNIITLKD 88
Query: 109 IIRPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           +      D    VY+V ELM     L +I+R  +  ++    + L+ + + ++Y+HS  V
Sbjct: 89  VY-----DDGKHVYLVTELMRGGELLDKILRQ-KFFSEREASFVLHTIGKTVEYLHSQGV 142
Query: 167 LHRDLKPSNLLL-----NASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCT 220
           +HRDLKPSN+L      N  C L+I DFG A+   +E   +     T  + APE+L    
Sbjct: 143 VHRDLKPSNILYVDESGNPEC-LRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKR-Q 200
Query: 221 EYTAAIDIWSVGCIL 235
            Y    DIWS+G +L
Sbjct: 201 GYDEGCDIWSLGILL 215

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 81.6 bits (200), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 104/218 (47%), Gaps = 15/218 (6%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 106
           RP+G+G +G V  A    ++  +A+K +  A          LR E+++  H+ H N++ +
Sbjct: 14  RPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVH 162
                      F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y H
Sbjct: 74  YGY--------FHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S  V+HRD+KP NLLL ++ +LKI DFG +   + +        T  Y  PE ++    +
Sbjct: 126 SKKVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPE-MIEGRMH 183
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
              +D+WS+G +  E +  +P F    Y    + I+ V
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRV 221

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 50  IGRGAYGIVCAAVNSET--REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           +G G+YG V   ++SET  R  V I K               +EI+LLR + H+NVI + 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 108 DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKYVHSAS 165
           D++   +K     +Y+V E     + +++ S  +     CQ   Y  QL+ GL+Y+HS  
Sbjct: 73  DVLYNEEK---QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG 129
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAPELLLNCTEY 222
           ++H+D+KP NLLL     LKI   G+A      +  D       +  ++ PE+      +
Sbjct: 130 IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTF 189
Query: 223 TA-AIDIWSVGCILGEIMT 240
           +   +DIWS G  L  I T
Sbjct: 190 SGFKVDIWSAGVTLYNITT 208

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 81.3 bits (199), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 107/209 (51%), Gaps = 22/209 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIK-LLRHMEHENVIAIKD 108
           IG G+Y +    ++  T  E A+K I  +       R    EI+ LLR+ +H N+I +KD
Sbjct: 30  IGVGSYSVCKRCIHKATNXEFAVKIIDKS------KRDPTEEIEILLRYGQHPNIITLKD 83
Query: 109 IIRPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           +      D    VY+V EL      L +I+R  +  ++      L+ + + ++Y+H+  V
Sbjct: 84  VY-----DDGKYVYVVTELXKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 167 LHRDLKPSNLL-LNASCD---LKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTE 221
           +HRDLKPSN+L ++ S +   ++I DFG A+   +E   +     T  + APE +L    
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPE-VLERQG 196
Query: 222 YTAAIDIWSVGCILGEIMTR-EPLFPGKD 249
           Y AA DIWS+G +L   +T   P   G D
Sbjct: 197 YDAACDIWSLGVLLYTXLTGYTPFANGPD 225

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 107/224 (47%), Gaps = 27/224 (12%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   +++  +A+K +     +      +  RE+++  H+ H N++ +
Sbjct: 18  RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 107 KDIIRPPKKDTFNDVYIVYELMD--------TDLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
                      F+D   VY +++         +L ++ R D+Q T      ++ +L   L
Sbjct: 78  YGY--------FHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTAT----YITELANAL 125
Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA--RTTSETDFMTEYVVTRWYRAPELL 216
            Y HS  V+HRD+KP NLLL ++ +LKI DFG +    +S  D +     T  Y  PE +
Sbjct: 126 SYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTL---CGTLDYLPPE-M 181
Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           +    +   +D+WS+G +  E +   P F    Y    R I+ V
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV 225

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 106/210 (50%), Gaps = 9/210 (4%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG+GA G V  A++  T +EVAI+++             + EI ++R  ++ N++   D 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 169
                    +++++V E +       + ++  + +        + L+ L+++HS  V+HR
Sbjct: 86  YL-----VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHR 140
Query: 170 DLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDI 228
           D+K  N+LL     +K+ DFG  A+ T E    +E V T ++ APE++     Y   +DI
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTR-KAYGPKVDI 199
Query: 229 WSVGCILGEIMTREPLFPGKDYVHQLRLIT 258
           WS+G +  E++  EP +  ++ +  L LI 
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIA 229

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 110/201 (54%), Gaps = 12/201 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGN-AFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G++  V  A +  T  EVAIK I   A       +R   E+K+   ++H +++ + +
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 109 IIRPPKKDTFNDVYIVYELM-DTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASV 166
                  +  N VY+V E+  + ++++ +++  +  +++  ++F++Q++ G+ Y+HS  +
Sbjct: 79  YF-----EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGI 133
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCTEYTA 224
           LHRDL  SNLLL  + ++KI DFGLA T  +      Y +  T  Y +PE+    + +  
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLA-TQLKMPHEKHYTLCGTPNYISPEIATR-SAHGL 191
Query: 225 AIDIWSVGCILGEIMTREPLF 245
             D+WS+GC+   ++   P F
Sbjct: 192 ESDVWSLGCMFYTLLIGRPPF 212

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 108/213 (50%), Gaps = 20/213 (9%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G+YG V  A++ ET + VAIK++    D     +  ++EI +++  +  +V+     
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGS 92
Query: 110 IRPPKKDTFNDVYIVYELMDT-DLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
                K+T  D++IV E      +  IIR  ++ LT+D     L   L+GL+Y+H    +
Sbjct: 93  YF---KNT--DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKI 147
Query: 168 HRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE---YVVTRWYRAPELLLNCTEYTA 224
           HRD+K  N+LLN     K+ DFG+A     TD M +    + T ++ APE++     Y  
Sbjct: 148 HRDIKAGNILLNTEGHAKLADFGVAGQL--TDXMAKRNXVIGTPFWMAPEVIQEIG-YNC 204
Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
             DIWS+G    E+   +P +     +H +R I
Sbjct: 205 VADIWSLGITAIEMAEGKPPYAD---IHPMRAI 234

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 97/195 (49%), Gaps = 17/195 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI--GNAFDNIIDARRTLREIKLLRHMEHENVI 104
           ++ IG G +G+     + ++ E VA+K I  G   D  +      REI   R + H N++
Sbjct: 24  VKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVK-----REIINHRSLRHPNIV 78
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
             K++I  P       + IV E     +L + I +  + ++D  ++F  QL+ G+ Y H+
Sbjct: 79  RFKEVILTPTH-----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 133
Query: 164 ASVLHRDLKPSNLLLNASCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
             V HRDLK  N LL+ S    LKI  FG ++++       + V T  Y APE+LL   E
Sbjct: 134 MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLK-KE 192
Query: 222 YTAAI-DIWSVGCIL 235
           Y   + D+WS G  L
Sbjct: 193 YDGKVADVWSCGVTL 207

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 16/201 (7%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           R +G GA+G V       +  E  IK I N   + +   +   EI++L+ ++H N+I I 
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERVIKTI-NKDRSQVPMEQIEAEIEVLKSLDHPNIIKIF 86
Query: 108 DIIRPPKKDTFNDVYIVYELMDTD--LHQIIRSD---QQLTDDHCQYFLYQLLRGLKYVH 162
           ++      + ++++YIV E  +    L +I+ +    + L++ +    + Q++  L Y H
Sbjct: 87  EVF-----EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 163 SASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 219
           S  V+H+DLKP N+L   +     +KI DFGLA      +  T    T  Y APE+    
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR- 200
Query: 220 TEYTAAIDIWSVGCILGEIMT 240
            + T   DIWS G ++  ++T
Sbjct: 201 -DVTFKCDIWSAGVVMYFLLT 220

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 80.5 bits (197), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 106/204 (51%), Gaps = 18/204 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA-RRTLREIKLLRHMEHENVIA 105
           +R IG G++G V  A +    E VAIKK+  +     +  +  ++E++ L+ + H N I 
Sbjct: 59  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 118
Query: 106 IKDI-IRPPKKDTFNDVYIVYEL---MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
            +   +R       +  ++V E      +DL ++ +  + L +       +  L+GL Y+
Sbjct: 119 YRGCYLRE------HTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYL 170
Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
           HS +++HRD+K  N+LL+    +K+GDFG A   +  +    +V T ++ APE++L   E
Sbjct: 171 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---XFVGTPYWMAPEVILAMDE 227
Query: 222 --YTAAIDIWSVGCILGEIMTREP 243
             Y   +D+WS+G    E+  R+P
Sbjct: 228 GQYDGKVDVWSLGITCIELAERKP 251

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 103/222 (46%), Gaps = 19/222 (8%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL------REIKLLRHMEHENV 103
           +G G + IV       T +E A K I      +  +RR +      RE+ +LR + H N+
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYAAKFIKKR--RLXSSRRGVSREEIEREVNILREIRHPNI 91
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           I + DI      +   DV ++ EL+   +L   +   + LT+D    FL Q+L G+ Y+H
Sbjct: 92  ITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 146
Query: 163 SASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
           S  + H DLKP N++L      +  +K+ DFG+A      +       T  + APE ++N
Sbjct: 147 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE-IVN 205
Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
                   D+WS+G I   +++    F G+     L  I+ V
Sbjct: 206 YEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV 247

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 111/226 (49%), Gaps = 24/226 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKI--------GNAFDNIIDARRTLREIKLLRHME-H 100
           IGRG   +V   V+  T  E A+K +            + + +A R  RE  +LR +  H
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATR--RETHILRQVAGH 159
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
            ++I + D       ++ + +++V++LM   +L   +     L++   +  +  LL  + 
Sbjct: 160 PHIITLID-----SYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS 214
Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 219
           ++H+ +++HRDLKP N+LL+ +  +++ DFG +      + + E   T  Y APE +L C
Sbjct: 215 FLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPE-ILKC 273
Query: 220 T------EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           +       Y   +D+W+ G IL  ++   P F  +  +  LR+I E
Sbjct: 274 SMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIME 319

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 96/195 (49%), Gaps = 17/195 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI--GNAFDNIIDARRTLREIKLLRHMEHENVI 104
           ++ IG G +G+     + ++ E VA+K I  G   D  +      REI   R + H N++
Sbjct: 24  VKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVK-----REIINHRSLRHPNIV 78
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
             K++I  P       + IV E     +L + I +  + ++D  ++F  QL+ G+ Y H+
Sbjct: 79  RFKEVILTPTH-----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 133
Query: 164 ASVLHRDLKPSNLLLNASCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
             V HRDLK  N LL+ S    LKI  FG ++++         V T  Y APE+LL   E
Sbjct: 134 MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK-KE 192
Query: 222 YTAAI-DIWSVGCIL 235
           Y   + D+WS G  L
Sbjct: 193 YDGKVADVWSCGVTL 207

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 110/216 (50%), Gaps = 11/216 (5%)
Query: 47  IRPIGRGAYG---IVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV 103
           ++ +G+G++G   +V      ++    A+K +  A   + D  RT  E  +L  + H  V
Sbjct: 33  LKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFV 92
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           + +    +     T   +Y++ + +   DL   +  +   T++  +++L +L  GL ++H
Sbjct: 93  VKLHYAFQ-----TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLH 147
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCTE 221
           S  +++RDLKP N+LL+    +K+ DFGL++   + +     +  T  Y APE ++N   
Sbjct: 148 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPE-VVNRQG 206
Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           ++ + D WS G ++ E++T    F GKD    + LI
Sbjct: 207 HSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLI 242

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 106/204 (51%), Gaps = 18/204 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA-RRTLREIKLLRHMEHENVIA 105
           +R IG G++G V  A +    E VAIKK+  +     +  +  ++E++ L+ + H N I 
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 106 IKDI-IRPPKKDTFNDVYIVYEL---MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
            +   +R       +  ++V E      +DL ++ +  + L +       +  L+GL Y+
Sbjct: 80  YRGCYLRE------HTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYL 131
Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
           HS +++HRD+K  N+LL+    +K+GDFG A   +  +    +V T ++ APE++L   E
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---XFVGTPYWMAPEVILAMDE 188
Query: 222 --YTAAIDIWSVGCILGEIMTREP 243
             Y   +D+WS+G    E+  R+P
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKP 212

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 103/222 (46%), Gaps = 19/222 (8%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL------REIKLLRHMEHENV 103
           +G G + IV       T +E A K I      +  +RR +      RE+ +LR + H N+
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYAAKFIKKR--RLSSSRRGVSREEIEREVNILREIRHPNI 77
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           I + DI      +   DV ++ EL+   +L   +   + LT+D    FL Q+L G+ Y+H
Sbjct: 78  ITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 132
Query: 163 SASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
           S  + H DLKP N++L      +  +K+ DFG+A      +       T  + APE ++N
Sbjct: 133 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE-IVN 191
Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
                   D+WS+G I   +++    F G+     L  I+ V
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV 233

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 110/213 (51%), Gaps = 23/213 (10%)
Query: 42  KYVPPIRPIGRGAYGIV--CA--AVNSETREEVAIK--KIGNAFDNIIDARRTLREIKLL 95
           +++  IR +G G +G V  C        T E+VA+K  K  +  ++I D ++   EI++L
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKK---EIEIL 77
Query: 96  RHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQY-FLYQ 153
           R++ HEN++  K I     +D  N + ++ E + +  L + +  ++   +   Q  +  Q
Sbjct: 78  RNLYHENIVKYKGIC---TEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQ 134
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR----- 208
           + +G+ Y+ S   +HRDL   N+L+ +   +KIGDFGL +   ETD     V        
Sbjct: 135 ICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEXXTVKDDRDSPV 193
Query: 209 -WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
            WY APE L+    Y A+ D+WS G  L E++T
Sbjct: 194 FWY-APECLMQSKFYIAS-DVWSFGVTLHELLT 224

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 103/222 (46%), Gaps = 19/222 (8%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL------REIKLLRHMEHENV 103
           +G G + IV       T +E A K I      +  +RR +      RE+ +LR + H N+
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKR--RLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           I + DI      +   DV ++ EL+   +L   +   + LT+D    FL Q+L G+ Y+H
Sbjct: 71  ITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 125
Query: 163 SASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
           S  + H DLKP N++L      +  +K+ DFG+A      +       T  + APE ++N
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE-IVN 184
Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
                   D+WS+G I   +++    F G+     L  I+ V
Sbjct: 185 YEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV 226

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/239 (29%), Positives = 112/239 (46%), Gaps = 28/239 (11%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           FEV +  + PI  +GRGAYG+V    +  + +  A+K+I  A  N  + +R L ++ +  
Sbjct: 29  FEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRI-RATVNSQEQKRLLXDLDISX 87
Query: 97  HMEHENVIAIKDIIRPPKKDTF-------NDVYIVYELMDTDL----HQIIRSDQQLTDD 145
                        +  P   TF        DV+I  EL DT L     Q+I   Q + +D
Sbjct: 88  RT-----------VDCPFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPED 136
Query: 146 HCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY 204
                   +++ L+++HS  SV+HRD+KPSN+L+NA   +K  DFG++    +       
Sbjct: 137 ILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDID 196
Query: 205 VVTRWYRAPELL---LNCTEYTAAIDIWSVGCILGEI-MTREPLFPGKDYVHQLRLITE 259
              + Y APE +   LN   Y+   DIWS+G    E+ + R P         QL+ + E
Sbjct: 197 AGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVE 255

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 110/213 (51%), Gaps = 23/213 (10%)
Query: 42  KYVPPIRPIGRGAYGIV--CA--AVNSETREEVAIK--KIGNAFDNIIDARRTLREIKLL 95
           +++  IR +G G +G V  C        T E+VA+K  K  +  ++I D ++   EI++L
Sbjct: 9   RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKK---EIEIL 65
Query: 96  RHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQY-FLYQ 153
           R++ HEN++  K I     +D  N + ++ E + +  L + +  ++   +   Q  +  Q
Sbjct: 66  RNLYHENIVKYKGIC---TEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQ 122
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR----- 208
           + +G+ Y+ S   +HRDL   N+L+ +   +KIGDFGL +   ETD     V        
Sbjct: 123 ICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEXXTVKDDRDSPV 181
Query: 209 -WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
            WY APE L+    Y A+ D+WS G  L E++T
Sbjct: 182 FWY-APECLMQSKFYIAS-DVWSFGVTLHELLT 212

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 35/237 (14%)
Query: 50  IGRGAYGIVCAAVNSETR-EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G GA+G V   ++ +     VA+K + N  D   +A R+  EI++L H+   N      
Sbjct: 22  LGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARS--EIQVLEHL---NTTDPNS 75
Query: 109 IIRPPKK----DTFNDVYIVYELMDTDLHQIIRSDQQLTD--DHCQYFLYQLLRGLKYVH 162
             R  +     +    + IV+EL+    +  I+ +  L    DH +   YQ+ + + ++H
Sbjct: 76  TFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH 135
Query: 163 SASVLHRDLKPSNLLLNAS-------------------CDLKIGDFGLARTTSETDFMTE 203
           S  + H DLKP N+L   S                    D+K+ DFG A  T + +  + 
Sbjct: 136 SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TYDDEHHST 193
Query: 204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
            V TR YRAPE++L    ++   D+WS+GCIL E      +FP  D    L ++  +
Sbjct: 194 LVSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERI 249

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 104/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ IG G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTIGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFND---VYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y+V E M   D+   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +K+ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 104/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ IG G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTIGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFND---VYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y+V E M   D+   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +K+ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 105/210 (50%), Gaps = 9/210 (4%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG+GA G V  A++  T +EVAI+++             + EI ++R  ++ N++   D 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 169
                    +++++V E +       + ++  + +        + L+ L+++HS  V+HR
Sbjct: 86  YL-----VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHR 140
Query: 170 DLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDI 228
           D+K  N+LL     +K+ DFG  A+ T E    +  V T ++ APE++     Y   +DI
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTR-KAYGPKVDI 199
Query: 229 WSVGCILGEIMTREPLFPGKDYVHQLRLIT 258
           WS+G +  E++  EP +  ++ +  L LI 
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIA 229

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 103/197 (52%), Gaps = 9/197 (4%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIG-NAFDNIIDARRTLREIKLLRHMEHENVIA 105
           +R IG+G++G VC    ++T++  A+K +         + R   +E+++++ +EH  ++ 
Sbjct: 20  LRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVN 79
Query: 106 IKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           +    +  +     D+++V +L+   DL   ++ +    ++  + F+ +L+  L Y+ + 
Sbjct: 80  LWYSFQDEE-----DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ 134
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN--CTEY 222
            ++HRD+KP N+LL+    + I DF +A        +T    T+ Y APE+  +     Y
Sbjct: 135 RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGY 194
Query: 223 TAAIDIWSVGCILGEIM 239
           + A+D WS+G    E++
Sbjct: 195 SFAVDWWSLGVTAYELL 211

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 105/210 (50%), Gaps = 9/210 (4%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG+GA G V  A++  T +EVAI+++             + EI ++R  ++ N++   D 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 169
                    +++++V E +       + ++  + +        + L+ L+++HS  V+HR
Sbjct: 86  YL-----VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHR 140
Query: 170 DLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDI 228
           D+K  N+LL     +K+ DFG  A+ T E    +  V T ++ APE++     Y   +DI
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDI 199
Query: 229 WSVGCILGEIMTREPLFPGKDYVHQLRLIT 258
           WS+G +  E++  EP +  ++ +  L LI 
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIA 229

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 110/216 (50%), Gaps = 14/216 (6%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+GA+ +V   +   T +E A K I     +  D ++  RE ++ R ++H N++ + D 
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 110 IRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           I    ++ F+  Y+V++L+   +L + I + +  ++    + + Q+L  + + H   ++H
Sbjct: 72  I---SEEGFH--YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVH 126
Query: 169 RDLKPSNLLLNASCD---LKIGDFGLA-RTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           RDLKP NLLL +      +K+ DFGLA     +      +  T  Y +PE+L     Y  
Sbjct: 127 RDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK-DPYGK 185
Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
            +D+W+ G IL  ++   P F  +D   Q RL  ++
Sbjct: 186 PVDMWACGVILYILLVGYPPFWDED---QHRLYQQI 218

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 105/210 (50%), Gaps = 9/210 (4%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG+GA G V  A++  T +EVAI+++             + EI ++R  ++ N++   D 
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 169
                    +++++V E +       + ++  + +        + L+ L+++HS  V+HR
Sbjct: 87  YL-----VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHR 141
Query: 170 DLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDI 228
           D+K  N+LL     +K+ DFG  A+ T E    +  V T ++ APE++     Y   +DI
Sbjct: 142 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTR-KAYGPKVDI 200
Query: 229 WSVGCILGEIMTREPLFPGKDYVHQLRLIT 258
           WS+G +  E++  EP +  ++ +  L LI 
Sbjct: 201 WSLGIMAIEMIEGEPPYLNENPLRALYLIA 230

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 112/218 (51%), Gaps = 26/218 (11%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNA-FDNI--IDARRTLREIKLLRHMEHENVIAI 106
           IG+GA+ +V   +N ET ++ A+K +  A F +   +      RE  +   ++H +++  
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV-- 89
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDL--HQIIRSDQQL--TDDHCQYFLYQLLRGLKYV 161
            +++     D    +Y+V+E MD  DL    + R+D     ++    +++ Q+L  L+Y 
Sbjct: 90  -ELLETYSSDGM--LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 162 HSASVLHRDLKPSNLLLNA---SCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLL 217
           H  +++HRD+KP N+LL +   S  +K+GDFG+A    E+  +    V T  + APE++ 
Sbjct: 147 HDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVVK 206
Query: 218 NCTEYTAAIDIWSVGCILGEIM--------TREPLFPG 247
               Y   +D+W  G IL  ++        T+E LF G
Sbjct: 207 R-EPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEG 243

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 28/209 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G  G V    N  T+E+ A+K +        D  +  RE++L  H        I  I
Sbjct: 24  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVEL--HWRASQCPHIVRI 74
Query: 110 IRPPKKDTFNDVY-------IVYELMDT-DLHQII--RSDQQLTDDHCQYFLYQLLRGLK 159
           +     D + ++Y       IV E +D  +L   I  R DQ  T+      +  +   ++
Sbjct: 75  V-----DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 129
Query: 160 YVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 216
           Y+HS ++ HRD+KP NLL  +   +  LK+ DFG A+ T+  + +TE   T +Y APE +
Sbjct: 130 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPE-V 188
Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLF 245
           L   +Y  + D+WS+G I+  ++   P F
Sbjct: 189 LGPEKYDKSCDMWSLGVIMYILLCGYPPF 217

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 25/209 (11%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT-LREIKLLRHMEHENVIAIKD 108
           +G+G +G      + ET E + +K++   FD   + +RT L+E+K++R +EH NV+    
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIR-FDE--ETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 109 IIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
           ++   K+  F   YI        L  II+S D Q        F   +  G+ Y+HS +++
Sbjct: 75  VLYKDKRLNFITEYI----KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNII 130
Query: 168 HRDLKPSNLLLNASCDLKIGDFGLA-------------RTTSETDFMTEYVV--TRWYRA 212
           HRDL   N L+  + ++ + DFGLA             R+  + D    Y V    ++ A
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMTR 241
           PE ++N   Y   +D++S G +L EI+ R
Sbjct: 191 PE-MINGRSYDEKVDVFSFGIVLCEIIGR 218

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 110/216 (50%), Gaps = 14/216 (6%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+GA+ +V   +   T +E A K I     +  D ++  RE ++ R ++H N++ + D 
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 110 IRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           I    ++ F+  Y+V++L+   +L + I + +  ++    + + Q+L  + + H   ++H
Sbjct: 72  I---SEEGFH--YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVH 126
Query: 169 RDLKPSNLLLNASCD---LKIGDFGLA-RTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           RDLKP NLLL +      +K+ DFGLA     +      +  T  Y +PE+L     Y  
Sbjct: 127 RDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK-DPYGK 185
Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
            +D+W+ G IL  ++   P F  +D   Q RL  ++
Sbjct: 186 PVDMWACGVILYILLVGYPPFWDED---QHRLYQQI 218

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           I  +G GA+G V  A N ET    A K I    +  ++    + EI +L   +H N++ +
Sbjct: 42  IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE--DYMVEIDILASCDHPNIVKL 99
Query: 107 KDIIRPPKKDTFNDVYIVYEL-----MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
            D          N+++I+ E      +D  + ++ R    LT+   Q    Q L  L Y+
Sbjct: 100 LDAFY-----YENNLWILIEFCAGGAVDAVMLELERP---LTESQIQVVCKQTLDALNYL 151
Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           H   ++HRDLK  N+L     D+K+ DFG+ A+ T        ++ T ++ APE+++  T
Sbjct: 152 HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET 211
Query: 221 E----YTAAIDIWSVGCILGEIMTREP 243
                Y    D+WS+G  L E+   EP
Sbjct: 212 SKDRPYDYKADVWSLGITLIEMAEIEP 238

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           I  +G GA+G V  A N ET    A K I    +  ++    + EI +L   +H N++ +
Sbjct: 42  IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE--DYMVEIDILASCDHPNIVKL 99
Query: 107 KDIIRPPKKDTFNDVYIVYEL-----MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
            D          N+++I+ E      +D  + ++ R    LT+   Q    Q L  L Y+
Sbjct: 100 LDAFY-----YENNLWILIEFCAGGAVDAVMLELERP---LTESQIQVVCKQTLDALNYL 151
Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           H   ++HRDLK  N+L     D+K+ DFG+ A+ T        ++ T ++ APE+++  T
Sbjct: 152 HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCET 211
Query: 221 E----YTAAIDIWSVGCILGEIMTREP 243
                Y    D+WS+G  L E+   EP
Sbjct: 212 SKDRPYDYKADVWSLGITLIEMAEIEP 238

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 10/214 (4%)
Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIK--KIGNAFDN--IIDAR--RTLRE 91
           E S KY   + P+G GA+G V  AV+ E  +EV +K  K     ++  I D +  +   E
Sbjct: 21  EYSQKY-STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLE 79
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           I +L  +EH N+I + DI    +   F  + +       DL   I    +L +    Y  
Sbjct: 80  IAILSRVEHANIIKVLDIF---ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIF 136
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYR 211
            QL+  + Y+    ++HRD+K  N+++     +K+ DFG A           +  T  Y 
Sbjct: 137 RQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYC 196
Query: 212 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 245
           APE+L+        +++WS+G  L  ++  E  F
Sbjct: 197 APEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF 230

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 105/216 (48%), Gaps = 14/216 (6%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+GA+ +V   V     +E A K I     +  D ++  RE ++ R ++H N++ + D 
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 110 IRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           I           Y++++L+   +L + I + +  ++    + + Q+L  + + H   V+H
Sbjct: 90  ISEEGHH-----YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVH 144
Query: 169 RDLKPSNLLLNA---SCDLKIGDFGLA-RTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           RDLKP NLLL +      +K+ DFGLA     E      +  T  Y +PE+L     Y  
Sbjct: 145 RDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK-DPYGK 203
Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
            +D+W+ G IL  ++   P F  +D   Q RL  ++
Sbjct: 204 PVDLWACGVILYILLVGYPPFWDED---QHRLYQQI 236

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           I  +G GA+G V  A N ET    A K I    +  ++    + EI +L   +H N++ +
Sbjct: 42  IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE--DYMVEIDILASCDHPNIVKL 99
Query: 107 KDIIRPPKKDTFNDVYIVYEL-----MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
            D          N+++I+ E      +D  + ++ R    LT+   Q    Q L  L Y+
Sbjct: 100 LDAFY-----YENNLWILIEFCAGGAVDAVMLELERP---LTESQIQVVCKQTLDALNYL 151
Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           H   ++HRDLK  N+L     D+K+ DFG+ A+ T        ++ T ++ APE+++  T
Sbjct: 152 HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCET 211
Query: 221 E----YTAAIDIWSVGCILGEIMTREP 243
                Y    D+WS+G  L E+   EP
Sbjct: 212 SKDRPYDYKADVWSLGITLIEMAEIEP 238

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 107/210 (50%), Gaps = 13/210 (6%)
Query: 47  IRPIGRGAYGIVC---AAVNSETREEVAIKKIGNAF--DNIIDARRTLREIKLLRHMEHE 101
           +R +G+G YG V        + T +  A+K +  A    N  D   T  E  +L  ++H 
Sbjct: 22  LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHP 81
Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
            ++   D+I   +  T   +Y++ E L   +L   +  +    +D   ++L ++   L +
Sbjct: 82  FIV---DLIYAFQ--TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNC 219
           +H   +++RDLKP N++LN    +K+ DFGL + +     +T  +  T  Y APE+L+  
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMR- 195
Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
           + +  A+D WS+G ++ +++T  P F G++
Sbjct: 196 SGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 107/210 (50%), Gaps = 13/210 (6%)
Query: 47  IRPIGRGAYGIVC---AAVNSETREEVAIKKIGNAF--DNIIDARRTLREIKLLRHMEHE 101
           +R +G+G YG V        + T +  A+K +  A    N  D   T  E  +L  ++H 
Sbjct: 22  LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHP 81
Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
            ++   D+I   +  T   +Y++ E L   +L   +  +    +D   ++L ++   L +
Sbjct: 82  FIV---DLIYAFQ--TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNC 219
           +H   +++RDLKP N++LN    +K+ DFGL + +     +T  +  T  Y APE+L+  
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILMR- 195
Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
           + +  A+D WS+G ++ +++T  P F G++
Sbjct: 196 SGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 20/215 (9%)
Query: 38  EVSSKYVPPIRPIGRGAYGIVCAA-VNSETREE--VAIKKIGNAFDNIIDARRTLREIKL 94
           E+   YV     IG G +G VC   + +  ++E  VAIK +   +      R  L E  +
Sbjct: 12  EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTER-QRREFLSEASI 70
Query: 95  LRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD-LHQIIR-SDQQLTDDHCQYFLY 152
           +   EH N+I ++ ++          V I+ E M+   L   +R +D Q T       L 
Sbjct: 71  MGQFEHPNIIRLEGVV-----TNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR 125
Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-------TTSETDFMTEYV 205
            +  G++Y+   S +HRDL   N+L+N++   K+ DFGL+R         +ET  +   +
Sbjct: 126 GIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKI 185
Query: 206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             RW  APE +    ++T+A D WS G ++ E+M+
Sbjct: 186 PIRWT-APEAIA-FRKFTSASDAWSYGIVMWEVMS 218

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 106/214 (49%), Gaps = 23/214 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR------EIKLLRHMEHENV 103
           IG G+ GIVC A    +  +VA+K        ++D R+  R      E+ ++R  +H NV
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVK--------MMDLRKQQRRELLFNEVVIMRDYQHFNV 104
Query: 104 IAI-KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           + + K  +         +++++ E +       I S  +L ++        +L+ L Y+H
Sbjct: 105 VEMYKSYL------VGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLH 158
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
           +  V+HRD+K  ++LL     +K+ DFG  A+ + +       V T ++ APE +++ + 
Sbjct: 159 AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPE-VISRSL 217
Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR 255
           Y   +DIWS+G ++ E++  EP +     V  ++
Sbjct: 218 YATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK 251

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 77.4 bits (189), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 108/237 (45%), Gaps = 35/237 (14%)
Query: 50  IGRGAYGIVCAAVNSETR-EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G GA+G V   ++ +     VA+K + N  D   +A R+  EI++L H+   N      
Sbjct: 22  LGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARS--EIQVLEHL---NTTDPNS 75
Query: 109 IIRPPKK----DTFNDVYIVYELMDTDLHQIIRSDQQLTD--DHCQYFLYQLLRGLKYVH 162
             R  +     +    + IV+EL+    +  I+ +  L    DH +   YQ+ + + ++H
Sbjct: 76  TFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH 135
Query: 163 SASVLHRDLKPSNLLLNAS-------------------CDLKIGDFGLARTTSETDFMTE 203
           S  + H DLKP N+L   S                    D+K+ DFG A  T + +  + 
Sbjct: 136 SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TYDDEHHST 193
Query: 204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
            V  R YRAPE++L    ++   D+WS+GCIL E      +FP  D    L ++  +
Sbjct: 194 LVXXRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERI 249

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 24/204 (11%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +GRGA+G+VC A      ++VAIK+I    ++  + +  + E++ L  + H N++ +   
Sbjct: 17  VGRGAFGVVCKA--KWRAKDVAIKQI----ESESERKAFIVELRQLSRVNHPNIVKLYGA 70
Query: 110 IRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQL---TDDHCQYFLYQLLRGLKYVHS-- 163
                    N V +V E  +   L+ ++   + L   T  H   +  Q  +G+ Y+HS  
Sbjct: 71  -------CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 123
Query: 164 -ASVLHRDLKPSNLLLNASCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
             +++HRDLKP NLLL A    LKI DFG A        MT    +  + APE+    + 
Sbjct: 124 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ--THMTNNKGSAAWMAPEVFEG-SN 180
Query: 222 YTAAIDIWSVGCILGEIMTREPLF 245
           Y+   D++S G IL E++TR   F
Sbjct: 181 YSEKCDVFSWGIILWEVITRRKPF 204

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 104/211 (49%), Gaps = 18/211 (8%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT---LREIKLLRHMEHENVIAI 106
           +G G++  V  A    T  E AIK +     +II   +     RE  ++  ++H   + +
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 94
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
               +  +K  F   Y      + +L + IR      +   +++  +++  L+Y+H   +
Sbjct: 95  YFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 150
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYT 223
           +HRDLKP N+LLN    ++I DFG A+     S+      +V T  Y +PELL   TE +
Sbjct: 151 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL---TEKS 207
Query: 224 A--AIDIWSVGCILGEIMTREPLF-PGKDYV 251
           A  + D+W++GCI+ +++   P F  G +Y+
Sbjct: 208 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 238

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 24/204 (11%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +GRGA+G+VC A      ++VAIK+I    ++  + +  + E++ L  + H N++ +   
Sbjct: 16  VGRGAFGVVCKA--KWRAKDVAIKQI----ESESERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 110 IRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQL---TDDHCQYFLYQLLRGLKYVHS-- 163
                    N V +V E  +   L+ ++   + L   T  H   +  Q  +G+ Y+HS  
Sbjct: 70  -------CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 164 -ASVLHRDLKPSNLLLNASCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
             +++HRDLKP NLLL A    LKI DFG A        MT    +  + APE+    + 
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ--THMTNNKGSAAWMAPEVFEG-SN 179
Query: 222 YTAAIDIWSVGCILGEIMTREPLF 245
           Y+   D++S G IL E++TR   F
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPF 203

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 105/210 (50%), Gaps = 9/210 (4%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG+GA G V  A++  T +EVAI+++             + EI ++R  ++ N++   D 
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 169
                    +++++V E +       + ++  + +        + L+ L+++HS  V+HR
Sbjct: 87  YL-----VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHR 141
Query: 170 DLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDI 228
           ++K  N+LL     +K+ DFG  A+ T E    +  V T ++ APE++     Y   +DI
Sbjct: 142 NIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDI 200
Query: 229 WSVGCILGEIMTREPLFPGKDYVHQLRLIT 258
           WS+G +  E++  EP +  ++ +  L LI 
Sbjct: 201 WSLGIMAIEMIEGEPPYLNENPLRALYLIA 230

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 77.0 bits (188), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 107/210 (50%), Gaps = 13/210 (6%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA-IKD 108
           IG+G++G V   +++ T+E VAIK I +  +   +     +EI +L   +   +      
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYITRYFGS 85
Query: 109 IIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
            ++  K      ++I+ E +       +     L + +    L ++L+GL Y+HS   +H
Sbjct: 86  YLKSTK------LWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIH 139
Query: 169 RDLKPSNLLLNASCDLKIGDFGLARTTSETDFM-TEYVVTRWYRAPELLLNCTEYTAAID 227
           RD+K +N+LL+   D+K+ DFG+A   ++T      +V T ++ APE ++  + Y    D
Sbjct: 140 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE-VIKQSAYDFKAD 198
Query: 228 IWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           IWS+G    E+   EP  P  D +H +R++
Sbjct: 199 IWSLGITAIELAKGEP--PNSD-LHPMRVL 225

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 103/209 (49%), Gaps = 26/209 (12%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE-NVIA 105
           IR +G G++G V    + ET    A+K        I+D ++ ++    L+ +EH  N   
Sbjct: 47  IRTLGTGSFGRVMLVKHKETGNHYAMK--------ILDKQKVVK----LKQIEHTLNEKR 94
Query: 106 IKDIIRPPK--------KDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLR 156
           I+  +  P         KD  N +Y+V E     ++   +R   + ++ H +++  Q++ 
Sbjct: 95  IQQAVNFPFLVKLEFSFKDNSN-LYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 216
             +Y+HS  +++RDLKP NLL++    +K+ DFG A+      +      T  Y APE++
Sbjct: 154 TFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXL--CGTPEYLAPEII 211
Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLF 245
           L    Y  A+D W++G ++ E+    P F
Sbjct: 212 L-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 105/217 (48%), Gaps = 30/217 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL---------LRHMEH 100
           +G G++  V  A    T  E AIK        I++ R  ++E K+         +  ++H
Sbjct: 41  LGEGSFSTVVLARELATSREYAIK--------ILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
              + +    +  +K  F   Y      + +L + IR      +   +++  +++  L+Y
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 148
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LLN    ++I DFG A+     S+      +V T  Y +PELL 
Sbjct: 149 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL- 207
Query: 218 NCTEYTA--AIDIWSVGCILGEIMTREPLF-PGKDYV 251
             TE +A  + D+W++GCI+ +++   P F  G +Y+
Sbjct: 208 --TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 242

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 104/211 (49%), Gaps = 18/211 (8%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT---LREIKLLRHMEHENVIAI 106
           +G G++  V  A    T  E AIK +     +II   +     RE  ++  ++H   + +
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 94
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
               +  +K  F   Y      + +L + IR      +   +++  +++  L+Y+H   +
Sbjct: 95  YFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 150
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYT 223
           +HRDLKP N+LLN    ++I DFG A+     S+      +V T  Y +PELL   TE +
Sbjct: 151 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKS 207
Query: 224 A--AIDIWSVGCILGEIMTREPLF-PGKDYV 251
           A  + D+W++GCI+ +++   P F  G +Y+
Sbjct: 208 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 238

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 104/211 (49%), Gaps = 18/211 (8%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT---LREIKLLRHMEHENVIAI 106
           +G G++  V  A    T  E AIK +     +II   +     RE  ++  ++H   + +
Sbjct: 22  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 79
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
               +  +K  F   Y      + +L + IR      +   +++  +++  L+Y+H   +
Sbjct: 80  YFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 135
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYT 223
           +HRDLKP N+LLN    ++I DFG A+     S+      +V T  Y +PELL   TE +
Sbjct: 136 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKS 192
Query: 224 A--AIDIWSVGCILGEIMTREPLF-PGKDYV 251
           A  + D+W++GCI+ +++   P F  G +Y+
Sbjct: 193 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 223

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 104/217 (47%), Gaps = 30/217 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL---------LRHMEH 100
           +G G++  V  A    T  E AIK        I++ R  ++E K+         +  ++H
Sbjct: 43  LGEGSFSTVVLARELATSREYAIK--------ILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
              + +    +  +K  F   Y      + +L + IR      +   +++  +++  L+Y
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 150
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE---YVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LLN    ++I DFG A+  S          +V T  Y +PELL 
Sbjct: 151 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 209
Query: 218 NCTEYTA--AIDIWSVGCILGEIMTREPLF-PGKDYV 251
             TE +A  + D+W++GCI+ +++   P F  G +Y+
Sbjct: 210 --TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 244

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 28/209 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G  G V    N  T+E+ A+K +        D  +  RE++L  H        I  I
Sbjct: 30  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVEL--HWRASQCPHIVRI 80
Query: 110 IRPPKKDTFNDVY-------IVYELMDT-DLHQII--RSDQQLTDDHCQYFLYQLLRGLK 159
           +     D + ++Y       IV E +D  +L   I  R DQ  T+      +  +   ++
Sbjct: 81  V-----DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 135
Query: 160 YVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 216
           Y+HS ++ HRD+KP NLL  +   +  LK+ DFG A+ T+  + +T    T +Y APE +
Sbjct: 136 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-V 194
Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLF 245
           L   +Y  + D+WS+G I+  ++   P F
Sbjct: 195 LGPEKYDKSCDMWSLGVIMYILLCGYPPF 223

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 105/217 (48%), Gaps = 30/217 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL---------LRHMEH 100
           +G G++  V  A    T  E AIK        I++ R  ++E K+         +  ++H
Sbjct: 38  LGEGSFSTVVLARELATSREYAIK--------ILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
              + +    +  +K  F   Y      + +L + IR      +   +++  +++  L+Y
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LLN    ++I DFG A+     S+      +V T  Y +PELL 
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELL- 204
Query: 218 NCTEYTA--AIDIWSVGCILGEIMTREPLF-PGKDYV 251
             TE +A  + D+W++GCI+ +++   P F  G +Y+
Sbjct: 205 --TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 239

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 28/209 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G  G V    N  T+E+ A+K +        D  +  RE++L  H        I  I
Sbjct: 31  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVEL--HWRASQCPHIVRI 81
Query: 110 IRPPKKDTFNDVY-------IVYELMDT-DLHQII--RSDQQLTDDHCQYFLYQLLRGLK 159
           +     D + ++Y       IV E +D  +L   I  R DQ  T+      +  +   ++
Sbjct: 82  V-----DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 136
Query: 160 YVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 216
           Y+HS ++ HRD+KP NLL  +   +  LK+ DFG A+ T+  + +T    T +Y APE +
Sbjct: 137 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-V 195
Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLF 245
           L   +Y  + D+WS+G I+  ++   P F
Sbjct: 196 LGPEKYDKSCDMWSLGVIMYILLCGYPPF 224

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 104/217 (47%), Gaps = 30/217 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL---------LRHMEH 100
           +G G++  V  A    T  E AIK        I++ R  ++E K+         +  ++H
Sbjct: 38  LGEGSFSTVVLARELATSREYAIK--------ILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
              + +    +  +K  F   Y      + +L + IR      +   +++  +++  L+Y
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE---YVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LLN    ++I DFG A+  S          +V T  Y +PELL 
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 204
Query: 218 NCTEYTA--AIDIWSVGCILGEIMTREPLF-PGKDYV 251
             TE +A  + D+W++GCI+ +++   P F  G +Y+
Sbjct: 205 --TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 239

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 20/215 (9%)
Query: 38  EVSSKYVPPIRPIGRGAYGIVCAA-VNSETREE--VAIKKIGNAFDNIIDARRTLREIKL 94
           E+   YV     IG G +G VC   + +  ++E  VAIK +   +      R  L E  +
Sbjct: 10  EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTER-QRREFLSEASI 68
Query: 95  LRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD-LHQIIR-SDQQLTDDHCQYFLY 152
           +   EH N+I ++ ++          V I+ E M+   L   +R +D Q T       L 
Sbjct: 69  MGQFEHPNIIRLEGVV-----TNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR 123
Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT----- 207
            +  G++Y+   S +HRDL   N+L+N++   K+ DFGL+R   E      Y  +     
Sbjct: 124 GIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKI 183
Query: 208 --RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             RW  APE +    ++T+A D WS G ++ E+M+
Sbjct: 184 PIRWT-APEAIA-FRKFTSASDAWSYGIVMWEVMS 216

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 103/211 (48%), Gaps = 18/211 (8%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT---LREIKLLRHMEHENVIAI 106
           +G G++  V  A    T  E AIK +     +II   +     RE  ++  ++H   + +
Sbjct: 16  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
               +  +K  F   Y      + +L + IR      +   +++  +++  L+Y+H   +
Sbjct: 74  YFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 129
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE---YVVTRWYRAPELLLNCTEYT 223
           +HRDLKP N+LLN    ++I DFG A+  S          +V T  Y +PELL   TE +
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKS 186
Query: 224 A--AIDIWSVGCILGEIMTREPLF-PGKDYV 251
           A  + D+W++GCI+ +++   P F  G +Y+
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 217

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 104/217 (47%), Gaps = 30/217 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL---------LRHMEH 100
           +G G++  V  A    T  E AIK        I++ R  ++E K+         +  ++H
Sbjct: 40  LGEGSFSTVVLARELATSREYAIK--------ILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
              + +    +  +K  F   Y      + +L + IR      +   +++  +++  L+Y
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE---YVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LLN    ++I DFG A+  S          +V T  Y +PELL 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 206
Query: 218 NCTEYTA--AIDIWSVGCILGEIMTREPLF-PGKDYV 251
             TE +A  + D+W++GCI+ +++   P F  G +Y+
Sbjct: 207 --TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 241

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 105/217 (48%), Gaps = 30/217 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL---------LRHMEH 100
           +G G++  V  A    T  E AIK        I++ R  ++E K+         +  ++H
Sbjct: 40  LGEGSFSTVVLARELATSREYAIK--------ILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
              + +    +  +K  F   Y      + +L + IR      +   +++  +++  L+Y
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LLN    ++I DFG A+     S+      +V T  Y +PELL 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 206
Query: 218 NCTEYTA--AIDIWSVGCILGEIMTREPLF-PGKDYV 251
             TE +A  + D+W++GCI+ +++   P F  G +Y+
Sbjct: 207 --TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 241

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 113/241 (46%), Gaps = 35/241 (14%)
Query: 46  PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           PI+ +GRG +G+V  A N       AIK+I    +  +   + +RE+K L  +EH  ++ 
Sbjct: 9   PIQCLGRGGFGVVFEAKNKVDDCNYAIKRI-RLPNRELAREKVMREVKALAKLEHPGIVR 67
Query: 106 ---------IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDH----CQYFLY 152
                      + ++P     +  +YI  +L   +  +   + +   ++     C +   
Sbjct: 68  YFNAWLEKNTTEKLQPSSPKVY--LYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125
Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD------------- 199
           Q+   ++++HS  ++HRDLKPSN+       +K+GDFGL     + +             
Sbjct: 126 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
             T  V T+ Y +PE  ++   Y+  +DI+S+G IL E+     L+P    + ++R +T+
Sbjct: 186 RHTGQVGTKLYMSPE-QIHGNSYSHKVDIFSLGLILFEL-----LYPFSTQMERVRTLTD 239
Query: 260 V 260
           V
Sbjct: 240 V 240

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 105/217 (48%), Gaps = 30/217 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL---------LRHMEH 100
           +G G++  V  A    T  E AIK        I++ R  ++E K+         +  ++H
Sbjct: 40  LGEGSFSTVVLARELATSREYAIK--------ILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
              + +    +  +K  F   Y      + +L + IR      +   +++  +++  L+Y
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LLN    ++I DFG A+     S+      +V T  Y +PELL 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 206
Query: 218 NCTEYTA--AIDIWSVGCILGEIMTREPLF-PGKDYV 251
             TE +A  + D+W++GCI+ +++   P F  G +Y+
Sbjct: 207 --TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 241

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 28/209 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G  G V    N  T+E+ A+K +        D  +  RE++L  H        I  I
Sbjct: 40  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVEL--HWRASQCPHIVRI 90
Query: 110 IRPPKKDTFNDVY-------IVYELMDT-DLHQII--RSDQQLTDDHCQYFLYQLLRGLK 159
           +     D + ++Y       IV E +D  +L   I  R DQ  T+      +  +   ++
Sbjct: 91  V-----DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 145
Query: 160 YVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 216
           Y+HS ++ HRD+KP NLL  +   +  LK+ DFG A+ T+  + +T    T +Y APE +
Sbjct: 146 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-V 204
Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLF 245
           L   +Y  + D+WS+G I+  ++   P F
Sbjct: 205 LGPEKYDKSCDMWSLGVIMYILLCGYPPF 233

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 112/240 (46%), Gaps = 34/240 (14%)
Query: 19  GVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNA 78
           G     G  ++ N   + ++V+S+       +G G  G V    N  T+E+ A+K +   
Sbjct: 1   GSHVKSGLQIKKNAIIDDYKVTSQV------LGLGINGKVLQIFNKRTQEKFALKMLQ-- 52
Query: 79  FDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY-------IVYELMDT- 130
                D  +  RE++L  H        I  I+     D + ++Y       IV E +D  
Sbjct: 53  -----DCPKARREVEL--HWRASQCPHIVRIV-----DVYENLYAGRKCLLIVMECLDGG 100
Query: 131 DLHQII--RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLK 185
           +L   I  R DQ  T+      +  +   ++Y+HS ++ HRD+KP NLL  +   +  LK
Sbjct: 101 ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK 160
Query: 186 IGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 245
           + DFG A+ T+  + +T    T +Y APE +L   +Y  + D+WS+G I+  ++   P F
Sbjct: 161 LTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPF 219

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 28/209 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G  G V    N  T+E+ A+K +        D  +  RE++L  H        I  I
Sbjct: 32  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVEL--HWRASQCPHIVRI 82
Query: 110 IRPPKKDTFNDVY-------IVYELMDT-DLHQII--RSDQQLTDDHCQYFLYQLLRGLK 159
           +     D + ++Y       IV E +D  +L   I  R DQ  T+      +  +   ++
Sbjct: 83  V-----DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 137
Query: 160 YVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 216
           Y+HS ++ HRD+KP NLL  +   +  LK+ DFG A+ T+  + +T    T +Y APE +
Sbjct: 138 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-V 196
Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLF 245
           L   +Y  + D+WS+G I+  ++   P F
Sbjct: 197 LGPEKYDKSCDMWSLGVIMYILLCGYPPF 225

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 103/211 (48%), Gaps = 18/211 (8%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT---LREIKLLRHMEHENVIAI 106
           +G G++  V  A    T  E AIK +     +II   +     RE  ++  ++H   + +
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
               +  +K  F   Y      + +L + IR      +   +++  +++  L+Y+H   +
Sbjct: 96  YFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE---YVVTRWYRAPELLLNCTEYT 223
           +HRDLKP N+LLN    ++I DFG A+  S          +V T  Y +PELL   TE +
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKS 208
Query: 224 A--AIDIWSVGCILGEIMTREPLF-PGKDYV 251
           A  + D+W++GCI+ +++   P F  G +Y+
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 239

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 104/217 (47%), Gaps = 30/217 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL---------LRHMEH 100
           +G G++  V  A    T  E AIK        I++ R  ++E K+         +  ++H
Sbjct: 41  LGEGSFSTVVLARELATSREYAIK--------ILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
              + +    +  +K  F   Y      + +L + IR      +   +++  +++  L+Y
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 148
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE---YVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LLN    ++I DFG A+  S          +V T  Y +PELL 
Sbjct: 149 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 207
Query: 218 NCTEYTA--AIDIWSVGCILGEIMTREPLF-PGKDYV 251
             TE +A  + D+W++GCI+ +++   P F  G +Y+
Sbjct: 208 --TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 242

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 103/211 (48%), Gaps = 18/211 (8%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT---LREIKLLRHMEHENVIAI 106
           +G G++  V  A    T  E AIK +     +II   +     RE  ++  ++H   + +
Sbjct: 17  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 74
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
               +  +K  F   Y      + +L + IR      +   +++  +++  L+Y+H   +
Sbjct: 75  YFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 130
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE---YVVTRWYRAPELLLNCTEYT 223
           +HRDLKP N+LLN    ++I DFG A+  S          +V T  Y +PELL   TE +
Sbjct: 131 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKS 187
Query: 224 A--AIDIWSVGCILGEIMTREPLF-PGKDYV 251
           A  + D+W++GCI+ +++   P F  G +Y+
Sbjct: 188 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 218

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 28/209 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G  G V    N  T+E+ A+K +        D  +  RE++L  H        I  I
Sbjct: 24  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVEL--HWRASQCPHIVRI 74
Query: 110 IRPPKKDTFNDVY-------IVYELMDT-DLHQII--RSDQQLTDDHCQYFLYQLLRGLK 159
           +     D + ++Y       IV E +D  +L   I  R DQ  T+      +  +   ++
Sbjct: 75  V-----DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 129
Query: 160 YVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 216
           Y+HS ++ HRD+KP NLL  +   +  LK+ DFG A+ T+  + +T    T +Y APE +
Sbjct: 130 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-V 188
Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLF 245
           L   +Y  + D+WS+G I+  ++   P F
Sbjct: 189 LGPEKYDKSCDMWSLGVIMYILLCGYPPF 217

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 103/211 (48%), Gaps = 18/211 (8%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT---LREIKLLRHMEHENVIAI 106
           +G G++  V  A    T  E AIK +     +II   +     RE  ++  ++H   + +
Sbjct: 15  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 72
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
               +  +K  F   Y      + +L + IR      +   +++  +++  L+Y+H   +
Sbjct: 73  YFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 128
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE---YVVTRWYRAPELLLNCTEYT 223
           +HRDLKP N+LLN    ++I DFG A+  S          +V T  Y +PELL   TE +
Sbjct: 129 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKS 185
Query: 224 A--AIDIWSVGCILGEIMTREPLF-PGKDYV 251
           A  + D+W++GCI+ +++   P F  G +Y+
Sbjct: 186 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 216

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 103/211 (48%), Gaps = 18/211 (8%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT---LREIKLLRHMEHENVIAI 106
           +G G++  V  A    T  E AIK +     +II   +     RE  ++  ++H   + +
Sbjct: 18  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 75
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
               +  +K  F   Y      + +L + IR      +   +++  +++  L+Y+H   +
Sbjct: 76  YFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 131
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE---YVVTRWYRAPELLLNCTEYT 223
           +HRDLKP N+LLN    ++I DFG A+  S          +V T  Y +PELL   TE +
Sbjct: 132 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKS 188
Query: 224 A--AIDIWSVGCILGEIMTREPLF-PGKDYV 251
           A  + D+W++GCI+ +++   P F  G +Y+
Sbjct: 189 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 219

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 28/209 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G  G V    N  T+E+ A+K +        D  +  RE++L  H        I  I
Sbjct: 25  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVEL--HWRASQCPHIVRI 75
Query: 110 IRPPKKDTFNDVY-------IVYELMDT-DLHQII--RSDQQLTDDHCQYFLYQLLRGLK 159
           +     D + ++Y       IV E +D  +L   I  R DQ  T+      +  +   ++
Sbjct: 76  V-----DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 130
Query: 160 YVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 216
           Y+HS ++ HRD+KP NLL  +   +  LK+ DFG A+ T+  + +T    T +Y APE +
Sbjct: 131 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-V 189
Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLF 245
           L   +Y  + D+WS+G I+  ++   P F
Sbjct: 190 LGPEKYDKSCDMWSLGVIMYILLCGYPPF 218

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 28/209 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G  G V    N  T+E+ A+K +        D  +  RE++L  H        I  I
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVEL--HWRASQCPHIVRI 76
Query: 110 IRPPKKDTFNDVY-------IVYELMDT-DLHQII--RSDQQLTDDHCQYFLYQLLRGLK 159
           +     D + ++Y       IV E +D  +L   I  R DQ  T+      +  +   ++
Sbjct: 77  V-----DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 160 YVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 216
           Y+HS ++ HRD+KP NLL  +   +  LK+ DFG A+ T+  + +T    T +Y APE +
Sbjct: 132 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-V 190
Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLF 245
           L   +Y  + D+WS+G I+  ++   P F
Sbjct: 191 LGPEKYDKSCDMWSLGVIMYILLCGYPPF 219

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 104/217 (47%), Gaps = 30/217 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL---------LRHMEH 100
           +G G++  V  A    T  E AIK        I++ R  ++E K+         +  ++H
Sbjct: 45  LGEGSFSTVVLARELATSREYAIK--------ILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
              + +    +  +K  F   Y      + +L + IR      +   +++  +++  L+Y
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 152
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE---YVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LLN    ++I DFG A+  S          +V T  Y +PELL 
Sbjct: 153 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 211
Query: 218 NCTEYTA--AIDIWSVGCILGEIMTREPLF-PGKDYV 251
             TE +A  + D+W++GCI+ +++   P F  G +Y+
Sbjct: 212 --TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 246

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 104/209 (49%), Gaps = 11/209 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG+G++G V   +++ T++ VAIK I +  +   +     +EI +L   +   V      
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGS 89
Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 169
                K     ++I+ E +       +       +      L ++L+GL Y+HS   +HR
Sbjct: 90  YLKGSK-----LWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHR 144
Query: 170 DLKPSNLLLNASCDLKIGDFGLARTTSETDFM-TEYVVTRWYRAPELLLNCTEYTAAIDI 228
           D+K +N+LL+   D+K+ DFG+A   ++T      +V T ++ APE ++  + Y +  DI
Sbjct: 145 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIQQSAYDSKADI 203
Query: 229 WSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           WS+G    E+   EP  P  D +H +R++
Sbjct: 204 WSLGITAIELAKGEP--PNSD-MHPMRVL 229

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 28/209 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G  G V    N  T+E+ A+K +        D  +  RE++L  H        I  I
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVEL--HWRASQCPHIVRI 120
Query: 110 IRPPKKDTFNDVY-------IVYELMDT-DLHQII--RSDQQLTDDHCQYFLYQLLRGLK 159
           +     D + ++Y       IV E +D  +L   I  R DQ  T+      +  +   ++
Sbjct: 121 V-----DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 175
Query: 160 YVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 216
           Y+HS ++ HRD+KP NLL  +   +  LK+ DFG A+ T+  + +T    T +Y APE +
Sbjct: 176 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-V 234
Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLF 245
           L   +Y  + D+WS+G I+  ++   P F
Sbjct: 235 LGPEKYDKSCDMWSLGVIMYILLCGYPPF 263

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 97/202 (48%), Gaps = 20/202 (9%)
Query: 50  IGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +G G +G VC+    + S+    VAIK +   +      R  L E  ++   +H N+I +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNIIRL 111
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + ++   K      V IV E M+   L   +R  D Q T       L  +  G+KY+   
Sbjct: 112 EGVVTKSKP-----VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY------VVTRWYRAPELLLN 218
             +HRDL   N+L+N++   K+ DFGLAR   E D    Y      +  RW  +PE +  
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLARVL-EDDPEAAYTTRGGKIPIRW-TSPEAIA- 223
Query: 219 CTEYTAAIDIWSVGCILGEIMT 240
             ++T+A D+WS G +L E+M+
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMS 245

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 28/209 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G  G V    N  T+E+ A+K +        D  +  RE++L  H        I  I
Sbjct: 76  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVEL--HWRASQCPHIVRI 126
Query: 110 IRPPKKDTFNDVY-------IVYELMDT-DLHQII--RSDQQLTDDHCQYFLYQLLRGLK 159
           +     D + ++Y       IV E +D  +L   I  R DQ  T+      +  +   ++
Sbjct: 127 V-----DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 181
Query: 160 YVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 216
           Y+HS ++ HRD+KP NLL  +   +  LK+ DFG A+ T+  + +T    T +Y APE +
Sbjct: 182 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-V 240
Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLF 245
           L   +Y  + D+WS+G I+  ++   P F
Sbjct: 241 LGPEKYDKSCDMWSLGVIMYILLCGYPPF 269

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 99/208 (47%), Gaps = 25/208 (12%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL---------LRHMEH 100
           +G G++  V  A    T  E AIK        I++ R  ++E K+         +  ++H
Sbjct: 40  LGEGSFSTVVLARELATSREYAIK--------ILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
              + +    +  +K  F   Y      + +L + IR      +   +++  +++  L+Y
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LLN    ++I DFG A+     S+      +V T  Y +PELL 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPLF 245
             +   ++ D+W++GCI+ +++   P F
Sbjct: 208 EKSAXKSS-DLWALGCIIYQLVAGLPPF 234

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 20/202 (9%)
Query: 50  IGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +G G +G VC+    + S+    VAIK +   +      R  L E  ++   +H N+I +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNIIRL 111
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + ++   K      V IV E M+   L   +R  D Q T       L  +  G+KY+   
Sbjct: 112 EGVVTKSKP-----VMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY------VVTRWYRAPELLLN 218
             +HRDL   N+L+N++   K+ DFGL+R   E D    Y      +  RW  +PE +  
Sbjct: 167 GAVHRDLAARNILINSNLVCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRW-TSPEAIA- 223
Query: 219 CTEYTAAIDIWSVGCILGEIMT 240
             ++T+A D+WS G +L E+M+
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMS 245

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ IG G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTIGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +K+ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 29/210 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL---------LRHMEH 100
           +G G++  V  A    T  E AIK        I++ R  ++E K+         +  ++H
Sbjct: 40  LGEGSFSTVVLARELATSREYAIK--------ILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
              + +    +  +K  F   Y      + +L + IR      +   +++  +++  L+Y
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE---YVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LLN    ++I DFG A+  S          +V T  Y +PELL 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 206
Query: 218 NCTEYTA--AIDIWSVGCILGEIMTREPLF 245
             TE +A  + D+W++GCI+ +++   P F
Sbjct: 207 --TEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 111/216 (51%), Gaps = 17/216 (7%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII---DARRTLREIKLLR-HMEHENVIA 105
           +G+G++G V  A   +T +  AIK +    D ++   D   T+ E ++L    EH  +  
Sbjct: 26  LGKGSFGKVFLAEFKKTNQFFAIKALKK--DVVLMDDDVECTMVEKRVLSLAWEHPFLTH 83
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           +    +     T  +++ V E ++  DL   I+S  +       ++  +++ GL+++HS 
Sbjct: 84  MFCTFQ-----TKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 138
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCTEYT 223
            +++RDLK  N+LL+    +KI DFG+ +     D  T E+  T  Y APE+LL   +Y 
Sbjct: 139 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLG-QKYN 197
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKD---YVHQLRL 256
            ++D WS G +L E++  +  F G+D     H +R+
Sbjct: 198 HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM 233

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 23/209 (11%)
Query: 48  RPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           + +G G +G V  A  N  T+  V   K G+     +     L E  +++ ++H+ ++ +
Sbjct: 21  KKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDKLVKL 75
Query: 107 KDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQY--FLYQLLRGLKYVHS 163
             ++      T   +YI+ E M    L   ++SD+       +   F  Q+  G+ ++  
Sbjct: 76  HAVV------TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 129
Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE---YVVTRWYRAPELLLNCT 220
            + +HRDL+ +N+L++AS   KI DFGLAR   + ++          +W  APE  +N  
Sbjct: 130 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPE-AINFG 187
Query: 221 EYTAAIDIWSVGCILGEIMT--REPLFPG 247
            +T   D+WS G +L EI+T  R P +PG
Sbjct: 188 SFTIKSDVWSFGILLMEIVTYGRIP-YPG 215

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 20/202 (9%)
Query: 50  IGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +G G +G VC+    + S+    VAIK +   +      R  L E  ++   +H N+I +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNIIRL 111
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + ++   K      V IV E M+   L   +R  D Q T       L  +  G+KY+   
Sbjct: 112 EGVVTKSKP-----VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY------VVTRWYRAPELLLN 218
             +HRDL   N+L+N++   K+ DFGL+R   E D    Y      +  RW  +PE +  
Sbjct: 167 GFVHRDLAARNILINSNLVCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRW-TSPEAIA- 223
Query: 219 CTEYTAAIDIWSVGCILGEIMT 240
             ++T+A D+WS G +L E+M+
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMS 245

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 9/216 (4%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           +RP+G+G +G V  A   + +  +A+K +  +  +      +  REI++  H+ H N++ 
Sbjct: 19  VRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILR 78
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + +     K+     +Y++ E     +L++ ++   +  +     F+ +L   L Y H  
Sbjct: 79  MYNYFHDRKR-----IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER 133
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
            V+HRD+KP NLL+    +LKI DFG +   + +        T  Y  PE++   T +  
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGKT-HDE 191
Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
            +D+W  G +  E +   P F    +    R I  V
Sbjct: 192 KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV 227

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 101/218 (46%), Gaps = 33/218 (15%)
Query: 41  SKYVPPIRPIGRGAYGIVCA----AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
            +Y+  IR +G G +G V        N  T E VA+K +       + +    REI++LR
Sbjct: 7   KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQ-REIEILR 65
Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHC----QYFLY 152
            + HE+++  K       + +   V +V E +       + S +     HC    Q  L+
Sbjct: 66  TLYHEHIVKYKGCCEDQGEKS---VQLVMEYVP------LGSLRDYLPRHCVGLAQLLLF 116
Query: 153 --QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR-- 208
             Q+  G+ Y+H+   +HR L   N+LL+    +KIGDFGLA+   E     EY   R  
Sbjct: 117 AQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVRED 173
Query: 209 ------WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                 WY APE L  C  Y A+ D+WS G  L E++T
Sbjct: 174 GDSPVFWY-APECLKECKFYYAS-DVWSFGVTLYELLT 209

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 23/209 (11%)
Query: 48  RPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           + +G G +G V  A  N  T+  V   K G+     +     L E  +++ ++H+ ++ +
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDKLVKL 248
Query: 107 KDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQY--FLYQLLRGLKYVHS 163
             ++      T   +YI+ E M    L   ++SD+       +   F  Q+  G+ ++  
Sbjct: 249 HAVV------TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302
Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCT 220
            + +HRDL+ +N+L++AS   KI DFGLAR   + ++          +W  APE  +N  
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPE-AINFG 360
Query: 221 EYTAAIDIWSVGCILGEIMT--REPLFPG 247
            +T   D+WS G +L EI+T  R P +PG
Sbjct: 361 SFTIKSDVWSFGILLMEIVTYGRIP-YPG 388

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 101/218 (46%), Gaps = 33/218 (15%)
Query: 41  SKYVPPIRPIGRGAYGIVCA----AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
            +Y+  IR +G G +G V        N  T E VA+K +       + +    REI++LR
Sbjct: 8   KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQ-REIEILR 66
Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHC----QYFLY 152
            + HE+++  K       + +   V +V E +       + S +     HC    Q  L+
Sbjct: 67  TLYHEHIVKYKGCCEDQGEKS---VQLVMEYVP------LGSLRDYLPRHCVGLAQLLLF 117
Query: 153 --QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR-- 208
             Q+  G+ Y+H+   +HR L   N+LL+    +KIGDFGLA+   E     EY   R  
Sbjct: 118 AQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVRED 174
Query: 209 ------WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                 WY APE L  C  Y A+ D+WS G  L E++T
Sbjct: 175 GDSPVFWY-APECLKECKFYYAS-DVWSFGVTLYELLT 210

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 20/202 (9%)
Query: 50  IGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +G G +G VC+    + S+    VAIK +   +      R  L E  ++   +H N+I +
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNIIRL 82
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + ++   K      V IV E M+   L   +R  D Q T       L  +  G+KY+   
Sbjct: 83  EGVVTKSKP-----VMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 137
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY------VVTRWYRAPELLLN 218
             +HRDL   N+L+N++   K+ DFGL+R   E D    Y      +  RW  +PE +  
Sbjct: 138 GYVHRDLAARNILINSNLVCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRW-TSPEAIA- 194
Query: 219 CTEYTAAIDIWSVGCILGEIMT 240
             ++T+A D+WS G +L E+M+
Sbjct: 195 YRKFTSASDVWSYGIVLWEVMS 216

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 20/202 (9%)
Query: 50  IGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +G G +G VC+    + S+    VAIK +   +      R  L E  ++   +H N+I +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNIIRL 111
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + ++   K      V IV E M+   L   +R  D Q T       L  +  G+KY+   
Sbjct: 112 EGVVTKSKP-----VMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY------VVTRWYRAPELLLN 218
             +HRDL   N+L+N++   K+ DFGL+R   E D    Y      +  RW  +PE +  
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRW-TSPEAIA- 223
Query: 219 CTEYTAAIDIWSVGCILGEIMT 240
             ++T+A D+WS G +L E+M+
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 20/202 (9%)
Query: 50  IGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +G G +G VC+    + S+    VAIK +   +      R  L E  ++   +H N+I +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNIIRL 111
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + ++   K      V IV E M+   L   +R  D Q T       L  +  G+KY+   
Sbjct: 112 EGVVTKSKP-----VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY------VVTRWYRAPELLLN 218
             +HRDL   N+L+N++   K+ DFGL+R   E D    Y      +  RW  +PE +  
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRW-TSPEAIA- 223
Query: 219 CTEYTAAIDIWSVGCILGEIMT 240
             ++T+A D+WS G +L E+M+
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 20/202 (9%)
Query: 50  IGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +G G +G VC+    + S+    VAIK +   +      R  L E  ++   +H N+I +
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNIIRL 82
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + ++   K      V IV E M+   L   +R  D Q T       L  +  G+KY+   
Sbjct: 83  EGVVTKSKP-----VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 137
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY------VVTRWYRAPELLLN 218
             +HRDL   N+L+N++   K+ DFGL+R   E D    Y      +  RW  +PE +  
Sbjct: 138 GYVHRDLAARNILINSNLVCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRW-TSPEAIA- 194
Query: 219 CTEYTAAIDIWSVGCILGEIMT 240
             ++T+A D+WS G +L E+M+
Sbjct: 195 YRKFTSASDVWSYGIVLWEVMS 216

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 20/202 (9%)
Query: 50  IGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +G G +G VC+    + S+    VAIK +   +      R  L E  ++   +H N+I +
Sbjct: 41  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNIIRL 99
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + ++   K      V IV E M+   L   +R  D Q T       L  +  G+KY+   
Sbjct: 100 EGVVTKSKP-----VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 154
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY------VVTRWYRAPELLLN 218
             +HRDL   N+L+N++   K+ DFGL+R   E D    Y      +  RW  +PE +  
Sbjct: 155 GYVHRDLAARNILINSNLVCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRW-TSPEAIA- 211
Query: 219 CTEYTAAIDIWSVGCILGEIMT 240
             ++T+A D+WS G +L E+M+
Sbjct: 212 YRKFTSASDVWSYGIVLWEVMS 233

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 20/202 (9%)
Query: 50  IGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +G G +G VC+    + S+    VAIK +   +      R  L E  ++   +H N+I +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNIIRL 111
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + ++   K      V IV E M+   L   +R  D Q T       L  +  G+KY+   
Sbjct: 112 EGVVTKSKP-----VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY------VVTRWYRAPELLLN 218
             +HRDL   N+L+N++   K+ DFGL+R   E D    Y      +  RW  +PE +  
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRW-TSPEAIA- 223
Query: 219 CTEYTAAIDIWSVGCILGEIMT 240
             ++T+A D+WS G +L E+M+
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 20/202 (9%)
Query: 50  IGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +G G +G VC+    + S+    VAIK +   +      R  L E  ++   +H N+I +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNIIRL 111
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + ++   K      V IV E M+   L   +R  D Q T       L  +  G+KY+   
Sbjct: 112 EGVVTKSKP-----VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY------VVTRWYRAPELLLN 218
             +HRDL   N+L+N++   K+ DFGL+R   E D    Y      +  RW  +PE +  
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRW-TSPEAIA- 223
Query: 219 CTEYTAAIDIWSVGCILGEIMT 240
             ++T+A D+WS G +L E+M+
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMS 245

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 20/202 (9%)
Query: 50  IGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +G G +G VC+    + S+    VAIK +   +      R  L E  ++   +H N+I +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNIIRL 111
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + ++   K      V IV E M+   L   +R  D Q T       L  +  G+KY+   
Sbjct: 112 EGVVTKSKP-----VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY------VVTRWYRAPELLLN 218
             +HRDL   N+L+N++   K+ DFGL+R   E D    Y      +  RW  +PE +  
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRW-TSPEAIA- 223
Query: 219 CTEYTAAIDIWSVGCILGEIMT 240
             ++T+A D+WS G +L E+M+
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMS 245

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 20/202 (9%)
Query: 50  IGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +G G +G VC+    + S+    VAIK +   +      R  L E  ++   +H N+I +
Sbjct: 51  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNIIRL 109
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + ++   K      V IV E M+   L   +R  D Q T       L  +  G+KY+   
Sbjct: 110 EGVVTKSKP-----VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 164
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY------VVTRWYRAPELLLN 218
             +HRDL   N+L+N++   K+ DFGL+R   E D    Y      +  RW  +PE +  
Sbjct: 165 GYVHRDLAARNILINSNLVCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRW-TSPEAIA- 221
Query: 219 CTEYTAAIDIWSVGCILGEIMT 240
             ++T+A D+WS G +L E+M+
Sbjct: 222 YRKFTSASDVWSYGIVLWEVMS 243

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 20/202 (9%)
Query: 50  IGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +G G +G VC+    + S+    VAIK +   +      R  L E  ++   +H N+I +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNIIRL 111
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + ++   K      V IV E M+   L   +R  D Q T       L  +  G+KY+   
Sbjct: 112 EGVVTKSKP-----VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY------VVTRWYRAPELLLN 218
             +HRDL   N+L+N++   K+ DFGL R   E D    Y      +  RW  +PE +  
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVL-EDDPEAAYTTRGGKIPIRW-TSPEAIA- 223
Query: 219 CTEYTAAIDIWSVGCILGEIMT 240
             ++T+A D+WS G +L E+M+
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMS 245

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 104/217 (47%), Gaps = 30/217 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL---------LRHMEH 100
           +G G++     A    T  E AIK        I++ R  ++E K+         +  ++H
Sbjct: 38  LGEGSFSTTVLARELATSREYAIK--------ILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
              + +    +  +K  F   Y      + +L + IR      +   +++  +++  L+Y
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LLN    ++I DFG A+     S+      +V T  Y +PELL 
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 204
Query: 218 NCTEYTA--AIDIWSVGCILGEIMTREPLF-PGKDYV 251
             TE +A  + D+W++GCI+ +++   P F  G +Y+
Sbjct: 205 --TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 239

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 20/203 (9%)
Query: 50  IGRGAYGIVCAA-VNSETREE--VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IG G +G VC+  +    + E  VAIK + + +      R  L E  ++   +H NVI +
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK-QRRDFLSEASIMGQFDHPNVIHL 99
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + ++    K T   V I+ E M+   L   +R +D Q T       L  +  G+KY+   
Sbjct: 100 EGVV---TKST--PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM 154
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLAR----TTSE---TDFMTEYVVTRWYRAPELLL 217
           + +HRDL   N+L+N++   K+ DFGL+R     TS+   T  +   +  RW  APE  +
Sbjct: 155 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW-TAPE-AI 212
Query: 218 NCTEYTAAIDIWSVGCILGEIMT 240
              ++T+A D+WS G ++ E+M+
Sbjct: 213 QYRKFTSASDVWSYGIVMWEVMS 235

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 24/214 (11%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA--RRTLREIKLLRHMEHENVIAIK 107
           IG G +G V  A      +EVA+K   +  D  I        +E KL   ++H N+IA++
Sbjct: 15  IGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 108 DI-IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
            + ++ P      ++ +V E         + S +++  D    +  Q+ RG+ Y+H  ++
Sbjct: 73  GVCLKEP------NLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 167 ---LHRDLKPSNLLLNASCD--------LKIGDFGLARTTSETDFMTEYVVTRWYRAPEL 215
              +HRDLK SN+L+    +        LKI DFGLAR    T  M+      W  APE 
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWM-APE- 184
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
           ++  + ++   D+WS G +L E++T E  F G D
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID 218

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 104/217 (47%), Gaps = 30/217 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL---------LRHMEH 100
           +G G++  V  A    T  E AIK        I++ R  ++E K+         +  ++H
Sbjct: 40  LGEGSFSTVVLARELATSREYAIK--------ILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
              + +    +  +K  F   Y      +  L + IR      +   +++  +++  L+Y
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYA----KNGCLLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLL 217
           +H   ++HRDLKP N+LLN    ++I DFG A+     S+      +V T  Y +PELL 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL- 206
Query: 218 NCTEYTA--AIDIWSVGCILGEIMTREPLF-PGKDYV 251
             TE +A  + D+W++GCI+ +++   P F  G +Y+
Sbjct: 207 --TEKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYL 241

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 109/224 (48%), Gaps = 36/224 (16%)
Query: 48  RPIGRGAYGIVCAA-----VNSETREEVAIKKIGNAFDNIIDARRTL-REIKLLRHMEHE 101
           R +G GA+G V  A        + +  VA+K + +A DN   AR+   RE +LL +++HE
Sbjct: 19  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDN---ARKDFHREAELLTNLQHE 75
Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-------------QQLTDDHC 147
           +++    +         + + +V+E M   DL++ +R+               +LT    
Sbjct: 76  HIVKFYGVCVEG-----DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQM 130
Query: 148 QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT----E 203
            +   Q+  G+ Y+ S   +HRDL   N L+  +  +KIGDFG++R    TD+       
Sbjct: 131 LHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 190
Query: 204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLF 245
            +  RW   PE ++   ++T   D+WS+G +L EI T  ++P +
Sbjct: 191 MLPIRWM-PPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWY 232

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 33/213 (15%)
Query: 50  IGRGAYGIVCAAVN-SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G G +G V   ++ +  + +VA+K I N       AR  +  +K ++  + EN      
Sbjct: 27  LGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVL 86
Query: 109 IIRPPKKDTFN---DVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHS 163
           +      D FN    + I +EL+  +  + ++ +  Q     H ++  YQL   L+++H 
Sbjct: 87  M-----SDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE 141
Query: 164 ASVLHRDLKPSNLLL-----------NASCD--------LKIGDFGLARTTSETDFMTEY 204
             + H DLKP N+L            + SC+        +++ DFG A  T + +  T  
Sbjct: 142 NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTI 199
Query: 205 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 237
           V TR YR PE++L    +    D+WS+GCIL E
Sbjct: 200 VATRHYRPPEVILELG-WAQPCDVWSIGCILFE 231

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 9/215 (4%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           RP+G+G +G V  A   + +  +A+K +  +  +      +  REI++  H+ H N++ +
Sbjct: 21  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 80
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            +     K+     +Y++ E     +L++ ++   +  +     F+ +L   L Y H   
Sbjct: 81  YNYFHDRKR-----IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK 135
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           V+HRD+KP NLL+    +LKI DFG +   + +        T  Y  PE++   T +   
Sbjct: 136 VIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGKT-HDEK 193
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           +D+W  G +  E +   P F    +    R I  V
Sbjct: 194 VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV 228

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 107/236 (45%), Gaps = 33/236 (13%)
Query: 50  IGRGAYGIVCAAVN-SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G G +G V   ++ +  + +VA+K I N       AR  +  +K ++  + EN      
Sbjct: 36  LGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVL 95
Query: 109 IIRPPKKDTFN---DVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHS 163
           +      D FN    + I +EL+  +  + ++ +  Q     H ++  YQL   L+++H 
Sbjct: 96  M-----SDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE 150
Query: 164 ASVLHRDLKPSNLLL-----------NASCD--------LKIGDFGLARTTSETDFMTEY 204
             + H DLKP N+L            + SC+        +++ DFG A  T + +  T  
Sbjct: 151 NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTI 208
Query: 205 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           V TR YR PE++L    +    D+WS+GCIL E      LF   +    L ++ ++
Sbjct: 209 VATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKI 263

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 100/198 (50%), Gaps = 8/198 (4%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG+G++G V   +++ T++ VAIK I +  +   +     +EI +L   +   V   
Sbjct: 32  LEKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYVTKY 90
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
                   KDT   ++I+ E +       +     L +      L ++L+GL Y+HS   
Sbjct: 91  YGSYL---KDT--KLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK 145
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM-TEYVVTRWYRAPELLLNCTEYTAA 225
           +HRD+K +N+LL+   ++K+ DFG+A   ++T      +V T ++ APE ++  + Y + 
Sbjct: 146 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAYDSK 204
Query: 226 IDIWSVGCILGEIMTREP 243
            DIWS+G    E+   EP
Sbjct: 205 ADIWSLGITAIELARGEP 222

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 107/236 (45%), Gaps = 33/236 (13%)
Query: 50  IGRGAYGIVCAAVN-SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G G +G V   ++ +  + +VA+K I N       AR  +  +K ++  + EN      
Sbjct: 59  LGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVL 118
Query: 109 IIRPPKKDTFN---DVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHS 163
           +      D FN    + I +EL+  +  + ++ +  Q     H ++  YQL   L+++H 
Sbjct: 119 M-----SDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE 173
Query: 164 ASVLHRDLKPSNLLL-----------NASCD--------LKIGDFGLARTTSETDFMTEY 204
             + H DLKP N+L            + SC+        +++ DFG A  T + +  T  
Sbjct: 174 NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTI 231
Query: 205 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           V TR YR PE++L    +    D+WS+GCIL E      LF   +    L ++ ++
Sbjct: 232 VATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKI 286

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 104/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKEIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NL+++    +K+ DFGLA+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 100/198 (50%), Gaps = 8/198 (4%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG+G++G V   +++ T++ VAIK I +  +   +     +EI +L   +   V   
Sbjct: 12  LEKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYVTKY 70
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
                   KDT   ++I+ E +       +     L +      L ++L+GL Y+HS   
Sbjct: 71  YGSYL---KDT--KLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK 125
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM-TEYVVTRWYRAPELLLNCTEYTAA 225
           +HRD+K +N+LL+   ++K+ DFG+A   ++T      +V T ++ APE ++  + Y + 
Sbjct: 126 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE-VIKQSAYDSK 184
Query: 226 IDIWSVGCILGEIMTREP 243
            DIWS+G    E+   EP
Sbjct: 185 ADIWSLGITAIELARGEP 202

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 100/198 (50%), Gaps = 8/198 (4%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG+G++G V   +++ T++ VAIK I +  +   +     +EI +L   +   V   
Sbjct: 12  LEKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYVTKY 70
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
                   KDT   ++I+ E +       +     L +      L ++L+GL Y+HS   
Sbjct: 71  YGSYL---KDT--KLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK 125
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM-TEYVVTRWYRAPELLLNCTEYTAA 225
           +HRD+K +N+LL+   ++K+ DFG+A   ++T      +V T ++ APE ++  + Y + 
Sbjct: 126 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAYDSK 184
Query: 226 IDIWSVGCILGEIMTREP 243
            DIWS+G    E+   EP
Sbjct: 185 ADIWSLGITAIELARGEP 202

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 99/195 (50%), Gaps = 8/195 (4%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG+G++G V   +++ T++ VAIK I +  +   +     +EI +L   +   V      
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88
Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 169
                KDT   ++I+ E +       +     L +      L ++L+GL Y+HS   +HR
Sbjct: 89  YL---KDT--KLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHR 143
Query: 170 DLKPSNLLLNASCDLKIGDFGLARTTSETDFM-TEYVVTRWYRAPELLLNCTEYTAAIDI 228
           D+K +N+LL+   ++K+ DFG+A   ++T      +V T ++ APE ++  + Y +  DI
Sbjct: 144 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE-VIKQSAYDSKADI 202
Query: 229 WSVGCILGEIMTREP 243
           WS+G    E+   EP
Sbjct: 203 WSLGITAIELARGEP 217

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 73.9 bits (180), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 47  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 97
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 98  AVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NL+++    +K+ DFG A+      +      T  Y APE++L   
Sbjct: 158 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 214
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/242 (23%), Positives = 116/242 (47%), Gaps = 35/242 (14%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIA 105
           IR +G G +G V    + + ++  A+K +     NI    R+ + E  +L+ ++++++  
Sbjct: 40  IRKMGDGTFGRVLLCQHIDNKKYYAVKVV----RNIKKYTRSAKIEADILKKIQNDDINN 95
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHS 163
              +    K   ++ + +++E +   L++II  +       +  + +  ++L+ L Y+  
Sbjct: 96  NNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK 155
Query: 164 ASVLHRDLKPSNLLLN-------------------------ASCDLKIGDFGLARTTSET 198
            S+ H DLKP N+LL+                          S  +K+ DFG A  T ++
Sbjct: 156 MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA--TFKS 213
Query: 199 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT 258
           D+    + TR YRAPE++LN   +  + D+WS GC+L E+ T   LF   +++  L ++ 
Sbjct: 214 DYHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMME 272
Query: 259 EV 260
            +
Sbjct: 273 SI 274

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 73.9 bits (180), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 47  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 97
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 98  AVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NL+++    +K+ DFG A+      +      T  Y APE++L   
Sbjct: 158 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 214
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 47  IKTLGTGSFGRVMLVKHKETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 97
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NL+++    +K+ DFG A+      +      T  Y APE++L   
Sbjct: 158 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 214
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 19/203 (9%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIK--KIGNAF-DNIIDARRTLREIKLLRHMEHENVIAI 106
           +G GA+  V       T +  A+K  K   AF D+ ++      EI +L+ ++HEN++ +
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE-----NEIAVLKKIKHENIVTL 71
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
           +DI      ++    Y+V +L+   +L   I      T+      + Q+L  +KY+H   
Sbjct: 72  EDIY-----ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG 126
Query: 166 VLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           ++HRDLKP NLL      +  + I DFGL++   +   M+    T  Y APE+L     Y
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSK-MEQNGIMSTACGTPGYVAPEVLAQ-KPY 184
Query: 223 TAAIDIWSVGCILGEIMTREPLF 245
           + A+D WS+G I   ++   P F
Sbjct: 185 SKAVDCWSIGVITYILLCGYPPF 207

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 110/216 (50%), Gaps = 17/216 (7%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII---DARRTLREIKLLR-HMEHENVIA 105
           +G+G++G V  A   +T +  AIK +    D ++   D   T+ E ++L    EH  +  
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKK--DVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           +    +     T  +++ V E ++  DL   I+S  +       ++  +++ GL+++HS 
Sbjct: 83  MFCTFQ-----TKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 137
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEYT 223
            +++RDLK  N+LL+    +KI DFG+ +     D  T  +  T  Y APE+LL   +Y 
Sbjct: 138 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLG-QKYN 196
Query: 224 AAIDIWSVGCILGEIMTREPLFPGKD---YVHQLRL 256
            ++D WS G +L E++  +  F G+D     H +R+
Sbjct: 197 HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM 232

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHKETGNHFAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 27/206 (13%)
Query: 48  RPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           + +G G +G V  A  N  T+  V   K G+     +     L E  +++ ++H+ ++ +
Sbjct: 188 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDKLVKL 242
Query: 107 KDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQY--FLYQLLRGLKYVHS 163
             ++      T   +YI+ E M    L   ++SD+       +   F  Q+  G+ ++  
Sbjct: 243 HAVV------TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 296
Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
            + +HRDL+ +N+L++AS   KI DFGLAR  ++          +W  APE  +N   +T
Sbjct: 297 RNYIHRDLRAANILVSASLVCKIADFGLARVGAK-------FPIKW-TAPE-AINFGSFT 347
Query: 224 AAIDIWSVGCILGEIMT--REPLFPG 247
              D+WS G +L EI+T  R P +PG
Sbjct: 348 IKSDVWSFGILLMEIVTYGRIP-YPG 372

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 111/215 (51%), Gaps = 20/215 (9%)
Query: 38  EVSSKYVPPIRPIGRGAYGIV--CA--AVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           +   +++  +R +G+G +G V  C    +   T E VA+KK+ ++ +  +  R   REI+
Sbjct: 9   QFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 66
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLY 152
           +L+ ++H+N++  K +     +    ++ ++ E +    L + ++  ++  D H +   Y
Sbjct: 67  ILKSLQHDNIVKYKGVCYSAGR---RNLKLIMEFLPYGSLREYLQKHKERID-HIKLLQY 122
Query: 153 --QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR-- 208
             Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     +       
Sbjct: 123 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 182
Query: 209 ---WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
              WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 183 PIFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 215

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHKETGNHFAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 86/170 (50%), Gaps = 7/170 (4%)
Query: 87  RTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDD 145
           R  RE +    + H  ++A+ D     +       YIV E +D   L  I+ ++  +T  
Sbjct: 58  RFRREAQNAAALNHPAIVAVYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK 116
Query: 146 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMT 202
                +    + L + H   ++HRD+KP+N+L++A+  +K+ DFG+AR  +++      T
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQT 176
Query: 203 EYVV-TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV 251
             V+ T  Y +PE     +   A  D++S+GC+L E++T EP F G   V
Sbjct: 177 AAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 104/216 (48%), Gaps = 14/216 (6%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+GA+ +V   V     +E A   I     +  D ++  RE ++ R ++H N++ + D 
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 110 IRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           I           Y++++L+   +L + I + +  ++    + + Q+L  + + H   V+H
Sbjct: 79  ISEEGHH-----YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVH 133
Query: 169 RDLKPSNLLLNA---SCDLKIGDFGLA-RTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
           R+LKP NLLL +      +K+ DFGLA     E      +  T  Y +PE+L     Y  
Sbjct: 134 RNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK-DPYGK 192
Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
            +D+W+ G IL  ++   P F  +D   Q RL  ++
Sbjct: 193 PVDLWACGVILYILLVGYPPFWDED---QHRLYQQI 225

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 67  IKTLGTGSFGRVMLVKHKETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 117
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 118 AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 177
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 178 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 234
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 235 GYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHKETGNHFAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NL+++    +K+ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 47  IKTLGTGSFGRVMLVKHKETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 97
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 214
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 47  IKTLGTGSFGRVMLVKHKETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 97
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 214
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 47  IKTLGTGSFGRVMLVKHKETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 97
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 214
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 39  IKTLGTGSFGRVMLVKHKETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 89
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 90  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 149
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 150 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 206
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 207 GYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 47  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 97
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   +  + H +++  Q++   +Y
Sbjct: 98  AVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEY 157
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NL+++    +K+ DFG A+      +      T  Y APE++L   
Sbjct: 158 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 214
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 50  IGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IGRG +G V       N   +   A+K + N   +I +  + L E  +++   H NV+++
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSAS 165
             I     +   + + ++  +   DL   IR++    T      F  Q+ +G+KY+ S  
Sbjct: 95  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 151
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNC 219
            +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T      +W       L  
Sbjct: 152 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQT 209
Query: 220 TEYTAAIDIWSVGCILGEIMTR-EPLFP 246
            ++T   D+WS G +L E+MTR  P +P
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAPPYP 237

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 50  IGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IGRG +G V       N   +   A+K + N   +I +  + L E  +++   H NV+++
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSAS 165
             I     +   + + ++  +   DL   IR++    T      F  Q+ +G+KY+ S  
Sbjct: 96  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 152
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNC 219
            +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T      +W       L  
Sbjct: 153 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQT 210
Query: 220 TEYTAAIDIWSVGCILGEIMTR-EPLFP 246
            ++T   D+WS G +L E+MTR  P +P
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTRGAPPYP 238

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 20/204 (9%)
Query: 48  RPIGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI 104
           R IG G +G VC+    +  +    VAIK +   +      R  L E  ++   +H NV+
Sbjct: 49  RVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEK-QRRDFLCEASIMGQFDHPNVV 107
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDTD-LHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVH 162
            ++ ++   K      V IV E M+   L   +R  D Q T       L  +  G++Y+ 
Sbjct: 108 HLEGVVTRGKP-----VMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLA 162
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELL 216
               +HRDL   N+L+N++   K+ DFGL+R   E D    Y  T      RW  APE  
Sbjct: 163 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVI-EDDPEAVYTTTGGKIPVRW-TAPE-A 219
Query: 217 LNCTEYTAAIDIWSVGCILGEIMT 240
           +   ++T+A D+WS G ++ E+M+
Sbjct: 220 IQYRKFTSASDVWSYGIVMWEVMS 243

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 99/220 (45%), Gaps = 15/220 (6%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           +G G + IV       T  E A K I      A    +      RE+ +LR + H NVI 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + D+      +   DV ++ EL+   +L   +   + L+++    F+ Q+L G+ Y+H+ 
Sbjct: 80  LHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 165 SVLHRDLKPSN-LLLNASC---DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
            + H DLKP N +LL+ +     +K+ DFGLA    +         T  + APE ++N  
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNYE 193
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
                 D+WS+G I   +++    F G      L  IT V
Sbjct: 194 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV 233

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 28/209 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G  G V    N  T+E+ A+K +        D  +  RE++L  H        I  I
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKXLQ-------DCPKARREVEL--HWRASQCPHIVRI 120
Query: 110 IRPPKKDTFNDVY-------IVYELMDT-DLHQII--RSDQQLTDDHCQYFLYQLLRGLK 159
           +     D + ++Y       IV E +D  +L   I  R DQ  T+         +   ++
Sbjct: 121 V-----DVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQ 175
Query: 160 YVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 216
           Y+HS ++ HRD+KP NLL  +   +  LK+ DFG A+ T+  + +T    T +Y APE +
Sbjct: 176 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-V 234
Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLF 245
           L   +Y  + D WS+G I   ++   P F
Sbjct: 235 LGPEKYDKSCDXWSLGVIXYILLCGYPPF 263

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 50  IGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IGRG +G V       N   +   A+K + N   +I +  + L E  +++   H NV+++
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 88
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSAS 165
             I     +   + + ++  +   DL   IR++    T      F  Q+ +G+KY+ S  
Sbjct: 89  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 145
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNC 219
            +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T      +W       L  
Sbjct: 146 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQT 203
Query: 220 TEYTAAIDIWSVGCILGEIMTR-EPLFP 246
            ++T   D+WS G +L E+MTR  P +P
Sbjct: 204 QKFTTKSDVWSFGVLLWELMTRGAPPYP 231

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 50  IGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IGRG +G V       N   +   A+K + N   +I +  + L E  +++   H NV+++
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSAS 165
             I     +   + + ++  +   DL   IR++    T      F  Q+ +G+KY+ S  
Sbjct: 97  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 153
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNC 219
            +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T      +W       L  
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQT 211
Query: 220 TEYTAAIDIWSVGCILGEIMTR-EPLFP 246
            ++T   D+WS G +L E+MTR  P +P
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 50  IGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IGRG +G V       N   +   A+K + N   +I +  + L E  +++   H NV+++
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 114
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSAS 165
             I     +   + + ++  +   DL   IR++    T      F  Q+ +G+KY+ S  
Sbjct: 115 LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 171
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNC 219
            +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T      +W       L  
Sbjct: 172 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQT 229
Query: 220 TEYTAAIDIWSVGCILGEIMTR-EPLFP 246
            ++T   D+WS G +L E+MTR  P +P
Sbjct: 230 QKFTTKSDVWSFGVLLWELMTRGAPPYP 257

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 50  IGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IGRG +G V       N   +   A+K + N   +I +  + L E  +++   H NV+++
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 115
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSAS 165
             I     +   + + ++  +   DL   IR++    T      F  Q+ +G+KY+ S  
Sbjct: 116 LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 172
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNC 219
            +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T      +W       L  
Sbjct: 173 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQT 230
Query: 220 TEYTAAIDIWSVGCILGEIMTR-EPLFP 246
            ++T   D+WS G +L E+MTR  P +P
Sbjct: 231 QKFTTKSDVWSFGVLLWELMTRGAPPYP 258

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 109/217 (50%), Gaps = 18/217 (8%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIV--CA--AVNSETREEVAIKKIGNAFDNIIDARRTLR 90
           N+ +   +++  ++ +G+G +G V  C    +   T E VA+KK+ ++ +  +  R   R
Sbjct: 21  NMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFER 78
Query: 91  EIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYF 150
           EI++L+ ++H+N++  K +     +       I+  L    L   ++  ++  D H +  
Sbjct: 79  EIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERID-HIKLL 135
Query: 151 LY--QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR 208
            Y  Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     +     
Sbjct: 136 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 195
Query: 209 -----WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 196 ESPIFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 230

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 109/217 (50%), Gaps = 18/217 (8%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIV--CA--AVNSETREEVAIKKIGNAFDNIIDARRTLR 90
           N+ +   +++  ++ +G+G +G V  C    +   T E VA+KK+ ++ +  +  R   R
Sbjct: 21  NMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFER 78
Query: 91  EIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYF 150
           EI++L+ ++H+N++  K +     +       I+  L    L   ++  ++  D H +  
Sbjct: 79  EIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERID-HIKLL 135
Query: 151 LY--QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR 208
            Y  Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     +     
Sbjct: 136 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 195
Query: 209 -----WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 196 ESPIFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 230

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 104/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKEIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NL+++    +++ DFGLA+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 50  IGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IGRG +G V       N   +   A+K + N   +I +  + L E  +++   H NV+++
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSAS 165
             I     +   + + ++  +   DL   IR++    T      F  Q+ +G+KY+ S  
Sbjct: 92  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 148
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNC 219
            +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T      +W       L  
Sbjct: 149 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQT 206
Query: 220 TEYTAAIDIWSVGCILGEIMTR-EPLFP 246
            ++T   D+WS G +L E+MTR  P +P
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTRGAPPYP 234

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 50  IGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IGRG +G V       N   +   A+K + N   +I +  + L E  +++   H NV+++
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSAS 165
             I     +   + + ++  +   DL   IR++    T      F  Q+ +G+KY+ S  
Sbjct: 97  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 153
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNC 219
            +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T      +W       L  
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQT 211
Query: 220 TEYTAAIDIWSVGCILGEIMTR-EPLFP 246
            ++T   D+WS G +L E+MTR  P +P
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 50  IGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IGRG +G V       N   +   A+K + N   +I +  + L E  +++   H NV+++
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSAS 165
             I     +   + + ++  +   DL   IR++    T      F  Q+ +G+KY+ S  
Sbjct: 94  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 150
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNC 219
            +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T      +W       L  
Sbjct: 151 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQT 208
Query: 220 TEYTAAIDIWSVGCILGEIMTR-EPLFP 246
            ++T   D+WS G +L E+MTR  P +P
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYP 236

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 86/170 (50%), Gaps = 7/170 (4%)
Query: 87  RTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDD 145
           R  RE +    + H  ++A+ D     +       YIV E +D   L  I+ ++  +T  
Sbjct: 58  RFRREAQNAAALNHPAIVAVYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK 116
Query: 146 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMT 202
                +    + L + H   ++HRD+KP+N++++A+  +K+ DFG+AR  +++      T
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 203 EYVV-TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV 251
             V+ T  Y +PE     +   A  D++S+GC+L E++T EP F G   V
Sbjct: 177 AAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 47  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 97
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 214
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + E+    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--AGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 99/220 (45%), Gaps = 15/220 (6%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           +G G + IV       T  E A K I      A    +      RE+ +LR + H NVI 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + D+      +   DV ++ EL+   +L   +   + L+++    F+ Q+L G+ Y+H+ 
Sbjct: 80  LHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 165 SVLHRDLKPSN-LLLNASC---DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
            + H DLKP N +LL+ +     +K+ DFGLA    +         T  + APE ++N  
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNYE 193
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
                 D+WS+G I   +++    F G      L  IT V
Sbjct: 194 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV 233

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 47  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 97
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL--CGTPEYLAPEIIL-SK 214
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 74/135 (54%), Gaps = 6/135 (4%)
Query: 122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 180
           YIV E +D   L  I+ ++  +T       +    + L + H   ++HRD+KP+N++++A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 181 SCDLKIGDFGLARTTSETD---FMTEYVV-TRWYRAPELLLNCTEYTAAIDIWSVGCILG 236
           +  +K+ DFG+AR  +++      T  V+ T  Y +PE     +   A  D++S+GC+L 
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLY 210
Query: 237 EIMTREPLFPGKDYV 251
           E++T EP F G   V
Sbjct: 211 EVLTGEPPFTGDSPV 225

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + E+    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 67  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 117
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 118 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 177
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 178 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTL--CGTPEYLAPEIIL-SK 234
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 235 GYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 50  IGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IGRG +G V       N   +   A+K + N   +I +  + L E  +++   H NV+++
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSAS 165
             I     +   + + ++  +   DL   IR++    T      F  Q+ +G+K++ S  
Sbjct: 97  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 153
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNC 219
            +HRDL   N +L+    +K+ DFGLAR   + +F + +  T      +W       L  
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQT 211
Query: 220 TEYTAAIDIWSVGCILGEIMTR-EPLFP 246
            ++T   D+WS G +L E+MTR  P +P
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 50  IGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IGRG +G V       N   +   A+K + N   +I +  + L E  +++   H NV+++
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSAS 165
             I     +   + + ++  +   DL   IR++    T      F  Q+ +G+K++ S  
Sbjct: 156 LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 212
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNC 219
            +HRDL   N +L+    +K+ DFGLAR   + +F + +  T      +W       L  
Sbjct: 213 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQT 270
Query: 220 TEYTAAIDIWSVGCILGEIMTR-EPLFP 246
            ++T   D+WS G +L E+MTR  P +P
Sbjct: 271 QKFTTKSDVWSFGVLLWELMTRGAPPYP 298

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 86/170 (50%), Gaps = 7/170 (4%)
Query: 87  RTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDD 145
           R  RE +    + H  ++A+ D     +       YIV E +D   L  I+ ++  +T  
Sbjct: 58  RFRREAQNAAALNHPAIVAVYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK 116
Query: 146 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMT 202
                +    + L + H   ++HRD+KP+N++++A+  +K+ DFG+AR  +++      T
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 203 EYVV-TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV 251
             V+ T  Y +PE     +   A  D++S+GC+L E++T EP F G   V
Sbjct: 177 AAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 85/170 (50%), Gaps = 7/170 (4%)
Query: 87  RTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDD 145
           R  RE +    + H  ++A+ D     +       YIV E +D   L  I+ ++  +T  
Sbjct: 75  RFRREAQNAAALNHPAIVAVYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK 133
Query: 146 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMT 202
                +    + L + H   ++HRD+KP+N++++A+  +K+ DFG+AR  +++      T
Sbjct: 134 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 193
Query: 203 EYVV-TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV 251
             V+ T  Y +PE         A  D++S+GC+L E++T EP F G   V
Sbjct: 194 AAVIGTAQYLSPE-QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 242

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   +  + H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NL+++    +K+ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 99/220 (45%), Gaps = 15/220 (6%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           +G G + IV       T  E A K I      A    +      RE+ +LR + H NVI 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + D+      +   DV ++ EL+   +L   +   + L+++    F+ Q+L G+ Y+H+ 
Sbjct: 80  LHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 165 SVLHRDLKPSN-LLLNASC---DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
            + H DLKP N +LL+ +     +K+ DFGLA    +         T  + APE ++N  
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNYE 193
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
                 D+WS+G I   +++    F G      L  IT V
Sbjct: 194 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV 233

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 39  IKTLGTGSFGRVMLVKHKETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 89
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   +  + H +++  Q++   +Y
Sbjct: 90  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEY 149
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 150 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 206
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 207 GYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 104/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 32  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 82
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 83  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 142
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L+  
Sbjct: 143 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL--CGTPEYLAPEIILS-K 199
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 200 GYNKAVDWWALGVLIYEMAAGYPPF 224

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 50  IGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IGRG +G V       N   +   A+K + N   +I +  + L E  +++   H NV+++
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 101
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSAS 165
             I     +   + + ++  +   DL   IR++    T      F  Q+ +G+K++ S  
Sbjct: 102 LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 158
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNC 219
            +HRDL   N +L+    +K+ DFGLAR   + +F + +  T      +W       L  
Sbjct: 159 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQT 216
Query: 220 TEYTAAIDIWSVGCILGEIMTR-EPLFP 246
            ++T   D+WS G +L E+MTR  P +P
Sbjct: 217 QKFTTKSDVWSFGVLLWELMTRGAPPYP 244

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 50  IGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IGRG +G V       N   +   A+K + N   +I +  + L E  +++   H NV+++
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSAS 165
             I     +   + + ++  +   DL   IR++    T      F  Q+ +G+K++ S  
Sbjct: 98  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 154
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNC 219
            +HRDL   N +L+    +K+ DFGLAR   + +F + +  T      +W       L  
Sbjct: 155 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQT 212
Query: 220 TEYTAAIDIWSVGCILGEIMTR-EPLFP 246
            ++T   D+WS G +L E+MTR  P +P
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAPPYP 240

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 98/212 (46%), Gaps = 33/212 (15%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA---- 105
           IG GA  +V AA  +  +E+VAIK+I N           L+EI+ +    H N+++    
Sbjct: 18  IGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 76
Query: 106 --IKDIIRPPKKDTFNDVYIVYELM------DTDLHQIIRSDQQ---LTDDHCQYFLYQL 154
             +KD           ++++V +L+      D   H + + + +   L +      L ++
Sbjct: 77  FVVKD-----------ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 125
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE------YVVTR 208
           L GL+Y+H    +HRD+K  N+LL     ++I DFG++   +    +T       +V T 
Sbjct: 126 LEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 185
Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
            + APE++     Y    DIWS G    E+ T
Sbjct: 186 CWMAPEVMEQVRGYDFKADIWSFGITAIELAT 217

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 111/227 (48%), Gaps = 39/227 (17%)
Query: 48  RPIGRGAYGIVCAAVN---SETREE--VAIKKIGNAFDNIIDARRTL-REIKLLRHMEHE 101
           R +G GA+G V  A     S T+++  VA+K +    D  + AR+   RE +LL +++HE
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK---DPTLAARKDFQREAELLTNLQHE 77
Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS---------DQQLTDDHCQYFL 151
           +++    +         + + +V+E M   DL++ +R+         D Q      +  L
Sbjct: 78  HIVKFYGVC-----GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 132
Query: 152 YQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT-- 202
            Q+L        G+ Y+ S   +HRDL   N L+ A+  +KIGDFG++R    TD+    
Sbjct: 133 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 192
Query: 203 --EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLF 245
               +  RW   PE ++   ++T   D+WS G IL EI T  ++P F
Sbjct: 193 GHTMLPIRWM-PPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWF 237

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 50  IGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IGRG +G V       N   +   A+K + N   +I +  + L E  +++   H NV+++
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSAS 165
             I     +   + + ++  +   DL   IR++    T      F  Q+ +G+K++ S  
Sbjct: 97  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 153
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNC 219
            +HRDL   N +L+    +K+ DFGLAR   + +F + +  T      +W       L  
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQT 211
Query: 220 TEYTAAIDIWSVGCILGEIMTR-EPLFP 246
            ++T   D+WS G +L E+MTR  P +P
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 25/199 (12%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL------REIKLLRHMEHENV 103
           +G G + +V       T  + A K I         +RR +      RE+ +L+ ++H NV
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKR--RTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           I + ++      +   DV ++ EL+   +L   +   + LT++    FL Q+L G+ Y+H
Sbjct: 77  ITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 163 SASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPEL 215
           S  + H DLKP N++L         +KI DFGLA    + DF  E+     T  + APE 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPE- 187
Query: 216 LLNCTEYTAAIDIWSVGCI 234
           ++N        D+WS+G I
Sbjct: 188 IVNYEPLGLEADMWSIGVI 206

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 25/199 (12%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL------REIKLLRHMEHENV 103
           +G G + +V       T  + A K I         +RR +      RE+ +L+ ++H NV
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKR--RTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           I + ++      +   DV ++ EL+   +L   +   + LT++    FL Q+L G+ Y+H
Sbjct: 77  ITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 163 SASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPEL 215
           S  + H DLKP N++L         +KI DFGLA    + DF  E+     T  + APE 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPE- 187
Query: 216 LLNCTEYTAAIDIWSVGCI 234
           ++N        D+WS+G I
Sbjct: 188 IVNYEPLGLEADMWSIGVI 206

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 25/199 (12%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL------REIKLLRHMEHENV 103
           +G G + +V       T  + A K I         +RR +      RE+ +L+ ++H NV
Sbjct: 19  LGSGVFAVVKKCREKSTGLQYAAKFIKKR--RTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           I + ++      +   DV ++ EL+   +L   +   + LT++    FL Q+L G+ Y+H
Sbjct: 77  ITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 163 SASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPEL 215
           S  + H DLKP N++L         +KI DFGLA    + DF  E+     T  + APE 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPE- 187
Query: 216 LLNCTEYTAAIDIWSVGCI 234
           ++N        D+WS+G I
Sbjct: 188 IVNYEPLGLEADMWSIGVI 206

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 25/199 (12%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL------REIKLLRHMEHENV 103
           +G G + +V       T  + A K I         +RR +      RE+ +L+ ++H NV
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKR--RTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           I + ++      +   DV ++ EL+   +L   +   + LT++    FL Q+L G+ Y+H
Sbjct: 77  ITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 163 SASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPEL 215
           S  + H DLKP N++L         +KI DFGLA    + DF  E+     T  + APE 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPE- 187
Query: 216 LLNCTEYTAAIDIWSVGCI 234
           ++N        D+WS+G I
Sbjct: 188 IVNYEPLGLEADMWSIGVI 206

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 99/220 (45%), Gaps = 15/220 (6%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           +G G + IV       T  E A K I      A    +      RE+ +LR + H NVI 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + D+      +   DV ++ EL+   +L   +   + L+++    F+ Q+L G+ Y+H+ 
Sbjct: 80  LHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 165 SVLHRDLKPSN-LLLNASC---DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
            + H DLKP N +LL+ +     +K+ DFGLA    +         T  + APE ++N  
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNYE 193
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
                 D+WS+G I   +++    F G      L  IT V
Sbjct: 194 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV 233

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 50  IGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IGRG +G V       N   +   A+K + N   +I +  + L E  +++   H NV+++
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSAS 165
             I     +   + + ++  +   DL   IR++    T      F  Q+ +G+K++ S  
Sbjct: 95  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 151
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNC 219
            +HRDL   N +L+    +K+ DFGLAR   + +F + +  T      +W       L  
Sbjct: 152 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQT 209
Query: 220 TEYTAAIDIWSVGCILGEIMTR-EPLFP 246
            ++T   D+WS G +L E+MTR  P +P
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAPPYP 237

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 25/199 (12%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL------REIKLLRHMEHENV 103
           +G G + +V       T  + A K I         +RR +      RE+ +L+ ++H NV
Sbjct: 19  LGSGKFAVVKKCREKSTGLQYAAKFIKKR--RTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           I + ++      +   DV ++ EL+   +L   +   + LT++    FL Q+L G+ Y+H
Sbjct: 77  ITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 163 SASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPEL 215
           S  + H DLKP N++L         +KI DFGLA    + DF  E+     T  + APE 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPE- 187
Query: 216 LLNCTEYTAAIDIWSVGCI 234
           ++N        D+WS+G I
Sbjct: 188 IVNYEPLGLEADMWSIGVI 206

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 25/199 (12%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL------REIKLLRHMEHENV 103
           +G G + +V       T  + A K I         +RR +      RE+ +L+ ++H NV
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKR--RTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           I + ++      +   DV ++ EL+   +L   +   + LT++    FL Q+L G+ Y+H
Sbjct: 76  ITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 163 SASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPEL 215
           S  + H DLKP N++L         +KI DFGLA    + DF  E+     T  + APE 
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPE- 186
Query: 216 LLNCTEYTAAIDIWSVGCI 234
           ++N        D+WS+G I
Sbjct: 187 IVNYEPLGLEADMWSIGVI 205

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 25/199 (12%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL------REIKLLRHMEHENV 103
           +G G + +V       T  + A K I         +RR +      RE+ +L+ ++H NV
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKR--RTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           I + ++      +   DV ++ EL+   +L   +   + LT++    FL Q+L G+ Y+H
Sbjct: 77  ITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 163 SASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPEL 215
           S  + H DLKP N++L         +KI DFGLA    + DF  E+     T  + APE 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPE- 187
Query: 216 LLNCTEYTAAIDIWSVGCI 234
           ++N        D+WS+G I
Sbjct: 188 IVNYEPLGLEADMWSIGVI 206

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 50  IGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IGRG +G V       N   +   A+K + N   +I +  + L E  +++   H NV+++
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSAS 165
             I     +   + + ++  +   DL   IR++    T      F  Q+ +G+K++ S  
Sbjct: 98  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 154
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNC 219
            +HRDL   N +L+    +K+ DFGLAR   + +F + +  T      +W       L  
Sbjct: 155 FVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALES--LQT 212
Query: 220 TEYTAAIDIWSVGCILGEIMTR-EPLFP 246
            ++T   D+WS G +L E+MTR  P +P
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAPPYP 240

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 16/202 (7%)
Query: 48  RPIGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI 104
           R IG G +G VC+    +  +    VAIK +   +      R  L E  ++   +H N+I
Sbjct: 28  RVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNII 86
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
            ++ ++   K       Y+    +DT L    ++D Q T       L  +  G+KY+   
Sbjct: 87  HLEGVVTKSKPVMIVTEYMENGSLDTFLK---KNDGQFTVIQLVGMLRGISAGMKYLSDM 143
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY------VVTRWYRAPELLLN 218
             +HRDL   N+L+N++   K+ DFGL+R   E D    Y      +  RW  APE +  
Sbjct: 144 GYVHRDLAARNILINSNLVCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRW-TAPEAIA- 200
Query: 219 CTEYTAAIDIWSVGCILGEIMT 240
             ++T+A D+WS G ++ E+++
Sbjct: 201 FRKFTSASDVWSYGIVMWEVVS 222

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + E+    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--XGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 20/202 (9%)
Query: 50  IGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IG G +G VC+    V  +    VAIK +   + +    R  L E  ++   +H N+I +
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDK-QRRDFLSEASIMGQFDHPNIIHL 95
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + ++   K      V I+ E M+   L   +R +D + T       L  +  G+KY+   
Sbjct: 96  EGVVTKCKP-----VMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDM 150
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY------VVTRWYRAPELLLN 218
           S +HRDL   N+L+N++   K+ DFG++R   E D    Y      +  RW  APE +  
Sbjct: 151 SAVHRDLAARNILVNSNLVCKVSDFGMSRVL-EDDPEAAYTTRGGKIPIRWT-APEAIAY 208
Query: 219 CTEYTAAIDIWSVGCILGEIMT 240
             ++T+A D+WS G ++ E+M+
Sbjct: 209 -RKFTSASDVWSYGIVMWEVMS 229

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 97/220 (44%), Gaps = 15/220 (6%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           +G G + IV       T  E A K I      A    +      RE+ +LR + H NVI 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + D+      +   DV ++ EL+   +L   +   + L+++    F+ Q+L G+ Y+H+ 
Sbjct: 80  LHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 165 SVLHRDLKPSNLLLNASC----DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
            + H DLKP N++L         +K+ DFGLA    +         T  + APE ++N  
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNYE 193
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
                 D+WS+G I   +++    F G      L  IT V
Sbjct: 194 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV 233

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 25/199 (12%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL------REIKLLRHMEHENV 103
           +G G + +V       T  + A K I         +RR +      RE+ +L+ ++H NV
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKR--RTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           I + ++      +   DV ++ EL+   +L   +   + LT++    FL Q+L G+ Y+H
Sbjct: 76  ITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 163 SASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPEL 215
           S  + H DLKP N++L         +KI DFGLA    + DF  E+     T  + APE 
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPE- 186
Query: 216 LLNCTEYTAAIDIWSVGCI 234
           ++N        D+WS+G I
Sbjct: 187 IVNYEPLGLEADMWSIGVI 205

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 25/199 (12%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL------REIKLLRHMEHENV 103
           +G G + +V       T  + A K I         +RR +      RE+ +L+ ++H NV
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKR--RTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           I + ++      +   DV ++ EL+   +L   +   + LT++    FL Q+L G+ Y+H
Sbjct: 77  ITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 163 SASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPEL 215
           S  + H DLKP N++L         +KI DFGLA    + DF  E+     T  + APE 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPE- 187
Query: 216 LLNCTEYTAAIDIWSVGCI 234
           ++N        D+WS+G I
Sbjct: 188 IVNYEPLGLEADMWSIGVI 206

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 85/166 (51%), Gaps = 7/166 (4%)
Query: 87  RTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDD 145
           R  RE +    + H  ++A+ D     +       YIV E +D   L  I+ ++  +T  
Sbjct: 58  RFRREAQNAAALNHPAIVAVYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK 116
Query: 146 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMT 202
                +    + L + H   ++HRD+KP+N++++A+  +K+ DFG+AR  +++      T
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 203 EYVV-TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG 247
             V+ T  Y +PE     +   A  D++S+GC+L E++T EP F G
Sbjct: 177 AAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + E+    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 98/212 (46%), Gaps = 33/212 (15%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA---- 105
           IG GA  +V AA  +  +E+VAIK+I N           L+EI+ +    H N+++    
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 106 --IKDIIRPPKKDTFNDVYIVYELM------DTDLHQIIRSDQQ---LTDDHCQYFLYQL 154
             +KD           ++++V +L+      D   H + + + +   L +      L ++
Sbjct: 82  FVVKD-----------ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE------YVVTR 208
           L GL+Y+H    +HRD+K  N+LL     ++I DFG++   +    +T       +V T 
Sbjct: 131 LEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
            + APE++     Y    DIWS G    E+ T
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELAT 222

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 104/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + E+    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 33  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 83
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 84  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 143
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L+  
Sbjct: 144 LHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILS-K 200
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 201 GYNKAVDWWALGVLIYEMAAGYPPF 225

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NL+++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   +  + H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + E+    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + E+    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 25/199 (12%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL------REIKLLRHMEHENV 103
           +G G + +V       T  + A K I         +RR +      RE+ +L+ ++H NV
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKR--RTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           I + ++      +   DV ++ EL+   +L   +   + LT++    FL Q+L G+ Y+H
Sbjct: 77  ITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 163 SASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPEL 215
           S  + H DLKP N++L         +KI DFGLA    + DF  E+     T  + APE 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPE- 187
Query: 216 LLNCTEYTAAIDIWSVGCI 234
           ++N        D+WS+G I
Sbjct: 188 IVNYEPLGLEADMWSIGVI 206

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 109/261 (41%), Gaps = 48/261 (18%)
Query: 34  GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIG-NAFDNI--IDARRTLR 90
           G+L E+  KY      IG+G+YG+V  A+ ++TR   AIK +  N    I   D  R   
Sbjct: 19  GSLLELQKKYHLK-GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKT 77
Query: 91  EIKLLRHMEHENVIAIKDIIRPP-----------------KKDTFNDVYIVYELMDTDLH 133
           E++L++ + H N+  + ++                     K + F D       MD    
Sbjct: 78  EVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKT 137
Query: 134 QII---RSDQQLTDDHCQYF----------------LYQLLRGLKYVHSASVLHRDLKPS 174
           QI      +++  +     F                + Q+   L Y+H+  + HRD+KP 
Sbjct: 138 QICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPE 197
Query: 175 NLLL--NASCDLKIGDFGLAR-----TTSETDFMTEYVVTRWYRAPELLLNCTE-YTAAI 226
           N L   N S ++K+ DFGL++        E   MT    T ++ APE+L    E Y    
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257
Query: 227 DIWSVGCILGEIMTREPLFPG 247
           D WS G +L  ++     FPG
Sbjct: 258 DAWSAGVLLHLLLMGAVPFPG 278

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + E+    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + E+    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 80/153 (52%), Gaps = 17/153 (11%)
Query: 90  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQ 148
           RE+ +L+ ++H NVI + ++      +   DV ++ EL+   +L   +   + LT++   
Sbjct: 63  REVSILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 149 YFLYQLLRGLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY 204
            FL Q+L G+ Y+HS  + H DLKP N++L         +KI DFGLA    + DF  E+
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF 174
Query: 205 ---VVTRWYRAPELLLNCTEYTAAIDIWSVGCI 234
                T  + APE ++N        D+WS+G I
Sbjct: 175 KNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVI 206

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + E+    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 47  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 97
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 214
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 109/217 (50%), Gaps = 24/217 (11%)
Query: 38  EVSSKYVPPIRPIGRGAYGIV--CA--AVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           +   +++  ++ +G+G +G V  C    +   T E VA+KK+ ++ +  +  R   REI+
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 63
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
           +L+ ++H+N++  K +     +       I+  L    L   ++  ++  D H +   Y 
Sbjct: 64  ILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERID-HIKLLQYT 120
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--- 208
            Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     E+   +   
Sbjct: 121 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD---KEFFKVKEPG 177
Query: 209 -----WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 178 ESPIFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 212

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 109/225 (48%), Gaps = 30/225 (13%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           +E+  + +  ++ +G G +G V     N+ T+  V   K G      +  +  L E  L+
Sbjct: 7   WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-----MSVQAFLEEANLM 61
Query: 96  RHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQ-------QLTDDHC 147
           + ++H+ ++ +  ++   +      +YI+ E M    L   ++SD+       +L D   
Sbjct: 62  KTLQHDKLVRLYAVVTKEEP-----IYIITEFMAKGSLLDFLKSDEGGKVLLPKLID--- 113
Query: 148 QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT 207
             F  Q+  G+ Y+   + +HRDL+ +N+L++ S   KI DFGLAR   + ++       
Sbjct: 114 --FSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAK 171
Query: 208 ---RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGK 248
              +W  APE  +N   +T   ++WS G +L EI+T   + +PG+
Sbjct: 172 FPIKW-TAPE-AINFGCFTIKSNVWSFGILLYEIVTYGKIPYPGR 214

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   +  + H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + ET    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 47  IKTLGTGSFGRVMLVKHMETGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 97
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   +  + H +++  Q++   +Y
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEY 157
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 214
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/131 (33%), Positives = 75/131 (57%), Gaps = 5/131 (3%)
Query: 119 NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 176
            ++ I  E MD   L Q+++  +++ ++        +LRGL Y+     ++HRD+KPSN+
Sbjct: 87  GEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNI 146
Query: 177 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 236
           L+N+  ++K+ DFG++    ++     +V TR Y APE  L  T Y+   DIWS+G  L 
Sbjct: 147 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMAPE-RLQGTHYSVQSDIWSMGLSLV 204
Query: 237 EI-MTREPLFP 246
           E+ + R P+ P
Sbjct: 205 ELAVGRYPIPP 215

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 110/227 (48%), Gaps = 30/227 (13%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           + +E+  + +  ++ +G G +G V     N+ T+  V   K G      +  +  L E  
Sbjct: 6   DAWEIPRESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-----MSVQAFLEEAN 60
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQ-------QLTDD 145
           L++ ++H+ ++ +  ++   +      +YI+ E M    L   ++SD+       +L D 
Sbjct: 61  LMKTLQHDKLVRLYAVVTREEP-----IYIITEYMAKGSLLDFLKSDEGGKVLLPKLID- 114
Query: 146 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 205
               F  Q+  G+ Y+   + +HRDL+ +N+L++ S   KI DFGLAR   + ++     
Sbjct: 115 ----FSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREG 170
Query: 206 VT---RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGK 248
                +W  APE  +N   +T   D+WS G +L EI+T   + +PG+
Sbjct: 171 AKFPIKW-TAPE-AINFGCFTIKSDVWSFGILLYEIVTYGKIPYPGR 215

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 82/157 (52%), Gaps = 16/157 (10%)
Query: 95  LRHMEHEN-------VIAIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLT 143
           L+ +EH N       ++    IIR     TF D   ++ +MD     +L  ++R  Q+  
Sbjct: 47  LKQVEHTNDERLMLSIVTHPFIIR--MWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP 104
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
           +   +++  ++   L+Y+HS  +++RDLKP N+LL+ +  +KI DFG A+   +  +   
Sbjct: 105 NPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXL- 163
Query: 204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
              T  Y APE +++   Y  +ID WS G ++ E++ 
Sbjct: 164 -CGTPDYIAPE-VVSTKPYNKSIDWWSFGILIYEMLA 198

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 20/203 (9%)
Query: 50  IGRGAYGIVCAA-VNSETREE--VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IG G +G VC+  +    + E  VAIK + + +      R  L E  ++   +H NVI +
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK-QRRDFLSEASIMGQFDHPNVIHL 73
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + ++    K T   V I+ E M+   L   +R +D Q T       L  +  G+KY+   
Sbjct: 74  EGVV---TKST--PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM 128
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLAR----TTSE---TDFMTEYVVTRWYRAPELLL 217
           + +HR L   N+L+N++   K+ DFGL+R     TS+   T  +   +  RW  APE  +
Sbjct: 129 NYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW-TAPE-AI 186
Query: 218 NCTEYTAAIDIWSVGCILGEIMT 240
              ++T+A D+WS G ++ E+M+
Sbjct: 187 QYRKFTSASDVWSYGIVMWEVMS 209

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 17/208 (8%)
Query: 50  IGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IGRG +G V       N   +   A+K + N   +I +  + L E  +++   H NV+++
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSAS 165
             I     +   + + ++  +   DL   IR++    T      F  Q+ +G+KY+ S  
Sbjct: 96  LGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 152
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNC 219
            +HRDL   N +L+    +K+ DFGLAR   + +  + +  T      +W       L  
Sbjct: 153 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALES--LQT 210
Query: 220 TEYTAAIDIWSVGCILGEIMTR-EPLFP 246
            ++T   D+WS G +L E+MTR  P +P
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTRGAPPYP 238

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 25/199 (12%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL------REIKLLRHMEHENV 103
           +G G + +V       T  + A K I         +RR +      RE+ +L+ ++H NV
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKR--RTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           I + ++      +   DV ++ EL+   +L   +   + LT++    FL Q+L G+ Y+H
Sbjct: 77  ITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 163 SASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPEL 215
           S  + H DLKP N++L         +KI DFGLA    + DF  E+     T  + APE 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPAFVAPE- 187
Query: 216 LLNCTEYTAAIDIWSVGCI 234
           ++N        D+WS+G I
Sbjct: 188 IVNYEPLGLEADMWSIGVI 206

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 25/199 (12%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL------REIKLLRHMEHENV 103
           +G G + +V       T  + A K I         +RR +      RE+ +L+ ++H NV
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKR--RTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           I + ++      +   DV ++ EL+   +L   +   + LT++    FL Q+L G+ Y+H
Sbjct: 77  ITLHEVY-----ENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 163 SASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPEL 215
           S  + H DLKP N++L         +KI DFGLA    + DF  E+     T  + APE 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPE- 187
Query: 216 LLNCTEYTAAIDIWSVGCI 234
           ++N        D+WS+G I
Sbjct: 188 IVNYEPLGLEADMWSIGVI 206

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 25/199 (12%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL------REIKLLRHMEHENV 103
           +G G + +V       T  + A K I         +RR +      RE+ +L+ ++H NV
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKR--RTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           I + ++      +   DV ++ EL+   +L   +   + LT++    FL Q+L G+ Y+H
Sbjct: 77  ITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 163 SASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPEL 215
           S  + H DLKP N++L         +KI DFGLA    + DF  E+     T  + APE 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPE- 187
Query: 216 LLNCTEYTAAIDIWSVGCI 234
           ++N        D+WS+G I
Sbjct: 188 IVNYEPLGLEADMWSIGVI 206

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + E+    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   +  + H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 20/202 (9%)
Query: 50  IGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IG G +G VC+    V  +    VAIK +   + +    R  L E  ++   +H N+I +
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDK-QRRDFLSEASIMGQFDHPNIIHL 80
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + ++   K      V I+ E M+   L   +R +D + T       L  +  G+KY+   
Sbjct: 81  EGVVTKCKP-----VMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDM 135
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY------VVTRWYRAPELLLN 218
           S +HRDL   N+L+N++   K+ DFG++R   E D    Y      +  RW  APE +  
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGMSRVL-EDDPEAAYTTRGGKIPIRWT-APEAIAY 193
Query: 219 CTEYTAAIDIWSVGCILGEIMT 240
             ++T+A D+WS G ++ E+M+
Sbjct: 194 -RKFTSASDVWSYGIVMWEVMS 214

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + E+    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 67  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 117
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   +  + H +++  Q++   +Y
Sbjct: 118 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEY 177
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 178 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 234
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 235 GYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 20/202 (9%)
Query: 50  IGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IG G +G VC+    V  +    VAIK +   + +    R  L E  ++   +H N+I +
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDK-QRRDFLSEASIMGQFDHPNIIHL 74
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + ++   K      V I+ E M+   L   +R +D + T       L  +  G+KY+   
Sbjct: 75  EGVVTKCKP-----VMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDM 129
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY------VVTRWYRAPELLLN 218
           S +HRDL   N+L+N++   K+ DFG++R   E D    Y      +  RW  APE +  
Sbjct: 130 SYVHRDLAARNILVNSNLVCKVSDFGMSRVL-EDDPEAAYTTRGGKIPIRW-TAPEAIAY 187
Query: 219 CTEYTAAIDIWSVGCILGEIMT 240
             ++T+A D+WS G ++ E+M+
Sbjct: 188 -RKFTSASDVWSYGIVMWEVMS 208

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + E+    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   +  + H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + E+    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   +  + H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L+  
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILS-K 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + E+    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   +  + H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 109/217 (50%), Gaps = 24/217 (11%)
Query: 38  EVSSKYVPPIRPIGRGAYGIV--CA--AVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           +   +++  ++ +G+G +G V  C    +   T E VA+KK+ ++ +  +  R   REI+
Sbjct: 7   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 64
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
           +L+ ++H+N++  K +     +       I+  L    L   ++  ++  D H +   Y 
Sbjct: 65  ILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERID-HIKLLQYT 121
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--- 208
            Q+ +G++Y+ +   +HR+L   N+L+     +KIGDFGL +   +     EY   +   
Sbjct: 122 SQICKGMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQD---KEYYKVKEPG 178
Query: 209 -----WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 179 ESPIFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 213

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + E+    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 41  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 91
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   +  + H +++  Q++   +Y
Sbjct: 92  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEY 151
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 152 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 208
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 209 GYNKAVDWWALGVLIYEMAAGYPPF 233

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 108/218 (49%), Gaps = 26/218 (11%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNA-FDNI--IDARRTLREIKLLRHMEHENVIAI 106
           IG+G + +V   +N ET ++ A+K +  A F +   +      RE  +   ++H +++ +
Sbjct: 34  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 93
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDL--HQIIRSDQQL--TDDHCQYFLYQLLRGLKYV 161
            +        +   +Y+V+E MD  DL    + R+D     ++    +++ Q+L  L+Y 
Sbjct: 94  LETY-----SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 148
Query: 162 HSASVLHRDLKPSNLLLNA---SCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLL 217
           H  +++HRD+KP  +LL +   S  +K+G FG+A    E+  +    V T  + APE++ 
Sbjct: 149 HDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVK 208
Query: 218 NCTEYTAAIDIWSVGCILGEIM--------TREPLFPG 247
               Y   +D+W  G IL  ++        T+E LF G
Sbjct: 209 R-EPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEG 245

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 14/201 (6%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G GA+G V  A N ET    A K I    +  ++    + EI++L   +H  ++ +   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE--DYIVEIEILATCDHPYIVKLLGA 76
Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQII--RSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
                K     ++I+ E         I    D+ LT+   Q    Q+L  L ++HS  ++
Sbjct: 77  YYHDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRII 131
Query: 168 HRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELL----LNCTEY 222
           HRDLK  N+L+    D+++ DFG+ A+          ++ T ++ APE++    +  T Y
Sbjct: 132 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPY 191
Query: 223 TAAIDIWSVGCILGEIMTREP 243
               DIWS+G  L E+   EP
Sbjct: 192 DYKADIWSLGITLIEMAQIEP 212

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 109/218 (50%), Gaps = 26/218 (11%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNA-FDNI--IDARRTLREIKLLRHMEHENVIAI 106
           IG+G + +V   +N ET ++ A+K +  A F +   +      RE  +   ++H +++  
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV-- 89
Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDL--HQIIRSDQQL--TDDHCQYFLYQLLRGLKYV 161
            +++     D    +Y+V+E MD  DL    + R+D     ++    +++ Q+L  L+Y 
Sbjct: 90  -ELLETYSSDGM--LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 162 HSASVLHRDLKPSNLLLNA---SCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLL 217
           H  +++HRD+KP  +LL +   S  +K+G FG+A    E+  +    V T  + APE++ 
Sbjct: 147 HDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVK 206
Query: 218 NCTEYTAAIDIWSVGCILGEIM--------TREPLFPG 247
               Y   +D+W  G IL  ++        T+E LF G
Sbjct: 207 R-EPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEG 243

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 14/201 (6%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G GA+G V  A N ET    A K I    +  ++    + EI++L   +H  ++ +   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE--DYIVEIEILATCDHPYIVKLLGA 84
Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQII--RSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
                K     ++I+ E         I    D+ LT+   Q    Q+L  L ++HS  ++
Sbjct: 85  YYHDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRII 139
Query: 168 HRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELL----LNCTEY 222
           HRDLK  N+L+    D+++ DFG+ A+          ++ T ++ APE++    +  T Y
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPY 199
Query: 223 TAAIDIWSVGCILGEIMTREP 243
               DIWS+G  L E+   EP
Sbjct: 200 DYKADIWSLGITLIEMAQIEP 220

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + E+    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ ++    P F
Sbjct: 214 GYNKAVDWWALGVLIYQMAAGYPPF 238

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 38  EVSSKYVPPIRPIGRGAYGIV--CA--AVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           +   +++  ++ +G+G +G V  C    +   T E VA+KK+ ++ +  +  R   REI+
Sbjct: 11  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 68
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
           +L+ ++H+N++  K +     +       I+  L    L   ++  ++  D H +   Y 
Sbjct: 69  ILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERID-HIKLLQYT 125
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--- 208
            Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     +        
Sbjct: 126 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 185
Query: 209 --WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 186 IFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 217

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 38  EVSSKYVPPIRPIGRGAYGIV--CA--AVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           +   +++  ++ +G+G +G V  C    +   T E VA+KK+ ++ +  +  R   REI+
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 63
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
           +L+ ++H+N++  K +     +       I+  L    L   ++  ++  D H +   Y 
Sbjct: 64  ILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERID-HIKLLQYT 120
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--- 208
            Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     +        
Sbjct: 121 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 180
Query: 209 --WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 181 IFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 212

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 38  EVSSKYVPPIRPIGRGAYGIV--CA--AVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           +   +++  ++ +G+G +G V  C    +   T E VA+KK+ ++ +  +  R   REI+
Sbjct: 13  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 70
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
           +L+ ++H+N++  K +     +       I+  L    L   ++  ++  D H +   Y 
Sbjct: 71  ILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERID-HIKLLQYT 127
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--- 208
            Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     +        
Sbjct: 128 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 187
Query: 209 --WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 188 IFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 219

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 38  EVSSKYVPPIRPIGRGAYGIV--CA--AVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           +   +++  ++ +G+G +G V  C    +   T E VA+KK+ ++ +  +  R   REI+
Sbjct: 4   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 61
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
           +L+ ++H+N++  K +     +       I+  L    L   ++  ++  D H +   Y 
Sbjct: 62  ILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERID-HIKLLQYT 118
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--- 208
            Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     +        
Sbjct: 119 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 178
Query: 209 --WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 179 IFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 210

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 38  EVSSKYVPPIRPIGRGAYGIV--CA--AVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           +   +++  ++ +G+G +G V  C    +   T E VA+KK+ ++ +  +  R   REI+
Sbjct: 9   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 66
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
           +L+ ++H+N++  K +     +       I+  L    L   ++  ++  D H +   Y 
Sbjct: 67  ILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERID-HIKLLQYT 123
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--- 208
            Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     +        
Sbjct: 124 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 183
Query: 209 --WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 184 IFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 215

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 38  EVSSKYVPPIRPIGRGAYGIV--CA--AVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           +   +++  ++ +G+G +G V  C    +   T E VA+KK+ ++ +  +  R   REI+
Sbjct: 12  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 69
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
           +L+ ++H+N++  K +     +       I+  L    L   ++  ++  D H +   Y 
Sbjct: 70  ILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERID-HIKLLQYT 126
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--- 208
            Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     +        
Sbjct: 127 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 186
Query: 209 --WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 187 IFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 218

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 38  EVSSKYVPPIRPIGRGAYGIV--CA--AVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           +   +++  ++ +G+G +G V  C    +   T E VA+KK+ ++ +  +  R   REI+
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 63
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
           +L+ ++H+N++  K +     +       I+  L    L   ++  ++  D H +   Y 
Sbjct: 64  ILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERID-HIKLLQYT 120
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--- 208
            Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     +        
Sbjct: 121 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 180
Query: 209 --WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 181 IFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 212

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 38  EVSSKYVPPIRPIGRGAYGIV--CA--AVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           +   +++  ++ +G+G +G V  C    +   T E VA+KK+ ++ +  +  R   REI+
Sbjct: 37  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 94
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
           +L+ ++H+N++  K +     +       I+  L    L   ++  ++  D H +   Y 
Sbjct: 95  ILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERID-HIKLLQYT 151
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--- 208
            Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     +        
Sbjct: 152 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 211
Query: 209 --WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 212 IFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 243

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 38  EVSSKYVPPIRPIGRGAYGIV--CA--AVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           +   +++  ++ +G+G +G V  C    +   T E VA+KK+ ++ +  +  R   REI+
Sbjct: 5   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 62
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
           +L+ ++H+N++  K +     +       I+  L    L   ++  ++  D H +   Y 
Sbjct: 63  ILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERID-HIKLLQYT 119
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--- 208
            Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     +        
Sbjct: 120 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 179
Query: 209 --WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 180 IFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 211

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 38  EVSSKYVPPIRPIGRGAYGIV--CA--AVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           +   +++  ++ +G+G +G V  C    +   T E VA+KK+ ++ +  +  R   REI+
Sbjct: 10  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 67
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
           +L+ ++H+N++  K +     +       I+  L    L   ++  ++  D H +   Y 
Sbjct: 68  ILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERID-HIKLLQYT 124
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--- 208
            Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     +        
Sbjct: 125 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 184
Query: 209 --WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 185 IFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 216

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 109/217 (50%), Gaps = 15/217 (6%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR----RTLREIKLLRHMEHEN 102
           ++ +G+G +G V       T    A+K +      +I A+     T+ E ++L++  H  
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRK---EVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           + A+K   +     T + +  V E  +  +L   +  ++  T++  +++  +++  L+Y+
Sbjct: 67  LTALKYAFQ-----THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  V++RD+K  NL+L+    +KI DFGL +   S+   M  +  T  Y APE+L +  
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-N 180
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           +Y  A+D W +G ++ E+M     F  +D+     LI
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 109/217 (50%), Gaps = 15/217 (6%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR----RTLREIKLLRHMEHEN 102
           ++ +G+G +G V       T    A+K +      +I A+     T+ E ++L++  H  
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRK---EVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           + A+K   +     T + +  V E  +  +L   +  ++  T++  +++  +++  L+Y+
Sbjct: 67  LTALKYAFQ-----THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  V++RD+K  NL+L+    +KI DFGL +   S+   M  +  T  Y APE+L +  
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLED-N 180
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           +Y  A+D W +G ++ E+M     F  +D+     LI
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 38  EVSSKYVPPIRPIGRGAYGIV--CA--AVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           +   +++  ++ +G+G +G V  C    +   T E VA+KK+ ++ +  +  R   REI+
Sbjct: 9   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 66
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
           +L+ ++H+N++  K +     +       I+  L    L   +++  +  D H +   Y 
Sbjct: 67  ILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQAHAERID-HIKLLQYT 123
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--- 208
            Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     +        
Sbjct: 124 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 183
Query: 209 --WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 184 IFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 215

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + E+    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NL+++    +++ DFG A+      +      T  Y APE+++   
Sbjct: 157 LHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIII-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 109/217 (50%), Gaps = 15/217 (6%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR----RTLREIKLLRHMEHEN 102
           ++ +G+G +G V       T    A+K +      +I A+     T+ E ++L++  H  
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRK---EVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           + A+K   +     T + +  V E  +  +L   +  ++  T++  +++  +++  L+Y+
Sbjct: 67  LTALKYAFQ-----THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  V++RD+K  NL+L+    +KI DFGL +   S+   M  +  T  Y APE+L +  
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLED-N 180
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           +Y  A+D W +G ++ E+M     F  +D+     LI
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 109/217 (50%), Gaps = 15/217 (6%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR----RTLREIKLLRHMEHEN 102
           ++ +G+G +G V       T    A+K +      +I A+     T+ E ++L++  H  
Sbjct: 13  LKLLGKGTFGKVILVREKATGRYYAMKILRK---EVIIAKDEVAHTVTESRVLQNTRHPF 69
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           + A+K   +     T + +  V E  +  +L   +  ++  T++  +++  +++  L+Y+
Sbjct: 70  LTALKYAFQ-----THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 124
Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  V++RD+K  NL+L+    +KI DFGL +   S+   M  +  T  Y APE+L +  
Sbjct: 125 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-N 183
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           +Y  A+D W +G ++ E+M     F  +D+     LI
Sbjct: 184 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 220

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 109/217 (50%), Gaps = 15/217 (6%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR----RTLREIKLLRHMEHEN 102
           ++ +G+G +G V       T    A+K +      +I A+     T+ E ++L++  H  
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRK---EVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           + A+K   +     T + +  V E  +  +L   +  ++  T++  +++  +++  L+Y+
Sbjct: 67  LTALKYAFQ-----THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  V++RD+K  NL+L+    +KI DFGL +   S+   M  +  T  Y APE+L +  
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-N 180
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           +Y  A+D W +G ++ E+M     F  +D+     LI
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 109/217 (50%), Gaps = 15/217 (6%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR----RTLREIKLLRHMEHEN 102
           ++ +G+G +G V       T    A+K +      +I A+     T+ E ++L++  H  
Sbjct: 15  LKLLGKGTFGKVILVREKATGRYYAMKILRK---EVIIAKDEVAHTVTESRVLQNTRHPF 71
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           + A+K   +     T + +  V E  +  +L   +  ++  T++  +++  +++  L+Y+
Sbjct: 72  LTALKYAFQ-----THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 126
Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  V++RD+K  NL+L+    +KI DFGL +   S+   M  +  T  Y APE+L +  
Sbjct: 127 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLED-N 185
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           +Y  A+D W +G ++ E+M     F  +D+     LI
Sbjct: 186 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 222

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 109/217 (50%), Gaps = 15/217 (6%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR----RTLREIKLLRHMEHEN 102
           ++ +G+G +G V       T    A+K +      +I A+     T+ E ++L++  H  
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRK---EVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           + A+K   +     T + +  V E  +  +L   +  ++  T++  +++  +++  L+Y+
Sbjct: 67  LTALKYAFQ-----THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  V++RD+K  NL+L+    +KI DFGL +   S+   M  +  T  Y APE+L +  
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLED-N 180
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           +Y  A+D W +G ++ E+M     F  +D+     LI
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + E+    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T  Y AP ++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPAIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 12/212 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G +G V     + T  ++A K I      + D      EI ++  ++H N+I + D 
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTR--GMKDKEEVKNEISVMNQLDHANLIQLYDA 154
Query: 110 IRPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
                 ++ ND+ +V E +D      +II     LT+     F+ Q+  G++++H   +L
Sbjct: 155 F-----ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYIL 209
Query: 168 HRDLKPSNLLL--NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           H DLKP N+L     +  +KI DFGLAR     + +     T  + APE ++N    +  
Sbjct: 210 HLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPE-VVNYDFVSFP 268
Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
            D+WSVG I   +++    F G +    L  I
Sbjct: 269 TDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI 300

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIK 93
           +E+  + +   R IG G +G V   +          VAIK   N   + +   + L+E  
Sbjct: 5   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR-EKFLQEAL 63
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
            +R  +H +++ +  +I      T N V+I+ EL      +     ++ + D     LY 
Sbjct: 64  TMRQFDHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYA 117
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTR 208
            QL   L Y+ S   +HRD+   N+L++A+  +K+GDFGL+R   ++ +       +  +
Sbjct: 118 YQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 177
Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIM 239
           W  APE  +N   +T+A D+W  G  + EI+
Sbjct: 178 WM-APE-SINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 19/222 (8%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL------REIKLLRHMEHENV 103
           +G G + IV       T  E A K I         +RR +      RE+ +LR + H N+
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRA--SRRGVCREEIEREVSILRQVLHPNI 77
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           I + D+      +   DV ++ EL+   +L   +   + L+++    F+ Q+L G+ Y+H
Sbjct: 78  ITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 163 SASVLHRDLKPSN-LLLNASC---DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
           +  + H DLKP N +LL+ +     +K+ DFGLA    +         T  + APE ++N
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVN 191
Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
                   D+WS+G I   +++    F G      L  IT V
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV 233

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 102/205 (49%), Gaps = 25/205 (12%)
Query: 50  IGRGAYGIVCAAV--NSETREEV--AIKKIGNAFDNIIDARRT--LREIKLLRHMEHENV 103
           IG G +G V   +   S  ++EV  AIK +   +    + +R   L E  ++    H N+
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVDFLGEAGIMGQFSHHNI 108
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTD-LHQIIR-SDQQLTDDHCQYFLYQLLRGLKYV 161
           I ++ +I       +  + I+ E M+   L + +R  D + +       L  +  G+KY+
Sbjct: 109 IRLEGVI-----SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 163
Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPEL 215
            + + +HRDL   N+L+N++   K+ DFGL+R   E D    Y  +      RW  APE 
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL-EDDPEATYTTSGGKIPIRW-TAPE- 220
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMT 240
            ++  ++T+A D+WS G ++ E+MT
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMT 245

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 106/220 (48%), Gaps = 33/220 (15%)
Query: 48  RPIGRGAYGIVCAA----VNSETREEVAIKKIGNAFDNII--DARRTLREIKLLRHM-EH 100
           +P+G GA+G V  A    ++ +  +E     +    D+    D    + E+++++ + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKH 100
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS----------------DQQLT 143
           +N+I   +++    +D    +Y++ E     +L + +R+                ++Q+T
Sbjct: 101 KNII---NLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
                   YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  D+  +
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 204 YVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               R    + APE L +   YT   D+WS G ++ EI T
Sbjct: 216 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 254

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 105/220 (47%), Gaps = 33/220 (15%)
Query: 48  RPIGRGAYGIVCAA----VNSETREEVAIKKIGNAFDNII--DARRTLREIKLLRHM-EH 100
           +P+G GA+G V  A    ++ +  +E     +    D+    D    + E+++++ + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS----------------DQQLT 143
           +N+I +   +    +D    +Y++ E     +L + +R+                ++Q+T
Sbjct: 101 KNIITL---LGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
                   YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  D+  +
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 204 YVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               R    + APE L +   YT   D+WS G ++ EI T
Sbjct: 216 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 254

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 106/220 (48%), Gaps = 23/220 (10%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           +EV  + +  +  +G G +G V     N  T+  V   K G+   +       L E  L+
Sbjct: 8   WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAF-----LAEANLM 62
Query: 96  RHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ--QLTDDHCQYFLY 152
           + ++H+ ++ +  ++      T   +YI+ E M+   L   +++    +LT +       
Sbjct: 63  KQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 116
Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE---YVVTRW 209
           Q+  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + ++          +W
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 176
Query: 210 YRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
             APE  +N   +T   D+WS G +L EI+T  R P +PG
Sbjct: 177 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 213

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 104/216 (48%), Gaps = 30/216 (13%)
Query: 48  RPIGRGAYGIVCAAV-----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE- 101
           +P+GRGA+G V  A       + T   VA+K +     +  + R  + E+K+L H+ H  
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHL 91
Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ------------LTDDHCQ 148
           NV+ +      P       + ++ E     +L   +RS +             LT +H  
Sbjct: 92  NVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLI 147
Query: 149 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFMTE---Y 204
            + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D++ +    
Sbjct: 148 XYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDAR 207
Query: 205 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 208 LPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 241

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 109/228 (47%), Gaps = 23/228 (10%)
Query: 29  QYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARR 87
           Q   + + +EV  + +  +  +G G +G V     N  T+  V   K G+   +      
Sbjct: 6   QKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAF---- 61
Query: 88  TLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ--QLTD 144
            L E  L++ ++H+ ++ +  ++      T   +YI+ E M+   L   +++    +LT 
Sbjct: 62  -LAEANLMKQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTI 114
Query: 145 DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY 204
           +       Q+  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + ++    
Sbjct: 115 NKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 174
Query: 205 VVT---RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
                 +W  APE  +N   +T   D+WS G +L EI+T  R P +PG
Sbjct: 175 GAKFPIKW-TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 219

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 105/220 (47%), Gaps = 33/220 (15%)
Query: 48  RPIGRGAYGIVCAA----VNSETREEVAIKKIGNAFDNII--DARRTLREIKLLRHM-EH 100
           +P+G GA+G V  A    ++ +  +E     +    D+    D    + E+++++ + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS----------------DQQLT 143
           +N+I   +++    +D    +Y++ E     +L + +R+                ++Q+T
Sbjct: 101 KNII---NLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
                   YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  D+   
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKN 215
Query: 204 YVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               R    + APE L +   YT   D+WS G ++ EI T
Sbjct: 216 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 254

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 106/220 (48%), Gaps = 23/220 (10%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           +EV  + +  +  +G G +G V     N  T+  V   K G+   +       L E  L+
Sbjct: 18  WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAF-----LAEANLM 72
Query: 96  RHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ--QLTDDHCQYFLY 152
           + ++H+ ++ +  ++      T   +YI+ E M+   L   +++    +LT +       
Sbjct: 73  KQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 126
Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RW 209
           Q+  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + ++          +W
Sbjct: 127 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 186
Query: 210 YRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
             APE  +N   +T   D+WS G +L EI+T  R P +PG
Sbjct: 187 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 223

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIK 93
           +E+  + +   R IG G +G V   +          VAIK   N   + +   + L+E  
Sbjct: 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSV-REKFLQEAL 443
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
            +R  +H +++ +  +I      T N V+I+ EL      +     ++ + D     LY 
Sbjct: 444 TMRQFDHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYA 497
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTR 208
            QL   L Y+ S   +HRD+   N+L++A+  +K+GDFGL+R   ++ +       +  +
Sbjct: 498 YQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 557
Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIM 239
           W  APE  +N   +T+A D+W  G  + EI+
Sbjct: 558 WM-APE-SINFRRFTSASDVWMFGVCMWEIL 586

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 106/220 (48%), Gaps = 23/220 (10%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           +EV  + +  +  +G G +G V     N  T+  V   K G+   +       L E  L+
Sbjct: 3   WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAF-----LAEANLM 57
Query: 96  RHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ--QLTDDHCQYFLY 152
           + ++H+ ++ +  ++      T   +YI+ E M+   L   +++    +LT +       
Sbjct: 58  KQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 111
Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RW 209
           Q+  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + ++          +W
Sbjct: 112 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 171
Query: 210 YRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
             APE  +N   +T   D+WS G +L EI+T  R P +PG
Sbjct: 172 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 208

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 109/228 (47%), Gaps = 23/228 (10%)
Query: 29  QYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARR 87
           Q   + + +EV  + +  +  +G G +G V     N  T+  V   K G+   +      
Sbjct: 5   QKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAF---- 60
Query: 88  TLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ--QLTD 144
            L E  L++ ++H+ ++ +  ++      T   +YI+ E M+   L   +++    +LT 
Sbjct: 61  -LAEANLMKQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTI 113
Query: 145 DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY 204
           +       Q+  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + ++    
Sbjct: 114 NKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 173
Query: 205 VVT---RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
                 +W  APE  +N   +T   D+WS G +L EI+T  R P +PG
Sbjct: 174 GAKFPIKW-TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 218

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 105/219 (47%), Gaps = 20/219 (9%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+G++G V  A    T E  AIK        I+     +++  +   M  + V+A+ D 
Sbjct: 27  LGKGSFGKVMLADRKGTEELYAIK--------ILKKDVVIQDDDVECTMVEKRVLALLD- 77
Query: 110 IRPPKK-------DTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
            +PP          T + +Y V E ++  DL   I+   +  +    ++  ++  GL ++
Sbjct: 78  -KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFL 136
Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCT 220
           H   +++RDLK  N++L++   +KI DFG+ +        T E+  T  Y APE++    
Sbjct: 137 HKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAY-Q 195
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
            Y  ++D W+ G +L E++  +P F G+D     + I E
Sbjct: 196 PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME 234

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 109/227 (48%), Gaps = 39/227 (17%)
Query: 43  YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN 102
           Y+   + +GRG + +V   ++  T +E A K         +  RR  ++ +    + HE 
Sbjct: 30  YILTSKELGRGKFAVVRQCISKSTGQEYAAK--------FLKKRRRGQDCR--AEILHE- 78
Query: 103 VIAIKDIIRP-PKKDTFNDVYI----------------VYELMDTDLHQIIRSDQQLTDD 145
            IA+ ++ +  P+    ++VY                 ++ L   +L +++      +++
Sbjct: 79  -IAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMV------SEN 131
Query: 146 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLARTTSETDFMT 202
                + Q+L G+ Y+H  +++H DLKP N+LL++     D+KI DFG++R       + 
Sbjct: 132 DVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELR 191
Query: 203 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
           E + T  Y APE +LN    T A D+W++G I   ++T    F G+D
Sbjct: 192 EIMGTPEYLAPE-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED 237

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I+ +G G++G V    + E+    A+K        I+D ++ ++ +K + H  +E  I  
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMK--------ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           A+        + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  +++RDLKP NLL++    +++ DFG A+      +      T    APE++L   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEALAPEIIL-SK 213
Query: 221 EYTAAIDIWSVGCILGEIMTREPLF 245
            Y  A+D W++G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 94/212 (44%), Gaps = 23/212 (10%)
Query: 42  KYVPPIRPIGRGAYGIVCA----AVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLR 96
           +Y+  IR +G G +G V        N  T E VA+K +    D     R   + EI +LR
Sbjct: 14  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--KADCGPQHRSGWKQEIDILR 71
Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 156
            + HE++I  K       + +     +V E +     +       +       F  Q+  
Sbjct: 72  TLYHEHIIKYKGCCEDQGEKSLQ---LVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICE 128
Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR-------- 208
           G+ Y+HS   +HR+L   N+LL+    +KIGDFGLA+   E     EY   R        
Sbjct: 129 GMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVF 185
Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           WY APE L     Y A+ D+WS G  L E++T
Sbjct: 186 WY-APECLKEYKFYYAS-DVWSFGVTLYELLT 215

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 105/220 (47%), Gaps = 33/220 (15%)
Query: 48  RPIGRGAYGIVCAA----VNSETREEVAIKKIGNAFDNII--DARRTLREIKLLRHM-EH 100
           +P+G GA+G V  A    ++ +  +E     +    D+    D    + E+++++ + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS----------------DQQLT 143
           +N+I    ++    +D    +Y++ E     +L + +R+                ++Q+T
Sbjct: 101 KNII---HLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
                   YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  D+  +
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 204 YVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               R    + APE L +   YT   D+WS G ++ EI T
Sbjct: 216 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 254

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 126/268 (47%), Gaps = 44/268 (16%)
Query: 22  THGGKYVQYNVYGNL--FEVSSK-YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNA 78
           + GGK  + +   N+  FE S K  V   + +G G+ G V    + + R  VA+K++   
Sbjct: 10  SRGGKKGRKSRIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRP-VAVKRMLID 68
Query: 79  FDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIR 137
           F +I      L EIKLL   + H NVI           D F  +YI  EL + +L  ++ 
Sbjct: 69  FCDI-----ALMEIKLLTESDDHPNVIRY---YCSETTDRF--LYIALELCNLNLQDLVE 118
Query: 138 SDQQLTDDHCQY--------FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLK---- 185
           S + ++D++ +          L Q+  G+ ++HS  ++HRDLKP N+L++ S        
Sbjct: 119 S-KNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQ 177
Query: 186 ---------IGDFGLART--TSETDF---MTEYVVTRWYRAPELLLNCTE--YTAAIDIW 229
                    I DFGL +   + +  F   +     T  +RAPELL   T+   T +IDI+
Sbjct: 178 TGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIF 237
Query: 230 SVGCILGEIMTREPLFPGKDYVHQLRLI 257
           S+GC+   I+++     G  Y  +  +I
Sbjct: 238 SMGCVFYYILSKGKHPFGDKYSRESNII 265

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 121/252 (48%), Gaps = 44/252 (17%)
Query: 22  THGGKYVQYNVYGNL--FEVSSK-YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNA 78
           + GGK  + +   N+  FE S K  V   + +G G+ G V    + + R  VA+K++   
Sbjct: 10  SRGGKKGRKSRIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRP-VAVKRMLID 68
Query: 79  FDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIR 137
           F +I      L EIKLL   + H NVI           D F  +YI  EL + +L  ++ 
Sbjct: 69  FCDI-----ALMEIKLLTESDDHPNVIRY---YCSETTDRF--LYIALELCNLNLQDLVE 118
Query: 138 SDQQLTDDHCQY--------FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLK---- 185
           S + ++D++ +          L Q+  G+ ++HS  ++HRDLKP N+L++ S        
Sbjct: 119 S-KNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQ 177
Query: 186 ---------IGDFGLART--TSETDF---MTEYVVTRWYRAPELLLNCTE--YTAAIDIW 229
                    I DFGL +   + +  F   +     T  +RAPELL   T+   T +IDI+
Sbjct: 178 TGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIF 237
Query: 230 SVGCILGEIMTR 241
           S+GC+   I+++
Sbjct: 238 SMGCVFYYILSK 249

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 106/220 (48%), Gaps = 33/220 (15%)
Query: 48  RPIGRGAYGIVCAA----VNSETREEVAIKKIGNAFDNII--DARRTLREIKLLRHM-EH 100
           +P+G GA+G V  A    ++ +  +E     +    D+    D    + E+++++ + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS----------------DQQLT 143
           +N+I   +++    +D    +Y++ E     +L + +R+                ++Q+T
Sbjct: 101 KNII---NLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
                   YQL RG++Y+ S   +HRDL   N+L+  +  ++I DFGLAR  +  D+  +
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKK 215
Query: 204 YVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               R    + APE L +   YT   D+WS G ++ EI T
Sbjct: 216 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 254

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 104/219 (47%), Gaps = 31/219 (14%)
Query: 48  RPIGRGAYGIVCAA----VNSETREEVAIKKIGNAFDNII--DARRTLREIKLLRHM-EH 100
           +P+G GA+G V  A    ++ +  +E     +    D+    D    + E+++++ + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS----------------DQQLTD 144
           +N+I   +++    +D    V + Y     +L + +R+                ++Q+T 
Sbjct: 101 KNII---NLLGACTQDGPLYVIVAYA-SKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 145 DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY 204
                  YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  D+  + 
Sbjct: 157 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 205 VVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
              R    + APE L +   YT   D+WS G ++ EI T
Sbjct: 217 TNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 254

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 107/223 (47%), Gaps = 23/223 (10%)
Query: 34  GNLFEVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREI 92
           G  +EV  + +  +  +G G +G V     N  T+  V   K G+   +       L E 
Sbjct: 1   GPEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAF-----LAEA 55
Query: 93  KLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ--QLTDDHCQY 149
            L++ ++H+ ++ +  ++      T   +YI+ E M+   L   +++    +LT +    
Sbjct: 56  NLMKQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 109
Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE---YVV 206
              Q+  G+ ++   + +HR+L+ +N+L++ +   KI DFGLAR   + ++         
Sbjct: 110 MAAQIAEGMAFIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 169
Query: 207 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
            +W  APE  +N   +T   D+WS G +L EI+T  R P +PG
Sbjct: 170 IKW-TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 209

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 105/220 (47%), Gaps = 33/220 (15%)
Query: 48  RPIGRGAYGIVCAA----VNSETREEVAIKKIGNAFDNII--DARRTLREIKLLRHM-EH 100
           +P+G GA+G V  A    ++ +  +E     +    D+    D    + E+++++ + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS----------------DQQLT 143
           +N+I   +++    +D    +Y++ E     +L + +R+                ++Q+T
Sbjct: 101 KNII---NLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
                   YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  D   +
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKK 215
Query: 204 YVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               R    + APE L +   YT   D+WS G ++ EI T
Sbjct: 216 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 254

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 105/220 (47%), Gaps = 33/220 (15%)
Query: 48  RPIGRGAYGIVCAA----VNSETREEVAIKKIGNAFDNII--DARRTLREIKLLRHM-EH 100
           +P+G GA+G V  A    ++ +  +E     +    D+    D    + E+++++ + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS----------------DQQLT 143
           +N+I   +++    +D    +Y++ E     +L + +R+                ++Q+T
Sbjct: 101 KNII---NLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMT 155
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
                   YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  D   +
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKK 215
Query: 204 YVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               R    + APE L +   YT   D+WS G ++ EI T
Sbjct: 216 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 254

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 104/216 (48%), Gaps = 30/216 (13%)
Query: 48  RPIGRGAYGIVCAAV-----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE- 101
           +P+GRGA+G V  A       + T   VA+K +     +  + R  + E+K+L H+ H  
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHL 91
Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ------------LTDDHCQ 148
           NV+ +      P       + ++ E     +L   +RS +             LT +H  
Sbjct: 92  NVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLI 147
Query: 149 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFMTE---Y 204
            + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D++ +    
Sbjct: 148 CYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 207
Query: 205 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 208 LPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 241

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 112/252 (44%), Gaps = 28/252 (11%)
Query: 25  GKY--VQYNVYGNLFE-VSSKYVPP---------------IRPIGRGAYGIVCAAVNSET 66
           GKY   + N Y   +E +  KYVP                +  +G GA+G+V   V   T
Sbjct: 16  GKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKAT 75
Query: 67  REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYE 126
                 K I   +   +D      EI ++  + H  +I + D      +D +  V I+  
Sbjct: 76  GRVFVAKFINTPYP--LDKYTVKNEISIMNQLHHPKLINLHDAF----EDKYEMVLILEF 129
Query: 127 LMDTDLH-QIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA--SCD 183
           L   +L  +I   D ++++     ++ Q   GLK++H  S++H D+KP N++     +  
Sbjct: 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASS 189
Query: 184 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREP 243
           +KI DFGLA   +  + +     T  + APE +++        D+W++G +   +++   
Sbjct: 190 VKIIDFGLATKLNPDEIVKVTTATAEFAAPE-IVDREPVGFYTDMWAIGVLGYVLLSGLS 248
Query: 244 LFPGKDYVHQLR 255
            F G+D +  L+
Sbjct: 249 PFAGEDDLETLQ 260

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 34/220 (15%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I  IG G +G V  A +    +   I+++   ++N     +  RE+K L  ++H N++  
Sbjct: 17  IELIGSGGFGQVFKAKHRIDGKTYVIRRV--KYNN----EKAEREVKALAKLDHVNIVHY 70
Query: 105 ------------AIKDIIRPPKKDTFND----------VYIVYELMDTD-LHQII--RSD 139
                          D +     D  N           ++I  E  D   L Q I  R  
Sbjct: 71  NGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG 130
Query: 140 QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD 199
           ++L          Q+ +G+ Y+HS  ++HRDLKPSN+ L  +  +KIGDFGL  +     
Sbjct: 131 EKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG 190
Query: 200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 239
             T    T  Y +PE  ++  +Y   +D++++G IL E++
Sbjct: 191 KRTRSKGTLRYMSPE-QISSQDYGKEVDLYALGLILAELL 229

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIK 93
           +E+  + +   R IG G +G V   +          VAIK   N   + +   + L+E  
Sbjct: 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSV-REKFLQEAL 443
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
            +R  +H +++ +  +I      T N V+I+ EL      +     ++ + D     LY 
Sbjct: 444 TMRQFDHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYA 497
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTR 208
            QL   L Y+ S   +HRD+   N+L++++  +K+GDFGL+R   ++ +       +  +
Sbjct: 498 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 557
Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIM 239
           W  APE  +N   +T+A D+W  G  + EI+
Sbjct: 558 WM-APE-SINFRRFTSASDVWMFGVCMWEIL 586

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 50  IGRGAYGIVCAA-VNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAI 106
           +G G +G+V    VN+ T   VA+KK+    D   +  +    +EIK++   +HEN++ +
Sbjct: 39  MGEGGFGVVYKGYVNNTT---VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT----DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
                       +D+ +VY  M      D    +     L+             G+ ++H
Sbjct: 96  LGF-----SSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH 150
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAPELLLNC 219
               +HRD+K +N+LL+ +   KI DFGLAR +   ++T   +  V T  Y APE L   
Sbjct: 151 ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALRG- 209
Query: 220 TEYTAAIDIWSVGCILGEIMTREP 243
            E T   DI+S G +L EI+T  P
Sbjct: 210 -EITPKSDIYSFGVVLLEIITGLP 232

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI-- 104
           I  IG G +G V  A +    +   IK++   ++N     +  RE+K L  ++H N++  
Sbjct: 16  IELIGSGGFGQVFKAKHRIDGKTYVIKRV--KYNN----EKAEREVKALAKLDHVNIVHY 69
Query: 105 --AIKDIIRPPKKDTFND-------VYIVYELMDTD-LHQII--RSDQQLTDDHCQYFLY 152
                     P+  + N        ++I  E  D   L Q I  R  ++L          
Sbjct: 70  NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFE 129
Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRA 212
           Q+ +G+ Y+HS  +++RDLKPSN+ L  +  +KIGDFGL  +            T  Y +
Sbjct: 130 QITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMS 189
Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIM 239
           PE  ++  +Y   +D++++G IL E++
Sbjct: 190 PE-QISSQDYGKEVDLYALGLILAELL 215

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 105/220 (47%), Gaps = 33/220 (15%)
Query: 48  RPIGRGAYGIVCAA----VNSETREEVAIKKIGNAFDNII--DARRTLREIKLLRHM-EH 100
           +P+G G +G V  A    ++ +  +E     +    D+    D    + E+++++ + +H
Sbjct: 30  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 89
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS----------------DQQLT 143
           +N+I   +++    +D    +Y++ E     +L + +R+                ++Q+T
Sbjct: 90  KNII---NLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 144
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
                   YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  D+  +
Sbjct: 145 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 204
Query: 204 YVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               R    + APE L +   YT   D+WS G ++ EI T
Sbjct: 205 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 243

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 97/215 (45%), Gaps = 29/215 (13%)
Query: 42  KYVPPIRPIGRGAYGIVCA----AVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLR 96
           +Y+  IR +G G +G V        N  T E VA+K +    D     R   + EI +LR
Sbjct: 14  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--KADCGPQHRSGWKQEIDILR 71
Query: 97  HMEHENVIAIKDIIRPPKKDTFNDV--YI-VYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
            + HE++I  K       + +   V  Y+ +  L D      I   Q L       F  Q
Sbjct: 72  TLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLL------FAQQ 125
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR----- 208
           +  G+ Y+H+   +HR+L   N+LL+    +KIGDFGLA+   E     EY   R     
Sbjct: 126 ICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVREDGDS 182
Query: 209 ---WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
              WY APE L     Y A+ D+WS G  L E++T
Sbjct: 183 PVFWY-APECLKEYKFYYAS-DVWSFGVTLYELLT 215

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 105/220 (47%), Gaps = 33/220 (15%)
Query: 48  RPIGRGAYGIVCAA----VNSETREEVAIKKIGNAFDNII--DARRTLREIKLLRHM-EH 100
           +P+G G +G V  A    ++ +  +E     +    D+    D    + E+++++ + +H
Sbjct: 33  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 92
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS----------------DQQLT 143
           +N+I   +++    +D    +Y++ E     +L + +R+                ++Q+T
Sbjct: 93  KNII---NLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 147
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
                   YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  D+  +
Sbjct: 148 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 207
Query: 204 YVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               R    + APE L +   YT   D+WS G ++ EI T
Sbjct: 208 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 246

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 108/228 (47%), Gaps = 23/228 (10%)
Query: 29  QYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARR 87
           Q   + + +EV  + +  +  +G G +G V     N  T+  V   K G+   +      
Sbjct: 8   QKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAF---- 63
Query: 88  TLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ--QLTD 144
            L E  L++ ++H+ ++ +  ++      T   +YI+ E M+   L   +++    +LT 
Sbjct: 64  -LAEANLMKQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTI 116
Query: 145 DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY 204
           +       Q+  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + +     
Sbjct: 117 NKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTARE 176
Query: 205 VVT---RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
                 +W  APE  +N   +T   D+WS G +L EI+T  R P +PG
Sbjct: 177 GAKFPIKW-TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 221

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 105/220 (47%), Gaps = 23/220 (10%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           +EV  + +  +  +G G +G V     N  T+  V   K G+   +       L E  L+
Sbjct: 8   WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAF-----LAEANLM 62
Query: 96  RHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ--QLTDDHCQYFLY 152
           + ++H+ ++ +  ++      T   +YI+ E M+   L   +++    +LT +       
Sbjct: 63  KQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 116
Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE---YVVTRW 209
           Q+  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + +           +W
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 176
Query: 210 YRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
             APE  +N   +T   D+WS G +L EI+T  R P +PG
Sbjct: 177 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 213

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 103/207 (49%), Gaps = 18/207 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG+G++G V  A +       A+K +          ++ + + K  +H+  E  + +
Sbjct: 43  LKVIGKGSFGKVLLARHKAEEVFYAVKVL---------QKKAILKKKEEKHIMSERNVLL 93
Query: 107 KDIIRPP------KKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
           K++  P          T + +Y V + ++  +L   ++ ++   +   +++  ++   L 
Sbjct: 94  KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALG 153
Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLN 218
           Y+HS ++++RDLKP N+LL++   + + DFGL +   E +  T  +  T  Y APE +L+
Sbjct: 154 YLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPE-VLH 212
Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLF 245
              Y   +D W +G +L E++   P F
Sbjct: 213 KQPYDRTVDWWCLGAVLYEMLYGLPPF 239

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 122/285 (42%), Gaps = 78/285 (27%)
Query: 46  PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR-RTLREIKLLRHMEHENVI 104
           PI+ +GRG +G+V  A N       AIK+I     N   AR + +RE+K L  +EH  ++
Sbjct: 10  PIQCMGRGGFGVVFEAKNKVDDCNYAIKRI--RLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 105 AIKD--IIRPPKK--DTFNDVYIVYELMDTDLH----------QIIRSDQ--------QL 142
              +  +  PP+K  +  +++++  E  D  L           +I R D         QL
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 143 TDDHCQYFLY----------------------------------QLLRGLKYVHSASVLH 168
                + +LY                                  Q+   ++++HS  ++H
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMH 187
Query: 169 RDLKPSNLLLNASCDLKIGDFGLARTTSETD-------FMTEY------VVTRWYRAPEL 215
           RDLKPSN+       +K+GDFGL     + +        M  Y      V T+ Y +PE 
Sbjct: 188 RDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPE- 246
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
            ++   Y+  +DI+S+G IL E+     L+     + ++R+IT+V
Sbjct: 247 QIHGNNYSHKVDIFSLGLILFEL-----LYSFSTQMERVRIITDV 286

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 108/228 (47%), Gaps = 23/228 (10%)
Query: 29  QYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARR 87
           Q   + + +EV  + +  +  +G G +G V     N  T+  V   K G+   +      
Sbjct: 9   QKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAF---- 64
Query: 88  TLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ--QLTD 144
            L E  L++ ++H+ ++ +  ++      T   +YI+ E M+   L   +++    +LT 
Sbjct: 65  -LAEANLMKQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTI 117
Query: 145 DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE- 203
           +       Q+  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + +     
Sbjct: 118 NKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTARE 177
Query: 204 --YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
                 +W  APE  +N   +T   D+WS G +L EI+T  R P +PG
Sbjct: 178 GAKFPIKW-TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 222

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 108/228 (47%), Gaps = 23/228 (10%)
Query: 29  QYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARR 87
           Q   + + +EV  + +  +  +G G +G V     N  T+  V   K G+   +      
Sbjct: 1   QKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAF---- 56
Query: 88  TLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ--QLTD 144
            L E  L++ ++H+ ++ +  ++      T   +YI+ E M+   L   +++    +LT 
Sbjct: 57  -LAEANLMKQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTI 109
Query: 145 DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE- 203
           +       Q+  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + +     
Sbjct: 110 NKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTARE 169
Query: 204 --YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
                 +W  APE  +N   +T   D+WS G +L EI+T  R P +PG
Sbjct: 170 GAKFPIKW-TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 214

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 105/220 (47%), Gaps = 33/220 (15%)
Query: 48  RPIGRGAYGIVCAA----VNSETREEVAIKKIGNAFDNII--DARRTLREIKLLRHM-EH 100
           +P+G G +G V  A    ++ +  +E     +    D+    D    + E+++++ + +H
Sbjct: 28  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 87
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS----------------DQQLT 143
           +N+I   +++    +D    +Y++ E     +L + +R+                ++Q+T
Sbjct: 88  KNII---NLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 142
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
                   YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  D+  +
Sbjct: 143 FKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKK 202
Query: 204 YVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               R    + APE L +   YT   D+WS G ++ EI T
Sbjct: 203 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 241

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 108/228 (47%), Gaps = 23/228 (10%)
Query: 29  QYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARR 87
           Q   + + +EV  + +  +  +G G +G V     N  T+  V   K G+   +      
Sbjct: 2   QKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAF---- 57
Query: 88  TLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ--QLTD 144
            L E  L++ ++H+ ++ +  ++      T   +YI+ E M+   L   +++    +LT 
Sbjct: 58  -LAEANLMKQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTI 110
Query: 145 DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE- 203
           +       Q+  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + +     
Sbjct: 111 NKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTARE 170
Query: 204 --YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
                 +W  APE  +N   +T   D+WS G +L EI+T  R P +PG
Sbjct: 171 GAKFPIKW-TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 215

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 105/220 (47%), Gaps = 33/220 (15%)
Query: 48  RPIGRGAYGIVCAA----VNSETREEVAIKKIGNAFDNII--DARRTLREIKLLRHM-EH 100
           +P+G G +G V  A    ++ +  +E     +    D+    D    + E+++++ + +H
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS----------------DQQLT 143
           +N+I   +++    +D    +Y++ E     +L + +R+                ++Q+T
Sbjct: 147 KNII---NLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
                   YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  D+  +
Sbjct: 202 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261
Query: 204 YVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               R    + APE L +   YT   D+WS G ++ EI T
Sbjct: 262 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 300

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 105/220 (47%), Gaps = 23/220 (10%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLL 95
           +EV  + +  +  +G G +G V     N  T+  V   K G+   +       L E  L+
Sbjct: 8   WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAF-----LAEANLM 62
Query: 96  RHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ--QLTDDHCQYFLY 152
           + ++H+ ++ +  ++      T   +YI+ E M+   L   +++    +LT +       
Sbjct: 63  KQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 116
Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RW 209
           Q+  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + +           +W
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 176
Query: 210 YRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
             APE  +N   +T   D+WS G +L EI+T  R P +PG
Sbjct: 177 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 213

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 106/221 (47%), Gaps = 36/221 (16%)
Query: 48  RPIGRGAYGIVCAAV-----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE- 101
           +P+GRGA+G V  A       + T   VA+K +     +  + R  + E+K+L H+ H  
Sbjct: 70  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHL 128
Query: 102 NVIAIKDIIRPPKKD--------TFNDV----------YIVYELMDTDLHQIIRSDQQLT 143
           NV+ +      P            F ++          ++ Y++   DL++       LT
Sbjct: 129 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-----LT 183
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFMT 202
            +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D++ 
Sbjct: 184 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 243
Query: 203 E---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           +    +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 244 KGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 282

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 106/221 (47%), Gaps = 36/221 (16%)
Query: 48  RPIGRGAYGIVCAAV-----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE- 101
           +P+GRGA+G V  A       + T   VA+K +     +  + R  + E+K+L H+ H  
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHL 82
Query: 102 NVIAIKDIIRPPKKD--------TFNDV----------YIVYELMDTDLHQIIRSDQQLT 143
           NV+ +      P            F ++          ++ Y++   DL++       LT
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-----LT 137
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFMT 202
            +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D++ 
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 197
Query: 203 E---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           +    +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 198 KGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 236

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 106/221 (47%), Gaps = 36/221 (16%)
Query: 48  RPIGRGAYGIVCAAV-----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE- 101
           +P+GRGA+G V  A       + T   VA+K +     +  + R  + E+K+L H+ H  
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHL 82
Query: 102 NVIAIKDIIRPPKKD--------TFNDV----------YIVYELMDTDLHQIIRSDQQLT 143
           NV+ +      P            F ++          ++ Y++   DL++       LT
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-----LT 137
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFMT 202
            +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D++ 
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 197
Query: 203 E---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           +    +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 198 KGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 236

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 108/228 (47%), Gaps = 23/228 (10%)
Query: 29  QYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARR 87
           Q   + + +EV  + +  +  +G G +G V     N  T+  V   K G+   +      
Sbjct: 6   QKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAF---- 61
Query: 88  TLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ--QLTD 144
            L E  L++ ++H+ ++ +  ++      T   +YI+ E M+   L   +++    +LT 
Sbjct: 62  -LAEANLMKQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTI 114
Query: 145 DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY 204
           +       Q+  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + +     
Sbjct: 115 NKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTARE 174
Query: 205 VVT---RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
                 +W  APE  +N   +T   D+WS G +L EI+T  R P +PG
Sbjct: 175 GAKFPIKW-TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 219

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA---- 105
           +G G YG V    + +T +  AIK +    D   +     +EI +L+   H   IA    
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYG 88
Query: 106 --IKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
             IK    PP  D  + +++V E       TDL +  + +  L ++   Y   ++LRGL 
Sbjct: 89  AFIKK--NPPGMD--DQLWLVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICREILRGLS 143
Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLN 218
           ++H   V+HRD+K  N+LL  + ++K+ DFG++     T      ++ T ++ APE++  
Sbjct: 144 HLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA- 202
Query: 219 CTE-----YTAAIDIWSVGCILGEIMTREP 243
           C E     Y    D+WS+G    E+    P
Sbjct: 203 CDENPDATYDFKSDLWSLGITAIEMAEGAP 232

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIK 93
           +E+  + +   R IG G +G V   +          VAIK   N   + +   + L+E  
Sbjct: 5   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSV-REKFLQEAL 63
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
            +R  +H +++ +  +I      T N V+I+ EL      +     ++ + D     LY 
Sbjct: 64  TMRQFDHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 117
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTR 208
            QL   L Y+ S   +HRD+   N+L++++  +K+GDFGL+R   ++ +       +  +
Sbjct: 118 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 177
Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIM 239
           W  APE  +N   +T+A D+W  G  + EI+
Sbjct: 178 WM-APE-SINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIK 93
           +E+  + +   R IG G +G V   +          VAIK   N   + +   + L+E  
Sbjct: 8   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV-REKFLQEAL 66
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
            +R  +H +++ +  +I      T N V+I+ EL      +     ++ + D     LY 
Sbjct: 67  TMRQFDHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 120
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTR 208
            QL   L Y+ S   +HRD+   N+L++++  +K+GDFGL+R   ++ +       +  +
Sbjct: 121 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 180
Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIM 239
           W  APE  +N   +T+A D+W  G  + EI+
Sbjct: 181 WM-APE-SINFRRFTSASDVWMFGVCMWEIL 209

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIK 93
           +E+  + +   R IG G +G V   +          VAIK   N   + +   + L+E  
Sbjct: 33  YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR-EKFLQEAL 91
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
            +R  +H +++ +  +I      T N V+I+ EL      +     ++ + D     LY 
Sbjct: 92  TMRQFDHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 145
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTR 208
            QL   L Y+ S   +HRD+   N+L++++  +K+GDFGL+R   ++ +       +  +
Sbjct: 146 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 205
Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIM 239
           W  APE  +N   +T+A D+W  G  + EI+
Sbjct: 206 WM-APE-SINFRRFTSASDVWMFGVCMWEIL 234

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIK 93
           +E+  + +   R IG G +G V   +          VAIK   N   + +   + L+E  
Sbjct: 2   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV-REKFLQEAL 60
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
            +R  +H +++ +  +I      T N V+I+ EL      +     ++ + D     LY 
Sbjct: 61  TMRQFDHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 114
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTR 208
            QL   L Y+ S   +HRD+   N+L++++  +K+GDFGL+R   ++ +       +  +
Sbjct: 115 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 174
Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIM 239
           W  APE  +N   +T+A D+W  G  + EI+
Sbjct: 175 WM-APE-SINFRRFTSASDVWMFGVCMWEIL 203

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 101/218 (46%), Gaps = 31/218 (14%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHM-EHEN 102
           + +G GA+G V  A      +E A+ K+      +  +  +    + E+K++ H+ +HEN
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIR----------------SDQQLTDDH 146
           ++ +               Y  Y     DL   +R                 ++QL+   
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCY----GDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRD 167
Query: 147 CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTE-- 203
             +F  Q+ +G+ ++ S + +HRD+   N+LL      KIGDFGLAR   ++++++ +  
Sbjct: 168 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 227
Query: 204 -YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             +  +W  APE + +C  YT   D+WS G +L EI +
Sbjct: 228 ARLPVKW-MAPESIFDCV-YTVQSDVWSYGILLWEIFS 263

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 104/219 (47%), Gaps = 31/219 (14%)
Query: 48  RPIGRGAYGIVCAA----VNSETREEVAIKKIGNAFDNII--DARRTLREIKLLRHM-EH 100
           +P+G GA+G V  A    ++ +  +E     +    D+    D    + E+++++ + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS----------------DQQLTD 144
           +N+I   +++    +D    V + Y     +L + +R+                ++Q+T 
Sbjct: 101 KNII---NLLGACTQDGPLYVIVGYA-SKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 145 DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY 204
                  YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  D+  + 
Sbjct: 157 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 205 VVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
              R    + APE L +   YT   D+WS G ++ EI T
Sbjct: 217 TNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 254

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 33/218 (15%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHM-EHEN 102
           + +G GA+G V  A      +E A+ K+      +  +  +    + E+K++ H+ +HEN
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 103 VIAIKDIIRPPKK-----------DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           ++ +                    D  N +     +++TD    I +    T D   +F 
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD-LLHFS 170
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM--TEYVV--- 206
            Q+ +G+ ++ S + +HRD+   N+LL      KIGDFGLAR     D M  + Y+V   
Sbjct: 171 SQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNYIVKGN 225
Query: 207 ----TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                +W  APE + +C  YT   D+WS G +L EI +
Sbjct: 226 ARLPVKWM-APESIFDCV-YTVQSDVWSYGILLWEIFS 261

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIK 93
           +E+  + +   R IG G +G V   +          VAIK   N   + +   + L+E  
Sbjct: 5   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV-REKFLQEAL 63
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
            +R  +H +++ +  +I      T N V+I+ EL      +     ++ + D     LY 
Sbjct: 64  TMRQFDHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 117
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTR 208
            QL   L Y+ S   +HRD+   N+L++++  +K+GDFGL+R   ++ +       +  +
Sbjct: 118 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 177
Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIM 239
           W  APE  +N   +T+A D+W  G  + EI+
Sbjct: 178 WM-APE-SINFRRFTSASDVWMFGVCMWEIL 206

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIK 93
           +E+  + +   R IG G +G V   +          VAIK   N   + +   + L+E  
Sbjct: 10  YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR-EKFLQEAL 68
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
            +R  +H +++ +  +I      T N V+I+ EL      +     ++ + D     LY 
Sbjct: 69  TMRQFDHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 122
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTR 208
            QL   L Y+ S   +HRD+   N+L++++  +K+GDFGL+R   ++ +       +  +
Sbjct: 123 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 182
Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIM 239
           W  APE  +N   +T+A D+W  G  + EI+
Sbjct: 183 WM-APE-SINFRRFTSASDVWMFGVCMWEIL 211

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 106/221 (47%), Gaps = 36/221 (16%)
Query: 48  RPIGRGAYGIVCAAV-----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE- 101
           +P+GRGA+G V  A       + T   VA+K +     +  + R  + E+K+L H+ H  
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHL 91
Query: 102 NVIAIKDIIRPPKKD--------TFNDV----------YIVYELMDTDLHQIIRSDQQLT 143
           NV+ +      P            F ++          ++ Y++   DL++       LT
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-----LT 146
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFMT 202
            +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D++ 
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 206
Query: 203 E---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           +    +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 207 KGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 245

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIK 93
           +E+  + +   R IG G +G V   +          VAIK   N   + +   + L+E  
Sbjct: 7   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR-EKFLQEAL 65
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
            +R  +H +++ +  +I      T N V+I+ EL      +     ++ + D     LY 
Sbjct: 66  TMRQFDHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 119
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTR 208
            QL   L Y+ S   +HRD+   N+L++++  +K+GDFGL+R   ++ +       +  +
Sbjct: 120 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 179
Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIM 239
           W  APE  +N   +T+A D+W  G  + EI+
Sbjct: 180 WM-APE-SINFRRFTSASDVWMFGVCMWEIL 208

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 50  IGRGAYGIVCAA-VNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAI 106
           +G G +G+V    VN+ T   VA+KK+    D   +  +    +EIK++   +HEN++ +
Sbjct: 39  MGEGGFGVVYKGYVNNTT---VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT----DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
                       +D+ +VY  M      D    +     L+             G+ ++H
Sbjct: 96  LGF-----SSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH 150
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAPELLLNC 219
               +HRD+K +N+LL+ +   KI DFGLAR +   ++T      V T  Y APE L   
Sbjct: 151 ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALRG- 209
Query: 220 TEYTAAIDIWSVGCILGEIMTREP 243
            E T   DI+S G +L EI+T  P
Sbjct: 210 -EITPKSDIYSFGVVLLEIITGLP 232

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 92/211 (43%), Gaps = 21/211 (9%)
Query: 42  KYVPPIRPIGRGAYGIVCA----AVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLR 96
           +Y+  IR +G G +G V        N  T E VA+K +    D     R   + EI +LR
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKA--DAGPQHRSGWKQEIDILR 88
Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 156
            + HE++I  K         +     +V E +     +       +       F  Q+  
Sbjct: 89  TLYHEHIIKYKGCCEDAGAASLQ---LVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICE 145
Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR-------W 209
           G+ Y+H+   +HRDL   N+LL+    +KIGDFGLA+   E      Y V         W
Sbjct: 146 GMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH--EXYRVREDGDSPVFW 203
Query: 210 YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           Y APE L     Y A+ D+WS G  L E++T
Sbjct: 204 Y-APECLKEYKFYYAS-DVWSFGVTLYELLT 232

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 33/218 (15%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHM-EHEN 102
           + +G GA+G V  A      +E A+ K+      +  +  +    + E+K++ H+ +HEN
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 103 VIAIKDIIRPPKK-----------DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFL 151
           ++ +                    D  N +     +++TD    I ++  L+     +F 
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAI-ANSTLSTRDLLHFS 170
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM--TEYVV--- 206
            Q+ +G+ ++ S + +HRD+   N+LL      KIGDFGLAR     D M  + Y+V   
Sbjct: 171 SQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNYIVKGN 225
Query: 207 ----TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                +W  APE + +C  YT   D+WS G +L EI +
Sbjct: 226 ARLPVKWM-APESIFDCV-YTVQSDVWSYGILLWEIFS 261

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 99/211 (46%), Gaps = 17/211 (8%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIK 93
           +E+  + +   R IG G +G V   +          VAIK   N   + +   + L+E  
Sbjct: 5   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSV-REKFLQEAL 63
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY- 152
            +R  +H +++ +  +I      T N V+I+ EL      +     ++ + D     LY 
Sbjct: 64  TMRQFDHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYA 117
Query: 153 -QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTR 208
            QL   L Y+ S   +HRD+   N+L++++  +K+GDFGL+R   ++         +  +
Sbjct: 118 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIK 177
Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIM 239
           W  APE  +N   +T+A D+W  G  + EI+
Sbjct: 178 WM-APE-SINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 112/231 (48%), Gaps = 16/231 (6%)
Query: 34  GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR----RTL 89
           G +  V+      ++ +G+G +G V       T    A+K +      +I A+     TL
Sbjct: 1   GAMARVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKK---EVIVAKDEVAHTL 57
Query: 90  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQ 148
            E ++L++  H  + A+K   +     T + +  V E  +  +L   +  ++  ++D  +
Sbjct: 58  TENRVLQNSRHPFLTALKYSFQ-----THDRLCFVMEYANGGELFFHLSRERVFSEDRAR 112
Query: 149 YFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVV 206
           ++  +++  L Y+HS  +V++RDLK  NL+L+    +KI DFGL +    +   M  +  
Sbjct: 113 FYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCG 172
Query: 207 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           T  Y APE+L +  +Y  A+D W +G ++ E+M     F  +D+     LI
Sbjct: 173 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 222

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 108/218 (49%), Gaps = 16/218 (7%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR----RTLREIKLLRHMEHEN 102
           ++ +G+G +G V       T    A+K +      +I A+     TL E ++L++  H  
Sbjct: 13  LKLLGKGTFGKVILVKEKATGRYYAMKILKK---EVIVAKDEVAHTLTENRVLQNSRHPF 69
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           + A+K   +     T + +  V E  +  +L   +  ++  ++D  +++  +++  L Y+
Sbjct: 70  LTALKYSFQ-----THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 124
Query: 162 HS-ASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNC 219
           HS  +V++RDLK  NL+L+    +KI DFGL +    +   M  +  T  Y APE+L + 
Sbjct: 125 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLED- 183
Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
            +Y  A+D W +G ++ E+M     F  +D+     LI
Sbjct: 184 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 221

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 108/218 (49%), Gaps = 16/218 (7%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR----RTLREIKLLRHMEHEN 102
           ++ +G+G +G V       T    A+K +      +I A+     TL E ++L++  H  
Sbjct: 15  LKLLGKGTFGKVILVKEKATGRYYAMKILKK---EVIVAKDEVAHTLTENRVLQNSRHPF 71
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           + A+K   +     T + +  V E  +  +L   +  ++  ++D  +++  +++  L Y+
Sbjct: 72  LTALKYSFQ-----THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 126
Query: 162 HS-ASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNC 219
           HS  +V++RDLK  NL+L+    +KI DFGL +    +   M  +  T  Y APE+L + 
Sbjct: 127 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLED- 185
Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
            +Y  A+D W +G ++ E+M     F  +D+     LI
Sbjct: 186 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 223

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/122 (31%), Positives = 69/122 (56%), Gaps = 4/122 (3%)
Query: 119 NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 176
            ++ I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KPSN+
Sbjct: 80  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 139
Query: 177 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 236
           L+N+  ++K+ DFG++    + +   E+V TR Y +PE  L  T Y+   DIWS+G  L 
Sbjct: 140 LVNSRGEIKLCDFGVSGQLID-EMANEFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 197
Query: 237 EI 238
           E+
Sbjct: 198 EM 199

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 100/200 (50%), Gaps = 17/200 (8%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIK-------KIGNAFDNIIDARRTLREIKLLRHMEH 100
           R IGRG +G V     ++T +  A+K       K+       ++ R  L    L+   + 
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML---SLVSTGDC 251
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
             ++ +      P K +F     + +LM+  DLH  +      ++   +++  +++ GL+
Sbjct: 252 PFIVCMSYAFHTPDKLSF-----ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 306
Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 219
           ++H+  V++RDLKP+N+LL+    ++I D GLA   S+       V T  Y APE+L   
Sbjct: 307 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKG 365
Query: 220 TEYTAAIDIWSVGCILGEIM 239
             Y ++ D +S+GC+L +++
Sbjct: 366 VAYDSSADWFSLGCMLFKLL 385

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 100/200 (50%), Gaps = 17/200 (8%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIK-------KIGNAFDNIIDARRTLREIKLLRHMEH 100
           R IGRG +G V     ++T +  A+K       K+       ++ R  L    L+   + 
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML---SLVSTGDC 251
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
             ++ +      P K +F     + +LM+  DLH  +      ++   +++  +++ GL+
Sbjct: 252 PFIVCMSYAFHTPDKLSF-----ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 306
Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 219
           ++H+  V++RDLKP+N+LL+    ++I D GLA   S+       V T  Y APE+L   
Sbjct: 307 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKG 365
Query: 220 TEYTAAIDIWSVGCILGEIM 239
             Y ++ D +S+GC+L +++
Sbjct: 366 VAYDSSADWFSLGCMLFKLL 385

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 100/200 (50%), Gaps = 17/200 (8%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIK-------KIGNAFDNIIDARRTLREIKLLRHMEH 100
           R IGRG +G V     ++T +  A+K       K+       ++ R  L    L+   + 
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML---SLVSTGDC 251
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
             ++ +      P K +F     + +LM+  DLH  +      ++   +++  +++ GL+
Sbjct: 252 PFIVCMSYAFHTPDKLSF-----ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 306
Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 219
           ++H+  V++RDLKP+N+LL+    ++I D GLA   S+       V T  Y APE+L   
Sbjct: 307 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKG 365
Query: 220 TEYTAAIDIWSVGCILGEIM 239
             Y ++ D +S+GC+L +++
Sbjct: 366 VAYDSSADWFSLGCMLFKLL 385

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 73/131 (55%), Gaps = 5/131 (3%)
Query: 119 NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 176
            ++ I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KPSN+
Sbjct: 139 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 198
Query: 177 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 236
           L+N+  ++K+ DFG++    ++     +V TR Y +PE  L  T Y+   DIWS+G  L 
Sbjct: 199 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 256
Query: 237 EI-MTREPLFP 246
           E+ + R P+ P
Sbjct: 257 EMAVGRYPIPP 267

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 30/217 (13%)
Query: 48  RPIGRGAYGIVCAAV-----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE- 101
           +P+GRGA+G V  A       + T   VA+K +     +  + R  + E+K+L H+ H  
Sbjct: 35  KPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHL 93
Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ--------------LTDDH 146
           NV+ +      P       + ++ E     +L   +RS +               LT +H
Sbjct: 94  NVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEH 149
Query: 147 CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV 206
              + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR   +         
Sbjct: 150 LIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 207 TRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
            R    + APE + +   YT   D+WS G +L EI +
Sbjct: 210 ARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 245

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 100/200 (50%), Gaps = 17/200 (8%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIK-------KIGNAFDNIIDARRTLREIKLLRHMEH 100
           R IGRG +G V     ++T +  A+K       K+       ++ R  L    L+   + 
Sbjct: 194 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML---SLVSTGDC 250
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
             ++ +      P K +F     + +LM+  DLH  +      ++   +++  +++ GL+
Sbjct: 251 PFIVCMSYAFHTPDKLSF-----ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 305
Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 219
           ++H+  V++RDLKP+N+LL+    ++I D GLA   S+       V T  Y APE+L   
Sbjct: 306 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKG 364
Query: 220 TEYTAAIDIWSVGCILGEIM 239
             Y ++ D +S+GC+L +++
Sbjct: 365 VAYDSSADWFSLGCMLFKLL 384

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 73/131 (55%), Gaps = 5/131 (3%)
Query: 119 NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 176
            ++ I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KPSN+
Sbjct: 104 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 163
Query: 177 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 236
           L+N+  ++K+ DFG++    ++     +V TR Y +PE  L  T Y+   DIWS+G  L 
Sbjct: 164 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 221
Query: 237 EI-MTREPLFP 246
           E+ + R P+ P
Sbjct: 222 EMAVGRYPIPP 232

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 106/224 (47%), Gaps = 23/224 (10%)
Query: 33  YGNLFEVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLRE 91
           + + +EV  + +  +  +G G  G V     N  T+  V   K G+   +       L E
Sbjct: 4   WEDAWEVPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDAF-----LAE 58
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ--QLTDDHCQ 148
             L++ ++H+ ++ +  ++      T   +YI+ E M+   L   +++    +LT +   
Sbjct: 59  ANLMKQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLL 112
Query: 149 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT- 207
               Q+  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + +         
Sbjct: 113 DMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKF 172
Query: 208 --RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
             +W  APE  +N   +T   D+WS G +L EI+T  R P +PG
Sbjct: 173 PIKW-TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 213

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 30/204 (14%)
Query: 50  IGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G +G V     N  TR  VAIK +       +     L+E ++++ + HE ++ +  
Sbjct: 23  LGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 77
Query: 109 IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKY 160
           ++      +   +YIV E M+   L   ++ +        QL D   Q     +  G+ Y
Sbjct: 78  VV------SEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQ-----IASGMAY 126
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLL 217
           V   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L
Sbjct: 127 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL 185
Query: 218 NCTEYTAAIDIWSVGCILGEIMTR 241
               +T   D+WS G +L E+ T+
Sbjct: 186 Y-GRFTIKSDVWSFGILLTELTTK 208

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 89/199 (44%), Gaps = 4/199 (2%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR-TLREIKLLRHMEHENVIAI 106
           R +G+G +G VCA     T +  A KK+              L E ++L  +    V+++
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
                   KD    V  +    D   H          +    ++  ++  GL+ +H   +
Sbjct: 250 AYAYE--TKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERI 307
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 226
           ++RDLKP N+LL+    ++I D GLA    E   +   V T  Y APE++ N   YT + 
Sbjct: 308 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN-ERYTFSP 366
Query: 227 DIWSVGCILGEIMTREPLF 245
           D W++GC+L E++  +  F
Sbjct: 367 DWWALGCLLYEMIAGQSPF 385

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 105/224 (46%), Gaps = 28/224 (12%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAA-----VNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           +EVS + +  +R +G+G++G+V        +  E    VA+K + N   ++ +    L E
Sbjct: 12  WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV-NESASLRERIEFLNE 70
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQ-- 148
             +++     +V+ +  ++   +        +V ELM   DL   +RS +   +++    
Sbjct: 71  ASVMKGFTCHHVVRLLGVVSKGQP-----TLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 149 --------YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 200
                       ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY 185
Query: 201 MTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             +     +  RW  APE L +   +T + D+WS G +L EI +
Sbjct: 186 YRKGGKGLLPVRWM-APESLKDGV-FTTSSDMWSFGVVLWEITS 227

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 31/211 (14%)
Query: 50  IGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G +G V     N  TR  +   K GN     +     L+E ++++ + HE ++ +  
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGN-----MSPEAFLQEAQVMKKLRHEKLVQLYA 247
Query: 109 IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKY 160
           ++      +   +YIV E M    L   ++ +        QL D        Q+  G+ Y
Sbjct: 248 VV------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD-----MAAQIASGMAY 296
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLL 217
           V   + +HRDL+ +N+L+  +   K+ DFGL R   + ++          +W  APE  L
Sbjct: 297 VERMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKW-TAPEAAL 355
Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPL-FPG 247
               +T   D+WS G +L E+ T+  + +PG
Sbjct: 356 Y-GRFTIKSDVWSFGILLTELTTKGRVPYPG 385

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 101/220 (45%), Gaps = 34/220 (15%)
Query: 48  RPIGRGAYGIVCAAV-----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE- 101
           +P+GRGA+G V  A       + T   VA+K +     +  + R  + E+K+L H+ H  
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHL 82
Query: 102 NVIAIKDIIRPPKKD--------TFNDV----------YIVYELMDTDLHQIIRSDQQLT 143
           NV+ +      P            F ++          ++ Y++   DL++       LT
Sbjct: 83  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-----LT 137
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
            +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR   +      
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 197
Query: 204 YVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               R    + APE + +   YT   D+WS G +L EI +
Sbjct: 198 KGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 236

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 73/131 (55%), Gaps = 5/131 (3%)
Query: 119 NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 176
            ++ I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KPSN+
Sbjct: 77  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 136
Query: 177 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 236
           L+N+  ++K+ DFG++    ++     +V TR Y +PE  L  T Y+   DIWS+G  L 
Sbjct: 137 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 194
Query: 237 EI-MTREPLFP 246
           E+ + R P+ P
Sbjct: 195 EMAVGRYPIPP 205

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 30/204 (14%)
Query: 50  IGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G +G V     N  TR  VAIK +       +     L+E ++++ + HE ++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 109 IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKY 160
           ++      +   +YIV E M    L   ++ +        QL D        Q+  G+ Y
Sbjct: 81  VV------SEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVD-----MAAQIASGMAY 129
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLL 217
           V   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L
Sbjct: 130 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL 188
Query: 218 NCTEYTAAIDIWSVGCILGEIMTR 241
               +T   D+WS G +L E+ T+
Sbjct: 189 Y-GRFTIKSDVWSFGILLTELTTK 211

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 101/220 (45%), Gaps = 34/220 (15%)
Query: 48  RPIGRGAYGIVCAAV-----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE- 101
           +P+GRGA+G V  A       + T   VA+K +     +  + R  + E+K+L H+ H  
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHL 82
Query: 102 NVIAIKDIIRPPKKD--------TFNDV----------YIVYELMDTDLHQIIRSDQQLT 143
           NV+ +      P            F ++          ++ Y++   DL++       LT
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-----LT 137
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
            +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR   +      
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 197
Query: 204 YVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               R    + APE + +   YT   D+WS G +L EI +
Sbjct: 198 KGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 236

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 89/199 (44%), Gaps = 4/199 (2%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR-TLREIKLLRHMEHENVIAI 106
           R +G+G +G VCA     T +  A KK+              L E ++L  +    V+++
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
                   KD    V  +    D   H          +    ++  ++  GL+ +H   +
Sbjct: 250 AYAYE--TKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERI 307
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 226
           ++RDLKP N+LL+    ++I D GLA    E   +   V T  Y APE++ N   YT + 
Sbjct: 308 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN-ERYTFSP 366
Query: 227 DIWSVGCILGEIMTREPLF 245
           D W++GC+L E++  +  F
Sbjct: 367 DWWALGCLLYEMIAGQSPF 385

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 119/257 (46%), Gaps = 30/257 (11%)
Query: 25  GKYVQYNVY-GNLFEVSSKYVPPIRPIGRGAYGIVC-----AAVNSETREEVAIKKIGNA 78
           G +   +VY  + +EV+ + +   R +G+G++G+V        V  E    VAIK +  A
Sbjct: 1   GSFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA 60
Query: 79  FDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIR 137
             ++ +    L E  +++     +V+ +  ++   +        ++ ELM   DL   +R
Sbjct: 61  -ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLR 114
Query: 138 SDQQLTDDH---CQYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCDLKIG 187
           S +   +++       L ++++       G+ Y+++   +HRDL   N ++     +KIG
Sbjct: 115 SLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 174
Query: 188 DFGLARTTSETDFMTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-RE 242
           DFG+ R   ETD+  +     +  RW  +PE L +   +T   D+WS G +L EI T  E
Sbjct: 175 DFGMTRDIYETDYYRKGGKGLLPVRWM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAE 232
Query: 243 PLFPGKDYVHQLRLITE 259
             + G      LR + E
Sbjct: 233 QPYQGLSNEQVLRFVME 249

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 30/204 (14%)
Query: 50  IGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G +G V     N  TR  VAIK +       +     L+E ++++ + HE ++ +  
Sbjct: 15  LGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 69
Query: 109 IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKY 160
           ++      +   +YIV E M    L   ++ +        QL D        Q+  G+ Y
Sbjct: 70  VV------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD-----MAAQIASGMAY 118
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLL 217
           V   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L
Sbjct: 119 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL 177
Query: 218 NCTEYTAAIDIWSVGCILGEIMTR 241
               +T   D+WS G +L E+ T+
Sbjct: 178 Y-GRFTIKSDVWSFGILLTELTTK 200

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHM-EHEN 102
           + +G GA+G V  A      +E A+ K+      +  +  +    + E+K++ H+ +HEN
Sbjct: 44  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 103
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDH------CQYFLYQLLR 156
           ++ +               Y  Y  +   L +   +D    D          +F  Q+ +
Sbjct: 104 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQ 163
Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTE---YVVTRWYRA 212
           G+ ++ S + +HRD+   N+LL      KIGDFGLAR   ++++++ +    +  +W  A
Sbjct: 164 GMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWM-A 222
Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMT 240
           PE + +C  YT   D+WS G +L EI +
Sbjct: 223 PESIFDCV-YTVQSDVWSYGILLWEIFS 249

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 105/221 (47%), Gaps = 36/221 (16%)
Query: 48  RPIGRGAYGIVCAAV-----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE- 101
           +P+GRGA+G V  A       + T   VA+K +     +  + R  + E+K+L H+ H  
Sbjct: 35  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHL 93
Query: 102 NVIAIKDIIRPPKKD--------TFNDV----------YIVYELMDTDLHQIIRSDQQLT 143
           NV+ +      P            F ++          ++ Y+    DL++       LT
Sbjct: 94  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDF-----LT 148
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFMT 202
            +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D++ 
Sbjct: 149 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 208
Query: 203 E---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           +    +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 209 KGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 247

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 55/105 (52%), Gaps = 4/105 (3%)
Query: 139 DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 198
           ++QL+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     
Sbjct: 137 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 196
Query: 199 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           D+  +    R    + APE L +   YT   D+WS G +L EI T
Sbjct: 197 DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFT 240

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 30/204 (14%)
Query: 50  IGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G +G V     N  TR  VAIK +       +     L+E ++++ + HE ++ +  
Sbjct: 17  LGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 71
Query: 109 IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKY 160
           ++      +   +YIV E M    L   ++ +        QL D        Q+  G+ Y
Sbjct: 72  VV------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD-----MAAQIASGMAY 120
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLL 217
           V   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L
Sbjct: 121 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL 179
Query: 218 NCTEYTAAIDIWSVGCILGEIMTR 241
               +T   D+WS G +L E+ T+
Sbjct: 180 Y-GRFTIKSDVWSFGILLTELTTK 202

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 101/220 (45%), Gaps = 34/220 (15%)
Query: 48  RPIGRGAYGIVCAAV-----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE- 101
           +P+GRGA+G V  A       + T   VA+K +     +  + R  + E+K+L H+ H  
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHL 91
Query: 102 NVIAIKDIIRPPKKD--------TFNDV----------YIVYELMDTDLHQIIRSDQQLT 143
           NV+ +      P            F ++          ++ Y++   DL++       LT
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-----LT 146
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
            +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR   +      
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 206
Query: 204 YVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               R    + APE + +   YT   D+WS G +L EI +
Sbjct: 207 KGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 245

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 73/131 (55%), Gaps = 5/131 (3%)
Query: 119 NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 176
            ++ I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KPSN+
Sbjct: 77  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 136
Query: 177 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 236
           L+N+  ++K+ DFG++    ++     +V TR Y +PE  L  T Y+   DIWS+G  L 
Sbjct: 137 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 194
Query: 237 EI-MTREPLFP 246
           E+ + R P+ P
Sbjct: 195 EMAVGRYPIPP 205

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHM-EHEN 102
           + +G GA+G V  A      +E A+ K+      +  +  +    + E+K++ H+ +HEN
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDH------CQYFLYQLLR 156
           ++ +               Y  Y  +   L +   +D    D          +F  Q+ +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQ 171
Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTE---YVVTRWYRA 212
           G+ ++ S + +HRD+   N+LL      KIGDFGLAR   ++++++ +    +  +W  A
Sbjct: 172 GMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWM-A 230
Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMT 240
           PE + +C  YT   D+WS G +L EI +
Sbjct: 231 PESIFDCV-YTVQSDVWSYGILLWEIFS 257

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 104/223 (46%), Gaps = 28/223 (12%)
Query: 38  EVSSKYVPPIRPIGRGAYGIVCAA-----VNSETREEVAIKKIGNAFDNIIDARRTLREI 92
           EVS + +  +R +G+G++G+V        +  E    VA+K + N   ++ +    L E 
Sbjct: 12  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV-NESASLRERIEFLNEA 70
Query: 93  KLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQ--- 148
            +++     +V+ +  ++   +        +V ELM   DL   +RS +   +++     
Sbjct: 71  SVMKGFTCHHVVRLLGVVSKGQP-----TLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 125
Query: 149 -------YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM 201
                      ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+ 
Sbjct: 126 PTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY 185
Query: 202 TE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
            +     +  RW  APE L +   +T + D+WS G +L EI +
Sbjct: 186 RKGGKGLLPVRWM-APESLKDGV-FTTSSDMWSFGVVLWEITS 226

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 30/204 (14%)
Query: 50  IGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G +G V     N  TR  VAIK +       +     L+E ++++ + HE ++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 109 IIRPPKKDTFNDVYIVYELMDTD-LHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKY 160
           ++      +   +YIV E M    L   ++ +        QL D        Q+  G+ Y
Sbjct: 81  VV------SEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVD-----MAAQIASGMAY 129
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLL 217
           V   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L
Sbjct: 130 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL 188
Query: 218 NCTEYTAAIDIWSVGCILGEIMTR 241
               +T   D+WS G +L E+ T+
Sbjct: 189 Y-GRFTIKSDVWSFGILLTELTTK 211

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 73/131 (55%), Gaps = 5/131 (3%)
Query: 119 NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 176
            ++ I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KPSN+
Sbjct: 77  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 136
Query: 177 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 236
           L+N+  ++K+ DFG++    ++     +V TR Y +PE  L  T Y+   DIWS+G  L 
Sbjct: 137 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 194
Query: 237 EI-MTREPLFP 246
           E+ + R P+ P
Sbjct: 195 EMAVGRYPIPP 205

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 30/204 (14%)
Query: 50  IGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G +G V     N  TR  VAIK +       +     L+E ++++ + HE ++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 109 IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKY 160
           ++      +   +YIV E M    L   ++ +        QL D        Q+  G+ Y
Sbjct: 81  VV------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD-----MAAQIASGMAY 129
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLL 217
           V   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L
Sbjct: 130 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL 188
Query: 218 NCTEYTAAIDIWSVGCILGEIMTR 241
               +T   D+WS G +L E+ T+
Sbjct: 189 Y-GRFTIKSDVWSFGILLTELTTK 211

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 30/204 (14%)
Query: 50  IGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G +G V     N  TR  VAIK +       +     L+E ++++ + HE ++ +  
Sbjct: 23  LGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 77
Query: 109 IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKY 160
           ++      +   +YIV E M+   L   ++ +        QL D   Q     +  G+ Y
Sbjct: 78  VV------SEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQ-----IASGMAY 126
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLL 217
           V   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L
Sbjct: 127 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKW-TAPEAAL 185
Query: 218 NCTEYTAAIDIWSVGCILGEIMTR 241
               +T   D+WS G +L E+ T+
Sbjct: 186 Y-GRFTIKSDVWSFGILLTELTTK 208

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 73/131 (55%), Gaps = 5/131 (3%)
Query: 119 NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 176
            ++ I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KPSN+
Sbjct: 77  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 136
Query: 177 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 236
           L+N+  ++K+ DFG++    ++     +V TR Y +PE  L  T Y+   DIWS+G  L 
Sbjct: 137 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 194
Query: 237 EI-MTREPLFP 246
           E+ + R P+ P
Sbjct: 195 EMAVGRYPIPP 205

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 73/131 (55%), Gaps = 5/131 (3%)
Query: 119 NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 176
            ++ I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KPSN+
Sbjct: 77  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 136
Query: 177 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 236
           L+N+  ++K+ DFG++    ++     +V TR Y +PE  L  T Y+   DIWS+G  L 
Sbjct: 137 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 194
Query: 237 EI-MTREPLFP 246
           E+ + R P+ P
Sbjct: 195 EMAVGRYPIPP 205

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 55/105 (52%), Gaps = 4/105 (3%)
Query: 139 DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 198
           ++QL+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     
Sbjct: 144 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 203
Query: 199 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           D+  +    R    + APE L +   YT   D+WS G +L EI T
Sbjct: 204 DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFT 247

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 30/204 (14%)
Query: 50  IGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G +G V     N  TR  VAIK +       +     L+E ++++ + HE ++ +  
Sbjct: 19  LGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 73
Query: 109 IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKY 160
           ++      +   +YIV E M    L   ++ +        QL D        Q+  G+ Y
Sbjct: 74  VV------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD-----MAAQIASGMAY 122
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLL 217
           V   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L
Sbjct: 123 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL 181
Query: 218 NCTEYTAAIDIWSVGCILGEIMTR 241
               +T   D+WS G +L E+ T+
Sbjct: 182 Y-GRFTIKSDVWSFGILLTELTTK 204

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 108/218 (49%), Gaps = 16/218 (7%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR----RTLREIKLLRHMEHEN 102
           ++ +G+G +G V       T    A+K +      +I A+     TL E ++L++  H  
Sbjct: 156 LKLLGKGTFGKVILVKEKATGRYYAMKILKK---EVIVAKDEVAHTLTENRVLQNSRHPF 212
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           + A+K   +     T + +  V E  +  +L   +  ++  ++D  +++  +++  L Y+
Sbjct: 213 LTALKYSFQ-----THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 267
Query: 162 HS-ASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNC 219
           HS  +V++RDLK  NL+L+    +KI DFGL +    +   M  +  T  Y APE+L + 
Sbjct: 268 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED- 326
Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
            +Y  A+D W +G ++ E+M     F  +D+     LI
Sbjct: 327 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 364

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 31/211 (14%)
Query: 50  IGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G +G V     N  TR  VAIK +       +     L+E ++++ + HE ++ +  
Sbjct: 192 LGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 109 IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKY 160
           ++      +   +YIV E M    L   ++ +        QL D        Q+  G+ Y
Sbjct: 247 VV------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD-----MAAQIASGMAY 295
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLL 217
           V   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L
Sbjct: 296 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL 354
Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPL-FPG 247
               +T   D+WS G +L E+ T+  + +PG
Sbjct: 355 Y-GRFTIKSDVWSFGILLTELTTKGRVPYPG 384

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 55/105 (52%), Gaps = 4/105 (3%)
Query: 139 DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 198
           ++QL+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     
Sbjct: 136 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 195
Query: 199 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           D+  +    R    + APE L +   YT   D+WS G +L EI T
Sbjct: 196 DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFT 239

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 108/218 (49%), Gaps = 16/218 (7%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR----RTLREIKLLRHMEHEN 102
           ++ +G+G +G V       T    A+K +      +I A+     TL E ++L++  H  
Sbjct: 153 LKLLGKGTFGKVILVKEKATGRYYAMKILKK---EVIVAKDEVAHTLTENRVLQNSRHPF 209
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           + A+K   +     T + +  V E  +  +L   +  ++  ++D  +++  +++  L Y+
Sbjct: 210 LTALKYSFQ-----THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 264
Query: 162 HS-ASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNC 219
           HS  +V++RDLK  NL+L+    +KI DFGL +    +   M  +  T  Y APE+L + 
Sbjct: 265 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED- 323
Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
            +Y  A+D W +G ++ E+M     F  +D+     LI
Sbjct: 324 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 361

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 30/204 (14%)
Query: 50  IGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G +G V     N  TR  VAIK +       +     L+E ++++ + HE ++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 109 IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKY 160
           ++      +   +YIV E M    L   ++ +        QL D        Q+  G+ Y
Sbjct: 81  VV------SEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVD-----MAAQIASGMAY 129
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLL 217
           V   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L
Sbjct: 130 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL 188
Query: 218 NCTEYTAAIDIWSVGCILGEIMTR 241
               +T   D+WS G +L E+ T+
Sbjct: 189 Y-GRFTIKSDVWSFGILLTELTTK 211

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 55/105 (52%), Gaps = 4/105 (3%)
Query: 139 DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 198
           ++QL+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     
Sbjct: 144 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 203
Query: 199 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           D+  +    R    + APE L +   YT   D+WS G +L EI T
Sbjct: 204 DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFT 247

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 55/105 (52%), Gaps = 4/105 (3%)
Query: 139 DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 198
           ++QL+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     
Sbjct: 133 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 192
Query: 199 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           D+  +    R    + APE L +   YT   D+WS G +L EI T
Sbjct: 193 DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFT 236

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 104/224 (46%), Gaps = 28/224 (12%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAA-----VNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           +EVS + +  +R +G+G++G+V        +  E    VA+K + N   ++ +    L E
Sbjct: 12  WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV-NESASLRERIEFLNE 70
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQ-- 148
             +++     +V+ +  ++   +        +V ELM   DL   +RS +   +++    
Sbjct: 71  ASVMKGFTCHHVVRLLGVVSKGQP-----TLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 149 --------YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 200
                       ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD 
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDX 185
Query: 201 MTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             +     +  RW  APE L +   +T + D+WS G +L EI +
Sbjct: 186 XRKGGKGLLPVRWM-APESLKDGV-FTTSSDMWSFGVVLWEITS 227

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 31/211 (14%)
Query: 50  IGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G +G V     N  TR  VAIK +       +     L+E ++++ + HE ++ +  
Sbjct: 192 LGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 109 IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKY 160
           ++      +   +YIV E M    L   ++ +        QL D        Q+  G+ Y
Sbjct: 247 VV------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD-----MAAQIASGMAY 295
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLL 217
           V   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L
Sbjct: 296 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL 354
Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPL-FPG 247
               +T   D+WS G +L E+ T+  + +PG
Sbjct: 355 Y-GRFTIKSDVWSFGILLTELTTKGRVPYPG 384

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 30/204 (14%)
Query: 50  IGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G +G V     N  TR  VAIK +       +     L+E ++++ + HE ++ +  
Sbjct: 275 LGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 329
Query: 109 IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKY 160
           ++      +   +YIV E M    L   ++ +        QL D        Q+  G+ Y
Sbjct: 330 VV------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD-----MAAQIASGMAY 378
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLL 217
           V   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L
Sbjct: 379 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL 437
Query: 218 NCTEYTAAIDIWSVGCILGEIMTR 241
               +T   D+WS G +L E+ T+
Sbjct: 438 -YGRFTIKSDVWSFGILLTELTTK 460

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 76/142 (53%), Gaps = 5/142 (3%)
Query: 119 NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 176
            ++ I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KPSN+
Sbjct: 96  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 155
Query: 177 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 236
           L+N+  ++K+ DFG++    ++     +V TR Y +PE  L  T Y+   DIWS+G  L 
Sbjct: 156 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 213
Query: 237 EI-MTREPLFPGKDYVHQLRLI 257
           E+ + R P+  G   +    L+
Sbjct: 214 EMAVGRYPIGSGSGSMAIFELL 235

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 104/224 (46%), Gaps = 28/224 (12%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAA-----VNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           +EVS + +  +R +G+G++G+V        +  E    VA+K + N   ++ +    L E
Sbjct: 9   WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV-NESASLRERIEFLNE 67
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQ-- 148
             +++     +V+ +  ++   +        +V ELM   DL   +RS +   +++    
Sbjct: 68  ASVMKGFTCHHVVRLLGVVSKGQP-----TLVVMELMAHGDLKSYLRSLRPEAENNPGRP 122
Query: 149 --------YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 200
                       ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD 
Sbjct: 123 PPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDX 182
Query: 201 MTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             +     +  RW  APE L +   +T + D+WS G +L EI +
Sbjct: 183 XRKGGKGLLPVRWM-APESLKDGV-FTTSSDMWSFGVVLWEITS 224

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 104/224 (46%), Gaps = 28/224 (12%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAA-----VNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           +EVS + +  +R +G+G++G+V        +  E    VA+K + N   ++ +    L E
Sbjct: 12  WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV-NESASLRERIEFLNE 70
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQ-- 148
             +++     +V+ +  ++   +        +V ELM   DL   +RS +   +++    
Sbjct: 71  ASVMKGFTCHHVVRLLGVVSKGQP-----TLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 149 --------YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 200
                       ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD 
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDX 185
Query: 201 MTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             +     +  RW  APE L +   +T + D+WS G +L EI +
Sbjct: 186 XRKGGKGLLPVRWM-APESLKDGV-FTTSSDMWSFGVVLWEITS 227

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 109/243 (44%), Gaps = 40/243 (16%)
Query: 48  RPIGRGAYGIVCAA---------VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM 98
           +P+G GA+G V  A          N  T+  V + K      ++ D    +  +K++   
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-- 132
Query: 99  EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS----------------DQQ 141
           +H+N+I   +++    +D    +Y++ E     +L + +++                ++Q
Sbjct: 133 KHKNII---NLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187
Query: 142 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM 201
           L+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     D+ 
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 247
Query: 202 TEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPGKDYVHQLRL 256
            +    R    + APE L +   YT   D+WS G +L EI T    P +PG       +L
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSP-YPGVPVEELFKL 305
Query: 257 ITE 259
           + E
Sbjct: 306 LKE 308

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 95/195 (48%), Gaps = 15/195 (7%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMD--TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           I + D    P  D+F    ++ E M+   DL   I     L ++  + F +Q+L  +++ 
Sbjct: 76  IRLLDWFERP--DSF---VLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 130
Query: 162 HSASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           H+  VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +    
Sbjct: 131 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHR 189
Query: 221 EYTAAIDIWSVGCIL 235
            +  +  +WS+G +L
Sbjct: 190 YHGRSAAVWSLGILL 204

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 105/221 (47%), Gaps = 36/221 (16%)
Query: 48  RPIGRGAYGIVCAAV-----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE- 101
           +P+GRGA+G V  A       + T   VA+K +     +  + R  + E+K+L H+ H  
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHL 91
Query: 102 NVIAIKDIIRPPKKD--------TFNDV----------YIVYELMDTDLHQIIRSDQQLT 143
           NV+ +      P            F ++          ++ Y++   DL++       LT
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-----LT 146
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFMT 202
            +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D + 
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVR 206
Query: 203 E---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           +    +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 207 KGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 245

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 30/204 (14%)
Query: 50  IGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G +G V     N  TR  VAIK +       +     L+E ++++ + HE ++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 109 IIRPPKKDTFNDVYIVYELMDTD-LHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKY 160
           ++      +   +YIV E M    L   ++ +        QL D        Q+  G+ Y
Sbjct: 81  VV------SEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVD-----MAAQIASGMAY 129
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLL 217
           V   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L
Sbjct: 130 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL 188
Query: 218 NCTEYTAAIDIWSVGCILGEIMTR 241
               +T   D+WS G +L E+ T+
Sbjct: 189 Y-GRFTIKSDVWSFGILLTELTTK 211

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 118/257 (45%), Gaps = 30/257 (11%)
Query: 25  GKYVQYNVY-GNLFEVSSKYVPPIRPIGRGAYGIV-----CAAVNSETREEVAIKKIGNA 78
           G +   +VY  + +EV+ + +   R +G+G++G+V        V  E    VAIK +  A
Sbjct: 1   GSFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA 60
Query: 79  FDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIR 137
             ++ +    L E  +++     +V+ +  ++   +        ++ ELM   DL   +R
Sbjct: 61  -ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLR 114
Query: 138 SDQQLTDDH---CQYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCDLKIG 187
           S +   +++       L ++++       G+ Y+++   +HRDL   N ++     +KIG
Sbjct: 115 SLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 174
Query: 188 DFGLARTTSETDFMTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-RE 242
           DFG+ R   ETD   +     +  RW  +PE L +   +T   D+WS G +L EI T  E
Sbjct: 175 DFGMTRDIXETDXXRKGGKGLLPVRWM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAE 232
Query: 243 PLFPGKDYVHQLRLITE 259
             + G      LR + E
Sbjct: 233 QPYQGLSNEQVLRFVME 249

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 55/105 (52%), Gaps = 4/105 (3%)
Query: 139 DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 198
           ++QL+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 199 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           D+  +    R    + APE L +   YT   D+WS G +L EI T
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFT 232

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 30/204 (14%)
Query: 50  IGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G +G V     N  TR  VAIK +       +     L+E ++++ + HE ++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKIRHEKLVQLYA 80
Query: 109 IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKY 160
           ++      +   +YIV E M    L   ++ +        QL D        Q+  G+ Y
Sbjct: 81  VV------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD-----MAAQIASGMAY 129
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLL 217
           V   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L
Sbjct: 130 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL 188
Query: 218 NCTEYTAAIDIWSVGCILGEIMTR 241
               +T   D+WS G +L E+ T+
Sbjct: 189 Y-GRFTIKSDVWSFGILLTELTTK 211

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 113/244 (46%), Gaps = 29/244 (11%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVC-----AAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           +EV+ + +   R +G+G++G+V        V  E    VAIK +  A  ++ +    L E
Sbjct: 42  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNE 100
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDH---C 147
             +++     +V+ +  ++   +        ++ ELM   DL   +RS +   +++    
Sbjct: 101 ASVMKEFNCHHVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPEMENNPVLA 155
Query: 148 QYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 200
              L ++++       G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+
Sbjct: 156 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 215
Query: 201 MTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLR 255
             +     +  RW  +PE L +   +T   D+WS G +L EI T  E  + G      LR
Sbjct: 216 YRKGGKGLLPVRWM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 273
Query: 256 LITE 259
            + E
Sbjct: 274 FVME 277

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 55/105 (52%), Gaps = 4/105 (3%)
Query: 139 DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 198
           ++QL+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     
Sbjct: 144 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 203
Query: 199 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           D+  +    R    + APE L +   YT   D+WS G +L EI T
Sbjct: 204 DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFT 247

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 31/211 (14%)
Query: 50  IGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G +G V     N  TR  VAIK +       +     L+E ++++ + HE ++ +  
Sbjct: 192 LGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 109 IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKY 160
           ++      +   +YIV E M    L   ++ +        QL D        Q+  G+ Y
Sbjct: 247 VV------SEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVD-----MAAQIASGMAY 295
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLL 217
           V   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L
Sbjct: 296 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL 354
Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPL-FPG 247
               +T   D+WS G +L E+ T+  + +PG
Sbjct: 355 Y-GRFTIKSDVWSFGILLTELTTKGRVPYPG 384

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 106/225 (47%), Gaps = 45/225 (20%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKD 108
           +G G+ G V    + + R  VA+K++   F +I      L EIKLL   + H NVI    
Sbjct: 23  LGYGSSGTVVFQGSFQGRP-VAVKRMLIDFCDI-----ALMEIKLLTESDDHPNVIRY-- 74
Query: 109 IIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQY--------FLYQLLRGLKY 160
                  D F  +YI  EL + +L  ++ S + ++D++ +          L Q+  G+ +
Sbjct: 75  -YCSETTDRF--LYIALELCNLNLQDLVES-KNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 161 VHSASVLHRDLKPSNLLLNASCDLK-------------IGDFGLART--TSETDFMTEY- 204
           +HS  ++HRDLKP N+L++ S                 I DFGL +   + ++ F T   
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 205 --VVTRWYRAPELLLNCTE------YTAAIDIWSVGCILGEIMTR 241
               T  +RAPELL            T +IDI+S+GC+   I+++
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 113/244 (46%), Gaps = 29/244 (11%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVC-----AAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           +EV+ + +   R +G+G++G+V        V  E    VAIK +  A  ++ +    L E
Sbjct: 11  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNE 69
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDH---C 147
             +++     +V+ +  ++   +        ++ ELM   DL   +RS +   +++    
Sbjct: 70  ASVMKEFNCHHVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPEMENNPVLA 124
Query: 148 QYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 200
              L ++++       G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+
Sbjct: 125 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 184
Query: 201 MTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLR 255
             +     +  RW  +PE L +   +T   D+WS G +L EI T  E  + G      LR
Sbjct: 185 YRKGGKGLLPVRWM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 242
Query: 256 LITE 259
            + E
Sbjct: 243 FVME 246

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 113/244 (46%), Gaps = 29/244 (11%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVC-----AAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           +EV+ + +   R +G+G++G+V        V  E    VAIK +  A  ++ +    L E
Sbjct: 13  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNE 71
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDH---C 147
             +++     +V+ +  ++   +        ++ ELM   DL   +RS +   +++    
Sbjct: 72  ASVMKEFNCHHVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 148 QYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 200
              L ++++       G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 186
Query: 201 MTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLR 255
             +     +  RW  +PE L +   +T   D+WS G +L EI T  E  + G      LR
Sbjct: 187 YRKGGKGLLPVRWM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 244
Query: 256 LITE 259
            + E
Sbjct: 245 FVME 248

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 30/204 (14%)
Query: 50  IGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G +G V     N  TR  VAIK +       +     L+E ++++ + HE ++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 109 IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKY 160
           ++      +   +YIV E M    L   ++ +        QL D        Q+  G+ Y
Sbjct: 81  VV------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD-----MAAQIASGMAY 129
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLL 217
           V   + +HRDL  +N+L+  +   K+ DFGLAR   + ++          +W  APE  L
Sbjct: 130 VERMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL 188
Query: 218 NCTEYTAAIDIWSVGCILGEIMTR 241
               +T   D+WS G +L E+ T+
Sbjct: 189 Y-GRFTIKSDVWSFGILLTELTTK 211

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 20/204 (9%)
Query: 50  IGRGAYGIVCAA-VNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAI 106
           +G G +G+V    VN+ T   VA+KK+    D   +  +    +EIK++   +HEN++ +
Sbjct: 33  MGEGGFGVVYKGYVNNTT---VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 89
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT----DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
                       +D+ +VY  M      D    +     L+             G+ ++H
Sbjct: 90  LGF-----SSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH 144
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAPELLLNC 219
               +HRD+K +N+LL+ +   KI DFGLAR +   ++       V T  Y APE L   
Sbjct: 145 ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRG- 203
Query: 220 TEYTAAIDIWSVGCILGEIMTREP 243
            E T   DI+S G +L EI+T  P
Sbjct: 204 -EITPKSDIYSFGVVLLEIITGLP 226

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 89/197 (45%), Gaps = 14/197 (7%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IGRG +G V +         VA+K         + A+  L+E ++L+   H N++ +  +
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-FLQEARILKQYSHPNIVRLIGV 180
Query: 110 IRPPKKDTFNDVYIVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVL 167
                      +YIV EL+   D    +R++  +L        +     G++Y+ S   +
Sbjct: 181 C-----TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCI 235
Query: 168 HRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTRWYRAPELLLNCTEYT 223
           HRDL   N L+     LKI DFG++R  ++  +        V  +W  APE  LN   Y+
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKW-TAPE-ALNYGRYS 293
Query: 224 AAIDIWSVGCILGEIMT 240
           +  D+WS G +L E  +
Sbjct: 294 SESDVWSFGILLWETFS 310

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 113/244 (46%), Gaps = 29/244 (11%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVC-----AAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           +EV+ + +   R +G+G++G+V        V  E    VAIK +  A  ++ +    L E
Sbjct: 13  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNE 71
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDH---C 147
             +++     +V+ +  ++   +        ++ ELM   DL   +RS +   +++    
Sbjct: 72  ASVMKEFNCHHVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 148 QYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 200
              L ++++       G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 186
Query: 201 MTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLR 255
             +     +  RW  +PE L +   +T   D+WS G +L EI T  E  + G      LR
Sbjct: 187 YRKGGKGLLPVRWM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 244
Query: 256 LITE 259
            + E
Sbjct: 245 FVME 248

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 113/244 (46%), Gaps = 29/244 (11%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVC-----AAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           +EV+ + +   R +G+G++G+V        V  E    VAIK +  A  ++ +    L E
Sbjct: 7   WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNE 65
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDH---C 147
             +++     +V+ +  ++   +        ++ ELM   DL   +RS +   +++    
Sbjct: 66  ASVMKEFNCHHVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPEMENNPVLA 120
Query: 148 QYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 200
              L ++++       G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 180
Query: 201 MTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLR 255
             +     +  RW  +PE L +   +T   D+WS G +L EI T  E  + G      LR
Sbjct: 181 YRKGGKGLLPVRWM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 238
Query: 256 LITE 259
            + E
Sbjct: 239 FVME 242

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 31/218 (14%)
Query: 48  RPIGRGAYGIVCAAV-----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE- 101
           +P+GRGA+G V  A       + T   VA+K +     +  + R  + E+K+L H+ H  
Sbjct: 34  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHL 92
Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ---------------LTDD 145
           NV+ +      P       + ++ E     +L   +RS +                LT +
Sbjct: 93  NVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLE 148
Query: 146 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 205
           H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR   +        
Sbjct: 149 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 206 VTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             R    + APE + +   YT   D+WS G +L EI +
Sbjct: 209 DARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 245

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 102/204 (50%), Gaps = 13/204 (6%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF---DNIIDARRTLREIKLLRHMEHENV 103
           +R IGRG+Y  V      +T    A+K +       D  ID  +T + +   +   H  +
Sbjct: 14  LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV-FEQASNHPFL 72
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           + +    +     T + ++ V E ++  DL   ++  ++L ++H +++  ++   L Y+H
Sbjct: 73  VGLHSCFQ-----TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 127
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCTE 221
              +++RDLK  N+LL++   +K+ D+G+ +      D  + +  T  Y APE +L   +
Sbjct: 128 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPE-ILRGED 186
Query: 222 YTAAIDIWSVGCILGEIMT-REPL 244
           Y  ++D W++G ++ E+M  R P 
Sbjct: 187 YGFSVDWWALGVLMFEMMAGRSPF 210

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 23/210 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 96
Query: 110 --IRPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
             + PP        YIV E M   +L   +R  + +++T     Y   Q+   ++Y+   
Sbjct: 97  CTLEPP-------FYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKK 149
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE L   T 
Sbjct: 150 NFIHRDLAARNCLVGENHVVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNT- 207
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKD 249
           ++   D+W+ G +L EI T    P +PG D
Sbjct: 208 FSIKSDVWAFGVLLWEIATYGMSP-YPGID 236

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 105/224 (46%), Gaps = 28/224 (12%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAA-----VNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           +EVS + +  +R +G+G++G+V        +  E    VA+K + N   ++ +    L E
Sbjct: 13  WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV-NESASLRERIEFLNE 71
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQ-- 148
             +++     +V+ +  ++   +        +V ELM   DL   +RS +   +++    
Sbjct: 72  ASVMKGFTCHHVVRLLGVVSKGQP-----TLVVMELMAHGDLKSYLRSLRPEAENNPGRP 126
Query: 149 --------YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 200
                       ++  G+ Y+++   +HR+L   N ++     +KIGDFG+ R   ETD+
Sbjct: 127 PPTLQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDY 186
Query: 201 MTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             +     +  RW  APE L +   +T + D+WS G +L EI +
Sbjct: 187 YRKGGKGLLPVRWM-APESLKDGV-FTTSSDMWSFGVVLWEITS 228

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 112/244 (45%), Gaps = 29/244 (11%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVC-----AAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           +EV+ + +   R +G+G++G+V        V  E    VAIK +  A  ++ +    L E
Sbjct: 20  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNE 78
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDH---C 147
             +++     +V+ +  ++            ++ ELM   DL   +RS +   +++    
Sbjct: 79  ASVMKEFNCHHVVRLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 133
Query: 148 QYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 200
              L ++++       G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 193
Query: 201 MTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLR 255
             +     +  RW  +PE L +   +T   D+WS G +L EI T  E  + G      LR
Sbjct: 194 YRKGGKGLLPVRWM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251
Query: 256 LITE 259
            + E
Sbjct: 252 FVME 255

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 102/204 (50%), Gaps = 13/204 (6%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF---DNIIDARRTLREIKLLRHMEHENV 103
           +R IGRG+Y  V      +T    A+K +       D  ID  +T + +   +   H  +
Sbjct: 10  LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV-FEQASNHPFL 68
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           + +    +     T + ++ V E ++  DL   ++  ++L ++H +++  ++   L Y+H
Sbjct: 69  VGLHSCFQ-----TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 123
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCTE 221
              +++RDLK  N+LL++   +K+ D+G+ +      D  + +  T  Y APE +L   +
Sbjct: 124 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPE-ILRGED 182
Query: 222 YTAAIDIWSVGCILGEIMT-REPL 244
           Y  ++D W++G ++ E+M  R P 
Sbjct: 183 YGFSVDWWALGVLMFEMMAGRSPF 206

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 105/224 (46%), Gaps = 28/224 (12%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAA-----VNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           +EVS + +  +R +G+G++G+V        +  E    VA+K + N   ++ +    L E
Sbjct: 12  WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV-NESASLRERIEFLNE 70
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQ-- 148
             +++     +V+ +  ++   +        +V ELM   DL   +RS +   +++    
Sbjct: 71  ASVMKGFTCHHVVRLLGVVSKGQP-----TLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 149 --------YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 200
                       ++  G+ Y+++   +HR+L   N ++     +KIGDFG+ R   ETD+
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDY 185
Query: 201 MTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             +     +  RW  APE L +   +T + D+WS G +L EI +
Sbjct: 186 YRKGGKGLLPVRWM-APESLKDGV-FTTSSDMWSFGVVLWEITS 227

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 111/244 (45%), Gaps = 29/244 (11%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIV-----CAAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           +EV+ + +   R +G+G++G+V        V  E    VAIK +  A  ++ +    L E
Sbjct: 5   WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNE 63
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDH---C 147
             +++     +V+ +  ++            ++ ELM   DL   +RS +   +++    
Sbjct: 64  ASVMKEFNCHHVVRLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 118
Query: 148 QYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 200
              L ++++       G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD 
Sbjct: 119 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDX 178
Query: 201 MTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLR 255
             +     +  RW  +PE L +   +T   D+WS G +L EI T  E  + G      LR
Sbjct: 179 XRKGGKGLLPVRWM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 236
Query: 256 LITE 259
            + E
Sbjct: 237 FVME 240

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 109/242 (45%), Gaps = 20/242 (8%)
Query: 17  VKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIG 76
           +K  +  G    Q   Y + + ++ K +  ++ IG+G +G V   +      +VA+K I 
Sbjct: 168 IKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCI- 224
Query: 77  NAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQI 135
               N   A+  L E  ++  + H N++ +  +I   K      +YIV E M    L   
Sbjct: 225 ---KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLYIVTEYMAKGSLVDY 277
Query: 136 IRSDQQ--LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR 193
           +RS  +  L  D    F   +   ++Y+   + +HRDL   N+L++     K+ DFGL +
Sbjct: 278 LRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337
Query: 194 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTRE----PLFPGKD 249
             S T   T  +  +W  APE L    +++   D+WS G +L EI +      P  P KD
Sbjct: 338 EASSTQ-DTGKLPVKW-TAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 394
Query: 250 YV 251
            V
Sbjct: 395 VV 396

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 112/244 (45%), Gaps = 29/244 (11%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVC-----AAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           +EV+ + +   R +G+G++G+V        V  E    VAIK +  A  ++ +    L E
Sbjct: 10  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNE 68
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDH---C 147
             +++     +V+ +  ++   +        ++ ELM   DL   +RS +    ++    
Sbjct: 69  ASVMKEFNCHHVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLA 123
Query: 148 QYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 200
              L ++++       G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+
Sbjct: 124 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 183
Query: 201 MTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLR 255
             +     +  RW  +PE L +   +T   D+WS G +L EI T  E  + G      LR
Sbjct: 184 YRKGGKGLLPVRWM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 241
Query: 256 LITE 259
            + E
Sbjct: 242 FVME 245

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 106/235 (45%), Gaps = 20/235 (8%)
Query: 24  GGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII 83
           G    Q   Y + + ++ K +  ++ IG+G +G V   +      +VA+K I     N  
Sbjct: 3   GSVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVM--LGDYRGNKVAVKCI----KNDA 56
Query: 84  DARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQ- 141
            A+  L E  ++  + H N++ +  +I   K      +YIV E M    L   +RS  + 
Sbjct: 57  TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRS 112
Query: 142 -LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 200
            L  D    F   +   ++Y+   + +HRDL   N+L++     K+ DFGL +  S T  
Sbjct: 113 VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 171
Query: 201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTRE----PLFPGKDYV 251
            T  +  +W  APE L    +++   D+WS G +L EI +      P  P KD V
Sbjct: 172 DTGKLPVKW-TAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 224

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 54/105 (51%), Gaps = 4/105 (3%)
Query: 139 DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 198
           ++QL+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     
Sbjct: 144 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 203
Query: 199 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           D   +    R    + APE L +   YT   D+WS G +L EI T
Sbjct: 204 DXXKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFT 247

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 30/204 (14%)
Query: 50  IGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G +G V     N  TR  VAIK +       +     L+E ++++ + HE ++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 109 IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKY 160
           ++      +   +YIV E M    L   ++ +        QL D        Q+  G+ Y
Sbjct: 81  VV------SEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVD-----MAAQIASGMAY 129
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLL 217
           V   + +HRDL+ +N+L+  +   K+ DFGLAR   + +           +W  APE  L
Sbjct: 130 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW-TAPEAAL 188
Query: 218 NCTEYTAAIDIWSVGCILGEIMTR 241
               +T   D+WS G +L E+ T+
Sbjct: 189 Y-GRFTIKSDVWSFGILLTELTTK 211

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 90/200 (45%), Gaps = 16/200 (8%)
Query: 50  IGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IG G  G VC     V  +    VAIK +   +      R  L E  ++   +H N+I +
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER-QRRDFLSEASIMGQFDHPNIIRL 115
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           + ++   +       Y+    +DT L      D Q T       L  +  G++Y+     
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLGY 172
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCT 220
           +HRDL   N+L++++   K+ DFGL+R   E D    Y  T      RW  APE +   T
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVL-EDDPDAAYTTTGGKIPIRWT-APEAIAFRT 230
Query: 221 EYTAAIDIWSVGCILGEIMT 240
            +++A D+WS G ++ E++ 
Sbjct: 231 -FSSASDVWSFGVVMWEVLA 249

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 102/204 (50%), Gaps = 13/204 (6%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF---DNIIDARRTLREIKLLRHMEHENV 103
           +R IGRG+Y  V      +T    A+K +       D  ID  +T + +   +   H  +
Sbjct: 25  LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV-FEQASNHPFL 83
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           + +    +     T + ++ V E ++  DL   ++  ++L ++H +++  ++   L Y+H
Sbjct: 84  VGLHSCFQ-----TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 138
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCTE 221
              +++RDLK  N+LL++   +K+ D+G+ +      D  + +  T  Y APE +L   +
Sbjct: 139 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPE-ILRGED 197
Query: 222 YTAAIDIWSVGCILGEIMT-REPL 244
           Y  ++D W++G ++ E+M  R P 
Sbjct: 198 YGFSVDWWALGVLMFEMMAGRSPF 221

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 103/225 (45%), Gaps = 20/225 (8%)
Query: 34  GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           G+ + ++ K +  ++ IG+G +G V   +      +VA+K I     N   A+  L E  
Sbjct: 4   GSGWALNMKELKLLQTIGKGEFGDVM--LGDYRGNKVAVKCI----KNDATAQAFLAEAS 57
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQ--LTDDHCQYF 150
           ++  + H N++ +  +I   K      +YIV E M    L   +RS  +  L  D    F
Sbjct: 58  VMTQLRHSNLVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 113
Query: 151 LYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWY 210
              +   ++Y+   + +HRDL   N+L++     K+ DFGL +  S T   T  +  +W 
Sbjct: 114 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPVKW- 171
Query: 211 RAPELLLNCTEYTAAIDIWSVGCILGEIMTRE----PLFPGKDYV 251
            APE L     ++   D+WS G +L EI +      P  P KD V
Sbjct: 172 TAPEALREAA-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 215

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 111/244 (45%), Gaps = 29/244 (11%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVC-----AAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           +EV+ + +   R +G+G++G+V        V  E    VAIK +  A  ++ +    L E
Sbjct: 20  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNE 78
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDH---C 147
             +++     +V+ +  ++            ++ ELM   DL   +RS +    ++    
Sbjct: 79  ASVMKEFNCHHVVRLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133
Query: 148 QYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 200
              L ++++       G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 193
Query: 201 MTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLR 255
             +     +  RW  +PE L +   +T   D+WS G +L EI T  E  + G      LR
Sbjct: 194 YRKGGKGLLPVRWM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251
Query: 256 LITE 259
            + E
Sbjct: 252 FVME 255

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 86/208 (41%), Gaps = 9/208 (4%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G+YG V    + E     A+K+  + F    D  R L E+       HE V      
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVG-----SHEKVGQHPCC 119
Query: 110 IRPPKK-DTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
           +R  +  +    +Y+  EL    L Q   +    L +     +L   L  L ++HS  ++
Sbjct: 120 VRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLV 179
Query: 168 HRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAID 227
           H D+KP+N+ L      K+GDFGL                  Y APELL     Y  A D
Sbjct: 180 HLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG--SYGTAAD 237
Query: 228 IWSVGCILGEIMTREPLFPGKDYVHQLR 255
           ++S+G  + E+     L  G +   QLR
Sbjct: 238 VFSLGLTILEVACNMELPHGGEGWQQLR 265

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/261 (22%), Positives = 112/261 (42%), Gaps = 31/261 (11%)
Query: 18  KGVLTHGGKYVQYNVYGNLFEVSSKYVP-PIR--------------PIGRGAYGIVCAAV 62
           +G +  G   V  N    +F++  +Y P P+                +G GA+G+V    
Sbjct: 118 QGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVT 177
Query: 63  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 122
              T    A K +    ++  D     +EI+ +  + H  ++ + D       +  N++ 
Sbjct: 178 ERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMV 230
Query: 123 IVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 180
           ++YE M       ++     ++++D    ++ Q+ +GL ++H  + +H DLKP N++   
Sbjct: 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT 290
Query: 181 --SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILG 236
             S +LK+ DFGL         +     T  + APE+        YT   D+WSVG +  
Sbjct: 291 KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYT---DMWSVGVLSY 347
Query: 237 EIMTREPLFPGKDYVHQLRLI 257
            +++    F G++    LR +
Sbjct: 348 ILLSGLSPFGGENDDETLRNV 368

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 111/244 (45%), Gaps = 29/244 (11%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVC-----AAVNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           +EV+ + +   R +G+G++G+V        V  E    VAIK +  A  ++ +    L E
Sbjct: 7   WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNE 65
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDH---C 147
             +++     +V+ +  ++            ++ ELM   DL   +RS +   +++    
Sbjct: 66  ASVMKEFNCHHVVRLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 120
Query: 148 QYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 200
              L ++++       G+ Y+++   +HRDL   N  +     +KIGDFG+ R   ETD+
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDY 180
Query: 201 MTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLR 255
             +     +  RW  +PE L +   +T   D+WS G +L EI T  E  + G      LR
Sbjct: 181 YRKGGKGLLPVRWM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 238
Query: 256 LITE 259
            + E
Sbjct: 239 FVME 242

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/259 (21%), Positives = 110/259 (42%), Gaps = 27/259 (10%)
Query: 18  KGVLTHGGKYVQYNVYGNLFEVSSKYVP-PIR--------------PIGRGAYGIVCAAV 62
           +G +  G   V  N    +F++  +Y P P+                +G GA+G+V    
Sbjct: 12  QGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVT 71
Query: 63  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 122
              T    A K +    ++  D     +EI+ +  + H  ++ + D       +  N++ 
Sbjct: 72  ERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMV 124
Query: 123 IVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 180
           ++YE M       ++     ++++D    ++ Q+ +GL ++H  + +H DLKP N++   
Sbjct: 125 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT 184
Query: 181 --SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 238
             S +LK+ DFGL         +     T  + APE +          D+WSVG +   +
Sbjct: 185 KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPE-VAEGKPVGYYTDMWSVGVLSYIL 243
Query: 239 MTREPLFPGKDYVHQLRLI 257
           ++    F G++    LR +
Sbjct: 244 LSGLSPFGGENDDETLRNV 262

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 104/219 (47%), Gaps = 20/219 (9%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+G++G V  +    T E  A+K        I+     +++  +   M  + V+A+   
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVK--------ILKKDVVIQDDDVECTMVEKRVLALPG- 78
Query: 110 IRPPKK-------DTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
            +PP          T + +Y V E ++  DL   I+   +  + H  ++  ++  GL ++
Sbjct: 79  -KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFL 137
Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCT 220
            S  +++RDLK  N++L++   +KI DFG+ +        T+ +  T  Y APE++    
Sbjct: 138 QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIA-YQ 196
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
            Y  ++D W+ G +L E++  +  F G+D     + I E
Sbjct: 197 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 235

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 94/194 (48%), Gaps = 7/194 (3%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G V  A       +VA+K +     +       LRE+ +++ + H N++     
Sbjct: 45  IGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS--ASVL 167
           +  P   +    Y+    +   LH+   + +QL +       Y + +G+ Y+H+    ++
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKS-GAREQLDERRRLSMAYDVAKGMNYLHNRNPPIV 161
Query: 168 HRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV-TRWYRAPELLLNCTEYTAAI 226
           HR+LK  NLL++    +K+ DFGL+R  + T   ++    T  + APE+L +      + 
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKS- 220
Query: 227 DIWSVGCILGEIMT 240
           D++S G IL E+ T
Sbjct: 221 DVYSFGVILWELAT 234

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 88/197 (44%), Gaps = 14/197 (7%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IGRG +G V +         VA+K         + A+  L+E ++L+   H N++ +  +
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-FLQEARILKQYSHPNIVRLIGV 180
Query: 110 IRPPKKDTFNDVYIVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVL 167
                      +YIV EL+   D    +R++  +L        +     G++Y+ S   +
Sbjct: 181 C-----TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCI 235
Query: 168 HRDLKPSNLLLNASCDLKIGDFGLARTTSE----TDFMTEYVVTRWYRAPELLLNCTEYT 223
           HRDL   N L+     LKI DFG++R  ++           V  +W  APE  LN   Y+
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWT-APE-ALNYGRYS 293
Query: 224 AAIDIWSVGCILGEIMT 240
           +  D+WS G +L E  +
Sbjct: 294 SESDVWSFGILLWETFS 310

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           +++E+  + +  I+ +G G +G V     N  T+  VAIK +       +     L E +
Sbjct: 2   DVWEIPRESLQLIKRLGNGQFGEVWMGTWNGNTK--VAIKTLK---PGTMSPESFLEEAQ 56
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ--QLTDDHCQYF 150
           +++ ++H+ ++ +  ++      +   +YIV E M+   L   ++  +   L   +    
Sbjct: 57  IMKKLKHDKLVQLYAVV------SEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDM 110
Query: 151 LYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT--- 207
             Q+  G+ Y+   + +HRDL+ +N+L+      KI DFGLAR   + +           
Sbjct: 111 AAQVAAGMAYIERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPI 170
Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR 241
           +W  APE  L    +T   D+WS G +L E++T+
Sbjct: 171 KW-TAPEAAL-YGRFTIKSDVWSFGILLTELVTK 202

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 93/194 (47%), Gaps = 7/194 (3%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G V  A       +VA+K +     +       LRE+ +++ + H N++     
Sbjct: 45  IGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS--ASVL 167
           +  P   +    Y+    +   LH+   + +QL +       Y + +G+ Y+H+    ++
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKS-GAREQLDERRRLSMAYDVAKGMNYLHNRNPPIV 161
Query: 168 HRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV-TRWYRAPELLLNCTEYTAAI 226
           HRDLK  NLL++    +K+ DFGL+R  +     ++    T  + APE+L +      + 
Sbjct: 162 HRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDEPSNEKS- 220
Query: 227 DIWSVGCILGEIMT 240
           D++S G IL E+ T
Sbjct: 221 DVYSFGVILWELAT 234

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 39  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 98
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 99  IRLLDWFERP--DSFVLILERPEPV-QDLFDFITERGALQEELARSFFWQVLEAVRHCHN 155
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 156 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 214
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 215 GRSAAVWSLGILL 227

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 104/224 (46%), Gaps = 28/224 (12%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAA-----VNSETREEVAIKKIGNAFDNIIDARRTLRE 91
           +EVS + +  +R +G+G++G+V        +  E    VA+K + N   ++ +    L E
Sbjct: 12  WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV-NESASLRERIEFLNE 70
Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQ-- 148
             +++     +V+ +  ++   +        +V ELM   DL   +RS +   +++    
Sbjct: 71  ASVMKGFTCHHVVRLLGVVSKGQP-----TLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 149 --------YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 200
                       ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ET +
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAY 185
Query: 201 MTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             +     +  RW  APE L +   +T + D+WS G +L EI +
Sbjct: 186 YRKGGKGLLPVRWM-APESLKDGV-FTTSSDMWSFGVVLWEITS 227

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 77  IRLLDWFERP--DSFVLILERPEPV-QDLFDFITERGALQEELARSFFWQVLEAVRHCHN 133
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 134 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 192
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 193 GRSAAVWSLGILL 205

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/112 (32%), Positives = 60/112 (53%), Gaps = 5/112 (4%)
Query: 137 RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLAR 193
           R DQ  T+      +  +   ++++HS ++ HRD+KP NLL  +      LK+ DFG A+
Sbjct: 120 RGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179
Query: 194 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 245
            T++    T    T +Y APE +L   +Y  + D+WS+G I+  ++   P F
Sbjct: 180 ETTQNALQTP-CYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPF 229

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 18/199 (9%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G V      +   +VA+K +          +    E+ +LR   H N++     
Sbjct: 32  IGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 110 IRPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
              P+      + IV +  +     H +  S+ +           Q  RG+ Y+H+ S++
Sbjct: 89  STAPQ------LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSII 142
Query: 168 HRDLKPSNLLLNASCDLKIGDFGLA----RTTSETDFMTEYVVTRWYRAPEL--LLNCTE 221
           HRDLK +N+ L+    +KIGDFGLA    R +    F        W  APE+  + +   
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM-APEVIRMQDSNP 201
Query: 222 YTAAIDIWSVGCILGEIMT 240
           Y+   D+++ G +L E+MT
Sbjct: 202 YSFQSDVYAFGIVLYELMT 220

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 111 IRLLDWFERP--DSFVLILERPEPV-QDLFDFITERGALQEELARSFFWQVLEAVRHCHN 167
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 168 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 226
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 227 GRSAAVWSLGILL 239

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/112 (32%), Positives = 60/112 (53%), Gaps = 5/112 (4%)
Query: 137 RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLAR 193
           R DQ  T+      +  +   ++++HS ++ HRD+KP NLL  +      LK+ DFG A+
Sbjct: 101 RGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 160
Query: 194 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 245
            T++    T    T +Y APE +L   +Y  + D+WS+G I+  ++   P F
Sbjct: 161 ETTQNALQTP-CYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPF 210

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 102/204 (50%), Gaps = 13/204 (6%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF---DNIIDARRTLREIKLLRHMEHENV 103
           +R IGRG+Y  V      +T    A++ +       D  ID  +T + +   +   H  +
Sbjct: 57  LRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHV-FEQASNHPFL 115
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           + +    +     T + ++ V E ++  DL   ++  ++L ++H +++  ++   L Y+H
Sbjct: 116 VGLHSCFQ-----TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 170
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCTE 221
              +++RDLK  N+LL++   +K+ D+G+ +      D  + +  T  Y APE +L   +
Sbjct: 171 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE-ILRGED 229
Query: 222 YTAAIDIWSVGCILGEIMT-REPL 244
           Y  ++D W++G ++ E+M  R P 
Sbjct: 230 YGFSVDWWALGVLMFEMMAGRSPF 253

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 18/199 (9%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G V      +   +VA+K +          +    E+ +LR   H N++     
Sbjct: 20  IGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 110 IRPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
              P+      + IV +  +     H +  S+ +           Q  RG+ Y+H+ S++
Sbjct: 77  STKPQ------LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSII 130
Query: 168 HRDLKPSNLLLNASCDLKIGDFGLA----RTTSETDFMTEYVVTRWYRAPEL--LLNCTE 221
           HRDLK +N+ L+    +KIGDFGLA    R +    F        W  APE+  + +   
Sbjct: 131 HRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM-APEVIRMQDSNP 189
Query: 222 YTAAIDIWSVGCILGEIMT 240
           Y+   D+++ G +L E+MT
Sbjct: 190 YSFQSDVYAFGIVLYELMT 208

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q+++     Y   Q+   ++Y+   
Sbjct: 76  CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 128
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE L    +
Sbjct: 129 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTFTAHAGAKFPIKWTAPESLAY-NK 186
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKD 249
           ++   D+W+ G +L EI T    P +PG D
Sbjct: 187 FSIKSDVWAFGVLLWEIATYGMSP-YPGID 215

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 45/225 (20%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKD 108
           +G G+ G V    + + R  VA+K++   F +I      L EIKLL   + H NVI    
Sbjct: 23  LGYGSSGTVVFQGSFQGRP-VAVKRMLIDFCDI-----ALMEIKLLTESDDHPNVIRY-- 74
Query: 109 IIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQY--------FLYQLLRGLKY 160
                  D F  +YI  EL + +L  ++ S + ++D++ +          L Q+  G+ +
Sbjct: 75  -YCSETTDRF--LYIALELCNLNLQDLVES-KNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 161 VHSASVLHRDLKPSNLLLNASCDLK-------------IGDFGLART--TSETDF---MT 202
           +HS  ++HRDLKP N+L++ S                 I DFGL +   + +  F   + 
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLN 190
Query: 203 EYVVTRWYRAPELLLNCTE------YTAAIDIWSVGCILGEIMTR 241
               T  +RAPELL            T +IDI+S+GC+   I+++
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 64  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 123
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 124 IRLLDWFERP--DSFVLILERPEPV-QDLFDFITERGALQEELARSFFWQVLEAVRHCHN 180
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 181 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 239
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 240 GRSAAVWSLGILL 252

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 18/199 (9%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G V      +   +VA+K +          +    E+ +LR   H N++     
Sbjct: 32  IGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 110 IRPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
              P+      + IV +  +     H +  S+ +           Q  RG+ Y+H+ S++
Sbjct: 89  STKPQ------LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSII 142
Query: 168 HRDLKPSNLLLNASCDLKIGDFGLA----RTTSETDFMTEYVVTRWYRAPEL--LLNCTE 221
           HRDLK +N+ L+    +KIGDFGLA    R +    F        W  APE+  + +   
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM-APEVIRMQDSNP 201
Query: 222 YTAAIDIWSVGCILGEIMT 240
           Y+   D+++ G +L E+MT
Sbjct: 202 YSFQSDVYAFGIVLYELMT 220

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 24/208 (11%)
Query: 47  IRPIGRGAYGIV--CA--AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN 102
           I  +G+G +G V  C    +   T   VA+K++ ++  +    R   REI++L+ +  + 
Sbjct: 16  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD--QQRDFQREIQILKALHSDF 73
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKY 160
           ++  + +   P + +     +V E + +   +      +   D  +  LY  Q+ +G++Y
Sbjct: 74  IVKYRGVSYGPGRQSLR---LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEY 130
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--------WYRA 212
           + S   +HRDL   N+L+ +   +KI DFGLA+         +Y V R        WY A
Sbjct: 131 LGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP---LDKDYYVVREPGQSPIFWY-A 186
Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMT 240
           PE L +   ++   D+WS G +L E+ T
Sbjct: 187 PESLSD-NIFSRQSDVWSFGVVLYELFT 213

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 77  IRLLDWFERP--DSFVLILERPEPV-QDLFDFITERGALQEELARSFFWQVLEAVRHCHN 133
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 134 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 192
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 193 GRSAAVWSLGILL 205

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 76  IRLLDWFERP--DSFVLILERPEPV-QDLFDFITERGALQEELARSFFWQVLEAVRHCHN 132
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 133 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 191
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 192 GRSAAVWSLGILL 204

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 99/208 (47%), Gaps = 19/208 (9%)
Query: 48  RPIGRGAYGIVCAAVNSETREE---VAIK--KIGNAFDNIIDARRTLREIKLLRHMEHEN 102
           R +G G +G V   V +  + E   VA+K  K     DN     + + E  ++++++H +
Sbjct: 14  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDN---KEKFMSEAVIMKNLDHPH 70
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           ++ +  II         ++Y   EL     H + R+   L       +  Q+ + + Y+ 
Sbjct: 71  IVKLIGIIEEEPTWIIMELYPYGELG----HYLERNKNSLKVLTLVLYSLQICKAMAYLE 126
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV---TRWYRAPELLLNC 219
           S + +HRD+   N+L+ +   +K+GDFGL+R   + D+    V     +W  +PE  +N 
Sbjct: 127 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKW-MSPE-SINF 184
Query: 220 TEYTAAIDIWSVGCILGEIMT--REPLF 245
             +T A D+W     + EI++  ++P F
Sbjct: 185 RRFTTASDVWMFAVCMWEILSFGKQPFF 212

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 24/208 (11%)
Query: 47  IRPIGRGAYGIV--CA--AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN 102
           I  +G+G +G V  C    +   T   VA+K++ ++  +    R   REI++L+ +  + 
Sbjct: 15  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD--QQRDFQREIQILKALHSDF 72
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKY 160
           ++  + +   P + +     +V E + +   +      +   D  +  LY  Q+ +G++Y
Sbjct: 73  IVKYRGVSYGPGRQSLR---LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEY 129
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--------WYRA 212
           + S   +HRDL   N+L+ +   +KI DFGLA+         +Y V R        WY A
Sbjct: 130 LGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP---LDKDYYVVREPGQSPIFWY-A 185
Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMT 240
           PE L +   ++   D+WS G +L E+ T
Sbjct: 186 PESLSD-NIFSRQSDVWSFGVVLYELFT 212

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 24/208 (11%)
Query: 47  IRPIGRGAYGIV--CA--AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN 102
           I  +G+G +G V  C    +   T   VA+K++ ++  +    R   REI++L+ +  + 
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD--QQRDFQREIQILKALHSDF 85
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKY 160
           ++  + +   P + +     +V E + +   +      +   D  +  LY  Q+ +G++Y
Sbjct: 86  IVKYRGVSYGPGRQSLR---LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEY 142
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--------WYRA 212
           + S   +HRDL   N+L+ +   +KI DFGLA+         +Y V R        WY A
Sbjct: 143 LGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP---LDKDYYVVREPGQSPIFWY-A 198
Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMT 240
           PE L +   ++   D+WS G +L E+ T
Sbjct: 199 PESLSD-NIFSRQSDVWSFGVVLYELFT 225

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 119 IRLLDWFERP--DSFVLILERPEPV-QDLFDFITERGALQEELARSFFWQVLEAVRHCHN 175
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 176 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 234
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 235 GRSAAVWSLGILL 247

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 92  IRLLDWFERP--DSFVLILERPEPV-QDLFDFITERGALQEELARSFFWQVLEAVRHCHN 148
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 149 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 207
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 208 GRSAAVWSLGILL 220

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 99/208 (47%), Gaps = 19/208 (9%)
Query: 48  RPIGRGAYGIVCAAVNSETREE---VAIK--KIGNAFDNIIDARRTLREIKLLRHMEHEN 102
           R +G G +G V   V +  + E   VA+K  K     DN     + + E  ++++++H +
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDN---KEKFMSEAVIMKNLDHPH 74
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           ++ +  II         ++Y   EL     H + R+   L       +  Q+ + + Y+ 
Sbjct: 75  IVKLIGIIEEEPTWIIMELYPYGELG----HYLERNKNSLKVLTLVLYSLQICKAMAYLE 130
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV---TRWYRAPELLLNC 219
           S + +HRD+   N+L+ +   +K+GDFGL+R   + D+    V     +W  +PE  +N 
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKW-MSPE-SINF 188
Query: 220 TEYTAAIDIWSVGCILGEIMT--REPLF 245
             +T A D+W     + EI++  ++P F
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQPFF 216

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 92  IRLLDWFERP--DSFVLILERPEPV-QDLFDFITERGALQEELARSFFWQVLEAVRHCHN 148
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 149 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 207
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 208 GRSAAVWSLGILL 220

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 92  IRLLDWFERP--DSFVLILERPEPV-QDLFDFITERGALQEELARSFFWQVLEAVRHCHN 148
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 149 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 207
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 208 GRSAAVWSLGILL 220

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 119 IRLLDWFERP--DSFVLILERPEPV-QDLFDFITERGALQEELARSFFWQVLEAVRHCHN 175
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 176 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 234
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 235 GRSAAVWSLGILL 247

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 72  IRLLDWFERP--DSFVLILERPEPV-QDLFDFITERGALQEELARSFFWQVLEAVRHCHN 128
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 129 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 187
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 188 GRSAAVWSLGILL 200

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 94/206 (45%), Gaps = 14/206 (6%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IGRGAYG V   V+  + + +A+K+I +  D     +  +    ++R  +   ++     
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRS-----DQQLTDDHCQYFLYQLLRGLKYV-HS 163
           +         D +I  ELM T   +  +      D  + ++         ++ L ++  +
Sbjct: 90  LF-----REGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144
Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE-- 221
             ++HRD+KPSN+LL+ S ++K+ DFG++    ++   T     R Y APE +       
Sbjct: 145 LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQ 204
Query: 222 -YTAAIDIWSVGCILGEIMTREPLFP 246
            Y    D+WS+G  L E+ T    +P
Sbjct: 205 GYDVRSDVWSLGITLYELATGRFPYP 230

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 77  IRLLDWFERP--DSFVLILERPEPV-QDLFDFITERGALQEELARSFFWQVLEAVRHCHN 133
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 134 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 192
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 193 GRSAAVWSLGILL 205

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 99/208 (47%), Gaps = 19/208 (9%)
Query: 48  RPIGRGAYGIVCAAVNSETREE---VAIK--KIGNAFDNIIDARRTLREIKLLRHMEHEN 102
           R +G G +G V   V +  + E   VA+K  K     DN     + + E  ++++++H +
Sbjct: 30  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDN---KEKFMSEAVIMKNLDHPH 86
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           ++ +  II         ++Y   EL     H + R+   L       +  Q+ + + Y+ 
Sbjct: 87  IVKLIGIIEEEPTWIIMELYPYGELG----HYLERNKNSLKVLTLVLYSLQICKAMAYLE 142
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV---TRWYRAPELLLNC 219
           S + +HRD+   N+L+ +   +K+GDFGL+R   + D+    V     +W  +PE  +N 
Sbjct: 143 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM-SPE-SINF 200
Query: 220 TEYTAAIDIWSVGCILGEIMT--REPLF 245
             +T A D+W     + EI++  ++P F
Sbjct: 201 RRFTTASDVWMFAVCMWEILSFGKQPFF 228

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 91  IRLLDWFERP--DSFVLILERPEPV-QDLFDFITERGALQEELARSFFWQVLEAVRHCHN 147
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 148 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 206
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 207 GRSAAVWSLGILL 219

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q+++     Y   Q+   ++Y+   
Sbjct: 76  CTREPP-------FYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 128
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE L    +
Sbjct: 129 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAY-NK 186
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKD 249
           ++   D+W+ G +L EI T    P +PG D
Sbjct: 187 FSIKSDVWAFGVLLWEIATYGMSP-YPGID 215

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 104 IRLLDWFERP--DSFVLILERPEPV-QDLFDFITERGALQEELARSFFWQVLEAVRHCHN 160
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 161 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 219
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 220 GRSAAVWSLGILL 232

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 72  IRLLDWFERP--DSFVLILERPEPV-QDLFDFITERGALQEELARSFFWQVLEAVRHCHN 128
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 129 XGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 187
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 188 GRSAAVWSLGILL 200

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 105 IRLLDWFERP--DSFVLILERPEPV-QDLFDFITERGALQEELARSFFWQVLEAVRHCHN 161
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 162 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 220
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 221 GRSAAVWSLGILL 233

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 72  IRLLDWFERP--DSFVLILERPEPV-QDLFDFITERGALQEELARSFFWQVLEAVRHCHN 128
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 129 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 187
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 188 GRSAAVWSLGILL 200

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 91  IRLLDWFERP--DSFVLILERPEPV-QDLFDFITERGALQEELARSFFWQVLEAVRHCHN 147
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 148 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 206
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 207 GRSAAVWSLGILL 219

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 105 IRLLDWFERP--DSFVLILERPEPV-QDLFDFITERGALQEELARSFFWQVLEAVRHCHN 161
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 162 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 220
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 221 GRSAAVWSLGILL 233

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 104 IRLLDWFERP--DSFVLILERPEPV-QDLFDFITERGALQEELARSFFWQVLEAVRHCHN 160
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 161 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 219
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 220 GRSAAVWSLGILL 232

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q+++     Y   Q+   ++Y+   
Sbjct: 78  CTREPP-------FYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE L    +
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY-NK 188
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKD 249
           ++   D+W+ G +L EI T    P +PG D
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSP-YPGID 217

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 15  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 74
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 75  IRLLDWFERP--DSFVLILERPEPV-QDLFDFITERGALQEELARSFFWQVLEAVRHCHN 131
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 132 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 190
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 191 GRSAAVWSLGILL 203

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 104 IRLLDWFERP--DSFVLILERPEPV-QDLFDFITERGALQEELARSFFWQVLEAVRHCHN 160
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 161 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 219
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 220 GRSAAVWSLGILL 232

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 105 IRLLDWFERP--DSFVLILERPEPV-QDLFDFITERGALQEELARSFFWQVLEAVRHCHN 161
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 162 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 220
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 221 GRSAAVWSLGILL 233

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 104 IRLLDWFERP--DSFVLILERPEPV-QDLFDFITERGALQEELARSFFWQVLEAVRHCHN 160
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 161 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 219
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 220 GRSAAVWSLGILL 232

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q+++     Y   Q+   ++Y+   
Sbjct: 78  CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE L    +
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY-NK 188
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKD 249
           ++   D+W+ G +L EI T    P +PG D
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSP-YPGID 217

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q+++     Y   Q+   ++Y+   
Sbjct: 78  CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE L    +
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY-NK 188
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKD 249
           ++   D+W+ G +L EI T    P +PG D
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSP-YPGID 217

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 104/221 (47%), Gaps = 33/221 (14%)
Query: 33  YGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREI 92
           YG+ +E+  K +  ++ +G G +G+V        + +VAIK I    +  +     + E 
Sbjct: 16  YGS-WEIDPKDLTFLKELGTGQFGVVKYG-KWRGQYDVAIKMIK---EGSMSEDEFIEEA 70
Query: 93  KLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT--------DLHQIIRSDQ--QL 142
           K++ ++ HE ++ +  +    +      ++I+ E M          ++    ++ Q  ++
Sbjct: 71  KVMMNLSHEKLVQLYGVCTKQRP-----IFIITEYMANGCLLNYLREMRHRFQTQQLLEM 125
Query: 143 TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT---SETD 199
             D C+         ++Y+ S   LHRDL   N L+N    +K+ DFGL+R      ET 
Sbjct: 126 CKDVCE--------AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETS 177
Query: 200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
            +      RW   PE+L+  +++++  DIW+ G ++ EI +
Sbjct: 178 SVGSKFPVRW-SPPEVLMY-SKFSSKSDIWAFGVLMWEIYS 216

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENV 103
           +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +      V
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           I + D    P  D+F  +    E +  DL   I     L ++  + F +Q+L  +++ H+
Sbjct: 105 IRLLDWFERP--DSFVLILERPEPV-QDLFDFITERGALQEELARSFFWQVLEAVRHCHN 161
Query: 164 ASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +     +
Sbjct: 162 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYH 220
Query: 223 TAAIDIWSVGCIL 235
             +  +WS+G +L
Sbjct: 221 GRSAAVWSLGILL 233

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q+++     Y   Q+   ++Y+   
Sbjct: 83  CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 135
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE L    +
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY-NK 193
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKD 249
           ++   D+W+ G +L EI T    P +PG D
Sbjct: 194 FSIKSDVWAFGVLLWEIATYGMSP-YPGID 222

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q+++     Y   Q+   ++Y+   
Sbjct: 78  CTREPP-------FYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE L    +
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY-NK 188
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKD 249
           ++   D+W+ G +L EI T    P +PG D
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSP-YPGID 217

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 104/219 (47%), Gaps = 20/219 (9%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+G++G V  +    T E  A+K        I+     +++  +   M  + V+A+   
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVK--------ILKKDVVIQDDDVECTMVEKRVLALPG- 399
Query: 110 IRPP-------KKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
            +PP          T + +Y V E ++  DL   I+   +  + H  ++  ++  GL ++
Sbjct: 400 -KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFL 458
Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCT 220
            S  +++RDLK  N++L++   +KI DFG+ +        T+ +  T  Y APE++    
Sbjct: 459 QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAY-Q 517
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
            Y  ++D W+ G +L E++  +  F G+D     + I E
Sbjct: 518 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 556

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/220 (22%), Positives = 103/220 (46%), Gaps = 32/220 (14%)
Query: 34  GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           G  +E+  K +  ++ +G G +G+V        + +VAIK I    +  +     + E K
Sbjct: 1   GGSWEIDPKDLTFLKELGTGQFGVVKYG-KWRGQYDVAIKMIK---EGSMSEDEFIEEAK 56
Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT--------DLHQIIRSDQ--QLT 143
           ++ ++ HE ++ +  +    +      ++I+ E M          ++    ++ Q  ++ 
Sbjct: 57  VMMNLSHEKLVQLYGVCTKQRP-----IFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 111
Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT- 202
            D C+         ++Y+ S   LHRDL   N L+N    +K+ DFGL+R   + ++ + 
Sbjct: 112 KDVCE--------AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 163
Query: 203 --EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                  RW   PE+L+  +++++  DIW+ G ++ EI +
Sbjct: 164 RGSKFPVRW-SPPEVLMY-SKFSSKSDIWAFGVLMWEIYS 201

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 20/222 (9%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           + ++ K +  ++ IG+G +G V   +      +VA+K I N       A+  L E  ++ 
Sbjct: 1   WALNMKELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCIKND----ATAQAFLAEASVMT 54
Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQ--LTDDHCQYFLYQ 153
            + H N++ +  +I   K      +YIV E M    L   +RS  +  L  D    F   
Sbjct: 55  QLRHSNLVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 110
Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
           +   ++Y+   + +HRDL   N+L++     K+ DFGL +  S T    +  V   + AP
Sbjct: 111 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK--WTAP 168
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTRE----PLFPGKDYV 251
           E L    +++   D+WS G +L EI +      P  P KD V
Sbjct: 169 EALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 209

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q++      Y   Q+   ++Y+   
Sbjct: 79  CTREPP-------FYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 131
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE L    +
Sbjct: 132 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLA-YNK 189
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKD 249
           ++   D+W+ G +L EI T    P +PG D
Sbjct: 190 FSIKSDVWAFGVLLWEIATYGMSP-YPGID 218

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q++      Y   Q+   ++Y+   
Sbjct: 78  CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 130
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE L    +
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY-NK 188
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKD 249
           ++   D+W+ G +L EI T    P +PG D
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSP-YPGID 217

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q++      Y   Q+   ++Y+   
Sbjct: 83  CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 135
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE L    +
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAY-NK 193
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKD 249
           ++   D+W+ G +L EI T    P +PG D
Sbjct: 194 FSIKSDVWAFGVLLWEIATYGMSP-YPGID 222

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 31/215 (14%)
Query: 48  RPI-------GRGAYGIVCAA-VNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRH 97
           RPI       G G +G+V    VN+ T   VA+KK+    D   +  +    +EIK+   
Sbjct: 21  RPISVGGNKXGEGGFGVVYKGYVNNTT---VAVKKLAAMVDITTEELKQQFDQEIKVXAK 77
Query: 98  MEHENVIAIKDIIRPPKKDTFNDVYIVY------ELMDTDLHQIIRSDQQLTDDHCQYFL 151
            +HEN++ +            +D+ +VY       L+D  L  +  +        C+   
Sbjct: 78  CQHENLVELLGF-----SSDGDDLCLVYVYXPNGSLLDR-LSCLDGTPPLSWHXRCK-IA 130
Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT---SETDFMTEYVVTR 208
                G+ ++H    +HRD+K +N+LL+ +   KI DFGLAR +   ++    +  V T 
Sbjct: 131 QGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTT 190
Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREP 243
            Y APE L    E T   DI+S G +L EI+T  P
Sbjct: 191 AYXAPEALRG--EITPKSDIYSFGVVLLEIITGLP 223

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 90
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q++      Y   Q+   ++Y+   
Sbjct: 91  CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 143
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE L    +
Sbjct: 144 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA-YNK 201
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKD 249
           ++   D+W+ G +L EI T    P +PG D
Sbjct: 202 FSIKSDVWAFGVLLWEIATYGMSP-YPGID 230

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q++      Y   Q+   ++Y+   
Sbjct: 83  CTREPP-------FYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 135
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE L    +
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY-NK 193
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKD 249
           ++   D+W+ G +L EI T    P +PG D
Sbjct: 194 FSIKSDVWAFGVLLWEIATYGMSP-YPGID 222

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q++      Y   Q+   ++Y+   
Sbjct: 82  CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 134
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE L    +
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY-NK 192
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKD 249
           ++   D+W+ G +L EI T    P +PG D
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSP-YPGID 221

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q++      Y   Q+   ++Y+   
Sbjct: 80  CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 132
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE L    +
Sbjct: 133 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA-YNK 190
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKD 249
           ++   D+W+ G +L EI T    P +PG D
Sbjct: 191 FSIKSDVWAFGVLLWEIATYGMSP-YPGID 219

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q++      Y   Q+   ++Y+   
Sbjct: 80  CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 132
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE L    +
Sbjct: 133 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY-NK 190
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKD 249
           ++   D+W+ G +L EI T    P +PG D
Sbjct: 191 FSIKSDVWAFGVLLWEIATYGMSP-YPGID 219

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q++      Y   Q+   ++Y+   
Sbjct: 78  CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 130
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE L    +
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY-NK 188
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKD 249
           ++   D+W+ G +L EI T    P +PG D
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSP-YPGID 217

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q++      Y   Q+   ++Y+   
Sbjct: 83  CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 135
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE L    +
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA-YNK 193
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKD 249
           ++   D+W+ G +L EI T    P +PG D
Sbjct: 194 FSIKSDVWAFGVLLWEIATYGMSP-YPGID 222

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q++      Y   Q+   ++Y+   
Sbjct: 83  CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 135
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE L    +
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY-NK 193
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKD 249
           ++   D+W+ G +L EI T    P +PG D
Sbjct: 194 FSIKSDVWAFGVLLWEIATYGMSP-YPGID 222

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 27/210 (12%)
Query: 50  IGRGAYGIVCAA---VNSETREEVAIKKIG-------NAFDNIIDARRTLREIKLLRHME 99
           +G G++G+V        S     VA+K +         A D+ I      RE+  +  ++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI------REVNAMHSLD 79
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
           H N+I +  ++  P      ++  +  L+D    ++ +            +  Q+  G+ 
Sbjct: 80  HRNLIRLYGVVLTPPMKMVTELAPLGSLLD----RLRKHQGHFLLGTLSRYAVQVAEGMG 135
Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEY-VVTRWYRAPEL 215
           Y+ S   +HRDL   NLLL     +KIGDFGL R   + D    M E+  V   + APE 
Sbjct: 136 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPES 195
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMT--REP 243
           L   T ++ A D W  G  L E+ T  +EP
Sbjct: 196 LKTRT-FSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 27/210 (12%)
Query: 50  IGRGAYGIVCAA---VNSETREEVAIKKIG-------NAFDNIIDARRTLREIKLLRHME 99
           +G G++G+V        S     VA+K +         A D+ I      RE+  +  ++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI------REVNAMHSLD 69
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
           H N+I +  ++  P      ++  +  L+D    ++ +            +  Q+  G+ 
Sbjct: 70  HRNLIRLYGVVLTPPMKMVTELAPLGSLLD----RLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEY-VVTRWYRAPEL 215
           Y+ S   +HRDL   NLLL     +KIGDFGL R   + D    M E+  V   + APE 
Sbjct: 126 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMT--REP 243
           L   T ++ A D W  G  L E+ T  +EP
Sbjct: 186 LKTRT-FSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 27/210 (12%)
Query: 50  IGRGAYGIVCAA---VNSETREEVAIKKIG-------NAFDNIIDARRTLREIKLLRHME 99
           +G G++G+V        S     VA+K +         A D+ I      RE+  +  ++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI------REVNAMHSLD 79
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
           H N+I +  ++  P      ++  +  L+D    ++ +            +  Q+  G+ 
Sbjct: 80  HRNLIRLYGVVLTPPMKMVTELAPLGSLLD----RLRKHQGHFLLGTLSRYAVQVAEGMG 135
Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEY-VVTRWYRAPEL 215
           Y+ S   +HRDL   NLLL     +KIGDFGL R   + D    M E+  V   + APE 
Sbjct: 136 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 195
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMT--REP 243
           L   T ++ A D W  G  L E+ T  +EP
Sbjct: 196 LKTRT-FSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 29/211 (13%)
Query: 50  IGRGAYGIVCAA---VNSETREEVAIKKIG-------NAFDNIIDARRTLREIKLLRHME 99
           +G G++G+V        S     VA+K +         A D+ I      RE+  +  ++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI------REVNAMHSLD 69
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
           H N+I +  ++  P      ++  +  L+D    ++ +            +  Q+  G+ 
Sbjct: 70  HRNLIRLYGVVLTPPMKMVTELAPLGSLLD----RLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEY--VVTRWYRAPE 214
           Y+ S   +HRDL   NLLL     +KIGDFGL R   + D    M E+  V   W  APE
Sbjct: 126 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWC-APE 184
Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMT--REP 243
            L   T ++ A D W  G  L E+ T  +EP
Sbjct: 185 SLKTRT-FSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 27/210 (12%)
Query: 50  IGRGAYGIVCAA---VNSETREEVAIKKIG-------NAFDNIIDARRTLREIKLLRHME 99
           +G G++G+V        S     VA+K +         A D+ I      RE+  +  ++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI------REVNAMHSLD 69
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
           H N+I +  ++  P      ++  +  L+D    ++ +            +  Q+  G+ 
Sbjct: 70  HRNLIRLYGVVLTPPMKMVTELAPLGSLLD----RLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEY-VVTRWYRAPEL 215
           Y+ S   +HRDL   NLLL     +KIGDFGL R   + D    M E+  V   + APE 
Sbjct: 126 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMT--REP 243
           L   T ++ A D W  G  L E+ T  +EP
Sbjct: 186 LKTRT-FSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 63/142 (44%), Gaps = 31/142 (21%)
Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDF-MTEYVV- 206
           ++  L + LK +H   ++HRD+KPSN L N       + DFGLA+ T +T   + ++V  
Sbjct: 122 YMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQS 181
Query: 207 ---------------------------TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 239
                                      T  +RAPE+L  C   T AID+WS G I   ++
Sbjct: 182 EAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLL 241
Query: 240 T-REPLFPGKDYVHQLRLITEV 260
           + R P +   D +  L  I  +
Sbjct: 242 SGRYPFYKASDDLTALAQIMTI 263

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 27/210 (12%)
Query: 50  IGRGAYGIVCAA---VNSETREEVAIKKIG-------NAFDNIIDARRTLREIKLLRHME 99
           +G G++G+V        S     VA+K +         A D+ I      RE+  +  ++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI------REVNAMHSLD 73
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
           H N+I +  ++  P      ++  +  L+D    ++ +            +  Q+  G+ 
Sbjct: 74  HRNLIRLYGVVLTPPMKMVTELAPLGSLLD----RLRKHQGHFLLGTLSRYAVQVAEGMG 129
Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEY-VVTRWYRAPEL 215
           Y+ S   +HRDL   NLLL     +KIGDFGL R   + D    M E+  V   + APE 
Sbjct: 130 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 189
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMT--REP 243
           L   T ++ A D W  G  L E+ T  +EP
Sbjct: 190 LKTRT-FSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 104/232 (44%), Gaps = 52/232 (22%)
Query: 48  RPIGRGAYGIVCAAV-----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHE 101
           + +G GA+G V  A       +    +VA+K +    D+  +    + E+K++  +  HE
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS-EREALMSELKMMTQLGSHE 109
Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSD-QQLTDDHCQY---------- 149
           N++ +              +Y+++E     DL   +RS  ++ ++D  +Y          
Sbjct: 110 NIVNLLGACTLS-----GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 150 ------------FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE 197
                       F YQ+ +G++++   S +HRDL   N+L+     +KI DFGLAR    
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR---- 220
Query: 198 TDFMTE--YVV-------TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
            D M++  YVV        +W  APE L     YT   D+WS G +L EI +
Sbjct: 221 -DIMSDSNYVVRGNARLPVKW-MAPESLFEGI-YTIKSDVWSYGILLWEIFS 269

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 101/209 (48%), Gaps = 14/209 (6%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII---DARRTLREIKLLR-HMEHEN 102
           IR +G+G++G V  A   ET +  A+K +    D I+   D   T+ E ++L     H  
Sbjct: 28  IRVLGKGSFGKVMLARVKETGDLYAVKVLKK--DVILQDDDVECTMTEKRILSLARNHPF 85
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           +  +    + P +     ++ V E ++  DL   I+  ++  +   +++  +++  L ++
Sbjct: 86  LTQLFCCFQTPDR-----LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFL 140
Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCT 220
           H   +++RDLK  N+LL+     K+ DFG+ +        T  +  T  Y APE+L    
Sbjct: 141 HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEML 200
Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKD 249
            Y  A+D W++G +L E++     F  ++
Sbjct: 201 -YGPAVDWWAMGVLLYEMLCGHAPFEAEN 228

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 27/210 (12%)
Query: 50  IGRGAYGIVCAA---VNSETREEVAIKKIG-------NAFDNIIDARRTLREIKLLRHME 99
           +G G++G+V        S     VA+K +         A D+ I      RE+  +  ++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI------REVNAMHSLD 73
Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
           H N+I +  ++  P      ++  +  L+D    ++ +            +  Q+  G+ 
Sbjct: 74  HRNLIRLYGVVLTPPMKMVTELAPLGSLLD----RLRKHQGHFLLGTLSRYAVQVAEGMG 129
Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEY-VVTRWYRAPEL 215
           Y+ S   +HRDL   NLLL     +KIGDFGL R   + D    M E+  V   + APE 
Sbjct: 130 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 189
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMT--REP 243
           L   T ++ A D W  G  L E+ T  +EP
Sbjct: 190 LKTRT-FSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G +G V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q+++     Y   Q+   ++Y+   
Sbjct: 76  CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 128
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE L    +
Sbjct: 129 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAY-NK 186
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKD 249
           ++   D+W+ G +L EI T    P +PG D
Sbjct: 187 FSIKSDVWAFGVLLWEIATYGMSP-YPGID 215

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/221 (22%), Positives = 105/221 (47%), Gaps = 33/221 (14%)
Query: 33  YGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREI 92
           YG+ +E+  K +  ++ +G G +G+V        + +VAIK I    +  +     + E 
Sbjct: 7   YGS-WEIDPKDLTFLKELGTGQFGVVKYG-KWRGQYDVAIKMIK---EGSMSEDEFIEEA 61
Query: 93  KLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT--------DLHQIIRSDQ--QL 142
           K++ ++ HE ++ +  +    +      ++I+ E M          ++    ++ Q  ++
Sbjct: 62  KVMMNLSHEKLVQLYGVCTKQRP-----IFIITEYMANGCLLNYLREMRHRFQTQQLLEM 116
Query: 143 TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 202
             D C+         ++Y+ S   LHRDL   N L+N    +K+ DFGL+R   + ++ +
Sbjct: 117 CKDVCE--------AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 168
Query: 203 EY---VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                   RW   PE+L+  +++++  DIW+ G ++ EI +
Sbjct: 169 SVGSKFPVRW-SPPEVLMY-SKFSSKSDIWAFGVLMWEIYS 207

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 89/200 (44%), Gaps = 16/200 (8%)
Query: 50  IGRGAYGIVCAA---VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IG G  G VC     V  +    VAIK +   +      R  L E  ++   +H N+I +
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER-QRRDFLSEASIMGQFDHPNIIRL 115
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           + ++   +       Y+    +DT L      D Q T       L  +  G++Y+     
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLGY 172
Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCT 220
           +HRDL   N+L++++   K+ DFGL+R   E D       T      RW  APE +   T
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVL-EDDPDAAXTTTGGKIPIRWT-APEAIAFRT 230
Query: 221 EYTAAIDIWSVGCILGEIMT 240
            +++A D+WS G ++ E++ 
Sbjct: 231 -FSSASDVWSFGVVMWEVLA 249

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 92/196 (46%), Gaps = 6/196 (3%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IGRG++  V   +++ET  EVA  ++ +      + +R   E + L+ ++H N++   D 
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS--VL 167
                K     V +        L   ++  +       + +  Q+L+GL+++H+ +  ++
Sbjct: 94  WESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTPPII 153
Query: 168 HRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 226
           HRDLK  N+ +   +  +KIGD GLA T     F    + T  + APE      +Y  ++
Sbjct: 154 HRDLKCDNIFITGPTGSVKIGDLGLA-TLKRASFAKAVIGTPEFXAPEXYEE--KYDESV 210
Query: 227 DIWSVGCILGEIMTRE 242
           D+++ G    E  T E
Sbjct: 211 DVYAFGXCXLEXATSE 226

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 17/208 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL----REIKLLRHMEHEN 102
           ++ IGRGA+G V   V  +  ++V   K+ + F+ I  +        R+I     M   N
Sbjct: 80  VKVIGRGAFGEV-QLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDI-----MAFAN 133
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
              +  +    + D +  +Y+V E M       + S+  + +   +++  +++  L  +H
Sbjct: 134 SPWVVQLFCAFQDDKY--LYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIH 191
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNCT 220
           S  ++HRD+KP N+LL+    LK+ DFG      ET  +     V T  Y +PE+L +  
Sbjct: 192 SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQG 251
Query: 221 E---YTAAIDIWSVGCILGEIMTREPLF 245
               Y    D WSVG  L E++  +  F
Sbjct: 252 GDGYYGRECDWWSVGVFLFEMLVGDTPF 279

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/221 (22%), Positives = 105/221 (47%), Gaps = 33/221 (14%)
Query: 33  YGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREI 92
           YG+ +E+  K +  ++ +G G +G+V        + +VAIK I    +  +     + E 
Sbjct: 16  YGS-WEIDPKDLTFLKELGTGQFGVVKYG-KWRGQYDVAIKMIK---EGSMSEDEFIEEA 70
Query: 93  KLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT--------DLHQIIRSDQ--QL 142
           K++ ++ HE ++ +  +    +      ++I+ E M          ++    ++ Q  ++
Sbjct: 71  KVMMNLSHEKLVQLYGVCTKQRP-----IFIITEYMANGCLLNYLREMRHRFQTQQLLEM 125
Query: 143 TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 202
             D C+         ++Y+ S   LHRDL   N L+N    +K+ DFGL+R   + ++ +
Sbjct: 126 CKDVCE--------AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 177
Query: 203 EY---VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                   RW   PE+L+  +++++  DIW+ G ++ EI +
Sbjct: 178 SVGSKFPVRW-SPPEVLMY-SKFSSKSDIWAFGVLMWEIYS 216

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 30/204 (14%)
Query: 50  IGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +G+G +G V     N  TR  VAIK +       +     L+E ++++ + HE ++ +  
Sbjct: 16  LGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 70
Query: 109 IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKY 160
           ++      +   + IV E M    L   ++ +        QL D        Q+  G+ Y
Sbjct: 71  VV------SEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVD-----MAAQIASGMAY 119
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLL 217
           V   + +HRDL+ +N+L+  +   K+ DFGLAR   + +           +W  APE  L
Sbjct: 120 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW-TAPEAAL 178
Query: 218 NCTEYTAAIDIWSVGCILGEIMTR 241
               +T   D+WS G +L E+ T+
Sbjct: 179 Y-GRFTIKSDVWSFGILLTELTTK 201

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 94/194 (48%), Gaps = 21/194 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +GRG++G V    + +T  + A+KK+       ++  R   E+     +    ++ +   
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKV------RLEVFRA-EELMACAGLTSPRIVPLYGA 134
Query: 110 IRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           +R         V I  EL++   L Q+++    L +D   Y+L Q L GL+Y+HS  +LH
Sbjct: 135 VR-----EGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILH 189
Query: 169 RDLKPSNLLLNA-SCDLKIGDFGLARTTSE----TDFMT-EYVV-TRWYRAPELLLNCTE 221
            D+K  N+LL++      + DFG A          D +T +Y+  T  + APE++L    
Sbjct: 190 GDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLG-RS 248
Query: 222 YTAAIDIWSVGCIL 235
             A +D+WS  C++
Sbjct: 249 CDAKVDVWSSCCMM 262

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 93/197 (47%), Gaps = 27/197 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +GRG++G V    + +T  + A+KK+       ++  R   E+     +    ++ +   
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKV------RLEVFRA-EELMACAGLTSPRIVPLYGA 153
Query: 110 IRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           +R         V I  EL++   L Q+++    L +D   Y+L Q L GL+Y+HS  +LH
Sbjct: 154 VR-----EGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILH 208
Query: 169 RDLKPSNLLLN------ASCDLK----IGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
            D+K  N+LL+      A CD      +   GL ++    D++     T  + APE++L 
Sbjct: 209 GDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPG---TETHMAPEVVLG 265
Query: 219 CTEYTAAIDIWSVGCIL 235
                A +D+WS  C++
Sbjct: 266 -RSCDAKVDVWSSCCMM 281

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/217 (22%), Positives = 102/217 (47%), Gaps = 32/217 (14%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           +E+  K +  ++ +G G +G+V        + +VAIK I    +  +     + E K++ 
Sbjct: 4   WEIDPKDLTFLKELGTGQFGVVKYG-KWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMM 59
Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT--------DLHQIIRSDQ--QLTDDH 146
           ++ HE ++ +  +    +      ++I+ E M          ++    ++ Q  ++  D 
Sbjct: 60  NLSHEKLVQLYGVCTKQRP-----IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 114
Query: 147 CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY-- 204
           C+         ++Y+ S   LHRDL   N L+N    +K+ DFGL+R   + ++ +    
Sbjct: 115 CE--------AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 166
Query: 205 -VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               RW   PE+L+  +++++  DIW+ G ++ EI +
Sbjct: 167 KFPVRW-SPPEVLMY-SKFSSKSDIWAFGVLMWEIYS 201

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA-RRTLREIKLLRHMEHENVIA 105
            R +GRG +G V A     T +  A KK+           +  + E K+L  +    +++
Sbjct: 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTD-----LHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           +         +T  D+ +V  +M+       ++ +   +    +    ++  Q++ GL++
Sbjct: 250 LAYAF-----ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNC 219
           +H  ++++RDLKP N+LL+   +++I D GLA         T+ Y  T  + APELLL  
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG- 363
Query: 220 TEYTAAIDIWSVGCILGE-IMTREPL 244
            EY  ++D +++G  L E I  R P 
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 100/218 (45%), Gaps = 15/218 (6%)
Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR----RTLREIKLLRHMEHENV 103
           RP+G+G +G V  A   ++   VA+K +   F + I+      +  REI++  H+ H N+
Sbjct: 29  RPLGKGKFGNVYLAREKKSHFIVALKVL---FKSQIEKEGVEHQLRREIEIQAHLHHPNI 85
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           + + +     ++     +Y++ E     +L++ ++      +      + +L   L Y H
Sbjct: 86  LRLYNYFYDRRR-----IYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCH 140
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
              V+HRD+KP NLLL    +LKI DFG +         T    T  Y  PE ++    +
Sbjct: 141 GKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKT-MCGTLDYLPPE-MIEGRMH 198
Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
              +D+W +G +  E++   P F    +    R I +V
Sbjct: 199 NEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKV 236

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA-RRTLREIKLLRHMEHENVIA 105
            R +GRG +G V A     T +  A KK+           +  + E K+L  +    +++
Sbjct: 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTD-----LHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           +         +T  D+ +V  +M+       ++ +   +    +    ++  Q++ GL++
Sbjct: 250 LAYAF-----ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNC 219
           +H  ++++RDLKP N+LL+   +++I D GLA         T+ Y  T  + APELLL  
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG- 363
Query: 220 TEYTAAIDIWSVGCILGE-IMTREPL 244
            EY  ++D +++G  L E I  R P 
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA-RRTLREIKLLRHMEHENVIA 105
            R +GRG +G V A     T +  A KK+           +  + E K+L  +    +++
Sbjct: 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTD-----LHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           +         +T  D+ +V  +M+       ++ +   +    +    ++  Q++ GL++
Sbjct: 250 LAYAF-----ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNC 219
           +H  ++++RDLKP N+LL+   +++I D GLA         T+ Y  T  + APELLL  
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG- 363
Query: 220 TEYTAAIDIWSVGCILGE-IMTREPL 244
            EY  ++D +++G  L E I  R P 
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA-RRTLREIKLLRHMEHENVIA 105
            R +GRG +G V A     T +  A KK+           +  + E K+L  +    +++
Sbjct: 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTD-----LHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           +         +T  D+ +V  +M+       ++ +   +    +    ++  Q++ GL++
Sbjct: 250 LAYAF-----ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNC 219
           +H  ++++RDLKP N+LL+   +++I D GLA         T+ Y  T  + APELLL  
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG- 363
Query: 220 TEYTAAIDIWSVGCILGE-IMTREPL 244
            EY  ++D +++G  L E I  R P 
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q+++     Y   Q+   ++Y+   
Sbjct: 285 CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 337
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HR+L   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE L    +
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA-YNK 395
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKD 249
           ++   D+W+ G +L EI T    P +PG D
Sbjct: 396 FSIKSDVWAFGVLLWEIATYGMSP-YPGID 424

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/217 (22%), Positives = 102/217 (47%), Gaps = 32/217 (14%)
Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           +E+  K +  ++ +G G +G+V        + +VAIK I    +  +     + E K++ 
Sbjct: 3   WEIDPKDLTFLKELGTGQFGVVKYG-KWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMM 58
Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT--------DLHQIIRSDQ--QLTDDH 146
           ++ HE ++ +  +    +      ++I+ E M          ++    ++ Q  ++  D 
Sbjct: 59  NLSHEKLVQLYGVCTKQRP-----IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 113
Query: 147 CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY-- 204
           C+         ++Y+ S   LHRDL   N L+N    +K+ DFGL+R   + ++ +    
Sbjct: 114 CE--------AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 165
Query: 205 -VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               RW   PE+L+  +++++  DIW+ G ++ EI +
Sbjct: 166 KFPVRW-SPPEVLMY-SKFSSKSDIWAFGVLMWEIYS 200

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 51/98 (52%), Gaps = 12/98 (12%)
Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--- 206
           F YQ+ +G+ ++ S + +HRDL   N+LL      KI DFGLAR        + YVV   
Sbjct: 168 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND---SNYVVKGN 224
Query: 207 ----TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                +W  APE + NC  YT   D+WS G  L E+ +
Sbjct: 225 ARLPVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFS 260

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 84/163 (51%), Gaps = 31/163 (19%)
Query: 91  EIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQL--TDDHCQ 148
           E++++  +++E  +  + II       +++VYI+YE M+ D   I++ D+     D +  
Sbjct: 93  ELQIITDIKNEYCLTCEGIIT-----NYDEVYIIYEYMEND--SILKFDEYFFVLDKNYT 145
Query: 149 YFL---------YQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 198
            F+           +L    Y+H+  ++ HRD+KPSN+L++ +  +K+ DFG      E+
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFG------ES 199
Query: 199 DFMTEYVV-----TRWYRAPELLLNCTEYTAA-IDIWSVGCIL 235
           ++M +  +     T  +  PE   N + Y  A +DIWS+G  L
Sbjct: 200 EYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 51/98 (52%), Gaps = 12/98 (12%)
Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--- 206
           F YQ+ +G+ ++ S + +HRDL   N+LL      KI DFGLAR        + YVV   
Sbjct: 166 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND---SNYVVKGN 222
Query: 207 ----TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                +W  APE + NC  YT   D+WS G  L E+ +
Sbjct: 223 ARLPVKWM-APESIFNCV-YTFESDVWSYGIFLWELFS 258

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 51/98 (52%), Gaps = 12/98 (12%)
Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--- 206
           F YQ+ +G+ ++ S + +HRDL   N+LL      KI DFGLAR        + YVV   
Sbjct: 173 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND---SNYVVKGN 229
Query: 207 ----TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                +W  APE + NC  YT   D+WS G  L E+ +
Sbjct: 230 ARLPVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFS 265

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 29/220 (13%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-----HE 101
           +R +G G +  V  A +      VA+K +     + +       EIKLL+ +       E
Sbjct: 24  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 102 NVIAIKDIIRPPKKDTFND-------VYIVYELMDTDLHQIIRSDQQ--LTDDHCQYFLY 152
           + +    I++    D FN        V +V+E++  +L  +I+  +   +   + +    
Sbjct: 81  DSMGANHILK--LLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 138
Query: 153 QLLRGLKYVHS-ASVLHRDLKPSNLLLNAS------CDLKIGDFGLARTTSETDFMTEYV 205
           QLL GL Y+H    ++H D+KP N+L+           +KI D G A    E    T  +
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE--HYTNSI 196
Query: 206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 245
            TR YR+PE+LL    +    DIWS  C++ E++T + LF
Sbjct: 197 QTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLF 235

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 17/208 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL----REIKLLRHMEHEN 102
           ++ IGRGA+G V    +  TR+  A+K + + F+ I  +        R+I     M   N
Sbjct: 79  VKVIGRGAFGEVQLVRHKSTRKVYAMKLL-SKFEMIKRSDSAFFWEERDI-----MAFAN 132
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
              +  +    + D +  +Y+V E M       + S+  + +   +++  +++  L  +H
Sbjct: 133 SPWVVQLFYAFQDDRY--LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIH 190
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNCT 220
           S   +HRD+KP N+LL+ S  LK+ DFG     ++   +     V T  Y +PE+L +  
Sbjct: 191 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 250
Query: 221 E---YTAAIDIWSVGCILGEIMTREPLF 245
               Y    D WSVG  L E++  +  F
Sbjct: 251 GDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 17/208 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL----REIKLLRHMEHEN 102
           ++ IGRGA+G V    +  TR+  A+K + + F+ I  +        R+I     M   N
Sbjct: 79  VKVIGRGAFGEVQLVRHKSTRKVYAMKLL-SKFEMIKRSDSAFFWEERDI-----MAFAN 132
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
              +  +    + D +  +Y+V E M       + S+  + +   +++  +++  L  +H
Sbjct: 133 SPWVVQLFYAFQDDRY--LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIH 190
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNCT 220
           S   +HRD+KP N+LL+ S  LK+ DFG     ++   +     V T  Y +PE+L +  
Sbjct: 191 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 250
Query: 221 E---YTAAIDIWSVGCILGEIMTREPLF 245
               Y    D WSVG  L E++  +  F
Sbjct: 251 GDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 100/210 (47%), Gaps = 23/210 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q++      Y   Q+   ++Y+   
Sbjct: 79  CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 131
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T     ++   + APE L    +
Sbjct: 132 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAPESLAY-NK 189
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKD 249
           ++   D+W+ G +L EI T    P +PG D
Sbjct: 190 FSIKSDVWAFGVLLWEIATYGMSP-YPGID 218

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 103/207 (49%), Gaps = 30/207 (14%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAIKD 108
           IG G++G V      +   +VA+K I    D   +  +  R E+ +LR   H N++    
Sbjct: 44  IGSGSFGTVYKG---KWHGDVAVK-ILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMG 99
Query: 109 IIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLL-------RGLKY 160
            +      T +++ IV +  + + L++       L     ++ ++QL+       +G+ Y
Sbjct: 100 YM------TKDNLAIVTQWCEGSSLYK------HLHVQETKFQMFQLIDIARQTAQGMDY 147
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE---TDFMTEYVVTRWYRAPEL-- 215
           +H+ +++HRD+K +N+ L+    +KIGDFGLA   S    +  + +   +  + APE+  
Sbjct: 148 LHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIR 207
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTRE 242
           + +   ++   D++S G +L E+MT E
Sbjct: 208 MQDNNPFSFQSDVYSYGIVLYELMTGE 234

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 323
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q++      Y   Q+   ++Y+   
Sbjct: 324 CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 376
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HR+L   N L+  +  +K+ DFGL+R  +  D  T +   ++   + APE L    +
Sbjct: 377 NFIHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA-YNK 434
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKD 249
           ++   D+W+ G +L EI T    P +PG D
Sbjct: 435 FSIKSDVWAFGVLLWEIATYGMSP-YPGID 463

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 29/220 (13%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-----HE 101
           +R +G G +  V  A +      VA+K +     + +       EIKLL+ +       E
Sbjct: 24  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 102 NVIAIKDIIRPPKKDTFND-------VYIVYELMDTDLHQIIRSDQQ--LTDDHCQYFLY 152
           + +    I++    D FN        V +V+E++  +L  +I+  +   +   + +    
Sbjct: 81  DSMGANHILK--LLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 138
Query: 153 QLLRGLKYVHS-ASVLHRDLKPSNLLLNAS------CDLKIGDFGLARTTSETDFMTEYV 205
           QLL GL Y+H    ++H D+KP N+L+           +KI D G A    E    T  +
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE--HYTNSI 196
Query: 206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 245
            TR YR+PE+LL    +    DIWS  C++ E++T + LF
Sbjct: 197 QTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLF 235

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 51/98 (52%), Gaps = 12/98 (12%)
Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--- 206
           F YQ+ +G+ ++ S + +HRDL   N+LL      KI DFGLAR        + YVV   
Sbjct: 150 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND---SNYVVKGN 206
Query: 207 ----TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                +W  APE + NC  YT   D+WS G  L E+ +
Sbjct: 207 ARLPVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFS 242

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 51/98 (52%), Gaps = 12/98 (12%)
Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--- 206
           F YQ+ +G+ ++ S + +HRDL   N+LL      KI DFGLAR        + YVV   
Sbjct: 173 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKND---SNYVVKGN 229
Query: 207 ----TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                +W  APE + NC  YT   D+WS G  L E+ +
Sbjct: 230 ARLPVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFS 265

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 100/210 (47%), Gaps = 23/210 (10%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 110 I--RPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSA 164
               PP        YI+ E M   +L   +R  + Q++      Y   Q+   ++Y+   
Sbjct: 80  CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 132
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           + +HRDL   N L+  +  +K+ DFGL+R  +  D  T     ++   + APE L    +
Sbjct: 133 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAPESLA-YNK 190
Query: 222 YTAAIDIWSVGCILGEIMT--REPLFPGKD 249
           ++   D+W+ G +L EI T    P +PG D
Sbjct: 191 FSIKSDVWAFGVLLWEIATYGMSP-YPGID 219

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 17/208 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL----REIKLLRHMEHEN 102
           ++ IGRGA+G V    +  TR+  A+K + + F+ I  +        R+I     M   N
Sbjct: 74  VKVIGRGAFGEVQLVRHKSTRKVYAMKLL-SKFEMIKRSDSAFFWEERDI-----MAFAN 127
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
              +  +    + D +  +Y+V E M       + S+  + +   +++  +++  L  +H
Sbjct: 128 SPWVVQLFYAFQDDRY--LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIH 185
Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNCT 220
           S   +HRD+KP N+LL+ S  LK+ DFG     ++   +     V T  Y +PE+L +  
Sbjct: 186 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 245
Query: 221 E---YTAAIDIWSVGCILGEIMTREPLF 245
               Y    D WSVG  L E++  +  F
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 27/197 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +GRG++G V    + +T  + A+KK+       ++  R + E+     +    ++ +   
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKV------RLEVFR-VEELVACAGLSSPRIVPLYGA 134
Query: 110 IRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           +R         V I  EL++   L Q+I+    L +D   Y+L Q L GL+Y+H+  +LH
Sbjct: 135 VR-----EGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILH 189
Query: 169 RDLKPSNLLLN------ASCD----LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
            D+K  N+LL+      A CD    L +   GL ++    D++     T  + APE+++ 
Sbjct: 190 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG---TETHMAPEVVMG 246
Query: 219 CTEYTAAIDIWSVGCIL 235
                A +DIWS  C++
Sbjct: 247 -KPCDAKVDIWSSCCMM 262

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 27/197 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +GRG++G V    + +T  + A+KK+       ++  R + E+     +    ++ +   
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKV------RLEVFR-VEELVACAGLSSPRIVPLYGA 118
Query: 110 IRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           +R         V I  EL++   L Q+I+    L +D   Y+L Q L GL+Y+H+  +LH
Sbjct: 119 VR-----EGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILH 173
Query: 169 RDLKPSNLLLN------ASCD----LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
            D+K  N+LL+      A CD    L +   GL ++    D++     T  + APE+++ 
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG---TETHMAPEVVMG 230
Query: 219 CTEYTAAIDIWSVGCIL 235
                A +DIWS  C++
Sbjct: 231 -KPCDAKVDIWSSCCMM 246

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 38/224 (16%)
Query: 50  IGRGAYGIVCAA-----VNSETREEVAIKKIGNAFDNIIDARRTL-REIKLLRHMEHENV 103
           +G GA+G V  A     +  + +  VA+K +  A ++   AR+   RE +LL  ++H+++
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES---ARQDFQREAELLTMLQHQHI 105
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRS---DQQLTDD------------HC 147
           +    +    +      + +V+E M   DL++ +RS   D +L                 
Sbjct: 106 VRFFGVCTEGRP-----LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 148 QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TE 203
                Q+  G+ Y+     +HRDL   N L+     +KIGDFG++R    TD+       
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220
Query: 204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLF 245
            +  RW   PE +L   ++T   D+WS G +L EI T  ++P +
Sbjct: 221 MLPIRWM-PPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWY 262

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 6/106 (5%)
Query: 139 DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 198
           ++ LT      F +Q+ +G++Y+   S++HRDL   N+L+     +KI DFGL+R   E 
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 199 DFMTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           D   +     +  +W     L  +   YT   D+WS G +L EI+T
Sbjct: 204 DSXVKRSQGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVT 247

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 38/224 (16%)
Query: 50  IGRGAYGIVCAA-----VNSETREEVAIKKIGNAFDNIIDARRTL-REIKLLRHMEHENV 103
           +G GA+G V  A     +  + +  VA+K +  A ++   AR+   RE +LL  ++H+++
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES---ARQDFQREAELLTMLQHQHI 76
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRS---DQQLTDD------------HC 147
           +    +    +      + +V+E M   DL++ +RS   D +L                 
Sbjct: 77  VRFFGVCTEGRP-----LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 131
Query: 148 QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TE 203
                Q+  G+ Y+     +HRDL   N L+     +KIGDFG++R    TD+       
Sbjct: 132 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 191
Query: 204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLF 245
            +  RW   PE +L   ++T   D+WS G +L EI T  ++P +
Sbjct: 192 MLPIRWM-PPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWY 233

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 57/96 (59%), Gaps = 6/96 (6%)
Query: 149 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTE---Y 204
           +F  Q+ +G+ ++ S + +HRD+   N+LL      KIGDFGLAR   ++++++ +    
Sbjct: 162 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 221
Query: 205 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           +  +W  APE + +C  YT   D+WS G +L EI +
Sbjct: 222 LPVKWM-APESIFDCV-YTVQSDVWSYGILLWEIFS 255

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 95/207 (45%), Gaps = 30/207 (14%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG---------NAFDNIIDARRTLREIKLLRHMEH 100
           IG G++G V      +   +VA+K +           AF N +   R  R + +L  M +
Sbjct: 16  IGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
                +  + +  +  +   +Y    +++T    I     +L D        Q  +G+ Y
Sbjct: 73  STAPQLAIVTQWCEGSS---LYHHLHIIETKFEMI-----KLID-----IARQTAQGMDY 119
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPEL-- 215
           +H+ S++HRDLK +N+ L+    +KIGDFGLA   S      ++     +  + APE+  
Sbjct: 120 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTRE 242
           + +   Y+   D+++ G +L E+MT +
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 38/224 (16%)
Query: 50  IGRGAYGIVCAA-----VNSETREEVAIKKIGNAFDNIIDARRTL-REIKLLRHMEHENV 103
           +G GA+G V  A     +  + +  VA+K +  A ++   AR+   RE +LL  ++H+++
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES---ARQDFQREAELLTMLQHQHI 82
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRS---DQQLTDD------------HC 147
           +    +    +      + +V+E M   DL++ +RS   D +L                 
Sbjct: 83  VRFFGVCTEGRP-----LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 137
Query: 148 QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TE 203
                Q+  G+ Y+     +HRDL   N L+     +KIGDFG++R    TD+       
Sbjct: 138 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 197
Query: 204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLF 245
            +  RW   PE +L   ++T   D+WS G +L EI T  ++P +
Sbjct: 198 MLPIRWM-PPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWY 239

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 24/216 (11%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKD 108
           +G GA+  V   +N  T +E A+K I     +I    R  RE+++L   + H NV+ + +
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHI--RSRVFREVEMLYQCQGHRNVLELIE 78
Query: 109 IIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
                ++D F   Y+V+E M    +   I   +   +      +  +   L ++H+  + 
Sbjct: 79  FFE--EEDRF---YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIA 133
Query: 168 HRDLKPSNLLL---NASCDLKIGDFGLAR--------TTSETDFMTEYVVTRWYRAPELL 216
           HRDLKP N+L    N    +KI DFGL          +   T  +     +  Y APE++
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV 193
Query: 217 LNCTE----YTAAIDIWSVGCILGEIMTREPLFPGK 248
              +E    Y    D+WS+G IL  +++  P F G+
Sbjct: 194 EAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGR 229

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 27/197 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +GRG++G V    + +T  + A+KK+       ++  R + E+     +    ++ +   
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKV------RLEVFR-VEELVACAGLSSPRIVPLYGA 132
Query: 110 IRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           +R         V I  EL++   L Q+I+    L +D   Y+L Q L GL+Y+H+  +LH
Sbjct: 133 VR-----EGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILH 187
Query: 169 RDLKPSNLLLN------ASCD----LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
            D+K  N+LL+      A CD    L +   GL ++    D++     T  + APE+++ 
Sbjct: 188 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG---TETHMAPEVVMG 244
Query: 219 CTEYTAAIDIWSVGCIL 235
                A +DIWS  C++
Sbjct: 245 -KPCDAKVDIWSSCCMM 260

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 101/233 (43%), Gaps = 34/233 (14%)
Query: 34  GNLFEVSSKYVPPIRPIGRGAYGIV-----CAAVNSETREEVAIKKIGNAFDNIIDARRT 88
           G L E+S   V  +  +G   +G V           E  + VAIK + +  +  +  R  
Sbjct: 1   GKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPL--REE 58
Query: 89  LREIKLLR-HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII-----RSDQQL 142
            R   +LR  ++H NV+ +  ++    KD    +   Y     DLH+ +      SD   
Sbjct: 59  FRHEAMLRARLQHPNVVCLLGVV---TKDQPLSMIFSY-CSHGDLHEFLVMRSPHSDVGS 114
Query: 143 TDDHCQ-----------YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 191
           TDD              + + Q+  G++Y+ S  V+H+DL   N+L+    ++KI D GL
Sbjct: 115 TDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGL 174
Query: 192 ARTTSETDFM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
            R     D+        +  RW  APE ++   +++   DIWS G +L E+ +
Sbjct: 175 FREVYAADYYKLLGNSLLPIRWM-APEAIMY-GKFSIDSDIWSYGVVLWEVFS 225

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 24/204 (11%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G V      +   +VA+K +          +    E+ +LR   H N++     
Sbjct: 21  IGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 110 IRPPKKDTF------NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
              P+          + +Y    +++T    I     +L D        Q  +G+ Y+H+
Sbjct: 78  STKPQLAIVTQWCEGSSLYHHLHIIETKFEMI-----KLID-----IARQTAQGMDYLHA 127
Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPEL--LLN 218
            S++HRDLK +N+ L+    +KIGDFGLA   S      ++     +  + APE+  + +
Sbjct: 128 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 219 CTEYTAAIDIWSVGCILGEIMTRE 242
              Y+   D+++ G +L E+MT +
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 24/204 (11%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G V      +   +VA+K +          +    E+ +LR   H N++     
Sbjct: 18  IGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 110 IRPPKKDTF------NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
              P+          + +Y    +++T    I     +L D        Q  +G+ Y+H+
Sbjct: 75  STKPQLAIVTQWCEGSSLYHHLHIIETKFEMI-----KLID-----IARQTAQGMDYLHA 124
Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPEL--LLN 218
            S++HRDLK +N+ L+    +KIGDFGLA   S      ++     +  + APE+  + +
Sbjct: 125 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 184
Query: 219 CTEYTAAIDIWSVGCILGEIMTRE 242
              Y+   D+++ G +L E+MT +
Sbjct: 185 KNPYSFQSDVYAFGIVLYELMTGQ 208

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 24/204 (11%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G V      +   +VA+K +          +    E+ +LR   H N++     
Sbjct: 16  IGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 110 IRPPKKDTF------NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
              P+          + +Y    +++T    I     +L D        Q  +G+ Y+H+
Sbjct: 73  STKPQLAIVTQWCEGSSLYHHLHIIETKFEMI-----KLID-----IARQTAQGMDYLHA 122
Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPEL--LLN 218
            S++HRDLK +N+ L+    +KIGDFGLA   S      ++     +  + APE+  + +
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 219 CTEYTAAIDIWSVGCILGEIMTRE 242
              Y+   D+++ G +L E+MT +
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 24/204 (11%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G V      +   +VA+K +          +    E+ +LR   H N++     
Sbjct: 21  IGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 110 IRPPKKDTF------NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
              P+          + +Y    +++T    I     +L D        Q  +G+ Y+H+
Sbjct: 78  STKPQLAIVTQWCEGSSLYHHLHIIETKFEMI-----KLID-----IARQTAQGMDYLHA 127
Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPEL--LLN 218
            S++HRDLK +N+ L+    +KIGDFGLA   S      ++     +  + APE+  + +
Sbjct: 128 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 219 CTEYTAAIDIWSVGCILGEIMTRE 242
              Y+   D+++ G +L E+MT +
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 99/208 (47%), Gaps = 24/208 (11%)
Query: 47  IRPIGRGAYGIV--CA--AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN 102
           I  +G+G +G V  C    +   T   VA+K++ ++  +    R   REI++L+ +  + 
Sbjct: 12  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD--QQRDFQREIQILKALHSDF 69
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKY 160
           ++  + +   P +    ++ +V E + +   +      +   D  +  LY  Q+ +G++Y
Sbjct: 70  IVKYRGVSYGPGRP---ELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEY 126
Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--------WYRA 212
           + S   +HRDL   N+L+ +   +KI DFGLA+         +  V R        WY A
Sbjct: 127 LGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP---LDKDXXVVREPGQSPIFWY-A 182
Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMT 240
           PE L +   ++   D+WS G +L E+ T
Sbjct: 183 PESLSD-NIFSRQSDVWSFGVVLYELFT 209

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 26/205 (12%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G V      +   +VA+K +          +    E+ +LR   H N++     
Sbjct: 16  IGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 110 IRPPKKDTF------NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
              P+          + +Y    +++T    I     +L D        Q  +G+ Y+H+
Sbjct: 73  STKPQLAIVTQWCEGSSLYHHLHIIETKFEMI-----KLID-----IARQTAQGMDYLHA 122
Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLA----RTTSETDFMTEYVVTRWYRAPEL--LL 217
            S++HRDLK +N+ L+    +KIGDFGLA    R +    F        W  APE+  + 
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM-APEVIRMQ 181
Query: 218 NCTEYTAAIDIWSVGCILGEIMTRE 242
           +   Y+   D+++ G +L E+MT +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 96/216 (44%), Gaps = 26/216 (12%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKD 108
           +G GAY  V  AV+ +  +E A+K I     +     R  RE++ L   + ++N++ + +
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGH--SRSRVFREVETLYQCQGNKNILELIE 78
Query: 109 IIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
                + DT    Y+V+E L    +   I+  +   +      +  +   L ++H+  + 
Sbjct: 79  FF---EDDT--RFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIA 133
Query: 168 HRDLKPSNLLLNAS--------CDLKIGDFGLARTTSETDFMTEYVVTRW----YRAPEL 215
           HRDLKP N+L  +         CD  +G  G+    S T   T  + T      Y APE+
Sbjct: 134 HRDLKPENILCESPEKVSPVKICDFDLGS-GMKLNNSCTPITTPELTTPCGSAEYMAPEV 192
Query: 216 LL----NCTEYTAAIDIWSVGCILGEIMTREPLFPG 247
           +       T Y    D+WS+G +L  +++  P F G
Sbjct: 193 VEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVG 228

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 17/209 (8%)
Query: 48  RPIGRGAYGIVCAAVNSE---TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI 104
           R +G+G +G V  A   +   +  +VA+K +        D    LRE   ++  +H +V 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 105 AIKDI-IRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ------QLTDDHCQYFLYQLLR 156
            +  + +R   K       ++   M   DLH  + + +       L       F+  +  
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT----RWYRA 212
           G++Y+ S + +HRDL   N +L     + + DFGL+R     D+  +   +    +W   
Sbjct: 149 GMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLAL 208
Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMTR 241
             L  N   YT   D+W+ G  + EIMTR
Sbjct: 209 ESLADNL--YTVHSDVWAFGVTMWEIMTR 235

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 93/203 (45%), Gaps = 24/203 (11%)
Query: 46  PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVI 104
           P   +G GA G +      + R+ VA+K+I     +  D     RE++LLR   EH NVI
Sbjct: 28  PKDVLGHGAEGTIVYRGMFDNRD-VAVKRILPECFSFAD-----REVQLLRESDEHPNVI 81
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDTDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHS 163
                    K   F   YI  EL    L + + + D           L Q   GL ++HS
Sbjct: 82  RY---FCTEKDRQFQ--YIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 164 ASVLHRDLKPSNLLL---NASCDLK--IGDFGLAR--TTSETDFMTEYVV--TRWYRAPE 214
            +++HRDLKP N+L+   NA   +K  I DFGL +        F     V  T  + APE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 215 LLL-NCTEY-TAAIDIWSVGCIL 235
           +L  +C E  T  +DI+S GC+ 
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVF 219

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/239 (23%), Positives = 102/239 (42%), Gaps = 33/239 (13%)
Query: 47  IRPIGRGAYGIVCAAVNSETR-EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN--- 102
           +  +G G +G V   V+       VA+K I N       AR  +  ++ +   + +N   
Sbjct: 38  VSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEKDPDNKNL 97
Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTD--DHCQYFLYQLLRGLKY 160
            + + D       D    + I +EL+       ++ +  L       ++  +QL + +K+
Sbjct: 98  CVQMFDWF-----DYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVKF 152
Query: 161 VHSASVLHRDLKPSNLLL-NASCDL------------------KIGDFGLARTTSETDFM 201
           +H   + H DLKP N+L  N+  +L                  ++ DFG A  T + +  
Sbjct: 153 LHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSA--TFDHEHH 210
Query: 202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           +  V TR YRAPE++L    ++   D+WS+GCI+ E      LF   D    L ++  +
Sbjct: 211 STIVSTRHYRAPEVILELG-WSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMERI 268

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G V      +   +VA+K +          +    E+ +LR   H N++     
Sbjct: 43  IGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 99
Query: 110 IRPPKKDTF------NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
              P+          + +Y    +++T    I     +L D        Q  +G+ Y+H+
Sbjct: 100 STKPQLAIVTQWCEGSSLYHHLHIIETKFEMI-----KLID-----IARQTAQGMDYLHA 149
Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLA----RTTSETDFMTEYVVTRWYRAPEL--LL 217
            S++HRDLK +N+ L+    +KIGDFGLA    R +    F        W  APE+  + 
Sbjct: 150 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM-APEVIRMQ 208
Query: 218 NCTEYTAAIDIWSVGCILGEIMT 240
           +   Y+   D+++ G +L E+MT
Sbjct: 209 DKNPYSFQSDVYAFGIVLYELMT 231

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/207 (22%), Positives = 97/207 (46%), Gaps = 32/207 (15%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ +G G +G+V        + +VAIK I    +  +     + E K++ ++ HE ++ +
Sbjct: 9   LKELGTGQFGVVKYG-KWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 107 KDIIRPPKKDTFNDVYIVYELMDT--------DLHQIIRSDQ--QLTDDHCQYFLYQLLR 156
             +    +      ++I+ E M          ++    ++ Q  ++  D C+        
Sbjct: 65  YGVCTKQRP-----IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE-------- 111
Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAP 213
            ++Y+ S   LHRDL   N L+N    +K+ DFGL+R   + ++ +        RW   P
Sbjct: 112 AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW-SPP 170
Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMT 240
           E+L+  +++++  DIW+ G ++ EI +
Sbjct: 171 EVLMY-SKFSSKSDIWAFGVLMWEIYS 196

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G V      +   +VA+K +          +    E+ +LR   H N++     
Sbjct: 36  IGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 92
Query: 110 IRPPKKDTF------NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
              P+          + +Y    +++T    I     +L D        Q  +G+ Y+H+
Sbjct: 93  STKPQLAIVTQWCEGSSLYHHLHIIETKFEMI-----KLID-----IARQTAQGMDYLHA 142
Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLA----RTTSETDFMTEYVVTRWYRAPEL--LL 217
            S++HRDLK +N+ L+    +KIGDFGLA    R +    F        W  APE+  + 
Sbjct: 143 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM-APEVIRMQ 201
Query: 218 NCTEYTAAIDIWSVGCILGEIMT 240
           +   Y+   D+++ G +L E+MT
Sbjct: 202 DKNPYSFQSDVYAFGIVLYELMT 224

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G V      +   +VA+K +          +    E+ +LR   H N++     
Sbjct: 44  IGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 110 IRPPKKDTF------NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
              P+          + +Y    +++T    I     +L D        Q  +G+ Y+H+
Sbjct: 101 STKPQLAIVTQWCEGSSLYHHLHIIETKFEMI-----KLID-----IARQTAQGMDYLHA 150
Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLA----RTTSETDFMTEYVVTRWYRAPEL--LL 217
            S++HRDLK +N+ L+    +KIGDFGLA    R +    F        W  APE+  + 
Sbjct: 151 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM-APEVIRMQ 209
Query: 218 NCTEYTAAIDIWSVGCILGEIMT 240
           +   Y+   D+++ G +L E+MT
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMT 232

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG G++G V      +   +VA+K +          +    E+ +LR   H N++     
Sbjct: 44  IGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 110 IRPPKKDTF------NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
              P+          + +Y    +++T    I     +L D        Q  +G+ Y+H+
Sbjct: 101 STKPQLAIVTQWCEGSSLYHHLHIIETKFEMI-----KLID-----IARQTAQGMDYLHA 150
Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLA----RTTSETDFMTEYVVTRWYRAPEL--LL 217
            S++HRDLK +N+ L+    +KIGDFGLA    R +    F        W  APE+  + 
Sbjct: 151 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM-APEVIRMQ 209
Query: 218 NCTEYTAAIDIWSVGCILGEIMT 240
           +   Y+   D+++ G +L E+MT
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMT 232

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 54/106 (50%), Gaps = 6/106 (5%)
Query: 139 DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 198
           ++ LT      F +Q+ +G++Y+    ++HRDL   N+L+     +KI DFGL+R   E 
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 199 DFMTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           D   +     +  +W     L  +   YT   D+WS G +L EI+T
Sbjct: 204 DSXVKRSQGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVT 247

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 96/199 (48%), Gaps = 16/199 (8%)
Query: 50  IGRGAYGIVCAAVNSETREE--VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           +G G +G V   V    +++  VAIK +    +   D    +RE +++  +++  ++ + 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA-DTEEMMREAQIMHQLDNPYIVRLI 76
Query: 108 DIIRPPKKDTFNDVYIVYELMDTD-LHQ-IIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            + +         + +V E+     LH+ ++   +++   +    L+Q+  G+KY+   +
Sbjct: 77  GVCQA------EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 130
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FMTEYVVTRW---YRAPELLLNCTE 221
            +HRDL   N+LL      KI DFGL++     D + T     +W   + APE  +N  +
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE-CINFRK 189
Query: 222 YTAAIDIWSVGCILGEIMT 240
           +++  D+WS G  + E ++
Sbjct: 190 FSSRSDVWSYGVTMWEALS 208

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 53/107 (49%), Gaps = 8/107 (7%)
Query: 139 DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 198
           ++ LT      F +Q+ +G++Y+    ++HRDL   N+L+     +KI DFGL+R   E 
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 199 DFMTEYVVTRWYRAPELLLNCTE-----YTAAIDIWSVGCILGEIMT 240
           D    YV     R P   +         YT   D+WS G +L EI+T
Sbjct: 204 D---SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 103/218 (47%), Gaps = 22/218 (10%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVI 104
           I+ IGRGA+G V A V  +  E +   KI N ++ +  A       E  +L + + + + 
Sbjct: 79  IKVIGRGAFGEV-AVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWIT 137
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQII-RSDQQLTDDHCQYFLYQLLRGLK 159
           A+           F D   +Y +MD     DL  ++ + + +L +D  ++++ +++  + 
Sbjct: 138 ALHY--------AFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAID 189
Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLL 217
            +H    +HRD+KP N+LL+ +  +++ DFG     ++   +   V   T  Y +PE+L 
Sbjct: 190 SIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQ 249
Query: 218 ----NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV 251
                  +Y    D WS+G  + E++  E  F  +  V
Sbjct: 250 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 287

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 103/218 (47%), Gaps = 22/218 (10%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVI 104
           I+ IGRGA+G V A V  +  E +   KI N ++ +  A       E  +L + + + + 
Sbjct: 95  IKVIGRGAFGEV-AVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWIT 153
Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD----TDLHQII-RSDQQLTDDHCQYFLYQLLRGLK 159
           A+           F D   +Y +MD     DL  ++ + + +L +D  ++++ +++  + 
Sbjct: 154 ALHY--------AFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAID 205
Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLL 217
            +H    +HRD+KP N+LL+ +  +++ DFG     ++   +   V   T  Y +PE+L 
Sbjct: 206 SIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQ 265
Query: 218 ----NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV 251
                  +Y    D WS+G  + E++  E  F  +  V
Sbjct: 266 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 303

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 49/209 (23%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G G  G V    N  T+E+ A+K +        D  +  RE++L  H        I  I
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVEL--HWRASQCPHIVRI 76
Query: 110 IRPPKKDTFNDVY-------IVYELMDT-DLHQII--RSDQQLTDDHCQYFLYQLLRGLK 159
           +     D + ++Y       IV E +D  +L   I  R DQ  T+      +  +   ++
Sbjct: 77  V-----DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 160 YVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 216
           Y+HS ++ HRD+KP NLL  +   +  LK+ DFG A+ T+                    
Sbjct: 132 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-------------------- 171
Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLF 245
               +Y  + D+WS+G I+  ++   P F
Sbjct: 172 --GEKYDKSCDMWSLGVIMYILLCGYPPF 198

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 100/217 (46%), Gaps = 32/217 (14%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IGRGA+G            EVA+ K+ NA  + + A + L + ++L+  E       
Sbjct: 79  LKVIGRGAFG------------EVAVVKLKNA--DKVFAMKILNKWEMLKRAETACFREE 124
Query: 107 KDIIRPPKKD-------TFNDVYIVYELMD----TDLHQII-RSDQQLTDDHCQYFLYQL 154
           +D++              F D   +Y +MD     DL  ++ + + +L ++  +++L ++
Sbjct: 125 RDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEM 184
Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRA 212
           +  +  VH    +HRD+KP N+L++ +  +++ DFG      E   +   V   T  Y +
Sbjct: 185 VIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 244
Query: 213 PELLLNCT----EYTAAIDIWSVGCILGEIMTREPLF 245
           PE+L         Y    D WS+G  + E++  E  F
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/191 (23%), Positives = 93/191 (48%), Gaps = 15/191 (7%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG-NAFDNIIDARRTLREIKLLRHMEHENVIAIKD 108
           +GRG +GIV   V + +++    K +     D ++      +EI +L    H N++ + +
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL----VKKEISILNIARHRNILHLHE 68
Query: 109 IIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASV 166
                  ++  ++ +++E +   D+ + I +   +L +     +++Q+   L+++HS ++
Sbjct: 69  SF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNI 123
Query: 167 LHRDLKPSNLLLNA--SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
            H D++P N++     S  +KI +FG AR     D          Y APE+  +    TA
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA 183
Query: 225 AIDIWSVGCIL 235
             D+WS+G ++
Sbjct: 184 T-DMWSLGTLV 193

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 59/103 (57%), Gaps = 6/103 (5%)
Query: 142 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDF 200
           LT +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D+
Sbjct: 195 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 254
Query: 201 MTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           + +    +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 255 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 295

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 59/103 (57%), Gaps = 6/103 (5%)
Query: 142 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDF 200
           LT +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D+
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249
Query: 201 MTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           + +    +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 250 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 290

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 93/212 (43%), Gaps = 29/212 (13%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR-HMEHENVIAIKD 108
            G+   G +      E  + VAIK + +  +  +  R   R   +LR  ++H NV+ +  
Sbjct: 39  FGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPL--REEFRHEAMLRARLQHPNVVCLLG 96
Query: 109 IIRPPKKDTFNDVYIVYELMDTDLHQII-----RSDQQLTDDHCQ-----------YFLY 152
           ++    KD    +   Y     DLH+ +      SD   TDD              + + 
Sbjct: 97  VV---TKDQPLSMIFSY-CSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 152
Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TEYVVTR 208
           Q+  G++Y+ S  V+H+DL   N+L+    ++KI D GL R     D+        +  R
Sbjct: 153 QIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIR 212
Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           W  APE ++   +++   DIWS G +L E+ +
Sbjct: 213 WM-APEAIMY-GKFSIDSDIWSYGVVLWEVFS 242

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 59/103 (57%), Gaps = 6/103 (5%)
Query: 142 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDF 200
           LT +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D+
Sbjct: 188 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 247
Query: 201 MTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           + +    +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 248 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 288

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 86/198 (43%), Gaps = 19/198 (9%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGN----AFDNIIDARRTLREIKLLRHME----HE 101
           +G+G +G V A      R +VAIK I       +  + D+     E+ LL  +     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYE--LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
            VI + D       +T     +V E  L   DL   I     L +   + F  Q++  ++
Sbjct: 99  GVIRLLDWF-----ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQ 153
Query: 160 YVHSASVLHRDLKPSNLL--LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 217
           + HS  V+HRD+K  N+L  L   C  K+ DFG      +  + T++  TR Y  PE + 
Sbjct: 154 HCHSRGVVHRDIKDENILIDLRRGC-AKLIDFGSGALLHDEPY-TDFDGTRVYSPPEWIS 211
Query: 218 NCTEYTAAIDIWSVGCIL 235
               +     +WS+G +L
Sbjct: 212 RHQYHALPATVWSLGILL 229

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 101/250 (40%), Gaps = 39/250 (15%)
Query: 35  NLFEVSSKYVPPIRPIGRGAY-----GIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL 89
           +L EV  K +  IR +G GA+     G V    N  +  +VA+K +   +    D    L
Sbjct: 38  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSE-QDELDFL 96
Query: 90  REIKLLRHMEHENV-----IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLT 143
            E  ++    H+N+     ++++ + R          +I+ ELM   DL   +R  +   
Sbjct: 97  MEALIISKFNHQNIVRCIGVSLQSLPR----------FILLELMAGGDLKSFLRETRPRP 146
Query: 144 DDHCQYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLAR 193
                  +  LL        G +Y+     +HRD+   N LL         KIGDFG+AR
Sbjct: 147 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206
Query: 194 TTSETDFMTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGK 248
                 +  +     +  +W   PE  +    +T+  D WS G +L EI +   + +P K
Sbjct: 207 DIYRASYYRKGGCAMLPVKWM-PPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSK 264
Query: 249 DYVHQLRLIT 258
                L  +T
Sbjct: 265 SNQEVLEFVT 274

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 59/103 (57%), Gaps = 6/103 (5%)
Query: 142 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDF 200
           LT +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D+
Sbjct: 197 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 256
Query: 201 MTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           + +    +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 257 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 297

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/241 (23%), Positives = 105/241 (43%), Gaps = 26/241 (10%)
Query: 19  GVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNA 78
           G L       Q +  G   E+    +   R +  G +  V  A +  +  E A+K++ + 
Sbjct: 5   GSLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN 64
Query: 79  FDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFN---DVYIVYELMDTDLHQ 134
            +     R  ++E+  ++ +  H N++         K+++     +  ++ EL    L +
Sbjct: 65  EEE--KNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVE 122
Query: 135 IIR---SDQQLTDDHCQYFLYQLLRGLKYVH--SASVLHRDLKPSNLLLNASCDLKIGDF 189
            ++   S   L+ D      YQ  R ++++H     ++HRDLK  NLLL+    +K+ DF
Sbjct: 123 FLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDF 182
Query: 190 GLARTTS---------ETDFMTEYVVTR----WYRAPELLLNCTEYTAA--IDIWSVGCI 234
           G A T S         +   + E  +TR     YR PE++   + +      DIW++GCI
Sbjct: 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCI 242
Query: 235 L 235
           L
Sbjct: 243 L 243

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 24/216 (11%)
Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKD 108
           +G GA+  V   +N  T +E A+K I     +I    R  RE+++L   + H NV+ + +
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHI--RSRVFREVEMLYQCQGHRNVLELIE 78
Query: 109 IIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
                ++D F   Y+V+E M    +   I   +   +      +  +   L ++H+  + 
Sbjct: 79  FFE--EEDRF---YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIA 133
Query: 168 HRDLKPSNLLL---NASCDLKIGDFGLAR--------TTSETDFMTEYVVTRWYRAPELL 216
           HRDLKP N+L    N    +KI DF L          +   T  +     +  Y APE++
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV 193
Query: 217 LNCTE----YTAAIDIWSVGCILGEIMTREPLFPGK 248
              +E    Y    D+WS+G IL  +++  P F G+
Sbjct: 194 EAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGR 229

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 28/109 (25%), Positives = 65/109 (59%), Gaps = 3/109 (2%)
Query: 140 QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSE 197
           ++ T+   Q ++ +++  L+++H   +++RD+K  N+LL+++  + + DFGL++     E
Sbjct: 154 ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 213
Query: 198 TDFMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLF 245
           T+   ++  T  Y AP+++    + +  A+D WS+G ++ E++T    F
Sbjct: 214 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 262

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 63/113 (55%), Gaps = 5/113 (4%)
Query: 132 LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 191
           L++ ++ ++ + D +    ++Q+  G+KY+  ++ +HRDL   N+LL      KI DFGL
Sbjct: 112 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 171
Query: 192 ART-TSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           ++   ++ ++       +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 172 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 63/113 (55%), Gaps = 5/113 (4%)
Query: 132 LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 191
           L++ ++ ++ + D +    ++Q+  G+KY+  ++ +HRDL   N+LL      KI DFGL
Sbjct: 114 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 173
Query: 192 ART-TSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           ++   ++ ++       +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 174 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 63/113 (55%), Gaps = 5/113 (4%)
Query: 132 LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 191
           L++ ++ ++ + D +    ++Q+  G+KY+  ++ +HRDL   N+LL      KI DFGL
Sbjct: 114 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 173
Query: 192 ART-TSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           ++   ++ ++       +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 174 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/199 (22%), Positives = 96/199 (48%), Gaps = 16/199 (8%)
Query: 50  IGRGAYGIVCAAVNSETREE--VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           +G G +G V   V    +++  VAIK +    +   D    +RE +++  +++  ++ + 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA-DTEEMMREAQIMHQLDNPYIVRLI 402
Query: 108 DIIRPPKKDTFNDVYIVYELMDTD-LHQ-IIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            + +         + +V E+     LH+ ++   +++   +    L+Q+  G+KY+   +
Sbjct: 403 GVCQ------AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 456
Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FMTEYVVTRW---YRAPELLLNCTE 221
            +HR+L   N+LL      KI DFGL++     D + T     +W   + APE  +N  +
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE-CINFRK 515
Query: 222 YTAAIDIWSVGCILGEIMT 240
           +++  D+WS G  + E ++
Sbjct: 516 FSSRSDVWSYGVTMWEALS 534

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 63/113 (55%), Gaps = 5/113 (4%)
Query: 132 LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 191
           L++ ++ ++ + D +    ++Q+  G+KY+  ++ +HRDL   N+LL      KI DFGL
Sbjct: 104 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 163
Query: 192 ART-TSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           ++   ++ ++       +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 164 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 63/113 (55%), Gaps = 5/113 (4%)
Query: 132 LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 191
           L++ ++ ++ + D +    ++Q+  G+KY+  ++ +HRDL   N+LL      KI DFGL
Sbjct: 98  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 157
Query: 192 ART-TSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           ++   ++ ++       +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 158 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 63/113 (55%), Gaps = 5/113 (4%)
Query: 132 LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 191
           L++ ++ ++ + D +    ++Q+  G+KY+  ++ +HRDL   N+LL      KI DFGL
Sbjct: 457 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 516
Query: 192 ART-TSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           ++   ++ ++       +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 517 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 63/113 (55%), Gaps = 5/113 (4%)
Query: 132 LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 191
           L++ ++ ++ + D +    ++Q+  G+KY+  ++ +HRDL   N+LL      KI DFGL
Sbjct: 456 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 515
Query: 192 ART-TSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           ++   ++ ++       +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 516 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 101/250 (40%), Gaps = 39/250 (15%)
Query: 35  NLFEVSSKYVPPIRPIGRGAY-----GIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL 89
           +L EV  K +  IR +G GA+     G V    N  +  +VA+K +        D    L
Sbjct: 24  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFL 82
Query: 90  REIKLLRHMEHENV-----IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLT 143
            E  ++  + H+N+     ++++ + R          +I+ ELM   DL   +R  +   
Sbjct: 83  MEALIISKLNHQNIVRCIGVSLQSLPR----------FILLELMAGGDLKSFLRETRPRP 132
Query: 144 DDHCQYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLAR 193
                  +  LL        G +Y+     +HRD+   N LL         KIGDFG+AR
Sbjct: 133 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192
Query: 194 TTSETDFMTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGK 248
                 +  +     +  +W   PE  +    +T+  D WS G +L EI +   + +P K
Sbjct: 193 DIYRASYYRKGGCAMLPVKWM-PPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSK 250
Query: 249 DYVHQLRLIT 258
                L  +T
Sbjct: 251 SNQEVLEFVT 260

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 63/113 (55%), Gaps = 5/113 (4%)
Query: 132 LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 191
           L++ ++ ++ + D +    ++Q+  G+KY+  ++ +HRDL   N+LL      KI DFGL
Sbjct: 94  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 153
Query: 192 ART-TSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           ++   ++ ++       +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 154 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 63/113 (55%), Gaps = 5/113 (4%)
Query: 132 LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 191
           L++ ++ ++ + D +    ++Q+  G+KY+  ++ +HRDL   N+LL      KI DFGL
Sbjct: 92  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 151
Query: 192 ART-TSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           ++   ++ ++       +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 152 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 101/250 (40%), Gaps = 39/250 (15%)
Query: 35  NLFEVSSKYVPPIRPIGRGAY-----GIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL 89
           +L EV  K +  IR +G GA+     G V    N  +  +VA+K +        D    L
Sbjct: 38  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFL 96
Query: 90  REIKLLRHMEHENV-----IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLT 143
            E  ++  + H+N+     ++++ + R          +I+ ELM   DL   +R  +   
Sbjct: 97  MEALIISKLNHQNIVRCIGVSLQSLPR----------FILLELMAGGDLKSFLRETRPRP 146
Query: 144 DDHCQYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLAR 193
                  +  LL        G +Y+     +HRD+   N LL         KIGDFG+AR
Sbjct: 147 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206
Query: 194 TTSETDFMTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGK 248
                 +  +     +  +W   PE  +    +T+  D WS G +L EI +   + +P K
Sbjct: 207 DIYRASYYRKGGCAMLPVKWM-PPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSK 264
Query: 249 DYVHQLRLIT 258
                L  +T
Sbjct: 265 SNQEVLEFVT 274

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 62/115 (53%), Gaps = 11/115 (9%)
Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW 209
           + +Q+ RG++++ S   +HRDL   N+LL+ +  +KI DFGLAR   +         TR 
Sbjct: 204 YSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRL 263
Query: 210 ---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG----KDYVHQLR 255
              + APE + +   Y+   D+WS G +L EI +    P +PG    +D+  +LR
Sbjct: 264 PLKWMAPESIFDKI-YSTKSDVWSYGVLLWEIFSLGGSP-YPGVQMDEDFCSRLR 316

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/199 (22%), Positives = 95/199 (47%), Gaps = 16/199 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG G +G+V        +++VAIK I    +  +     + E +++  + H  ++ +
Sbjct: 12  VQEIGSGQFGLVHLGYWL-NKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQL 67
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTD-LHQIIRSDQQL-TDDHCQYFLYQLLRGLKYVHSA 164
             +           + +V+E M+   L   +R+ + L   +        +  G+ Y+  A
Sbjct: 68  YGVCLEQAP-----ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 122
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
           SV+HRDL   N L+  +  +K+ DFG+ R   +  + T    T++   + +PE + + + 
Sbjct: 123 SVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPE-VFSFSR 180
Query: 222 YTAAIDIWSVGCILGEIMT 240
           Y++  D+WS G ++ E+ +
Sbjct: 181 YSSKSDVWSFGVLMWEVFS 199

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 131 DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 189
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 190 GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 235
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 203 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 247

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 100/250 (40%), Gaps = 39/250 (15%)
Query: 35  NLFEVSSKYVPPIRPIGRGAY-----GIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL 89
           +L EV  K +  IR +G GA+     G V    N  +  +VA+K +        D    L
Sbjct: 38  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFL 96
Query: 90  REIKLLRHMEHENV-----IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLT 143
            E  ++    H+N+     ++++ + R          +I+ ELM   DL   +R  +   
Sbjct: 97  MEALIISKFNHQNIVRCIGVSLQSLPR----------FILMELMAGGDLKSFLRETRPRP 146
Query: 144 DDHCQYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLAR 193
                  +  LL        G +Y+     +HRD+   N LL         KIGDFG+AR
Sbjct: 147 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206
Query: 194 TTSETDFMTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGK 248
                 +  +     +  +W   PE  +    +T+  D WS G +L EI +   + +P K
Sbjct: 207 DIYRASYYRKGGCAMLPVKWM-PPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSK 264
Query: 249 DYVHQLRLIT 258
                L  +T
Sbjct: 265 SNQEVLEFVT 274

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 100/250 (40%), Gaps = 39/250 (15%)
Query: 35  NLFEVSSKYVPPIRPIGRGAY-----GIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL 89
           +L EV  K +  IR +G GA+     G V    N  +  +VA+K +        D    L
Sbjct: 24  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFL 82
Query: 90  REIKLLRHMEHENV-----IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLT 143
            E  ++    H+N+     ++++ + R          +I+ ELM   DL   +R  +   
Sbjct: 83  MEALIISKFNHQNIVRCIGVSLQSLPR----------FILLELMAGGDLKSFLRETRPRP 132
Query: 144 DDHCQYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLAR 193
                  +  LL        G +Y+     +HRD+   N LL         KIGDFG+AR
Sbjct: 133 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192
Query: 194 TTSETDFMTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGK 248
                 +  +     +  +W   PE  +    +T+  D WS G +L EI +   + +P K
Sbjct: 193 DIYRASYYRKGGCAMLPVKWM-PPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSK 250
Query: 249 DYVHQLRLIT 258
                L  +T
Sbjct: 251 SNQEVLEFVT 260

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 100/250 (40%), Gaps = 39/250 (15%)
Query: 35  NLFEVSSKYVPPIRPIGRGAY-----GIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL 89
           +L EV  K +  IR +G GA+     G V    N  +  +VA+K +        D    L
Sbjct: 23  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFL 81
Query: 90  REIKLLRHMEHENV-----IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLT 143
            E  ++    H+N+     ++++ + R          +I+ ELM   DL   +R  +   
Sbjct: 82  MEALIISKFNHQNIVRCIGVSLQSLPR----------FILMELMAGGDLKSFLRETRPRP 131
Query: 144 DDHCQYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLAR 193
                  +  LL        G +Y+     +HRD+   N LL         KIGDFG+AR
Sbjct: 132 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
Query: 194 TTSETDFMTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGK 248
                 +  +     +  +W   PE  +    +T+  D WS G +L EI +   + +P K
Sbjct: 192 DIYRASYYRKGGCAMLPVKWM-PPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSK 249
Query: 249 DYVHQLRLIT 258
                L  +T
Sbjct: 250 SNQEVLEFVT 259

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 100/250 (40%), Gaps = 39/250 (15%)
Query: 35  NLFEVSSKYVPPIRPIGRGAY-----GIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL 89
           +L EV  K +  IR +G GA+     G V    N  +  +VA+K +        D    L
Sbjct: 30  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFL 88
Query: 90  REIKLLRHMEHENV-----IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLT 143
            E  ++    H+N+     ++++ + R          +I+ ELM   DL   +R  +   
Sbjct: 89  MEALIISKFNHQNIVRCIGVSLQSLPR----------FILLELMAGGDLKSFLRETRPRP 138
Query: 144 DDHCQYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLAR 193
                  +  LL        G +Y+     +HRD+   N LL         KIGDFG+AR
Sbjct: 139 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 198
Query: 194 TTSETDFMTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGK 248
                 +  +     +  +W   PE  +    +T+  D WS G +L EI +   + +P K
Sbjct: 199 DIYRASYYRKGGCAMLPVKWM-PPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSK 256
Query: 249 DYVHQLRLIT 258
                L  +T
Sbjct: 257 SNQEVLEFVT 266

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 100/250 (40%), Gaps = 39/250 (15%)
Query: 35  NLFEVSSKYVPPIRPIGRGAY-----GIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL 89
           +L EV  K +  IR +G GA+     G V    N  +  +VA+K +        D    L
Sbjct: 50  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFL 108
Query: 90  REIKLLRHMEHENV-----IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLT 143
            E  ++    H+N+     ++++ + R          +I+ ELM   DL   +R  +   
Sbjct: 109 MEALIISKFNHQNIVRCIGVSLQSLPR----------FILLELMAGGDLKSFLRETRPRP 158
Query: 144 DDHCQYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLAR 193
                  +  LL        G +Y+     +HRD+   N LL         KIGDFG+AR
Sbjct: 159 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 218
Query: 194 TTSETDFMTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGK 248
                 +  +     +  +W   PE  +    +T+  D WS G +L EI +   + +P K
Sbjct: 219 DIYRASYYRKGGCAMLPVKWM-PPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSK 276
Query: 249 DYVHQLRLIT 258
                L  +T
Sbjct: 277 SNQEVLEFVT 286

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 100/250 (40%), Gaps = 39/250 (15%)
Query: 35  NLFEVSSKYVPPIRPIGRGAY-----GIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL 89
           +L EV  K +  IR +G GA+     G V    N  +  +VA+K +        D    L
Sbjct: 40  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFL 98
Query: 90  REIKLLRHMEHENV-----IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLT 143
            E  ++    H+N+     ++++ + R          +I+ ELM   DL   +R  +   
Sbjct: 99  MEALIISKFNHQNIVRCIGVSLQSLPR----------FILLELMAGGDLKSFLRETRPRP 148
Query: 144 DDHCQYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLAR 193
                  +  LL        G +Y+     +HRD+   N LL         KIGDFG+AR
Sbjct: 149 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 208
Query: 194 TTSETDFMTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGK 248
                 +  +     +  +W   PE  +    +T+  D WS G +L EI +   + +P K
Sbjct: 209 DIYRASYYRKGGCAMLPVKWM-PPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSK 266
Query: 249 DYVHQLRLIT 258
                L  +T
Sbjct: 267 SNQEVLEFVT 276

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 92/216 (42%), Gaps = 27/216 (12%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIK---KIGNAFDNIIDARRTLREIKLLRHMEHENV 103
           ++ +G GA+G V   +     E V I    KI N           + E  ++  M+H ++
Sbjct: 43  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 102
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           + +  +   P       + +V +LM     L  +      +       +  Q+ +G+ Y+
Sbjct: 103 VRLLGVCLSPT------IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYL 156
Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMTE--YVVTRWYRAPELLL 217
               ++HRDL   N+L+ +   +KI DFGLAR     E ++  +   +  +W     + L
Sbjct: 157 EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKW-----MAL 211
Query: 218 NCTEY---TAAIDIWSVGCILGEIMTREPLFPGKDY 250
            C  Y   T   D+WS G  + E+MT    F GK Y
Sbjct: 212 ECIHYRKFTHQSDVWSYGVTIWELMT----FGGKPY 243

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 100/250 (40%), Gaps = 39/250 (15%)
Query: 35  NLFEVSSKYVPPIRPIGRGAY-----GIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL 89
           +L EV  K +  IR +G GA+     G V    N  +  +VA+K +        D    L
Sbjct: 23  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFL 81
Query: 90  REIKLLRHMEHENV-----IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLT 143
            E  ++    H+N+     ++++ + R          +I+ ELM   DL   +R  +   
Sbjct: 82  MEALIISKFNHQNIVRCIGVSLQSLPR----------FILLELMAGGDLKSFLRETRPRP 131
Query: 144 DDHCQYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLAR 193
                  +  LL        G +Y+     +HRD+   N LL         KIGDFG+AR
Sbjct: 132 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
Query: 194 TTSETDFMTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGK 248
                 +  +     +  +W   PE  +    +T+  D WS G +L EI +   + +P K
Sbjct: 192 DIYRASYYRKGGCAMLPVKWM-PPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSK 249
Query: 249 DYVHQLRLIT 258
                L  +T
Sbjct: 250 SNQEVLEFVT 259

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 100/250 (40%), Gaps = 39/250 (15%)
Query: 35  NLFEVSSKYVPPIRPIGRGAY-----GIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL 89
           +L EV  K +  IR +G GA+     G V    N  +  +VA+K +        D    L
Sbjct: 15  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFL 73
Query: 90  REIKLLRHMEHENV-----IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLT 143
            E  ++    H+N+     ++++ + R          +I+ ELM   DL   +R  +   
Sbjct: 74  MEALIISKFNHQNIVRCIGVSLQSLPR----------FILLELMAGGDLKSFLRETRPRP 123
Query: 144 DDHCQYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLAR 193
                  +  LL        G +Y+     +HRD+   N LL         KIGDFG+AR
Sbjct: 124 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 183
Query: 194 TTSETDFMTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGK 248
                 +  +     +  +W   PE  +    +T+  D WS G +L EI +   + +P K
Sbjct: 184 DIYRASYYRKGGCAMLPVKWM-PPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSK 241
Query: 249 DYVHQLRLIT 258
                L  +T
Sbjct: 242 SNQEVLEFVT 251

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/114 (27%), Positives = 62/114 (54%), Gaps = 7/114 (6%)
Query: 132 LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 191
           L++ ++ ++ + D +    ++Q+  G+KY+  ++ +HRDL   N+LL      KI DFGL
Sbjct: 98  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 157
Query: 192 ART--TSETDFMTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           ++     E  +  +       +WY APE  +N  ++++  D+WS G ++ E  +
Sbjct: 158 SKALRADENXYKAQTHGKWPVKWY-APE-CINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 100/250 (40%), Gaps = 39/250 (15%)
Query: 35  NLFEVSSKYVPPIRPIGRGAY-----GIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL 89
           +L EV  K +  IR +G GA+     G V    N  +  +VA+K +        D    L
Sbjct: 64  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFL 122
Query: 90  REIKLLRHMEHENV-----IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLT 143
            E  ++    H+N+     ++++ + R          +I+ ELM   DL   +R  +   
Sbjct: 123 MEALIISKFNHQNIVRCIGVSLQSLPR----------FILLELMAGGDLKSFLRETRPRP 172
Query: 144 DDHCQYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLAR 193
                  +  LL        G +Y+     +HRD+   N LL         KIGDFG+AR
Sbjct: 173 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
Query: 194 TTSETDFMTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGK 248
                 +  +     +  +W   PE  +    +T+  D WS G +L EI +   + +P K
Sbjct: 233 DIYRAGYYRKGGCAMLPVKWM-PPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSK 290
Query: 249 DYVHQLRLIT 258
                L  +T
Sbjct: 291 SNQEVLEFVT 300

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 100/250 (40%), Gaps = 39/250 (15%)
Query: 35  NLFEVSSKYVPPIRPIGRGAY-----GIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL 89
           +L EV  K +  IR +G GA+     G V    N  +  +VA+K +        D    L
Sbjct: 41  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFL 99
Query: 90  REIKLLRHMEHENV-----IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLT 143
            E  ++    H+N+     ++++ + R          +I+ ELM   DL   +R  +   
Sbjct: 100 MEALIISKFNHQNIVRCIGVSLQSLPR----------FILLELMAGGDLKSFLRETRPRP 149
Query: 144 DDHCQYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLAR 193
                  +  LL        G +Y+     +HRD+   N LL         KIGDFG+AR
Sbjct: 150 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 209
Query: 194 TTSETDFMTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGK 248
                 +  +     +  +W   PE  +    +T+  D WS G +L EI +   + +P K
Sbjct: 210 DIYRAGYYRKGGCAMLPVKWM-PPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSK 267
Query: 249 DYVHQLRLIT 258
                L  +T
Sbjct: 268 SNQEVLEFVT 277

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 92/216 (42%), Gaps = 27/216 (12%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIK---KIGNAFDNIIDARRTLREIKLLRHMEHENV 103
           ++ +G GA+G V   +     E V I    KI N           + E  ++  M+H ++
Sbjct: 20  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 79
Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           + +  +   P       + +V +LM     L  +      +       +  Q+ +G+ Y+
Sbjct: 80  VRLLGVCLSPT------IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYL 133
Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMTE--YVVTRWYRAPELLL 217
               ++HRDL   N+L+ +   +KI DFGLAR     E ++  +   +  +W     + L
Sbjct: 134 EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKW-----MAL 188
Query: 218 NCTEY---TAAIDIWSVGCILGEIMTREPLFPGKDY 250
            C  Y   T   D+WS G  + E+MT    F GK Y
Sbjct: 189 ECIHYRKFTHQSDVWSYGVTIWELMT----FGGKPY 220

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 8/150 (5%)
Query: 117 TFNDVYIVYELMDTDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPS 174
           T  DV+I  ELM T   ++ +  Q  + +         +++ L Y+     V+HRD+KPS
Sbjct: 95  TNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPS 154
Query: 175 NLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL----LNCTEYTAAIDIWS 230
           N+LL+    +K+ DFG++    +            Y APE +        +Y    D+WS
Sbjct: 155 NILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWS 214
Query: 231 VGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           +G  L E+ T +  FP K+      ++T+V
Sbjct: 215 LGISLVELATGQ--FPYKNCKTDFEVLTKV 242

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/233 (22%), Positives = 99/233 (42%), Gaps = 26/233 (11%)
Query: 31  NVY--GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT 88
           N+Y  G++  + +K+   I+ +G G +  V            A+K+I        D    
Sbjct: 16  NLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRI--LCHEQQDREEA 73
Query: 89  LREIKLLRHMEHENVIA-IKDIIRPPKKDTFNDVYIVYELMD-----TDLHQIIRSDQQL 142
            RE  + R   H N++  +   +R  ++   ++ +++           ++ ++      L
Sbjct: 74  QREADMHRLFNHPNILRLVAYCLR--ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFL 131
Query: 143 TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-------ARTT 195
           T+D   + L  + RGL+ +H+    HRDLKP+N+LL       + D G           +
Sbjct: 132 TEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGS 191
Query: 196 SETDFMTEYVVTRW---YRAPELL---LNCTEYTAAIDIWSVGCILGEIMTRE 242
            +   + ++   R    YRAPEL     +C       D+WS+GC+L  +M  E
Sbjct: 192 RQALTLQDWAAQRCTISYRAPELFSVQSHCV-IDERTDVWSLGCVLYAMMFGE 243

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/227 (23%), Positives = 87/227 (38%), Gaps = 40/227 (17%)
Query: 47  IRPIGRGAYGIVCAA-----VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE 101
           +R IG GA+G V  A     +  E    VA+K +       + A    RE  L+   ++ 
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-REAALMAEFDNP 110
Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS----------------------- 138
           N++ +  +    K       Y+ Y     DL++ +RS                       
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAY----GDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 139 -DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE 197
               L+         Q+  G+ Y+     +HRDL   N L+  +  +KI DFGL+R    
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 198 TDFM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
            D+      + +  RW     +  N   YT   D+W+ G +L EI +
Sbjct: 227 ADYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFS 271

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/250 (24%), Positives = 100/250 (40%), Gaps = 39/250 (15%)
Query: 35  NLFEVSSKYVPPIRPIGRGAY-----GIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL 89
           +L EV  K +  IR +G GA+     G V    N  +  +VA+K +        D    L
Sbjct: 24  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFL 82
Query: 90  REIKLLRHMEHENV-----IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLT 143
            E  ++    H+N+     ++++ + R          +I+ ELM   DL   +R  +   
Sbjct: 83  MEALIISKFNHQNIVRCIGVSLQSLPR----------FILLELMAGGDLKSFLRETRPRP 132
Query: 144 DDHCQYFLYQLLR-------GLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLAR 193
                  +  LL        G +Y+     +HRD+   N LL         KIGDFG+A+
Sbjct: 133 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ 192
Query: 194 TTSETDFMTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGK 248
                 +  +     +  +W   PE  +    +T+  D WS G +L EI +   + +P K
Sbjct: 193 DIYRASYYRKGGCAMLPVKWM-PPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSK 250
Query: 249 DYVHQLRLIT 258
                L  +T
Sbjct: 251 SNQEVLEFVT 260

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/199 (21%), Positives = 94/199 (47%), Gaps = 16/199 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG G +G+V        +++VAIK I    +  +     + E +++  + H  ++ +
Sbjct: 12  VQEIGSGQFGLVHLGYWL-NKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQL 67
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTD-LHQIIRSDQQL-TDDHCQYFLYQLLRGLKYVHSA 164
             +           + +V+E M+   L   +R+ + L   +        +  G+ Y+  A
Sbjct: 68  YGVCLEQAP-----ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 122
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
            V+HRDL   N L+  +  +K+ DFG+ R   +  + T    T++   + +PE + + + 
Sbjct: 123 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPE-VFSFSR 180
Query: 222 YTAAIDIWSVGCILGEIMT 240
           Y++  D+WS G ++ E+ +
Sbjct: 181 YSSKSDVWSFGVLMWEVFS 199

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/199 (21%), Positives = 94/199 (47%), Gaps = 16/199 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG G +G+V        +++VAIK I    +  +     + E +++  + H  ++ +
Sbjct: 10  VQEIGSGQFGLVHLGYWL-NKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTD-LHQIIRSDQQL-TDDHCQYFLYQLLRGLKYVHSA 164
             +           + +V+E M+   L   +R+ + L   +        +  G+ Y+  A
Sbjct: 66  YGVCLEQAP-----ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
            V+HRDL   N L+  +  +K+ DFG+ R   +  + T    T++   + +PE + + + 
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPE-VFSFSR 178
Query: 222 YTAAIDIWSVGCILGEIMT 240
           Y++  D+WS G ++ E+ +
Sbjct: 179 YSSKSDVWSFGVLMWEVFS 197

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/199 (21%), Positives = 94/199 (47%), Gaps = 16/199 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG G +G+V        +++VAIK I    +  +     + E +++  + H  ++ +
Sbjct: 15  VQEIGSGQFGLVHLGYWL-NKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQL 70
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTD-LHQIIRSDQQL-TDDHCQYFLYQLLRGLKYVHSA 164
             +           + +V+E M+   L   +R+ + L   +        +  G+ Y+  A
Sbjct: 71  YGVCLEQAP-----ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 125
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
            V+HRDL   N L+  +  +K+ DFG+ R   +  + T    T++   + +PE + + + 
Sbjct: 126 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPE-VFSFSR 183
Query: 222 YTAAIDIWSVGCILGEIMT 240
           Y++  D+WS G ++ E+ +
Sbjct: 184 YSSKSDVWSFGVLMWEVFS 202

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 110/264 (41%), Gaps = 66/264 (25%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE----- 101
           IR +G G +  V    + + +  VA+K + +A      A   L EIKLL+ +        
Sbjct: 36  IRKLGWGHFSTVWLCWDMQGKRFVAMKVVKSAQHYTETA---LDEIKLLKCVRESDPSDP 92
Query: 102 NVIAIKDIIRPPKKDTFNDVYI--VYELMDTDL-HQIIRSDQQLTDDHC-QYFLYQLLRG 157
           N   +  +I   K    N +++  V+E++   L   II+S+ Q     C +  + Q+L+G
Sbjct: 93  NKDMVVQLIDDFKISGMNGIHVCMVFEVLGHHLLKWIIKSNYQGLPVRCVKSIIRQVLQG 152
Query: 158 LKYVHS-ASVLHRDLKPSNLLL--------------------------------NASCDL 184
           L Y+HS   ++H D+KP N+L+                                  + DL
Sbjct: 153 LDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQKAGAPPPSGSAVSTAPAADL 212
Query: 185 ---------------KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 229
                          KI D G A    +    TE + TR YR+ E+L+    Y+   DIW
Sbjct: 213 LVNPLDPRNADKIRVKIADLGNACWVHK--HFTEDIQTRQYRSIEVLIGAG-YSTPADIW 269
Query: 230 SVGCILGEIMTREPLF---PGKDY 250
           S  C+  E+ T + LF    G+DY
Sbjct: 270 STACMAFELATGDYLFEPHSGEDY 293

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/199 (21%), Positives = 94/199 (47%), Gaps = 16/199 (8%)
Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG G +G+V        +++VAIK I    +  +     + E +++  + H  ++ +
Sbjct: 32  VQEIGSGQFGLVHLGYWL-NKDKVAIKTIK---EGSMSEDDFIEEAEVMMKLSHPKLVQL 87
Query: 107 KDIIRPPKKDTFNDVYIVYELMDTD-LHQIIRSDQQL-TDDHCQYFLYQLLRGLKYVHSA 164
             +           + +V+E M+   L   +R+ + L   +        +  G+ Y+  A
Sbjct: 88  YGVCLEQAP-----ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 142
Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTE 221
            V+HRDL   N L+  +  +K+ DFG+ R   +  + T    T++   + +PE + + + 
Sbjct: 143 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPE-VFSFSR 200
Query: 222 YTAAIDIWSVGCILGEIMT 240
           Y++  D+WS G ++ E+ +
Sbjct: 201 YSSKSDVWSFGVLMWEVFS 219
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	260
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-161
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-158
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-158
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-156
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-155
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-155
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-155
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-155
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-153
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-151
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-150
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-150
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-138
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-133
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-133
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-131
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-129
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-107
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-98
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-86
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-85
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-85
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	5e-85
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	9e-85
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-84
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	5e-84
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	8e-84
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-83
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-83
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-82
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-77
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-52
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-52
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-52
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-52
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-51
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	8e-51
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-50
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-49
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-49
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-49
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	5e-49
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	8e-49
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-48
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-47
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-47
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	7e-47
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	9e-47
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-46
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-46
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-46
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-46
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-46
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-45
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-45
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	6e-45
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	9e-45
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-44
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-44
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-44
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-44
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-44
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-43
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-43
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-43
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-43
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-43
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-43
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-43
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-43
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-43
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	7e-43
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	8e-43
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-42
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	6e-42
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	6e-42
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	6e-42
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	8e-42
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-41
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-41
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	5e-41
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-41
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	8e-41
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	9e-41
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	9e-41
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-40
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-40
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-40
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-40
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-40
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-40
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-40
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-40
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	6e-40
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	6e-40
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-39
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-39
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-39
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-38
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	9e-38
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-37
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-37
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-37
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-37
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	7e-37
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	8e-37
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-36
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-36
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-36
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-36
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-36
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-36
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-36
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	8e-36
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-35
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-35
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-35
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-35
3an0_A	340	Dual specificity mitogen-activated protein kinase;	5e-35
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-34
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-34
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-34
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-34
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-34
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-34
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-34
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	6e-34
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-33
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-33
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-33
2dyl_A	318	Dual specificity mitogen-activated protein kinase	4e-33
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-33
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-32
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-32
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-32
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-32
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-32
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	9e-32
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-31
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-31
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-30
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-29
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-29
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-29
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-28
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-28
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-28
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	9e-28
3soc_A	322	Activin receptor type-2A; structural genomics cons	9e-28
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-27
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	5e-27
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-26
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-26
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-26
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-26
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-26
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-25
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-25
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-25
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-25
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-25
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-25
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-25
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	4e-25
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	7e-25
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	7e-25
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	9e-25
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	9e-25
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-24
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-24
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-24
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-24
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-24
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-24
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-24
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-24
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-24
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-24
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-24
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-24
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-24
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-24
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	5e-24
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	6e-24
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	8e-24
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	9e-24
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-23
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-23
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-23
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-23
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	5e-23
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-22
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-22
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-22
3ork_A	311	Serine/threonine protein kinase; structural genomi	6e-22
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-21
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	7e-21
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-20
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-20
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-20
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-20
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	6e-20
3uqc_A	286	Probable conserved transmembrane protein; structur	7e-20
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	9e-20
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-19
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-19
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-19
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-19
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-19
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-19
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	5e-19
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	8e-19
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	9e-19
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-18
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-18
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-18
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-18
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-18
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-18
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-18
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	6e-18
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-17
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	7e-17
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-16
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-15
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-15
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-14
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-14
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-12
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-12
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-12
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-12
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-12
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	5e-12
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-08
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	3e-05

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  451 bits (1162), Expect = e-161
 Identities = 95/250 (38%), Positives = 139/250 (55%), Gaps = 12/250 (4%)

Query: 21  LTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNA-- 78
           +   G+    ++   L  + S Y    R I  G+YG VCA V+SE    VAIK++ N   
Sbjct: 2   MQAKGEAAMRDLIAELHAMQSPYTV-QRFISSGSYGAVCAGVDSEG-IPVAIKRVFNTVS 59

Query: 79  -------FDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD 131
                    +    +R LREI+LL H  H N++ ++DI    ++   + +Y+V ELM TD
Sbjct: 60  DGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD 119

Query: 132 LHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG 190
           L Q+I   +  ++  H QYF+Y +L GL  +H A V+HRDL P N+LL  + D+ I DF 
Sbjct: 120 LAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN 179

Query: 191 LARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY 250
           LAR  +     T YV  RWYRAPEL++    +T  +D+WS GC++ E+  R+ LF G  +
Sbjct: 180 LAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF 239

Query: 251 VHQLRLITEV 260
            +QL  I EV
Sbjct: 240 YNQLNKIVEV 249

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  443 bits (1141), Expect = e-158
 Identities = 122/235 (51%), Positives = 164/235 (69%), Gaps = 14/235 (5%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           + +SS +      +G GAYG+VC+A +  T E VAIKKI   FD  + A RTLREIK+L+
Sbjct: 7   YNISSDFQL-KSLLGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILK 64

Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 156
           H +HEN+I I +I RP   + FN+VYI+ ELM TDLH++I + Q L+DDH QYF+YQ LR
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLR 123

Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-----------TSETDFMTEYV 205
            +K +H ++V+HRDLKPSNLL+N++CDLK+ DFGLAR            T +   M E+V
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183

Query: 206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
            TRWYRAPE++L   +Y+ A+D+WS GCIL E+  R P+FPG+DY HQL LI  +
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI 238

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  442 bits (1139), Expect = e-158
 Identities = 130/244 (53%), Positives = 171/244 (70%), Gaps = 7/244 (2%)

Query: 21  LTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD 80
           +          V G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F+
Sbjct: 7   MAAAAAAGPEMVRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFE 64

Query: 81  NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ 140
           +    +RTLREIK+L    HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q
Sbjct: 65  HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-Q 123

Query: 141 QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---- 196
            L++DH  YFLYQ+LRGLKY+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR       
Sbjct: 124 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183

Query: 197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL 256
            T F+TEYV TRWYRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  
Sbjct: 184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH 243

Query: 257 ITEV 260
           I  +
Sbjct: 244 ILGI 247

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  437 bits (1125), Expect = e-156
 Identities = 112/241 (46%), Positives = 155/241 (64%), Gaps = 6/241 (2%)

Query: 21  LTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD 80
           L     + + +V    +E+   YV     +G GAYG VC+A++  + E+VAIKK+   F 
Sbjct: 4   LIRKKGFYKQDVNKTAWELPKTYVS-PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ 62

Query: 81  NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSD 139
           + I A+R  RE+ LL+HM+HENVI + D+  P      F D Y+V   M TDL +I+   
Sbjct: 63  SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG-- 120

Query: 140 QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD 199
            + +++  QY +YQ+L+GLKY+HSA V+HRDLKP NL +N  C+LKI DFGLAR      
Sbjct: 121 LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD--A 178

Query: 200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
            MT YVVTRWYRAPE++L+   Y   +DIWSVGCI+ E++T + LF GKDY+ QL  I +
Sbjct: 179 EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 238

Query: 260 V 260
           V
Sbjct: 239 V 239

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  436 bits (1124), Expect = e-155
 Identities = 108/247 (43%), Positives = 156/247 (63%), Gaps = 28/247 (11%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
             V  KY   ++ +G+GAYGIV  +++  T E VA+KKI +AF N  DA+RT REI +L 
Sbjct: 5   RHVLRKYEL-VKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILT 63

Query: 97  HM-EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLL 155
            +  HEN++ + +++R        DVY+V++ M+TDLH +IR+   L   H QY +YQL+
Sbjct: 64  ELSGHENIVNLLNVLRAD---NDRDVYLVFDYMETDLHAVIRA-NILEPVHKQYVVYQLI 119

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART--------------------- 194
           + +KY+HS  +LHRD+KPSN+LLNA C +K+ DFGL+R+                     
Sbjct: 120 KVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179

Query: 195 -TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 253
              +   +T+YV TRWYRAPE+LL  T+YT  ID+WS+GCILGEI+  +P+FPG   ++Q
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239

Query: 254 LRLITEV 260
           L  I  V
Sbjct: 240 LERIIGV 246

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  435 bits (1121), Expect = e-155
 Identities = 122/236 (51%), Positives = 169/236 (71%), Gaps = 5/236 (2%)

Query: 26  KYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA 85
            + +  +   ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A
Sbjct: 14  TFYRQELNKTIWEVPERYQN-LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 72

Query: 86  RRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTD 144
           +RT RE++LL+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTD
Sbjct: 73  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTD 131

Query: 145 DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY 204
           DH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T+  D MT Y
Sbjct: 132 DHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA--DEMTGY 189

Query: 205 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           V TRWYRAPE++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  +
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 245

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  435 bits (1121), Expect = e-155
 Identities = 110/237 (46%), Positives = 160/237 (67%), Gaps = 5/237 (2%)

Query: 25  GKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIID 84
             + +  V    +EV + Y   ++P+G GAYG VC+AV+  T  +VAIKK+   F + + 
Sbjct: 9   SGFYRQEVTKTAWEVRAVYRD-LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF 67

Query: 85  ARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLT 143
           A+R  RE++LL+HM HENVI + D+  P +  D F D Y+V   M TDL ++++  ++L 
Sbjct: 68  AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLG 126

Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
           +D  Q+ +YQ+L+GL+Y+H+A ++HRDLKP NL +N  C+LKI DFGLAR       MT 
Sbjct: 127 EDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD--SEMTG 184

Query: 204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           YVVTRWYRAPE++LN   YT  +DIWSVGCI+ E++T + LF G D++ QL+ I +V
Sbjct: 185 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV 241

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  437 bits (1126), Expect = e-155
 Identities = 101/288 (35%), Positives = 147/288 (51%), Gaps = 52/288 (18%)

Query: 24  GGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII 83
            G+   Y        V   Y+     IGRG+YG V  A +  T + VAIKK+   F+++I
Sbjct: 9   SGRENLYFQGIKNVHVPDNYII-KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLI 67

Query: 84  DARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLT 143
           D +R LREI +L  ++ + +I + D+I P     F+++YIV E+ D+DL ++ ++   LT
Sbjct: 68  DCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLT 127

Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS------- 196
           ++H +  LY LL G  ++H + ++HRDLKP+N LLN  C +K+ DFGLART +       
Sbjct: 128 EEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNI 187

Query: 197 ----------------ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                               +T +VVTRWYRAPEL+L    YT +IDIWS GCI  E++ 
Sbjct: 188 VNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

Query: 241 -----------REPLFPG-----------------KDYVHQLRLITEV 260
                      R PLFPG                 K    QL +I  +
Sbjct: 248 MLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNI 295

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  427 bits (1101), Expect = e-153
 Identities = 102/245 (41%), Positives = 154/245 (62%), Gaps = 20/245 (8%)

Query: 30  YNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL 89
            N++G  F++ S+Y+  ++P+G G  G+V +AV+++  + VAIKKI     +    +  L
Sbjct: 2   MNIHG--FDLGSRYMD-LKPLGCGGNGLVFSAVDNDCDKRVAIKKI--VLTDPQSVKHAL 56

Query: 90  REIKLLRHMEHENVIAIKDIIRPPKK---------DTFNDVYIVYELMDTDLHQIIRSDQ 140
           REIK++R ++H+N++ + +I+ P               N VYIV E M+TDL  ++    
Sbjct: 57  REIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ-G 115

Query: 141 QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTS--- 196
            L ++H + F+YQLLRGLKY+HSA+VLHRDLKP+NL +N     LKIGDFGLAR      
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY 175

Query: 197 -ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR 255
                ++E +VT+WYR+P LLL+   YT AID+W+ GCI  E++T + LF G   + Q++
Sbjct: 176 SHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQ 235

Query: 256 LITEV 260
           LI E 
Sbjct: 236 LILES 240

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  425 bits (1094), Expect = e-151
 Identities = 105/236 (44%), Positives = 151/236 (63%), Gaps = 5/236 (2%)

Query: 26  KYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA 85
            +    +  + F V  +Y   ++PIG GA GIVCAA ++     VAIKK+   F N   A
Sbjct: 10  NFYSVEIGDSTFTVLKRYQN-LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA 68

Query: 86  RRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTD 144
           +R  RE+ L++ + H+N+I + ++  P K  + F DVYIV ELMD +L Q+I+   +L  
Sbjct: 69  KRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDH 126

Query: 145 DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY 204
           +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART   +  MT Y
Sbjct: 127 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 186

Query: 205 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           VVTR+YRAPE++L    Y   +DIWSVGCI+GE++    LFPG D++ Q   + E 
Sbjct: 187 VVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 241

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  426 bits (1098), Expect = e-150
 Identities = 106/237 (44%), Positives = 155/237 (65%), Gaps = 5/237 (2%)

Query: 25  GKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIID 84
            ++    V  + F V  +Y   ++PIG GA GIVCAA ++     VAIKK+   F N   
Sbjct: 46  NQFYSVEVGDSTFTVLKRYQN-LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH 104

Query: 85  ARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLT 143
           A+R  RE+ L++ + H+N+I++ ++  P K  + F DVY+V ELMD +L Q+I+   +L 
Sbjct: 105 AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELD 162

Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
            +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART   +  MT 
Sbjct: 163 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 222

Query: 204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           YVVTR+YRAPE++L    Y   +DIWSVGCI+GE++  + LFPG+DY+ Q   + E 
Sbjct: 223 YVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 278

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  426 bits (1096), Expect = e-150
 Identities = 103/318 (32%), Positives = 152/318 (47%), Gaps = 60/318 (18%)

Query: 2   AAAAKDSSSGGATSSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAA 61
           +      S        +                + +++  +Y      IG G+YG VC A
Sbjct: 14  SGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEI-RHLIGTGSYGHVCEA 72

Query: 62  VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV 121
            +   +  VAIKKI   F+++ID +R LREI +L  + H++V+ + DI+ P   + F+++
Sbjct: 73  YDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132

Query: 122 YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 181
           Y+V E+ D+D  ++ R+   LT+ H +  LY LL G+KYVHSA +LHRDLKP+N L+N  
Sbjct: 133 YVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQD 192

Query: 182 CDLKIGDFGLARTTSETD----------------------------FMTEYVVTRWYRAP 213
           C +K+ DFGLART    +                             +T +VVTRWYRAP
Sbjct: 193 CSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAP 252

Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMT-----------REPLFPGKDYV----------- 251
           EL+L    YT AID+WS+GCI  E++            R PLFPG               
Sbjct: 253 ELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGND 312

Query: 252 ---------HQLRLITEV 260
                     QL +I  +
Sbjct: 313 FKFHTRGNRDQLNVIFNI 330

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  393 bits (1011), Expect = e-138
 Identities = 81/249 (32%), Positives = 122/249 (48%), Gaps = 15/249 (6%)

Query: 24  GGKYVQYNVYGNLFEVSSKYVP---PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD 80
            G  +  N      E S K +      R  G+G +G V       T   VAIKK+     
Sbjct: 2   PGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV---IQ 58

Query: 81  NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY--IVYELMDTDLHQIIRS 138
           +     R L+ ++ L  + H N++ ++       +    D+Y  +V E +   LH+  R+
Sbjct: 59  DPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRN 118

Query: 139 ----DQQLTDDHCQYFLYQLLRGLKYVH--SASVLHRDLKPSNLLLN-ASCDLKIGDFGL 191
                        + FL+QL+R +  +H  S +V HRD+KP N+L+N A   LK+ DFG 
Sbjct: 119 YYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS 178

Query: 192 ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV 251
           A+  S ++    Y+ +R+YRAPEL+     YT A+DIWSVGCI  E+M  EP+F G +  
Sbjct: 179 AKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA 238

Query: 252 HQLRLITEV 260
            QL  I  V
Sbjct: 239 GQLHEIVRV 247

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  382 bits (982), Expect = e-133
 Identities = 81/266 (30%), Positives = 137/266 (51%), Gaps = 13/266 (4%)

Query: 1   MAAAAKDSSSGGATSSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCA 60
                + S+ G    S     +     V     G        Y    + IG G++G+V  
Sbjct: 14  CKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTD-TKVIGNGSFGVVYQ 72

Query: 61  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP-KKDTFN 119
           A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++       +K    
Sbjct: 73  AKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126

Query: 120 DVYIVYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 175
            + +V + +   ++++ R    + Q L   + + ++YQL R L Y+HS  + HRD+KP N
Sbjct: 127 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQN 186

Query: 176 LLLNASCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 234
           LLL+     LK+ DFG A+     +    Y+ +R+YRAPEL+   T+YT++ID+WS GC+
Sbjct: 187 LLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCV 246

Query: 235 LGEIMTREPLFPGKDYVHQLRLITEV 260
           L E++  +P+FPG   V QL  I +V
Sbjct: 247 LAELLLGQPIFPGDSGVDQLVEIIKV 272

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  380 bits (978), Expect = e-133
 Identities = 75/262 (28%), Positives = 132/262 (50%), Gaps = 44/262 (16%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
            E SSK     + +G G++GIVC   + E+ +  A+KK+      + D R   RE+ +++
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV------LQDPRYKNRELDIMK 55

Query: 97  HMEHENVIAIKDIIR---------------------------------PPKKDTFNDVYI 123
            ++H N+I + D                                             + +
Sbjct: 56  VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115

Query: 124 VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 179
           + E +   LH++++    S + +  +    ++YQL R + ++HS  + HRD+KP NLL+N
Sbjct: 116 IMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN 175

Query: 180 A-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 238
           +    LK+ DFG A+    ++    Y+ +R+YRAPEL+L  TEYT +ID+WS+GC+ GE+
Sbjct: 176 SKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235

Query: 239 MTREPLFPGKDYVHQLRLITEV 260
           +  +PLF G+  + QL  I ++
Sbjct: 236 ILGKPLFSGETSIDQLVRIIQI 257

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  374 bits (962), Expect = e-131
 Identities = 71/238 (29%), Positives = 125/238 (52%), Gaps = 14/238 (5%)

Query: 26  KYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA 85
           +Y  Y  +   +     Y   +R +GRG Y  V  A+N    E+V +K +       +  
Sbjct: 21  EYWDYESHVVEWGNQDDYQL-VRKLGRGKYSEVFEAINITNNEKVVVKIL-----KPVKK 74

Query: 86  RRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTD 144
           ++  REIK+L ++    N+I + DI++ P         +   + +TD  Q+    Q LTD
Sbjct: 75  KKIKREIKILENLRGGPNIITLADIVKDPVS--RTPALVFEHVNNTDFKQLY---QTLTD 129

Query: 145 DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTE 203
              ++++Y++L+ L Y HS  ++HRD+KP N++++     L++ D+GLA           
Sbjct: 130 YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 189

Query: 204 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITEV 260
            V +R+++ PELL++   Y  ++D+WS+GC+L  ++ R EP F G D   QL  I +V
Sbjct: 190 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 247

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  371 bits (954), Expect = e-129
 Identities = 82/244 (33%), Positives = 128/244 (52%), Gaps = 14/244 (5%)

Query: 23  HGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI 82
           +    V  +      +    Y    + IG G++G+V  A   E+ E VAIKK+      +
Sbjct: 22  NKVIKVLASDGKTGEQREIAYTN-CKVIGNGSFGVVFQAKLVESDE-VAIKKV------L 73

Query: 83  IDARRTLREIKLLRHMEHENVIAIKDIIRPP-KKDTFNDVYIVYELMDTDLHQIIRS--- 138
            D R   RE++++R ++H NV+ +K        K     + +V E +   +++  R    
Sbjct: 74  QDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAK 133

Query: 139 -DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD-LKIGDFGLARTTS 196
             Q +     + ++YQLLR L Y+HS  + HRD+KP NLLL+     LK+ DFG A+   
Sbjct: 134 LKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193

Query: 197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL 256
             +    Y+ +R+YRAPEL+   T YT  IDIWS GC++ E+M  +PLFPG+  + QL  
Sbjct: 194 AGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVE 253

Query: 257 ITEV 260
           I +V
Sbjct: 254 IIKV 257

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  310 bits (797), Expect = e-107
 Identities = 75/221 (33%), Positives = 133/221 (60%), Gaps = 8/221 (3%)

Query: 42  KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE 101
           KY   I  IG G+YG+V    N +T + VAIKK   + D+ +  +  LREI++L+ ++H 
Sbjct: 4   KYEK-IGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62

Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMDTDL-HQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           N++ + ++ R  ++     +++V+E  D  + H++ R  + + +   +   +Q L+ + +
Sbjct: 63  NLVNLLEVFRRKRR-----LHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNC 219
            H  + +HRD+KP N+L+     +K+ DFG AR  T  +D+  + V TRWYR+PELL+  
Sbjct: 118 CHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGD 177

Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           T+Y   +D+W++GC+  E+++  PL+PGK  V QL LI + 
Sbjct: 178 TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKT 218

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  289 bits (743), Expect = 2e-98
 Identities = 79/226 (34%), Positives = 132/226 (58%), Gaps = 8/226 (3%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           F+   KY   +  +G G+YG+V    N +T   VAIKK   + D+ +  +  +REIKLL+
Sbjct: 21  FQSMEKYEN-LGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLK 79

Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLL 155
            + HEN++ + ++ +  K+      Y+V+E +D  +   +      L     Q +L+Q++
Sbjct: 80  QLRHENLVNLLEVCKKKKR-----WYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQII 134

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPE 214
            G+ + HS +++HRD+KP N+L++ S  +K+ DFG ART  +  +   + V TRWYRAPE
Sbjct: 135 NGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPE 194

Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           LL+   +Y  A+D+W++GC++ E+   EPLFPG   + QL  I   
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMC 240

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  260 bits (667), Expect = 1e-86
 Identities = 86/215 (40%), Positives = 124/215 (57%), Gaps = 14/215 (6%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR-----TLREIKLLRHMEHENVI 104
           +G G +  V  A +  T + VAIKKI     +  +A+       LREIKLL+ + H N+I
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKI--KLGHRSEAKDGINRTALREIKLLQELSHPNII 75

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHS 163
            + D          +++ +V++ M+TDL  II+     LT  H + ++   L+GL+Y+H 
Sbjct: 76  GLLDAFG-----HKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 130

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEY 222
             +LHRDLKP+NLLL+ +  LK+ DFGLA++  S     T  VVTRWYRAPELL     Y
Sbjct: 131 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMY 190

Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
              +D+W+VGCIL E++ R P  PG   + QL  I
Sbjct: 191 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI 225

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  255 bits (654), Expect = 3e-85
 Identities = 83/218 (38%), Positives = 117/218 (53%), Gaps = 13/218 (5%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR-----TLREIKLLRHM---EHE 101
           IG GAYG V  A +  +   VA+K +     N           T+RE+ LLR +   EH 
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSV--RVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74

Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLRGLK 159
           NV+ + D+    + D    V +V+E +D DL   +       L  +  +  + Q LRGL 
Sbjct: 75  NVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLD 134

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 219
           ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    +T  VVT WYRAPE+LL  
Sbjct: 135 FLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQS 194

Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           T Y   +D+WSVGCI  E+  R+PLF G     QL  I
Sbjct: 195 T-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 231

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  255 bits (654), Expect = 5e-85
 Identities = 81/223 (36%), Positives = 124/223 (55%), Gaps = 23/223 (10%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR------TLREIKLLRHMEH 100
           I  +G G YG V  A+++ T E VAIK+I       ++          +RE+ LL+ ++H
Sbjct: 39  ITKLGEGTYGEVYKAIDTVTNETVAIKRI------RLEHEEEGVPGTAIREVSLLKELQH 92

Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
            N+I +K +I    +     +++++E  + DL + +  +  ++    + FLYQL+ G+ +
Sbjct: 93  RNIIELKSVIHHNHR-----LHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNF 147

Query: 161 VHSASVLHRDLKPSNLLLNASCD-----LKIGDFGLART-TSETDFMTEYVVTRWYRAPE 214
            HS   LHRDLKP NLLL+ S       LKIGDFGLAR         T  ++T WYR PE
Sbjct: 148 CHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPE 207

Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           +LL    Y+ ++DIWS+ CI  E++ + PLFPG   + QL  I
Sbjct: 208 ILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKI 250

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  254 bits (652), Expect = 9e-85
 Identities = 84/218 (38%), Positives = 118/218 (54%), Gaps = 18/218 (8%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA-----RRTLREIKLLRHMEHE 101
           +  +G G Y  V    +  T   VA+K+I       ++         +RE+ LL+ ++H 
Sbjct: 7   LDKLGEGTYATVYKGKSKLTDNLVALKEI------RLEHEEGAPCTAIREVSLLKDLKHA 60

Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKY 160
           N++ + DII   K      + +V+E +D DL Q +      +   + + FL+QLLRGL Y
Sbjct: 61  NIVTLHDIIHTEKS-----LTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAY 115

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNC 219
            H   VLHRDLKP NLL+N   +LK+ DFGLAR  +  T      VVT WYR P++LL  
Sbjct: 116 CHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGS 175

Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           T+Y+  ID+W VGCI  E+ T  PLFPG     QL  I
Sbjct: 176 TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFI 213

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  254 bits (652), Expect = 2e-84
 Identities = 82/220 (37%), Positives = 123/220 (55%), Gaps = 15/220 (6%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKI--GNAFDNI-IDARRTLREIKLLRHMEHENVIAI 106
           IG+G +G V  A + +T ++VA+KK+   N  +   I A   LREIK+L+ ++HENV+ +
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA---LREIKILQLLKHENVVNL 81

Query: 107 KDII---RPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVH 162
            +I      P       +Y+V++  + DL  ++ +   + T    +  +  LL GL Y+H
Sbjct: 82  IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 141

Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLAR-----TTSETDFMTEYVVTRWYRAPELLL 217
              +LHRD+K +N+L+     LK+ DFGLAR       S+ +  T  VVT WYR PELLL
Sbjct: 142 RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLL 201

Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
              +Y   ID+W  GCI+ E+ TR P+  G    HQL LI
Sbjct: 202 GERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 241

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  252 bits (647), Expect = 5e-84
 Identities = 86/223 (38%), Positives = 129/223 (57%), Gaps = 23/223 (10%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR-----TLREIKLLRHMEHE 101
           +  +G G Y  V   +N  T   VA+K++       +D+        +REI L++ ++HE
Sbjct: 10  LEKLGNGTYATVYKGLNKTTGVYVALKEV------KLDSEEGTPSTAIREISLMKELKHE 63

Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS------DQQLTDDHCQYFLYQLL 155
           N++ + D+I    K     + +V+E MD DL + + S       + L  +  +YF +QLL
Sbjct: 64  NIVRLYDVIHTENK-----LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPE 214
           +GL + H   +LHRDLKP NLL+N    LK+GDFGLAR      +  +  VVT WYRAP+
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPD 178

Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           +L+    Y+ +IDIWS GCIL E++T +PLFPG +   QL+LI
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLI 221

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  251 bits (643), Expect = 8e-84
 Identities = 86/219 (39%), Positives = 121/219 (55%), Gaps = 20/219 (9%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR------TLREIKLLRHMEH 100
           +  IG G YG+V  A N    E  A+KKI       ++         T+REI +L+ ++H
Sbjct: 7   LEKIGEGTYGVVYKAQN-NYGETFALKKI------RLEKEDEGIPSTTIREISILKELKH 59

Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLK 159
            N++ + D+I   K+     + +V+E +D DL +++   +  L     + FL QLL G+ 
Sbjct: 60  SNIVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLN 218
           Y H   VLHRDLKP NLL+N   +LKI DFGLAR         T  +VT WYRAP++L+ 
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174

Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
             +Y+  IDIWSVGCI  E++   PLFPG     QL  I
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI 213

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  250 bits (642), Expect = 1e-83
 Identities = 87/220 (39%), Positives = 125/220 (56%), Gaps = 20/220 (9%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR------TLREIKLLRHMEH 100
           +  IG G YG V  A N ET E VA+K++       +D          LREI LL+ ++H
Sbjct: 7   LEKIGEGTYGTVFKAKNRETHEIVALKRV------RLDDDDEGVPSSALREICLLKELKH 60

Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLK 159
           +N++ + D++   KK     + +V+E  D DL +   S +  L  +  + FL+QLL+GL 
Sbjct: 61  KNIVRLHDVLHSDKK-----LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLN 218
           + HS +VLHRDLKP NLL+N + +LK+ +FGLAR         +  VVT WYR P++L  
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175

Query: 219 CTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLI 257
              Y+ +ID+WS GCI  E+     PLFPG D   QL+ I
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 215

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  251 bits (643), Expect = 1e-83
 Identities = 84/219 (38%), Positives = 126/219 (57%), Gaps = 20/219 (9%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR------TLREIKLLRHMEH 100
           +  +G G YG+V  A +S     VA+K+I       +DA         +REI LL+ + H
Sbjct: 26  LEKVGEGTYGVVYKAKDS-QGRIVALKRI------RLDAEDEGIPSTAIREISLLKELHH 78

Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLK 159
            N++++ D+I   +      + +V+E M+ DL +++      L D   + +LYQLLRG+ 
Sbjct: 79  PNIVSLIDVIHSERC-----LTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVA 133

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLN 218
           + H   +LHRDLKP NLL+N+   LK+ DFGLAR         T  VVT WYRAP++L+ 
Sbjct: 134 HCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG 193

Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
             +Y+ ++DIWS+GCI  E++T +PLFPG     QL  I
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKI 232

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  248 bits (636), Expect = 3e-82
 Identities = 84/220 (38%), Positives = 123/220 (55%), Gaps = 19/220 (8%)

Query: 50  IGRGAYGIVCAAVNS-ETREEVAIKKIGNAFDNIIDARR------TLREIKLLRHM---E 99
           IG GAYG V  A +       VA+K++       +          T+RE+ +LRH+   E
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRV------RVQTGEEGMPLSTIREVAVLRHLETFE 72

Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLRG 157
           H NV+ + D+    + D    + +V+E +D DL   +    +  +  +  +  ++QLLRG
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 132

Query: 158 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 217
           L ++HS  V+HRDLKP N+L+ +S  +K+ DFGLAR  S    +T  VVT WYRAPE+LL
Sbjct: 133 LDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 192

Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
             + Y   +D+WSVGCI  E+  R+PLF G   V QL  I
Sbjct: 193 QSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 231

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  238 bits (609), Expect = 3e-77
 Identities = 83/240 (34%), Positives = 120/240 (50%), Gaps = 37/240 (15%)

Query: 50  IGRGAYGIVCAAVN--SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           +GRG YG V  A     +  ++ A+K+I      I  +    REI LLR ++H NVI+++
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIE--GTGISMS--ACREIALLRELKHPNVISLQ 84

Query: 108 DIIRPPKKDTFNDVYIVYELMDTDLHQIIRS---------DQQLTDDHCQYFLYQLLRGL 158
            +           V+++++  + DL  II+            QL     +  LYQ+L G+
Sbjct: 85  KVFLSHAD---RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141

Query: 159 KYVHSASVLHRDLKPSNLLLNASCD----LKIGDFGLARTTSE-----TDFMTEYVVTRW 209
            Y+H+  VLHRDLKP+N+L+         +KI D G AR  +       D     VVT W
Sbjct: 142 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV-VVTFW 200

Query: 210 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD---------YVHQLRLITEV 260
           YRAPELLL    YT AIDIW++GCI  E++T EP+F  +          +  QL  I  V
Sbjct: 201 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 260

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  175 bits (446), Expect = 1e-52
 Identities = 67/221 (30%), Positives = 120/221 (54%), Gaps = 15/221 (6%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG+G++G V  A + +  + VA+K + N        R+   EI++L H+  ++    
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNT 158

Query: 107 KDIIRPPKKDTF---NDVYIVYELMDTDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYV 161
            ++I     + F   N + + +EL+  +L+++I+    Q  +    + F + +L+ L  +
Sbjct: 159 MNVIH--MLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL 216

Query: 162 HSASVLHRDLKPSNLLLN--ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 219
           H   ++H DLKP N+LL       +K+ DFG +    E   +  Y+ +R+YRAPE++L  
Sbjct: 217 HKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTYIQSRFYRAPEVILGA 274

Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
             Y   ID+WS+GCIL E++T  PL PG+D   QL  + E+
Sbjct: 275 -RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIEL 314

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  172 bits (438), Expect = 1e-52
 Identities = 54/211 (25%), Positives = 85/211 (40%), Gaps = 9/211 (4%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIA 105
           +  +G G+YG V    + E     A+K+  + F    D  R L E+     + +H   + 
Sbjct: 62  LSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVR 121

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           ++             +Y+  EL    L Q        L +     +L   L  L ++HS 
Sbjct: 122 LEQAWE-----EGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
            ++H D+KP+N+ L      K+GDFGL                  Y APELL     Y  
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG--SYGT 234

Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLR 255
           A D++S+G  + E+     L  G +   QLR
Sbjct: 235 AADVFSLGLTILEVACNMELPHGGEGWQQLR 265

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  172 bits (438), Expect = 3e-52
 Identities = 62/242 (25%), Positives = 113/242 (46%), Gaps = 11/242 (4%)

Query: 22  THGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN 81
            H    V        F+   KYV  ++ IG G++G      ++E   +  IK+I  +  +
Sbjct: 5   HHHSSGVDLGTENLYFQSMEKYVR-LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS 63

Query: 82  IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ 140
             +   + RE+ +L +M+H N++  ++            +YIV +  +  DL + I + +
Sbjct: 64  SKEREESRREVAVLANMKHPNIVQYRESFE-----ENGSLYIVMDYCEGGDLFKRINAQK 118

Query: 141 Q--LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 198
                +D    +  Q+   LK+VH   +LHRD+K  N+ L     +++GDFG+AR  + T
Sbjct: 119 GVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178

Query: 199 DFMTEYVV-TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
             +    + T +Y +PE+  N   Y    DIW++GC+L E+ T +  F      + +  I
Sbjct: 179 VELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI 237

Query: 258 TE 259
             
Sbjct: 238 IS 239

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  170 bits (432), Expect = 4e-52
 Identities = 54/225 (24%), Positives = 96/225 (42%), Gaps = 23/225 (10%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           I  IG G +G V  A +    +   IK++        +  +  RE+K L  ++H N++  
Sbjct: 16  IELIGSGGFGQVFKAKHRIDGKTYVIKRVK------YNNEKAEREVKALAKLDHVNIVHY 69

Query: 107 KD-----------IIRPPKKDTFNDVYIVYELMDT-DLHQII--RSDQQLTDDHCQYFLY 152
                          +   +     ++I  E  D   L Q I  R  ++L          
Sbjct: 70  NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFE 129

Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRA 212
           Q+ +G+ Y+HS  +++RDLKPSN+ L  +  +KIGDFGL  +       T    T  Y +
Sbjct: 130 QITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMS 189

Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           PE + +  +Y   +D++++G IL E++         +       +
Sbjct: 190 PEQISS-QDYGKEVDLYALGLILAELLH--VCDTAFETSKFFTDL 231

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  168 bits (427), Expect = 4e-51
 Identities = 68/250 (27%), Positives = 111/250 (44%), Gaps = 37/250 (14%)

Query: 33  YGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREI 92
           Y + FE        I  +G+GA+G V  A N+      AIKKI +  + +      L E+
Sbjct: 4   YASDFEE-------IAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL---STILSEV 53

Query: 93  KLLRHMEHENVIAIKD--------IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLT 143
            LL  + H+ V+            +         + ++I  E  +   L+ +I S+    
Sbjct: 54  MLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQ 113

Query: 144 D-DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET---- 198
             D       Q+L  L Y+HS  ++HRDLKP N+ ++ S ++KIGDFGLA+    +    
Sbjct: 114 QRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173

Query: 199 -----------DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG 247
                      D +T  + T  Y A E+L     Y   ID++S+G I  E++   P   G
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTG 231

Query: 248 KDYVHQLRLI 257
            + V+ L+ +
Sbjct: 232 MERVNILKKL 241

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  169 bits (429), Expect = 8e-51
 Identities = 34/236 (14%), Positives = 64/236 (27%), Gaps = 32/236 (13%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
            P+  G   +V    + E  E+ A+K     A ++  +  R          +  E+    
Sbjct: 68  EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127

Query: 107 K---------DIIRPPKKDTFND------------VYIVYELMDTDLHQIIR-------S 138
           +         D +    +  F                ++      DL  +          
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187

Query: 139 DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 198
                         QL+R    + S  ++H    P NL +     L +GD          
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR 247

Query: 199 DFMTEYVVTRWYRAPELL-LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 253
                  V   Y   E L  +   +T A++ W +G  +  +      F       +
Sbjct: 248 --GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  164 bits (418), Expect = 5e-50
 Identities = 66/224 (29%), Positives = 101/224 (45%), Gaps = 15/224 (6%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G+YG           + +  K++        + +  + E+ LLR ++H N++  
Sbjct: 11  LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70

Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQ----LTDDHCQYFLYQLLRGLKYV 161
            D I      T    YIV E  +  DL  +I    +    L ++     + QL   LK  
Sbjct: 71  YDRIIDRTNTTL---YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 127

Query: 162 HS-----ASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPEL 215
           H       +VLHRDLKP+N+ L+   ++K+GDFGLAR    +T F   +V T +Y +PE 
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQ 187

Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           +     Y    DIWS+GC+L E+    P F           I E
Sbjct: 188 MNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 230

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  164 bits (417), Expect = 1e-49
 Identities = 58/238 (24%), Positives = 102/238 (42%), Gaps = 28/238 (11%)

Query: 46  PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           PI+ +GRG +G+V  A N       AIK+I    +  +   + +RE+K L  +EH  ++ 
Sbjct: 9   PIQCLGRGGFGVVFEAKNKVDDCNYAIKRI-RLPNRELAREKVMREVKALAKLEHPGIVR 67

Query: 106 IKD-------IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLT---DDHCQYFLYQL 154
             +         +         +YI  +L    +L   +     +       C +   Q+
Sbjct: 68  YFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQI 127

Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM------------- 201
              ++++HS  ++HRDLKPSN+       +K+GDFGL     + +               
Sbjct: 128 AEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187

Query: 202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           T  V T+ Y +PE +     Y+  +DI+S+G IL E++   P     + V  L  +  
Sbjct: 188 TGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY--PFSTQMERVRTLTDVRN 242

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  163 bits (415), Expect = 3e-49
 Identities = 50/229 (21%), Positives = 95/229 (41%), Gaps = 23/229 (10%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH--ENVI 104
           ++ IG G    V   +N E ++  AIK +     +         EI  L  ++   + +I
Sbjct: 33  LKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 91

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
            + D        T   +Y+V E  + DL+  ++  + +     + +   +L  +  +H  
Sbjct: 92  RLYDYEI-----TDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE---TDFMTEYVVTRWYRAPELLLNC-- 219
            ++H DLKP+N L+     LK+ DFG+A        +      V T  Y  PE + +   
Sbjct: 147 GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205

Query: 220 --------TEYTAAIDIWSVGCILGEIMTREPLFPG-KDYVHQLRLITE 259
                   ++ +   D+WS+GCIL  +   +  F    + + +L  I +
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 254

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  163 bits (414), Expect = 4e-49
 Identities = 66/218 (30%), Positives = 110/218 (50%), Gaps = 18/218 (8%)

Query: 41  SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR---RTLREIKLLRH 97
           + +    + IGRG +  V  A        VA+KK+     +++DA+     ++EI LL+ 
Sbjct: 32  ANFRI-EKKIGRGQFSEVYRAACLLDGVPVALKKV--QIFDLMDAKARADCIKEIDLLKQ 88

Query: 98  MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQ----LTDDHCQYFLY 152
           + H NVI              N++ IV EL D  DL ++I+  ++    + +     +  
Sbjct: 89  LNHPNVIKYYASFI-----EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV 143

Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYR 211
           QL   L+++HS  V+HRD+KP+N+ + A+  +K+GD GL R  +S+T      V T +Y 
Sbjct: 144 QLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 203

Query: 212 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
           +PE +     Y    DIWS+GC+L E+   +  F G  
Sbjct: 204 SPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDK 240

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  164 bits (418), Expect = 5e-49
 Identities = 72/223 (32%), Positives = 117/223 (52%), Gaps = 17/223 (7%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
              IG+G++G V  A +   +E VAIK I N         +   E++LL  M   +    
Sbjct: 59  DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEMK 115

Query: 107 KDIIRPPKKDTF---NDVYIVYELMDTDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYV 161
             I+    K  F   N + +V+E++  +L+ ++R+     ++ +  + F  Q+   L ++
Sbjct: 116 YYIVHL--KRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 173

Query: 162 HS--ASVLHRDLKPSNLLL--NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 217
            +   S++H DLKP N+LL       +KI DFG +        + +Y+ +R+YR+PE+LL
Sbjct: 174 ATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRIYQYIQSRFYRSPEVLL 231

Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
               Y  AID+WS+GCIL E+ T EPLF G + V Q+  I EV
Sbjct: 232 GM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV 273

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  165 bits (419), Expect = 8e-49
 Identities = 68/210 (32%), Positives = 110/210 (52%), Gaps = 19/210 (9%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKI------GNAFDNIIDARRTLRE 91
            +  +Y+   + +G GA G V  A   +T ++VAI+ I        +      A     E
Sbjct: 132 ALRDEYIM-SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190

Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYF 150
           I++L+ + H  +I IK+       D   D YIV ELM+  +L   +  +++L +  C+ +
Sbjct: 191 IEILKKLNHPCIIKIKNFF-----DA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLY 244

Query: 151 LYQLLRGLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVT 207
            YQ+L  ++Y+H   ++HRDLKP N+LL++    C +KI DFG ++   ET  M     T
Sbjct: 245 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 304

Query: 208 RWYRAPELLLNCTE--YTAAIDIWSVGCIL 235
             Y APE+L++     Y  A+D WS+G IL
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  162 bits (412), Expect = 1e-48
 Identities = 69/210 (32%), Positives = 110/210 (52%), Gaps = 19/210 (9%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKI------GNAFDNIIDARRTLRE 91
            +  +Y+   + +G GA G V  A   +T ++VAIK I        +      A     E
Sbjct: 7   ALRDEYIM-SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65

Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYF 150
           I++L+ + H  +I IK+       D   D YIV ELM+  +L   +  +++L +  C+ +
Sbjct: 66  IEILKKLNHPCIIKIKNFF-----DA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLY 119

Query: 151 LYQLLRGLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVT 207
            YQ+L  ++Y+H   ++HRDLKP N+LL++    C +KI DFG ++   ET  M     T
Sbjct: 120 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 179

Query: 208 RWYRAPELLLNCTE--YTAAIDIWSVGCIL 235
             Y APE+L++     Y  A+D WS+G IL
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  160 bits (406), Expect = 1e-47
 Identities = 50/229 (21%), Positives = 95/229 (41%), Gaps = 23/229 (10%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH--ENVI 104
           ++ IG G    V   +N E ++  AIK +     +         EI  L  ++   + +I
Sbjct: 14  LKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 72

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
            + D        T   +Y+V E  + DL+  ++  + +     + +   +L  +  +H  
Sbjct: 73  RLYDYEI-----TDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 127

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE---TDFMTEYVVTRWYRAPELLLN--- 218
            ++H DLKP+N L+     LK+ DFG+A        +      V T  Y  PE + +   
Sbjct: 128 GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186

Query: 219 -------CTEYTAAIDIWSVGCILGEIMTREPLFPG-KDYVHQLRLITE 259
                   ++ +   D+WS+GCIL  +   +  F    + + +L  I +
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 235

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  165 bits (418), Expect = 4e-47
 Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 10/221 (4%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
              +G G +G V   ++ +T E+VAIK+      +  +  R   EI++++ + H NV++ 
Sbjct: 19  KERLGTGGFGYVLRWIHQDTGEQVAIKQC-RQELSPKNRERWCLEIQIMKKLNHPNVVSA 77

Query: 107 KDIIRPPKKDTFND-VYIVYELMDT-DLHQIIRS---DQQLTDDHCQYFLYQLLRGLKYV 161
           +++    +K   ND   +  E  +  DL + +        L +   +  L  +   L+Y+
Sbjct: 78  REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137

Query: 162 HSASVLHRDLKPSNLLLNASCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
           H   ++HRDLKP N++L         KI D G A+   + +  TE+V T  Y APELL  
Sbjct: 138 HENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQ 197

Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
             +YT  +D WS G +  E +T    F       Q      
Sbjct: 198 -KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR 237

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  157 bits (399), Expect = 7e-47
 Identities = 44/225 (19%), Positives = 92/225 (40%), Gaps = 19/225 (8%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
             +G+GA   V    + +T +  AIK   N    +      +RE ++L+ + H+N++ + 
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVF-NNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73

Query: 108 DIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQ---LTDDHCQYFLYQLLRGLKYVHS 163
            I    ++ T     ++ E      L+ ++        L +      L  ++ G+ ++  
Sbjct: 74  AIE---EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130

Query: 164 ASVLHRDLKPSNLLLNASCD----LKIGDFGLARTTSETDFMTEYVVTRWYRAPELL--- 216
             ++HR++KP N++     D     K+ DFG AR   + +       T  Y  P++    
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERA 190

Query: 217 ----LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
                +  +Y A +D+WS+G       T    F   +   + + +
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  158 bits (402), Expect = 9e-47
 Identities = 59/247 (23%), Positives = 108/247 (43%), Gaps = 19/247 (7%)

Query: 2   AAAAKDSSSGGATSSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAA 61
            A AK  +      +        G   +   +    E   KY P    IGRG   +V   
Sbjct: 55  LAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDP-KDVIGRGVSSVVRRC 113

Query: 62  VNSETREEVAIKKI------GNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPK 114
           V+  T  E A+K +       +          T RE  +LR +  H ++I + D      
Sbjct: 114 VHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY---- 169

Query: 115 KDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP 173
            ++ + +++V++LM   +L   +     L++   +  +  LL  + ++H+ +++HRDLKP
Sbjct: 170 -ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKP 228

Query: 174 SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE-----YTAAIDI 228
            N+LL+ +  +++ DFG +      + + E   T  Y APE+L    +     Y   +D+
Sbjct: 229 ENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDL 288

Query: 229 WSVGCIL 235
           W+ G IL
Sbjct: 289 WACGVIL 295

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  159 bits (403), Expect = 1e-46
 Identities = 49/228 (21%), Positives = 93/228 (40%), Gaps = 23/228 (10%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH--ENVI 104
           ++ IG G    V   +N E ++  AIK +     +         EI  L  ++   + +I
Sbjct: 61  LKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 119

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
            + D        T   +Y+V E  + DL+  ++  + +     + +   +L  +  +H  
Sbjct: 120 RLYDYEI-----TDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE---TDFMTEYVVTRWYRAPELLLN--- 218
            ++H DLKP+N L+     LK+ DFG+A        +      V    Y  PE + +   
Sbjct: 175 GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233

Query: 219 -------CTEYTAAIDIWSVGCILGEIMTREPLFPG-KDYVHQLRLIT 258
                   ++ +   D+WS+GCIL  +   +  F    + + +L  I 
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 281

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  156 bits (397), Expect = 1e-46
 Identities = 57/212 (26%), Positives = 100/212 (47%), Gaps = 20/212 (9%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKI-------GNAFDNIIDARRTLR 90
                Y P    +GRG   +V   ++  T +E A+K I        +A +       TL+
Sbjct: 14  GFYENYEP-KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 72

Query: 91  EIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQ 148
           E+ +LR +  H N+I +KD       +T    ++V++LM   +L   +     L++   +
Sbjct: 73  EVDILRKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR 127

Query: 149 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR 208
             +  LL  +  +H  +++HRDLKP N+LL+   ++K+ DFG +      + + E   T 
Sbjct: 128 KIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTP 187

Query: 209 WYRAPELL-----LNCTEYTAAIDIWSVGCIL 235
            Y APE++      N   Y   +D+WS G I+
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  155 bits (393), Expect = 3e-46
 Identities = 55/192 (28%), Positives = 101/192 (52%), Gaps = 10/192 (5%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
             +G+GA+ +V   V+  T  E A K I     +  D ++  RE ++ R ++H N++ + 
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71

Query: 108 DIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           D I        +  Y+V++L+   +L + I + +  ++    + + Q+L  + Y HS  +
Sbjct: 72  DSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGI 126

Query: 167 LHRDLKPSNLLLNASCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
           +HR+LKP NLLL +      +K+ DFGLA   ++++    +  T  Y +PE +L    Y+
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE-VLKKDPYS 185

Query: 224 AAIDIWSVGCIL 235
             +DIW+ G IL
Sbjct: 186 KPVDIWACGVIL 197

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  158 bits (401), Expect = 4e-46
 Identities = 58/221 (26%), Positives = 91/221 (41%), Gaps = 24/221 (10%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKD 108
           +G GA G +          +VA+K+I     +  D     RE++LLR   EH NVI    
Sbjct: 32  LGHGAEGTIVYR-GMFDNRDVAVKRILPECFSFAD-----REVQLLRESDEHPNVIRYFC 85

Query: 109 IIRPPKKDTFNDVYIVYELMDTDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 167
             +          YI  EL    L + + + D           L Q   GL ++HS +++
Sbjct: 86  TEK-----DRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIV 140

Query: 168 HRDLKPSNLLL-----NASCDLKIGDFGLAR----TTSETDFMTEYVVTRWYRAPELLLN 218
           HRDLKP N+L+     +      I DFGL +            +    T  + APE+L  
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200

Query: 219 CTE--YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
             +   T  +DI+S GC+   +++      GK    Q  ++
Sbjct: 201 DCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL 241

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  157 bits (399), Expect = 4e-46
 Identities = 44/225 (19%), Positives = 92/225 (40%), Gaps = 19/225 (8%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
             +G+GA   V    + +T +  AIK   N    +      +RE ++L+ + H+N++ + 
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVF-NNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73

Query: 108 DIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQ---LTDDHCQYFLYQLLRGLKYVHS 163
            I    ++ T     ++ E      L+ ++        L +      L  ++ G+ ++  
Sbjct: 74  AIE---EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130

Query: 164 ASVLHRDLKPSNLLLNASCD----LKIGDFGLARTTSETDFMTEYVVTRWYRAPELL--- 216
             ++HR++KP N++     D     K+ DFG AR   + +       T  Y  P++    
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERA 190

Query: 217 ----LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
                +  +Y A +D+WS+G       T    F   +   + + +
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  152 bits (386), Expect = 4e-45
 Identities = 56/197 (28%), Positives = 91/197 (46%), Gaps = 15/197 (7%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHENV 103
             +G G + IV       T +E A K I     ++    +      RE+ +LR + H N+
Sbjct: 11  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           I + DI      +   DV ++ EL+   +L   +   + LT+D    FL Q+L G+ Y+H
Sbjct: 71  ITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 125

Query: 163 SASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
           S  + H DLKP N++L      +  +K+ DFG+A      +       T  + APE ++N
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE-IVN 184

Query: 219 CTEYTAAIDIWSVGCIL 235
                   D+WS+G I 
Sbjct: 185 YEPLGLEADMWSIGVIT 201

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  154 bits (391), Expect = 4e-45
 Identities = 62/241 (25%), Positives = 104/241 (43%), Gaps = 35/241 (14%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-----EHE 101
           +R +G G +  V  A +      VA+K +               EIKLL+ +       E
Sbjct: 24  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV---YTEAAEDEIKLLQRVNDADNTKE 80

Query: 102 NVIAIKDIIRPPKKDTFND-------VYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLY 152
           + +    I++    D FN        V +V+E++  +L  +I+    + +   + +    
Sbjct: 81  DSMGANHILK--LLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 138

Query: 153 QLLRGLKYVHS-ASVLHRDLKPSNLLLNASCD------LKIGDFGLARTTSETDFMTEYV 205
           QLL GL Y+H    ++H D+KP N+L+           +KI D G A    E    T  +
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSI 196

Query: 206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY------VHQLRLITE 259
            TR YR+PE+LL    +    DIWS  C++ E++T + LF   +          +  I E
Sbjct: 197 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255

Query: 260 V 260
           +
Sbjct: 256 L 256

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  151 bits (384), Expect = 6e-45
 Identities = 53/234 (22%), Positives = 87/234 (37%), Gaps = 33/234 (14%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIA 105
           +  IG G +G V   V        AIK+        +D +  LRE+     + +H +V+ 
Sbjct: 16  LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR 75

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDT-DLHQII----RSDQQLTDDHCQYFLYQLLRGLKY 160
                    +D  + + I  E  +   L   I    R      +   +  L Q+ RGL+Y
Sbjct: 76  YFSAW---AED--DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130

Query: 161 VHSASVLHRDLKPSNLLLN-------------------ASCDLKIGDFGLARTTSETDFM 201
           +HS S++H D+KPSN+ ++                        KIGD G     S     
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE 190

Query: 202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR 255
                   + A E+L     +    DI+++   +      EPL    D  H++R
Sbjct: 191 ---EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIR 241

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  152 bits (385), Expect = 9e-45
 Identities = 51/229 (22%), Positives = 86/229 (37%), Gaps = 20/229 (8%)

Query: 34  GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           G++  + +K+   I+ +G G +  V            A+K+I        D     RE  
Sbjct: 21  GHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRI--LCHEQQDREEAQREAD 78

Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQ----LTDDHCQ 148
           + R   H N++ +       +       +++        L   I   +     LT+D   
Sbjct: 79  MHRLFNHPNILRLVAYCLRERGAKHE-AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL 137

Query: 149 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART------TSETDFMT 202
           + L  + RGL+ +H+    HRDLKP+N+LL       + D G           S      
Sbjct: 138 WLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197

Query: 203 EYVVTR----WYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLF 245
           +    +     YRAPEL             D+WS+GC+L  +M  E  +
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY 246

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  152 bits (387), Expect = 1e-44
 Identities = 55/192 (28%), Positives = 101/192 (52%), Gaps = 10/192 (5%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
             +G+GA+ +V   V+  T  E A K I     +  D ++  RE ++ R ++H N++ + 
Sbjct: 35  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94

Query: 108 DIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           D I        +  Y+V++L+   +L + I + +  ++    + + Q+L  + Y HS  +
Sbjct: 95  DSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGI 149

Query: 167 LHRDLKPSNLLLNASCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
           +HR+LKP NLLL +      +K+ DFGLA   ++++    +  T  Y +PE +L    Y+
Sbjct: 150 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE-VLKKDPYS 208

Query: 224 AAIDIWSVGCIL 235
             +DIW+ G IL
Sbjct: 209 KPVDIWACGVIL 220

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  155 bits (394), Expect = 2e-44
 Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 11/206 (5%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           + +G GAYG V    +  T  E AIK I     +     + L E+ +L+ ++H N++ + 
Sbjct: 43  KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102

Query: 108 DIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           D       +   + Y+V E     +L   I    +  +      + Q+L G+ Y+H  ++
Sbjct: 103 DFF-----EDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNI 157

Query: 167 LHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
           +HRDLKP NLLL        +KI DFGL+        M E + T +Y APE+L     Y 
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKK--YD 215

Query: 224 AAIDIWSVGCILGEIMTREPLFPGKD 249
              D+WS+G IL  ++   P F G+ 
Sbjct: 216 EKCDVWSIGVILFILLAGYPPFGGQT 241

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  151 bits (383), Expect = 2e-44
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 15/197 (7%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHENV 103
             +G G + IV       T  E A K I      A    +      RE+ +LR + H NV
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           I + D+      +   DV ++ EL+   +L   +   + L+++    F+ Q+L G+ Y+H
Sbjct: 78  ITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132

Query: 163 SASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
           +  + H DLKP N++L         +K+ DFGLA    +         T  + APE ++N
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVN 191

Query: 219 CTEYTAAIDIWSVGCIL 235
                   D+WS+G I 
Sbjct: 192 YEPLGLEADMWSIGVIT 208

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  150 bits (380), Expect = 3e-44
 Identities = 61/192 (31%), Positives = 102/192 (53%), Gaps = 11/192 (5%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
             +G+G++G V    +  T++E A+K I  A     D    LRE++LL+ ++H N++ + 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 108 DIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           +I+     +  +  YIV EL    +L   I   ++ ++      + Q+  G+ Y+H  ++
Sbjct: 88  EIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNI 142

Query: 167 LHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
           +HRDLKP N+LL      CD+KI DFGL+    +   M + + T +Y APE+L     Y 
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YD 200

Query: 224 AAIDIWSVGCIL 235
              D+WS G IL
Sbjct: 201 EKCDVWSAGVIL 212

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  151 bits (384), Expect = 4e-44
 Identities = 53/197 (26%), Positives = 88/197 (44%), Gaps = 15/197 (7%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHENV 103
             +G G + IV       T  E A K I      A    +      RE+ +LR + H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           I + D+      +   DV ++ EL+   +L   +   + L+++    F+ Q+L G+ Y+H
Sbjct: 78  ITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132

Query: 163 SASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
           +  + H DLKP N++L         +K+ DFGLA    +         T  + APE ++N
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVN 191

Query: 219 CTEYTAAIDIWSVGCIL 235
                   D+WS+G I 
Sbjct: 192 YEPLGLEADMWSIGVIT 208

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  150 bits (380), Expect = 1e-43
 Identities = 61/241 (25%), Positives = 108/241 (44%), Gaps = 37/241 (15%)

Query: 47  IRPIGRGAYGIVCAAVNSET-REEVAIKKIGNAFDNIIDARRT--LREIKLLRHMEHENV 103
           +  +G GA+G V   ++ +     VA+K + N     +D        EI++L H+   + 
Sbjct: 19  VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN-----VDRYCEAARSEIQVLEHLNTTDP 73

Query: 104 IAIKDIIRPPKKDTF---NDVYIVYELMDTDLHQIIRSDQQ--LTDDHCQYFLYQLLRGL 158
            +    ++    + F     + IV+EL+    +  I+ +       DH +   YQ+ + +
Sbjct: 74  NSTFRCVQ--MLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSV 131

Query: 159 KYVHSASVLHRDLKPSNLLLN-------------------ASCDLKIGDFGLARTTSETD 199
            ++HS  + H DLKP N+L                      + D+K+ DFG A  T + +
Sbjct: 132 NFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TYDDE 189

Query: 200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
             +  V TR YRAPE++L    ++   D+WS+GCIL E      +FP  D    L ++  
Sbjct: 190 HHSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMER 248

Query: 260 V 260
           +
Sbjct: 249 I 249

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  149 bits (378), Expect = 1e-43
 Identities = 53/197 (26%), Positives = 89/197 (45%), Gaps = 15/197 (7%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHENV 103
             +G G + +V       T  + A K I      +    +      RE+ +L+ ++H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           I + ++      +   DV ++ EL+   +L   +   + LT++    FL Q+L G+ Y+H
Sbjct: 77  ITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131

Query: 163 SASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
           S  + H DLKP N++L         +KI DFGLA      +       T  + APE ++N
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190

Query: 219 CTEYTAAIDIWSVGCIL 235
                   D+WS+G I 
Sbjct: 191 YEPLGLEADMWSIGVIT 207

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  148 bits (376), Expect = 1e-43
 Identities = 63/225 (28%), Positives = 108/225 (48%), Gaps = 27/225 (12%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIID---------ARRTLREIKLLRHM 98
           R +G+G +       +++T+E  A K        I+            +   EI + R +
Sbjct: 21  RFLGKGGFAKCFEISDADTKEVFAGK--------IVPKSLLLKPHQREKMSMEISIHRSL 72

Query: 99  EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRG 157
            H++V+           +  + V++V EL     L ++ +  + LT+   +Y+L Q++ G
Sbjct: 73  AHQHVVGFHGFF-----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLG 127

Query: 158 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPEL 215
            +Y+H   V+HRDLK  NL LN   ++KIGDFGLA T  E D   + V+  T  Y APE+
Sbjct: 128 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKVLCGTPNYIAPEV 186

Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           L     ++  +D+WS+GCI+  ++  +P F           I + 
Sbjct: 187 LSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN 230

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  152 bits (387), Expect = 2e-43
 Identities = 61/207 (29%), Positives = 106/207 (51%), Gaps = 12/207 (5%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIG-NAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           R +G+G++G V    +  T +E A+K I         D    LRE++LL+ ++H N++ +
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91

Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            +       +     Y+V E+    +L   I S ++ ++      + Q+L G+ Y+H   
Sbjct: 92  YEFF-----EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146

Query: 166 VLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           ++HRDLKP NLLL   +   +++I DFGL+     +  M + + T +Y APE+L     Y
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--Y 204

Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKD 249
               D+WS G IL  +++  P F G +
Sbjct: 205 DEKCDVWSTGVILYILLSGCPPFNGAN 231

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  149 bits (378), Expect = 2e-43
 Identities = 63/225 (28%), Positives = 108/225 (48%), Gaps = 27/225 (12%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIID---------ARRTLREIKLLRHM 98
           R +G+G +       +++T+E  A K        I+            +   EI + R +
Sbjct: 47  RFLGKGGFAKCFEISDADTKEVFAGK--------IVPKSLLLKPHQREKMSMEISIHRSL 98

Query: 99  EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRG 157
            H++V+           +  + V++V EL     L ++ +  + LT+   +Y+L Q++ G
Sbjct: 99  AHQHVVGFHGFF-----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLG 153

Query: 158 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPEL 215
            +Y+H   V+HRDLK  NL LN   ++KIGDFGLA T  E D   + V+  T  Y APE+
Sbjct: 154 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKVLCGTPNYIAPEV 212

Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           L     ++  +D+WS+GCI+  ++  +P F           I + 
Sbjct: 213 LSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN 256

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  149 bits (379), Expect = 2e-43
 Identities = 57/241 (23%), Positives = 105/241 (43%), Gaps = 37/241 (15%)

Query: 47  IRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRT--LREIKLLRHMEHENV 103
           +  +G G +G V   + ++  + +VA+K I N     +   R     EI +L+ ++ ++ 
Sbjct: 24  VGNLGEGTFGKVVECLDHARGKSQVALKIIRN-----VGKYREAARLEINVLKKIKEKDK 78

Query: 104 IAIKDIIRPPKKDTF---NDVYIVYELMDTDLHQIIR--SDQQLTDDHCQYFLYQLLRGL 158
                 +     D F     + I +EL+  +  + ++  + Q     H ++  YQL   L
Sbjct: 79  ENKFLCVL--MSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHAL 136

Query: 159 KYVHSASVLHRDLKPSNLLLN-------------------ASCDLKIGDFGLARTTSETD 199
           +++H   + H DLKP N+L                      +  +++ DFG A  T + +
Sbjct: 137 RFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHE 194

Query: 200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
             T  V TR YR PE++L    +    D+WS+GCIL E      LF   +    L ++ +
Sbjct: 195 HHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK 253

Query: 260 V 260
           +
Sbjct: 254 I 254

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  148 bits (377), Expect = 2e-43
 Identities = 50/205 (24%), Positives = 97/205 (47%), Gaps = 13/205 (6%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRH 97
             ++ Y+   + +GRG + +V   ++  T +E A K +             L EI +L  
Sbjct: 25  NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLEL 84

Query: 98  MEH-ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DL-HQII-RSDQQLTDDHCQYFLYQ 153
            +    VI + ++      +  +++ ++ E     ++    +    + ++++     + Q
Sbjct: 85  AKSCPRVINLHEVY-----ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQ 139

Query: 154 LLRGLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWY 210
           +L G+ Y+H  +++H DLKP N+LL       D+KI DFG++R       + E + T  Y
Sbjct: 140 ILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEY 199

Query: 211 RAPELLLNCTEYTAAIDIWSVGCIL 235
            APE +LN    T A D+W++G I 
Sbjct: 200 LAPE-ILNYDPITTATDMWNIGIIA 223

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  149 bits (379), Expect = 2e-43
 Identities = 58/249 (23%), Positives = 114/249 (45%), Gaps = 49/249 (19%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT--LREIKLLRHMEHENVI 104
           IR +G G +G V    + + ++  A+K + N     I         E  +L+ +++++  
Sbjct: 40  IRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-----IKKYTRSAKIEADILKKIQNDD-- 92

Query: 105 AIKD---IIRPPKKDTF---NDVYIVYELMDTDLHQIIRSDQQ--LTDDHCQYFLYQLLR 156
              +   I++      F   + + +++E +   L++II  +       +  + +  ++L+
Sbjct: 93  --INNNNIVK--YHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILK 148

Query: 157 GLKYVHSASVLHRDLKPSNLLLN-------------------------ASCDLKIGDFGL 191
            L Y+   S+ H DLKP N+LL+                          S  +K+ DFG 
Sbjct: 149 ALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208

Query: 192 ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV 251
           A  T ++D+    + TR YRAPE++LN   +  + D+WS GC+L E+ T   LF   +++
Sbjct: 209 A--TFKSDYHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTHEHM 265

Query: 252 HQLRLITEV 260
             L ++  +
Sbjct: 266 EHLAMMESI 274

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  147 bits (374), Expect = 5e-43
 Identities = 42/192 (21%), Positives = 91/192 (47%), Gaps = 13/192 (6%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
             +GRG +GIV   V + +++    K +     + +  ++   EI +L    H N++ + 
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK---EISILNIARHRNILHLH 67

Query: 108 DIIRPPKKDTFNDVYIVYELMD-TDLH-QIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
           +       ++  ++ +++E +   D+  +I  S  +L +     +++Q+   L+++HS +
Sbjct: 68  ESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122

Query: 166 VLHRDLKPSNLLLNASCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
           + H D++P N++        +KI +FG AR     D          Y APE +      +
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE-VHQHDVVS 181

Query: 224 AAIDIWSVGCIL 235
            A D+WS+G ++
Sbjct: 182 TATDMWSLGTLV 193

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  146 bits (370), Expect = 7e-43
 Identities = 57/192 (29%), Positives = 90/192 (46%), Gaps = 13/192 (6%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
             IGRG++G V  AV   TR   A KKI      + D  R  +EI++++ ++H N+I + 
Sbjct: 15  NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKY--FVEDVDRFKQEIEIMKSLDHPNIIRLY 72

Query: 108 DIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           +       +   D+Y+V EL    +L + +   +   +      +  +L  + Y H  +V
Sbjct: 73  ETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNV 127

Query: 167 LHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
            HRDLKP N L    +    LK+ DFGLA        M   V T +Y +P++L     Y 
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL--YG 185

Query: 224 AAIDIWSVGCIL 235
              D WS G ++
Sbjct: 186 PECDEWSAGVMM 197

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  150 bits (382), Expect = 8e-43
 Identities = 65/206 (31%), Positives = 110/206 (53%), Gaps = 11/206 (5%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
             +G+G++G V    +  T++E A+K I  A     D    LRE++LL+ ++H N++ + 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 108 DIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           +I+     +  +  YIV EL    +L   I   ++ ++      + Q+  G+ Y+H  ++
Sbjct: 88  EIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNI 142

Query: 167 LHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
           +HRDLKP N+LL      CD+KI DFGL+    +   M + + T +Y APE+L     Y 
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YD 200

Query: 224 AAIDIWSVGCILGEIMTREPLFPGKD 249
              D+WS G IL  +++  P F GK+
Sbjct: 201 EKCDVWSAGVILYILLSGTPPFYGKN 226

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  148 bits (375), Expect = 1e-42
 Identities = 44/192 (22%), Positives = 87/192 (45%), Gaps = 12/192 (6%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
             +G GA+G+V   V   T      K I       +D      EI ++  + H  +I + 
Sbjct: 57  EELGSGAFGVVHRCVEKATGRVFVAKFI--NTPYPLDKYTVKNEISIMNQLHHPKLINLH 114

Query: 108 DIIRPPKKDTFNDVYIVYELMD-TDLH-QIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
           D       +   ++ ++ E +   +L  +I   D ++++     ++ Q   GLK++H  S
Sbjct: 115 DAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169

Query: 166 VLHRDLKPSNLLL--NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
           ++H D+KP N++     +  +KI DFGLA   +  + +     T  + APE +++     
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE-IVDREPVG 228

Query: 224 AAIDIWSVGCIL 235
              D+W++G + 
Sbjct: 229 FYTDMWAIGVLG 240

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  143 bits (364), Expect = 6e-42
 Identities = 55/196 (28%), Positives = 93/196 (47%), Gaps = 16/196 (8%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           R +G GA+G V       +  E  IK I N   + +   +   EI++L+ ++H N+I I 
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERVIKTI-NKDRSQVPMEQIEAEIEVLKSLDHPNIIKIF 86

Query: 108 DIIRPPKKDTFNDVYIVYELMD-----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           ++      + ++++YIV E  +       +       + L++ +    + Q++  L Y H
Sbjct: 87  EVF-----EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141

Query: 163 SASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 219
           S  V+H+DLKP N+L    +    +KI DFGLA      +  T    T  Y APE+    
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR- 200

Query: 220 TEYTAAIDIWSVGCIL 235
            + T   DIWS G ++
Sbjct: 201 -DVTFKCDIWSAGVVM 215

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  146 bits (370), Expect = 6e-42
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 13/203 (6%)

Query: 38  EVSSKY-VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
            V+S Y V     +G G +G V     + T  ++A K I      + D      EI ++ 
Sbjct: 84  AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKII--KTRGMKDKEEVKNEISVMN 141

Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLH-QIIRSDQQLTDDHCQYFLYQL 154
            ++H N+I + D       ++ ND+ +V E +D  +L  +II     LT+     F+ Q+
Sbjct: 142 QLDHANLIQLYDAF-----ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQI 196

Query: 155 LRGLKYVHSASVLHRDLKPSNLLL--NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRA 212
             G++++H   +LH DLKP N+L     +  +KI DFGLAR     + +     T  + A
Sbjct: 197 CEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLA 256

Query: 213 PELLLNCTEYTAAIDIWSVGCIL 235
           PE ++N    +   D+WSVG I 
Sbjct: 257 PE-VVNYDFVSFPTDMWSVGVIA 278

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  149 bits (379), Expect = 6e-42
 Identities = 45/192 (23%), Positives = 86/192 (44%), Gaps = 12/192 (6%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
             +G GA+G+V       T    A K +     +  D     +EI+ +  + H  ++ + 
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFAAKFV--MTPHESDKETVRKEIQTMSVLRHPTLVNLH 220

Query: 108 DIIRPPKKDTFNDVYIVYELMD-TDL-HQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
           D       +  N++ ++YE M   +L  ++     ++++D    ++ Q+ +GL ++H  +
Sbjct: 221 DAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275

Query: 166 VLHRDLKPSNLLL--NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
            +H DLKP N++     S +LK+ DFGL         +     T  + APE +       
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPE-VAEGKPVG 334

Query: 224 AAIDIWSVGCIL 235
              D+WSVG + 
Sbjct: 335 YYTDMWSVGVLS 346

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  148 bits (376), Expect = 8e-42
 Identities = 61/217 (28%), Positives = 103/217 (47%), Gaps = 22/217 (10%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKI-----------GNAFDNIIDARRTLREIKLLR 96
           R +G GAYG V          E AIK I            +  +          EI LL+
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLL 155
            ++H N+I + D+      +     Y+V E  +  +L + I +  +  +      + Q+L
Sbjct: 102 SLDHPNIIKLFDVF-----EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQIL 156

Query: 156 RGLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRA 212
            G+ Y+H  +++HRD+KP N+LL   N+  ++KI DFGL+   S+   + + + T +Y A
Sbjct: 157 SGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIA 216

Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
           PE+L     Y    D+WS G I+  ++   P F G++
Sbjct: 217 PEVLKKK--YNEKCDVWSCGVIMYILLCGYPPFGGQN 251

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  143 bits (363), Expect = 4e-41
 Identities = 58/192 (30%), Positives = 89/192 (46%), Gaps = 14/192 (7%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
             +GRGA  IV       T++  A+K +       +D +    EI +L  + H N+I +K
Sbjct: 59  SELGRGATSIVYRCKQKGTQKPYALKVL----KKTVDKKIVRTEIGVLLRLSHPNIIKLK 114

Query: 108 DIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           +I      +T  ++ +V EL+   +L   I      ++      + Q+L  + Y+H   +
Sbjct: 115 EIF-----ETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGI 169

Query: 167 LHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
           +HRDLKP NLL         LKI DFGL++       M     T  Y APE +L    Y 
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPE-ILRGCAYG 228

Query: 224 AAIDIWSVGCIL 235
             +D+WSVG I 
Sbjct: 229 PEVDMWSVGIIT 240

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  142 bits (359), Expect = 4e-41
 Identities = 52/212 (24%), Positives = 103/212 (48%), Gaps = 8/212 (3%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IGRG++  V   +++ET  EVA  ++ +      + +R   E ++L+ ++H N++   D 
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93

Query: 110 IRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS--ASV 166
                K     + +V ELM +  L   ++  + +     + +  Q+L+GL+++H+    +
Sbjct: 94  WESTVKGK-KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPI 152

Query: 167 LHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           +HRDLK  N+ +      +KIGD GLA     + F    + T  + APE+     +Y  +
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYEE--KYDES 209

Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           +D+++ G  + E+ T E  +       Q+   
Sbjct: 210 VDVYAFGMCMLEMATSEYPYSECQNAAQIYRR 241

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  143 bits (362), Expect = 5e-41
 Identities = 51/200 (25%), Positives = 97/200 (48%), Gaps = 18/200 (9%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNA---FDNIIDARRTLREIKLLRHMEHENVI 104
             IG+G + +V   +N ET ++ A+K +  A       +      RE  +   ++H +++
Sbjct: 30  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD-TDL-HQIIR---SDQQLTDDHCQYFLYQLLRGLK 159
            + +        +   +Y+V+E MD  DL  +I++   +    ++    +++ Q+L  L+
Sbjct: 90  ELLETY-----SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144

Query: 160 YVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPEL 215
           Y H  +++HRD+KP  +LL     S  +K+G FG+A    E+       V T  + APE 
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPE- 203

Query: 216 LLNCTEYTAAIDIWSVGCIL 235
           ++    Y   +D+W  G IL
Sbjct: 204 VVKREPYGKPVDVWGCGVIL 223

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  145 bits (367), Expect = 5e-41
 Identities = 61/236 (25%), Positives = 101/236 (42%), Gaps = 44/236 (18%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRH 97
            + +  V   + +G G+ G V     S     VA+K++   F +I        EIKLL  
Sbjct: 12  SLKNLVVSE-KILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIAL-----MEIKLLTE 64

Query: 98  M-EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII-------RSDQQLTDDHCQY 149
             +H NVI            T   +YI  EL + +L  ++        + +   + +   
Sbjct: 65  SDDHPNVIRYYCSE-----TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS 119

Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-------------CDLKIGDFGLART-- 194
            L Q+  G+ ++HS  ++HRDLKP N+L++ S               + I DFGL +   
Sbjct: 120 LLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179

Query: 195 ---TSETDFMTEYVVTRWYRAPELLLNCTE------YTAAIDIWSVGCILGEIMTR 241
              +S    +     T  +RAPELL            T +IDI+S+GC+   I+++
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  143 bits (362), Expect = 8e-41
 Identities = 38/250 (15%), Positives = 82/250 (32%), Gaps = 43/250 (17%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHENV 103
             +G+        A + ET E   +           + I   +  +  ++LLR ++++  
Sbjct: 79  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138

Query: 104 I-------AIKDIIRPPKK-------DTFND-----VYIVYELMDTD-------LHQIIR 137
                      D+++ P+K           D      + +Y  M ++       L     
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198

Query: 138 SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE 197
           + + L          Q++R L  +H   ++H  L+P +++L+    + +  F        
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 258

Query: 198 TDFMTEYVVTRWYRAPELLLNC----------TEYTAAIDIWSVGCILGEIMTREPLFPG 247
                   V+R +  PEL              T  T + D W++G ++  I   +     
Sbjct: 259 R---VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK 315

Query: 248 KDYVHQLRLI 257
              +     I
Sbjct: 316 DAALGGSEWI 325

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  141 bits (358), Expect = 9e-41
 Identities = 55/192 (28%), Positives = 91/192 (47%), Gaps = 13/192 (6%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
             +G GA+  V       T +  A+K I  +            EI +L+ ++HEN++ ++
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKS--PAFRDSSLENEIAVLKKIKHENIVTLE 72

Query: 108 DIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
           DI      ++    Y+V +L+   +L   I      T+      + Q+L  +KY+H   +
Sbjct: 73  DIY-----ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGI 127

Query: 167 LHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
           +HRDLKP NLL      +  + I DFGL++   +   M+    T  Y APE +L    Y+
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSK-MEQNGIMSTACGTPGYVAPE-VLAQKPYS 185

Query: 224 AAIDIWSVGCIL 235
            A+D WS+G I 
Sbjct: 186 KAVDCWSIGVIT 197

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  142 bits (359), Expect = 9e-41
 Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 21/202 (10%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +GRG++G V    + +T  + A+KK+      +   R    E+     +    ++ +   
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKV-----RLEVFRV--EELVACAGLSSPRIVPLYGA 118

Query: 110 IRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           +R         V I  EL++   L Q+I+    L +D   Y+L Q L GL+Y+H+  +LH
Sbjct: 119 VR-----EGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILH 173

Query: 169 RDLKPSNLLLNAS-CDLKIGDFGLAR-----TTSETDFMTEYVV-TRWYRAPELLLNCTE 221
            D+K  N+LL++      + DFG A         ++    +Y+  T  + APE+++    
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG-KP 232

Query: 222 YTAAIDIWSVGCILGEIMTREP 243
             A +DIWS  C++  ++    
Sbjct: 233 CDAKVDIWSSCCMMLHMLNGCH 254

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  141 bits (358), Expect = 1e-40
 Identities = 59/270 (21%), Positives = 102/270 (37%), Gaps = 74/270 (27%)

Query: 40  SSKYVP---PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           +S+Y+    PI+ +GRG +G+V  A N       AIK+I    +  +   + +RE+K L 
Sbjct: 1   ASRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRI-RLPNRELAREKVMREVKALA 59

Query: 97  HMEHENVIAIKD------------------------------------------------ 108
            +EH  ++   +                                                
Sbjct: 60  KLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFS 119

Query: 109 ----IIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTD---DHCQYFLYQLLRGLKY 160
               + +         +YI  +L    +L   +     L D     C +   Q+   +++
Sbjct: 120 TKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEF 179

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-------------MTEYVVT 207
           +HS  ++HRDLKPSN+       +K+GDFGL     + +               T  V T
Sbjct: 180 LHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239

Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGE 237
           + Y +PE +     Y+  +DI+S+G IL E
Sbjct: 240 KLYMSPEQIHG-NNYSHKVDIFSLGLILFE 268

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  144 bits (365), Expect = 1e-40
 Identities = 52/203 (25%), Positives = 96/203 (47%), Gaps = 12/203 (5%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRH 97
             + +Y      +G+GA+ +V   V     +E A   I     +  D ++  RE ++ R 
Sbjct: 8   RFTEEYQL-FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRL 66

Query: 98  MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLR 156
           ++H N++ + D I           Y++++L+   +L + I + +  ++    + + Q+L 
Sbjct: 67  LKHPNIVRLHDSI-----SEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE 121

Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLART-TSETDFMTEYVVTRWYRA 212
            + + H   V+HR+LKP NLLL +      +K+ DFGLA     E      +  T  Y +
Sbjct: 122 AVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLS 181

Query: 213 PELLLNCTEYTAAIDIWSVGCIL 235
           PE +L    Y   +D+W+ G IL
Sbjct: 182 PE-VLRKDPYGKPVDLWACGVIL 203

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  140 bits (356), Expect = 1e-40
 Identities = 55/222 (24%), Positives = 106/222 (47%), Gaps = 42/222 (18%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI------------------------GNAFDNI 82
              IG+G+YG+V  A N       A+K +                        G      
Sbjct: 18  KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77

Query: 83  IDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYE------LMDTDLHQII 136
               +  +EI +L+ ++H NV+ + +++  P +D    +Y+V+E      +M+      +
Sbjct: 78  GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNED---HLYMVFELVNQGPVME------V 128

Query: 137 RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS 196
            + + L++D  +++   L++G++Y+H   ++HRD+KPSNLL+     +KI DFG++    
Sbjct: 129 PTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188

Query: 197 ETDFMTEYVV-TRWYRAPELLLNCT-EYT-AAIDIWSVGCIL 235
            +D +    V T  + APE L      ++  A+D+W++G  L
Sbjct: 189 GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  139 bits (353), Expect = 3e-40
 Identities = 56/229 (24%), Positives = 105/229 (45%), Gaps = 34/229 (14%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIID---------ARRTLREIKLLRHM 98
             +G+G++  V  A +  T  EVAIK        +ID          +R   E+K+   +
Sbjct: 17  NLLGKGSFAGVYRAESIHTGLEVAIK--------MIDKKAMYKAGMVQRVQNEVKIHCQL 68

Query: 99  EHENVIAIKDIIRPPKKDTFNDVYIV--Y----ELMDTDLHQIIRSDQQLTDDHCQYFLY 152
           +H +++ + +       +  N VY+V       E+       +    +  +++  ++F++
Sbjct: 69  KHPSILELYNYF-----EDSNYVYLVLEMCHNGEMNR----YLKNRVKPFSENEARHFMH 119

Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA-RTTSETDFMTEYVVTRWYR 211
           Q++ G+ Y+HS  +LHRDL  SNLLL  + ++KI DFGLA +     +       T  Y 
Sbjct: 120 QIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYI 179

Query: 212 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           +PE+    + +    D+WS+GC+   ++   P F      + L  +   
Sbjct: 180 SPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA 227

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  141 bits (356), Expect = 3e-40
 Identities = 66/280 (23%), Positives = 108/280 (38%), Gaps = 58/280 (20%)

Query: 22  THGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKI---GNA 78
              G+   Y   G+L E+  KY      IG+G+YG+V  A+ ++TR   AIK +      
Sbjct: 7   HSSGRENLYFQGGSLLELQKKYHL-KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIR 65

Query: 79  FDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM---------- 128
             N  D  R   E++L++ + H N+  + ++      +    + +V EL           
Sbjct: 66  QINPKDVERIKTEVRLMKKLHHPNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLN 120

Query: 129 -------------------------------DTDLHQIIRSDQQLTDDHCQYFLYQLLRG 157
                                           +        D    +      + Q+   
Sbjct: 121 VFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180

Query: 158 LKYVHSASVLHRDLKPSNLLL--NASCDLKIGDFGLAR-----TTSETDFMTEYVVTRWY 210
           L Y+H+  + HRD+KP N L   N S ++K+ DFGL++        E   MT    T ++
Sbjct: 181 LHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYF 240

Query: 211 RAPELLLNCTE-YTAAIDIWSVGCILGEIMTREPLFPGKD 249
            APE+L    E Y    D WS G +L  ++     FPG +
Sbjct: 241 VAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVN 280

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  140 bits (356), Expect = 3e-40
 Identities = 62/198 (31%), Positives = 97/198 (48%), Gaps = 25/198 (12%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR--TLREIKLLRHM-EHENVI 104
             IG G+Y +    ++  T  E A+K        IID  +     EI++L    +H N+I
Sbjct: 28  EDIGVGSYSVCKRCIHKATNMEFAVK--------IIDKSKRDPTEEIEILLRYGQHPNII 79

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
            +KD+      D    VY+V ELM   +L   I   +  ++      L+ + + ++Y+H+
Sbjct: 80  TLKDVY-----DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA 134

Query: 164 ASVLHRDLKPSNLLL-----NASCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLL 217
             V+HRDLKPSN+L      N    ++I DFG A+   +E   +     T  + APE +L
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPES-IRICDFGFAKQLRAENGLLMTPCYTANFVAPE-VL 192

Query: 218 NCTEYTAAIDIWSVGCIL 235
               Y AA DIWS+G +L
Sbjct: 193 ERQGYDAACDIWSLGVLL 210

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  142 bits (359), Expect = 4e-40
 Identities = 38/246 (15%), Positives = 76/246 (30%), Gaps = 36/246 (14%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRH------ 97
             +G+        A + ET E   +           + I   +  +  ++LLR       
Sbjct: 84  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 98  -MEHENVIAIKDIIRPPKKDTFNDV------------YIVYELMDTDLHQIIRS------ 138
              H   I   D+++ P+K     V            + +Y  M ++L            
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 139 -DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE 197
             + L          Q++R L  +H   ++H  L+P +++L+    + +  F        
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 263

Query: 198 TDFM--TEYVVTRWYRAPELLL----NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV 251
           +               A  +L     + T  T A D W++G  +  I   +        +
Sbjct: 264 SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAAL 323

Query: 252 HQLRLI 257
                I
Sbjct: 324 GGSEWI 329

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  140 bits (354), Expect = 5e-40
 Identities = 53/238 (22%), Positives = 101/238 (42%), Gaps = 26/238 (10%)

Query: 34  GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           G   E+    +   R +  G +  V  A +  +  E A+K++    +     R  ++E+ 
Sbjct: 20  GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRL--LSNEEEKNRAIIQEVC 77

Query: 94  LLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQ--LTDDH 146
            ++ +  H N++         K+++         L +      +  + + + +  L+ D 
Sbjct: 78  FMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDT 137

Query: 147 CQYFLYQLLRGLKYVHSAS--VLHRDLKPSNLLLNASCDLKIGDFGLART---------T 195
                YQ  R ++++H     ++HRDLK  NLLL+    +K+ DFG A T         +
Sbjct: 138 VLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWS 197

Query: 196 SETDFMTEYVVTR----WYRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPG 247
           ++   + E  +TR     YR PE+  L +        DIW++GCIL  +  R+  F  
Sbjct: 198 AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  141 bits (357), Expect = 6e-40
 Identities = 55/195 (28%), Positives = 94/195 (48%), Gaps = 16/195 (8%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAI 106
           + +G G  G V    N  T+E+ A+K +        D  +  RE++L     +  +++ I
Sbjct: 68  QVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRI 120

Query: 107 KDIIRPPKKDTFNDVYIVYELMD--TDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHS 163
            D+           + IV E +D      +I  R DQ  T+      +  +   ++Y+HS
Sbjct: 121 VDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 179

Query: 164 ASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
            ++ HRD+KP NLL      +  LK+ DFG A+ T+  + +T    T +Y APE +L   
Sbjct: 180 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPE 238

Query: 221 EYTAAIDIWSVGCIL 235
           +Y  + D+WS+G I+
Sbjct: 239 KYDKSCDMWSLGVIM 253

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  138 bits (351), Expect = 6e-40
 Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 14/201 (6%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+G YGIV A  +   +  +AIK+I               EI L +H++H+N++     
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLH--EEIALHKHLKHKNIVQYLGS 87

Query: 110 IRPPKKDTFNDVYIVYELMDTD-LHQIIRSDQ---QLTDDHCQYFLYQLLRGLKYVHSAS 165
                      + I  E +    L  ++RS     +  +    ++  Q+L GLKY+H   
Sbjct: 88  FS-----ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ 142

Query: 166 VLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVV-TRWYRAPE-LLLNCTEY 222
           ++HRD+K  N+L+N  S  LKI DFG ++  +  +  TE    T  Y APE +      Y
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY 202

Query: 223 TAAIDIWSVGCILGEIMTREP 243
             A DIWS+GC + E+ T +P
Sbjct: 203 GKAADIWSLGCTIIEMATGKP 223

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  139 bits (351), Expect = 1e-39
 Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 15/198 (7%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI------GNAFDNIIDARRTLREIKLLRHMEH 100
           + P+G GA+G V  AV+ E  +EV +K I       + +       +   EI +L  +EH
Sbjct: 29  MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH 88

Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT--DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
            N+I + DI      +      +V E   +  DL   I    +L +    Y   QL+  +
Sbjct: 89  ANIIKVLDIF-----ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143

Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
            Y+    ++HRD+K  N+++     +K+ DFG A           +  T  Y APE+L+ 
Sbjct: 144 GYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMG 203

Query: 219 CTEYT-AAIDIWSVGCIL 235
              Y    +++WS+G  L
Sbjct: 204 -NPYRGPELEMWSLGVTL 220

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  138 bits (350), Expect = 3e-39
 Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 17/205 (8%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRH 97
            V+  Y    + +G G  G V    +  T ++ A+K +        D+ +  +E+     
Sbjct: 25  AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY-------DSPKARQEVDHHWQ 77

Query: 98  -MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD--LHQII-RSDQQLTDDHCQYFLYQ 153
                +++ I D+           + I+ E M+      +I  R DQ  T+      +  
Sbjct: 78  ASGGPHIVCILDVYENMHHGK-RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRD 136

Query: 154 LLRGLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWY 210
           +   ++++HS ++ HRD+KP NLL         LK+ DFG A+ T++    T    T +Y
Sbjct: 137 IGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYY 195

Query: 211 RAPELLLNCTEYTAAIDIWSVGCIL 235
            APE +L   +Y  + D+WS+G I+
Sbjct: 196 VAPE-VLGPEKYDKSCDMWSLGVIM 219

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  136 bits (345), Expect = 4e-39
 Identities = 52/222 (23%), Positives = 103/222 (46%), Gaps = 23/222 (10%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR---RTLREIKLLRHMEHENVI 104
           RP+G+G +G V  A   +++  +A+K +      +  A    +  RE+++  H+ H N++
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRHPNIL 72

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
            +        +     VY++ E      +++ ++   +  +     ++ +L   L Y HS
Sbjct: 73  RLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT-----EYVVTRWYRAPELLLN 218
             V+HRD+KP NLLL ++ +LKI DFG +     +         +Y+       PE++  
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYL------PPEMIEG 181

Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
              +   +D+WS+G +  E +  +P F    Y    + I+ V
Sbjct: 182 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 222

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  136 bits (345), Expect = 1e-38
 Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 23/203 (11%)

Query: 42  KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR---TLREIKLLRHM 98
                 +P+G G++ I    V+ ++ +  A+K        II  R    T +EI  L+  
Sbjct: 11  DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVK--------IISKRMEANTQKEITALKLC 62

Query: 99  -EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLR 156
             H N++ + ++            ++V EL++  +L + I+  +  ++    Y + +L+ 
Sbjct: 63  EGHPNIVKLHEVF-----HDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVS 117

Query: 157 GLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRA 212
            + ++H   V+HRDLKP NLL    N + ++KI DFG AR    +   +     T  Y A
Sbjct: 118 AVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAA 177

Query: 213 PELLLNCTEYTAAIDIWSVGCIL 235
           PE LLN   Y  + D+WS+G IL
Sbjct: 178 PE-LLNQNGYDESCDLWSLGVIL 199

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  134 bits (339), Expect = 9e-38
 Identities = 51/188 (27%), Positives = 96/188 (51%), Gaps = 8/188 (4%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG+G +  V  A +  T  EVAIK I     N    ++  RE+++++ + H N++ + ++
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 110 IRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 168
           I     +T   +Y++ E     ++   + +  ++ +   +    Q++  ++Y H   ++H
Sbjct: 83  I-----ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVH 137

Query: 169 RDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT-AAID 227
           RDLK  NLLL+A  ++KI DFG +   +    +  +     Y APEL     +Y    +D
Sbjct: 138 RDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQG-KKYDGPEVD 196

Query: 228 IWSVGCIL 235
           +WS+G IL
Sbjct: 197 VWSLGVIL 204

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  132 bits (335), Expect = 1e-37
 Identities = 52/222 (23%), Positives = 97/222 (43%), Gaps = 23/222 (10%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR---RTLREIKLLRHMEHENVI 104
           RP+G+G +G V  A   + +  +A+K +      +       +  REI++  H+ H N++
Sbjct: 20  RPLGKGKFGNVYLAREKQNKFIMALKVLFK--SQLEKEGVEHQLRREIEIQSHLRHPNIL 77

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
            + +     K+     +Y++ E     +L++ ++   +  +     F+ +L   L Y H 
Sbjct: 78  RMYNYFHDRKR-----IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 132

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT-----EYVVTRWYRAPELLLN 218
             V+HRD+KP NLL+    +LKI DFG +         T     +Y+       PE++  
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYL------PPEMIEG 186

Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
              +   +D+W  G +  E +   P F    +    R I  V
Sbjct: 187 K-THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV 227

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  133 bits (336), Expect = 1e-37
 Identities = 52/200 (26%), Positives = 84/200 (42%), Gaps = 19/200 (9%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLR----HME 99
             +G+G +G V A      R +VAIK I       +  + D+     E+ LL        
Sbjct: 37  PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96

Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT--DLHQIIRSDQQLTDDHCQYFLYQLLRG 157
           H  VI + D       +T     +V E      DL   I     L +   + F  Q++  
Sbjct: 97  HPGVIRLLDWF-----ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA 151

Query: 158 LKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 216
           +++ HS  V+HRD+K  N+L++      K+ DFG      +  +   +  TR Y  PE +
Sbjct: 152 IQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD-FDGTRVYSPPEWI 210

Query: 217 LNCTEYTAA-IDIWSVGCIL 235
               +Y A    +WS+G +L
Sbjct: 211 SR-HQYHALPATVWSLGILL 229

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  132 bits (335), Expect = 3e-37
 Identities = 48/199 (24%), Positives = 88/199 (44%), Gaps = 17/199 (8%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEHE- 101
              +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +    
Sbjct: 48  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 107

Query: 102 -NVIAIKDIIRPPKKDTFNDVYIVYELMDT--DLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
             VI + D       +  +   ++ E  +   DL   I     L ++  + F +Q+L  +
Sbjct: 108 SGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 162

Query: 159 KYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 217
           ++ H+  VLHRD+K  N+L++    +LK+ DFG      +T +   +  TR Y  PE + 
Sbjct: 163 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIR 221

Query: 218 NCTEYTAA-IDIWSVGCIL 235
               Y      +WS+G +L
Sbjct: 222 Y-HRYHGRSAAVWSLGILL 239

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  130 bits (329), Expect = 7e-37
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 26/217 (11%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT--LREIKLLRHMEHENVIAIK 107
           IG G +G V  A       EVA+K   +  D  I        +E KL   ++H N+IA++
Sbjct: 15  IGIGGFGKVYRAFWIGD--EVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72

Query: 108 DI-IRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-- 163
            + ++ P       + +V E      L++++   +++  D    +  Q+ RG+ Y+H   
Sbjct: 73  GVCLKEPN------LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEA 125

Query: 164 -ASVLHRDLKPSNLLLNASCD--------LKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
              ++HRDLK SN+L+    +        LKI DFGLAR    T  M+      W  APE
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAW-MAPE 184

Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV 251
           ++   + ++   D+WS G +L E++T E  F G D +
Sbjct: 185 VI-RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL 220

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  130 bits (329), Expect = 8e-37
 Identities = 69/204 (33%), Positives = 99/204 (48%), Gaps = 32/204 (15%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIK-----KIGNAFDNIIDARRTLREIKLLRHMEHE 101
           ++ +G GAYG V  AVN  T E VA+K     +  +  +NI       +EI + + + HE
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK------KEICINKMLNHE 65

Query: 102 NVIAIKDIIRPPKKDTFNDVYIV--Y----ELMDTDLHQIIRSDQQLTDDHCQYFLYQLL 155
           NV+              N  Y+   Y    EL D      I  D  + +   Q F +QL+
Sbjct: 66  NVVKFYGHR-----REGNIQYLFLEYCSGGELFDR-----IEPDIGMPEPDAQRFFHQLM 115

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRA 212
            G+ Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y A
Sbjct: 116 AGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175

Query: 213 PELLLNCTEYTAA-IDIWSVGCIL 235
           PELL    E+ A  +D+WS G +L
Sbjct: 176 PELLKR-REFHAEPVDVWSCGIVL 198

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  131 bits (331), Expect = 1e-36
 Identities = 52/214 (24%), Positives = 86/214 (40%), Gaps = 24/214 (11%)

Query: 39  VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRH- 97
               Y      +G GA+  V   +N  T +E A+K I           R  RE+++L   
Sbjct: 10  FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKII--EKQPGHIRSRVFREVEMLYQC 67

Query: 98  MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 156
             H NV+ + +       +  +  Y+V+E M    +   I   +   +      +  +  
Sbjct: 68  QGHRNVLELIEFF-----EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVAS 122

Query: 157 GLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLAR--------TTSETDFMTEYV 205
            L ++H+  + HRDLKP N+L    N    +KI DF L          +   T  +    
Sbjct: 123 ALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182

Query: 206 VTRWYRAPELLLNCTE----YTAAIDIWSVGCIL 235
            +  Y APE++   +E    Y    D+WS+G IL
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  130 bits (330), Expect = 1e-36
 Identities = 64/227 (28%), Positives = 105/227 (46%), Gaps = 24/227 (10%)

Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
           +L  +  K +     +GRGA+G+VC A       +VAIK+I    ++  + +  + E++ 
Sbjct: 1   SLHMIDYKEIEVEEVVGRGAFGVVCKAKWRAK--DVAIKQI----ESESERKAFIVELRQ 54

Query: 95  LRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ---QLTDDHCQYF 150
           L  + H N++ +            N V +V E  +   L+ ++   +     T  H   +
Sbjct: 55  LSRVNHPNIVKLYGA-------CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW 107

Query: 151 LYQLLRGLKYVHS---ASVLHRDLKPSNLLLNASCD-LKIGDFGLARTTSETDFMTEYVV 206
             Q  +G+ Y+HS    +++HRDLKP NLLL A    LKI DFG A        MT    
Sbjct: 108 CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKG 165

Query: 207 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 253
           +  + APE +   + Y+   D++S G IL E++TR   F        
Sbjct: 166 SAAWMAPE-VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF 211

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  130 bits (330), Expect = 2e-36
 Identities = 58/190 (30%), Positives = 102/190 (53%), Gaps = 8/190 (4%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIG-NAFDNIIDARRTLREIKLLRHMEHENVIAI 106
             +G G++G V  A + +T+++VA+K I            R  REI  L+ + H ++I +
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74

Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
            D+I      T  D+ +V E    +L   I   +++T+D  + F  Q++  ++Y H   +
Sbjct: 75  YDVI-----TTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKI 129

Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT-AA 225
           +HRDLKP NLLL+ + ++KI DFGL+   ++ +F+     +  Y APE++     Y    
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVING-KLYAGPE 188

Query: 226 IDIWSVGCIL 235
           +D+WS G +L
Sbjct: 189 VDVWSCGIVL 198

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  129 bits (327), Expect = 2e-36
 Identities = 50/227 (22%), Positives = 98/227 (43%), Gaps = 27/227 (11%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKI-GNAFDNIIDARRTL----REIKLLRHMEHENVI 104
           IG+G +G+V      + +  VAIK +     +   +         RE+ ++ ++ H N++
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86

Query: 105 AIKDI-IRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYV 161
            +  +   PP         +V E +   DL+  +      +        +  +  G++Y+
Sbjct: 87  KLYGLMHNPP--------RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYM 138

Query: 162 HS--ASVLHRDLKPSNLLL-----NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 214
            +    ++HRDL+  N+ L     NA    K+ DFGL++ +  +  ++  +    + APE
Sbjct: 139 QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS--VSGLLGNFQWMAPE 196

Query: 215 LLLNCTE-YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
            +    E YT   D +S   IL  I+T E  F    Y  +++ I  +
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG-KIKFINMI 242

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  130 bits (328), Expect = 2e-36
 Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 25/203 (12%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIK--------KIGNAFDNIIDARRTLREIKLLRHME 99
             +G G+YG V   ++SET    A+K        +I N   N+       +EI+LLR + 
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANV------KKEIQLLRRLR 64

Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELM---DTDLHQIIRSDQQLTDDHCQYFLYQLLR 156
           H+NVI + D++   +K     +Y+V E       ++   +  +++        +  QL+ 
Sbjct: 65  HKNVIQLVDVLYNEEK---QKMYMVMEYCVCGMQEMLDSV-PEKRFPVCQAHGYFCQLID 120

Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAP 213
           GL+Y+HS  ++H+D+KP NLLL     LKI   G+A      +  D       +  ++ P
Sbjct: 121 GLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180

Query: 214 ELLLNCTEYT-AAIDIWSVGCIL 235
           E+      ++   +DIWS G  L
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTL 203

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  128 bits (324), Expect = 5e-36
 Identities = 56/191 (29%), Positives = 93/191 (48%), Gaps = 9/191 (4%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIG-NAFDNIIDARRTLREIKLLRHMEHENVIAI 106
             +G G +G V    +  T  +VA+K +      ++    +  REI+ L+   H ++I +
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76

Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
             +I      T  D ++V E +   +L   I    ++ +   +    Q+L  + Y H   
Sbjct: 77  YQVI-----STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 131

Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT-A 224
           V+HRDLKP N+LL+A  + KI DFGL+   S+ +F+     +  Y APE++     Y   
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG-RLYAGP 190

Query: 225 AIDIWSVGCIL 235
            +DIWS G IL
Sbjct: 191 EVDIWSCGVIL 201

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  129 bits (326), Expect = 5e-36
 Identities = 69/204 (33%), Positives = 99/204 (48%), Gaps = 32/204 (15%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIK-----KIGNAFDNIIDARRTLREIKLLRHMEHE 101
           ++ +G GAYG V  AVN  T E VA+K     +  +  +NI       +EI + + + HE
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK------KEICINKMLNHE 65

Query: 102 NVIAIKDIIRPPKKDTFNDVYIV--Y----ELMDTDLHQIIRSDQQLTDDHCQYFLYQLL 155
           NV+              N  Y+   Y    EL D      I  D  + +   Q F +QL+
Sbjct: 66  NVVKFYGHR-----REGNIQYLFLEYCSGGELFDR-----IEPDIGMPEPDAQRFFHQLM 115

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRA 212
            G+ Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y A
Sbjct: 116 AGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175

Query: 213 PELLLNCTEYTAA-IDIWSVGCIL 235
           PELL    E+ A  +D+WS G +L
Sbjct: 176 PELLKR-REFHAEPVDVWSCGIVL 198

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  128 bits (323), Expect = 8e-36
 Identities = 50/213 (23%), Positives = 94/213 (44%), Gaps = 16/213 (7%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           + IG G++G V          +VA+K +          +    E+ +LR   H N++   
Sbjct: 30  QRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86

Query: 108 DIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSAS 165
                P+      + IV +  +   L+  + + + +           Q  RG+ Y+H+ S
Sbjct: 87  GYSTAPQ------LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS 140

Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLAR---TTSETDFMTEYVVTRWYRAPELLLNCTE- 221
           ++HRDLK +N+ L+    +KIGDFGLA      S +    +   +  + APE++      
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200

Query: 222 -YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 253
            Y+   D+++ G +L E+MT +  +   +   Q
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 233

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  127 bits (322), Expect = 1e-35
 Identities = 66/238 (27%), Positives = 114/238 (47%), Gaps = 27/238 (11%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIK-LL 95
            EV +  + PI  +GRGAYG+V    +  + + +A+K+I  A  N  + +R L ++   +
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISM 60

Query: 96  RHMEHENVIA-----IKDIIRPPKKDTFNDVYIVYELMDT----DLHQIIRSDQQLTDDH 146
           R ++    +       ++           DV+I  ELMDT       Q+I   Q + +D 
Sbjct: 61  RTVDCPFTVTFYGALFRE----------GDVWICMELMDTSLDKFYKQVIDKGQTIPEDI 110

Query: 147 CQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 205
                  +++ L+++HS  SV+HRD+KPSN+L+NA   +K+ DFG++    +        
Sbjct: 111 LGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA 170

Query: 206 VTRWYRAPE---LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
             + Y APE     LN   Y+   DIWS+G  + E+      FP   +    + + +V
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR--FPYDSWGTPFQQLKQV 226

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  128 bits (323), Expect = 1e-35
 Identities = 52/210 (24%), Positives = 99/210 (47%), Gaps = 17/210 (8%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA-IKD 108
           IG G++G V  A    +  +VA+K +     +       LRE+ +++ + H N++  +  
Sbjct: 45  IGAGSFGTVHRAEWHGS--DVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102

Query: 109 IIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD---QQLTDDHCQYFLYQLLRGLKYVHS- 163
           + +PP       + IV E +    L++++      +QL +       Y + +G+ Y+H+ 
Sbjct: 103 VTQPPN------LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156

Query: 164 -ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLLNCTE 221
              ++HR+LK  NLL++    +K+ DFGL+R  + T         T  + APE +L    
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPE-VLRDEP 215

Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYV 251
                D++S G IL E+ T +  +   +  
Sbjct: 216 SNEKSDVYSFGVILWELATLQQPWGNLNPA 245

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  129 bits (326), Expect = 1e-35
 Identities = 61/198 (30%), Positives = 96/198 (48%), Gaps = 23/198 (11%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-----REIKLLRHMEHE 101
           ++ IG G +G+     +  T+E VA+K         I+    +     REI   R + H 
Sbjct: 25  VKDIGSGNFGVARLMRDKLTKELVAVK--------YIERGAAIDENVQREIINHRSLRHP 76

Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           N++  K++I      T   + I+ E     +L++ I +  + ++D  ++F  QLL G+ Y
Sbjct: 77  NIVRFKEVI-----LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSY 131

Query: 161 VHSASVLHRDLKPSNLLL--NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 218
            HS  + HRDLK  N LL  + +  LKI DFG ++++         V T  Y APE+LL 
Sbjct: 132 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 191

Query: 219 CTEYT-AAIDIWSVGCIL 235
             EY     D+WS G  L
Sbjct: 192 -QEYDGKIADVWSCGVTL 208

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  127 bits (322), Expect = 2e-35
 Identities = 55/217 (25%), Positives = 100/217 (46%), Gaps = 29/217 (13%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRT-LREIKLLRHMEHENVIA-IK 107
           +G+G +G      + ET E + +K++    +   + +RT L+E+K++R +EH NV+  I 
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDE---ETQRTFLKEVKVMRCLEHPNVLKFIG 74

Query: 108 DIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            + +  +      +  + E +    L  II+S D Q        F   +  G+ Y+HS +
Sbjct: 75  VLYKDKR------LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN 128

Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---------------MTEYVVTRWY 210
           ++HRDL   N L+  + ++ + DFGLAR   +                      V   ++
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188

Query: 211 RAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG 247
            APE++     Y   +D++S G +L EI+ R    P 
Sbjct: 189 MAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPD 224

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  125 bits (316), Expect = 1e-34
 Identities = 51/219 (23%), Positives = 92/219 (42%), Gaps = 27/219 (12%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA-I 106
             IG+G +G V          EVAI+ I    DN    +   RE+   R   HENV+  +
Sbjct: 39  ELIGKGRFGQVYHGR---WHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95

Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSA 164
              + PP       + I+  L     L+ ++R     L  +  +    ++++G+ Y+H+ 
Sbjct: 96  GACMSPPH------LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK 149

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY----VVTRWYR--APELLLN 218
            +LH+DLK  N+  + +  + I DFGL   +             +   W    APE++  
Sbjct: 150 GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208

Query: 219 CTE--------YTAAIDIWSVGCILGEIMTREPLFPGKD 249
            +         ++   D++++G I  E+  RE  F  + 
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP 247

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  126 bits (318), Expect = 1e-34
 Identities = 36/228 (15%), Positives = 76/228 (33%), Gaps = 33/228 (14%)

Query: 47  IRPIGRGAYGIVCAAV-----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE 101
              +G GA+  V  A      +++ +++  +K    A  N  +     + ++ L+     
Sbjct: 70  HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQH 127

Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIR-----SDQQLTDDHCQYFLYQLL 155
             +              N   +V EL     L   I       ++ +       F  ++L
Sbjct: 128 MFMKFYSAH-----LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCD-----------LKIGDFGLARTTS---ETDFM 201
             ++ VH   ++H D+KP N +L                L + D G +       +    
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242

Query: 202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
           T    T  ++  E+L N   +   ID + V   +  ++    +    +
Sbjct: 243 TAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNE 289

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  126 bits (317), Expect = 2e-34
 Identities = 53/224 (23%), Positives = 99/224 (44%), Gaps = 20/224 (8%)

Query: 34  GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
             + E+       I  +G G  G+V    +  +   +A K I +         + +RE++
Sbjct: 25  QKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIRNQIIRELQ 83

Query: 94  LLRHMEHENVIA-----IKDIIRPPKKDTFNDVYIVYELMDTD-LHQIIRSDQQLTDDHC 147
           +L       ++        D           ++ I  E MD   L Q+++   ++ +   
Sbjct: 84  VLHECNSPYIVGFYGAFYSD----------GEISICMEHMDGGSLDQVLKKAGRIPEQIL 133

Query: 148 QYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV 206
                 +++GL Y+     ++HRD+KPSN+L+N+  ++K+ DFG++    ++   + +V 
Sbjct: 134 GKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-FVG 192

Query: 207 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY 250
           TR Y +PE L   T Y+   DIWS+G  L E+       P  D 
Sbjct: 193 TRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  125 bits (316), Expect = 2e-34
 Identities = 45/239 (18%), Positives = 95/239 (39%), Gaps = 44/239 (18%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI---------------GNAFDNIIDARRTLRE 91
           IR + +G +  +      +  +  A+KK                 +             E
Sbjct: 36  IRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNE 93

Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV--Y----ELMDTDLHQIIRSDQQ---L 142
           ++++  +++E  +  + II       +++VYI+  Y     ++  D +  +        +
Sbjct: 94  LQIITDIKNEYCLTCEGII-----TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148

Query: 143 TDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM 201
                +  +  +L    Y+H+  ++ HRD+KPSN+L++ +  +K+ DFG +    +    
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK 208

Query: 202 T-----EYVVTRWYRAPELLLNCTEY-TAAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
                 E++       PE   N + Y  A +DIWS+G  L  +      F  K  + +L
Sbjct: 209 GSRGTYEFM------PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  123 bits (310), Expect = 5e-34
 Identities = 35/205 (17%), Positives = 70/205 (34%), Gaps = 16/205 (7%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +     G +          ++ +K +     +   +R    E   LR   H NV+ +   
Sbjct: 18  LNENHSGELWKGRWQGN--DIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75

Query: 110 IRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQY--FLYQLLRGLKYVHSAS- 165
            + P         ++   M    L+ ++        D  Q   F   + RG+ ++H+   
Sbjct: 76  CQSPPAPHP---TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEP 132

Query: 166 -VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN--CTEY 222
            +    L   +++++     +I    +  +      M       W  APE L        
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAP---AWV-APEALQKKPEDTN 188

Query: 223 TAAIDIWSVGCILGEIMTREPLFPG 247
             + D+WS   +L E++TRE  F  
Sbjct: 189 RRSADMWSFAVLLWELVTREVPFAD 213

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  124 bits (312), Expect = 5e-34
 Identities = 52/208 (25%), Positives = 95/208 (45%), Gaps = 15/208 (7%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIA 105
           +  +G G YG V    + +T +  AIK +    D   + ++   EI +L+    H N+  
Sbjct: 29  VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ---EINMLKKYSHHRNIAT 85

Query: 106 IKDI-IRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
                I+       + +++V E       TDL +  +    L ++   Y   ++LRGL +
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSH 144

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLLNC 219
           +H   V+HRD+K  N+LL  + ++K+ DFG++     T      ++ T ++ APE++   
Sbjct: 145 LHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 204

Query: 220 TE----YTAAIDIWSVGCILGEIMTREP 243
                 Y    D+WS+G    E+    P
Sbjct: 205 ENPDATYDFKSDLWSLGITAIEMAEGAP 232

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  126 bits (319), Expect = 6e-34
 Identities = 58/191 (30%), Positives = 97/191 (50%), Gaps = 9/191 (4%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIG-NAFDNIIDARRTLREIKLLRHMEHENVIAI 106
             +G G +G V    +  T  +VA+K +      ++    +  REI+ L+   H ++I +
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81

Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
             +I      T +D+++V E +   +L   I  + +L +   +    Q+L G+ Y H   
Sbjct: 82  YQVI-----STPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM 136

Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT-A 224
           V+HRDLKP N+LL+A  + KI DFGL+   S+ +F+     +  Y APE++     Y   
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG-RLYAGP 195

Query: 225 AIDIWSVGCIL 235
            +DIWS G IL
Sbjct: 196 EVDIWSSGVIL 206

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  122 bits (309), Expect = 2e-33
 Identities = 57/206 (27%), Positives = 102/206 (49%), Gaps = 22/206 (10%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-REIKLLRHMEHENVIA 105
           +R IG G++G V  A +    E VAIKK+  +     +  + + +E++ L+ + H N I 
Sbjct: 59  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 118

Query: 106 IKDIIRPPKKDTF---NDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYV 161
            +          +   +  ++V E        ++    + L +       +  L+GL Y+
Sbjct: 119 YRG--------CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 170

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
           HS +++HRD+K  N+LL+    +K+GDFG A   +  +     V T ++ APE++L   E
Sbjct: 171 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF---VGTPYWMAPEVILAMDE 227

Query: 222 --YTAAIDIWSVG--CILGEIMTREP 243
             Y   +D+WS+G  CI  E+  R+P
Sbjct: 228 GQYDGKVDVWSLGITCI--ELAERKP 251

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  122 bits (307), Expect = 3e-33
 Identities = 51/228 (22%), Positives = 106/228 (46%), Gaps = 26/228 (11%)

Query: 34  GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
              ++ +++ +  +  IGRGAYG V   V+  + + +A+K+I  +  +  + ++ L ++ 
Sbjct: 14  EQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLD 72

Query: 94  -LLRHMEHENVIA-----IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-----DQQL 142
            ++R  +   ++       ++           D +I  ELM T   +  +      D  +
Sbjct: 73  VVMRSSDCPYIVQFYGALFRE----------GDCWICMELMSTSFDKFYKYVYSVLDDVI 122

Query: 143 TDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM 201
            ++         ++ L ++     ++HRD+KPSN+LL+ S ++K+ DFG++    ++   
Sbjct: 123 PEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK 182

Query: 202 TEYVVTRWYRAPELL---LNCTEYTAAIDIWSVGCILGEIMTREPLFP 246
           T     R Y APE +    +   Y    D+WS+G  L E+ T    +P
Sbjct: 183 TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYP 230

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  121 bits (306), Expect = 4e-33
 Identities = 56/207 (27%), Positives = 100/207 (48%), Gaps = 27/207 (13%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIG--NAFDNIIDARRTLREIKLLRHMEHENVI 104
           +  +G G+YG V  A++ ET + VAIK++   +    II      +EI +++  +  +V+
Sbjct: 34  LEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEII------KEISIMQQCDSPHVV 87

Query: 105 AIKDIIRPPKKDTF---NDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRG 157
                       ++    D++IV E       +D+ ++   ++ LT+D     L   L+G
Sbjct: 88  KYYG--------SYFKNTDLWIVMEYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKG 137

Query: 158 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELL 216
           L+Y+H    +HRD+K  N+LLN     K+ DFG+  + T         + T ++ APE++
Sbjct: 138 LEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI 197

Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREP 243
                Y    DIWS+G    E+   +P
Sbjct: 198 QE-IGYNCVADIWSLGITAIEMAEGKP 223

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  121 bits (306), Expect = 4e-33
 Identities = 54/250 (21%), Positives = 103/250 (41%), Gaps = 32/250 (12%)

Query: 10  SGGATSSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREE 69
           S G++    G LT GG+          ++     +  +  +G G  G V      +T   
Sbjct: 2   SSGSSGKQTGYLTIGGQ---------RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHV 52

Query: 70  VAIKKIGNAFDNIIDARRTLREIK-LLRHMEHENVIA-----IKDIIRPPKKDTFNDVYI 123
           +A+K++  + +   + +R L ++  +L+  +   ++      I +           DV+I
Sbjct: 53  IAVKQMRRSGNKE-ENKRILMDLDVVLKSHDCPYIVQCFGTFITN----------TDVFI 101

Query: 124 VYELMDTDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNAS 181
             ELM T   ++  R    + +         +++ L Y+     V+HRD+KPSN+LL+  
Sbjct: 102 AMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDER 161

Query: 182 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE----LLLNCTEYTAAIDIWSVGCILGE 237
             +K+ DFG++    +            Y APE          +Y    D+WS+G  L E
Sbjct: 162 GQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221

Query: 238 IMTREPLFPG 247
           + T +  +  
Sbjct: 222 LATGQFPYKN 231

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  121 bits (305), Expect = 5e-33
 Identities = 51/208 (24%), Positives = 96/208 (46%), Gaps = 36/208 (17%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHEN 102
              IG G+ GIVC A    +  +VA+K +        + +        E+ ++R  +H N
Sbjct: 50  YVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLF------NEVVIMRDYQHFN 103

Query: 103 VIAIKDIIRPPKKDTF---NDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLL 155
           V+ +          ++    +++++ E +     TD+   +R    L ++        +L
Sbjct: 104 VVEMYK--------SYLVGEELWVLMEFLQGGALTDIVSQVR----LNEEQIATVCEAVL 151

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPE 214
           + L Y+H+  V+HRD+K  ++LL     +K+ DFG  A+ + +       V T ++ APE
Sbjct: 152 QALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPE 211

Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTRE 242
           ++   + Y   +DIWS+G     IM  E
Sbjct: 212 VISR-SLYATEVDIWSLG-----IMVIE 233

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  120 bits (302), Expect = 1e-32
 Identities = 48/195 (24%), Positives = 81/195 (41%), Gaps = 37/195 (18%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAI 106
           + +G G  G V    N  T+E+ A+K +        D  +  RE++L     +  +++ I
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRI 76

Query: 107 KDIIRPPKKDTFNDVYIVYELMDTD--LHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHS 163
            D+           + IV E +D      +I  R DQ  T+      +  +   ++Y+HS
Sbjct: 77  VDVYENLYAGRKC-LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 135

Query: 164 ASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
            ++ HRD+KP NLL      +  LK+ DFG                     A E      
Sbjct: 136 INIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------AKETTG--E 173

Query: 221 EYTAAIDIWSVGCIL 235
           +Y  + D+WS+G I+
Sbjct: 174 KYDKSCDMWSLGVIM 188

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  120 bits (302), Expect = 1e-32
 Identities = 54/204 (26%), Positives = 99/204 (48%), Gaps = 28/204 (13%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
              IG+GA G V  A++  T +EVAI+++             + EI ++R  ++ N++  
Sbjct: 25  FEKIGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRENKNPNIVNY 82

Query: 107 KDIIRPPKKDTF---NDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
            D        ++   +++++V E +     TD    + ++  + +        + L+ L+
Sbjct: 83  LD--------SYLVGDELWVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALE 130

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLN 218
           ++HS  V+HRD+K  N+LL     +K+ DFG  A+ T E    +  V T ++ APE++  
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190

Query: 219 CTEYTAAIDIWSVGCILGEIMTRE 242
              Y   +DIWS+G     IM  E
Sbjct: 191 -KAYGPKVDIWSLG-----IMAIE 208

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  121 bits (306), Expect = 1e-32
 Identities = 47/215 (21%), Positives = 81/215 (37%), Gaps = 27/215 (12%)

Query: 47  IRPIGRGA--YGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI 104
           +  IG+G      V  A    T E V +++I     +         E+ + +   H N++
Sbjct: 30  LTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIV 89

Query: 105 AIKDIIRPPKKDTF---NDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRG 157
             +         TF   N++++V   M      DL      D  + +    Y L  +L+ 
Sbjct: 90  PYRA--------TFIADNELWVVTSFMAYGSAKDLICTHFMDG-MNELAIAYILQGVLKA 140

Query: 158 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA--------RTTSETDFMTEYVVTRW 209
           L Y+H    +HR +K S++L++    + +              R     DF    V    
Sbjct: 141 LDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP 200

Query: 210 YRAPELLL-NCTEYTAAIDIWSVGCILGEIMTREP 243
           + +PE+L  N   Y A  DI+SVG    E+     
Sbjct: 201 WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHV 235

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  119 bits (301), Expect = 2e-32
 Identities = 53/216 (24%), Positives = 98/216 (45%), Gaps = 35/216 (16%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIG--NAFDNIIDARRTLREIKLLRHMEHENVIA-- 105
           IG GA  +V AA  +  +E+VAIK+I       ++ +  +   EI+ +    H N+++  
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLK---EIQAMSQCHHPNIVSYY 79

Query: 106 ---IKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQ-----LTDDHCQYFLYQ 153
              +            +++++V +L+      D+ + I +  +     L +      L +
Sbjct: 80  TSFVVK----------DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129

Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE------YVVT 207
           +L GL+Y+H    +HRD+K  N+LL     ++I DFG++   +    +T       +V T
Sbjct: 130 VLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189

Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREP 243
             + APE++     Y    DIWS G    E+ T   
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA 225

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  119 bits (300), Expect = 2e-32
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 32/213 (15%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHEN 102
           +  +G GA+G V  A N ET    A K I        ++ I       EI++L   +H  
Sbjct: 24  VGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYI------VEIEILATCDHPY 77

Query: 103 VIAIKDIIRPPKKDTF---NDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLL 155
           ++ +           +     ++I+ E         +  ++  D+ LT+   Q    Q+L
Sbjct: 78  IVKLLG--------AYYHDGKLWIMIEFCPGGAVDAI--MLELDRGLTEPQIQVVCRQML 127

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPE 214
             L ++HS  ++HRDLK  N+L+    D+++ DFG+ A+          ++ T ++ APE
Sbjct: 128 EALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPE 187

Query: 215 LLLNCT----EYTAAIDIWSVGCILGEIMTREP 243
           +++  T     Y    DIWS+G  L E+   EP
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 220

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  118 bits (298), Expect = 9e-32
 Identities = 55/216 (25%), Positives = 87/216 (40%), Gaps = 28/216 (12%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA- 105
           ++ IG+G YG V         E+VA+K     F     +     EI     M HEN++  
Sbjct: 42  VKQIGKGRYGEVWMGKWRG--EKVAVKVF---FTTEEASWFRETEIYQTVLMRHENILGF 96

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           I   I+     T   +Y++ +  +   L+  ++S   L         Y  + GL ++H+ 
Sbjct: 97  IAADIKGTGSWT--QLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTE 153

Query: 165 --------SVLHRDLKPSNLLLNASCDLKIGDFGLAR-----TTSETDFMTEYVVTRWYR 211
                   ++ HRDLK  N+L+  +    I D GLA      T          V T+ Y 
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213

Query: 212 APELL-----LNCTEYTAAIDIWSVGCILGEIMTRE 242
            PE+L      N  +     D++S G IL E+  R 
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRC 249

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  117 bits (295), Expect = 1e-31
 Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 26/207 (12%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIG--NAFDNIIDARRTLREIKLLRHMEHENVI 104
           +  IG+G++G V   +++ T++ VAIK I    A D I D ++   EI +L   +   V 
Sbjct: 27  LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYVT 83

Query: 105 AIKDIIRPPKKDTF---NDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRG 157
                       ++     ++I+ E +      DL +       L +      L ++L+G
Sbjct: 84  KYYG--------SYLKDTKLWIIMEYLGGGSALDLLE----PGPLDETQIATILREILKG 131

Query: 158 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELL 216
           L Y+HS   +HRD+K +N+LL+   ++K+ DFG+A   ++T      +V T ++ APE++
Sbjct: 132 LDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 191

Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREP 243
              + Y +  DIWS+G    E+   EP
Sbjct: 192 KQ-SAYDSKADIWSLGITAIELARGEP 217

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  117 bits (294), Expect = 2e-31
 Identities = 50/215 (23%), Positives = 89/215 (41%), Gaps = 32/215 (14%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE--IKLLRHMEHENVIA-I 106
           +G+G YG V         E VA+K       +  D +   RE  +     + HEN++  I
Sbjct: 16  VGKGRYGEVWRGSWQG--ENVAVKIF-----SSRDEKSWFRETELYNTVMLRHENILGFI 68

Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA- 164
              +      T   ++++    +   L+  ++    L    C   +  +  GL ++H   
Sbjct: 69  ASDMTSRHSST--QLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEI 125

Query: 165 -------SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV-----TRWYRA 212
                  ++ HRDLK  N+L+  +    I D GLA   S++    +        T+ Y A
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185

Query: 213 PELL-----LNCTEYTAAIDIWSVGCILGEIMTRE 242
           PE+L     ++C +    +DIW+ G +L E+  R 
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRM 220

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  116 bits (292), Expect = 1e-29
 Identities = 50/209 (23%), Positives = 89/209 (42%), Gaps = 13/209 (6%)

Query: 47  IRPIGRGAYGIVCAAV--NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI 104
              I  G  G +  A+  N   R  V +K + ++ D        + E + L  + H +++
Sbjct: 85  KGCIAHGGLGWIYLALDRNVNGRP-VVLKGLVHSGDAE-AQAMAMAERQFLAEVVHPSIV 142

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
            I + +    +      YIV E +    L +     Q+L       +L ++L  L Y+HS
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPALSYLHS 200

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
             +++ DLKP N++L     LK+ D G     +   ++     T  ++APE++   T  T
Sbjct: 201 IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYL---YGTPGFQAPEIVR--TGPT 254

Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVH 252
            A DI++VG  L  +    P   G+    
Sbjct: 255 VATDIYTVGRTLAALTLDLPTRNGRYVDG 283

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  112 bits (283), Expect = 1e-29
 Identities = 50/222 (22%), Positives = 84/222 (37%), Gaps = 32/222 (14%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLRE--IKLLRHMEHENVIA-I 106
           IG+G +G V         EEVA+K       +  + R   RE  I     + HEN++  I
Sbjct: 50  IGKGRFGEVWRGKWRG--EEVAVKIF-----SSREERSWFREAEIYQTVMLRHENILGFI 102

Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA- 164
               +     T   +++V +  +   L   +     +T +           GL ++H   
Sbjct: 103 AADNKDNGTWT--QLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEI 159

Query: 165 -------SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV-----TRWYRA 212
                  ++ HRDLK  N+L+  +    I D GLA          +        T+ Y A
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219

Query: 213 PELL-----LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
           PE+L     +   E     DI+++G +  EI  R  +    +
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  110 bits (278), Expect = 5e-29
 Identities = 56/244 (22%), Positives = 108/244 (44%), Gaps = 26/244 (10%)

Query: 23  HGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAV----NSETREEVAIKKIGNA 78
           H   + Q     +      +++  I  +G+G +G V           T   VA+K++   
Sbjct: 4   HHHHHAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ-- 61

Query: 79  FDNIIDARRT-LREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQII 136
             +  D +R   REI++L+ +  + ++  + +   P + +   + +V E + +  L   +
Sbjct: 62  -HSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS---LRLVMEYLPSGCLRDFL 117

Query: 137 RS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT 195
           +    +L       +  Q+ +G++Y+ S   +HRDL   N+L+ +   +KI DFGLA+  
Sbjct: 118 QRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL 177

Query: 196 SETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFP 246
                   YVV         WY APE L +   ++   D+WS G +L E+ T   +   P
Sbjct: 178 PLDK--DYYVVREPGQSPIFWY-APESLSDNI-FSRQSDVWSFGVVLYELFTYCDKSCSP 233

Query: 247 GKDY 250
             ++
Sbjct: 234 SAEF 237

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  109 bits (274), Expect = 1e-28
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 25/209 (11%)

Query: 47  IRPIGRGAYGIVCAAV----NSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHMEH 100
           IR +G G +G V           T E+VA+K  K  +  ++I D     +EI++LR++ H
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD---LKKEIEILRNLYH 82

Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGL 158
           EN++  K I     +D  N + ++ E + +  L + +     ++       +  Q+ +G+
Sbjct: 83  ENIVKYKGIC---TEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGM 139

Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYR 211
            Y+ S   +HRDL   N+L+ +   +KIGDFGL +          Y V         WY 
Sbjct: 140 DYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK--EYYTVKDDRDSPVFWY- 196

Query: 212 APELLLNCTEYTAAIDIWSVGCILGEIMT 240
           APE L+    +  A D+WS G  L E++T
Sbjct: 197 APECLMQSK-FYIASDVWSFGVTLHELLT 224

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  109 bits (273), Expect = 3e-28
 Identities = 52/207 (25%), Positives = 99/207 (47%), Gaps = 22/207 (10%)

Query: 47  IRPIGRGAYGIVCAAV----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN 102
           ++ +G+G +G V           T E VA+KK+ ++ +     R   REI++L+ ++H+N
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDN 103

Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKY 160
           ++  K +     +     + ++ E +    L   ++   +++       +  Q+ +G++Y
Sbjct: 104 IVKYKGVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY 160

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAP 213
           + +   +HRDL   N+L+     +KIGDFGL +   +      Y V         WY AP
Sbjct: 161 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK--EYYKVKEPGESPIFWY-AP 217

Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMT 240
           E L     ++ A D+WS G +L E+ T
Sbjct: 218 ESLTESK-FSVASDVWSFGVVLYELFT 243

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  108 bits (271), Expect = 3e-28
 Identities = 51/216 (23%), Positives = 103/216 (47%), Gaps = 22/216 (10%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAV----NSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           +   +++  ++ +G+G +G V           T E VA+KK+ ++ +     R   REI+
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIE 63

Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFL 151
           +L+ ++H+N++  K +     +     + ++ E +    L   ++   +++       + 
Sbjct: 64  ILKSLQHDNIVKYKGVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120

Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---- 207
            Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +      + V     
Sbjct: 121 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK--EFFKVKEPGE 178

Query: 208 ---RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               WY APE L     ++ A D+WS G +L E+ T
Sbjct: 179 SPIFWY-APESLTESK-FSVASDVWSFGVVLYELFT 212

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  108 bits (272), Expect = 9e-28
 Identities = 54/222 (24%), Positives = 95/222 (42%), Gaps = 25/222 (11%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIK--KIGNAFDNIIDARRTLREIKLL 95
            ++ + +     IGRG +G V +         VA+K  +     D        L+E ++L
Sbjct: 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKF---LQEARIL 166

Query: 96  RHMEHENVIAIKDII--RPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFL 151
           +   H N++ +  +   + P       +YIV EL+   D    +R+   +L        +
Sbjct: 167 KQYSHPNIVRLIGVCTQKQP-------IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMV 219

Query: 152 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---- 207
                G++Y+ S   +HRDL   N L+     LKI DFG++R  ++  +     +     
Sbjct: 220 GDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPV 279

Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
           +W  APE L     Y++  D+WS G +L E  +    P +P 
Sbjct: 280 KWT-APEALNYGR-YSSESDVWSFGILLWETFSLGASP-YPN 318

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  107 bits (269), Expect = 9e-28
 Identities = 56/234 (23%), Positives = 94/234 (40%), Gaps = 35/234 (14%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHENVIA 105
             RG +G V  A      E VA+K        ++ N         E+  L  M+HEN++ 
Sbjct: 32  KARGRFGCVWKAQLLN--EYVAVKIFPIQDKQSWQNE-------YEVYSLPGMKHENILQ 82

Query: 106 -IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
            I    R    D   D++++    +   L   +++   ++ +   +    + RGL Y+H 
Sbjct: 83  FIGAEKRGTSVDV--DLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHE 139

Query: 164 A----------SVLHRDLKPSNLLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWY 210
                      ++ HRD+K  N+LL  +    I DFGLA               V TR Y
Sbjct: 140 DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRY 199

Query: 211 RAPELL----LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
            APE+L        +    ID++++G +L E+ +R     G    + L    E+
Sbjct: 200 MAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  106 bits (267), Expect = 5e-27
 Identities = 57/267 (21%), Positives = 104/267 (38%), Gaps = 75/267 (28%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-----EHE 101
           IR +G G +  V  + + + ++ VA+K +  + ++  +      EI+LL+ +        
Sbjct: 42  IRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETAL--DEIRLLKSVRNSDPNDP 98

Query: 102 NVIAIKDIIRPPKKDTFND-------VYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLY 152
           N    ++++     D F         + +V+E++   L + I     Q L     +  + 
Sbjct: 99  N----REMVVQLL-DDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQ 153

Query: 153 QLLRGLKYVHS-ASVLHRDLKPSNLLLNAS------------------------------ 181
           Q+L+GL Y+H+   ++H D+KP N+LL+ +                              
Sbjct: 154 QVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213

Query: 182 -------------------CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
                                +KI D G A    +    TE + TR YR+ E+L+    Y
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF--TEDIQTRQYRSLEVLIGS-GY 270

Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKD 249
               DIWS  C+  E+ T + LF    
Sbjct: 271 NTPADIWSTACMAFELATGDYLFEPHS 297

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  104 bits (262), Expect = 5e-27
 Identities = 46/213 (21%), Positives = 100/213 (46%), Gaps = 25/213 (11%)

Query: 48  RPIGRGAYGIVCAAV--NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           + +G G +G V        +  + VA+K + N  ++       L E  +++ +++  ++ 
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82

Query: 106 IKDII-RPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           +  I              +V E+ +   L++ ++ ++ + D +    ++Q+  G+KY+  
Sbjct: 83  MIGICEAES-------WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 135

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELL 216
           ++ +HRDL   N+LL      KI DFGL++     +    Y          +WY APE  
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE--NYYKAQTHGKWPVKWY-APE-C 191

Query: 217 LNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
           +N  ++++  D+WS G ++ E  +  ++P + G
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQKP-YRG 223

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  104 bits (261), Expect = 1e-26
 Identities = 61/208 (29%), Positives = 89/208 (42%), Gaps = 25/208 (12%)

Query: 47  IRPIGRGAYGIVCAAV----NSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHMEH 100
           IR +G G +G V        N  T E VA+K  K      +        +EI +LR + H
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSG---WKQEIDILRTLYH 92

Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
           E++I  K         +   + +V E +    L   +     +       F  Q+  G+ 
Sbjct: 93  EHIIKYKGCCEDAGAAS---LQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMA 148

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRA 212
           Y+H+   +HRDL   N+LL+    +KIGDFGLA+   E      Y V         WY A
Sbjct: 149 YLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH--EYYRVREDGDSPVFWY-A 205

Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMT 240
           PE L     +  A D+WS G  L E++T
Sbjct: 206 PECLKEYK-FYYASDVWSFGVTLYELLT 232

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  103 bits (260), Expect = 2e-26
 Identities = 51/218 (23%), Positives = 92/218 (42%), Gaps = 32/218 (14%)

Query: 47  IRPIGRGAYGIVCAAV----NSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHMEH 100
           I+ +G GA+G V   +      + +  VAIK  +   +     +    L E  ++  +++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE---ILDEAYVMASVDN 76

Query: 101 ENVIAIKDII-RPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRG 157
            +V  +  I            V ++ +LM    L   +R     +   +   +  Q+ +G
Sbjct: 77  PHVCRLLGICLTST-------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129

Query: 158 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYR 211
           + Y+    ++HRDL   N+L+     +KI DFGLA+     +   EY         +W  
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWM- 186

Query: 212 APELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
           A E  +    YT   D+WS G  + E+MT   +P + G
Sbjct: 187 ALE-SILHRIYTHQSDVWSYGVTVWELMTFGSKP-YDG 222

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  102 bits (257), Expect = 3e-26
 Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 34/228 (14%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAV---NSETREEVAIK--KIGNAFDNIIDARRTLRE 91
           +E+  + +   R IG G +G V   +          VAIK  K   +          L+E
Sbjct: 10  YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKF---LQE 66

Query: 92  IKLLRHMEHENVIAIKDII-RPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQ 148
              +R  +H +++ +  +I   P       V+I+ EL    +L   ++     L      
Sbjct: 67  ALTMRQFDHPHIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKYSLDLASLI 119

Query: 149 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT- 207
            + YQL   L Y+ S   +HRD+   N+L++++  +K+GDFGL+R   ++     Y    
Sbjct: 120 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKAS 175

Query: 208 ------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
                 +W  APE  +N   +T+A D+W  G  + EI+    +P F G
Sbjct: 176 KGKLPIKWM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQG 220

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  102 bits (257), Expect = 4e-26
 Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 16/208 (7%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA---RRTLREIKLLRHMEHENV 103
            R +GRG  G V  A ++     VA+K +     +  D     R  RE +    ++  +V
Sbjct: 39  RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSS--DPVFRTRMQREARTAGRLQEPHV 96

Query: 104 IAIKDIIRPPKKDTFNDV-YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           + I D          +   Y+   L++  DL  ++R    L        + Q+   L   
Sbjct: 97  VPIHDF------GEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAA 150

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-MTEYVV-TRWYRAPELLLNC 219
           H+A   HRD+KP N+L++A     + DFG+A  T++         V T +Y APE     
Sbjct: 151 HAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE- 209

Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPG 247
           +  T   DI+++ C+L E +T  P + G
Sbjct: 210 SHATYRADIYALTCVLYECLTGSPPYQG 237

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  102 bits (256), Expect = 6e-26
 Identities = 60/226 (26%), Positives = 97/226 (42%), Gaps = 26/226 (11%)

Query: 35  NLFEVSSKYVPPI--------RPIGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNII 83
            L +     V             IGRG +G V       N   +   A+K + N   +I 
Sbjct: 10  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIG 68

Query: 84  DARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQ 141
           +  + L E  +++   H NV+++  I    +        +V   M   DL   IR+    
Sbjct: 69  EVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GSPLVVLPYMKHGDLRNFIRNETHN 124

Query: 142 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM 201
            T      F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + ++ 
Sbjct: 125 PTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY 184

Query: 202 TEYVVT------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR 241
           + +  T      +W  A E  L   ++T   D+WS G +L E+MTR
Sbjct: 185 SVHNKTGAKLPVKWM-ALE-SLQTQKFTTKSDVWSFGVLLWELMTR 228

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  101 bits (253), Expect = 1e-25
 Identities = 58/217 (26%), Positives = 91/217 (41%), Gaps = 28/217 (12%)

Query: 47  IRPIGRGAYGIVCAAV---NSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHEN 102
           +  +G G++G+V        S     VA+K +  +           +RE+  +  ++H N
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 103 VIAIKDII-RPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLK 159
           +I +  ++  PP       + +V EL     L   +R             +  Q+  G+ 
Sbjct: 83  LIRLYGVVLTPP-------MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 135

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRA 212
           Y+ S   +HRDL   NLLL     +KIGDFGL R   + D    YV+         W  A
Sbjct: 136 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND--DHYVMQEHRKVPFAWC-A 192

Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
           PE  L    ++ A D W  G  L E+ T  +EP + G
Sbjct: 193 PE-SLKTRTFSHASDTWMFGVTLWEMFTYGQEP-WIG 227

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =   99 bits (250), Expect = 2e-25
 Identities = 46/224 (20%), Positives = 96/224 (42%), Gaps = 33/224 (14%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           E+  + +  ++ +G G +G+V       +    VA+K I    +  +      +E + + 
Sbjct: 4   ELKREEITLLKELGSGQFGVVKLGKWKGQYD--VAVKMIK---EGSMSEDEFFQEAQTMM 58

Query: 97  HMEHENVIAIKDII--RPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLY 152
            + H  ++    +     P       +YIV E +    L   +RS  + L         Y
Sbjct: 59  KLSHPKLVKFYGVCSKEYP-------IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCY 111

Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT----- 207
            +  G+ ++ S   +HRDL   N L++    +K+ DFG+ R   +     +YV +     
Sbjct: 112 DVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD----DQYVSSVGTKF 167

Query: 208 --RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
             +W  APE + +  +Y++  D+W+ G ++ E+ +  + P +  
Sbjct: 168 PVKWS-APE-VFHYFKYSSKSDVWAFGILMWEVFSLGKMP-YDL 208

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  101 bits (254), Expect = 3e-25
 Identities = 60/229 (26%), Positives = 96/229 (41%), Gaps = 32/229 (13%)

Query: 35  NLFEVSSKYVPPI--------RPIGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNII 83
            L +     V             IGRG +G V       N   +   A+K + N   +I 
Sbjct: 74  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIG 132

Query: 84  DARRTLREIKLLRHMEHENVIAIKDII---RPPKKDTFNDVYIVYELMDT-DLHQIIRS- 138
           +  + L E  +++   H NV+++  I                +V   M   DL   IR+ 
Sbjct: 133 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS-------PLVVLPYMKHGDLRNFIRNE 185

Query: 139 DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 198
               T      F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + 
Sbjct: 186 THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245

Query: 199 DFMTEYVVT------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR 241
           +F + +  T      +W  A E  L   ++T   D+WS G +L E+MTR
Sbjct: 246 EFDSVHNKTGAKLPVKWM-ALE-SLQTQKFTTKSDVWSFGVLLWELMTR 292

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =   99 bits (250), Expect = 3e-25
 Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 35/223 (15%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKI-----GNAFDNIIDARRTLREI 92
            ++ K +  ++ IG+G +G V        +  VA+K I       AF         L E 
Sbjct: 17  ALNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAF---------LAEA 65

Query: 93  KLLRHMEHENVIAIKDII---RPPKKDTFNDVYIVYELMDT-DLHQIIRSD--QQLTDDH 146
            ++  + H N++ +  +I   +         +YIV E M    L   +RS     L  D 
Sbjct: 66  SVMTQLRHSNLVQLLGVIVEEKGG-------LYIVTEYMAKGSLVDYLRSRGRSVLGGDC 118

Query: 147 CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV 206
              F   +   ++Y+   + +HRDL   N+L++     K+ DFGL +  S T    +  V
Sbjct: 119 LLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV 178

Query: 207 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
            +W  APE  L   +++   D+WS G +L EI +  R P +P 
Sbjct: 179 -KWT-APE-ALREKKFSTKSDVWSFGILLWEIYSFGRVP-YPR 217

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  100 bits (250), Expect = 3e-25
 Identities = 48/206 (23%), Positives = 95/206 (46%), Gaps = 28/206 (13%)

Query: 50  IGRGAYGIVCAAV--NSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           +G G +G V   V    + + +VAIK  K G    +  +    +RE +++  +++  ++ 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEM---MREAQIMHQLDNPYIVR 74

Query: 106 IKDII-RPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVH 162
           +  +            + +V E+     LH+ +    +++   +    L+Q+  G+KY+ 
Sbjct: 75  LIGVCQAEA-------LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE 127

Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPEL 215
             + +HRDL   N+LL      KI DFGL++     D  + Y          +WY APE 
Sbjct: 128 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD--SYYTARSAGKWPLKWY-APE- 183

Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTR 241
            +N  ++++  D+WS G  + E ++ 
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALSY 209

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  100 bits (251), Expect = 3e-25
 Identities = 49/224 (21%), Positives = 86/224 (38%), Gaps = 26/224 (11%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAV---NSETREEVAIK--KIGNAFDNIIDARRTLRE 91
             +    +   + +G G +G V          T  +VA+K  K+ N+     +    L E
Sbjct: 29  VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQR--EIEEFLSE 86

Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS------DQQLTD 144
              ++   H NVI +  +             ++   M   DLH  +         + +  
Sbjct: 87  AACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL 146

Query: 145 DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY 204
                F+  +  G++Y+ + + LHRDL   N +L     + + DFGL++     D    Y
Sbjct: 147 QTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD---YY 203

Query: 205 VVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR 241
                     +W  A E L +   YT+  D+W+ G  + EI TR
Sbjct: 204 RQGRIAKMPVKWI-AIESLAD-RVYTSKSDVWAFGVTMWEIATR 245

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  100 bits (251), Expect = 4e-25
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 25/217 (11%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAV----NSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           E+    V   + IG G +G V   +    + +    VAIK +  A          L E  
Sbjct: 40  EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAG 98

Query: 94  LLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQY 149
           ++    H N+I ++ +I    P       + I+ E M+   L + +R  D + +      
Sbjct: 99  IMGQFSHHNIIRLEGVISKYKP-------MMIITEYMENGALDKFLREKDGEFSVLQLVG 151

Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-- 207
            L  +  G+KY+ + + +HRDL   N+L+N++   K+ DFGL+R   E D    Y  +  
Sbjct: 152 MLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL-EDDPEATYTTSGG 210

Query: 208 ----RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               RW  APE  ++  ++T+A D+WS G ++ E+MT
Sbjct: 211 KIPIRWT-APE-AISYRKFTSASDVWSFGIVMWEVMT 245

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 99.6 bits (249), Expect = 4e-25
 Identities = 55/224 (24%), Positives = 100/224 (44%), Gaps = 31/224 (13%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRH 97
           E+    +     +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ 
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKE 65

Query: 98  MEHENVIAIKDII--RPPKKDTFNDVYIVYELMDT-DLHQIIRSD--QQLTDDHCQYFLY 152
           ++H N++ +  +    PP        YI+ E M   +L   +R    Q+++     Y   
Sbjct: 66  IKHPNLVQLLGVCTREPP-------FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118

Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT----- 207
           Q+   ++Y+   + +HRDL   N L+  +  +K+ DFGL+R     D    Y        
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGD---TYTAHAGAKF 174

Query: 208 --RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
             +W  APE  L   +++   D+W+ G +L EI T    P +PG
Sbjct: 175 PIKWT-APE-SLAYNKFSIKSDVWAFGVLLWEIATYGMSP-YPG 215

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  102 bits (255), Expect = 7e-25
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 14/209 (6%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII---DARRTLREIKLLRHMEHENV 103
            R +G+G +G VCA     T +  A KK+      I         L E ++L  +    V
Sbjct: 189 YRVLGKGGFGEVCACQVRATGKMYACKKLEK--KRIKKRKGEAMALNEKQILEKVNSRFV 246

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDT-DL-HQIIRSDQQ-LTDDHCQYFLYQLLRGLKY 160
           +++              + +V  LM+  DL   I    Q    +    ++  ++  GL+ 
Sbjct: 247 VSLAYAYETKDA-----LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLED 301

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +H   +++RDLKP N+LL+    ++I D GLA    E   +   V T  Y APE++ N  
Sbjct: 302 LHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN-E 360

Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKD 249
            YT + D W++GC+L E++  +  F  + 
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQSPFQQRK 389

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 98.8 bits (247), Expect = 7e-25
 Identities = 52/228 (22%), Positives = 101/228 (44%), Gaps = 34/228 (14%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAV---NSETREEVAIK--KIGNAFDNIIDARRTLRE 91
           + ++ + V   R +G G +G V   V   +   +  VA+K  K     DN       + E
Sbjct: 7   YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK---FMSE 63

Query: 92  IKLLRHMEHENVIAIKDII-RPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQ 148
             ++++++H +++ +  II   P        +I+ EL    +L   +      L      
Sbjct: 64  AVIMKNLDHPHIVKLIGIIEEEP-------TWIIMELYPYGELGHYLERNKNSLKVLTLV 116

Query: 149 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT- 207
            +  Q+ + + Y+ S + +HRD+   N+L+ +   +K+GDFGL+R   + D    Y    
Sbjct: 117 LYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED----YYKAS 172

Query: 208 ------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
                 +W  +PE  +N   +T A D+W     + EI++  ++P F  
Sbjct: 173 VTRLPIKWM-SPE-SINFRRFTTASDVWMFAVCMWEILSFGKQP-FFW 217

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 98.4 bits (246), Expect = 9e-25
 Identities = 44/224 (19%), Positives = 97/224 (43%), Gaps = 33/224 (14%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
            +    +  ++ IG G +G+V      ++ +  VAIK I    +  +     + E +++ 
Sbjct: 4   VIDPSELTFVQEIGSGQFGLVHLGYWLNKDK--VAIKTIR---EGAMSEEDFIEEAEVMM 58

Query: 97  HMEHENVIAIKDII--RPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLY 152
            + H  ++ +  +   + P       + +V E M+   L   +R+       +       
Sbjct: 59  KLSHPKLVQLYGVCLEQAP-------ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCL 111

Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT----- 207
            +  G+ Y+  A V+HRDL   N L+  +  +K+ DFG+ R   +     +Y  +     
Sbjct: 112 DVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD----DQYTSSTGTKF 167

Query: 208 --RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
             +W  +PE + + + Y++  D+WS G ++ E+ +  + P +  
Sbjct: 168 PVKWA-SPE-VFSFSRYSSKSDVWSFGVLMWEVFSEGKIP-YEN 208

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  101 bits (254), Expect = 9e-25
 Identities = 47/205 (22%), Positives = 95/205 (46%), Gaps = 26/205 (12%)

Query: 50  IGRGAYGIVCAAV--NSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           +G G +G V   V    + + +VAIK  K G    +  +    +RE +++  +++  ++ 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEM---MREAQIMHQLDNPYIVR 400

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHS 163
           +  +           + +V E+     LH+ +    +++   +    L+Q+  G+KY+  
Sbjct: 401 LIGVC------QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE 454

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELL 216
            + +HR+L   N+LL      KI DFGL++     D  + Y          +WY APE  
Sbjct: 455 KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD--SYYTARSAGKWPLKWY-APE-C 510

Query: 217 LNCTEYTAAIDIWSVGCILGEIMTR 241
           +N  ++++  D+WS G  + E ++ 
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALSY 535

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  100 bits (250), Expect = 1e-24
 Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 28/218 (12%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAV-NSETREE--VAIK--KIGNAFDNIIDARRTLREI 92
           E+ +  +   + +G G +G VC+      +++E  VAIK  K+G         R  L E 
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK---QRRDFLGEA 97

Query: 93  KLLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQ 148
            ++   +H N+I ++ ++    P       V IV E M+   L   +R  D Q T     
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKP-------VMIVTEYMENGSLDSFLRKHDAQFTVIQLV 150

Query: 149 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT- 207
             L  +  G+KY+     +HRDL   N+L+N++   K+ DFGL R   E D    Y    
Sbjct: 151 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL-EDDPEAAYTTRG 209

Query: 208 -----RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                RW  +PE  +   ++T+A D+WS G +L E+M+
Sbjct: 210 GKIPIRWT-SPE-AIAYRKFTSASDVWSYGIVLWEVMS 245

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 99.3 bits (248), Expect = 1e-24
 Identities = 51/218 (23%), Positives = 92/218 (42%), Gaps = 32/218 (14%)

Query: 47  IRPIGRGAYGIVCAAV----NSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHMEH 100
           I+ +G GA+G V   +      + +  VAIK  +   +     +    L E  ++  +++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE---ILDEAYVMASVDN 76

Query: 101 ENVIAIKDII-RPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRG 157
            +V  +  I            V ++ +LM    L   +R     +   +   +  Q+ +G
Sbjct: 77  PHVCRLLGICLTST-------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129

Query: 158 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYR 211
           + Y+    ++HRDL   N+L+     +KI DFGLA+     +   EY         +W  
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWM- 186

Query: 212 APELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
           A E  +    YT   D+WS G  + E+MT   +P + G
Sbjct: 187 ALE-SILHRIYTHQSDVWSYGVTVWELMTFGSKP-YDG 222

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 98.8 bits (247), Expect = 1e-24
 Identities = 54/213 (25%), Positives = 97/213 (45%), Gaps = 21/213 (9%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII---DARRTLREIKLLRHMEHENV 103
            + +G G++  V  A    T  E AIK +     +II         RE  ++  ++H   
Sbjct: 35  GKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFF 92

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDT----DLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
           + +          TF D   +Y  +      +L + IR      +   +++  +++  L+
Sbjct: 93  VKLYF--------TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 144

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR---TTSETDFMTEYVVTRWYRAPELL 216
           Y+H   ++HRDLKP N+LLN    ++I DFG A+     S+      +V T  Y +PELL
Sbjct: 145 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 204

Query: 217 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
                   + D+W++GCI+ +++   P F   +
Sbjct: 205 TE-KSACKSSDLWALGCIIYQLVAGLPPFRAGN 236

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 98.1 bits (245), Expect = 1e-24
 Identities = 51/224 (22%), Positives = 98/224 (43%), Gaps = 33/224 (14%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           E+  K +  ++ +G G +G+V       +   +VAIK I    +  +     + E K++ 
Sbjct: 20  EIDPKDLTFLKELGTGQFGVVKYGKWRGQY--DVAIKMIK---EGSMSEDEFIEEAKVMM 74

Query: 97  HMEHENVIAIKDII--RPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLY 152
           ++ HE ++ +  +   + P       ++I+ E M    L   +R    +           
Sbjct: 75  NLSHEKLVQLYGVCTKQRP-------IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK 127

Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT----- 207
            +   ++Y+ S   LHRDL   N L+N    +K+ DFGL+R   +     EY  +     
Sbjct: 128 DVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD----DEYTSSVGSKF 183

Query: 208 --RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
             RW   PE+L+    +++  DIW+ G ++ EI +  + P +  
Sbjct: 184 PVRWS-PPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMP-YER 224

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  100 bits (251), Expect = 2e-24
 Identities = 53/217 (24%), Positives = 98/217 (45%), Gaps = 31/217 (14%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
              +G G YG V   V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQL 281

Query: 107 KDII--RPPKKDTFNDVYIVYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYV 161
             +    PP        YI+ E M   +L   +R    Q+++     Y   Q+   ++Y+
Sbjct: 282 LGVCTREPP-------FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 334

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPE 214
              + +HR+L   N L+  +  +K+ DFGL+R  +       Y          +W  APE
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG----DTYTAHAGAKFPIKWT-APE 389

Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPGKD 249
             L   +++   D+W+ G +L EI T    P +PG D
Sbjct: 390 -SLAYNKFSIKSDVWAFGVLLWEIATYGMSP-YPGID 424

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 98.6 bits (246), Expect = 2e-24
 Identities = 53/213 (24%), Positives = 87/213 (40%), Gaps = 23/213 (10%)

Query: 47  IRPIGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV 103
            R +G+G +G V  A       +  +VA+K +        D    LRE   ++  +H +V
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 104 IAIKDI-IRPPKKDTFNDVYIVYELMDT-DLHQIIRS------DQQLTDDHCQYFLYQLL 155
             +  + +R   K       ++   M   DLH  + +         L       F+  + 
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------R 208
            G++Y+ S + +HRDL   N +L     + + DFGL+R     D    Y          +
Sbjct: 148 CGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD---YYRQGCASKLPVK 204

Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR 241
           W  A E L +   YT   D+W+ G  + EIMTR
Sbjct: 205 WL-ALESLAD-NLYTVHSDVWAFGVTMWEIMTR 235

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 97.7 bits (244), Expect = 2e-24
 Identities = 58/220 (26%), Positives = 107/220 (48%), Gaps = 25/220 (11%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           EV  + +  +  +G G +G V     N  T+  VA+K +       +     L E  L++
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLK---QGSMSPDAFLAEANLMK 63

Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQ 153
            ++H+ ++ +  ++      T   +YI+ E M+   L   +++    +LT +       Q
Sbjct: 64  QLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117

Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT----RW 209
           +  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + ++ T         +W
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKW 176

Query: 210 YRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
             APE +   T +T   D+WS G +L EI+T  R P +PG
Sbjct: 177 T-APEAINYGT-FTIKSDVWSFGILLTEIVTHGRIP-YPG 213

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 98.5 bits (246), Expect = 2e-24
 Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 26/217 (11%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAV---NSETREEVAIKKI-GNAFDNIIDARRTLREIK 93
           E+ +  +   + IG G  G VC        +    VAIK +     +     R  L E  
Sbjct: 45  EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER--QRRDFLSEAS 102

Query: 94  LLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQY 149
           ++   +H N+I ++ ++              IV E M+   L   +R+ D Q T      
Sbjct: 103 IMGQFDHPNIIRLEGVVTRGRL-------AMIVTEYMENGSLDTFLRTHDGQFTIMQLVG 155

Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-- 207
            L  +  G++Y+     +HRDL   N+L++++   K+ DFGL+R   E D    Y  T  
Sbjct: 156 MLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL-EDDPDAAYTTTGG 214

Query: 208 ----RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               RW  APE  +    +++A D+WS G ++ E++ 
Sbjct: 215 KIPIRWT-APE-AIAFRTFSSASDVWSFGVVMWEVLA 249

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  100 bits (251), Expect = 2e-24
 Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 34/228 (14%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAV---NSETREEVAIK--KIGNAFDNIIDARRTLRE 91
           +E+  + +   R IG G +G V   +          VAIK  K   +          L+E
Sbjct: 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK---FLQE 441

Query: 92  IKLLRHMEHENVIAIKDII-RPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQ 148
              +R  +H +++ +  +I   P       V+I+ EL    +L   ++     L      
Sbjct: 442 ALTMRQFDHPHIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKFSLDLASLI 494

Query: 149 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT- 207
            + YQL   L Y+ S   +HRD+   N+L++++  +K+GDFGL+R   ++     Y    
Sbjct: 495 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKAS 550

Query: 208 ------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
                 +W  APE  +N   +T+A D+W  G  + EI+    +P F G
Sbjct: 551 KGKLPIKWM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQG 595

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 98.4 bits (245), Expect = 2e-24
 Identities = 56/231 (24%), Positives = 82/231 (35%), Gaps = 42/231 (18%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           IGRG YG V      E    VA+K         F N        + I  +  MEH+N+  
Sbjct: 21  IGRGRYGAVYKGSLDE--RPVAVKVFSFANRQNFIN-------EKNIYRVPLMEHDNIAR 71

Query: 106 -IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
            I    R           +V E      L + +               + + RGL Y+H+
Sbjct: 72  FIVGDERVTADGRME-YLLVMEYYPNGSLXKYLS-LHTSDWVSSCRLAHSVTRGLAYLHT 129

Query: 164 A---------SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---------MTEYV 205
                     ++ HRDL   N+L+       I DFGL+   +                 V
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189

Query: 206 VTRWYRAPELL------LNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKD 249
            T  Y APE+L       +       +D++++G I  EI  R   LFPG+ 
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 98.2 bits (245), Expect = 3e-24
 Identities = 42/219 (19%), Positives = 89/219 (40%), Gaps = 34/219 (15%)

Query: 47  IRPIGRGAYGIVCAAV----NSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHMEH 100
           ++ +G G +G V   V        +  V IK  +  +   +          +  +  ++H
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQA---VTDHMLAIGSLDH 74

Query: 101 ENVIAIKDII-RPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRG 157
            +++ +  +            + +V + +    L   +R     L       +  Q+ +G
Sbjct: 75  AHIVRLLGLCPGSS-------LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKG 127

Query: 158 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWY 210
           + Y+    ++HR+L   N+LL +   +++ DFG+A      D   + ++        +W 
Sbjct: 128 MYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD---KQLLYSEAKTPIKWM 184

Query: 211 RAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
            A E  ++  +YT   D+WS G  + E+MT   EP + G
Sbjct: 185 -ALE-SIHFGKYTHQSDVWSYGVTVWELMTFGAEP-YAG 220

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 97.4 bits (243), Expect = 3e-24
 Identities = 39/235 (16%), Positives = 81/235 (34%), Gaps = 34/235 (14%)

Query: 36  LFEVSSKYVPPIRPIGRGAYGIVCAAV-------NSETREEVAIKKIGNAFDNIIDARRT 88
             ++ ++ +     +G+G +  +   V             EV +K +  A  N   +   
Sbjct: 2   FHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRN--YSESF 59

Query: 89  LREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTD 144
                ++  + H++++    +               +V E +    L   ++     +  
Sbjct: 60  FEAASMMSKLSHKHLVLNYGVCVCGDE-------NILVQEFVKFGSLDTYLKKNKNCINI 112

Query: 145 DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL--------KIGDFGLARTTS 196
                   QL   + ++   +++H ++   N+LL    D         K+ D G++ T  
Sbjct: 113 LWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL 172

Query: 197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPGKD 249
             D + E +   W   PE + N      A D WS G  L EI +   +P     D
Sbjct: 173 PKDILQERI--PWV-PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP-LSALD 223

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 99.9 bits (249), Expect = 4e-24
 Identities = 49/212 (23%), Positives = 97/212 (45%), Gaps = 17/212 (8%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII---DARRTLREIKLLRHMEHENV 103
            R +GRG +G V A     T +  A KK+      +      +  + E K+L  +    +
Sbjct: 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNK--KRLKKRKGYQGAMVEKKILAKVHSRFI 247

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMD-----TDLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
           +++              + +V  +M+       ++ +   +    +    ++  Q++ GL
Sbjct: 248 VSLAYAFETKTD-----LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302

Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLL 217
           +++H  ++++RDLKP N+LL+   +++I D GLA         T+ Y  T  + APELLL
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL 362

Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
              EY  ++D +++G  L E++     F  + 
Sbjct: 363 G-EEYDFSVDYFALGVTLYEMIAARGPFRARG 393

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 99.0 bits (247), Expect = 5e-24
 Identities = 61/223 (27%), Positives = 106/223 (47%), Gaps = 31/223 (13%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           E+  + +   + +G G +G V  A  N  T+  VA+K +       +     L E  +++
Sbjct: 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTK--VAVKTMK---PGSMSVEAFLAEANVMK 238

Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQ 153
            ++H+ ++ +  ++      T   +YI+ E M    L   ++SD   +        F  Q
Sbjct: 239 TLQHDKLVKLHAVV------TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ 292

Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------ 207
           +  G+ ++   + +HRDL+ +N+L++AS   KI DFGLAR   +     EY         
Sbjct: 293 IAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED----NEYTAREGAKFP 348

Query: 208 -RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 247
            +W  APE  +N   +T   D+WS G +L EI+T  R P +PG
Sbjct: 349 IKWT-APE-AINFGSFTIKSDVWSFGILLMEIVTYGRIP-YPG 388

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 96.9 bits (242), Expect = 5e-24
 Identities = 63/206 (30%), Positives = 103/206 (50%), Gaps = 12/206 (5%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIA 105
           +  +G G    V  A ++    +VAIK I     +     +R  RE+     + H+N+++
Sbjct: 16  VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 106 IKDIIRPPKKDTFNDV-YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
           + D+      D  +D  Y+V E ++   L + I S   L+ D    F  Q+L G+K+ H 
Sbjct: 76  MIDV------DEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCTE 221
             ++HRD+KP N+L++++  LKI DFG+A+  SET       V  T  Y +PE       
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG-EA 188

Query: 222 YTAAIDIWSVGCILGEIMTREPLFPG 247
                DI+S+G +L E++  EP F G
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPPFNG 214

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 99.0 bits (247), Expect = 6e-24
 Identities = 64/255 (25%), Positives = 108/255 (42%), Gaps = 35/255 (13%)

Query: 6   KDSSSGGATSSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSE 65
              + G  T  +K  +  G    Q   Y + + ++ K +  ++ IG+G +G V       
Sbjct: 157 TTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRG 216

Query: 66  TREEVAIKKI-----GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII---RPPKKDT 117
            +  VA+K I       AF         L E  ++  + H N++ +  +I   +      
Sbjct: 217 NK--VAVKCIKNDATAQAF---------LAEASVMTQLRHSNLVQLLGVIVEEKGG---- 261

Query: 118 FNDVYIVYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 174
              +YIV E M    L   +RS     L  D    F   +   ++Y+   + +HRDL   
Sbjct: 262 ---LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAAR 318

Query: 175 NLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 234
           N+L++     K+ DFGL +  S T    +  V +W  APE  L   +++   D+WS G +
Sbjct: 319 NVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-KWT-APE-ALREKKFSTKSDVWSFGIL 375

Query: 235 LGEIMT--REPLFPG 247
           L EI +  R P +P 
Sbjct: 376 LWEIYSFGRVP-YPR 389

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 98.8 bits (246), Expect = 8e-24
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 23/210 (10%)

Query: 47  IRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA 105
              +G+G +G V     N  TR  VAIK +       +     L+E ++++ + HE ++ 
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQ 326

Query: 106 IKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVH 162
           +  ++      +   +YIV E M    L   ++ +  + L          Q+  G+ YV 
Sbjct: 327 LYAVV------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 380

Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNC 219
             + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE     
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT-APE-AALY 438

Query: 220 TEYTAAIDIWSVGCILGEIMT--REPLFPG 247
             +T   D+WS G +L E+ T  R P +PG
Sbjct: 439 GRFTIKSDVWSFGILLTELTTKGRVP-YPG 467

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 98.3 bits (245), Expect = 9e-24
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 23/210 (10%)

Query: 47  IRPIGRGAYGIVCAAV-NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA 105
              +G+G +G V     N  TR  VAIK +       +     L+E ++++ + HE ++ 
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQ 243

Query: 106 IKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVH 162
           +  ++      +   +YIV E M    L   ++ +  + L          Q+  G+ YV 
Sbjct: 244 LYAVV------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 297

Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNC 219
             + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE     
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT-APE-AALY 355

Query: 220 TEYTAAIDIWSVGCILGEIMT--REPLFPG 247
             +T   D+WS G +L E+ T  R P +PG
Sbjct: 356 GRFTIKSDVWSFGILLTELTTKGRVP-YPG 384

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 97.5 bits (243), Expect = 1e-23
 Identities = 43/219 (19%), Positives = 92/219 (42%), Gaps = 26/219 (11%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII---DARRTLREIKLLRHMEHENV 103
           ++ IGRGA+  V      +T +  A+K +     +++   +      E  +L + +   +
Sbjct: 66  LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNK--WDMLKRGEVSCFREERDVLVNGDRRWI 123

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMD----TDL-HQIIRSDQQLTDDHCQYFLYQLLRGL 158
             +           F D   +Y +M+     DL   + +  +++  +  +++L +++  +
Sbjct: 124 TQLHF--------AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAI 175

Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA-RTTSETDFMTEYVV-TRWYRAPELL 216
             VH    +HRD+KP N+LL+    +++ DFG   +  ++    +   V T  Y +PE+L
Sbjct: 176 DSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEIL 235

Query: 217 LN------CTEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
                      Y    D W++G    E+   +  F    
Sbjct: 236 QAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS 274

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 98.4 bits (245), Expect = 2e-23
 Identities = 53/206 (25%), Positives = 98/206 (47%), Gaps = 15/206 (7%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII---DARRTLREIKLL---RHMEH 100
            R IGRG +G V     ++T +  A+K +      I         L E  +L      + 
Sbjct: 194 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDK--KRIKMKQGETLALNERIMLSLVSTGDC 251

Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
             ++ +      P K     +  + +LM+  DLH  +      ++   +++  +++ GL+
Sbjct: 252 PFIVCMSYAFHTPDK-----LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 306

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 219
           ++H+  V++RDLKP+N+LL+    ++I D GLA   S+       V T  Y APE+L   
Sbjct: 307 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-SVGTHGYMAPEVLQKG 365

Query: 220 TEYTAAIDIWSVGCILGEIMTREPLF 245
             Y ++ D +S+GC+L +++     F
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSPF 391

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 95.4 bits (238), Expect = 2e-23
 Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 28/211 (13%)

Query: 47  IRPIGRGAYGIVCAAV---NSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHMEHE 101
            R IG+G +G+V        ++ R + AIK          +      LRE  L+R + H 
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEA---FLREGLLMRGLNHP 82

Query: 102 NVI---AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLR 156
           NV+    I               +++   M   DL Q IRS  +  T      F  Q+ R
Sbjct: 83  NVLALIGIMLPPEGL-------PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVAR 135

Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWY 210
           G++Y+     +HRDL   N +L+ S  +K+ DFGLAR   + ++ +           +W 
Sbjct: 136 GMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT 195

Query: 211 RAPELLLNCTEYTAAIDIWSVGCILGEIMTR 241
            A E L     +T   D+WS G +L E++TR
Sbjct: 196 -ALESLQT-YRFTTKSDVWSFGVLLWELLTR 224

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 96.6 bits (241), Expect = 2e-23
 Identities = 49/212 (23%), Positives = 106/212 (50%), Gaps = 19/212 (8%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII---DARRTLREIKLLRHMEHENV 103
           +R IG+G++G VC    ++T++  A+K +       +   + R   +E+++++ +EH  +
Sbjct: 20  LRAIGKGSFGKVCIVQKNDTKKMYAMKYMNK--QKCVERNEVRNVFKELQIMQGLEHPFL 77

Query: 104 IAIKDIIRPPKKDTF---NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
           + +          +F    D+++V +L+   DL   ++ +    ++  + F+ +L+  L 
Sbjct: 78  VNLWY--------SFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALD 129

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN- 218
           Y+ +  ++HRD+KP N+LL+    + I DF +A        +T    T+ Y APE+  + 
Sbjct: 130 YLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSR 189

Query: 219 -CTEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
               Y+ A+D WS+G    E++     +  + 
Sbjct: 190 KGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS 221

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 94.7 bits (236), Expect = 5e-23
 Identities = 59/246 (23%), Positives = 97/246 (39%), Gaps = 55/246 (22%)

Query: 35  NLFEVSSKYVPP-----------IRPIGRGAYGIVCAAV-----NSETREEVAIK--KIG 76
             F  +  YVP             R +G+G++G+V   V       E    VAIK     
Sbjct: 7   EYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA 66

Query: 77  NAFDNIIDARRTLREIKLLRHMEHENVIAIKDII---RPPKKDTFNDVYIVYELMDT-DL 132
            +    I+    L E  +++     +V+ +  ++   +P          ++ ELM   DL
Sbjct: 67  ASMRERIE---FLNEASVMKEFNCHHVVRLLGVVSQGQPT--------LVIMELMTRGDL 115

Query: 133 HQIIRS----------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC 182
              +RS              +         ++  G+ Y+++   +HRDL   N ++    
Sbjct: 116 KSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 175

Query: 183 DLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCIL 235
            +KIGDFG+ R   ETD+   Y          RW  +PE L +   +T   D+WS G +L
Sbjct: 176 TVKIGDFGMTRDIYETDY---YRKGGKGLLPVRWM-SPESLKDGV-FTTYSDVWSFGVVL 230

Query: 236 GEIMTR 241
            EI T 
Sbjct: 231 WEIATL 236

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 94.1 bits (234), Expect = 2e-22
 Identities = 46/217 (21%), Positives = 95/217 (43%), Gaps = 24/217 (11%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII---DARRTLREIKLLRHMEHENV 103
           ++ IGRGA+G V         +  A+K +      ++   +      E  +L + + + +
Sbjct: 79  LKVIGRGAFGEVAVVKLKNADKVFAMKILNK--WEMLKRAETACFREERDVLVNGDSKWI 136

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMD----TDL-HQIIRSDQQLTDDHCQYFLYQLLRGL 158
             +           F D   +Y +MD     DL   + + + +L ++  +++L +++  +
Sbjct: 137 TTLHY--------AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAI 188

Query: 159 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA-RTTSETDFMTEYVV-TRWYRAPELL 216
             VH    +HRD+KP N+L++ +  +++ DFG   +   +    +   V T  Y +PE+L
Sbjct: 189 DSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248

Query: 217 LNCTE----YTAAIDIWSVGCILGEIMTREPLFPGKD 249
                    Y    D WS+G  + E++  E  F  + 
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 285

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 92.7 bits (231), Expect = 3e-22
 Identities = 47/214 (21%), Positives = 104/214 (48%), Gaps = 28/214 (13%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARR---TLREIKLLRHMEHENV 103
           I+ +G G++G V    + E+    A+K +      ++  ++   TL E ++L+ +    +
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDK--QKVVKLKQIEHTLNEKRILQAVNFPFL 103

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDT----DLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
           + ++         +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +
Sbjct: 104 VKLEF--------SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAPEL 215
           Y+HS  +++RDLKP NLL++    +++ DFG A+      +      E +      APE+
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEAL------APEI 209

Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
           +L+   Y  A+D W++G ++ E+    P F    
Sbjct: 210 ILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 93.2 bits (232), Expect = 5e-22
 Identities = 54/215 (25%), Positives = 95/215 (44%), Gaps = 23/215 (10%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII---DARRTLREIKLLRHMEHENV 103
           ++ IGRGA+G V    +  TR+  A+K +      +I   D+     E  ++       V
Sbjct: 74  VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSK--FEMIKRSDSAFFWEERDIMAFANSPWV 131

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
           + +           F D   +Y +M+     DL  ++ +   + +   +++  +++  L 
Sbjct: 132 VQLFY--------AFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALD 182

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA-RTTSETDFMTEYVV-TRWYRAPELLL 217
            +HS   +HRD+KP N+LL+ S  LK+ DFG   +   E     +  V T  Y +PE+L 
Sbjct: 183 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 242

Query: 218 NC---TEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
           +      Y    D WSVG  L E++  +  F    
Sbjct: 243 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 277

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 91.5 bits (228), Expect = 6e-22
 Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 12/209 (5%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA---RRTLREIKLLRHMEHENV 103
              +G G    V  A +     +VA+K +        D     R  RE +    + H  +
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLAR--DPSFYLRFRREAQNAAALNHPAI 74

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           +A+ D             YIV E +D   L  I+ ++  +T       +    + L + H
Sbjct: 75  VAVYDTGEAETPAG-PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133

Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVV-TRWYRAPELLLN 218
              ++HRD+KP+N++++A+  +K+ DFG+AR  +++      T  V+ T  Y +PE    
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193

Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPG 247
                A  D++S+GC+L E++T EP F G
Sbjct: 194 -DSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 91.2 bits (227), Expect = 1e-21
 Identities = 64/266 (24%), Positives = 111/266 (41%), Gaps = 48/266 (18%)

Query: 9   SSGGATSSVKGVLTHGGKYV----QYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAA--- 61
            SG + S  +G  +    ++    QY     +  +  + +     +G GA+G V  A   
Sbjct: 4   GSGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECH 63

Query: 62  --VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII--RPPKKDT 117
             +  + +  VA+K +  A ++    +   RE +LL  ++H++++    +     P    
Sbjct: 64  NLLPEQDKMLVAVKALKEASES--ARQDFQREAELLTMLQHQHIVRFFGVCTEGRP---- 117

Query: 118 FNDVYIVYELMDT-DLHQIIRS---------------DQQLTDDHCQYFLYQLLRGLKYV 161
              + +V+E M   DL++ +RS                  L          Q+  G+ Y+
Sbjct: 118 ---LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL 174

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPE 214
                +HRDL   N L+     +KIGDFG++R    TD+   Y V        RW   PE
Sbjct: 175 AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY---YRVGGRTMLPIRWM-PPE 230

Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMT 240
            +L   ++T   D+WS G +L EI T
Sbjct: 231 SILY-RKFTTESDVWSFGVVLWEIFT 255

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 88.4 bits (220), Expect = 7e-21
 Identities = 54/240 (22%), Positives = 92/240 (38%), Gaps = 48/240 (20%)

Query: 34  GNLFEVSSKYVPPIRPIGRGAYGIVCAAV-----NSETREEVAIK--KIGNAFDNIIDAR 86
           G L E+S   V  +  +G   +G V           E  + VAIK  K         +  
Sbjct: 1   GKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREE-- 58

Query: 87  RTLREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYELMDT-DLHQIIRS----- 138
               E  L   ++H NV+ +  ++    P       + +++      DLH+ +       
Sbjct: 59  -FRHEAMLRARLQHPNVVCLLGVVTKDQP-------LSMIFSYCSHGDLHEFLVMRSPHS 110

Query: 139 -----------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG 187
                         L      + + Q+  G++Y+ S  V+H+DL   N+L+    ++KI 
Sbjct: 111 DVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKIS 170

Query: 188 DFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           D GL R     D    Y +        RW  APE ++    ++   DIWS G +L E+ +
Sbjct: 171 DLGLFREVYAAD---YYKLLGNSLLPIRWM-APEAIMYGK-FSIDSDIWSYGVVLWEVFS 225

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 88.5 bits (220), Expect = 1e-20
 Identities = 59/251 (23%), Positives = 91/251 (36%), Gaps = 48/251 (19%)

Query: 23  HGGKYVQYNVYGNLFEVSSKY-VPP-----IRPIGRGAYGIVCAAV-----NSETREEVA 71
           H      Y   G    +S    VP      IR +G GA+G V         N  +  +VA
Sbjct: 5   HHHHNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVA 64

Query: 72  IK--KIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI--IRPPKKDTFNDVYIVYEL 127
           +K      +  + +D    L E  ++    H+N++    +     P        +I+ EL
Sbjct: 65  VKTLPEVCSEQDELD---FLMEALIISKFNHQNIVRCIGVSLQSLP-------RFILMEL 114

Query: 128 MDT-DLHQIIRS-------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 179
           M   DL   +R           L      +    +  G +Y+     +HRD+   N LL 
Sbjct: 115 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLT 174

Query: 180 ASCD---LKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIW 229
                   KIGDFG+AR      +   Y          +W   PE  +    +T+  D W
Sbjct: 175 CPGPGRVAKIGDFGMARDIYRASY---YRKGGCAMLPVKWM-PPEAFME-GIFTSKTDTW 229

Query: 230 SVGCILGEIMT 240
           S G +L EI +
Sbjct: 230 SFGVLLWEIFS 240

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 87.3 bits (217), Expect = 2e-20
 Identities = 60/235 (25%), Positives = 104/235 (44%), Gaps = 47/235 (20%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAA-----VNSETREEVAIKKIGNAFDNIIDARRTLREI 92
            +  + +   R +G GA+G V  A       ++ +  VA+K + +        +   RE 
Sbjct: 11  HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA--ARKDFQREA 68

Query: 93  KLLRHMEHENVI---AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS---------- 138
           +LL +++HE+++    +     P        + +V+E M   DL++ +R+          
Sbjct: 69  ELLTNLQHEHIVKFYGVCGDGDP--------LIMVFEYMKHGDLNKFLRAHGPDAMILVD 120

Query: 139 ------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA 192
                   +L      +   Q+  G+ Y+ S   +HRDL   N L+ A+  +KIGDFG++
Sbjct: 121 GQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180

Query: 193 RTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           R    TD+   Y V        RW   PE ++   ++T   D+WS G IL EI T
Sbjct: 181 RDVYSTDY---YRVGGHTMLPIRWM-PPESIMY-RKFTTESDVWSFGVILWEIFT 230

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 87.4 bits (217), Expect = 3e-20
 Identities = 53/221 (23%), Positives = 84/221 (38%), Gaps = 42/221 (19%)

Query: 47  IRPIGRGAYGIVCAA-----VNSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHME 99
           IR +G GA+G V         N  +  +VA+K      +  + +D    L E  ++    
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD---FLMEALIISKFN 132

Query: 100 HENVIAIKDI--IRPPKKDTFNDVYIVYELMDT-DLHQIIRS-------DQQLTDDHCQY 149
           H+N++    +     P        +I+ ELM   DL   +R           L      +
Sbjct: 133 HQNIVRCIGVSLQSLP-------RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 185

Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLARTTSETDFMTEYVV 206
               +  G +Y+     +HRD+   N LL         KIGDFG+AR      +   Y  
Sbjct: 186 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY---YRK 242

Query: 207 T-------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                   +W   PE  +    +T+  D WS G +L EI +
Sbjct: 243 GGCAMLPVKWM-PPEAFMEGI-FTSKTDTWSFGVLLWEIFS 281

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 86.9 bits (216), Expect = 3e-20
 Identities = 66/246 (26%), Positives = 104/246 (42%), Gaps = 55/246 (22%)

Query: 47  IRPIGRGAYGIVCAA-----VNSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHM- 98
            +P+GRGA+G V  A       + T   VA+K  K G            + E+K+L H+ 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA---LMSELKILIHIG 88

Query: 99  EHENVI----AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS--------------- 138
            H NV+    A      P        + ++ E     +L   +RS               
Sbjct: 89  HHLNVVNLLGACTKPGGP--------LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 140

Query: 139 -DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE 197
               LT +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR   +
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 200

Query: 198 TDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPGK 248
                +YV         +W  APE + +   YT   D+WS G +L EI +    P +PG 
Sbjct: 201 DP---DYVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASP-YPGV 254

Query: 249 DYVHQL 254
               + 
Sbjct: 255 KIDEEF 260

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 86.5 bits (215), Expect = 6e-20
 Identities = 52/215 (24%), Positives = 103/215 (47%), Gaps = 33/215 (15%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII---DARRTLREIKLLRHMEHENVIAI 106
           +G+G +G V       T    A+K +    + II   +   T+ E ++L++  H  + A+
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRK--EVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 107 KDIIRPPKKDTFNDVYIV--Y----ELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           K   +   +     +  V  Y    EL     H  +  ++  T++  +++  +++  L+Y
Sbjct: 71  KYAFQTHDR-----LCFVMEYANGGELF---FH--LSRERVFTEERARFYGAEIVSALEY 120

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW------YRAPE 214
           +HS  V++RD+K  NL+L+    +KI DFGL +     + +++    +       Y APE
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKTFCGTPEYLAPE 175

Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
           +L +  +Y  A+D W +G ++ E+M     F  +D
Sbjct: 176 VLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 85.6 bits (212), Expect = 7e-20
 Identities = 26/213 (12%), Positives = 54/213 (25%), Gaps = 36/213 (16%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIA 105
           +   G         A+++    +VA+  +           + TL     L  ++   V  
Sbjct: 36  LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 106 IKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + D++      T     +V E +    L ++  +    +       +  L       H A
Sbjct: 96  VLDVV-----HTRAGGLVVAEWIRGGSLQEVADT--SPSPVGAIRAMQSLAAAADAAHRA 148

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
            V      PS + ++   D+ +                                      
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPATMPDA---------------------------NP 181

Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
             DI  +G  L  ++      P       L   
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA 214

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 85.8 bits (213), Expect = 9e-20
 Identities = 59/228 (25%), Positives = 95/228 (41%), Gaps = 47/228 (20%)

Query: 47  IRPIGRGAYGIVCAA-----VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EH 100
            + +G GA+G V  A     + S+    VA+K +     ++ +    + E+K+L ++  H
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALMSELKVLSYLGNH 86

Query: 101 ENVIAIKDI--IRPPKKDTFNDVYIVYELM-DTDLHQIIRS------------------D 139
            N++ +     I  P         ++ E     DL   +R                   +
Sbjct: 87  MNIVNLLGACTIGGP-------TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139

Query: 140 QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD 199
             L  +    F YQ+ +G+ ++ S + +HRDL   N+LL      KI DFGLAR      
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 200 FMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               YVV        +W  APE + NC  YT   D+WS G  L E+ +
Sbjct: 200 ---NYVVKGNARLPVKWM-APESIFNCV-YTFESDVWSYGIFLWELFS 242

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 86.3 bits (214), Expect = 1e-19
 Identities = 55/211 (26%), Positives = 102/211 (48%), Gaps = 24/211 (11%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII---DARRTLREIKLLRHMEHENVIAI 106
           +G+G +G V       T    A+K +    + I+   +   TL E ++L++  H  + A+
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKK--EVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213

Query: 107 KDIIRPPKKDTFNDVYIV--Y----ELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           K   +   +     +  V  Y    EL     H  +  ++  ++D  +++  +++  L Y
Sbjct: 214 KYSFQTHDR-----LCFVMEYANGGELF---FH--LSRERVFSEDRARFYGAEIVSALDY 263

Query: 161 VHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLN 218
           +HS  +V++RDLK  NL+L+    +KI DFGL +    +   M  +  T  Y APE+L +
Sbjct: 264 LHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED 323

Query: 219 CTEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
             +Y  A+D W +G ++ E+M     F  +D
Sbjct: 324 -NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 353

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 85.4 bits (212), Expect = 1e-19
 Identities = 58/229 (25%), Positives = 95/229 (41%), Gaps = 53/229 (23%)

Query: 47  IRPIGRGAYGIVCAA-----VNSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHM- 98
            + +G GA+G V  A        +   +VA+K  K     D        + E+K++ H+ 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA---LMSELKIMSHLG 107

Query: 99  EHENVIAI-----KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-------------- 138
           +HEN++ +          P        V ++ E     DL   +R               
Sbjct: 108 QHENIVNLLGACTHG--GP--------VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157

Query: 139 DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 198
           +   +     +F  Q+ +G+ ++ S + +HRD+   N+LL      KIGDFGLAR     
Sbjct: 158 NSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 217

Query: 199 DFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                Y+V        +W  APE + +C  YT   D+WS G +L EI +
Sbjct: 218 S---NYIVKGNARLPVKWM-APESIFDCV-YTVQSDVWSYGILLWEIFS 261

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 84.9 bits (211), Expect = 2e-19
 Identities = 51/217 (23%), Positives = 99/217 (45%), Gaps = 34/217 (15%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIK---KIGNAFDNII---DARRTLREIKLLRHMEH 100
           +R +G G++G V    +       A+K   K     + ++       T  E  +L  + H
Sbjct: 11  LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKK-----EIVVRLKQVEHTNDERLMLSIVTH 65

Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLR 156
             +I +          TF D   ++ +MD     +L  ++R  Q+  +   +++  ++  
Sbjct: 66  PFIIRMWG--------TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL 117

Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TEYVVTRWYRA 212
            L+Y+HS  +++RDLKP N+LL+ +  +KI DFG A+   +  +      +Y+      A
Sbjct: 118 ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYI------A 171

Query: 213 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
           PE++     Y  +ID WS G ++ E++     F   +
Sbjct: 172 PEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSN 207

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 85.0 bits (211), Expect = 2e-19
 Identities = 58/224 (25%), Positives = 88/224 (39%), Gaps = 47/224 (20%)

Query: 47  IRPIGRGAYGIVCAAV--NSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHM-EHEN 102
              IG G +G V  A       R + AIK++   A  +  D R    E+++L  +  H N
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD--DHRDFAGELEVLCKLGHHPN 87

Query: 103 VIAIKDI--IRPPKKDTFNDVYIVYELMDT-DLHQIIRS----------------DQQLT 143
           +I +      R         +Y+  E     +L   +R                    L+
Sbjct: 88  IINLLGACEHRGY-------LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140

Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 203
                +F   + RG+ Y+     +HRDL   N+L+  +   KI DFGL+R          
Sbjct: 141 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE------V 194

Query: 204 YVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           YV         RW  A E  LN + YT   D+WS G +L EI++
Sbjct: 195 YVKKTMGRLPVRWM-AIE-SLNYSVYTTNSDVWSYGVLLWEIVS 236

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 84.6 bits (210), Expect = 3e-19
 Identities = 50/226 (22%), Positives = 100/226 (44%), Gaps = 48/226 (21%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IR +G+G++G V  A   ET +  A+K               L++  +L+  + E  +  
Sbjct: 28  IRVLGKGSFGKVMLARVKETGDLYAVK--------------VLKKDVILQDDDVECTMTE 73

Query: 107 KDIIRPPKKDTF-----------NDVYIV--Y----ELMDTDLHQIIRSDQQLTDDHCQY 149
           K I+   +   F           + ++ V  +    +LM    H  I+  ++  +   ++
Sbjct: 74  KRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLM---FH--IQKSRRFDEARARF 128

Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW 209
           +  +++  L ++H   +++RDLK  N+LL+     K+ DFG+ +     + +   V T  
Sbjct: 129 YAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK-----EGICNGVTTAT 183

Query: 210 ------YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
                 Y APE+L     Y  A+D W++G +L E++     F  ++
Sbjct: 184 FCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAEN 228

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 84.2 bits (209), Expect = 4e-19
 Identities = 56/221 (25%), Positives = 102/221 (46%), Gaps = 38/221 (17%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
            + +G+G++G V  A   +T +  AIK               L++  +L   + E  +  
Sbjct: 22  HKMLGKGSFGKVFLAEFKKTNQFFAIK--------------ALKKDVVLMDDDVECTMVE 67

Query: 107 KDI----IRPP----KKDTF---NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQL 154
           K +       P       TF    +++ V E ++  DL   I+S  +       ++  ++
Sbjct: 68  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI 127

Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW----- 209
           + GL+++HS  +++RDLK  N+LL+    +KI DFG+ +     + M     T       
Sbjct: 128 ILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK-----ENMLGDAKTNTFCGTP 182

Query: 210 -YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
            Y APE+LL   +Y  ++D WS G +L E++  +  F G+D
Sbjct: 183 DYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 85.1 bits (210), Expect = 5e-19
 Identities = 50/227 (22%), Positives = 100/227 (44%), Gaps = 50/227 (22%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  +G+G++G V  +    T E  A+K               L++  +++  + E  +  
Sbjct: 346 LMVLGKGSFGKVMLSERKGTDELYAVK--------------ILKKDVVIQDDDVECTMVE 391

Query: 107 KDIIRPPKKDTF-----------NDVYIV--Y----ELMDTDLHQIIRSDQQLTDDHCQY 149
           K ++  P K  F           + +Y V  Y    +LM    H  I+   +  + H  +
Sbjct: 392 KRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLM---YH--IQQVGRFKEPHAVF 446

Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT------- 202
           +  ++  GL ++ S  +++RDLK  N++L++   +KI DFG+ +        T       
Sbjct: 447 YAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTP 506

Query: 203 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
           +Y+      APE++     Y  ++D W+ G +L E++  +  F G+D
Sbjct: 507 DYI------APEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED 546

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 83.1 bits (206), Expect = 8e-19
 Identities = 58/238 (24%), Positives = 92/238 (38%), Gaps = 62/238 (26%)

Query: 47  IRPIGRGAYGIVCAAV-----NSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHME 99
            + +G G +G V  A             VA+K  K   +   + D    L E  +L+ + 
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD---LLSEFNVLKQVN 84

Query: 100 HENVIAI-----KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS--------------- 138
           H +VI +     +D   P          ++ E      L   +R                
Sbjct: 85  HPHVIKLYGACSQD--GPL--------LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134

Query: 139 ---------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF 189
                    ++ LT      F +Q+ +G++Y+    ++HRDL   N+L+     +KI DF
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDF 194

Query: 190 GLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           GL+R   E D    YV         +W  A E L +   YT   D+WS G +L EI+T
Sbjct: 195 GLSRDVYEED---SYVKRSQGRIPVKWM-AIESLFDHI-YTTQSDVWSFGVLLWEIVT 247

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 83.6 bits (207), Expect = 9e-19
 Identities = 66/283 (23%), Positives = 115/283 (40%), Gaps = 64/283 (22%)

Query: 7   DSSSGGATSSVKGVLTHGGKYVQYNVYGNLFEVSSKYVPP-------------IRPIGRG 53
            + S  + +S   ++    +         L  VS   +P               +P+G G
Sbjct: 33  SAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEG 92

Query: 54  AYGIVCAAV-------NSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHM-EHENV 103
            +G V  A          +    VA+K  K      ++ D    + E+++++ + +H+N+
Sbjct: 93  CFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD---LVSEMEMMKMIGKHKNI 149

Query: 104 IAIKDI--IRPPKKDTFNDVYIVYELMDT-DLHQIIRS----------------DQQLTD 144
           I +        P       +Y++ E     +L + +R+                ++Q+T 
Sbjct: 150 INLLGACTQDGP-------LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202

Query: 145 DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY 204
                  YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  D    Y
Sbjct: 203 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID---YY 259

Query: 205 VVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
             T       +W  APE L +   YT   D+WS G ++ EI T
Sbjct: 260 KKTTNGRLPVKWM-APEALFDRV-YTHQSDVWSFGVLMWEIFT 300

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 82.7 bits (205), Expect = 1e-18
 Identities = 62/233 (26%), Positives = 104/233 (44%), Gaps = 57/233 (24%)

Query: 47  IRPIGRGAYGIVCAAV-------NSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRH 97
            +P+G GA+G V  A          +    VA+K  K      ++ D    + E+++++ 
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD---LVSEMEMMKM 96

Query: 98  M-EHENVIAI-----KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS------------ 138
           + +H+N+I +     +D   P         Y++ E     +L + +R+            
Sbjct: 97  IGKHKNIINLLGACTQD--GPL--------YVIVEYASKGNLREYLRARRPPGMEYSYDI 146

Query: 139 ----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART 194
               ++Q+T        YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR 
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206

Query: 195 TSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
            +  D    Y  T       +W  APE L +   YT   D+WS G ++ EI T
Sbjct: 207 INNID---YYKKTTNGRLPVKWM-APEALFDRV-YTHQSDVWSFGVLMWEIFT 254

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 81.9 bits (203), Expect = 3e-18
 Identities = 49/224 (21%), Positives = 99/224 (44%), Gaps = 50/224 (22%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           +G+G++G V  +    T E  A+K               L++  +++  + E  +  K +
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVK--------------ILKKDVVIQDDDVECTMVEKRV 73

Query: 110 IRPPKKDTF-----------NDVYIV--Y----ELMDTDLHQIIRSDQQLTDDHCQYFLY 152
           +  P K  F           + +Y V  Y    +LM    + I +  +   + H  ++  
Sbjct: 74  LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLM----YHIQQVGR-FKEPHAVFYAA 128

Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT-------EYV 205
           ++  GL ++ S  +++RDLK  N++L++   +KI DFG+ +        T       +Y+
Sbjct: 129 EIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYI 188

Query: 206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
                 APE++     Y  ++D W+ G +L E++  +  F G+D
Sbjct: 189 ------APEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 81.6 bits (202), Expect = 3e-18
 Identities = 55/234 (23%), Positives = 91/234 (38%), Gaps = 54/234 (23%)

Query: 47  IRPIGRGAYGIVCAA-----VNSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHM- 98
            + +G GA+G V  A       +    +VA+K  K              + E+K++  + 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREA---LMSELKMMTQLG 106

Query: 99  EHENVI------AIKD---II----------------RPPKKDTFNDVYIVYELMDTDLH 133
            HEN++       +     +I                R    +   +      L + +  
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166

Query: 134 QIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR 193
            ++  +  L       F YQ+ +G++++   S +HRDL   N+L+     +KI DFGLAR
Sbjct: 167 NVLTFEDLL------CFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 220

Query: 194 TTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
                     YVV        +W  APE L     YT   D+WS G +L EI +
Sbjct: 221 DIMSDS---NYVVRGNARLPVKWM-APESLFEGI-YTIKSDVWSYGILLWEIFS 269

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 81.5 bits (202), Expect = 4e-18
 Identities = 45/221 (20%), Positives = 95/221 (42%), Gaps = 38/221 (17%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R IGRG+Y  V      +T    A+K               +++  +    + + V   
Sbjct: 14  LRVIGRGSYAKVLLVRLKKTDRIYAMK--------------VVKKELVNDDEDIDWVQTE 59

Query: 107 KDIIRPPKKDTF-----------NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQL 154
           K +        F           + ++ V E ++  DL   ++  ++L ++H +++  ++
Sbjct: 60  KHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI 119

Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW----- 209
              L Y+H   +++RDLK  N+LL++   +K+ D+G+ +     + +     T       
Sbjct: 120 SLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSTFCGTP 174

Query: 210 -YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
            Y APE+L    +Y  ++D W++G ++ E+M     F    
Sbjct: 175 NYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVG 214

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 81.6 bits (202), Expect = 4e-18
 Identities = 57/238 (23%), Positives = 89/238 (37%), Gaps = 62/238 (26%)

Query: 47  IRPIGRGAYGIVCAA-----VNSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHME 99
           +R IG GA+G V  A     +  E    VA+K  K   + D   D     RE  L+   +
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD---FQREAALMAEFD 108

Query: 100 HENVIAI-----KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS--------------- 138
           + N++ +         +P          +++E M   DL++ +RS               
Sbjct: 109 NPNIVKLLGVCAVG--KPM--------CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 158

Query: 139 ---------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF 189
                       L+         Q+  G+ Y+     +HRDL   N L+  +  +KI DF
Sbjct: 159 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADF 218

Query: 190 GLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
           GL+R     D    Y          RW   PE +     YT   D+W+ G +L EI +
Sbjct: 219 GLSRNIYSAD---YYKADGNDAIPIRWM-PPESIFYNR-YTTESDVWAYGVVLWEIFS 271

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 81.5 bits (202), Expect = 4e-18
 Identities = 51/224 (22%), Positives = 104/224 (46%), Gaps = 50/224 (22%)

Query: 50  IGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 109
           IG+G++G V  A +       A+K               L++  +L+  E +++++ +++
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVK--------------VLQKKAILKKKEEKHIMSERNV 91

Query: 110 ----IRPP----KKDTF---NDVYIV--Y----ELMDTDLHQIIRSDQQLTDDHCQYFLY 152
               ++ P       +F   + +Y V  Y    EL     H  ++ ++   +   +++  
Sbjct: 92  LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELF---YH--LQRERCFLEPRARFYAA 146

Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT-------EYV 205
           ++   L Y+HS ++++RDLKP N+LL++   + + DFGL +   E +  T       EY+
Sbjct: 147 EIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYL 206

Query: 206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
                 APE+L     Y   +D W +G +L E++   P F  ++
Sbjct: 207 ------APEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 81.6 bits (202), Expect = 5e-18
 Identities = 44/221 (19%), Positives = 95/221 (42%), Gaps = 38/221 (17%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R IGRG+Y  V      +T    A++               +++  +    + + V   
Sbjct: 57  LRVIGRGSYAKVLLVRLKKTDRIYAMR--------------VVKKELVNDDEDIDWVQTE 102

Query: 107 KDIIRPPKKDTF-----------NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQL 154
           K +        F           + ++ V E ++  DL   ++  ++L ++H +++  ++
Sbjct: 103 KHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI 162

Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW----- 209
              L Y+H   +++RDLK  N+LL++   +K+ D+G+ +     + +     T       
Sbjct: 163 SLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSTFCGTP 217

Query: 210 -YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
            Y APE+L    +Y  ++D W++G ++ E+M     F    
Sbjct: 218 NYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVG 257

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 81.3 bits (201), Expect = 6e-18
 Identities = 59/228 (25%), Positives = 100/228 (43%), Gaps = 47/228 (20%)

Query: 47  IRPIGRGAYGIVCAAV-------NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM- 98
            +P+G GA+G V  A              +VA+K +  +     D    + E+++++ + 
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKMIG 132

Query: 99  EHENVIAIKDI--IRPPKKDTFNDVYIVYELMDT-DLHQIIRS----------------D 139
           +H+N+I +        P       +Y++ E     +L + +++                +
Sbjct: 133 KHKNIINLLGACTQDGP-------LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185

Query: 140 QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD 199
           +QL+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     D
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245

Query: 200 FMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
               Y  T       +W  APE L +   YT   D+WS G +L EI T
Sbjct: 246 ---YYKKTTNGRLPVKWM-APEALFDRI-YTHQSDVWSFGVLLWEIFT 288

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 79.9 bits (198), Expect = 1e-17
 Identities = 54/221 (24%), Positives = 105/221 (47%), Gaps = 35/221 (15%)

Query: 47  IRPIGRGAYGIVCAA---VNSETREEVAIKKIGNAF--DNIIDARRTLREIKLLRHMEHE 101
           +R +G+G YG V        + T +  A+K +  A    N  D   T  E  +L  ++H 
Sbjct: 22  LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHP 81

Query: 102 NVIAIKDIIRPPKKDTFNDVYIV--Y----ELMDTDLHQIIRSDQQLTDDHCQYFLYQLL 155
            ++ +    +   K     +Y++  Y    EL    +   +  +    +D   ++L ++ 
Sbjct: 82  FIVDLIYAFQTGGK-----LYLILEYLSGGELF---MQ--LEREGIFMEDTACFYLAEIS 131

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT-------EYVVTR 208
             L ++H   +++RDLKP N++LN    +K+ DFGL + +     +T       EY+   
Sbjct: 132 MALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYM--- 188

Query: 209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
              APE+L+  + +  A+D WS+G ++ +++T  P F G++
Sbjct: 189 ---APEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 77.6 bits (192), Expect = 7e-17
 Identities = 53/224 (23%), Positives = 105/224 (46%), Gaps = 43/224 (19%)

Query: 47  IRPIGRGAYGIVCAA---VNSETREEVAIK---KIGNAFDNII--DARRTLREIKLLRHM 98
           ++ +G+G++G V        S+ R+  A+K   K       +   D  RT  E  +L  +
Sbjct: 29  LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKK-----ATLKVRDRVRTKMERDILVEV 83

Query: 99  EHENVIAIKDIIRPPKKDTFNDVYIV--Y----ELMDTDLHQIIRSDQQLTDDHCQYFLY 152
            H  ++ +    +   K     +Y++  +    +L        +  +   T++  +++L 
Sbjct: 84  NHPFIVKLHYAFQTEGK-----LYLILDFLRGGDLF---TR--LSKEVMFTEEDVKFYLA 133

Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT-------EYV 205
           +L   L ++HS  +++RDLKP N+LL+    +K+ DFGL++ + + +          EY+
Sbjct: 134 ELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYM 193

Query: 206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
                 APE++     +T + D WS G ++ E++T    F GKD
Sbjct: 194 ------APEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 77.3 bits (190), Expect = 1e-16
 Identities = 36/123 (29%), Positives = 60/123 (48%), Gaps = 12/123 (9%)

Query: 125 YELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 184
              ++ +          LT +H   + +Q+ +G++++ S   +HRDL   N+LL+    +
Sbjct: 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVV 232

Query: 185 KIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGE 237
           KI DFGLAR   +     +YV         +W  APE + +   YT   D+WS G +L E
Sbjct: 233 KICDFGLARDIYKDP---DYVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWE 287

Query: 238 IMT 240
           I +
Sbjct: 288 IFS 290

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 74.6 bits (184), Expect = 1e-15
 Identities = 41/229 (17%), Positives = 103/229 (44%), Gaps = 47/229 (20%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH-ENVIA 105
           ++ +G GAYG V          +++    G  +     A + L++  +++  +  E+   
Sbjct: 59  LKVLGTGAYGKVFLV------RKISGHDTGKLY-----AMKVLKKATIVQKAKTTEHTRT 107

Query: 106 IKDIIRPPKKDTF-----------NDVYIV--Y----ELMDTDLHQIIRSDQQLTDDHCQ 148
            + ++   ++  F             ++++  Y    EL     H  +   ++ T+   Q
Sbjct: 108 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELF---TH--LSQRERFTEHEVQ 162

Query: 149 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR 208
            ++ +++  L+++H   +++RD+K  N+LL+++  + + DFGL++     +F+ +     
Sbjct: 163 IYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK-----EFVADETERA 217

Query: 209 W-------YRAPELLLNCTE-YTAAIDIWSVGCILGEIMTREPLFPGKD 249
           +       Y AP+++      +  A+D WS+G ++ E++T    F    
Sbjct: 218 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 266

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 73.4 bits (179), Expect = 2e-15
 Identities = 38/242 (15%), Positives = 73/242 (30%), Gaps = 56/242 (23%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIID------ARRTLREIKLLRHME- 99
              IG G +G V   +       VAIK I     ++++          L EI + + +  
Sbjct: 25  CEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSL 82

Query: 100 --------HENVIAIKDII-------------------------RPPKKDTFNDVYIVYE 126
                    E  I +  +                            P     + ++IV E
Sbjct: 83  LSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLE 142

Query: 127 LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLK 185
                +       +  +    +  L+QL   L    ++    HRDL   N+LL  +   K
Sbjct: 143 FEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKK 202

Query: 186 IGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 245
           +      ++++                  L ++  +YT +        +  ++   E LF
Sbjct: 203 LHYTLNGKSSTIPSC-------------GLQVSIIDYTLSRLERDGIVVFCDVSMDEDLF 249

Query: 246 PG 247
            G
Sbjct: 250 TG 251

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 71.0 bits (175), Expect = 1e-14
 Identities = 33/90 (36%), Positives = 49/90 (54%), Gaps = 9/90 (10%)

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW-----Y 210
            G+ ++H    +HRD+K +N+LL+ +   KI DFGLAR + +       + +R      Y
Sbjct: 144 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA--QTVMTSRIVGTTAY 201

Query: 211 RAPELLLNCTEYTAAIDIWSVGCILGEIMT 240
            APE L    E T   DI+S G +L EI+T
Sbjct: 202 MAPEALRG--EITPKSDIYSFGVVLLEIIT 229

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 70.1 bits (172), Expect = 3e-14
 Identities = 37/154 (24%), Positives = 64/154 (41%), Gaps = 16/154 (10%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-REIKLLRHMEHENVIA 105
            + IG G +G +    N  T E VAIK      + +      L  E +  + +   +   
Sbjct: 14  GKKIGCGNFGELRLGKNLYTNEYVAIK-----LEPMKSRAPQLHLEYRFYKQLG--SGDG 66

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSA 164
           I  +        +N   +V EL+   L  +    D+  +         QL+  ++YVHS 
Sbjct: 67  IPQVYYFGPCGKYN--AMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK 124

Query: 165 SVLHRDLKPSNLLL-----NASCDLKIGDFGLAR 193
           ++++RD+KP N L+          + I DF LA+
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 65.9 bits (161), Expect = 1e-12
 Identities = 31/165 (18%), Positives = 60/165 (36%), Gaps = 23/165 (13%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHMEHENVI 104
            + IG G +G++  A  +   E+ A    K+        +      E+K  + +  ++ I
Sbjct: 42  GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQ-----ENGPLFSELKFYQRVAKKDCI 96

Query: 105 AIKDIIRPPKKDTFNDVY--------------IVYELMDTDLHQIIRSDQQLTDDHCQYF 150
                 +          Y              +V E +  DL +I   +           
Sbjct: 97  KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQL 156

Query: 151 LYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI--GDFGLAR 193
             ++L  L+Y+H    +H D+K +NLLL      ++   D+GL+ 
Sbjct: 157 GIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 65.5 bits (160), Expect = 1e-12
 Identities = 39/152 (25%), Positives = 68/152 (44%), Gaps = 14/152 (9%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-REIKLLRHMEHENVIA 105
            R IG G++G +    +    EEVAIK      + +      L  E K+ + M+    + 
Sbjct: 14  GRKIGSGSFGDIYLGTDIAAGEEVAIK-----LECVKTKHPQLHIESKIYKMMQ--GGVG 66

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSA 164
           I  I     +  +N   +V EL+   L  +     ++ +         Q++  ++Y+HS 
Sbjct: 67  IPTIRWCGAEGDYN--VMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 124

Query: 165 SVLHRDLKPSNLLLNASCD---LKIGDFGLAR 193
           + +HRD+KP N L+        + I DFGLA+
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 65.3 bits (160), Expect = 1e-12
 Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 16/95 (16%)

Query: 156 RGLKYVHSAS---VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW--- 209
           RGL Y+H      ++HRD+K +N+LL+   +  +GDFGLA+     D    +V T     
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD---THVTTAVRGT 198

Query: 210 --YRAPELLLN--CTEYTAAIDIWSVGCILGEIMT 240
             + APE L     +E T   D++  G +L E++T
Sbjct: 199 IGHIAPEYLSTGKSSEKT---DVFGYGVMLLELIT 230

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 65.4 bits (159), Expect = 2e-12
 Identities = 43/152 (28%), Positives = 72/152 (47%), Gaps = 14/152 (9%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL-REIKLLRHMEHENVIA 105
            R IG G++G +    N +T EEVAIK      +N+      L  E K+ R ++      
Sbjct: 12  GRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLLYESKIYRILQ--GGTG 64

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSA 164
           I ++     +  +N   +V +L+   L  +     ++L+         Q++  +++VHS 
Sbjct: 65  IPNVRWFGVEGDYN--VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122

Query: 165 SVLHRDLKPSNLLLNASCD---LKIGDFGLAR 193
           S LHRD+KP N L+        + I DFGLA+
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 63.9 bits (156), Expect = 4e-12
 Identities = 35/170 (20%), Positives = 71/170 (41%), Gaps = 23/170 (13%)

Query: 31  NVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTL- 89
           NV G  ++V        R IG G++G++    N    ++VAIK     F+        L 
Sbjct: 6   NVVGVHYKV-------GRRIGEGSFGVIFEGTNLLNNQQVAIK-----FEPRRSDAPQLR 53

Query: 90  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQ 148
            E +  + +       I ++    ++   N   +V +L+   L  ++    ++ +     
Sbjct: 54  DEYRTYKLLA--GCTGIPNVYYFGQEGLHN--VLVIDLLGPSLEDLLDLCGRKFSVKTVA 109

Query: 149 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLK-----IGDFGLAR 193
               Q+L  ++ +H  S+++RD+KP N L+            + DFG+ +
Sbjct: 110 MAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 63.8 bits (156), Expect = 5e-12
 Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 21/106 (19%)

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW-----Y 210
           RGL Y+H+ +++HRD+K  N+LL+ +   KI DFG+++  +E D    ++ T       Y
Sbjct: 150 RGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELD--QTHLSTVVKGTLGY 207

Query: 211 RAPELLLNCTEY------TAAIDIWSVGCILGEIMT-REPLFPGKD 249
             P       EY      T   D++S G +L E++  R  +     
Sbjct: 208 IDP-------EYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 55.5 bits (134), Expect = 3e-09
 Identities = 25/179 (13%), Positives = 60/179 (33%), Gaps = 48/179 (26%)

Query: 47  IRPIGRGAYGIVCAAVNSETR--------EEVAIK---KIGNAFDNIIDARRTLR--EIK 93
                R   GI+  A  + T         ++ ++K   K G  F+     +R  +  ++ 
Sbjct: 47  KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVN 106

Query: 94  LLRHMEHENVIAIKDIIRPPK-------KDTFNDVYIVYELMDTDLHQIIRSDQ------ 140
             + +    ++AI      P        +D +   ++V   +   L   +          
Sbjct: 107 KWKKLYSTPLLAI------PTCMGFGVHQDKYR--FLVLPSLGRSLQSALDVSPKHVLSE 158

Query: 141 ----QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI--GDFGLAR 193
               Q+          +LL  L+++H    +H ++   N+ ++     ++    +G A 
Sbjct: 159 RSVLQVAC--------RLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 53.6 bits (129), Expect = 1e-08
 Identities = 34/166 (20%), Positives = 62/166 (37%), Gaps = 22/166 (13%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
             PIG+G +G +  A +  + E V             D      E+K  +       I  
Sbjct: 40  GLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQK 98

Query: 107 KDIIRPPK----------------KDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQY 149
               R  K                  ++   +++ +   +DL +I  +  ++ +      
Sbjct: 99  WIRTRKLKYLGVPKYWGSGLHDKNGKSYR--FMIMDRFGSDLQKIYEANAKRFSRKTVLQ 156

Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI--GDFGLAR 193
              ++L  L+Y+H    +H D+K SNLLLN     ++   D+GLA 
Sbjct: 157 LSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 43.9 bits (104), Expect = 3e-05
 Identities = 26/120 (21%), Positives = 47/120 (39%), Gaps = 18/120 (15%)

Query: 80  DNIIDARRTLREIKLLRHMEHENVIA--IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIR 137
           D  I   RT RE + L  ++   + A  I D+      D  N   ++  +       +I 
Sbjct: 378 DENIRKSRTAREARYLALVKDFGIPAPYIFDV------DLDNKRIMMSYINGKLAKDVIE 431

Query: 138 SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE 197
            +            Y++   +  +H   V+H DL  SN + +    + I DFGL + ++ 
Sbjct: 432 DNLD--------IAYKIGEIVGKLHKNDVIHNDLTTSNFIFDKDLYI-I-DFGLGKISNL 481

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	260
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.87
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.77
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.37
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.23
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.22
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.2
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.91
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.72
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.71
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.53
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.51
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.21
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.17
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.12
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	98.12
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.08
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.74
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.63
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.61
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.52
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.45
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.39
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.3
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.25
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.24
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.22
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.2
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.03
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.46
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.46
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	92.19
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	89.03
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	88.35
2x6h_A	696	GH13170P, VPS34, phosphotidylinositol 3 kinase 59F	83.45

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=7.8e-56  Score=360.40  Aligned_cols=213  Identities=23%  Similarity=0.400  Sum_probs=191.4

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc-cchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      .++|++++.||+|+||+||+|+++.+++.||+|++.+.. ........+.+|+++|++++||||+++++++.++     .
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~  105 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD-----E  105 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----C
Confidence            467889999999999999999999999999999996532 1222356788999999999999999999999887     6


Q ss_pred             cEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          120 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       120 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      .+||||||++ |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       106 ~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          106 KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            6999999998 699999999999999999999999999999999999999999999999999999999999999876432


Q ss_pred             ---cccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          199 ---DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       199 ---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                         ....+.+||+.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+.+++|.+
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~  248 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK  248 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CCcccccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence               23445689999999999987 7889999999999999999999999999999999888864

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=8.2e-55  Score=349.70  Aligned_cols=213  Identities=27%  Similarity=0.491  Sum_probs=175.9

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      ..|++++.||+|+||+||++.++.+++.||+|++..... .......+.+|++++++++||||+++++++..+     +.
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~   87 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK-----DE   87 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-----CE
Confidence            357789999999999999999999999999999965432 223356788999999999999999999999887     66


Q ss_pred             EEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCcc
Q 024959          121 VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  200 (260)
Q Consensus       121 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~  200 (260)
                      +|+||||++|+|.+.+.+.+++++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||+++.......
T Consensus        88 ~~ivmEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~  167 (275)
T 3hyh_A           88 IIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF  167 (275)
T ss_dssp             EEEEEECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred             EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999988776666


Q ss_pred             cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       201 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      ..+.+||+.|+|||.+.+....+.++|||||||++|+|++|..||.+.+..+.++.|.+
T Consensus       168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~  226 (275)
T 3hyh_A          168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN  226 (275)
T ss_dssp             -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc
Confidence            66778999999999998844457899999999999999999999999998888887753

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.4e-54  Score=357.10  Aligned_cols=212  Identities=26%  Similarity=0.476  Sum_probs=185.3

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      +.|++++.||+|+||+||++.++.+++.||||++............+.+|+++|++|+|||||++++++.++     ..+
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~-----~~~   98 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEEN-----GSL   98 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC-----CEE
Confidence            467889999999999999999999999999999977655666778899999999999999999999999877     669


Q ss_pred             EEEEecCC-cchHHHhhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          122 YIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      |||||||+ |+|.+++...  ..+++..++.++.||+.+|+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A           99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence            99999998 6999999754  45799999999999999999999999999999999999999999999999999877654


Q ss_pred             c-ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          199 D-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       199 ~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      . .....+||+.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+.+.+|.+
T Consensus       179 ~~~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~  239 (350)
T 4b9d_A          179 VELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS  239 (350)
T ss_dssp             HHHHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             cccccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc
Confidence            3 2344578999999999988 7899999999999999999999999999999988888753

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.8e-53  Score=356.05  Aligned_cols=218  Identities=62%  Similarity=1.063  Sum_probs=195.0

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC-CCCcc
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFND  120 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~-~~~~~  120 (260)
                      +.|++++.||+|+||+||+|.++.+|+.||||+++...........+.+|+++|+.++|||||++++++..... .....
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            45789999999999999999999999999999998776666677888999999999999999999999876532 23367


Q ss_pred             EEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC--
Q 024959          121 VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET--  198 (260)
Q Consensus       121 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~--  198 (260)
                      +||||||++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....  
T Consensus       134 ~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~  213 (398)
T 4b99_A          134 VYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPA  213 (398)
T ss_dssp             EEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-----
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCcc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999865332  


Q ss_pred             ---cccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          199 ---DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       199 ---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                         ....+.+||+.|+|||.+.+...++.++||||+||++|+|++|..||.+.+..++++.|.+
T Consensus       214 ~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~  277 (398)
T 4b99_A          214 EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMM  277 (398)
T ss_dssp             --CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHH
T ss_pred             ccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence               2334568899999999998866789999999999999999999999999999999998864

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.8e-53  Score=351.42  Aligned_cols=210  Identities=26%  Similarity=0.504  Sum_probs=187.6

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      .++|++++.||+|+||+||+|.++.+++.||||++......  ..+.+.+|+++|+.++|||||++++++..+     +.
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~  145 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DE  145 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CE
Confidence            45688899999999999999999999999999999654322  345678999999999999999999999887     66


Q ss_pred             EEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC-
Q 024959          121 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-  198 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~-  198 (260)
                      +|||||||+ |+|.+++.. .++++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++...... 
T Consensus       146 ~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  224 (346)
T 4fih_A          146 LWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  224 (346)
T ss_dssp             EEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred             EEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence            999999998 588888765 57999999999999999999999999999999999999999999999999999876544 


Q ss_pred             cccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          199 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       199 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      ....+.+||+.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+.++.|.+
T Consensus       225 ~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~  284 (346)
T 4fih_A          225 PRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD  284 (346)
T ss_dssp             CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred             CcccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc
Confidence            34456789999999999877 7899999999999999999999999999999888888753

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=8.7e-54  Score=348.20  Aligned_cols=216  Identities=25%  Similarity=0.445  Sum_probs=183.9

Q ss_pred             EeccccCCCcccccccCceEEEEEEeC---CCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           38 EVSSKYVPPIRPIGRGAYGIVCAAVNS---ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        38 ~~~~~~~~~~~~lg~G~~g~vy~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      ......|++++.||+|+||+||+|++.   .+++.||+|+++...........+.+|++++++++|||||++++++..+ 
T Consensus        20 ~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-   98 (304)
T 3ubd_A           20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTE-   98 (304)
T ss_dssp             CCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEET-
T ss_pred             cCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-
Confidence            344567889999999999999999874   4678999999966533322334677899999999999999999999877 


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                          ..+|+||||++ |+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus        99 ----~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~  174 (304)
T 3ubd_A           99 ----GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK  174 (304)
T ss_dssp             ----TEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEE
T ss_pred             ----CEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccce
Confidence                66999999998 6999999999999999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCC-cccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          194 TTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       194 ~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      ..... ....+.+||+.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+.+..|.+
T Consensus       175 ~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~  240 (304)
T 3ubd_A          175 ESIDHEKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK  240 (304)
T ss_dssp             C-----CCCCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             eccCCCccccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHc
Confidence            65433 33455689999999999987 7899999999999999999999999999999999888764

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.2e-52  Score=336.69  Aligned_cols=209  Identities=25%  Similarity=0.412  Sum_probs=181.4

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      .+++++.+.||+|+||+||+|.++.++..||+|.+..........+.+.+|++++++++|||||++++++..... ....
T Consensus        25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~-~~~~  103 (290)
T 3fpq_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK-GKKC  103 (290)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEET-TEEE
T ss_pred             CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccC-CCcE
Confidence            455567778999999999999999999999999997665566677889999999999999999999999865311 1145


Q ss_pred             EEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCeEecc-CCCEEEeecccccccC
Q 024959          121 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKPSNLLLNA-SCDLKIGDFGLARTTS  196 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~H~di~~~nili~~-~~~~~l~df~~~~~~~  196 (260)
                      +|||||||+ |+|.+++.+...+++..++.++.||++||+|||+++  |+||||||+|||++. ++.+||+|||+++...
T Consensus       104 ~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            899999998 699999999999999999999999999999999998  999999999999974 7899999999997654


Q ss_pred             CCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024959          197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  253 (260)
Q Consensus       197 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~  253 (260)
                      .. ...+.+||+.|+|||.+.+  .++.++|||||||++|+|++|..||.+.+....
T Consensus       184 ~~-~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~  237 (290)
T 3fpq_A          184 AS-FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ  237 (290)
T ss_dssp             TT-SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH
T ss_pred             CC-ccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH
Confidence            43 3456689999999998864  589999999999999999999999987655443

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4e-52  Score=343.20  Aligned_cols=217  Identities=25%  Similarity=0.397  Sum_probs=182.2

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEeC-----CCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeece
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNS-----ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI  109 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~  109 (260)
                      ..+.+...++.+.+.||+|+||+||++..+     .++..||||+++..  .....+.+.+|+++|++++|||||+++++
T Consensus        34 ~~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~  111 (329)
T 4aoj_A           34 CVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGV  111 (329)
T ss_dssp             CSCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             hhcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            456677888889999999999999999865     36788999999754  44566789999999999999999999999


Q ss_pred             ecCCCCCCCccEEEEEecCC-cchHHHhhhC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCC
Q 024959          110 IRPPKKDTFNDVYIVYELMD-TDLHQIIRSD---------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP  173 (260)
Q Consensus       110 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~---------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~  173 (260)
                      +.+.     ..++||||||+ |+|.+++...               .++++.++..++.|++++|+|||+++++||||||
T Consensus       112 ~~~~-----~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp  186 (329)
T 4aoj_A          112 CTEG-----RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLAT  186 (329)
T ss_dssp             ECSS-----SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred             EEEC-----CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccH
Confidence            9877     55999999998 7999998753               3589999999999999999999999999999999


Q ss_pred             CCeEeccCCCEEEeecccccccCCCc---ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCC
Q 024959          174 SNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKD  249 (260)
Q Consensus       174 ~nili~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~  249 (260)
                      +|||++.++.+||+|||+++......   ......+++.|+|||.+.+ ..++.++|||||||++|||+| |+.||.+.+
T Consensus       187 ~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~  265 (329)
T 4aoj_A          187 RNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWYQLS  265 (329)
T ss_dssp             GGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC
T ss_pred             hhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCCCCC
Confidence            99999999999999999998654432   2234567999999999987 789999999999999999999 899999999


Q ss_pred             hHHHHHHhhc
Q 024959          250 YVHQLRLITE  259 (260)
Q Consensus       250 ~~~~~~~i~~  259 (260)
                      ..+.+..|.+
T Consensus       266 ~~~~~~~i~~  275 (329)
T 4aoj_A          266 NTEAIDCITQ  275 (329)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHHc
Confidence            9888877753

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.1e-52  Score=352.98  Aligned_cols=210  Identities=26%  Similarity=0.504  Sum_probs=187.8

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      .++|++++.||+|+||.||+|.++.+++.||||++......  ..+.+.+|+++|+.++|||||+++++|...     +.
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~  222 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DE  222 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEEEEC-----CE
Confidence            46688999999999999999999999999999999654322  345678999999999999999999999887     66


Q ss_pred             EEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC-
Q 024959          121 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-  198 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~-  198 (260)
                      +|||||||+ |+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++...... 
T Consensus       223 ~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~  301 (423)
T 4fie_A          223 LWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  301 (423)
T ss_dssp             EEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred             EEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence            999999998 588887754 56999999999999999999999999999999999999999999999999999876544 


Q ss_pred             cccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          199 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       199 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      ......+||+.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+.++.|.+
T Consensus       302 ~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~  361 (423)
T 4fie_A          302 PRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD  361 (423)
T ss_dssp             CCBCCCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred             ccccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc
Confidence            34456789999999999987 7899999999999999999999999999999988888753

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.3e-52  Score=345.23  Aligned_cols=206  Identities=24%  Similarity=0.353  Sum_probs=179.4

Q ss_pred             ccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCc
Q 024959           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      ...+|++.+.||+|+||+||++.++.+++.||||+++....       ..+|+.+++.++|||||++++++.+.     .
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~-----~  123 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREG-----P  123 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEET-----T
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEEC-----C
Confidence            34567788899999999999999999999999999965422       24699999999999999999999876     5


Q ss_pred             cEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCC-CEEEeecccccccCC
Q 024959          120 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSE  197 (260)
Q Consensus       120 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~-~~~l~df~~~~~~~~  197 (260)
                      .+||||||++ |+|.+++...+.+++..++.++.|++.+|+|||+++|+||||||+|||++.+| .+||+|||+++....
T Consensus       124 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~  203 (336)
T 4g3f_A          124 WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQP  203 (336)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred             EEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence            6999999998 69999999989999999999999999999999999999999999999999987 599999999987654


Q ss_pred             Ccc------cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          198 TDF------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       198 ~~~------~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ...      ....+||+.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+.+.+|.
T Consensus       204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~  269 (336)
T 4g3f_A          204 DGLGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA  269 (336)
T ss_dssp             ----------CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH
T ss_pred             CCcccceecCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH
Confidence            321      123468999999999988 789999999999999999999999999887766666554

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-51  Score=334.90  Aligned_cols=215  Identities=23%  Similarity=0.351  Sum_probs=182.9

Q ss_pred             cceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCC
Q 024959           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (260)
Q Consensus        34 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~  113 (260)
                      ...|++..+.+++.+.||+|+||+||++..+.   .||||+++.........+.+.+|++++++++|||||++++++..+
T Consensus        28 ~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~  104 (307)
T 3omv_A           28 SYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKD  104 (307)
T ss_dssp             -CCCBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             CcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECC
Confidence            35699999999999999999999999998654   589999977666667778899999999999999999999988543


Q ss_pred             CCCCCccEEEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccc
Q 024959          114 KKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (260)
Q Consensus       114 ~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~  191 (260)
                            .++||||||+ |+|.+++.. ..++++.++..++.|+++||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus       105 ------~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGl  178 (307)
T 3omv_A          105 ------NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGL  178 (307)
T ss_dssp             ------SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSS
T ss_pred             ------eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccC
Confidence                  3799999998 699999876 46799999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCC---cccccccccccccccccccCc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          192 ARTTSET---DFMTEYVVTRWYRAPELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       192 ~~~~~~~---~~~~~~~~~~~~~~PE~~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      ++.....   .......||+.|+|||.+...  ..++.++|||||||++|||+||+.||.+.+..+.+..+
T Consensus       179 a~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~  249 (307)
T 3omv_A          179 ATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFM  249 (307)
T ss_dssp             CBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH
T ss_pred             ceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHH
Confidence            9765432   223445789999999998642  46899999999999999999999999987766555443

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.4e-51  Score=335.74  Aligned_cols=215  Identities=27%  Similarity=0.446  Sum_probs=185.6

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeC-----CCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceec
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNS-----ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIR  111 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~  111 (260)
                      ..+...++.+.+.||+|+||+||++.+.     .++..||||+++..  .....+.+.+|+++|++++|||||++++++.
T Consensus         8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~   85 (299)
T 4asz_A            8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCV   85 (299)
T ss_dssp             CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence            3567788889999999999999999875     35788999999764  4455678999999999999999999999998


Q ss_pred             CCCCCCCccEEEEEecCC-cchHHHhhhC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeE
Q 024959          112 PPKKDTFNDVYIVYELMD-TDLHQIIRSD-------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL  177 (260)
Q Consensus       112 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nil  177 (260)
                      ++     +.+++|||||+ |+|.+++...             ..+++.++..++.|++++|+|||+++++||||||+|||
T Consensus        86 ~~-----~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NIL  160 (299)
T 4asz_A           86 EG-----DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCL  160 (299)
T ss_dssp             SS-----SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             eC-----CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEE
Confidence            77     55999999998 7999999753             36999999999999999999999999999999999999


Q ss_pred             eccCCCEEEeecccccccCCCccc---ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 024959          178 LNASCDLKIGDFGLARTTSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQ  253 (260)
Q Consensus       178 i~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~  253 (260)
                      ++.++.+||+|||+++........   ....+++.|+|||.+.+ ..++.++|||||||++|||+| |+.||.+.+..+.
T Consensus       161 l~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~  239 (299)
T 4asz_A          161 VGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV  239 (299)
T ss_dssp             ECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred             ECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            999999999999999865444322   23457899999999987 789999999999999999998 8999999999888


Q ss_pred             HHHhhc
Q 024959          254 LRLITE  259 (260)
Q Consensus       254 ~~~i~~  259 (260)
                      +..|.+
T Consensus       240 ~~~i~~  245 (299)
T 4asz_A          240 IECITQ  245 (299)
T ss_dssp             HHHHHH
T ss_pred             HHHHHc
Confidence            877753

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.6e-50  Score=329.55  Aligned_cols=218  Identities=23%  Similarity=0.379  Sum_probs=185.9

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEeC-----CCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeece
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNS-----ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI  109 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~  109 (260)
                      ...++....+++.+.||+|+||+||+|...     .+++.||||+++... .....+.+.+|+.++++++|||||+++++
T Consensus        19 ~~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~   97 (308)
T 4gt4_A           19 KLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGV   97 (308)
T ss_dssp             CCCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CcccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceE
Confidence            345677777888999999999999999853     467889999997543 23345779999999999999999999999


Q ss_pred             ecCCCCCCCccEEEEEecCC-cchHHHhhhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCC
Q 024959          110 IRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK  172 (260)
Q Consensus       110 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~  172 (260)
                      +..+     ..+++|||||+ |+|.+++...                ..+++..+..++.|++++|+|||+++++|||||
T Consensus        98 ~~~~-----~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK  172 (308)
T 4gt4_A           98 VTKD-----QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLA  172 (308)
T ss_dssp             ECSS-----SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             EEEC-----CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence            9876     55899999998 7999998642                358999999999999999999999999999999


Q ss_pred             CCCeEeccCCCEEEeecccccccCCCc---ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 024959          173 PSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGK  248 (260)
Q Consensus       173 ~~nili~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~  248 (260)
                      |+|||++.++.+||+|||+++......   ......+++.|+|||.+.+ ..++.++|||||||++|||+| |..||.+.
T Consensus       173 ~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~  251 (308)
T 4gt4_A          173 TRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGY  251 (308)
T ss_dssp             GGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTC
T ss_pred             ccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-CCCCccchhhhHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999997654332   2334577999999999987 789999999999999999998 89999999


Q ss_pred             ChHHHHHHhhc
Q 024959          249 DYVHQLRLITE  259 (260)
Q Consensus       249 ~~~~~~~~i~~  259 (260)
                      +..+.++.|.+
T Consensus       252 ~~~~~~~~i~~  262 (308)
T 4gt4_A          252 SNQDVVEMIRN  262 (308)
T ss_dssp             CHHHHHHHHHT
T ss_pred             CHHHHHHHHHc
Confidence            99888887753

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4.2e-49  Score=327.73  Aligned_cols=216  Identities=28%  Similarity=0.459  Sum_probs=184.2

Q ss_pred             ecceeEeccccCCCcccccccCceEEEEEEeCCC-----CeEEEEEecCCcccchHHHHHHHHHHHHHHHcCC-CCeeee
Q 024959           33 YGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSET-----REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH-ENVIAI  106 (260)
Q Consensus        33 ~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~-----~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~iv~~  106 (260)
                      ....||++.+.|++++.||+|+||+||+|.+..+     ++.||+|.++... .......+.+|+++|.+++| ||||++
T Consensus        55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            3467999999999999999999999999987653     3679999997653 34456778999999999975 899999


Q ss_pred             eceecCCCCCCCccEEEEEecCC-cchHHHhhhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q 024959          107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHR  169 (260)
Q Consensus       107 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~  169 (260)
                      +++|....    ..+++|||||+ |+|.+++...                ..+++..+..++.|++++|+|||+++++||
T Consensus       134 ~g~~~~~~----~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHR  209 (353)
T 4ase_A          134 LGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR  209 (353)
T ss_dssp             EEEECCTT----SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             EEEEEecC----CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecC
Confidence            99986542    34899999998 7999999753                348999999999999999999999999999


Q ss_pred             cCCCCCeEeccCCCEEEeecccccccCCCcc---cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCC
Q 024959          170 DLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLF  245 (260)
Q Consensus       170 di~~~nili~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf  245 (260)
                      ||||+|||++.++.+||+|||+++.......   .....+++.|+|||.+.+ ..++.++|||||||++|||+| |..||
T Consensus       210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El~t~G~~Pf  288 (353)
T 4ase_A          210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPY  288 (353)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-CCCCCcccEeehHHHHHHHHhCCCCCC
Confidence            9999999999999999999999987644332   234467899999999987 789999999999999999998 99999


Q ss_pred             CCCChHHHH
Q 024959          246 PGKDYVHQL  254 (260)
Q Consensus       246 ~~~~~~~~~  254 (260)
                      .+.+..+.+
T Consensus       289 ~~~~~~~~~  297 (353)
T 4ase_A          289 PGVKIDEEF  297 (353)
T ss_dssp             TTCCCSHHH
T ss_pred             CCCCHHHHH
Confidence            987754443

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1e-48  Score=319.23  Aligned_cols=201  Identities=28%  Similarity=0.469  Sum_probs=162.0

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC------
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD------  116 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~------  116 (260)
                      +|++++.||+|+||+||+|.++.+++.||||+++... .....+.+.+|+++|++++|||||++++++......      
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            4678899999999999999999999999999996542 344567788999999999999999999998754321      


Q ss_pred             -CCccEEEEEecCC-cchHHHhhhCCC---CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccc
Q 024959          117 -TFNDVYIVYELMD-TDLHQIIRSDQQ---LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (260)
Q Consensus       117 -~~~~~~lv~e~~~-~~l~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~  191 (260)
                       ....+|+||||++ ++|.+++.....   .++..++.++.|+++||+|||++||+||||||+|||++.++.+||+|||+
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGl  164 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGL  164 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCcc
Confidence             1134799999998 699999987654   44566889999999999999999999999999999999999999999999


Q ss_pred             ccccCCCcc-------------cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 024959          192 ARTTSETDF-------------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK  248 (260)
Q Consensus       192 ~~~~~~~~~-------------~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  248 (260)
                      ++.......             ....+||+.|+|||.+.+ ..++.++|||||||++|+|++   ||.+.
T Consensus       165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~~~  230 (299)
T 4g31_A          165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQ  230 (299)
T ss_dssp             C--------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred             ceecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCCCc
Confidence            987654321             123468999999999987 789999999999999999996   88643

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.5e-47  Score=336.34  Aligned_cols=210  Identities=23%  Similarity=0.398  Sum_probs=191.4

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      +.|++++.||+|+||.||+|.++.+|+.||+|++...  .....+.+.+|+++|+.++||||++++++|...     ..+
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~~  229 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD-----NEM  229 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS-----SEE
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc--chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----CEE
Confidence            4678999999999999999999999999999999654  344567788999999999999999999999887     669


Q ss_pred             EEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccC--CCEEEeecccccccCC
Q 024959          122 YIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS--CDLKIGDFGLARTTSE  197 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~--~~~~l~df~~~~~~~~  197 (260)
                      |+|||||. |+|.+++.. ...+++..++.++.||+++|+|||+++|+||||||+|||++.+  +.+||+|||++.....
T Consensus       230 ~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~  309 (573)
T 3uto_A          230 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  309 (573)
T ss_dssp             EEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred             EEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence            99999998 699998865 4689999999999999999999999999999999999999854  8899999999998887


Q ss_pred             CcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          198 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       198 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      .......+||+.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..++++.|.+
T Consensus       310 ~~~~~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~  370 (573)
T 3uto_A          310 KQSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS  370 (573)
T ss_dssp             TSEEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT
T ss_pred             CCceeeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHh
Confidence            777777789999999999988 7889999999999999999999999999999999988864

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.3e-47  Score=337.81  Aligned_cols=206  Identities=24%  Similarity=0.404  Sum_probs=178.2

Q ss_pred             EeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc----cchHHHHHHHHHHHHHHHcCCCCeeeeeceecCC
Q 024959           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF----DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (260)
Q Consensus        38 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~  113 (260)
                      .+..++|++++.||+|+||.||+|+++.+++.||+|++.+..    ...........++.+++.++|||||+++++|.+.
T Consensus       185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~  264 (689)
T 3v5w_A          185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP  264 (689)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred             CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence            455678899999999999999999999999999999995432    1111222223345666777899999999999887


Q ss_pred             CCCCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccc
Q 024959          114 KKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (260)
Q Consensus       114 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~  192 (260)
                           ..+|+||||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++
T Consensus       265 -----~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA  339 (689)
T 3v5w_A          265 -----DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA  339 (689)
T ss_dssp             -----SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             -----CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEeccccee
Confidence                 66999999998 699999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 024959          193 RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  249 (260)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  249 (260)
                      ....... ..+.+||+.|+|||.+.....++.++|+|||||++|+|++|..||.+.+
T Consensus       340 ~~~~~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~  395 (689)
T 3v5w_A          340 CDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK  395 (689)
T ss_dssp             EECSSCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGG
T ss_pred             eecCCCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            8766543 3456899999999999754679999999999999999999999997643

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.5e-47  Score=318.76  Aligned_cols=207  Identities=29%  Similarity=0.455  Sum_probs=175.5

Q ss_pred             cccCCCcccccccCceEEEEEEeC---CCCeEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCCC
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNS---ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~  116 (260)
                      .+.|++.+.||+|+||+||+|.++   .+++.||+|.+....    ...++.+|+++|+.+ +||||+++++++...   
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~---   92 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN---   92 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET---
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC---
Confidence            356789999999999999999875   467889999986542    234577899999998 599999999999877   


Q ss_pred             CCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccC-CCEEEeecccccc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDFGLART  194 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~-~~~~l~df~~~~~  194 (260)
                        +.+|+||||++ ++|.+++.   .+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus        93 --~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~  167 (361)
T 4f9c_A           93 --DHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG  167 (361)
T ss_dssp             --TEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             --CEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence              66999999998 68998874   59999999999999999999999999999999999999876 7999999999975


Q ss_pred             cCCCc-----------------------------ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCC
Q 024959          195 TSETD-----------------------------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF  245 (260)
Q Consensus       195 ~~~~~-----------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf  245 (260)
                      .....                             .....+||+.|+|||.+.+...++.++||||+||++|+|++|+.||
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf  247 (361)
T 4f9c_A          168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF  247 (361)
T ss_dssp             CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred             cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence            54321                             1223468999999999987567899999999999999999999998


Q ss_pred             -CCCChHHHHHHhhc
Q 024959          246 -PGKDYVHQLRLITE  259 (260)
Q Consensus       246 -~~~~~~~~~~~i~~  259 (260)
                       .+.+..+++..|.+
T Consensus       248 ~~~~~~~~~l~~I~~  262 (361)
T 4f9c_A          248 YKASDDLTALAQIMT  262 (361)
T ss_dssp             SCCSSHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHH
Confidence             56677778777753

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.8e-45  Score=304.86  Aligned_cols=212  Identities=24%  Similarity=0.446  Sum_probs=192.0

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      ..|++.+.||+|+||.||++.+..+++.||+|++............+.+|+++++.++||||+++++++...     ...
T Consensus        15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~~   89 (328)
T 3fe3_A           15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETE-----KTL   89 (328)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEE
T ss_pred             CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----CEE
Confidence            456789999999999999999999999999999977655666778889999999999999999999999876     569


Q ss_pred             EEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCcc
Q 024959          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  200 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~  200 (260)
                      ++|||+++ ++|.+++...+++++..++.++.|++.+|+|||++|++|+||||+||+++.++.++|+|||++........
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  169 (328)
T 3fe3_A           90 YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK  169 (328)
T ss_dssp             EEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG
T ss_pred             EEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc
Confidence            99999997 69999998888999999999999999999999999999999999999999999999999999987776666


Q ss_pred             cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       201 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      .....+++.|+|||.+.+....+.++||||||+++|+|++|..||.+.+..+..+.|.
T Consensus       170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~  227 (328)
T 3fe3_A          170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL  227 (328)
T ss_dssp             GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            6677889999999999884444589999999999999999999999999888777664

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=8e-46  Score=303.24  Aligned_cols=198  Identities=24%  Similarity=0.299  Sum_probs=158.8

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      +++.+.+.||+|+||+||++.+  +|+.||||++....   ........|+..+.+++||||+++++++...... ...+
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~-~~~~   76 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGT-WTQL   76 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS-SEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCC-ceEE
Confidence            4566889999999999999987  47899999996532   1222233566666788999999999999765321 1358


Q ss_pred             EEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCCCCCeEeccCCCEEEeecccc
Q 024959          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA--------SVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~--------~i~H~di~~~nili~~~~~~~l~df~~~  192 (260)
                      ||||||++ |+|.+++.. .+++++.+..++.|++++|+|||++        +|+||||||+|||++.++.+||+|||++
T Consensus        77 ~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           77 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            99999998 699998865 4689999999999999999999976        8999999999999999999999999999


Q ss_pred             cccCCCcc-----cccccccccccccccccCcC-----CCCChhhHHHHHHHHHHHHhCCCCCC
Q 024959          193 RTTSETDF-----MTEYVVTRWYRAPELLLNCT-----EYTAAIDIWSVGCILGEIMTREPLFP  246 (260)
Q Consensus       193 ~~~~~~~~-----~~~~~~~~~~~~PE~~~~~~-----~~~~~~Di~slG~~l~~ll~g~~pf~  246 (260)
                      +.......     .....||+.|+|||.+.+..     .++.++|||||||++|||++|..||.
T Consensus       156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~  219 (303)
T 3hmm_A          156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG  219 (303)
T ss_dssp             EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred             ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCC
Confidence            76544322     22347899999999987532     35678999999999999999977654

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.5e-44  Score=309.98  Aligned_cols=222  Identities=47%  Similarity=0.877  Sum_probs=189.4

Q ss_pred             cceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCC
Q 024959           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (260)
Q Consensus        34 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~  113 (260)
                      ...+.+ .+.|++++.||+|+||.||++.+..+++.||||++...........++.+|+++++.++||||+++++++...
T Consensus        55 ~~~~~~-~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  133 (464)
T 3ttj_A           55 DSTFTV-LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ  133 (464)
T ss_dssp             -CEEEE-ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             Ccceee-cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccC
Confidence            344444 4556799999999999999999999999999999987666666778889999999999999999999999765


Q ss_pred             CC-CCCccEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccc
Q 024959          114 KK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (260)
Q Consensus       114 ~~-~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~  192 (260)
                      .. .....+|+|||++++++.+.+..  .+++..++.++.|++.+|+|||+.|++||||||+||+++.++.+||+|||++
T Consensus       134 ~~~~~~~~~~lv~E~~~~~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          134 KTLEEFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             CSTTTCCEEEEEEECCSEEHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             CccccCCeEEEEEeCCCCCHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEee
Confidence            43 23356899999999988887754  5999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          193 RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      .............+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..+++..|.+
T Consensus       212 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~  277 (464)
T 3ttj_A          212 RTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE  277 (464)
T ss_dssp             -----CCCC----CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             eecCCCcccCCCcccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            88776655566788999999999988 6889999999999999999999999999999999888754

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.3e-44  Score=311.21  Aligned_cols=213  Identities=46%  Similarity=0.856  Sum_probs=174.1

Q ss_pred             eeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC
Q 024959           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (260)
Q Consensus        36 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~  115 (260)
                      .|.+. +.|++++.||+|+||+||++.++.+++.||||++............+.+|+++++.++||||+++++++.....
T Consensus        48 ~~~~~-~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  126 (458)
T 3rp9_A           48 DWQIP-DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV  126 (458)
T ss_dssp             SCCSC-TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred             cCccC-CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCc
Confidence            34443 55779999999999999999999999999999997766667777889999999999999999999999977655


Q ss_pred             CCCccEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccccc
Q 024959          116 DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (260)
Q Consensus       116 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~  195 (260)
                      .....+|+|||+++++|.+++.....+++..++.++.||+.+|+|||+.|++||||||+|||++.++.+||+|||++...
T Consensus       127 ~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          127 EKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             TTCCCEEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             ccCceEEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence            55577999999999999999999889999999999999999999999999999999999999999999999999999865


Q ss_pred             CCCc----------------------------ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-------
Q 024959          196 SETD----------------------------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-------  240 (260)
Q Consensus       196 ~~~~----------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-------  240 (260)
                      ....                            ......+|+.|+|||.+.....++.++|||||||++|+|++       
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~  286 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA  286 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence            4321                            12334668999999987665779999999999999999998       


Q ss_pred             ----CCCCCCCCC
Q 024959          241 ----REPLFPGKD  249 (260)
Q Consensus       241 ----g~~pf~~~~  249 (260)
                          |.+||.+.+
T Consensus       287 ~~~~~~p~f~g~~  299 (458)
T 3rp9_A          287 YHADRGPLFPGSS  299 (458)
T ss_dssp             SGGGCCCSCC---
T ss_pred             ccccccccCCCCc
Confidence                788888765

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.8e-44  Score=298.58  Aligned_cols=213  Identities=24%  Similarity=0.422  Sum_probs=187.3

Q ss_pred             ccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCC
Q 024959           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~  118 (260)
                      ..+.|++++.||+|+||.||++.++.+++.||+|++..... .......+.+|+++++.++||||+++++++...     
T Consensus         3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-----   77 (337)
T 1o6l_A            3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----   77 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-----
T ss_pred             ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC-----
Confidence            45677889999999999999999999999999999965321 122345678899999999999999999999877     


Q ss_pred             ccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccC-
Q 024959          119 NDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-  196 (260)
Q Consensus       119 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~-  196 (260)
                      ..+++||||++ ++|.+++.....+++..++.++.||+.+|+|||++|++||||||+||+++.++.++|+|||++.... 
T Consensus        78 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           78 DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            56999999998 5999999888899999999999999999999999999999999999999999999999999998643 


Q ss_pred             CCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       197 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      .........+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+..+.|.
T Consensus       158 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~  218 (337)
T 1o6l_A          158 DGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL  218 (337)
T ss_dssp             TTCCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCCcccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            2334455678999999999987 778999999999999999999999999988887777664

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.5e-44  Score=302.19  Aligned_cols=215  Identities=48%  Similarity=0.907  Sum_probs=180.4

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-CCCeeeeeceecCCCCCCCc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~~~  119 (260)
                      .+.|++++.||+|+||.||++.+..+++.||+|++............+.+|+.+++.+. ||||+++++++.....   .
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---~   84 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND---R   84 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS---S
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC---C
Confidence            34577899999999999999999999999999999776666777888899999999997 9999999999976532   4


Q ss_pred             cEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC-
Q 024959          120 DVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-  198 (260)
Q Consensus       120 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~-  198 (260)
                      .+|+|||+++++|.+.+.. ..+++..+..++.|++.+|+|||+.|++||||||+||+++.++.++|+|||++...... 
T Consensus        85 ~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  163 (388)
T 3oz6_A           85 DVYLVFDYMETDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR  163 (388)
T ss_dssp             CEEEEEECCSEEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred             EEEEEecccCcCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence            6899999999999998876 57999999999999999999999999999999999999999999999999999765321 


Q ss_pred             ---------------------cccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          199 ---------------------DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       199 ---------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                                           .......+++.|+|||.+.+...++.++|||||||++|+|++|..||.+.+..+++..|
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i  243 (388)
T 3oz6_A          164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI  243 (388)
T ss_dssp             CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence                                 11233467999999999987677899999999999999999999999999999998887


Q ss_pred             hc
Q 024959          258 TE  259 (260)
Q Consensus       258 ~~  259 (260)
                      .+
T Consensus       244 ~~  245 (388)
T 3oz6_A          244 IG  245 (388)
T ss_dssp             HH
T ss_pred             HH
Confidence            53

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-43  Score=297.79  Aligned_cols=225  Identities=48%  Similarity=0.902  Sum_probs=190.4

Q ss_pred             eeecceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeecee
Q 024959           31 NVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII  110 (260)
Q Consensus        31 ~~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~  110 (260)
                      ......|++. ..|++++.||+|+||.||++.+..+++.||+|++............+.+|+++++.++||||+++++++
T Consensus        15 ~~~~~~~~~~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~   93 (367)
T 1cm8_A           15 EVTKTAWEVR-AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVF   93 (367)
T ss_dssp             ECSSSEECCB-SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEE
T ss_pred             EecCceeeec-ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeE
Confidence            3445667774 456689999999999999999999999999999977666666778889999999999999999999999


Q ss_pred             cCCCC-CCCccEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeec
Q 024959          111 RPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF  189 (260)
Q Consensus       111 ~~~~~-~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df  189 (260)
                      ..... .....+|+|||+++++|.+++.. ..+++..++.++.|++.+|+|||+.|++|+||||+||+++.++.++|+||
T Consensus        94 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Df  172 (367)
T 1cm8_A           94 TPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDF  172 (367)
T ss_dssp             CSCSSTTTCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred             ecCCccccCceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEee
Confidence            77642 22345799999998899998876 57999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          190 GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      |++......  .....+++.|+|||.+.+...++.++|+|||||++++|++|..||.+.+..+++..|.+
T Consensus       173 g~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~  240 (367)
T 1cm8_A          173 GLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK  240 (367)
T ss_dssp             TTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             ecccccccc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            999876543  33456799999999998767789999999999999999999999999999988888753

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=6.1e-44  Score=299.08  Aligned_cols=213  Identities=26%  Similarity=0.430  Sum_probs=189.6

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccch----HHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI----IDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      .+.|++++.||+|+||.||++.++.+++.||+|++.......    .....+.+|+.+++.++||||+++++++...   
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~---   87 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR---   87 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS---
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC---
Confidence            455778999999999999999999999999999996543221    1246788999999999999999999999876   


Q ss_pred             CCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCC----CEEEeeccc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC----DLKIGDFGL  191 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~----~~~l~df~~  191 (260)
                        ..+++|||+++ ++|.+++.....+++..++.++.||+.+|.|||+.|++|+||+|+||+++.++    .++|+|||+
T Consensus        88 --~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~  165 (361)
T 2yab_A           88 --TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (361)
T ss_dssp             --SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred             --CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence              56999999996 79999998888999999999999999999999999999999999999998876    799999999


Q ss_pred             ccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          192 ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      +.............+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+.+..|.+
T Consensus       166 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~  232 (361)
T 2yab_A          166 AHEIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITA  232 (361)
T ss_dssp             CEECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT
T ss_pred             ceEcCCCCccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            988776655666788999999999987 7789999999999999999999999999998888877753

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.9e-44  Score=301.45  Aligned_cols=215  Identities=23%  Similarity=0.397  Sum_probs=183.0

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~  116 (260)
                      +..+.|++++.||+|+||.||++.++.+++.||+|++..... .......+.+|.++++.+ +||||+++++++...   
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~---   96 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP---   96 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS---
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC---
Confidence            445677889999999999999999999999999999965321 222345677899999988 699999999999877   


Q ss_pred             CCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccccc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~  195 (260)
                        ..+|+||||++ ++|.+++.....+++..++.++.||+.+|+|||++|++||||||+||+++.++.++|+|||+++..
T Consensus        97 --~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A           97 --DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             --SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             --CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence              56999999998 599999998899999999999999999999999999999999999999999999999999999864


Q ss_pred             CC-CcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          196 SE-TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       196 ~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      .. .......++++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+.++.|.+
T Consensus       175 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~  238 (353)
T 3txo_A          175 ICNGVTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN  238 (353)
T ss_dssp             CC---------CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             ccCCccccccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence            33 233445678999999999977 6789999999999999999999999999999888888753

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.3e-43  Score=297.60  Aligned_cols=212  Identities=28%  Similarity=0.474  Sum_probs=190.1

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      .+.|++.+.||+|+||.||++.++.++..||+|++............+.+|+++++.++||||+++++++...     ..
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~  102 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-----SF  102 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----CE
Confidence            4557789999999999999999999999999999976655556677888999999999999999999999877     56


Q ss_pred             EEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccC---CCEEEeecccccccC
Q 024959          121 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTS  196 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~---~~~~l~df~~~~~~~  196 (260)
                      .++|||++. ++|.+.+.....+++..++.++.|++++|.|||++|++|+||+|+||+++.+   +.++|+|||++....
T Consensus       103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~  182 (362)
T 2bdw_A          103 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  182 (362)
T ss_dssp             EEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred             EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence            899999998 5999999888899999999999999999999999999999999999999765   459999999998877


Q ss_pred             CCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       197 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      .........+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+.+..|.
T Consensus       183 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~  243 (362)
T 2bdw_A          183 DSEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK  243 (362)
T ss_dssp             TCCSCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCcccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            6655556678999999999987 678999999999999999999999999988877777664

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.3e-43  Score=302.64  Aligned_cols=214  Identities=44%  Similarity=0.805  Sum_probs=184.2

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      +.+.+ .+.|++++.||+|+||.||++.++.+++.||||++............+.+|+++++.++||||+++++++....
T Consensus        20 ~~~~i-~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~   98 (432)
T 3n9x_A           20 KNVHV-PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDD   98 (432)
T ss_dssp             GGCCC-CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred             Cccee-cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence            34445 34556899999999999999999999999999999877667777888999999999999999999999998776


Q ss_pred             CCCCccEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          115 KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                      ......+|+|||+++++|.+++.....+++..++.++.||+.+|+|||+.|++||||||+||+++.++.+||+|||++..
T Consensus        99 ~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A           99 LLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             TTTCCCEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             CCcCCeEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence            55556799999999999999999988999999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCcc-----------------------cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-----------
Q 024959          195 TSETDF-----------------------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-----------  240 (260)
Q Consensus       195 ~~~~~~-----------------------~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-----------  240 (260)
                      ......                       .....+++.|+|||.+.....++.++|||||||++|+|++           
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~  258 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN  258 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence            654321                       2455779999999997665789999999999999999997           


Q ss_pred             CCCCCCCCC
Q 024959          241 REPLFPGKD  249 (260)
Q Consensus       241 g~~pf~~~~  249 (260)
                      |.++|.+.+
T Consensus       259 ~~p~f~g~~  267 (432)
T 3n9x_A          259 RFPLFPGSS  267 (432)
T ss_dssp             CCCSCCCSC
T ss_pred             ccccCCCcc
Confidence            566666654

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.1e-43  Score=288.04  Aligned_cols=212  Identities=39%  Similarity=0.692  Sum_probs=185.8

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      +.|++++.||+|++|+||++.++.+++.||+|++............+.+|++++++++||||+++++++...     ..+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~   76 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC-----CEE
Confidence            356789999999999999999999999999999976655555667888999999999999999999999876     569


Q ss_pred             EEEEecCCcchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC-c
Q 024959          122 YIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-D  199 (260)
Q Consensus       122 ~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~-~  199 (260)
                      ++|||++++++.+.+.. ...+++..++.++.|++.+|++||++|++|+||||+||+++.++.++|+|||++...... .
T Consensus        77 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  156 (292)
T 3o0g_A           77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred             EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence            99999999988887766 678999999999999999999999999999999999999999999999999999876543 2


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHhh
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGKDYVHQLRLIT  258 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~p-f~~~~~~~~~~~i~  258 (260)
                      ......+++.|+|||.+.+...++.++||||||+++|+|++|..| |.+.+..+.++.|.
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~  216 (292)
T 3o0g_A          157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF  216 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHH
T ss_pred             cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHH
Confidence            334456789999999998756689999999999999999987666 77777777777664

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.8e-43  Score=290.95  Aligned_cols=212  Identities=39%  Similarity=0.710  Sum_probs=180.5

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      .+.|++++.||+|+||+||++.+.. ++.||+|++............+.+|+++++.++||||+++++++...     ..
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~   93 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE-----RC   93 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS-----SC
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC-----CE
Confidence            3456678999999999999999864 88999999976544444557788999999999999999999999876     55


Q ss_pred             EEEEEecCCcchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC-
Q 024959          121 VYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-  198 (260)
Q Consensus       121 ~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~-  198 (260)
                      .++|||+++++|.+.+... ..+++..++.++.|++.+|+|||++|++|+||||+||+++.++.++|+|||++...... 
T Consensus        94 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  173 (311)
T 3niz_A           94 LTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV  173 (311)
T ss_dssp             EEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred             EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence            8999999999999888764 45999999999999999999999999999999999999999999999999999876543 


Q ss_pred             cccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          199 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       199 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      .......+++.|+|||.+.+...++.++||||||+++|+|++|..||.+.+..+.+..|.
T Consensus       174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  233 (311)
T 3niz_A          174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIF  233 (311)
T ss_dssp             C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHH
T ss_pred             ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            233345679999999999875678999999999999999999999999988877777664

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.6e-43  Score=291.99  Aligned_cols=212  Identities=41%  Similarity=0.743  Sum_probs=172.5

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      ...|++++.||+|+||.||++.++.+++.||+|.+..... ......+.+|+++++.++||||+++++++...     +.
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~   77 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTE-----NK   77 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCT-----TE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEEC-----Ce
Confidence            4567899999999999999999999999999999865432 22335677899999999999999999999876     56


Q ss_pred             EEEEEecCCcchHHHhhhC------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          121 VYIVYELMDTDLHQIIRSD------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       121 ~~lv~e~~~~~l~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                      .++|||+++++|.+++...      ..+++..++.++.|++++|.|||++|++|+||||+||+++.++.++|+|||++..
T Consensus        78 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~  157 (317)
T 2pmi_A           78 LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARA  157 (317)
T ss_dssp             EEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence            9999999999999988653      4589999999999999999999999999999999999999999999999999987


Q ss_pred             cCCC-cccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          195 TSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       195 ~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      .... .......+++.|+|||.+.+...++.++||||||+++|+|++|..||.+.+..++++.|.
T Consensus       158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~  222 (317)
T 2pmi_A          158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIF  222 (317)
T ss_dssp             TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            6543 233445679999999999875678999999999999999999999999999988887764

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=8.2e-44  Score=295.23  Aligned_cols=213  Identities=38%  Similarity=0.692  Sum_probs=178.6

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      .+.|++++.||+|++|.||++.+..+++.||+|++............+.+|+++++.++||||+++++++...     ..
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~  107 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN-----HR  107 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET-----TE
T ss_pred             hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC-----CE
Confidence            4567789999999999999999999999999999976655555566778999999999999999999999877     56


Q ss_pred             EEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec-----cCCCEEEeeccccccc
Q 024959          121 VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN-----ASCDLKIGDFGLARTT  195 (260)
Q Consensus       121 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~-----~~~~~~l~df~~~~~~  195 (260)
                      +++|||+++++|.+++.....+++..++.++.|++.+|+|||++|++|+||||+||+++     .++.++|+|||++...
T Consensus       108 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~  187 (329)
T 3gbz_A          108 LHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF  187 (329)
T ss_dssp             EEEEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence            99999999999999999999999999999999999999999999999999999999994     4455999999999765


Q ss_pred             CCC-cccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          196 SET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       196 ~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ... .......+++.|+|||.+.+...++.++||||||+++|+|++|..||.+.+..+.+..|.
T Consensus       188 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~  251 (329)
T 3gbz_A          188 GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIF  251 (329)
T ss_dssp             C-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHH
Confidence            533 233344668999999999875668999999999999999999999999999888887764

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=9.9e-44  Score=299.64  Aligned_cols=213  Identities=23%  Similarity=0.474  Sum_probs=185.9

Q ss_pred             eecceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc-cchHHHHHHHHHHHHHHHcCCCCeeeeecee
Q 024959           32 VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDII  110 (260)
Q Consensus        32 ~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~  110 (260)
                      ++.....+..+.|++++.||+|+||.||++.++.+++.||+|++.... ........+.+|+++++.++||||+++++++
T Consensus         5 ~~~~~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~   84 (384)
T 4fr4_A            5 VFDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF   84 (384)
T ss_dssp             ---CCCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ccCCCCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            344555677788899999999999999999999999999999985432 1122346778999999999999999999999


Q ss_pred             cCCCCCCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeec
Q 024959          111 RPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF  189 (260)
Q Consensus       111 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df  189 (260)
                      ...     ..+++|||++. ++|.+++.....+++..++.++.|++.+|.|||++|++|+||||+||+++.++.++|+||
T Consensus        85 ~~~-----~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DF  159 (384)
T 4fr4_A           85 QDE-----EDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDF  159 (384)
T ss_dssp             ECS-----SEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred             EeC-----CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEecc
Confidence            877     56999999997 699999998889999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcccccccccccccccccccCc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 024959          190 GLARTTSETDFMTEYVVTRWYRAPELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKD  249 (260)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  249 (260)
                      |++.............+++.|+|||.+...  ..++.++|+||||+++|+|++|..||...+
T Consensus       160 G~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~  221 (384)
T 4fr4_A          160 NIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS  221 (384)
T ss_dssp             TTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCT
T ss_pred             ceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCC
Confidence            999887766666677899999999998742  457899999999999999999999997543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4.7e-43  Score=288.01  Aligned_cols=220  Identities=37%  Similarity=0.639  Sum_probs=184.4

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccc---hHHHHHHHHHHHHHHHc---CCCCeeeeeceecC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN---IIDARRTLREIKLLRHM---EHENVIAIKDIIRP  112 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l---~~~~iv~~~~~~~~  112 (260)
                      +....|++++.||+|+||+||++.+..+++.||+|++......   ......+.+|+++++.+   +||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            3456788999999999999999999999999999998543211   11123344566666555   59999999999987


Q ss_pred             CCCCCCccEEEEEecCCcchHHHhhhCCC--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecc
Q 024959          113 PKKDTFNDVYIVYELMDTDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG  190 (260)
Q Consensus       113 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~  190 (260)
                      .........+++||+++++|.+++.....  +++..++.++.|++++|+|||+++++|+||||+||+++.++.++|+|||
T Consensus        86 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg  165 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG  165 (308)
T ss_dssp             CCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred             cCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCc
Confidence            65433346899999999999999987654  9999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          191 LARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      ++.............+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+.+..|.+
T Consensus       166 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~  233 (308)
T 3g33_A          166 LARIYSYQMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD  233 (308)
T ss_dssp             CTTTSTTCCCSGGGGCCCSSCCHHHHHT-SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHH
T ss_pred             cccccCCCcccCCccccccccCchHHcC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            9987766665666788999999999987 7789999999999999999999999999999888887753

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.9e-44  Score=299.31  Aligned_cols=207  Identities=28%  Similarity=0.467  Sum_probs=182.4

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccc-hHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN-IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      ..|.+.+.||+|+||.||++.+..+++.||+|++...... ......+.+|+++++.++||||+++++++...     ..
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~   83 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP-----TD   83 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----CE
Confidence            4567899999999999999999999999999998543211 11234678999999999999999999999887     56


Q ss_pred             EEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCcc
Q 024959          121 VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  200 (260)
Q Consensus       121 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~  200 (260)
                      .++||||++++|.+.+.....+++..++.++.|++++|.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus        84 ~~lv~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~  163 (336)
T 3h4j_B           84 IVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF  163 (336)
T ss_dssp             EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT
T ss_pred             EEEEEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc
Confidence            99999999999999999889999999999999999999999999999999999999999999999999999988777666


Q ss_pred             cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024959          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  253 (260)
Q Consensus       201 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~  253 (260)
                      .....+++.|+|||.+.+....++++||||||+++|+|++|..||.+.+..+.
T Consensus       164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~  216 (336)
T 3h4j_B          164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL  216 (336)
T ss_dssp             TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC
T ss_pred             cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH
Confidence            66778899999999998744447899999999999999999999987655443

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.1e-43  Score=296.65  Aligned_cols=220  Identities=23%  Similarity=0.370  Sum_probs=187.2

Q ss_pred             cceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHc-CCCCeeeeeceec
Q 024959           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHM-EHENVIAIKDIIR  111 (260)
Q Consensus        34 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~  111 (260)
                      .+.-.+....|++++.||+|+||.||++.++.+++.||+|++..... .......+..|.+++..+ +||+|+++++++.
T Consensus        12 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~   91 (353)
T 2i0e_A           12 GNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ   91 (353)
T ss_dssp             -------CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE
T ss_pred             CCcCCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE
Confidence            34445667788899999999999999999999999999999965321 112345677899999887 7999999999998


Q ss_pred             CCCCCCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecc
Q 024959          112 PPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG  190 (260)
Q Consensus       112 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~  190 (260)
                      ..     ..+|+||||++ ++|.+++.....+++..++.++.|++.+|+|||++|++||||||+||+++.++.++|+|||
T Consensus        92 ~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG  166 (353)
T 2i0e_A           92 TM-----DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG  166 (353)
T ss_dssp             CS-----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             cC-----CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCC
Confidence            76     56999999997 5999999988899999999999999999999999999999999999999999999999999


Q ss_pred             cccccCC-CcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          191 LARTTSE-TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       191 ~~~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      ++..... ........+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+..+.|.+
T Consensus       167 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~  235 (353)
T 2i0e_A          167 MCKENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME  235 (353)
T ss_dssp             TCBCCCCTTCCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             cccccccCCcccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Confidence            9986432 334455678999999999987 7789999999999999999999999999998888877753

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.8e-43  Score=300.88  Aligned_cols=212  Identities=25%  Similarity=0.426  Sum_probs=187.0

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      .+.|++.+.||+|+||.||++.++.+++.+|+|++............+.+|+++++.++||||+++++++...     ..
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~   84 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEE-----GH   84 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS-----SE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC-----CE
Confidence            3456788999999999999999999999999999976655555677888999999999999999999999877     66


Q ss_pred             EEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec---cCCCEEEeecccccccC
Q 024959          121 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN---ASCDLKIGDFGLARTTS  196 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~---~~~~~~l~df~~~~~~~  196 (260)
                      .++|||++. ++|.+.+.....+++..+..++.||+++|.|||++|++|+||||+||+++   .++.++|+|||++....
T Consensus        85 ~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           85 HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             EEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence            999999997 59999999999999999999999999999999999999999999999998   45789999999997765


Q ss_pred             CCc-ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          197 ETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       197 ~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+.++.|.
T Consensus       165 ~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~  226 (444)
T 3soa_A          165 GEQQAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIK  226 (444)
T ss_dssp             TTCCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             CCCceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence            443 2345678999999999987 678999999999999999999999999998888877765

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.3e-43  Score=293.87  Aligned_cols=215  Identities=26%  Similarity=0.412  Sum_probs=186.0

Q ss_pred             EeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCC
Q 024959           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKK  115 (260)
Q Consensus        38 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~  115 (260)
                      .+..+.|++.+.||+|+||.||++.++.+++.||+|+++.... .......+..|.++++.+ +||||+++++++...  
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~--   90 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK--   90 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC--
Confidence            4556778889999999999999999999999999999965321 112345567888888877 899999999999876  


Q ss_pred             CCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          116 DTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       116 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                         ..+|+||||++ ++|.+++.....+++..++.++.|++.+|+|||++|++||||||+||+++.++.++|+|||++..
T Consensus        91 ---~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           91 ---ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             ---SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             ---CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence               56999999997 69999999888999999999999999999999999999999999999999999999999999976


Q ss_pred             cCC-CcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          195 TSE-TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       195 ~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ... ........+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+.++.|.
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~  231 (345)
T 1xjd_A          168 NMLGDAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR  231 (345)
T ss_dssp             CCCTTCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             cccCCCcccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            432 233455678999999999987 778999999999999999999999999999888877764

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-43  Score=291.52  Aligned_cols=211  Identities=23%  Similarity=0.424  Sum_probs=186.5

Q ss_pred             ccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCC
Q 024959           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~  118 (260)
                      ..+.|++++.||+|+||.||++.++.+++.||+|++..... .......+.+|..+++.++||||+++++++...     
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-----   78 (318)
T 1fot_A            4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA-----   78 (318)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS-----
T ss_pred             ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC-----
Confidence            34667889999999999999999999999999999965321 112345677899999999999999999999876     


Q ss_pred             ccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCC
Q 024959          119 NDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (260)
Q Consensus       119 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~  197 (260)
                      ..+|+||||++ ++|.+++.....+++..++.++.|++.+|++||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus        79 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           79 QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             CEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            56999999998 59999999989999999999999999999999999999999999999999999999999999987654


Q ss_pred             CcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          198 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       198 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      .  .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+..+.|.
T Consensus       159 ~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~  216 (318)
T 1fot_A          159 V--TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL  216 (318)
T ss_dssp             C--BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             c--cccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            3  334578999999999987 778999999999999999999999999998888877765

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=5.6e-43  Score=294.13  Aligned_cols=225  Identities=53%  Similarity=0.993  Sum_probs=178.5

Q ss_pred             eeecceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeecee
Q 024959           31 NVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII  110 (260)
Q Consensus        31 ~~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~  110 (260)
                      ..-+..|++.. .|++++.||+|+||.||++.+..+++.||+|++............+.+|+++++.++||||+++++++
T Consensus        19 ~~~~~~~~~~~-~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~   97 (367)
T 2fst_X           19 ELNKTIWEVPE-RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF   97 (367)
T ss_dssp             EETTEEEEEET-TEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             eecCcccCCCC-ceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            34456777764 46699999999999999999999999999999977666666778889999999999999999999998


Q ss_pred             cCCCC-CCCccEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeec
Q 024959          111 RPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF  189 (260)
Q Consensus       111 ~~~~~-~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df  189 (260)
                      ..... .....+++++|+++++|.+++.. ..+++..++.++.||+++|+|||+.|++|+||||+||+++.++.++|+||
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DF  176 (367)
T 2fst_X           98 TPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDF  176 (367)
T ss_dssp             CSCSSGGGCCCCEEEEECCCEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-
T ss_pred             ecCCccccCCeEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeec
Confidence            76532 22255899999999999888765 67999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          190 GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      |++......  .....+++.|+|||.+.+...++.++|||||||++|+|++|..||.+.+..+++..|.+
T Consensus       177 G~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~  244 (367)
T 2fst_X          177 GLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR  244 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             ccccccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            999765433  33456789999999998767789999999999999999999999999999888887754

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.8e-43  Score=287.96  Aligned_cols=210  Identities=40%  Similarity=0.693  Sum_probs=180.1

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~  122 (260)
                      .|++++.||+|+||.||++.+ .+++.+|+|++............+.+|+++++.++||||+++++++...     ...+
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~   76 (288)
T 1ob3_A            3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRLV   76 (288)
T ss_dssp             SEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCEE
T ss_pred             cchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC-----CeEE
Confidence            467889999999999999998 6688999999966544333446678999999999999999999999876     5599


Q ss_pred             EEEecCCcchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC-cc
Q 024959          123 IVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DF  200 (260)
Q Consensus       123 lv~e~~~~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~-~~  200 (260)
                      +|||+++++|.+++... ..+++..++.++.|++++|+|||++|++|+||+|+||+++.++.++|+|||++...... ..
T Consensus        77 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  156 (288)
T 1ob3_A           77 LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK  156 (288)
T ss_dssp             EEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             EEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccc
Confidence            99999999999998764 67999999999999999999999999999999999999999999999999998765433 22


Q ss_pred             cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       201 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      .....+++.|+|||.+.+...++.++||||||+++|+|++|..||.+.+..+.+..|.
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~  214 (288)
T 1ob3_A          157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF  214 (288)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            3344678999999999775678999999999999999999999999998888777664

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.8e-43  Score=297.35  Aligned_cols=215  Identities=21%  Similarity=0.419  Sum_probs=179.8

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHH-HHHcCCCCeeeeeceecCCCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKL-LRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~-l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      +....|++++.||+|+||.||++.++.+++.||+|++..... .......+.+|..+ ++.++||||+++++.+...   
T Consensus        35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~---  111 (373)
T 2r5t_A           35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA---  111 (373)
T ss_dssp             CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS---
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC---
Confidence            345678889999999999999999999999999999965432 22234455666665 5677899999999999877   


Q ss_pred             CCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccccc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~  195 (260)
                        ..+|+||||++ ++|.+++.....+++..++.++.||+.+|+|||++|++||||||+||+++.++.++|+|||+++..
T Consensus       112 --~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~  189 (373)
T 2r5t_A          112 --DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN  189 (373)
T ss_dssp             --SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred             --CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence              56999999998 599999998889999999999999999999999999999999999999999999999999999763


Q ss_pred             C-CCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          196 S-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       196 ~-~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      . .........+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+..+.|.+
T Consensus       190 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~  253 (373)
T 2r5t_A          190 IEHNSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN  253 (373)
T ss_dssp             BCCCCCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHH
T ss_pred             ccCCCccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Confidence            3 3334456678999999999987 7789999999999999999999999999998888887753

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.5e-42  Score=292.13  Aligned_cols=216  Identities=48%  Similarity=0.865  Sum_probs=180.3

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC-CCCc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFN  119 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~-~~~~  119 (260)
                      .+.|++++.||+|+||.||++.+..+++.||+|++............+.+|+.+++.++||||+++++++..... ....
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            455778999999999999999999999999999997665566667788899999999999999999999976542 2234


Q ss_pred             cEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc
Q 024959          120 DVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (260)
Q Consensus       120 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~  199 (260)
                      ..++|||+++++|.+.+.  ..+++..+..++.|++.+|+|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus       104 ~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~  181 (371)
T 2xrw_A          104 DVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF  181 (371)
T ss_dssp             EEEEEEECCSEEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC--------
T ss_pred             ceEEEEEcCCCCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccccc
Confidence            689999999999998886  468999999999999999999999999999999999999999999999999998776554


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+++..|.+
T Consensus       182 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~  240 (371)
T 2xrw_A          182 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE  240 (371)
T ss_dssp             --------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC
T ss_pred             ccCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            4555678999999999987 6789999999999999999999999999999888877653

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.9e-43  Score=289.71  Aligned_cols=212  Identities=26%  Similarity=0.435  Sum_probs=187.4

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccch----HHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI----IDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      .+.|.+.+.||+|+||.||++.++.++..||+|++.......    .....+.+|+.+++.++||||+++++++...   
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~---   86 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK---   86 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS---
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC---
Confidence            345778999999999999999999999999999986543211    1356788999999999999999999999876   


Q ss_pred             CCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCC----CEEEeeccc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC----DLKIGDFGL  191 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~----~~~l~df~~  191 (260)
                        ...++|||+++ ++|.+++.....+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++    .++|+|||+
T Consensus        87 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  164 (326)
T 2y0a_A           87 --TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  164 (326)
T ss_dssp             --SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred             --CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence              56999999997 69999998888999999999999999999999999999999999999998877    799999999


Q ss_pred             ccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          192 ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      +.............+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+.+..+.
T Consensus       165 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~  230 (326)
T 2y0a_A          165 AHKIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS  230 (326)
T ss_dssp             CEECCTTSCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred             CeECCCCCccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH
Confidence            988766555556678999999999977 778999999999999999999999999988877776654

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=4.6e-43  Score=296.55  Aligned_cols=206  Identities=22%  Similarity=0.415  Sum_probs=179.0

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCC
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPK  114 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~  114 (260)
                      ..+..+.|++++.||+|+||.||++.++.+++.||+|+++.... .......+.+|..+++++ +||||+++++++... 
T Consensus        47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~-  125 (396)
T 4dc2_A           47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-  125 (396)
T ss_dssp             --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS-
T ss_pred             cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC-
Confidence            34566778899999999999999999999999999999975432 222345577899999887 799999999999877 


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                          ..+++||||++ ++|..++.....+++..++.++.||+.+|+|||++|++||||||+||+++.++.++|+|||+++
T Consensus       126 ----~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~  201 (396)
T 4dc2_A          126 ----SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK  201 (396)
T ss_dssp             ----SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             ----CEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceee
Confidence                56999999998 5999999988899999999999999999999999999999999999999999999999999998


Q ss_pred             cc-CCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 024959          194 TT-SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK  248 (260)
Q Consensus       194 ~~-~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  248 (260)
                      .. .........++++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...
T Consensus       202 ~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~  256 (396)
T 4dc2_A          202 EGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIV  256 (396)
T ss_dssp             CCCCTTCCBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred             ecccCCCccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence            63 33344556688999999999988 78899999999999999999999999643

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1e-42  Score=290.24  Aligned_cols=203  Identities=23%  Similarity=0.425  Sum_probs=179.9

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~  116 (260)
                      +..+.|++++.||+|+||.||++.++.+++.||+|++..... .......+.+|..+++.+ +||||+++++++...   
T Consensus         6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~---   82 (345)
T 3a8x_A            6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE---   82 (345)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS---
T ss_pred             CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC---
Confidence            345678889999999999999999999999999999975432 344566778899999988 799999999999876   


Q ss_pred             CCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccccc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~  195 (260)
                        ..+|+|||+++ ++|.+++.....+++..++.++.|++.+|+|||++|++||||||+||+++.++.++|+|||++...
T Consensus        83 --~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~  160 (345)
T 3a8x_A           83 --SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  160 (345)
T ss_dssp             --SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred             --CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence              56999999997 599999988889999999999999999999999999999999999999999999999999999864


Q ss_pred             C-CCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 024959          196 S-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG  247 (260)
Q Consensus       196 ~-~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~  247 (260)
                      . .........+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||..
T Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~  212 (345)
T 3a8x_A          161 LRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDI  212 (345)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             cCCCCcccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence            3 2334455678999999999987 7789999999999999999999999975

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-43  Score=288.72  Aligned_cols=208  Identities=22%  Similarity=0.388  Sum_probs=186.0

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      +.|++.+.||+|+||.||++.+..+++.+++|.+...   ......+.+|+++++.++||||+++++++...     ..+
T Consensus         5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~   76 (321)
T 1tki_A            5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESM-----EEL   76 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEET-----TEE
T ss_pred             hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecC-----CEE
Confidence            4567899999999999999999999999999999653   23456678999999999999999999999876     569


Q ss_pred             EEEEecCC-cchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecc--CCCEEEeecccccccCC
Q 024959          122 YIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA--SCDLKIGDFGLARTTSE  197 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~--~~~~~l~df~~~~~~~~  197 (260)
                      ++|||+++ ++|.+++... ..+++..++.++.|++++|.|||++|++|+||+|+||+++.  ++.++|+|||++.....
T Consensus        77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~  156 (321)
T 1tki_A           77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence            99999998 5999998765 47999999999999999999999999999999999999987  78999999999988776


Q ss_pred             CcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          198 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       198 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ........+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+.++.|.
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  216 (321)
T 1tki_A          157 GDNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM  216 (321)
T ss_dssp             TCEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             CCccccccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH
Confidence            666666778999999999987 667899999999999999999999999998888777765

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.1e-42  Score=284.47  Aligned_cols=209  Identities=26%  Similarity=0.465  Sum_probs=182.6

Q ss_pred             ccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCc
Q 024959           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      ..+.|++.+.||+|+||.||++.+..+++.||+|.+......  ....+.+|+.+++.++||||+++++++...     .
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~   90 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVG-----D   90 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----T
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--HHHHHHHHHHHHhcCCCCCCCeEeEEEEEC-----C
Confidence            356688999999999999999999999999999998654332  345678999999999999999999999876     5


Q ss_pred             cEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          120 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       120 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      .+++|||+++ ++|.+++... .+++..++.++.|++.+|+|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus        91 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (297)
T 3fxz_A           91 ELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (297)
T ss_dssp             EEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence            6899999996 6898887664 6999999999999999999999999999999999999999999999999998776544


Q ss_pred             c-ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          199 D-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       199 ~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      . ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+.......+
T Consensus       170 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~  228 (297)
T 3fxz_A          170 QSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI  228 (297)
T ss_dssp             TCCBCCCCSCGGGCCHHHHHC-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             ccccCCccCCcCccChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            3 2334578999999999987 77899999999999999999999999988877665544

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.1e-43  Score=302.19  Aligned_cols=217  Identities=22%  Similarity=0.372  Sum_probs=187.4

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~  115 (260)
                      ..+..+.|++++.||+|+||.||++.++.+++.||+|++..... .......+.+|..++..++||||+++++++...  
T Consensus        69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~--  146 (437)
T 4aw2_A           69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD--  146 (437)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS--
T ss_pred             ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC--
Confidence            34566788899999999999999999999999999999954211 111123377899999999999999999999887  


Q ss_pred             CCCccEEEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          116 DTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       116 ~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                         ..+|+||||++ ++|.+++.. ...+++..++.++.|++.+|+|||+++++||||||+||+++.++.+||+|||++.
T Consensus       147 ---~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~  223 (437)
T 4aw2_A          147 ---NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCL  223 (437)
T ss_dssp             ---SEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             ---CEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhh
Confidence               56999999996 699999987 5789999999999999999999999999999999999999999999999999997


Q ss_pred             ccCCCccc--cccccccccccccccc----CcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          194 TTSETDFM--TEYVVTRWYRAPELLL----NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       194 ~~~~~~~~--~~~~~~~~~~~PE~~~----~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ........  ....+++.|+|||.+.    +...++.++|+||||+++|+|++|..||.+.+..+...+|.
T Consensus       224 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~  294 (437)
T 4aw2_A          224 KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM  294 (437)
T ss_dssp             ECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             hcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhh
Confidence            76544322  3357899999999986    23568999999999999999999999999999988888875

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=4.1e-43  Score=293.11  Aligned_cols=212  Identities=22%  Similarity=0.425  Sum_probs=187.8

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~  117 (260)
                      .....|++++.||+|+||.||++.++.+++.||+|++..... .......+.+|+++++.++||||+++++++...    
T Consensus        38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----  113 (350)
T 1rdq_E           38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN----  113 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS----
T ss_pred             CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC----
Confidence            445678889999999999999999999999999999854321 112346678899999999999999999999876    


Q ss_pred             CccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccC
Q 024959          118 FNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (260)
Q Consensus       118 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~  196 (260)
                       ..+|+||||++ ++|.+++.....+++..++.++.||+.+|+|||++|++||||+|+||+++.++.++|+|||++....
T Consensus       114 -~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~  192 (350)
T 1rdq_E          114 -SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK  192 (350)
T ss_dssp             -SEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             -CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceecc
Confidence             56999999997 6999999988899999999999999999999999999999999999999999999999999998765


Q ss_pred             CCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       197 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ..  .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+..+.|.
T Consensus       193 ~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~  251 (350)
T 1rdq_E          193 GR--TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV  251 (350)
T ss_dssp             SC--BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CC--cccccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHH
Confidence            43  334578999999999987 778999999999999999999999999999888887765

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.1e-43  Score=301.84  Aligned_cols=217  Identities=25%  Similarity=0.383  Sum_probs=186.3

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~  115 (260)
                      +.+....|++++.||+|+||.||++.++.+++.||+|++..... .......+.+|+.+++.++||||+++++++...  
T Consensus        64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--  141 (410)
T 3v8s_A           64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD--  141 (410)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS--
T ss_pred             cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--
Confidence            45667788899999999999999999999999999999854211 111123467899999999999999999999876  


Q ss_pred             CCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          116 DTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       116 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                         ..+|+||||++ ++|.+++.. ..+++..++.++.|++.+|+|||++|++||||||+||+++.++.++|+|||++..
T Consensus       142 ---~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~  217 (410)
T 3v8s_A          142 ---RYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  217 (410)
T ss_dssp             ---SEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             ---CEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEe
Confidence               56999999996 699988765 4799999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCcc--cccccccccccccccccCcCC---CCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          195 TSETDF--MTEYVVTRWYRAPELLLNCTE---YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       195 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~---~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      ......  .....+++.|+|||.+.+...   ++.++|+||||+++|+|++|..||.+.+..+..++|.+
T Consensus       218 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~  287 (410)
T 3v8s_A          218 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN  287 (410)
T ss_dssp             CCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred             eccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHh
Confidence            665432  335678999999999976321   67899999999999999999999999999888888753

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=9.3e-43  Score=284.54  Aligned_cols=208  Identities=29%  Similarity=0.432  Sum_probs=178.9

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc-cchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      .+.|++++.||+|++|.||++.+..++..|++|.+.... ........+.+|+.+++.++||||+++++++...     .
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~   84 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED-----D   84 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS-----S
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC-----C
Confidence            456778999999999999999999999999999985433 3445567888999999999999999999999876     5


Q ss_pred             cEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          120 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       120 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      .+++|||+++ ++|.+++....++++..++.++.|++++|++||++|++|+||+|+||+++.++.++|+|||++......
T Consensus        85 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  164 (294)
T 4eqm_A           85 CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET  164 (294)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred             eEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence            6999999997 599999998889999999999999999999999999999999999999999999999999999876544


Q ss_pred             cc--cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024959          199 DF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  254 (260)
Q Consensus       199 ~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  254 (260)
                      ..  .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+..
T Consensus       165 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  221 (294)
T 4eqm_A          165 SLTQTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA  221 (294)
T ss_dssp             ----------CCSSCCHHHHHT-CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH
T ss_pred             cccccCccccCccccCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence            22  233467999999999988 77899999999999999999999999988775543

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.2e-42  Score=285.68  Aligned_cols=220  Identities=23%  Similarity=0.371  Sum_probs=180.2

Q ss_pred             EeeecceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeece
Q 024959           30 YNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI  109 (260)
Q Consensus        30 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~  109 (260)
                      ....+..+++....|++.+.||+|+||+||++.+  ++..||+|++............+.+|++++++++||||++++++
T Consensus        25 ~~~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~  102 (309)
T 3p86_A           25 GAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA  102 (309)
T ss_dssp             -------CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cCCCcccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            3455678889999999999999999999999976  46789999998766666677889999999999999999999999


Q ss_pred             ecCCCCCCCccEEEEEecCC-cchHHHhhhCCC---CCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCeEeccCCC
Q 024959          110 IRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ---LTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKPSNLLLNASCD  183 (260)
Q Consensus       110 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lh~~~--i~H~di~~~nili~~~~~  183 (260)
                      +...     ...++|||+++ ++|.+++.....   +++..++.++.|++++|++||+.|  ++|+||||+||+++.++.
T Consensus       103 ~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~  177 (309)
T 3p86_A          103 VTQP-----PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT  177 (309)
T ss_dssp             ECST-----TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCC
T ss_pred             EEEC-----CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCc
Confidence            9876     45899999997 599999887654   999999999999999999999999  999999999999999999


Q ss_pred             EEEeecccccccCCCc-ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          184 LKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       184 ~~l~df~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      ++|+|||++....... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+....+
T Consensus       178 ~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~  251 (309)
T 3p86_A          178 VKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV  251 (309)
T ss_dssp             EEECCCC-----------------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH
T ss_pred             EEECCCCCCccccccccccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            9999999987544332 2334567999999999987 77899999999999999999999999998887776654

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.4e-42  Score=284.06  Aligned_cols=212  Identities=34%  Similarity=0.675  Sum_probs=181.3

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      +.|++++.||+|++|.||++.+..+++.||+|++............+.+|++++++++||||+++++++...     ...
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~   77 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK-----RRL   77 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecC-----CeE
Confidence            346788999999999999999999999999999977655666677788999999999999999999999876     568


Q ss_pred             EEEEecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc-
Q 024959          122 YIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (260)
Q Consensus       122 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~-  199 (260)
                      ++|||++++ +|.+++.....+++..++.++.|++++|++||+.|++|+||+|+||+++.++.++|+|||++....... 
T Consensus        78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  157 (311)
T 4agu_A           78 HLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD  157 (311)
T ss_dssp             EEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence            999999995 667777777889999999999999999999999999999999999999999999999999998765432 


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ......+++.|+|||.+.+...++.++|+||||+++|+|++|..||.+.+..+....+.
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~  216 (311)
T 4agu_A          158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIR  216 (311)
T ss_dssp             --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            23445678999999999876778999999999999999999999999999888776654

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.6e-42  Score=287.26  Aligned_cols=215  Identities=24%  Similarity=0.465  Sum_probs=177.4

Q ss_pred             EeccccCCCcccccccCceEEEEEEeC---CCCeEEEEEecCCccc--chHHHHHHHHHHHHHHHcCCCCeeeeeceecC
Q 024959           38 EVSSKYVPPIRPIGRGAYGIVCAAVNS---ETREEVAIKKIGNAFD--NIIDARRTLREIKLLRHMEHENVIAIKDIIRP  112 (260)
Q Consensus        38 ~~~~~~~~~~~~lg~G~~g~vy~~~~~---~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~  112 (260)
                      .+..+.|++.+.||+|+||.||++.+.   .+++.||+|+++....  .......+.+|+++++.++||||+++++++..
T Consensus        13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   92 (327)
T 3a62_A           13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT   92 (327)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence            345677888999999999999999985   6889999999976432  22344567789999999999999999999987


Q ss_pred             CCCCCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccc
Q 024959          113 PKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (260)
Q Consensus       113 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~  191 (260)
                      .     ..+++|||+++ ++|.+++.....+++..++.++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||+
T Consensus        93 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  167 (327)
T 3a62_A           93 G-----GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGL  167 (327)
T ss_dssp             S-----SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred             C-----CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCc
Confidence            6     56999999997 69999999888999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCC-cccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          192 ARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       192 ~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      +...... .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+.++.|.
T Consensus       168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~  234 (327)
T 3a62_A          168 CKESIHDGTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL  234 (327)
T ss_dssp             C----------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             ccccccCCccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            8764332 22344567999999999987 778999999999999999999999999998888777764

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.5e-42  Score=290.57  Aligned_cols=217  Identities=28%  Similarity=0.492  Sum_probs=185.2

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEeC-------CCCeEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeee
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNS-------ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAI  106 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~  106 (260)
                      ..|++..+.|++.+.||+|+||.||++.+.       .++..||+|+++.. ........+.+|+++++.+ +||||+++
T Consensus        74 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~  152 (370)
T 2psq_A           74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINL  152 (370)
T ss_dssp             TTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCE
T ss_pred             ccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence            346777788999999999999999999864       35567999999765 3445667889999999999 89999999


Q ss_pred             eceecCCCCCCCccEEEEEecCC-cchHHHhhhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceec
Q 024959          107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ----------------QLTDDHCQYFLYQLLRGLKYVHSASVLHR  169 (260)
Q Consensus       107 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~  169 (260)
                      ++++...     ..+|+||||++ ++|.+++....                .+++..++.++.||+.+|+|||++|++|+
T Consensus       153 ~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr  227 (370)
T 2psq_A          153 LGACTQD-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR  227 (370)
T ss_dssp             EEEECSS-----SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             EEEEccC-----CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence            9999876     55899999998 59999987643                48899999999999999999999999999


Q ss_pred             cCCCCCeEeccCCCEEEeecccccccCCCcc---cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCC
Q 024959          170 DLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLF  245 (260)
Q Consensus       170 di~~~nili~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf  245 (260)
                      ||||+||+++.++.+||+|||++........   .....+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||
T Consensus       228 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~  306 (370)
T 2psq_A          228 DLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPY  306 (370)
T ss_dssp             CCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             ccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCC
Confidence            9999999999999999999999986554322   222345678999999987 778999999999999999999 99999


Q ss_pred             CCCChHHHHHHhh
Q 024959          246 PGKDYVHQLRLIT  258 (260)
Q Consensus       246 ~~~~~~~~~~~i~  258 (260)
                      .+.+..+..+.+.
T Consensus       307 ~~~~~~~~~~~~~  319 (370)
T 2psq_A          307 PGIPVEELFKLLK  319 (370)
T ss_dssp             TTCCGGGHHHHHH
T ss_pred             CCCCHHHHHHHHh
Confidence            9988777666553

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.4e-42  Score=290.16  Aligned_cols=220  Identities=36%  Similarity=0.613  Sum_probs=187.3

Q ss_pred             ccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC---
Q 024959           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD---  116 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~---  116 (260)
                      ....|++++.||+|++|.||++.+..+++.||+|++............+.+|+++++.++||||+++++++......   
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            34667789999999999999999999999999999866544444455678999999999999999999998764321   


Q ss_pred             CCccEEEEEecCCcchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccccc
Q 024959          117 TFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (260)
Q Consensus       117 ~~~~~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~  195 (260)
                      ....+++|||+++++|.+.+... ..+++..++.++.|++.+|++||++|++|+||+|+||+++.++.++|+|||++...
T Consensus        95 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~  174 (351)
T 3mi9_A           95 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF  174 (351)
T ss_dssp             --CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence            12568999999999888887764 67999999999999999999999999999999999999999999999999999765


Q ss_pred             CCC-----cccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          196 SET-----DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       196 ~~~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      ...     .......+++.|+|||.+.+...++.++||||||+++|+|++|..||.+.+..+.+..|.+
T Consensus       175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~  243 (351)
T 3mi9_A          175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ  243 (351)
T ss_dssp             CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence            422     2223456789999999998756789999999999999999999999999999888877653

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=5.1e-42  Score=288.89  Aligned_cols=229  Identities=47%  Similarity=0.867  Sum_probs=194.2

Q ss_pred             ceeeEEeeecceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCee
Q 024959           25 GKYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI  104 (260)
Q Consensus        25 ~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv  104 (260)
                      ..+.........|++... |.+.+.||+|+||.||++.+..+++.||+|++............+.+|+.+++.++||||+
T Consensus        26 ~g~~~~~~~~~~~~l~~~-y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  104 (371)
T 4exu_A           26 KGFYKQDVNKTAWELPKT-YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVI  104 (371)
T ss_dssp             TTEEEEEETTEEEEEETT-EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             ccceeeeeccceeccccc-EEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCch
Confidence            344556667788888655 5589999999999999999999999999999987666666778889999999999999999


Q ss_pred             eeeceecCCCCC-CCccEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCC
Q 024959          105 AIKDIIRPPKKD-TFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD  183 (260)
Q Consensus       105 ~~~~~~~~~~~~-~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~  183 (260)
                      ++++++...... ....+++|||+++++|.+.+.  ..+++..++.++.|++.+|+|||+.|++|+||+|+||+++.++.
T Consensus       105 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~  182 (371)
T 4exu_A          105 GLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE  182 (371)
T ss_dssp             CCSEEECSCSSSTTCCCCEEEEECCCEEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC
T ss_pred             hhhhheeccCCcccceeEEEEEccccccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCC
Confidence            999999876432 122459999999999988874  45999999999999999999999999999999999999999999


Q ss_pred             EEEeecccccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          184 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       184 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ++|+|||++......  .....+++.|+|||.+.+...++.++||||||+++|+|++|..||.+.+..+.+..|.
T Consensus       183 ~kL~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~  255 (371)
T 4exu_A          183 LKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL  255 (371)
T ss_dssp             EEECSTTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             EEEEecCcccccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            999999999765443  2345678999999999876778999999999999999999999999999888887764

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4e-43  Score=298.55  Aligned_cols=218  Identities=20%  Similarity=0.299  Sum_probs=188.0

Q ss_pred             eeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        36 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      ...+..+.|++++.||+|+||.||++.++.+++.||+|++.+... .......+.+|..++..++||||+++++++... 
T Consensus        55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~-  133 (412)
T 2vd5_A           55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE-  133 (412)
T ss_dssp             HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS-
T ss_pred             hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC-
Confidence            345667788899999999999999999999999999999964211 111234467899999999999999999999877 


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccc
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~  192 (260)
                          ..+|+||||++ ++|.+++... ..+++..++.++.||+.+|+|||++|++||||||+||+++.++.+||+|||++
T Consensus       134 ----~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla  209 (412)
T 2vd5_A          134 ----NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSC  209 (412)
T ss_dssp             ----SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             ----CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhh
Confidence                56999999996 7999999874 58999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCcc--cccccccccccccccccC------cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          193 RTTSETDF--MTEYVVTRWYRAPELLLN------CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       193 ~~~~~~~~--~~~~~~~~~~~~PE~~~~------~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ........  .....+++.|+|||.+..      ...++.++|+||||+++|+|++|..||.+.+..+...+|.
T Consensus       210 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~  283 (412)
T 2vd5_A          210 LKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV  283 (412)
T ss_dssp             EECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             eeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            87655433  234578999999999873      2567899999999999999999999999999988888775

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=4.9e-42  Score=278.67  Aligned_cols=212  Identities=28%  Similarity=0.475  Sum_probs=190.2

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      .+.|++.+.||+|++|.||++.+..+++.|++|++............+.+|++++++++||||+++++++...     ..
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~   79 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-----SF   79 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC-----CE
Confidence            4567789999999999999999999999999999977655666677888999999999999999999999876     56


Q ss_pred             EEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCC---EEEeecccccccC
Q 024959          121 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLARTTS  196 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~---~~l~df~~~~~~~  196 (260)
                      .++|||+++ ++|.+.+.....+++..++.++.|++.+|.+||++|++|+||+|+||+++.++.   ++|+|||++....
T Consensus        80 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           80 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            899999998 589999888889999999999999999999999999999999999999987655   9999999998877


Q ss_pred             CCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       197 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      .........+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+....+.
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~  220 (284)
T 3kk8_A          160 DSEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK  220 (284)
T ss_dssp             SSCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             cCccccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHH
Confidence            7666666778999999999987 678999999999999999999999999988877776654

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.5e-42  Score=293.40  Aligned_cols=217  Identities=34%  Similarity=0.663  Sum_probs=183.0

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC-
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-  115 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~-  115 (260)
                      ++.....|++++.||+|+||.||++.+..+++.||+|++......      ..+|+++++.++||||+++++++..... 
T Consensus         2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~   75 (383)
T 3eb0_A            2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDE   75 (383)
T ss_dssp             ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred             CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCcc
Confidence            345567788999999999999999999999999999998654221      2379999999999999999999854321 


Q ss_pred             --------------------------------CCCccEEEEEecCCcchHHHhh----hCCCCCHHHHHHHHHHHHHHHH
Q 024959          116 --------------------------------DTFNDVYIVYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLK  159 (260)
Q Consensus       116 --------------------------------~~~~~~~lv~e~~~~~l~~~l~----~~~~~~~~~~~~~~~~i~~~l~  159 (260)
                                                      .....+++|||+++++|.+.+.    .+..+++..++.++.||+++|+
T Consensus        76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~  155 (383)
T 3eb0_A           76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG  155 (383)
T ss_dssp             ----------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence                                            1224588999999998777665    3678999999999999999999


Q ss_pred             HHHhCCceeccCCCCCeEec-cCCCEEEeecccccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHH
Q 024959          160 YVHSASVLHRDLKPSNLLLN-ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI  238 (260)
Q Consensus       160 ~lh~~~i~H~di~~~nili~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l  238 (260)
                      |||+.|++|+||||+||+++ .++.++|+|||++.............+++.|+|||.+.+...++.++||||||+++|+|
T Consensus       156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el  235 (383)
T 3eb0_A          156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL  235 (383)
T ss_dssp             HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred             HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence            99999999999999999997 67899999999998877666666778899999999998756689999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHhhc
Q 024959          239 MTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       239 l~g~~pf~~~~~~~~~~~i~~  259 (260)
                      ++|..||.+.+..+++..|.+
T Consensus       236 l~g~~pf~~~~~~~~~~~i~~  256 (383)
T 3eb0_A          236 ILGKPLFSGETSIDQLVRIIQ  256 (383)
T ss_dssp             HHSSCSSCCSSHHHHHHHHHH
T ss_pred             HhCCCCCCCCChHHHHHHHHH
Confidence            999999999999888887753

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=5.8e-42  Score=287.88  Aligned_cols=221  Identities=56%  Similarity=0.983  Sum_probs=190.7

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      +.+.+ ...|++++.||+|+||.||++.+..++..||+|++... ........+.+|++++++++||||+++++++....
T Consensus        21 ~~~~~-~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   98 (364)
T 3qyz_A           21 QVFDV-GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT   98 (364)
T ss_dssp             CBCCC-TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred             Eeccc-cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCC
Confidence            34444 34567899999999999999999999999999999753 34445677889999999999999999999998765


Q ss_pred             CCCCccEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          115 KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                      .......++|||+++++|.+++.. ..+++..++.++.|++.+|+|||++|++|+||+|+||+++.++.++|+|||++..
T Consensus        99 ~~~~~~~~iv~e~~~~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A           99 IEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             TTTCCCEEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             ccccceEEEEEcccCcCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            444467999999999999998865 4699999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCcc----cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          195 TSETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       195 ~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ......    .....+++.|+|||.+.+...++.++||||||+++|+|++|..||.+.+..+.+..|.
T Consensus       178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~  245 (364)
T 3qyz_A          178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL  245 (364)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHH
T ss_pred             cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH
Confidence            654322    2334779999999998775678999999999999999999999999999888877764

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.9e-42  Score=289.25  Aligned_cols=210  Identities=30%  Similarity=0.471  Sum_probs=167.0

Q ss_pred             EeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCC
Q 024959           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (260)
Q Consensus        38 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~  117 (260)
                      +...+.|++.+.||+|+||.||++.+..+++.||+|++....    ....+.+|++++++++||||+++++++...    
T Consensus        49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----  120 (349)
T 2w4o_A           49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETP----  120 (349)
T ss_dssp             SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECS----
T ss_pred             ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecC----
Confidence            444566788999999999999999999999999999996532    345677899999999999999999999876    


Q ss_pred             CccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecc---CCCEEEeeccccc
Q 024959          118 FNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLAR  193 (260)
Q Consensus       118 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~---~~~~~l~df~~~~  193 (260)
                       ...++|||+++ ++|.+++.....+++..++.++.|++++|.|||+.|++|+||+|+||+++.   ++.++|+|||++.
T Consensus       121 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~  199 (349)
T 2w4o_A          121 -TEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK  199 (349)
T ss_dssp             -SEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred             -CeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence             56999999997 699999988888999999999999999999999999999999999999975   7899999999998


Q ss_pred             ccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHh
Q 024959          194 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH-QLRLI  257 (260)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-~~~~i  257 (260)
                      ............+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+ .++.|
T Consensus       200 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i  263 (349)
T 2w4o_A          200 IVEHQVLMKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRI  263 (349)
T ss_dssp             -------------CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHH
T ss_pred             ccCcccccccccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHH
Confidence            7665555556678999999999987 678999999999999999999999997766544 44433

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4.5e-43  Score=302.08  Aligned_cols=216  Identities=25%  Similarity=0.422  Sum_probs=178.7

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~  115 (260)
                      ..+....|++++.||+|+||.||++.+..+++.||+|++..... .......+.+|+++++.++||||+++++++...  
T Consensus       143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--  220 (446)
T 4ejn_A          143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH--  220 (446)
T ss_dssp             -CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET--
T ss_pred             cCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC--
Confidence            34556678899999999999999999999999999999965321 223445677899999999999999999999877  


Q ss_pred             CCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          116 DTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       116 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                         ..+++||||++ ++|.+++.....+++..++.++.|++.+|+|||+ .|++|+||||+||+++.++.++|+|||++.
T Consensus       221 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~  297 (446)
T 4ejn_A          221 ---DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK  297 (446)
T ss_dssp             ---TEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCC
T ss_pred             ---CEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCce
Confidence               56999999998 5999999888899999999999999999999998 999999999999999999999999999997


Q ss_pred             ccCC-CcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          194 TTSE-TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       194 ~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      .... ........+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+..+.|.
T Consensus       298 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~  362 (446)
T 4ejn_A          298 EGIKDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL  362 (446)
T ss_dssp             TTCC-----CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             eccCCCcccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence            6433 333445678999999999987 778999999999999999999999999998888777764

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-42  Score=290.61  Aligned_cols=210  Identities=23%  Similarity=0.443  Sum_probs=185.9

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      .+.|++.+.||+|+||.||++.++.+++.+++|++....  ......+.+|+++++.++||||+++++++...     ..
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~  122 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDK-----YE  122 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS-----SE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC-----CE
Confidence            356788999999999999999999999999999996542  33456788999999999999999999999876     56


Q ss_pred             EEEEEecCC-cchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecc--CCCEEEeecccccccC
Q 024959          121 VYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA--SCDLKIGDFGLARTTS  196 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~--~~~~~l~df~~~~~~~  196 (260)
                      .++|||+++ ++|.+++... ..+++..++.++.|++.+|+|||++|++|+||+|+||+++.  ++.++|+|||++....
T Consensus       123 ~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~  202 (387)
T 1kob_A          123 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN  202 (387)
T ss_dssp             EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             EEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence            999999997 6999988765 47999999999999999999999999999999999999974  4779999999998877


Q ss_pred             CCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       197 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      .........+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+.+..|.
T Consensus       203 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~  263 (387)
T 1kob_A          203 PDEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK  263 (387)
T ss_dssp             TTSCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred             CCcceeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            6655556678999999999987 778999999999999999999999999998887777664

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.3e-42  Score=300.19  Aligned_cols=214  Identities=28%  Similarity=0.446  Sum_probs=189.0

Q ss_pred             ccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCC
Q 024959           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~  118 (260)
                      ....|.+.+.||+|+||.||++.+..+++.||+|++..... .......+.+|+++++.++||||+++++++...     
T Consensus        14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-----   88 (476)
T 2y94_A           14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP-----   88 (476)
T ss_dssp             EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----
T ss_pred             eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----
Confidence            34567789999999999999999999999999999964321 112345678999999999999999999999877     


Q ss_pred             ccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCC
Q 024959          119 NDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (260)
Q Consensus       119 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~  197 (260)
                      ..+++|||+++ ++|.+++..+..+++..++.++.|++.+|+|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus        89 ~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           89 SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             SEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            56999999996 69999999888999999999999999999999999999999999999999999999999999988776


Q ss_pred             CcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          198 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       198 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ........+++.|+|||.+.+....+.++||||||+++|+|++|..||.+.+..+..+.|.
T Consensus       169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~  229 (476)
T 2y94_A          169 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKIC  229 (476)
T ss_dssp             TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHH
T ss_pred             cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHh
Confidence            6556667889999999999874445789999999999999999999999988888777765

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.3e-43  Score=288.61  Aligned_cols=211  Identities=39%  Similarity=0.700  Sum_probs=176.5

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~  122 (260)
                      .|++++.||+|+||.||++.+..+++.||+|++..... ......+.+|+++++.++||||+++++++...     ...+
T Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~   76 (324)
T 3mtl_A            3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTE-----KSLT   76 (324)
T ss_dssp             SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECS-----SCEE
T ss_pred             ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeC-----CEEE
Confidence            46788999999999999999999999999999965321 11122345799999999999999999999876     5589


Q ss_pred             EEEecCCcchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc-c
Q 024959          123 IVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-F  200 (260)
Q Consensus       123 lv~e~~~~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~-~  200 (260)
                      +|||+++++|.+++... ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++....... .
T Consensus        77 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~  156 (324)
T 3mtl_A           77 LVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT  156 (324)
T ss_dssp             EEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred             EEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccc
Confidence            99999999999998875 459999999999999999999999999999999999999999999999999987654332 2


Q ss_pred             cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       201 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      .....+++.|+|||.+.+...++.++||||||+++|+|++|..||.+.+..+++..|.+
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~  215 (324)
T 3mtl_A          157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFR  215 (324)
T ss_dssp             ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            33456789999999998767789999999999999999999999999999888877653

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=5.3e-42  Score=283.37  Aligned_cols=212  Identities=27%  Similarity=0.440  Sum_probs=187.9

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccch----HHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI----IDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      .+.|++.+.||+|++|.||++.+..+++.|++|++.......    .....+.+|+++++.++||||+++++++...   
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---   87 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR---   87 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS---
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC---
Confidence            455778999999999999999999999999999986543221    1356788999999999999999999999876   


Q ss_pred             CCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCC----CEEEeeccc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC----DLKIGDFGL  191 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~----~~~l~df~~  191 (260)
                        ...++|||+++ ++|.+++.....+++..++.++.|++++|++||+.|++|+||+|+||+++.++    .++|+|||+
T Consensus        88 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~  165 (321)
T 2a2a_A           88 --TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (321)
T ss_dssp             --SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred             --CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence              56999999996 69999999888999999999999999999999999999999999999999887    799999999


Q ss_pred             ccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          192 ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      +.............+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+.+..|.
T Consensus       166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~  231 (321)
T 2a2a_A          166 AHEIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT  231 (321)
T ss_dssp             CEECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred             ceecCccccccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            988776655556678999999999987 778999999999999999999999999988887777664

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=9.8e-42  Score=282.95  Aligned_cols=218  Identities=36%  Similarity=0.669  Sum_probs=183.8

Q ss_pred             eeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC
Q 024959           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (260)
Q Consensus        36 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~  115 (260)
                      .+....+.|++++.||+|++|.||++.+..+++.|++|++............+.+|+++++.++||||+++++++...  
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--   96 (331)
T 4aaa_A           19 LYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK--   96 (331)
T ss_dssp             CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--
T ss_pred             hhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC--
Confidence            333445667789999999999999999999999999999876656666667788999999999999999999999876  


Q ss_pred             CCCccEEEEEecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          116 DTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       116 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                         ...++|||++++ +|.++......+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus        97 ---~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  173 (331)
T 4aaa_A           97 ---KRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFART  173 (331)
T ss_dssp             ---TEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred             ---CEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCcee
Confidence               568999999996 5555556677899999999999999999999999999999999999999999999999999976


Q ss_pred             cCCC-cccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          195 TSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       195 ~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      .... .......+++.|+|||.+.+...++.++||||||+++|+|++|..||.+.+..+.+..+.
T Consensus       174 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~  238 (331)
T 4aaa_A          174 LAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIM  238 (331)
T ss_dssp             ----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             ecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence            5443 223445678999999999875578999999999999999999999999999888776654

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.1e-42  Score=284.57  Aligned_cols=215  Identities=25%  Similarity=0.374  Sum_probs=178.0

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      .+.|++.+.||+|++|.||++.+..+++.||+|++..... .......+.+|+++++.++||||+++++++....... .
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~-~   89 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG-P   89 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE-E
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC-c
Confidence            4456689999999999999999999999999999976533 3445667889999999999999999999987653211 2


Q ss_pred             cEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          120 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       120 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      ..++||||++ ++|.+++.....+++..++.++.|++++|+|||+++++|+||+|+||+++.++.++|+|||++......
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  169 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS  169 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred             ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence            4599999997 699999998889999999999999999999999999999999999999999999999999999765443


Q ss_pred             c----ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          199 D----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       199 ~----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      .    ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+...++
T Consensus       170 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~  231 (311)
T 3ork_A          170 GNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH  231 (311)
T ss_dssp             ------------CCTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             ccccccccccCcCcccCCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            2    1223457999999999987 67899999999999999999999999988876665443

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3.6e-42  Score=294.15  Aligned_cols=212  Identities=33%  Similarity=0.614  Sum_probs=180.3

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC-CCCc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFN  119 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~-~~~~  119 (260)
                      ...|++.+.||+|+||.||++.+..+++.||||++.....      ...+|+++++.++||||+++++++..... ....
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~  126 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV  126 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence            3457789999999999999999999999999999855321      23469999999999999999998854321 1123


Q ss_pred             cEEEEEecCCcchHHHhh----hCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccC-CCEEEeecccccc
Q 024959          120 DVYIVYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDFGLART  194 (260)
Q Consensus       120 ~~~lv~e~~~~~l~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~-~~~~l~df~~~~~  194 (260)
                      .+++||||+++++.+.+.    ....+++..++.++.||+++|+|||+.|++|+||||+|||++.+ +.+||+|||+++.
T Consensus       127 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~  206 (420)
T 1j1b_A          127 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  206 (420)
T ss_dssp             EEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             eEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence            477999999988777664    35789999999999999999999999999999999999999965 5689999999987


Q ss_pred             cCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          195 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ...........+++.|+|||.+.+...++.++|||||||++|+|++|..||.+.+..+++.+|.
T Consensus       207 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~  270 (420)
T 1j1b_A          207 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII  270 (420)
T ss_dssp             CCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             cccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            7665555566789999999999875678999999999999999999999999999888887765

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.4e-42  Score=299.63  Aligned_cols=210  Identities=31%  Similarity=0.571  Sum_probs=183.9

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      +.|++++.||+|+||+||++.++.+++.||+|++............+.+|+++++.++||||+++++++...     ..+
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~   96 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS-----SSF   96 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEE
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC-----CEE
Confidence            446678999999999999999999999999999865433333456788999999999999999999999876     569


Q ss_pred             EEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec---cCCCEEEeecccccccCC
Q 024959          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN---ASCDLKIGDFGLARTTSE  197 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~---~~~~~~l~df~~~~~~~~  197 (260)
                      ++|||++. ++|.+.+.....+++..++.++.|++.+|.|||++|++|+||||+||+++   .++.++|+|||++.....
T Consensus        97 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  176 (486)
T 3mwu_A           97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (486)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence            99999997 59999998888999999999999999999999999999999999999995   456799999999987766


Q ss_pred             CcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          198 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       198 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ........+++.|+|||.+.+  .++.++||||||+++|+|++|..||.+.+..+.++.|.
T Consensus       177 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  235 (486)
T 3mwu_A          177 NTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE  235 (486)
T ss_dssp             C----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            665666788999999999875  48899999999999999999999999999888877764

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=6.3e-42  Score=290.08  Aligned_cols=217  Identities=20%  Similarity=0.274  Sum_probs=186.9

Q ss_pred             ceeEeccccCCCccccccc--CceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecC
Q 024959           35 NLFEVSSKYVPPIRPIGRG--AYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRP  112 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G--~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~  112 (260)
                      ..+......|++++.||+|  ++|.||++.++.+++.||+|++............+.+|+++++.++||||+++++++..
T Consensus        18 s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   97 (389)
T 3gni_B           18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA   97 (389)
T ss_dssp             CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             hcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE
Confidence            4455566778889999999  99999999999999999999997765556667788899999999999999999999987


Q ss_pred             CCCCCCccEEEEEecCC-cchHHHhhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeec
Q 024959          113 PKKDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF  189 (260)
Q Consensus       113 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df  189 (260)
                      .     ..+++|||+++ ++|.+++...  ..+++..++.++.||+.+|+|||++|++|+||||+||+++.++.++|+||
T Consensus        98 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~df  172 (389)
T 3gni_B           98 D-----NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGL  172 (389)
T ss_dssp             T-----TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCG
T ss_pred             C-----CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccc
Confidence            6     56999999998 6999998775  67999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCC--------cccccccccccccccccccCc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 024959          190 GLARTTSET--------DFMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  256 (260)
Q Consensus       190 ~~~~~~~~~--------~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  256 (260)
                      |.+......        .......+++.|+|||.+.+. ..++.++|||||||++|+|++|..||.+.+..+.+..
T Consensus       173 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  248 (389)
T 3gni_B          173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE  248 (389)
T ss_dssp             GGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHH
T ss_pred             ccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            987543221        112234678889999999764 4688999999999999999999999988776655544

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.3e-41  Score=278.23  Aligned_cols=204  Identities=26%  Similarity=0.423  Sum_probs=178.4

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      ..+..+.|.+.+.||+|+||.||++.+..+++.+++|.+..  ........+.+|+++++.++||||+++++++...   
T Consensus         5 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~---   79 (310)
T 3s95_A            5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD---   79 (310)
T ss_dssp             EEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET---
T ss_pred             eeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC---
Confidence            34566778889999999999999999999999999998855  3455677889999999999999999999999876   


Q ss_pred             CCccEEEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                        ...++|||+++ ++|.+++.. ...+++..+..++.|++++|+|||+++++|+||+|+||+++.++.++|+|||++..
T Consensus        80 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  157 (310)
T 3s95_A           80 --KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARL  157 (310)
T ss_dssp             --TEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEE
T ss_pred             --CeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeeccccee
Confidence              56899999997 599999987 57799999999999999999999999999999999999999999999999999976


Q ss_pred             cCCCcccc---------------cccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 024959          195 TSETDFMT---------------EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK  248 (260)
Q Consensus       195 ~~~~~~~~---------------~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  248 (260)
                      ........               ...+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~  225 (310)
T 3s95_A          158 MVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDY  225 (310)
T ss_dssp             CC--------------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred             cccccccccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcch
Confidence            54433221               3467899999999987 78899999999999999999999998753

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.7e-41  Score=281.95  Aligned_cols=213  Identities=28%  Similarity=0.464  Sum_probs=186.6

Q ss_pred             ccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc-cchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCC
Q 024959           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~  118 (260)
                      ..+.|.+.+.||+|+||.||++.+..+++.+++|++.... ........+.+|+.+++.++||||+++++++...     
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----  113 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN-----  113 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-----
Confidence            3456778999999999999999999999999999986543 2344567788999999999999999999999876     


Q ss_pred             ccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCC
Q 024959          119 NDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (260)
Q Consensus       119 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~  197 (260)
                      ...++|||+++ ++|.+++.....+++..++.++.|++++|++||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus       114 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          114 DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             CeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            56999999998 69999988888999999999999999999999999999999999999999999999999999987653


Q ss_pred             C-cccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          198 T-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       198 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      . .......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+..+....+.
T Consensus       194 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~  254 (335)
T 2owb_A          194 DGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK  254 (335)
T ss_dssp             TTCCBCCCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             CcccccccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHh
Confidence            3 22334567899999999987 678999999999999999999999999888776665543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.2e-42  Score=290.02  Aligned_cols=204  Identities=30%  Similarity=0.440  Sum_probs=165.4

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~  118 (260)
                      .....|++++.||+|+||.||++.+..+++.||+|++......   ...+.+|+.+++.++||||+++++++...     
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----   88 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DENVQREIINHRSLRHPNIVRFKEVILTP-----   88 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---CHHHHHHHHHHHHCCCTTBCCEEEEEECS-----
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---cHHHHHHHHHHHhCCCCCCCcEEEEEeeC-----
Confidence            3456677899999999999999999999999999999654322   24577899999999999999999999877     


Q ss_pred             ccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCC--EEEeeccccccc
Q 024959          119 NDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD--LKIGDFGLARTT  195 (260)
Q Consensus       119 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~--~~l~df~~~~~~  195 (260)
                      ..+++||||++ ++|.+++....++++..++.++.|++.+|+|||++|++|+||||+||+++.++.  ++|+|||++...
T Consensus        89 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~  168 (361)
T 3uc3_A           89 THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  168 (361)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred             CEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence            56999999997 699999988889999999999999999999999999999999999999987765  999999999865


Q ss_pred             CCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024959          196 SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (260)
Q Consensus       196 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  250 (260)
                      ..........+++.|+|||.+.+....+.++||||||+++|+|++|..||.+.+.
T Consensus       169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~  223 (361)
T 3uc3_A          169 VLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE  223 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----
T ss_pred             cccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc
Confidence            5555555667899999999998733334459999999999999999999987554

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4.2e-42  Score=308.79  Aligned_cols=219  Identities=23%  Similarity=0.372  Sum_probs=188.3

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHc-CCCCeeeeeceecC
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHM-EHENVIAIKDIIRP  112 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~  112 (260)
                      ....+....|++++.||+|+||.||++.++.+++.||||+++.... .......+..|.+++..+ +||+|+++++++..
T Consensus       334 ~~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~  413 (674)
T 3pfq_A          334 NRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT  413 (674)
T ss_dssp             ------CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC
T ss_pred             ccccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe
Confidence            4445667788899999999999999999999999999999965311 122345677888999887 69999999999987


Q ss_pred             CCCCCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccc
Q 024959          113 PKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (260)
Q Consensus       113 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~  191 (260)
                      .     ..+|+||||++ ++|.+++.....+++..++.++.||+.+|+|||++||+||||||+|||++.++.++|+|||+
T Consensus       414 ~-----~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGl  488 (674)
T 3pfq_A          414 M-----DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM  488 (674)
T ss_dssp             S-----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTT
T ss_pred             C-----CEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecce
Confidence            6     56999999998 69999999888999999999999999999999999999999999999999999999999999


Q ss_pred             ccccC-CCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          192 ARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       192 ~~~~~-~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      ++... .........+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+.++.|.+
T Consensus       489 a~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  556 (674)
T 3pfq_A          489 CKENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME  556 (674)
T ss_dssp             CEECCCTTCCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHS
T ss_pred             eeccccCCcccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Confidence            98643 3334455678999999999987 7889999999999999999999999999999998888764

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=9.8e-42  Score=283.08  Aligned_cols=218  Identities=24%  Similarity=0.383  Sum_probs=166.9

Q ss_pred             cceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-CCCeeeeeceecC
Q 024959           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRP  112 (260)
Q Consensus        34 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~  112 (260)
                      ...+++....|++.+.||+|+||.||++.+..+++.|++|++...  .......+.+|+.+++++. ||||+++++++..
T Consensus        20 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~   97 (337)
T 3ll6_A           20 GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASI   97 (337)
T ss_dssp             TCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             cceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence            467788888899999999999999999999999999999998543  3445677889999999996 9999999999853


Q ss_pred             CCC---CCCccEEEEEecCCcchHHHhhh---CCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCeEeccCCCE
Q 024959          113 PKK---DTFNDVYIVYELMDTDLHQIIRS---DQQLTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKPSNLLLNASCDL  184 (260)
Q Consensus       113 ~~~---~~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~H~di~~~nili~~~~~~  184 (260)
                      ...   .....++++||+++++|.+++..   ...+++..++.++.|++.+|.|||+.+  ++|+||+|+||+++.++.+
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~  177 (337)
T 3ll6_A           98 GKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI  177 (337)
T ss_dssp             CTTTSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCE
T ss_pred             cccccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCE
Confidence            221   22256899999999999998865   567999999999999999999999999  9999999999999999999


Q ss_pred             EEeecccccccCCCcccc-------------ccccccccccccccc--CcCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 024959          185 KIGDFGLARTTSETDFMT-------------EYVVTRWYRAPELLL--NCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  249 (260)
Q Consensus       185 ~l~df~~~~~~~~~~~~~-------------~~~~~~~~~~PE~~~--~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  249 (260)
                      +|+|||++..........             ...+++.|+|||.+.  ....++.++||||||+++|+|++|..||.+.+
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  257 (337)
T 3ll6_A          178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA  257 (337)
T ss_dssp             EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence            999999998765432211             345788999999983  22667889999999999999999999998765


Q ss_pred             hHHH
Q 024959          250 YVHQ  253 (260)
Q Consensus       250 ~~~~  253 (260)
                      ....
T Consensus       258 ~~~~  261 (337)
T 3ll6_A          258 KLRI  261 (337)
T ss_dssp             ----
T ss_pred             HHHh
Confidence            5443

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=8.9e-42  Score=287.42  Aligned_cols=204  Identities=28%  Similarity=0.429  Sum_probs=176.5

Q ss_pred             cccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEEEEe
Q 024959           47 IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYE  126 (260)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv~e  126 (260)
                      .+.||+|+||.||++.+..++..|++|++...  .......+.+|++++++++||||+++++++...     ...++|||
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~lv~E  166 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTR--GMKDKEEVKNEISVMNQLDHANLIQLYDAFESK-----NDIVLVME  166 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEccc--ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----CEEEEEEe
Confidence            56799999999999999999999999999764  334567788999999999999999999999876     56999999


Q ss_pred             cCC-cchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEe--ccCCCEEEeecccccccCCCcccc
Q 024959          127 LMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL--NASCDLKIGDFGLARTTSETDFMT  202 (260)
Q Consensus       127 ~~~-~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili--~~~~~~~l~df~~~~~~~~~~~~~  202 (260)
                      |++ ++|.+.+... ..+++..++.++.|++++|+|||+.+++|+||+|+||++  +.++.++|+|||++..........
T Consensus       167 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~  246 (373)
T 2x4f_A          167 YVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK  246 (373)
T ss_dssp             CCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCC
T ss_pred             CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccc
Confidence            997 5898888654 579999999999999999999999999999999999999  556789999999998877666556


Q ss_pred             cccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          203 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       203 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ...+++.|+|||.+.. ..++.++||||||+++|+|++|..||.+.+..+.+..|.
T Consensus       247 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~  301 (373)
T 2x4f_A          247 VNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNIL  301 (373)
T ss_dssp             CCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             cccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            6678999999999876 678899999999999999999999999999888877765

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=8.2e-42  Score=278.04  Aligned_cols=206  Identities=28%  Similarity=0.421  Sum_probs=165.3

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      +++..+.|++++.||+|++|.||++.+..+++.||+|++............+.++...++.++||||+++++++...   
T Consensus         2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~---   78 (290)
T 3fme_A            2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE---   78 (290)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS---
T ss_pred             CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc---
Confidence            45677888899999999999999999999999999999976644444445555666678888999999999999876   


Q ss_pred             CCccEEEEEecCCcchHHHhhh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEeccCCCEEEeeccc
Q 024959          117 TFNDVYIVYELMDTDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGL  191 (260)
Q Consensus       117 ~~~~~~lv~e~~~~~l~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~H~di~~~nili~~~~~~~l~df~~  191 (260)
                        ...++|||+++++|.+.+..    ...+++..++.++.|++.+|++||++ |++|+||+|+||+++.++.++|+|||+
T Consensus        79 --~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T 3fme_A           79 --GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGI  156 (290)
T ss_dssp             --SSEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC--
T ss_pred             --CCEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCC
Confidence              55899999999988777653    57899999999999999999999998 999999999999999999999999999


Q ss_pred             ccccCCCccccccccccccccccccc---CcCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 024959          192 ARTTSETDFMTEYVVTRWYRAPELLL---NCTEYTAAIDIWSVGCILGEIMTREPLFPG  247 (260)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~~Di~slG~~l~~ll~g~~pf~~  247 (260)
                      +.............+++.|+|||.+.   ....++.++|+||||+++|+|++|..||..
T Consensus       157 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  215 (290)
T 3fme_A          157 SGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS  215 (290)
T ss_dssp             -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred             cccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence            98776665555567899999999972   336688999999999999999999999986

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.7e-42  Score=283.42  Aligned_cols=207  Identities=21%  Similarity=0.350  Sum_probs=178.3

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~  118 (260)
                      .....|++.+.||+|+||.||++.+..+++.||+|++..... ......+.+|++++++++||||+++++++.....   
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---   81 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT---   81 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT---
T ss_pred             CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCC---
Confidence            345667789999999999999999999999999999975432 2234667899999999999999999999877643   


Q ss_pred             ccEEEEEecCC-cchHHHhhhCC---CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEe----ccCCCEEEeecc
Q 024959          119 NDVYIVYELMD-TDLHQIIRSDQ---QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFG  190 (260)
Q Consensus       119 ~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili----~~~~~~~l~df~  190 (260)
                      ...++|||+++ ++|.+++....   .+++..++.++.|++++|+|||+.|++|+||||+||++    +.++.++|+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg  161 (319)
T 4euu_A           82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG  161 (319)
T ss_dssp             CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred             ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence            46899999997 69999987643   39999999999999999999999999999999999999    777789999999


Q ss_pred             cccccCCCcccccccccccccccccccC-------cCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 024959          191 LARTTSETDFMTEYVVTRWYRAPELLLN-------CTEYTAAIDIWSVGCILGEIMTREPLFPGKD  249 (260)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  249 (260)
                      ++.............+++.|+|||.+..       ...++.++||||||+++|+|++|..||...+
T Consensus       162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  227 (319)
T 4euu_A          162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE  227 (319)
T ss_dssp             TCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred             CceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9988777666666778999999999862       2678899999999999999999999997544

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=4.3e-42  Score=299.53  Aligned_cols=211  Identities=31%  Similarity=0.511  Sum_probs=182.2

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      ...|++++.||+|+||.||++.++.++..+|+|++............+.+|+++++.++||||+++++++...     ..
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~  110 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK-----RN  110 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----CE
Confidence            3457789999999999999999999999999999976543333456788999999999999999999999876     56


Q ss_pred             EEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccC---CCEEEeecccccccC
Q 024959          121 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTS  196 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~---~~~~l~df~~~~~~~  196 (260)
                      +++||||++ ++|.+.+.....+++..++.++.|++++|.|||++|++|+||||+||+++.+   +.++|+|||++....
T Consensus       111 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~  190 (494)
T 3lij_A          111 YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE  190 (494)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred             EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence            999999998 5999999888899999999999999999999999999999999999999764   459999999998877


Q ss_pred             CCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       197 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      .........+++.|+|||.+.  ..++.++||||||+++|+|++|..||.+.+..+.++.|.
T Consensus       191 ~~~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  250 (494)
T 3lij_A          191 NQKKMKERLGTAYYIAPEVLR--KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE  250 (494)
T ss_dssp             TTBCBCCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCccccccCCCcCeeCHHHHc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            666666678899999999886  458999999999999999999999999999888887764

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.6e-42  Score=284.67  Aligned_cols=213  Identities=40%  Similarity=0.695  Sum_probs=179.7

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccch---HHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCC
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI---IDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~  117 (260)
                      .+.|++++.||+|++|.||++.+..+++.||+|++.......   .....+.+|+++++.++||||+++++++...    
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----   84 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK----   84 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT----
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC----
Confidence            456778999999999999999999999999999996532221   1124677899999999999999999999876    


Q ss_pred             CccEEEEEecCCcchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccC
Q 024959          118 FNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (260)
Q Consensus       118 ~~~~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~  196 (260)
                       ...++|||+++++|.+.+... ..+++..++.++.|++++|+|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus        85 -~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (346)
T 1ua2_A           85 -SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG  163 (346)
T ss_dssp             -TCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred             -CceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence             558999999999999888764 468999999999999999999999999999999999999999999999999998764


Q ss_pred             CCc-ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          197 ETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       197 ~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ... ......+++.|+|||.+.+...++.++||||||+++|+|++|.+||.+.+..+++..|.
T Consensus       164 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~  226 (346)
T 1ua2_A          164 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF  226 (346)
T ss_dssp             SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            432 33445679999999999775668899999999999999999999999999988887764

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=5e-42  Score=285.80  Aligned_cols=217  Identities=24%  Similarity=0.372  Sum_probs=186.2

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEeC-----CCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeece
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNS-----ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI  109 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~  109 (260)
                      ..+++..+.|++++.||+|+||.||++.+.     .+++.|++|+++... .......+.+|+++++.++||||++++++
T Consensus        40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~  118 (343)
T 1luf_A           40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGV  118 (343)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            346778889999999999999999999987     455889999997653 34456778899999999999999999999


Q ss_pred             ecCCCCCCCccEEEEEecCC-cchHHHhhhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhC
Q 024959          110 IRPPKKDTFNDVYIVYELMD-TDLHQIIRSD------------------------QQLTDDHCQYFLYQLLRGLKYVHSA  164 (260)
Q Consensus       110 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~------------------------~~~~~~~~~~~~~~i~~~l~~lh~~  164 (260)
                      +...     ...++|||+++ ++|.+++...                        ..+++..++.++.|++++|++||++
T Consensus       119 ~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~  193 (343)
T 1luf_A          119 CAVG-----KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER  193 (343)
T ss_dssp             ECSS-----SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             EccC-----CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            9876     55899999998 5999998763                        5699999999999999999999999


Q ss_pred             CceeccCCCCCeEeccCCCEEEeecccccccCCCc---ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-
Q 024959          165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-  240 (260)
Q Consensus       165 ~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-  240 (260)
                      |++|+||+|+||+++.++.++|+|||++.......   ......+++.|+|||.+.+ ..++.++|+||||+++|+|++ 
T Consensus       194 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~  272 (343)
T 1luf_A          194 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSY  272 (343)
T ss_dssp             TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTT
T ss_pred             CeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc-CCcCcccccHHHHHHHHHHHhc
Confidence            99999999999999999999999999987654332   1223456788999999887 678999999999999999999 


Q ss_pred             CCCCCCCCChHHHHHHhh
Q 024959          241 REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       241 g~~pf~~~~~~~~~~~i~  258 (260)
                      |..||.+.+..+....+.
T Consensus       273 g~~p~~~~~~~~~~~~~~  290 (343)
T 1luf_A          273 GLQPYYGMAHEEVIYYVR  290 (343)
T ss_dssp             TCCTTTTSCHHHHHHHHH
T ss_pred             CCCcCCCCChHHHHHHHh
Confidence            999999988887776654

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1e-41  Score=280.48  Aligned_cols=204  Identities=25%  Similarity=0.350  Sum_probs=173.7

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCCCCCcc
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      +.|++.+.||+|+||+||++.+..+++.||||++...............|+..+..+ +||||+++++++...     ..
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~-----~~  131 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG-----GI  131 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC-----CE
Confidence            557788999999999999999999999999999877655555666666677666666 899999999999876     56


Q ss_pred             EEEEEecCCcchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc
Q 024959          121 VYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (260)
Q Consensus       121 ~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~  199 (260)
                      .++|||+++++|.+.+.. ...+++..++.++.|++.+|+|||+.+++|+||||+||+++.++.++|+|||++.......
T Consensus       132 ~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~  211 (311)
T 3p1a_A          132 LYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG  211 (311)
T ss_dssp             EEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred             EEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence            999999999999998876 4569999999999999999999999999999999999999999999999999998877666


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  252 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~  252 (260)
                      ......+++.|+|||.+.+  .++.++||||||+++|+|++|..||.+.+..+
T Consensus       212 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~  262 (311)
T 3p1a_A          212 AGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQ  262 (311)
T ss_dssp             ---CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH
T ss_pred             CCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence            5566678999999998875  58999999999999999999977776544433

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.1e-41  Score=297.63  Aligned_cols=212  Identities=28%  Similarity=0.488  Sum_probs=184.5

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccch-----------HHHHHHHHHHHHHHHcCCCCeeeeece
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI-----------IDARRTLREIKLLRHMEHENVIAIKDI  109 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-----------~~~~~~~~e~~~l~~l~~~~iv~~~~~  109 (260)
                      .+.|.+++.||+|+||+||++.++.++..+|+|++.......           .....+.+|+++++.++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            456778999999999999999999999999999996543211           224667899999999999999999999


Q ss_pred             ecCCCCCCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCC---CEE
Q 024959          110 IRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC---DLK  185 (260)
Q Consensus       110 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~---~~~  185 (260)
                      +...     ..+++|||+++ ++|.+.+.....+++..++.++.|++.+|+|||++|++|+||+|+||+++.++   .++
T Consensus       115 ~~~~-----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~k  189 (504)
T 3q5i_A          115 FEDK-----KYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIK  189 (504)
T ss_dssp             EECS-----SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred             EEcC-----CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEE
Confidence            9876     56999999997 59999998888999999999999999999999999999999999999998775   699


Q ss_pred             EeecccccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          186 IGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       186 l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      |+|||++.............+++.|+|||.+.+  .++.++||||||+++|+|++|..||.+.+..+.++.|.+
T Consensus       190 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  261 (504)
T 3q5i_A          190 IVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK  261 (504)
T ss_dssp             ECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             EEECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence            999999988776666666788999999999864  589999999999999999999999999998888877653

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.1e-41  Score=274.00  Aligned_cols=209  Identities=30%  Similarity=0.491  Sum_probs=186.1

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      .+.|++.+.||+|++|.||++.+..++..+++|++......  ....+.+|+++++.++||||+++++++...     ..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~   80 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETFEDN-----TD   80 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----Ce
Confidence            34567889999999999999999999999999998654332  356788999999999999999999999876     56


Q ss_pred             EEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEe---ccCCCEEEeecccccccC
Q 024959          121 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTS  196 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili---~~~~~~~l~df~~~~~~~  196 (260)
                      .++|||+++ ++|.+.+.....+++..++.++.|++.+|++||++|++|+||+|+||++   +.++.++|+|||++....
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           81 IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            899999997 5999999888899999999999999999999999999999999999999   778899999999998877


Q ss_pred             CCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       197 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      .........+++.|+|||.+.+  .++.++|+||||+++|+|++|..||.+.+..+....+.
T Consensus       161 ~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  220 (277)
T 3f3z_A          161 PGKMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIR  220 (277)
T ss_dssp             TTSCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CccchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            6666666778999999999865  38899999999999999999999999988877776654

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.7e-41  Score=281.63  Aligned_cols=216  Identities=56%  Similarity=0.959  Sum_probs=185.3

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      ...|.+.+.||+|++|.||++.+..+++.||+|++... ........+.+|+++++.++||||+++++++..........
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            45667899999999999999999999999999999643 34445667889999999999999999999987765444567


Q ss_pred             EEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCcc
Q 024959          121 VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  200 (260)
Q Consensus       121 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~  200 (260)
                      .++|||+++++|.+.+.. ..+++..++.++.|++.+|++||++|++|+||+|+||+++.++.++|+|||++........
T Consensus        89 ~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  167 (353)
T 2b9h_A           89 VYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA  167 (353)
T ss_dssp             EEEEECCCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred             EEEEEeccCccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccc
Confidence            999999999999998876 5799999999999999999999999999999999999999999999999999986553321


Q ss_pred             -----------cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          201 -----------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       201 -----------~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                                 .....+++.|+|||.+.....++.++|+||||+++|+|++|..||.+.+..+++..|.
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~  236 (353)
T 2b9h_A          168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIF  236 (353)
T ss_dssp             ------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             cccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence                       1223568899999998765778999999999999999999999999998877766553

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.8e-41  Score=284.31  Aligned_cols=211  Identities=27%  Similarity=0.489  Sum_probs=184.6

Q ss_pred             EeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-----CCCeeeeeceecC
Q 024959           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-----HENVIAIKDIIRP  112 (260)
Q Consensus        38 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~iv~~~~~~~~  112 (260)
                      .+..+.|.+++.||+|+||.||++.+..+++.||+|++...   ......+..|+.+++.++     ||||+++++++..
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~  107 (360)
T 3llt_A           31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY  107 (360)
T ss_dssp             CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred             eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence            34466778999999999999999999999999999999642   334556778999999996     9999999999987


Q ss_pred             CCCCCCccEEEEEecCCcchHHHhhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecc----------
Q 024959          113 PKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA----------  180 (260)
Q Consensus       113 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~----------  180 (260)
                      .     ...++|||+++++|.+++....  .+++..++.++.||+.+|+|||++|++|+||||+||+++.          
T Consensus       108 ~-----~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~  182 (360)
T 3llt_A          108 Y-----DHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITV  182 (360)
T ss_dssp             T-----TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEE
T ss_pred             C-----CeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccch
Confidence            6     5689999999999999998754  5999999999999999999999999999999999999975          


Q ss_pred             ---------------CCCEEEeecccccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCC
Q 024959          181 ---------------SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF  245 (260)
Q Consensus       181 ---------------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf  245 (260)
                                     ++.++|+|||++......  .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||
T Consensus       183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf  259 (360)
T 3llt_A          183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLLF  259 (360)
T ss_dssp             ECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred             hcccccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcC-CCCCCccchHHHHHHHHHHHHCCCCC
Confidence                           788999999999765443  234567999999999987 77899999999999999999999999


Q ss_pred             CCCChHHHHHHhhc
Q 024959          246 PGKDYVHQLRLITE  259 (260)
Q Consensus       246 ~~~~~~~~~~~i~~  259 (260)
                      .+.+..+.++.|.+
T Consensus       260 ~~~~~~~~~~~~~~  273 (360)
T 3llt_A          260 RTHEHMEHLAMMES  273 (360)
T ss_dssp             CCSSHHHHHHHHHH
T ss_pred             CCCcHHHHHHHHHH
Confidence            99998888777643

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.8e-41  Score=283.42  Aligned_cols=218  Identities=41%  Similarity=0.741  Sum_probs=178.7

Q ss_pred             ccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc---------chHHHHHHHHHHHHHHHcCCCCeeeeecee
Q 024959           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD---------NIIDARRTLREIKLLRHMEHENVIAIKDII  110 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~---------~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~  110 (260)
                      ....|++.+.||+|++|.||++.+.. +..||+|++.....         .......+.+|+++++.++||||+++++++
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   98 (362)
T 3pg1_A           20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF   98 (362)
T ss_dssp             TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence            34667789999999999999999866 88999998854321         233457788999999999999999999998


Q ss_pred             cCCCCCCCccEEEEEecCCcchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeec
Q 024959          111 RPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF  189 (260)
Q Consensus       111 ~~~~~~~~~~~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df  189 (260)
                      ..........+++|||+++++|.+.+... ..+++..++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+||
T Consensus        99 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df  178 (362)
T 3pg1_A           99 VHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDF  178 (362)
T ss_dssp             EECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred             EeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEec
Confidence            65443333578999999999999988764 47999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          190 GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      |++.............+++.|+|||.+.+...++.++||||||+++|+|++|..||.+.+..+.++.|.
T Consensus       179 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~  247 (362)
T 3pg1_A          179 NLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV  247 (362)
T ss_dssp             TC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             CcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            999876665555566788999999999876778999999999999999999999999999888887765

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.3e-41  Score=282.10  Aligned_cols=199  Identities=21%  Similarity=0.257  Sum_probs=174.3

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCCCCCc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      ...|++.+.||+|+||.||++.+..+++.||+|++.....    ...+.+|+++++.+ +||||+++++++...     .
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-----~   78 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPCG-----K   78 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEET-----T
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEecC-----C
Confidence            4567789999999999999999999999999999865422    23577899999999 899999999999876     5


Q ss_pred             cEEEEEecCCcchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCC-----EEEeeccccc
Q 024959          120 DVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD-----LKIGDFGLAR  193 (260)
Q Consensus       120 ~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~-----~~l~df~~~~  193 (260)
                      ..++|||+++++|.+++.. ...+++..++.++.|++.+|+|||+.|++|+||||+||+++.++.     ++|+|||++.
T Consensus        79 ~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~  158 (330)
T 2izr_A           79 YNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK  158 (330)
T ss_dssp             EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred             ccEEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence            6899999998899999887 478999999999999999999999999999999999999998877     9999999998


Q ss_pred             ccCCCcc--------cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 024959          194 TTSETDF--------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  249 (260)
Q Consensus       194 ~~~~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  249 (260)
                      .......        .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~  221 (330)
T 2izr_A          159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLK  221 (330)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             eeecCCCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccc
Confidence            6544322        234577999999999988 778999999999999999999999998844

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=278.52  Aligned_cols=212  Identities=26%  Similarity=0.500  Sum_probs=173.8

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccc------------------------hHHHHHHHHHHHHHHH
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN------------------------IIDARRTLREIKLLRH   97 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~------------------------~~~~~~~~~e~~~l~~   97 (260)
                      ..|++.+.||+|+||.||++.+..+++.||+|++......                        ....+.+.+|+++++.
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            4566889999999999999999999999999998654211                        1123567899999999


Q ss_pred             cCCCCeeeeeceecCCCCCCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCe
Q 024959           98 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL  176 (260)
Q Consensus        98 l~~~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~ni  176 (260)
                      ++||||+++++++.....   ..+++|||+++ ++|.++ .....+++..++.++.|++++|+|||+.|++|+||+|+||
T Consensus        93 l~h~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni  168 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNE---DHLYMVFELVNQGPVMEV-PTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL  168 (298)
T ss_dssp             CCCTTBCCEEEEEECSSS---SEEEEEEECCTTCBSCCS-SCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             CCCCCCCeEEEEEEcCCC---CEEEEEEecCCCCcHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence            999999999999986432   56899999998 466554 4456899999999999999999999999999999999999


Q ss_pred             EeccCCCEEEeecccccccCCCc-ccccccccccccccccccCcCC--CCChhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024959          177 LLNASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCTE--YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  253 (260)
Q Consensus       177 li~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~--~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~  253 (260)
                      +++.++.++|+|||++....... ......+++.|+|||.+.+...  .+.++||||||+++|+|++|..||.+.+....
T Consensus       169 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  248 (298)
T 2zv2_A          169 LVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL  248 (298)
T ss_dssp             EECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHH
Confidence            99999999999999998765442 2344578999999999976332  36789999999999999999999998877665


Q ss_pred             HHHh
Q 024959          254 LRLI  257 (260)
Q Consensus       254 ~~~i  257 (260)
                      ...|
T Consensus       249 ~~~~  252 (298)
T 2zv2_A          249 HSKI  252 (298)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            5554

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=3.2e-41  Score=281.58  Aligned_cols=209  Identities=27%  Similarity=0.463  Sum_probs=182.2

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc-cchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      .+.|.+.+.||+|+||.||++.+..+++.||+|++.... ........+.+|+++++.++||||+++++++...     .
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~  127 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----H  127 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----T
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----C
Confidence            344677899999999999999999999999999996543 2334557788999999999999999999999876     5


Q ss_pred             cEEEEEecCCcchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          120 DVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       120 ~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      ..++|||++.++|.+.+.. ...+++..++.++.|++++|.+||++|++|+||+|+||+++.++.++|+|||++......
T Consensus       128 ~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  207 (348)
T 1u5q_A          128 TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  207 (348)
T ss_dssp             EEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             eEEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence            6899999999999888864 678999999999999999999999999999999999999999999999999998766543


Q ss_pred             cccccccccccccccccccC--cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          199 DFMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       199 ~~~~~~~~~~~~~~PE~~~~--~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                         ....+++.|+|||.+..  ...++.++||||||+++|+|++|..||.+.+..+.+..+
T Consensus       208 ---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~  265 (348)
T 1u5q_A          208 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI  265 (348)
T ss_dssp             ---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             ---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence               34567999999999852  366889999999999999999999999988877666554

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.7e-41  Score=281.83  Aligned_cols=224  Identities=48%  Similarity=0.880  Sum_probs=188.8

Q ss_pred             EeeecceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeece
Q 024959           30 YNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI  109 (260)
Q Consensus        30 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~  109 (260)
                      .+.-...|++... |.+.+.||+|++|.||++.++.+++.||+|++............+.+|+.+++.++||||++++++
T Consensus        13 ~~~~~~~~~l~~~-y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   91 (353)
T 3coi_A           13 QDVNKTAWELPKT-YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV   91 (353)
T ss_dssp             EEETTEEEEEETT-EEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             EeecCcccccCce-EEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhhe
Confidence            3444567777554 558999999999999999999999999999997766666667788999999999999999999999


Q ss_pred             ecCCCCC-CCccEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEee
Q 024959          110 IRPPKKD-TFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD  188 (260)
Q Consensus       110 ~~~~~~~-~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~d  188 (260)
                      +...... ....+++|||+++++|.+.+.  ..+++..++.++.|++++|++||++|++|+||+|+||+++.++.++|+|
T Consensus        92 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~D  169 (353)
T 3coi_A           92 FTPASSLRNFYDFYLVMPFMQTDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILD  169 (353)
T ss_dssp             ECSCSSGGGCCCCEEEEECCSEEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECS
T ss_pred             EecccccccceeEEEEeccccCCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEee
Confidence            9876431 113469999999998888764  3599999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          189 FGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       189 f~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ||++......  .....+++.|+|||.+.+...++.++|+||||+++|+|++|..||.+.+..+.+..|.
T Consensus       170 fg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~  237 (353)
T 3coi_A          170 FGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL  237 (353)
T ss_dssp             TTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHH
T ss_pred             cccccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9998765433  2345678999999998876678999999999999999999999999999888777664

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.9e-41  Score=287.47  Aligned_cols=215  Identities=36%  Similarity=0.592  Sum_probs=181.2

Q ss_pred             EeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC-C
Q 024959           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-D  116 (260)
Q Consensus        38 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~-~  116 (260)
                      +.....|++.+.||+|+||.||++.+..++. +++|++.....      ...+|+++++.++||||+++++++..... .
T Consensus        36 ~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  108 (394)
T 4e7w_A           36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKK  108 (394)
T ss_dssp             CEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSS
T ss_pred             CcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCC
Confidence            3445567899999999999999999988766 77777744321      12369999999999999999999865432 2


Q ss_pred             CCccEEEEEecCCcchHHHhh----hCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec-cCCCEEEeeccc
Q 024959          117 TFNDVYIVYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN-ASCDLKIGDFGL  191 (260)
Q Consensus       117 ~~~~~~lv~e~~~~~l~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~-~~~~~~l~df~~  191 (260)
                      ....+++||||+++++.+.+.    ....+++..++.++.|++.+|+|||++|++||||||+||+++ .++.++|+|||+
T Consensus       109 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~  188 (394)
T 4e7w_A          109 DEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGS  188 (394)
T ss_dssp             SCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             CceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence            224478999999987766554    367899999999999999999999999999999999999999 789999999999


Q ss_pred             ccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          192 ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      +.............+++.|+|||.+.+...++.++|||||||++|+|++|..||.+.+..+++..|.+
T Consensus       189 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~  256 (394)
T 4e7w_A          189 AKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIK  256 (394)
T ss_dssp             CEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             cccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            98876666566677899999999998756789999999999999999999999999999888877653

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.4e-41  Score=281.36  Aligned_cols=215  Identities=24%  Similarity=0.376  Sum_probs=182.7

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCCCCe---EEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCC
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~---~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~  113 (260)
                      .++....|.+.+.||+|+||.||++.+..++.   .|++|+++... .......+.+|+++++.++||||+++++++...
T Consensus        44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  122 (325)
T 3kul_A           44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG  122 (325)
T ss_dssp             CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred             cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            46677888899999999999999999986554   49999997643 344567788999999999999999999999766


Q ss_pred             CCCCCccEEEEEecCC-cchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccc
Q 024959          114 KKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (260)
Q Consensus       114 ~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~  191 (260)
                           ...++|||+++ ++|.+++... ..+++..++.++.|++.+|++||+.|++|+||+|+||+++.++.++|+|||+
T Consensus       123 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  197 (325)
T 3kul_A          123 -----RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGL  197 (325)
T ss_dssp             -----GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSS
T ss_pred             -----CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCc
Confidence                 55899999997 5999998754 6799999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCccc----ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          192 ARTTSETDFM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       192 ~~~~~~~~~~----~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      +.........    ....+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||.+.+..+....+.
T Consensus       198 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~  268 (325)
T 3kul_A          198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE  268 (325)
T ss_dssp             CEECC----CCEECC---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH
T ss_pred             ccccccCccceeeccCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence            9876543211    12234668999999976 678899999999999999999 999999998888777664

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.3e-41  Score=284.36  Aligned_cols=210  Identities=25%  Similarity=0.437  Sum_probs=176.5

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc---chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCC
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD---NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~  117 (260)
                      .+.|++.+.||+|+||.||++.++.+++.||+|++.....   .......+.+|+++++.++||||+++++++...    
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~----   98 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD----   98 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET----
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC----
Confidence            4567789999999999999999999999999999853211   111246688999999999999999999999876    


Q ss_pred             CccEEEEEecCC-cchHHHhhh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCC---EEEeec
Q 024959          118 FNDVYIVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDF  189 (260)
Q Consensus       118 ~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~---~~l~df  189 (260)
                       ..+++|||+++ ++|.+.+..    ...+++..++.++.|++++|+|||+++++|+||||+||+++.++.   ++|+||
T Consensus        99 -~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Df  177 (351)
T 3c0i_A           99 -GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGF  177 (351)
T ss_dssp             -TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred             -CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecC
Confidence             56999999998 688777754    345899999999999999999999999999999999999987654   999999


Q ss_pred             ccccccCCCcc-cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          190 GLARTTSETDF-MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       190 ~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      |++........ .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+ .+.++.|
T Consensus       178 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i  244 (351)
T 3c0i_A          178 GVAIQLGESGLVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGI  244 (351)
T ss_dssp             TTCEECCTTSCBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHH
T ss_pred             cceeEecCCCeeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHH
Confidence            99987665433 344578999999999987 678999999999999999999999998754 3344433

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=8.7e-42  Score=296.97  Aligned_cols=213  Identities=30%  Similarity=0.520  Sum_probs=189.1

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~  117 (260)
                      +..+.|++.+.||+|+||.||++.++.+++.||+|++..... .......+.+|+++++.++||||+++++++...    
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----   98 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDK----   98 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECS----
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC----
Confidence            345567789999999999999999999999999999854322 233456788999999999999999999999876    


Q ss_pred             CccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEe---ccCCCEEEeeccccc
Q 024959          118 FNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLAR  193 (260)
Q Consensus       118 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili---~~~~~~~l~df~~~~  193 (260)
                       ...++|||++. ++|.+.+.....+++..++.++.|++.+|.|||++|++|+||||+||++   +.++.++|+|||++.
T Consensus        99 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A           99 -GYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             -SEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             -CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence             56999999997 6999999998999999999999999999999999999999999999999   567889999999998


Q ss_pred             ccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          194 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ............+++.|+|||.+.+  .++.++||||||+++|+|++|..||.+.+..+.++.|.
T Consensus       178 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  240 (484)
T 3nyv_A          178 HFEASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE  240 (484)
T ss_dssp             HBCCCCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             EcccccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            8776666666788999999999865  58999999999999999999999999999988887765

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=4.9e-42  Score=283.82  Aligned_cols=203  Identities=32%  Similarity=0.456  Sum_probs=174.2

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      +.|++++.||+|+||.||++.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++...     ...
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~   80 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREG-----NIQ   80 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECS-----SEE
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecC-----CeE
Confidence            456789999999999999999999999999999854422 22345678999999999999999999999877     568


Q ss_pred             EEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC--
Q 024959          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET--  198 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~--  198 (260)
                      ++|||+++ ++|.+++.....+++..++.++.|++.+|+|||++|++|+||+|+||+++.++.++|+|||++......  
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  160 (323)
T 3tki_A           81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (323)
T ss_dssp             EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence            99999997 599999988888999999999999999999999999999999999999999999999999999764322  


Q ss_pred             -cccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024959          199 -DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (260)
Q Consensus       199 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  250 (260)
                       .......+++.|+|||.+.+....+.++||||||+++|+|++|..||.+.+.
T Consensus       161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  213 (323)
T 3tki_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD  213 (323)
T ss_dssp             ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT
T ss_pred             ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch
Confidence             2233457799999999998744457889999999999999999999987655

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.4e-41  Score=273.53  Aligned_cols=211  Identities=28%  Similarity=0.445  Sum_probs=181.2

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccch----HHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCC
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI----IDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~  117 (260)
                      +.|++.+.||+|++|.||++.+..+++.+++|+++......    .....+.+|+++++.++||||+++++++...    
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----   80 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK----   80 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS----
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC----
Confidence            45678999999999999999999999999999986542211    1356788999999999999999999999876    


Q ss_pred             CccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCC----CEEEeecccc
Q 024959          118 FNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC----DLKIGDFGLA  192 (260)
Q Consensus       118 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~----~~~l~df~~~  192 (260)
                       ...++|||+++ ++|.+++.....+++..++.++.|++++|.+||+.|++|+||+|+||+++.++    .++|+|||++
T Consensus        81 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~  159 (283)
T 3bhy_A           81 -TDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA  159 (283)
T ss_dssp             -SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             -CeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence             56899999997 69999998888999999999999999999999999999999999999998877    7999999999


Q ss_pred             cccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          193 RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      .............+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+.+..+.
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~  224 (283)
T 3bhy_A          160 HKIEAGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS  224 (283)
T ss_dssp             EECC--------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             eeccCCCcccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhH
Confidence            87766555555678999999999977 678999999999999999999999999988877766654

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.5e-41  Score=271.05  Aligned_cols=214  Identities=20%  Similarity=0.388  Sum_probs=183.9

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      ..|.+..+.|++.+.||+|++|.||++.+.. +..|++|++......   ..++.+|++++++++||||+++++++... 
T Consensus         3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-   77 (269)
T 4hcu_A            3 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-   77 (269)
T ss_dssp             --CBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSS-
T ss_pred             ccEEeChhhceeeheecCCCccEEEEEEecC-CCeEEEEEecccccC---HHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence            3577888899999999999999999999874 677999999765433   35688999999999999999999999876 


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccc
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~  192 (260)
                          ...++|||+++ ++|.+++.. ...+++..++.++.|++++|++||+.+++|+||+|+||+++.++.++|+|||++
T Consensus        78 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~  153 (269)
T 4hcu_A           78 ----APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT  153 (269)
T ss_dssp             ----SSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGG
T ss_pred             ----CceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccc
Confidence                55899999997 589998865 456899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCc--ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          193 RTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       193 ~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      .......  ......+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+.+..+..+.+.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~  221 (269)
T 4hcu_A          154 RFVLDDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS  221 (269)
T ss_dssp             GGBCCHHHHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred             ccccccccccccCcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Confidence            7655432  1223344678999999976 678999999999999999999 999999998888777664

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.7e-41  Score=297.47  Aligned_cols=206  Identities=27%  Similarity=0.437  Sum_probs=181.7

Q ss_pred             EeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        38 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      .+....|++.+.||+|+||.||++.++.+++.||+|++..... .......+.+|+++++.++||||+++++++...   
T Consensus       180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~---  256 (576)
T 2acx_A          180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK---  256 (576)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS---
T ss_pred             CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC---
Confidence            3566778899999999999999999999999999999954321 112245577899999999999999999999876   


Q ss_pred             CCccEEEEEecCC-cchHHHhhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                        ..+++||||++ ++|.+++....  .+++..++.++.||+.+|+|||++|++|+||||+||+++.++.++|+|||++.
T Consensus       257 --~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~  334 (576)
T 2acx_A          257 --DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAV  334 (576)
T ss_dssp             --SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             --CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccce
Confidence              56999999997 69999887654  49999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 024959          194 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  249 (260)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  249 (260)
                      ............+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+
T Consensus       335 ~~~~~~~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~  389 (576)
T 2acx_A          335 HVPEGQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRK  389 (576)
T ss_dssp             ECCTTCCEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred             ecccCccccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence            8776655566788999999999987 678999999999999999999999998764

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=4e-41  Score=283.00  Aligned_cols=218  Identities=27%  Similarity=0.395  Sum_probs=183.0

Q ss_pred             cceeEeccccCCCcccccccCceEEEEEE-----eCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeec
Q 024959           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAV-----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD  108 (260)
Q Consensus        34 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~-----~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~  108 (260)
                      ....++..+.|++++.||+|+||.||++.     +..++..||+|+++.. ........+.+|+.+++.++||||+++++
T Consensus        63 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~  141 (367)
T 3l9p_A           63 SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIG  141 (367)
T ss_dssp             GGSCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cchhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            35567788889999999999999999999     4557788999999754 33445567889999999999999999999


Q ss_pred             eecCCCCCCCccEEEEEecCC-cchHHHhhhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecc
Q 024959          109 IIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA  180 (260)
Q Consensus       109 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~  180 (260)
                      ++...     ...++|||+++ ++|.+++...       ..+++..++.++.|++++|+|||++|++||||||+||+++.
T Consensus       142 ~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~  216 (367)
T 3l9p_A          142 VSLQS-----LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTC  216 (367)
T ss_dssp             EECSS-----SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESC
T ss_pred             EEecC-----CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEec
Confidence            99876     45799999996 6999998764       35899999999999999999999999999999999999985


Q ss_pred             CC---CEEEeecccccccCCC---cccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 024959          181 SC---DLKIGDFGLARTTSET---DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQ  253 (260)
Q Consensus       181 ~~---~~~l~df~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~  253 (260)
                      ++   .++|+|||++......   .......+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||.+.+..+.
T Consensus       217 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~  295 (367)
T 3l9p_A          217 PGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV  295 (367)
T ss_dssp             SSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             CCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            54   4999999998753221   22233456889999999987 778999999999999999998 9999999998887


Q ss_pred             HHHhh
Q 024959          254 LRLIT  258 (260)
Q Consensus       254 ~~~i~  258 (260)
                      .+.+.
T Consensus       296 ~~~i~  300 (367)
T 3l9p_A          296 LEFVT  300 (367)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            77664

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=7e-42  Score=288.62  Aligned_cols=218  Identities=23%  Similarity=0.386  Sum_probs=188.0

Q ss_pred             cceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCC
Q 024959           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (260)
Q Consensus        34 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~  113 (260)
                      ...|++..+.|++.+.||+|+||.||++.++.+++.||+|.++.. ........+.+|+++++.++||||+++++++...
T Consensus       106 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  184 (377)
T 3cbl_A          106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK  184 (377)
T ss_dssp             CCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             ccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC
Confidence            457888899999999999999999999999999999999999754 2334556788999999999999999999999776


Q ss_pred             CCCCCccEEEEEecCC-cchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccc
Q 024959          114 KKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (260)
Q Consensus       114 ~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~  191 (260)
                           ...++|||+++ ++|.+++... ..+++..+..++.|++++|+|||+++++|+||+|+||+++.++.+||+|||+
T Consensus       185 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~  259 (377)
T 3cbl_A          185 -----QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGM  259 (377)
T ss_dssp             -----SSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred             -----CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCC
Confidence                 45899999997 6999998764 4699999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCcccc---cccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          192 ARTTSETDFMT---EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       192 ~~~~~~~~~~~---~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      +..........   ...++..|+|||.+.. ..++.++||||||+++|+|++ |..||.+.+..+..+.+.
T Consensus       260 s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~  329 (377)
T 3cbl_A          260 SREEADGVYAASGGLRQVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE  329 (377)
T ss_dssp             CEECTTSEEECCSSCCEEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH
T ss_pred             ceecCCCceeecCCCCCCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            97654432211   1234677999999976 678899999999999999998 999999988877666553

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.3e-41  Score=280.42  Aligned_cols=208  Identities=23%  Similarity=0.351  Sum_probs=177.1

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCC--CCeeeeeceecC
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH--ENVIAIKDIIRP  112 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~iv~~~~~~~~  112 (260)
                      +++++..+.|++++.||+|+||.||++.+. +++.||+|++............+.+|+++++.++|  |||+++++++..
T Consensus         2 e~i~~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~   80 (343)
T 3dbq_A            2 ECISVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT   80 (343)
T ss_dssp             CCEESSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             ceeeeecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee
Confidence            456778888999999999999999999985 57889999997665566667888999999999986  999999999987


Q ss_pred             CCCCCCccEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccc
Q 024959          113 PKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (260)
Q Consensus       113 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~  192 (260)
                      .     ..+++|||+.+++|.+++.....+++..++.++.|++++|+|||+.+++|+||||+||+++ ++.++|+|||++
T Consensus        81 ~-----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a  154 (343)
T 3dbq_A           81 D-----QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIA  154 (343)
T ss_dssp             S-----SEEEEEECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSS
T ss_pred             C-----CEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccc
Confidence            7     5699999988889999999999999999999999999999999999999999999999996 678999999999


Q ss_pred             cccCCCcc---cccccccccccccccccC----------cCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 024959          193 RTTSETDF---MTEYVVTRWYRAPELLLN----------CTEYTAAIDIWSVGCILGEIMTREPLFPGKD  249 (260)
Q Consensus       193 ~~~~~~~~---~~~~~~~~~~~~PE~~~~----------~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  249 (260)
                      ........   .....+++.|+|||.+.+          ...++.++||||||+++|+|++|..||.+..
T Consensus       155 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  224 (343)
T 3dbq_A          155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII  224 (343)
T ss_dssp             CCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             cccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh
Confidence            87654332   234568999999999853          2567889999999999999999999998643

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.2e-41  Score=283.66  Aligned_cols=216  Identities=28%  Similarity=0.481  Sum_probs=183.9

Q ss_pred             eecceeEeccccCCCcccccccCceEEEEEE-----eCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeee
Q 024959           32 VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAV-----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIA  105 (260)
Q Consensus        32 ~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~-----~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~  105 (260)
                      .....|++..+.|++.+.||+|+||.||++.     +..+++.||+|+++.. ........+.+|+++++++ +||||++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            3456788999999999999999999999998     5667789999999764 3344567788999999999 7899999


Q ss_pred             eeceecCCCCCCCccEEEEEecCC-cchHHHhhhCCC-------------------------------------------
Q 024959          106 IKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ-------------------------------------------  141 (260)
Q Consensus       106 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~-------------------------------------------  141 (260)
                      +++++....    ..+++||||++ ++|.+++.....                                           
T Consensus        91 ~~~~~~~~~----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (359)
T 3vhe_A           91 LLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSG  166 (359)
T ss_dssp             EEEEECSTT----SCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------
T ss_pred             eeeeeecCC----CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccc
Confidence            999987653    34799999998 599999876433                                           


Q ss_pred             -----------------------CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          142 -----------------------LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       142 -----------------------~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                                             +++..++.++.|++++|.|||+++++|+||||+||+++.++.++|+|||++......
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  246 (359)
T 3vhe_A          167 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD  246 (359)
T ss_dssp             -----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred             cccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence                                   899999999999999999999999999999999999999999999999999865433


Q ss_pred             c---ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 024959          199 D---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQ  253 (260)
Q Consensus       199 ~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~  253 (260)
                      .   ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||.+.+..+.
T Consensus       247 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  304 (359)
T 3vhe_A          247 PDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  304 (359)
T ss_dssp             TTCEEC--CEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred             ccchhccccCCCceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH
Confidence            2   2233456788999999987 778999999999999999998 9999988765443

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.3e-41  Score=282.88  Aligned_cols=218  Identities=28%  Similarity=0.474  Sum_probs=188.5

Q ss_pred             cceeEeccccCCCcccccccCceEEEEEEeCC-------CCeEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeee
Q 024959           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSE-------TREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIA  105 (260)
Q Consensus        34 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~  105 (260)
                      ...|++..+.|.+.+.||+|+||.||++.+..       .+..||+|+++.. ........+.+|+++++.+ +||||++
T Consensus        61 ~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~  139 (382)
T 3tt0_A           61 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIIN  139 (382)
T ss_dssp             CTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhh
Confidence            46678889999999999999999999998643       3467999999765 3445567888999999999 8999999


Q ss_pred             eeceecCCCCCCCccEEEEEecCC-cchHHHhhhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 024959          106 IKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ----------------QLTDDHCQYFLYQLLRGLKYVHSASVLH  168 (260)
Q Consensus       106 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H  168 (260)
                      +++++...     ...++|||+++ ++|.+++....                .+++..++.++.|++++|++||+.+++|
T Consensus       140 ~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH  214 (382)
T 3tt0_A          140 LLGACTQD-----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIH  214 (382)
T ss_dssp             EEEEECSS-----SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             heeeeccC-----CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEec
Confidence            99999876     55899999997 59999997643                4999999999999999999999999999


Q ss_pred             ccCCCCCeEeccCCCEEEeecccccccCCCc---ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCC
Q 024959          169 RDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPL  244 (260)
Q Consensus       169 ~di~~~nili~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p  244 (260)
                      +||||+||+++.++.++|+|||++.......   ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |..|
T Consensus       215 ~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p  293 (382)
T 3tt0_A          215 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSP  293 (382)
T ss_dssp             SCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             CCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999999998665432   2223345788999999987 778999999999999999999 9999


Q ss_pred             CCCCChHHHHHHhh
Q 024959          245 FPGKDYVHQLRLIT  258 (260)
Q Consensus       245 f~~~~~~~~~~~i~  258 (260)
                      |.+.+..+..+.+.
T Consensus       294 ~~~~~~~~~~~~~~  307 (382)
T 3tt0_A          294 YPGVPVEELFKLLK  307 (382)
T ss_dssp             STTCCHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHH
Confidence            99998887777664

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-42  Score=288.25  Aligned_cols=214  Identities=21%  Similarity=0.376  Sum_probs=177.3

Q ss_pred             eeecceeEeccccCCCcccccccCceEEEEEEeC---CCCeEEEEEecCCccc--chHHHHHHHHHHHHHHHc-CCCCee
Q 024959           31 NVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNS---ETREEVAIKKIGNAFD--NIIDARRTLREIKLLRHM-EHENVI  104 (260)
Q Consensus        31 ~~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~---~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~iv  104 (260)
                      +..+....+....|++.+.||+|+||.||++.+.   .+++.||+|+++....  .......+.+|+++++.+ +||||+
T Consensus        43 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv  122 (355)
T 1vzo_A           43 NLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLV  122 (355)
T ss_dssp             ECSSCCCCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBC
T ss_pred             cCccccccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCcee
Confidence            3334444556678899999999999999999984   5789999999865321  112234566799999999 699999


Q ss_pred             eeeceecCCCCCCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCC
Q 024959          105 AIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD  183 (260)
Q Consensus       105 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~  183 (260)
                      ++++++...     ..+++||||++ ++|.+++.....+++..++.++.|++.+|.|||+++++|+||||+||+++.++.
T Consensus       123 ~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~  197 (355)
T 1vzo_A          123 TLHYAFQTE-----TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH  197 (355)
T ss_dssp             CEEEEEEET-----TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC
T ss_pred             EEEEEEeeC-----ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCc
Confidence            999999776     56899999998 599999998889999999999999999999999999999999999999999999


Q ss_pred             EEEeecccccccCCCc--ccccccccccccccccccCc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 024959          184 LKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKD  249 (260)
Q Consensus       184 ~~l~df~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  249 (260)
                      ++|+|||++.......  ......+++.|+|||.+.+. ..++.++||||||+++|+|++|..||...+
T Consensus       198 ~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~  266 (355)
T 1vzo_A          198 VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG  266 (355)
T ss_dssp             EEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred             EEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCC
Confidence            9999999997654332  22334679999999999752 457899999999999999999999997543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.2e-40  Score=271.81  Aligned_cols=212  Identities=27%  Similarity=0.463  Sum_probs=185.4

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc-cchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      .+.|.+.+.||+|++|.||++.+..+++.+++|++.... ........+.+|+.+++.++||||+++++++...     .
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~   88 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN-----D   88 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----S
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC-----C
Confidence            455678999999999999999999999999999986543 2344567788999999999999999999999876     5


Q ss_pred             cEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          120 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       120 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      ..++|||+++ ++|.+++.....+++..++.++.|++++|++||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        89 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  168 (294)
T 2rku_A           89 FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  168 (294)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence            6899999998 699999888889999999999999999999999999999999999999999999999999999776533


Q ss_pred             -cccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          199 -DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       199 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                       .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+....+.
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  228 (294)
T 2rku_A          169 GERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK  228 (294)
T ss_dssp             TCCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             ccccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence             22334567889999999977 678999999999999999999999999888777665543

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=5.2e-41  Score=272.53  Aligned_cols=215  Identities=21%  Similarity=0.397  Sum_probs=182.8

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      ..|++..+.|++++.||+|+||.||++.+. ++..|++|++......   ...+.+|+++++.++||||+++++++... 
T Consensus        17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-   91 (283)
T 3gen_A           17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-   91 (283)
T ss_dssp             CTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSS-
T ss_pred             CCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC---HHHHHHHHHHHhcCCCCCEeeEEEEEecC-
Confidence            456788888999999999999999999886 4678999999765433   35688999999999999999999999876 


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccc
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~  192 (260)
                          ...++|||+++ ++|.+++.. ...+++..++.++.|++++|.+||++|++|+||+|+||+++.++.++|+|||++
T Consensus        92 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~  167 (283)
T 3gen_A           92 ----RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS  167 (283)
T ss_dssp             ----SSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGG
T ss_pred             ----CCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccc
Confidence                55899999996 699999876 567999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCcc--cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhc
Q 024959          193 RTTSETDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       193 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~~  259 (260)
                      ........  .....+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+..+....|.+
T Consensus       168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~  236 (283)
T 3gen_A          168 RYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ  236 (283)
T ss_dssp             GGBCCHHHHSTTSTTSCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT
T ss_pred             ccccccccccccCCccCcccCCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhc
Confidence            76654322  122344678999999987 678999999999999999998 9999999888887776653

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=8.8e-41  Score=282.99  Aligned_cols=208  Identities=22%  Similarity=0.352  Sum_probs=177.5

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC--CCCeeeeeceecC
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME--HENVIAIKDIIRP  112 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~iv~~~~~~~~  112 (260)
                      ....+....|++++.||+|+||.||++.+.. ++.||+|++............+.+|+++++.++  ||||+++++++..
T Consensus        49 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~  127 (390)
T 2zmd_A           49 ECISVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT  127 (390)
T ss_dssp             CCEEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             ccccccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec
Confidence            4566677778899999999999999999876 889999999766555666788899999999997  5999999999987


Q ss_pred             CCCCCCccEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccc
Q 024959          113 PKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (260)
Q Consensus       113 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~  192 (260)
                      .     ..+++|||+.+++|.+++.....+++..++.++.||+.+|.|||+.+++|+||||+||+++ ++.+||+|||++
T Consensus       128 ~-----~~~~lv~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a  201 (390)
T 2zmd_A          128 D-----QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIA  201 (390)
T ss_dssp             S-----SEEEEEEECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSS
T ss_pred             C-----CEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCcc
Confidence            7     5599999977789999999988999999999999999999999999999999999999995 578999999999


Q ss_pred             cccCCCc---ccccccccccccccccccC----------cCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 024959          193 RTTSETD---FMTEYVVTRWYRAPELLLN----------CTEYTAAIDIWSVGCILGEIMTREPLFPGKD  249 (260)
Q Consensus       193 ~~~~~~~---~~~~~~~~~~~~~PE~~~~----------~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  249 (260)
                      .......   ......+++.|+|||.+.+          ...++.++||||||+++|+|++|..||.+..
T Consensus       202 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~  271 (390)
T 2zmd_A          202 NQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII  271 (390)
T ss_dssp             CCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             ccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh
Confidence            8765432   2234578999999999864          1357889999999999999999999998754

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=4.3e-41  Score=294.10  Aligned_cols=206  Identities=25%  Similarity=0.416  Sum_probs=179.4

Q ss_pred             EeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        38 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      .+....|++.+.||+|+||.||++.++.+++.||+|++..... .......+.+|+++++.++||||+++++++...   
T Consensus       181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~---  257 (543)
T 3c4z_A          181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK---  257 (543)
T ss_dssp             CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS---
T ss_pred             cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC---
Confidence            3556778889999999999999999999999999999964321 112245678899999999999999999999876   


Q ss_pred             CCccEEEEEecCC-cchHHHhhhC----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRSD----QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~  191 (260)
                        ..+|+||||++ ++|.+++...    ..+++..++.++.||+.+|+|||++|++|+||||+||+++.++.++|+|||+
T Consensus       258 --~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGl  335 (543)
T 3c4z_A          258 --TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGL  335 (543)
T ss_dssp             --SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             --CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecce
Confidence              56999999998 6999888763    4699999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCcc-cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 024959          192 ARTTSETDF-MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  249 (260)
Q Consensus       192 ~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  249 (260)
                      +........ .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+
T Consensus       336 a~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~  393 (543)
T 3c4z_A          336 AVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARG  393 (543)
T ss_dssp             CEECCTTCCCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred             eeeccCCCcccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence            987655433 234578999999999987 788999999999999999999999998763

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=4.8e-41  Score=272.29  Aligned_cols=212  Identities=25%  Similarity=0.441  Sum_probs=181.9

Q ss_pred             ccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccc-hHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCC
Q 024959           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN-IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~  118 (260)
                      ..+.|++.+.||+|++|.||++.+..++..|++|++...... ......+.+|+.+++.++||||+++++++...     
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----   81 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-----   81 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC-----
Confidence            456677899999999999999999999999999998543211 11245678899999999999999999999876     


Q ss_pred             ccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCC
Q 024959          119 NDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (260)
Q Consensus       119 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~  197 (260)
                      ...++|||+++ ++|.+.+.....+++..++.++.|++.+|++||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           82 TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            56899999998 69999998888999999999999999999999999999999999999999999999999998865544


Q ss_pred             CcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          198 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       198 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      .. .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+..+.+.
T Consensus       162 ~~-~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~  220 (279)
T 3fdn_A          162 SR-RTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS  220 (279)
T ss_dssp             -------CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             cc-ccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH
Confidence            32 234567899999999987 778899999999999999999999999998888777664

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=8.8e-42  Score=283.62  Aligned_cols=202  Identities=27%  Similarity=0.426  Sum_probs=177.8

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccch------HHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI------IDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~------~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~  115 (260)
                      +.|++.+.||+|+||.||++.+..+++.||+|++.......      .....+.+|+++++.++||||+++++++...  
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--  101 (335)
T 3dls_A           24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ--  101 (335)
T ss_dssp             HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS--
T ss_pred             cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC--
Confidence            45668899999999999999999999999999986543211      1234566799999999999999999999876  


Q ss_pred             CCCccEEEEEecCC-c-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          116 DTFNDVYIVYELMD-T-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       116 ~~~~~~~lv~e~~~-~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                         ..+++|||+++ + +|.+++.....+++..++.++.|++.+|.|||++|++|+||||+||+++.++.++|+|||++.
T Consensus       102 ---~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  178 (335)
T 3dls_A          102 ---GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAA  178 (335)
T ss_dssp             ---SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             ---CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccce
Confidence               56899999986 4 899999998899999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 024959          194 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK  248 (260)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  248 (260)
                      ............+++.|+|||.+.+....+.++||||||+++|+|++|..||...
T Consensus       179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  233 (335)
T 3dls_A          179 YLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL  233 (335)
T ss_dssp             ECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSG
T ss_pred             ECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhH
Confidence            8777666666778999999999987444488999999999999999999999753

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.8e-41  Score=282.97  Aligned_cols=203  Identities=20%  Similarity=0.266  Sum_probs=173.4

Q ss_pred             cceeEeccccCCCcccccccCceEEEEE-----EeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC---CCCeee
Q 024959           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAA-----VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME---HENVIA  105 (260)
Q Consensus        34 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~-----~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~iv~  105 (260)
                      ...+++..+.|.+.+.||+|+||.||++     .+..+++.||+|++....     ...+..|+++++.++   |+||++
T Consensus        57 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~  131 (365)
T 3e7e_A           57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMK  131 (365)
T ss_dssp             SCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCC
T ss_pred             ceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhh
Confidence            3567788888999999999999999999     467788999999997542     345667788888886   899999


Q ss_pred             eeceecCCCCCCCccEEEEEecCC-cchHHHhhh-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec
Q 024959          106 IKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS-----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN  179 (260)
Q Consensus       106 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~  179 (260)
                      +++.+...     ...++||||++ ++|.+++..     ...+++..++.++.|++.+|+|||++|++||||||+||+++
T Consensus       132 ~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~  206 (365)
T 3e7e_A          132 FYSAHLFQ-----NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILG  206 (365)
T ss_dssp             EEEEEECS-----SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC
T ss_pred             hheeeecC-----CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEec
Confidence            99999877     55899999998 699999874     56799999999999999999999999999999999999998


Q ss_pred             c-----------CCCEEEeecccccccC---CCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCC
Q 024959          180 A-----------SCDLKIGDFGLARTTS---ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF  245 (260)
Q Consensus       180 ~-----------~~~~~l~df~~~~~~~---~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf  245 (260)
                      .           ++.++|+|||++....   .........+++.|+|||.+.+ ..++.++||||||+++|+|++|..||
T Consensus       207 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf  285 (365)
T 3e7e_A          207 NGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMK  285 (365)
T ss_dssp             GGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCCC
T ss_pred             ccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC-CCCCccccHHHHHHHHHHHHhCCCcc
Confidence            8           8999999999996533   3334455678999999999988 67899999999999999999999998


Q ss_pred             CC
Q 024959          246 PG  247 (260)
Q Consensus       246 ~~  247 (260)
                      ..
T Consensus       286 ~~  287 (365)
T 3e7e_A          286 VK  287 (365)
T ss_dssp             EE
T ss_pred             cc
Confidence            54

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3.6e-41  Score=277.21  Aligned_cols=217  Identities=26%  Similarity=0.431  Sum_probs=186.3

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEeC-----CCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeece
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNS-----ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI  109 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~  109 (260)
                      ..|++..+.|.+.+.||+|+||.||++.+.     .++..|++|++... ........+.+|+++++.++||||++++++
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   94 (314)
T 2ivs_A           16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGA   94 (314)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence            567888899999999999999999999873     45588999999754 344556788899999999999999999999


Q ss_pred             ecCCCCCCCccEEEEEecCC-cchHHHhhhCCC------------------------CCHHHHHHHHHHHHHHHHHHHhC
Q 024959          110 IRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ------------------------LTDDHCQYFLYQLLRGLKYVHSA  164 (260)
Q Consensus       110 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~------------------------~~~~~~~~~~~~i~~~l~~lh~~  164 (260)
                      +...     ...++|||+++ ++|.+++.....                        +++..++.++.|++++|++||++
T Consensus        95 ~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~  169 (314)
T 2ivs_A           95 CSQD-----GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM  169 (314)
T ss_dssp             ECSS-----SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT
T ss_pred             EecC-----CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC
Confidence            9876     55899999998 699999986543                        89999999999999999999999


Q ss_pred             CceeccCCCCCeEeccCCCEEEeecccccccCCCccc---ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-
Q 024959          165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-  240 (260)
Q Consensus       165 ~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-  240 (260)
                      |++|+||+|+||+++.++.++|+|||++.........   ....+++.|+|||.+.+ ..++.++||||||+++|+|++ 
T Consensus       170 ~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~  248 (314)
T 2ivs_A          170 KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTL  248 (314)
T ss_dssp             TEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTT
T ss_pred             CCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHHHHhC
Confidence            9999999999999999999999999999766543322   22344678999999987 678899999999999999999 


Q ss_pred             CCCCCCCCChHHHHHHhh
Q 024959          241 REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       241 g~~pf~~~~~~~~~~~i~  258 (260)
                      |..||.+.+..+..+.+.
T Consensus       249 g~~p~~~~~~~~~~~~~~  266 (314)
T 2ivs_A          249 GGNPYPGIPPERLFNLLK  266 (314)
T ss_dssp             SCCSSTTCCGGGHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHhh
Confidence            999999888776665543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.9e-41  Score=280.83  Aligned_cols=212  Identities=25%  Similarity=0.429  Sum_probs=179.3

Q ss_pred             cccCCCc-ccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-CCCeeeeeceecCCCCCCC
Q 024959           41 SKYVPPI-RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTF  118 (260)
Q Consensus        41 ~~~~~~~-~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~~  118 (260)
                      ..+|.+. +.||+|+||.||++.++.+++.||+|++............+.+|+.+++.++ ||||+++++++...     
T Consensus        27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~-----  101 (327)
T 3lm5_A           27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT-----  101 (327)
T ss_dssp             HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----
T ss_pred             hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC-----
Confidence            4444455 8899999999999999999999999999765544444667889999999995 69999999999876     


Q ss_pred             ccEEEEEecCC-cchHHHhhh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecc---CCCEEEeecccc
Q 024959          119 NDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLA  192 (260)
Q Consensus       119 ~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~---~~~~~l~df~~~  192 (260)
                      ...++|||++. ++|.+++..  ...+++..++.++.|++.+|++||++|++|+||+|+||+++.   ++.++|+|||++
T Consensus       102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a  181 (327)
T 3lm5_A          102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS  181 (327)
T ss_dssp             SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGC
T ss_pred             CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccc
Confidence            56999999998 588888855  367999999999999999999999999999999999999987   789999999999


Q ss_pred             cccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          193 RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      .............+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+....|.
T Consensus       182 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  246 (327)
T 3lm5_A          182 RKIGHACELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS  246 (327)
T ss_dssp             EEC---------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             cccCCccccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH
Confidence            88776655566678999999999987 778999999999999999999999999998887776654

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.7e-41  Score=279.43  Aligned_cols=217  Identities=39%  Similarity=0.650  Sum_probs=182.4

Q ss_pred             cccCCCcccccccCceEEEEEEeC-CCCeEEEEEecCCcccchHHHHHHHHHHHHHHHc---CCCCeeeeeceecCCCCC
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNS-ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM---EHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~iv~~~~~~~~~~~~  116 (260)
                      .+.|++.+.||+|++|.||++.+. .+++.|++|++............+.+|+.+++.+   +||||+++++++......
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~   89 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   89 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence            466778999999999999999995 6788999999865432222223455667666666   899999999998733222


Q ss_pred             CCccEEEEEecCCcchHHHhhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          117 TFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       117 ~~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                      .....++|||+++++|.+++....  .+++..++.++.|++++|.+||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus        90 ~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~  169 (326)
T 1blx_A           90 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI  169 (326)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred             CCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccccc
Confidence            226689999999999999988743  499999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          195 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ...........+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+.+..|.
T Consensus       170 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~  232 (326)
T 1blx_A          170 YSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL  232 (326)
T ss_dssp             CCGGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             ccCCCCccccccccceeCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence            665555555677999999999987 678999999999999999999999999999888877764

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=4.5e-41  Score=271.91  Aligned_cols=214  Identities=27%  Similarity=0.423  Sum_probs=176.8

Q ss_pred             ccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCC
Q 024959           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~  118 (260)
                      ....|.+.+.||+|++|.||++.+..+++.|++|++..... .......+.+|+.+++.++||||+++++++...     
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----   83 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP-----   83 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-----
Confidence            34567789999999999999999999999999999854321 112345678999999999999999999999876     


Q ss_pred             ccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCC
Q 024959          119 NDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (260)
Q Consensus       119 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~  197 (260)
                      ...++|||+++ ++|.+++.....+++..++.++.|++++|.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           84 TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            56999999997 59999998888999999999999999999999999999999999999999999999999999987766


Q ss_pred             CcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          198 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       198 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ........+++.|+|||.+.+....+.++|+||||+++|+|++|..||.+.+..+..+.|.
T Consensus       164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  224 (276)
T 2h6d_A          164 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIR  224 (276)
T ss_dssp             -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh
Confidence            5555556778999999999874444689999999999999999999999888777666553

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=5.9e-41  Score=276.07  Aligned_cols=226  Identities=20%  Similarity=0.300  Sum_probs=179.0

Q ss_pred             eeecceeEeccccCCCcccccccCceEEEEEEeCC---CCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeee
Q 024959           31 NVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSE---TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK  107 (260)
Q Consensus        31 ~~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~  107 (260)
                      ......+.+..+.|.+.+.||+|++|.||++.+..   ++..|++|.+............+.+|++++++++||||++++
T Consensus        23 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~  102 (313)
T 3brb_A           23 QNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLL  102 (313)
T ss_dssp             -CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCC
T ss_pred             hhhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeee
Confidence            33456777888889999999999999999998765   556899999977655666678889999999999999999999


Q ss_pred             ceecCCCCCCCccEEEEEecCC-cchHHHhh------hCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecc
Q 024959          108 DIIRPPKKDTFNDVYIVYELMD-TDLHQIIR------SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA  180 (260)
Q Consensus       108 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~------~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~  180 (260)
                      +++...........++|||+++ ++|.+++.      ....+++..++.++.|++++|.+||+.|++|+||+|+||+++.
T Consensus       103 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~  182 (313)
T 3brb_A          103 GVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRD  182 (313)
T ss_dssp             EEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECT
T ss_pred             EEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcC
Confidence            9998765443346799999998 59999884      3456999999999999999999999999999999999999999


Q ss_pred             CCCEEEeecccccccCCCc---ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 024959          181 SCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRL  256 (260)
Q Consensus       181 ~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~  256 (260)
                      ++.++|+|||++.......   ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||.+.+..+..+.
T Consensus       183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  261 (313)
T 3brb_A          183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY  261 (313)
T ss_dssp             TSCEEECSCSCC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred             CCcEEEeecCcceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH
Confidence            9999999999987654432   1222345778999999987 778999999999999999999 9999998887766555


Q ss_pred             h
Q 024959          257 I  257 (260)
Q Consensus       257 i  257 (260)
                      +
T Consensus       262 ~  262 (313)
T 3brb_A          262 L  262 (313)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.7e-41  Score=279.26  Aligned_cols=223  Identities=22%  Similarity=0.362  Sum_probs=170.1

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEeCCCCe---EEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceec
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIR  111 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~---~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~  111 (260)
                      ..+.+..+.|++.+.||+|++|.||++.+..++.   .||+|+++...........+.+|+++++.++||||+++++++.
T Consensus        16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   95 (323)
T 3qup_A           16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL   95 (323)
T ss_dssp             CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred             hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence            4456777889999999999999999999887765   7999999776555566788999999999999999999999998


Q ss_pred             CCCCCC-CccEEEEEecCC-cchHHHhhhCC------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCC
Q 024959          112 PPKKDT-FNDVYIVYELMD-TDLHQIIRSDQ------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD  183 (260)
Q Consensus       112 ~~~~~~-~~~~~lv~e~~~-~~l~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~  183 (260)
                      .....+ ....++|||++. ++|.+++....      .+++..++.++.|++++|+|||++|++|+||||+||+++.++.
T Consensus        96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~  175 (323)
T 3qup_A           96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT  175 (323)
T ss_dssp             CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC
T ss_pred             ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCC
Confidence            764321 123489999998 59998886532      6999999999999999999999999999999999999999999


Q ss_pred             EEEeecccccccCCCccc---ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          184 LKIGDFGLARTTSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       184 ~~l~df~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      ++|+|||++.........   ....+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||.+.+..+..+.+.
T Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~  253 (323)
T 3qup_A          176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI  253 (323)
T ss_dssp             EEECCCCC-----------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred             EEEeeccccccccccccccccccccCcccccCchhhcC-CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh
Confidence            999999999765443322   22344678999999987 778999999999999999999 999999988877766553

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.3e-40  Score=275.00  Aligned_cols=206  Identities=25%  Similarity=0.475  Sum_probs=178.8

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~l  123 (260)
                      +...+.||+|++|.||++.+..+++.||||++......  ....+.+|+.+++.++||||+++++++...     ...++
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~l  119 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHFNVVEMYKSYLVG-----EELWV  119 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--SHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEEE
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCcceEEEEEEEC-----CEEEE
Confidence            45567899999999999999999999999998654332  346688999999999999999999999876     56999


Q ss_pred             EEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc-cc
Q 024959          124 VYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FM  201 (260)
Q Consensus       124 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~-~~  201 (260)
                      ||||++ ++|.+++. ...+++..+..++.|++++|+|||+.|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus       120 v~e~~~~~~L~~~l~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  198 (321)
T 2c30_A          120 LMEFLQGGALTDIVS-QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR  198 (321)
T ss_dssp             EECCCCSCBHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCB
T ss_pred             EEecCCCCCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccc
Confidence            999997 57877765 4579999999999999999999999999999999999999999999999999987765432 23


Q ss_pred             ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          202 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       202 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+.+..+.
T Consensus       199 ~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~  254 (321)
T 2c30_A          199 KSLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR  254 (321)
T ss_dssp             CCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred             ccccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence            44578999999999977 778999999999999999999999999888877666553

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=8.4e-41  Score=271.15  Aligned_cols=216  Identities=25%  Similarity=0.417  Sum_probs=173.6

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEeCCC---CeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceec
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSET---REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIR  111 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~  111 (260)
                      ..+++..+.|++.+.||+|+||.||++.+..+   +..+++|.+... ........+.+|+.+++.++||||+++++++.
T Consensus         8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   86 (281)
T 1mp8_A            8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT   86 (281)
T ss_dssp             -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence            45678888899999999999999999998654   456999998764 33445677889999999999999999999985


Q ss_pred             CCCCCCCccEEEEEecCC-cchHHHhhhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeec
Q 024959          112 PPKKDTFNDVYIVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF  189 (260)
Q Consensus       112 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df  189 (260)
                      .      +..++|||+++ ++|.+++.... .+++..++.++.|++++|.+||++|++|+||+|+||+++.++.++|+||
T Consensus        87 ~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df  160 (281)
T 1mp8_A           87 E------NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF  160 (281)
T ss_dssp             S------SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-
T ss_pred             c------CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcc
Confidence            4      34789999998 59999987654 7999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCccc--ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          190 GLARTTSETDFM--TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       190 ~~~~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      |++.........  ....+++.|+|||.+.. ..++.++|+||||+++|+|++ |..||.+.+..+....|.
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~  231 (281)
T 1mp8_A          161 GLSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE  231 (281)
T ss_dssp             ------------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred             ccccccCcccccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH
Confidence            999776544322  22344678999999976 678999999999999999996 999999888777666654

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.7e-40  Score=270.16  Aligned_cols=213  Identities=28%  Similarity=0.476  Sum_probs=185.5

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc-------cchHHHHHHHHHHHHHHHcC-CCCeeeeeceecC
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-------DNIIDARRTLREIKLLRHME-HENVIAIKDIIRP  112 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~-------~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~  112 (260)
                      .+.|++.+.||+|++|.||++.++.+++.|++|++....       ........+.+|+++++++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            345668899999999999999999999999999986432       11234566789999999996 9999999999987


Q ss_pred             CCCCCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccc
Q 024959          113 PKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (260)
Q Consensus       113 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~  191 (260)
                      .     ...++|||+++ ++|.+++.....+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||+
T Consensus        96 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  170 (298)
T 1phk_A           96 N-----TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF  170 (298)
T ss_dssp             S-----SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             C-----CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccc
Confidence            6     56999999998 69999999888999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCccccccccccccccccccc-----CcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          192 ARTTSETDFMTEYVVTRWYRAPELLL-----NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      +.............+++.|+|||.+.     ....++.++|+||||+++|+|++|..||.+.+..+..+.|.
T Consensus       171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  242 (298)
T 1phk_A          171 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM  242 (298)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             hhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHh
Confidence            98776665556667899999999985     23567889999999999999999999999888777666553

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1e-40  Score=274.37  Aligned_cols=216  Identities=26%  Similarity=0.421  Sum_probs=185.0

Q ss_pred             ecceeEeccccCCCcccccccCceEEEEEEe-----CCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeee
Q 024959           33 YGNLFEVSSKYVPPIRPIGRGAYGIVCAAVN-----SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAI  106 (260)
Q Consensus        33 ~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~  106 (260)
                      +...|++....|++.+.||+|+||.||++.+     ..++..|++|++.... .......+.+|+++++++ +||||+++
T Consensus        14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~   92 (313)
T 1t46_A           14 YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNL   92 (313)
T ss_dssp             CCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeE
Confidence            3566888889999999999999999999984     5677899999997643 344567788999999999 89999999


Q ss_pred             eceecCCCCCCCccEEEEEecCC-cchHHHhhhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCce
Q 024959          107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ------------------QLTDDHCQYFLYQLLRGLKYVHSASVL  167 (260)
Q Consensus       107 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~------------------~~~~~~~~~~~~~i~~~l~~lh~~~i~  167 (260)
                      ++++...     ...++|||+++ ++|.+++....                  .+++..++.++.|++++|.+||+.|++
T Consensus        93 ~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~  167 (313)
T 1t46_A           93 LGACTIG-----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCI  167 (313)
T ss_dssp             EEEECSS-----SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             EEEEecC-----CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            9999876     45899999997 59999987653                  489999999999999999999999999


Q ss_pred             eccCCCCCeEeccCCCEEEeecccccccCCCcc---cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCC
Q 024959          168 HRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REP  243 (260)
Q Consensus       168 H~di~~~nili~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~  243 (260)
                      |+||+|+||+++.++.++|+|||++........   .....+++.|+|||.+.+ ..++.++||||||+++|+|++ |..
T Consensus       168 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~  246 (313)
T 1t46_A          168 HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSS  246 (313)
T ss_dssp             CSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             cCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999987655432   223345778999999877 778999999999999999998 999


Q ss_pred             CCCCCChHHHHH
Q 024959          244 LFPGKDYVHQLR  255 (260)
Q Consensus       244 pf~~~~~~~~~~  255 (260)
                      ||.+.+....+.
T Consensus       247 p~~~~~~~~~~~  258 (313)
T 1t46_A          247 PYPGMPVDSKFY  258 (313)
T ss_dssp             SSTTCCSSHHHH
T ss_pred             CCCcccchhHHH
Confidence            998877554433

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.4e-40  Score=272.80  Aligned_cols=215  Identities=45%  Similarity=0.825  Sum_probs=176.5

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC-----
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-----  115 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~-----  115 (260)
                      ...|++++.||+|++|.||++.+..+++.|++|.+...  .......+.+|+++++.++||||+++++++.....     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   87 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD   87 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence            44566899999999999999999999999999998653  34566788899999999999999999999865421     


Q ss_pred             ----CCCccEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec-cCCCEEEeecc
Q 024959          116 ----DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN-ASCDLKIGDFG  190 (260)
Q Consensus       116 ----~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~-~~~~~~l~df~  190 (260)
                          ......++|||+++++|.+++.. .++++..++.++.|++++|++||++|++|+||+|+||+++ .++.++|+|||
T Consensus        88 ~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg  166 (320)
T 2i6l_A           88 VGSLTELNSVYIVQEYMETDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFG  166 (320)
T ss_dssp             ---CCSCSEEEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCT
T ss_pred             cccccccCceeEEeeccCCCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCc
Confidence                12256899999999999998754 6799999999999999999999999999999999999997 56789999999


Q ss_pred             cccccCCC----cccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          191 LARTTSET----DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       191 ~~~~~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ++......    .......++..|+|||.+.....++.++|+||||+++|+|++|..||.+.+..+.++.|.
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  238 (320)
T 2i6l_A          167 LARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL  238 (320)
T ss_dssp             TCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             cccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            99865432    122334558889999998765778999999999999999999999999999887777654

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1e-40  Score=280.96  Aligned_cols=217  Identities=25%  Similarity=0.416  Sum_probs=175.1

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEeC---CCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceec
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNS---ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIR  111 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~  111 (260)
                      -..++....|.+.+.||+|+||.||++.++   .++..||+|.++... .......+.+|++++++++||||+++++++.
T Consensus        38 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  116 (373)
T 2qol_A           38 FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVT  116 (373)
T ss_dssp             TSCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             HHhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            344677788999999999999999999886   467789999997653 3445678899999999999999999999998


Q ss_pred             CCCCCCCccEEEEEecCC-cchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeec
Q 024959          112 PPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF  189 (260)
Q Consensus       112 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df  189 (260)
                      ..     ...++|||+++ ++|.+++... ..+++..++.++.|++++|+|||+++++|+||+|+||+++.++.++|+||
T Consensus       117 ~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Df  191 (373)
T 2qol_A          117 KS-----KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDF  191 (373)
T ss_dssp             SS-----SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             eC-----CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcC
Confidence            76     55899999996 6999999775 47999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCccc----ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          190 GLARTTSETDFM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       190 ~~~~~~~~~~~~----~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      |++.........    ....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+.+..+..+.+.
T Consensus       192 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~  264 (373)
T 2qol_A          192 GLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD  264 (373)
T ss_dssp             ----------------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH
T ss_pred             ccccccccCCccceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            999766543211    11233567999999987 778999999999999999998 999999888877766654

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.6e-40  Score=274.96  Aligned_cols=193  Identities=29%  Similarity=0.561  Sum_probs=152.0

Q ss_pred             cccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-CCCeeeeeceecCCCCCCCccEEEEE
Q 024959           47 IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDVYIVY  125 (260)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~~~~~~lv~  125 (260)
                      .+.||+|+||.||++.++.+++.||+|++...     ....+.+|+.+++.+. ||||+++++++...     ...++||
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~-----~~~~lv~   85 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQ-----LHTFLVM   85 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SEEEEEE
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC-----CEEEEEE
Confidence            47899999999999999999999999999543     2355678999999997 99999999999876     5689999


Q ss_pred             ecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCC---CEEEeecccccccCCCc-c
Q 024959          126 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC---DLKIGDFGLARTTSETD-F  200 (260)
Q Consensus       126 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~---~~~l~df~~~~~~~~~~-~  200 (260)
                      |+++ ++|.+++.....+++..++.++.|++.+|+|||++|++|+||+|+||+++.++   .++|+|||++....... .
T Consensus        86 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~  165 (325)
T 3kn6_A           86 ELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP  165 (325)
T ss_dssp             CCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred             EccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence            9997 59999999999999999999999999999999999999999999999997765   79999999997654432 3


Q ss_pred             cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024959          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (260)
Q Consensus       201 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  250 (260)
                      .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+.
T Consensus       166 ~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  214 (325)
T 3kn6_A          166 LKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDR  214 (325)
T ss_dssp             -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC----
T ss_pred             ccccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCcc
Confidence            344567999999999977 7789999999999999999999999987543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=8.5e-41  Score=271.74  Aligned_cols=208  Identities=29%  Similarity=0.437  Sum_probs=173.7

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      +.|.+.+.||+|+||.||++.+..++..+++|++..... ......+.+|+++++.++||||+++++++...     ...
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~   95 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY-----HNM   95 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEE
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheecC-----CeE
Confidence            345678999999999999999999999999999866432 22356788999999999999999999999876     568


Q ss_pred             EEEEecCC-cchHHHhhh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEe---ccCCCEEEeeccccc
Q 024959          122 YIVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLAR  193 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili---~~~~~~~l~df~~~~  193 (260)
                      ++|||+++ ++|.+.+..    ...+++..++.++.|++++|++||+.|++|+||+|+||++   +.++.++|+|||++.
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~  175 (285)
T 3is5_A           96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE  175 (285)
T ss_dssp             EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred             EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence            99999998 588888754    4789999999999999999999999999999999999999   445789999999998


Q ss_pred             ccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          194 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      ............+++.|+|||.+.  ..++.++|+||||+++|+|++|..||.+.+..+....+
T Consensus       176 ~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~  237 (285)
T 3is5_A          176 LFKSDEHSTNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA  237 (285)
T ss_dssp             C----------CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             ecCCcccCcCcccccCcCChHHhc--cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhh
Confidence            766655556667899999999985  45789999999999999999999999988876665543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3.4e-40  Score=268.71  Aligned_cols=214  Identities=23%  Similarity=0.370  Sum_probs=183.9

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      ........+|.+.+.||+|++|.||++.+..++..|++|.+............+.+|+.+++.++||||+++++++....
T Consensus        19 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   98 (290)
T 1t4h_A           19 VGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV   98 (290)
T ss_dssp             CEECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred             hhcccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc
Confidence            34455566788899999999999999999999999999999776556667788899999999999999999999886532


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCeEec-cCCCEEEeecc
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKPSNLLLN-ASCDLKIGDFG  190 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~H~di~~~nili~-~~~~~~l~df~  190 (260)
                      . ....+++|||+++ ++|.+++.....+++..++.++.|++.+|.+||+.+  ++|+||+|+||+++ .++.++|+|||
T Consensus        99 ~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg  177 (290)
T 1t4h_A           99 K-GKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG  177 (290)
T ss_dssp             S-SCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred             C-CCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence            1 1256899999997 599999998889999999999999999999999999  99999999999997 78999999999


Q ss_pred             cccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 024959          191 LARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  252 (260)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~  252 (260)
                      ++....... .....+++.|+|||.+.+  .++.++|+||||+++|+|++|..||.+.+...
T Consensus       178 ~~~~~~~~~-~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~  236 (290)
T 1t4h_A          178 LATLKRASF-AKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAA  236 (290)
T ss_dssp             GGGGCCTTS-BEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH
T ss_pred             Ccccccccc-cccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH
Confidence            997654442 334567899999998864  48999999999999999999999998755543

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.3e-42  Score=293.13  Aligned_cols=218  Identities=16%  Similarity=0.190  Sum_probs=169.4

Q ss_pred             eeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc-cchHHHHHHHHHHH---HHHHcCCCCeeeee----
Q 024959           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIK---LLRHMEHENVIAIK----  107 (260)
Q Consensus        36 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~---~l~~l~~~~iv~~~----  107 (260)
                      .|....+.|.+.+.||+|+||.||++.+..+++.||||++.... ........+.+|++   .++.++||||++++    
T Consensus        67 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~  146 (377)
T 3byv_A           67 ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI  146 (377)
T ss_dssp             SSSCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBC
T ss_pred             ecCCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhh
Confidence            33444667888999999999999999999999999999986432 23335677889994   55555799999998    


Q ss_pred             ---ceecCCCCC-------CC-----ccEEEEEecCCcchHHHhhhCCCCCH-------HHHHHHHHHHHHHHHHHHhCC
Q 024959          108 ---DIIRPPKKD-------TF-----NDVYIVYELMDTDLHQIIRSDQQLTD-------DHCQYFLYQLLRGLKYVHSAS  165 (260)
Q Consensus       108 ---~~~~~~~~~-------~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~-------~~~~~~~~~i~~~l~~lh~~~  165 (260)
                         +++......       ..     ...|++||+++++|.+++.....+++       ..++.++.|++++|+|||++|
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  226 (377)
T 3byv_A          147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG  226 (377)
T ss_dssp             CCSEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hhhhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence               444433110       00     13789999999999999987655555       888889999999999999999


Q ss_pred             ceeccCCCCCeEeccCCCEEEeecccccccCCCcccccccccccccccccccCc----------CCCCChhhHHHHHHHH
Q 024959          166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC----------TEYTAAIDIWSVGCIL  235 (260)
Q Consensus       166 i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~----------~~~~~~~Di~slG~~l  235 (260)
                      ++|+||||+||+++.++.+||+|||++.....  ......+ +.|+|||.+.+.          ..++.++||||||+++
T Consensus       227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il  303 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI  303 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred             eecCCCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence            99999999999999999999999999986443  2334456 899999999873          2789999999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHH
Q 024959          236 GEIMTREPLFPGKDYVHQLRL  256 (260)
Q Consensus       236 ~~ll~g~~pf~~~~~~~~~~~  256 (260)
                      |+|++|..||.+.+..+....
T Consensus       304 ~elltg~~Pf~~~~~~~~~~~  324 (377)
T 3byv_A          304 YWIWCADLPITKDAALGGSEW  324 (377)
T ss_dssp             HHHHHSSCCC------CCSGG
T ss_pred             HHHHHCCCCCcccccccchhh
Confidence            999999999987665444433

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=8.9e-41  Score=271.76  Aligned_cols=214  Identities=24%  Similarity=0.435  Sum_probs=186.9

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      ..|++....|++.+.||+|++|.||++.+..++..|++|.+....   .....+.+|+++++.++||||+++++++... 
T Consensus         6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-   81 (288)
T 3kfa_A            6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-   81 (288)
T ss_dssp             CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred             hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccC-
Confidence            467788889999999999999999999999999999999997542   2456788999999999999999999999876 


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccc
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~  191 (260)
                          ...++|||+++ ++|.+++...  ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||+
T Consensus        82 ----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~  157 (288)
T 3kfa_A           82 ----PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL  157 (288)
T ss_dssp             ----SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCG
T ss_pred             ----CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCcc
Confidence                55899999998 6999999863  4599999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCcc--cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHh
Q 024959          192 ARTTSETDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLI  257 (260)
Q Consensus       192 ~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  257 (260)
                      +........  .....+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+.+..+..+.+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~  225 (288)
T 3kfa_A          158 SRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL  225 (288)
T ss_dssp             GGTSCSSSSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred             ceeccCCccccccCCccccCcCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            987654432  223345778999999977 678999999999999999999 99999988876665554

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.4e-40  Score=274.26  Aligned_cols=206  Identities=32%  Similarity=0.634  Sum_probs=177.8

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-CCCeeeeeceecCCCCCCCc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~~~  119 (260)
                      .+.|++++.||+|++|.||++.+..+++.||+|++....     ...+.+|+++++.++ ||||+++++++.....   .
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~---~  106 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVS---R  106 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT---C
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCC---C
Confidence            456778999999999999999999999999999996432     356889999999997 9999999999987433   5


Q ss_pred             cEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCC-CEEEeecccccccCC
Q 024959          120 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSE  197 (260)
Q Consensus       120 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~-~~~l~df~~~~~~~~  197 (260)
                      ..++|||+++ ++|.+++.   .+++..++.++.|++.+|++||++|++|+||+|+||+++.++ .++|+|||++.....
T Consensus       107 ~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          107 TPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             CEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             ceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            6899999998 57777764   489999999999999999999999999999999999999776 899999999987766


Q ss_pred             CcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHh
Q 024959          198 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF-PGKDYVHQLRLI  257 (260)
Q Consensus       198 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf-~~~~~~~~~~~i  257 (260)
                      ........++..|+|||.+.+...++.++||||||+++|+|++|..|| .+.+..+.+..+
T Consensus       184 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~  244 (330)
T 3nsz_A          184 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI  244 (330)
T ss_dssp             TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHH
T ss_pred             CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHH
Confidence            655666678999999999987677899999999999999999999999 444555555443

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.4e-40  Score=283.59  Aligned_cols=208  Identities=32%  Similarity=0.588  Sum_probs=182.3

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHc------CCCCeeeeeceecCCC
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM------EHENVIAIKDIIRPPK  114 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~iv~~~~~~~~~~  114 (260)
                      ...|++++.||+|+||.||++.+..+++.||+|++...   ......+.+|+++++.+      +|+||+++++.+... 
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~-  171 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR-  171 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET-
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC-
Confidence            44577899999999999999999999999999999753   33445677888888887      477999999999876 


Q ss_pred             CCCCccEEEEEecCCcchHHHhhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCC--EEEeecc
Q 024959          115 KDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD--LKIGDFG  190 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~--~~l~df~  190 (260)
                          ..+++|||+++++|.+++....  .+++..++.++.||+.+|+|||+.+++|+||||+||+++.++.  ++|+|||
T Consensus       172 ----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          172 ----NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             ----TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             ----CeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecc
Confidence                5689999999999999988754  5999999999999999999999999999999999999999887  9999999


Q ss_pred             cccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          191 LARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      ++......  .....+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+++..|.+
T Consensus       248 ~a~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~  313 (429)
T 3kvw_A          248 SSCYEHQR--VYTYIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIE  313 (429)
T ss_dssp             TCEETTCC--CCSSCSCGGGCCHHHHHT-BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             cceecCCc--ccccCCCCCccChHHHhC-CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            98765433  334577999999999988 6789999999999999999999999999999988887754

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.5e-41  Score=279.29  Aligned_cols=215  Identities=27%  Similarity=0.423  Sum_probs=180.3

Q ss_pred             cceeEeccccCCCcccccccCceEEEEEEe-----CCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeeee
Q 024959           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVN-----SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIK  107 (260)
Q Consensus        34 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~  107 (260)
                      ...|++..+.|++.+.||+|+||.||++.+     ..++..|++|++.... .......+.+|+++++++ +||||++++
T Consensus        37 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~  115 (344)
T 1rjb_A           37 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLL  115 (344)
T ss_dssp             CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence            456889999999999999999999999997     3466789999997542 233456788999999999 899999999


Q ss_pred             ceecCCCCCCCccEEEEEecCC-cchHHHhhhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHh
Q 024959          108 DIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ-----------------------QLTDDHCQYFLYQLLRGLKYVHS  163 (260)
Q Consensus       108 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-----------------------~~~~~~~~~~~~~i~~~l~~lh~  163 (260)
                      +++...     ...++|||+++ ++|.+++....                       .+++..++.++.|++++|++||+
T Consensus       116 ~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  190 (344)
T 1rjb_A          116 GACTLS-----GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF  190 (344)
T ss_dssp             EEECSS-----SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeeC-----CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh
Confidence            999876     55899999997 59999987643                       37999999999999999999999


Q ss_pred             CCceeccCCCCCeEeccCCCEEEeecccccccCCCcc---cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh
Q 024959          164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT  240 (260)
Q Consensus       164 ~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~  240 (260)
                      .|++|+||+|+||+++.++.++|+|||++........   .....+++.|+|||.+.+ ..++.++||||||+++|+|++
T Consensus       191 ~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t  269 (344)
T 1rjb_A          191 KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFS  269 (344)
T ss_dssp             TTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTT
T ss_pred             CCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-CCCChhHhHHHHHHHHHHHHc
Confidence            9999999999999999999999999999976543322   223345778999999877 678999999999999999998


Q ss_pred             -CCCCCCCCChHHHHH
Q 024959          241 -REPLFPGKDYVHQLR  255 (260)
Q Consensus       241 -g~~pf~~~~~~~~~~  255 (260)
                       |..||.+.+....+.
T Consensus       270 ~g~~p~~~~~~~~~~~  285 (344)
T 1rjb_A          270 LGVNPYPGIPVDANFY  285 (344)
T ss_dssp             TSCCSSTTCCCSHHHH
T ss_pred             CCCCCcccCCcHHHHH
Confidence             999998877554443

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.5e-40  Score=267.77  Aligned_cols=212  Identities=19%  Similarity=0.377  Sum_probs=182.2

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      +++..+.|++.+.||+|++|.||++.+.. +..|++|++......   ...+.+|+++++.++||||+++++++...   
T Consensus         3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---   75 (268)
T 3sxs_A            3 MELKREEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVKFYGVCSKE---   75 (268)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTTBC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred             eEechhheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCCCc---HHHHHHHHHHHHhCCCCCEeeEEEEEccC---
Confidence            46778888999999999999999998764 567999999765433   35688999999999999999999999776   


Q ss_pred             CCccEEEEEecCC-cchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                        ...++|||+++ ++|.+++... ..+++..++.++.|++++|++||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus        76 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~  153 (268)
T 3sxs_A           76 --YPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY  153 (268)
T ss_dssp             --SSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEE
T ss_pred             --CceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCcccee
Confidence              55899999997 6899998775 4599999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCccc--ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          195 TSETDFM--TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       195 ~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      .......  ....+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+..+....+.
T Consensus       154 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~  219 (268)
T 3sxs_A          154 VLDDQYVSSVGTKFPVKWSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS  219 (268)
T ss_dssp             CCTTCEEECCSCCCCGGGCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred             cchhhhhcccCCCcCcccCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH
Confidence            6554322  22344677999999976 678899999999999999999 999999888877766554

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.3e-40  Score=270.41  Aligned_cols=213  Identities=23%  Similarity=0.400  Sum_probs=185.0

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~  117 (260)
                      +..+.|.+.+.||+|++|.||++.+..++..|++|++..... .......+.+|+++++.++||||+++++++...    
T Consensus        11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----   86 (284)
T 2vgo_A           11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR----   86 (284)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS----
T ss_pred             hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC----
Confidence            445667789999999999999999999999999999854321 111245678999999999999999999999876    


Q ss_pred             CccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccC
Q 024959          118 FNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (260)
Q Consensus       118 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~  196 (260)
                       ...++|||+++ ++|.+.+.....+++..++.++.|++++|.+||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus        87 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~  165 (284)
T 2vgo_A           87 -KRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP  165 (284)
T ss_dssp             -SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred             -CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence             56899999997 5999999988899999999999999999999999999999999999999999999999999987655


Q ss_pred             CCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       197 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+..+..+.|.
T Consensus       166 ~~~-~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~  225 (284)
T 2vgo_A          166 SLR-RRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV  225 (284)
T ss_dssp             SSC-BCCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             ccc-cccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHh
Confidence            432 334567899999999987 678999999999999999999999999888877766654

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.6e-40  Score=272.48  Aligned_cols=208  Identities=28%  Similarity=0.459  Sum_probs=180.1

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      +.|.+.+.||+|++|.||++.+..+++.|++|++.....  .....+.+|+.+++.++||||+++++++...     ...
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   81 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYEST-----THY   81 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECS-----SEE
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccC-----CEE
Confidence            456688999999999999999999999999999975422  2345678999999999999999999999876     568


Q ss_pred             EEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEe---ccCCCEEEeecccccccCC
Q 024959          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSE  197 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili---~~~~~~~l~df~~~~~~~~  197 (260)
                      ++|||+++ ++|.+.+.....+++..++.++.|++.+|.+||+.|++|+||+|+||++   +.++.++|+|||++.....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  161 (304)
T 2jam_A           82 YLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN  161 (304)
T ss_dssp             EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred             EEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence            99999997 6999999888899999999999999999999999999999999999999   7788999999999876543


Q ss_pred             CcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          198 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       198 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      . ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+.++.|.
T Consensus       162 ~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~  220 (304)
T 2jam_A          162 G-IMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIK  220 (304)
T ss_dssp             B-TTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred             C-ccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            3 2334467899999999987 778999999999999999999999999888877776654

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.1e-40  Score=283.27  Aligned_cols=201  Identities=27%  Similarity=0.450  Sum_probs=162.1

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHH-cCCCCeeeeeceecCCCCCCCc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRH-MEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~-l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      .+|+.+.+.||+|+||.||++.++.+++.||+|++...       ..+.+|+.++.+ .+||||+++++++..... ...
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~-~~~  132 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYA-GRK  132 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET-TEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc-CCc
Confidence            34443347899999999999999999999999999542       345678887744 479999999998864111 115


Q ss_pred             cEEEEEecCC-cchHHHhhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecc---CCCEEEeeccccc
Q 024959          120 DVYIVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLAR  193 (260)
Q Consensus       120 ~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~---~~~~~l~df~~~~  193 (260)
                      .+|+||||++ ++|.+++....  .+++..++.++.|++.+|.|||++|++|+||||+||+++.   ++.+||+|||++.
T Consensus       133 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~  212 (400)
T 1nxk_A          133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  212 (400)
T ss_dssp             EEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence            6899999997 59999998753  5999999999999999999999999999999999999987   7889999999998


Q ss_pred             ccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024959          194 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (260)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  250 (260)
                      ............+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+.
T Consensus       213 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~  268 (400)
T 1nxk_A          213 ETTSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHG  268 (400)
T ss_dssp             ECC-----------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTT
T ss_pred             ccCCCCccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCcc
Confidence            7766555566778999999999977 7889999999999999999999999977653

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3.2e-40  Score=277.33  Aligned_cols=212  Identities=27%  Similarity=0.482  Sum_probs=184.6

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc------chHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCC
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD------NIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPK  114 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~  114 (260)
                      ..|.+.+.||+|++|.||++.++.+|+.||||++.....      .......+.+|+.+++.+ +||||+++++++... 
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-  172 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS-  172 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS-
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC-
Confidence            446788999999999999999999999999999855431      112345677899999999 799999999999776 


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                          ...++||||++ ++|.+++.....+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus       173 ----~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~  248 (365)
T 2y7j_A          173 ----SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC  248 (365)
T ss_dssp             ----SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             ----CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccc
Confidence                56999999998 5999999888899999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCcccccccccccccccccccC-----cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          194 TTSETDFMTEYVVTRWYRAPELLLN-----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ............+++.|+|||.+.+     ...++.++||||||+++|+|++|..||.+.+....++.|.
T Consensus       249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~  318 (365)
T 2y7j_A          249 HLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIM  318 (365)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             ccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            8776655566788999999999863     2357889999999999999999999999888777766654

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.8e-40  Score=275.67  Aligned_cols=218  Identities=28%  Similarity=0.489  Sum_probs=185.7

Q ss_pred             cceeEeccccCCCcccccccCceEEEEEEeC-------CCCeEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeee
Q 024959           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNS-------ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIA  105 (260)
Q Consensus        34 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~  105 (260)
                      ...|++..+.|++.+.||+|+||.||++.+.       .++..|++|++.... .......+.+|+++++++ +||||++
T Consensus        27 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~  105 (334)
T 2pvf_A           27 DPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIIN  105 (334)
T ss_dssp             CTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEee
Confidence            4668888999999999999999999999975       456789999997643 445567788999999999 8999999


Q ss_pred             eeceecCCCCCCCccEEEEEecCC-cchHHHhhhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 024959          106 IKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ----------------QLTDDHCQYFLYQLLRGLKYVHSASVLH  168 (260)
Q Consensus       106 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H  168 (260)
                      +++++...     ...++|||+++ ++|.+++....                .+++..++.++.|++++|++||+.|++|
T Consensus       106 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH  180 (334)
T 2pvf_A          106 LLGACTQD-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIH  180 (334)
T ss_dssp             EEEEECSS-----SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             EEEEEccC-----CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeC
Confidence            99999876     55899999997 59999987643                3899999999999999999999999999


Q ss_pred             ccCCCCCeEeccCCCEEEeecccccccCCCcc---cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCC
Q 024959          169 RDLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPL  244 (260)
Q Consensus       169 ~di~~~nili~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p  244 (260)
                      +||+|+||+++.++.++|+|||++........   .....+++.|+|||.+.+ ..++.++||||||+++|+|++ |..|
T Consensus       181 ~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p  259 (334)
T 2pvf_A          181 RDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSP  259 (334)
T ss_dssp             SCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             CCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcC-CCcChHHHHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999987654432   122344678999999877 678899999999999999999 9999


Q ss_pred             CCCCChHHHHHHhh
Q 024959          245 FPGKDYVHQLRLIT  258 (260)
Q Consensus       245 f~~~~~~~~~~~i~  258 (260)
                      |.+.+..+..+.+.
T Consensus       260 ~~~~~~~~~~~~~~  273 (334)
T 2pvf_A          260 YPGIPVEELFKLLK  273 (334)
T ss_dssp             STTCCHHHHHHHHH
T ss_pred             cCcCCHHHHHHHHh
Confidence            99988877766553

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3.4e-40  Score=271.89  Aligned_cols=219  Identities=21%  Similarity=0.326  Sum_probs=166.8

Q ss_pred             cceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCC
Q 024959           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (260)
Q Consensus        34 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~  113 (260)
                      ++.+....+.|++++.||+|++|.||++.+..+++.|++|++............+.++..+++.++||||+++++++...
T Consensus        17 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~   96 (318)
T 2dyl_A           17 GQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN   96 (318)
T ss_dssp             SSEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             chhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Confidence            46677778888899999999999999999999999999999976544444444455666678888999999999999877


Q ss_pred             CCCCCccEEEEEecCCcchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEeccCCCEEEeeccc
Q 024959          114 KKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGL  191 (260)
Q Consensus       114 ~~~~~~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~H~di~~~nili~~~~~~~l~df~~  191 (260)
                           ...++|||++++.+..+... ...+++..++.++.|++++|.+||+. |++|+||+|+||+++.++.++|+|||+
T Consensus        97 -----~~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  171 (318)
T 2dyl_A           97 -----TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGI  171 (318)
T ss_dssp             -----SEEEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             -----CcEEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCC
Confidence                 56999999997666666544 67899999999999999999999995 999999999999999999999999999


Q ss_pred             ccccCCCcccccccccccccccccccC----cCCCCChhhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHh
Q 024959          192 ARTTSETDFMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGK-DYVHQLRLI  257 (260)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~~~~PE~~~~----~~~~~~~~Di~slG~~l~~ll~g~~pf~~~-~~~~~~~~i  257 (260)
                      +.............+++.|+|||.+..    ...++.++||||||+++|+|++|..||... +..+.+..+
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~  242 (318)
T 2dyl_A          172 SGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV  242 (318)
T ss_dssp             C--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred             chhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHH
Confidence            977665555555678999999999852    256788999999999999999999999873 344444433

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.6e-40  Score=270.25  Aligned_cols=210  Identities=31%  Similarity=0.573  Sum_probs=184.5

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      +.|++.+.||+|++|.||++.+..+++.|++|++............+.+|++++++++||||+++++++...     ...
T Consensus        22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   96 (287)
T 2wei_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS-----SSF   96 (287)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEE
T ss_pred             hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCC-----CeE
Confidence            456688999999999999999999999999999966544444567788999999999999999999999876     568


Q ss_pred             EEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccC---CCEEEeecccccccCC
Q 024959          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSE  197 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~---~~~~l~df~~~~~~~~  197 (260)
                      ++|||+++ ++|.+.+.....+++..++.++.|++.+|.+||++|++|+||+|+||+++.+   +.++|+|||++.....
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~  176 (287)
T 2wei_A           97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (287)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred             EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence            99999997 6999998888899999999999999999999999999999999999999754   4699999999987766


Q ss_pred             CcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          198 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       198 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ........+++.|+|||.+.+  .++.++|+||||+++|+|++|..||.+.+..+..+.+.
T Consensus       177 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  235 (287)
T 2wei_A          177 NTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE  235 (287)
T ss_dssp             CSSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            555555667899999999875  47899999999999999999999999988877776654

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=6.4e-41  Score=271.38  Aligned_cols=214  Identities=30%  Similarity=0.470  Sum_probs=181.5

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      .+.|++.+.||+|++|.||++.+..+++.|++|.+..........+.+.+|++++++++||||+++++++.....   ..
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---~~   81 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN---TT   81 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGG---TE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCC---ce
Confidence            356778999999999999999999999999999997665556667888999999999999999999998754322   56


Q ss_pred             EEEEEecCC-cchHHHhhhC----CCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeccCCCCCeEeccCCCEEEeecc
Q 024959          121 VYIVYELMD-TDLHQIIRSD----QQLTDDHCQYFLYQLLRGLKYVHSAS-----VLHRDLKPSNLLLNASCDLKIGDFG  190 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lh~~~-----i~H~di~~~nili~~~~~~~l~df~  190 (260)
                      .++|||+++ ++|.+++...    ..+++..++.++.|++.+|++||+.+     ++|+||+|+||+++.++.++|+|||
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            899999997 5999988753    45999999999999999999999999     9999999999999999999999999


Q ss_pred             cccccCCCcc-cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          191 LARTTSETDF-MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       191 ~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ++........ .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+..+..+.|.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~  229 (279)
T 2w5a_A          162 LARILNHDTSFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR  229 (279)
T ss_dssp             HHHHC---CHHHHHHHSCCTTCCHHHHHC-C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             hheeeccccccccccCCCccccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHh
Confidence            9877654322 233467889999999987 678899999999999999999999999888776666553

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.8e-40  Score=278.21  Aligned_cols=216  Identities=33%  Similarity=0.529  Sum_probs=173.6

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC--CCC
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK--DTF  118 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~--~~~  118 (260)
                      .+.|.+.+.||+|+||.||++.+..+++.||+|++.....   ......++++.++.++||||+++++++.....  ...
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~   98 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR---FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD   98 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTT---CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc---ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence            4556788999999999999999999999999998854322   22346678888889999999999999865332  111


Q ss_pred             ccEEEEEecCCcchHHHhh----hCCCCCHHHHHHHHHHHHHHHHHHH--hCCceeccCCCCCeEecc-CCCEEEeeccc
Q 024959          119 NDVYIVYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVH--SASVLHRDLKPSNLLLNA-SCDLKIGDFGL  191 (260)
Q Consensus       119 ~~~~lv~e~~~~~l~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lh--~~~i~H~di~~~nili~~-~~~~~l~df~~  191 (260)
                      ...++|||+++++|.+.+.    ....+++..++.++.|++.+|.+||  +.|++|+||||+||+++. ++.++|+|||+
T Consensus        99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~  178 (360)
T 3e3p_A           99 IYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS  178 (360)
T ss_dssp             EEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred             eeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence            3478999999988766554    4677999999999999999999999  999999999999999997 89999999999


Q ss_pred             ccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          192 ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      +.............+++.|+|||.+.+...++.++||||||+++|+|++|..||.+.+..+.+..|.+
T Consensus       179 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~  246 (360)
T 3e3p_A          179 AKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR  246 (360)
T ss_dssp             CBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             ceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHH
Confidence            98877666666677899999999997756689999999999999999999999999999888877653

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.3e-40  Score=290.05  Aligned_cols=215  Identities=23%  Similarity=0.422  Sum_probs=187.4

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      ..|++....|++.+.||+|+||.||++.++.++..||+|.++....   ....+.+|++++++++||||+++++++... 
T Consensus       213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-  288 (495)
T 1opk_A          213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-  288 (495)
T ss_dssp             SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred             cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc---chHHHHHHHHHHHhcCCCCEeeEEEEEecC-
Confidence            5688889999999999999999999999999899999999976433   256788999999999999999999999876 


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccc
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~  191 (260)
                          ..+++|||+++ ++|.+++...  ..+++..++.++.|++.+|+|||+++++|+||+|+||+++.++.+||+|||+
T Consensus       289 ----~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~  364 (495)
T 1opk_A          289 ----PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGL  364 (495)
T ss_dssp             ----SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTC
T ss_pred             ----CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeeccc
Confidence                45899999998 7999999863  4689999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCccc--ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          192 ARTTSETDFM--TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       192 ~~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      +.........  ....++..|+|||.+.. ..++.++||||||+++|+|++ |..||.+.+..+..+.+.
T Consensus       365 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~  433 (495)
T 1opk_A          365 SRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE  433 (495)
T ss_dssp             EECCTTCCEECCTTCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH
T ss_pred             ceeccCCceeecCCCcCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            9876543222  22344678999999976 678999999999999999999 999999988776665543

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.5e-40  Score=270.98  Aligned_cols=217  Identities=19%  Similarity=0.340  Sum_probs=181.2

Q ss_pred             ceeEeccccCCCcc-cccccCceEEEEE--EeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceec
Q 024959           35 NLFEVSSKYVPPIR-PIGRGAYGIVCAA--VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIR  111 (260)
Q Consensus        35 ~~~~~~~~~~~~~~-~lg~G~~g~vy~~--~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~  111 (260)
                      ..+.+....|.+.+ .||+|++|.||++  .+..+++.|++|++............+.+|+++++.++||||+++++++.
T Consensus         9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   88 (291)
T 1xbb_A            9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE   88 (291)
T ss_dssp             --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC
Confidence            44566667777777 9999999999999  45667889999999776555556778899999999999999999999993


Q ss_pred             CCCCCCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecc
Q 024959          112 PPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG  190 (260)
Q Consensus       112 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~  190 (260)
                      .      ...++|||+++ ++|.+++.....+++..++.++.|++++|++||+.|++|+||+|+||+++.++.++|+|||
T Consensus        89 ~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg  162 (291)
T 1xbb_A           89 A------ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFG  162 (291)
T ss_dssp             S------SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred             C------CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCC
Confidence            3      44899999998 6999999998899999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcccc----cccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          191 LARTTSETDFMT----EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       191 ~~~~~~~~~~~~----~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      ++..........    ...+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+.+..+..+.+.
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~  234 (291)
T 1xbb_A          163 LSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE  234 (291)
T ss_dssp             TCEECCTTCSEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred             cceeeccCCCcccccccCCCCceeeChHHhcc-CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            998765443221    1234578999999976 667889999999999999999 999999988877666553

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=5e-40  Score=269.43  Aligned_cols=214  Identities=28%  Similarity=0.403  Sum_probs=180.2

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc--chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCc
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD--NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      ..|.+.+.||+|++|.||++.+..+++.+++|++.....  .......+.+|+++++.++||||+++++++.....   .
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---~   81 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEK---Q   81 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC------
T ss_pred             cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC---C
Confidence            457799999999999999999999999999999965421  12345678899999999999999999999854432   5


Q ss_pred             cEEEEEecCCcchHHHhhh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCC
Q 024959          120 DVYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (260)
Q Consensus       120 ~~~lv~e~~~~~l~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~  197 (260)
                      ..++|||+++++|.+.+..  ...+++..++.++.|++++|.+||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~  161 (305)
T 2wtk_C           82 KMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP  161 (305)
T ss_dssp             CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             eEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence            6899999999888888775  46799999999999999999999999999999999999999999999999999976543


Q ss_pred             C---cccccccccccccccccccCcC-CCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          198 T---DFMTEYVVTRWYRAPELLLNCT-EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       198 ~---~~~~~~~~~~~~~~PE~~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      .   .......+++.|+|||.+.+.. ..+.++||||||+++|+|++|..||.+.+..+..+.|.
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~  226 (305)
T 2wtk_C          162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIG  226 (305)
T ss_dssp             TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHh
Confidence            2   2233456789999999987622 24679999999999999999999999988877766654

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.2e-40  Score=271.37  Aligned_cols=207  Identities=26%  Similarity=0.388  Sum_probs=171.0

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      .+.|++.+.||+|++|.||++.+..+++.|++|++..... .......+.+|+.+++.++||||+++++++...     .
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~  107 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID-----G  107 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----T
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC-----C
Confidence            3557789999999999999999999999999999976533 334457788999999999999999999999876     5


Q ss_pred             cEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          120 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       120 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      ..++|||+++ ++|.+++.....+++..++.++.|++++|++||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            6899999998 599999998889999999999999999999999999999999999999999999999999998765543


Q ss_pred             c--ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024959          199 D--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  253 (260)
Q Consensus       199 ~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~  253 (260)
                      .  ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+....
T Consensus       188 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  243 (309)
T 2h34_A          188 KLTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQLSVM  243 (309)
T ss_dssp             ---------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH
T ss_pred             ccccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH
Confidence            2  2234467899999999987 7788999999999999999999999987765533

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.5e-40  Score=273.11  Aligned_cols=210  Identities=25%  Similarity=0.440  Sum_probs=161.0

Q ss_pred             cceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHH-HHHHcCCCCeeeeeceecC
Q 024959           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIK-LLRHMEHENVIAIKDIIRP  112 (260)
Q Consensus        34 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~iv~~~~~~~~  112 (260)
                      .+.|.+..+.|++++.||+|+||.||++.++.+++.|++|++....... ....+..|+. +++.++||||+++++++..
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~h~niv~~~~~~~~   92 (327)
T 3aln_A           14 EQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK-EQKQLLMDLDVVMRSSDCPYIVQFYGALFR   92 (327)
T ss_dssp             CEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHH-HHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred             HHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCch-HHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence            5778888999999999999999999999999999999999997653333 3344555555 7777899999999999987


Q ss_pred             CCCCCCccEEEEEecCCcchHHHhhh-----CCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEeccCCCEEE
Q 024959          113 PKKDTFNDVYIVYELMDTDLHQIIRS-----DQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKI  186 (260)
Q Consensus       113 ~~~~~~~~~~lv~e~~~~~l~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~H~di~~~nili~~~~~~~l  186 (260)
                      .     ...++|||+++++|.+++..     ...+++..++.++.|++.+|.+||+. |++|+||+|+||+++.++.++|
T Consensus        93 ~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl  167 (327)
T 3aln_A           93 E-----GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKL  167 (327)
T ss_dssp             S-----SEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEE
T ss_pred             C-----CceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEE
Confidence            6     56899999999998888763     67899999999999999999999998 9999999999999999999999


Q ss_pred             eecccccccCCCccccccccccccccccccc---CcCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 024959          187 GDFGLARTTSETDFMTEYVVTRWYRAPELLL---NCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  249 (260)
Q Consensus       187 ~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  249 (260)
                      +|||++.............+++.|+|||.+.   ....++.++||||||+++|+|++|..||.+.+
T Consensus       168 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  233 (327)
T 3aln_A          168 CDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN  233 (327)
T ss_dssp             CCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-
T ss_pred             ccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence            9999998766554444557889999999984   22568899999999999999999999998754

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4e-40  Score=265.03  Aligned_cols=213  Identities=20%  Similarity=0.380  Sum_probs=183.6

Q ss_pred             eeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC
Q 024959           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (260)
Q Consensus        36 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~  115 (260)
                      .|.+....|++.+.||+|++|.||++.+. ++..|++|.+......   .+.+.+|+++++.++||||+++++++...  
T Consensus         2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--   75 (267)
T 3t9t_A            2 KWVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--   75 (267)
T ss_dssp             -CBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSS--
T ss_pred             ceEEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEccC--
Confidence            46778888999999999999999999987 5678999999765433   35688999999999999999999999876  


Q ss_pred             CCCccEEEEEecCC-cchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          116 DTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       116 ~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                         ...++|||+++ ++|.+++... ..+++..++.++.|++++|++||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus        76 ---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~  152 (267)
T 3t9t_A           76 ---APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR  152 (267)
T ss_dssp             ---SSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGG
T ss_pred             ---CCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccc
Confidence               55899999997 6999998775 568999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCc--ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          194 TTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       194 ~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      ......  ......++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+.+..+..+.|.
T Consensus       153 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~  219 (267)
T 3t9t_A          153 FVLDDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS  219 (267)
T ss_dssp             GBCCHHHHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred             ccccccccccccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHh
Confidence            654432  1123345678999999976 678899999999999999999 999999988877776654

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.2e-40  Score=270.67  Aligned_cols=202  Identities=18%  Similarity=0.243  Sum_probs=175.0

Q ss_pred             EeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCCC
Q 024959           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        38 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~  116 (260)
                      .+..+.|++.+.||+|++|.||++.+..+++.||+|++.....    ...+.+|++.++.+ +|++++++++++...   
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~---   78 (298)
T 1csn_A            6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEG---   78 (298)
T ss_dssp             CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEET---
T ss_pred             cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc----cHHHHHHHHHHHHHhcCCCCCeEEeecCCC---
Confidence            3456677889999999999999999999999999999854322    23577899999999 699999999998766   


Q ss_pred             CCccEEEEEecCCcchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCC-----EEEeecc
Q 024959          117 TFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD-----LKIGDFG  190 (260)
Q Consensus       117 ~~~~~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~-----~~l~df~  190 (260)
                        ...++|||+++++|.+++... .++++..++.++.|++++|++||++|++|+||+|+||+++.++.     ++|+|||
T Consensus        79 --~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg  156 (298)
T 1csn_A           79 --LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG  156 (298)
T ss_dssp             --TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred             --ceeEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence              568999999988999999875 46999999999999999999999999999999999999987766     9999999


Q ss_pred             cccccCCCcc--------cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 024959          191 LARTTSETDF--------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  249 (260)
Q Consensus       191 ~~~~~~~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  249 (260)
                      ++........        .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~  222 (298)
T 1csn_A          157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLK  222 (298)
T ss_dssp             TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             cccccccccccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhh
Confidence            9986554322        234467899999999987 778999999999999999999999998743

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3.1e-40  Score=268.89  Aligned_cols=214  Identities=23%  Similarity=0.372  Sum_probs=171.7

Q ss_pred             cceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCC
Q 024959           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (260)
Q Consensus        34 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~  113 (260)
                      ...+++....|++.+.||+|+||.||++.+..   .+++|+++.........+.+.+|+++++.++||||++++++... 
T Consensus        16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-   91 (289)
T 3og7_A           16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-   91 (289)
T ss_dssp             --CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-
T ss_pred             CCCCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC-
Confidence            46678889999999999999999999998754   59999998776677777889999999999999999999997643 


Q ss_pred             CCCCCccEEEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccc
Q 024959          114 KKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (260)
Q Consensus       114 ~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~  191 (260)
                           ...++|||+++ ++|.+.+.. ...+++..++.++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||+
T Consensus        92 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~  166 (289)
T 3og7_A           92 -----PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGL  166 (289)
T ss_dssp             -----SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-
T ss_pred             -----CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEcccee
Confidence                 34789999998 689888854 46799999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCC---cccccccccccccccccccC--cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 024959          192 ARTTSET---DFMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  256 (260)
Q Consensus       192 ~~~~~~~---~~~~~~~~~~~~~~PE~~~~--~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  256 (260)
                      +......   .......+++.|+|||.+..  ...++.++||||||+++|+|++|..||.+.+..+.+..
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~  236 (289)
T 3og7_A          167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIE  236 (289)
T ss_dssp             -----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHH
T ss_pred             ccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHH
Confidence            8755432   22234467899999999862  25678899999999999999999999988766554443

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.6e-40  Score=273.21  Aligned_cols=205  Identities=23%  Similarity=0.364  Sum_probs=175.3

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      .+...+.|.+.+.||+|+||.||++.+. +++.|++|.+.....  .....+.+|+++++.++||||+++++++...   
T Consensus        34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---  107 (321)
T 2qkw_B           34 LEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESS--QGIEEFETEIETLSFCRHPHLVSLIGFCDER---  107 (321)
T ss_dssp             CCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCS--SHHHHHHHHHHGGGSCCCTTBCCEEEECCCT---
T ss_pred             HHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC---
Confidence            3445677889999999999999999975 578999999866432  3466788999999999999999999999876   


Q ss_pred             CCccEEEEEecCC-cchHHHhhhCC----CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRSDQ----QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~  191 (260)
                        ...++|||+++ ++|.+++....    .+++..++.++.|++++|++||++|++|+||+|+||+++.++.++|+|||+
T Consensus       108 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  185 (321)
T 2qkw_B          108 --NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGI  185 (321)
T ss_dssp             --TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred             --CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence              55899999997 59988886543    589999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCc---ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024959          192 ARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (260)
Q Consensus       192 ~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  250 (260)
                      +.......   ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+...
T Consensus       186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~p~~~~~~  246 (321)
T 2qkw_B          186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSLP  246 (321)
T ss_dssp             CEECSSSSCCCCBCCCEEETTTCCHHHHHH-CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS
T ss_pred             ccccccccccccccccCCCccccCHHHhcC-CCCCcccchHhHHHHHHHHHhCCCcccccCc
Confidence            87644322   2233457899999999877 6789999999999999999999999976543

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=9.3e-41  Score=272.67  Aligned_cols=206  Identities=23%  Similarity=0.439  Sum_probs=172.4

Q ss_pred             eEeccccCCCcccccccCceEEEEEE----eCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecC
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAV----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRP  112 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~----~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~  112 (260)
                      .++..+.|++++.||+|+||.||++.    +..+++.||+|++...  .......+.+|+++++.++||||+++++++..
T Consensus         5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   82 (295)
T 3ugc_A            5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS   82 (295)
T ss_dssp             -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred             CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            45667888899999999999999998    6678899999999753  44456778899999999999999999999865


Q ss_pred             CCCCCCccEEEEEecCC-cchHHHhhhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecc
Q 024959          113 PKKDTFNDVYIVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG  190 (260)
Q Consensus       113 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~  190 (260)
                      ...   ..+++|||+++ ++|.+++.... .+++..++.++.|++.+|++||+.+++|+||+|+||+++.++.++|+|||
T Consensus        83 ~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg  159 (295)
T 3ugc_A           83 AGR---RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG  159 (295)
T ss_dssp             HHH---TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             CCC---CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCc
Confidence            422   34799999996 69999998754 59999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcc----cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 024959          191 LARTTSETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK  248 (260)
Q Consensus       191 ~~~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  248 (260)
                      ++........    .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~  220 (295)
T 3ugc_A          160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSP  220 (295)
T ss_dssp             SCC-------------CTTCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred             ccccccCCcceeeeccCCCCccceeCcHHhcC-CCCChHHHHHHHHHHHHHHHhcccccCCC
Confidence            9986544321    222345677999999987 67899999999999999999999998643

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=9.5e-41  Score=280.49  Aligned_cols=208  Identities=16%  Similarity=0.184  Sum_probs=168.5

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCC-----CeEEEEEecCCcccchHHH---------HHHHHHHHHHHHcCCCCee
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSET-----REEVAIKKIGNAFDNIIDA---------RRTLREIKLLRHMEHENVI  104 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~-----~~~~~iK~~~~~~~~~~~~---------~~~~~e~~~l~~l~~~~iv  104 (260)
                      +..+.|++.+.||+|+||.||++.+..+     ++.||+|++..........         .....|+..++.++||||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            4566788899999999999999998765     5789999986543211111         1223455566777899999


Q ss_pred             eeeceecCCCCCCCccEEEEEecCCcchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec--cC
Q 024959          105 AIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN--AS  181 (260)
Q Consensus       105 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~--~~  181 (260)
                      ++++++..... .....++|||+++++|.+++... ..+++..++.++.|++.+|+|||+.+++|+||||+||+++  .+
T Consensus       112 ~~~~~~~~~~~-~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~  190 (364)
T 3op5_A          112 KYWGSGLHDKN-GKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP  190 (364)
T ss_dssp             CEEEEEEEEET-TEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred             eEEeeeeeccC-CcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence            99999876422 11458999999988999999875 6799999999999999999999999999999999999999  88


Q ss_pred             CCEEEeecccccccCCCccc--------ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 024959          182 CDLKIGDFGLARTTSETDFM--------TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK  248 (260)
Q Consensus       182 ~~~~l~df~~~~~~~~~~~~--------~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  248 (260)
                      +.++|+|||++.........        ....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.
T Consensus       191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~Pf~~~  264 (364)
T 3op5_A          191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-VAPSRRGDLEILGYCMIQWLTGHLPWEDN  264 (364)
T ss_dssp             TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence            99999999999765433211        23347999999999987 67899999999999999999999999864

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.2e-40  Score=285.45  Aligned_cols=211  Identities=26%  Similarity=0.426  Sum_probs=181.1

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      ..|++..+.|++.+.||+|+||.||++.+.  ++.||||+++...    ..+.+.+|++++++++||||+++++++....
T Consensus       186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  259 (450)
T 1k9a_A          186 SGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK  259 (450)
T ss_dssp             TTCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT
T ss_pred             cccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC
Confidence            568888999999999999999999999875  6799999997643    3467889999999999999999999987652


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhhCCC--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccc
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~  191 (260)
                          ...++|||+++ ++|.+++.....  +++..++.++.|++++|+|||+++++|+||+|+||+++.++.+||+|||+
T Consensus       260 ----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~  335 (450)
T 1k9a_A          260 ----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL  335 (450)
T ss_dssp             ----SCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             ----CceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCC
Confidence                35899999997 599999987543  79999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          192 ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      +.......  ....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+.+..+..+.+.
T Consensus       336 a~~~~~~~--~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~  400 (450)
T 1k9a_A          336 TKEASSTQ--DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE  400 (450)
T ss_dssp             CEECC--------CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH
T ss_pred             cccccccc--cCCCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            98654332  22355788999999987 778999999999999999998 999999887776666553

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.2e-40  Score=277.70  Aligned_cols=213  Identities=27%  Similarity=0.456  Sum_probs=175.8

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc---chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCC
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD---NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~  117 (260)
                      .+.|++.+.||+|+||.||++.+..++..|++|++.....   .......+.+|+++++.++||||+++++++...    
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----  100 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE----  100 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS----
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC----
Confidence            3456689999999999999999999999999999854311   223457788999999999999999999999876    


Q ss_pred             CccEEEEEecCC-cchHHHhhh----------------------------------------CCCCCHHHHHHHHHHHHH
Q 024959          118 FNDVYIVYELMD-TDLHQIIRS----------------------------------------DQQLTDDHCQYFLYQLLR  156 (260)
Q Consensus       118 ~~~~~lv~e~~~-~~l~~~l~~----------------------------------------~~~~~~~~~~~~~~~i~~  156 (260)
                       ...++|||+++ ++|.+++..                                        ...+++..++.++.|+++
T Consensus       101 -~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          101 -QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             -SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             -CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence             56999999997 699988852                                        112467889999999999


Q ss_pred             HHHHHHhCCceeccCCCCCeEeccCC--CEEEeecccccccCCCc-----ccccccccccccccccccCc-CCCCChhhH
Q 024959          157 GLKYVHSASVLHRDLKPSNLLLNASC--DLKIGDFGLARTTSETD-----FMTEYVVTRWYRAPELLLNC-TEYTAAIDI  228 (260)
Q Consensus       157 ~l~~lh~~~i~H~di~~~nili~~~~--~~~l~df~~~~~~~~~~-----~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di  228 (260)
                      +|+|||+.+++|+||+|+||+++.++  .++|+|||++.......     ......+++.|+|||.+.+. ..++.++||
T Consensus       180 ~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di  259 (345)
T 3hko_A          180 ALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA  259 (345)
T ss_dssp             HHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred             HHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence            99999999999999999999998776  89999999987643221     22345679999999998642 567899999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          229 WSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       229 ~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ||||+++|+|++|..||.+.+..+....+.
T Consensus       260 wslG~il~el~~g~~pf~~~~~~~~~~~~~  289 (345)
T 3hko_A          260 WSAGVLLHLLLMGAVPFPGVNDADTISQVL  289 (345)
T ss_dssp             HHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCCCCCChHHHHHHHH
Confidence            999999999999999999998887777654

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=7.3e-41  Score=286.01  Aligned_cols=204  Identities=33%  Similarity=0.540  Sum_probs=165.8

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc------chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD------NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      .+.|.+.+.||+|+||.||++.+..+++.||+|++.....      .......+.+|++++++++||||+++++++..  
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--  211 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA--  211 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES--
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec--
Confidence            3557789999999999999999999999999999865321      11223357789999999999999999999854  


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCC---CEEEeecc
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC---DLKIGDFG  190 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~---~~~l~df~  190 (260)
                          ...++|||+++ ++|.+.+.....+++..++.++.|++.+|+|||+++++|+||||+||+++.++   .++|+|||
T Consensus       212 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG  287 (419)
T 3i6u_A          212 ----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG  287 (419)
T ss_dssp             ----SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred             ----CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecc
Confidence                34789999997 59999988888999999999999999999999999999999999999997544   59999999


Q ss_pred             cccccCCCcccccccccccccccccccC--cCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024959          191 LARTTSETDFMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (260)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  250 (260)
                      ++.............+++.|+|||.+.+  ...++.++||||||+++|+|++|..||.+.+.
T Consensus       288 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~  349 (419)
T 3i6u_A          288 HSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT  349 (419)
T ss_dssp             TTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS
T ss_pred             cceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc
Confidence            9988776655566788999999999853  35678899999999999999999999986544

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=269.32  Aligned_cols=209  Identities=26%  Similarity=0.446  Sum_probs=157.5

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      .+.|++.+.||+|++|.||++.+..+++.|++|++..... .......+.+|+++++.++||||+++++++...     .
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~   84 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS-----N   84 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS-----S
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC-----C
Confidence            3457789999999999999999999999999999954321 111236688999999999999999999999876     5


Q ss_pred             cEEEEEecCC-cchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCC
Q 024959          120 DVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (260)
Q Consensus       120 ~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~  197 (260)
                      ..++|||+++ ++|.+++... ..+++..++.++.|++++|++||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           85 YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             eEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            6899999997 5899988765 6799999999999999999999999999999999999999999999999999887653


Q ss_pred             Cc-ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024959          198 TD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  255 (260)
Q Consensus       198 ~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~  255 (260)
                      .. ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+..+.+.
T Consensus       165 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~  222 (278)
T 3cok_A          165 PHEKHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN  222 (278)
T ss_dssp             ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----
T ss_pred             CCCcceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH
Confidence            32 2234567899999999877 678899999999999999999999998776554443

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.5e-40  Score=276.79  Aligned_cols=205  Identities=30%  Similarity=0.474  Sum_probs=173.6

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCCCCCc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      .+.|++.+.||+|+||.||++.++.+++.||+|++.....      ...+|++++.++ +||||+++++++...     .
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~~-----~   89 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDDG-----K   89 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEECS-----S
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEcC-----C
Confidence            4456788999999999999999999999999999966432      234688888888 799999999999876     5


Q ss_pred             cEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccC----CCEEEeecccccc
Q 024959          120 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS----CDLKIGDFGLART  194 (260)
Q Consensus       120 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~----~~~~l~df~~~~~  194 (260)
                      ..|+|||+++ ++|.+.+.....+++..++.++.|++.+|+|||++|++|+||||+||++..+    +.++|+|||++..
T Consensus        90 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           90 YVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            6999999997 6999999998899999999999999999999999999999999999998543    3499999999986


Q ss_pred             cCCC-cccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHh
Q 024959          195 TSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK---DYVHQLRLI  257 (260)
Q Consensus       195 ~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~---~~~~~~~~i  257 (260)
                      .... .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.   +..+.++.|
T Consensus       170 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i  235 (342)
T 2qr7_A          170 LRAENGLLMTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI  235 (342)
T ss_dssp             CBCTTCCBCCSSCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHH
T ss_pred             CcCCCCceeccCCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHH
Confidence            5433 33445577999999999876 56788999999999999999999999863   344444444

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.9e-40  Score=274.84  Aligned_cols=211  Identities=24%  Similarity=0.370  Sum_probs=171.1

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCeE----EEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREE----VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~----~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      +....|++.+.||+|+||.||++.+..+++.    |++|.+... ........+.+|++++++++||||+++++++... 
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-   89 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   89 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-
Confidence            4566778899999999999999998877765    477777543 2233456788999999999999999999999864 


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccc
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~  192 (260)
                           ..++++|++. ++|.+++.. ...+++..++.++.|++++|+|||+++++|+||||+||+++.++.++|+|||++
T Consensus        90 -----~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a  164 (327)
T 3poz_A           90 -----TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA  164 (327)
T ss_dssp             -----SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred             -----CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcce
Confidence                 2678888887 699999877 567999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCccc---ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHh
Q 024959          193 RTTSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLI  257 (260)
Q Consensus       193 ~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  257 (260)
                      .........   ....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+.+..+..+.+
T Consensus       165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~  232 (327)
T 3poz_A          165 KLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL  232 (327)
T ss_dssp             HHHTTTCC-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred             eEccCCcccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHH
Confidence            865543322   22344778999999987 788999999999999999999 99999988776655544

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.5e-40  Score=272.43  Aligned_cols=218  Identities=26%  Similarity=0.463  Sum_probs=186.1

Q ss_pred             cceeEeccccCCCcccccccCceEEEEEEeC-----CCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeec
Q 024959           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNS-----ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD  108 (260)
Q Consensus        34 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~  108 (260)
                      .+.|++..+.|++.+.||+|++|.||++.+.     .++..|++|.+... ........+.+|+++++.++||||+++++
T Consensus        17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   95 (322)
T 1p4o_A           17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLG   95 (322)
T ss_dssp             CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred             hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence            4567888888999999999999999999876     45788999999754 33445667889999999999999999999


Q ss_pred             eecCCCCCCCccEEEEEecCC-cchHHHhhhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeE
Q 024959          109 IIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL  177 (260)
Q Consensus       109 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nil  177 (260)
                      ++...     ...++|||+++ ++|.+++...          ..+++..++.++.|++.+|.+||++|++|+||+|+||+
T Consensus        96 ~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIl  170 (322)
T 1p4o_A           96 VVSQG-----QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCM  170 (322)
T ss_dssp             EECSS-----SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEE
T ss_pred             EEccC-----CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEE
Confidence            99776     45899999997 5999988652          45799999999999999999999999999999999999


Q ss_pred             eccCCCEEEeecccccccCCCcc---cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 024959          178 LNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQ  253 (260)
Q Consensus       178 i~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~  253 (260)
                      ++.++.++|+|||++........   .....+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||.+.+..+.
T Consensus       171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  249 (322)
T 1p4o_A          171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV  249 (322)
T ss_dssp             ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH
T ss_pred             EcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH
Confidence            99999999999999876543321   122345788999999877 678999999999999999999 8999999888777


Q ss_pred             HHHhh
Q 024959          254 LRLIT  258 (260)
Q Consensus       254 ~~~i~  258 (260)
                      .+.+.
T Consensus       250 ~~~~~  254 (322)
T 1p4o_A          250 LRFVM  254 (322)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            76654

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.6e-40  Score=280.72  Aligned_cols=198  Identities=39%  Similarity=0.690  Sum_probs=156.7

Q ss_pred             CcccccccCceEEEEEEeC--CCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEE
Q 024959           46 PIRPIGRGAYGIVCAAVNS--ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (260)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~l  123 (260)
                      ..+.||+|+||.||++.++  .+++.||+|++......    ..+.+|+++++.++||||+++++++.....   ..+++
T Consensus        25 ~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~---~~~~l   97 (405)
T 3rgf_A           25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHAD---RKVWL   97 (405)
T ss_dssp             SSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTT---TEEEE
T ss_pred             cCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCC---CeEEE
Confidence            3668999999999999966  56789999999754322    357789999999999999999999954322   56899


Q ss_pred             EEecCCcchHHHhhhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEe----ccCCCEEEeecc
Q 024959          124 VYELMDTDLHQIIRSD---------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFG  190 (260)
Q Consensus       124 v~e~~~~~l~~~l~~~---------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili----~~~~~~~l~df~  190 (260)
                      ||||++++|.+.+...         ..+++..++.++.||+.+|.|||++|++|+||||+||++    +.++.++|+|||
T Consensus        98 v~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  177 (405)
T 3rgf_A           98 LFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG  177 (405)
T ss_dssp             EEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTT
T ss_pred             EEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECC
Confidence            9999999998887631         249999999999999999999999999999999999999    677899999999


Q ss_pred             cccccCCC----cccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024959          191 LARTTSET----DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (260)
Q Consensus       191 ~~~~~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  250 (260)
                      ++......    .......+++.|+|||.+.+...++.++|||||||++|+|++|..||.+.+.
T Consensus       178 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  241 (405)
T 3rgf_A          178 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE  241 (405)
T ss_dssp             CCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred             CceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence            99866543    2233456799999999998756689999999999999999999999987665

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.2e-41  Score=286.39  Aligned_cols=205  Identities=21%  Similarity=0.360  Sum_probs=176.1

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~  118 (260)
                      ...+.|.+.+.||+|+||.||++.+..+++.||+|++..... ......+.+|+++++.++||||+++++++.....   
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~---   81 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT---   81 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT---
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCC---
Confidence            345667789999999999999999999999999999975422 2234667799999999999999999999987643   


Q ss_pred             ccEEEEEecCC-cchHHHhhhCC---CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEe----ccCCCEEEeecc
Q 024959          119 NDVYIVYELMD-TDLHQIIRSDQ---QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFG  190 (260)
Q Consensus       119 ~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili----~~~~~~~l~df~  190 (260)
                      ...++||||++ ++|.+++....   .+++..++.++.|++.+|+|||++|++|+||||+||++    +.++.++|+|||
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG  161 (396)
T 4eut_A           82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG  161 (396)
T ss_dssp             CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred             CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence            45899999997 69999987643   39999999999999999999999999999999999999    677779999999


Q ss_pred             cccccCCCcccccccccccccccccccCc-------CCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 024959          191 LARTTSETDFMTEYVVTRWYRAPELLLNC-------TEYTAAIDIWSVGCILGEIMTREPLFPG  247 (260)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-------~~~~~~~Di~slG~~l~~ll~g~~pf~~  247 (260)
                      ++.............+++.|+|||.+...       ..++.++||||||+++|+|++|..||..
T Consensus       162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~  225 (396)
T 4eut_A          162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP  225 (396)
T ss_dssp             GCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEEC
T ss_pred             CceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            99887766666667789999999998641       3457789999999999999999999964

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=5.6e-40  Score=264.52  Aligned_cols=213  Identities=15%  Similarity=0.217  Sum_probs=182.6

Q ss_pred             eeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC
Q 024959           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (260)
Q Consensus        36 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~  115 (260)
                      .+++..+.|.+.+.||+|++|.||++.+.  +..+++|++............+.+|++++++++||||+++++++.....
T Consensus         4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   81 (271)
T 3kmu_A            4 HSGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA   81 (271)
T ss_dssp             CCCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred             cCCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence            45677788899999999999999999885  6789999998766566677889999999999999999999999987633


Q ss_pred             CCCccEEEEEecCC-cchHHHhhhCC--CCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCeEeccCCCEEEeecc
Q 024959          116 DTFNDVYIVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKPSNLLLNASCDLKIGDFG  190 (260)
Q Consensus       116 ~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~--i~H~di~~~nili~~~~~~~l~df~  190 (260)
                         ...++|||+++ ++|.+++....  .+++..++.++.|++++|.|||+.+  ++|+||+|+||+++.++.++|.||+
T Consensus        82 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~  158 (271)
T 3kmu_A           82 ---PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMAD  158 (271)
T ss_dssp             ---SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGG
T ss_pred             ---CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecc
Confidence               45899999998 59999998765  4899999999999999999999999  9999999999999999999999999


Q ss_pred             cccccCCCcccccccccccccccccccCcC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          191 LARTTSETDFMTEYVVTRWYRAPELLLNCT--EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      +.......    ...+++.|+|||.+.+..  .++.++||||||+++|+|++|..||.+.+..+....+
T Consensus       159 ~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~  223 (271)
T 3kmu_A          159 VKFSFQSP----GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV  223 (271)
T ss_dssp             SCCTTSCT----TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHH
T ss_pred             ceeeeccc----CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHH
Confidence            87553332    346688999999998622  2233799999999999999999999988887765544

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.8e-40  Score=278.41  Aligned_cols=212  Identities=25%  Similarity=0.407  Sum_probs=184.4

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      ...++..+.|++.+.||+|++|.||++.+..++..|++|++.... .......+.+|+++++.++||||+++++++... 
T Consensus        26 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-  103 (360)
T 3eqc_A           26 KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-  103 (360)
T ss_dssp             TCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET-
T ss_pred             cccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC-
Confidence            344667778889999999999999999999999999999997652 344567788999999999999999999999876 


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEeccCCCEEEeecccc
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~H~di~~~nili~~~~~~~l~df~~~  192 (260)
                          ...++|||+++ ++|.+++.....+++..+..++.|++.+|.+||+. |++|+||+|+||+++.++.++|+|||++
T Consensus       104 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  179 (360)
T 3eqc_A          104 ----GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS  179 (360)
T ss_dssp             ----TEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred             ----CEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCC
Confidence                56999999997 59999999888999999999999999999999986 9999999999999999999999999998


Q ss_pred             cccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024959          193 RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  254 (260)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  254 (260)
                      ...... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+..+..
T Consensus       180 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  239 (360)
T 3eqc_A          180 GQLIDS-MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE  239 (360)
T ss_dssp             HHHHHH-C----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHH
T ss_pred             cccccc-cccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            654322 2234467899999999987 77899999999999999999999999987765543

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.7e-40  Score=274.97  Aligned_cols=213  Identities=24%  Similarity=0.346  Sum_probs=178.1

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCeEE--EEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEV--AIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKK  115 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~--~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~  115 (260)
                      +....|++.+.||+|++|.||++.+..++..+  ++|.+... ........+.+|+++++++ +||||+++++++...  
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--   98 (327)
T 1fvr_A           22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--   98 (327)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--
T ss_pred             ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC--
Confidence            44567788999999999999999999888765  89988643 2333456788999999999 899999999999776  


Q ss_pred             CCCccEEEEEecCC-cchHHHhhhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEe
Q 024959          116 DTFNDVYIVYELMD-TDLHQIIRSDQ----------------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL  178 (260)
Q Consensus       116 ~~~~~~~lv~e~~~-~~l~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili  178 (260)
                         ...++|||+++ ++|.+++....                .+++..++.++.|++++|++||++|++|+||+|+||++
T Consensus        99 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~  175 (327)
T 1fvr_A           99 ---GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV  175 (327)
T ss_dssp             ---TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             ---CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEE
Confidence               56999999997 59999987654                79999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeecccccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHh
Q 024959          179 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLI  257 (260)
Q Consensus       179 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  257 (260)
                      +.++.++|+|||++.............+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||.+.+..+..+.+
T Consensus       176 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~  254 (327)
T 1fvr_A          176 GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL  254 (327)
T ss_dssp             CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred             cCCCeEEEcccCcCccccccccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh
Confidence            9999999999999875444333334455788999999876 677899999999999999998 99999998887776665


Q ss_pred             h
Q 024959          258 T  258 (260)
Q Consensus       258 ~  258 (260)
                      .
T Consensus       255 ~  255 (327)
T 1fvr_A          255 P  255 (327)
T ss_dssp             G
T ss_pred             h
Confidence            4

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3.4e-40  Score=267.17  Aligned_cols=216  Identities=23%  Similarity=0.452  Sum_probs=185.3

Q ss_pred             eecceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceec
Q 024959           32 VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIR  111 (260)
Q Consensus        32 ~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~  111 (260)
                      ++...|++..+.|++.+.||+|++|.||++.+. ++..|++|.+......   ...+.+|+++++.++||||+++++++.
T Consensus         3 ~~~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~   78 (279)
T 1qpc_A            3 WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVT   78 (279)
T ss_dssp             TTTCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cchhhcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEc
Confidence            456789999999999999999999999999976 4578999999764332   456889999999999999999999986


Q ss_pred             CCCCCCCccEEEEEecCC-cchHHHhhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEee
Q 024959          112 PPKKDTFNDVYIVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD  188 (260)
Q Consensus       112 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~d  188 (260)
                      .+      ..++|||+++ ++|.+++....  .+++..++.++.|++++|++||+.|++|+||+|+||+++.++.++|+|
T Consensus        79 ~~------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~D  152 (279)
T 1qpc_A           79 QE------PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIAD  152 (279)
T ss_dssp             SS------SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECC
T ss_pred             CC------CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECC
Confidence            43      3789999996 69999987643  799999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCccc--ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          189 FGLARTTSETDFM--TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       189 f~~~~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      ||++.........  ....++..|+|||.+.+ ..++.++||||||+++++|++ |..||.+.+..+..+.+.
T Consensus       153 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  224 (279)
T 1qpc_A          153 FGLARLIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE  224 (279)
T ss_dssp             CTTCEECSSSCEECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred             CcccccccCcccccccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHh
Confidence            9999876544322  22344678999999976 668899999999999999999 999999988877766654

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-39  Score=270.77  Aligned_cols=215  Identities=25%  Similarity=0.402  Sum_probs=177.4

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCCCC----eEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecC
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETR----EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRP  112 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~  112 (260)
                      .++....|.+.+.||+|++|.||++.+..++    ..|++|.+.... .......+.+|+++++.++||||+++++++..
T Consensus        39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  117 (333)
T 1mqb_A           39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK  117 (333)
T ss_dssp             CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence            4777888889999999999999999876543    459999997643 34456678899999999999999999999977


Q ss_pred             CCCCCCccEEEEEecCC-cchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecc
Q 024959          113 PKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG  190 (260)
Q Consensus       113 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~  190 (260)
                      .     ...++|||+++ ++|.+++... ..+++..++.++.|++++|++||+.|++|+||+|+||+++.++.++|+|||
T Consensus       118 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg  192 (333)
T 1mqb_A          118 Y-----KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFG  192 (333)
T ss_dssp             S-----SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             C-----CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCC
Confidence            6     55899999998 5999998764 679999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCccc----ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          191 LARTTSETDFM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       191 ~~~~~~~~~~~----~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      ++.........    ....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+.+..+..+.+.
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~  264 (333)
T 1mqb_A          193 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN  264 (333)
T ss_dssp             C-----------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred             cchhhccccccccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence            99775543211    12234678999999987 778999999999999999998 999999888877776654

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.9e-40  Score=273.42  Aligned_cols=215  Identities=25%  Similarity=0.405  Sum_probs=182.3

Q ss_pred             cceeEeccccCCCcccccccCceEEEEEEeCCCCe-----EEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeeee
Q 024959           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETRE-----EVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIK  107 (260)
Q Consensus        34 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~  107 (260)
                      ...|++....|.+.+.||+|+||.||++.+..++.     .|++|.+.... .......+.+|+++++.+ +||||++++
T Consensus        38 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~  116 (333)
T 2i1m_A           38 NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLL  116 (333)
T ss_dssp             CGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence            45688889999999999999999999999877654     79999997643 344567788999999999 899999999


Q ss_pred             ceecCCCCCCCccEEEEEecCC-cchHHHhhh--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCC
Q 024959          108 DIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS--------------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK  172 (260)
Q Consensus       108 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~--------------~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~  172 (260)
                      +++...     ...++|||+++ ++|.+++..              ...+++..++.++.|++.+|++||+.|++|+||+
T Consensus       117 ~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk  191 (333)
T 2i1m_A          117 GACTHG-----GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVA  191 (333)
T ss_dssp             EEECSS-----SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             EEEecC-----CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcc
Confidence            999876     45899999997 599998865              3468999999999999999999999999999999


Q ss_pred             CCCeEeccCCCEEEeecccccccCCCcc---cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 024959          173 PSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGK  248 (260)
Q Consensus       173 ~~nili~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~  248 (260)
                      |+||+++.++.++|+|||++........   .....+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||.+.
T Consensus       192 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~  270 (333)
T 2i1m_A          192 ARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNPYPGI  270 (333)
T ss_dssp             GGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             cceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhcc-CCCChHHHHHHHHHHHHHHHcCCCCCCccc
Confidence            9999999999999999999976543321   223345778999999887 678999999999999999998 99999887


Q ss_pred             ChHHHHH
Q 024959          249 DYVHQLR  255 (260)
Q Consensus       249 ~~~~~~~  255 (260)
                      +....+.
T Consensus       271 ~~~~~~~  277 (333)
T 2i1m_A          271 LVNSKFY  277 (333)
T ss_dssp             CSSHHHH
T ss_pred             chhHHHH
Confidence            6544443

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=5.8e-40  Score=271.88  Aligned_cols=203  Identities=27%  Similarity=0.440  Sum_probs=168.9

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC------
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK------  115 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~------  115 (260)
                      +.|++++.||+|+||.||++.++.+++.||+|++.... .......+.+|++++++++||||+++++++.+...      
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            34668899999999999999999999999999996543 33356778899999999999999999998855421      


Q ss_pred             ----------------------------------------------CCCccEEEEEecCC-cchHHHhhhCCC---CCHH
Q 024959          116 ----------------------------------------------DTFNDVYIVYELMD-TDLHQIIRSDQQ---LTDD  145 (260)
Q Consensus       116 ----------------------------------------------~~~~~~~lv~e~~~-~~l~~~l~~~~~---~~~~  145 (260)
                                                                    ......++|||+++ ++|.+++.....   .++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                          01124899999998 599999887543   5666


Q ss_pred             HHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc-------------ccccccccccccc
Q 024959          146 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-------------FMTEYVVTRWYRA  212 (260)
Q Consensus       146 ~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~-------------~~~~~~~~~~~~~  212 (260)
                      .++.++.|++++|+|||++|++|+||||+||+++.++.++|+|||++.......             ......+++.|+|
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a  244 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS  244 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence            789999999999999999999999999999999999999999999998765542             2233467999999


Q ss_pred             cccccCcCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 024959          213 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFP  246 (260)
Q Consensus       213 PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~  246 (260)
                      ||.+.+ ..++.++||||||+++|+|++|..|+.
T Consensus       245 PE~~~~-~~~~~~~Di~slG~il~el~~~~~~~~  277 (332)
T 3qd2_B          245 PEQIHG-NNYSHKVDIFSLGLILFELLYSFSTQM  277 (332)
T ss_dssp             HHHHHC-CCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred             hHHhcC-CCCcchhhHHHHHHHHHHHHHcCCChh
Confidence            999987 778999999999999999999887763

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.7e-39  Score=266.10  Aligned_cols=211  Identities=26%  Similarity=0.440  Sum_probs=181.7

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~  118 (260)
                      ...+.|++++.||+|++|.||++.+..+++.|++|++..... ......+.+|+.+++.++||||+++++++...     
T Consensus        19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----   92 (303)
T 3a7i_A           19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-----   92 (303)
T ss_dssp             CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----
T ss_pred             ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----
Confidence            345567789999999999999999999999999999965432 23456788999999999999999999999876     


Q ss_pred             ccEEEEEecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCC
Q 024959          119 NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (260)
Q Consensus       119 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~  197 (260)
                      ...++|||++++ +|.+++.. .++++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        93 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  171 (303)
T 3a7i_A           93 TKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  171 (303)
T ss_dssp             TEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred             CeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCc
Confidence            568999999984 88887654 6799999999999999999999999999999999999999999999999999976554


Q ss_pred             Cc-ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          198 TD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       198 ~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      .. ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+
T Consensus       172 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  231 (303)
T 3a7i_A          172 TQIKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI  231 (303)
T ss_dssp             TBCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             cccccCccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHh
Confidence            32 2334567899999999987 67889999999999999999999999988776655544

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.1e-40  Score=272.87  Aligned_cols=203  Identities=33%  Similarity=0.552  Sum_probs=172.3

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc------chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD------NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~  115 (260)
                      +.|++.+.||+|+||.||++.+..+++.|++|++.....      .......+.+|+++++.++||||+++++++..+  
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--   87 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE--   87 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS--
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC--
Confidence            456789999999999999999999999999999865321      112234577899999999999999999998654  


Q ss_pred             CCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCC---EEEeeccc
Q 024959          116 DTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGL  191 (260)
Q Consensus       116 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~---~~l~df~~  191 (260)
                          .+++|||+++ ++|.+.+.....+++..++.++.|++.+|.+||++|++|+||+|+||+++.++.   ++|+|||+
T Consensus        88 ----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~  163 (322)
T 2ycf_A           88 ----DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH  163 (322)
T ss_dssp             ----SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred             ----ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence                3799999997 599999988889999999999999999999999999999999999999987654   99999999


Q ss_pred             ccccCCCccccccccccccccccccc--CcCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024959          192 ARTTSETDFMTEYVVTRWYRAPELLL--NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (260)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~~~~PE~~~--~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  250 (260)
                      +.............+++.|+|||.+.  +...++.++||||||+++|+|++|..||.+.+.
T Consensus       164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  224 (322)
T 2ycf_A          164 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT  224 (322)
T ss_dssp             CEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC
T ss_pred             ceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch
Confidence            98876655445567799999999974  236688999999999999999999999976543

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=9e-40  Score=265.03  Aligned_cols=215  Identities=20%  Similarity=0.388  Sum_probs=178.4

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEeCC---CCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceec
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSE---TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIR  111 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~  111 (260)
                      ..+.+..+.|++.+.||+|++|.||++.+..   ++..|++|.+.... .......+.+|+++++.++||||+++++++.
T Consensus         5 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   83 (281)
T 3cc6_A            5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE   83 (281)
T ss_dssp             CCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred             ccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence            4566778888899999999999999998643   34569999997653 3445678889999999999999999999986


Q ss_pred             CCCCCCCccEEEEEecCC-cchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeec
Q 024959          112 PPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF  189 (260)
Q Consensus       112 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df  189 (260)
                      .+      ..++|||+++ ++|.+++... ..+++..++.++.|++++|.+||++|++|+||+|+||+++.++.++|+||
T Consensus        84 ~~------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df  157 (281)
T 3cc6_A           84 EE------PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDF  157 (281)
T ss_dssp             SS------SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCC
T ss_pred             CC------CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCcc
Confidence            53      3589999998 6999998764 56999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcc--cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHh
Q 024959          190 GLARTTSETDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLI  257 (260)
Q Consensus       190 ~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  257 (260)
                      |++........  .....+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+..+..+.+
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~  227 (281)
T 3cc6_A          158 GLSRYIEDEDYYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL  227 (281)
T ss_dssp             CGGGCC---------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH
T ss_pred             CCCcccccccccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHH
Confidence            99876654332  223345778999999976 678999999999999999998 99999877766555444

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=9.4e-40  Score=263.47  Aligned_cols=210  Identities=29%  Similarity=0.430  Sum_probs=167.0

Q ss_pred             EeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccc--hHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC
Q 024959           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN--IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (260)
Q Consensus        38 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~  115 (260)
                      ++....|++.+.||+|++|.||++.+.  +..+++|++......  ....+.+.+|+++++.++||||+++++++...  
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--   78 (271)
T 3dtc_A            3 EIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE--   78 (271)
T ss_dssp             BCCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred             ccchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC--
Confidence            456677889999999999999999875  678999998654322  22346788999999999999999999999876  


Q ss_pred             CCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCCCCeEecc--------CCC
Q 024959          116 DTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS---VLHRDLKPSNLLLNA--------SCD  183 (260)
Q Consensus       116 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~H~di~~~nili~~--------~~~  183 (260)
                         ...++|||+++ ++|.+++ ....+++..++.++.|++++|++||+.+   ++|+||+|+||+++.        ++.
T Consensus        79 ---~~~~lv~e~~~~~~L~~~~-~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~  154 (271)
T 3dtc_A           79 ---PNLCLVMEFARGGPLNRVL-SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKI  154 (271)
T ss_dssp             -----CEEEEECCTTEEHHHHH-TSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCC
T ss_pred             ---CceEEEEEcCCCCCHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcc
Confidence               55899999997 5777766 4568999999999999999999999999   899999999999986        678


Q ss_pred             EEEeecccccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          184 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       184 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      ++|+|||++........ ....+++.|+|||.+.+ ..++.++|+||||+++++|++|..||.+.+.......+
T Consensus       155 ~kl~Dfg~~~~~~~~~~-~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~  226 (271)
T 3dtc_A          155 LKITDFGLAREWHRTTK-MSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV  226 (271)
T ss_dssp             EEECCCCC--------------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH
T ss_pred             eEEccCCcccccccccc-cCCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Confidence            99999999976554432 24567899999999987 67899999999999999999999999988876655443

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=8.1e-40  Score=265.72  Aligned_cols=202  Identities=24%  Similarity=0.335  Sum_probs=174.7

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCCCCCcc
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      ..|++.+.||+|++|.||++.+..+++.|++|++............+.+|+..+..+ +||||+++++++...     ..
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~-----~~   85 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED-----DH   85 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET-----TE
T ss_pred             chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC-----Ce
Confidence            456688999999999999999999999999999977655566677888999999999 899999999999876     56


Q ss_pred             EEEEEecCC-cchHHHhhhC----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccC--------------
Q 024959          121 VYIVYELMD-TDLHQIIRSD----QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS--------------  181 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~--------------  181 (260)
                      .++|||+++ ++|.+++...    ..+++..++.++.|++++|.+||++|++|+||+|+||+++.+              
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------------
T ss_pred             EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            899999997 5999998764    679999999999999999999999999999999999999844              


Q ss_pred             -----CCEEEeecccccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH
Q 024959          182 -----CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  251 (260)
Q Consensus       182 -----~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~  251 (260)
                           ..++|+|||.+.......   ...+++.|+|||.+.+...++.++||||||+++++|++|.+|+...+..
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~  237 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW  237 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH
T ss_pred             ccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH
Confidence                 479999999988766543   3357899999999987556678999999999999999999887655443

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=5.2e-40  Score=283.50  Aligned_cols=214  Identities=25%  Similarity=0.459  Sum_probs=184.9

Q ss_pred             cceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCC
Q 024959           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (260)
Q Consensus        34 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~  113 (260)
                      ...|++..+.|.+.+.||+|+||.||++.++. +..||||+++....   ..+.+.+|+++++.++||||+++++++.. 
T Consensus       180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-  254 (454)
T 1qcf_A          180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVTK-  254 (454)
T ss_dssp             TTCSBCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSB---CHHHHHHHHHHHTTCCCTTBCCEEEEECS-
T ss_pred             ccceeechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCc---cHHHHHHHHHHHhhCCCCCEeeEEEEEeC-
Confidence            46789999999999999999999999999864 57899999976432   35678899999999999999999999863 


Q ss_pred             CCCCCccEEEEEecCC-cchHHHhhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecc
Q 024959          114 KKDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG  190 (260)
Q Consensus       114 ~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~  190 (260)
                           ...++|||++. ++|.+++...  ..+++..++.++.|++.+|+|||+++++|+||+|+||+++.++.+||+|||
T Consensus       255 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG  329 (454)
T 1qcf_A          255 -----EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFG  329 (454)
T ss_dssp             -----SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTT
T ss_pred             -----CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCC
Confidence                 34799999997 6999998754  378999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcc--cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          191 LARTTSETDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       191 ~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      ++........  .....++..|+|||.+.. ..++.++||||||+++|+|++ |..||.+.+..+..+.+.
T Consensus       330 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~  399 (454)
T 1qcf_A          330 LARVIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE  399 (454)
T ss_dssp             GGGGBCCHHHHTTCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred             CceEcCCCceeccCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            9987654321  122344678999999976 678999999999999999999 999999998888776654

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=7.2e-40  Score=269.71  Aligned_cols=213  Identities=29%  Similarity=0.485  Sum_probs=181.4

Q ss_pred             cceeEeccccCCCcccccccCceEEEEEEe-----CCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeeee
Q 024959           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVN-----SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIK  107 (260)
Q Consensus        34 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~  107 (260)
                      ...|++..+.|++.+.||+|+||.||++.+     ..+++.|++|++.... .......+.+|+++++.+ +||||++++
T Consensus        19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            456778888999999999999999999984     4577899999997653 344556788999999999 699999999


Q ss_pred             ceecCCCCCCCccEEEEEecCC-cchHHHhhhCCC----------------CCHHHHHHHHHHHHHHHHHHHhCCceecc
Q 024959          108 DIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ----------------LTDDHCQYFLYQLLRGLKYVHSASVLHRD  170 (260)
Q Consensus       108 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~----------------~~~~~~~~~~~~i~~~l~~lh~~~i~H~d  170 (260)
                      +++....    ..+++|||+++ ++|.+++.....                +++..++.++.|++++|.+||+.|++|+|
T Consensus        98 ~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~d  173 (316)
T 2xir_A           98 GACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD  173 (316)
T ss_dssp             EEECCTT----SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             EEEecCC----CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCccccc
Confidence            9987652    34899999998 599999987544                89999999999999999999999999999


Q ss_pred             CCCCCeEeccCCCEEEeecccccccCCCcc---cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCC
Q 024959          171 LKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFP  246 (260)
Q Consensus       171 i~~~nili~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~  246 (260)
                      |+|+||+++.++.++|+|||++........   .....+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||.
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~  252 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYP  252 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence            999999999999999999999976544322   223455788999999987 778999999999999999998 999998


Q ss_pred             CCChHH
Q 024959          247 GKDYVH  252 (260)
Q Consensus       247 ~~~~~~  252 (260)
                      +.+..+
T Consensus       253 ~~~~~~  258 (316)
T 2xir_A          253 GVKIDE  258 (316)
T ss_dssp             TCCCSH
T ss_pred             ccchhH
Confidence            776443

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=4.7e-40  Score=267.63  Aligned_cols=208  Identities=17%  Similarity=0.258  Sum_probs=176.8

Q ss_pred             EeccccCCCcccccccCceEEEEEEeCCCC-------eEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeecee
Q 024959           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETR-------EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII  110 (260)
Q Consensus        38 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~-------~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~  110 (260)
                      ++..+.|.+.+.||+|+||.||++.+..++       ..|++|++....  ....+.+.+|+++++.++||||+++++++
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   81 (289)
T 4fvq_A            4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVC   81 (289)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred             EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence            456778889999999999999999998876       469999996543  33456788999999999999999999999


Q ss_pred             cCCCCCCCccEEEEEecCC-cchHHHhhhCCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCC-----
Q 024959          111 RPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD-----  183 (260)
Q Consensus       111 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~-----  183 (260)
                      ...     ...++|||+++ ++|.+++..... +++..++.++.|++++|.+||+++++|+||+|+||+++.++.     
T Consensus        82 ~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~  156 (289)
T 4fvq_A           82 VCG-----DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGN  156 (289)
T ss_dssp             CCT-----TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTB
T ss_pred             EeC-----CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccc
Confidence            876     45799999998 699999987654 999999999999999999999999999999999999998887     


Q ss_pred             ---EEEeecccccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 024959          184 ---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLR  255 (260)
Q Consensus       184 ---~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~  255 (260)
                         ++|+|||++......   ....+++.|+|||.+.+...++.++||||||+++|+|++ +.+||...+......
T Consensus       157 ~~~~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~  229 (289)
T 4fvq_A          157 PPFIKLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ  229 (289)
T ss_dssp             CCEEEECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred             cceeeeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH
Confidence               999999998665433   234567889999999875678999999999999999999 556666666554443

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.7e-40  Score=274.88  Aligned_cols=212  Identities=20%  Similarity=0.340  Sum_probs=175.5

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCeE----EEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREE----VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~----~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      +....|++++.||+|+||.||++.+..++..    +++|.+.... .......+.+|+.+++.++||||+++++++..  
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--   86 (325)
T 3kex_A           10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG--   86 (325)
T ss_dssp             CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB--
T ss_pred             cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--
Confidence            4456788899999999999999999888776    7777764432 11223456689999999999999999999853  


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccc
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~  192 (260)
                          ...++|||++. ++|.+++... ..+++..++.++.|++++|+|||+.|++|+||||+||+++.++.++|+|||++
T Consensus        87 ----~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a  162 (325)
T 3kex_A           87 ----SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVA  162 (325)
T ss_dssp             ----SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred             ----CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcc
Confidence                34889999998 6999998774 57999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCc---ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          193 RTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       193 ~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      .......   ......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+.+..+....+.
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~  231 (325)
T 3kex_A          163 DLLPPDDKQLLYSEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE  231 (325)
T ss_dssp             GGSCCCTTCCC-----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH
T ss_pred             cccCcccccccccCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH
Confidence            8764432   2233455778999999987 678999999999999999999 999999888776666554

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2e-39  Score=268.52  Aligned_cols=217  Identities=27%  Similarity=0.397  Sum_probs=177.8

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEE-----eCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeece
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAV-----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI  109 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~-----~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~  109 (260)
                      ...++..+.|++++.||+|++|.||++.     +..++..|++|.+... ........+.+|+.++++++||||++++++
T Consensus        23 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~  101 (327)
T 2yfx_A           23 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGV  101 (327)
T ss_dssp             GSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEE
Confidence            4456778888999999999999999998     5567889999999754 334456678899999999999999999999


Q ss_pred             ecCCCCCCCccEEEEEecCC-cchHHHhhhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecc-
Q 024959          110 IRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-  180 (260)
Q Consensus       110 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~-  180 (260)
                      +...     ...++|||+++ ++|.+++...       ..+++..++.++.|++++|.+||+.|++|+||+|+||+++. 
T Consensus       102 ~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~  176 (327)
T 2yfx_A          102 SLQS-----LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCP  176 (327)
T ss_dssp             ECSS-----SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCS
T ss_pred             EcCC-----CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecC
Confidence            9876     45799999996 6999999875       34899999999999999999999999999999999999984 


Q ss_pred             --CCCEEEeecccccccCCCc---ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 024959          181 --SCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL  254 (260)
Q Consensus       181 --~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~  254 (260)
                        +..++|+|||++.......   ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||.+.+..+..
T Consensus       177 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  255 (327)
T 2yfx_A          177 GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL  255 (327)
T ss_dssp             STTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             CCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHH
Confidence              4469999999987543222   1223455788999999977 678999999999999999998 99999998887776


Q ss_pred             HHhh
Q 024959          255 RLIT  258 (260)
Q Consensus       255 ~~i~  258 (260)
                      +.+.
T Consensus       256 ~~~~  259 (327)
T 2yfx_A          256 EFVT  259 (327)
T ss_dssp             HHHH
T ss_pred             HHHh
Confidence            6654

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=5.1e-40  Score=265.62  Aligned_cols=203  Identities=32%  Similarity=0.460  Sum_probs=175.7

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      +.|++.+.||+|++|.||++.+..+++.|++|++..... ......+.+|+.+++.++||||+++++++...     ...
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   80 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREG-----NIQ   80 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEE
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC-----CEE
Confidence            346678999999999999999999999999999865432 23456788999999999999999999999876     568


Q ss_pred             EEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc-
Q 024959          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~-  199 (260)
                      ++|||+++ ++|.+++.....+++..++.++.|++++|++||+.|++|+||+|+||+++.++.++|+|||++....... 
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  160 (276)
T 2yex_A           81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (276)
T ss_dssp             EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             EEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence            99999998 5999998888889999999999999999999999999999999999999999999999999987643221 


Q ss_pred             --ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024959          200 --FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (260)
Q Consensus       200 --~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  250 (260)
                        ......+++.|+|||.+.+....+.++|+||||+++|+|++|..||.+.+.
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~  213 (276)
T 2yex_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD  213 (276)
T ss_dssp             ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT
T ss_pred             hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Confidence              233456789999999998744457789999999999999999999987654

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.6e-39  Score=275.55  Aligned_cols=202  Identities=29%  Similarity=0.466  Sum_probs=174.3

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC--------CCCeeeeeceecC
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME--------HENVIAIKDIIRP  112 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~--------~~~iv~~~~~~~~  112 (260)
                      .+.|++.+.||+|+||.||++.+..+++.||+|++...   ......+.+|+++++.++        |+||+++++++..
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~  112 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI  112 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence            56678999999999999999999999999999999653   334567889999999995        7889999999873


Q ss_pred             CCCCCCccEEEEEecCCcchHHHhhhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEeccCC-------
Q 024959          113 PKKDTFNDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASC-------  182 (260)
Q Consensus       113 ~~~~~~~~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~-~i~H~di~~~nili~~~~-------  182 (260)
                      ... ....+++|||++++++.+.+...  ..+++..++.++.||+++|+|||++ |++|+||||+||+++.++       
T Consensus       113 ~~~-~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~  191 (397)
T 1wak_A          113 SGV-NGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA  191 (397)
T ss_dssp             EET-TEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred             cCC-CCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence            211 11568999999999888888764  5699999999999999999999998 999999999999998775       


Q ss_pred             ------------------------------------------CEEEeecccccccCCCcccccccccccccccccccCcC
Q 024959          183 ------------------------------------------DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT  220 (260)
Q Consensus       183 ------------------------------------------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~  220 (260)
                                                                .++|+|||++......  .....+++.|+|||.+.+ .
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~-~  268 (397)
T 1wak_A          192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIG-S  268 (397)
T ss_dssp             HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHT-S
T ss_pred             hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcC-C
Confidence                                                      7999999999776543  334567999999999988 6


Q ss_pred             CCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 024959          221 EYTAAIDIWSVGCILGEIMTREPLFPGKD  249 (260)
Q Consensus       221 ~~~~~~Di~slG~~l~~ll~g~~pf~~~~  249 (260)
                      .++.++||||||+++|+|++|..||.+.+
T Consensus       269 ~~~~~~DiwslG~il~elltg~~pf~~~~  297 (397)
T 1wak_A          269 GYNTPADIWSTACMAFELATGDYLFEPHS  297 (397)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred             CCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            78999999999999999999999998765

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.5e-40  Score=273.49  Aligned_cols=209  Identities=24%  Similarity=0.306  Sum_probs=174.5

Q ss_pred             cceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCC
Q 024959           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (260)
Q Consensus        34 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~  113 (260)
                      ...+.+....|++.+.||+|+||.||++.+.  ++.||+|++...   ........+|+.++++++||||+++++++...
T Consensus        16 ~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   90 (322)
T 3soc_A           16 TENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRG   90 (322)
T ss_dssp             CCCEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred             ccccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccC
Confidence            4566788888999999999999999999876  689999999653   23344556789999999999999999999765


Q ss_pred             CCCCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhC----------CceeccCCCCCeEeccCC
Q 024959          114 KKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA----------SVLHRDLKPSNLLLNASC  182 (260)
Q Consensus       114 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~----------~i~H~di~~~nili~~~~  182 (260)
                      ... ...+++|||+++ ++|.+++.. ..+++..++.++.|++++|+|||+.          +++|+||||+||+++.++
T Consensus        91 ~~~-~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~  168 (322)
T 3soc_A           91 TSV-DVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL  168 (322)
T ss_dssp             CSS-SEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC
T ss_pred             CCC-CceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC
Confidence            321 145799999997 599999866 4599999999999999999999999          999999999999999999


Q ss_pred             CEEEeecccccccCCCcc---cccccccccccccccccCc----CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 024959          183 DLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNC----TEYTAAIDIWSVGCILGEIMTREPLFPGKD  249 (260)
Q Consensus       183 ~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~----~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  249 (260)
                      .+||+|||++........   .....+++.|+|||.+.+.    ..++.++||||||+++|+|++|..||.+..
T Consensus       169 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~  242 (322)
T 3soc_A          169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV  242 (322)
T ss_dssp             CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred             eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence            999999999976544322   2335679999999998763    234567899999999999999999997653

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.1e-39  Score=268.69  Aligned_cols=200  Identities=26%  Similarity=0.409  Sum_probs=167.0

Q ss_pred             cCCC-cccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCCCCCcc
Q 024959           43 YVPP-IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        43 ~~~~-~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      .|.+ .+.||+|+||.||++.+..+++.||+|++......  ....+.+|+++++++ +||||+++++++...     ..
T Consensus        13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~-----~~   85 (316)
T 2ac3_A           13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH--IRSRVFREVEMLYQCQGHRNVLELIEFFEEE-----DR   85 (316)
T ss_dssp             SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC--CHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TE
T ss_pred             eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch--hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC-----CE
Confidence            3445 47899999999999999999999999999654322  346788999999985 799999999999876     56


Q ss_pred             EEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCC---EEEeecccccccC
Q 024959          121 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLARTTS  196 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~---~~l~df~~~~~~~  196 (260)
                      +++|||+++ ++|.+++.....+++..++.++.|++++|++||+++++|+||+|+||+++.++.   ++|+|||++....
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A           86 FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             EEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence            999999997 699999998889999999999999999999999999999999999999988766   9999999987543


Q ss_pred             CCc--------ccccccccccccccccccC----cCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 024959          197 ETD--------FMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKD  249 (260)
Q Consensus       197 ~~~--------~~~~~~~~~~~~~PE~~~~----~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  249 (260)
                      ...        ......+++.|+|||.+..    ...++.++||||||+++|+|++|..||.+.+
T Consensus       166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  230 (316)
T 2ac3_A          166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC  230 (316)
T ss_dssp             ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred             cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence            221        1223457899999999864    1346889999999999999999999998764

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.1e-40  Score=271.22  Aligned_cols=214  Identities=25%  Similarity=0.398  Sum_probs=160.0

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      ..|.+....|++.+.||+|++|.||++.+..+++.|++|.+.... .......+.+|+++++.++||||+++++++... 
T Consensus         8 ~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-   85 (303)
T 2vwi_A            8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK-CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK-   85 (303)
T ss_dssp             -----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESS-
T ss_pred             cccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh-cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeec-
Confidence            457788888999999999999999999999899999999986542 223456678899999999999999999999877 


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhh--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEE
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRS--------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLK  185 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~--------~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~  185 (260)
                          ...++|||+++ ++|.+++..        ...+++..++.++.|++++|.+||+.|++|+||+|+||+++.++.++
T Consensus        86 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~k  161 (303)
T 2vwi_A           86 ----DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQ  161 (303)
T ss_dssp             ----SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEE
T ss_pred             ----CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEE
Confidence                45899999996 689888863        45699999999999999999999999999999999999999999999


Q ss_pred             EeecccccccCCCc------ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024959          186 IGDFGLARTTSETD------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  254 (260)
Q Consensus       186 l~df~~~~~~~~~~------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  254 (260)
                      |+|||++.......      ......+++.|+|||.+.+...++.++|+||||+++|+|++|..||.+.+.....
T Consensus       162 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  236 (303)
T 2vwi_A          162 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL  236 (303)
T ss_dssp             ECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH
T ss_pred             EEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH
Confidence            99999987654321      1223467889999999875456889999999999999999999999876654433

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-39  Score=264.00  Aligned_cols=214  Identities=21%  Similarity=0.366  Sum_probs=179.6

Q ss_pred             eEeccccCCCcc-cccccCceEEEEEEeC--CCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCC
Q 024959           37 FEVSSKYVPPIR-PIGRGAYGIVCAAVNS--ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (260)
Q Consensus        37 ~~~~~~~~~~~~-~lg~G~~g~vy~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~  113 (260)
                      +.+..+.|.+.+ .||+|++|.||++.+.  .++..|++|+++.. ........+.+|+++++.++||||+++++++.. 
T Consensus         4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-   81 (287)
T 1u59_A            4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-   81 (287)
T ss_dssp             CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred             ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC-
Confidence            445556665666 9999999999999854  46788999999765 344567788899999999999999999999943 


Q ss_pred             CCCCCccEEEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccc
Q 024959          114 KKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (260)
Q Consensus       114 ~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~  191 (260)
                           ...++|||+++ ++|.+++.. ...+++..++.++.|++++|.+||+.|++|+||+|+||+++.++.++|+|||+
T Consensus        82 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~  156 (287)
T 1u59_A           82 -----EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGL  156 (287)
T ss_dssp             -----SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred             -----CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccc
Confidence                 34899999998 599998865 45699999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCccc----ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          192 ARTTSETDFM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       192 ~~~~~~~~~~----~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      +.........    ....+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+.+..+..+.|.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~  227 (287)
T 1u59_A          157 SKALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE  227 (287)
T ss_dssp             CEECTTCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH
T ss_pred             eeeeccCcceeeccccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHh
Confidence            9876543221    22234788999999976 678899999999999999998 999999988877766654

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.7e-39  Score=268.50  Aligned_cols=209  Identities=29%  Similarity=0.519  Sum_probs=180.2

Q ss_pred             eccccCCCcccccccCceEEEEEEe-CCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCC------Ceeeeeceec
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVN-SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE------NVIAIKDIIR  111 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~------~iv~~~~~~~  111 (260)
                      +..+.|++.+.||+|++|.||++.+ ..+++.||+|+++..   ......+.+|+++++.++|+      +++++++++.
T Consensus        11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~   87 (339)
T 1z57_A           11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE   87 (339)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred             CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence            3356677899999999999999998 567899999999653   33456778899999998755      4999999998


Q ss_pred             CCCCCCCccEEEEEecCCcchHHHhhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecc---------
Q 024959          112 PPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---------  180 (260)
Q Consensus       112 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~---------  180 (260)
                      ..     ...++|||+++++|.+++....  ++++..++.++.|++++|+|||++|++|+||+|+||+++.         
T Consensus        88 ~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~  162 (339)
T 1z57_A           88 HH-----GHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP  162 (339)
T ss_dssp             ET-----TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred             cC-----CcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCC
Confidence            76     5699999999999999998765  6899999999999999999999999999999999999987         


Q ss_pred             ----------CCCEEEeecccccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024959          181 ----------SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (260)
Q Consensus       181 ----------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  250 (260)
                                ++.++|+|||++......  .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+.
T Consensus       163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~  239 (339)
T 1z57_A          163 KIKRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDS  239 (339)
T ss_dssp             ---CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred             ccccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence                      668999999999775443  234567999999999987 7789999999999999999999999999988


Q ss_pred             HHHHHHhh
Q 024959          251 VHQLRLIT  258 (260)
Q Consensus       251 ~~~~~~i~  258 (260)
                      .+.+..+.
T Consensus       240 ~~~~~~~~  247 (339)
T 1z57_A          240 KEHLAMME  247 (339)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            87766553

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=7.9e-40  Score=292.26  Aligned_cols=204  Identities=21%  Similarity=0.375  Sum_probs=175.0

Q ss_pred             ccccccCceEEEEEE--eCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEEEE
Q 024959           48 RPIGRGAYGIVCAAV--NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY  125 (260)
Q Consensus        48 ~~lg~G~~g~vy~~~--~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv~  125 (260)
                      +.||+|+||.||++.  ++.+++.||||+++...........+.+|+++++.++||||+++++++...      ..++||
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------~~~lv~  448 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE------SWMLVM  448 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS------SEEEEE
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC------CEEEEE
Confidence            479999999999994  456678899999987655555567899999999999999999999998643      378999


Q ss_pred             ecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCcc----
Q 024959          126 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF----  200 (260)
Q Consensus       126 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~----  200 (260)
                      |+++ ++|.+++.....+++..++.++.||+.+|+|||+++++|+||||+||+++.++.+||+|||++........    
T Consensus       449 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  528 (635)
T 4fl3_A          449 EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  528 (635)
T ss_dssp             ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred             EccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence            9998 69999999889999999999999999999999999999999999999999999999999999987654322    


Q ss_pred             cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       201 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      .....+++.|+|||.+.. ..++.++||||||+++|+|++ |..||.+.+..+..+.|.
T Consensus       529 ~~~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~  586 (635)
T 4fl3_A          529 QTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE  586 (635)
T ss_dssp             ------CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred             ccCCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            122234678999999977 778999999999999999998 999999999888777664

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.3e-39  Score=263.38  Aligned_cols=205  Identities=22%  Similarity=0.371  Sum_probs=173.3

Q ss_pred             EeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHH-----HHHHHHHHHHHHcCCCCeeeeeceecC
Q 024959           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA-----RRTLREIKLLRHMEHENVIAIKDIIRP  112 (260)
Q Consensus        38 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~-----~~~~~e~~~l~~l~~~~iv~~~~~~~~  112 (260)
                      .+..+.|++.+.||+|++|.||++.+..+++.||+|++..........     +.+.+|+++++.++||||+++++++..
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   94 (287)
T 4f0f_A           15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN   94 (287)
T ss_dssp             BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred             hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence            345567778999999999999999999999999999986543322111     678899999999999999999999976


Q ss_pred             CCCCCCccEEEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCeEeccCCC-----
Q 024959          113 PKKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKPSNLLLNASCD-----  183 (260)
Q Consensus       113 ~~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~H~di~~~nili~~~~~-----  183 (260)
                      .       .++|||+++ ++|.+.+.. ...+++..++.++.|++.+|++||+.+  ++|+||+|+||+++.++.     
T Consensus        95 ~-------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~  167 (287)
T 4f0f_A           95 P-------PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVC  167 (287)
T ss_dssp             T-------TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCC
T ss_pred             C-------CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCcee
Confidence            5       369999998 699887765 457999999999999999999999999  999999999999988776     


Q ss_pred             EEEeecccccccCCCcccccccccccccccccccC-cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH
Q 024959          184 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN-CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  251 (260)
Q Consensus       184 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~  251 (260)
                      ++|+|||++......  .....+++.|+|||.+.. ...++.++||||||+++|+|++|..||...+..
T Consensus       168 ~kl~Dfg~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~  234 (287)
T 4f0f_A          168 AKVADFGLSQQSVHS--VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG  234 (287)
T ss_dssp             EEECCCTTCBCCSSC--EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC
T ss_pred             EEeCCCCcccccccc--ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc
Confidence            999999999755443  344567899999999843 245688999999999999999999999876543

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.3e-39  Score=266.59  Aligned_cols=209  Identities=28%  Similarity=0.475  Sum_probs=174.1

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      .....+.|++.+.||+|++|.||++.+..+++.|++|.+....    ....+.+|+++++.++||||+++++++...   
T Consensus        24 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---   96 (314)
T 3com_A           24 TKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKN---   96 (314)
T ss_dssp             ------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEET---
T ss_pred             hhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeC---
Confidence            3445667788999999999999999999999999999996542    235678899999999999999999999876   


Q ss_pred             CCccEEEEEecCCc-chHHHhh-hCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          117 TFNDVYIVYELMDT-DLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       117 ~~~~~~lv~e~~~~-~l~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                        ...++|||++++ +|.+++. ....+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus        97 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  174 (314)
T 3com_A           97 --TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQ  174 (314)
T ss_dssp             --TEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             --CEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchh
Confidence              568999999984 9999887 467899999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCc-ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024959          195 TSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  255 (260)
Q Consensus       195 ~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~  255 (260)
                      ..... ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+......
T Consensus       175 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~  235 (314)
T 3com_A          175 LTDTMAKRNTVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF  235 (314)
T ss_dssp             CBTTBSCBCCCCSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred             hhhhccccCccCCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence            54432 2334567899999999987 678999999999999999999999999877655443

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.8e-39  Score=267.52  Aligned_cols=210  Identities=24%  Similarity=0.352  Sum_probs=174.9

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      +.+.+..+.|++.+.||+|++|.||++.+..+++.||+|++...  .......+.+|+++++.++||||+++++++....
T Consensus        22 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   99 (317)
T 2buj_A           22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRER   99 (317)
T ss_dssp             EEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE
T ss_pred             cEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc
Confidence            55667788888999999999999999999999999999998543  3456677889999999999999999999986321


Q ss_pred             CCCCccEEEEEecCCc-chHHHhhh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeec
Q 024959          115 KDTFNDVYIVYELMDT-DLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF  189 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~~-~l~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df  189 (260)
                      . .....++|||++++ +|.+++..    ...+++..++.++.|++++|++||+.+++|+||+|+||+++.++.++|+||
T Consensus       100 ~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~df  178 (317)
T 2buj_A          100 G-AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDL  178 (317)
T ss_dssp             T-TEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred             C-CCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEec
Confidence            1 11468999999985 99888875    567999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCccc----------ccccccccccccccccCcC--CCCChhhHHHHHHHHHHHHhCCCCCCC
Q 024959          190 GLARTTSETDFM----------TEYVVTRWYRAPELLLNCT--EYTAAIDIWSVGCILGEIMTREPLFPG  247 (260)
Q Consensus       190 ~~~~~~~~~~~~----------~~~~~~~~~~~PE~~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~  247 (260)
                      |++.........          ....+++.|+|||.+....  .++.++||||||+++|+|++|..||..
T Consensus       179 g~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  248 (317)
T 2buj_A          179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM  248 (317)
T ss_dssp             SSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred             CcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence            988765432111          1234588899999987522  368899999999999999999999953

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=7.5e-40  Score=273.12  Aligned_cols=208  Identities=14%  Similarity=0.170  Sum_probs=168.2

Q ss_pred             EeccccCCCcccccccCceEEEEEEeCC---CCeEEEEEecCCcccchH---------HHHHHHHHHHHHHHcCCCCeee
Q 024959           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSE---TREEVAIKKIGNAFDNII---------DARRTLREIKLLRHMEHENVIA  105 (260)
Q Consensus        38 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~---~~~~~~iK~~~~~~~~~~---------~~~~~~~e~~~l~~l~~~~iv~  105 (260)
                      ++..+.|.+.+.||+|+||.||++.+..   ++..+++|+.........         ....+.+|+..++.++||||++
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~  112 (345)
T 2v62_A           33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL  112 (345)
T ss_dssp             CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred             cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence            3456778899999999999999999987   788999999865432111         1123557888899999999999


Q ss_pred             eeceecCCCCCCCccEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCC--C
Q 024959          106 IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC--D  183 (260)
Q Consensus       106 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~--~  183 (260)
                      +++++..... .....++|||+++++|.+++.....+++..++.++.|++.+|+|||+.+++|+||+|+||+++.++  .
T Consensus       113 ~~~~~~~~~~-~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~  191 (345)
T 2v62_A          113 FYGSGLTEFK-GRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQ  191 (345)
T ss_dssp             EEEEEEEESS-SCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTS
T ss_pred             eecccccccC-CCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCc
Confidence            9999876221 115689999999889999998888999999999999999999999999999999999999998877  9


Q ss_pred             EEEeecccccccCCCc--------ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 024959          184 LKIGDFGLARTTSETD--------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG  247 (260)
Q Consensus       184 ~~l~df~~~~~~~~~~--------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~  247 (260)
                      ++|+|||++.......        ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+
T Consensus       192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~  262 (345)
T 2v62_A          192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-VALSRRSDVEILGYCMLRWLCGKLPWEQ  262 (345)
T ss_dssp             EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred             EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            9999999997654322        1134467899999999987 6789999999999999999999999965

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=9.4e-40  Score=264.54  Aligned_cols=213  Identities=26%  Similarity=0.434  Sum_probs=172.9

Q ss_pred             eecceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceec
Q 024959           32 VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIR  111 (260)
Q Consensus        32 ~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~  111 (260)
                      .+...|.+..+.|++.+.||+|++|.||++.+.  ++.|++|++....    ..+.+.+|+++++.++||||+++++++.
T Consensus        11 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~   84 (278)
T 1byg_A           11 FYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIV   84 (278)
T ss_dssp             ----CCBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEEC
T ss_pred             hhhccccCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            334567788889999999999999999999875  7899999997542    4567889999999999999999999876


Q ss_pred             CCCCCCCccEEEEEecCCc-chHHHhhhCCC--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEee
Q 024959          112 PPKKDTFNDVYIVYELMDT-DLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD  188 (260)
Q Consensus       112 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~d  188 (260)
                      ...    ...++|||++++ +|.+++.....  +++..++.++.|++++|++||++|++|+||+|+||+++.++.++|+|
T Consensus        85 ~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~D  160 (278)
T 1byg_A           85 EEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSD  160 (278)
T ss_dssp             CC------CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECC
T ss_pred             cCC----CceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEee
Confidence            542    358999999984 99999876543  89999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHh
Q 024959          189 FGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLI  257 (260)
Q Consensus       189 f~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  257 (260)
                      ||++.......  ....+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+..+....+
T Consensus       161 fg~~~~~~~~~--~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~  227 (278)
T 1byg_A          161 FGLTKEASSTQ--DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV  227 (278)
T ss_dssp             CCC--------------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH
T ss_pred             ccccccccccc--cCCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            99987654432  23345788999999977 778999999999999999998 99999988776665554

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.7e-40  Score=277.59  Aligned_cols=208  Identities=15%  Similarity=0.180  Sum_probs=158.2

Q ss_pred             ccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHc--CCCCeeeeec-------e
Q 024959           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHM--EHENVIAIKD-------I  109 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l--~~~~iv~~~~-------~  109 (260)
                      ....|.+.+.||+|+||.||++.+..+++.||+|++..... .......+.+|+++++.+  +||||++++.       +
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred             CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence            34457789999999999999999999999999999977543 334556667786555555  5999888553       3


Q ss_pred             ecCCCCC------------CCccEEEEEecCCcchHHHhhhC-CCCCHHHH------HHHHHHHHHHHHHHHhCCceecc
Q 024959          110 IRPPKKD------------TFNDVYIVYELMDTDLHQIIRSD-QQLTDDHC------QYFLYQLLRGLKYVHSASVLHRD  170 (260)
Q Consensus       110 ~~~~~~~------------~~~~~~lv~e~~~~~l~~~l~~~-~~~~~~~~------~~~~~~i~~~l~~lh~~~i~H~d  170 (260)
                      +......            ....+++||||++++|.+++... ..+++..+      ..++.||+++|+|||++|++|+|
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD  219 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH  219 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence            3222110            01348999999999999999863 34555555      67789999999999999999999


Q ss_pred             CCCCCeEeccCCCEEEeecccccccCCCcccccccccccccccccccC-cCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 024959          171 LKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN-CTEYTAAIDIWSVGCILGEIMTREPLFPGKD  249 (260)
Q Consensus       171 i~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  249 (260)
                      |||+|||++.++.+||+|||++.......  ....+++.|+|||.+.+ ...++.++||||||+++|+|++|..||.+.+
T Consensus       220 ikp~NIll~~~~~~kL~DFG~a~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~  297 (371)
T 3q60_A          220 FTPDNLFIMPDGRLMLGDVSALWKVGTRG--PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT  297 (371)
T ss_dssp             CSGGGEEECTTSCEEECCGGGEEETTCEE--EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCC
T ss_pred             CCHHHEEECCCCCEEEEecceeeecCCCc--cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcC
Confidence            99999999999999999999998765432  24455799999999964 2467899999999999999999999998773

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.4e-40  Score=270.60  Aligned_cols=212  Identities=24%  Similarity=0.364  Sum_probs=171.6

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCeEE----EEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEV----AIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~----~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      +....|++++.||+|+||.||++.+..+++.+    ++|.+.... .......+.+|+.+++.++||||+++++++... 
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-   89 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   89 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-
Confidence            45677889999999999999999998887755    666664432 223456788999999999999999999999764 


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccc
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~  192 (260)
                           ..++++|++. ++|.+++.. ...+++..++.++.|++.+|.|||++|++|+||||+||+++.++.++|+|||++
T Consensus        90 -----~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a  164 (327)
T 3lzb_A           90 -----TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA  164 (327)
T ss_dssp             -----SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred             -----CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence                 2678888887 699999876 467999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCccc---ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          193 RTTSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       193 ~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      .........   ....+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||.+.+..+..+.+.
T Consensus       165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~  233 (327)
T 3lzb_A          165 KLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE  233 (327)
T ss_dssp             ---------------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred             eEccCccccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Confidence            875443222   22344678999999987 778999999999999999999 999999888766655543

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.7e-39  Score=265.84  Aligned_cols=211  Identities=27%  Similarity=0.435  Sum_probs=175.0

Q ss_pred             ccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCc
Q 024959           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      ..+.|++++.||+|++|.||++.+..++..+++|++.....  .....+.+|+++++.++||||+++++++...     .
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~   89 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYIVEIEILATCDHPYIVKLLGAYYHD-----G   89 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC------
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH--HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC-----C
Confidence            35567789999999999999999999999999999865432  2456788999999999999999999999876     5


Q ss_pred             cEEEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCC
Q 024959          120 DVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (260)
Q Consensus       120 ~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~  197 (260)
                      ..++|||+++ ++|.+++.. ...+++..++.++.|++++|.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        90 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (302)
T 2j7t_A           90 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK  169 (302)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred             eEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence            5899999998 588887765 56799999999999999999999999999999999999999999999999998753221


Q ss_pred             C-ccccccccccccccccccc----CcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          198 T-DFMTEYVVTRWYRAPELLL----NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       198 ~-~~~~~~~~~~~~~~PE~~~----~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      . .......+++.|+|||.+.    ....++.++|+||||+++|+|++|..||...+.......+
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  234 (302)
T 2j7t_A          170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI  234 (302)
T ss_dssp             HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH
Confidence            1 1122346788999999984    2366889999999999999999999999988877665544

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.8e-39  Score=279.92  Aligned_cols=214  Identities=25%  Similarity=0.429  Sum_probs=180.0

Q ss_pred             cceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCC
Q 024959           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (260)
Q Consensus        34 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~  113 (260)
                      ...|++..+.|++.+.||+|+||.||++.++.+ ..||+|+++.....   .+.+.+|++++++++||||+++++++.. 
T Consensus       176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-  250 (452)
T 1fmk_A          176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-  250 (452)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             ccccccChhHceeeeeecCCCCeEEEEEEECCC-ceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-
Confidence            467889999999999999999999999998764 67999999764322   4578899999999999999999999865 


Q ss_pred             CCCCCccEEEEEecCC-cchHHHhhh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecc
Q 024959          114 KKDTFNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG  190 (260)
Q Consensus       114 ~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~  190 (260)
                           ...++|||+++ ++|.+++..  ...+++..+..++.|++++|+|||+++++|+||+|+||+++.++.+||+|||
T Consensus       251 -----~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG  325 (452)
T 1fmk_A          251 -----EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG  325 (452)
T ss_dssp             -----SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             -----CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCc
Confidence                 33789999997 699999875  3569999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcc--cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          191 LARTTSETDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       191 ~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      ++........  .....++..|+|||.+.. ..++.++||||||+++|+|++ |..||.+.+..+..+.+.
T Consensus       326 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~  395 (452)
T 1fmk_A          326 LARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE  395 (452)
T ss_dssp             TTC--------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred             cceecCCCceecccCCcccccccCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            9976544321  223345678999999987 678999999999999999999 999999998887777654

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=8.1e-40  Score=267.83  Aligned_cols=205  Identities=25%  Similarity=0.442  Sum_probs=171.6

Q ss_pred             eEeccccCCCcccccccCceEEEEEE----eCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecC
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAV----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRP  112 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~----~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~  112 (260)
                      ..+..+.|++++.||+|++|.||++.    +..+++.||+|++.... .......+.+|+++++.++||||+++++++..
T Consensus        16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   94 (302)
T 4e5w_A           16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTE   94 (302)
T ss_dssp             TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence            34556678889999999999999998    67789999999997543 22234678899999999999999999999987


Q ss_pred             CCCCCCccEEEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecc
Q 024959          113 PKKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG  190 (260)
Q Consensus       113 ~~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~  190 (260)
                      ...   ..+++|||+++ ++|.+++.. ...+++..++.++.|++.+|++||+.|++|+||+|+||+++.++.++|+|||
T Consensus        95 ~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg  171 (302)
T 4e5w_A           95 DGG---NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFG  171 (302)
T ss_dssp             ------CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred             CCC---ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccc
Confidence            643   45899999997 599999854 5679999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcc----cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 024959          191 LARTTSETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFP  246 (260)
Q Consensus       191 ~~~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~  246 (260)
                      ++........    .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..|+.
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~  230 (302)
T 4e5w_A          172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDSDS  230 (302)
T ss_dssp             TCEECCTTCCEEECCCCTTCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred             ccccccCCCcceeccCCCCCCccccCCeeecC-CCCCcchhHHHHHHHHHHHHHccCCCc
Confidence            9987655432    223455778999999977 677899999999999999999998764

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=6.7e-39  Score=263.81  Aligned_cols=214  Identities=23%  Similarity=0.352  Sum_probs=178.0

Q ss_pred             EEeeecceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC--CCCeeee
Q 024959           29 QYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME--HENVIAI  106 (260)
Q Consensus        29 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~iv~~  106 (260)
                      .-+.+.+.+.+..+.|++.+.||+|++|.||++.+.. ++.|++|++............+.+|+++++.++  ||||+++
T Consensus        15 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~   93 (313)
T 3cek_A           15 TENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL   93 (313)
T ss_dssp             -----CCEEEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCE
T ss_pred             CCCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEE
Confidence            3455667888999999999999999999999999864 788999999766556667788899999999997  5999999


Q ss_pred             eceecCCCCCCCccEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEE
Q 024959          107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI  186 (260)
Q Consensus       107 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l  186 (260)
                      ++++...     ...++|||+.+++|.+++.....+++..++.++.|++++|.+||+.+++|+||+|+||+++ ++.++|
T Consensus        94 ~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL  167 (313)
T 3cek_A           94 YDYEITD-----QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKL  167 (313)
T ss_dssp             EEEEECS-----SEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEE
T ss_pred             EEEeecC-----CEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEE
Confidence            9999876     5699999977789999999989999999999999999999999999999999999999996 488999


Q ss_pred             eecccccccCCCcc---cccccccccccccccccCc----------CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 024959          187 GDFGLARTTSETDF---MTEYVVTRWYRAPELLLNC----------TEYTAAIDIWSVGCILGEIMTREPLFPGKD  249 (260)
Q Consensus       187 ~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~----------~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  249 (260)
                      +|||++........   .....+++.|+|||.+.+.          ..++.++||||||+++|+|++|..||....
T Consensus       168 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  243 (313)
T 3cek_A          168 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII  243 (313)
T ss_dssp             CCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             eeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence            99999976544322   2344679999999998641          357889999999999999999999997654

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.8e-39  Score=268.86  Aligned_cols=205  Identities=23%  Similarity=0.391  Sum_probs=176.3

Q ss_pred             eccccCCCcccccccCceEEEEEE----eCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAV----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~----~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      +..+.|++++.||+|++|.||++.    +..+++.|++|++...  .......+.+|++++++++||||+++++++....
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   97 (327)
T 3lxl_A           20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG   97 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence            445678889999999999999998    5778999999999764  3445677889999999999999999999987543


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccc
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~  192 (260)
                      .   ...++|||+++ ++|.+++.. ...+++..++.++.|++.+|++||+.|++|+||+|+||+++.++.++|+|||++
T Consensus        98 ~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~  174 (327)
T 3lxl_A           98 R---QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA  174 (327)
T ss_dssp             S---CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred             C---ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccc
Confidence            3   56899999996 699999876 456999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCcc----cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 024959          193 RTTSETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  249 (260)
Q Consensus       193 ~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  249 (260)
                      ........    .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||....
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~  234 (327)
T 3lxl_A          175 KLLPLDKDYYVVREPGQSPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYCDKSCSPS  234 (327)
T ss_dssp             EECCTTCSEEECSSCCCSCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred             eecccCCccceeeccCCccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCCCCCcccc
Confidence            87654432    122345777999999877 677899999999999999999999986544

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.1e-39  Score=265.01  Aligned_cols=216  Identities=24%  Similarity=0.409  Sum_probs=174.1

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDT  117 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~  117 (260)
                      .....|++.+.||+|++|.||++.+..+++.|++|++......   ...+.+|+.+++++ +||||+++++++.......
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   97 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   97 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence            3456677899999999999999999999999999998654322   35678899999999 7999999999987643211


Q ss_pred             -CccEEEEEecCC-cchHHHhhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          118 -FNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       118 -~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                       ....++|||+++ ++|.+++...  ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  177 (326)
T 2x7f_A           98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  177 (326)
T ss_dssp             CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred             ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence             256899999998 4999998764  579999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCc-ccccccccccccccccccC----cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          194 TTSETD-FMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       194 ~~~~~~-~~~~~~~~~~~~~PE~~~~----~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      ...... ......+++.|+|||.+..    ...++.++||||||+++|+|++|..||.+.+.......+
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  246 (326)
T 2x7f_A          178 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI  246 (326)
T ss_dssp             -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             ecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh
Confidence            654332 2334567899999999862    256789999999999999999999999988876655444

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.1e-39  Score=269.18  Aligned_cols=207  Identities=28%  Similarity=0.404  Sum_probs=174.3

Q ss_pred             eeEeccccCCCcccccccCceEEEEEE----eCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceec
Q 024959           36 LFEVSSKYVPPIRPIGRGAYGIVCAAV----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIR  111 (260)
Q Consensus        36 ~~~~~~~~~~~~~~lg~G~~g~vy~~~----~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~  111 (260)
                      .-.+..++|++++.||+|+||.||++.    +..+++.||+|++... ........+.+|+++++.++||||+++++++.
T Consensus        25 ~~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  103 (318)
T 3lxp_A           25 PTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCE  103 (318)
T ss_dssp             CCBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEe
Confidence            344567777899999999999998774    4457889999999765 34455677889999999999999999999998


Q ss_pred             CCCCCCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecc
Q 024959          112 PPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG  190 (260)
Q Consensus       112 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~  190 (260)
                      ....   ..+++|||+++ ++|.+++... .+++..++.++.|++.+|++||+.|++|+||+|+||+++.++.++|+|||
T Consensus       104 ~~~~---~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg  179 (318)
T 3lxp_A          104 DAGA---ASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFG  179 (318)
T ss_dssp             ETTT---TEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGG
T ss_pred             cCCC---ceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcc
Confidence            7533   56899999997 5999988664 49999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcc----cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 024959          191 LARTTSETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK  248 (260)
Q Consensus       191 ~~~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  248 (260)
                      ++........    .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||...
T Consensus       180 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~  240 (318)
T 3lxp_A          180 LAKAVPEGHEYYRVREDGDSPVFWYAPECLKE-YKFYYASDVWSFGVTLYELLTHCDSSQSP  240 (318)
T ss_dssp             GCEECCTTCSEEEC---CCCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred             ccccccccccccccccCCCCCceeeChHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence            9987655432    223345778999999987 67789999999999999999999999754

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=7.4e-39  Score=270.61  Aligned_cols=208  Identities=34%  Similarity=0.560  Sum_probs=180.2

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-CC-----CeeeeeceecCCC
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HE-----NVIAIKDIIRPPK  114 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~-----~iv~~~~~~~~~~  114 (260)
                      ...|++.+.||+|+||.||++.+..+++.||+|++...   ......+..|+++++.++ |+     +|+++++++... 
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~-  128 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR-  128 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET-
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC-
Confidence            45677899999999999999999999999999999753   234566777888888885 55     489999998876 


Q ss_pred             CCCCccEEEEEecCCcchHHHhhhC--CCCCHHHHHHHHHHHHHHHHHHH--hCCceeccCCCCCeEec--cCCCEEEee
Q 024959          115 KDTFNDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVH--SASVLHRDLKPSNLLLN--ASCDLKIGD  188 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh--~~~i~H~di~~~nili~--~~~~~~l~d  188 (260)
                          ...++|||+++++|.+++...  ..+++..++.++.|++.+|.+||  +.|++|+||||+||+++  .++.++|+|
T Consensus       129 ----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D  204 (382)
T 2vx3_A          129 ----NHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD  204 (382)
T ss_dssp             ----TEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred             ----CceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence                569999999999999999875  46999999999999999999999  57999999999999995  467899999


Q ss_pred             cccccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          189 FGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       189 f~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      ||++......  .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+++..|.+
T Consensus       205 FG~a~~~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~  272 (382)
T 2vx3_A          205 FGSSCQLGQR--IYQYIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVE  272 (382)
T ss_dssp             CTTCEETTCC--CCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             ccCceecccc--cccccCCccccChHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            9999876543  334577899999999988 6789999999999999999999999999999888887754

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.6e-39  Score=265.21  Aligned_cols=201  Identities=22%  Similarity=0.263  Sum_probs=168.6

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      .+.|++.+.||+|++|.||++.+..+++.||+|++....    ....+.+|+++++.++|++++..+..+....    ..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~----~~   79 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEG----DY   79 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEET----TE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc----cchHHHHHHHHHHHhcCCCCCCeeeeecCCC----Cc
Confidence            456778999999999999999999999999999874432    2235778999999999888777766664322    55


Q ss_pred             EEEEEecCCcchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEe---ccCCCEEEeecccccccC
Q 024959          121 VYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTS  196 (260)
Q Consensus       121 ~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili---~~~~~~~l~df~~~~~~~  196 (260)
                      .++|||+++++|.+++.. ...+++..++.++.|++.+|.|||++|++|+||+|+||++   +.++.++|+|||++....
T Consensus        80 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           80 NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             EEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             eEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            899999999899999875 5679999999999999999999999999999999999999   788999999999998655


Q ss_pred             CCcc--------cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024959          197 ETDF--------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (260)
Q Consensus       197 ~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  250 (260)
                      ....        .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+.
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  220 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKA  220 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCCCcccch
Confidence            4322        224567999999999987 6789999999999999999999999987543

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1e-38  Score=266.73  Aligned_cols=207  Identities=27%  Similarity=0.498  Sum_probs=178.5

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCC-eEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCC------eeeeeceecCC
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETR-EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN------VIAIKDIIRPP  113 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~-~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~------iv~~~~~~~~~  113 (260)
                      .+.|++.+.||+|++|.||++.+..++ ..||+|++...   ......+.+|+++++.++|++      ++.+++++...
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~   94 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH   94 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence            566778999999999999999998776 78999999653   334567778999999997655      88888888776


Q ss_pred             CCCCCccEEEEEecCCcchHHHhhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEe-------------
Q 024959          114 KKDTFNDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL-------------  178 (260)
Q Consensus       114 ~~~~~~~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili-------------  178 (260)
                           ...++|||++++++.+.+...  ..+++..++.++.||+.+|++||++|++|+||+|+||++             
T Consensus        95 -----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~  169 (355)
T 2eu9_A           95 -----GHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHK  169 (355)
T ss_dssp             -----TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred             -----CeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccc
Confidence                 568999999999998888765  479999999999999999999999999999999999999             


Q ss_pred             ------ccCCCEEEeecccccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 024959          179 ------NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  252 (260)
Q Consensus       179 ------~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~  252 (260)
                            +.++.++|+|||++......  .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+
T Consensus       170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  246 (355)
T 2eu9_A          170 SCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE  246 (355)
T ss_dssp             CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             cccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeec-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                  56789999999999765443  234567999999999987 778999999999999999999999999998887


Q ss_pred             HHHHhh
Q 024959          253 QLRLIT  258 (260)
Q Consensus       253 ~~~~i~  258 (260)
                      .+..+.
T Consensus       247 ~~~~~~  252 (355)
T 2eu9_A          247 HLVMME  252 (355)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            766554

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.4e-38  Score=261.47  Aligned_cols=202  Identities=31%  Similarity=0.487  Sum_probs=164.0

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCc-ccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNA-FDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      ...|++.+.||+|++|.||++.+..++..|++|++... .........+.+|+++++.++||||+++++++...     .
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~  105 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-----N  105 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----T
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----C
Confidence            44577899999999999999999999999999998653 23445667788999999999999999999999876     5


Q ss_pred             cEEEEEecCCc-chHHHhhh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          120 DVYIVYELMDT-DLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       120 ~~~lv~e~~~~-~l~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                      ..++|||++++ +|.+++..    ...+++..++.++.|++++|.+||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~  185 (310)
T 2wqm_A          106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF  185 (310)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-----
T ss_pred             cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceee
Confidence            69999999985 89888864    56799999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCc-ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 024959          195 TSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK  248 (260)
Q Consensus       195 ~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  248 (260)
                      ..... ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.
T Consensus       186 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~  239 (310)
T 2wqm_A          186 FSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGD  239 (310)
T ss_dssp             -------------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred             ecCCCccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            54432 2233467889999999987 77899999999999999999999999764

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=5.7e-39  Score=261.98  Aligned_cols=200  Identities=23%  Similarity=0.271  Sum_probs=170.5

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      .+.|++.+.||+|++|.||++.+..+++.||+|++......    ..+.+|+++++.++|++++..+..+....    ..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~----~~   79 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEG----DY   79 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEET----TE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCC----Cc
Confidence            45667899999999999999999999999999998654322    35778999999999888777666654322    55


Q ss_pred             EEEEEecCCcchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEe---ccCCCEEEeecccccccC
Q 024959          121 VYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTS  196 (260)
Q Consensus       121 ~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili---~~~~~~~l~df~~~~~~~  196 (260)
                      .++|||+++++|.+++.. ...+++..++.++.|++++|++||++|++|+||+|+||++   +.++.++|+|||++....
T Consensus        80 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           80 NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             EEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             eEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            899999998899999974 5679999999999999999999999999999999999999   478899999999997655


Q ss_pred             CCcc--------cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 024959          197 ETDF--------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  249 (260)
Q Consensus       197 ~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  249 (260)
                      ....        .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~  219 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLK  219 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             ccccccccccccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcC
Confidence            4432        234567899999999987 678999999999999999999999998743

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.2e-39  Score=283.64  Aligned_cols=214  Identities=25%  Similarity=0.429  Sum_probs=184.3

Q ss_pred             cceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCC
Q 024959           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (260)
Q Consensus        34 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~  113 (260)
                      ...|++..+.|++.+.||+|+||.||++.+..+ ..||||+++.....   .+.+.+|+++++.++||||+++++++.. 
T Consensus       259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-  333 (535)
T 2h8h_A          259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-  333 (535)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTT-EEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             ccceecchhhhhhheecccCCCeEEEEEEECCC-ceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence            467889999999999999999999999998764 67999999764322   4578899999999999999999999865 


Q ss_pred             CCCCCccEEEEEecCC-cchHHHhhh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecc
Q 024959          114 KKDTFNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG  190 (260)
Q Consensus       114 ~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~  190 (260)
                           ...++|||++. ++|.+++..  ...+++..++.++.||+++|+|||+++++|+||+|+|||++.++.+||+|||
T Consensus       334 -----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG  408 (535)
T 2h8h_A          334 -----EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG  408 (535)
T ss_dssp             -----SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTT
T ss_pred             -----ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccc
Confidence                 33799999998 599999875  3569999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcc--cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          191 LARTTSETDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       191 ~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      ++........  .....++..|+|||.+.. ..++.++||||||+++|+|++ |..||.+.+..+.++.|.
T Consensus       409 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~  478 (535)
T 2h8h_A          409 LARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE  478 (535)
T ss_dssp             STTTCCCHHHHTTCSTTSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH
T ss_pred             cceecCCCceecccCCcCcccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            9976654321  122344678999999887 678999999999999999999 999999998888777664

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=7.8e-40  Score=273.09  Aligned_cols=216  Identities=21%  Similarity=0.343  Sum_probs=181.8

Q ss_pred             cceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccch---------------HHHHHHHHHHHHHHHc
Q 024959           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI---------------IDARRTLREIKLLRHM   98 (260)
Q Consensus        34 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~---------------~~~~~~~~e~~~l~~l   98 (260)
                      ..........|++.+.||+|++|.||++.+  +++.|++|.+.......               .....+.+|+++++.+
T Consensus        23 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  100 (348)
T 2pml_X           23 VKEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI  100 (348)
T ss_dssp             ESSSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC
T ss_pred             hhhcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC
Confidence            344445566788999999999999999998  78999999985432111               0126788999999999


Q ss_pred             CCCCeeeeeceecCCCCCCCccEEEEEecCCc-chHHH------hhh--CCCCCHHHHHHHHHHHHHHHHHHHh-CCcee
Q 024959           99 EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQI------IRS--DQQLTDDHCQYFLYQLLRGLKYVHS-ASVLH  168 (260)
Q Consensus        99 ~~~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~------l~~--~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H  168 (260)
                      +||||+++++++...     ...++|||++++ +|.++      +..  ...+++..++.++.|++++|.+||+ .|++|
T Consensus       101 ~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H  175 (348)
T 2pml_X          101 KNEYCLTCEGIITNY-----DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICH  175 (348)
T ss_dssp             CCTTBCCCSEEEESS-----SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEEC
T ss_pred             CCCCcceEEEEEeeC-----CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEee
Confidence            999999999999877     569999999985 89888      655  5789999999999999999999999 99999


Q ss_pred             ccCCCCCeEeccCCCEEEeecccccccCCCcccccccccccccccccccCcCCCCC-hhhHHHHHHHHHHHHhCCCCCCC
Q 024959          169 RDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA-AIDIWSVGCILGEIMTREPLFPG  247 (260)
Q Consensus       169 ~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~~Di~slG~~l~~ll~g~~pf~~  247 (260)
                      +||+|+||+++.++.++|+|||++...... ......++..|+|||.+.+...++. ++|+||||+++|+|++|..||..
T Consensus       176 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  254 (348)
T 2pml_X          176 RDVKPSNILMDKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL  254 (348)
T ss_dssp             CCCCGGGEEECTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cCCChHhEEEcCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999999999875444 3445577899999999987435555 99999999999999999999988


Q ss_pred             CCh-HHHHHHh
Q 024959          248 KDY-VHQLRLI  257 (260)
Q Consensus       248 ~~~-~~~~~~i  257 (260)
                      .+. .+..+.+
T Consensus       255 ~~~~~~~~~~i  265 (348)
T 2pml_X          255 KISLVELFNNI  265 (348)
T ss_dssp             SSCSHHHHHHH
T ss_pred             CCcHHHHHHHH
Confidence            777 5555554

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=272.47  Aligned_cols=202  Identities=11%  Similarity=0.130  Sum_probs=167.9

Q ss_pred             ccccCCCcccccccCceEEEEEEeCC--------CCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceec
Q 024959           40 SSKYVPPIRPIGRGAYGIVCAAVNSE--------TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIR  111 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~--------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~  111 (260)
                      ..+.|++.+.||+|++|.||++.+..        +++.||+|++...       ..+.+|++++++++||||+++++.+.
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~  112 (352)
T 2jii_A           40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLY  112 (352)
T ss_dssp             TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred             cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhc
Confidence            35678889999999999999999987        4789999999653       35778999999999999998544322


Q ss_pred             CCCC-----------CCCccEEEEEecCCcchHHHhhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEe
Q 024959          112 PPKK-----------DTFNDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL  178 (260)
Q Consensus       112 ~~~~-----------~~~~~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili  178 (260)
                      ....           ......++|||+++++|.+++...  ..+++..++.++.|++++|+|||++|++|+||+|+||++
T Consensus       113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~  192 (352)
T 2jii_A          113 STPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV  192 (352)
T ss_dssp             TCTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred             cCCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence            1100           011568999999988999999886  789999999999999999999999999999999999999


Q ss_pred             ccCC--CEEEeecccccccCCCcc--------cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 024959          179 NASC--DLKIGDFGLARTTSETDF--------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK  248 (260)
Q Consensus       179 ~~~~--~~~l~df~~~~~~~~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  248 (260)
                      +.++  .++|+|||++........        .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-CGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            9988  899999999976543321        123467899999999987 67899999999999999999999999876


Q ss_pred             C
Q 024959          249 D  249 (260)
Q Consensus       249 ~  249 (260)
                      +
T Consensus       272 ~  272 (352)
T 2jii_A          272 L  272 (352)
T ss_dssp             T
T ss_pred             C
Confidence            4

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-38  Score=258.96  Aligned_cols=208  Identities=29%  Similarity=0.452  Sum_probs=172.3

Q ss_pred             CCCcccccccCceEEEEEEeCCCCe---EEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~---~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      |.+.+.||+|+||.||++.+..++.   .+++|.+... ........+.+|+++++.++||||+++++++....    ..
T Consensus        23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~   97 (298)
T 3pls_A           23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE----GL   97 (298)
T ss_dssp             EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS----SC
T ss_pred             EccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC----CC
Confidence            3456889999999999998655443   7999998754 34456678889999999999999999999997653    23


Q ss_pred             EEEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          121 VYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      .+++||++. ++|.+++.. ...+++..++.++.|++++|++||++|++|+||+|+||+++.++.++|+|||++......
T Consensus        98 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  177 (298)
T 3pls_A           98 PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR  177 (298)
T ss_dssp             CEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred             cEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence            489999986 799999877 567899999999999999999999999999999999999999999999999999755432


Q ss_pred             c-----ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHh
Q 024959          199 D-----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLI  257 (260)
Q Consensus       199 ~-----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  257 (260)
                      .     ......+++.|+|||.+.+ ..++.++||||||+++|+|++ +.+||...+..+....+
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~  241 (298)
T 3pls_A          178 EYYSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL  241 (298)
T ss_dssp             GGGCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHH
T ss_pred             cccccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHh
Confidence            2     2223455788999999987 778999999999999999999 56667766665555544

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.4e-38  Score=260.03  Aligned_cols=211  Identities=27%  Similarity=0.430  Sum_probs=173.2

Q ss_pred             cccCCCcccccccCceEEEEEEeCCC---CeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCC
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSET---REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~  117 (260)
                      ...|.+.+.||+|+||.||++.+..+   ...+++|.+... ........+.+|+.++++++||||+++++++....   
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---   99 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE---   99 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS---
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC---
Confidence            34466789999999999999986543   345899998754 34456678889999999999999999999875543   


Q ss_pred             CccEEEEEecCCc-chHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccccc
Q 024959          118 FNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (260)
Q Consensus       118 ~~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~  195 (260)
                       ...++|||++++ +|.+++.. ...+++..++.++.|++++|++||++|++|+||+|+||+++.++.++|+|||++...
T Consensus       100 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A          100 -GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             -SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             -CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccc
Confidence             457899999985 99999876 456899999999999999999999999999999999999999999999999999765


Q ss_pred             CCCcc-----cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHh
Q 024959          196 SETDF-----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLI  257 (260)
Q Consensus       196 ~~~~~-----~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  257 (260)
                      .....     .....+++.|+|||.+.+ ..++.++|+||||+++|+|++ |.+||.+.+..+....+
T Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~  245 (298)
T 3f66_A          179 YDKEYYSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL  245 (298)
T ss_dssp             SCGGGCBC-----CCBCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH
T ss_pred             cccchhccccccCCCCCccccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH
Confidence            44321     223345678999999977 678999999999999999999 77788877766555444

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.9e-39  Score=268.56  Aligned_cols=204  Identities=25%  Similarity=0.388  Sum_probs=173.2

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      ..+....+.|.+.+.||+|++|.||++.+. +++.||+|++...... .....+.+|+++++.++||||+++++++... 
T Consensus        23 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-   99 (326)
T 3uim_A           23 RELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP-   99 (326)
T ss_dssp             HHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCS-
T ss_pred             HHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecC-
Confidence            455677788999999999999999999754 5789999999654221 1223578999999999999999999999876 


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCCCCeEeccCCCEEE
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRSDQ----QLTDDHCQYFLYQLLRGLKYVHSA---SVLHRDLKPSNLLLNASCDLKI  186 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lh~~---~i~H~di~~~nili~~~~~~~l  186 (260)
                          ...++|||+++ ++|.+++....    .+++..++.++.|++.+|++||+.   |++|+||+|+||+++.++.++|
T Consensus       100 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl  175 (326)
T 3uim_A          100 ----TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV  175 (326)
T ss_dssp             ----SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred             ----CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence                45799999997 59999987643    499999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCc--ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 024959          187 GDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFP  246 (260)
Q Consensus       187 ~df~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~  246 (260)
                      +|||++.......  ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.
T Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~  236 (326)
T 3uim_A          176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFD  236 (326)
T ss_dssp             CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHH-SEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred             ccCccccccCcccccccccccCCcCccCHHHhcc-CCCCccccchhHHHHHHHHHhCCCccc
Confidence            9999998765432  2333457999999999877 668999999999999999999999995

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=3.5e-39  Score=261.65  Aligned_cols=198  Identities=27%  Similarity=0.410  Sum_probs=172.1

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC------
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK------  115 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~------  115 (260)
                      ..|++.+.||+|++|.||++.+..+++.|++|.+....      ..+.+|+++++.++||||+++++++.....      
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            44668899999999999999999999999999996542      246689999999999999999998754111      


Q ss_pred             -----CCCccEEEEEecCCc-chHHHhhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEe
Q 024959          116 -----DTFNDVYIVYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG  187 (260)
Q Consensus       116 -----~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~  187 (260)
                           .....+++|||++++ +|.+++...  ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~  164 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIG  164 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEEC
Confidence                 112458999999995 999998754  679999999999999999999999999999999999999999999999


Q ss_pred             ecccccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 024959          188 DFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFP  246 (260)
Q Consensus       188 df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~  246 (260)
                      |||++.............+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.
T Consensus       165 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~  222 (284)
T 2a19_B          165 DFGLVTSLKNDGKRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAF  222 (284)
T ss_dssp             CCTTCEESSCCSCCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred             cchhheeccccccccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcch
Confidence            9999988766655556678999999999987 778999999999999999999998874

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.1e-38  Score=260.12  Aligned_cols=198  Identities=28%  Similarity=0.392  Sum_probs=168.9

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc--cchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF--DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      +...+.||+|++|.||++.+  ++..+++|++....  ......+.+.+|+++++.++||||+++++++...     ...
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~  105 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDG-----DDL  105 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSC
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecC-----Cce
Confidence            44668999999999999986  46789999986532  2334567788999999999999999999999876     458


Q ss_pred             EEEEecCC-cchHHHhhh---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCC
Q 024959          122 YIVYELMD-TDLHQIIRS---DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~  197 (260)
                      ++|||+++ ++|.+++..   ...+++..++.++.|++++|++||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  185 (307)
T 2nru_A          106 CLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEK  185 (307)
T ss_dssp             EEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccc
Confidence            99999996 699888864   45699999999999999999999999999999999999999999999999999876554


Q ss_pred             Ccc---cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024959          198 TDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (260)
Q Consensus       198 ~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  250 (260)
                      ...   .....+++.|+|||.+.+  .++.++|+||||+++|+|++|..||.+.+.
T Consensus       186 ~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~  239 (307)
T 2nru_A          186 FAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHRE  239 (307)
T ss_dssp             CSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred             ccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence            321   233467899999998865  478999999999999999999999987654

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.4e-39  Score=286.09  Aligned_cols=213  Identities=20%  Similarity=0.355  Sum_probs=174.4

Q ss_pred             EeccccCCCcc-cccccCceEEEEEEeC--CCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           38 EVSSKYVPPIR-PIGRGAYGIVCAAVNS--ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        38 ~~~~~~~~~~~-~lg~G~~g~vy~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      .+....+.+.+ .||+|+||.||++.++  .++..||||+++... .......+.+|+++++.++||||+++++++..+ 
T Consensus       331 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-  408 (613)
T 2ozo_A          331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-  408 (613)
T ss_dssp             BCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESS-
T ss_pred             eccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccC-
Confidence            33344444444 7999999999999775  356679999997652 233467789999999999999999999998653 


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccc
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~  192 (260)
                           .+++|||+++ ++|.+++.. ...+++..++.++.|++.+|+|||+++++|+||+|+||+++.++.+||+|||++
T Consensus       409 -----~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla  483 (613)
T 2ozo_A          409 -----ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLS  483 (613)
T ss_dssp             -----SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTT
T ss_pred             -----CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCc
Confidence                 3899999998 589998875 456999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCccc----ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          193 RTTSETDFM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       193 ~~~~~~~~~----~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      .........    ....+++.|+|||.+.. ..++.++||||||+++|+|++ |..||.+.+..+..+.|.
T Consensus       484 ~~~~~~~~~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~  553 (613)
T 2ozo_A          484 KALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE  553 (613)
T ss_dssp             TTCC--------------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH
T ss_pred             ccccCCCceeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Confidence            876443221    11233578999999976 778999999999999999998 999999999888777764

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.5e-38  Score=275.24  Aligned_cols=200  Identities=25%  Similarity=0.329  Sum_probs=169.4

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCC-CeeeeeceecCCCCCCCc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE-NVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~-~iv~~~~~~~~~~~~~~~  119 (260)
                      .+.|++++.||+|+||.||++.+..+++.||||++......    ..+.+|+++++.++|+ ++..+..++...     .
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~-----~   76 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEG-----D   76 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEET-----T
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeC-----C
Confidence            45677999999999999999999999999999988654322    3477899999999874 444554444433     5


Q ss_pred             cEEEEEecCCcchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEe---ccCCCEEEeeccccccc
Q 024959          120 DVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTT  195 (260)
Q Consensus       120 ~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili---~~~~~~~l~df~~~~~~  195 (260)
                      ..++|||+++++|.+++.. ...+++..++.++.||+.+|+|||+++++|+||||+|||+   +.++.++|+|||++...
T Consensus        77 ~~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~  156 (483)
T 3sv0_A           77 YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY  156 (483)
T ss_dssp             EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             EEEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence            5899999999999999985 6689999999999999999999999999999999999999   58899999999999876


Q ss_pred             CCCccc--------ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024959          196 SETDFM--------TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (260)
Q Consensus       196 ~~~~~~--------~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  250 (260)
                      ......        ....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~  218 (483)
T 3sv0_A          157 RDTSTHQHIPYRENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKA  218 (483)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred             cCCccccccccccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence            544321        24567999999999988 7789999999999999999999999987554

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.8e-39  Score=269.75  Aligned_cols=209  Identities=27%  Similarity=0.436  Sum_probs=164.8

Q ss_pred             cCCCcccccccCceEEEEEEeCCC---CeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCc
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSET---REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      .|.+.+.||+|+||.||++.+..+   +..+++|.+... ........+.+|+.++++++||||+++++++....    .
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~----~  164 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----G  164 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS----S
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC----C
Confidence            355678999999999999987543   346899998654 34456778899999999999999999999875542    4


Q ss_pred             cEEEEEecCC-cchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCC
Q 024959          120 DVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (260)
Q Consensus       120 ~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~  197 (260)
                      ..++|||+++ ++|.+++... ..+++..++.++.|++++|+|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus       165 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          165 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             CeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccc
Confidence            4789999998 5999999764 4689999999999999999999999999999999999999999999999999976543


Q ss_pred             Ccc-----cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHh
Q 024959          198 TDF-----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLI  257 (260)
Q Consensus       198 ~~~-----~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  257 (260)
                      ...     .....+++.|+|||.+.+ ..++.++||||||+++|+|++ |.+||.+.+..+....+
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~  309 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL  309 (373)
T ss_dssp             -------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH
T ss_pred             cccccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH
Confidence            321     122345678999999987 778999999999999999999 78899877665544443

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2e-39  Score=267.49  Aligned_cols=219  Identities=23%  Similarity=0.331  Sum_probs=180.4

Q ss_pred             eeecceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeecee
Q 024959           31 NVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII  110 (260)
Q Consensus        31 ~~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~  110 (260)
                      ......|++..+.|++.+.||+|++|.||++.+..   .+++|+++...........+.+|+.++++++||||+++++++
T Consensus        22 ~~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   98 (319)
T 2y4i_B           22 SIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC   98 (319)
T ss_dssp             CCCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEE
T ss_pred             ccccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence            34567888999999999999999999999998864   489999876543333445567899999999999999999999


Q ss_pred             cCCCCCCCccEEEEEecCC-cchHHHhhhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEee
Q 024959          111 RPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD  188 (260)
Q Consensus       111 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~d  188 (260)
                      ...     ...++|||+++ ++|.+++.... .+++..++.++.|++++|++||+.|++|+||+|+||+++ ++.++|+|
T Consensus        99 ~~~-----~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~D  172 (319)
T 2y4i_B           99 MSP-----PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITD  172 (319)
T ss_dssp             ECS-----SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECC
T ss_pred             ecC-----CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEee
Confidence            877     45899999997 69999988754 799999999999999999999999999999999999998 67999999


Q ss_pred             cccccccCCC------cccccccccccccccccccC--------cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024959          189 FGLARTTSET------DFMTEYVVTRWYRAPELLLN--------CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  254 (260)
Q Consensus       189 f~~~~~~~~~------~~~~~~~~~~~~~~PE~~~~--------~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  254 (260)
                      ||++......      .......+++.|+|||.+..        ...++.++||||||+++|+|++|..||.+.+.....
T Consensus       173 fg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~  252 (319)
T 2y4i_B          173 FGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII  252 (319)
T ss_dssp             CSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH
T ss_pred             cCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            9987654321      12233457889999999874        245788999999999999999999999988887766


Q ss_pred             HHhh
Q 024959          255 RLIT  258 (260)
Q Consensus       255 ~~i~  258 (260)
                      ..+.
T Consensus       253 ~~~~  256 (319)
T 2y4i_B          253 WQMG  256 (319)
T ss_dssp             HHHH
T ss_pred             HHhc
Confidence            6553

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.2e-38  Score=259.54  Aligned_cols=215  Identities=26%  Similarity=0.376  Sum_probs=171.1

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCC-CC--eEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecC
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSE-TR--EEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRP  112 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~-~~--~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~  112 (260)
                      ..+..+.|++.+.||+|++|.||++.+.. ++  ..|++|+++.... .....+.+.+|+++++.++||||+++++++..
T Consensus        13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   92 (291)
T 1u46_A           13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT   92 (291)
T ss_dssp             EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence            34456778889999999999999998643 33  3689999865432 33456788899999999999999999999976


Q ss_pred             CCCCCCccEEEEEecCC-cchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecc
Q 024959          113 PKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG  190 (260)
Q Consensus       113 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~  190 (260)
                      +.      .++|+|+++ ++|.+++... ..+++..++.++.|++++|.+||+.+++|+||+|+||+++.++.++|+|||
T Consensus        93 ~~------~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg  166 (291)
T 1u46_A           93 PP------MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFG  166 (291)
T ss_dssp             SS------CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred             CC------ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccc
Confidence            42      689999998 6999988764 679999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCccc----ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          191 LARTTSETDFM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       191 ~~~~~~~~~~~----~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      ++.........    ....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+.+..+....+.
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~  238 (291)
T 1u46_A          167 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID  238 (291)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred             ccccccccccchhhhccCCCCceeeCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHH
Confidence            98776544321    22345678999999976 667899999999999999999 999999988877776654

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=4.1e-38  Score=256.81  Aligned_cols=206  Identities=29%  Similarity=0.458  Sum_probs=171.2

Q ss_pred             EeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCC
Q 024959           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (260)
Q Consensus        38 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~  117 (260)
                      ......+.....||+|++|.||++.+..++..|++|.+....  ....+.+.+|+.+++.++||||+++++++...    
T Consensus        18 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----   91 (295)
T 2clq_A           18 DYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN----   91 (295)
T ss_dssp             EECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEET----
T ss_pred             cccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC----
Confidence            333444556678999999999999999999999999996542  33456788999999999999999999999776    


Q ss_pred             CccEEEEEecCC-cchHHHhhhC---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecc-CCCEEEeecccc
Q 024959          118 FNDVYIVYELMD-TDLHQIIRSD---QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLA  192 (260)
Q Consensus       118 ~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~-~~~~~l~df~~~  192 (260)
                       ...++|||+++ ++|.+++...   ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++. ++.++|+|||++
T Consensus        92 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~  170 (295)
T 2clq_A           92 -GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTS  170 (295)
T ss_dssp             -TEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTC
T ss_pred             -CcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccc
Confidence             56899999997 6999988764   35678999999999999999999999999999999999987 899999999999


Q ss_pred             cccCCCc-ccccccccccccccccccCc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024959          193 RTTSETD-FMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (260)
Q Consensus       193 ~~~~~~~-~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  250 (260)
                      ....... ......+++.|+|||.+.+. ..++.++|+||||+++|+|++|..||...+.
T Consensus       171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  230 (295)
T 2clq_A          171 KRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE  230 (295)
T ss_dssp             EESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS
T ss_pred             cccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc
Confidence            7765432 23345678999999998753 2378899999999999999999999976543

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=263.53  Aligned_cols=207  Identities=23%  Similarity=0.440  Sum_probs=174.4

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEE----eCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeecee
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAV----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII  110 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~----~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~  110 (260)
                      ....+..+.|++++.||+|++|.||++.    +..+++.|++|++...  .......+.+|+++++.++||||+++++++
T Consensus        34 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  111 (326)
T 2w1i_A           34 DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVC  111 (326)
T ss_dssp             ---CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence            3455667788899999999999999998    5678899999999764  344567788999999999999999999998


Q ss_pred             cCCCCCCCccEEEEEecCC-cchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEee
Q 024959          111 RPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD  188 (260)
Q Consensus       111 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~d  188 (260)
                      .....   ..+++|||+++ ++|.+++... ..+++..++.++.|++++|++||+.|++|+||+|+||+++.++.++|+|
T Consensus       112 ~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~D  188 (326)
T 2w1i_A          112 YSAGR---RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGD  188 (326)
T ss_dssp             CC-------CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECC
T ss_pred             EecCC---CceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEec
Confidence            76532   45899999997 5999999875 4699999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCccc----ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 024959          189 FGLARTTSETDFM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG  247 (260)
Q Consensus       189 f~~~~~~~~~~~~----~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~  247 (260)
                      ||++.........    ....++..|+|||.+.+ ..++.++||||||+++|+|++|..||..
T Consensus       189 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~~~~~  250 (326)
T 2w1i_A          189 FGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKS  250 (326)
T ss_dssp             CTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred             CcchhhccccccccccccCCCCceeEECchhhcC-CCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence            9999876554321    22345677999999877 6678999999999999999999998863

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.9e-38  Score=258.69  Aligned_cols=195  Identities=32%  Similarity=0.516  Sum_probs=162.5

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~  118 (260)
                      +..+.|++.+.||+|+||.||++.+.  ++.|++|.+...    .....+.+|++++++++||||+++++++...     
T Consensus         5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----   73 (307)
T 2eva_A            5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLNP-----   73 (307)
T ss_dssp             CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTTT-----
T ss_pred             CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC-----
Confidence            45667788999999999999999875  578999999643    2456788999999999999999999988643     


Q ss_pred             ccEEEEEecCC-cchHHHhhhCC---CCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCCCCeEeccCCC-EEEeecc
Q 024959          119 NDVYIVYELMD-TDLHQIIRSDQ---QLTDDHCQYFLYQLLRGLKYVHS---ASVLHRDLKPSNLLLNASCD-LKIGDFG  190 (260)
Q Consensus       119 ~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lh~---~~i~H~di~~~nili~~~~~-~~l~df~  190 (260)
                        .++||||++ ++|.+++....   .+++..++.++.|++++|+|||+   +|++|+||+|+||+++.++. ++|+|||
T Consensus        74 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg  151 (307)
T 2eva_A           74 --VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG  151 (307)
T ss_dssp             --TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCC
T ss_pred             --cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccc
Confidence              689999997 59999988754   47889999999999999999999   89999999999999998887 7999999


Q ss_pred             cccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 024959          191 LARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  249 (260)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  249 (260)
                      ++......  .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+
T Consensus       152 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~  207 (307)
T 2eva_A          152 TACDIQTH--MTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIG  207 (307)
T ss_dssp             C--------------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTC
T ss_pred             cccccccc--cccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhC
Confidence            98765433  223457899999999987 778999999999999999999999998643

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.6e-38  Score=266.24  Aligned_cols=204  Identities=27%  Similarity=0.452  Sum_probs=171.4

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-----------CCCeeeee
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-----------HENVIAIK  107 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------~~~iv~~~  107 (260)
                      +....|++.+.||+|++|.||++.+..+++.||+|++...   ......+.+|++++++++           ||||++++
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~   92 (373)
T 1q8y_A           16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL   92 (373)
T ss_dssp             ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred             ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence            4566788999999999999999999999999999999643   334566778999998886           78999999


Q ss_pred             ceecCCCCCCCccEEEEEecCCcchHHHhhh--CCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEecc----
Q 024959          108 DIIRPPKKDTFNDVYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNA----  180 (260)
Q Consensus       108 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~H~di~~~nili~~----  180 (260)
                      +++...... ...++++||+++++|.+++..  ...+++..++.++.||+.+|++||++ |++|+||+|+||+++.    
T Consensus        93 ~~~~~~~~~-~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           93 DHFNHKGPN-GVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEEEEEETT-EEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred             HHhhccCCC-CceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCC
Confidence            998764311 136899999999999999886  35599999999999999999999998 9999999999999953    


Q ss_pred             --CCCEEEeecccccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 024959          181 --SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  249 (260)
Q Consensus       181 --~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  249 (260)
                        .+.++|+|||++......  .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~  239 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDE  239 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             cCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence              347999999999776543  234467999999999988 678999999999999999999999998765

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=4.4e-38  Score=281.92  Aligned_cols=216  Identities=25%  Similarity=0.410  Sum_probs=181.4

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEeCCC---CeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceec
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSET---REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIR  111 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~  111 (260)
                      ..+++....|++.+.||+|+||.||++.+..+   +..+++|.++.. ........+.+|+.+++.++||||+++++++.
T Consensus       383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  461 (656)
T 2j0j_A          383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT  461 (656)
T ss_dssp             GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            45677778888999999999999999998653   457999998754 34445678889999999999999999999985


Q ss_pred             CCCCCCCccEEEEEecCC-cchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeec
Q 024959          112 PPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF  189 (260)
Q Consensus       112 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df  189 (260)
                      +      +..++|||+++ ++|.+++... ..+++..++.++.|++.+|+|||++|++|+||+|+||+++.++.++|+||
T Consensus       462 ~------~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DF  535 (656)
T 2j0j_A          462 E------NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF  535 (656)
T ss_dssp             S------SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCC
T ss_pred             c------CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEec
Confidence            4      34789999998 6999998865 46999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcccc--cccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          190 GLARTTSETDFMT--EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       190 ~~~~~~~~~~~~~--~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      |++..........  ...+++.|+|||.+.. ..++.++||||||+++|+|++ |..||.+.+..+.+..|.
T Consensus       536 G~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~  606 (656)
T 2j0j_A          536 GLSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE  606 (656)
T ss_dssp             CCCCSCCC----------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred             CCCeecCCCcceeccCCCCCcceeCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence            9998765443222  2344678999999976 678999999999999999997 999999988887776664

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5.8e-39  Score=265.11  Aligned_cols=208  Identities=25%  Similarity=0.387  Sum_probs=175.2

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccch----HHHHHHHHHHHHHHHcC--CCCeeeeec
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI----IDARRTLREIKLLRHME--HENVIAIKD  108 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~~e~~~l~~l~--~~~iv~~~~  108 (260)
                      ...+.....|++.+.||+|+||.||++.+..+++.|++|++.......    .....+.+|+.++++++  ||||+++++
T Consensus        36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~  115 (320)
T 3a99_A           36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD  115 (320)
T ss_dssp             ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred             cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence            344556677889999999999999999999999999999986542211    12234567999999996  599999999


Q ss_pred             eecCCCCCCCccEEEEEecCC--cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec-cCCCEE
Q 024959          109 IIRPPKKDTFNDVYIVYELMD--TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN-ASCDLK  185 (260)
Q Consensus       109 ~~~~~~~~~~~~~~lv~e~~~--~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~-~~~~~~  185 (260)
                      ++...     ...++|+|++.  ++|.+++.....+++..++.++.|++++|++||+.+++|+||+|+||+++ .++.++
T Consensus       116 ~~~~~-----~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~k  190 (320)
T 3a99_A          116 WFERP-----DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK  190 (320)
T ss_dssp             EEECS-----SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEE
T ss_pred             EEecC-----CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEE
Confidence            99877     56899999997  69999999888999999999999999999999999999999999999998 678999


Q ss_pred             EeecccccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 024959          186 IGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK  248 (260)
Q Consensus       186 l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  248 (260)
                      |+|||++....... .....+++.|+|||.+.+....+.++||||||+++|+|++|..||...
T Consensus       191 L~Dfg~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  252 (320)
T 3a99_A          191 LIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD  252 (320)
T ss_dssp             ECCCTTCEECCSSC-BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred             EeeCcccccccccc-ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence            99999998766543 334567899999999876444478899999999999999999999754

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.3e-38  Score=260.49  Aligned_cols=200  Identities=26%  Similarity=0.432  Sum_probs=162.9

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHH--cCCCCeeeeeceecCCCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRH--MEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~--l~~~~iv~~~~~~~~~~~~  116 (260)
                      ...+.|++.+.||+|+||.||++.+  +++.||+|++...     ....+.+|.+++..  ++||||+++++++..... 
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~-   76 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRH-   76 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET-
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccC-
Confidence            3456778899999999999999987  5789999999653     23445566677666  789999999998654321 


Q ss_pred             CCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeccCCCCCeEeccCCCEEEe
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH--------SASVLHRDLKPSNLLLNASCDLKIG  187 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh--------~~~i~H~di~~~nili~~~~~~~l~  187 (260)
                      .....++|||+++ ++|.+++. ...+++..++.++.|++++|+|||        +.+++|+||||+||+++.++.++|+
T Consensus        77 ~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           77 SSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             TEEEEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred             CCceeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence            1145899999998 59999884 457999999999999999999999        9999999999999999999999999


Q ss_pred             ecccccccCCCccc-----ccccccccccccccccCcC-----CCCChhhHHHHHHHHHHHHhC----------CCCCCC
Q 024959          188 DFGLARTTSETDFM-----TEYVVTRWYRAPELLLNCT-----EYTAAIDIWSVGCILGEIMTR----------EPLFPG  247 (260)
Q Consensus       188 df~~~~~~~~~~~~-----~~~~~~~~~~~PE~~~~~~-----~~~~~~Di~slG~~l~~ll~g----------~~pf~~  247 (260)
                      |||++.........     ....+++.|+|||.+.+..     .++.++||||||+++|+|++|          ..||.+
T Consensus       156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            99998754433221     2336799999999997732     334689999999999999999          888854

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=6e-39  Score=263.94  Aligned_cols=206  Identities=25%  Similarity=0.337  Sum_probs=166.5

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccch----HHHHHHHHHHHHHHHc----CCCCeeeeec
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI----IDARRTLREIKLLRHM----EHENVIAIKD  108 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~~e~~~l~~l----~~~~iv~~~~  108 (260)
                      .+...+.|++.+.||+|++|.||++.+..+++.|++|++.......    .....+.+|+.+++++    +||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            3344566778999999999999999999999999999996543221    1223445799999999    8999999999


Q ss_pred             eecCCCCCCCccEEEEEec-CC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec-cCCCEE
Q 024959          109 IIRPPKKDTFNDVYIVYEL-MD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN-ASCDLK  185 (260)
Q Consensus       109 ~~~~~~~~~~~~~~lv~e~-~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~-~~~~~~  185 (260)
                      ++...     ...++|+|+ +. ++|.+++.....+++..++.++.|++++|++||+.|++|+||+|+||+++ .++.++
T Consensus       106 ~~~~~-----~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          106 WFETQ-----EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             EC----------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEE
T ss_pred             EEecC-----CeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEE
Confidence            99776     458899998 55 69999999888999999999999999999999999999999999999999 789999


Q ss_pred             EeecccccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 024959          186 IGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK  248 (260)
Q Consensus       186 l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  248 (260)
                      |+|||++....... .....++..|+|||.+.+....+.++||||||+++|+|++|..||...
T Consensus       181 l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  242 (312)
T 2iwi_A          181 LIDFGSGALLHDEP-YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD  242 (312)
T ss_dssp             ECCCSSCEECCSSC-BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred             EEEcchhhhcccCc-ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh
Confidence            99999988766543 334567899999999876344456899999999999999999999753

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.2e-38  Score=264.83  Aligned_cols=207  Identities=23%  Similarity=0.390  Sum_probs=146.1

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      +.+..+|..+.+.||+|++|.||++.++.+++.||+|++...   .   ....+....++.++||||+++++++..... 
T Consensus        24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~-   96 (336)
T 3fhr_A           24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---P---KARQEVDHHWQASGGPHIVCILDVYENMHH-   96 (336)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---H---HHHHHHHHHHHHTTSTTBCCEEEEEEEEET-
T ss_pred             ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---H---HHHHHHHHHHHhcCCCChHHHHHHHhhccC-
Confidence            344444443355799999999999999999999999999643   1   112233344667789999999999875321 


Q ss_pred             CCccEEEEEecCC-cchHHHhhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecc---CCCEEEeecc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFG  190 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~---~~~~~l~df~  190 (260)
                      .....++|||+++ ++|.+++....  .+++..++.++.|++.+|.|||++|++|+||+|+||+++.   ++.++|+|||
T Consensus        97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A           97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence            1145899999998 49999998753  6999999999999999999999999999999999999976   4559999999


Q ss_pred             cccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 024959          191 LARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  252 (260)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~  252 (260)
                      ++...... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+...
T Consensus       177 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  236 (336)
T 3fhr_A          177 FAKETTQN-ALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQA  236 (336)
T ss_dssp             TCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             cceecccc-ccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchh
Confidence            99766543 2334567899999999876 677889999999999999999999997665443

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=7.9e-38  Score=277.28  Aligned_cols=210  Identities=28%  Similarity=0.407  Sum_probs=180.0

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC-CCCcc
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFND  120 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~-~~~~~  120 (260)
                      ..|++.+.||+|+||.||++.+..+++.||+|++... ........+.+|++++++++||||+++++++..... .....
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            4577999999999999999999999999999999764 344556778899999999999999999999866322 11356


Q ss_pred             EEEEEecCC-cchHHHhhhCC---CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCC---EEEeeccccc
Q 024959          121 VYIVYELMD-TDLHQIIRSDQ---QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLAR  193 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~---~~l~df~~~~  193 (260)
                      .++||||++ ++|.+++....   .+++..++.++.|++.+|+|||+.|++|+||+|+||+++.++.   ++|+|||++.
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~  172 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK  172 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence            899999996 69999988744   6999999999999999999999999999999999999997765   8999999998


Q ss_pred             ccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024959          194 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  253 (260)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~  253 (260)
                      ............+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+......
T Consensus       173 ~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~  231 (676)
T 3qa8_A          173 ELDQGELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ  231 (676)
T ss_dssp             BTTSCCCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHH
T ss_pred             ccccccccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhh
Confidence            8776665666788999999999977 7889999999999999999999999987655443

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=9.2e-38  Score=255.37  Aligned_cols=196  Identities=31%  Similarity=0.478  Sum_probs=162.5

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC------
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK------  115 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~------  115 (260)
                      ..|++++.||+|++|.||++.+..+++.|++|.+..   .......+.+|+++++.++||||+++++++.....      
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            346688999999999999999999999999999954   23456778899999999999999999998765321      


Q ss_pred             --CCCccEEEEEecCC-cchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccc
Q 024959          116 --DTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (260)
Q Consensus       116 --~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~  191 (260)
                        ......++|||+++ ++|.+++... ..+++..++.++.|++++|++||++|++|+||+|+||+++.++.++|+|||+
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  162 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL  162 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence              12256899999997 5999999864 4688899999999999999999999999999999999999999999999999


Q ss_pred             ccccCCC---------------cccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh
Q 024959          192 ARTTSET---------------DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT  240 (260)
Q Consensus       192 ~~~~~~~---------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~  240 (260)
                      +......               .......+++.|+|||.+.+...++.++|+||||+++|+|++
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~  226 (303)
T 1zy4_A          163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY  226 (303)
T ss_dssp             CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred             hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence            8765432               122334578899999999875678999999999999999998

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.5e-38  Score=284.47  Aligned_cols=201  Identities=22%  Similarity=0.338  Sum_probs=168.9

Q ss_pred             EeccccCCCcccccccCceEEEEEEeCC-CCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSE-TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        38 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      ++....|++.+.||+|+||.||++.+.. +++.|+||++... ........+.+|+++++.++||||+++++++......
T Consensus        76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  154 (681)
T 2pzi_A           76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH  154 (681)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred             CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence            3445678899999999999999999976 7899999998654 3344566788999999999999999999999876443


Q ss_pred             CCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccccc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~  195 (260)
                      .....|+||||++ ++|.+.+..  .+++..++.++.||+++|.|||++|++|+||||+||+++.+ .++|+|||++...
T Consensus       155 ~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~  231 (681)
T 2pzi_A          155 GDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI  231 (681)
T ss_dssp             SCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred             CCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence            2234799999998 588776544  79999999999999999999999999999999999999885 8999999999876


Q ss_pred             CCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 024959          196 SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG  247 (260)
Q Consensus       196 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~  247 (260)
                      ...   ....+++.|+|||.+.+ . ++.++||||||+++++|++|..||.+
T Consensus       232 ~~~---~~~~gt~~y~aPE~~~~-~-~~~~sDi~slG~~l~~l~~g~~~~~~  278 (681)
T 2pzi_A          232 NSF---GYLYGTPGFQAPEIVRT-G-PTVATDIYTVGRTLAALTLDLPTRNG  278 (681)
T ss_dssp             TCC---SCCCCCTTTSCTTHHHH-C-SCHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred             ccC---CccCCCccccCHHHHcC-C-CCCceehhhhHHHHHHHHhCCCCCcc
Confidence            554   34567999999999876 3 38899999999999999999998865

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=8.7e-37  Score=248.17  Aligned_cols=177  Identities=14%  Similarity=0.069  Sum_probs=153.2

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccc-hHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN-IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      ...|++.+.||+|+||.||++.+..+++.||+|++...... ......+.+|+..+..++||||+++++++...     .
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~  104 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR-----A  104 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----T
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC-----C
Confidence            45567889999999999999999999999999999765433 44567788999999999999999999999876     5


Q ss_pred             cEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          120 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       120 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      ..|+||||++ ++|.+++..+  .....+..++.|++++|+|||++|++|+||||+||+++.++.++|++++.       
T Consensus       105 ~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~-------  175 (286)
T 3uqc_A          105 GGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT-------  175 (286)
T ss_dssp             EEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC-------
T ss_pred             cEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc-------
Confidence            6899999998 5899988543  45667889999999999999999999999999999999999999985443       


Q ss_pred             cccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH
Q 024959          199 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  251 (260)
Q Consensus       199 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~  251 (260)
                                  ++        .++.++||||||+++|+|++|..||.+.+..
T Consensus       176 ------------~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~  208 (286)
T 3uqc_A          176 ------------MP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVR  208 (286)
T ss_dssp             ------------CT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBC
T ss_pred             ------------cC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcc
Confidence                        22        3678999999999999999999999886653

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=4e-37  Score=263.57  Aligned_cols=206  Identities=27%  Similarity=0.327  Sum_probs=162.9

Q ss_pred             eeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCC
Q 024959           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPK  114 (260)
Q Consensus        36 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~  114 (260)
                      .+.+....|.+.+.||+|++|+||. ....+++.||||++......     .+.+|+++++.+ +||||+++++++... 
T Consensus        18 ~~~i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~~~~-   90 (432)
T 3p23_A           18 VVIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTEKDR-   90 (432)
T ss_dssp             CEEETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEEEET-
T ss_pred             cEEEccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEEecC-
Confidence            4555566677889999999999764 34567889999998654322     245799999999 799999999998776 


Q ss_pred             CCCCccEEEEEecCCcchHHHhhhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecc-----CCCEEEee
Q 024959          115 KDTFNDVYIVYELMDTDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-----SCDLKIGD  188 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~-----~~~~~l~d  188 (260)
                          ...++|||+++++|.+++.... .+++..++.++.|++++|+|||+.|++|+||||+||+++.     ...++|+|
T Consensus        91 ----~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~D  166 (432)
T 3p23_A           91 ----QFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISD  166 (432)
T ss_dssp             ----TEEEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECC
T ss_pred             ----CEEEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEec
Confidence                5689999999999999988654 4666677899999999999999999999999999999953     23588999


Q ss_pred             cccccccCCCc----ccccccccccccccccccC--cCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 024959          189 FGLARTTSETD----FMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVH  252 (260)
Q Consensus       189 f~~~~~~~~~~----~~~~~~~~~~~~~PE~~~~--~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~  252 (260)
                      ||++.......    ......+++.|+|||.+.+  ...++.++|||||||++|+|++ |..||.......
T Consensus       167 FG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~  237 (432)
T 3p23_A          167 FGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ  237 (432)
T ss_dssp             TTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH
T ss_pred             ccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH
Confidence            99998765432    2234567999999999974  2556789999999999999999 999997655433

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.1e-37  Score=258.79  Aligned_cols=201  Identities=24%  Similarity=0.291  Sum_probs=158.6

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHH--HHHHHHHcCCCCeeeeeceecCCC
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR--EIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~--e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      ..+..+.|++.+.||+|+||.||++.+  +++.||+|++....     ...+..  ++..+..++||||+++++.+....
T Consensus         8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~   80 (336)
T 3g2f_A            8 PSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVT   80 (336)
T ss_dssp             -CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred             CCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccc
Confidence            445667788999999999999999976  57899999996432     223333  444445578999999998654433


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhC---------CceeccCCCCCeEeccCCCE
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA---------SVLHRDLKPSNLLLNASCDL  184 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~---------~i~H~di~~~nili~~~~~~  184 (260)
                      ......+++||||++ ++|.+++... ..++..++.++.|++++|.|||+.         +++|+||||+||+++.++.+
T Consensus        81 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  159 (336)
T 3g2f_A           81 ADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC  159 (336)
T ss_dssp             TTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred             cCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence            333356899999996 6999988654 448899999999999999999999         99999999999999999999


Q ss_pred             EEeecccccccCCCc---------ccccccccccccccccccCc------CCCCChhhHHHHHHHHHHHHhCCCCC
Q 024959          185 KIGDFGLARTTSETD---------FMTEYVVTRWYRAPELLLNC------TEYTAAIDIWSVGCILGEIMTREPLF  245 (260)
Q Consensus       185 ~l~df~~~~~~~~~~---------~~~~~~~~~~~~~PE~~~~~------~~~~~~~Di~slG~~l~~ll~g~~pf  245 (260)
                      +|+|||++.......         ......+++.|+|||.+.+.      ..++.++||||||+++|+|++|..||
T Consensus       160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~  235 (336)
T 3g2f_A          160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL  235 (336)
T ss_dssp             EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred             EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence            999999997654322         12234679999999998752      23456899999999999999996665

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=5.4e-37  Score=263.18  Aligned_cols=199  Identities=31%  Similarity=0.425  Sum_probs=157.1

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCCCCCc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      .+++.+.+.||+|+||+||.+. ..+++.||||.+....     ...+.+|+++++.+ +||||+++++++...     .
T Consensus        14 ~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-----~   82 (434)
T 2rio_A           14 KNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTD-----R   82 (434)
T ss_dssp             SSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECS-----S
T ss_pred             hheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecC-----C
Confidence            3445567889999999998754 4568999999985431     34567899999887 799999999999876     5


Q ss_pred             cEEEEEecCCcchHHHhhhCCCC-------CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccC-----------
Q 024959          120 DVYIVYELMDTDLHQIIRSDQQL-------TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-----------  181 (260)
Q Consensus       120 ~~~lv~e~~~~~l~~~l~~~~~~-------~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~-----------  181 (260)
                      ..++|||+++++|.+++......       ++..++.++.|++.+|+|||++|++|+||||+||+++.+           
T Consensus        83 ~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~  162 (434)
T 2rio_A           83 FLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGA  162 (434)
T ss_dssp             EEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred             eEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCC
Confidence            69999999999999999875433       233457899999999999999999999999999999754           


Q ss_pred             --CCEEEeecccccccCCCcc-----cccccccccccccccccC------cCCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 024959          182 --CDLKIGDFGLARTTSETDF-----MTEYVVTRWYRAPELLLN------CTEYTAAIDIWSVGCILGEIMT-REPLFPG  247 (260)
Q Consensus       182 --~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~~PE~~~~------~~~~~~~~Di~slG~~l~~ll~-g~~pf~~  247 (260)
                        +.++|+|||++........     .....+++.|+|||.+.+      ...++.++|||||||++|+|++ |..||.+
T Consensus       163 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~  242 (434)
T 2rio_A          163 ENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD  242 (434)
T ss_dssp             CSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred             CceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence              4799999999987655432     223467999999999865      2567899999999999999999 9999976


Q ss_pred             CCh
Q 024959          248 KDY  250 (260)
Q Consensus       248 ~~~  250 (260)
                      ...
T Consensus       243 ~~~  245 (434)
T 2rio_A          243 KYS  245 (434)
T ss_dssp             TTT
T ss_pred             chh
Confidence            544

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.3e-36  Score=250.52  Aligned_cols=199  Identities=24%  Similarity=0.361  Sum_probs=165.6

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHH--cCCCCeeeeeceecCCCCCCC
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRH--MEHENVIAIKDIIRPPKKDTF  118 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~--l~~~~iv~~~~~~~~~~~~~~  118 (260)
                      .+.|.+.+.||+|++|.||++.+  +++.||+|++...     ....+.+|.++++.  ++||||+++++++...... .
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~-~  112 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGT-W  112 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS-C
T ss_pred             cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc-c
Confidence            45677899999999999999987  4789999999643     23456788888888  6899999999999876421 1


Q ss_pred             ccEEEEEecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeccCCCCCeEeccCCCEEEeec
Q 024959          119 NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH--------SASVLHRDLKPSNLLLNASCDLKIGDF  189 (260)
Q Consensus       119 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh--------~~~i~H~di~~~nili~~~~~~~l~df  189 (260)
                      ...++|||++++ +|.+++.. ..+++..++.++.|++.+|++||        +.+++|+||+|+||+++.++.++|+||
T Consensus       113 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  191 (342)
T 1b6c_B          113 TQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  191 (342)
T ss_dssp             CCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred             ceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence            368999999985 99999875 46899999999999999999999        899999999999999999999999999


Q ss_pred             ccccccCCCcc-----cccccccccccccccccCcCC-----CCChhhHHHHHHHHHHHHhC----------CCCCCCC
Q 024959          190 GLARTTSETDF-----MTEYVVTRWYRAPELLLNCTE-----YTAAIDIWSVGCILGEIMTR----------EPLFPGK  248 (260)
Q Consensus       190 ~~~~~~~~~~~-----~~~~~~~~~~~~PE~~~~~~~-----~~~~~Di~slG~~l~~ll~g----------~~pf~~~  248 (260)
                      |++........     .....+++.|+|||.+.+...     ++.++||||||+++|+|++|          ..||...
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~  270 (342)
T 1b6c_B          192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL  270 (342)
T ss_dssp             TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence            99876544331     234467899999999976322     23689999999999999999          7898764

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-37  Score=266.00  Aligned_cols=215  Identities=15%  Similarity=0.136  Sum_probs=163.2

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc-cchHHHHHHHHHHHHHHHcCC-CCeeee---------e
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEH-ENVIAI---------K  107 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~-~~iv~~---------~  107 (260)
                      .....+...+.||+|+||+||++.+..+++.||||++.... ......+.+.+|+.+++.++| ++....         .
T Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~  154 (413)
T 3dzo_A           75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  154 (413)
T ss_dssp             SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred             CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence            34445667889999999999999999999999999987332 222335678899999999976 222111         1


Q ss_pred             c------------eecCCCCCCCccEEEEEecCCcchHHHhhh-------CCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 024959          108 D------------IIRPPKKDTFNDVYIVYELMDTDLHQIIRS-------DQQLTDDHCQYFLYQLLRGLKYVHSASVLH  168 (260)
Q Consensus       108 ~------------~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~-------~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H  168 (260)
                      +            .+..........++++|+.+.++|.+++..       +..+++..++.++.|++++|+|||++|++|
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH  234 (413)
T 3dzo_A          155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH  234 (413)
T ss_dssp             EEEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             hhcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            1            111111111245889999999999988841       345788899999999999999999999999


Q ss_pred             ccCCCCCeEeccCCCEEEeecccccccCCCccccccccccccccccccc---------CcCCCCChhhHHHHHHHHHHHH
Q 024959          169 RDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL---------NCTEYTAAIDIWSVGCILGEIM  239 (260)
Q Consensus       169 ~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~---------~~~~~~~~~Di~slG~~l~~ll  239 (260)
                      |||||+|||++.++.+||+|||++......  .....+ +.|+|||.+.         ....++.++||||||+++|+|+
T Consensus       235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell  311 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW  311 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred             CCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence            999999999999999999999998765544  344466 9999999983         2255788999999999999999


Q ss_pred             hCCCCCCCCChHHHHHH
Q 024959          240 TREPLFPGKDYVHQLRL  256 (260)
Q Consensus       240 ~g~~pf~~~~~~~~~~~  256 (260)
                      +|..||.+.+..+....
T Consensus       312 tg~~Pf~~~~~~~~~~~  328 (413)
T 3dzo_A          312 CADLPNTDDAALGGSEW  328 (413)
T ss_dssp             HSSCCCCTTGGGSCSGG
T ss_pred             HCCCCCCCcchhhhHHH
Confidence            99999988765544433

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-36  Score=250.80  Aligned_cols=198  Identities=25%  Similarity=0.366  Sum_probs=158.1

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHc--CCCCeeeeeceecCCCCCCC
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM--EHENVIAIKDIIRPPKKDTF  118 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l--~~~~iv~~~~~~~~~~~~~~  118 (260)
                      .+.|++.+.||+|+||.||++.+.  ++.||+|++....     .....+|.+++..+  +||||+++++++...... .
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~-~  107 (337)
T 3mdy_A           36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGS-W  107 (337)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG-G
T ss_pred             ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC-C
Confidence            456778999999999999999875  7899999985431     23344455555544  899999999998765321 1


Q ss_pred             ccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCCCCCeEeccCCCEEEeec
Q 024959          119 NDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA--------SVLHRDLKPSNLLLNASCDLKIGDF  189 (260)
Q Consensus       119 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~--------~i~H~di~~~nili~~~~~~~l~df  189 (260)
                      ...++|||+++ ++|.+++... .+++..++.++.|++.+|.|||+.        +++|+||||+||+++.++.++|+||
T Consensus       108 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  186 (337)
T 3mdy_A          108 TQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL  186 (337)
T ss_dssp             CEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred             CceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence            45899999997 5999998654 799999999999999999999998        9999999999999999999999999


Q ss_pred             ccccccCCCccc-----ccccccccccccccccCcCCCCC------hhhHHHHHHHHHHHHhC----------CCCCCCC
Q 024959          190 GLARTTSETDFM-----TEYVVTRWYRAPELLLNCTEYTA------AIDIWSVGCILGEIMTR----------EPLFPGK  248 (260)
Q Consensus       190 ~~~~~~~~~~~~-----~~~~~~~~~~~PE~~~~~~~~~~------~~Di~slG~~l~~ll~g----------~~pf~~~  248 (260)
                      |++.........     ....+++.|+|||.+.+ .....      ++||||||+++|+|++|          ..||...
T Consensus       187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~  265 (337)
T 3mdy_A          187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE-SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL  265 (337)
T ss_dssp             TTCEECC---------CCSSCSCGGGCCHHHHTT-CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCceeeccccccccCCCCCCccCcceeChhhccc-ccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence            999765443222     23467999999999977 33344      39999999999999999          7777543

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.5e-37  Score=258.22  Aligned_cols=200  Identities=21%  Similarity=0.203  Sum_probs=157.4

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc------chHHHHHHHHHHHHHHHcC---------CCCe
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD------NIIDARRTLREIKLLRHME---------HENV  103 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~e~~~l~~l~---------~~~i  103 (260)
                      +..+.|++++.||+|+||.||++.+  +++.||+|++.....      .......+.+|+++++.++         ||||
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni   94 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF   94 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred             cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence            3456788999999999999999988  578999999965421      1223366788999988886         5555


Q ss_pred             eee-----------------eceecCCC--------CCCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHH
Q 024959          104 IAI-----------------KDIIRPPK--------KDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRG  157 (260)
Q Consensus       104 v~~-----------------~~~~~~~~--------~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~  157 (260)
                      +++                 ++++....        ......+++||||++ |++.+.+.. ..+++..++.++.||+.+
T Consensus        95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred             hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence            555                 44444310        001266999999986 556666543 678999999999999999


Q ss_pred             HHHHH-hCCceeccCCCCCeEeccCC--------------------CEEEeecccccccCCCcccccccccccccccccc
Q 024959          158 LKYVH-SASVLHRDLKPSNLLLNASC--------------------DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL  216 (260)
Q Consensus       158 l~~lh-~~~i~H~di~~~nili~~~~--------------------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~  216 (260)
                      |+||| ++|++||||||+|||++.++                    .+||+|||++......    ...+++.|+|||.+
T Consensus       174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~  249 (336)
T 2vuw_A          174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLF  249 (336)
T ss_dssp             HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGG
T ss_pred             HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhh
Confidence            99999 99999999999999999887                    8999999999876543    34779999999999


Q ss_pred             cCcCCCCChhhHHHHHHH-HHHHHhCCCCCCC
Q 024959          217 LNCTEYTAAIDIWSVGCI-LGEIMTREPLFPG  247 (260)
Q Consensus       217 ~~~~~~~~~~Di~slG~~-l~~ll~g~~pf~~  247 (260)
                      .+ .. +.++|||||+++ .++++.|..||.+
T Consensus       250 ~g-~~-~~~~Diwsl~~~~~~~~~~g~~p~~~  279 (336)
T 2vuw_A          250 TG-DG-DYQFDIYRLMKKENNNRWGEYHPYSN  279 (336)
T ss_dssp             CC-CS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred             cC-CC-ccceehhhhhCCCCcccccccCCCcc
Confidence            87 33 889999998766 7778889999964

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.5e-35  Score=242.40  Aligned_cols=185  Identities=26%  Similarity=0.454  Sum_probs=150.5

Q ss_pred             EeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHH-HHcCCCCeeeeeceecCCCCC
Q 024959           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL-RHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        38 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l-~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      .+..+|+.+.+.||+|++|.||++.+..+++.||+|++...       ..+.+|+.++ +.++||||+++++++..... 
T Consensus        14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~-   85 (299)
T 3m2w_A           14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYA-   85 (299)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET-
T ss_pred             ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcC-
Confidence            34445553447899999999999999999999999999542       3456788877 55589999999999865110 


Q ss_pred             CCccEEEEEecCC-cchHHHhhhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecc---CCCEEEeecc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFG  190 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~---~~~~~l~df~  190 (260)
                      ....+++|||+++ ++|.+++....  .+++..++.++.|++.+|+|||+.|++|+||+|+||+++.   ++.++|+|||
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg  165 (299)
T 3m2w_A           86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  165 (299)
T ss_dssp             TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence            1156899999997 59999998754  6999999999999999999999999999999999999998   7889999999


Q ss_pred             cccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 024959          191 LARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  252 (260)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~  252 (260)
                      ++.....                      ..++.++|+||||+++|+|++|..||.+.+...
T Consensus       166 ~a~~~~~----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~  205 (299)
T 3m2w_A          166 FAKETTG----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA  205 (299)
T ss_dssp             TCEECTT----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-----
T ss_pred             ccccccc----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh
Confidence            8754321                      346779999999999999999999997765443

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=4.5e-33  Score=245.50  Aligned_cols=183  Identities=17%  Similarity=0.110  Sum_probs=131.6

Q ss_pred             cccccCceEEEEEEeCCCCeEEEEEecCCcc--------cchHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCCCCCc
Q 024959           49 PIGRGAYGIVCAAVNSETREEVAIKKIGNAF--------DNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        49 ~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~--------~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      ....|+.|....++....|+.+++|++....        ........+.+|+++|+++ .|+||++++++++++     .
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~-----~  315 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA-----Q  315 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS-----S
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC-----C
Confidence            4566777777777777788999999996542        1233456788999999999 699999999999988     6


Q ss_pred             cEEEEEecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          120 DVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       120 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      ..||||||++| +|.+++..++++++.   .++.||+++|+|+|++||+||||||+|||++.+|.+||+|||+++.....
T Consensus       316 ~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          316 SGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             EEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             EEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            69999999985 999999999999875   47899999999999999999999999999999999999999999876544


Q ss_pred             c-ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhC
Q 024959          199 D-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR  241 (260)
Q Consensus       199 ~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g  241 (260)
                      . ...+.++|+.|++||.+.+  .+...+|+|++|++++.+.++
T Consensus       393 ~~~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~  434 (569)
T 4azs_A          393 CSWPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQP  434 (569)
T ss_dssp             -CCSHHHHHHHHHHHHHHC-------------------CCCCTT
T ss_pred             CccccCceechhhccHHHhCC--CCCCcccccccccchhhhccc
Confidence            2 3445678999999999976  356789999999987776544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=9.7e-28  Score=210.43  Aligned_cols=185  Identities=21%  Similarity=0.221  Sum_probs=138.1

Q ss_pred             CCcccccccCceEEEEEEeCCCCeEEEEEecCCccc------chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCC
Q 024959           45 PPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD------NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (260)
Q Consensus        45 ~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~  118 (260)
                      ...+.||+|+||.||++.  ..+..+++|.......      .....+++.+|++++++++||||+++..++...     
T Consensus       339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~-----  411 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL-----  411 (540)
T ss_dssp             ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET-----
T ss_pred             CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC-----
Confidence            346789999999999994  3456788887533221      112245678999999999999999443333333     


Q ss_pred             ccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCC
Q 024959          119 NDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (260)
Q Consensus       119 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~  197 (260)
                      ...++||||++ ++|.+++..        +..++.|++++|+|||+++++|+||||+||+++.  .++|+|||+++....
T Consensus       412 ~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          412 DNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             TTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             CccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            33699999997 799998776        5689999999999999999999999999999998  999999999988766


Q ss_pred             Cccc--------ccccccccccccccccCc-CCCCChhhHHHHHHHHHHHHhCCCCCC
Q 024959          198 TDFM--------TEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFP  246 (260)
Q Consensus       198 ~~~~--------~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~  246 (260)
                      ....        ....+++.|+|||.+... ..|+...|+|+..+-..+-..+..+|.
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            4322        245779999999998641 335667899999988888887777764

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=3.6e-24  Score=173.23  Aligned_cols=147  Identities=19%  Similarity=0.221  Sum_probs=114.6

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccch----------------HHHHHHHHHHHHHHHcCCCCee
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNI----------------IDARRTLREIKLLRHMEHENVI  104 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~----------------~~~~~~~~e~~~l~~l~~~~iv  104 (260)
                      ...|.+.+.||+|++|.||++.+ .+++.||+|++.......                .....+.+|++++++++  | +
T Consensus        89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~  164 (282)
T 1zar_A           89 GKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-L  164 (282)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-S
T ss_pred             CeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-C
Confidence            33455679999999999999999 889999999996432111                24567889999999998  5 6


Q ss_pred             eeeceecCCCCCCCccEEEEEecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCC
Q 024959          105 AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD  183 (260)
Q Consensus       105 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~  183 (260)
                      ++++++..      +..++|||++++ +|.+ +.      ......++.|++++|.+||+.|++|+||||+||+++ ++.
T Consensus       165 ~v~~~~~~------~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~  230 (282)
T 1zar_A          165 AVPKVYAW------EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEG  230 (282)
T ss_dssp             SSCCEEEE------ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTE
T ss_pred             CcCeEEec------cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCc
Confidence            66665533      336999999974 8877 32      123557999999999999999999999999999999 999


Q ss_pred             EEEeecccccccCCCccccccccccccccccccc
Q 024959          184 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL  217 (260)
Q Consensus       184 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~  217 (260)
                      ++|+|||++....            .+.+||.+.
T Consensus       231 vkl~DFG~a~~~~------------~~~a~e~l~  252 (282)
T 1zar_A          231 IWIIDFPQSVEVG------------EEGWREILE  252 (282)
T ss_dssp             EEECCCTTCEETT------------STTHHHHHH
T ss_pred             EEEEECCCCeECC------------CCCHHHHHH
Confidence            9999999986433            246777664

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.87  E-value=1.5e-22  Score=161.81  Aligned_cols=141  Identities=17%  Similarity=0.115  Sum_probs=108.5

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeE--EEEEecCCcccc----------------------hHHHHHHHHHHHHHHHcC
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREE--VAIKKIGNAFDN----------------------IIDARRTLREIKLLRHME   99 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~--~~iK~~~~~~~~----------------------~~~~~~~~~e~~~l~~l~   99 (260)
                      +.+.+.||+|++|.||++.+..+|+.  ||||+++.....                      ......+.+|++.++++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            45778999999999999998778888  999987543111                      112235778999999998


Q ss_pred             CCCe--eeeeceecCCCCCCCccEEEEEecCCc------chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHH-hCCceecc
Q 024959          100 HENV--IAIKDIIRPPKKDTFNDVYIVYELMDT------DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH-SASVLHRD  170 (260)
Q Consensus       100 ~~~i--v~~~~~~~~~~~~~~~~~~lv~e~~~~------~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~i~H~d  170 (260)
                      |+++  +.+++.         ...++||||+++      +|.+....   .++..+..++.|++.+|.+|| +.|++|+|
T Consensus       129 ~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrD  196 (258)
T 1zth_A          129 EAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHAD  196 (258)
T ss_dssp             HTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSS
T ss_pred             hCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCC
Confidence            7754  333332         235899999953      67665433   235567889999999999999 99999999


Q ss_pred             CCCCCeEeccCCCEEEeecccccccCCC
Q 024959          171 LKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       171 i~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      |+|.|||++.  .++|+|||++....++
T Consensus       197 lkp~NILl~~--~~~liDFG~a~~~~~~  222 (258)
T 1zth_A          197 LSEYNIMYID--KVYFIDMGQAVTLRHP  222 (258)
T ss_dssp             CSTTSEEESS--SEEECCCTTCEETTST
T ss_pred             CCHHHEEEcC--cEEEEECcccccCCCc
Confidence            9999999988  8999999999765433

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.77  E-value=5.2e-19  Score=147.24  Aligned_cols=143  Identities=14%  Similarity=0.131  Sum_probs=99.7

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccc---------------hH-----HHHHHHHHHHHHHHcCCCC
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN---------------II-----DARRTLREIKLLRHMEHEN  102 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~---------------~~-----~~~~~~~e~~~l~~l~~~~  102 (260)
                      -|++.++||.|++|.||+|.+. +|+.||||+++.....               ..     ......+|...|.++.+.+
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            3788999999999999999985 5889999987432110               00     0111235666677664443


Q ss_pred             eeeeeceecCCCCCCCccEEEEEecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccC
Q 024959          103 VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS  181 (260)
Q Consensus       103 iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~  181 (260)
                      +.-...+..       ...+||||+++| .|.++..      .+....++.|++.+|.+||+.|++||||||.|||++++
T Consensus       175 v~vp~p~~~-------~~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~d  241 (397)
T 4gyi_A          175 FPVPEPIAQ-------SRHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREE  241 (397)
T ss_dssp             CSCCCEEEE-------ETTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEE
T ss_pred             CCCCeeeec-------cCceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCC
Confidence            321111111       123799999986 5543321      22345788999999999999999999999999999887


Q ss_pred             CC----------EEEeecccccccCCCc
Q 024959          182 CD----------LKIGDFGLARTTSETD  199 (260)
Q Consensus       182 ~~----------~~l~df~~~~~~~~~~  199 (260)
                      +.          +.|+||+.+....++.
T Consensus       242 gd~~d~~~~~~~~~iID~~Q~V~~~hp~  269 (397)
T 4gyi_A          242 KDAEDPSSITLTPIIIXFPQMVSMDHPN  269 (397)
T ss_dssp             ECSSCTTSEEEEEEECCCTTCEETTSTT
T ss_pred             CCcccccccccceEEEEeCCcccCCCCC
Confidence            63          8999999987766553

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.37  E-value=2e-12  Score=103.04  Aligned_cols=137  Identities=14%  Similarity=0.106  Sum_probs=102.0

Q ss_pred             CCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-CCCeeeeeceecCCCCCCCccEE
Q 024959           44 VPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDVY  122 (260)
Q Consensus        44 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~~~~~~  122 (260)
                      |++...++.|+.+.||++...  +..+++|........  ....+.+|+++++.+. +..+++++++....     ...|
T Consensus        16 ~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~-----~~~~   86 (263)
T 3tm0_A           16 YRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHD-----GWSN   86 (263)
T ss_dssp             SEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEET-----TEEE
T ss_pred             ceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEEecC-----CceE
Confidence            445667777888999999754  578999998642211  1235778999999985 56677888887654     5589


Q ss_pred             EEEecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 024959          123 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS--------------------------------------  163 (260)
Q Consensus       123 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~--------------------------------------  163 (260)
                      +|||+++| ++.+.+.     +......++.++++++..||+                                      
T Consensus        87 lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (263)
T 3tm0_A           87 LLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED  161 (263)
T ss_dssp             EEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred             EEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence            99999997 6655421     122334678899999999998                                      


Q ss_pred             ---------------------CCceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          164 ---------------------ASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       164 ---------------------~~i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                                           ..++|+|++|.||++++++.+.|+||+.+..
T Consensus       162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                 4489999999999998765567999997643

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.23  E-value=7.4e-11  Score=98.29  Aligned_cols=143  Identities=13%  Similarity=0.195  Sum_probs=103.1

Q ss_pred             CcccccccCceEEEEEEeCCCCeEEEEEecC--CcccchHHHHHHHHHHHHHHHcCC--CCeeeeeceecCCCCCCCccE
Q 024959           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIG--NAFDNIIDARRTLREIKLLRHMEH--ENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~--~~~~~~~~~~~~~~e~~~l~~l~~--~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      .++.|+.|..+.+|++...  +..+++|+..  ... .......+.+|+++++.+..  ..+++++.++.....  ....
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~-~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~--~g~~  116 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSK-LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESV--IGRA  116 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTT--TSSC
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCC-CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCc--cCCe
Confidence            3577899999999999765  3578888886  321 11234567789999999973  457788887765522  1347


Q ss_pred             EEEEecCCcc-hHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 024959          122 YIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-------------------------------------  163 (260)
Q Consensus       122 ~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-------------------------------------  163 (260)
                      |+|||+++|. +.+.  ....++......++.++++.|..||+                                     
T Consensus       117 ~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (359)
T 3dxp_A          117 FYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI  194 (359)
T ss_dssp             EEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred             EEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence            8999999973 3221  12346788888999999999999997                                     


Q ss_pred             ---------------------CCceeccCCCCCeEeccCCC--EEEeeccccccc
Q 024959          164 ---------------------ASVLHRDLKPSNLLLNASCD--LKIGDFGLARTT  195 (260)
Q Consensus       164 ---------------------~~i~H~di~~~nili~~~~~--~~l~df~~~~~~  195 (260)
                                           ..++|+|+++.||+++.++.  +.|+||+.+...
T Consensus       195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                 35899999999999987753  689999988643

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.22  E-value=3.2e-11  Score=98.26  Aligned_cols=187  Identities=16%  Similarity=0.171  Sum_probs=118.4

Q ss_pred             cccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-CCC--eeeeeceecCCCCCCCccEEE
Q 024959           47 IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HEN--VIAIKDIIRPPKKDTFNDVYI  123 (260)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~--iv~~~~~~~~~~~~~~~~~~l  123 (260)
                      ++.++.|....||++.     ..+++|+....    .....+.+|++.++.+. +..  +++++.......  .....|+
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~--~~~~~~~   93 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSE--TYQMSFA   93 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCS--SCSCSCE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCC--CCCcceE
Confidence            4568899999999873     46899987432    34567888999998884 333  333443332221  1123578


Q ss_pred             EEecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 024959          124 VYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS---------------------------------------  163 (260)
Q Consensus       124 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~---------------------------------------  163 (260)
                      ||++++| .+.....  ..++.++...++.++++.+..||+                                       
T Consensus        94 vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (304)
T 3sg8_A           94 GFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK  171 (304)
T ss_dssp             EEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred             EEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence            9999997 4443222  346777778888888888888885                                       


Q ss_pred             -------------------CCceeccCCCCCeEecc--CCCEEEeecccccccCCCcccccccccccccccccc----cC
Q 024959          164 -------------------ASVLHRDLKPSNLLLNA--SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL----LN  218 (260)
Q Consensus       164 -------------------~~i~H~di~~~nili~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~----~~  218 (260)
                                         ..++|+|+++.||+++.  ++.+.|+||+.+.................-..|+..    ..
T Consensus       172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~  251 (304)
T 3sg8_A          172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH  251 (304)
T ss_dssp             HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence                               13699999999999988  455789999988654332111110000000111111    00


Q ss_pred             cCC---------CCChhhHHHHHHHHHHHHhCCCCCC
Q 024959          219 CTE---------YTAAIDIWSVGCILGEIMTREPLFP  246 (260)
Q Consensus       219 ~~~---------~~~~~Di~slG~~l~~ll~g~~pf~  246 (260)
                      ...         .....+.|+++.+++.+.+|..+|-
T Consensus       252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            011         1223689999999999999988773

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.20  E-value=2.6e-11  Score=96.26  Aligned_cols=128  Identities=13%  Similarity=0.092  Sum_probs=90.4

Q ss_pred             cccc-ccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCC--eeeeeceecCCCCCCCccEEEE
Q 024959           48 RPIG-RGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN--VIAIKDIIRPPKKDTFNDVYIV  124 (260)
Q Consensus        48 ~~lg-~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--iv~~~~~~~~~~~~~~~~~~lv  124 (260)
                      ..++ .|..+.||++.. .++..+++|.....     ....+.+|+.+++.+.+.+  +++++++....     +..++|
T Consensus        25 ~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~-----~~~~~v   93 (264)
T 1nd4_A           25 AQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEA-----GRDWLL   93 (264)
T ss_dssp             EECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS-----SCEEEE
T ss_pred             EecccCCCCceEEEEec-CCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCC-----CCCEEE
Confidence            3444 555689999965 45678999998543     1234668889888886434  45677777654     448999


Q ss_pred             EecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 024959          125 YELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS--------------------------------------  165 (260)
Q Consensus       125 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--------------------------------------  165 (260)
                      ||+++| ++ + ..   ...   ...++.++++.+..||+..                                      
T Consensus        94 ~e~i~G~~l-~-~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (264)
T 1nd4_A           94 LGEVPGQDL-L-SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL  165 (264)
T ss_dssp             EECCSSEET-T-TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred             EEecCCccc-C-cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence            999986 44 3 11   122   2256677778888888643                                      


Q ss_pred             --------------------ceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          166 --------------------VLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       166 --------------------i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                                          ++|+|++|.||++++++.+.|+||+.+..
T Consensus       166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                99999999999998776567999998644

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.72  E-value=2.1e-07  Score=75.72  Aligned_cols=137  Identities=20%  Similarity=0.203  Sum_probs=90.9

Q ss_pred             CcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCC---CeeeeeceecCCCCCCCccEE
Q 024959           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE---NVIAIKDIIRPPKKDTFNDVY  122 (260)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~iv~~~~~~~~~~~~~~~~~~  122 (260)
                      .++.++.|....||++     +..+++|+...    ......+.+|+++|+.+.+.   .+++++.+....    ....+
T Consensus        23 ~v~~l~~G~~n~v~~v-----g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~----~g~~~   89 (306)
T 3tdw_A           23 SVESLGEGFRNYAILV-----NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRS----DGNPF   89 (306)
T ss_dssp             CEEEEEECSSEEEEEE-----TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECT----TSCEE
T ss_pred             eeeecCCCcceeEEEE-----CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccC----CCceE
Confidence            4566888888899998     45788998632    23456788999999999742   244555555321    14468


Q ss_pred             EEEecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------
Q 024959          123 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-------------------------------------  164 (260)
Q Consensus       123 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~-------------------------------------  164 (260)
                      ++||+++| .+.....  ..++......++.++.+.|..||+.                                     
T Consensus        90 ~v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~  167 (306)
T 3tdw_A           90 VGYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDES  167 (306)
T ss_dssp             EEEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHH
T ss_pred             EEEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchh
Confidence            99999997 4443211  1234444455555555555555532                                     


Q ss_pred             -----------------------CceeccCCCCCeEecc---CCCE-EEeecccccccCC
Q 024959          165 -----------------------SVLHRDLKPSNLLLNA---SCDL-KIGDFGLARTTSE  197 (260)
Q Consensus       165 -----------------------~i~H~di~~~nili~~---~~~~-~l~df~~~~~~~~  197 (260)
                                             .++|+|+++.||+++.   ++.+ .|+||+.+.....
T Consensus       168 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd~  227 (306)
T 3tdw_A          168 LRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISDP  227 (306)
T ss_dssp             HHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEECG
T ss_pred             hHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCCH
Confidence                                   3599999999999987   4554 8999998765443

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.71  E-value=2.6e-07  Score=73.56  Aligned_cols=132  Identities=20%  Similarity=0.233  Sum_probs=88.6

Q ss_pred             ccccCce-EEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-CCCeeeeeceecCCCCCCCccEEEEEec
Q 024959           50 IGRGAYG-IVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDVYIVYEL  127 (260)
Q Consensus        50 lg~G~~g-~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~~~~~~lv~e~  127 (260)
                      +..|..+ .||+......+..+++|+....     ....+.+|...|+.+. +--+.++++++...     +..++|||+
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~-----~~~~lvme~  101 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTP-----DDAWLLTTA  101 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEET-----TEEEEEEEC
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEEC-----CeEEEEEEe
Confidence            3344444 6899988877888999987532     3456778999999885 22255677776655     458999999


Q ss_pred             CCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 024959          128 MDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA------------------------------------------  164 (260)
Q Consensus       128 ~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~------------------------------------------  164 (260)
                      ++| ++.+.....    ......+..++...|..||..                                          
T Consensus       102 l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (272)
T 4gkh_A          102 IPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE  177 (272)
T ss_dssp             CCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred             eCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence            986 444433221    112233444555555555531                                          


Q ss_pred             ----------------CceeccCCCCCeEeccCCCEEEeeccccccc
Q 024959          165 ----------------SVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (260)
Q Consensus       165 ----------------~i~H~di~~~nili~~~~~~~l~df~~~~~~  195 (260)
                                      .++|+|+.+.||+++.++.+-|+||+.+...
T Consensus       178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g  224 (272)
T 4gkh_A          178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA  224 (272)
T ss_dssp             HHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             HHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence                            1689999999999998776789999987543

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.53  E-value=6.1e-07  Score=75.59  Aligned_cols=77  Identities=17%  Similarity=0.058  Sum_probs=47.5

Q ss_pred             cccccccCceEEEEEEeCCCCeEEEEEecCCccc--c---hHHHHHHHHHHHHHHHcCC--C-CeeeeeceecCCCCCCC
Q 024959           47 IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD--N---IIDARRTLREIKLLRHMEH--E-NVIAIKDIIRPPKKDTF  118 (260)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~--~---~~~~~~~~~e~~~l~~l~~--~-~iv~~~~~~~~~~~~~~  118 (260)
                      .+.+|.|..+.||++....++..+++|.......  .   .....++..|.++++.+..  | .+++++.+...      
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d~~------  108 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTE------  108 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETT------
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEcCC------
Confidence            5679999999999997766677899997643211  0   0112345678888887742  3 34456554322      


Q ss_pred             ccEEEEEecCCc
Q 024959          119 NDVYIVYELMDT  130 (260)
Q Consensus       119 ~~~~lv~e~~~~  130 (260)
                       ..++|||++++
T Consensus       109 -~~~lvmE~l~g  119 (397)
T 2olc_A          109 -MAVTVMEDLSH  119 (397)
T ss_dssp             -TTEEEECCCTT
T ss_pred             -ccEEEEEeCCC
Confidence             25799999975

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.21  E-value=2.4e-05  Score=64.11  Aligned_cols=32  Identities=19%  Similarity=0.251  Sum_probs=28.2

Q ss_pred             CCceeccCCCCCeEeccCCCEEEeeccccccc
Q 024959          164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (260)
Q Consensus       164 ~~i~H~di~~~nili~~~~~~~l~df~~~~~~  195 (260)
                      ..++|+|+.+.||+++.++.+.|+||+.+...
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~g  253 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSFD  253 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCEEC
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcccC
Confidence            57999999999999988888999999987543

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.17  E-value=1.7e-06  Score=71.72  Aligned_cols=82  Identities=9%  Similarity=0.112  Sum_probs=50.4

Q ss_pred             cccc-cccCceEEEEEEeC--C----CCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcC-C--CCeeeeeceecCCCC
Q 024959           47 IRPI-GRGAYGIVCAAVNS--E----TREEVAIKKIGNAFD-NIIDARRTLREIKLLRHME-H--ENVIAIKDIIRPPKK  115 (260)
Q Consensus        47 ~~~l-g~G~~g~vy~~~~~--~----~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~--~~iv~~~~~~~~~~~  115 (260)
                      .+.| +.|....+|++...  .    ++..+++|....... .......+.+|+.+++.+. +  -.+++++.+......
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4567 78888999998653  0    156789998754320 0000134567788888774 2  245667776654321


Q ss_pred             CCCccEEEEEecCCc
Q 024959          116 DTFNDVYIVYELMDT  130 (260)
Q Consensus       116 ~~~~~~~lv~e~~~~  130 (260)
                        ....|+|||+++|
T Consensus       105 --~g~~~~v~e~l~G  117 (357)
T 3ats_A          105 --LGTPFFLMDYVEG  117 (357)
T ss_dssp             --TSSCEEEEECCCC
T ss_pred             --cCCceEEEEecCC
Confidence              1346899999986

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=98.12  E-value=1.8e-05  Score=63.92  Aligned_cols=68  Identities=12%  Similarity=0.077  Sum_probs=42.1

Q ss_pred             cccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCe-eeeeceecCCCCCCCccEEEEE
Q 024959           47 IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV-IAIKDIIRPPKKDTFNDVYIVY  125 (260)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-v~~~~~~~~~~~~~~~~~~lv~  125 (260)
                      +++|+.|....+|++      ..+++|+.......   .....+|+..++.+...++ ++++....+.       -++++
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~~~~~~~~-------~~~v~   86 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE---YINRANEAVAAREAAKAGVSPEVLHVDPAT-------GVMVT   86 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEECTTT-------CCEEE
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccc---eeCHHHHHHHHHHHHHcCCCCceEEEECCC-------CEEEE
Confidence            678888999999999      46899988543111   1122457777776642222 4566554332       36899


Q ss_pred             ecC-Cc
Q 024959          126 ELM-DT  130 (260)
Q Consensus       126 e~~-~~  130 (260)
                      |++ ++
T Consensus        87 e~i~~g   92 (301)
T 3dxq_A           87 RYIAGA   92 (301)
T ss_dssp             ECCTTC
T ss_pred             eecCCC
Confidence            999 64

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.08  E-value=4e-05  Score=64.97  Aligned_cols=34  Identities=12%  Similarity=0.260  Sum_probs=28.9

Q ss_pred             HhCCceeccCCCCCeEeccCCCEEEeecccccccC
Q 024959          162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (260)
Q Consensus       162 h~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~  196 (260)
                      +...++|||+++.||+++.++ +.++||+.+....
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~  263 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGP  263 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEEC
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCc
Confidence            346799999999999998876 9999999886544

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.74  E-value=0.0002  Score=58.14  Aligned_cols=73  Identities=12%  Similarity=0.077  Sum_probs=54.0

Q ss_pred             CcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC---CCCeeeeeceecCCCCCCCccEE
Q 024959           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME---HENVIAIKDIIRPPKKDTFNDVY  122 (260)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~iv~~~~~~~~~~~~~~~~~~  122 (260)
                      -.+.|+.|....+|++..  ++..+++|+....     ....+..|++.|+.|.   ...+++++.+....     ...+
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~-----g~~~  107 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ-----GHSF  107 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS-----SEEE
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC-----CceE
Confidence            356789999999999975  3568899987532     2456778888888884   24566777776554     4589


Q ss_pred             EEEecCCc
Q 024959          123 IVYELMDT  130 (260)
Q Consensus       123 lv~e~~~~  130 (260)
                      +|||++++
T Consensus       108 lvme~l~G  115 (312)
T 3jr1_A          108 LLLEALNK  115 (312)
T ss_dssp             EEEECCCC
T ss_pred             EEEEeccC
Confidence            99999985

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.63  E-value=0.0005  Score=57.30  Aligned_cols=136  Identities=14%  Similarity=0.213  Sum_probs=79.9

Q ss_pred             cccccccCceEEEEEEeCC-------CCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-CCCeeeeeceecCCCCCCC
Q 024959           47 IRPIGRGAYGIVCAAVNSE-------TREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTF  118 (260)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~~  118 (260)
                      ++.|..|....+|++....       ++..+++|+......   ......+|.++++.|. +.-.+++++.+..      
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~---~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~------  125 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQ---GVDSLVLESVMFAILAERSLGPQLYGVFPE------  125 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---C---CHHHHHHHHHHHHHHHHTTSSCCEEEEETT------
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccc---hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC------
Confidence            4667778889999998753       346899999743211   2345568888888885 3223566666542      


Q ss_pred             ccEEEEEecCCc-chH-----------HH---hhh----C----CCC--CHHHHHHHHHHHHH-----------------
Q 024959          119 NDVYIVYELMDT-DLH-----------QI---IRS----D----QQL--TDDHCQYFLYQLLR-----------------  156 (260)
Q Consensus       119 ~~~~lv~e~~~~-~l~-----------~~---l~~----~----~~~--~~~~~~~~~~~i~~-----------------  156 (260)
                         .+|||+++| .+.           ..   +.+    .    +..  -+.++..+..++-.                 
T Consensus       126 ---g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l  202 (379)
T 3feg_A          126 ---GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSL  202 (379)
T ss_dssp             ---EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTH
T ss_pred             ---ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHH
Confidence               289999985 211           11   111    1    111  13455555544422                 


Q ss_pred             --HHHHH----Hh----CCceeccCCCCCeEeccC----CCEEEeecccccc
Q 024959          157 --GLKYV----HS----ASVLHRDLKPSNLLLNAS----CDLKIGDFGLART  194 (260)
Q Consensus       157 --~l~~l----h~----~~i~H~di~~~nili~~~----~~~~l~df~~~~~  194 (260)
                        .+..|    ..    ..++|+|+.+.||+++.+    +.+.++||.++..
T Consensus       203 ~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          203 KDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence              22333    22    249999999999999876    7899999998853

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.61  E-value=0.00019  Score=60.94  Aligned_cols=71  Identities=14%  Similarity=0.151  Sum_probs=46.9

Q ss_pred             cccccccCceEEEEEEeCC-------CCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCe-eeeeceecCCCCCCC
Q 024959           47 IRPIGRGAYGIVCAAVNSE-------TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV-IAIKDIIRPPKKDTF  118 (260)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-v~~~~~~~~~~~~~~  118 (260)
                      ++.|+.|....+|++....       .+..+++|+.... ..   ...+.+|..+++.+...++ +++++.+..      
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~------  147 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG------  147 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT------
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC------
Confidence            4668888889999998653       2468999998442 11   1334578888888853333 556665532      


Q ss_pred             ccEEEEEecCCc
Q 024959          119 NDVYIVYELMDT  130 (260)
Q Consensus       119 ~~~~lv~e~~~~  130 (260)
                         .+|+||++|
T Consensus       148 ---g~v~e~l~G  156 (429)
T 1nw1_A          148 ---GRLEEYIPS  156 (429)
T ss_dssp             ---EEEECCCCE
T ss_pred             ---CEEEEEeCC
Confidence               278899875

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.52  E-value=0.00085  Score=50.95  Aligned_cols=100  Identities=15%  Similarity=0.105  Sum_probs=68.6

Q ss_pred             chHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEeccCCCEEEeecccccccCCCcccccccccc
Q 024959          131 DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR  208 (260)
Q Consensus       131 ~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  208 (260)
                      +|.++++. +.+++++++|.++.|.+..|..+-. ..-...=+.|..|++..+|++.+.+ ..+.           ....
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~~  101 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGEP  101 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------cccc
Confidence            79999886 6789999999999999999887732 2223445567899999999887774 1110           1122


Q ss_pred             cccccccccCcCCCCChhhHHHHHHHHHHHHhCCCC
Q 024959          209 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL  244 (260)
Q Consensus       209 ~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~p  244 (260)
                      .+.+||...  ...+.+.-|||||++||..+--..|
T Consensus       102 ~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A          102 PPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -----CCSS--SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             CCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCC
Confidence            356887753  3456889999999999999884444

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.45  E-value=0.0032  Score=53.83  Aligned_cols=72  Identities=21%  Similarity=0.202  Sum_probs=45.9

Q ss_pred             cccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCe-eeeeceecCCCCCCCccEEEEE
Q 024959           47 IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV-IAIKDIIRPPKKDTFNDVYIVY  125 (260)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-v~~~~~~~~~~~~~~~~~~lv~  125 (260)
                      ++.|+.|-...+|++.....+..+++|+........   -+..+|..+++.|...++ +++++.+. +        .+|+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~---idR~~E~~vl~~L~~~gl~P~ll~~~~-~--------G~v~  180 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI---INREREKKISCILYNKNIAKKIYVFFT-N--------GRIE  180 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC---SCHHHHHHHHHHHTTSSSBCCEEEEET-T--------EEEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh---cCHHHHHHHHHHHHhcCCCCCEEEEeC-C--------eEEE
Confidence            456778888999999876545789999874321111   112478888888864444 46666662 1        2599


Q ss_pred             ecCCc
Q 024959          126 ELMDT  130 (260)
Q Consensus       126 e~~~~  130 (260)
                      ||++|
T Consensus       181 e~I~G  185 (458)
T 2qg7_A          181 EFMDG  185 (458)
T ss_dssp             ECCCS
T ss_pred             EeeCC
Confidence            99875

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.39  E-value=0.0005  Score=54.99  Aligned_cols=72  Identities=11%  Similarity=-0.010  Sum_probs=48.4

Q ss_pred             CcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCC---CeeeeeceecCCCCCCCccEE
Q 024959           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE---NVIAIKDIIRPPKKDTFNDVY  122 (260)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~iv~~~~~~~~~~~~~~~~~~  122 (260)
                      -++.+|.|..+.||++.. .+|+.+++|+.......  ....+..|++.|+.|...   -+++++++.         .-+
T Consensus        19 ~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~---------~~~   86 (288)
T 3f7w_A           19 AVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPA--LDGLFRAEALGLDWLGRSFGSPVPQVAGWD---------DRT   86 (288)
T ss_dssp             EEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCC--CTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---------TTE
T ss_pred             EEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcc--hhhHHHHHHHHHHHHHhhCCCCcceEEecc---------Cce
Confidence            457789999999999975 46789999987543221  123467899999988522   233444432         137


Q ss_pred             EEEecCC
Q 024959          123 IVYELMD  129 (260)
Q Consensus       123 lv~e~~~  129 (260)
                      +|||++.
T Consensus        87 lv~e~l~   93 (288)
T 3f7w_A           87 LAMEWVD   93 (288)
T ss_dssp             EEEECCC
T ss_pred             EEEEeec
Confidence            8899986

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.30  E-value=0.00049  Score=56.25  Aligned_cols=34  Identities=26%  Similarity=0.358  Sum_probs=28.3

Q ss_pred             CCceeccCCCCCeEeccC----CCEEEeecccccccCC
Q 024959          164 ASVLHRDLKPSNLLLNAS----CDLKIGDFGLARTTSE  197 (260)
Q Consensus       164 ~~i~H~di~~~nili~~~----~~~~l~df~~~~~~~~  197 (260)
                      ..++|+|+.+.||+++.+    +.+.|+||+.+.....
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~  220 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHR  220 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECT
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCC
Confidence            469999999999999874    6799999998865443

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.25  E-value=0.0015  Score=54.15  Aligned_cols=72  Identities=15%  Similarity=0.161  Sum_probs=41.5

Q ss_pred             cccccccCceEEEEEEeCC--------CCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCC-eeeeeceecCCCCCC
Q 024959           47 IRPIGRGAYGIVCAAVNSE--------TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN-VIAIKDIIRPPKKDT  117 (260)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~--------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-iv~~~~~~~~~~~~~  117 (260)
                      ++.++.|....+|++....        .+..+++|+.......   ......|.+.++.+...+ .+++++...      
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~---~~~~~~E~~~l~~L~~~g~~P~~~~~~~------  108 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE---LYNTISEFEVYKTMSKYKIAPQLLNTFN------  108 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG---TSCHHHHHHHHHHHHHTTSSCCEEEEET------
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc---eecHHHHHHHHHHHHhcCCCCceEEecC------
Confidence            4567788889999997653        1257899988543211   112346777777774223 345555441      


Q ss_pred             CccEEEEEecCCc
Q 024959          118 FNDVYIVYELMDT  130 (260)
Q Consensus       118 ~~~~~lv~e~~~~  130 (260)
                         -++|+|+++|
T Consensus       109 ---~~~v~e~i~G  118 (369)
T 3c5i_A          109 ---GGRIEEWLYG  118 (369)
T ss_dssp             ---TEEEEECCCS
T ss_pred             ---CcEEEEEecC
Confidence               1579999875

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.22  E-value=0.003  Score=51.15  Aligned_cols=142  Identities=11%  Similarity=0.062  Sum_probs=73.3

Q ss_pred             cccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCC--eeeeeceecCCCC-CCCccEEE
Q 024959           47 IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN--VIAIKDIIRPPKK-DTFNDVYI  123 (260)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--iv~~~~~~~~~~~-~~~~~~~l  123 (260)
                      ++.|+.|....+|++....  ..+++|......    ....+..|..+++.+...+  +++++........ ...+..++
T Consensus        27 ~~~i~~G~~n~~~~v~~~~--g~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~  100 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTTK--DPLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAA  100 (322)
T ss_dssp             EEEECC---EEEEEEEESS--CCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEE
T ss_pred             eeccCCCcccceEEEEeCC--ccEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEE
Confidence            4567778889999997643  368899886521    1223445677776664222  2333322111000 00134689


Q ss_pred             EEecCCcch-------------------HHHhhhCC-C----CC---HHHHHH------------HHHHHHHHHHHHHh-
Q 024959          124 VYELMDTDL-------------------HQIIRSDQ-Q----LT---DDHCQY------------FLYQLLRGLKYVHS-  163 (260)
Q Consensus       124 v~e~~~~~l-------------------~~~l~~~~-~----~~---~~~~~~------------~~~~i~~~l~~lh~-  163 (260)
                      ++++++|.-                   +....... +    ..   +.....            +...+.+.++.+.. 
T Consensus       101 l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~  180 (322)
T 2ppq_A          101 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH  180 (322)
T ss_dssp             EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhh
Confidence            999998621                   11000000 0    11   111000            00113334455542 


Q ss_pred             ------CCceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          164 ------ASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       164 ------~~i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                            .+++|+|+.+.||+++.++.+.++||+.+..
T Consensus       181 ~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          181 WPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             CCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence                  3699999999999998876568999997743

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.20  E-value=0.0067  Score=49.18  Aligned_cols=76  Identities=13%  Similarity=0.111  Sum_probs=44.4

Q ss_pred             ccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCC--eeeeeceecCCCC--CCCccEEE
Q 024959           48 RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN--VIAIKDIIRPPKK--DTFNDVYI  123 (260)
Q Consensus        48 ~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--iv~~~~~~~~~~~--~~~~~~~l  123 (260)
                      ..++ |....||++... +|+.+++|........   ...+..|..+++.+....  +++++..  .+..  ...+..++
T Consensus        32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~~---~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~  104 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFA  104 (328)
T ss_dssp             EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEE
T ss_pred             Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCCC---HHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEE
Confidence            4566 788899988543 3567999998532111   234556777777774222  3344433  1111  00145678


Q ss_pred             EEecCCc
Q 024959          124 VYELMDT  130 (260)
Q Consensus       124 v~e~~~~  130 (260)
                      ++++++|
T Consensus       105 l~~~i~G  111 (328)
T 1zyl_A          105 VFPSVGG  111 (328)
T ss_dssp             EEECCCC
T ss_pred             EEEecCC
Confidence            9999986

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.03  E-value=0.01  Score=48.59  Aligned_cols=32  Identities=19%  Similarity=0.258  Sum_probs=27.8

Q ss_pred             CCceeccCCCCCeEeccCCCEEEeeccccccc
Q 024959          164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (260)
Q Consensus       164 ~~i~H~di~~~nili~~~~~~~l~df~~~~~~  195 (260)
                      ..++|+|+.+.||+++.++.+.|+||+.+...
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            35999999999999998888999999877543

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=96.46  E-value=0.011  Score=49.70  Aligned_cols=29  Identities=28%  Similarity=0.392  Sum_probs=25.0

Q ss_pred             ceeccCCCCCeEe------ccCCCEEEeecccccc
Q 024959          166 VLHRDLKPSNLLL------NASCDLKIGDFGLART  194 (260)
Q Consensus       166 i~H~di~~~nili------~~~~~~~l~df~~~~~  194 (260)
                      ++|+|+.+.||++      ++++.+.++||.++..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            7899999999999      3457799999999854

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.46  E-value=0.013  Score=49.45  Aligned_cols=72  Identities=11%  Similarity=0.087  Sum_probs=45.1

Q ss_pred             cccccccCceEEEEEEeCCC-------CeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-CCCeeeeeceecCCCCCCC
Q 024959           47 IRPIGRGAYGIVCAAVNSET-------REEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTF  118 (260)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~-------~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~~  118 (260)
                      ++++..|-...+|++.....       +..+++|+.......   .-+..+|.++++.+. +.-.+++++.+.       
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~---~idR~~E~~~l~~L~~~gi~P~l~~~~~-------  144 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK---FYDSKVELDVFRYLSNINIAPNIIADFP-------  144 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C---CCCHHHHHHHHHHHHHTTSSCCEEEEET-------
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch---hcCHHHHHHHHHHHHhcCCCCCEEEEcC-------
Confidence            45677788899999987531       467999987543211   112346777777774 322345555332       


Q ss_pred             ccEEEEEecCCc
Q 024959          119 NDVYIVYELMDT  130 (260)
Q Consensus       119 ~~~~lv~e~~~~  130 (260)
                        -+.|+||++|
T Consensus       145 --~~~I~efI~G  154 (424)
T 3mes_A          145 --EGRIEEFIDG  154 (424)
T ss_dssp             --TEEEEECCCS
T ss_pred             --CCEEEEEeCC
Confidence              2688999986

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=92.19  E-value=0.017  Score=49.50  Aligned_cols=63  Identities=11%  Similarity=0.032  Sum_probs=17.0

Q ss_pred             CcccccccCceEEEEEEeCCCCeEEEE------EecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceec
Q 024959           46 PIRPIGRGAYGIVCAAVNSETREEVAI------KKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIR  111 (260)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~~~i------K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~  111 (260)
                      +.+.||   ||+||.+.......+||+      |..+...........+.++..+++.++|||+++.+.+..
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            455665   999999988765567888      666543333444566788999999999999999887653

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=89.03  E-value=0.64  Score=35.22  Aligned_cols=81  Identities=19%  Similarity=0.139  Sum_probs=55.7

Q ss_pred             CCCCeeeeeceecCCCCCCCccEEEEEecCC--cchHHHhhhCCCCCHHHHHHHHHHHHHHHH-HHHhCCceeccCCCCC
Q 024959           99 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD--TDLHQIIRSDQQLTDDHCQYFLYQLLRGLK-YVHSASVLHRDLKPSN  175 (260)
Q Consensus        99 ~~~~iv~~~~~~~~~~~~~~~~~~lv~e~~~--~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~-~lh~~~i~H~di~~~n  175 (260)
                      .+|++  ...+-..+     +.+.+.++.-+  .++...    ..++....++++.+|+.... ++  ..-+|--++|+|
T Consensus        48 ~~~~f--~~~I~~~e-----D~~~i~y~~~~~~~~f~~i----~~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~N  114 (219)
T 4ano_A           48 VDPCI--VRDIDVSE-----DEVKVVIKPPSSFLTFAAI----RKTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPEN  114 (219)
T ss_dssp             SCSSS--EEEEEECS-----SEEEEEEECCTTCEEHHHH----HTSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGG
T ss_pred             cCCCC--CeEEEEeC-----CEEEEEEEcCcccCcHHHH----HhcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCce
Confidence            58888  33333333     33555555443  255543    34778888888888888665 34  445888999999


Q ss_pred             eEeccCCCEEEeecccc
Q 024959          176 LLLNASCDLKIGDFGLA  192 (260)
Q Consensus       176 ili~~~~~~~l~df~~~  192 (260)
                      ++++.++.+++.-.|.-
T Consensus       115 L~f~~~~~p~i~hRGi~  131 (219)
T 4ano_A          115 LMFNRALEPFFLHVGVK  131 (219)
T ss_dssp             EEECTTCCEEESCCEET
T ss_pred             EEEeCCCcEEEEEcCCc
Confidence            99999999999987753

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=88.35  E-value=0.48  Score=35.77  Aligned_cols=113  Identities=13%  Similarity=0.110  Sum_probs=71.8

Q ss_pred             CCCCeeeeeceecCCCCCCCccEEEEEecCC--cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCe
Q 024959           99 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD--TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL  176 (260)
Q Consensus        99 ~~~~iv~~~~~~~~~~~~~~~~~~lv~e~~~--~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~ni  176 (260)
                      .+|+++.. .+-...     +.+.+.++.-+  .++..    -...+....++++.+|+....++  ..-+|--++|+|+
T Consensus        43 ~~~~Fl~~-~I~e~e-----D~v~~~y~~~~~~~~f~~----ik~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL  110 (215)
T 4ann_A           43 HSPYFIDA-ELTELR-----DSFQIHYDINDNHTPFDN----IKSFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDEL  110 (215)
T ss_dssp             CCTTBCCE-EEEECS-----SEEEEEECCCTTSEEGGG----GGGSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGE
T ss_pred             cCCcccce-EEEEcc-----cEEEEEEEcCcccCCHHH----HHhcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceE
Confidence            48888865 344433     33455554333  13333    23467888999999999877544  3348889999999


Q ss_pred             EeccCCCEEEeecccccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCC
Q 024959          177 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF  245 (260)
Q Consensus       177 li~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf  245 (260)
                      +++.++.+++.-.|....                ++|.      ..+...=+-..=+++..+++++..|
T Consensus       111 ~f~~~~~p~i~~RGik~~----------------l~P~------~~~ee~fL~qyKAliiall~~K~~F  157 (215)
T 4ann_A          111 FFTRDGLPIAKTRGLQNV----------------VDPL------PVSEAEFLTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             EECTTSCEEESCCEETTT----------------BSCC------CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred             EEcCCCCEEEEEccCccC----------------CCCC------CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence            999999999987775321                2332      1222333344667778888877766

>2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A*

Probab=83.45  E-value=25  Score=31.57  Aligned_cols=26  Identities=35%  Similarity=0.319  Sum_probs=23.6

Q ss_pred             ccCCCCCeEeccCCCEEEeecccccc
Q 024959          169 RDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       169 ~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                      +|=.++||+++.+|.+.-+|||.+-.
T Consensus       551 GDRH~~NILid~tG~v~HIDFG~~f~  576 (696)
T 2x6h_A          551 GDRHLDNLLLTTNGKLFHIDFGYILG  576 (696)
T ss_dssp             CCCCTTTEEECTTSCEEECCCCSCTT
T ss_pred             CCCCCcceEEeCCCCEEEEeehhhhc
Confidence            78899999999999999999998743

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	260
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-62
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-59
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-59
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	8e-59
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	9e-59
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-58
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	7e-58
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-57
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-57
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-57
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-56
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-56
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-56
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-55
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-55
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-55
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	6e-55
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-54
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-53
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-53
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-53
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-53
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-51
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-50
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-50
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-50
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-50
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-50
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-48
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-48
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-48
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	5e-48
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-47
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	8e-46
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-45
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	9e-45
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-44
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-44
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	6e-44
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	7e-43
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-42
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	8e-42
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-40
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-40
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-39
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-39
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-39
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-39
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	6e-39
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-38
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-38
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-37
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-37
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-37
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-37
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-36
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-36
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-36
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-35
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	7e-34
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-32
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	7e-32
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	6e-23

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 1e-62
 Identities = 127/231 (54%), Positives = 166/231 (71%), Gaps = 7/231 (3%)

Query: 34  GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIK 93
           G +F+V  +Y   +  IG GAYG+VC+A ++  +  VAIKKI + F++    +RTLREIK
Sbjct: 1   GQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIK 58

Query: 94  LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQ 153
           +L    HEN+I I DIIR P  +   DVY+V  LM  DL++++++ Q L++DH  YFLYQ
Sbjct: 59  ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQ 117

Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR----TTSETDFMTEYVVTRW 209
           +LRGLKY+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV TRW
Sbjct: 118 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177

Query: 210 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           YRAPE++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  +
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI 228

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 3e-59
 Identities = 110/235 (46%), Positives = 160/235 (68%), Gaps = 5/235 (2%)

Query: 27  YVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR 86
           + +  V    +EV + Y   ++P+G GAYG VC+AV+  T  +VAIKK+   F + + A+
Sbjct: 4   FYRQEVTKTAWEVRAVYRD-LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK 62

Query: 87  RTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDD 145
           R  RE++LL+HM HENVI + D+  P +  D F D Y+V   M TDL ++++  ++L +D
Sbjct: 63  RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGED 121

Query: 146 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 205
             Q+ +YQ+L+GL+Y+H+A ++HRDLKP NL +N  C+LKI DFGLAR       MT YV
Sbjct: 122 RIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYV 179

Query: 206 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           VTRWYRAPE++LN   YT  +DIWSVGCI+ E++T + LF G D++ QL+ I +V
Sbjct: 180 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV 234

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 3e-59
 Identities = 64/215 (29%), Positives = 97/215 (45%), Gaps = 10/215 (4%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ +G GAYG V  AVN  T E VA+K + +    +       +EI + + + HENV+  
Sbjct: 10  VQTLGEGAYGEVQLAVNRVTEEAVAVKIV-DMKRAVDCPENIKKEICINKMLNHENVVKF 68

Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLH-QIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
               R       N  Y+  E          I  D  + +   Q F +QL+ G+ Y+H   
Sbjct: 69  YGHRREG-----NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123

Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLAR---TTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           + HRD+KP NLLL+   +LKI DFGLA      +    + +   T  Y APELL     +
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183

Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
              +D+WS G +L  ++  E  +       Q    
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 218

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 8e-59
 Identities = 121/236 (51%), Positives = 168/236 (71%), Gaps = 5/236 (2%)

Query: 26  KYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA 85
            + +  +   ++EV  +Y   + P+G GAYG VCAA +++T   VA+KK+   F +II A
Sbjct: 3   TFYRQELNKTIWEVPERYQN-LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 61

Query: 86  RRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTD 144
           +RT RE++LL+HM+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTD
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTD 120

Query: 145 DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY 204
           DH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T +   MT Y
Sbjct: 121 DHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGY 178

Query: 205 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           V TRWYRAPE++LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  +
Sbjct: 179 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 234

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 9e-59
 Identities = 50/205 (24%), Positives = 93/205 (45%), Gaps = 10/205 (4%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           I  +G G  G+V    +  +   +A K I           + +RE+++L       ++  
Sbjct: 11  ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA-IRNQIIRELQVLHECNSPYIVGF 69

Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA- 164
                     +  ++ I  E MD   L Q+++   ++ +         +++GL Y+    
Sbjct: 70  YGAFY-----SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
            ++HRD+KPSN+L+N+  ++K+ DFG++    ++     +V TR Y +PE L     Y+ 
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGT-HYSV 182

Query: 225 AIDIWSVGCILGEIMTREPLFPGKD 249
             DIWS+G  L E+       P  D
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPD 207

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 2e-58
 Identities = 53/216 (24%), Positives = 101/216 (46%), Gaps = 9/216 (4%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIA 105
            RP+G+G +G V  A   +++  +A+K +     +      +  RE+++  H+ H N++ 
Sbjct: 11  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 70

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           +              VY++ E      +++ ++   +  +     ++ +L   L Y HS 
Sbjct: 71  LYGYFHDA-----TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
            V+HRD+KP NLLL ++ +LKI DFG +     +   T    T  Y  PE++     +  
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-LCGTLDYLPPEMIEG-RMHDE 183

Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
            +D+WS+G +  E +  +P F    Y    + I+ V
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 219

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  184 bits (469), Expect = 7e-58
 Identities = 57/217 (26%), Positives = 104/217 (47%), Gaps = 12/217 (5%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           +R IG G++G V  A +    E VAIKK+  +   +    +  ++E++ L+ + H N I 
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79

Query: 106 IKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
            +           +  ++V E    +    +    + L +       +  L+GL Y+HS 
Sbjct: 80  YRGCYLRE-----HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE--Y 222
           +++HRD+K  N+LL+    +K+GDFG A   +       +V T ++ APE++L   E  Y
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQY 191

Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
              +D+WS+G    E+  R+P     + +  L  I +
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 1e-57
 Identities = 61/236 (25%), Positives = 105/236 (44%), Gaps = 20/236 (8%)

Query: 37  FEVSSKYVPP------IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR 90
           +E  ++ + P      I  +G GA+G V  A N ET    A K I    +   +    + 
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE--ELEDYMV 58

Query: 91  EIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDL--HQIIRSDQQLTDDHCQ 148
           EI +L   +H N++ + D          N+++I+ E          ++  ++ LT+   Q
Sbjct: 59  EIDILASCDHPNIVKLLDAFYYE-----NNLWILIEFCAGGAVDAVMLELERPLTESQIQ 113

Query: 149 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVT 207
               Q L  L Y+H   ++HRDLK  N+L     D+K+ DFG++   T        ++ T
Sbjct: 114 VVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGT 173

Query: 208 RWYRAPELLLNCT----EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
            ++ APE+++  T     Y    D+WS+G  L E+   EP     + +  L  I +
Sbjct: 174 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK 229

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 3e-57
 Identities = 79/223 (35%), Positives = 122/223 (54%), Gaps = 9/223 (4%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG+G +G V  A + +T ++VA+KK+    +        LREIK+L+ ++HENV+ +
Sbjct: 15  LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNL 74

Query: 107 KDIIRPPKKDTF---NDVYIVYELMDTDLHQI-IRSDQQLTDDHCQYFLYQLLRGLKYVH 162
            +I R            +Y+V++  + DL  +      + T    +  +  LL GL Y+H
Sbjct: 75  IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 134

Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLAR-----TTSETDFMTEYVVTRWYRAPELLL 217
              +LHRD+K +N+L+     LK+ DFGLAR       S+ +  T  VVT WYR PELLL
Sbjct: 135 RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLL 194

Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
              +Y   ID+W  GCI+ E+ TR P+  G    HQL LI+++
Sbjct: 195 GERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 3e-57
 Identities = 69/224 (30%), Positives = 104/224 (46%), Gaps = 15/224 (6%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G+YG           + +  K++        + +  + E+ LLR ++H N++  
Sbjct: 9   LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 68

Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQII----RSDQQLTDDHCQYFLYQLLRGLKYV 161
            D I      T   +YIV E  +  DL  +I    +  Q L ++     + QL   LK  
Sbjct: 69  YDRIIDRTNTT---LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125

Query: 162 HSAS-----VLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPEL 215
           H  S     VLHRDLKP+N+ L+   ++K+GDFGLAR    +T F   +V T +Y +PE 
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPE- 184

Query: 216 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
            +N   Y    DIWS+GC+L E+    P F           I E
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 228

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  182 bits (462), Expect = 2e-56
 Identities = 48/217 (22%), Positives = 94/217 (43%), Gaps = 12/217 (5%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
              +G GA+G+V       T    A K +    ++  D     +EI+ +  + H  ++ +
Sbjct: 31  HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHPTLVNL 88

Query: 107 KDIIRPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
            D          N++ ++YE M       ++     ++++D    ++ Q+ +GL ++H  
Sbjct: 89  HDAFEDD-----NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 143

Query: 165 SVLHRDLKPSNLLLNA--SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           + +H DLKP N++     S +LK+ DFGL         +     T  + APE+       
Sbjct: 144 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG-KPV 202

Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
               D+WSVG +   +++    F G++    LR +  
Sbjct: 203 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS 239

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 2e-56
 Identities = 85/219 (38%), Positives = 122/219 (55%), Gaps = 10/219 (4%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIID---ARRTLREIKLLRHMEHENV 103
           +  +G G +  V  A +  T + VAIKKI     +       R  LREIKLL+ + H N+
Sbjct: 3   LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 62

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 162
           I + D          +++ +V++ M+TD    I  +   LT  H + ++   L+GL+Y+H
Sbjct: 63  IGLLDAFGHK-----SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 117

Query: 163 SASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTE 221
              +LHRDLKP+NLLL+ +  LK+ DFGLA++  S     T  VVTRWYRAPELL     
Sbjct: 118 QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARM 177

Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           Y   +D+W+VGCIL E++ R P  PG   + QL  I E 
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFET 216

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 3e-56
 Identities = 56/224 (25%), Positives = 108/224 (48%), Gaps = 10/224 (4%)

Query: 35  NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL 94
           ++ +   KY      IG+GA G V  A++  T +EVAI+++             + EI +
Sbjct: 14  SVGDPKKKYTR-FEKIGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILV 70

Query: 95  LRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
           +R  ++ N++   D          +++++V E +       + ++  + +        + 
Sbjct: 71  MRENKNPNIVNYLDSYL-----VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCREC 125

Query: 155 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAP 213
           L+ L+++HS  V+HRD+K  N+LL     +K+ DFG     T E    +  V T ++ AP
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185

Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           E++     Y   +DIWS+G +  E++  EP +  ++ +  L LI
Sbjct: 186 EVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 1e-55
 Identities = 75/220 (34%), Positives = 128/220 (58%), Gaps = 12/220 (5%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
            + IG G++G+V  A   ++ E VAIKK+        D R   RE++++R ++H N++ +
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCNIVRL 78

Query: 107 KDIIRPP-KKDTFNDVYIVYELMDTDLHQII----RSDQQLTDDHCQYFLYQLLRGLKYV 161
           +       +K     + +V + +   ++++     R+ Q L   + + ++YQL R L Y+
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138

Query: 162 HSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           HS  + HRD+KP NLLL+  +  LK+ DFG A+     +    Y+ +R+YRAPEL+   T
Sbjct: 139 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 198

Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           +YT++ID+WS GC+L E++  +P+FPG   V QL  I +V
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 238

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  178 bits (453), Expect = 4e-55
 Identities = 48/217 (22%), Positives = 95/217 (43%), Gaps = 12/217 (5%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  +G GA+G+V   V   T      K I       +D      EI ++  + H  +I +
Sbjct: 34  LEELGSGAFGVVHRCVEKATGRVFVAKFINT--PYPLDKYTVKNEISIMNQLHHPKLINL 91

Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQ-IIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
            D           ++ ++ E +   +L   I   D ++++     ++ Q   GLK++H  
Sbjct: 92  HDAFEDK-----YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 146

Query: 165 SVLHRDLKPSNLLLNASCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           S++H D+KP N++        +KI DFGLA   +  + +     T  + APE++      
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR-EPV 205

Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
               D+W++G +   +++    F G+D +  L+ +  
Sbjct: 206 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR 242

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 5e-55
 Identities = 106/236 (44%), Positives = 155/236 (65%), Gaps = 5/236 (2%)

Query: 26  KYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA 85
           ++    V  + F V  +Y   ++PIG GA GIVCAA ++     VAIKK+   F N   A
Sbjct: 2   QFYSVEVGDSTFTVLKRYQN-LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA 60

Query: 86  RRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTD 144
           +R  RE+ L++ + H+N+I++ ++  P K  + F DVY+V ELMD +L Q+I+   +L  
Sbjct: 61  KRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDH 118

Query: 145 DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY 204
           +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART   +  MT Y
Sbjct: 119 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 178

Query: 205 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           VVTR+YRAPE++L    Y   +DIWSVGCI+GE++  + LFPG+DY+ Q   + E 
Sbjct: 179 VVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  176 bits (446), Expect = 6e-55
 Identities = 61/228 (26%), Positives = 107/228 (46%), Gaps = 19/228 (8%)

Query: 46  PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR-------RTLREIKLLRHM 98
           P   +GRG   +V   ++  T +E A+K I         A         TL+E+ +LR +
Sbjct: 7   PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66

Query: 99  -EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 156
             H N+I +KD       +T    ++V++LM   +L   +     L++   +  +  LL 
Sbjct: 67  SGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 121

Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 216
            +  +H  +++HRDLKP N+LL+   ++K+ DFG +      + + E   T  Y APE++
Sbjct: 122 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEII 181

Query: 217 L-----NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
                 N   Y   +D+WS G I+  ++   P F  +  +  LR+I  
Sbjct: 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 229

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 5e-54
 Identities = 50/218 (22%), Positives = 94/218 (43%), Gaps = 11/218 (5%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIA 105
            + +G G++  V  A    T  E AIK +               RE  ++  ++H   + 
Sbjct: 13  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 72

Query: 106 IKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           +    +         +Y         +L + IR      +   +++  +++  L+Y+H  
Sbjct: 73  LYFTFQDD-----EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLLNCTE 221
            ++HRDLKP N+LLN    ++I DFG A+     S+      +V T  Y +PELL     
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-KS 186

Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
              + D+W++GCI+ +++   P F   +     + I +
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 224

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 3e-53
 Identities = 83/220 (37%), Positives = 124/220 (56%), Gaps = 7/220 (3%)

Query: 47  IRPIGRGAYGIVCAAVNSETR-EEVAIKKIGNAFDNIIDARRTLREIKLLRHM---EHEN 102
           +  IG GAYG V  A + +     VA+K++            T+RE+ +LRH+   EH N
Sbjct: 12  VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 71

Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELM--DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           V+ + D+    + D    + +V+E +  D   +     +  +  +  +  ++QLLRGL +
Sbjct: 72  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 131

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
           +HS  V+HRDLKP N+L+ +S  +K+ DFGLAR  S    +T  VVT WYRAPE+LL  +
Sbjct: 132 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ-S 190

Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
            Y   +D+WSVGCI  E+  R+PLF G   V QL  I +V
Sbjct: 191 SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 230

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 3e-53
 Identities = 52/217 (23%), Positives = 107/217 (49%), Gaps = 8/217 (3%)

Query: 42  KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE 101
           +++     IGRG++  V   +++ET  EVA  ++ +      + +R   E ++L+ ++H 
Sbjct: 9   RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68

Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           N++   D      K     + +V ELM +  L   ++  + +     + +  Q+L+GL++
Sbjct: 69  NIVRFYDSWESTVKGK-KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF 127

Query: 161 VHSAS--VLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 217
           +H+ +  ++HRDLK  N+ +   +  +KIGD GLA       F    + T  + APE+  
Sbjct: 128 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYE 186

Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
              +Y  ++D+++ G  + E+ T E  +       Q+
Sbjct: 187 E--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI 221

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 4e-53
 Identities = 90/217 (41%), Positives = 124/217 (57%), Gaps = 8/217 (3%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N  T E VA+KKI    +        +REI LL+ + H N++ +
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66

Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHSA 164
            D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS 
Sbjct: 67  LDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYT 223
            VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181

Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
            A+DIWS+GCI  E++TR  LFPG   + QL  I   
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRT 218

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  171 bits (435), Expect = 7e-53
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 11/215 (5%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
              +G GA+  V  A +  T++ VAIK I        +      EI +L  ++H N++A+
Sbjct: 14  RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGS-MENEIAVLHKIKHPNIVAL 72

Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            DI           +Y++ +L+   +L   I      T+      ++Q+L  +KY+H   
Sbjct: 73  DDIYESG-----GHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127

Query: 166 VLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 222
           ++HRDLKP NLL    +    + I DFGL++       ++    T  Y APE+L     Y
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ-KPY 186

Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           + A+D WS+G I   ++   P F  ++       I
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI 221

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 1e-51
 Identities = 48/226 (21%), Positives = 103/226 (45%), Gaps = 14/226 (6%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRH 97
           E+  KY+     +GRG +GIV   V + +++    K +        D     +EI +L  
Sbjct: 2   ELYEKYMI-AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT---DQVLVKKEISILNI 57

Query: 98  MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLL 155
             H N++ + +       ++  ++ +++E +   D+ + I +   +L +     +++Q+ 
Sbjct: 58  ARHRNILHLHESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC 112

Query: 156 RGLKYVHSASVLHRDLKPSNLLLNA--SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 213
             L+++HS ++ H D++P N++     S  +KI +FG AR     D          Y AP
Sbjct: 113 EALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAP 172

Query: 214 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           E+  +    + A D+WS+G ++  +++    F  +     +  I  
Sbjct: 173 EVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN 217

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 1e-50
 Identities = 49/218 (22%), Positives = 97/218 (44%), Gaps = 16/218 (7%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
            + IG G++G V      +   +VA+K +          +    E+ +LR   H N++  
Sbjct: 13  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69

Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSA 164
                     T   + IV +  + + L+  +   + +           Q  +G+ Y+H+ 
Sbjct: 70  MGY------STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE---TDFMTEYVVTRWYRAPELLL--NC 219
           S++HRDLK +N+ L+    +KIGDFGLA   S    +    +   +  + APE++   + 
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183

Query: 220 TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
             Y+   D+++ G +L E+MT +  +   +   Q+  +
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM 221

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (417), Expect = 2e-50
 Identities = 79/216 (36%), Positives = 115/216 (53%), Gaps = 6/216 (2%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG V  A N ET E VA+K++    D+       LREI LL+ ++H+N++ +
Sbjct: 7   LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 66

Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 166
            D++            +               +  L  +  + FL+QLL+GL + HS +V
Sbjct: 67  HDVLH----SDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV 122

Query: 167 LHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           LHRDLKP NLL+N + +LK+ +FGLAR         +  VVT WYR P++L     Y+ +
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182

Query: 226 IDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITEV 260
           ID+WS GCI  E+     PLFPG D   QL+ I  +
Sbjct: 183 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 218

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  165 bits (418), Expect = 3e-50
 Identities = 72/239 (30%), Positives = 130/239 (54%), Gaps = 16/239 (6%)

Query: 26  KYVQYNVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDA 85
           +Y  Y  +   +     Y   +R +GRG Y  V  A+N    E+V +K +       +  
Sbjct: 20  EYWDYESHVVEWGNQDDYQL-VRKLGRGKYSEVFEAINITNNEKVVVKIL-----KPVKK 73

Query: 86  RRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT 143
           ++  REIK+L ++    N+I + DI++ P   T     +V+E ++ TD  Q+ ++   LT
Sbjct: 74  KKIKREIKILENLRGGPNIITLADIVKDPVSRTP---ALVFEHVNNTDFKQLYQT---LT 127

Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMT 202
           D   ++++Y++L+ L Y HS  ++HRD+KP N++++     L++ D+GLA          
Sbjct: 128 DYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN 187

Query: 203 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITEV 260
             V +R+++ PELL++   Y  ++D+WS+GC+L  ++  +EP F G D   QL  I +V
Sbjct: 188 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 246

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 4e-50
 Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 16/217 (7%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIK-LLRHMEHENVIAI 106
           + +G G  G V    N  T+E+ A+K +        D  +  RE++   R  +  +++ I
Sbjct: 18  QVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRI 70

Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQII--RSDQQLTDDHCQYFLYQLLRGLKYVHS 163
            D+           + IV E +D  +L   I  R DQ  T+      +  +   ++Y+HS
Sbjct: 71  VDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 129

Query: 164 ASVLHRDLKPSNLLLNASCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 220
            ++ HRD+KP NLL  +      LK+ DFG A+ T+  + +T    T +Y APE +L   
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPE 188

Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           +Y  + D+WS+G I+  ++   P F     +     +
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM 225

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  163 bits (414), Expect = 4e-50
 Identities = 83/216 (38%), Positives = 118/216 (54%), Gaps = 8/216 (3%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +  IG G YG+V  A N+   E  A+KKI    ++      T+REI +L+ ++H N++ +
Sbjct: 7   LEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65

Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            D+I   K+     + +V+E +D      +   +  L     + FL QLL G+ Y H   
Sbjct: 66  YDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120

Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEYTA 224
           VLHRDLKP NLL+N   +LKI DFGLAR            +VT WYRAP++L+   +Y+ 
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180

Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
            IDIWSVGCI  E++   PLFPG     QL  I  +
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRI 216

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  162 bits (411), Expect = 1e-48
 Identities = 50/216 (23%), Positives = 99/216 (45%), Gaps = 11/216 (5%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHEN 102
            R IGRG +G V     ++T +  A+K +             A      + L+   +   
Sbjct: 9   HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 68

Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           ++ +      P     + +  + +LM+  DLH  +      ++   +++  +++ GL+++
Sbjct: 69  IVCMSYAFHTP-----DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 221
           H+  V++RDLKP+N+LL+    ++I D GLA   S+       V T  Y APE+L     
Sbjct: 124 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVA 182

Query: 222 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           Y ++ D +S+GC+L +++     F       +  + 
Sbjct: 183 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 218

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 1e-48
 Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 15/223 (6%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHEN 102
              +G G + +V       T  + A K I      +    +      RE+ +L+ ++H N
Sbjct: 15  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 74

Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           VI + ++      +   DV ++ EL+    L   +   + LT++    FL Q+L G+ Y+
Sbjct: 75  VITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129

Query: 162 HSASVLHRDLKPSNLLLN----ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 217
           HS  + H DLKP N++L         +KI DFGLA      +       T  + APE++ 
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV- 188

Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEV 260
           N        D+WS+G I   +++    F G      L  ++ V
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 231

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 2e-48
 Identities = 50/220 (22%), Positives = 101/220 (45%), Gaps = 15/220 (6%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHM--EH 100
              +G G +G V + +       VAIK +     + +  + +  R   E+ LL+ +    
Sbjct: 9   GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 68

Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMD--TDLHQIIRSDQQLTDDHCQYFLYQLLRGL 158
             VI + D    P     +   ++ E  +   DL   I     L ++  + F +Q+L  +
Sbjct: 69  SGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123

Query: 159 KYVHSASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 217
           ++ H+  VLHRD+K  N+L++ +  +LK+ DFG      +T   T++  TR Y  PE + 
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 182

Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
               +  +  +WS+G +L +++  +  F   + + + ++ 
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF 222

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 5e-48
 Identities = 56/217 (25%), Positives = 104/217 (47%), Gaps = 10/217 (4%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRH-MEHENVI 104
            + +G+G++G V  A   +T +  AIK +  +      D   T+ E ++L    EH  + 
Sbjct: 7   HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 66

Query: 105 AIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
            +    +     T  +++ V E ++  DL   I+S  +       ++  +++ GL+++HS
Sbjct: 67  HMFCTFQ-----TKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCTEY 222
             +++RDLK  N+LL+    +KI DFG+ +           +  T  Y APE+LL   +Y
Sbjct: 122 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG-QKY 180

Query: 223 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
             ++D WS G +L E++  +  F G+D       I  
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM 217

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  155 bits (393), Expect = 5e-47
 Identities = 53/217 (24%), Positives = 95/217 (43%), Gaps = 8/217 (3%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIA 105
              +G G    V  A +     +VA+K +  +   +     R  RE +    + H  ++A
Sbjct: 12  GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 71

Query: 106 IKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           + D             YIV E +D   L  I+ ++  +T       +    + L + H  
Sbjct: 72  VYDTGEAETPA-GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN 130

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLAR----TTSETDFMTEYVVTRWYRAPELLLNCT 220
            ++HRD+KP+N++++A+  +K+ DFG+AR    + +        + T  Y +PE      
Sbjct: 131 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG-D 189

Query: 221 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
              A  D++S+GC+L E++T EP F G   V      
Sbjct: 190 SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH 226

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 8e-46
 Identities = 53/217 (24%), Positives = 93/217 (42%), Gaps = 17/217 (7%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG+G +G V          +VA+K I     N   A+  L E  ++  + H N++ +
Sbjct: 12  LQTIGKGEFGDVMLGDY--RGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQL 65

Query: 107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHS 163
             +I     +    +YIV E M    L   +RS     L  D    F   +   ++Y+  
Sbjct: 66  LGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 223
            + +HRDL   N+L++     K+ DFGL +  S T       +   + APE L    +++
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALRE-KKFS 178

Query: 224 AAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITE 259
              D+WS G +L EI +     +P       +  + +
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 215

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 4e-45
 Identities = 53/214 (24%), Positives = 104/214 (48%), Gaps = 9/214 (4%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           ++ +G+G +G V       T    A+K +         +   T+ E ++L++  H  + A
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           +K   +       + +  V E  +   L   +  ++  T++  +++  +++  L+Y+HS 
Sbjct: 70  LKYAFQTH-----DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYT 223
            V++RD+K  NL+L+    +KI DFGL +   S+   M  +  T  Y APE+L +  +Y 
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYG 183

Query: 224 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
            A+D W +G ++ E+M     F  +D+     LI
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  151 bits (381), Expect = 9e-45
 Identities = 47/215 (21%), Positives = 98/215 (45%), Gaps = 10/215 (4%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           +R +G G++G V    +       A+K +       +     T  E  +L  + H  +I 
Sbjct: 9   LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 68

Query: 106 IKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           +    +         ++++ + ++  +L  ++R  Q+  +   +++  ++   L+Y+HS 
Sbjct: 69  MWGTFQDA-----QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 224
            +++RDLKP N+LL+ +  +KI DFG A+   +         T  Y APE +++   Y  
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPE-VVSTKPYNK 180

Query: 225 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 259
           +ID WS G ++ E++     F   + +     I  
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN 215

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  151 bits (383), Expect = 1e-44
 Identities = 46/212 (21%), Positives = 99/212 (46%), Gaps = 8/212 (3%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           I+ +G G++G V    + E+    A+K +       +     TL E ++L+ +    ++ 
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105

Query: 106 IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
           ++   +    D  N   ++  +   ++   +R   + ++ H +++  Q++   +Y+HS  
Sbjct: 106 LEFSFK----DNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161

Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 225
           +++RDLKP NLL++    +++ DFG A+             T    APE++L+   Y  A
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILS-KGYNKA 218

Query: 226 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
           +D W++G ++ E+    P F     +     I
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 2e-44
 Identities = 42/220 (19%), Positives = 98/220 (44%), Gaps = 15/220 (6%)

Query: 48  RPIGRGAYGIVCAAV--NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA 105
           + +G G +G V        +  + VA+K + N  ++       L E  +++ +++  ++ 
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 106 IKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
           +  I             +V E+ +   L++ ++ ++ + D +    ++Q+  G+KY+  +
Sbjct: 73  MIGIC------EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 126

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLAR----TTSETDFMTEYVVTRWYRAPELLLNCT 220
           + +HRDL   N+LL      KI DFGL++      +     T       + APE +    
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY- 185

Query: 221 EYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITE 259
           ++++  D+WS G ++ E  +  +  + G        ++ +
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 225

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 6e-44
 Identities = 52/229 (22%), Positives = 103/229 (44%), Gaps = 17/229 (7%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           +EV  + +  +  +G G +G V     +   + VA+K +       +     L E  L++
Sbjct: 8   WEVPRETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSL---KQGSMSPDAFLAEANLMK 63

Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDL---HQIIRSDQQLTDDHCQYFLYQ 153
            ++H+ ++ +  ++      T   +YI+ E M+           S  +LT +       Q
Sbjct: 64  QLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117

Query: 154 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF--MTEYVVTRWYR 211
           +  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + ++           + 
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 177

Query: 212 APELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITE 259
           APE  +N   +T   D+WS G +L EI+T     +PG      ++ +  
Sbjct: 178 APE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 7e-43
 Identities = 51/219 (23%), Positives = 93/219 (42%), Gaps = 17/219 (7%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
              +G+G +G V     + T   VAIK +       +     L+E ++++ + HE ++ +
Sbjct: 22  EVKLGQGCFGEVWMGTWNGTTR-VAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQL 77

Query: 107 KDIIRPPKKDTFNDVYIVYELMD---TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 163
             ++      +   +YIV E M            + + L          Q+  G+ YV  
Sbjct: 78  YAVV------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131

Query: 164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNCTE 221
            + +HRDL+ +N+L+  +   K+ DFGLAR   + ++           + APE  L    
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GR 190

Query: 222 YTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITE 259
           +T   D+WS G +L E+ T+    +PG      L  +  
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 229

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (360), Expect = 5e-42
 Identities = 51/221 (23%), Positives = 89/221 (40%), Gaps = 16/221 (7%)

Query: 47  IRPIGRGAYGIVCAAV---NSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHEN 102
           +  +G G++G+V        S     VA+K +  +           +RE+  +  ++H N
Sbjct: 13  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72

Query: 103 VIAIKDIIRPPKKDTFNDVYIVYELMD--TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
           +I +  ++          + +V EL    + L ++ +            +  Q+  G+ Y
Sbjct: 73  LIRLYGVV------LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLL 217
           + S   +HRDL   NLLL     +KIGDFGL R   + D    M E+    +       L
Sbjct: 127 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186

Query: 218 NCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLI 257
               ++ A D W  G  L E+ T  +  + G +    L  I
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 227

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 8e-42
 Identities = 45/219 (20%), Positives = 97/219 (44%), Gaps = 17/219 (7%)

Query: 50  IGRGAYGIVCAAVNSETRE--EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
           +G G +G V   V    ++  +VAIK +    +   D    +RE +++  +++  ++ + 
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA-DTEEMMREAQIMHQLDNPYIVRLI 75

Query: 108 DIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSAS 165
            + +         + +V E+     LH+ +    +++   +    L+Q+  G+KY+   +
Sbjct: 76  GVCQAEA------LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 129

Query: 166 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD----FMTEYVVTRWYRAPELLLNCTE 221
            +HRDL   N+LL      KI DFGL++     D      +       + APE  +N  +
Sbjct: 130 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE-CINFRK 188

Query: 222 YTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITE 259
           +++  D+WS G  + E ++  +  +        +  I +
Sbjct: 189 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 227

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 1e-40
 Identities = 57/245 (23%), Positives = 99/245 (40%), Gaps = 41/245 (16%)

Query: 47  IRPIGRGAYGIVCAAVNSETRE-----EVAIKKIGNAFDNIIDARRTLREIKLLRHME-H 100
            + +G GA+G V  A      +     +VA+K +    D+  +    + E+K++  +  H
Sbjct: 42  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS-EREALMSELKMMTQLGSH 100

Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ------------------ 141
           EN++ +              +Y+++E     DL   +RS ++                  
Sbjct: 101 ENIVNLLGACT-----LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155

Query: 142 -----LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS 196
                LT +    F YQ+ +G++++   S +HRDL   N+L+     +KI DFGLAR   
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215

Query: 197 ETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVH 252
                       +   + APE L     YT   D+WS G +L EI +     +PG     
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274

Query: 253 QLRLI 257
               +
Sbjct: 275 NFYKL 279

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 2e-40
 Identities = 43/218 (19%), Positives = 93/218 (42%), Gaps = 15/218 (6%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ +G G +G+V        + +VAIK I    +  +     + E K++ ++ HE ++ +
Sbjct: 9   LKELGTGQFGVVKYGKW-RGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQL 64

Query: 107 KDIIRPPKKDTFNDVYIVYELM--DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 164
             +           ++I+ E M     L+ +     +            +   ++Y+ S 
Sbjct: 65  YGVCTKQ-----RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNCTEY 222
             LHRDL   N L+N    +K+ DFGL+R   + ++           +  PE+L+  +++
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKF 178

Query: 223 TAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITE 259
           ++  DIW+ G ++ EI +  +  +           I +
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 216

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  136 bits (344), Expect = 1e-39
 Identities = 46/225 (20%), Positives = 96/225 (42%), Gaps = 7/225 (3%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR 96
           +E+    +     +G G YG V   V  +    VA+K +    ++ ++    L+E  +++
Sbjct: 12  WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMK 68

Query: 97  HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 156
            ++H N++ +  +            ++ Y  +   L +   + Q+++     Y   Q+  
Sbjct: 69  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISS 126

Query: 157 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPEL 215
            ++Y+   + +HRDL   N L+  +  +K+ DFGL+R  T +T                 
Sbjct: 127 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186

Query: 216 LLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITE 259
            L   +++   D+W+ G +L EI T     +PG D      L+ +
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 231

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 1e-39
 Identities = 38/220 (17%), Positives = 93/220 (42%), Gaps = 13/220 (5%)

Query: 47  IRPIGRGAYGIVCAA---VNSETREEVAIKKI--GNAFDNIIDARRTLREIKLLRHMEHE 101
           ++ +G GAYG V         +T +  A+K +              T  E ++L H+   
Sbjct: 29  LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS 88

Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 160
             +    +       T   ++++ + ++  +L   +   ++ T+   Q ++ +++  L++
Sbjct: 89  PFL----VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEH 144

Query: 161 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE---TDFMTEYVVTRWYRAPELLL 217
           +H   +++RD+K  N+LL+++  + + DFGL++                  +     +  
Sbjct: 145 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 204

Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
             + +  A+D WS+G ++ E++T    F      +    I
Sbjct: 205 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 244

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  136 bits (344), Expect = 2e-39
 Identities = 55/233 (23%), Positives = 98/233 (42%), Gaps = 17/233 (7%)

Query: 38  EVSSKYVPPIRPIGRGAYGIVCAAVNSETREE---VAIKKIGNAFDNIIDARRTLREIKL 94
           E+    V   + IG G +G VC+       +    VAIK + + +      R  L E  +
Sbjct: 22  EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK-QRRDFLSEASI 80

Query: 95  LRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII--RSDQQLTDDHCQYFLY 152
           +   +H NVI ++ ++          V I+ E M+         ++D Q T       L 
Sbjct: 81  MGQFDHPNVIHLEGVVTKS-----TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR 135

Query: 153 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRA 212
            +  G+KY+   + +HRDL   N+L+N++   K+ DFGL+R   +      Y      + 
Sbjct: 136 GIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKI 195

Query: 213 PELLL-----NCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITE 259
           P            ++T+A D+WS G ++ E+M+  E  +        +  I +
Sbjct: 196 PIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ 248

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  135 bits (341), Expect = 4e-39
 Identities = 45/223 (20%), Positives = 80/223 (35%), Gaps = 21/223 (9%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
            R IG G++G +    +    EEVAIK       +     +   E K+ + M+    I  
Sbjct: 12  GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPT 67

Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQI-IRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 165
                       +   +V EL+   L  +     ++ +         Q++  ++Y+HS +
Sbjct: 68  IRWC----GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 123

Query: 166 VLHRDLKPSNLL---LNASCDLKIGDFGLARTTSETD--------FMTEYVVTRWYRAPE 214
            +HRD+KP N L         + I DFGLA+   +                 T  Y +  
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183

Query: 215 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 257
             L   E +   D+ S+G +L         + G     + +  
Sbjct: 184 THLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 225

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  135 bits (340), Expect = 6e-39
 Identities = 42/244 (17%), Positives = 84/244 (34%), Gaps = 30/244 (12%)

Query: 31  NVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLR 90
           NV G  ++V        R IG G++G++    N    ++VAIK       +    R   R
Sbjct: 1   NVVGVHYKV-------GRRIGEGSFGVIFEGTNLLNNQQVAIKFE-PRRSDAPQLRDEYR 52

Query: 91  EIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQY 149
             KLL       +  +                +V +L+   L  ++    ++ +      
Sbjct: 53  TYKLLAG--CTGIPNVYYFG-----QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAM 105

Query: 150 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-----DLKIGDFGLAR--------TTS 196
              Q+L  ++ +H  S+++RD+KP N L+          + + DFG+ +           
Sbjct: 106 AAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 165

Query: 197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL 256
                     T  Y +    L   E +   D+ ++G +    +     + G       + 
Sbjct: 166 PYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK 224

Query: 257 ITEV 260
              +
Sbjct: 225 YERI 228

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 4e-38
 Identities = 43/218 (19%), Positives = 95/218 (43%), Gaps = 15/218 (6%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           ++ IG G +G+V        +++VAIK I    +  +     + E +++  + H  ++ +
Sbjct: 10  VQEIGSGQFGLVHLGYW-LNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQL 65

Query: 107 KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTD-DHCQYFLYQLLRGLKYVHSA 164
             +           + +V+E M+   L   +R+ + L   +        +  G+ Y+  A
Sbjct: 66  YGVCLEQ-----APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMTEYVVTRWYRAPELLLNCTEY 222
            V+HRDL   N L+  +  +K+ DFG+ R     +    T       + +PE+    + Y
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRY 179

Query: 223 TAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITE 259
           ++  D+WS G ++ E+ +  +  +  +     +  I+ 
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST 217

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  133 bits (334), Expect = 5e-38
 Identities = 51/247 (20%), Positives = 93/247 (37%), Gaps = 41/247 (16%)

Query: 47  IRPIGRGAYGIVCAA-----VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE 101
           +R IG GA+G V  A     +  E    VA+K +       +      RE  L+   ++ 
Sbjct: 18  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ-ADFQREAALMAEFDNP 76

Query: 102 NVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS---------------------- 138
           N++ +  +           + +++E M   DL++ +RS                      
Sbjct: 77  NIVKLLGVCAVG-----KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131

Query: 139 --DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS 196
                L+         Q+  G+ Y+     +HRDL   N L+  +  +KI DFGL+R   
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191

Query: 197 ETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVH 252
             D+        +   +  PE +     YT   D+W+ G +L EI +     + G  +  
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250

Query: 253 QLRLITE 259
            +  + +
Sbjct: 251 VIYYVRD 257

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 1e-37
 Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 17/221 (7%)

Query: 50  IGRGAYGIVCAAV---NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           IGRG +G V       N   +   A+K + N   +I +  + L E  +++   H NV+++
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93

Query: 107 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQ--YFLYQLLRGLKYVHSA 164
             I    +        +V   M     +    ++           F  Q+ +G+K++ S 
Sbjct: 94  LGICLRSE----GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 149

Query: 165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-----MTEYVVTRWYRAPELLLNC 219
             +HRDL   N +L+    +K+ DFGLAR   + +F      T   +   + A E L   
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 209

Query: 220 TEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITE 259
            ++T   D+WS G +L E+MTR  P +P  +       + +
Sbjct: 210 -KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 1e-37
 Identities = 54/234 (23%), Positives = 92/234 (39%), Gaps = 28/234 (11%)

Query: 47  IRPIGRGAYGIVCAAVNSET--REEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENV 103
              IG G +G V  A   +   R + AIK++   + +  D R    E+++L  +  H N+
Sbjct: 15  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNI 73

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIR----------------SDQQLTDDH 146
           I +              +Y+  E     +L   +R                +   L+   
Sbjct: 74  INLLGACEHR-----GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128

Query: 147 CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV 206
             +F   + RG+ Y+     +HRDL   N+L+  +   KI DFGL+R        T   +
Sbjct: 129 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 188

Query: 207 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITE 259
              + A E  LN + YT   D+WS G +L EI++     + G         + +
Sbjct: 189 PVRWMAIE-SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 3e-37
 Identities = 55/221 (24%), Positives = 97/221 (43%), Gaps = 16/221 (7%)

Query: 47  IRPIGRGAYGIVCAAVNSETREE---VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV 103
            R IG G +G V   +          VAIK   N   + +   + L+E   +R  +H ++
Sbjct: 12  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV-REKFLQEALTMRQFDHPHI 70

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM--DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           + +  +I      T N V+I+ EL         +      L       + YQL   L Y+
Sbjct: 71  VKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNC 219
            S   +HRD+   N+L++++  +K+GDFGL+R   ++ +   ++  +   + APE  +N 
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE-SINF 183

Query: 220 TEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITE 259
             +T+A D+W  G  + EI+      F G      +  I  
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 224

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 5e-37
 Identities = 48/222 (21%), Positives = 90/222 (40%), Gaps = 16/222 (7%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIK---KIGNAFDNIIDARRTLREIKLLRHMEHENV 103
           I+ +G GA+G V   +     E+V I    K      +    +  L E  ++  +++ +V
Sbjct: 14  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 73

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELMD--TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
             +  I           V ++ +LM     L  +      +   +   +  Q+ +G+ Y+
Sbjct: 74  CRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLN 218
               ++HRDL   N+L+     +KI DFGLA+     +         V   + A E +L+
Sbjct: 128 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187

Query: 219 CTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITE 259
              YT   D+WS G  + E+MT     + G        ++ +
Sbjct: 188 R-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 228

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 1e-36
 Identities = 49/221 (22%), Positives = 84/221 (38%), Gaps = 26/221 (11%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 107
             IG+G +G V         EEVA+K   +  +    +     EI     + HEN++   
Sbjct: 9   ESIGKGRFGEVWRGK--WRGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFI 63

Query: 108 DIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-- 164
                    T+  +++V +  +   L   +     +T +           GL ++H    
Sbjct: 64  AADNKDN-GTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIV 121

Query: 165 ------SVLHRDLKPSNLLLNASCDLKIGDFGLAR-----TTSETDFMTEYVVTRWYRAP 213
                 ++ HRDLK  N+L+  +    I D GLA      T +        V T+ Y AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

Query: 214 ELLLNC-----TEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
           E+L +       E     DI+++G +  EI  R  +    +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 222

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 2e-36
 Identities = 56/240 (23%), Positives = 96/240 (40%), Gaps = 36/240 (15%)

Query: 47  IRPIGRGAYGIVCAA-----VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-H 100
            + +G GA+G V  A     + S+    VA+K +     ++ +    + E+K+L ++  H
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALMSELKVLSYLGNH 86

Query: 101 ENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS------------------DQQ 141
            N++ +                ++ E     DL   +R                   +  
Sbjct: 87  MNIVNLLGACTIG-----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141

Query: 142 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR---TTSET 198
           L  +    F YQ+ +G+ ++ S + +HRDL   N+LL      KI DFGLAR     S  
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201

Query: 199 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLI 257
                  +   + APE + NC  YT   D+WS G  L E+ +     +PG     +   +
Sbjct: 202 VVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (321), Expect = 3e-36
 Identities = 49/217 (22%), Positives = 93/217 (42%), Gaps = 17/217 (7%)

Query: 48  RPIGRGAYGIVCAAVNSETREE----VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV 103
           + IG G +G V   +   +  +    VAIK +   +         L E  ++    H N+
Sbjct: 13  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK-QRVDFLGEAGIMGQFSHHNI 71

Query: 104 IAIKDIIRPPKKDTFNDVYIVYELM--DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 161
           I ++ +I       +  + I+ E M        +   D + +       L  +  G+KY+
Sbjct: 72  IRLEGVIS-----KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126

Query: 162 HSASVLHRDLKPSNLLLNASCDLKIGDFGLAR----TTSETDFMTEYVVTRWYRAPELLL 217
            + + +HRDL   N+L+N++   K+ DFGL+R        T   +   +   + APE + 
Sbjct: 127 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 186

Query: 218 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL 254
                +A+ D+WS G ++ E+MT       +   H++
Sbjct: 187 YRKFTSAS-DVWSFGIVMWEVMTYGERPYWELSNHEV 222

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 2e-35
 Identities = 58/243 (23%), Positives = 107/243 (44%), Gaps = 27/243 (11%)

Query: 37  FEVSSKYVPPIRPIGRGAYGIVCAAVN-----SETREEVAIKKIGNAFDNIIDARRTLRE 91
           +EV+ + +   R +G+G++G+V   V       E    VAIK + N   ++ +    L E
Sbjct: 15  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFLNE 73

Query: 92  IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ--------- 141
             +++     +V+ +  ++            ++ ELM   DL   +RS +          
Sbjct: 74  ASVMKEFNCHHVVRLLGVVSQG-----QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 128

Query: 142 -LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 200
             +         ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+
Sbjct: 129 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 188

Query: 201 ---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRL 256
                + ++   + +PE L +   +T   D+WS G +L EI T  E  + G      LR 
Sbjct: 189 YRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 247

Query: 257 ITE 259
           + E
Sbjct: 248 VME 250

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 7e-34
 Identities = 59/242 (24%), Positives = 106/242 (43%), Gaps = 36/242 (14%)

Query: 47  IRPIGRGAYGIVCAAVNSETREE-------VAIKKIGNAFDNIIDARRTLREIKLLRHM- 98
            +P+G GA+G V  A      ++       VA+K + +      D    + E+++++ + 
Sbjct: 18  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK-DLSDLISEMEMMKMIG 76

Query: 99  EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIR----------------SDQQ 141
           +H+N+I +              +Y++ E     +L + ++                 ++Q
Sbjct: 77  KHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131

Query: 142 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM 201
           L+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     D+ 
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191

Query: 202 TE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLI 257
            +     +   + APE L +   YT   D+WS G +L EI T     +PG       +L+
Sbjct: 192 KKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250

Query: 258 TE 259
            E
Sbjct: 251 KE 252

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 2e-32
 Identities = 60/238 (25%), Positives = 103/238 (43%), Gaps = 33/238 (13%)

Query: 47  IRPIGRGAYGIVCAAV-----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE 101
            +P+GRGA+G V  A       + T   VA+K +        + R  + E+K+L H+ H 
Sbjct: 18  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALMSELKILIHIGHH 76

Query: 102 -NVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ----------------LT 143
            NV+ +      P       + ++ E     +L   +RS +                 LT
Sbjct: 77  LNVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 144 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---F 200
            +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR   +      
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192

Query: 201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLI 257
             +  +   + APE + +   YT   D+WS G +L EI +     +PG     +    
Sbjct: 193 KGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  118 bits (295), Expect = 7e-32
 Identities = 48/222 (21%), Positives = 83/222 (37%), Gaps = 25/222 (11%)

Query: 47  IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 106
           +R +G G +  V  A +      VA+K +     + +       EIKLL+ +   +    
Sbjct: 18  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 107 KDIIRP------------PKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL 154
             +                       +       +          + +   + +    QL
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134

Query: 155 LRGLKYV-HSASVLHRDLKPSNLLLNAS------CDLKIGDFGLARTTSETDFMTEYVVT 207
           L GL Y+     ++H D+KP N+L+           +KI D G A    E       + T
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN--SIQT 192

Query: 208 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 249
           R YR+PE+LL    +    DIWS  C++ E++T + LF   +
Sbjct: 193 REYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDE 233

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 90.6 bits (224), Expect = 6e-23
 Identities = 27/198 (13%), Positives = 57/198 (28%), Gaps = 30/198 (15%)

Query: 48  RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDAR--------RTLREIKLLRHME 99
           + +G G    V    + E   E  +K       +    +                    E
Sbjct: 6   KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 100 HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 159
              +  ++ +  P     +    ++ EL+D      +R       ++    L  +L  + 
Sbjct: 65  FRALQKLQGLAVPKVYA-WEGNAVLMELIDAKELYRVR------VENPDEVLDMILEEVA 117

Query: 160 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-----FMTEYVVTRWYRAPE 214
             +   ++H DL   N+L++    + I DF  +    E             +  ++    
Sbjct: 118 KFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFS--- 173

Query: 215 LLLNCTEYTAAIDIWSVG 232
                  Y    DI S  
Sbjct: 174 -----RTYRTEKDINSAI 186

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	260
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.46
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.4
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.82
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.63
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.2
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.73

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-52  Score=332.29  Aligned_cols=211  Identities=25%  Similarity=0.451  Sum_probs=188.8

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc-cchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      ++|++++.||+|+||+||+|.++.+++.||+|++.... ........+.+|+++++.++||||+++++++.++     ..
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~   80 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-----TR   80 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC-----CE
Confidence            46788999999999999999999999999999985432 1222346678999999999999999999999887     56


Q ss_pred             EEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc
Q 024959          121 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~  199 (260)
                      .|+||||++ |+|.+++.....+++..++.++.||++||+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~  160 (263)
T d2j4za1          81 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR  160 (263)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred             EEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence            999999998 6999999998999999999999999999999999999999999999999999999999999998765543


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                       .....||+.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+.++.|.+
T Consensus       161 -~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~  218 (263)
T d2j4za1         161 -RTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR  218 (263)
T ss_dssp             -CEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred             -ccccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence             345678999999999988 7789999999999999999999999999999888888754

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-51  Score=330.68  Aligned_cols=209  Identities=26%  Similarity=0.464  Sum_probs=184.8

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      .+.|++++.||+|+||+||+|.++.+++.||+|++......  ..+.+.+|+++++.++||||+++++++..+     +.
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~   91 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVG-----DE   91 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEEC-----CE
Confidence            45688999999999999999999999999999998654332  346788999999999999999999999887     56


Q ss_pred             EEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC-
Q 024959          121 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-  198 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~-  198 (260)
                      +|+||||++ ++|.+++.. ..+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||++...... 
T Consensus        92 ~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~  170 (293)
T d1yhwa1          92 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (293)
T ss_dssp             EEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence            999999998 588877654 57999999999999999999999999999999999999999999999999999876543 


Q ss_pred             cccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          199 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       199 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      .......||+.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.
T Consensus       171 ~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~  229 (293)
T d1yhwa1         171 SKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA  229 (293)
T ss_dssp             CCBCCCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred             ccccccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence            33455678999999999988 778999999999999999999999999988877776653

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-51  Score=329.37  Aligned_cols=214  Identities=30%  Similarity=0.484  Sum_probs=177.9

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      .++|++++.||+|+||+||++.++.+++.||+|.+..........+.+.+|++++++++||||+++++++.+...   ..
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~---~~   79 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN---TT   79 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCC---CE
Confidence            356788999999999999999999999999999997766566677888999999999999999999999875432   45


Q ss_pred             EEEEEecCC-cchHHHhhh----CCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeccCCCCCeEeccCCCEEEeecc
Q 024959          121 VYIVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSAS-----VLHRDLKPSNLLLNASCDLKIGDFG  190 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~-----i~H~di~~~nili~~~~~~~l~df~  190 (260)
                      +|+||||++ |+|.+++.+    +..+++..++.++.|+++||+|||+++     ++||||||+|||++.++.+||+|||
T Consensus        80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG  159 (269)
T d2java1          80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  159 (269)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHH
T ss_pred             EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecc
Confidence            899999998 699998764    567999999999999999999999876     9999999999999999999999999


Q ss_pred             cccccCCCc-ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          191 LARTTSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       191 ~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ++....... ......+|+.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+....|.
T Consensus       160 ~a~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~  227 (269)
T d2java1         160 LARILNHDTSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR  227 (269)
T ss_dssp             HHHHC-----------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             ceeecccCCCccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence            998765543 3345678999999999977 778999999999999999999999999999888887765

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-51  Score=333.11  Aligned_cols=213  Identities=23%  Similarity=0.408  Sum_probs=186.8

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc-cchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      .++|++++.||+|+||+||+|.++.+++.||||++.... ........+.+|++++++++||||+++++++..+     +
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~   81 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD-----E   81 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS-----S
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC-----C
Confidence            356889999999999999999999999999999986432 1222346688999999999999999999999877     6


Q ss_pred             cEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          120 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       120 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      .+|+||||++ ++|.+++...+.+++..++.++.|++.+|+|||++|++||||||+||+++.++.++|+|||+++.....
T Consensus        82 ~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          82 KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccC
Confidence            6999999998 699999999999999999999999999999999999999999999999999999999999999876533


Q ss_pred             c---ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          199 D---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       199 ~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      .   ......||+.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+.+++|.+
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~  224 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK  224 (288)
T ss_dssp             --------CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT
T ss_pred             CcccccccccCCccccCceeecc-CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHc
Confidence            2   2334578999999999988 7789999999999999999999999999999988888764

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-52  Score=331.08  Aligned_cols=203  Identities=32%  Similarity=0.456  Sum_probs=175.8

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      ++|++++.||+|+||+||+|.++.+++.||+|++..... ....+.+.+|++++++++||||+++++++.++     +.+
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~-----~~~   78 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREG-----NIQ   78 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEET-----TEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-----cee
Confidence            456789999999999999999999999999999865422 22345688999999999999999999999887     669


Q ss_pred             EEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC--
Q 024959          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET--  198 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~--  198 (260)
                      |+||||++ ++|.+++.....+++..++.++.||++||+|||++|++||||||+|||++.++.+||+|||+++.....  
T Consensus        79 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          79 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             EEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            99999998 599999988889999999999999999999999999999999999999999999999999999865433  


Q ss_pred             -cccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024959          199 -DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (260)
Q Consensus       199 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  250 (260)
                       .......||+.|+|||.+.+...++.++|||||||++|+|++|..||...+.
T Consensus       159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~  211 (271)
T d1nvra_         159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD  211 (271)
T ss_dssp             ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSST
T ss_pred             cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCCh
Confidence             2234567899999999998744456789999999999999999999977654

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.2e-51  Score=332.31  Aligned_cols=212  Identities=28%  Similarity=0.454  Sum_probs=171.6

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      .+.|++++.||+|+||+||+|.++.+++.||||++...... .....+.+|+++++.++||||+++++++..+     ..
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~   81 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESG-----GH   81 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECS-----SE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CE
Confidence            35578899999999999999999999999999999654322 2335677899999999999999999999877     66


Q ss_pred             EEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec---cCCCEEEeecccccccC
Q 024959          121 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN---ASCDLKIGDFGLARTTS  196 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~---~~~~~~l~df~~~~~~~  196 (260)
                      +|+||||++ ++|.+++...+.+++..++.++.||+.||+|||++|++||||||+||++.   .++.+||+|||+++...
T Consensus        82 ~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          82 LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             EEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             EEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            999999998 69999999999999999999999999999999999999999999999994   47889999999998877


Q ss_pred             CCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       197 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      .........||+.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+....|.+
T Consensus       162 ~~~~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~  223 (307)
T d1a06a_         162 PGSVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK  223 (307)
T ss_dssp             -----------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHT
T ss_pred             CCCeeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence            6666667789999999999987 7789999999999999999999999999998888877753

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-50  Score=332.15  Aligned_cols=213  Identities=24%  Similarity=0.418  Sum_probs=190.7

Q ss_pred             ccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCC
Q 024959           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF  118 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~  118 (260)
                      .-++|++++.||+|+||.||+|.++.+++.||+|++.+... .......+.+|+++|++++||||+++++++.+.     
T Consensus         3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----   77 (337)
T d1o6la_           3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----   77 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-----
T ss_pred             chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc-----
Confidence            34568889999999999999999999999999999965321 222356778999999999999999999999987     


Q ss_pred             ccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCC
Q 024959          119 NDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (260)
Q Consensus       119 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~  197 (260)
                      ..+|+||||++ |+|.+++.....+++..++.++.||+.||+|||++|++||||||+|||++.+|.+||+|||+++....
T Consensus        78 ~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          78 DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             cccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            66999999998 69999999999999999999999999999999999999999999999999999999999999987544


Q ss_pred             -CcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          198 -TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       198 -~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                       .......+||+.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+..+..+.|.
T Consensus       158 ~~~~~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~  218 (337)
T d1o6la_         158 DGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL  218 (337)
T ss_dssp             TTCCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCcccccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHh
Confidence             334456788999999999988 788999999999999999999999999999988887765

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-50  Score=320.76  Aligned_cols=213  Identities=24%  Similarity=0.406  Sum_probs=181.7

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      ++|+++.+.||+|+||+||+|.++.++..||+|.+..........+.+.+|++++++++||||+++++++..... ....
T Consensus         8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~-~~~~   86 (270)
T d1t4ha_           8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK-GKKC   86 (270)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS-SCEE
T ss_pred             CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccc-cCCE
Confidence            345556678999999999999999999999999997665556667788999999999999999999999865321 1156


Q ss_pred             EEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCeEec-cCCCEEEeecccccccC
Q 024959          121 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKPSNLLLN-ASCDLKIGDFGLARTTS  196 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~H~di~~~nili~-~~~~~~l~df~~~~~~~  196 (260)
                      +|+||||++ ++|.+++.+...+++..++.++.||+++|+|||+++  ++||||||+|||++ .++.+||+|||+++...
T Consensus        87 ~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          87 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            899999998 599999999899999999999999999999999998  99999999999996 47899999999997654


Q ss_pred             CCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHh
Q 024959          197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH-QLRLI  257 (260)
Q Consensus       197 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-~~~~i  257 (260)
                      .. ......||+.|+|||.+.+  .++.++|||||||++|+|++|..||.+.+... ..+.|
T Consensus       167 ~~-~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i  225 (270)
T d1t4ha_         167 AS-FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV  225 (270)
T ss_dssp             TT-SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH
T ss_pred             CC-ccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHH
Confidence            43 3345678999999998865  58999999999999999999999998765544 34443

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-50  Score=325.11  Aligned_cols=213  Identities=26%  Similarity=0.428  Sum_probs=191.1

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc----chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD----NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~----~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      .++|++++.||+|+||+||+|.++.+|+.||+|++.....    .....+.+.+|+++|++++||||+++++++...   
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~---   85 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK---   85 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS---
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC---
Confidence            4568899999999999999999999999999999854321    112356788999999999999999999999887   


Q ss_pred             CCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCC----CEEEeeccc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC----DLKIGDFGL  191 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~----~~~l~df~~  191 (260)
                        ..+|+||||++ ++|.+++...+.+++..++.++.|+++||+|||+++++||||||+||+++.++    .+||+|||+
T Consensus        86 --~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~  163 (293)
T d1jksa_          86 --TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  163 (293)
T ss_dssp             --SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             --CEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhh
Confidence              66999999998 69999999888999999999999999999999999999999999999998776    499999999


Q ss_pred             ccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          192 ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      +.............+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+.+..|.+
T Consensus       164 a~~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~  230 (293)
T d1jksa_         164 AHKIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA  230 (293)
T ss_dssp             CEECTTSCBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT
T ss_pred             hhhcCCCccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHh
Confidence            988877666667788999999999987 7789999999999999999999999999999988888754

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.7e-50  Score=332.55  Aligned_cols=210  Identities=23%  Similarity=0.402  Sum_probs=189.7

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      +.|++++.||+|+||.||+|.++.+|+.||+|++...  .....+.+.+|+++|++++||||+++++++...     +.+
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~   98 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD-----NEM   98 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET-----TEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEE
Confidence            3578899999999999999999999999999999764  334567788999999999999999999999876     669


Q ss_pred             EEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecc--CCCEEEeecccccccCC
Q 024959          122 YIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA--SCDLKIGDFGLARTTSE  197 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~--~~~~~l~df~~~~~~~~  197 (260)
                      |+||||++ |+|.+.+.. ...+++..++.++.||+.||+|||++|++||||||+|||++.  ++.+||+|||++.....
T Consensus        99 ~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~  178 (350)
T d1koaa2          99 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  178 (350)
T ss_dssp             EEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred             EEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence            99999998 699998854 567999999999999999999999999999999999999964  57899999999998877


Q ss_pred             CcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          198 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       198 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      ........+|+.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+.++.|.+
T Consensus       179 ~~~~~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~  239 (350)
T d1koaa2         179 KQSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS  239 (350)
T ss_dssp             TSCEEEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             ccccceecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            776777788999999999987 7789999999999999999999999999999998888764

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=4.9e-50  Score=332.09  Aligned_cols=210  Identities=23%  Similarity=0.445  Sum_probs=189.6

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      ++|++++.||+|+||+||+|.++.+++.||+|++....  ......+.+|+++|++++||||+++++++..+     ..+
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~~  101 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDK-----YEM  101 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS-----SEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEE
Confidence            45789999999999999999999999999999986542  33456788999999999999999999999877     669


Q ss_pred             EEEEecCC-cchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec--cCCCEEEeecccccccCC
Q 024959          122 YIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN--ASCDLKIGDFGLARTTSE  197 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~--~~~~~~l~df~~~~~~~~  197 (260)
                      |+||||++ ++|.+.+... .++++..++.++.||+.||+|||++|++||||||+|||++  .++.+||+|||++.....
T Consensus       102 ~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~  181 (352)
T d1koba_         102 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  181 (352)
T ss_dssp             EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             EEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC
Confidence            99999998 6898877664 4799999999999999999999999999999999999997  568999999999998887


Q ss_pred             CcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          198 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       198 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      ........+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+.+.+|.+
T Consensus       182 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  242 (352)
T d1koba_         182 DEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR  242 (352)
T ss_dssp             TSCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH
T ss_pred             CCceeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            776777788999999999987 7889999999999999999999999999999998888754

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-51  Score=327.92  Aligned_cols=211  Identities=27%  Similarity=0.448  Sum_probs=183.7

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      .+.|++++.||+|+||+||+|.++.+++.||+|++....  ....+.+.+|++++++++||||+++++++..+     +.
T Consensus        11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~   83 (288)
T d2jfla1          11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYE-----NN   83 (288)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred             ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-----Ce
Confidence            346788999999999999999999999999999996543  23456788999999999999999999999877     56


Q ss_pred             EEEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          121 VYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      +++||||++ ++|.+++.. ...+++..++.++.||++||+|||++|++||||||+|||++.++.+||+|||++......
T Consensus        84 ~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~  163 (288)
T d2jfla1          84 LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  163 (288)
T ss_dssp             EEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence            999999998 688888665 567999999999999999999999999999999999999999999999999998765433


Q ss_pred             -cccccccccccccccccccC----cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          199 -DFMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       199 -~~~~~~~~~~~~~~PE~~~~----~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                       .......|++.|+|||.+..    ...++.++|||||||++|+|++|..||.+.+..+.+..|.
T Consensus       164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~  228 (288)
T d2jfla1         164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA  228 (288)
T ss_dssp             HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH
T ss_pred             cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence             22335678999999999852    2567899999999999999999999999998888777664

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-51  Score=334.37  Aligned_cols=206  Identities=25%  Similarity=0.421  Sum_probs=182.9

Q ss_pred             EeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCC
Q 024959           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT  117 (260)
Q Consensus        38 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~  117 (260)
                      ++..++|++++.||+|+||+||+|.++.+++.||+|+++.... ......+.+|+++|+.++||||++++++|..+    
T Consensus         2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----   76 (322)
T d1s9ja_           2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSD----   76 (322)
T ss_dssp             CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC-TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS----
T ss_pred             CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC----
Confidence            4667888999999999999999999999999999999976532 33457788999999999999999999999887    


Q ss_pred             CccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEeccCCCEEEeeccccccc
Q 024959          118 FNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  195 (260)
Q Consensus       118 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~di~~~nili~~~~~~~l~df~~~~~~  195 (260)
                       ..+++||||++ ++|.+++.+.+.+++..++.++.|+++||.|||+ +||+||||||+|||++.++.+||+|||++...
T Consensus        77 -~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~  155 (322)
T d1s9ja_          77 -GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  155 (322)
T ss_dssp             -SEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             -CEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence             56999999998 5999999988899999999999999999999997 59999999999999999999999999999865


Q ss_pred             CCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH
Q 024959          196 SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  251 (260)
Q Consensus       196 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~  251 (260)
                      .... ..+..||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..
T Consensus       156 ~~~~-~~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~  209 (322)
T d1s9ja_         156 IDSM-ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK  209 (322)
T ss_dssp             HHHT-C---CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTT
T ss_pred             CCCc-cccccCCccccCchHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence            4332 335688999999999998 78999999999999999999999999876653

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.6e-50  Score=326.82  Aligned_cols=209  Identities=27%  Similarity=0.449  Sum_probs=183.6

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      +.|++++.||+|+||+||+|.+..+++.||||++..... .....+.+.+|++++++++||||+++++++..+     ..
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~   89 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HT   89 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC-----CE
Confidence            457789999999999999999999999999999865433 344567788999999999999999999999876     56


Q ss_pred             EEEEEecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc
Q 024959          121 VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (260)
Q Consensus       121 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~  199 (260)
                      +|+||||+.+ ++..++..+.++++..++.++.||++||.|||++|++||||||+|||++.++.+||+|||++...... 
T Consensus        90 ~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-  168 (309)
T d1u5ra_          90 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  168 (309)
T ss_dssp             EEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred             EEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC-
Confidence            9999999985 55555667788999999999999999999999999999999999999999999999999999876543 


Q ss_pred             ccccccccccccccccccCc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          200 FMTEYVVTRWYRAPELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                        ....||+.|+|||.+.+.  ..++.++|||||||++|+|++|..||.+.+..+.+..|.
T Consensus       169 --~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~  227 (309)
T d1u5ra_         169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA  227 (309)
T ss_dssp             --CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred             --CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence              345789999999998642  458899999999999999999999999998888777664

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.3e-50  Score=328.79  Aligned_cols=211  Identities=22%  Similarity=0.422  Sum_probs=188.9

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      .++|++++.||+|+||+||+|.++.+|+.||||+++.... .....+.+.+|+.+++.++||||+++++++...     .
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~   77 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA-----Q   77 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS-----S
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeC-----C
Confidence            3568899999999999999999999999999999964321 222356788999999999999999999999887     6


Q ss_pred             cEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          120 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       120 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      .+|+||||+. ++|..++.....+++..++.++.||+.+|+|||++|++||||||+|||++.++.+||+|||+++.....
T Consensus        78 ~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          78 QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             EEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            6999999998 588898889999999999999999999999999999999999999999999999999999999887654


Q ss_pred             cccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          199 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       199 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                        .....||+.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+.+++|.+
T Consensus       158 --~~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~  215 (316)
T d1fota_         158 --TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN  215 (316)
T ss_dssp             --BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred             --cccccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHc
Confidence              345678999999999987 7789999999999999999999999999999988888753

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-49  Score=319.63  Aligned_cols=212  Identities=24%  Similarity=0.373  Sum_probs=180.2

Q ss_pred             eeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC
Q 024959           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (260)
Q Consensus        36 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~  115 (260)
                      .||++.+.|++.+.||+|+||+||++..+.   .||||+++.........+.+.+|++++++++||||+++++++..+  
T Consensus         2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~--   76 (276)
T d1uwha_           2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP--   76 (276)
T ss_dssp             CCBCCTTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--
T ss_pred             CcccccccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEecc--
Confidence            589999999999999999999999997643   599999976655566778899999999999999999999987543  


Q ss_pred             CCCccEEEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          116 DTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       116 ~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                          .+++||||++ |+|.+++.. +.++++..+..++.|++++|+|||+++++||||||+|||++.++.+||+|||++.
T Consensus        77 ----~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~  152 (276)
T d1uwha_          77 ----QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT  152 (276)
T ss_dssp             ----SCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSC
T ss_pred             ----EEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEcccccee
Confidence                4799999998 699999875 4679999999999999999999999999999999999999999999999999997


Q ss_pred             ccCCCc---ccccccccccccccccccCc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 024959          194 TTSETD---FMTEYVVTRWYRAPELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  256 (260)
Q Consensus       194 ~~~~~~---~~~~~~~~~~~~~PE~~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  256 (260)
                      ......   ......+|+.|+|||.+...  ..++.++|||||||++|||++|..||.+.+...++..
T Consensus       153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~  220 (276)
T d1uwha_         153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF  220 (276)
T ss_dssp             C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH
T ss_pred             eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHH
Confidence            654332   23345679999999998642  4578999999999999999999999998877655543

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-49  Score=329.10  Aligned_cols=210  Identities=22%  Similarity=0.432  Sum_probs=188.2

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcc-cchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      +.|++++.||+|+||.||+|.++.+++.||||++.... ......+.+.+|+++|+.++||||+++++++...     ..
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~  115 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN-----SN  115 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccc-----cc
Confidence            56788999999999999999999999999999985432 1222346788999999999999999999999887     56


Q ss_pred             EEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc
Q 024959          121 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~  199 (260)
                      +++|||++. ++|.+.+...+.+++..++.++.||+.||.|||+++++||||||+|||++.++.+||+|||+++..... 
T Consensus       116 ~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-  194 (350)
T d1rdqe_         116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             cccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence            899999998 689999988889999999999999999999999999999999999999999999999999999877543 


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                       .....|++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+.+.+|.+
T Consensus       195 -~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~  252 (350)
T d1rdqe_         195 -TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS  252 (350)
T ss_dssp             -BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             -cccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhc
Confidence             345678999999999987 7789999999999999999999999999999888887753

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=9.4e-49  Score=314.46  Aligned_cols=213  Identities=27%  Similarity=0.470  Sum_probs=189.4

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccc-------hHHHHHHHHHHHHHHHcC-CCCeeeeeceecCC
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN-------IIDARRTLREIKLLRHME-HENVIAIKDIIRPP  113 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~  113 (260)
                      ++|++++.||+|+||+||+|.++.+++.||||++......       ....+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            5678899999999999999999999999999998554211       223456789999999997 99999999999887


Q ss_pred             CCCCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccc
Q 024959          114 KKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (260)
Q Consensus       114 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~  192 (260)
                           ...|+||||++ ++|.+++..+..+++..++.++.||++||+|||++|++||||||+||+++.++.+||+|||++
T Consensus        83 -----~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a  157 (277)
T d1phka_          83 -----TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS  157 (277)
T ss_dssp             -----SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             -----cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchhe
Confidence                 66999999997 699999999899999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCcccccccccccccccccccC-----cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          193 RTTSETDFMTEYVVTRWYRAPELLLN-----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      .............+++.|+|||.+.+     ...++.++||||+||++|+|++|..||.+.+..+..+.|.+
T Consensus       158 ~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~  229 (277)
T d1phka_         158 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS  229 (277)
T ss_dssp             EECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             eEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHh
Confidence            88776666666788999999999863     24568899999999999999999999999999888887653

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.4e-49  Score=317.73  Aligned_cols=214  Identities=24%  Similarity=0.420  Sum_probs=184.4

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      ..||+..+.|++.+.||+|+||+||+|.++.+++.||||+++.....   .+++.+|++++++++||||+++++++..+ 
T Consensus        10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~-   85 (287)
T d1opja_          10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTRE-   85 (287)
T ss_dssp             CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred             cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEeeC-
Confidence            35889999999999999999999999999999999999999765332   45788999999999999999999999876 


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccc
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~  191 (260)
                          ..+++||||++ |+|.+++...  ..+++..++.++.|+++||+|||++|++||||||+|||++.++.+||+|||+
T Consensus        86 ----~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~  161 (287)
T d1opja_          86 ----PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL  161 (287)
T ss_dssp             ----SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCC
T ss_pred             ----CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccc
Confidence                55899999998 6999988653  5789999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCcc--cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCC-CCCCCChHHHHHHh
Q 024959          192 ARTTSETDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREP-LFPGKDYVHQLRLI  257 (260)
Q Consensus       192 ~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~-pf~~~~~~~~~~~i  257 (260)
                      ++.......  .....+++.|+|||.+.+ ..++.++||||||+++|+|++|.. ||.+.+..+..+.|
T Consensus       162 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i  229 (287)
T d1opja_         162 SRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL  229 (287)
T ss_dssp             TTTCCSSSSEEETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred             eeecCCCCceeeccccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH
Confidence            987655432  233456889999999987 778999999999999999999655 55666655555544

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-48  Score=319.25  Aligned_cols=209  Identities=21%  Similarity=0.387  Sum_probs=187.3

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      +.|++++.||+|+||+||+|.++.+++.||+|+++...   .....+.+|+++|+.++||||+++++++.+.     ..+
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~~   76 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESM-----EEL   76 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET-----TEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----CEE
Confidence            34678999999999999999999999999999997642   2345677999999999999999999999877     569


Q ss_pred             EEEEecCC-cchHHHhhhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccC--CCEEEeecccccccCC
Q 024959          122 YIVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS--CDLKIGDFGLARTTSE  197 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~--~~~~l~df~~~~~~~~  197 (260)
                      |+||||++ ++|.+++...+ .+++.+++.++.||++||+|||+.|++||||||+||+++.+  ..++|+|||++.....
T Consensus        77 ~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~  156 (321)
T d1tkia_          77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence            99999998 59999998755 79999999999999999999999999999999999999854  5799999999988877


Q ss_pred             CcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          198 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       198 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      ........+++.|+|||...+ ..++.++|||||||++|+|++|..||.+.+..+.+.+|.+
T Consensus       157 ~~~~~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~  217 (321)
T d1tkia_         157 GDNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN  217 (321)
T ss_dssp             TCEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred             CCcccccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            666667788999999999987 7789999999999999999999999999999988888754

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-49  Score=319.09  Aligned_cols=209  Identities=41%  Similarity=0.702  Sum_probs=178.0

Q ss_pred             CcccccccCceEEEEEEeCCCCeEEEEEecCCcccchH---HHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEE
Q 024959           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNII---DARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY  122 (260)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~  122 (260)
                      .++.||+|+||+||+|.++.+++.||||+++.......   ....+.+|+++++.++||||+++++++..+     ..+|
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~-----~~~~   76 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK-----SNIS   76 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT-----TCCE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC-----Ccee
Confidence            46789999999999999999999999999965432221   234678999999999999999999999887     5589


Q ss_pred             EEEecCCcchHH-HhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc-c
Q 024959          123 IVYELMDTDLHQ-IIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-F  200 (260)
Q Consensus       123 lv~e~~~~~l~~-~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~-~  200 (260)
                      +||||+.+.+.. +...+..+++..++.++.||++||+|||++|++||||||+||+++.++.+||+|||++....... .
T Consensus        77 ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~  156 (299)
T d1ua2a_          77 LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA  156 (299)
T ss_dssp             EEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred             ehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence            999999965544 44446779999999999999999999999999999999999999999999999999998765543 3


Q ss_pred             cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          201 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       201 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      .....+++.|+|||.+.....++.++|||||||++|+|++|..||.+.+..+++.+|.+
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~  215 (299)
T d1ua2a_         157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFE  215 (299)
T ss_dssp             CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHH
Confidence            34557899999999998757789999999999999999999999999999999888754

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.8e-48  Score=316.39  Aligned_cols=215  Identities=27%  Similarity=0.429  Sum_probs=174.1

Q ss_pred             EeccccCCCcccccccCceEEEEEEeCCCCe---EEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        38 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~---~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      ++....|++.+.||+|+||+||+|.++.+++   .|++|.+.... .....+.+.+|+++|++++||||+++++++..+ 
T Consensus        22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-   99 (299)
T d1jpaa_          22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS-   99 (299)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-
T ss_pred             hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-
Confidence            4556778889999999999999999887654   58899886543 344567789999999999999999999999776 


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccc
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~  192 (260)
                          ..+++||||++ |+|.+++.. ...+++.++..++.|+++||+|||+++++||||||+|||++.++.+||+|||++
T Consensus       100 ----~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla  175 (299)
T d1jpaa_         100 ----TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLS  175 (299)
T ss_dssp             ----SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred             ----CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccc
Confidence                55899999998 688887776 457999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCccc------ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhc
Q 024959          193 RTTSETDFM------TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       193 ~~~~~~~~~------~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~~  259 (260)
                      +........      ....+++.|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+..+.+..|.+
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~  248 (299)
T d1jpaa_         176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ  248 (299)
T ss_dssp             --------------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT
T ss_pred             eEccCCCCcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            876543221      12345788999999987 788999999999999999998 8999999998888777653

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-48  Score=318.15  Aligned_cols=211  Identities=26%  Similarity=0.417  Sum_probs=184.6

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHH-HcCCCCeeeeeceecCCCCCCCc
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLR-HMEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~-~l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      ++|++++.||+|+||+||+|.++.+++.||||++++... .......+..|..++. .++||||+++++++.+.     +
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~-----~   76 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK-----E   76 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-----S
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC-----C
Confidence            457789999999999999999999999999999964321 1223345566666654 68999999999999887     6


Q ss_pred             cEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC
Q 024959          120 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  198 (260)
Q Consensus       120 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~  198 (260)
                      .+|+||||++ |+|.+++.....+++..++.++.||+.||+|||+++++||||||+|||++.++.+||+|||+++.....
T Consensus        77 ~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~  156 (320)
T d1xjda_          77 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  156 (320)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             ceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence            6999999998 699999999999999999999999999999999999999999999999999999999999999865543


Q ss_pred             -cccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          199 -DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       199 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                       .......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..+.++.|.
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~  216 (320)
T d1xjda_         157 DAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR  216 (320)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             cccccccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence             33344678999999999988 788999999999999999999999999999999888875

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.2e-48  Score=312.19  Aligned_cols=215  Identities=25%  Similarity=0.362  Sum_probs=180.1

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCcc
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      +.|++.+.||+|+||+||+|.+..+++.||||+++.... .......+.+|+++++.++||||+++++++...... ...
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~-~~~   85 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA-GPL   85 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSS-SEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCC-Cce
Confidence            446789999999999999999999999999999976543 344567788999999999999999999998765321 135


Q ss_pred             EEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc
Q 024959          121 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  199 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~  199 (260)
                      +|+||||++ ++|.+.+...+.+++.+++.++.||+++|+|||++|++||||||+||+++.++..+++|||.+.......
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~  165 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG  165 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred             EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence            899999998 5899999888999999999999999999999999999999999999999999999999999886544332


Q ss_pred             ----ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          200 ----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       200 ----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                          ......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+.+.++.
T Consensus       166 ~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~  227 (277)
T d1o6ya_         166 NSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV  227 (277)
T ss_dssp             -------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             ccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHH
Confidence                3334578999999999987 778999999999999999999999999988877766543

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-48  Score=316.18  Aligned_cols=212  Identities=42%  Similarity=0.731  Sum_probs=183.3

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      +.|++++.||+|+||+||+|.+..+++.||+|+++...........+.+|++++++++||||+++++++..+     ..+
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~-----~~~   76 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-----NKL   76 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccc-----cce
Confidence            367789999999999999999999999999999976544434457788999999999999999999999887     669


Q ss_pred             EEEEecCCcchHHHhhh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCC-
Q 024959          122 YIVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-  198 (260)
Q Consensus       122 ~lv~e~~~~~l~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~-  198 (260)
                      |+|||++++++.+.+..  ...+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||+++..... 
T Consensus        77 ~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          77 YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             EEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             eEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc
Confidence            99999999887776654  456999999999999999999999999999999999999999999999999999876543 


Q ss_pred             cccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          199 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       199 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      .......+++.|+|||.+.....++.++|+||||+++|+|++|+.||.+.+..+++.+|.
T Consensus       157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~  216 (298)
T d1gz8a_         157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF  216 (298)
T ss_dssp             BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHH
Confidence            344455789999999998875667899999999999999999999999999888877653

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-48  Score=320.07  Aligned_cols=218  Identities=26%  Similarity=0.416  Sum_probs=182.7

Q ss_pred             cceeEeccccCCCcccccccCceEEEEEEeCCCCe-----EEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeeee
Q 024959           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETRE-----EVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIK  107 (260)
Q Consensus        34 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~  107 (260)
                      ...|+++.+.|++++.||+|+||+||+|.+..+++     .||+|.+.... .......+.+|+.+++++ +||||++++
T Consensus        29 ~~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~  107 (325)
T d1rjba_          29 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLL  107 (325)
T ss_dssp             CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEE
Confidence            35688999999999999999999999999865443     68999886542 233456788999999998 899999999


Q ss_pred             ceecCCCCCCCccEEEEEecCC-cchHHHhhhC-----------------------CCCCHHHHHHHHHHHHHHHHHHHh
Q 024959          108 DIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-----------------------QQLTDDHCQYFLYQLLRGLKYVHS  163 (260)
Q Consensus       108 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-----------------------~~~~~~~~~~~~~~i~~~l~~lh~  163 (260)
                      +++...     ..+++||||++ |+|.+++...                       ..+++..++.++.|+++||+|||+
T Consensus       108 ~~~~~~-----~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~  182 (325)
T d1rjba_         108 GACTLS-----GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF  182 (325)
T ss_dssp             EEECSS-----SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeeC-----CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            999887     55899999998 6999998754                       248999999999999999999999


Q ss_pred             CCceeccCCCCCeEeccCCCEEEeecccccccCCCcc---cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh
Q 024959          164 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT  240 (260)
Q Consensus       164 ~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~  240 (260)
                      ++++||||||+||+++.++.+||+|||+++.......   .....+++.|+|||.+.+ ..++.++|||||||++|||++
T Consensus       183 ~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt  261 (325)
T d1rjba_         183 KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFS  261 (325)
T ss_dssp             TTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTT
T ss_pred             CCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-CCCCcceeccchhHHHHHHHh
Confidence            9999999999999999999999999999976544332   234456899999999987 788999999999999999997


Q ss_pred             -CCCCCCCCChHHHHHHhh
Q 024959          241 -REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       241 -g~~pf~~~~~~~~~~~i~  258 (260)
                       |..||.+.+..+.+.++.
T Consensus       262 ~g~~Pf~~~~~~~~~~~~~  280 (325)
T d1rjba_         262 LGVNPYPGIPVDANFYKLI  280 (325)
T ss_dssp             TSCCSSTTCCCSHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHH
Confidence             899999887766665553

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-48  Score=307.69  Aligned_cols=209  Identities=20%  Similarity=0.407  Sum_probs=171.6

Q ss_pred             ccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCc
Q 024959           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      ..+.|++++.||+|+||+||++.++. +..||||++......   .+++.+|++++++++||||+++++++..+     +
T Consensus         3 dp~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-----~   73 (263)
T d1sm2a_           3 DPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----A   73 (263)
T ss_dssp             CCSCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS-----S
T ss_pred             ChHHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCcCc---HHHHHHHHHHHHhcCCCCcccccceeccC-----C
Confidence            44567789999999999999999864 578999999764333   35689999999999999999999999877     5


Q ss_pred             cEEEEEecCC-cchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCC
Q 024959          120 DVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (260)
Q Consensus       120 ~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~  197 (260)
                      .+++||||++ |+|.+++... ..+++..+..++.|+++||+|||+++++||||||+||+++.++.+||+|||+++....
T Consensus        74 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  153 (263)
T d1sm2a_          74 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  153 (263)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------
T ss_pred             ceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccC
Confidence            5899999998 6999987764 5689999999999999999999999999999999999999999999999999987654


Q ss_pred             Ccc--cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          198 TDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       198 ~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      ...  .....+++.|+|||.+.+ ..++.++||||||+++|||++ |.+||...+..+..+.|.
T Consensus       154 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~  216 (263)
T d1sm2a_         154 DQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS  216 (263)
T ss_dssp             -----------CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHH
T ss_pred             CCceeecceecCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Confidence            432  223467899999999987 778999999999999999999 678888888877777664

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-48  Score=311.67  Aligned_cols=216  Identities=23%  Similarity=0.449  Sum_probs=185.0

Q ss_pred             eecceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceec
Q 024959           32 VYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIR  111 (260)
Q Consensus        32 ~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~  111 (260)
                      .+.+.|++..+.|++.+.||+|+||.||+|.++ ++..||||+++.....   .+.+.+|++++++++||||+++++++.
T Consensus         3 ~~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~   78 (272)
T d1qpca_           3 WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVT   78 (272)
T ss_dssp             TTTCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCCCCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeec
Confidence            367889999999999999999999999999986 4678999999764333   456899999999999999999999885


Q ss_pred             CCCCCCCccEEEEEecCC-cchHHHhhh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEee
Q 024959          112 PPKKDTFNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD  188 (260)
Q Consensus       112 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~d  188 (260)
                      .+      ..++||||++ |+|.+.+..  ..++++..+..++.|++++|.|||+++++||||||+||+++.++.+||+|
T Consensus        79 ~~------~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~D  152 (272)
T d1qpca_          79 QE------PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIAD  152 (272)
T ss_dssp             SS------SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECC
T ss_pred             cC------CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeecc
Confidence            43      3689999998 688887654  34699999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCcc--cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          189 FGLARTTSETDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       189 f~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      ||+++.......  .....+++.|+|||.+.. ..++.++||||||+++|||+| |.+||...+..+.++.|.
T Consensus       153 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~  224 (272)
T d1qpca_         153 FGLARLIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE  224 (272)
T ss_dssp             CTTCEECSSSCEECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred             ccceEEccCCccccccccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            999987655432  233466889999999886 678999999999999999999 566777777777777664

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.8e-48  Score=322.22  Aligned_cols=206  Identities=24%  Similarity=0.387  Sum_probs=176.9

Q ss_pred             ccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCccc----chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC
Q 024959           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD----NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~----~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~  115 (260)
                      +-+.|++++.||+|+||.||+|.++.+++.||+|++.....    .........+++++++.++||||+++++++...  
T Consensus         2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~--   79 (364)
T d1omwa3           2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--   79 (364)
T ss_dssp             CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS--
T ss_pred             CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC--
Confidence            34568889999999999999999999999999999854321    111122223456677777899999999999887  


Q ss_pred             CCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          116 DTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       116 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                         +.+|+||||++ ++|.+++.....+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||++..
T Consensus        80 ---~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~  156 (364)
T d1omwa3          80 ---DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD  156 (364)
T ss_dssp             ---SEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred             ---CEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeee
Confidence               56999999998 69999999999999999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH
Q 024959          195 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  251 (260)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~  251 (260)
                      ..... .....||+.|+|||.+.....++.++|||||||++|+|++|..||.+.+..
T Consensus       157 ~~~~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~  212 (364)
T d1omwa3         157 FSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK  212 (364)
T ss_dssp             CSSSC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS
T ss_pred             cCCCc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH
Confidence            66543 345678999999999976567899999999999999999999999876543

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-48  Score=310.57  Aligned_cols=204  Identities=21%  Similarity=0.378  Sum_probs=174.8

Q ss_pred             ccccccCceEEEEEEeC--CCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEEEE
Q 024959           48 RPIGRGAYGIVCAAVNS--ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY  125 (260)
Q Consensus        48 ~~lg~G~~g~vy~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~lv~  125 (260)
                      +.||+|+||+||+|.++  .+++.||||+++.........+.+.+|++++++++||||+++++++..+      ..++||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~------~~~lvm   86 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE------SWMLVM   86 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS------SEEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC------CEEEEE
Confidence            46999999999999754  4567899999976655556677899999999999999999999998643      378999


Q ss_pred             ecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCccc---
Q 024959          126 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM---  201 (260)
Q Consensus       126 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~~---  201 (260)
                      ||++ |+|.+++.....+++..+..++.||+.||+|||+++++||||||+||+++.++.++|+|||+++........   
T Consensus        87 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  166 (277)
T d1xbba_          87 EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  166 (277)
T ss_dssp             ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred             EcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence            9998 699999999999999999999999999999999999999999999999999999999999999876544322   


Q ss_pred             -ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          202 -TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       202 -~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                       ....+++.|+|||.+.+ ..++.++||||||+++|||++ |..||.+.+..+..+.|.
T Consensus       167 ~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~  224 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE  224 (277)
T ss_dssp             ----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred             ccccCCCceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH
Confidence             22356889999999987 678999999999999999998 899999999888777765

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-47  Score=302.80  Aligned_cols=210  Identities=21%  Similarity=0.393  Sum_probs=183.3

Q ss_pred             ccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCc
Q 024959           40 SSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~  119 (260)
                      ..+.|+++++||+|+||+||++.++ ++..||||.++.....   .+.+.+|++++++++||||+++++++..+     +
T Consensus         2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~-----~   72 (258)
T d1k2pa_           2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-----R   72 (258)
T ss_dssp             CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC---HHHHHHHHHHHHTCCCTTBCCEEEEECCS-----S
T ss_pred             ChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC---HHHHHHHHHHHHhcCCCceeeEEEEEeeC-----C
Confidence            4567889999999999999999985 6788999999765333   35789999999999999999999999876     5


Q ss_pred             cEEEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCC
Q 024959          120 DVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  197 (260)
Q Consensus       120 ~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~  197 (260)
                      .+++||||++ |+|.+++.. ...+++..++.++.|+++||+|||++|++|+||+|+||+++.++.+||+|||+++....
T Consensus        73 ~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  152 (258)
T d1k2pa_          73 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  152 (258)
T ss_dssp             SEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSS
T ss_pred             ceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccC
Confidence            6999999997 688888654 56799999999999999999999999999999999999999999999999999976554


Q ss_pred             Ccc--cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhc
Q 024959          198 TDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       198 ~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~~  259 (260)
                      ...  .....+++.|+|||.+.+ ..++.++||||||+++|||++ |+.||.+.+..+..++|.+
T Consensus       153 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~  216 (258)
T d1k2pa_         153 DEYTSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ  216 (258)
T ss_dssp             SSCCCCCCSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT
T ss_pred             CCceeecccCCCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHh
Confidence            432  223467889999999987 778999999999999999998 8999999999988887754

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-48  Score=315.19  Aligned_cols=220  Identities=38%  Similarity=0.656  Sum_probs=185.6

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCC-CeEEEEEecCCcccchHHHHHHHHHHHHHHHc---CCCCeeeeeceecCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSET-REEVAIKKIGNAFDNIIDARRTLREIKLLRHM---EHENVIAIKDIIRPPK  114 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~-~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~iv~~~~~~~~~~  114 (260)
                      ...+.|++++.||+|+||+||+|.+..+ ++.||||+++...........+.+|+++++.|   +||||+++++++....
T Consensus         4 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~   83 (305)
T d1blxa_           4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   83 (305)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence            3456788999999999999999999765 67799999865433332333455677776666   7999999999987544


Q ss_pred             CCCCccEEEEEecCCcchHHHhh--hCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccc
Q 024959          115 KDTFNDVYIVYELMDTDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~~~l~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~  192 (260)
                      ......++++||++++.+.....  ....+++..++.++.|++++|+|||+++++||||||+|||++.++.++|+|||++
T Consensus        84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~  163 (305)
T d1blxa_          84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA  163 (305)
T ss_dssp             CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred             cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhh
Confidence            43346789999999976555443  3567999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          193 RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      .............||+.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+++..|.+
T Consensus       164 ~~~~~~~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~  229 (305)
T d1blxa_         164 RIYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD  229 (305)
T ss_dssp             CCCCGGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             hhhcccccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence            88777766777889999999999987 7899999999999999999999999999999998888753

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-47  Score=308.09  Aligned_cols=213  Identities=21%  Similarity=0.367  Sum_probs=180.4

Q ss_pred             eccccCCCcc-cccccCceEEEEEEeCC--CCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC
Q 024959           39 VSSKYVPPIR-PIGRGAYGIVCAAVNSE--TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (260)
Q Consensus        39 ~~~~~~~~~~-~lg~G~~g~vy~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~  115 (260)
                      +..+.+.+.. .||+|+||+||+|.++.  ++..||||+++.. ........+.+|+++|++++||||+++++++..+  
T Consensus         5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--   81 (285)
T d1u59a_           5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE--   81 (285)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS--
T ss_pred             ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC--
Confidence            4455565666 49999999999998754  4557999999765 3445667899999999999999999999998643  


Q ss_pred             CCCccEEEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          116 DTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       116 ~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                          .+++||||++ |+|.+++.. +..+++..+..++.|+++||+|||+++++||||||+||+++.++.+||+|||+++
T Consensus        82 ----~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~  157 (285)
T d1u59a_          82 ----ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSK  157 (285)
T ss_dssp             ----SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             ----eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhh
Confidence                3799999998 699998765 4679999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCccc----ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhc
Q 024959          194 TTSETDFM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       194 ~~~~~~~~----~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~~  259 (260)
                      ........    ....+++.|+|||.+.. ..++.++|||||||++|||++ |..||.+.+..+..+.|.+
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~  227 (285)
T d1u59a_         158 ALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ  227 (285)
T ss_dssp             ECTTCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT
T ss_pred             cccccccccccccccccCccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            76544322    23356889999999977 678999999999999999998 9999999998888877753

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=312.48  Aligned_cols=224  Identities=48%  Similarity=0.892  Sum_probs=188.5

Q ss_pred             eeecceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeecee
Q 024959           31 NVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII  110 (260)
Q Consensus        31 ~~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~  110 (260)
                      +.-...|++. +.|++++.||+|+||+||+|.++.+++.||||+++.........+.+.+|+++|+.++||||++++++|
T Consensus         8 ~~~~~~~~~~-~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~   86 (346)
T d1cm8a_           8 EVTKTAWEVR-AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVF   86 (346)
T ss_dssp             ECSSSEECCB-SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEE
T ss_pred             eccCceeecC-CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEe
Confidence            3334557774 556799999999999999999999999999999987666666778889999999999999999999999


Q ss_pred             cCCCCC-CCccEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeec
Q 024959          111 RPPKKD-TFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF  189 (260)
Q Consensus       111 ~~~~~~-~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df  189 (260)
                      ...... ....+|+|||+++.+|...+. ..++++..++.++.||+.||+|||++|++||||||+|||++.++.++|+||
T Consensus        87 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Df  165 (346)
T d1cm8a_          87 TPDETLDDFTDFYLVMPFMGTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDF  165 (346)
T ss_dssp             CSCSSTTTCCCCEEEEECCSEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred             ccCccccccceEEEEEecccccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccc
Confidence            876532 224689999999877777654 567999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          190 GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      |++......  .....+++.|+|||.+.+...++.++|||||||++|+|++|..||.+.+..+.+..+.
T Consensus       166 g~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~  232 (346)
T d1cm8a_         166 GLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM  232 (346)
T ss_dssp             TTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             cceeccCCc--cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHH
Confidence            999877654  3456789999999999876778999999999999999999999999999888776654

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-46  Score=311.49  Aligned_cols=221  Identities=56%  Similarity=1.007  Sum_probs=187.8

Q ss_pred             cceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCC
Q 024959           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (260)
Q Consensus        34 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~  113 (260)
                      ++.|++..+ |++++.||+|+||+||+|.++.+++.||||++... ........+.+|+++|+.++||||+++++++...
T Consensus         1 ~~~~~i~~r-Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~   78 (345)
T d1pmea_           1 GQVFDVGPR-YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAP   78 (345)
T ss_dssp             CCCCCCCTT-EEEEEECC---CCCEEEEEETTTCSEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCS
T ss_pred             CCccCcCCC-eEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh-cChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeec
Confidence            356777665 67999999999999999999999999999999654 3455567889999999999999999999999877


Q ss_pred             CCCCCccEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          114 KKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       114 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                      .......++++++.++++|.+++..+ ++++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||++.
T Consensus        79 ~~~~~~~~~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~  157 (345)
T d1pmea_          79 TIEQMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR  157 (345)
T ss_dssp             STTTCCCEEEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             cccccceEEEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCcee
Confidence            65444567888888889999998654 79999999999999999999999999999999999999999999999999997


Q ss_pred             ccCCCc----ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          194 TTSETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       194 ~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      ......    ......+++.|+|||.+.....++.++||||+||++++|++|..||.+.+..++...+
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~  225 (345)
T d1pmea_         158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI  225 (345)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHH
Confidence            654432    2344567899999999877677899999999999999999999999998887776654

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-47  Score=303.68  Aligned_cols=216  Identities=25%  Similarity=0.414  Sum_probs=175.7

Q ss_pred             eeEeccccCCCcccccccCceEEEEEEeCCC---CeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecC
Q 024959           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNSET---REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRP  112 (260)
Q Consensus        36 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~  112 (260)
                      .||+..+.|++++.||+|+||.||+|.+..+   +..|++|.++.. ........+.+|++++++++||||+++++++.+
T Consensus         1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~   79 (273)
T d1mp8a_           1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE   79 (273)
T ss_dssp             CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            3889999999999999999999999988654   356889988654 344456788999999999999999999999854


Q ss_pred             CCCCCCccEEEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecc
Q 024959          113 PKKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG  190 (260)
Q Consensus       113 ~~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~  190 (260)
                            +.+++|||++. +++.+++.. ...+++..++.++.|++++|+|||+++++||||||+||+++.++.+||+|||
T Consensus        80 ------~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG  153 (273)
T d1mp8a_          80 ------NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG  153 (273)
T ss_dssp             ------SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--
T ss_pred             ------CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccch
Confidence                  34799999998 688887665 5579999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcc--cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhc
Q 024959          191 LARTTSETDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       191 ~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~~  259 (260)
                      ++........  .....+++.|+|||.+.. ..++.++|||||||++|||++ |.+||.+.+..+..+.|.+
T Consensus       154 ~a~~~~~~~~~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~  224 (273)
T d1mp8a_         154 LSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN  224 (273)
T ss_dssp             -----------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred             hheeccCCcceeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence            9987554322  233456889999999987 788999999999999999998 8999999998888777653

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-46  Score=301.96  Aligned_cols=214  Identities=25%  Similarity=0.415  Sum_probs=172.0

Q ss_pred             EeccccCCCcccccccCceEEEEEEeCCCC----eEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCC
Q 024959           38 EVSSKYVPPIRPIGRGAYGIVCAAVNSETR----EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP  113 (260)
Q Consensus        38 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~  113 (260)
                      |+....|++.+.||+|+||.||+|.++.++    ..||||++.... .......+.+|++++++++||||+++++++...
T Consensus         3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~   81 (283)
T d1mqba_           3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY   81 (283)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence            455667778899999999999999876654    469999996543 344556788999999999999999999999876


Q ss_pred             CCCCCccEEEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccc
Q 024959          114 KKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  191 (260)
Q Consensus       114 ~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~  191 (260)
                           ...++|||++. +++.+.+.. ...+++..+..++.|++.+|+|||+++++||||||+|||++.++.+||+|||+
T Consensus        82 -----~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGl  156 (283)
T d1mqba_          82 -----KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGL  156 (283)
T ss_dssp             -----SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             -----CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccch
Confidence                 55899999998 467776665 46799999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCc----ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHhh
Q 024959          192 ARTTSETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       192 ~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g-~~pf~~~~~~~~~~~i~  258 (260)
                      ++......    ......+++.|+|||.+.+ ..++.++||||||+++|||+++ .+||.+.+..+.++.|.
T Consensus       157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~  227 (283)
T d1mqba_         157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN  227 (283)
T ss_dssp             -----------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred             hhcccCCCccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHh
Confidence            98654432    1223456889999999987 7889999999999999999994 56667677766666654

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=8.8e-47  Score=305.23  Aligned_cols=211  Identities=40%  Similarity=0.698  Sum_probs=181.3

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      +.|++++.||+|+||+||+|.++ +++.||||++............+.+|+.++++++||||+++++++..+     +..
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~   75 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRL   75 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccC-----Cce
Confidence            35678999999999999999986 678999999976544444467888999999999999999999999887     569


Q ss_pred             EEEEecCCcchHHHhh-hCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCcc
Q 024959          122 YIVYELMDTDLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  200 (260)
Q Consensus       122 ~lv~e~~~~~l~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~  200 (260)
                      ++++|++.+.+...+. ..+.+++..++.++.|++.||+|||+.+|+||||||+||+++.++.+||+|||.+........
T Consensus        76 ~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             eEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence            9999999976666554 477899999999999999999999999999999999999999999999999999987654432


Q ss_pred             -cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          201 -MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       201 -~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                       .....+++.|++||.+.+...++.++|+||||+++|+|++|+.||.+.+..+++.+|.
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~  214 (286)
T d1ob3a_         156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF  214 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence             3344678899999999876778999999999999999999999999999888887764

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-47  Score=312.23  Aligned_cols=203  Identities=27%  Similarity=0.431  Sum_probs=172.0

Q ss_pred             cCCCc-ccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCCCCCcc
Q 024959           43 YVPPI-RPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFND  120 (260)
Q Consensus        43 ~~~~~-~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~~~~  120 (260)
                      .|.++ +.||+|+||+||+|.+..+++.||||+++..       ..+.+|++++.++ +||||++++++|..... ....
T Consensus        12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~-~~~~   83 (335)
T d2ozaa1          12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYA-GRKC   83 (335)
T ss_dssp             TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET-TEEE
T ss_pred             CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeeccc-CCCE
Confidence            34455 5699999999999999999999999999642       3466789886655 79999999999864211 1156


Q ss_pred             EEEEEecCC-cchHHHhhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecc---CCCEEEeecccccc
Q 024959          121 VYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLART  194 (260)
Q Consensus       121 ~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~---~~~~~l~df~~~~~  194 (260)
                      +|+|||||+ |+|.+++...  ..+++.+++.++.||+.||+|||++|++||||||+||+++.   ++.+||+|||+++.
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~  163 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  163 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeee
Confidence            899999998 6999999764  46999999999999999999999999999999999999975   46799999999988


Q ss_pred             cCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024959          195 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  254 (260)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  254 (260)
                      ...........|++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+..
T Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~  222 (335)
T d2ozaa1         164 TTSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS  222 (335)
T ss_dssp             CCCCCCCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---
T ss_pred             ccCCCccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH
Confidence            777766777789999999999877 77899999999999999999999999877654443

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-46  Score=302.07  Aligned_cols=215  Identities=25%  Similarity=0.416  Sum_probs=178.3

Q ss_pred             ecceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecC
Q 024959           33 YGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRP  112 (260)
Q Consensus        33 ~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~  112 (260)
                      ..+.|+++.+.|++.+.||+|+||.||+|.++.+ ..||||+++.....   .+.+.+|+.++++++||||+++++++.+
T Consensus         8 ~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~   83 (285)
T d1fmka3           8 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE   83 (285)
T ss_dssp             STTCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEec
Confidence            4577899999999999999999999999999766 56999999765333   3568999999999999999999999854


Q ss_pred             CCCCCCccEEEEEecCC-cchHHHhhh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeec
Q 024959          113 PKKDTFNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF  189 (260)
Q Consensus       113 ~~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df  189 (260)
                      +      ..++||||+. |+|...+..  ...+++..++.++.|++.+|+|||+++++||||||+||+++.++++||+||
T Consensus        84 ~------~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~Df  157 (285)
T d1fmka3          84 E------PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADF  157 (285)
T ss_dssp             S------SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             C------CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEccc
Confidence            3      3689999998 577777654  457999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCc--ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHhh
Q 024959          190 GLARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       190 ~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g-~~pf~~~~~~~~~~~i~  258 (260)
                      |+++......  ......+++.|+|||.+.. ..++.++||||||+++|||++| .+||.+.+..+.+..|.
T Consensus       158 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~  228 (285)
T d1fmka3         158 GLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE  228 (285)
T ss_dssp             CTTC--------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred             chhhhccCCCceeeccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            9998664433  2233567899999999987 7789999999999999999995 56667777777777664

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-45  Score=304.67  Aligned_cols=219  Identities=47%  Similarity=0.881  Sum_probs=181.0

Q ss_pred             eeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC
Q 024959           36 LFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK  115 (260)
Q Consensus        36 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~  115 (260)
                      .+.+. +.|++++.||+|+||+||+|.++.+++.||||++...........++.+|+.+++.++||||++++++|.....
T Consensus        12 ~f~i~-~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~   90 (355)
T d2b1pa1          12 TFTVL-KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT   90 (355)
T ss_dssp             EEEEE-TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred             ceeec-CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccc
Confidence            44443 44779999999999999999999999999999998776666677788999999999999999999999976543


Q ss_pred             -CCCccEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          116 -DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       116 -~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                       .....+|+||||+.+++.+.+  ...+++..++.++.|++.||+|||++|++|+||||+||+++.++.++++|||++..
T Consensus        91 ~~~~~~~~iv~Ey~~~~l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~  168 (355)
T d2b1pa1          91 LEEFQDVYLVMELMDANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_dssp             TTTCCEEEEEEECCSEEHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             cccCceeEEEEeccchHHHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhc
Confidence             233679999999998887766  45689999999999999999999999999999999999999999999999999988


Q ss_pred             cCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          195 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      ...........+|+.|+|||.+.+ ..+++++||||+||++++|++|+.||.+.+...++.+|.
T Consensus       169 ~~~~~~~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~  231 (355)
T d2b1pa1         169 AGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI  231 (355)
T ss_dssp             ------------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             cccccccccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHH
Confidence            777766667788999999999988 788999999999999999999999999999888887764

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-46  Score=307.16  Aligned_cols=210  Identities=34%  Similarity=0.621  Sum_probs=180.6

Q ss_pred             cCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC-CCCccE
Q 024959           43 YVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDV  121 (260)
Q Consensus        43 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~-~~~~~~  121 (260)
                      .|..++.||+|+||+||+|.++.+++.||||++.....      ...+|+++|++++||||++++++|..... .....+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~   94 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL   94 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence            45567899999999999999999999999999965432      23479999999999999999999865432 222457


Q ss_pred             EEEEecCCcchHHHh----hhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCC-CEEEeecccccccC
Q 024959          122 YIVYELMDTDLHQII----RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTS  196 (260)
Q Consensus       122 ~lv~e~~~~~l~~~l----~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~-~~~l~df~~~~~~~  196 (260)
                      ++||||+++++.+.+    .....+++..++.++.|+++||+|||++||+||||||+|||++.++ .+||+|||++....
T Consensus        95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~  174 (350)
T d1q5ka_          95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  174 (350)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred             EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence            899999997655544    3466899999999999999999999999999999999999999775 89999999998887


Q ss_pred             CCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          197 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       197 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      .........+++.|+|||.+.+...++.++|||||||++|+|++|..||...+..+++..|.
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~  236 (350)
T d1q5ka_         175 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII  236 (350)
T ss_dssp             TTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHH
T ss_pred             CCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHH
Confidence            77666777889999999998876789999999999999999999999999999988887764

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-45  Score=302.57  Aligned_cols=219  Identities=36%  Similarity=0.610  Sum_probs=181.7

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCC---CC
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK---DT  117 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~---~~  117 (260)
                      ...|.+++.||+|+||+||+|.++.+++.||||++...........++.+|+++|+.++||||+++++++.....   ..
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            466778999999999999999999999999999986654444455678899999999999999999999866432   11


Q ss_pred             CccEEEEEecCCcchHHHh-hhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccC
Q 024959          118 FNDVYIVYELMDTDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  196 (260)
Q Consensus       118 ~~~~~lv~e~~~~~l~~~l-~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~  196 (260)
                      ....+++||++++.+.... .....+++..++.++.|++++|+|||++|++||||||+||+++.++.++|+|||++....
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~  168 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS  168 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence            2458999999997655544 456789999999999999999999999999999999999999999999999999997654


Q ss_pred             CCc-----ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q 024959          197 ETD-----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       197 ~~~-----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  259 (260)
                      ...     ......+|+.|+|||.+.+...++.++|||||||++|+|++|..||.+.+..+.+..|.+
T Consensus       169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~  236 (318)
T d3blha1         169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ  236 (318)
T ss_dssp             C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHH
Confidence            322     223346799999999998767789999999999999999999999999999888887754

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-45  Score=300.23  Aligned_cols=218  Identities=24%  Similarity=0.376  Sum_probs=186.0

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEeC-----CCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeece
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNS-----ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI  109 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~  109 (260)
                      ..+|++.+.|++++.||+|+||+||+|..+     .+++.||||+++... ......++.+|+++++.++||||++++++
T Consensus         6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~   84 (301)
T d1lufa_           6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGV   84 (301)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence            347788888999999999999999999865     356789999997643 34456778999999999999999999999


Q ss_pred             ecCCCCCCCccEEEEEecCC-cchHHHhhhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhC
Q 024959          110 IRPPKKDTFNDVYIVYELMD-TDLHQIIRSD------------------------QQLTDDHCQYFLYQLLRGLKYVHSA  164 (260)
Q Consensus       110 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~------------------------~~~~~~~~~~~~~~i~~~l~~lh~~  164 (260)
                      +...     ...+++||+++ ++|.+++...                        ..+++..+..++.|++.+|+|||++
T Consensus        85 ~~~~-----~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~  159 (301)
T d1lufa_          85 CAVG-----KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER  159 (301)
T ss_dssp             ECSS-----SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             eccC-----CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC
Confidence            9876     55899999998 6999988642                        2488999999999999999999999


Q ss_pred             CceeccCCCCCeEeccCCCEEEeecccccccCCCc---ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhC
Q 024959          165 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR  241 (260)
Q Consensus       165 ~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g  241 (260)
                      +++||||||+||+++.++.+||+|||+++......   ......+++.|+|||.+.+ ..++.++||||||+++|||++|
T Consensus       160 ~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~  238 (301)
T d1lufa_         160 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSY  238 (301)
T ss_dssp             TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTT
T ss_pred             CeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHcc
Confidence            99999999999999999999999999997654432   2233466889999999987 7899999999999999999998


Q ss_pred             C-CCCCCCChHHHHHHhhc
Q 024959          242 E-PLFPGKDYVHQLRLITE  259 (260)
Q Consensus       242 ~-~pf~~~~~~~~~~~i~~  259 (260)
                      . +||.+.+..+....|.+
T Consensus       239 ~~~p~~~~~~~e~~~~v~~  257 (301)
T d1lufa_         239 GLQPYYGMAHEEVIYYVRD  257 (301)
T ss_dssp             TCCTTTTSCHHHHHHHHHT
T ss_pred             CCCCCCCCCHHHHHHHHHc
Confidence            5 78999999888887653

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-45  Score=302.23  Aligned_cols=224  Identities=54%  Similarity=0.982  Sum_probs=189.1

Q ss_pred             eeecceeEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeecee
Q 024959           31 NVYGNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII  110 (260)
Q Consensus        31 ~~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~  110 (260)
                      ..-...|+++ +.|++++.||+|+||+||+|.+..+++.||||++............+.+|+++|+.++||||+++++++
T Consensus         8 ~~~~~~~~~~-~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~   86 (348)
T d2gfsa1           8 ELNKTIWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF   86 (348)
T ss_dssp             ECSSSEEEEE-TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             ecCCccccCC-CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            3345678885 457799999999999999999999999999999987766667778889999999999999999999998


Q ss_pred             cCCCCC-CCccEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeec
Q 024959          111 RPPKKD-TFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF  189 (260)
Q Consensus       111 ~~~~~~-~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df  189 (260)
                      ...... ....+++++++.+++|.+++. .+++++..++.++.||+.||+|||++|++||||||+||+++.++.++++||
T Consensus        87 ~~~~~~~~~~~~~i~~~~~gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~df  165 (348)
T d2gfsa1          87 TPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDF  165 (348)
T ss_dssp             CSCSSTTTCCCCEEEEECCSEEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred             eeccccccCceEEEEEeecCCchhhhcc-cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccccccccc
Confidence            765432 223466666666689988875 457999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 024959          190 GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  258 (260)
                      |++......  .....+++.|+|||...+...++.++|||||||++|+|++|..||.+.+.......|.
T Consensus       166 g~a~~~~~~--~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~  232 (348)
T d2gfsa1         166 GLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL  232 (348)
T ss_dssp             ----CCTGG--GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             chhcccCcc--cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            998765433  3456778999999998876677899999999999999999999999999988887765

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-46  Score=303.05  Aligned_cols=210  Identities=24%  Similarity=0.362  Sum_probs=171.6

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCe----EEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETRE----EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      ..+|++++.||+|+||+||+|.+..+++    +||+|.++... .....+.+.+|++++++++||||+++++++.++   
T Consensus         8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~---   83 (317)
T d1xkka_           8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS---   83 (317)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS---
T ss_pred             HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---
Confidence            3468889999999999999999987775    58888876432 222456789999999999999999999999765   


Q ss_pred             CCccEEEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                         ..++++|++. ++|.+.+.. ...+++..++.++.|+++||+|||+++++||||||+||+++.++.+||+|||+++.
T Consensus        84 ---~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~  160 (317)
T d1xkka_          84 ---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL  160 (317)
T ss_dssp             ---SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred             ---CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeecccccee
Confidence               2566667766 788887766 56799999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCccc---ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          195 TSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       195 ~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      .......   ....+++.|+|||.+.+ ..++.++||||||+++|||+| |..||.+.+..+..+.|.
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~  227 (317)
T d1xkka_         161 LGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE  227 (317)
T ss_dssp             TTTTCC--------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH
T ss_pred             cccccccccccccccCccccChHHHhc-CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Confidence            6543322   23356899999999987 778999999999999999998 899999888777666553

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-45  Score=298.64  Aligned_cols=217  Identities=28%  Similarity=0.474  Sum_probs=182.0

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEeCCCC-------eEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeee
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSETR-------EEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAI  106 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~-------~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~  106 (260)
                      ..|+++.+.|++++.||+|+||.||+|++..++       ..||||+++... .......+.+|...+.++ +||||+++
T Consensus         6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~   84 (299)
T d1fgka_           6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINL   84 (299)
T ss_dssp             TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEec
Confidence            459999999999999999999999999875543       479999997654 334567788899988888 79999999


Q ss_pred             eceecCCCCCCCccEEEEEecCC-cchHHHhhhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q 024959          107 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHR  169 (260)
Q Consensus       107 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~  169 (260)
                      ++++.++     ...++||||+. |+|.+++...                ..+++.++..++.||+.||+|||+.+++||
T Consensus        85 ~~~~~~~-----~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHr  159 (299)
T d1fgka_          85 LGACTQD-----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR  159 (299)
T ss_dssp             EEEECSS-----SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             ccccccC-----CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEee
Confidence            9999876     55899999998 6999998654                358999999999999999999999999999


Q ss_pred             cCCCCCeEeccCCCEEEeecccccccCCCc---ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCC
Q 024959          170 DLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLF  245 (260)
Q Consensus       170 di~~~nili~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf  245 (260)
                      ||||+|||++.++.+||+|||++.......   ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||
T Consensus       160 DiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~  238 (299)
T d1fgka_         160 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPY  238 (299)
T ss_dssp             CCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             eecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCC
Confidence            999999999999999999999988654433   2233567889999999987 789999999999999999998 79999


Q ss_pred             CCCChHHHHHHhh
Q 024959          246 PGKDYVHQLRLIT  258 (260)
Q Consensus       246 ~~~~~~~~~~~i~  258 (260)
                      .+.+..+..+.|.
T Consensus       239 ~~~~~~~~~~~i~  251 (299)
T d1fgka_         239 PGVPVEELFKLLK  251 (299)
T ss_dssp             TTCCHHHHHHHHH
T ss_pred             CCCCHHHHHHHHH
Confidence            9998887777664

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-46  Score=301.09  Aligned_cols=201  Identities=25%  Similarity=0.421  Sum_probs=172.1

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccc----hHHHHHHHHHHHHHHHcC--CCCeeeeeceecCCCC
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDN----IIDARRTLREIKLLRHME--HENVIAIKDIIRPPKK  115 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~~e~~~l~~l~--~~~iv~~~~~~~~~~~  115 (260)
                      +.|++.+.||+|+||+||+|.+..+++.||||++......    .....++.+|+.++++++  ||||+++++++...  
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~--   81 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP--   81 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS--
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC--
Confidence            4567899999999999999999999999999998643211    111233568999999997  89999999999887  


Q ss_pred             CCCccEEEEEecCC--cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccC-CCEEEeecccc
Q 024959          116 DTFNDVYIVYELMD--TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDFGLA  192 (260)
Q Consensus       116 ~~~~~~~lv~e~~~--~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~-~~~~l~df~~~  192 (260)
                         +..++|||++.  +++.+++..+..+++..++.++.|+++||+|||++|++||||||+||+++.+ +.++|+|||++
T Consensus        82 ---~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          82 ---DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             ---SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             ---CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccc
Confidence               56999999996  4788888888899999999999999999999999999999999999999854 78999999999


Q ss_pred             cccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 024959          193 RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK  248 (260)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  248 (260)
                      ....... .....||+.|+|||.+.+...++.++|||||||++|+|++|..||.+.
T Consensus       159 ~~~~~~~-~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~  213 (273)
T d1xwsa_         159 ALLKDTV-YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD  213 (273)
T ss_dssp             EECCSSC-BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred             eeccccc-ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence            8765443 345678999999999987455567899999999999999999999864

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-46  Score=296.16  Aligned_cols=209  Identities=26%  Similarity=0.432  Sum_probs=174.9

Q ss_pred             eEeccccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCC
Q 024959           37 FEVSSKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD  116 (260)
Q Consensus        37 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  116 (260)
                      |+++.+.|++++.||+|+||.||++.++  +..||||+++.+.    ..+.+.+|++++++++||||+++++++.+..  
T Consensus         2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~--   73 (262)
T d1byga_           2 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK--   73 (262)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC---
T ss_pred             CccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecC--
Confidence            8899999999999999999999999885  5789999997542    3467889999999999999999999886542  


Q ss_pred             CCccEEEEEecCC-cchHHHhhhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          117 TFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       117 ~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                        ..+++||||++ |+|.+++.+.  ..+++..++.++.|+++||.|||+.+++|+||+|+||+++.++.++|+|||+++
T Consensus        74 --~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~  151 (262)
T d1byga_          74 --GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK  151 (262)
T ss_dssp             ---CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred             --CcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccce
Confidence              34799999998 6999998664  358999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 024959          194 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  258 (260)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  258 (260)
                      ......  ....++..|+|||.+.+ ..+++++||||||+++|||++ |.+||...+..+....|.
T Consensus       152 ~~~~~~--~~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~  214 (262)
T d1byga_         152 EASSTQ--DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE  214 (262)
T ss_dssp             ------------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT
T ss_pred             ecCCCC--ccccccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Confidence            655432  33456889999999987 678999999999999999998 799999888877777664

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-45  Score=294.11  Aligned_cols=212  Identities=38%  Similarity=0.652  Sum_probs=185.0

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      +.|++++.||+|+||+||+|.+..+++.||||+++..........++.+|+.+++.++||||+++++++...     ...
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-----~~~   76 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccc-----cce
Confidence            357789999999999999999999999999999976655556778899999999999999999999999887     568


Q ss_pred             EEEEecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCc-
Q 024959          122 YIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  199 (260)
Q Consensus       122 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~-  199 (260)
                      +++++++.+ .+..++...+.+++..++.++.|++++|+|||++|++||||||+||+++.++.+||+|||.+....... 
T Consensus        77 ~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~  156 (292)
T d1unla_          77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred             eEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence            999999985 666666778899999999999999999999999999999999999999999999999999998766543 


Q ss_pred             ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHhh
Q 024959          200 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGKDYVHQLRLIT  258 (260)
Q Consensus       200 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~p-f~~~~~~~~~~~i~  258 (260)
                      ......+++.|.|||.+.....++.++|||||||++|+|++|..| |.+.+..++++.|.
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~  216 (292)
T d1unla_         157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF  216 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHH
T ss_pred             cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHH
Confidence            333345578899999988756689999999999999999999887 56677777776654

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-45  Score=295.20  Aligned_cols=214  Identities=26%  Similarity=0.387  Sum_probs=171.8

Q ss_pred             eccccCCCcccccccCceEEEEEEeCC-C--CeEEEEEecCCccc-chHHHHHHHHHHHHHHHcCCCCeeeeeceecCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSE-T--REEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK  114 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~-~--~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  114 (260)
                      +..++|++.+.||+|+||.||+|.... +  ...||||+++.... .....+.+.+|++++++++||||+++++++..+ 
T Consensus         5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-   83 (273)
T d1u46a_           5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-   83 (273)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred             EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-
Confidence            456778899999999999999997643 2  24689999865432 334567889999999999999999999999653 


Q ss_pred             CCCCccEEEEEecCC-cchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccc
Q 024959          115 KDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (260)
Q Consensus       115 ~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~  192 (260)
                           ..++||||++ +++.+.+.. ...+++..+..++.|+++||.|||+++++||||||+||+++.++.+||+|||++
T Consensus        84 -----~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~  158 (273)
T d1u46a_          84 -----PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM  158 (273)
T ss_dssp             -----SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             -----chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhh
Confidence                 3689999998 688877665 457999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCccc----ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhc
Q 024959          193 RTTSETDFM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITE  259 (260)
Q Consensus       193 ~~~~~~~~~----~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~~  259 (260)
                      .........    ....++..|+|||.+.+ ..++.++||||||+++|||++ |..||.+.+..+....|.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~  229 (273)
T d1u46a_         159 RALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK  229 (273)
T ss_dssp             EECCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT
T ss_pred             hhcccCCCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHh
Confidence            876554322    22345778999999987 778999999999999999998 8999999999998887753

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-45  Score=296.21  Aligned_cols=217  Identities=28%  Similarity=0.461  Sum_probs=172.5

Q ss_pred             cceeEeccccCCCcccccccCceEEEEEEeCC-----CCeEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeeee
Q 024959           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVNSE-----TREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIK  107 (260)
Q Consensus        34 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~  107 (260)
                      ...|+++.+.|++++.||+|+||.||+|.+..     +++.||+|.++... .......+.+|...+.++ +|+||+.++
T Consensus         5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~   83 (299)
T d1ywna1           5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL   83 (299)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence            46788999999999999999999999998654     45689999997543 334456677788888777 589999999


Q ss_pred             ceecCCCCCCCccEEEEEecCC-cchHHHhhhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecc
Q 024959          108 DIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRD  170 (260)
Q Consensus       108 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~d  170 (260)
                      +++....    ..+++||||++ |+|.+++...                ..+++..+..++.|+++||+|||+++++|||
T Consensus        84 ~~~~~~~----~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrD  159 (299)
T d1ywna1          84 GACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD  159 (299)
T ss_dssp             EEECSTT----SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             eeeccCC----CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCc
Confidence            9886643    45899999998 7999998653                2489999999999999999999999999999


Q ss_pred             CCCCCeEeccCCCEEEeecccccccCCCc---ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhC-CCCCC
Q 024959          171 LKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFP  246 (260)
Q Consensus       171 i~~~nili~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g-~~pf~  246 (260)
                      |||+|||++.++.+||+|||+++......   ......+|+.|+|||.+.+ ..++.++|||||||++|||++| ..||.
T Consensus       160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~  238 (299)
T d1ywna1         160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYP  238 (299)
T ss_dssp             CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCC
Confidence            99999999999999999999997654432   2234467999999999987 7889999999999999999986 56898


Q ss_pred             CCChHHHHHH
Q 024959          247 GKDYVHQLRL  256 (260)
Q Consensus       247 ~~~~~~~~~~  256 (260)
                      +.+..+.+..
T Consensus       239 ~~~~~~~~~~  248 (299)
T d1ywna1         239 GVKIDEEFCR  248 (299)
T ss_dssp             TCCCSHHHHH
T ss_pred             CCCHHHHHHH
Confidence            8776554443

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-45  Score=296.74  Aligned_cols=214  Identities=24%  Similarity=0.338  Sum_probs=179.5

Q ss_pred             eccccCCCcccccccCceEEEEEEeCCCCeE--EEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeeeeceecCCCC
Q 024959           39 VSSKYVPPIRPIGRGAYGIVCAAVNSETREE--VAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKK  115 (260)
Q Consensus        39 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~--~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~  115 (260)
                      ++-+.|++.+.||+|+||+||+|.++.++..  |+||.+.... .....+.+.+|+++|+++ +||||+++++++..+  
T Consensus         7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~--   83 (309)
T d1fvra_           7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--   83 (309)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--
T ss_pred             cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC--
Confidence            3456777899999999999999999888764  6777765432 233456789999999999 699999999999876  


Q ss_pred             CCCccEEEEEecCC-cchHHHhhhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEe
Q 024959          116 DTFNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL  178 (260)
Q Consensus       116 ~~~~~~~lv~e~~~-~~l~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili  178 (260)
                         ..+++||||++ |+|.+++...                ..+++..+..++.|+++||.|||+++++||||||+|||+
T Consensus        84 ---~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~  160 (309)
T d1fvra_          84 ---GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV  160 (309)
T ss_dssp             ---TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             ---CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEE
Confidence               56999999998 7999998643                579999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeecccccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHh
Q 024959          179 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTRE-PLFPGKDYVHQLRLI  257 (260)
Q Consensus       179 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~-~pf~~~~~~~~~~~i  257 (260)
                      +.++.+||+|||++.............++..|+|||.+.+ ..++.++||||||+++|||++|. +||.+.+..+..+.|
T Consensus       161 ~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i  239 (309)
T d1fvra_         161 GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL  239 (309)
T ss_dssp             CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred             cCCCceEEccccccccccccccccceecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            9999999999999987665555555677899999999987 77899999999999999999965 689999988888776


Q ss_pred             hc
Q 024959          258 TE  259 (260)
Q Consensus       258 ~~  259 (260)
                      .+
T Consensus       240 ~~  241 (309)
T d1fvra_         240 PQ  241 (309)
T ss_dssp             GG
T ss_pred             Hh
Confidence            53

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-44  Score=294.07  Aligned_cols=218  Identities=26%  Similarity=0.462  Sum_probs=188.2

Q ss_pred             ceeEeccccCCCcccccccCceEEEEEEeCC-----CCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeece
Q 024959           35 NLFEVSSKYVPPIRPIGRGAYGIVCAAVNSE-----TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI  109 (260)
Q Consensus        35 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~  109 (260)
                      +.|++..+.+++++.||+|+||+||+|.++.     ++..||||+++.. ........+.+|++++++++||||++++++
T Consensus        13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~   91 (308)
T d1p4oa_          13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGV   91 (308)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence            5699999999999999999999999998753     3578999999754 344556778999999999999999999999


Q ss_pred             ecCCCCCCCccEEEEEecCC-cchHHHhhhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEe
Q 024959          110 IRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL  178 (260)
Q Consensus       110 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili  178 (260)
                      +..+     ...++|||+++ |+|.+++...          ..+++..+..++.|+++||.|||+++++||||||+|||+
T Consensus        92 ~~~~-----~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl  166 (308)
T d1p4oa_          92 VSQG-----QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV  166 (308)
T ss_dssp             ECSS-----SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE
T ss_pred             EecC-----CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee
Confidence            9776     55899999998 6888887542          347899999999999999999999999999999999999


Q ss_pred             ccCCCEEEeecccccccCCCcc---cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhC-CCCCCCCChHHHH
Q 024959          179 NASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQL  254 (260)
Q Consensus       179 ~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g-~~pf~~~~~~~~~  254 (260)
                      +.++++||+|||+++.......   .....+++.|++||.+.+ ..++.++||||||+++|||++| ..||.+.+..+.+
T Consensus       167 d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~  245 (308)
T d1p4oa_         167 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL  245 (308)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH
T ss_pred             cCCceEEEeecccceeccCCcceeeccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            9999999999999976544322   233356899999999987 7789999999999999999997 5899999999888


Q ss_pred             HHhhc
Q 024959          255 RLITE  259 (260)
Q Consensus       255 ~~i~~  259 (260)
                      +.|++
T Consensus       246 ~~i~~  250 (308)
T d1p4oa_         246 RFVME  250 (308)
T ss_dssp             HHHHT
T ss_pred             HHHHh
Confidence            87754

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-44  Score=293.03  Aligned_cols=217  Identities=25%  Similarity=0.408  Sum_probs=186.0

Q ss_pred             cceeEeccccCCCcccccccCceEEEEEEe-----CCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHc-CCCCeeeee
Q 024959           34 GNLFEVSSKYVPPIRPIGRGAYGIVCAAVN-----SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIK  107 (260)
Q Consensus        34 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~  107 (260)
                      ...|+++.+.|++.+.||+|+||.||+|.+     ..++..||||+++... .......+.+|+.+++.+ +||||++++
T Consensus        15 ~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~   93 (311)
T d1t46a_          15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLL   93 (311)
T ss_dssp             CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence            456889999999999999999999999975     3466789999997653 445567788999999999 699999999


Q ss_pred             ceecCCCCCCCccEEEEEecCC-cchHHHhhhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 024959          108 DIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ------------------QLTDDHCQYFLYQLLRGLKYVHSASVLH  168 (260)
Q Consensus       108 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~------------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H  168 (260)
                      +++...     ...++||||++ ++|.+++....                  .+++..+..++.||+++|+|||+++++|
T Consensus        94 g~~~~~-----~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivH  168 (311)
T d1t46a_          94 GACTIG-----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIH  168 (311)
T ss_dssp             EEECSS-----SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             EEEeeC-----CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence            999877     45899999998 68888886533                  5899999999999999999999999999


Q ss_pred             ccCCCCCeEeccCCCEEEeecccccccCCCcc---cccccccccccccccccCcCCCCChhhHHHHHHHHHHHHh-CCCC
Q 024959          169 RDLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPL  244 (260)
Q Consensus       169 ~di~~~nili~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p  244 (260)
                      |||||+||+++.++.++++|||.++.......   .....+++.|+|||.+.. ..++.++||||||+++|+|++ |.+|
T Consensus       169 rDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~  247 (311)
T d1t46a_         169 RDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSP  247 (311)
T ss_dssp             SCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             cccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCC
Confidence            99999999999999999999999987654432   233467899999999987 788999999999999999998 7777


Q ss_pred             CCCCChHHHHHHh
Q 024959          245 FPGKDYVHQLRLI  257 (260)
Q Consensus       245 f~~~~~~~~~~~i  257 (260)
                      |.+.+..+.+.++
T Consensus       248 ~~~~~~~~~~~~~  260 (311)
T d1t46a_         248 YPGMPVDSKFYKM  260 (311)
T ss_dssp             STTCCSSHHHHHH
T ss_pred             CCCCCHHHHHHHH
Confidence            8887776666554

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=9.9e-44  Score=292.58  Aligned_cols=206  Identities=31%  Similarity=0.603  Sum_probs=176.4

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-CCCeeeeeceecCCCCCCCc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~~~  119 (260)
                      .+.|++++.||+|+||+||+|.++.+++.||||+++...     ..++.+|+++|+.++ ||||+++++++.....   .
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~---~  105 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVS---R  105 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT---C
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCC---C
Confidence            356889999999999999999999999999999996532     356788999999996 9999999999976533   5


Q ss_pred             cEEEEEecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCC-CEEEeecccccccCC
Q 024959          120 DVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSE  197 (260)
Q Consensus       120 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~-~~~l~df~~~~~~~~  197 (260)
                      .+++|||++++ +|...   .+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .++|+|||++.....
T Consensus       106 ~~~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         106 TPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             SEEEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             ceeEEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC
Confidence            68999999995 65443   45799999999999999999999999999999999999998655 589999999988777


Q ss_pred             CcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHh
Q 024959          198 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD-YVHQLRLI  257 (260)
Q Consensus       198 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~-~~~~~~~i  257 (260)
                      ........+++.|+|||.+.+...++.++|+|||||++++|++|..||...+ ..++...|
T Consensus       183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i  243 (328)
T d3bqca1         183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI  243 (328)
T ss_dssp             TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHH
T ss_pred             CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHH
Confidence            6666677889999999999886678999999999999999999999996544 44444443

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.6e-44  Score=291.32  Aligned_cols=200  Identities=18%  Similarity=0.230  Sum_probs=171.6

Q ss_pred             cccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCC-CCeeeeeceecCCCCCCCc
Q 024959           41 SKYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH-ENVIAIKDIIRPPKKDTFN  119 (260)
Q Consensus        41 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~iv~~~~~~~~~~~~~~~  119 (260)
                      .+.|++++.||+|+||+||+|.+..+++.||||++.....    ...+.+|++.++.++| +|++.+++++...     .
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-----~   74 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEG-----L   74 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEET-----T
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC----cHHHHHHHHHHHHhcCCCCCCEEEEEeecC-----C
Confidence            4566789999999999999999999999999999854322    2346678899999975 8999999998776     5


Q ss_pred             cEEEEEecCCcchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecc-----CCCEEEeeccccc
Q 024959          120 DVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-----SCDLKIGDFGLAR  193 (260)
Q Consensus       120 ~~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~-----~~~~~l~df~~~~  193 (260)
                      ..++|||+++++|.+.+... ..+++..+..++.|++.+|++||++|++||||||+||+++.     ++.++|+|||+++
T Consensus        75 ~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~  154 (293)
T d1csna_          75 HNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  154 (293)
T ss_dssp             EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             ccEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeE
Confidence            68999999999999998764 57999999999999999999999999999999999999964     5789999999998


Q ss_pred             ccCCCc--------ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024959          194 TTSETD--------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  250 (260)
Q Consensus       194 ~~~~~~--------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  250 (260)
                      ......        ......||+.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~  218 (293)
T d1csna_         155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKA  218 (293)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred             EcccCccccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccc
Confidence            654321        2234568999999999987 7899999999999999999999999986544

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-44  Score=295.67  Aligned_cols=213  Identities=20%  Similarity=0.357  Sum_probs=179.1

Q ss_pred             ccccCCCcccccccCceEEEEEEe---CCCCeEEEEEecCCccc--chHHHHHHHHHHHHHHHcCC-CCeeeeeceecCC
Q 024959           40 SSKYVPPIRPIGRGAYGIVCAAVN---SETREEVAIKKIGNAFD--NIIDARRTLREIKLLRHMEH-ENVIAIKDIIRPP  113 (260)
Q Consensus        40 ~~~~~~~~~~lg~G~~g~vy~~~~---~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~~-~~iv~~~~~~~~~  113 (260)
                      ..++|++++.||+|+||+||+|.+   +.+++.||||+++....  .....+.+.+|++++++++| |||+++++++...
T Consensus        22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~  101 (322)
T d1vzoa_          22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  101 (322)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence            346688999999999999999987   44789999999865421  22234567789999999976 8999999999887


Q ss_pred             CCCCCccEEEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccc
Q 024959          114 KKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (260)
Q Consensus       114 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~  192 (260)
                           ..++++||++. ++|.+.+.....+++..++.++.||+.||+|||+++++||||||+||+++.++.++|+|||++
T Consensus       102 -----~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a  176 (322)
T d1vzoa_         102 -----TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS  176 (322)
T ss_dssp             -----TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             -----CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccch
Confidence                 56999999998 699999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCC--cccccccccccccccccccCc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 024959          193 RTTSET--DFMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  257 (260)
Q Consensus       193 ~~~~~~--~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  257 (260)
                      ......  .......+++.|++||.+... ..++.++|||||||++|+|++|..||.+.+..+....|
T Consensus       177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i  244 (322)
T d1vzoa_         177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI  244 (322)
T ss_dssp             EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH
T ss_pred             hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            765443  233456779999999999763 34688999999999999999999999887655444443

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.3e-43  Score=283.82  Aligned_cols=202  Identities=22%  Similarity=0.250  Sum_probs=166.2

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeee-ceecCCCCCCCcc
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK-DIIRPPKKDTFND  120 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~-~~~~~~~~~~~~~  120 (260)
                      ..|++++.||+|+||+||+|.+..+++.||||++......    ..+..|+++++.++|++++..+ +++...     ..
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~-----~~   77 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEG-----DY   77 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEET-----TE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecC-----CE
Confidence            3477899999999999999999999999999988654322    3467899999999877655554 444444     56


Q ss_pred             EEEEEecCCcchHHHhhh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec---cCCCEEEeecccccccC
Q 024959          121 VYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN---ASCDLKIGDFGLARTTS  196 (260)
Q Consensus       121 ~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~---~~~~~~l~df~~~~~~~  196 (260)
                      .++|||++++++.+.+.. ...+++..+..++.|++.+|+|||++|++||||||+||+++   .+..++|+|||+++...
T Consensus        78 ~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          78 NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             EEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             EEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence            899999999988777665 56899999999999999999999999999999999999985   34579999999998765


Q ss_pred             CCc--------ccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024959          197 ETD--------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  253 (260)
Q Consensus       197 ~~~--------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~  253 (260)
                      ...        ......||+.|+|||.+.+ ..++.++|||||||++|+|++|..||...+..+.
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~  221 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK  221 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC----
T ss_pred             ccccccceeccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCcccccchHHH
Confidence            432        2234468999999999988 7789999999999999999999999987665443

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-42  Score=280.71  Aligned_cols=196  Identities=28%  Similarity=0.427  Sum_probs=163.5

Q ss_pred             cccccccCceEEEEEEeCCCC---eEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccEEE
Q 024959           47 IRPIGRGAYGIVCAAVNSETR---EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI  123 (260)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~~l  123 (260)
                      .+.||+|+||+||+|.+..++   ..||||.++.. .......++.+|++++++++||||+++++++....    ..+++
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~~l  106 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GSPLV  106 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT----TEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC----CceEE
Confidence            467999999999999986543   36899998653 45556788999999999999999999999976432    45899


Q ss_pred             EEecCC-cchHHHhhhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeecccccccCCCccc
Q 024959          124 VYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  201 (260)
Q Consensus       124 v~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  201 (260)
                      ||||++ ++|.+++... ..+++..+..++.|+++||.|||+.+++||||||+|||++.++.+||+|||+++........
T Consensus       107 v~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             EEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            999999 6888877754 46778889999999999999999999999999999999999999999999999865443221


Q ss_pred             -----ccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 024959          202 -----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK  248 (260)
Q Consensus       202 -----~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  248 (260)
                           ....+++.|+|||.+.. ..++.++||||||+++|||++|..||...
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~  237 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPD  237 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC-
T ss_pred             cceecccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCC
Confidence                 22356889999999887 77899999999999999999977766543

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-42  Score=278.85  Aligned_cols=199  Identities=24%  Similarity=0.292  Sum_probs=158.7

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCeeeeeceecCCCCCCCccE
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV  121 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~~~~~  121 (260)
                      +.|.+.+.||+|+||.||++..  +++.||||++....   ........|+..+..++||||+++++++...... ...+
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~-~~~~   76 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGT-WTQL   76 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS-SEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCc-ceEE
Confidence            4566888999999999999976  57899999996432   1112223455556678999999999999765321 1358


Q ss_pred             EEEEecCC-cchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHh--------CCceeccCCCCCeEeccCCCEEEeecccc
Q 024959          122 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS--------ASVLHRDLKPSNLLLNASCDLKIGDFGLA  192 (260)
Q Consensus       122 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~--------~~i~H~di~~~nili~~~~~~~l~df~~~  192 (260)
                      ++||||+. ++|.+++.+. ++++..++.++.|++.+|++||+        +|++||||||+|||++.++.+||+|||++
T Consensus        77 ~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            99999998 6999998764 68999999999999999999996        58999999999999999999999999999


Q ss_pred             cccCCCc-----ccccccccccccccccccCcC-----CCCChhhHHHHHHHHHHHHhCCCCCCC
Q 024959          193 RTTSETD-----FMTEYVVTRWYRAPELLLNCT-----EYTAAIDIWSVGCILGEIMTREPLFPG  247 (260)
Q Consensus       193 ~~~~~~~-----~~~~~~~~~~~~~PE~~~~~~-----~~~~~~Di~slG~~l~~ll~g~~pf~~  247 (260)
                      +......     ......+++.|+|||.+.+..     .++.++|||||||++|||++|..||..
T Consensus       156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~  220 (303)
T d1vjya_         156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI  220 (303)
T ss_dssp             EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred             ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence            8654432     223456899999999987532     246689999999999999999888744

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.1e-36  Score=253.49  Aligned_cols=199  Identities=28%  Similarity=0.439  Sum_probs=159.6

Q ss_pred             ccCCCcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-----------CCCeeeeecee
Q 024959           42 KYVPPIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-----------HENVIAIKDII  110 (260)
Q Consensus        42 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------~~~iv~~~~~~  110 (260)
                      ..|++++.||+|+||+||+|.++.+++.||||+++..   ....+.+.+|+++++.++           |+||+++++++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~   89 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   89 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence            3478999999999999999999999999999999754   233456778898888875           47899999988


Q ss_pred             cCCCCCCCccEEEEEecCC--cchHHHh--hhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEeccCCC--
Q 024959          111 RPPKKDTFNDVYIVYELMD--TDLHQII--RSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCD--  183 (260)
Q Consensus       111 ~~~~~~~~~~~~lv~e~~~--~~l~~~l--~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~di~~~nili~~~~~--  183 (260)
                      .....   ...+++++++.  +......  .....+++..++.++.|+++||++||+ .||+||||||+|||++.++.  
T Consensus        90 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~  166 (362)
T d1q8ya_          90 NHKGP---NGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE  166 (362)
T ss_dssp             EEEET---TEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred             eeccc---cceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence            65432   34555555554  3333333  335679999999999999999999997 89999999999999987654  


Q ss_pred             ----EEEeecccccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 024959          184 ----LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  249 (260)
Q Consensus       184 ----~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  249 (260)
                          ++++|||.+......  .....+++.|+|||.+.. ..++.++|+||+||++++|++|+.||...+
T Consensus       167 ~~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~~~  233 (362)
T d1q8ya_         167 NLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDE  233 (362)
T ss_dssp             TEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             ccceeeEeecccccccccc--cccccccccccChhhccc-cCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence                899999998765543  345678999999999987 778999999999999999999999997654

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=5.1e-26  Score=172.03  Aligned_cols=170  Identities=16%  Similarity=0.141  Sum_probs=119.6

Q ss_pred             CcccccccCceEEEEEEeCCCCeEEEEEecCCccc----------------chHHHHHHHHHHHHHHHcCCCCeeeeece
Q 024959           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFD----------------NIIDARRTLREIKLLRHMEHENVIAIKDI  109 (260)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~----------------~~~~~~~~~~e~~~l~~l~~~~iv~~~~~  109 (260)
                      +.+.||+|+||+||+|.+. +|+.||||+++....                .........+|...+.++.+++++..++.
T Consensus         4 vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            6789999999999999985 578999998743211                01122334568889999999999988765


Q ss_pred             ecCCCCCCCccEEEEEecCCcchHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEeccCCCEEEeec
Q 024959          110 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF  189 (260)
Q Consensus       110 ~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~~~nili~~~~~~~l~df  189 (260)
                      ..         .+++||++++....      .++...+..++.|+++++.+||++|++|+||||+||+++++ .++|+||
T Consensus        83 ~~---------~~lvme~~~~~~~~------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDF  146 (191)
T d1zara2          83 EG---------NAVLMELIDAKELY------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDF  146 (191)
T ss_dssp             ET---------TEEEEECCCCEEGG------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred             cC---------CEEEEEeecccccc------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEEC
Confidence            42         26999999963221      24555677899999999999999999999999999999865 4899999


Q ss_pred             ccccccCCCcccccccccccccccccccCcCCCCChhhHHHHHHHH
Q 024959          190 GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL  235 (260)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l  235 (260)
                      |++....++............ -.+.+ . +.++.++|+||+.--+
T Consensus       147 G~a~~~~~~~~~~~l~rd~~~-~~~~f-~-r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         147 PQSVEVGEEGWREILERDVRN-IITYF-S-RTYRTEKDINSAIDRI  189 (191)
T ss_dssp             TTCEETTSTTHHHHHHHHHHH-HHHHH-H-HHHCCCCCHHHHHHHH
T ss_pred             CCcccCCCCCcHHHHHHHHHH-HHHHH-c-CCCCCcccHHHHHHHH
Confidence            999776654321110000000 01111 2 4567788999976433

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.46  E-value=4.5e-07  Score=69.89  Aligned_cols=135  Identities=14%  Similarity=0.113  Sum_probs=79.9

Q ss_pred             CcccccccCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-CCCeeeeeceecCCCCCCCccEEEE
Q 024959           46 PIRPIGRGAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDVYIV  124 (260)
Q Consensus        46 ~~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~~~~~~lv  124 (260)
                      +.+..+.++.+.||++..  ++..+++|........  ....+.+|...++.+. +--+.+++.+...+     +..++|
T Consensus        18 ~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~-----~~~~lv   88 (263)
T d1j7la_          18 CVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHD-----GWSNLL   88 (263)
T ss_dssp             EEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEET-----TEEEEE
T ss_pred             EEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEEecC-----CceEEE
Confidence            344444444578999853  4456788887543221  2234567888888774 22245566665544     457899


Q ss_pred             EecCCc-chHHHhhhCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 024959          125 YELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS----------------------------------------  163 (260)
Q Consensus       125 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~----------------------------------------  163 (260)
                      |++++| .+.+.....     .....++.++++.+..||+                                        
T Consensus        89 ~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T d1j7la_          89 MSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             EECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred             EEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence            999986 433322110     0111122333333333331                                        


Q ss_pred             -------------------CCceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          164 -------------------ASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       164 -------------------~~i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                                         ..++|+|+.|.||++++++.+.|+||+.+..
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                               1278999999999999876667999998754

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.40  E-value=3.1e-07  Score=75.31  Aligned_cols=77  Identities=17%  Similarity=0.047  Sum_probs=46.8

Q ss_pred             cccccccCceEEEEEEeCCCCeEEEEEecCCcc----c-chHHHHHHHHHHHHHHHcC--C-CCeeeeeceecCCCCCCC
Q 024959           47 IRPIGRGAYGIVCAAVNSETREEVAIKKIGNAF----D-NIIDARRTLREIKLLRHME--H-ENVIAIKDIIRPPKKDTF  118 (260)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~~~~~~~iK~~~~~~----~-~~~~~~~~~~e~~~l~~l~--~-~~iv~~~~~~~~~~~~~~  118 (260)
                      .+.||.|....||++.+..+++.+++|......    . -.....+...|.+.|+.+.  . ..+++++.+....     
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~~-----  105 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEM-----  105 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETTT-----
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCCC-----
Confidence            456898999999999988878889998643210    0 0112234456777777663  2 3455666654433     


Q ss_pred             ccEEEEEecCCc
Q 024959          119 NDVYIVYELMDT  130 (260)
Q Consensus       119 ~~~~lv~e~~~~  130 (260)
                        .++|||++++
T Consensus       106 --~~lvmE~L~~  115 (392)
T d2pula1         106 --AVTVMEDLSH  115 (392)
T ss_dssp             --TEEEECCCTT
T ss_pred             --CEEEEeccCC
Confidence              5789999874

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.82  E-value=3.1e-05  Score=58.84  Aligned_cols=71  Identities=11%  Similarity=0.057  Sum_probs=45.8

Q ss_pred             cccccCc-eEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCC--eeeeeceecCCCCCCCccEEEEE
Q 024959           49 PIGRGAY-GIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN--VIAIKDIIRPPKKDTFNDVYIVY  125 (260)
Q Consensus        49 ~lg~G~~-g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--iv~~~~~~~~~~~~~~~~~~lv~  125 (260)
                      .+..|.. +.||++... ++..+++|.......     ..+.+|...++.+....  +++++.+...+     +..++||
T Consensus        17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~-----~~~~~v~   85 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEA-----GRDWLLL   85 (255)
T ss_dssp             ECSCTTSSCEEEEEECT-TSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECS-----SCEEEEE
T ss_pred             EcCCcccCCeEEEEEeC-CCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccc-----cceEEEE
Confidence            3444543 678988754 456788898755422     23566777777774222  45666666555     4589999


Q ss_pred             ecCCc
Q 024959          126 ELMDT  130 (260)
Q Consensus       126 e~~~~  130 (260)
                      ++++|
T Consensus        86 ~~i~G   90 (255)
T d1nd4a_          86 GEVPG   90 (255)
T ss_dssp             ECCSS
T ss_pred             Eeeec
Confidence            99975

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.63  E-value=5.6e-05  Score=61.51  Aligned_cols=71  Identities=14%  Similarity=0.109  Sum_probs=47.9

Q ss_pred             cccccccCceEEEEEEeCC-------CCeEEEEEecCCcccchHHHHHHHHHHHHHHHcC-CCCeeeeeceecCCCCCCC
Q 024959           47 IRPIGRGAYGIVCAAVNSE-------TREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTF  118 (260)
Q Consensus        47 ~~~lg~G~~g~vy~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~~  118 (260)
                      +++|+.|-.-.+|++....       .++.+++++.-.. ..   .....+|..+++.+. +.-.+++++++..      
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~------  116 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG------  116 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT------
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-ch---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC------
Confidence            4678888889999998653       3456888887532 22   223457888888885 4334567777743      


Q ss_pred             ccEEEEEecCCc
Q 024959          119 NDVYIVYELMDT  130 (260)
Q Consensus       119 ~~~~lv~e~~~~  130 (260)
                         .+|+||++|
T Consensus       117 ---g~I~efi~g  125 (395)
T d1nw1a_         117 ---GRLEEYIPS  125 (395)
T ss_dssp             ---EEEECCCCE
T ss_pred             ---ceEEEEecc
Confidence               478899875

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.20  E-value=0.0024  Score=50.05  Aligned_cols=136  Identities=15%  Similarity=0.107  Sum_probs=73.5

Q ss_pred             cCceEEEEEEeCCCCeEEEEEecCCcccchHHHHHHHHHHHHHHHcCCCCee--eeeceecCCCCCCCccEEEEEecCCc
Q 024959           53 GAYGIVCAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI--AIKDIIRPPKKDTFNDVYIVYELMDT  130 (260)
Q Consensus        53 G~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv--~~~~~~~~~~~~~~~~~~lv~e~~~~  130 (260)
                      +.-..||++.. .+|..+++|+......   ...++.+|...+..|....+.  .....-...........+.++++++|
T Consensus        33 s~EN~vy~v~~-~dg~~~VlK~~rp~~~---s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          33 SYENRVYQFQD-EDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             CSSSEEEEECC-TTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             cccceeEEEEc-CCCCEEEEEEeCCCCC---CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence            33467999976 4578899999854322   245567788888887532222  11111111111122457888888864


Q ss_pred             c------hHH------Hh-------hhC------------------------CCCCHH---HHHHHHHHHHHHHHHHH--
Q 024959          131 D------LHQ------II-------RSD------------------------QQLTDD---HCQYFLYQLLRGLKYVH--  162 (260)
Q Consensus       131 ~------l~~------~l-------~~~------------------------~~~~~~---~~~~~~~~i~~~l~~lh--  162 (260)
                      .      ...      .+       ...                        ..++..   .....+.++...+...-  
T Consensus       109 ~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~  188 (325)
T d1zyla1         109 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE  188 (325)
T ss_dssp             EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred             cCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccc
Confidence            1      111      11       000                        011111   12223333333333321  


Q ss_pred             --hCCceeccCCCCCeEeccCCCEEEeecccccc
Q 024959          163 --SASVLHRDLKPSNLLLNASCDLKIGDFGLART  194 (260)
Q Consensus       163 --~~~i~H~di~~~nili~~~~~~~l~df~~~~~  194 (260)
                        ..+++|+|+.+.||+++++  ..++||+.+..
T Consensus       189 ~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         189 DFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             cCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence              1358999999999999743  56899997754

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.73  E-value=0.0038  Score=48.50  Aligned_cols=30  Identities=30%  Similarity=0.287  Sum_probs=26.8

Q ss_pred             CCceeccCCCCCeEeccCCCEEEeeccccc
Q 024959          164 ASVLHRDLKPSNLLLNASCDLKIGDFGLAR  193 (260)
Q Consensus       164 ~~i~H~di~~~nili~~~~~~~l~df~~~~  193 (260)
                      .|++|+|+.++||+++++...-++||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            469999999999999988777999999874